Citrus Sinensis ID: 047768
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1009 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.968 | 0.967 | 0.455 | 0.0 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.965 | 0.944 | 0.437 | 0.0 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.980 | 0.964 | 0.458 | 0.0 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.953 | 0.820 | 0.310 | 1e-136 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.803 | 0.827 | 0.356 | 1e-132 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.853 | 0.687 | 0.330 | 1e-129 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.928 | 0.833 | 0.311 | 1e-128 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.893 | 0.722 | 0.341 | 1e-125 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.948 | 0.843 | 0.295 | 1e-123 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.887 | 0.784 | 0.302 | 1e-122 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 796 bits (2056), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/1002 (45%), Positives = 635/1002 (63%), Gaps = 25/1002 (2%)
Query: 16 LAKALALSNETDCLSLLAIKSQL-HDPLGVTSSWNRSACVNLCQHWTGVTCGRRNQRVTK 74
L + ++ETD +LL KSQ+ D V SSWN S LC +W GVTCGR+N+RVT
Sbjct: 14 LLETHGFTDETDRQALLQFKSQVSEDKRVVLSSWNHS--FPLC-NWKGVTCGRKNKRVTH 70
Query: 75 LDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRI 134
L+L +GG++SP +GNLSFL +++ +N F G IP +G L RLE L + N G I
Sbjct: 71 LELGRLQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPI 130
Query: 135 PTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSAL 194
P L +CS+L+ N L G +P EL S L NL L++ N + G+LP S+GNL+ L
Sbjct: 131 PLGLYNCSRLLNLRLDSNRLGGSVPSELGS--LTNLVQLNLYGNNMRGKLPTSLGNLTLL 188
Query: 195 RVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTG 254
+ + N L G+IP ++QLT + L + N+FSG PP++YN+SSL + + N F+G
Sbjct: 189 EQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSG 248
Query: 255 SLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKD 314
L ++G LPNL +F + N FTGS+P + SN S LE L + EN G + F + +
Sbjct: 249 RLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPN 307
Query: 315 LSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFN 374
L +L L TN LG+ ++ DL+F+ LTNCT+L+ L + N GG LP SIANLS L+ +
Sbjct: 308 LKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLD 367
Query: 375 LGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPS 434
LG I G+IP I NL+NL L ++ N L+G +P +G+L NL+ L L +N L G IP+
Sbjct: 368 LGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPA 427
Query: 435 SLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSL 494
+GN+T+L L N +G +P SLGNC +L+ + NKL G +P +I++I L L L
Sbjct: 428 FIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQL-LRL 486
Query: 495 DLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIP 554
D+S N L GSLP +G L++L L + N+ SG++P TLG C ++E + L+GN F G IP
Sbjct: 487 DMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIP 546
Query: 555 QSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFS 614
L L +KE+DLS N+ SG IP+Y + S L+YLNLS+N+ EG+VP KGIF+N T S
Sbjct: 547 D-LKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVS 605
Query: 615 IVGNGKLCGGLDELHLPSCQARGS---RKPNVNLVKVVIPVIGGSCLIL---SVCIFIFY 668
IVGN LCGG+ L C ++ +K + L KVVI V G L+L + + +
Sbjct: 606 IVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIW 665
Query: 669 ARRRRSAHKSSN--TSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENG 726
R+R+ +++N S +E +SY +L ATN FSSSN +G GSFG VYK +L
Sbjct: 666 LRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEK 725
Query: 727 MLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQ 786
+VAVKV+N++++G KSF AECE+L+ IRHRNL+K++T CSSIDF+G +F+AL+YE+M
Sbjct: 726 KVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMP 785
Query: 787 NGSLEEWLHQRDDQ---LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNV 843
NGSL+ WLH + + L+L++RLNI IDVAS ++YLH HC PI H DLKPSNV
Sbjct: 786 NGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNV 845
Query: 844 LLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGV 903
LLD D+ AHVSDFGLA+ L + SS+ GV+GTIGY APEYG+GG+ S+ G V
Sbjct: 846 LLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSA-GVRGTIGYAAPEYGVGGQPSINGDV 904
Query: 904 YSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRV 963
YS+GILLLE+FT +RPT +F TL+ + K ALPE++++IVD S+L + R V
Sbjct: 905 YSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHI-GLRVGFPVV 963
Query: 964 RNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFL 1005
ECL V + G+ C ESP +R+ + VV +L R+ F
Sbjct: 964 ---ECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFF 1002
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 780 bits (2013), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/1020 (43%), Positives = 638/1020 (62%), Gaps = 46/1020 (4%)
Query: 8 IILLVSIALAKALALSNETDCLSLLAIKSQL--HDPLGVTSSWNRSACVNLCQHWTGVTC 65
+ LL+ + + SNETD +LL KSQ+ ++ V +SWN S+ C +W GVTC
Sbjct: 12 LTLLLQVCIFAQARFSNETDMQALLEFKSQVSENNKREVLASWNHSS--PFC-NWIGVTC 68
Query: 66 GRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVL 125
GRR +RV L+L + G++SP +GNLSFLR +N+ADN F IP ++G LFRL+ L +
Sbjct: 69 GRRRERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNM 128
Query: 126 ANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLP 185
+ N GRIP++LS+CS+L T N+L +P EL S L L L + N LTG P
Sbjct: 129 SYNLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGS--LSKLAILDLSKNNLTGNFP 186
Query: 186 ASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEI 245
AS+GNL++L+ +D N++ G+IP +++LT + + + N FSG PP++YNISSL +
Sbjct: 187 ASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESL 246
Query: 246 YLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQV 305
L N F+G+L + G LPNLR ++ TN FTG++P + +N S+LE ++ N G +
Sbjct: 247 SLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSI 306
Query: 306 SINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIAN 365
++F L++L LG+ N LGN +++ L+F+ + NCT+L+YL + N GG LP SIAN
Sbjct: 307 PLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIAN 366
Query: 366 LSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHA 425
LST L LG+N I GTIP I NLV+L L +E N L+G +P G+L NLQ++ L++
Sbjct: 367 LSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYS 426
Query: 426 NFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQIL 485
N + G IPS GN+T L L +N+ G IP SLG C+ L+ + N+L G +PQ+IL
Sbjct: 427 NAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEIL 486
Query: 486 EITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQ 545
+I +L+ +DLS+N L G P VG L+ LV LG + N+ SG++P +G C S+E++ +Q
Sbjct: 487 QIPSLAY-IDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQ 545
Query: 546 GNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKG 605
GNSF G IP +S L S+K +D S NN SG+IP+YL +L L+ LNLS N FEG VPT G
Sbjct: 546 GNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTG 604
Query: 606 IFKNKTGFSIVGNGKLCGGLDELHLPSCQARGS---RKPNVNLVKVVIPVIGGSC----- 657
+F+N T S+ GN +CGG+ E+ L C + S RKP + V V+ G C
Sbjct: 605 VFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKP----LSVRKKVVSGICIGIAS 660
Query: 658 --LILSVCIFIFYARRRRSAHKS----SNTSQMEQQFPMVSYKELSKATNEFSSSNTIGR 711
LI+ V ++ +R++ + S S+++ + VSY+EL AT+ FSS+N IG
Sbjct: 661 LLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGS 720
Query: 712 GSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSID 771
G+FG V+KG+L LVAVKV+NL + G +KSF AECE + IRHRNL+K++T+CSS+D
Sbjct: 721 GNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLD 780
Query: 772 FKGVDFKALVYEYMQNGSLEEWLHQRD-DQLGICNLSLI--QRLNIVIDVASAVEYLHHH 828
+G DF+ALVYE+M GSL+ WL D +++ + SL ++LNI IDVASA+EYLH H
Sbjct: 781 SEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVH 840
Query: 829 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVA 888
C P+ H D+KPSN+LLD D+ AHVSDFGLA+ L + + SS+ GV+GTIGY A
Sbjct: 841 CHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSA-GVRGTIGYAA 899
Query: 889 PEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDP 948
PEYG+GG+ S++G VYS+GILLLE+F+ ++PT+ F LH + K
Sbjct: 900 PEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTK------------- 946
Query: 949 SLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQR 1008
S+L S + +E L V++ G+ CS E P DRM + V +L R F +
Sbjct: 947 SILSGCTSSGGSNAI--DEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSSK 1004
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 775 bits (2001), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 470/1026 (45%), Positives = 662/1026 (64%), Gaps = 37/1026 (3%)
Query: 4 LRIIII--LLVSIAL-------AKALALSNETDCLSLLAIKSQLHDPLGVT-SSWNRSAC 53
+R+I++ LLVS++L A+ + L+ ETD +LL KSQ+ + V SWN S
Sbjct: 8 MRLILVSALLVSVSLEHSDMVCAQTIRLTEETDKQALLEFKSQVSETSRVVLGSWNDS-- 65
Query: 54 VNLCQHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDR 113
+ LC WTGV CG +++RVT +DL + G++SP+VGNLSFLR +N+ADN FHG IP
Sbjct: 66 LPLCS-WTGVKCGLKHRRVTGVDLGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSE 124
Query: 114 IGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGL 173
+GNLFRL+ L ++NN F G IP LS+CS L T N+L +P E L L L
Sbjct: 125 VGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLEF--GSLSKLVLL 182
Query: 174 SVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIP 233
S+G N LTG+ PAS+GNL++L+++D N++ G+IP +++L + + + N F+G P
Sbjct: 183 SLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFP 242
Query: 234 PSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEV 293
P +YN+SSL+ + + GN F+G+L + G LPNL+ + N+FTG++P++ SN S+L
Sbjct: 243 PPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQ 302
Query: 294 LHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADN 353
L + N G++ ++F L++L +LGL N LGN ++ DLDF+ LTNC++LQYL + N
Sbjct: 303 LDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFN 362
Query: 354 GFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIG 413
GG LP IANLST L + +LG N I G+IP GI NLV+L +L + N LTG +P +G
Sbjct: 363 KLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLG 422
Query: 414 ELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPR 473
EL L+ + L++N L G IPSSLGN++ LTYL N+ +G+IP SLG+C L+
Sbjct: 423 ELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGT 482
Query: 474 NKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTL 533
NKL G++P +++E+ +L + L++S NLL G L +G LK L+ L ++ N+ SGQIP TL
Sbjct: 483 NKLNGSIPHELMELPSL-VVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTL 541
Query: 534 GACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLS 593
C SLE++ LQGNSF G IP + LT ++ LDLS+NN SG IP+Y+ N S LQ LNLS
Sbjct: 542 ANCLSLEFLLLQGNSFVGPIPD-IRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLS 600
Query: 594 YNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDELHLPSCQARGSRKPNVNLVKVVIPVI 653
N+F+G VPT+G+F+N + S+ GN LCGG+ L L C R+ + ++ K++ +
Sbjct: 601 LNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRR-HSSVRKIITICV 659
Query: 654 G-----GSCLILSVCIFIFYARRRRSAHKSSNT-----SQMEQQFPMVSYKELSKATNEF 703
L L V +Y R +S ++N S ++ + +SY EL K T F
Sbjct: 660 SAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGF 719
Query: 704 SSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKI 763
SSSN IG G+FG V+KG L VA+KV+NL ++G +KSF AECEAL IRHRNL+K+
Sbjct: 720 SSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKL 779
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRD-DQLGICN--LSLIQRLNIVIDVAS 820
VTICSS DF+G DF+ALVYE+M NG+L+ WLH + ++ G + L L RLNI IDVAS
Sbjct: 780 VTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVAS 839
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
A+ YLH +C PI H D+KPSN+LLD D+ AHVSDFGLA+ L + SS GV
Sbjct: 840 ALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDR-DTFHIQFSSAGV 898
Query: 881 KGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940
+GTIGY APEYG+GG S+ G VYS+GI+LLEIFT +RPT +F +GLTLH F K AL +
Sbjct: 899 RGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQK 958
Query: 941 K-VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999
+ ++I D ++L ++ ECL V + GV+CS ESP +R+ M + + KL
Sbjct: 959 RQALDITDETIL----RGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVS 1014
Query: 1000 ARQNFL 1005
R++F
Sbjct: 1015 IRESFF 1020
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1251), Expect = e-136, Method: Compositional matrix adjust.
Identities = 361/1164 (31%), Positives = 556/1164 (47%), Gaps = 202/1164 (17%)
Query: 14 IALAKALALSNETDCLSLLAIKSQL-HDPLGVTSSWNRSACVNLCQHWTGVTCGRRNQRV 72
IALAK S E + +L + K+ + +DPLGV S W + C +WTG+TC V
Sbjct: 20 IALAKQ---SFEPEIEALKSFKNGISNDPLGVLSDWTIIGSLRHC-NWTGITCDSTGH-V 74
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG 132
+ L + + G+LSP + NL++L+ +++ N F G+IP IG L L L+L N FSG
Sbjct: 75 VSVSLLEKQLEGVLSPAIANLTYLQVLDLTSNSFTGKIPAEIGKLTELNQLILYLNYFSG 134
Query: 133 RIPTNLSHCSKLITFSAHRNNLVGEIPEELISRR----------------------LFNL 170
IP+ + + N L G++PEE+ L +L
Sbjct: 135 SIPSGIWELKNIFYLDLRNNLLSGDVPEEICKTSSLVLIGFDYNNLTGKIPECLGDLVHL 194
Query: 171 QGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSG 230
Q N LTG +P SIG L+ L +D+ N+L GKIP L +L L + +N G
Sbjct: 195 QMFVAAGNHLTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEG 254
Query: 231 TIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNAS- 289
IP + N SSLV++ LY N+ TG +P E+G NL L+ IY N T S+P S +
Sbjct: 255 DIPAEIGNCSSLVQLELYDNQLTGKIPAELG-NLVQLQALRIYKNKLTSSIPSSLFRLTQ 313
Query: 290 -----------------------NLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLG 326
+LEVL L N F G+ + L++L++L + N +
Sbjct: 314 LTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNIS 373
Query: 327 NGAANDLDFV----------DLLT--------NCTKLQYLYLADNGFGGVLPHSIANLST 368
DL + +LLT NCT L+ L L+ N G +P ++
Sbjct: 374 GELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMNL 433
Query: 369 ALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGT--------------------- 407
I ++G+N G IP I N NL +L + N LTGT
Sbjct: 434 TFI--SIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSL 491
Query: 408 ---IPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLL---------------------- 442
IP IG LK+L +L+LH+N G IP + NLTLL
Sbjct: 492 TGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMK 551
Query: 443 --------------------------TYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKL 476
TYLS N G+IP SL + L F N L
Sbjct: 552 LLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLL 611
Query: 477 TGALPQQIL-EITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGA 535
TG +P ++L + + L L+ S+NLL G++P +G L+ + + ++ N FSG IP +L A
Sbjct: 612 TGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQA 671
Query: 536 CT---SLEYVE----------------------LQGNSFSGTIPQSLSSLTSIKELDLSQ 570
C +L++ + L NSFSG IPQS ++T + LDLS
Sbjct: 672 CKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSS 731
Query: 571 NNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDELHL 630
NN +G+IP+ L NLS L++L L+ N+ +G VP G+FKN ++GN LCG + L
Sbjct: 732 NNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGS--KKPL 789
Query: 631 PSCQARGSRKPNVNLVKVVIPVIGG--------SCLILSVCIFIFYARRRRSAHKSSNTS 682
C + +V++ ++G +++ C + S+ S
Sbjct: 790 KPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDL 849
Query: 683 QMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KG 740
+ KEL +AT+ F+S+N IG S VYKG L E+G ++AVKV+NL++
Sbjct: 850 DSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEFSAE 908
Query: 741 GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQ 800
K F E + L ++HRNL+KI+ ++ KALV +M+NG+LE+ +H
Sbjct: 909 SDKWFYTEAKTLSQLKHRNLVKILGFA----WESGKTKALVLPFMENGNLEDTIHGSAAP 964
Query: 801 LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
+G SL++++++ + +AS ++YLH PIVH DLKP+N+LLD D VAHVSDFG A+
Sbjct: 965 IG----SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTAR 1020
Query: 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPT 920
L G+ T +S+ +GTIGY+APE+ + + + V+S+GI+++E+ T++RPT
Sbjct: 1021 ILGFREDGS---TTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPT 1077
Query: 921 E--SMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNS-RRVRNEECLVAVIKTGV 977
++ +TL + ++++ +V L+ E +S ++ EE + +K +
Sbjct: 1078 SLNDEDSQDMTLRQLVEKSIGNGRKGMVR----VLDMELGDSIVSLKQEEAIEDFLKLCL 1133
Query: 978 ACSIESPFDRMEMTDVVVKLCHAR 1001
C+ P DR +M +++ L R
Sbjct: 1134 FCTSSRPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 473 bits (1218), Expect = e-132, Method: Compositional matrix adjust.
Identities = 323/906 (35%), Positives = 482/906 (53%), Gaps = 95/906 (10%)
Query: 163 ISRRLFNLQGLSVGD---NQLTGQLPASIGNL-SALRVIDIRTNRLWGKIPITLSQLTSL 218
IS + NL GL+V D N G++P IG+L L+ + + N L G IP L L L
Sbjct: 82 ISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQELGLLNRL 141
Query: 219 AYLHVGDNHFSGTIPPSVY---NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTN 275
YL +G N +G+IP ++ + SSL I L N TG +P+ +L LR ++++N
Sbjct: 142 VYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSN 201
Query: 276 NFTGSLPDSFSNASNLEVLHLAENQFRGQV-SINFNGLKDLSMLGLATN-FLGNGAANDL 333
TG++P S SN++NL+ + L N G++ S + + L L L+ N F+ + +L
Sbjct: 202 KLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNL 261
Query: 334 D-FVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIA--- 389
+ F L N + LQ L LA N GG + S+ +LS L+ +L +N+I+G+IPP I+
Sbjct: 262 EPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLL 321
Query: 390 ---------------------NLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFL 428
L L + + N LTG IP +G++ L LL + N L
Sbjct: 322 NLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNL 381
Query: 429 QGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILE-I 487
G+IP S GNL+ L L N+L G +P SLG C NL N LTG +P +++ +
Sbjct: 382 SGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNL 441
Query: 488 TTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGN 547
L L L+LS N L+G +PL + + ++ + ++ N+ SG+IP LG+C +LE++ L N
Sbjct: 442 RNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRN 501
Query: 548 SFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIF 607
FS T+P SL L +KELD+S N +G IP + S L++LN S+N G V KG F
Sbjct: 502 GFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSF 561
Query: 608 KNKTGFSIVGNGKLCGGLDELHLPSCQARGS---RKPNVNLVKVVIPVIGGSCLILSVCI 664
T S +G+ LCG + + +C+ + V L + PV+ C+
Sbjct: 562 SKLTIESFLGDSLLCGSIKGMQ--ACKKKHKYPSVLLPVLLSLIATPVL---------CV 610
Query: 665 FIF--------------YARRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIG 710
F + YA+ + N Q + ++P +SY++L AT F++S+ IG
Sbjct: 611 FGYPLVQRSRFGKNLTVYAKEEVEDEEKQN--QNDPKYPRISYQQLIAATGGFNASSLIG 668
Query: 711 RGSFGFVYKGVLHENGMLVAVKVIN----LEQKGGSKSFAAECEALRSIRHRNLIKIVTI 766
G FG VYKGVL N VAVKV++ LE G SF EC+ L+ RHRNLI+I+T
Sbjct: 669 SGRFGHVYKGVLRNNTK-VAVKVLDPKTALEFSG---SFKRECQILKRTRHRNLIRIITT 724
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
CS F ALV M NGSLE L+ + NL LIQ +NI DVA + YLH
Sbjct: 725 CSK-----PGFNALVLPLMPNGSLERHLYP--GEYSSKNLDLIQLVNICSDVAEGIAYLH 777
Query: 827 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK----- 881
H+ +VH DLKPSN+LLD +M A V+DFG+++ + V ET S+ V
Sbjct: 778 HYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQG-----VEETVSTDDSVSFGSTD 832
Query: 882 ----GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937
G++GY+APEYG+G AS G VYS+G+LLLEI + RRPT+ + NEG +LHEF K
Sbjct: 833 GLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSH 892
Query: 938 LPEKVMEIVDPSLLPLEEERTNSRRVR-NEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996
P+ + I++ +L + + + + E ++ +I+ G+ C+ +P R +M DV +
Sbjct: 893 YPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHE 952
Query: 997 LCHARQ 1002
+ ++
Sbjct: 953 MGRLKE 958
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 462 bits (1190), Expect = e-129, Method: Compositional matrix adjust.
Identities = 316/955 (33%), Positives = 488/955 (51%), Gaps = 94/955 (9%)
Query: 64 TCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETL 123
T N + +L L + G + + N L+ +++++N G+IPD + L L L
Sbjct: 331 TICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNL 390
Query: 124 VLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQ 183
L NNS G + +++S+ + L F+ + NNL G++P+E+ L L+ + + +N+ +G+
Sbjct: 391 YLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEI--GFLGKLEIMYLYENRFSGE 448
Query: 184 LPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLV 243
+P IGN + L+ ID NRL G+IP ++ +L L LH+ +N G IP S+ N +
Sbjct: 449 MPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMT 508
Query: 244 EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRG 303
I L N+ +GS+P G L L F+IY N+ G+LPDS N NL ++ + N+F G
Sbjct: 509 VIDLADNQLSGSIPSSFGF-LTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNG 567
Query: 304 QVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLY--LADNGFGGVLPH 361
+S C YL + +NGF G +P
Sbjct: 568 SIS---------------------------------PLCGSSSYLSFDVTENGFEGDIPL 594
Query: 362 SIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLL 421
+ ST L LGKNQ G IP + L+ L + N L+G IP +G K L +
Sbjct: 595 ELGK-STNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHI 653
Query: 422 HLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALP 481
L+ N+L G IP+ LG L LL L +N G++P + + N++ F N L G++P
Sbjct: 654 DLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIP 713
Query: 482 QQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLE- 540
Q+I + L+ +L+L +N L+G LP +G L L L ++RN +G+IPV +G L+
Sbjct: 714 QEIGNLQALN-ALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQS 772
Query: 541 YVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGE 600
++L N+F+G IP ++S+L ++ LDLS N G++P + ++ L YLNLSYN+ EG+
Sbjct: 773 ALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGK 832
Query: 601 VPTKGIFKNKTGFSIVGNGKLCGGLDELHLPSCQARGSR-----KPNVNLVKVVIPVIGG 655
+ K F + VGN LCG L C GS+ P ++ I +
Sbjct: 833 L--KKQFSRWQADAFVGNAGLCGS----PLSHCNRAGSKNQRSLSPKTVVIISAISSLAA 886
Query: 656 SCLILSVCIFIFYA-----RRRRSAHKSSNTSQMEQQFPMVS---------YKELSKATN 701
L++ V I F ++ R + + +++ Q P+ S + ++ +AT+
Sbjct: 887 IALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATH 946
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS-KSFAAECEALRSIRHRNL 760
+ IG G G VYK L +NG +AVK I + S KSF E + L +IRHR+L
Sbjct: 947 YLNEEFMIGSGGSGKVYKAEL-KNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHL 1005
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
+K++ CSS K L+YEYM NGS+ +WLH ++ L RL I + +A
Sbjct: 1006 VKLMGYCSS---KADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQ 1062
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
VEYLH+ C PPIVH D+K SNVLLD ++ AH+ DFGLAK L+ GN S+
Sbjct: 1063 GVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILT----GNYDTNTESNTMF 1118
Query: 881 KGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP- 939
G+ GY+APEY +A+ + VYS GI+L+EI T + PTE+MF+E + + + L
Sbjct: 1119 AGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDT 1178
Query: 940 -------EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDR 987
EK+++ SLLP EEE V++ + C+ P +R
Sbjct: 1179 PPGSEAREKLIDSELKSLLPCEEEAA-----------YQVLEIALQCTKSYPQER 1222
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 460 bits (1183), Expect = e-128, Method: Compositional matrix adjust.
Identities = 344/1106 (31%), Positives = 524/1106 (47%), Gaps = 169/1106 (15%)
Query: 26 TDCLSLLAIKSQ-LHDPLGVTSSWN---RSACVNLCQHWTGVTCGRRNQR-------VTK 74
+D LL +K++ D L +WN + C +W GV C + VT
Sbjct: 35 SDGQFLLELKNRGFQDSLNRLHNWNGIDETPC-----NWIGVNCSSQGSSSSSNSLVVTS 89
Query: 75 LDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRI 134
LDL + ++ GI+SP +G L L Y+N+A N G+IP IGN +LE + L NN F G I
Sbjct: 90 LDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSI 149
Query: 135 PTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSAL 194
P ++ S+L +F+ N L G +PEE+ L+NL+ L N LTG LP S+GNL+ L
Sbjct: 150 PVEINKLSQLRSFNICNNKLSGPLPEEI--GDLYNLEELVAYTNNLTGPLPRSLGNLNKL 207
Query: 195 ------------------------RVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSG 230
+++ + N + G++P + L L + + N FSG
Sbjct: 208 TTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSG 267
Query: 231 TIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASN 290
IP + N++SL + LYGN G +P EIG N+ +L+ +Y N G++P S
Sbjct: 268 FIPKDIGNLTSLETLALYGNSLVGPIPSEIG-NMKSLKKLYLYQNQLNGTIPKELGKLSK 326
Query: 291 LEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFV------DL------ 338
+ + +EN G++ + + + +L +L L N L N+L + DL
Sbjct: 327 VMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLT 386
Query: 339 ------LTNCTKLQYLYLADNGFGGVLPHSIANLS-----------------------TA 369
N T ++ L L N GV+P + S +
Sbjct: 387 GPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSN 446
Query: 370 LIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQ 429
LI NLG N+I+G IPPG+ +L LR+ NRLTG P + +L NL + L N
Sbjct: 447 LILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFS 506
Query: 430 GTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITT 489
G +P +G L L AN N+P + NL+ F N LTG +P +I
Sbjct: 507 GPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKM 566
Query: 490 LSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSF 549
L LDLS N GSLP +G+L L L ++ N+FSG IP T+G T L +++ GN F
Sbjct: 567 LQ-RLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLF 625
Query: 550 SGTIPQSLSSLTSIK-ELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK---- 604
SG+IP L L+S++ ++LS N+FSG+IP + NL L YL+L+ NH GE+PT
Sbjct: 626 SGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENL 685
Query: 605 --------------------GIFKNKTGFSIVGNGKLCGGLDELHLPSCQARGSRKPNVN 644
IF+N T S +GN LCGG HL SC S P+++
Sbjct: 686 SSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGG----HLRSCDPSHSSWPHIS 741
Query: 645 LVKVVIPVIG------------GSCLILSVCIFIF---------YARRRRSAHKSSNTSQ 683
+K G S L++++ + Y + + S+
Sbjct: 742 SLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYF 801
Query: 684 MEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN-------L 736
+ ++ + K++ +AT F S +GRG+ G VYK V+ +G +AVK +
Sbjct: 802 VPKE--RFTVKDILEATKGFHDSYIVGRGACGTVYKAVM-PSGKTIAVKKLESNREGNNN 858
Query: 737 EQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQ 796
SF AE L IRHRN++++ + C +G + L+YEYM GSL E LH
Sbjct: 859 NSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYH---QGSNSNLLLYEYMSRGSLGELLHG 915
Query: 797 RDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856
++ R I + A + YLHH C+P I+H D+K +N+L+D + AHV DF
Sbjct: 916 GKSH----SMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDF 971
Query: 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR 916
GLAK + PL V V G+ GY+APEY + + + +YS+G++LLE+ T
Sbjct: 972 GLAKVIDM-PLSKSVS------AVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTG 1024
Query: 917 RRPTESMFNEGLTLHEFAKRALPEKVM--EIVDPSLLPLEEERTNSRRVRNEECLVAVIK 974
+ P + + +G L + + + + + EI+DP L +E++ + ++ V K
Sbjct: 1025 KAPVQPL-EQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNH-------MITVTK 1076
Query: 975 TGVACSIESPFDRMEMTDVVVKLCHA 1000
V C+ SP DR M +VV+ L +
Sbjct: 1077 IAVLCTKSSPSDRPTMREVVLMLIES 1102
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1160), Expect = e-125, Method: Compositional matrix adjust.
Identities = 334/977 (34%), Positives = 486/977 (49%), Gaps = 75/977 (7%)
Query: 75 LDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRI-GNLFRLETLVLANNSFSGR 133
LDL ++ G + N+S L + +A+N G +P I N LE LVL+ SG
Sbjct: 292 LDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGE 351
Query: 134 IPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSA 193
IP LS C L N+L G IPE L L L L + +N L G L SI NL+
Sbjct: 352 IPVELSKCQSLKQLDLSNNSLAGSIPEALF--ELVELTDLYLHNNTLEGTLSPSISNLTN 409
Query: 194 LRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFT 253
L+ + + N L GK+P +S L L L + +N FSG IP + N +SL I ++GN F
Sbjct: 410 LQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFE 469
Query: 254 GSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLK 313
G +P IG+ L L + N G LP S N L +L LA+NQ G + +F LK
Sbjct: 470 GEIPPSIGR-LKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLK 528
Query: 314 DLSMLGLATNFLGNGAANDLDFVDLLTN---------------CTKLQYLY--LADNGFG 356
L L L N L + L + LT C YL + +NGF
Sbjct: 529 GLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFE 588
Query: 357 GVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELK 416
+P + N S L LGKNQ+ G IP + + L+ L M +N LTGTIP + K
Sbjct: 589 DEIPLELGN-SQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCK 647
Query: 417 NLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKL 476
L + L+ NFL G IP LG L+ L L +N ++P L NC L+ N L
Sbjct: 648 KLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSL 707
Query: 477 TGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGAC 536
G++PQ+I + L++ L+L N +GSLP +G L L L ++RN +G+IPV +G
Sbjct: 708 NGSIPQEIGNLGALNV-LNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQL 766
Query: 537 TSLE-YVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYN 595
L+ ++L N+F+G IP ++ +L+ ++ LDLS N +G++P + ++ L YLN+S+N
Sbjct: 767 QDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFN 826
Query: 596 HFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDELHLPSC-QARGSRKPNVNLVKVVIPVIG 654
+ G++ K F S +GN LCG L C + R + K + V+ +
Sbjct: 827 NLGGKL--KKQFSRWPADSFLGNTGLCGS----PLSRCNRVRSNNKQQGLSARSVVIISA 880
Query: 655 GSCL----ILSVCIFIFYARRR---------RSAHKSSNTSQMEQQFPM---------VS 692
S L ++ + I +F+ +R +A+ SS++S P+ +
Sbjct: 881 ISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIR 940
Query: 693 YKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS-KSFAAECEA 751
++++ +AT+ S IG G G VYK L ENG VAVK I + S KSF+ E +
Sbjct: 941 WEDIMEATHNLSEEFMIGSGGSGKVYKAEL-ENGETVAVKKILWKDDLMSNKSFSREVKT 999
Query: 752 LRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICN--LSLI 809
L IRHR+L+K++ CSS K L+YEYM+NGS+ +WLH+ L L
Sbjct: 1000 LGRIRHRHLVKLMGYCSS---KSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWE 1056
Query: 810 QRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGN 869
RL I + +A VEYLHH C PPIVH D+K SNVLLD +M AH+ DFGLAK L+ N
Sbjct: 1057 ARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTE----N 1112
Query: 870 VVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLT 929
S+ + GY+APEY +A+ + VYS GI+L+EI T + PT+S+F +
Sbjct: 1113 CDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMD 1172
Query: 930 LHEFAKRALP---EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFD 986
+ + + L +++DP L PL E+ V++ + C+ SP +
Sbjct: 1173 MVRWVETHLEVAGSARDKLIDPKLKPL--------LPFEEDAACQVLEIALQCTKTSPQE 1224
Query: 987 RMEMTDVVVKLCHARQN 1003
R L H N
Sbjct: 1225 RPSSRQACDSLLHVYNN 1241
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 442 bits (1136), Expect = e-123, Method: Compositional matrix adjust.
Identities = 326/1102 (29%), Positives = 527/1102 (47%), Gaps = 145/1102 (13%)
Query: 1 MQQLRIIIILLVSIALAKALALSNETDCLSLLAIKSQLHD----PLGVTSSWNRSACVNL 56
+ I + L ++ ++ A +NE A+ S LH P V S WN S +
Sbjct: 15 VSHFSITLSLFLAFFISSTSASTNEVS-----ALISWLHSSNSPPPSVFSGWNPSDS-DP 68
Query: 57 CQHWTGVTCGRRNQRVT-------------------------KLDLRNQSIGGILSPYVG 91
CQ W +TC + ++ KL + N ++ G +S +G
Sbjct: 69 CQ-WPYITCSSSDNKLVTEINVVSVQLALPFPPNISSFTSLQKLVISNTNLTGAISSEIG 127
Query: 92 NLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHR 151
+ S L I+++ N GEIP +G L L+ L L +N +G+IP L C L
Sbjct: 128 DCSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFD 187
Query: 152 NNLVGEIPEELISRRLFNLQGLSVGDN-QLTGQLPASIGNLSALRVIDIRTNRLWGKIPI 210
N L +P EL ++ L+ + G N +L+G++P IGN L+V+ + ++ G +P+
Sbjct: 188 NYLSENLPLEL--GKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPV 245
Query: 211 TLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNF 270
+L QL+ L L V SG IP + N S L+ ++LY N +G+LP E+GK L NL
Sbjct: 246 SLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGK-LQNLEKM 304
Query: 271 VIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAA 330
+++ NN G +P+ +L + L+ N F G + +F L +L L L++N +
Sbjct: 305 LLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIP 364
Query: 331 NDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIAN 390
+ +L+NCTKL + N G++P I L I F +N++ G IP +A
Sbjct: 365 S------ILSNCTKLVQFQIDANQISGLIPPEIGLLKELNI-FLGWQNKLEGNIPDELAG 417
Query: 391 LVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLL-------- 442
NL +L + N LTG++P + +L+NL L L +N + G IP +GN T L
Sbjct: 418 CQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNN 477
Query: 443 ----------------TYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILE 486
++L NNL G +P + NC+ L N L G LP +
Sbjct: 478 RITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSS 537
Query: 487 ITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQG 546
+T L + LD+S N L G +P +G+L SL RL +++N F+G+IP +LG CT+L+ ++L
Sbjct: 538 LTKLQV-LDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSS 596
Query: 547 NSFSGTIPQSL-------------------------SSLTSIKELDLSQNNFSGQIPKYL 581
N+ SGTIP+ L S+L + LD+S N SG + L
Sbjct: 597 NNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDL-SAL 655
Query: 582 ENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCG-GLDELHLP-SCQARGSR 639
L L LN+S+N F G +P +F+ G + GN LC G + S Q R
Sbjct: 656 SGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRSCFVSNSSQLTTQR 715
Query: 640 KPNVNLVKVVIPVIGGSCLILSV--CIFIFYARRRRSAHKSSNTSQMEQQFPMVSYKELS 697
+ + +++ I ++ +L+V + + A++ S T + + +++L+
Sbjct: 716 GVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTPFQKLN 775
Query: 698 KATNE----FSSSNTIGRGSFGFVYKGVLHENGMLVAVK------VINLEQK----GGSK 743
N IG+G G VYK + N ++AVK V NL +K G
Sbjct: 776 FTVEHVLKCLVEGNVIGKGCSGIVYKAEM-PNREVIAVKKLWPVTVPNLNEKTKSSGVRD 834
Query: 744 SFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGI 803
SF+AE + L SIRH+N+++ + C + + + L+Y+YM NGSL LH+R G+
Sbjct: 835 SFSAEVKTLGSIRHKNIVRFLGCCWN-----KNTRLLMYDYMSNGSLGSLLHERS---GV 886
Query: 804 CNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863
C+L R I++ A + YLHH C PPIVH D+K +N+L+ D ++ DFGLAK +
Sbjct: 887 CSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVD 946
Query: 864 ASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923
SS + G+ GY+APEYG + + + VYSYG+++LE+ T ++P +
Sbjct: 947 DGDFAR------SSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPT 1000
Query: 924 FNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIES 983
+GL + ++ K+ + ++++D L +R E ++ + + C
Sbjct: 1001 IPDGLHIVDWVKKI---RDIQVIDQGL--------QARPESEVEEMMQTLGVALLCINPI 1049
Query: 984 PFDRMEMTDVVV---KLCHARQ 1002
P DR M DV ++C R+
Sbjct: 1050 PEDRPTMKDVAAMLSEICQERE 1071
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1133), Expect = e-122, Method: Compositional matrix adjust.
Identities = 318/1051 (30%), Positives = 509/1051 (48%), Gaps = 156/1051 (14%)
Query: 57 CQHWTGVTCGRRN-----------------------QRVTKLDLRNQSIGGILSPYVGNL 93
C +WT +TC + + + KL + ++ G L +G+
Sbjct: 69 CNNWTFITCSSQGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTGTLPESLGDC 128
Query: 94 SFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNN 153
L+ ++++ N G+IP + L LETL+L +N +G+IP ++S CSKL + N
Sbjct: 129 LGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNL 188
Query: 154 LVGEIPEELISRRLFNLQGLSVGDN-QLTGQLPASIGNLSALRVIDIRTNRLWGKIPITL 212
L G IP EL +L L+ + +G N +++GQ+P+ IG+ S L V+ + + G +P +L
Sbjct: 189 LTGSIPTEL--GKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSL 246
Query: 213 SQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVI 272
+L L L + SG IP + N S LV+++LY N +GS+P EIG+ L L +
Sbjct: 247 GKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQ-LTKLEQLFL 305
Query: 273 YTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATN-FLGNGAAN 331
+ N+ G +P+ N SNL+++ L+ N G + + L L ++ N F G+
Sbjct: 306 WQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGS---- 361
Query: 332 DLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANL 391
++NC+ L L L N G++P + L T L F NQ+ G+IPPG+A+
Sbjct: 362 ---IPTTISNCSSLVQLQLDKNQISGLIPSELGTL-TKLTLFFAWSNQLEGSIPPGLADC 417
Query: 392 VNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANN 451
+L +L + N LTGTIP + L+NL L L +N L G IP +GN + L L G N
Sbjct: 418 TDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNR 477
Query: 452 LQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGN 511
+ G IP +G+ K + F N+L G +P +I + L + +DLS+N L GSLP V +
Sbjct: 478 ITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQM-IDLSNNSLEGSLPNPVSS 536
Query: 512 LKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQN 571
L L L ++ NQFSG+IP +LG SL + L N FSG+IP SL + ++ LDL N
Sbjct: 537 LSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSN 596
Query: 572 NFSGQIPKYL---ENLSF------------------------------------------ 586
SG+IP L ENL
Sbjct: 597 ELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAPLAN 656
Query: 587 ---LQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDELHLPSC---------- 633
L LN+SYN F G +P +F+ + + GN KLC + SC
Sbjct: 657 IENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQD----SCFLTYRKGNGL 712
Query: 634 ----QARGSRKPNVNLVK-----VVIPVIGGSCLILSVCIFIFYARRRRSAHKSSNTSQM 684
A +RK + L VV+ ++G + + ARR + S +
Sbjct: 713 GDDGDASRTRKLRLTLALLITLTVVLMILGA--------VAVIRARRNIDNERDSELGET 764
Query: 685 EQQFPMVSYKELSKATNE----FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVI------ 734
++ +++L+ + ++ N IG+G G VY+ + +NG ++AVK +
Sbjct: 765 -YKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADV-DNGEVIAVKKLWPAMVN 822
Query: 735 ---NLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLE 791
+ + K SF+AE + L +IRH+N+++ + C + + + L+Y+YM NGSL
Sbjct: 823 GGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWN-----RNTRLLMYDYMPNGSLG 877
Query: 792 EWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 851
LH+R +L R I++ A + YLHH C PPIVH D+K +N+L+ D
Sbjct: 878 SLLHERRGS----SLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEP 933
Query: 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLL 911
+++DFGLAK + +G T V G+ GY+APEYG + + + VYSYG+++L
Sbjct: 934 YIADFGLAKLVDEGDIGRCSNT------VAGSYGYIAPEYGYSMKITEKSDVYSYGVVVL 987
Query: 912 EIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVA 971
E+ T ++P + EG+ L ++ ++ +E++D +L SR + ++
Sbjct: 988 EVLTGKQPIDPTVPEGIHLVDWVRQN--RGSLEVLDSTL--------RSRTEAEADEMMQ 1037
Query: 972 VIKTGVACSIESPFDRMEMTDVVVKLCHARQ 1002
V+ T + C SP +R M DV L +Q
Sbjct: 1038 VLGTALLCVNSSPDERPTMKDVAAMLKEIKQ 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1009 | ||||||
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.964 | 0.935 | 0.502 | 0.0 | |
| 224127492 | 1022 | predicted protein [Populus trichocarpa] | 0.977 | 0.964 | 0.488 | 0.0 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 0.982 | 0.520 | 0.497 | 0.0 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.969 | 0.954 | 0.494 | 0.0 | |
| 255581223 | 1015 | receptor-kinase, putative [Ricinus commu | 0.979 | 0.973 | 0.499 | 0.0 | |
| 224081190 | 1011 | predicted protein [Populus trichocarpa] | 0.983 | 0.981 | 0.482 | 0.0 | |
| 255577438 | 1028 | receptor-kinase, putative [Ricinus commu | 0.977 | 0.959 | 0.476 | 0.0 | |
| 224116466 | 1008 | predicted protein [Populus trichocarpa] | 0.978 | 0.979 | 0.483 | 0.0 | |
| 224115346 | 1017 | predicted protein [Populus trichocarpa] | 0.961 | 0.953 | 0.494 | 0.0 | |
| 224113117 | 1006 | predicted protein [Populus trichocarpa] | 0.967 | 0.970 | 0.490 | 0.0 |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 912 bits (2356), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 508/1010 (50%), Positives = 672/1010 (66%), Gaps = 37/1010 (3%)
Query: 24 NETDCLSLLAIKSQL-HDPLGVTSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQSI 82
NETD L+LLAIK+Q+ DPLG+T+SWN S V+ C +WTGVTCG R+QRV L+L + +
Sbjct: 37 NETDRLALLAIKAQITQDPLGITTSWNDS--VHFC-NWTGVTCGHRHQRVNTLNLNSLHL 93
Query: 83 GGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCS 142
G LSP +GNL+FL +N+ N+FHG+IP +G L RL L L NNSFSG IP NLS CS
Sbjct: 94 VGSLSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCS 153
Query: 143 KLITFSAHRNNLVGEIPEELISR-RLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRT 201
L+ F NNL+G IP L S ++ +Q + N LTG +P S+GNL++++ +
Sbjct: 154 NLVYFRLGFNNLIGRIPSWLGSYPKVVRMQ---LHYNNLTGPVPDSLGNLTSIKSLSFAV 210
Query: 202 NRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIG 261
N L G IP L QL +L ++ +G N FSG IP SVYN+SSL L N+ GSLP ++
Sbjct: 211 NHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLA 270
Query: 262 KNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLA 321
LPNL+ I N+FTGSLP S SNASNL + + F G+VSI+F G+ +L L LA
Sbjct: 271 FTLPNLQVLNIGNNDFTGSLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLA 330
Query: 322 TNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIY 381
+N LG G A+DL F++ L C L+ L L+ + FGGVLP+SIANLST L+ L NQ+
Sbjct: 331 SNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLS 390
Query: 382 GTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTL 441
GTIPPGI NLVNL L + N TG+IP +IG L+ L + L N L G IPSSLGN+T
Sbjct: 391 GTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITR 450
Query: 442 LTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLL 501
L L N+L G IP S GN L N L G +P++++++ +L++SL+L+ N L
Sbjct: 451 LYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQL 510
Query: 502 NGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLT 561
G LP V LK+L L ++ N+ SG+IP LG+C +LE++ ++GN F G+IP S SL
Sbjct: 511 TGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLR 570
Query: 562 SIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKL 621
+ +LDLS+NN SGQIP++L+ LS L LNLS+N+FEG++PTKG+F N T S+ GN KL
Sbjct: 571 GLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKL 629
Query: 622 CGGLDELHLPSCQA----RGSRKPNVNLVKVVIPVIGGSCLILSVCIFIFYARRRRSAHK 677
CGG+ ELHLP+C G K + L+ ++ G LI+S+ + R RR +
Sbjct: 630 CGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVI---NRLRRVKRE 686
Query: 678 SSNTSQMEQQFPM-VSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINL 736
S TS + + VSY L KAT FSS+N IG G FG VYKG+L ++ +VAVKVI L
Sbjct: 687 PSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQL 746
Query: 737 EQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLH- 795
Q+G KSF AECEALR+IRHRNL+K++T CSS+D++G DFKALVYE+M NGSLE WLH
Sbjct: 747 HQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHP 806
Query: 796 -----QRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV 850
+ +D L I LSL QRLNI IDVASA++YLHHHC PIVH DLKPSN+LLD+DM
Sbjct: 807 VPTPDEINDVLRI--LSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMT 864
Query: 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILL 910
AHV DFGLA+F+ + G + SSSIG+KGTIGY APEYG+G + S G YSYGILL
Sbjct: 865 AHVGDFGLARFIPEAA-GRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILL 923
Query: 911 LEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLE--EERTNS-------- 960
LE+FT +RPTESMF++ L LH F K ALPE++ +I+DP L E EE T +
Sbjct: 924 LEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAH 983
Query: 961 -RRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQRI 1009
+R + ECL+++++ GV+CS+ESP +RM +T+ + +L R+ LG +
Sbjct: 984 MKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILLGNGV 1033
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 912 bits (2356), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/1019 (48%), Positives = 671/1019 (65%), Gaps = 33/1019 (3%)
Query: 8 IILLVSIALAKALALSNETDCLSLLAIKSQLH-DPLGVTSSWNRSACVNLCQHWTGVTCG 66
I LLVS + + + NETD LSLL K+Q+ DPLG SSWN S+ CQ W+GVTCG
Sbjct: 18 IYLLVSFSFS--IYGGNETDKLSLLTFKAQITGDPLGKLSSWNESS--QFCQ-WSGVTCG 72
Query: 67 RRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLA 126
RR+QRV +LDL + + G LSP++GNLSFLR +N+A+N IP +G LFRLE LVL
Sbjct: 73 RRHQRVVELDLHSYQLVGSLSPHIGNLSFLRILNLANNSLSLYIPQELGRLFRLEELVLR 132
Query: 127 NNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPA 186
NN+F G IP N+S C+ L R NL G++P EL L LQ L++ N G++P
Sbjct: 133 NNTFDGGIPANISRCANLRILDFSRGNLTGKLPAEL--GLLSKLQVLTIELNNFVGEIPY 190
Query: 187 SIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIY 246
S GNLSA+ I N L G IP QL L L +G N+ SG IPPS++N+SSL +
Sbjct: 191 SFGNLSAINAIYGSINNLEGSIPNVFGQLKRLKILSLGANNLSGMIPPSIFNLSSLTLLS 250
Query: 247 LYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVS 306
N+ GSLP +G LPNL+ F I+TN F G +P +FSNASNL + N F G+V
Sbjct: 251 FPVNQLYGSLPHTLGLTLPNLQVFNIHTNQFGGLIPATFSNASNLLSFQIGSNNFNGKVP 310
Query: 307 INFNGLKDLSMLGLATNFLGNGAANDLDFV-DLLTNCTKLQYLYLADNGFGGVLPHSIAN 365
+ DL +LG+ N LG G NDL+FV L N T L+ L +DN FGGVLP ++N
Sbjct: 311 -PLSSSHDLQVLGVGDNNLGKGENNDLNFVYPLANNMTSLEALDTSDNNFGGVLPEIVSN 369
Query: 366 LSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHA 425
ST L+ +NQI G+IP I NL+NL +L +E N+LTG IP +G+L+ L L L+
Sbjct: 370 FSTKLMKMTFARNQIRGSIPTQIGNLINLEALGLETNQLTGMIPSSMGKLQKLSDLFLNG 429
Query: 426 NFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQIL 485
N + G IPSS+GN+T L ++ NNL+G+IP SLGN + L+ +N L+G +P++++
Sbjct: 430 NKISGMIPSSMGNMTSLGRVNMRLNNLEGSIPPSLGNWQKLLSLALSQNNLSGPIPKELV 489
Query: 486 EITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQ 545
I +LS+ L LS+N L GSLP+ + L +L L +++N+FSG+IP +LG+C SLE + L+
Sbjct: 490 SIPSLSMYLVLSENELTGSLPIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCVSLESLHLE 549
Query: 546 GNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKG 605
N G IP +LSSL +I+EL+LS NN +GQIP++LE+ L+ LNLS+N FEGEVP +G
Sbjct: 550 ENFLQGPIPITLSSLRAIQELNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPVQG 609
Query: 606 IFKNKTGFSIVGNGKLCGGLDELHL---PSCQARGSRKPNVNLVKVVIPVIGGSCLILSV 662
F+N + SI GN KLCGG+ +L+L PS + S+ P L+ ++ V G +IL +
Sbjct: 610 AFQNTSAISIFGNKKLCGGIPQLNLTRCPSSEPTNSKSP-TKLIWIIGSVCGFLGVILII 668
Query: 663 CIFIFYARRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVL 722
+FY R++ +++ +E FP V+Y++L AT+ FSS+N IG GSFG V+KG+L
Sbjct: 669 SFLLFYCFRKKKDKPAASQPSLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGIL 728
Query: 723 HENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVY 782
+ ++VAVKV+NL +KG SKSF AECEAL+SIRHRNL+K++T CSSIDF+G DFKALVY
Sbjct: 729 GPDKIVVAVKVLNLLRKGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVY 788
Query: 783 EYMQNGSLEEWLH---QRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLK 839
E+M NG+LEEWLH D+ G L L+ RLNI I +ASA+ YLHH CQ PI+H DLK
Sbjct: 789 EFMVNGNLEEWLHPVQTSDEANGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLK 848
Query: 840 PSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASM 899
PSN+LLD +M AHV DFGLA+F S + +SS+G+KGTIGY APEYG+GG+ S
Sbjct: 849 PSNILLDTNMTAHVGDFGLARFHSEA------SNQTSSVGLKGTIGYAAPEYGIGGKVST 902
Query: 900 RGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTN 959
G VYSYGILLLE+FT +RP + MF +GL LH +AK ALP++++E+VDP LL E N
Sbjct: 903 YGDVYSYGILLLEMFTGKRPVDGMFKDGLNLHSYAKMALPDRIVEVVDP-LLVREIRSVN 961
Query: 960 SRRVRN---------EECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQRI 1009
S CL+ +IK GVACS+E P +RM++ DVV +L + LG R+
Sbjct: 962 SSDEMGMYHIGPHEISACLMTIIKMGVACSVELPRERMDIGDVVTELNRIKDTLLGTRM 1020
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 909 bits (2348), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 511/1028 (49%), Positives = 676/1028 (65%), Gaps = 37/1028 (3%)
Query: 6 IIIILLVSIALAKALALSNETDCLSLLAIKSQL-HDPLGVTSSWNRSACVNLCQHWTGVT 64
II + S + + NETD L+LLAIK+Q+ DPLG+T+SWN S V+ C +WTGVT
Sbjct: 50 IIFLHSPSPTTSSTILYGNETDRLALLAIKAQITQDPLGITTSWNDS--VHFC-NWTGVT 106
Query: 65 CGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLV 124
CG R+QRV L+L + + G LSP +GNL+FL +N+ N+FHG+IP +G L RL L
Sbjct: 107 CGHRHQRVNTLNLSSLHLVGSLSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALN 166
Query: 125 LANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISR-RLFNLQGLSVGDNQLTGQ 183
L NNSFSG IP NLS CS L+ F NNL+G IP L S ++ +Q + N LTG
Sbjct: 167 LTNNSFSGEIPANLSRCSNLVYFRLGFNNLIGRIPSWLGSYPKVVRMQ---LHYNNLTGP 223
Query: 184 LPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLV 243
+P S+GNL++++ + N L G IP L QL +L ++ +G N FSG IP SVYN+SSL
Sbjct: 224 VPDSLGNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLE 283
Query: 244 EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRG 303
L N+ GSLP ++ LPNL+ I N+FTG LP S SNASNL + + F G
Sbjct: 284 VFSLPYNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGPLPSSLSNASNLLEFDITMSNFTG 343
Query: 304 QVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSI 363
+VSI+F G+ +L L LA+N LG G A+DL F++ L C L+ L L+ + FGGVLP+SI
Sbjct: 344 KVSIDFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSI 403
Query: 364 ANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHL 423
ANLST L+ L NQ+ GTIPPGI NLVNL L + N TG+IP +IG L+ L + L
Sbjct: 404 ANLSTQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDL 463
Query: 424 HANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQ 483
N L G IPSSLGN+T L L N+L G IP S GN L N L G +P++
Sbjct: 464 SRNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEK 523
Query: 484 ILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVE 543
++++ +L++SL+L+ N L G LP V LK+L L ++ N+ SG+IP LG+C +LE++
Sbjct: 524 VMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLH 583
Query: 544 LQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPT 603
++GN F G+IP S SL + +LDLS+NN SGQIP++L+ LS L LNLS+N+FEG++PT
Sbjct: 584 MEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPT 642
Query: 604 KGIFKNKTGFSIVGNGKLCGGLDELHLPSCQA----RGSRKPNVNLVKVVIPVIGGSCLI 659
KG+F N T S+ GN KLCGG+ ELHLP+C G K + L+ ++ G LI
Sbjct: 643 KGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLI 702
Query: 660 LSVCIFIFYARRRRSAHKSSNTSQMEQQFPM-VSYKELSKATNEFSSSNTIGRGSFGFVY 718
+S+ + R RR + S TS + + VSY L KAT FSS+N IG G FG VY
Sbjct: 703 MSLLVI---NRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVY 759
Query: 719 KGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778
KG L ++ +VAVKVI L Q+G KSF AECEALR+IRHRNL+K++T CSS+D++G DFK
Sbjct: 760 KGXLGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFK 819
Query: 779 ALVYEYMQNGSLEEWLH------QRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPP 832
ALVYE+M NGSLE WLH + +D L I LSL QRLNI IDVASA++YLHHHC P
Sbjct: 820 ALVYEFMPNGSLENWLHPVPTPDEINDVLRI--LSLPQRLNIAIDVASALDYLHHHCHKP 877
Query: 833 IVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYG 892
IVH DLKPSN+LLD+DM AHV DFGLA+F+ + G + SSSIG+KGTIGY APEYG
Sbjct: 878 IVHCDLKPSNILLDNDMTAHVGDFGLARFIPEAA-GRSHPSQSSSIGLKGTIGYAAPEYG 936
Query: 893 LGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLP 952
+G + S G YSYGILLLE+FT +RPTESMF++ L LH F K ALPE++ +I+DP L
Sbjct: 937 MGTKVSALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLS 996
Query: 953 LE--EERTNS---------RRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001
E EE T + +R + ECL+++++ GV+CS+ESP +RM +T+ + +L R
Sbjct: 997 SEAKEEETTAADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIR 1056
Query: 1002 QNFLGQRI 1009
+ LG I
Sbjct: 1057 KILLGNGI 1064
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 904 bits (2335), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/996 (49%), Positives = 668/996 (67%), Gaps = 18/996 (1%)
Query: 24 NETDCLSLLAIKSQL-HDPLGVTSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQSI 82
NETD LSLLA+KSQ+ +DP G+ SSWN S ++ C W+GV CG+R++RV ++DL + +
Sbjct: 32 NETDRLSLLALKSQITNDPFGMLSSWNES--LHFCD-WSGVICGKRHRRVVEIDLHSAQL 88
Query: 83 GGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCS 142
G LSP++GNLSFLR + + +N F IP +G+LFRL L L NN+F G+IP N+SHCS
Sbjct: 89 VGSLSPHIGNLSFLRILKLENNRFSHNIPQELGHLFRLRMLSLENNTFDGKIPVNISHCS 148
Query: 143 KLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTN 202
L+ S NNL G++P EL S L LQ N L G +P+S GNLSA+ I N
Sbjct: 149 NLLILSLSGNNLTGKLPIELGS--LSKLQVFFFQFNYLVGGIPSSFGNLSAIIQIFGAGN 206
Query: 203 RLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGK 262
L G IP ++ QL SL G N+ +G IPPS+YN+SSL+ + N+ G+LP ++G
Sbjct: 207 YLQGGIPNSIGQLKSLKSFSFGRNNMTGMIPPSIYNLSSLMRFAVPVNQLHGNLPPDLGL 266
Query: 263 NLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLAT 322
LPNL ++ N F+GS+P +FSNAS + V+ L+ N G+V + + L L L +
Sbjct: 267 TLPNLEILLMSFNRFSGSIPPTFSNASTIAVIELSNNNLTGRVP-DLSSLSKLRWLIVDV 325
Query: 323 NFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYG 382
N+LGNG +DL F+ L N T L+ L + DN FGG+LP I+N S L G+NQI G
Sbjct: 326 NYLGNGNDDDLSFLPPLANKTSLEELSINDNNFGGLLPKIISNFSENLKRMTFGRNQIRG 385
Query: 383 TIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLL 442
+IP GI NL+ L++L +E N+LTG IP+ IG+L+NL +L L N + G IPSS+GN+T L
Sbjct: 386 SIPSGIGNLIGLDTLGLEMNQLTGVIPNSIGKLQNLGVLALGGNKISGNIPSSMGNITSL 445
Query: 443 TYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLN 502
+ ANNLQG IP SLGNC+NL+ +N L+G++P++++ I + S L LS+N L
Sbjct: 446 LEVYLSANNLQGRIPSSLGNCQNLLILHLDQNNLSGSIPKEVISIPSSSRILVLSENQLT 505
Query: 503 GSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTS 562
GSLPL VG L +L ++ N+ SG+IP TLG+C SLE++ ++GN F G IP+SLSSL +
Sbjct: 506 GSLPLEVGKLANLGYFNLSHNRLSGEIPRTLGSCVSLEFLYMEGNLFQGPIPESLSSLRA 565
Query: 563 IKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLC 622
++ L+LS NN SG+IPK+L L L L+LS+N+ EGEVP +GIF +GFS++GN KLC
Sbjct: 566 LQILNLSHNNLSGEIPKFLAELKLLTSLDLSFNNLEGEVPVQGIFARASGFSMLGNKKLC 625
Query: 623 GGLDELHLPSC-QARGSRKPNVNLVKVVIPVIGGSCLILSVCIFIFYARRRRSAHKSSNT 681
GG+ +L+L C + + + +K++I + G I+ V ++ + + + ++
Sbjct: 626 GGMPQLNLSRCTSKKSRKLKSSTKLKLIIAIPCGFVGIILVVSYMLFFFLKEKKSRPASG 685
Query: 682 SQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG 741
S E F V+Y++L +ATN FS +N IG GSFG VYKG+L +G VAVKV NL ++G
Sbjct: 686 SPWESTFQRVAYEDLLQATNGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGA 745
Query: 742 SKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQ---RD 798
SKSF AEC AL +IRHRNL+K++T CS IDF+G DFKALVYE+M NGSLEEWLH D
Sbjct: 746 SKSFMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPAQISD 805
Query: 799 DQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858
+ +LSL+QRLNI IDVASA++YLH+HCQ IVH DLKPSNVLLD D+ AHV DFGL
Sbjct: 806 EAHRRRDLSLLQRLNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDLTAHVGDFGL 865
Query: 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR 918
A+ L + ++ +SSIG+KGTIGY APEYGLG E S G VYSYGILLLE+FT RR
Sbjct: 866 ARLLPQASHQLCLDQ-TSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRR 924
Query: 919 PTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTN--SRRV----RNEECLVAV 972
PT+ +F +GL LH FAK ALP V E++DP L+ EE + SRR+ + ECL A+
Sbjct: 925 PTDGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEETSGDASRRMSHIGNHMECLAAI 984
Query: 973 IKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQR 1008
+K GVACS E P +RME++ V V+L R LG +
Sbjct: 985 VKVGVACSAEFPRERMEISSVAVELRRIRHILLGPQ 1020
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255581223|ref|XP_002531424.1| receptor-kinase, putative [Ricinus communis] gi|223528974|gb|EEF30966.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 899 bits (2323), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/1010 (49%), Positives = 664/1010 (65%), Gaps = 22/1010 (2%)
Query: 9 ILLVSIALAKALALSNETDCLSLLAIKSQL-HDPLGVTSSWNRSACVNLCQHWTGVTCGR 67
+LL S LA + N TD L+LL K+++ DPLG WN S + CQ W GVTC R
Sbjct: 16 LLLSSFTLAACVINGNLTDRLALLDFKAKITDDPLGFMPLWNDST--HFCQ-WYGVTCSR 72
Query: 68 RNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLAN 127
R+QRV L+LR+ + G +SP++GNLSFLR + + +N F IP +G L RL+ L L+N
Sbjct: 73 RHQRVAILNLRSLQLAGSISPHIGNLSFLRDLYLQNNSFSHGIPPEVGRLRRLQRLRLSN 132
Query: 128 NSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPAS 187
NS +G IP+N+S CSKL N L GEIPEEL L LQ +S+ N +G +P S
Sbjct: 133 NSLTGNIPSNISACSKLSEIYFAYNQLEGEIPEEL--SLLAKLQVISIQKNYFSGSIPPS 190
Query: 188 IGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYL 247
IGNLS+L+V+ N L G IP + QL +L ++ + N+ SGTIPPS+YN+SS+ + +
Sbjct: 191 IGNLSSLQVLSAPENYLSGNIPDAIGQLNNLIFISLSVNNLSGTIPPSIYNLSSINTLNI 250
Query: 248 YGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSI 307
N+ G LP +G LPNL+ F I N+F GS+P SFSNASNL L ++EN+ G+V
Sbjct: 251 VYNQIQGRLPSNLGITLPNLQVFAIARNDFIGSIPSSFSNASNLVWLIMSENKLTGRVP- 309
Query: 308 NFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLS 367
+ L +L +LGL N+LG ANDLDFV L NCT L L + +N F GVLP SI+N S
Sbjct: 310 SLEQLHNLQILGLGYNYLG-LEANDLDFVSSLVNCTNLWRLEIHNNKFHGVLPESISNFS 368
Query: 368 TALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANF 427
T + +N I G IP I+NLVNL L M N+L+G IP G L L++LHL N
Sbjct: 369 TTFSQLVIAENNIAGRIPSSISNLVNLERLEMANNQLSGNIPSNFGNLNMLKVLHLFGNK 428
Query: 428 LQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEI 487
L GTIPSSLGNLT+L LSF NNLQG IP SL C+NLM +N L+G++P Q+ +
Sbjct: 429 LSGTIPSSLGNLTMLLTLSFYDNNLQGRIPSSLAECENLMVLDLAKNNLSGSIPLQVFGL 488
Query: 488 TTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGN 547
++LS++LDLS N G +P+ VGNLK L +LGI+ N SG+IP +LG+C LE + LQGN
Sbjct: 489 SSLSIALDLSANHFTGVIPMEVGNLKDLEQLGISDNMLSGRIPDSLGSCIKLEVLALQGN 548
Query: 548 SFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIF 607
F G +P SLSSL ++ LD S NN SG+IP++L++ L+ LNLSYN+FEG VP +GIF
Sbjct: 549 FFDGLVPSSLSSLRGLRVLDFSSNNLSGEIPEFLQSFDLLESLNLSYNNFEGRVPVEGIF 608
Query: 608 KNKTGFSIVGNGKLCGGLDELHLPSCQARGSRKPNVNLVKVVIPVIGGSCLILSVCIF-- 665
+N + ++GN KLCGG+ E HL C A+ +K + L+K+VI I + + IF
Sbjct: 609 RNASTTLVMGNDKLCGGIPEFHLAKCNAKSPKKLTL-LLKIVISTICSLLGLSFILIFAL 667
Query: 666 IFYARRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHEN 725
F+ R+++ S + VS++ L +AT+ FSS+N IGRGSFG VYKG L E
Sbjct: 668 TFWLRKKKEEPTSDPYGHLLLN---VSFQSLLRATDGFSSANLIGRGSFGHVYKGFLDEG 724
Query: 726 GMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYM 785
+ +AVKV+NL G S SF AECEALR+IRHRNL+K++T CS ID++G DFKALVYEYM
Sbjct: 725 NVTIAVKVLNLLHHGASTSFIAECEALRNIRHRNLVKVLTACSGIDYQGNDFKALVYEYM 784
Query: 786 QNGSLEEWLH---QRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSN 842
NGSLEEWLH + ++ +L+L+QRLNI IDVASA++YLH+ C PIVH DLKPSN
Sbjct: 785 VNGSLEEWLHPIPRTEEVEPPRSLNLLQRLNIAIDVASALDYLHNQCTTPIVHCDLKPSN 844
Query: 843 VLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGG 902
VLLD +M HVSDFGLAK LS S + + SSSIGV+GT+G+ PEYG+G S G
Sbjct: 845 VLLDSEMNGHVSDFGLAKILSEST-NSFPVSQSSSIGVRGTVGFAPPEYGVGSNVSTYGD 903
Query: 903 VYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLL---PLEEERTN 959
VYSYGILLLE+FT +RPT+ MF E L LH FA+ A +++ E+ DP LL + E R N
Sbjct: 904 VYSYGILLLELFTGKRPTDDMFKEDLNLHNFAEIAFRDQLAEVADPILLQETAVRETRLN 963
Query: 960 SRRV-RNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQR 1008
SR+ R EECL ++++ GVACS E P +RM++ DVV L R + R
Sbjct: 964 SRKCQRLEECLFSMLRIGVACSTEMPQERMKINDVVTGLHAIRDKLVRIR 1013
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 899 bits (2323), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/1007 (48%), Positives = 665/1007 (66%), Gaps = 15/1007 (1%)
Query: 7 IIILLVSIALAKALALSNETDCLSLLAIKSQLHDPLGVTSSWNRSACVNLCQHWTGVTCG 66
+++L++ ++ + +L NETD LSLLA K+Q+ DPL SSWN A + C+ W+GV CG
Sbjct: 14 LLLLIIQLSFSFSLHEGNETDRLSLLAFKAQITDPLDALSSWN--ASTHFCK-WSGVICG 70
Query: 67 RRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLA 126
R+QR+ +L+L++ + G LSP++GNLSFLR +N+ N F +IP +G LFRL+ LVL
Sbjct: 71 HRHQRIVELNLQSSQLTGNLSPHIGNLSFLRVLNLEGNYFSRDIPQELGRLFRLQRLVLG 130
Query: 127 NNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPA 186
NN+FSG IP N+S CS L+ NNL G+IP +L S L L + N L G +P+
Sbjct: 131 NNTFSGEIPVNISSCSNLLVLHLGSNNLTGKIPAQLGS--LSKLGAFVLQGNNLVGDIPS 188
Query: 187 SIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIY 246
S GNLS+++ N L G IP +L L L Y V +N SGTIP S+ NISSL +
Sbjct: 189 SFGNLSSVQNFFWTKNYLRGGIPESLGNLKRLKYFAVAENDLSGTIPSSICNISSLAYVS 248
Query: 247 LYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVS 306
L N+ GSLP ++G NLPNL VI N+ G +P + SNAS + ++ L+ N G++
Sbjct: 249 LGQNQLHGSLPPDLGLNLPNLAYLVINFNHLNGPIPATLSNASKIFLVDLSYNNLTGKIP 308
Query: 307 INFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANL 366
+ L DL L + N LGNG +DL F+ L N T L+ L + DN FGGVLP ++N
Sbjct: 309 -DLASLPDLQKLLVHHNDLGNGEEDDLSFLYTLANSTNLESLGINDNNFGGVLPEIVSNF 367
Query: 367 STALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHAN 426
ST L G+NQI+G+IP I NL++L++L +E N+L G IP IG+L+NL L+L+ N
Sbjct: 368 STNLKGITFGRNQIHGSIPTEIGNLISLDTLSLETNQLHGIIPSSIGKLQNLAALYLNEN 427
Query: 427 FLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILE 486
+ G+IPSSLGN+T L +SF NNLQG IP SLGN L+ +N L+G +P+++L
Sbjct: 428 KISGSIPSSLGNITSLVEVSFAQNNLQGTIPASLGNWHKLLILDLSQNNLSGPIPKEVLG 487
Query: 487 ITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQG 546
I++LS+ L L DN L GSLP VG L +L L +++N+ SG+IP +L +C SLE ++L G
Sbjct: 488 ISSLSVLLYLHDNQLTGSLPSEVGQLVNLGFLRVSKNRLSGEIPKSLDSCKSLEGLDLGG 547
Query: 547 NSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGI 606
N F G +P LSSL +++ L LS NN SGQIP++L++ L+ L+LSYN FEGEVP +G+
Sbjct: 548 NFFEGPVPD-LSSLRALQMLLLSYNNLSGQIPQFLKDFKLLETLDLSYNDFEGEVPEQGV 606
Query: 607 FKNKTGFSIVGNGKLCGGLDELHLPSCQARGSRKP--NVNLVKVVIPVIGGSCLILSVCI 664
F+N + S+ GN KLCGG+ +L LP C + +P + L+ ++ G ++L
Sbjct: 607 FENTSRISVQGNKKLCGGIPQLDLPKCTSNEPARPKSHTKLILIIAIPCGFLGIVLMTSF 666
Query: 665 FIFYARRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHE 724
+FY+R+ + S + E F ++Y++L +AT+ FSSSN +G G+FG VY+G L
Sbjct: 667 LLFYSRKTKDEPASGPS--WESSFQRLTYQDLLQATDGFSSSNLVGAGAFGSVYRGTLTS 724
Query: 725 NGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEY 784
+G +VAVKV+NL +KG SKSF AEC AL +IRHRNL+K++T CSS DF+G DFKALVYE+
Sbjct: 725 DGAVVAVKVLNLLRKGASKSFMAECAALINIRHRNLVKVITACSSNDFQGNDFKALVYEF 784
Query: 785 MQNGSLEEWLHQ---RDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPS 841
M NGSLEEWLH D NL L+QRLNI IDVASA++YLH+HCQ P+VH DLKPS
Sbjct: 785 MVNGSLEEWLHPVHISDVTPETRNLDLVQRLNIAIDVASALDYLHNHCQVPVVHCDLKPS 844
Query: 842 NVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRG 901
NVLL DM A V DFGLA+FL + + SSS+G+KGTIGY APEYG+G E S G
Sbjct: 845 NVLLGDDMTACVGDFGLARFLPEAS-NQLPADESSSVGLKGTIGYAAPEYGMGSEVSTYG 903
Query: 902 GVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSR 961
VYSYGILLLE+FT RRPT+ MF +G LH +AK LP+ V+E VDP+L EE N
Sbjct: 904 DVYSYGILLLEMFTGRRPTDGMFKDGHNLHNYAKMVLPDNVLEFVDPTLREHEEMNHNDD 963
Query: 962 RVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQR 1008
+ EC+V++IK G+ACS E P +RM + +VVV+L R+ G++
Sbjct: 964 SHKVMECMVSIIKVGLACSAELPGERMGIANVVVELHRIREMLDGRK 1010
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2319), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/1019 (47%), Positives = 678/1019 (66%), Gaps = 33/1019 (3%)
Query: 4 LRIIIILLVSIALAKALALSNETDCLSLLAIKSQL-HDPLGVTSSWNRSACVNLCQHWTG 62
L ++ + ++ ++ + NETD LSLLA K+ + DPL + SSWN S ++ C+ W+G
Sbjct: 12 LWVLFLKMIQLSCSSLSGRGNETDRLSLLAFKAHITDDPLHILSSWNES--LHFCK-WSG 68
Query: 63 VTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLET 122
+TCG R+QRV ++DL + + G L+ ++GNLSFLR +N+ +N IP IG LFRL T
Sbjct: 69 ITCGSRHQRVIEIDLESSRLSGSLTAFIGNLSFLRVLNLQNNSLSHYIPQEIGRLFRLRT 128
Query: 123 LVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTG 182
L+L NSFSG IP N+S+CS L+T RNNL G++P EL + L LQ N LTG
Sbjct: 129 LILRRNSFSGEIPVNISYCSNLLTLRLGRNNLTGKLPAEL--KSLSKLQMFEFEINYLTG 186
Query: 183 QLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSL 242
++ S NLS+L +I N G+IP ++ QL SL +G ++FSG IPPS++N+SSL
Sbjct: 187 EISPSFSNLSSLEIIYGTRNNFHGEIPNSIGQLKSLQTFSLGGSNFSGVIPPSIFNLSSL 246
Query: 243 VEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFR 302
+ + N+ G+LP ++G++LP L +Y N F+GS+P + SNASNL L +++N F
Sbjct: 247 TILSVPINQLHGNLPPDLGQSLPKLEVLRLYANKFSGSIPPTISNASNLVALDVSQNNFT 306
Query: 303 GQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHS 362
G+V + L +LS +G+ N LGNG +DL F+ L N T L+ L + +N GGVLP
Sbjct: 307 GKVP-SLARLHNLSYIGIHKNNLGNGEDDDLSFLYTLANNTNLEILAITENNLGGVLPEM 365
Query: 363 IANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLH 422
++N ST L+ G+N+I G IP I NL+ L +L E N LTG+IP +G+LKNL L+
Sbjct: 366 LSNFSTKLVHMAFGRNKIRGRIPSEIDNLIRLEALGFERNELTGSIPSSLGKLKNLIKLY 425
Query: 423 LHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQ 482
L+ N + G+IPSSLGN+T L+ +S NNL+G+IP SLGNC+ ++ RN L+G +P+
Sbjct: 426 LNDNNISGSIPSSLGNITSLSTISLKVNNLEGSIPSSLGNCQQMLLMDLSRNNLSGTIPK 485
Query: 483 QILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYV 542
+++ I +LS+SLDLS+N GSLP+ VG L +L L +++N+ SG+IP +LG+CT LE +
Sbjct: 486 ELISIPSLSISLDLSENQFTGSLPMEVGGLVNLGYLDVSKNKLSGEIPKSLGSCTRLETL 545
Query: 543 ELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVP 602
LQGN+F GTIP SLSSL I +L+LS NN +GQIP + L+ L+LSYN FEGEVP
Sbjct: 546 YLQGNAFQGTIPVSLSSLRGINDLNLSHNNLTGQIPNFFAEFKSLEKLDLSYNDFEGEVP 605
Query: 603 TKGIFKNKTGFSIVGNGKLCGGLDELHLPSCQARGSRKPNVN-----LVKVVIPVIGGSC 657
+G+FKN + FSI GN LCGG+ E++LP C S KP + ++ V + G
Sbjct: 606 AEGVFKNASAFSISGNKNLCGGIPEINLPRCTLNKSMKPKTSHKLRLIIVVACCGVVGVL 665
Query: 658 LILSVCIFIFYARRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFV 717
L+ S +F R+ +K ++ S ++ F VSY+ L KAT+ FSS+N IG GSFG V
Sbjct: 666 LLTSALLFCCLKMRK---NKEASGSSLDIFFQKVSYQNLLKATDGFSSANLIGAGSFGSV 722
Query: 718 YKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777
YKG+L + ++AVKV+NL+ KG S+SF EC+AL ++RHRNL+K++T CSS DF+ DF
Sbjct: 723 YKGILAPDETIIAVKVLNLQHKGASRSFMTECQALANVRHRNLVKVLTACSSSDFEENDF 782
Query: 778 KALVYEYMQNGSLEEWLH--QRDDQLGICN-LSLIQRLNIVIDVASAVEYLHHHCQPPIV 834
KALVYEYM NGSLEEWLH Q DQ LSLI+RL+I IDVASA++YLH+ CQ P+V
Sbjct: 783 KALVYEYMVNGSLEEWLHPTQNPDQDQPPRILSLIERLSISIDVASALDYLHNQCQVPVV 842
Query: 835 HGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG 894
H DLKPSN+LLD DM AHV DFGLA+FL A+ +PSSSIG++GT+GY APEYG+G
Sbjct: 843 HCDLKPSNILLDSDMTAHVGDFGLARFLIAA---PHHSSPSSSIGIRGTVGYAAPEYGMG 899
Query: 895 GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLE 954
+ S G VY+YGILLLE+FT ++PT++MF +GL LH AK A+P+++ DP LL E
Sbjct: 900 SDVSTYGDVYTYGILLLELFTGKKPTDAMFKDGLNLHILAKMAMPDRLALAADPFLLITE 959
Query: 955 EERTNSR------------RVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001
+E T++ R + CL +++K GV CS ESP DRM+++DV +L R
Sbjct: 960 DEGTSASATSASHRITCIARDKVLGCLNSILKIGVDCSAESPRDRMDISDVANELVRIR 1018
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116466|ref|XP_002331904.1| predicted protein [Populus trichocarpa] gi|222874576|gb|EEF11707.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2319), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 484/1001 (48%), Positives = 676/1001 (67%), Gaps = 14/1001 (1%)
Query: 11 LVSIALAKALALSNETDCLSLLAIKSQLHDPLGVTSSWNRSACVNLCQHWTGVTCGRRNQ 70
++ + + +LA +E D LSLLA K+Q+ DP SSWN S ++ CQ W+GV CGR++Q
Sbjct: 13 IIQHSFSFSLARGSEIDKLSLLAFKAQISDPTTKLSSWNES--LHFCQ-WSGVKCGRQHQ 69
Query: 71 RVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSF 130
RV +LDL + + G LSP +GNLSFLR +++ +N F IP IG L RL+TL+L NNSF
Sbjct: 70 RVIELDLHSSQLVGSLSPSIGNLSFLRLLSLENNSFTNAIPQEIGRLVRLQTLILGNNSF 129
Query: 131 SGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGN 190
SG IP+N+SHCS L+ + NNL G +P L S L LQ S N L G++P S N
Sbjct: 130 SGEIPSNISHCSNLLKLNLEGNNLTGNLPAGLGS--LSKLQVFSFRKNNLDGKIPLSFEN 187
Query: 191 LSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGN 250
LS++ ID N + G IP ++ +L +L + +G N+ SGTIP S+YNISSL+ L N
Sbjct: 188 LSSIIEIDGTLNNIQGGIPSSIGKLKTLNFFSLGSNNLSGTIPASLYNISSLIHFSLPYN 247
Query: 251 RFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFN 310
+F G+LP IG LPNL+ I+ N +G LP + NA+ ++L+ N+F G+V
Sbjct: 248 QFHGTLPPNIGLTLPNLQYLGIHDNRLSGQLPATLINATKFTEIYLSYNKFTGKVP-TLA 306
Query: 311 GLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTAL 370
+ +L +L + N LG G +DL F+ L+N +KL+ LY+ +N FGGVLP I+N ST L
Sbjct: 307 IMPNLRILSMEENGLGKGEDDDLSFLYTLSNSSKLEDLYIDNNNFGGVLPDIISNFSTKL 366
Query: 371 IDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQG 430
G NQI GTIP GI NLV+L++L +EAN LTG+IP IG+L+NL L+ N L G
Sbjct: 367 KQMAFGSNQIRGTIPDGIGNLVSLDTLGLEANHLTGSIPSSIGKLQNLADFFLNENKLSG 426
Query: 431 TIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTL 490
+IPSSLGN+T L ++F NNLQG+IP SLGNC+NL+ +N L+G +P+++L I++L
Sbjct: 427 SIPSSLGNITSLMQINFDQNNLQGSIPPSLGNCQNLLVLALSQNNLSGPIPKEVLSISSL 486
Query: 491 SLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFS 550
S+ L LS+N L GSLP VG L +L + I++N+ SG+IP +LG+C SLE++ L GN
Sbjct: 487 SMYLVLSENQLTGSLPFEVGKLVTLGYMDISKNRLSGEIPASLGSCESLEHLYLDGNFLQ 546
Query: 551 GTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNK 610
G I +SL SL ++++L+LS NN SGQIPK+L +L LQ L+LS+N EGEVP G+F+N
Sbjct: 547 GPISESLRSLRALQDLNLSHNNLSGQIPKFLGDLK-LQSLDLSFNDLEGEVPMHGVFENT 605
Query: 611 TGFSIVGNGKLCGGLDELHLPSCQARGSRKPNVNLVKVVIPVIGGSCLILSVCIFIFYAR 670
+ SI GN LCGG+ +L+LP+C+++ ++ + + + + + G ++ + F+F
Sbjct: 606 SAVSIAGNKNLCGGILQLNLPTCRSKSTKPKSSTKLTLTVAIPCGFIGLIFIASFLFLCC 665
Query: 671 RRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVA 730
++S K+ N E F V+YK+L +ATN FSS N +G GSFG VYKGVL +G+ VA
Sbjct: 666 LKKSLRKTKNELSCEMPFRTVAYKDLLQATNGFSSGNLVGAGSFGSVYKGVLAFDGVTVA 725
Query: 731 VKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSL 790
VKV NL ++G SKSF EC AL +IRHRNL+K++ C+ +D +G DFKALVYE+M NGSL
Sbjct: 726 VKVFNLLREGASKSFMRECAALLNIRHRNLVKVLFACAGVDVQGNDFKALVYEFMINGSL 785
Query: 791 EEWLHQ-RDDQLGI---CNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD 846
EEWLH L + NL+LIQRLNI IDVA+A++YLH+ C+ PIVH DLKPSNVLLD
Sbjct: 786 EEWLHPIHTLDLEVHQPKNLNLIQRLNIAIDVANALDYLHNQCKMPIVHCDLKPSNVLLD 845
Query: 847 HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSY 906
DM AHV DFGL KFLS + + +SS+G+KGT+GY APEYG+G E S G V+SY
Sbjct: 846 GDMTAHVGDFGLLKFLSEA-SCQSSSSQTSSVGLKGTVGYAAPEYGIGSEVSTFGDVHSY 904
Query: 907 GILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNE 966
GILLLE+ T +RPT+SMF +GL LH + K ALP++V++I DP LL ++ + ++
Sbjct: 905 GILLLEMITGKRPTDSMFKDGLELHSYVKIALPDRVVDIADPKLLTEVDQGKGTDQIV-- 962
Query: 967 ECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQ 1007
ECL+++ K GV CS + P +RM++++VV +L + NFLG+
Sbjct: 963 ECLISISKIGVFCSEKFPKERMDISNVVAELNRTKANFLGR 1003
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115346|ref|XP_002317009.1| predicted protein [Populus trichocarpa] gi|222860074|gb|EEE97621.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 896 bits (2315), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/1008 (49%), Positives = 675/1008 (66%), Gaps = 38/1008 (3%)
Query: 14 IALAKALALSNETDCLSLLAIKSQL-HDPLGVTSSWNRSACVNLCQHWTGVTCGRRNQRV 72
I+ A SN TD L+LL KS++ HDP + SWN S ++ CQ W GV CGRR++RV
Sbjct: 26 ISSVSATTFSNFTDRLALLDFKSKIIHDPQNIFGSWNDS--LHFCQ-WQGVRCGRRHERV 82
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG 132
T L L + + G +SP +GNLSFL +++++N G+IPD +G LFRL+ LVL NNSF G
Sbjct: 83 TVLKLESSGLVGSISPALGNLSFLWGLDLSNNTLQGKIPDGLGRLFRLQILVLNNNSFVG 142
Query: 133 RIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLS 192
IP NLSHCSKL NNLVG+IP EL+S L L+ L + N L+G +P IGNL+
Sbjct: 143 EIPGNLSHCSKLDYLGLASNNLVGKIPAELVS--LSKLEKLVIHKNNLSGAIPPFIGNLT 200
Query: 193 ALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRF 252
+L I N G+IP TL QL +L L +G N SGTIP +YN+S+L + L N+
Sbjct: 201 SLNSISAAANNFQGRIPDTLGQLKNLESLGLGTNFLSGTIPLPIYNLSTLSILSLSENQL 260
Query: 253 TGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGL 312
G LP +IG +LPNL+ I N F+GS+P S SN+SNL+VL +N F G++S+NF GL
Sbjct: 261 QGYLPSDIGVSLPNLQYIQIRANQFSGSIPLSISNSSNLQVLEAGDNSFSGKLSVNFGGL 320
Query: 313 KDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALID 372
K L+++ L+ N +G+G +L F+D L NCT L + + N F G+LP+S+ NLST L
Sbjct: 321 KHLAVVSLSFNKMGSGEPGELSFLDSLINCTSLYAIDIVGNHFEGMLPNSLGNLSTGLTF 380
Query: 373 FNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTI 432
LG+NQ++G I GI NL+NLN+L +E N+L+G IP IG+L+ LQ L N L G I
Sbjct: 381 LGLGQNQLFGGIHSGIGNLINLNTLGLEFNQLSGPIPLDIGKLRMLQRFSLSYNRLSGHI 440
Query: 433 PSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSL 492
PSS+GNLTLL N LQG IP S+GNC+ L+ RN L+G P+++ I++LS+
Sbjct: 441 PSSIGNLTLLLEFDLQGNQLQGTIPSSIGNCQKLLLLHLSRNNLSGNAPKELFAISSLSV 500
Query: 493 SLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGT 552
SLDLS N NGSLP +G+LKSL +L ++ N+FSG+IP TL +CTSLEY+ +Q N F G+
Sbjct: 501 SLDLSQNYFNGSLPSEIGSLKSLAKLNVSYNEFSGEIPSTLASCTSLEYLYMQHNFFQGS 560
Query: 553 IPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTG 612
IP S S+L I++LDLS NN SGQIPK+L+ + L LNLS+N FEGEVPTKG F N T
Sbjct: 561 IPSSFSTLRGIQKLDLSHNNLSGQIPKFLDTFALLT-LNLSFNDFEGEVPTKGAFGNATA 619
Query: 613 FSIVGNGKLCGGLDELHLPSCQARGSRKPNVNLVKVVIPVIGGSCLILSVCIFI-FYARR 671
S+ GN KLCGG+ EL LP C + S+K + L +++ I L ++V F+ Y R
Sbjct: 620 ISVDGNKKLCGGISELKLPKCNFKKSKKWKIPLWLILLLTIACGFLGVAVVSFVLLYLSR 679
Query: 672 RRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAV 731
R+ +SS S +++ P VSY+ L KATN FSS N IG G FG VY+G+L ++ +VA+
Sbjct: 680 RKRKEQSSELS-LKEPLPKVSYEMLLKATNGFSSDNLIGEGGFGSVYRGILDQDDTVVAI 738
Query: 732 KVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGS-- 789
KV+NL+ +G SKSF AECEALR++RHRNL+KI+T CSS+DF+G +FKALVYE+M NGS
Sbjct: 739 KVLNLQTRGASKSFVAECEALRNVRHRNLLKIITSCSSVDFQGNEFKALVYEFMPNGSLE 798
Query: 790 -LEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD 848
LE+WL+ + L L+QRLNI+IDVASA+EYLHH +VH DLKPSN+LLD +
Sbjct: 799 ILEKWLYSHN-----YFLDLLQRLNIMIDVASALEYLHHGNATLVVHCDLKPSNILLDEN 853
Query: 849 MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGI 908
MVAHVSDFG+AK L ++ +T + + T+GY+APEYGLG + S+ G +YSYGI
Sbjct: 854 MVAHVSDFGIAKLLGEGH--SITQTMTLA-----TVGYMAPEYGLGSQVSIYGDIYSYGI 906
Query: 909 LLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLP---LEEERTNSRRVRN 965
LLE+ TR+RPT++MF L LH FA+ ALPE+V+ IVDPSLL ++ R ++ + N
Sbjct: 907 PLLEMITRKRPTDNMFEGTLNLHGFARMALPEQVLNIVDPSLLSSGNVKAGRMSNTSLEN 966
Query: 966 E-----------ECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQ 1002
EC+ ++I+ G++CS E P DR+E+ + +LC R+
Sbjct: 967 PTSSSGEIGTLVECVTSLIQIGLSCSRELPRDRLEINHAITELCSIRK 1014
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113117|ref|XP_002316396.1| predicted protein [Populus trichocarpa] gi|222865436|gb|EEF02567.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 892 bits (2304), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/996 (49%), Positives = 669/996 (67%), Gaps = 20/996 (2%)
Query: 26 TDCLSLLAIKSQL-HDPLGVTSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQSIGG 84
TD LSLLA K+Q+ DPLG SSWN S ++ C+ W+G CGRR+QRV +LDL + + G
Sbjct: 15 TDRLSLLAFKAQITDDPLGALSSWNES--LHFCE-WSGAKCGRRHQRVVELDLHSCKLAG 71
Query: 85 ILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKL 144
LSP++GNLSFLR +++++N F IP +G L RL+ L L NN+FSG IP N+S+CS L
Sbjct: 72 SLSPHIGNLSFLRILDLSNNSFSQNIPQELGRLLRLQQLNLENNTFSGEIPANISNCSNL 131
Query: 145 ITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRL 204
NNL+G+IP EL S L NLQ + N L G++P S NLS++ +I + N L
Sbjct: 132 QLIDLKGNNLIGKIPAELGS--LLNLQACLLVTNHLVGEIPLSFENLSSVEIIGVGDNHL 189
Query: 205 WGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNL 264
G IP + +L L L V N+ SGTIPPS+YN+SSL + N+F GSLP ++G+ L
Sbjct: 190 QGSIPYGIGKLKRLRKLSVPLNNLSGTIPPSIYNLSSLTLFSVAINQFHGSLPSDLGQKL 249
Query: 265 PNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNF 324
P+L V Y N F G +P + SNAS L V+ N F G+V F L +L LG+ +N
Sbjct: 250 PSLEVLVFYANRFNGPIPVTISNASTLSVIDFGNNSFTGKVP-PFANLPNLQYLGIDSNE 308
Query: 325 LGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTI 384
LGNG DL F+ L N T L+ L ++DN GG+ P I+N S+ ++G+NQ+ G+I
Sbjct: 309 LGNGEEGDLSFLQSLANYTNLEELGMSDNNLGGMFPEIISNFSSQFTTLSMGRNQVRGSI 368
Query: 385 PPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTY 444
P I NL++L++L +E N+LTG IP IG+LKNL L L N + G IPSSLGN+T L
Sbjct: 369 PVDIGNLISLDTLMLETNQLTGVIPTSIGKLKNLHGLTLVENKISGNIPSSLGNVTSLVE 428
Query: 445 LSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGS 504
L ANNLQG IP SL NC+NLM +N L+G L +Q++ + +LS+SLDLS N L G
Sbjct: 429 LYLSANNLQGGIPSSLANCQNLMSLKLAQNNLSGPLTKQVIGMASLSVSLDLSHNQLIGP 488
Query: 505 LPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIK 564
LP VG L +L L ++ N+ SG+IP +LG+C LEY+ L+GN G+IP+ LSSL +++
Sbjct: 489 LPSEVGRLVNLGYLDVSHNRLSGEIPGSLGSCIMLEYLHLEGNFLQGSIPELLSSLRALQ 548
Query: 565 ELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGG 624
L+LS NN +GQIP++L + LQ L+LS+NH EGE+PT+ +F N + S++GN KLCGG
Sbjct: 549 YLNLSYNNLTGQIPRFLADFQLLQRLDLSFNHLEGEMPTQRVFGNVSAVSVLGNDKLCGG 608
Query: 625 LDELHLPSCQARGSRKPNVNL-VKVVIPVIGGSCLILSVCIFIFYARRRRSAHKSSNTSQ 683
+ +L+L C + RKP + +K+VI + G + L + + R++ ++ ++ +
Sbjct: 609 ISQLNLSRCTSNELRKPKFSTKLKLVISIPCGFIIALLLISSLLIHSWRKTKNEPASGAS 668
Query: 684 MEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSK 743
E F V+Y+EL +AT FSSSN IG GSFG VYK +L +GM+VAVKV NL +KG SK
Sbjct: 669 WEVSFRRVTYEELYQATGGFSSSNFIGGGSFGSVYKAILAPDGMIVAVKVFNLLRKGASK 728
Query: 744 SFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWL---HQRDDQ 800
S+ AEC AL +IRHRNL+KI+T CSS+DF+G DFKALVYE+M NGSLEEWL H D++
Sbjct: 729 SYMAECAALINIRHRNLVKILTACSSLDFRGNDFKALVYEFMVNGSLEEWLHPVHTSDEE 788
Query: 801 LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
NL+LIQRLN+ IDVASA++YLH+HCQ +VH DLKPSNVLLD DM AHV DFGLA+
Sbjct: 789 REQGNLNLIQRLNVAIDVASALDYLHYHCQMAVVHCDLKPSNVLLDGDMTAHVGDFGLAR 848
Query: 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPT 920
F + + + +SSIG+KGT+GY APEYG+G E S G VYSYGILLLEI T + PT
Sbjct: 849 FRPEASV-QLSSNQNSSIGLKGTVGYAAPEYGIGNEVSTYGDVYSYGILLLEILTGKTPT 907
Query: 921 ESMFNEGLTLHEFAKRALPEKVMEIVDPSLL-PLEEERTNS----RRVRNE---ECLVAV 972
+ F EGL LH++ K ALP++V+E+VDP LL +E+ N+ +R+ N+ ECLV++
Sbjct: 908 DGSFKEGLNLHKYVKMALPDRVVEVVDPILLREIEQTSANASDGMKRIGNDKVLECLVSI 967
Query: 973 IKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQR 1008
++ GV+CS++ P +R +++VV +L R LG R
Sbjct: 968 MEVGVSCSVDLPRERTNISNVVAELHRIRGILLGTR 1003
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1009 | ||||||
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.961 | 0.946 | 0.454 | 8.5e-223 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.965 | 0.963 | 0.437 | 1.1e-213 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.960 | 0.959 | 0.446 | 1.9e-211 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.962 | 0.962 | 0.435 | 3.9e-211 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.954 | 0.934 | 0.435 | 1.7e-210 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.962 | 0.947 | 0.429 | 2.2e-199 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.700 | 0.869 | 0.404 | 1.4e-133 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.521 | 0.421 | 0.322 | 2.1e-125 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.888 | 0.764 | 0.323 | 1.3e-121 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.837 | 0.862 | 0.342 | 1.2e-120 |
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2151 (762.2 bits), Expect = 8.5e-223, P = 8.5e-223
Identities = 453/996 (45%), Positives = 638/996 (64%)
Query: 23 SNETDCLSLLAIKSQLHDPLGVT-SSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQS 81
+ ETD +LL KSQ+ + V SWN S + LC WTGV CG +++RVT +DL
Sbjct: 36 TEETDKQALLEFKSQVSETSRVVLGSWNDS--LPLCS-WTGVKCGLKHRRVTGVDLGGLK 92
Query: 82 IGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHC 141
+ G++SP+VGNLSFLR +N+ADN FHG IP +GNLFRL+ L ++NN F G IP LS+C
Sbjct: 93 LTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNC 152
Query: 142 SKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRT 201
S L T N+L +P E S L L LS+G N LTG+ PAS+GNL++L+++D
Sbjct: 153 SSLSTLDLSSNHLEQGVPLEFGS--LSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIY 210
Query: 202 NRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIG 261
N++ G+IP +++L + + + N F+G PP +YN+SSL+ + + GN F+G+L + G
Sbjct: 211 NQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFG 270
Query: 262 KNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLA 321
LPNL+ + N+FTG++P++ SN S+L L + N G++ ++F L++L +LGL
Sbjct: 271 SLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLN 330
Query: 322 TNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIY 381
N LGN ++ DLDF+ LTNC++LQYL + N GG LP IANLST L + +LG N I
Sbjct: 331 NNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLIS 390
Query: 382 GTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTL 441
G+IP GI NLV+L +L + N LTG +P +GEL L+ + L++N L G IPSSLGN++
Sbjct: 391 GSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISG 450
Query: 442 LTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTXXXXXXXXXXXX 501
LTYL N+ +G+IP SLG+C L+ NKL G++P +++E+ +
Sbjct: 451 LTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLV 510
Query: 502 XXXXXXXVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLT 561
+G LK L+ L ++ N+ SGQIP TL C SLE++ LQGNSF G IP + LT
Sbjct: 511 GPLRQD-IGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD-IRGLT 568
Query: 562 SIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKL 621
++ LDLS+NN SG IP+Y+ N S LQ LNLS N+F+G VPT+G+F+N + S+ GN L
Sbjct: 569 GLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINL 628
Query: 622 CGGLDELHLPSCQARGSRKPNV--NLVKVVIPVIGGSCLILSVCI--FIFYARRRRSAHK 677
CGG+ L L C R+ + ++ + + + + L+L +C+ +Y R +S
Sbjct: 629 CGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRA 688
Query: 678 SSNT-----SQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVK 732
++N S ++ + +SY EL K T FSSSN IG G+FG V+KG L VA+K
Sbjct: 689 NNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIK 748
Query: 733 VINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEE 792
V+NL ++G +KSF AECEAL IRHRNL+K+VTICSS DF+G DF+ALVYE+M NG+L+
Sbjct: 749 VLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDM 808
Query: 793 WLHQRD-DQLGICN--LSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM 849
WLH + ++ G + L L RLNI IDVASA+ YLH +C PI H D+KPSN+LLD D+
Sbjct: 809 WLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDL 868
Query: 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGIL 909
AHVSDFGLA+ L + SS GV+GTIGY APEYG+GG S+ G VYS+GI+
Sbjct: 869 TAHVSDFGLAQLLLKFDR-DTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIV 927
Query: 910 LLEIFTRRRPTESMFNEGLTLHEFAKRALPEK-VMEIVDPSLLPLEEERTNSRRVRNEEC 968
LLEIFT +RPT +F +GLTLH F K AL ++ ++I D ++L ++ EC
Sbjct: 928 LLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETIL----RGAYAQHFNMVEC 983
Query: 969 LVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004
L V + GV+CS ESP +R+ M + + KL R++F
Sbjct: 984 LTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESF 1019
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2065 (732.0 bits), Expect = 1.1e-213, P = 1.1e-213
Identities = 437/998 (43%), Positives = 630/998 (63%)
Query: 23 SNETDCLSLLAIKSQLHD-PLGVTSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQS 81
++ETD +LL KSQ+ + V SSWN S LC +W VTCGR+++RVT L+L
Sbjct: 21 TDETDRQALLEFKSQVSEGKRDVLSSWNNS--FPLC-NWKWVTCGRKHKRVTHLNLGGLQ 77
Query: 82 IGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHC 141
+GGI+SP +GN+SFL ++++DN F G IP +GNLFRLE L +A NS G IP LS+C
Sbjct: 78 LGGIVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNC 137
Query: 142 SKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRT 201
S+L+ + N L +P EL S L L L +G N L G+LP S+GNL++L+ +
Sbjct: 138 SRLLNLDLYSNPLRQGVPSELGS--LTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTD 195
Query: 202 NRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIG 261
N + G++P L++L+ + L + N F G PP++YN+S+L +++L+G+ F+GSL + G
Sbjct: 196 NNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFG 255
Query: 262 KNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLA 321
LPN+R + N+ G++P + SN S L+ + +N G + NF + L L L+
Sbjct: 256 NLLPNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLS 315
Query: 322 TNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIY 381
N LG+ DL+F+D LTNCT LQ L + GG LP SIAN+ST LI NL N +
Sbjct: 316 ENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFF 375
Query: 382 GTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTL 441
G+IP I NL+ L L++ N LTG +P +G+L L LL L++N + G IPS +GNLT
Sbjct: 376 GSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQ 435
Query: 442 LTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTXXXXXXXXXXXX 501
L L N+ +G +P SLG C +++ NKL G +P++I++I T
Sbjct: 436 LEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLS 495
Query: 502 XXXXXXXVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLT 561
+G+L++LV+L + N+FSG +P TLG C ++E + LQGNSF G IP ++ L
Sbjct: 496 GSLPND-IGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIP-NIRGLM 553
Query: 562 SIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKL 621
++ +DLS N+ SG IP+Y N S L+YLNLS N+F G+VP+KG F+N T + GN L
Sbjct: 554 GVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNL 613
Query: 622 CGGLDELHLPSCQARG---SRKPNVNLVKVVIPV-IGGSCLILSVC--IFIFYARRRRSA 675
CGG+ +L L C A+ K + +L KV I V IG + L+L V + + + R+RR
Sbjct: 614 CGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKN 673
Query: 676 HKSSNT--SQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKV 733
+++N S++E +SY +L ATN FSSSN +G GSFG V+K +L +VAVKV
Sbjct: 674 QQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKV 733
Query: 734 INLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEW 793
+N++++G KSF AECE+L+ RHRNL+K++T C+S DF+G +F+AL+YEY+ NGS++ W
Sbjct: 734 LNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMW 793
Query: 794 LHQRD-DQLGIC--NLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV 850
LH + +++ L+L++RLNIVIDVAS ++YLH HC PI H DLKPSNVLL+ D+
Sbjct: 794 LHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLT 853
Query: 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILL 910
AHVSDFGLA+ L + + SS+ GV+GTIGY APEYG+GG+ S+ G VYS+G+LL
Sbjct: 854 AHVSDFGLARLLLKFDKESFLNQLSSA-GVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLL 912
Query: 911 LEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLV 970
LE+FT +RPT+ +F LTLH + K ALPEKV EI D ++L + R R ECL
Sbjct: 913 LEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIGL-RVG---FRTAECLT 968
Query: 971 AVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQR 1008
V++ G+ C E P +R+ ++V +L R+ F R
Sbjct: 969 LVLEVGLRCCEEYPTNRLATSEVAKELISIRERFFKTR 1006
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2044 (724.6 bits), Expect = 1.9e-211, P = 1.9e-211
Identities = 444/994 (44%), Positives = 625/994 (62%)
Query: 23 SNETDCLSLLAIKSQL-HDPLGVTSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQS 81
++ETD +LL KSQ+ D V SSWN S LC +W GVTCGR+N+RVT L+L
Sbjct: 21 TDETDRQALLQFKSQVSEDKRVVLSSWNHS--FPLC-NWKGVTCGRKNKRVTHLELGRLQ 77
Query: 82 IGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHC 141
+GG++SP +GNLSFL +++ +N F G IP +G L RLE L + N G IP L +C
Sbjct: 78 LGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNC 137
Query: 142 SKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRT 201
S+L+ N L G +P EL S L NL L++ N + G+LP S+GNL+ L + +
Sbjct: 138 SRLLNLRLDSNRLGGSVPSELGS--LTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSH 195
Query: 202 NRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIG 261
N L G+IP ++QLT + L + N+FSG PP++YN+SSL + + N F+G L ++G
Sbjct: 196 NNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLG 255
Query: 262 KNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLA 321
LPNL +F + N FTGS+P + SN S LE L + EN G + F + +L +L L
Sbjct: 256 ILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLH 314
Query: 322 TNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIY 381
TN LG+ ++ DL+F+ LTNCT+L+ L + N GG LP SIANLS L+ +LG I
Sbjct: 315 TNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLIS 374
Query: 382 GTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTL 441
G+IP I NL+NL L ++ N L+G +P +G+L NL+ L L +N L G IP+ +GN+T+
Sbjct: 375 GSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTM 434
Query: 442 LTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTXXXXXXXXXXXX 501
L L N +G +P SLGNC +L+ + NKL G +P +I++I
Sbjct: 435 LETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLI 494
Query: 502 XXXXXXXVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLT 561
+G L++L L + N+ SG++P TLG C ++E + L+GN F G IP L L
Sbjct: 495 GSLPQD-IGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD-LKGLV 552
Query: 562 SIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKL 621
+KE+DLS N+ SG IP+Y + S L+YLNLS+N+ EG+VP KGIF+N T SIVGN L
Sbjct: 553 GVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDL 612
Query: 622 CGGLDELHLPSCQARGS---RKPNVNLVKVVIPVIGGSCLILSV---CIFIFYARRRRSA 675
CGG+ L C ++ +K + L KVVI V G L+L + + + + R+R+
Sbjct: 613 CGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKN 672
Query: 676 HKSSNT--SQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKV 733
+++N S +E +SY +L ATN FSSSN +G GSFG VYK +L +VAVKV
Sbjct: 673 KETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKV 732
Query: 734 INLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEW 793
+N++++G KSF AECE+L+ IRHRNL+K++T CSSIDF+G +F+AL+YE+M NGSL+ W
Sbjct: 733 LNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMW 792
Query: 794 LHQRD-DQLGICN--LSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV 850
LH + +++ + L+L++RLNI IDVAS ++YLH HC PI H DLKPSNVLLD D+
Sbjct: 793 LHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLT 852
Query: 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILL 910
AHVSDFGLA+ L + SS+ GV+GTIGY APEYG+GG+ S+ G VYS+GILL
Sbjct: 853 AHVSDFGLARLLLKFDEESFFNQLSSA-GVRGTIGYAAPEYGVGGQPSINGDVYSFGILL 911
Query: 911 LEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLV 970
LE+FT +RPT +F TL+ + K ALPE++++IVD S+L + R V ECL
Sbjct: 912 LEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGL-RVGFPVV---ECLT 967
Query: 971 AVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004
V + G+ C ESP +R+ + VV +L R+ F
Sbjct: 968 MVFEVGLRCCEESPMNRLATSIVVKELISIRERF 1001
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2041 (723.5 bits), Expect = 3.9e-211, P = 3.9e-211
Identities = 435/999 (43%), Positives = 624/999 (62%)
Query: 23 SNETDCLSLLAIKSQLHDPL-GVTSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQS 81
++E+D +LL IKSQ+ + S+WN S LC W V CGR+++RVT+LDL
Sbjct: 21 TDESDRQALLEIKSQVSESKRDALSAWNNS--FPLCS-WKWVRCGRKHKRVTRLDLGGLQ 77
Query: 82 IGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHC 141
+GG++SP +GNLSFL Y+++++N F G IP +GNLFRL+ L + N G IP +LS+C
Sbjct: 78 LGGVISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNC 137
Query: 142 SKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRT 201
S+L+ NNL +P EL S R L L +G N L G+ P I NL++L V+++
Sbjct: 138 SRLLYLDLFSNNLGDGVPSELGSLR--KLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGY 195
Query: 202 NRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIG 261
N L G+IP ++ L+ + L + N+FSG PP+ YN+SSL +YL GN F+G+L + G
Sbjct: 196 NHLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFG 255
Query: 262 KNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLA 321
LPN+ ++ N TG++P + +N S LE+ + +N+ G +S NF L++L L LA
Sbjct: 256 NLLPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELA 315
Query: 322 TNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIY 381
N LG+ + DL F+D LTNC+ L L ++ N GG LP SI N+ST L NL N IY
Sbjct: 316 NNSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIY 375
Query: 382 GTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTL 441
G+IP I NL+ L SL + N LTG +P +G L L L L +N G IPS +GNLT
Sbjct: 376 GSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQ 435
Query: 442 LTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTXXXXXXXXXXXX 501
L L N+ +G +P SLG+C +++ NKL G +P++I++I T
Sbjct: 436 LVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLS 495
Query: 502 XXXXXXXVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLT 561
+G L++LV L + N SG +P TLG C S+E + LQ N F GTIP + L
Sbjct: 496 GSLPND-IGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPD-IKGLM 553
Query: 562 SIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKL 621
+K +DLS NN SG I +Y EN S L+YLNLS N+FEG VPT+GIF+N T S+ GN L
Sbjct: 554 GVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNL 613
Query: 622 CGGLDELHLPSCQARG----SRKPNVNLVKVVIPV-IGGSCLILSVCIFIFYARRRRSAH 676
CG + EL L C A+ +R P++ L KV I V +G + L+L + + + ++R++
Sbjct: 614 CGSIKELKLKPCIAQAPPVETRHPSL-LKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQ 672
Query: 677 KSSNTSQ--MEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVI 734
K +N++ +E +SY +L AT+ FSSSN +G GSFG V+K +L +VAVKV+
Sbjct: 673 KINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVL 732
Query: 735 NLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWL 794
N++++G KSF AECE+L+ IRHRNL+K++T C+SIDF+G +F+AL+YE+M NGSL++WL
Sbjct: 733 NMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWL 792
Query: 795 HQRD-DQLGICN--LSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 851
H + +++ + L+L++RLNI IDVAS ++YLH HC PI H DLKPSN+LLD D+ A
Sbjct: 793 HPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTA 852
Query: 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLL 911
HVSDFGLA+ L + SS+ GV+GTIGY APEYG+GG+ S+ G VYS+G+L+L
Sbjct: 853 HVSDFGLARLLLKFDQESFFNQLSSA-GVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVL 911
Query: 912 EIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNE--ECL 969
E+FT +RPT +F TL+ + K ALPE+V++I D S+L + RV ECL
Sbjct: 912 EMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSILH------SGLRVGFPVLECL 965
Query: 970 VAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQR 1008
++ G+ C ESP +R+ ++ +L R+ F R
Sbjct: 966 KGILDVGLRCCEESPLNRLATSEAAKELISIRERFFKTR 1004
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2035 (721.4 bits), Expect = 1.7e-210, P = 1.7e-210
Identities = 436/1001 (43%), Positives = 623/1001 (62%)
Query: 23 SNETDCLSLLAIKSQL--HDPLGVTSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQ 80
SNETD +LL KSQ+ ++ V +SWN S+ C +W GVTCGRR +RV L+L
Sbjct: 27 SNETDMQALLEFKSQVSENNKREVLASWNHSS--PFC-NWIGVTCGRRRERVISLNLGGF 83
Query: 81 SIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSH 140
+ G++SP +GNLSFLR +N+ADN F IP ++G LFRL+ L ++ N GRIP++LS+
Sbjct: 84 KLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSN 143
Query: 141 CSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIR 200
CS+L T N+L +P EL S L L L + N LTG PAS+GNL++L+ +D
Sbjct: 144 CSRLSTVDLSSNHLGHGVPSELGS--LSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFA 201
Query: 201 TNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEI 260
N++ G+IP +++LT + + + N FSG PP++YNISSL + L N F+G+L +
Sbjct: 202 YNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADF 261
Query: 261 GKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGL 320
G LPNLR ++ TN FTG++P + +N S+LE ++ N G + ++F L++L LG+
Sbjct: 262 GYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGI 321
Query: 321 ATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQI 380
N LGN +++ L+F+ + NCT+L+YL + N GG LP SIANLST L LG+N I
Sbjct: 322 RNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLI 381
Query: 381 YGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLT 440
GTIP I NLV+L L +E N L+G +P G+L NLQ++ L++N + G IPS GN+T
Sbjct: 382 SGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMT 441
Query: 441 LLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTXXXXXXXXXXX 500
L L +N+ G IP SLG C+ L+ + N+L G +PQ+IL+I +
Sbjct: 442 RLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFL 501
Query: 501 XXXXXXXXVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSL 560
VG L+ LV LG + N+ SG++P +G C S+E++ +QGNSF G IP +S L
Sbjct: 502 TGHFPEE-VGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRL 559
Query: 561 TSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGK 620
S+K +D S NN SG+IP+YL +L L+ LNLS N FEG VPT G+F+N T S+ GN
Sbjct: 560 VSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTN 619
Query: 621 LCGGLDELHLPSCQARGS---RKPNVNLVKVVIPV-IGGSCLILSVCI--FIFYARRRRS 674
+CGG+ E+ L C + S RKP KVV + IG + L+L + + ++ +R++
Sbjct: 620 ICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKK 679
Query: 675 AHKS----SNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVA 730
+ S S+++ + VSY+EL AT+ FSS+N IG G+FG V+KG+L LVA
Sbjct: 680 NNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVA 739
Query: 731 VKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSL 790
VKV+NL + G +KSF AECE + IRHRNL+K++T+CSS+D +G DF+ALVYE+M GSL
Sbjct: 740 VKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSL 799
Query: 791 EEWLHQRD-DQLGICNLSLI--QRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH 847
+ WL D +++ + SL ++LNI IDVASA+EYLH HC P+ H D+KPSN+LLD
Sbjct: 800 DMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDD 859
Query: 848 DMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYG 907
D+ AHVSDFGLA+ L + + SS+ GV+GTIGY APEYG+GG+ S++G VYS+G
Sbjct: 860 DLTAHVSDFGLAQLLYKYDRESFLNQFSSA-GVRGTIGYAAPEYGMGGQPSIQGDVYSFG 918
Query: 908 ILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEE 967
ILLLE+F+ ++PT+ F LH + K S+L S + +E
Sbjct: 919 ILLLEMFSGKKPTDESFAGDYNLHSYTK-------------SILSGCTSSGGSNAI--DE 963
Query: 968 CLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQR 1008
L V++ G+ CS E P DRM + V +L R F +
Sbjct: 964 GLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSSK 1004
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1930 (684.5 bits), Expect = 2.2e-199, P = 2.2e-199
Identities = 426/991 (42%), Positives = 599/991 (60%)
Query: 27 DCLSLLAIKSQLHDPLGVT-SSWNRSACVNLCQHWTGVTCGRRNQR----VTKLDLRNQS 81
D L+LL+ KS L G + +SWN S C W GV CGRR +R V KL LR+ +
Sbjct: 32 DELALLSFKSSLLYQGGQSLASWNTSGHGQHCT-WVGVVCGRRRRRHPHRVVKLLLRSSN 90
Query: 82 IGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHC 141
+ GI+SP +GNLSFLR +++ DN GEIP + L RL+ L L++NS G IP + C
Sbjct: 91 LSGIISPSLGNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGAC 150
Query: 142 SKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRT 201
+KL + N L G IP E I L +L L + N L+G++P+++GNL++L+ D+
Sbjct: 151 TKLTSLDLSHNQLRGMIPRE-IGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSF 209
Query: 202 NRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIG 261
NRL G IP +L QL+SL +++G N+ SG IP S++N+SSL + N+ G +P
Sbjct: 210 NRLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAF 269
Query: 262 KNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLA 321
K L L + TN F G +P S +NAS+L V+ + N F G ++ F L++L+ L L
Sbjct: 270 KTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLW 329
Query: 322 TNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIY 381
N +D F+ LTNC+KLQ L L +N GGVLP+S +NLST+L L N+I
Sbjct: 330 RNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKIT 389
Query: 382 GTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTL 441
G+IP I NL+ L L + N G++P +G LKNL +L + N L G+IP ++GNLT
Sbjct: 390 GSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTE 449
Query: 442 LTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTXXXXXXXXXXXX 501
L L G N G IP++L N NL+ N L+G +P ++ I T
Sbjct: 450 LNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNL 509
Query: 502 XXXXXXXVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLT 561
+G+LK+LV N+ SG+IP TLG C L Y+ LQ N SG+IP +L L
Sbjct: 510 EGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLK 569
Query: 562 SIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKL 621
++ LDLS NN SGQIP L +++ L LNLS+N F GEVPT G F +G SI GN KL
Sbjct: 570 GLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKL 629
Query: 622 CGGLDELHLPSCQARGSRKPNVNLVKVVIPVIGGSCLILSVCIFIFYARRRRSAHKSSNT 681
CGG+ +LHLP C + + ++ + + + ++ S+ + I + +R + S T
Sbjct: 630 CGGIPDLHLPRCCPLLENRKHFPVLPISVSLAAALAILSSLYLLITWHKRTKKG-APSRT 688
Query: 682 SQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG 741
S + P+VSY +L KAT+ F+ +N +G GSFG VYKG L+ VAVKV+ LE
Sbjct: 689 SM--KGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDH-VAVKVLKLENPKA 745
Query: 742 SKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLH-QRDDQ 800
KSF AECEALR++RHRNL+KIVTICSSID +G DFKA+VY++M NGSLE+W+H + +DQ
Sbjct: 746 LKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQ 805
Query: 801 LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
+L+L +R+ I++DVA A++YLH H P+VH D+K SNVLLD DMVAHV DFGLA+
Sbjct: 806 ADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLAR 865
Query: 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPT 920
L ++++ +SS+G GTIGY APEYG+G AS G +YSYGIL+LEI T +RPT
Sbjct: 866 ILVDGT--SLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPT 923
Query: 921 ESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEER----TNSRRVRN-EECLVAVIKT 975
+S F L L ++ + L +V ++VD L+ L+ E TN+ R EC+V +++
Sbjct: 924 DSTFRPDLGLRQYVELGLHGRVTDVVDTKLI-LDSENWLNSTNNSPCRRITECIVWLLRL 982
Query: 976 GVACSIESPFDRMEMTDVVVKLCHARQNFLG 1006
G++CS E P R D++ +L +QN G
Sbjct: 983 GLSCSQELPSSRTPTGDIIDELNAIKQNLSG 1013
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1309 (465.8 bits), Expect = 1.4e-133, P = 1.4e-133
Identities = 293/725 (40%), Positives = 420/725 (57%)
Query: 99 INIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEI 158
+ + ++ G I +GNL L TL L++N SG+IP LS S+L + N+L GEI
Sbjct: 83 LRLRSSNLAGIISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSLSGEI 142
Query: 159 PEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSL 218
P L L +L L + +N L+G +P+S+G L+ L + + N L G IP + QL L
Sbjct: 143 PAAL--GNLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRL 200
Query: 219 AYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFT 278
++L + N+ SG IP ++NISSL + N+ +G+LP NLP+L+ +Y N F
Sbjct: 201 SFLSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFH 260
Query: 279 GSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDL 338
G +P S NASN+ + + N F G V +++L L L ND F+
Sbjct: 261 GRIPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTA 320
Query: 339 LTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLR 398
LTNC+ LQ + L FGGVLP S++NLS++L+ ++ N+I G++P I NLVNL L
Sbjct: 321 LTNCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLS 380
Query: 399 MEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPF 458
+ N LTG++P +LKNL+ L + N L G++P ++GNLT LT + N G IP
Sbjct: 381 LANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPS 440
Query: 459 SLGNCKNLMFFFAPRNKLTGALPQQILEITTXXXXXXXXXXXXXXXXXXXVGNLKSLVRL 518
+LGN L N G +P +I I +G LK++V
Sbjct: 441 TLGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEF 500
Query: 519 GIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIP 578
N+ SG+ P T+G C L+++ LQ N +G+IP +L+ L + LDLS NN SGQIP
Sbjct: 501 HADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIP 560
Query: 579 KYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDELHLPSCQARGS 638
L ++ L LNLS+N F GEVPT G+F N + I GN +CGG+ ELHLP+C + S
Sbjct: 561 MSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLK-S 619
Query: 639 RKPNVNLVKVVIPVIGGSCLILSVCIF-IFY----ARRRRSAHKSSNTSQMEQQFPMVSY 693
RK + + +++ VI CL+ ++ +F + Y +RR + TS Q PM++Y
Sbjct: 620 RKKKKHQILLLVVVI---CLVSTLAVFSLLYMLLTCHKRRKKEVPATTSM--QGHPMITY 674
Query: 694 KELSKATNEFSSSNTIGRGSFGFVYKGVLH-ENG---MLVAVKVINLEQKGGSKSFAAEC 749
K+L KAT+ FSSS+ +G GSFG VYKG ++G LVAV+V+ LE KSF AEC
Sbjct: 675 KQLVKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAEC 734
Query: 750 EALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLH-QRDDQLGICNLSL 808
E LR+ RHRNL+KIVTICSSID +G DFKA+VY++M NGSLE+WLH + +DQ +L+L
Sbjct: 735 ETLRNTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETNDQAEQRHLTL 794
Query: 809 IQRLN 813
QR++
Sbjct: 795 HQRVS 799
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 716 (257.1 bits), Expect = 2.1e-125, Sum P(2) = 2.1e-125
Identities = 173/537 (32%), Positives = 268/537 (49%)
Query: 68 RNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLAN 127
R + + L+L N S+ G + +G +S L+Y+++ N G IP + +L L+TL L+
Sbjct: 237 RLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSA 296
Query: 128 NSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPAS 187
N+ +G IP + S+L+ N+L G +P+ + S NL+ L + QL+G++P
Sbjct: 297 NNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNT-NLEQLVLSGTQLSGEIPVE 355
Query: 188 IGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYL 247
+ +L+ +D+ N L G IP L +L L L++ +N GT+ PS+ N+++L + L
Sbjct: 356 LSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVL 415
Query: 248 YGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSI 307
Y N G LP EI L L +Y N F+G +P N ++L+++ + N F G++
Sbjct: 416 YHNNLEGKLPKEISA-LRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPP 474
Query: 308 NFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLS 367
+ LK+L++L L N L G L NC +L L LADN G +P S L
Sbjct: 475 SIGRLKELNLLHLRQNELVGGLPASLG------NCHQLNILDLADNQLSGSIPSSFGFLK 528
Query: 368 TALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANF 427
L L N + G +P + +L NL + + NRL GTI + G L + N
Sbjct: 529 -GLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSF-DVTNNG 586
Query: 428 LQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEI 487
+ IP LGN L L G N L G IP++LG + L N LTG +P Q++ +
Sbjct: 587 FEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLV-L 645
Query: 488 TTXXXXXXXXXXXXXXXXXXXVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGN 547
+G L L L ++ NQF +P L CT L + L GN
Sbjct: 646 CKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGN 705
Query: 548 SFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK 604
S +G+IPQ + +L ++ L+L +N FSG +P+ + LS L L LS N GE+P +
Sbjct: 706 SLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVE 762
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1196 (426.1 bits), Expect = 1.3e-121, P = 1.3e-121
Identities = 305/943 (32%), Positives = 493/943 (52%)
Query: 75 LDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRI 134
L L + G + +GN S L + + DN G+IP +GNL +L+ L + N + I
Sbjct: 245 LVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSI 304
Query: 135 PTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSAL 194
P++L ++L N+LVG I EE+ L +L+ L++ N TG+ P SI NL L
Sbjct: 305 PSSLFRLTQLTHLGLSENHLVGPISEEI--GFLESLEVLTLHSNNFTGEFPQSITNLRNL 362
Query: 195 RVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTG 254
V+ + N + G++P L LT+L L DN +G IP S+ N + L + L N+ TG
Sbjct: 363 TVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTG 422
Query: 255 SLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKD 314
+P G+ NL I N+FTG +PD N SNLE L +A+N G + L+
Sbjct: 423 EIPRGFGRM--NLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQK 480
Query: 315 LSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFN 374
L +L ++ N L ++ N L LYL NGF G +P ++NL T L
Sbjct: 481 LRILQVSYNSLTGPIPREIG------NLKDLNILYLHSNGFTGRIPREMSNL-TLLQGLR 533
Query: 375 LGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPS 434
+ N + G IP + ++ L+ L + N+ +G IP + +L++L L L N G+IP+
Sbjct: 534 MYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPA 593
Query: 435 SLGNLTLLTYLSFGANNLQGNIPFSL-GNCKNLMFFFA-PRNKLTGALPQQILEITTXXX 492
SL +L+LL N L G IP L + KN+ + N LTG +P+++ ++
Sbjct: 594 SLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQE 653
Query: 493 XXXXXXXXXXXXXXXXVGNLKSLVRLGIARNQFSGQIP--VTLGACTSLEYVELQGNSFS 550
K++ L ++N SG IP V G + + L NSFS
Sbjct: 654 IDLSNNLFSGSIPRSLQA-CKNVFTLDFSQNNLSGHIPDEVFQGMDMIIS-LNLSRNSFS 711
Query: 551 GTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNK 610
G IPQS ++T + LDLS NN +G+IP+ L NLS L++L L+ N+ +G VP G+FKN
Sbjct: 712 GEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNI 771
Query: 611 TGFSIVGNGKLCGGLDELHLPSCQARGSRKPNVNLVKVVIPVIGGSCLILSVCIFIFYA- 669
++GN LCG L P C + +V++ ++G + +L V + +
Sbjct: 772 NASDLMGNTDLCGSKKPLK-P-CTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILT 829
Query: 670 ---RRRRSAHKSSNTS--QMEQQFPMVSY--KELSKATNEFSSSNTIGRGSFGFVYKGVL 722
++ + SS +S ++ + + KEL +AT+ F+S+N IG S VYKG L
Sbjct: 830 CCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL 889
Query: 723 HENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780
E+G ++AVKV+NL++ K F E + L ++HRNL+KI+ ++ KAL
Sbjct: 890 -EDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFA----WESGKTKAL 944
Query: 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKP 840
V +M+NG+LE+ +H +G SL++++++ + +AS ++YLH PIVH DLKP
Sbjct: 945 VLPFMENGNLEDTIHGSAAPIG----SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKP 1000
Query: 841 SNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMR 900
+N+LLD D VAHVSDFG A+ L G+ T +S+ +GTIGY+APE+ + + +
Sbjct: 1001 ANILLDSDRVAHVSDFGTARILGFREDGS---TTASTSAFEGTIGYLAPEFAYMRKVTTK 1057
Query: 901 GGVYSYGILLLEIFTRRRPTE--SMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERT 958
V+S+GI+++E+ T++RPT ++ +TL + ++++ +V + L +
Sbjct: 1058 ADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMELGDSIV 1117
Query: 959 NSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001
+ ++ EE + +K + C+ P DR +M +++ L R
Sbjct: 1118 S---LKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1187 (422.9 bits), Expect = 1.2e-120, P = 1.2e-120
Identities = 310/905 (34%), Positives = 475/905 (52%)
Query: 123 LVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTG 182
L ++ G I ++++ + L RN VG+IP E+ S L+ LS+ +N L G
Sbjct: 71 LDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHE-TLKQLSLSENLLHG 129
Query: 183 QLPASIGNLSALRVIDIRTNRLWGKIPITL---SQLTSLAYLHVGDNHFSGTIPPSVY-N 238
+P +G L+ L +D+ +NRL G IP+ L +SL Y+ + +N +G IP + + +
Sbjct: 130 NIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCH 189
Query: 239 ISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDS-FSNASNLEVLHLA 297
+ L + L+ N+ TG++P + N NL+ + +N +G LP S L+ L+L+
Sbjct: 190 LKELRFLLLWSNKLTGTVPSSLS-NSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLS 248
Query: 298 ENQF---RGQVSIN--FNGL---KDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLY 349
N F ++ F L DL L LA N LG + + + + L ++
Sbjct: 249 YNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSV-----NLVQIH 303
Query: 350 LADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIP 409
L N G +P I+NL + NL N + G IP + L L + + N LTG IP
Sbjct: 304 LDQNRIHGSIPPEISNLLNLTL-LNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIP 362
Query: 410 HVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFF 469
+G++ L LL + N L G+IP S GNL+ L L N+L G +P SLG C NL
Sbjct: 363 MELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEIL 422
Query: 470 FAPRNKLTGALPQQILE-ITTXXXXXXXXXXXXXXXXXXXVGNLKSLVRLGIARNQFSGQ 528
N LTG +P +++ + + + ++ + ++ N+ SG+
Sbjct: 423 DLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGK 482
Query: 529 IPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQ 588
IP LG+C +LE++ L N FS T+P SL L +KELD+S N +G IP + S L+
Sbjct: 483 IPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLK 542
Query: 589 YLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDELHLPSCQARGSRKPNVNLVKV 648
+LN S+N G V KG F T S +G+ LCG + + +C+ + + P+V L+ V
Sbjct: 543 HLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--ACKKK-HKYPSV-LLPV 598
Query: 649 VIPVIGGSCLILSVCIFIF-YARRRR-----SAHKSSNTSQMEQQ------FPMVSYKEL 696
++ +I L C+F + +R R + + E+Q +P +SY++L
Sbjct: 599 LLSLIATPVL----CVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQL 654
Query: 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSI 755
AT F++S+ IG G FG VYKGVL N VAVKV++ + S SF EC+ L+
Sbjct: 655 IAATGGFNASSLIGSGRFGHVYKGVLRNNTK-VAVKVLDPKTALEFSGSFKRECQILKRT 713
Query: 756 RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
RHRNLI+I+T CS G F ALV M NGSLE L+ + NL LIQ +NI
Sbjct: 714 RHRNLIRIITTCSK---PG--FNALVLPLMPNGSLERHLYP--GEYSSKNLDLIQLVNIC 766
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
DVA + YLHH+ +VH DLKPSN+LLD +M A V+DFG+++ + + V T
Sbjct: 767 SDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQG--VEETVSTDD 824
Query: 876 S-SIG-----VKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLT 929
S S G + G++GY+APEYG+G AS G VYS+G+LLLEI + RRPT+ + NEG +
Sbjct: 825 SVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSS 884
Query: 930 LHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRN-EECLVAVIKTGVACSIESPFDRM 988
LHEF K P+ + I++ +L + + + + E ++ +I+ G+ C+ +P R
Sbjct: 885 LHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRP 944
Query: 989 EMTDV 993
+M DV
Sbjct: 945 DMLDV 949
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4550 | 0.9682 | 0.9673 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.01230100 | hypothetical protein (1022 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1009 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-122 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-34 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-20 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-11 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-08 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 3e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 5e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.001 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.001 | |
| COG3173 | 321 | COG3173, COG3173, Predicted aminoglycoside phospho | 0.001 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.004 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 396 bits (1018), Expect = e-122
Identities = 297/917 (32%), Positives = 455/917 (49%), Gaps = 69/917 (7%)
Query: 31 LLAIKSQLHDPLGVTSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYV 90
LL+ KS ++DPL S+WN SA V L W G+TC + RV +DL ++I G +S +
Sbjct: 34 LLSFKSSINDPLKYLSNWNSSADVCL---WQGITC-NNSSRVVSIDLSGKNISGKISSAI 89
Query: 91 GNLSFLRYINIADNDFHGEIPDRIGNL-FRLETLVLANNSFSGRIPTNLSHCSKLITFSA 149
L +++ IN+++N G IPD I L L L+NN+F+G IP L T
Sbjct: 90 FRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN--LETLDL 147
Query: 150 HRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIP 209
N L GEIP ++ S +L+ L +G N L G++P S+ NL++L + + +N+L G+IP
Sbjct: 148 SNNMLSGEIPNDIGS--FSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIP 205
Query: 210 ITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRN 269
L Q+ SL ++++G N+ SG IP + ++SL + L N TG +P +G NL NL+
Sbjct: 206 RELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLKNLQY 264
Query: 270 FVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGL-ATNFLGNG 328
+Y N +G +P S + L L L++N G++ L++L +L L + NF G
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK- 323
Query: 329 AANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI 388
LT+ +LQ L L N F G +P ++ + L +L N + G IP G+
Sbjct: 324 ------IPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNN-LTVLDLSTNNLTGEIPEGL 376
Query: 389 ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFG 448
+ NL L + +N L G IP +G ++L+ + L N G +PS L L+ +L
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 449 ANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQI----LEITTLSLSLDLSDNLLNGS 504
NNLQG I + +L RNK G LP LE +LDLS N +G+
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLE------NLDLSRNQFSGA 490
Query: 505 LPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIK 564
+P +G+L L++L ++ N+ SG+IP L +C L ++L N SG IP S S + +
Sbjct: 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550
Query: 565 ELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGG 624
+LDLSQN SG+IPK L N+ L +N+S+NH G +P+ G F ++ GN LCGG
Sbjct: 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG 610
Query: 625 LDELHLPSCQARGSRKPNVNLVKVVIPVIGGSCLILSVCIFIFYARRRRSAHK--SSNTS 682
LP C + RK + + L L F+F R K +
Sbjct: 611 DTTSGLPPC--KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDG 668
Query: 683 QMEQQFPMVSYKELSKATNEFSSS----NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ 738
E QF S S N+ SS N I RG G YKG +NGM VK IN +
Sbjct: 669 TWELQF-FDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DV 726
Query: 739 KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRD 798
S A+ + ++H N++K++ +C S KG L++EY++ +L E L
Sbjct: 727 NSIPSSEIAD---MGKLQHPNIVKLIGLCRS--EKGA---YLIHEYIEGKNLSEVLR--- 775
Query: 799 DQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858
NLS +R I I +A A+ +LH C P +V G+L P +++D H
Sbjct: 776 ------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH------ 823
Query: 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR 918
L S G + I + YVAPE + + + +Y +G++L+E+ T +
Sbjct: 824 ---LRLSLPGLLCTDTKCFI----SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKS 876
Query: 919 PTESMFNEGLTLHEFAK 935
P ++ F ++ E+A+
Sbjct: 877 PADAEFGVHGSIVEWAR 893
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 4e-42
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSK-SFAAECEALRSIRHRNLIKIVTIC 767
+G G FG VY + G VA+K+I E E E L+ + H N++K+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 768 SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH 827
+ LV EY + GSL++ L + + LS + L I++ + +EYLH
Sbjct: 61 EDENHLY-----LVMEYCEGGSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHS 110
Query: 828 HCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGY 886
+ I+H DLKP N+LLD D ++DFGL+K L+ S + GT Y
Sbjct: 111 N---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLT--------SDKSLLKTIVGTPAY 159
Query: 887 VAPEYGLG-GEASMRGGVYSYGILLLEI 913
+APE LG G S + ++S G++L E+
Sbjct: 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 8e-39
Identities = 75/249 (30%), Positives = 109/249 (43%), Gaps = 28/249 (11%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLE-QKGGSKSFAAECEALRSIRHRNLIKIVT 765
+G GSFG VY + G LVA+KVI + K + E + L+ ++H N IV
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPN---IVR 61
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ + + + LV EY + G L + L +R LS + + + SA+EYL
Sbjct: 62 LYDVFEDEDKLY--LVMEYCEGGDLFDLLKKRG------RLSEDEARFYLRQILSALEYL 113
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H IVH DLKP N+LLD D ++DFGLA+ L + GT
Sbjct: 114 HSKG---IVHRDLKPENILLDEDGHVKLADFGLARQL---------DPGEKLTTFVGTPE 161
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEI 945
Y+APE LG ++S G++L E+ T + P F L E K+ K
Sbjct: 162 YMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFP 217
Query: 946 VDPSLLPLE 954
+ E
Sbjct: 218 PPEWDISPE 226
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 9e-38
Identities = 72/217 (33%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSK--SFAAECEALRSIRHRNLIKIVT 765
+G GSFG VYK G +VAVK++ + K + E LR + H N++++
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL-- 63
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
I + D D LV EY + G L ++L + LS + I + + +EYL
Sbjct: 64 IDAFEDK---DHLYLVMEYCEGGDLFDYLSRG------GPLSEDEAKKIALQILRGLEYL 114
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL--SASPLGNVVETPSSSIGVKGT 883
H + I+H DLKP N+LLD + V ++DFGLAK L S+S L V GT
Sbjct: 115 HSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV----------GT 161
Query: 884 IGYVAPE-YGLGGEASMRGGVYSYGILLLEIFTRRRP 919
Y+APE G + V+S G++L E+ T + P
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 67/230 (29%), Positives = 102/230 (44%), Gaps = 47/230 (20%)
Query: 707 NTIGRGSFGFVYKGVLHENG---MLVAVKVI----NLEQKGGSKSFAAECEALRSIRHRN 759
+G G+FG VYKG L VAVK + + E++ K F E ++ + H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER---KDFLKEARVMKKLGHPN 57
Query: 760 LIKIVTICSSID--FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGIC---NLSLIQRLNI 814
+++++ +C+ + + LV EYM+ G L ++L + LSL L+
Sbjct: 58 VVRLLGVCTEEEPLY-------LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110
Query: 815 VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETP 874
I +A +EYL VH DL N L+ D+V +SDFGL++ +
Sbjct: 111 AIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSR-----------DVY 156
Query: 875 SSSIGVKGTIGYV-----APEYGLGG---EASMRGGVYSYGILLLEIFTR 916
K T G + APE G S V+S+G+LL EIFT
Sbjct: 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSD---VWSFGVLLWEIFTL 203
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 708 TIGRGSFGFVYKGVL----HENGMLVAVKVINLE-QKGGSKSFAAECEALRSIRHRNLIK 762
+G G+FG VYKG L + + VAVK + + + + F E +R + H N++K
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
++ +C+ + +V EYM+ G L +L + LSL L+ + +A +
Sbjct: 66 LLGVCTE-----EEPLYIVMEYMEGGDLLSYLRKNRP-----KLSLSDLLSFALQIARGM 115
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
EYL +H DL N L+ ++V +SDFGL++ L G K
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR-------GGKL 165
Query: 883 TIGYVAPE---YGLGGEASMRGGVYSYGILLLEIFTR 916
I ++APE G S V+S+G+LL EIFT
Sbjct: 166 PIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTL 199
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 30/217 (13%)
Query: 708 TIGRGSFGFVYKGVL----HENGMLVAVKVINLEQKGGS-KSFAAECEALRSIRHRNLIK 762
+G G+FG VYKG L + VAVK + + + F E +R + H N++K
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
++ +C+ + +V EYM G L ++L + + LSL L+ + +A +
Sbjct: 66 LLGVCTE-----EEPLMIVMEYMPGGDLLDYLRKNRPKE----LSLSDLLSFALQIARGM 116
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
EYL +H DL N L+ ++V +SDFGL++ L V G K
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK-------GGKL 166
Query: 883 TIGYVAPE---YGLGGEASMRGGVYSYGILLLEIFTR 916
I ++APE G S V+S+G+LL EIFT
Sbjct: 167 PIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTL 200
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 40/222 (18%)
Query: 708 TIGRGSFGFVYKGVLH----ENGMLVAVKVINLE-QKGGSKSFAAECEALRSIRHRNLIK 762
+G G+FG VYKG L VAVK + + + F E ++ + H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
++ +C+ +G +V EYM G L ++L + + L+L L + + +A +
Sbjct: 66 LLGVCT----QGEPLY-IVTEYMPGGDLLDFLRKHGE-----KLTLKDLLQMALQIAKGM 115
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
EYL VH DL N L+ ++V +SDFGL++ + K
Sbjct: 116 EYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIY-----------EDDYYRKR 161
Query: 883 TIGYV-----APE---YGLGGEASMRGGVYSYGILLLEIFTR 916
G + APE G S V+S+G+LL EIFT
Sbjct: 162 GGGKLPIKWMAPESLKDGKFTSKS---DVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 20/220 (9%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG--SKSFAAECEALRSIRHRN 759
E++ +GRGSFG VY + + G L+AVK + L ++ E L S++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
+++ + ++ + EY+ GSL L + G +I++ +
Sbjct: 61 IVRYYGSERDEEKNTLN---IFLEYVSGGSLSSLLKK----FGKLPEPVIRKY--TRQIL 111
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
+ YLH + IVH D+K +N+L+D D V ++DFG AK L +ET +
Sbjct: 112 EGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD------IETGEGTGS 162
Query: 880 VKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
V+GT ++APE G E ++S G ++E+ T + P
Sbjct: 163 VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 74/215 (34%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNL 760
E TIG+G FG V G G VAVK + + +++F AE + ++RH NL
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTA-AQAFLAEASVMTTLRHPNL 62
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
++++ + + + +V EYM GSL ++L R + ++L Q+L +DV
Sbjct: 63 VQLLGVV--LQGNPL---YIVTEYMAKGSLVDYLRSRGRAV----ITLAQQLGFALDVCE 113
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
+EYL + VH DL NVL+ D+VA VSDFGLAK AS S + V
Sbjct: 114 GMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--EAS-----QGQDSGKLPV 163
Query: 881 KGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
K T APE + S + V+S+GILL EI++
Sbjct: 164 KWT----APEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 69/225 (30%), Positives = 111/225 (49%), Gaps = 22/225 (9%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLI 761
EF+ +G G FG V++G L +N + VA+K++ + + F E +AL+ +RH++LI
Sbjct: 7 EFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
+ +CS + ++ E M+ GSL +L + Q L + +++ VA
Sbjct: 66 SLFAVCS-----VGEPVYIITELMEKGSLLAFLRSPEGQ----VLPVASLIDMACQVAEG 116
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
+ YL +H DL N+L+ D+V V+DFGLA+ + V + I K
Sbjct: 117 MAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED----VYLSSDKKIPYK 169
Query: 882 GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR-PTESMFN 925
T APE G S + V+S+GILL E+FT + P M N
Sbjct: 170 WT----APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 76/233 (32%), Positives = 115/233 (49%), Gaps = 37/233 (15%)
Query: 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSF---AAECEALRSIRHRNLIK 762
N IG G+FG VY V + G L+AVK I + Q K+ A E + L ++H NL+K
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRI-QDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 763 IVTICSSIDFKGVDF---KALVY-EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
+ GV+ K ++ EY G+LEE L I + +I+ + +
Sbjct: 64 ---------YYGVEVHREKVYIFMEYCSGGTLEELLEHG----RILDEHVIRVY--TLQL 108
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS--PLGNVVETPSS 876
+ YLH H IVH D+KP+N+ LDH+ V + DFG A L + +G V++
Sbjct: 109 LEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS--- 162
Query: 877 SIGVKGTIGYVAPEYGLGGEASMRGG---VYSYGILLLEIFTRRRPTESMFNE 926
+ GT Y+APE GG+ G ++S G ++LE+ T +RP + NE
Sbjct: 163 ---LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 22/218 (10%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLI 761
F IG+G FG VYK G VA+KVI LE K + E + L+ +H N
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPN-- 58
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
IV S K D +V E+ GSL++ L + L ++ + + ++
Sbjct: 59 -IVKYYGSYLKK--DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCK-----ELLKG 110
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
+EYLH + I+H D+K +N+LL D + DFGL+ LS + N + +
Sbjct: 111 LEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN------TMV--- 158
Query: 882 GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
GT ++APE G + ++S GI +E+ + P
Sbjct: 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 23/223 (10%)
Query: 706 SNTIGRGSFGFVYKGVLHEN----GMLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNL 760
+G G FG V G VAVK +N + +S F E E LR++ H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
+K +C + + L+ EY+ +GSL ++L + DQ+ +L + L +
Sbjct: 69 VKYKGVCEKPGGRSL---RLIMEYLPSGSLRDYLQRHRDQI-----NLKRLLLFSSQICK 120
Query: 821 AVEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
++YL +H DL N+L++ + + +SDFGLAK L V+ P S
Sbjct: 121 GMDYLGSQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES-- 174
Query: 880 VKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922
I + APE + S V+S+G+ L E+FT P++S
Sbjct: 175 ---PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 709 IGRGSFGFVYKGVLHENGML-VAVKVINLEQKGGSKS---FAAECEALRSIRHRNLIKIV 764
+G G FG V+ G NG VAVK + K G+ S F E + ++ +RH L+++
Sbjct: 14 LGAGQFGEVWMGTW--NGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
+CS + +V EYM GSL ++L + + L L Q +++ +A + Y
Sbjct: 68 AVCS-----EEEPIYIVTEYMSKGSLLDFLKSGEGK----KLRLPQLVDMAAQIAEGMAY 118
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
L +H DL N+L+ ++V ++DFGLA+ + + ++ G K I
Sbjct: 119 LE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIE-------DDEYTAREGAKFPI 168
Query: 885 GYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR-PTESMFN 925
+ APE G +++ V+S+GILL EI T R P M N
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 77/229 (33%), Positives = 110/229 (48%), Gaps = 24/229 (10%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRH- 757
+ +G GSFG VY + LVA+KV+ + + + F E + L S+ H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
N++K+ F+ LV EY+ GSLE+ L + + LS + L I+
Sbjct: 58 PNIVKLYDF-----FQDEGSLYLVMEYVDGGSLEDLLKKIGRKG---PLSESEALFILAQ 109
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAKFLSASPLGNVVETPSS 876
+ SA+EYLH I+H D+KP N+LLD D V + DFGLAK L + + S
Sbjct: 110 ILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPS 166
Query: 877 SIGVKGTIGYVAPEYGLG---GEASMRGGVYSYGILLLEIFTRRRPTES 922
+ GT GY+APE LG AS ++S GI L E+ T P E
Sbjct: 167 TS--VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 74/280 (26%), Positives = 118/280 (42%), Gaps = 39/280 (13%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEAL-RSIR 756
++F IG GSF V E A+K+++ L ++ K E E L R
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 757 HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI 816
H +IK+ + D + + F V EY NG L +++ + G + +
Sbjct: 61 HPGIIKL--YYTFQDEENLYF---VLEYAPNGELLQYIRKY----GSLDEKCTR--FYAA 109
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPL---GNVVET 873
++ A+EYLH I+H DLKP N+LLD DM ++DFG AK L + T
Sbjct: 110 EILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 874 PSSSIGVK---------GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMF 924
S K GT YV+PE A +++ G ++ ++ T + P
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS- 225
Query: 925 NEGLTLHEFAKRAL------PEKVMEIVDPSLLPLE-EER 957
NE LT + K P ++++ LL L+ ++R
Sbjct: 226 NEYLTFQKILKLEYSFPPNFPPDAKDLIE-KLLVLDPQDR 264
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 67/230 (29%), Positives = 110/230 (47%), Gaps = 38/230 (16%)
Query: 709 IGRGSFGFVYKGVLHENG---MLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNLIKIV 764
IG G FG V +G L G + VA+K + + F E + H N+I++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL- 70
Query: 765 TICSSIDFKGVDFKA----LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
+GV K+ ++ EYM+NGSL+++L + D + ++ Q + ++ +AS
Sbjct: 71 --------EGVVTKSRPVMIITEYMENGSLDKFLRENDGKF-----TVGQLVGMLRGIAS 117
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
++YL VH DL N+L++ ++V VSDFGL++ L S T I +
Sbjct: 118 GMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE--ATYTTKGGKIPI 172
Query: 881 KGTIGYVAPE---YGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
+ T APE Y AS V+S+GI++ E+ + RP M N+
Sbjct: 173 RWT----APEAIAYRKFTSAS---DVWSFGIVMWEVMSYGERPYWDMSNQ 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 8e-23
Identities = 74/216 (34%), Positives = 108/216 (50%), Gaps = 29/216 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
IG G FG V +G G VAVK I + +++F E + + H+NL++++ +
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGV-- 67
Query: 769 SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH 828
I G+ +V E M G+L +L R G +S+IQ L +DVA +EYL
Sbjct: 68 -ILHNGL---YIVMELMSKGNLVNFLRTR----GRALVSVIQLLQFSLDVAEGMEYLE-- 117
Query: 829 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVA 888
+VH DL N+L+ D VA VSDFGLA+ +G +S + VK T A
Sbjct: 118 -SKKLVHRDLAARNILVSEDGVAKVSDFGLAR---VGSMG----VDNSKLPVKWT----A 165
Query: 889 PEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESM 923
PE + S + V+SYG+LL E+F+ R P M
Sbjct: 166 PEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 9e-23
Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 34/218 (15%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINL-EQKGGSKSFAAECEALRSIRHRNLIKIVTIC 767
+G+GS G VYK G + A+K I++ + K E + LRS ++K
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----- 63
Query: 768 SSIDFKGVDFK----ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
G +K ++V EYM GSL + L ++ ++ L+ I R + ++
Sbjct: 64 ----CYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQ-----ILKGLD 113
Query: 824 YLH--HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
YLH H I+H D+KPSN+L++ ++DFG++K L + ++ +
Sbjct: 114 YLHTKRH----IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-----NTFV--- 161
Query: 882 GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
GT+ Y++PE G S ++S G+ LLE + P
Sbjct: 162 GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 75/269 (27%), Positives = 122/269 (45%), Gaps = 41/269 (15%)
Query: 702 EFSSSNTIGRGSFGFV----YKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRH 757
E + +G G FG V ++G + VA+K+I E F E + + + H
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKID-----VAIKMIR-EGAMSEDDFIEEAKVMMKLSH 58
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
NL+++ +C+ + F +V EYM NG L +L +R +LG L L++ D
Sbjct: 59 PNLVQLYGVCTK---QRPIF--IVTEYMANGCLLNYLRERKGKLGTEWL-----LDMCSD 108
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
V A+EYL + +H DL N L+ D V VSDFGLA+++ + + +SS
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV-------LDDQYTSS 158
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFN--------EGL 928
G K + + PE S + V+S+G+L+ E+F+ + P E N G
Sbjct: 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY 218
Query: 929 TLHEFAKRALPEKVMEIVDPSLLPLEEER 957
L+ + P +V I+ E+R
Sbjct: 219 RLYR--PKLAPTEVYTIMYSCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-22
Identities = 76/217 (35%), Positives = 108/217 (49%), Gaps = 26/217 (11%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLI 761
E TIG+G FG V G G VAVK I + +++F AE + +RH NL+
Sbjct: 7 ELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
+++ + ++ KG + +V EYM GSL ++L R G L L +DV A
Sbjct: 63 QLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEA 114
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
+EYL + VH DL NVL+ D VA VSDFGL K S++ + + VK
Sbjct: 115 MEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-------QDTGKLPVK 164
Query: 882 GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR 918
T APE + S + V+S+GILL EI++ R
Sbjct: 165 WT----APEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 72/221 (32%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS---KSFAAECEALRSIRHRNLIKIVT 765
+G G FG V++G+ + N VAVK + K G+ K F AE + ++ +RH LI++
Sbjct: 14 LGAGQFGEVWEGLWN-NTTPVAVKTL----KPGTMDPKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+C+ + +V E M+ GSL E+L + L L Q +++ VAS + YL
Sbjct: 69 VCTL-----EEPIYIVTELMKYGSLLEYLQGGAGR----ALKLPQLIDMAAQVASGMAYL 119
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
+H DL NVL+ + + V+DFGLA+ + ++ E + G K I
Sbjct: 120 EAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE----DIYE---AREGAKFPIK 169
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFN 925
+ APE L S++ V+S+GILL EI T R P M N
Sbjct: 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 26/221 (11%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRN 759
+ + IGRG+FG VYKG+ E G VA+K I+LE+ KS E + L++++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 760 LIKIVTICSSIDF-KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
++K I + D ++ EY +NGSL + + + G SL+ V V
Sbjct: 61 IVKY------IGSIETSDSLYIILEYAENGSLRQIIK----KFGPFPESLVAVY--VYQV 108
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
+ YLH + ++H D+K +N+L D V ++DFG+A L+ V +S
Sbjct: 109 LQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLND------VSKDDAS- 158
Query: 879 GVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
V GT ++APE AS ++S G ++E+ T P
Sbjct: 159 -VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 57/214 (26%), Positives = 112/214 (52%), Gaps = 20/214 (9%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLI 761
+ + + +G G +G VY+GV + + VAVK + E + F E ++ I+H NL+
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 65
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
+++ +C+ + F ++ E+M G+L ++L + + Q ++ + L + ++SA
Sbjct: 66 QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE----VNAVVLLYMATQISSA 116
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
+EYL +H DL N L+ + + V+DFGL++ ++ +T ++ G K
Sbjct: 117 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTAHAGAK 166
Query: 882 GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
I + APE + S++ V+++G+LL EI T
Sbjct: 167 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 69/235 (29%), Positives = 108/235 (45%), Gaps = 56/235 (23%)
Query: 709 IGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGS-----KSFAAECEALRSIRHR 758
+G G+FG V+ G + + LVAVK + K + K F E E L + +H
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTL----KETASNDARKDFEREAELLTNFQHE 68
Query: 759 NLIKIVTICSSIDFKGV----DFKALVYEYMQNGSLEEWL--HQRDDQLGICN------L 806
N++K F GV D +V+EYM++G L ++L H D L
Sbjct: 69 NIVK---------FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 807 SLIQRLNIVIDVASAVEYL--HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSA 864
+L Q L I + +AS + YL H VH DL N L+ +D+V + DFG+++
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR---- 170
Query: 865 SPLGNVVETPSSSIGVKGT----IGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+V T +G G I ++ PE + + + V+S+G++L EIFT
Sbjct: 171 ----DVYTTDYYRVG--GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 8e-21
Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSK-SFAAECEALRSIRHRNLIKIVTIC 767
IG+G+FG VYKGVL N VAVK K F E E L+ H N++K++ +C
Sbjct: 3 IGKGNFGDVYKGVLKGN-TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 768 SSIDFKGVDFKAL--VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
V + + V E + GSL +L ++ ++L + L L + +D A+ +EYL
Sbjct: 62 -------VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL-----LQMSLDAAAGMEYL 109
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT-I 884
+H DL N L+ + V +SDFG+ S G + S G+K I
Sbjct: 110 ESKN---CIHRDLAARNCLVGENNVLKISDFGM----SREEEGGIYT---VSDGLKQIPI 159
Query: 885 GYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ APE G + V+SYGILL E F+
Sbjct: 160 KWTAPEALNYGRYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
+G+GSFG V + G L A+KV+ + ++ + E L I H ++K
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--L 58
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ F+ + LV EY G L L + G + + ++ A+EYL
Sbjct: 59 HYA---FQTEEKLYLVLEYAPGGELFSHLSKE----GRFSEERARF--YAAEIVLALEYL 109
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H I++ DLKP N+LLD D ++DFGLAK L + ++ GT
Sbjct: 110 HSL---GIIYRDLKPENILLDADGHIKLTDFGLAK-----ELSSEGSRTNTFC---GTPE 158
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
Y+APE LG +S G+LL E+ T + P
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 2e-20
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 40/221 (18%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTI 766
IG G++G VYK + G LVA+K I +E + G + E + L+ +RH N++++ I
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNL-SLIQRLNIVIDVASAVEYL 825
+S + +V+EYM + L L + + + +++L ++YL
Sbjct: 67 VTSKGKGSI---YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQL------LEGLQYL 116
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLG----NVVETPSSSIGVK 881
H + I+H D+K SN+L+++D V ++DFGLA+ + V+
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI---------- 163
Query: 882 GTIGYVAPEYGLG-----GEASMRGGVYSYGILLLEIFTRR 917
T+ Y PE LG E M +S G +L E+F +
Sbjct: 164 -TLWYRPPELLLGATRYGPEVDM----WSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 71/234 (30%), Positives = 119/234 (50%), Gaps = 43/234 (18%)
Query: 709 IGRGSFGFVYKGVLHENG---MLVAVKVINLEQKGG-----SKSFAAECEALRSIRHRNL 760
IG G FG V +G L G + VA+K + K G + F +E + H N+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTL----KSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 761 IKIVTICSSIDFKGVDFKA----LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI 816
I + +GV K+ ++ E+M+NG+L+ +L Q D Q ++IQ + ++
Sbjct: 68 IHL---------EGVVTKSRPVMIITEFMENGALDSFLRQNDGQF-----TVIQLVGMLR 113
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL---SASPLGNVVET 873
+A+ ++YL + VH DL N+L++ ++V VSDFGL++FL ++ P T
Sbjct: 114 GIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP------T 164
Query: 874 PSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
+SS+G K I + APE + + V+SYGI++ E+ + RP M N+
Sbjct: 165 YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (227), Expect = 3e-20
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEA--LRSIRHRNLIKIV 764
IG+GSFG VY +G L +K I+L + A E L+ + H N+IK
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
F+ +V EY G L + + ++ + G Q L+ + + A++Y
Sbjct: 66 E-----SFEEKGKLCIVMEYADGGDLSQKIKKQK-KEGK-PFPEEQILDWFVQLCLALKY 118
Query: 825 LH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
LH I+H D+KP N+ L + + + DFG++K LS + V+ + + GT
Sbjct: 119 LHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-----STVDLAKTVV---GT 166
Query: 884 IGYVAPE------YGLGGEASMRGGVYSYGILLLEIFTRRRP 919
Y++PE Y + + ++S G +L E+ T + P
Sbjct: 167 PYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 709 IGRGSFGFVYKGVLHENGML-VAVKVINLEQKGGSKS---FAAECEALRSIRHRNLIKIV 764
+G+G FG V+ G NG VA+K + K G+ S F E + ++ +RH L+++
Sbjct: 14 LGQGCFGEVWMGTW--NGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 67
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
+ S + +V EYM GSL ++L + L L Q +++ +AS + Y
Sbjct: 68 AVVSE------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAY 117
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
+ + VH DL+ +N+L+ ++V V+DFGLA+ + + ++ G K I
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPI 167
Query: 885 GYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR-PTESMFN 925
+ APE L G +++ V+S+GILL E+ T+ R P M N
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 73/257 (28%), Positives = 122/257 (47%), Gaps = 37/257 (14%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA--ECEALRSIRHRNLIKIVTI 766
+GRG+FG V+ + LV +K I +EQ + AA EC+ L+ + H N+I+
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE- 66
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
+ ++ K + +V EY G+L E++ +R CN SL+ I+ + LH
Sbjct: 67 -NFLEDKAL---MIVMEYAPGGTLAEYIQKR------CN-SLLDEDTILHFFVQILLALH 115
Query: 827 HHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H I+H DLK N+LLD H MV + DFG++K LS + S + V GT
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---------SKSKAYTVVGTPC 166
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEI 945
Y++PE G + + +++ G +L E+ + +R F LP V++I
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELASLKRA-------------FEAANLPALVLKI 213
Query: 946 VDPSLLPLEEERTNSRR 962
+ + P+ + + R
Sbjct: 214 MSGTFAPISDRYSPDLR 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 29/229 (12%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNL 760
+E + IG G FG V+ G E VA+K I E + F E + + + H L
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKL 61
Query: 761 IKIVTIC---SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
+++ +C S I LV+E+M++G L ++L + + L L + +D
Sbjct: 62 VQLYGVCTERSPI--------CLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLD 108
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
V + YL ++H DL N L+ + V VSDFG+ +F+ + + +SS
Sbjct: 109 VCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV-------LDDQYTSS 158
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFN 925
G K + + +PE + S + V+S+G+L+ E+F+ + P E+ N
Sbjct: 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN 207
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 30/222 (13%)
Query: 709 IGRGSFGFVYKGVLHENG----MLVAVKVINLEQKGGSKSFAA---ECEALRSIRHRNLI 761
+G G+FG VYKGV G + VA+KV L ++ K+ E + S+ H +++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKV--LREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
+++ IC S L+ + M G L +++ D +G L LN + +A
Sbjct: 73 RLLGICLSSQV------QLITQLMPLGCLLDYVRNHKDNIGSQYL-----LNWCVQIAKG 121
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
+ YL +VH DL NVL+ ++DFGLAK L E + G K
Sbjct: 122 MSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD------EKEYHAEGGK 172
Query: 882 GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTES 922
I ++A E L + + V+SYG+ + E+ T +P E
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 9e-19
Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 29/221 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS---KSFAAECEALRSIRHRNLIKIVT 765
+G G FG V+ G + N VAVK + K G+ +SF E + ++ +RH L+++
Sbjct: 14 LGNGQFGEVWMGTWNGNTK-VAVKTL----KPGTMSPESFLEEAQIMKKLRHDKLVQLYA 68
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ S +V EYM GSL ++L + + L L +++ VA+ + Y+
Sbjct: 69 VVSEEPI------YIVTEYMSKGSLLDFLKDGEGR----ALKLPNLVDMAAQVAAGMAYI 118
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
+ +H DL+ +N+L+ +V ++DFGLA+ + + ++ G K I
Sbjct: 119 E---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-------TARQGAKFPIK 168
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR-PTESMFN 925
+ APE L G +++ V+S+GILL E+ T+ R P M N
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 64/235 (27%), Positives = 113/235 (48%), Gaps = 31/235 (13%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENG---MLVAVKVINLEQKGG-----SKSFAAECEAL 752
+ + IG G FG V++G+L G + VA+K + K G + F +E +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL----KPGYTEKQRQDFLSEASIM 60
Query: 753 RSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRL 812
H N+I++ + + FK ++ EYM+NG+L+++L D + S Q +
Sbjct: 61 GQFSHHNIIRLEGVVTK--FKPA---MIITEYMENGALDKYLRDHDGEF-----SSYQLV 110
Query: 813 NIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVE 872
++ +A+ ++YL VH DL N+L++ ++ VSDFGL++ L P E
Sbjct: 111 GMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP-----E 162
Query: 873 TPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
++ G K I + APE + + V+S+GI++ E+ + RP M N
Sbjct: 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 70/230 (30%), Positives = 110/230 (47%), Gaps = 37/230 (16%)
Query: 709 IGRGSFGFVYKGVLHENG---MLVAVKVINLEQKGG-----SKSFAAECEALRSIRHRNL 760
IG G FG V G L G + VA+K + K G + F +E + H N+
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTL----KAGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 761 IK---IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
I +VT + +V EYM+NGSL+ +L + D Q ++IQ + ++
Sbjct: 68 IHLEGVVTKSKPV--------MIVTEYMENGSLDAFLRKHDGQF-----TVIQLVGMLRG 114
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
+AS ++YL VH DL N+L++ ++V VSDFGL++ L P E ++
Sbjct: 115 IASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EAAYTT 166
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
G K I + APE + + V+SYGI++ E+ + RP M N+
Sbjct: 167 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 63/222 (28%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 709 IGRGSFGFVYKGVLHENGML-VAVKVINLEQKGGS---KSFAAECEALRSIRHRNLIKIV 764
+G+G FG V+ G NG VA+K + K G+ ++F E + ++ +RH L+ +
Sbjct: 14 LGQGCFGEVWMGTW--NGTTKVAIKTL----KPGTMMPEAFLQEAQIMKKLRHDKLVPLY 67
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
+ S + +V E+M GSL ++L + D + L L Q +++ +A + Y
Sbjct: 68 AVVSE------EPIYIVTEFMGKGSLLDFLKEGDGK----YLKLPQLVDMAAQIADGMAY 117
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
+ + +H DL+ +N+L+ ++V ++DFGLA+ + + ++ G K I
Sbjct: 118 IE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-------TARQGAKFPI 167
Query: 885 GYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR-PTESMFN 925
+ APE L G +++ V+S+GILL E+ T+ R P M N
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 69/262 (26%), Positives = 109/262 (41%), Gaps = 41/262 (15%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS---FAAECEALRSIRHRNLIKIVT 765
+G G FG V G VA+K+I K GS S F E + + + H L+++
Sbjct: 12 LGTGQFGVVKYGKW-RGQYDVAIKMI----KEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 766 ICSS---IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
+C+ I +V EYM NG L +L + Q L + DV +
Sbjct: 67 VCTKQRPI--------YIVTEYMSNGCLLNYLRE-----HGKRFQPSQLLEMCKDVCEGM 113
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
YL +H DL N L+D VSDFGL++++ + + +SS+G K
Sbjct: 114 AYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV-------LDDEYTSSVGSKF 163
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNEGLTLHEFAKRAL--- 938
+ + PE L + S + V+++G+L+ E+++ + P E N L
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP 223
Query: 939 ---PEKVMEIVDPSLLPLEEER 957
EKV I+ EER
Sbjct: 224 HLASEKVYAIMYSCWHEKAEER 245
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 63/247 (25%), Positives = 110/247 (44%), Gaps = 52/247 (21%)
Query: 695 ELSKATNEFSSSNTIGRGSFGFVYKGVL---HENGMLVAVKVINLEQKGGSK---SFAAE 748
E+ + F +G G+FG VYKG L +E +V + L++ K F E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 749 CEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQR----------D 798
E + ++H N++ ++ +C+ K +++EY+ +G L E+L +
Sbjct: 59 AELMSDLQHPNIVCLLGVCT----KEQPT-CMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 799 DQLGICNLSLIQRLNIVIDVASAVEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857
D+ +L L+I I +A+ +EYL HH VH DL N L+ + +SDFG
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFG 169
Query: 858 LA---------KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGI 908
L+ + S S L + ++ PE L G+ + ++S+G+
Sbjct: 170 LSRDIYSADYYRVQSKSLL---------------PVRWMPPEAILYGKFTTESDIWSFGV 214
Query: 909 LLLEIFT 915
+L EIF+
Sbjct: 215 VLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (212), Expect = 6e-18
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 40/207 (19%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTI 766
+G G++G VYK + G +VA+K I L+ + G + E L+ ++H N++K++ +
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 767 CSSIDFKGVDFK-ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ K LV+EY L+++L +R L + +LI+ I+ + + Y
Sbjct: 67 IHTER------KLYLVFEYCDM-DLKKYLDKRPGPL---SPNLIKS--IMYQLLRGLAYC 114
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLG----NVVETPSSSIGVK 881
H H I+H DLKP N+L++ D V ++DFGLA+ PL VV
Sbjct: 115 HSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFG-IPLRTYTHEVV---------- 160
Query: 882 GTIGYVAPEYGLGGEASMRGGVYSYGI 908
T+ Y APE LG + YS +
Sbjct: 161 -TLWYRAPEILLGSKH------YSTAV 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 35/226 (15%)
Query: 700 TNEFSSSNTIGRGSFGFVYKGVLHENG----MLVAVKVINLEQKGGSKSFAAECE---AL 752
E +G G FG V+KG+ G + VA+K I + + G ++F + A+
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAM 63
Query: 753 RSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRL 812
S+ H +++++ IC + LV + GSL + + Q D L L L
Sbjct: 64 GSLDHAYIVRLLGICPGASLQ------LVTQLSPLGSLLDHVRQHRDSLDPQRL-----L 112
Query: 813 NIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP---LGN 869
N + +A + YL H +VH +L N+LL D + ++DFG+A L +
Sbjct: 113 NWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYS 169
Query: 870 VVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+TP I ++A E L G + + V+SYG+ + E+ +
Sbjct: 170 EHKTP---------IKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 32/229 (13%)
Query: 685 EQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS 744
+ P YK L K IG G+ G VYK G VA+K + L ++ +
Sbjct: 13 SEGDPRELYKNLEK----------IGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKEL 61
Query: 745 FAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGIC 804
E ++ +H N IV S + +V EYM GSL + + Q ++
Sbjct: 62 IINEILIMKDCKHPN---IVDYYDSYLVGDELW--VVMEYMDGGSLTDIITQNFVRMNEP 116
Query: 805 NLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSA 864
++ + R +V +EYLH ++H D+K N+LL D ++DFG A L+
Sbjct: 117 QIAYVCR-----EVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168
Query: 865 SPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEI 913
+S V GT ++APE + + ++S GI+ +E+
Sbjct: 169 E-----KSKRNS---VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
+G G FG V+ G + VA+K IN E + F E + + + H L+++ +C
Sbjct: 12 LGSGQFGVVHLGKWRAQ-IKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC- 68
Query: 769 SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH 828
K + +V E+M+NG L +L QR +L L L++ DV +EYL
Sbjct: 69 -TQQKPL---YIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEGMEYLE-- 117
Query: 829 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVA 888
+ +H DL N L+ V VSDFG+ +++ + + +SS G K + +
Sbjct: 118 -RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV-------LDDEYTSSSGAKFPVKWSP 169
Query: 889 PEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFN 925
PE + S + V+S+G+L+ E+FT + P E N
Sbjct: 170 PEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 37/221 (16%)
Query: 707 NTIGRGSFGFVYKGVLHE-NGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
+G G+ G V K VLH G ++AVK I LE EA++ R L I+
Sbjct: 7 GELGAGNSGVVSK-VLHRPTGKIMAVKTIRLEIN----------EAIQKQILREL-DILH 54
Query: 766 ICSS---IDFKGVDFK----ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
C+S + F G + ++ EYM GSL++ L + ++ L I + V
Sbjct: 55 KCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAV 109
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
+ YLH + I+H D+KPSN+L++ + DFG++ L S V
Sbjct: 110 LKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV------- 160
Query: 879 GVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
GT Y+APE G + S++ ++S G+ L+E+ T R P
Sbjct: 161 ---GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-17
Identities = 59/223 (26%), Positives = 105/223 (47%), Gaps = 32/223 (14%)
Query: 709 IGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKI 763
+G G+FG V+ H ++ MLVAVK + + + F E E L ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWL--HQRDDQL-------GICNLSLIQRLNI 814
+C+ +V+EYM++G L +L H D ++ L+L Q L I
Sbjct: 73 YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 815 VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETP 874
+AS + YL VH DL N L+ +V + DFG+++ ++ T
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYSTD 176
Query: 875 SSSIGVKGT--IGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+G + I ++ PE L + + ++S+G++L EIFT
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 34/224 (15%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRN 759
F IG+G+FG V + + A+K +N + +KG ++ E L+ + H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH-P 60
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQR----DDQLGICNLSLIQRLNIV 815
+ V + S F+ + LV + + G L L Q+ ++Q+ +
Sbjct: 61 FL--VNLWYS--FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF----------WI 106
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
++ A+EYLH I+H D+KP N+LLD H++DF +A ++ L
Sbjct: 107 CEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT------ 157
Query: 876 SSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
GT GY+APE S+ +S G+ E +RP
Sbjct: 158 ---STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 79/298 (26%), Positives = 133/298 (44%), Gaps = 61/298 (20%)
Query: 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINL--EQKGGSKSFAAECEALRS 754
+ ++F IG G++G VYK + G LVA+K + L E++G + E + LR
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 755 IRHRNLIKIVTICSSIDFKGVDFKA------LVYEYMQN---GSLEEWLHQRDDQLGICN 805
+ HRN++ + I + +DFK LV+EYM + G LE G+ +
Sbjct: 63 LNHRNIVNLKEIVTD-KQDALDFKKDKGAFYLVFEYMDHDLMGLLES---------GLVH 112
Query: 806 LSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865
S + + + + Y H + +H D+K SN+LL++ ++DFGLA+ ++
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 866 ---PLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGG----VYSYGILLLEIFTRRR 918
P N V T+ Y PE LG E R G V+S G +L E+FT++
Sbjct: 170 ESRPYTNKVI----------TLWYRPPELLLGEE---RYGPAIDVWSCGCILGELFTKK- 215
Query: 919 PTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLP----------LEEERTNSRRVRNE 966
+F E A+ L ++ P++ P ++ ++ RR+R E
Sbjct: 216 ---PIFQANQ---ELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE 267
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 9e-17
Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 60/231 (25%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSK---SFAA--ECEALRSIRHRNLIKI 763
+G G++ VYK E G +VA+K I L ++ +K +F A E + L+ ++H N+I +
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI---DVAS 820
+ + F LV+E+M+ LE+ +I+ +IV+ D+ S
Sbjct: 68 LDV-----FGHKSNINLVFEFME-TDLEK---------------VIKDKSIVLTPADIKS 106
Query: 821 -------AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLG----N 869
+EYLH + I+H DLKP+N+L+ D V ++DFGLA+ SP
Sbjct: 107 YMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQ 162
Query: 870 VVETPSSSIGVKGTIGYVAPEYGLGGEASMRGG---VYSYGILLLEIFTRR 917
VV T Y APE G A G ++S G + E+ R
Sbjct: 163 VV-----------TRWYRAPELLFG--ARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 60/221 (27%), Positives = 110/221 (49%), Gaps = 29/221 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS---FAAECEALRSIRHRNLIKIVT 765
+G G FG V+ G + VA+K + K GS S F AE ++ ++H L+++
Sbjct: 14 LGAGQFGEVWMG-YYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ + ++ EYM+NGSL ++L + GI L++ + +++ +A + ++
Sbjct: 69 VVTQEPI------YIITEYMENGSLVDFLKTPE---GI-KLTINKLIDMAAQIAEGMAFI 118
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
+ +H DL+ +N+L+ + ++DFGLA+ + + ++ G K I
Sbjct: 119 E---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-------TAREGAKFPIK 168
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR-PTESMFN 925
+ APE G +++ V+S+GILL EI T R P M N
Sbjct: 169 WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 56/188 (29%), Positives = 85/188 (45%), Gaps = 25/188 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTI 766
IG G+ G V+K E G VA+K + L + G E +AL++ +H ++K++ +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
G F LV EYM L E L + L + ++ ++ V Y+H
Sbjct: 68 FP----HGSGF-VLVMEYMP-SDLSEVLRDEERPL---PEAQVKSYMRML--LKGVAYMH 116
Query: 827 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGY 886
I+H DLKP+N+L+ D V ++DFGLA+ S S + T Y
Sbjct: 117 ---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE----PRLYSHQV---ATRWY 166
Query: 887 VAPE--YG 892
APE YG
Sbjct: 167 RAPELLYG 174
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 7e-16
Identities = 75/253 (29%), Positives = 119/253 (47%), Gaps = 41/253 (16%)
Query: 674 SAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKV 733
S+ SS+++ S EL + N IG G+ G VYK + G L A+KV
Sbjct: 54 SSSSSSSSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALKV 106
Query: 734 I--NLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLE 791
I N E + E E LR + H N++K C + + + L+ E+M GSLE
Sbjct: 107 IYGNHED-TVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLE 160
Query: 792 EWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 851
H D+Q L+ + R + S + YLH IVH D+KPSN+L++
Sbjct: 161 G-THIADEQF----LADVAR-----QILSGIAYLHRR---HIVHRDIKPSNLLINSAKNV 207
Query: 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE-----YGLGGEASMRGGVYSY 906
++DFG+++ L+ + ++ +SS+ GTI Y++PE G G ++S
Sbjct: 208 KIADFGVSRILAQT-----MDPCNSSV---GTIAYMSPERINTDLNHGAYDGYAGDIWSL 259
Query: 907 GILLLEIFTRRRP 919
G+ +LE + R P
Sbjct: 260 GVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 709 IGRGSFGFVYKGVLHENG---MLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKI- 763
+G GSFG V +G +G + VAVK + ++ F E + S+ H NLI++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 764 -VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
V + + +V E GSL + L R D LG +S + + + +A+ +
Sbjct: 63 GVVLTHPL--------MMVTELAPLGSLLDRL--RKDALGHFLISTL--CDYAVQIANGM 110
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
YL +H DL N+LL D + DFGL + L + +K
Sbjct: 111 RYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMR-----ALPQNEDHYVMEEHLKV 162
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ APE S V+ +G+ L E+FT
Sbjct: 163 PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 29/222 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS---------KSFAAECEALRSIRHRN 759
IG GSFG VY G+ +G L+AVK + L S + A E L+ ++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
+++ + SS+D D + EY+ GS+ L + G +L++ N V +
Sbjct: 68 IVQYLG--SSLD---ADHLNIFLEYVPGGSVAALL----NNYGAFEETLVR--NFVRQIL 116
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPL--GNVVETPSSS 877
+ YLH+ I+H D+K +N+L+D+ +SDFG++K L A+ L PS
Sbjct: 117 KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-- 171
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
++G++ ++APE + + ++S G L++E+ T + P
Sbjct: 172 --LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 68/225 (30%), Positives = 101/225 (44%), Gaps = 35/225 (15%)
Query: 709 IGRGSFGFV----YKGVLHENGMLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNLIKI 763
+G G FG V Y G +VAVK + E + S + E L+++ H N++K
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
CS KG+ L+ EY+ GSL ++L + L+L Q L + +
Sbjct: 72 KGCCSEQGGKGL---QLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMA 121
Query: 824 YLH--HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGN----VVETPSSS 877
YLH H+ +H DL NVLLD+D + + DFGLAK A P G+ V E S
Sbjct: 122 YLHSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAK---AVPEGHEYYRVREDGDSP 173
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922
+ + A E + S V+S+G+ L E+ T +S
Sbjct: 174 ------VFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 25/159 (15%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALR---SIR----HRNLI 761
+G G+FG VY E G LVA+K + K S+ EC LR S+R H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM----KKKFYSW-EECMNLREVKSLRKLNEHPNIV 61
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
K+ + F+ D V+EYM G+L + + R + S +I+ +
Sbjct: 62 KLKEV-----FRENDELYFVFEYM-EGNLYQLMKDRKGKP----FSESVIRSIIYQILQG 111
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
+ ++H H H DLKP N+L+ V ++DFGLA+
Sbjct: 112 LAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 30/220 (13%)
Query: 709 IGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSK-SFAAECEALRSIRHRNLIK 762
+G+GSFG VY+G+ E VA+K +N + F E ++ ++++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 763 IVTICSSIDFKGVDFKALV-YEYMQNGSLEEWLHQRDDQLGICNL----SLIQRLNIVID 817
++ + S+ LV E M G L+ +L R + +L + + + +
Sbjct: 74 LLGVVSTGQ------PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
+A + YL VH DL N ++ D+ + DFG+ + ++ ET
Sbjct: 128 IADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DIYETDYYR 176
Query: 878 IGVKGT--IGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
G KG + ++APE G + + V+S+G++L E+ T
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 68/269 (25%), Positives = 108/269 (40%), Gaps = 39/269 (14%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG-SKSFAAECEALRSIRHRN 759
+ + +G G+ G V K L GM+ A+K I + K E E +S +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 760 LIKIVTIC-----SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNI 814
++K SSI + EY + GSL+ + + G ++ + I
Sbjct: 61 IVKYYGAFLDESSSSI--------GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK--I 110
Query: 815 VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETP 874
V + YLH I+H D+KPSN+LL + DFG++ G +V +
Sbjct: 111 AESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS--------GELVNSL 159
Query: 875 SSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934
+ + GT Y+APE G S+ V+S G+ LLE+ R P E
Sbjct: 160 AGTF--TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP---------EGE 208
Query: 935 KRALP-EKVMEIVDPSLLPLEEERTNSRR 962
P E + IV+ L++E N +
Sbjct: 209 PPLGPIELLSYIVNMPNPELKDEPGNGIK 237
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 24/212 (11%)
Query: 709 IGRGSFGFVYKGVLHENG---MLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIV 764
+G G+FG V KGV + VAVK + E G K F E + + H +++++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
+C LV E G L ++L +R + + + VA + Y
Sbjct: 63 GVCKGEPL------MLVMELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAY 110
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
L VH DL NVLL + A +SDFG+++ L A G+ + ++ + +
Sbjct: 111 LE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA---GS--DYYRATTAGRWPL 162
Query: 885 GYVAPEYGLGGEASMRGGVYSYGILLLEIFTR 916
+ APE G+ S + V+SYG+ L E F+
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-15
Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENG----MLVAVKVINLEQKGGSKS---FAAECEALRS 754
E +G G+FG VYKG+ G + VA+K++N + G K+ F E + S
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN--ETTGPKANVEFMDEALIMAS 65
Query: 755 IRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNI 814
+ H +L++++ +C S + LV + M +G L +++H+ D +G L LN
Sbjct: 66 MDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNW 114
Query: 815 VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETP 874
+ +A + YL + +VH DL NVL+ ++DFGLA+ L E
Sbjct: 115 CVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD------EKE 165
Query: 875 SSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
++ G K I ++A E + + + V+SYG+ + E+ T
Sbjct: 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 706 SNTIGRGSFGFVYKGVLHENGMLVAVK--VINLEQKGGSKSFAAECEALRSIR---HRNL 760
IG G++G VYK G VA+K + L ++G S E L+ + H N+
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
++++ +C LV+E++ ++ L + L +++ +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS-ASPLGNVVETPSSSIG 879
V++LH H IVH DLKP N+L+ D ++DFGLA+ S L +VV
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV------- 168
Query: 880 VKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
T+ Y APE L + ++S G + E+F RRRP
Sbjct: 169 ---TLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 709 IGRGSFGFV----YKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIV 764
+G+G+FG V Y + G +VAVK + + F E E L+S++H N++K
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK-- 69
Query: 765 TICSSIDFKGVDFKA------LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
+KGV + A LV EY+ GSL ++L + ++L L L +
Sbjct: 70 -------YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYAS-----QI 117
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
+EYL VH DL N+L++ + + DFGL K L V P S
Sbjct: 118 CKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES- 173
Query: 879 GVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
I + APE + S+ V+S+G++L E+FT
Sbjct: 174 ----PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 60/237 (25%), Positives = 89/237 (37%), Gaps = 57/237 (24%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKS-FAAECEALRSIRHRNLIKIV 764
TIG+GSFG V K +G ++ K I+ K +E LR ++H N IV
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN---IV 62
Query: 765 TICSSIDFKGVDFKA----LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQR--------- 811
I +D +V EY + G L LIQ+
Sbjct: 63 RYYDRI----IDRSNQTLYIVMEYCEGGDLA---------------QLIQKCKKERKYIE 103
Query: 812 ----LNIVIDVASAVEYLHH--HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865
I+ + A+ H+ ++H DLKP+N+ LD + + DFGLAK L
Sbjct: 104 EEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL--- 160
Query: 866 PLGNVVETPSSSIGVK---GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
S K GT Y++PE + ++S G L+ E+ P
Sbjct: 161 --------GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 35/225 (15%)
Query: 709 IGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKI 763
+G G+FG V+ + ++ MLVAVK + K F E E L +++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWL--HQRDDQLGI--------CNLSLIQRLN 813
+C D +V+EYM++G L ++L H D + + L L Q L+
Sbjct: 73 YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 814 IVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP---LGNV 870
I +AS + YL VH DL N L+ +++ + DFG+++ + ++ +G
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 871 VETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
P I ++ PE + + + V+S+G++L EIFT
Sbjct: 185 TMLP---------IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 60/228 (26%), Positives = 107/228 (46%), Gaps = 32/228 (14%)
Query: 692 SYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA-ECE 750
++K+L K +G G++ VYKG G +VA+K I+L+ + G+ S A E
Sbjct: 1 NFKQLEK----------LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREIS 50
Query: 751 ALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQ 810
++ ++H N IV + I + + LV+EYM L++++ + L
Sbjct: 51 LMKELKHEN---IVRLHDVIHTE--NKLMLVFEYMDK-DLKKYMDTHGVR---GALDPNT 101
Query: 811 RLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNV 870
+ + + + H + ++H DLKP N+L++ ++DFGLA+ G
Sbjct: 102 VKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR-----AFGIP 153
Query: 871 VETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRR 917
V T S+ + T+ Y AP+ LG S ++S G ++ E+ T R
Sbjct: 154 VNTFSNEV---VTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 68/260 (26%), Positives = 116/260 (44%), Gaps = 45/260 (17%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINL----------EQKGGSKSFAAECEALRSIRHR 758
IG+G++G VY + G ++AVK + L QK K+ +E E L+ + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 759 NLIKIVTICSSIDF-KGVDFKALVYEYMQNGSLEEWL--HQRDDQLGICNLSLIQRLNIV 815
N I + F ++ ++ EY+ GS+ L + R ++ L++
Sbjct: 69 N------IVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE------QLVRFF--T 114
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
V + YLH I+H DLK N+L+D D + +SDFG++K S N
Sbjct: 115 EQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK-KSDDIYDN-----D 165
Query: 876 SSIGVKGTIGYVAPE----YGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLH 931
++ ++G++ ++APE Y G A + ++S G ++LE+F RRP
Sbjct: 166 QNMSMQGSVFWMAPEVIHSYSQGYSAKV--DIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223
Query: 932 EFAKRA---LPEKVMEIVDP 948
KR+ +P V + P
Sbjct: 224 LGNKRSAPPIPPDVSMNLSP 243
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 32/212 (15%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEA--LRSIRHRNLI---KI 763
+G GS+ VYKG+ NG LVA+KVI+++ + G F A EA L+ ++H N++ I
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
+ ++ F V+EYM L +++ Q L N+ L + + +
Sbjct: 72 IHTKETLTF--------VFEYMHT-DLAQYMIQHPGGLHPYNVRL-----FMFQLLRGLA 117
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
Y+H I+H DLKP N+L+ + ++DFGLA+ S +T SS + T
Sbjct: 118 YIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP-----SQTYSSEV---VT 166
Query: 884 IGYVAPEYGLGG-EASMRGGVYSYGILLLEIF 914
+ Y P+ LG + S ++ G + +E+
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 57/210 (27%), Positives = 106/210 (50%), Gaps = 27/210 (12%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS---FAAECEALRSIRHRNLIKIVT 765
+G G FG V+ G + N VAVK + K G+ S F E +++++H L+++
Sbjct: 14 LGAGQFGEVWMGYYN-NSTKVAVKTL----KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ + + ++ EYM GSL ++L + D+ G + L + ++ +A + Y+
Sbjct: 69 VVTK-----EEPIYIITEYMAKGSLLDFL--KSDEGG--KVLLPKLIDFSAQIAEGMAYI 119
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
+ +H DL+ +NVL+ ++ ++DFGLA+ + + ++ G K I
Sbjct: 120 E---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-------TAREGAKFPIK 169
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ APE G +++ V+S+GILL EI T
Sbjct: 170 WTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-14
Identities = 47/121 (38%), Positives = 63/121 (52%), Gaps = 6/121 (4%)
Query: 518 LGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQI 577
LG+ G IP + L+ + L GNS G IP SL S+TS++ LDLS N+F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 578 PKYLENLSFLQYLNLSYNHFEGEVPTK--GIFKNKTGFSIVGNGKLCG--GLDEL--HLP 631
P+ L L+ L+ LNL+ N G VP G ++ F+ N LCG GL HL
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLS 542
Query: 632 S 632
Sbjct: 543 V 543
|
Length = 623 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 61/237 (25%), Positives = 93/237 (39%), Gaps = 25/237 (10%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
+G+G FG V + G + A K ++ L+++ G + E + L + R
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR-----FI 55
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ + F+ D LV M G L+ ++ +G + + + +E+L
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYN----VGEPGFPEARAIFYAAQIICGLEHL 111
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H Q IV+ DLKP NVLLD +SD GLA L G GT G
Sbjct: 112 H---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---------KKIKGRAGTPG 159
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942
Y+APE G ++ G L E+ R P E + E +R L V
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ-RKEKVEKEELKRRTLEMAV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
I +G++G V+ G + A+KVI + +K E + L + +V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS---PYVVK 57
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ S F+G LV EY+ G L L +G + + + + ++ A+EYL
Sbjct: 58 LYYS--FQGKKNLYLVMEYLPGGDLASLLEN----VGSLDEDVAR--IYIAEIVLALEYL 109
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H + I+H DLKP N+L+D + ++DFGL+K N+ + + GT
Sbjct: 110 HSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
Y+APE LG S +S G +L E
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 29/214 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINL--EQKGGSKSFAAECEALRSIRHRNLIKIVTI 766
IG G++G VYK G +VA+K I L E +G K+ E + L+ + H N+IK++ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
F+ LV+E+M L + + +D Q G+ SLI+ + + + + + H
Sbjct: 67 -----FRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPE-SLIK--SYLYQLLQGLAFCH 115
Query: 827 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGY 886
H I+H DLKP N+L++ + V ++DFGLA+ + T T Y
Sbjct: 116 SH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR---PYTHYVV-----TRWY 164
Query: 887 VAPEYGLGGEASMRG---GVYSYGILLLEIFTRR 917
APE LG ++S G + E+ +RR
Sbjct: 165 RAPELLLG--DKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 16/161 (9%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVK--VINLEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
+G G++G V K G +VA+K + + + K+ E + LR +RH N++ +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
KG + LV+EY++ LE L L ++ + + A+ Y
Sbjct: 68 AFRR---KGRLY--LVFEYVERTLLEL-LEASPGGLPP---DAVRS--YIWQLLQAIAYC 116
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP 866
H H I+H D+KP N+L+ V + DFG A+ L A P
Sbjct: 117 HSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 66/241 (27%), Positives = 114/241 (47%), Gaps = 37/241 (15%)
Query: 709 IGRGSFGFVYK----GVL-HENGMLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNLIK 762
IG+G+FG V++ G+L +E +VAVK++ E ++ F E + H N++K
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQ----------------LGICNL 806
++ +C+ G L++EYM G L E+L R + L L
Sbjct: 73 LLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 807 SLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP 866
S ++L I VA+ + YL + VH DL N L+ +MV ++DFGL++ + ++
Sbjct: 128 SCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 867 LGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFN 925
E + +I I ++ PE + V++YG++L EIF+ +P M +
Sbjct: 185 YYKASE--NDAI----PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238
Query: 926 E 926
E
Sbjct: 239 E 239
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-14
Identities = 50/164 (30%), Positives = 74/164 (45%), Gaps = 32/164 (19%)
Query: 30 SLLAIKSQLHDPLGVTSSWNRSACVNLCQHWTGVTCG----RRNQRVTKLDLRNQSIGGI 85
+L +KS L PL WN CV W+G C + + L L NQ + G
Sbjct: 376 ALQTLKSSLGLPLRF--GWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGF 433
Query: 86 LSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLI 145
+ + L L+ IN++ N G IP +G++ LE L L+ NSF+G IP +L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG------ 487
Query: 146 TFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIG 189
+L S R+ NL G N L+G++PA++G
Sbjct: 488 ---------------QLTSLRILNLNG-----NSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 26/219 (11%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINL--EQKGGSKSFAAECEALRSIRHRNL 760
F IG G++G VYK G +VA+K I L E +G + E L+ + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 761 IKIVTICSSIDFKGVDFKA-LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
+K++ + + + K LV+E++ + L++++ D + + L + + +
Sbjct: 62 VKLLDVIHT------ENKLYLVFEFL-HQDLKKFM----DASPLSGIPLPLIKSYLFQLL 110
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
+ + H H ++H DLKP N+L++ + ++DFGLA+ G V T + +
Sbjct: 111 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEV- 161
Query: 880 VKGTIGYVAPEYGLGGE-ASMRGGVYSYGILLLEIFTRR 917
T+ Y APE LG + S ++S G + E+ TRR
Sbjct: 162 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 8e-14
Identities = 59/230 (25%), Positives = 89/230 (38%), Gaps = 50/230 (21%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA----ECEALRSIRHRNLIK 762
IG G++G V V G VA+K I+ A E + LR +RH N+I
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENIIG 63
Query: 763 IVTICSSIDFKGVDFKAL--VYEYMQNGSLEEWLHQRDD-QLGICNLSLIQRLNIVIDVA 819
++ I DF + V E M+ L + + L Q L
Sbjct: 64 LLDI--LRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQIL------- 113
Query: 820 SAVEYLH--HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
++YLH + ++H DLKPSN+L++ + + DFGLA+ + T
Sbjct: 114 RGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT---- 164
Query: 878 IGVKGTIGYV------APEYGLGGEASMRGG----VYSYGILLLEIFTRR 917
YV APE L S R ++S G + E+ TR+
Sbjct: 165 -------EYVVTRWYRAPELLLS---SSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS-KSFAAECEALRSIRHRNLIKIVTIC 767
IG G+ VY + N VA+K I+LE+ S E +A+ H N++K
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK--YYT 66
Query: 768 SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH 827
S F D LV Y+ GSL + + + G + ++I ++ +V +EYLH
Sbjct: 67 S---FVVGDELWLVMPYLSGGSLLDIMKSSYPR-GGLDEAIIA--TVLKEVLKGLEYLHS 120
Query: 828 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYV 887
+ Q +H D+K N+LL D ++DFG +SAS T GT ++
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFG----VSASLADGGDRTRKVRKTFVGTPCWM 173
Query: 888 APE-----YGLGGEASMRGGVYSYGILLLEIFTRRRP 919
APE +G +A + +S+GI +E+ T P
Sbjct: 174 APEVMEQVHGYDFKADI----WSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 40/218 (18%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVI------NLEQKGGSKSFAAECEALRSIRHRNLIK 762
IGRG+FG V+ G L + VAVK +L+ K F E L+ H N+++
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57
Query: 763 IVTICSSIDFKGVDFKALVY---EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
++ +C+ K +Y E +Q G +L +L + L + +V + A
Sbjct: 58 LIGVCTQ--------KQPIYIVMELVQGGDFLTFLRTEGPRLKVKEL-----IQMVENAA 104
Query: 820 SAVEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
+ +EYL HC +H DL N L+ V +SDFG+++ +S+
Sbjct: 105 AGMEYLESKHC----IHRDLAARNCLVTEKNVLKISDFGMSREEEDG-------VYASTG 153
Query: 879 GVKGT-IGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
G+K + + APE G S V+S+GILL E F+
Sbjct: 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 64/240 (26%), Positives = 107/240 (44%), Gaps = 23/240 (9%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA--ECEALRSIRHRN 759
+F N IG+GSFG V+K V + + A+K I+L + + A E L +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
+I+ S +D KG +V EY +NG L + L + + L Q I +
Sbjct: 61 IIRYYE--SFLD-KGK--LNIVMEYAENGDLHKLLKMQRGR----PLPEDQVWRFFIQIL 111
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
+ +LH I+H D+K N+ LD + D G+AK LS + N T
Sbjct: 112 LGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFANT------ 160
Query: 880 VKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939
+ GT Y++PE + + V++ G++L E T + P ++ N+G + + + P
Sbjct: 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRGVFP 219
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 72/299 (24%), Positives = 128/299 (42%), Gaps = 46/299 (15%)
Query: 708 TIGRGSFGFVY----KGVLHENG-MLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNLI 761
T+GRG FG V+ KG+ E G LV VK + + +S F E + R + H+N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWL---HQRDDQLGICNLSLIQRLNIVIDV 818
+++ +C + + ++ EY G L+++L +D++L LS Q++ + +
Sbjct: 72 RLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
A +++L + VH DL N L+ VS L+K + S +
Sbjct: 127 ALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA----- 178
Query: 879 GVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938
+ ++APE + S + V+S+G+L+ E+FT + GL+ E R L
Sbjct: 179 --LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT----QGELPFYGLSDEEVLNR-L 231
Query: 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997
+E+ P E C + K C +P DR +++V L
Sbjct: 232 QAGKLELPVP-----------------EGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 43/224 (19%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS-----KSFAAECEALRSIRHRNLIKI 763
+G GSFG VY+G+ ++G AVK ++L G + K E L ++H N+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 764 VTICSSIDFKGVDFKALVY-EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
+ D ++ E + GSL + L ++ + L R + +
Sbjct: 68 LGTEREED------NLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTR-----QILLGL 115
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
EYLH VH D+K +N+L+D + V ++DFG+AK V S + KG
Sbjct: 116 EYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK---------QVVEFSFAKSFKG 163
Query: 883 TIGYVAPE-------YGLGGEASMRGGVYSYGILLLEIFTRRRP 919
+ ++APE YGL + ++S G +LE+ T + P
Sbjct: 164 SPYWMAPEVIAQQGGYGLAAD------IWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
+G GS+G VYK + E G +VA+KV+ +E + E L+ ++K
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVK------ 62
Query: 769 SIDFKGVDFKA----LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRL--NIVIDVASAV 822
+ G FK +V EY GS+ D + I N +L + I+ +
Sbjct: 63 ---YYGSYFKNTDLWIVMEYCGAGSV-------SDIMKITNKTLTEEEIAAILYQTLKGL 112
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
EYLH + +H D+K N+LL+ + A ++DFG++ G + +T + V G
Sbjct: 113 EYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVS--------GQLTDTMAKRNTVIG 161
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
T ++APE + + ++S GI +E+ + P
Sbjct: 162 TPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 9/164 (5%)
Query: 703 FSSSNTIGRGSFGFVYKGVL-HENGML--VAVKVINLEQKGGS--KSFAAECEALRSIRH 757
+G G FG V +G L ++G VAVK + L+ S + F +E ++ H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 758 RNLIKIVTIC-SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI 816
N++K++ +C + + + ++ +M++G L +L L L L ++
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
D+A +EYL + +H DL N +L DM V+DFGL+K
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 52/237 (21%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFA---AECEALRSIRHRN 759
F+ IG GSFG VY +VA+K ++ K ++ + E L+ +RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 760 LIKIVTICSSIDFKGVDFKA----LVYEYMQNGSLEEWLH------QRDDQLGICNLSLI 809
+I++KG + LV EY GS + L Q + IC+ +L
Sbjct: 77 ---------TIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGAL- 125
Query: 810 QRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGN 869
+ YLH H + +H D+K N+LL ++DFG A SP +
Sbjct: 126 ----------QGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASL--VSPANS 170
Query: 870 VVETPSSSIGVKGTIGYVAPEYGLG---GEASMRGGVYSYGILLLEIFTRRRPTESM 923
V TP ++APE L G+ + V+S GI +E+ R+ P +M
Sbjct: 171 FVGTPY----------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVI--NLEQKGGSKSFAAECEALRSIRHRNLIKIVTI 766
+G+G+FG V+KG L + VAVK +L Q+ K F +E L+ H N++K++ +
Sbjct: 3 LGKGNFGEVFKGTLKDK-TPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
C+ +V E + G +L ++ D+L Q + +D A+ + YL
Sbjct: 61 CTQ-----RQPIYIVMELVPGGDFLSFLRKKKDEL-----KTKQLVKFALDAAAGMAYLE 110
Query: 827 -HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT-I 884
+C +H DL N L+ + V +SDFG+++ + SS G+K I
Sbjct: 111 SKNC----IHRDLAARNCLVGENNVLKISDFGMSR----QEDDGIY----SSSGLKQIPI 158
Query: 885 GYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ APE G S V+SYGILL E F+
Sbjct: 159 KWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 75/295 (25%), Positives = 120/295 (40%), Gaps = 38/295 (12%)
Query: 709 IGRGSFGFV----YKGVLHENGMLVAVKVINLEQKGG-SKSFAAECEALRSIRHRNLIKI 763
+G G FG V Y G VAVK + E G E E LR++ H N++K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
IC+ G+ L+ E++ +GSL+E+L + +++ +L Q+L + + ++
Sbjct: 72 KGICTEDGGNGIK---LIMEFLPSGSLKEYLPRNKNKI-----NLKQQLKYAVQICKGMD 123
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK-- 881
YL VH DL NVL++ + + DFGL K +ET VK
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK---------AIETDKEYYTVKDD 171
Query: 882 --GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939
+ + APE + + + V+S+G+ L E+ T S + F K P
Sbjct: 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESS------PMTLFLKMIGP 225
Query: 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVV 994
V + LEE + R R C V + C P R +++
Sbjct: 226 THGQMTVTRLVRVLEEGK---RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 63/225 (28%), Positives = 109/225 (48%), Gaps = 34/225 (15%)
Query: 709 IGRGSFGFVYKGVLHENGM----LVAVKV---INLEQKGGSKSFAAECEALRSIRHRNLI 761
+G +FG +YKG L+ GM LVA+K IN Q+ G F E + + H N++
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE--FQQEASLMAELHHPNIV 70
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRD---------DQLGICNLSLIQR- 811
++ + + +++EY+ G L E+L R D+ G SL
Sbjct: 71 CLLGVVTQ-----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 812 -LNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNV 870
L+I I +A+ +EYL H VH DL N+L+ + +SD GL++ + ++ V
Sbjct: 126 FLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182
Query: 871 VETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
P S + ++ ++ PE + G+ S ++S+G++L EIF+
Sbjct: 183 --QPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 38/203 (18%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA----ECEALRSIRH 757
E+ N I G++G VY+ + G +VA+K + +E++ + F E L ++H
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQH 63
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNG--SLEEWLHQRDDQLGICNLSLIQRLNIV 815
N IVT+ + +D +V EY+++ SL E + Q + ++
Sbjct: 64 PN---IVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQP--------FLQSEVKCLM 112
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLG----NVV 871
+ + S V +LH + I+H DLK SN+LL++ + + DFGLA+ SPL VV
Sbjct: 113 LQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVV 168
Query: 872 ETPSSSIGVKGTIGYVAPEYGLG 894
T+ Y APE LG
Sbjct: 169 -----------TLWYRAPELLLG 180
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 69/267 (25%), Positives = 120/267 (44%), Gaps = 29/267 (10%)
Query: 709 IGRGSFGFVYKGV--LHENGMLVAVKVI-NLEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
+G G+FG V KGV + + + VA+KV+ N +K E E + + + +++++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+C + LV E G L ++L + D++ + N+ + V+ ++YL
Sbjct: 63 VCEAEAL------MLVMEMASGGPLNKFLSGKKDEITVSNVVELMH-----QVSMGMKYL 111
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
VH DL NVLL + A +SDFGL+K L A + K +
Sbjct: 112 E---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS-----AGKWPLK 163
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFN-EGLTLHEFAKR-----AL 938
+ APE + S R V+SYGI + E F+ ++P + M E ++ E KR
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAEC 223
Query: 939 PEKVMEIVDPSLLPLEEERTNSRRVRN 965
P ++ ++ + E+R N +V
Sbjct: 224 PPEMYALMKDCWIYKWEDRPNFAKVEE 250
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 55/256 (21%)
Query: 696 LSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI 755
L T F IG G++G VYK + G LVA+K++++ + + E LR
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKY 59
Query: 756 -RHRNLIKIVTICSSIDFKGVDFKA----------LVYEYMQNGS---LEEWLHQRDDQL 801
H N+ F G K LV E GS L + L ++ +L
Sbjct: 60 SNHPNI---------ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL 110
Query: 802 GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS--DFGLA 859
++ I R + + YLH + ++H D+K N+LL + A V DFG++
Sbjct: 111 KEEWIAYILR-----ETLRGLAYLHEN---KVIHRDIKGQNILLTKN--AEVKLVDFGVS 160
Query: 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPE-----YGLGGEASMRGGVYSYGILLLEI- 913
L ++ + ++ I GT ++APE R V+S GI +E+
Sbjct: 161 AQLDST-----LGRRNTFI---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA 212
Query: 914 -----FTRRRPTESMF 924
P ++F
Sbjct: 213 DGKPPLCDMHPMRALF 228
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 25/219 (11%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENG----MLVAVKVI-NLEQKGGSKSFAAECEALRSIR 756
EF +G G+FG VYKG+ G + VA+K + +K E + S+
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 757 HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI 816
+ ++ +++ IC + + L+ + M G L +++ + D +G L LN +
Sbjct: 68 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 116
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
+A + YL +VH DL NVL+ ++DFGLAK L A E
Sbjct: 117 QIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD------EKEYH 167
Query: 877 SIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ G K I ++A E L + + V+SYG+ + E+ T
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNLIKIVTI 766
IGRG++G VY+G G +VA+K+INL+ S E L +R I
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLH-QRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
S KG ++ EY + GS+ + + I +I R +V A++Y+
Sbjct: 68 YGSY-LKGPRL-WIIMEYAEGGSVRTLMKAGPIAEKYIS---VIIR-----EVLVALKYI 117
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H ++H D+K +N+L+ + + DFG+A L + S GT
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL--------NQNSSKRSTFVGTPY 166
Query: 886 YVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRP 919
++APE G+ + ++S GI + E+ T P
Sbjct: 167 WMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-13
Identities = 34/94 (36%), Positives = 54/94 (57%), Gaps = 1/94 (1%)
Query: 348 LYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGT 407
L L + G G +P+ I+ L L NL N I G IPP + ++ +L L + N G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 408 IPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTL 441
IP +G+L +L++L+L+ N L G +P++LG L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 41/261 (15%)
Query: 709 IGRGSFGFV-----YKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKI 763
+G G+FG V Y ++ +LVAVK + K F E E L +++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWL--HQRDDQLGI-----CNLSLIQRLNIVI 816
+C +G D +V+EYM++G L ++L H D L L+ Q L+I
Sbjct: 73 YGVC----VEG-DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
+A+ + YL VH DL N L+ +++ + DFG+++ +V T
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--------DVYSTDYY 176
Query: 877 SIGVKGT--IGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFN-------- 925
+G I ++ PE + + + V+S G++L EIFT ++P + N
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236
Query: 926 EGLTLHEFAKRALPEKVMEIV 946
+G L R P++V +++
Sbjct: 237 QGRVLQR--PRTCPKEVYDLM 255
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 33/225 (14%)
Query: 707 NTIGRGSFGFVYKGVL------HENGMLVAVKVINLEQKGGS----KSFAAECEALRSIR 756
N +G G+FG VY+G + VAVK + +KG + K F E + +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57
Query: 757 HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQ-RDDQLGICNLSLIQRLNIV 815
H N++K++ +C + + ++ E M+ G L +L R ++ G L+L + L+I
Sbjct: 58 HPNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLL-----DHDMVAHVSDFGLAKFLSASPLGNV 870
+DVA YL Q +H DL N L+ D D V + DFGLA+ + S
Sbjct: 113 LDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK 169
Query: 871 VETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ V+ ++APE L G+ + + V+S+G+L+ EI T
Sbjct: 170 --EGEGLLPVR----WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-13
Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 41/230 (17%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSKSFAAECEALRSI 755
N S T+G G+FG V + + + M VAVK++ + ++E EAL S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK------PTAHSSEREALMSE 88
Query: 756 --------RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLS 807
H N++ ++ C+ G ++ EY G L +L ++ + L+
Sbjct: 89 LKIMSHLGNHENIVNLLGACTI---GGPIL--VITEYCCYGDLLNFLRRKRESF----LT 139
Query: 808 LIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK-FLSAS 865
L L+ VA + +L +C +H DL NVLL H + + DFGLA+ ++ S
Sbjct: 140 LEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDS 195
Query: 866 PLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
N V ++ + VK ++APE + V+SYGILL EIF+
Sbjct: 196 ---NYVVKGNARLPVK----WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 50/199 (25%), Positives = 99/199 (49%), Gaps = 18/199 (9%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA--ECEALRSIRHR 758
+++ IG+G+FG V+K + +VA+K + +E + A E + L+ ++H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 759 NLIKIVTICSSIDFKGVDFKA---LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
N++ ++ IC + +K LV+E+ ++ L L ++ + LS I++ ++
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKF---TLSEIKK--VM 125
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
+ + + Y+H + I+H D+K +N+L+ D + ++DFGLA+ S S P+
Sbjct: 126 KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK----PN 178
Query: 876 SSIGVKGTIGYVAPEYGLG 894
T+ Y PE LG
Sbjct: 179 RYTNRVVTLWYRPPELLLG 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 23/224 (10%)
Query: 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFA---AECEALRSIR 756
F IG+G F VYK + +G +VA+K + + + +K+ E + L+ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 757 HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWL-HQRDDQLGICNLSLIQRLNIV 815
H N+IK + S I+ ++ +V E G L + H + + I ++
Sbjct: 61 HPNVIKYLA--SFIENNELN---IVLELADAGDLSRMIKHFKKQKRLIPERTI---WKYF 112
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
+ + SA+E++H I+H D+KP+NV + V + D GL +F S+ +T +
Sbjct: 113 VQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KTTA 162
Query: 876 SSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
+ V GT Y++PE + + ++S G LL E+ + P
Sbjct: 163 AHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 26/197 (13%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRN 759
EF N IG G++G VY+ +G +VA+K + ++ + G S E L ++RH N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQN--GSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
IV + + K +D LV EY + SL + + S Q +++
Sbjct: 68 ---IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMP--------TPFSESQVKCLMLQ 116
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
+ ++YLH + I+H DLK SN+LL ++DFGLA+ + P +
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG------LPAKPMTP 167
Query: 878 IGVKGTIGYVAPEYGLG 894
V T+ Y APE LG
Sbjct: 168 KVV--TLWYRAPELLLG 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 22/195 (11%)
Query: 709 IGRGSFGFVYKGVLHEN--GMLVAVKVI---NLEQKGGSKSFAAECEALRSIRHRNLIKI 763
IGRG++G VYK G A+K + G S+S E LR ++H N++ +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
V + K V L+++Y ++ + R + S+++ +++ + + V
Sbjct: 68 VEVFLEHADKSV---YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK--SLLWQILNGVH 122
Query: 824 YLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
YLH + ++H DLKP+N+L+ V + D GLA+ +PL + +
Sbjct: 123 YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPL----KPLADLDP 174
Query: 880 VKGTIGYVAPEYGLG 894
V TI Y APE LG
Sbjct: 175 VVVTIWYRAPELLLG 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 28/216 (12%)
Query: 708 TIGRGSFGFVYKGVLH---ENGMLVAVKVINLEQKGGSKSFAA--ECEALRSIRHRNLIK 762
+G+G+FG + L+ E+ LV K +NL + + A E L ++H N
Sbjct: 7 VLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN--- 60
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
I+ + + EY G+L + + ++ QL L + + SAV
Sbjct: 61 IIAYYNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQL----FEEEMVLWYLFQIVSAV 114
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
Y+H + I+H D+K N+ L + + DFG++K L + ET V G
Sbjct: 115 SYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM--AET------VVG 163
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR 918
T Y++PE G + + + +++ G +L E+ T +R
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-12
Identities = 35/85 (41%), Positives = 56/85 (65%)
Query: 494 LDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTI 553
L L + L G +P + L+ L + ++ N G IP +LG+ TSLE ++L NSF+G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 554 PQSLSSLTSIKELDLSQNNFSGQIP 578
P+SL LTS++ L+L+ N+ SG++P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 58/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA---ECEALRSIRHRNLIKIVT 765
+G G FG V+ +++ VAVK + K GS S A E +++++H L+K+
Sbjct: 14 LGAGQFGEVWMATYNKHTK-VAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ + + ++ E+M GSL ++L + L + ++ +A + ++
Sbjct: 69 VVTK------EPIYIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQIAEGMAFI 118
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
Q +H DL+ +N+L+ +V ++DFGLA+ + + ++ G K I
Sbjct: 119 E---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-------TAREGAKFPIK 168
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFN 925
+ APE G +++ V+S+GILL+EI T R P M N
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 55/219 (25%), Positives = 107/219 (48%), Gaps = 24/219 (10%)
Query: 708 TIGRGSFGFVYKGVLHENGML--VAVKVINLE--QKGGSKSFAAECEALRSIRHRNLIKI 763
T+G G FG V +G L+++ + VAVK + + + + F +E ++ H N++++
Sbjct: 6 TLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRL 65
Query: 764 VTIC-SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRL--NIVIDVAS 820
+ +C +++ +G ++ +M++G L +L +LG C L ++ + D+AS
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLY--SRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPL---GNVVETPSSS 877
+EYL +H DL N +L+ +M V+DFGL+K + G + + P
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR 916
I ++ V + + V+S+G+ + EI TR
Sbjct: 181 IAIESLADRV---------YTTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS-----KSFAAECEALRSIRHRNLIKI 763
+G+G+FG VY + G +AVK + + + E + L++++H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
C D F EYM GS+++ L G ++ ++ I VE
Sbjct: 70 YG-CLRDDETLSIF----MEYMPGGSVKDQLKA----YGALTETVTRKYTRQI--LEGVE 118
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG---- 879
YLH + IVH D+K +N+L D + DFG +K L +T SS
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL---------QTICSSGTGMKS 166
Query: 880 VKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
V GT +++PE G + V+S G ++E+ T + P
Sbjct: 167 VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 64/234 (27%), Positives = 109/234 (46%), Gaps = 41/234 (17%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEAL-RSIR 756
N+ + IG G+FG V K + ++G+ + + +++ K + FA E E L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 757 HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLH-----QRDDQLGICN-----L 806
H N+I ++ C + +G + A+ EY +G+L ++L + D I N L
Sbjct: 67 HPNIINLLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 807 SLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP 866
S Q L+ DVA ++YL Q +H DL N+L+ + VA ++DFGL++
Sbjct: 122 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------ 172
Query: 867 LGNVVETPSSSIGVKGTIG-----YVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ VK T+G ++A E + V+SYG+LL EI +
Sbjct: 173 --------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 13/157 (8%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
IG G++G VYK G LVA+KVI LE + E L+ RH N IV
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN---IVAYFG 67
Query: 769 SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH 828
S + D +V EY GSL++ L ++ + R + + YLH
Sbjct: 68 S--YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLHET 120
Query: 829 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865
+ +H D+K +N+LL D ++DFG++ L+A+
Sbjct: 121 GK---IHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLE--QKGGSKSFAAECEALRSIR---HRNLIKI 763
IG G++G VYK +G VA+K + ++ + G S E L+ + H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
+ +C++ LV+E++ L +L D++ L +++ ++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYL----DKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
+LH +C IVH DLKP N+L+ ++DFGLA+ S + TP V T
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC----QMALTP-----VVVT 170
Query: 884 IGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
+ Y APE L + ++S G + E+F RR+P
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 28/221 (12%)
Query: 707 NTIGRGSFGFVYKGVLHENG---MLVAVKVIN-LEQKGGSKSFAAECEALRSIRHRNLIK 762
IG+G FG VY G L ++ + AVK +N + + F E ++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
++ IC + +G +V YM++G L ++ R + N ++ + + VA +
Sbjct: 61 LLGIC--LPSEGSPL--VVLPYMKHGDLRNFI--RSETH---NPTVKDLIGFGLQVAKGM 111
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI---- 878
EYL VH DL N +LD V+DFGLA+ ++ + S+
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYYSVHNHT 160
Query: 879 GVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
G K + ++A E + + + V+S+G+LL E+ TR P
Sbjct: 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 36/225 (16%)
Query: 707 NTIGRGSFGFVYKG-VLHENG----MLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNL 760
+G G+FG VY+G +G + VAVK + +S F E + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 761 IKIVTICSSIDFKGVDFKALVY----EYMQNGSLEEWL-HQRDDQLGICNLSLIQRLNIV 815
++++ GV F+ L E M G L+ +L R +L++ L
Sbjct: 72 VRLI---------GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFGLAKFLSASPLGNVVE 872
DVA +YL + +H D+ N LL VA ++DFG+A+ ++
Sbjct: 123 RDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--------DIYR 171
Query: 873 TPSSSIGVKGT--IGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
G + I ++ PE L G + + V+S+G+LL EIF+
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-12
Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 32/232 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
IG+G G VY VA+K I E K F E + + H ++ + +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 766 ICSSID--------FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
ICS D +G K+L+ Q SL + L ++ S+ L+I
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKT--------SVGAFLSIFHK 121
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSA------SPLGNVV 871
+ + +EY+H ++H DLKP N+LL + D+G A F +
Sbjct: 122 ICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 872 ETPSSSIGVKG----TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
SS+ + G T Y+APE LG AS +Y+ G++L ++ T P
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 30/83 (36%), Positives = 52/83 (62%), Gaps = 2/83 (2%)
Query: 154 LVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLS 213
L G IP ++ +L +LQ +++ N + G +P S+G++++L V+D+ N G IP +L
Sbjct: 430 LRGFIPNDI--SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG 487
Query: 214 QLTSLAYLHVGDNHFSGTIPPSV 236
QLTSL L++ N SG +P ++
Sbjct: 488 QLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 33/88 (37%), Positives = 49/88 (55%)
Query: 374 NLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIP 433
L + G IP I+ L +L S+ + N + G IP +G + +L++L L N G+IP
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 434 SSLGNLTLLTYLSFGANNLQGNIPFSLG 461
SLG LT L L+ N+L G +P +LG
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 35/227 (15%)
Query: 708 TIGRGSFGFVYKGVL-----HENGMLVAVKVINLEQKGGSKSFA---AECEALRSI-RHR 758
+G G+FG V K VAVK+ L+ K + +E E ++ I +H+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQR----------DDQLGICNLSL 808
N+I ++ +C+ +G + +V EY +G+L ++L R D + L+
Sbjct: 77 NIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 809 IQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLG 868
++ VA +E+L +H DL NVL+ D V ++DFGLA+ + +
Sbjct: 132 KDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH--ID 186
Query: 869 NVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+T + + VK ++APE + + V+S+G+LL EIFT
Sbjct: 187 YYRKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 44/159 (27%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVI--NLEQKGGSKSFAAECEALRSIRHRNLIKIVTI 766
+G GS+G V K E G +VA+K + + K K E L+ +RH NL+ ++ +
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
F+ LV+E++ + L++ L + + L + S +++ + + +E+ H
Sbjct: 69 -----FRRKKRLYLVFEFVDHTVLDD-LEKYPNGL---DESRVRK--YLFQILRGIEFCH 117
Query: 827 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865
H I+H D+KP N+L+ V + DFG A+ L+A
Sbjct: 118 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENG----MLVAVKVI--NLEQKGGSKSFAAECEALRSI 755
E +G G+FG VYKG+ +G + VA+KV+ N K +K E + +
Sbjct: 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA-NKEILDEAYVMAGV 66
Query: 756 RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
+ +++ IC + + LV + M G L +++ + D++G +L LN
Sbjct: 67 GSPYVCRLLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDL-----LNWC 115
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
+ +A + YL + +VH DL NVL+ ++DFGLA+ L ++ ET
Sbjct: 116 VQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL------DIDETEY 166
Query: 876 SSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ G K I ++A E L + + V+SYG+ + E+ T
Sbjct: 167 HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 39/229 (17%)
Query: 709 IGRGSFGFVYKGVLH-------ENGMLVAVKVINLEQKGGSKSFA---AECEALRSI-RH 757
+G G FG V + + + + VAVK+ L+ K A +E E ++ I +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM--LKDNATDKDLADLISEMELMKLIGKH 77
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQR-----DDQLGICN-----LS 807
+N+I ++ +C+ +G + ++ EY G+L E+L R D I LS
Sbjct: 78 KNIINLLGVCTQ---EGPLY--VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132
Query: 808 LIQRLNIVIDVASAVEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP 866
++ VA +EYL C +H DL NVL+ D V ++DFGLA+
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLAR--GVHD 186
Query: 867 LGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ +T + + VK ++APE + + V+S+GIL+ EIFT
Sbjct: 187 IDYYKKTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 66/237 (27%), Positives = 102/237 (43%), Gaps = 22/237 (9%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
+G+G FG V + G L A K +N L+++ G + E L + R IV+
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRF---IVS 57
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ + K D LV M G L ++ D++ + + S +E+L
Sbjct: 58 LAYAFQTK-TDL-CLVMTIMNGGDLRYHIYNVDEENP--GFPEPRACFYTAQIISGLEHL 113
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H I++ DLKP NVLLD+D +SD GLA L + S + G GT G
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK--------DGQSKTKGYAGTPG 162
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942
++APE G E ++ G+ L E+ R P + E + E +R L + V
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR-GEKVENKELKQRILNDSV 218
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 24/217 (11%)
Query: 709 IGRGSFGFVYKGV-LHENGMLVAVKVINL--EQKGGSKSFAAECEALR---SIRHRNLIK 762
IG G++G V+K L G VA+K + + ++G S E LR + H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
+ +C+ LV+E++ L +L + + G+ ++ +++ + +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEP-GVPTETI---KDMMFQLLRGL 123
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
++LH H +VH DLKP N+L+ ++DFGLA+ S V
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--------- 171
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
T+ Y APE L + ++S G + E+F RR+P
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 728 LVAVKVINL-EQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQ 786
LVAVKV+ + F E + L + N+ +++ +C+ ++ EYM+
Sbjct: 48 LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV-----DPPLCMIMEYME 102
Query: 787 NGSLEEWL--HQRDDQLGICNLSLIQR---LNIVIDVASAVEYLHHHCQPPIVHGDLKPS 841
NG L ++L H + CN + L + +AS + YL VH DL
Sbjct: 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159
Query: 842 NVLLDHDMVAHVSDFGLAKFLSASPL----GNVVETPSSSIGVKGTIGYVAPEYGLGGEA 897
N L+ + ++DFG+++ L +S G P I ++A E L G+
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAP-LP---------IRWMAWESVLLGKF 209
Query: 898 SMRGGVYSYGILLLEIFT--RRRPTESMFNE 926
+ + V+++G+ L EI T R +P E + ++
Sbjct: 210 TTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 44/226 (19%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNL 760
F+ IG+GSFG VYK + +VA+KVI+LE EA I ++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE------------EAEDEI--EDI 46
Query: 761 IKIVTICSSIDFKGV---------DFK-ALVYEYMQNGSLEEWLH-QRDDQLGICNLSLI 809
+ + S + K ++ EY GS + L + D+ I
Sbjct: 47 QQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIA----- 101
Query: 810 QRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGN 869
I+ +V +EYL H + I H D+K +N+LL + ++DFG++ G
Sbjct: 102 ---FILREVLLGLEYL--HEEGKI-HRDIKAANILLSEEGDVKLADFGVS--------GQ 147
Query: 870 VVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ T S GT ++APE + ++S GI +E+
Sbjct: 148 LTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 15/220 (6%)
Query: 703 FSSSNTIGRGSFGFVYKGVLH-ENGML--VAVKVINLEQKGGS--KSFAAECEALRSIRH 757
F+ +G+G FG V + L E+G VAVK++ + S + F E ++ H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 758 RNLIKIVTICSSIDFKG-VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI 816
N+IK++ + KG + ++ +M++G L +L L L + +I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
D+AS +EYL +H DL N +L+ +M V+DFGL+K + + G+ +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYS---GDYYRQGCA 174
Query: 877 SIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR 916
S K + ++A E + V+++G+ + EI TR
Sbjct: 175 S---KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 70/269 (26%), Positives = 116/269 (43%), Gaps = 46/269 (17%)
Query: 709 IGRGSFGFVYKGVLHENGM-LVAVKVINL-------EQKGGSKSFA---AECEALR-SIR 756
+G G+FG VYK NG L+A+K IN+ +++ KS +E ++ +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 757 HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI 816
H N+++ F D +V + ++ L E + ++ + + NI +
Sbjct: 68 HPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQ--RFTEERIWNIFV 120
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
+ A+ YLH + IVH DL P+N++L D ++DFGLAK + P S
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK----------QKQPES 168
Query: 877 SI-GVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935
+ V GTI Y PE + V+++G +L ++ T + P S L+L
Sbjct: 169 KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS--TNMLSL----- 221
Query: 936 RALPEKVMEIVDPSLLPLEEERTNSRRVR 964
+IV+ PL E S V
Sbjct: 222 ------ATKIVEAVYEPLPEG-MYSEDVT 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 58/228 (25%), Positives = 108/228 (47%), Gaps = 35/228 (15%)
Query: 709 IGRGSFGFVY----KGVLHENGM----------LVAVKVINLE-QKGGSKSFAAECEALR 753
+G G FG V+ +G+ G LVAVK++ + K F E + +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 754 SIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRD--DQLGICN----LS 807
+++ N+I+++ +C S D ++ EYM+NG L ++L QR+ N +S
Sbjct: 73 RLKNPNIIRLLGVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 808 LIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPL 867
+ L + + +AS ++YL VH DL N L+ + ++DFG+++ L +
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS--- 181
Query: 868 GNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
G+ ++ I ++A E L G+ + V+++G+ L E+FT
Sbjct: 182 GDYYRIQGRAV---LPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 56/188 (29%), Positives = 79/188 (42%), Gaps = 32/188 (17%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFA---AECEALRSIRHRNLIKIV 764
T+G GSFG V +G A+K+++ + K E L+SIRH L+ +
Sbjct: 8 TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67
Query: 765 TICSSIDFKGVDFKAL--VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
F+ D L V EY+ G L L + V A+
Sbjct: 68 G-----SFQ--DDSNLYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLAL 114
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
EYLH IV+ DLKP N+LLD D ++DFG AK V+ + ++ G
Sbjct: 115 EYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAK---------RVKGRTYTLC--G 160
Query: 883 TIGYVAPE 890
T Y+APE
Sbjct: 161 TPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-11
Identities = 33/82 (40%), Positives = 51/82 (62%), Gaps = 1/82 (1%)
Query: 476 LTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGA 535
L G +P I ++ L S++LS N + G++P +G++ SL L ++ N F+G IP +LG
Sbjct: 430 LRGFIPNDISKLRHLQ-SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 536 CTSLEYVELQGNSFSGTIPQSL 557
TSL + L GNS SG +P +L
Sbjct: 489 LTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 57/175 (32%), Positives = 84/175 (48%), Gaps = 31/175 (17%)
Query: 690 MVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAEC 749
+ +YK+L K +G GS+ VYKG G LVA+K I LE + G+ F A
Sbjct: 4 LETYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIR 52
Query: 750 EA--LRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICN-- 805
EA L+ ++H N IVT+ I K LV+EY+ L++++ L + N
Sbjct: 53 EASLLKDLKHAN---IVTLHDIIHTK--KTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVR 106
Query: 806 LSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
L L Q L + Y H ++H DLKP N+L+ ++DFGLA+
Sbjct: 107 LFLFQLLR-------GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 58/231 (25%), Positives = 103/231 (44%), Gaps = 47/231 (20%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE-QKGGSKSFAA-ECEALRSIRHRN 759
+++ IG G++G VYKG + G +VA+K I LE ++ G S A E L+ ++H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 760 LIKIVTICSS-------IDFKGVDFKALV-----YEYMQNGSLEEWLHQRDDQLGICNLS 807
++ + + +F +D K + +YM ++ +L+Q
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQ----------- 109
Query: 808 LIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPL 867
+ + + H ++H DLKP N+L+D+ V ++DFGLA+
Sbjct: 110 ----------ILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR-----AF 151
Query: 868 GNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRR 917
G V + + T+ Y APE LG S ++S G + E+ T++
Sbjct: 152 GIPVRVYTHEV---VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 49/171 (28%), Positives = 75/171 (43%), Gaps = 33/171 (19%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA---------ECEALRSIRHR 758
IG G++G V + +G VA+K I +F E + LR +H
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKI-------PHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 759 NLIKIVTICSSIDFKGVDFKA--LVYEYMQNGSLEEWLHQRDD-QLGICNLSLIQRLNIV 815
N+I I I G DFK +V + M++ L +H L Q L
Sbjct: 65 NIIAIRDILRP---PGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR-- 118
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP 866
++Y+H ++H DLKPSN+L++ D + DFG+A+ LS+SP
Sbjct: 119 -----GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 63/272 (23%), Positives = 121/272 (44%), Gaps = 36/272 (13%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFA---AECEALRSIRHRN 759
F IGRG F VY+ +G+ VA+K + + +K+ A E + L+ + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
+IK S I+ ++ +V E G L + Q + + + + +
Sbjct: 64 VIKYYA--SFIEDNELN---IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY--FVQLC 116
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
SA+E++H ++H D+KP+NV + V + D GL +F S+ +++
Sbjct: 117 SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--------TTAAHS 165
Query: 880 VKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR--- 936
+ GT Y++PE + + ++S G LL E+ + P + + + L+ K+
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEQ 222
Query: 937 ----ALP-----EKVMEIVDPSLLPLEEERTN 959
LP E++ ++V+ + P E+R +
Sbjct: 223 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPD 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-11
Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 37/228 (16%)
Query: 709 IGRGSFGFVYK----GVLHE---NGMLVAVKVINLEQKGGSKSFA---AECEALRSI-RH 757
+G G FG V G+ + + VAVK+ L+ K + +E E ++ I +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQR-----DDQLGIC-----NLS 807
+N+I ++ C+ + LV EY G+L E+L R D C L+
Sbjct: 78 KNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 808 LIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPL 867
++ VA +EYL +H DL NVL+ D V ++DFGLA+ +
Sbjct: 133 FKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR--DVHNI 187
Query: 868 GNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+T + + VK ++APE + + V+S+G+LL EIFT
Sbjct: 188 DYYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 58/226 (25%), Positives = 86/226 (38%), Gaps = 46/226 (20%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVI---NLEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
I +G+FG VY G A+KV+ ++ K + AE R+I
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE----RAIMMIQGESPYV 59
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRL---------NIVI 816
F+ D+ LV EY+ G SLI+ L +
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCA---------------SLIKTLGGLPEDWAKQYIA 104
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
+V VE LH Q I+H D+KP N+L+D ++DFGL++ N +E
Sbjct: 105 EVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR--------NGLENKKF 153
Query: 877 SIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922
GT Y+APE LG +S G ++ E P +
Sbjct: 154 V----GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 78/299 (26%), Positives = 121/299 (40%), Gaps = 58/299 (19%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFA---AECEALRSIRHRN 759
F + IG GSFG VY +VAVK ++ K ++ + E + L+ ++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 760 LIKIVTICSSIDFKGVDFKA----LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
+I++KG K LV EY GS + L L ++ I
Sbjct: 83 ---------TIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITH---- 128
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
+ YLH H ++H D+K N+LL ++DFG A +SP + V TP
Sbjct: 129 -GALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK--SSPANSFVGTPY 182
Query: 876 SSIGVKGTIGYVAPEYGLG---GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHE 932
++APE L G+ + V+S GI +E+ R+ P +M N L+
Sbjct: 183 ----------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYH 231
Query: 933 FAKRALP--------EKVMEIVDPSLLPLEEERTNS---------RRVRNEECLVAVIK 974
A+ P + VD L + +ER S RR R L+ +I+
Sbjct: 232 IAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQ 290
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 36/101 (35%), Positives = 55/101 (54%), Gaps = 2/101 (1%)
Query: 177 DNQ-LTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPS 235
DNQ L G +P I L L+ I++ N + G IP +L +TSL L + N F+G+IP S
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 236 VYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNN 276
+ ++SL + L GN +G +P +G R +T+N
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALG-GRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 41/228 (17%)
Query: 707 NTIGRGSFGFVYKGVLHENG--MLVAVKVIN-LEQKGGSKSFAAECEALRSI-RHRNLIK 762
+ IG G+FG V + ++ ++G M A+K++ + + FA E E L + H N+I
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQR----------DDQLGICNLSLIQRL 812
++ C + +G + A+ EY G+L ++L + + L+ Q L
Sbjct: 68 LLGACEN---RGYLYIAI--EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 813 NIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVE 872
DVA+ ++YL + +H DL NVL+ ++ + ++DFGL++
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR------------ 167
Query: 873 TPSSSIGVKGTIG-----YVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ VK T+G ++A E + + V+S+G+LL EI +
Sbjct: 168 --GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 63/244 (25%), Positives = 111/244 (45%), Gaps = 46/244 (18%)
Query: 695 ELSKATNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGG-SKSFAAE 748
E++ +T F +G FG VYKG L E VA+K + + +G + F E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 749 CEALRSIRHRN---LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQR-------- 797
++H N L+ +VT + ++++ Y + L E+L R
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPL--------SMIFSYCSHSDLHEFLVMRSPHSDVGS 110
Query: 798 --DDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855
DD+ L ++IV +A+ +E+L H +VH DL NVL+ + +SD
Sbjct: 111 TDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISD 167
Query: 856 FGLAKFLSASP----LGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLL 911
GL + + A+ +GN + P I +++PE + G+ S+ ++SYG++L
Sbjct: 168 LGLFREVYAADYYKLMGNSL-LP---------IRWMSPEAIMYGKFSIDSDIWSYGVVLW 217
Query: 912 EIFT 915
E+F+
Sbjct: 218 EVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 61/244 (25%), Positives = 106/244 (43%), Gaps = 40/244 (16%)
Query: 702 EFSSSN---TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHR 758
E+ + +G+G++G VY + +A+K I + E ++HR
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
N+++ + S F FK + E + GSL L + L ++I +++
Sbjct: 66 NIVQYLGSDSENGF----FK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE- 119
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
++YLH + IVH D+K NVL++ + V +SDFG +K L+ + ET
Sbjct: 120 --GLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTET---- 168
Query: 878 IGVKGTIGYVAPEY------GLGGEASMRGGVYSYGILLLEIFTRR-------RPTESMF 924
GT+ Y+APE G G A ++S G ++E+ T + P +MF
Sbjct: 169 --FTGTLQYMAPEVIDKGPRGYGAPAD----IWSLGCTIVEMATGKPPFIELGEPQAAMF 222
Query: 925 NEGL 928
G+
Sbjct: 223 KVGM 226
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 37/216 (17%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
IG+G+FG VY+ + + A+KV++ K A+ E +I RN++ +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS------KKEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 769 SIDFKGVDFK-------ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI-DVAS 820
S G+ F LV +YM G L W Q++ + R I ++
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELF-WHLQKEGRFSE------DRAKFYIAELVL 107
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF-LSASPLGNVVETPSSSIG 879
A+E+LH + IV+ DLKP N+LLD + DFGL+K L+ + N
Sbjct: 108 ALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--------- 155
Query: 880 VKGTIGYVAPEYGLGGEASMRGGV--YSYGILLLEI 913
GT Y+APE L E V +S G+L+ E+
Sbjct: 156 FCGTTEYLAPEV-LLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 51/165 (30%), Positives = 71/165 (43%), Gaps = 34/165 (20%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVIN--LEQKGGSKSFAAECEALRSIRHRNLIKIVTI 766
IGRG++G V E VA+K I + + +K E + LR + H N+I I I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 767 CSSID---FKGVDFKALVYEYMQNGSLEEWLHQ--------RDDQLGICNLSLIQRLNIV 815
F V +VYE M LHQ DD C L Q L
Sbjct: 73 MPPPHREAFNDV---YIVYELMDTD-----LHQIIRSSQTLSDDH---CQYFLYQLLR-- 119
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
++Y+H ++H DLKPSN+LL+ + + DFGLA+
Sbjct: 120 -----GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 77/245 (31%), Positives = 121/245 (49%), Gaps = 13/245 (5%)
Query: 378 NQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELK-NLQLLHLHANFLQGTIPSSL 436
N++ I + L NL SL ++ N +T IP +IG LK NL+ L L N ++ ++PS L
Sbjct: 103 NRLRSNISE-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPL 159
Query: 437 GNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDL 496
NL L L N+L ++P L N NL NK++ LP +I ++ L LDL
Sbjct: 160 RNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE-ELDL 216
Query: 497 SDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQS 556
S+N + L + NLK+L L ++ N+ +P ++G ++LE ++L N + S
Sbjct: 217 SNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ--ISSISS 272
Query: 557 LSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIV 616
L SLT+++ELDLS N+ S L L L L + + +I+
Sbjct: 273 LGSLTNLRELDLSGNSLSN--ALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNIL 330
Query: 617 GNGKL 621
NG+
Sbjct: 331 SNGET 335
|
Length = 394 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 38/229 (16%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIK 762
F+ IG+GSFG V+KG+ + +VA+K+I+LE+ AE E + I+ I
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54
Query: 763 IVTICSS---IDFKGVDFKA----LVYEYMQNGSLEEWLHQRD-DQLGICNLSLIQRLNI 814
+++ C S + G K ++ EY+ GS + L D+ I +
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATM-------- 106
Query: 815 VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETP 874
+ ++ ++YLH + +H D+K +NVLL ++DFG+A G + +T
Sbjct: 107 LKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA--------GQLTDTQ 155
Query: 875 SSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923
GT ++APE + ++S GI +E+ P M
Sbjct: 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 52/171 (30%), Positives = 86/171 (50%), Gaps = 27/171 (15%)
Query: 692 SYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA--EC 749
SY++L K +G GS+ VYKG NG LVA+KVI L+++ G+ F A E
Sbjct: 6 SYEKLEK----------LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREA 54
Query: 750 EALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLI 809
L+ ++H N++ + I + + LV+EY+ L +++ + L N+ L
Sbjct: 55 SLLKGLKHANIVLLHDIIHT-----KETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKL- 107
Query: 810 QRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
+ + + Y+H Q I+H DLKP N+L+ ++DFGLA+
Sbjct: 108 ----FLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIK 762
F+ IG+GSFG V+KG+ + +VA+K+I+LE+ AE E + I+ I
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54
Query: 763 IVTICSS---IDFKGVDFKA----LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
+++ C S + G K ++ EY+ GS + L L Q I+
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATIL 107
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
++ ++YLH + +H D+K +NVLL ++DFG+A G + +T
Sbjct: 108 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--------GQLTDTQI 156
Query: 876 SSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922
GT ++APE + ++S GI +E+ + P S
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPHS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 36/228 (15%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIK 762
F+ IG+GSFG VYKG+ + +VA+K+I+LE+ AE E + I+ I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54
Query: 763 IVTICSS---IDFKGVDFKA----LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
+++ C S + G K ++ EY+ GS + L + L ++ I R
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILR---- 108
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
++ ++YLH + +H D+K +NVLL ++DFG+A G + +T
Sbjct: 109 -EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVA--------GQLTDTQI 156
Query: 876 SSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923
GT ++APE + ++S GI +E+ P +
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 74/288 (25%), Positives = 115/288 (39%), Gaps = 55/288 (19%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFA---AECEALRSIRHRN 759
FS IG GSFG VY N +VA+K ++ K ++ + E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 760 LIKIVTICSSIDFKGVDFKA----LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
+I ++G + LV EY GS + L L Q + I
Sbjct: 77 ---------TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPL--------QEVEIA 118
Query: 816 IDVASAVE---YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVE 872
A++ YLH H ++H D+K N+LL + + DFG A + +P V
Sbjct: 119 AVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM--APANXFVG 173
Query: 873 TPSSSIGVKGTIGYVAPEYGLG---GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLT 929
TP ++APE L G+ + V+S GI +E+ R+ P +M N
Sbjct: 174 TPY----------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSA 222
Query: 930 LHEFAKRALP--------EKVMEIVDPSLLPLEEERTNSRRVRNEECL 969
L+ A+ P E VD L + ++R S + +
Sbjct: 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 36/218 (16%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAA-ECEALRSIRHRNLIKIVTI 766
IG G++G VYK G +VA+K I LE G S A E L+ + H N+++++ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 767 CSSIDFKGVDFKA-LVYEYMQNGSLEEWL-HQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
S + K LV+E++ + L++++ L LI+ + + + Y
Sbjct: 67 VHS------ENKLYLVFEFL-DLDLKKYMDSSPLTGLD---PPLIKSY--LYQLLQGIAY 114
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGN----VVETPSSSIGV 880
H H ++H DLKP N+L+D + ++DFGLA+ P+ VV
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV--------- 161
Query: 881 KGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRR 917
T+ Y APE LG S ++S G + E+ RR
Sbjct: 162 --TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 55/229 (24%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 709 IGRGSFGFVYKGVLHENG---MLVAVKVINLEQKGGS----KSFAAECEALRSIRHRNLI 761
+G G FG + +G L + VA+ + + G S + F AE L H N++
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTL---RAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 762 K---IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
+ ++T +++ +V EYM NG+L+ +L + + Q L Q + ++ +
Sbjct: 70 RLEGVITRGNTM--------MIVTEYMSNGALDSFLRKHEGQ-----LVAGQLMGMLPGL 116
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
AS ++YL + VH L VL++ D+V +S F + + E +++
Sbjct: 117 ASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ-------EDKSEAIYTTM 166
Query: 879 GVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
K + + APE S V+S+GI++ E+ + RP M +
Sbjct: 167 SGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 28/174 (16%)
Query: 693 YKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVK-VINLEQKGGSKSFAA-ECE 750
Y++LSK IG GS+G V+K E G +VA+K + E K A E
Sbjct: 3 YEKLSK----------IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR 52
Query: 751 ALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQ 810
L+ ++H NL+ ++ + F+ LV+EY + L E L + + LI+
Sbjct: 53 MLKQLKHPNLVNLIEV-----FRRKRKLHLVFEYCDHTVLNE-LEKNPRGV---PEHLIK 103
Query: 811 RLNIVIDVASAVEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863
+ I+ AV + H H+C +H D+KP N+L+ + DFG A+ L+
Sbjct: 104 K--IIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILT 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 53/226 (23%), Positives = 102/226 (45%), Gaps = 32/226 (14%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHE----NGMLVAVKVINLEQKGGSKS----FAAECEALRS 754
+ S+ + G+FG ++ G+L + V VK + + S+ E L
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV---KDHASEIQVTLLLQESCLLYG 64
Query: 755 IRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQ-RD-DQLGICNLSLIQRL 812
+ H+N++ I+ +C + ++Y YM G+L+ +L Q R + LS Q +
Sbjct: 65 LSHQNILPILHVCIE----DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 813 NIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP---LGN 869
++ I +A + YLH ++H D+ N ++D ++ ++D L++ L LG+
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 870 VVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
P + ++A E + E S V+S+G+LL E+ T
Sbjct: 178 NENRP---------VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 26/199 (13%)
Query: 729 VAVKVINLEQKGGSKS-FAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVYEYMQ 786
VAVK++ + S +E E ++ I +H+N+I ++ C+ G + ++ EY
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYAS 107
Query: 787 NGSLEEWLHQR----------DDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHG 836
G+L E+L R Q+ LS ++ VA +EYL +H
Sbjct: 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHR 164
Query: 837 DLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE 896
DL NVL+ D V ++DFGLA+ + + +T + + VK ++APE
Sbjct: 165 DLAARNVLVTEDNVMKIADFGLARDIHH--IDYYKKTTNGRLPVK----WMAPEALFDRI 218
Query: 897 ASMRGGVYSYGILLLEIFT 915
+ + V+S+G+LL EIFT
Sbjct: 219 YTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 7e-10
Identities = 79/301 (26%), Positives = 124/301 (41%), Gaps = 62/301 (20%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFA---AECEALRSIRHRN 759
F+ IG GSFG VY +VA+K ++ K ++ + E + L+ I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 760 LIKIVTICSSIDFKGVDFKA----LVYEYMQNGSLEEWL--HQRDDQLGICNLSLIQRLN 813
SI++KG + LV EY GS + L H++ L ++
Sbjct: 87 ---------SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKP-------LQEVEIAA 129
Query: 814 IVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVET 873
I + YLH H ++H D+K N+LL ++DFG A ASP + V T
Sbjct: 130 ITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI--ASPANSFVGT 184
Query: 874 PSSSIGVKGTIGYVAPEYGLG---GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL 930
P ++APE L G+ + V+S GI +E+ R+ P +M N L
Sbjct: 185 PY----------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSAL 233
Query: 931 HEFAKRALP--------EKVMEIVDPSLLPLEEERTNSR---------RVRNEECLVAVI 973
+ A+ P + VD L + ++R S R R E L+ +I
Sbjct: 234 YHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLI 293
Query: 974 K 974
+
Sbjct: 294 Q 294
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 14/155 (9%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG---SKSFAAECEALRSIRHRNLIKIVT 765
IG G FG V G ++ V V L F E + RS++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLH-QRDDQLGICNLSLIQRLNIVIDVASAVEY 824
C+ V LV E+ G L+ +L R +L + + +QR+ ++A + +
Sbjct: 63 QCTE-----VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLH 115
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859
LH + +H DL N LL D+ + D+GL+
Sbjct: 116 LHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 7e-10
Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 57/188 (30%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA---ECEALRSIR--------- 756
+G+G++G V+K + +VA+K K F A +A R+ R
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALK----------KIFDAFRNATDAQRTFREIMFLQELG 64
Query: 757 -HRNLIKIVTICSSIDFKGVDFKA-------LVYEYMQNGSLEEWLHQ--RDDQLGICNL 806
H N++K++ + KA LV+EYM E LH R I L
Sbjct: 65 DHPNIVKLLNV----------IKAENDKDIYLVFEYM-----ETDLHAVIRA---NI--L 104
Query: 807 SLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP 866
+ + I+ + A++Y+H ++H DLKPSN+LL+ D ++DFGLA+ S S
Sbjct: 105 EDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLAR--SLSE 159
Query: 867 LGNVVETP 874
L E P
Sbjct: 160 LEENPENP 167
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-10
Identities = 66/259 (25%), Positives = 108/259 (41%), Gaps = 51/259 (19%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTI 766
+G G+ G VYK ++AVKVI L+ E + I ++I+
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLD---------ITVELQKQIMSE--LEILYK 55
Query: 767 CSS---IDFKGVDFK----ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
C S I F G F ++ E+M GSL+ + + LG I + V
Sbjct: 56 CDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG----------RIAVAVV 105
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
+ YL I+H D+KPSN+L++ + DFG++ L S V
Sbjct: 106 KGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-------- 154
Query: 880 VKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939
GT Y+APE G + + V+S GI +E+ R P + +L +P
Sbjct: 155 --GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-------MP 205
Query: 940 EKVMEIV---DPSLLPLEE 955
++++ + DP +LP+ +
Sbjct: 206 LQLLQCIVDEDPPVLPVGQ 224
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 67/252 (26%), Positives = 117/252 (46%), Gaps = 43/252 (17%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
IG GS G V + +G LVAVK ++L ++ + E +R +H N++++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 84
Query: 769 SIDFKGVDFKALVYEYMQNGSLEEWL-HQR--DDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ D +V E+++ G+L + + H R ++Q+ L++++ L+++
Sbjct: 85 --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVL---------- 132
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H Q ++H D+K ++LL HD +SDFG +S E P V GT
Sbjct: 133 --HAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-------EVPRRKSLV-GTPY 181
Query: 886 YVAPE----YGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNE-GLTLHEFAKRALPE 940
++APE G E ++S GI+++E+ P FNE L + + LP
Sbjct: 182 WMAPELISRLPYGPEVD----IWSLGIMVIEMVDGEPP---YFNEPPLKAMKMIRDNLPP 234
Query: 941 KV--MEIVDPSL 950
K+ + V PSL
Sbjct: 235 KLKNLHKVSPSL 246
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 40/198 (20%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVK------VINLEQKGGSKSFAAECEALRSI 755
+ T+G G+FG V+ + A+K VI L+Q+ + E L+ +
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKEV 58
Query: 756 RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQR---DDQLGICNLSLIQRL 812
H +I++ + D + F ++ EY+ G L +L + G+ S
Sbjct: 59 SHPFIIRL--FWTEHDQR---FLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS----- 108
Query: 813 NIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVE 872
++ A+EYLH IV+ DLKP N+LLD + ++DFG AK L
Sbjct: 109 ----EIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--------- 152
Query: 873 TPSSSIGVKGTIGYVAPE 890
+ + GT Y+APE
Sbjct: 153 --DRTWTLCGTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 60/214 (28%), Positives = 86/214 (40%), Gaps = 26/214 (12%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
+G G FG V + A+K + + + G + +E E L H ++K+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ D K + + EY G L L R + V A EYL
Sbjct: 60 -RTFKDKKYIYM---LMEYCLGGELWTILRDRG------LFDEYTARFYIACVVLAFEYL 109
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H+ I++ DLKP N+LLD + + DFG AK L + +T + GT
Sbjct: 110 HNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAK-----KLKSGQKTWT----FCGTPE 157
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
YVAPE L +S GILL E+ T R P
Sbjct: 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 21/221 (9%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS---FAAECEALRSIRHR 758
F IGRG F VY+ + VA+K + + + +K+ E + L+ + H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
N+IK + S I+ ++ +V E G L + + Q + + + + +
Sbjct: 63 NVIKYLD--SFIEDNELN---IVLELADAGDLSQMIKYFKKQKRLIPERTVWKY--FVQL 115
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
SAVE++H ++H D+KP+NV + V + D GL +F S+ +++
Sbjct: 116 CSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--------TTAAH 164
Query: 879 GVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
+ GT Y++PE + + ++S G LL E+ + P
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 57/241 (23%), Positives = 106/241 (43%), Gaps = 29/241 (12%)
Query: 699 ATNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSK-SFAAECEAL 752
A + + S +G+GSFG VY+G+ E VA+K +N + F E +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 753 RSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQ-RDDQLGICNLS---L 808
+ ++++++ + S V + E M G L+ +L R + + L
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118
Query: 809 IQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLG 868
+ + + ++A + YL+ + VH DL N ++ D + DFG+ +
Sbjct: 119 KKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-------- 167
Query: 869 NVVETPSSSIGVKG--TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFN 925
++ ET G KG + +++PE G + V+S+G++L EI T +P + M N
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227
Query: 926 E 926
E
Sbjct: 228 E 228
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-09
Identities = 31/78 (39%), Positives = 46/78 (58%)
Query: 404 LTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNC 463
L G IP+ I +L++LQ ++L N ++G IP SLG++T L L N+ G+IP SLG
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 464 KNLMFFFAPRNKLTGALP 481
+L N L+G +P
Sbjct: 490 TSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 25/220 (11%)
Query: 709 IGRGSFGFVYKGVLH--ENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIV 764
+G G+FG V KG+ ++ VAVK++ + + E ++ + + +++++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
IC + + LV E + G L ++L Q++ + N++ +V V+ ++Y
Sbjct: 63 GICEAESW------MLVMELAELGPLNKFL-QKNKHVTEKNIT-----ELVHQVSMGMKY 110
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
L VH DL NVLL A +SDFGL+K L A N + + K +
Sbjct: 111 LEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE--NYYKAKTHG---KWPV 162
Query: 885 GYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESM 923
+ APE + S + V+S+G+L+ E F+ ++P + M
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 63/248 (25%), Positives = 105/248 (42%), Gaps = 54/248 (21%)
Query: 692 SYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVK-VINLEQKGGSKSFAA-EC 749
Y+ L K +G G+FG VYK + G +VA+K ++ +K G A E
Sbjct: 9 DYEILGK----------LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREI 58
Query: 750 EALRSIRHRNLIKIVTICSSIDFKGVDFKALVY---EYMQ---NGSLEEWLHQRDDQLGI 803
+ L+ ++H N++ ++ + K + VY YM +G LE +
Sbjct: 59 KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE---NPS------ 109
Query: 804 CNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863
L+ Q ++ + + YLH + I+H D+K +N+L+D+ + ++DFGLA+
Sbjct: 110 VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR--- 163
Query: 864 ASPLGNVVETPSSSIGVKGTIG------------YVAPEYGLGGEASMRGGVYSYGI--L 909
+ P + G G Y PE L GE V +GI +
Sbjct: 164 ------PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPEL-LLGERRYTTAVDIWGIGCV 216
Query: 910 LLEIFTRR 917
E+FTRR
Sbjct: 217 FAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 708 TIGRGSFGFVYKGV--LHENGML-VAVKV--INLEQKGGSKSFAAECEALRSIRHRNLIK 762
IG G FG VY+GV EN + VAVK K F E +R H +++K
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHIVK 71
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
++ + + + +V E G L +L L + +L L +++A+
Sbjct: 72 LIGVIT------ENPVWIVMELAPLGELRSYLQVNKYSLDLASLIL-----YSYQLSTAL 120
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
YL VH D+ NVL+ + DFGL+++L +S G K
Sbjct: 121 AYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE------SYYKASKG-KL 170
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR 916
I ++APE + V+ +G+ + EI
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILML 204
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
+G+GS+G VYK + A+K ++L GS S +A+ IR ++ V +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDL----GSMSQKEREDAVNEIR---ILASVNHPN 60
Query: 769 SIDFKG--VDFKAL--VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
I +K +D L V EY G L + + +R + + I R I I + ++
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR--IFIQLLRGLQA 118
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
LH I+H DLK +N+LL + + + D G++K L + + TP
Sbjct: 119 LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH--------- 166
Query: 885 GYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTE 921
Y+APE G S + ++S G LL E+ T P E
Sbjct: 167 -YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 37/108 (34%), Positives = 52/108 (48%), Gaps = 25/108 (23%)
Query: 428 LQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEI 487
L+G IP+ + L L ++ N+++GNIP SLG+ I
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGS------------------------I 465
Query: 488 TTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGA 535
T+L LDLS N NGS+P +G L SL L + N SG++P LG
Sbjct: 466 TSLE-VLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-GSKSFAA-ECEALRSIRHRNLIKIVTI 766
IG G++G VYK +A+K I LEQ+ G S A E L+ ++H N++++ +
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 767 CSSIDFKGVDFKA-LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
S + + LV+EY+ + L++ + D N LI+ + + + Y
Sbjct: 70 VHS------EKRLYLVFEYL-DLDLKKHMDSSPDFAK--NPRLIK--TYLYQILRGIAYC 118
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
H H ++H DLKP N+L+D A ++DFGLA+ G V T + + T+
Sbjct: 119 HSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-----AFGIPVRTFTHEV---VTL 167
Query: 885 GYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRR 917
Y APE LG S ++S G + E+ ++
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
+G G++ V+KG LVA+K I LE + G A C A+R + +K I +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-----APCTAIREVSLLKNLKHANIVT 67
Query: 769 SIDFKGVDFK-ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNI-VIDVASAVEYLH 826
D + LV+EY+ + L+++L D G NL + + I + + + Y H
Sbjct: 68 LHDIIHTERCLTLVFEYLDS-DLKQYL----DNCG--NLMSMHNVKIFMFQLLRGLSYCH 120
Query: 827 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGY 886
I+H DLKP N+L++ ++DFGLA+ S V T + S V T+ Y
Sbjct: 121 KR---KILHRDLKPQNLLINEKGELKLADFGLARAKS-------VPTKTYSNEVV-TLWY 169
Query: 887 VAPEYGLGG-EASMRGGVYSYGILLLEIFTRR 917
P+ LG E S ++ G +L E+ T R
Sbjct: 170 RPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-09
Identities = 55/168 (32%), Positives = 83/168 (49%), Gaps = 29/168 (17%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVI---NLEQKGGSKSFAAECEALRSIRHR 758
EF I RG+FG VY G N L AVKV+ ++ K AE +AL
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA----- 59
Query: 759 NLIK---IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQR---DDQLGICNLSLIQRL 812
L K IV + S+ + + LV EY+ G ++ LH D+++ + +S
Sbjct: 60 -LSKSPFIVHLYYSL--QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----- 111
Query: 813 NIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
+VA A++YLH H I+H DLKP N+L+ ++ ++DFGL+K
Sbjct: 112 ----EVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 56/188 (29%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEAL-RSIRHRNLIKI 763
IG+GSFG V +G AVKV+ + +K K AE L ++++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLH-QRDDQLGICNLSLIQRLNIVIDVASAV 822
F+ D V +Y+ G L + H QR+ R ++ASA+
Sbjct: 62 -----HYSFQTADKLYFVLDYVNGGEL--FFHLQRER----SFPEPRARF-YAAEIASAL 109
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
YLH I++ DLKP N+LLD ++DFGL K +E ++ G
Sbjct: 110 GYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--------EGIEHSKTTSTFCG 158
Query: 883 TIGYVAPE 890
T Y+APE
Sbjct: 159 TPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 63/243 (25%), Positives = 98/243 (40%), Gaps = 60/243 (24%)
Query: 703 FSSSN-----TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS-KSFAAECEALRSIR 756
F++ + IGRG+FG V K + +G ++AVK I K + + + +R
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MR 58
Query: 757 HRNLIKIVT------------IC-----SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDD 799
+ IV IC S+D F VYE + + E +
Sbjct: 59 SSDCPYIVKFYGALFREGDCWICMELMDISLD----KFYKYVYE-VLKSVIPE------E 107
Query: 800 QLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859
LG I + A+ YL + I+H D+KPSN+LLD + + DFG++
Sbjct: 108 ILG----------KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS 155
Query: 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEAS---MRGGVYSYGILLLEIFTR 916
L S + +T + G Y+APE +R V+S GI L E+ T
Sbjct: 156 GQLVDS----IAKTRDA-----GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
Query: 917 RRP 919
+ P
Sbjct: 207 KFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEA--LRSIRHRNLIKIVTI 766
IG GSFG +Y + +K I+L + + A++ E L ++H N IVT
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN---IVTF 64
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
+S G F +V EY G L + +++ Q G+ S Q L+ + ++ ++++H
Sbjct: 65 FASFQENGRLF--IVMEYCDGGDLMKRINR---QRGVL-FSEDQILSWFVQISLGLKHIH 118
Query: 827 HHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
I+H D+K N+ L + MVA + DFG+A+ L+ + +E + + GT
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-----DSMELAYTCV---GTPY 167
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922
Y++PE + + ++S G +L E+ T + P E
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 65/253 (25%), Positives = 111/253 (43%), Gaps = 36/253 (14%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEA--LRSIRHRNLIKIVTI 766
+G+GS+G V +G +K +NL + AAE EA L ++H N IV
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN---IVAY 64
Query: 767 CSSIDFKGVD-FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
S ++G D +V + + G L L ++ +L L Q + + +A A++YL
Sbjct: 65 RES--WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL----LPENQVVEWFVQIAMALQYL 118
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H + I+H DLK NV L + V D G+A+ L N + S+ I GT
Sbjct: 119 H---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-----NQCDMASTLI---GTPY 167
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEI 945
Y++PE + + V++ G + E+ T + H F + + V I
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLK-------------HAFNAKDMNSLVYRI 214
Query: 946 VDPSLLPLEEERT 958
++ L P+ ++ +
Sbjct: 215 IEGKLPPMPKDYS 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 66/243 (27%), Positives = 100/243 (41%), Gaps = 31/243 (12%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSK--SFAAECEALRSIRHR 758
+F + +GRG FG V G + A+KV+ + SF E + SI +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
I F+ D LV EY G L L++ +DQ + + Q +
Sbjct: 61 PWI----PQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF---DEDMAQ-----FYL 108
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
A V +H Q VH D+KP NVL+D ++DFG A L+A+ V +
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN--KMVN--SKLPV 164
Query: 879 GVKGTIGYVAPEY--GLGGEASMRGGV----YSYGILLLEIFTRRRPTESMFNEGLTLHE 932
GT Y+APE + G+ GV +S G++ E+ R P F+EG +
Sbjct: 165 ---GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP----FHEGTSAKT 217
Query: 933 FAK 935
+
Sbjct: 218 YNN 220
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-09
Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 24/294 (8%)
Query: 134 IPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSA 193
NL + L + + N L I E L L NL L + +N +T +P IG L +
Sbjct: 85 GSENLLNLLPLPSLDLNLNRLRSNISELL---ELTNLTSLDLDNNNIT-DIPPLIGLLKS 140
Query: 194 -LRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRF 252
L+ +D+ N++ +P L L +L L + N S +P + N+S+L + L GN+
Sbjct: 141 NLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI 198
Query: 253 TGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGL 312
+ LP EI L + + +NN L S SN NL L L+ N+ L
Sbjct: 199 S-DLPPEI--ELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPES-IGNL 254
Query: 313 KDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALID 372
+L L L+ N + + + L + T L+ L L+ N LP L+
Sbjct: 255 SNLETLDLSNNQISS--------ISSLGSLTNLRELDLSGNSLSNALP---LIALLLLLL 303
Query: 373 FNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHAN 426
L + N + LN+ + + P + L++L L N
Sbjct: 304 ELLLNLLLTLKALELKLNSILLNNNILSNGET--SSPEALSILESLNNLWTLDN 355
|
Length = 394 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 30/222 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
+G G+FG VYK E G+ A K+I +E + + F E + L +H N IV +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN---IVGLYE 69
Query: 769 SIDFKGVDFKALVY-EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH 827
+ ++ K + E+ G+L+ + + + L + + R + A+ +LH
Sbjct: 70 AYFYEN---KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCR-----QMLEALNFLHS 121
Query: 828 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL-AKFLSASPLGNVVETPSSSIGVKGTIGY 886
H ++H DLK N+LL D ++DFG+ AK S ++ + I GT +
Sbjct: 122 H---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST------LQKRDTFI---GTPYW 169
Query: 887 VAPEYGLGGEAS-----MRGGVYSYGILLLEIFTRRRPTESM 923
+APE + ++S GI L+E+ P +
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 40/225 (17%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
IG GS G V G VAVK ++L ++ + E +R +H N IV + S
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN---IVEMYS 83
Query: 769 SIDFKGVDFKALVYEYMQNGSLEEWL-HQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH 827
S + D +V E+++ G+L + + H R ++ I + L V A+ +LH
Sbjct: 84 S--YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCL--------AVLKALSFLHA 133
Query: 828 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYV 887
++H D+K ++LL D +SDFG +S E P V GT ++
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS-------KEVPRRKSLV-GTPYWM 182
Query: 888 APE------YGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNE 926
APE YG ++S GI+++E+ P FNE
Sbjct: 183 APEVISRLPYG------TEVDIWSLGIMVIEMVDGEPP---YFNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 61/259 (23%), Positives = 110/259 (42%), Gaps = 33/259 (12%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSK---SFAAECEALRSIRHRNLIKIVT 765
IG G FG V ++ + + V V L+ SK F + + R ++H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 766 IC-SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
C +I + LV+EY + G L+ +L Q L L+QR+ ++A+ V +
Sbjct: 63 QCVEAIPY------LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTH 114
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
+H H +H DL N L D+ V D+G+ + +ET +
Sbjct: 115 MHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE---DYIETEDDKC---VPL 165
Query: 885 GYVAPEYG-------LGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937
++APE + E + V++ G+ L E+F S ++ L+ K
Sbjct: 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK-- 223
Query: 938 LPEKVMEIVDPSL-LPLEE 955
++ +++ P L LP E
Sbjct: 224 --DQQVKLFKPQLELPYSE 240
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 64/245 (26%), Positives = 115/245 (46%), Gaps = 32/245 (13%)
Query: 709 IGRGSFGFVY---KGVLHENGMLVAVKVIN----LEQKGGSKSFAAECEALRSIRHRNLI 761
+G G++G V+ K H+ G L A+KV+ +++ ++ E + L ++R +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI-DVAS 820
VT+ + F+ L+ +Y+ G L L+QR+ + + + + I ++
Sbjct: 68 --VTLHYA--FQTDTKLHLILDYVNGGELFTHLYQRE------HFTE-SEVRVYIAEIVL 116
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
A+++LH Q I++ D+K N+LLD + ++DFGL+K A E +
Sbjct: 117 ALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA-------EEEERAYSF 166
Query: 881 KGTIGYVAPEYGLGGEASMRGGV--YSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938
GTI Y+APE GG V +S G+L E+ T P ++ E + E ++R L
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF-TVDGEQNSQSEISRRIL 225
Query: 939 PEKVM 943
K
Sbjct: 226 KSKPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-09
Identities = 65/251 (25%), Positives = 105/251 (41%), Gaps = 47/251 (18%)
Query: 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLE--QKGGSKSFAAECEALRSIRHRNLIKI 763
S +G G+ G V +G AVKV+++E + AE L + +++K
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK- 95
Query: 764 VTICSSIDF--------KGVDFKALVYEYMQNGSLEEWLHQR--------DDQLGICNLS 807
C DF + V ALV +Y G L + + R + + G+
Sbjct: 96 ---CHE-DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL---- 147
Query: 808 LIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPL 867
+ I V AV HH ++H D+K +N+LL + + + DFG +K +A+
Sbjct: 148 ------LFIQVLLAV---HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS 198
Query: 868 GNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEG 927
+V T GT YVAPE S + ++S G+LL E+ T +RP +G
Sbjct: 199 DDVGRT------FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-----DG 247
Query: 928 LTLHEFAKRAL 938
+ E + L
Sbjct: 248 ENMEEVMHKTL 258
|
Length = 496 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-09
Identities = 60/230 (26%), Positives = 112/230 (48%), Gaps = 44/230 (19%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNL 760
++F + +G G+ G V K +G+++A K+I+LE K A+R+ R L
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK----------PAIRNQIIREL 54
Query: 761 IKIVTICSS---IDFKGVDFK----ALVYEYMQNGSLEEWLHQR----DDQLGICNLSLI 809
+++ C+S + F G + ++ E+M GSL++ L + ++ LG
Sbjct: 55 -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG------- 106
Query: 810 QRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGN 869
+ I V + YL Q I+H D+KPSN+L++ + DFG++ G
Sbjct: 107 ---KVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--------GQ 153
Query: 870 VVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
++++ ++S GT Y++PE G S++ ++S G+ L+E+ R P
Sbjct: 154 LIDSMANSF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 63/238 (26%), Positives = 105/238 (44%), Gaps = 31/238 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
+G G+FG VYK E G L A KVI + + + + E E L + H ++K++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL---G 76
Query: 769 SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH 828
+ + G + ++ E+ G+++ + + D L + +I R + A++YLH
Sbjct: 77 AFYWDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQIQVICR-----QMLEALQYLH-- 127
Query: 829 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVA 888
I+H DLK NVLL D ++DFG++ V+T GT ++A
Sbjct: 128 -SMKIIHRDLKAGNVLLTLDGDIKLADFGVS--------AKNVKTLQRRDSFIGTPYWMA 178
Query: 889 PEYGLGGEASMRGGVYSY-------GILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939
PE + +M+ Y Y GI L+E+ + P N L + AK P
Sbjct: 179 PEVVMC--ETMKDTPYDYKADIWSLGITLIEM-AQIEPPHHELNPMRVLLKIAKSEPP 233
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-09
Identities = 58/187 (31%), Positives = 86/187 (45%), Gaps = 28/187 (14%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVIN----LEQKGGSKSFAAECEALRSIRHRNLIKIV 764
IG+GSFG V +G AVKV+ L++K + A L++++H L+ +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLH-QRDDQLGICNLSLIQRLNIVIDVASAVE 823
F+ + V +Y+ G L + H QR+ C L R +VASA+
Sbjct: 62 ----HYSFQTAEKLYFVLDYVNGGEL--FFHLQRER----CFLEPRARF-YAAEVASAIG 110
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
YLH I++ DLKP N+LLD ++DFGL K VE ++ GT
Sbjct: 111 YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--------EGVEPEETTSTFCGT 159
Query: 884 IGYVAPE 890
Y+APE
Sbjct: 160 PEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 66/258 (25%), Positives = 117/258 (45%), Gaps = 51/258 (19%)
Query: 685 EQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYK----GVLHEN---GMLVAVKVINLE 737
E + P E S+ ++ + +G G FG V G+ + + VAVK+ L+
Sbjct: 1 EYELPEDPRWEFSR--DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKM--LK 56
Query: 738 QKGGSKSFA---AECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEW 793
K + +E E ++ I +H+N+I ++ C+ G + ++ EY G+L E+
Sbjct: 57 DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREY 111
Query: 794 LHQR---------------DDQLGICNLSLIQRLNIVIDVASAVEYL-HHHCQPPIVHGD 837
L R D+Q+ +L ++ VA +EYL C +H D
Sbjct: 112 LRARRPPGMEYSYDIARVPDEQMTFKDL-----VSCTYQVARGMEYLASQKC----IHRD 162
Query: 838 LKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA 897
L NVL+ + V ++DFGLA+ + + +T + + VK ++APE
Sbjct: 163 LAARNVLVTENNVMKIADFGLAR--DVNNIDYYKKTTNGRLPVK----WMAPEALFDRVY 216
Query: 898 SMRGGVYSYGILLLEIFT 915
+ + V+S+G+L+ EIFT
Sbjct: 217 THQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 18/155 (11%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-GSKSFAA-ECEALRSIRHRNLIKIVTI 766
IG G++G V+K E +VA+K + L+ G S A E L+ ++H+N++++ +
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 767 CSSIDFKGVDFK-ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
S D K LV+EY L+++ D G + +++ + + + +
Sbjct: 68 LHS------DKKLTLVFEYCDQ-DLKKYF---DSCNGDIDPEIVKSF--MFQLLKGLAFC 115
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
H H ++H DLKP N+L++ + ++DFGLA+
Sbjct: 116 HSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 57/231 (24%), Positives = 106/231 (45%), Gaps = 29/231 (12%)
Query: 709 IGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSK-SFAAECEALRSIRHRNLIK 762
+G+GSFG VY+G E VAVK +N + F E ++ ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLH----QRDDQLGICNLSLIQRLNIVIDV 818
++ + S KG +V E M +G L+ +L + ++ G +L + + + ++
Sbjct: 74 LLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
A + YL+ VH DL N ++ HD + DFG+ + ++ ET
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYYRK 177
Query: 879 GVKG--TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNE 926
G KG + ++APE G + ++S+G++L EI + +P + + NE
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSK-----SFAAECEALRSIRHRNLIKI 763
IG G FG V G H GM A +V+ E + + F E + R + H N+++
Sbjct: 3 IGNGWFGKVLLGEAH-RGMSKA-RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 764 VTIC-SSIDFKGVDFKALVYEYMQNGSLEEWLHQ-RDDQLGICNLSLIQRLNIVIDVASA 821
+ C SI + LV E+ G L+ +L R + ++QR+ +VAS
Sbjct: 61 LGQCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASG 112
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
+ +LH Q +H DL N L D+ + D+GLA L P + ++ ++
Sbjct: 113 LLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLR 167
Query: 882 GTIGYVAPEYG---LGGEASMRGGVYSYGILLLEIFT 915
+ G L + + + ++S G+ + E+FT
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 29/226 (12%)
Query: 703 FSSSNTIGRGSFGFVY---KGVLHENGMLVAVKVI---NLEQKGGSKSFA-AECEALRSI 755
F +G G++G V+ K H++G L A+KV+ + QK + E + L I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 756 RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
R + + D K L+ +Y+ G L L QR+ + +
Sbjct: 62 RQSPFLVTLHYAFQTDTK----LHLILDYINGGELFTHLSQRER---------FKEQEVQ 108
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
I V L H + I++ D+K N+LLD + ++DFGL+K +
Sbjct: 109 IYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-------HEDEVE 161
Query: 876 SSIGVKGTIGYVAPEYGLGGEASMRGGV--YSYGILLLEIFTRRRP 919
+ GTI Y+AP+ GG+ V +S G+L+ E+ T P
Sbjct: 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 61/231 (26%), Positives = 118/231 (51%), Gaps = 46/231 (19%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHE-NGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRN 759
++F + +G G+ G V+K V H+ +G+++A K+I+LE K A+R+ R
Sbjct: 5 DDFEKISELGAGNGGVVFK-VSHKPSGLIMARKLIHLEIK----------PAIRNQIIRE 53
Query: 760 LIKIVTICSS---IDFKGVDFK----ALVYEYMQNGSLEEWLHQR----DDQLGICNLSL 808
L +++ C+S + F G + ++ E+M GSL++ L + + LG ++++
Sbjct: 54 L-QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 809 IQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLG 868
I+ L YL + I+H D+KPSN+L++ + DFG++ G
Sbjct: 113 IKGLT----------YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--------G 152
Query: 869 NVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
++++ ++S GT Y++PE G S++ ++S G+ L+E+ R P
Sbjct: 153 QLIDSMANSF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 48/208 (23%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 727 MLVAVKVINLE-QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYM 785
+LVAVK++ + K F E + + ++ N+I+++ +C + D ++ EYM
Sbjct: 47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT-----SDPLCMITEYM 101
Query: 786 QNGSLEEWL--HQRDDQLGICNLSLIQRLNIV---IDVASAVEYLHHHCQPPIVHGDLKP 840
+NG L ++L H+ + ++ I ++ +AS ++YL VH DL
Sbjct: 102 ENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLAT 158
Query: 841 SNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMR 900
N L+ + ++DFG+++ L + G+ ++ I +++ E L G+ +
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYS---GDYYRIQGRAV---LPIRWMSWESILLGKFTTA 212
Query: 901 GGVYSYGILLLEIFT--RRRPTESMFNE 926
V+++G+ L EI T + +P + +E
Sbjct: 213 SDVWAFGVTLWEILTLCKEQPYSQLSDE 240
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAA---ECEALRSI 755
E++ +G+G++G VY G L G L+AVK + L+ K + E + L+S+
Sbjct: 1 EWTKGEVLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59
Query: 756 RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
+H N+++ + C +D + + E++ GS+ L ++ G + +
Sbjct: 60 KHVNIVQYLGTC--LDDNTIS---IFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQ 110
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS-ASPLGNVVETP 874
I V YLH++C +VH D+K +NV+L + + + DFG A+ L+ G
Sbjct: 111 I--LDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165
Query: 875 SSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923
S + GT ++APE + ++S G + E+ T + P SM
Sbjct: 166 KS---MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 41/228 (17%)
Query: 707 NTIGRGSFGFVYKGVLHENG--MLVAVKVIN-LEQKGGSKSFAAECEALRSI-RHRNLIK 762
+ IG G+FG V K + ++G M A+K + K + FA E E L + H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRD----------DQLGICNLSLIQRL 812
++ C +G + A+ EY +G+L ++L + LS Q L
Sbjct: 61 LLGACEH---RGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 813 NIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVE 872
+ DVA ++YL Q +H DL N+L+ + VA ++DFGL++
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR------------ 160
Query: 873 TPSSSIGVKGTIG-----YVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ VK T+G ++A E + V+SYG+LL EI +
Sbjct: 161 --GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 71/247 (28%), Positives = 110/247 (44%), Gaps = 33/247 (13%)
Query: 702 EFSSSNTIGRGSFGFVY---KGVLHENGMLVAVKVIN---LEQKGGSKSFA-AECEALRS 754
F +G G++G V+ K H+ G L A+KV+ L QK + E L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 755 IRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNI 814
+R + + + K L+ +Y+ G + L+QRD N S +
Sbjct: 61 VRQSPFLVTLHYAFQTEAK----LHLILDYVSGGEMFTHLYQRD------NFSEDEVRFY 110
Query: 815 VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK-FLSASPLGNVVET 873
++ A+E+LH + IV+ D+K N+LLD + ++DFGL+K FLS E
Sbjct: 111 SGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS--------EE 159
Query: 874 PSSSIGVKGTIGYVAPEY--GLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLH 931
+ GTI Y+APE G GG +S GIL+ E+ T P ++ E T
Sbjct: 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDW-WSLGILIFELLTGASPF-TLEGERNTQS 217
Query: 932 EFAKRAL 938
E ++R L
Sbjct: 218 EVSRRIL 224
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 43/246 (17%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
+G+G FG V + G + A K ++ L++K G K E E L + N IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV---NSPFIVN 57
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ + + K LV M G L+ ++ +G L + + ++ + + +L
Sbjct: 58 LAYAFESK--THLCLVMSLMNGGDLKYHIYN----VGERGLEMERVIHYSAQITCGILHL 111
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETP--SSSIGVKGT 883
H IV+ D+KP NVLLD +SD GLA VE + GT
Sbjct: 112 H---SMDIVYRDMKPENVLLDDQGNCRLSDLGLA-----------VELKDGKTITQRAGT 157
Query: 884 IGYVAPEYGLGGEASMRGGVYSY-------GILLLEIFTRRRPTESMFNEGLTLHEFAKR 936
GY+APE ++ YSY G + E+ R P + E + E +R
Sbjct: 158 NGYMAPEI-------LKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD-HKEKVAKEELKRR 209
Query: 937 ALPEKV 942
L ++V
Sbjct: 210 TLEDEV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 30/219 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLE--QKGGSKSFAAECEALRSIRHRNLI-KIVT 765
IG G++G VYK G LVA+K LE ++G + E L+ + I +++
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWL--HQRDDQLGICNLSLIQRLNIVIDVASAVE 823
+ + G LV+EY+ + L++++ + R + I+ + + V
Sbjct: 69 VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPL-PAKTIKSF--MYQLLKGVA 124
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAKFLSASPLGN----VVETPSSSI 878
+ H H ++H DLKP N+L+D + ++D GL + S P+ + +V
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV------- 173
Query: 879 GVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTR 916
T+ Y APE LG S ++S G + E+ +
Sbjct: 174 ----TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
IGRG FG VY + G + A+K ++ ++ K G E L ++ R ++ +V+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--------ETL-ALNERIMLSLVS 52
Query: 766 -------ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
+C S F D + + + M G L H Q G+ S + ++
Sbjct: 53 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGV--FSEAEMRFYAAEI 106
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
+E++H+ +V+ DLKP+N+LLD +SD GLA S + P +S+
Sbjct: 107 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-------KKPHASV 156
Query: 879 GVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRP 919
GT GY+APE G A +S G +L ++ P
Sbjct: 157 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 23/205 (11%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
IG+G+ G VY + G VA+K +NL+Q+ + E +R +H N++ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLD--- 83
Query: 769 SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH 828
+ D +V EY+ GSL D + + Q + + A+E+LH +
Sbjct: 84 --SYLVGDELWVVMEYLAGGSLT-------DVVTETCMDEGQIAAVCRECLQALEFLHSN 134
Query: 829 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVA 888
++H D+K N+LL D ++DFG ++ E S V GT ++A
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-------EQSKRSTMV-GTPYWMA 183
Query: 889 PEYGLGGEASMRGGVYSYGILLLEI 913
PE + ++S GI+ +E+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/236 (25%), Positives = 107/236 (45%), Gaps = 27/236 (11%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
+G G+FG VYK E G+L A KVI+ + + + + E + L S H N++K++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 70
Query: 769 SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH 828
F + ++ E+ G+++ + + + L + ++ + + A+ YLH
Sbjct: 71 ---FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-----EALNYLH-- 120
Query: 829 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVA 888
+ I+H DLK N+L D ++DFG+ ++ ++ S I GT ++A
Sbjct: 121 -ENKIIHRDLKAGNILFTLDGDIKLADFGV-----SAKNTRTIQRRDSFI---GTPYWMA 171
Query: 889 PEYGLGGEASMR-----GGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939
PE + + R V+S GI L+E+ + P N L + AK P
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEM-AQIEPPHHELNPMRVLLKIAKSEPP 226
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 61/237 (25%), Positives = 98/237 (41%), Gaps = 48/237 (20%)
Query: 708 TIGRGSFGFVYKG-VLHENGM----LVAVKVINLEQKGGSKS----FAAECEALRSIRHR 758
T+G G FG V K G VAVK++ ++ S S +E L+ + H
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHP 63
Query: 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQ------------------RDDQ 800
++IK+ CS G L+ EY + GSL +L + D
Sbjct: 64 HVIKLYGACSQ---DGPLL--LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 801 LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
L++ ++ ++ ++YL + +VH DL NVL+ +SDFGL++
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 861 FLSASPLGNVVETPSSSIGVKGTI--GYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+V E S KG I ++A E + + V+S+G+LL EI T
Sbjct: 176 --------DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 52/217 (23%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 716 FVYKGVLHENGMLVAVKVINLEQKGGSK---SFAAECEALRSIRHRNLIKI----VTICS 768
+YKG+ N V ++ KG E + LR I N++KI + I
Sbjct: 35 SIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 769 SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH 828
+ +L+ EY G L E L + D LS +L++ ID + L+ +
Sbjct: 93 DLPRL-----SLILEYCTRGYLREVLDKEKD------LSFKTKLDMAIDCCKGLYNLYKY 141
Query: 829 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVA 888
P + +L + L+ + + GL K LS+ P NV + Y +
Sbjct: 142 TNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV-----------NFMVYFS 188
Query: 889 PEYGLG--GEASMRGGVYSYGILLLEIFTRRRPTESM 923
+ E +++ +YS G++L EIFT + P E++
Sbjct: 189 YKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRN 759
F +G+G FG V + G + A K + ++++ G E + L + R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
++ + + ++ D LV M G L+ ++ +G + + ++
Sbjct: 62 VVSL-----AYAYETKDALCLVLTLMNGGDLKFHIYH----MGEAGFEEGRAVFYAAEIC 112
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
+E LH Q IV+ DLKP N+LLD +SD GLA + P G ++ G
Sbjct: 113 CGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHV---PEGQTIK------G 160
Query: 880 VKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
GT+GY+APE + ++ G LL E+ + P
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 59/238 (24%)
Query: 708 TIGRGSFGFVYKGVLHE-NGMLVAVKVI-----NLEQKGGSKSFAAECEALRSIRHRNLI 761
+GRG++G V K + H G ++AVK I + EQK + + S+R +
Sbjct: 8 ELGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQK----RLLMDLDI--SMRSVDCP 60
Query: 762 KIVTICSSIDFKGVDFKA----LVYEYMQNGSLEEW--------LHQRDDQLGICNLSLI 809
VT F G F+ + E M SL+++ L +D LG
Sbjct: 61 YTVT------FYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGK------ 107
Query: 810 QRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGN 869
I + + A+EYLH + ++H D+KPSNVL++ + + DFG++ G
Sbjct: 108 ----IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS--------GY 153
Query: 870 VVETPSSSIGVKGTIGYVAPEYGLGGEASMRG-----GVYSYGILLLEIFTRRRPTES 922
+V++ + +I G Y+APE + E + +G V+S GI ++E+ T R P +S
Sbjct: 154 LVDSVAKTIDA-GCKPYMAPER-INPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 61/251 (24%), Positives = 109/251 (43%), Gaps = 28/251 (11%)
Query: 709 IGRGSFGFVYKGVLHENGML---VAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
IG G FG VY+ + + K+ NLE +++ E +I + I +
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLE----NETIVMETLVYNNIYDIDKIALWK 75
Query: 766 ICSSIDFKGV-------DFK--ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI 816
+ID G+ FK + Y ++ L E + ++ N LI+ NI+
Sbjct: 76 NIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIK--NIMK 133
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
D+ + +EY+H H I HGD+KP N+++D + ++ D+G+A G +E
Sbjct: 134 DMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIH--GKHIEYSKE 188
Query: 877 SIGV-KGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLH---- 931
+ +GT+ Y + G + RG + S G +L+ + P + + G +H
Sbjct: 189 QKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248
Query: 932 EFAKRALPEKV 942
+F KR K+
Sbjct: 249 DFIKRLHEGKI 259
|
Length = 294 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 33/219 (15%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVT--- 765
IGRG FG VY + G + A+K ++ K K E AL R ++ +V+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALN---ERIMLSLVSTGD 55
Query: 766 ----ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
+C + F D + + M G L H Q G+ S + ++
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDL----HYHLSQHGV--FSEKEMRFYATEIILG 109
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
+E++H+ +V+ DLKP+N+LLD +SD GLA S + P +S+
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-------KKPHASV--- 156
Query: 882 GTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRP 919
GT GY+APE G A +S G +L ++ P
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA-ECEALRSIRHRNLIKIVT 765
+ +G G++ VYKG LVA+K I LE + G+ A E L+ ++H N IVT
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN---IVT 68
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ I + LV+EY+ + L+++L + + + N+ L + + + Y
Sbjct: 69 LHDIIHTEKS--LTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF-----LFQLLRGLNYC 120
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H ++H DLKP N+L++ ++DFGLA+ S + T + S V T+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS-------IPTKTYSNEVV-TLW 169
Query: 886 YVAPEYGLGG-EASMRGGVYSYGILLLEIFTRR 917
Y P+ LG + S + ++ G + E+ T R
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEA--LRSIRHRNLIKI 763
+GRG+FG VY + G +AVK + + Q+ + A ECE L+++RH +++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
+ K + ++ EYM GS+++ L G ++ +R I V
Sbjct: 70 YGCLRDPEEKKL---SIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQI--LQGVS 120
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK-- 881
YLH + IVH D+K +N+L D + DFG +K + + S G+K
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM--------SGTGIKSV 169
Query: 882 -GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
GT +++PE G + V+S ++E+ T + P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 63/261 (24%), Positives = 116/261 (44%), Gaps = 56/261 (21%)
Query: 709 IGRGSFGFVYKGVLHE-NGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNL--IKIVT 765
+G G+ G V K V H G ++A KV+++ K S+R + L ++I+
Sbjct: 13 LGAGNGGSVSK-VKHIPTGTVMAKKVVHIGAK-------------SSVRKQILRELQIMH 58
Query: 766 ICSS---IDFKGVDFKA-----LVYEYMQNGSLEEWLHQ----RDDQLGICNLSLIQRLN 813
C S + F G F + E+M GSL+ + + LG +++++ L
Sbjct: 59 ECRSPYIVSFYGA-FLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLT 117
Query: 814 IVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVET 873
+ +V H I+H D+KPSN+L++ + DFG+ S + ++ +T
Sbjct: 118 YLYNV--------HR----IMHRDIKPSNILVNSRGQIKLCDFGV----SGELINSIADT 161
Query: 874 PSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933
GT Y++PE GG+ +++ V+S GI ++E+ + P F+ +
Sbjct: 162 ------FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA--FSNIDDDGQD 213
Query: 934 AKRALPEKVMEIVD--PSLLP 952
+ + + +IV P LP
Sbjct: 214 DPMGILDLLQQIVQEPPPRLP 234
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 7e-08
Identities = 51/227 (22%), Positives = 88/227 (38%), Gaps = 64/227 (28%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRH 757
++F IGRG+FG V+ + G + A+KV+ + ++ AE + L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
++K+ S F+ + LV EYM G L ++L+ R ++ +
Sbjct: 61 PWIVKL--YYS---FQDEEHLYLVMEYMPGGDL---------------MNLLIRKDVFPE 100
Query: 818 ---------VASAVEYLH--HHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAK---- 860
+ A++ +H +H D+KP N+L+D D H+ +DFGL K
Sbjct: 101 ETARFYIAELVLALDSVHKLGF-----IHRDIKPDNILIDAD--GHIKLADFGLCKKMNK 153
Query: 861 ------FLSASPLGNVVETPSSSIGVK-----------GTIGYVAPE 890
+L+ S + GT Y+APE
Sbjct: 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 65/249 (26%), Positives = 111/249 (44%), Gaps = 26/249 (10%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVI--NLEQKGGSKSFAAECEALRSIRHR 758
N+F +G G++G V K E +VA+K + E + ++ E + LR+++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
N IV + + +G + LV+EY++ LE + S I +L
Sbjct: 61 N---IVELKEAFRRRGKLY--LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------ 109
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
A+ + H + IVH D+KP N+L+ H+ V + DFG A+ LS N E +
Sbjct: 110 IKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA--- 163
Query: 879 GVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR--PTESMFNEGLTLHEFAKR 936
T Y +PE LG ++S G +L E+ + P ES ++ T+ +
Sbjct: 164 ----TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLG- 218
Query: 937 ALPEKVMEI 945
LP + M++
Sbjct: 219 PLPAEQMKL 227
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINL--EQKGGSKSFAA-ECEA--LRSIRHRNLIKI 763
+G+G+FG VY + G +A K + E SK +A ECE L++++H +I
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE---RI 66
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
V + + + EYM GS+++ L G S+ ++ + +
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTR--QILEGMS 120
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
YLH + IVH D+K +N+L D + DFG +K L + + + V GT
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ-----TICMSGTGIRSVTGT 172
Query: 884 IGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
+++PE G + V+S G ++E+ T + P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
+G G++ V+KG LVA+K I LE + G A C A+R + +K I +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-----APCTAIREVSLLKDLKHANIVT 68
Query: 769 SIDFKGVDFK-ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI-DVASAVEYLH 826
D D LV+EY L++ L Q D G N+ + + I + + + Y H
Sbjct: 69 LHDIVHTDKSLTLVFEY-----LDKDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCH 121
Query: 827 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGY 886
++H DLKP N+L++ ++DFGLA+ S V T + S V T+ Y
Sbjct: 122 RR---KVLHRDLKPQNLLINERGELKLADFGLARAKS-------VPTKTYSNEVV-TLWY 170
Query: 887 VAPEYGLG-GEASMRGGVYSYGILLLEIFTRR 917
P+ LG E S + ++ G + E+ + R
Sbjct: 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 68/240 (28%), Positives = 112/240 (46%), Gaps = 58/240 (24%)
Query: 709 IGRGSFGFVYKGVLHE-NGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTIC 767
+G G+ G V K VLH +G+++A K+I+LE K A+R+ R L K++ C
Sbjct: 9 LGAGNGGVVTK-VLHRPSGLIMARKLIHLEIK----------PAIRNQIIREL-KVLHEC 56
Query: 768 SS---IDFKGVDFK----ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRL--NIVIDV 818
+S + F G + ++ E+M GSL DQ+ L R+ NI+ +
Sbjct: 57 NSPYIVGFYGAFYSDGEISICMEHMDGGSL--------DQV----LKKAGRIPENILGKI 104
Query: 819 ASAV----EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETP 874
+ AV YL + I+H D+KPSN+L++ + DFG++ L S + V
Sbjct: 105 SIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--- 159
Query: 875 SSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPT--------ESMFNE 926
GT Y++PE G +++ ++S G+ L+E+ R P E+MF
Sbjct: 160 -------GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR 212
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 49/229 (21%)
Query: 709 IGRGSFGFVYKGVLHE-NGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTI- 766
+G+G++G VYK VLH G+ +A+K I LE L + +I + I
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLE--------------LDESKFNQIIMELDIL 53
Query: 767 --CSS---IDFKGVDF-KALVY---EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
S +DF G F + VY EYM GSL++ L+ +++R I
Sbjct: 54 HKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRR--ITYA 110
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS-S 876
V +++L I+H D+KP+NVL++ + + DFG++ GN+V + + +
Sbjct: 111 VVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVS--------GNLVASLAKT 160
Query: 877 SIGVKGTIGYVAPEYGLGGEASMRG------GVYSYGILLLEIFTRRRP 919
+IG + Y+APE G + V+S G+ +LE+ R P
Sbjct: 161 NIGCQ---SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 54/195 (27%), Positives = 85/195 (43%), Gaps = 34/195 (17%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVK------VINLEQKGGSKSFAAECEALRSI 755
+F T+G GSFG V G A+K ++ ++Q + A E L +
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV---QHVAQEKSILMEL 75
Query: 756 RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
H ++ + +CS D V F + E++ G L + H R +++ +V
Sbjct: 76 SHPFIVNM--MCSFQDENRVYF---LLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELV 128
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
+ A EYLH I++ DLKP N+LLD+ V+DFG AK + P
Sbjct: 129 L----AFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----------KVPD 170
Query: 876 SSIGVKGTIGYVAPE 890
+ + GT Y+APE
Sbjct: 171 RTFTLCGTPEYLAPE 185
|
Length = 329 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 69/268 (25%), Positives = 111/268 (41%), Gaps = 34/268 (12%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
IG GS G V G VAVK ++L ++ + E +R H N++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN--- 86
Query: 769 SIDFKGVDFKALVYEYMQNGSLEEWL-HQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH 827
+ D +V E+++ G+L + + H R ++ I + L V A+ YLH+
Sbjct: 87 --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCL--------SVLRALSYLHN 136
Query: 828 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYV 887
++H D+K ++LL D +SDFG +S E P V GT ++
Sbjct: 137 Q---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-------EVPKRKSLV-GTPYWM 185
Query: 888 APEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNE-GLTLHEFAKRALPEKVMEI- 945
APE ++S GI+++E+ P FNE L + LP +V +
Sbjct: 186 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPP---YFNEPPLQAMRRIRDNLPPRVKDSH 242
Query: 946 ----VDPSLLPLEEERTNSRRVRNEECL 969
V L L R S+R +E L
Sbjct: 243 KVSSVLRGFLDLMLVREPSQRATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 69/244 (28%), Positives = 113/244 (46%), Gaps = 48/244 (19%)
Query: 690 MVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAEC 749
M+ + L T+ + TIG+G++G VYK ++G L AVK+++ + AE
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEY 69
Query: 750 EALRSI-RHRNLIKIVTICSSIDFKGVDFKA---------LVYEYMQNGSLEEWLHQRDD 799
L+S+ H N++K F G+ +KA LV E GS+ E +
Sbjct: 70 NILQSLPNHPNVVK---------FYGMFYKADKLVGGQLWLVLELCNGGSVTELV----K 116
Query: 800 QLGICNLSLIQRLN---IVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856
L IC QRL+ I + A+ L H I+H D+K +N+LL + + DF
Sbjct: 117 GLLICG----QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF 172
Query: 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE-------YGLGGEASMRGGVYSYGIL 909
G++ L+++ L ++S+ GT ++APE Y +A R V+S GI
Sbjct: 173 GVSAQLTSTRLRR-----NTSV---GTPFWMAPEVIACEQQYDYSYDA--RCDVWSLGIT 222
Query: 910 LLEI 913
+E+
Sbjct: 223 AIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 54/216 (25%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 727 MLVAVKVINLE-QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYM 785
+LVAVK++ + K F E + L ++ N+I+++ +C D ++ EYM
Sbjct: 47 LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITEYM 101
Query: 786 QNGSLEEWL--HQRDDQLGICN-----------LSLIQRLNIVIDVASAVEYLHHHCQPP 832
+NG L ++L H DD+ N +S L++ + +AS ++YL
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLN 158
Query: 833 IVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYG 892
VH DL N L+ ++ ++DFG+++ L A G+ ++ I ++A E
Sbjct: 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYA---GDYYRIQGRAV---LPIRWMAWECI 212
Query: 893 LGGEASMRGGVYSYGILLLEIFT--RRRPTESMFNE 926
L G+ + V+++G+ L EI + +P + +E
Sbjct: 213 LMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 65/239 (27%), Positives = 94/239 (39%), Gaps = 44/239 (18%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
+G+G G V+ L G L A+KV++ + ++ K E E L ++ H + T
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP---FLPT 65
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ +S F+ + LV +Y G L Q G C + R +V A+EYL
Sbjct: 66 LYAS--FQTETYLCLVMDYCPGGEL---FRLLQRQPGKCLSEEVARF-YAAEVLLALEYL 119
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASP------LGNVVETPSSS 877
H IV+ DLKP N+LL H+ SDF L+K P L S +
Sbjct: 120 H--LLG-IVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 878 IGVK---------------GTIGYVAPEYGLGGEASMRGGV--YSYGILLLEIFTRRRP 919
GT Y+APE G V ++ GILL E+ P
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 55/239 (23%), Positives = 97/239 (40%), Gaps = 25/239 (10%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRN 759
F +G+G FG V + G + A K + ++++ G E + L + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
++ + + ++ D LV M G L+ ++ +G + L ++
Sbjct: 62 VVNL-----AYAYETKDALCLVLTIMNGGDLKFHIYN----MGNPGFEEERALFYAAEIL 112
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
+E LH + V+ DLKP N+LLD +SD GLA + P G + G
Sbjct: 113 CGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKI---PEGESIR------G 160
Query: 880 VKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938
GT+GY+APE ++ + G L+ E+ + P E + E +R L
Sbjct: 161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR-KEKVKREEVDRRVL 218
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 2e-07
Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 41/188 (21%)
Query: 757 HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI 816
+ N IK+ +++ KG L+ +Y+++G L + L + LS + I+
Sbjct: 68 NPNFIKLYYSVTTL--KGH---VLIMDYIKDGDLFDLLKKEGK------LSEAEVKKIIR 116
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV-AHVSDFGLAKFLSASPLGNVVETPS 875
+ A+ LH H I+H D+K NVL D ++ D+GL K ++ TPS
Sbjct: 117 QLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK---------IIGTPS 164
Query: 876 SSIGVKGTIGYVAPEYGLGGEASMRGGVYSY-------GILLLEIFTRRRPTESMFNEGL 928
GT+ Y +PE ++G Y G+L E+ T + P + +E L
Sbjct: 165 CY---DGTLDYFSPE-------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL 214
Query: 929 TLHEFAKR 936
L KR
Sbjct: 215 DLESLLKR 222
|
Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 49/161 (30%), Positives = 75/161 (46%), Gaps = 26/161 (16%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVIN--LEQKGGSKSFAAECEALRSIRHRNLIKIVTI 766
IG+GS+G V + G VA+K IN E + E + LR +RH ++++I I
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 767 C---SSIDFKGVDFKALVYEYMQNGSLEEWLHQ----RDDQLGICNLSLIQRLNIVIDVA 819
S +FK + +V+E M E LHQ DD L+ + +
Sbjct: 68 MLPPSRREFKDI---YVVFELM-----ESDLHQVIKANDD------LTPEHHQFFLYQLL 113
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
A++Y+H + H DLKP N+L + D + DFGLA+
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 55/241 (22%), Positives = 102/241 (42%), Gaps = 26/241 (10%)
Query: 679 SNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ 738
S+ +E+ +VS + K F IG+G+ G VY + G VA++ +NL+Q
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 739 KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRD 798
+ + E +R ++ N++ + + D +V EY+ GSL + + +
Sbjct: 58 QPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETC 112
Query: 799 DQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858
G Q + + A+E+LH + ++H D+K N+LL D ++DFG
Sbjct: 113 MDEG-------QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162
Query: 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR 918
+ S + GT ++APE + ++S GI+ +E+
Sbjct: 163 C--------AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 919 P 919
P
Sbjct: 215 P 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 35/125 (28%), Positives = 63/125 (50%), Gaps = 12/125 (9%)
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
++A A+++LH I++ DLKP N+LLD + ++DFGL+K ++
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------ESIDHEKK 154
Query: 877 SIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM-FNEGLTLHEFAK 935
+ GT+ Y+APE + +S+G+L+ E+ T P + E +T+ AK
Sbjct: 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214
Query: 936 RALPE 940
+P+
Sbjct: 215 LGMPQ 219
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 35/145 (24%), Positives = 69/145 (47%), Gaps = 20/145 (13%)
Query: 708 TIGRGSFGFVYKGVLHENG-------MLVAVKVINLEQKGGSKSFAAECEALRSIRHRNL 760
++G+G+F ++KG+ E G V +KV++ + S+SF + + H++L
Sbjct: 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHL 61
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
+ +C D +V EY++ GSL+ +L + + + I +L + +A
Sbjct: 62 VLNYGVCV-----CGDESIMVQEYVKFGSLDTYLKKNKNLINI-----SWKLEVAKQLAW 111
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLL 845
A+ +L + HG++ NVLL
Sbjct: 112 ALHFLE---DKGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 59/240 (24%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 682 SQMEQQFPMVSYKELS-KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN--LEQ 738
S+ + QF V + + + IG G+ G V G+ VAVK ++ +
Sbjct: 1 SEEDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN 60
Query: 739 KGGSKSFAAECEALRSIRHRNLIKIVTICSSI----DFKGVDFKALVYEYMQNGSLEEWL 794
+ +K E L+ + H+N+I ++ + + +F+ V LV E M + +L + +
Sbjct: 61 QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV---YLVMELM-DANLCQVI 116
Query: 795 HQRDDQLGICNLSLIQRLNIVI-DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 853
H D +R++ ++ + +++LH I+H DLKPSN+++ D +
Sbjct: 117 HMELDH---------ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 164
Query: 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEI 913
DFGLA+ N + TP T Y APE LG ++S G ++ E+
Sbjct: 165 LDFGLARTACT----NFMMTPYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 56/186 (30%), Positives = 82/186 (44%), Gaps = 26/186 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVIN----LEQKGGSKSFAAECEALRSIRHRNLIKIV 764
IG+GSFG V AVKV+ L++K + L++++H L+ +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
F+ D V +Y+ G L L QR+ C L R ++ASA+ Y
Sbjct: 62 ----HFSFQTADKLYFVLDYINGGELFYHL-QRER----CFLEPRARF-YAAEIASALGY 111
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
LH IV+ DLKP N+LLD ++DFGL K +E ++ GT
Sbjct: 112 LH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--------ENIEHNGTTSTFCGTP 160
Query: 885 GYVAPE 890
Y+APE
Sbjct: 161 EYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-07
Identities = 38/111 (34%), Positives = 55/111 (49%), Gaps = 11/111 (9%)
Query: 806 LSLIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSA 864
L+ + L+ VA +E+L +C VH DL NVLL + + DFGLA+ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMH 289
Query: 865 SPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
N V S+ + VK ++APE + V+SYGILL EIF+
Sbjct: 290 D--SNYVSKGSTFLPVK----WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 54/236 (22%), Positives = 100/236 (42%), Gaps = 26/236 (11%)
Query: 684 MEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSK 743
+E+ +VS + K F IG+G+ G VY + G VA+K +NL+Q+ +
Sbjct: 5 LEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE 61
Query: 744 SFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGI 803
E +R ++ N++ + + D +V EY+ GSL + + + G
Sbjct: 62 LIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG- 115
Query: 804 CNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863
Q + + A+++LH + ++H D+K N+LL D ++DFG
Sbjct: 116 ------QIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC---- 162
Query: 864 ASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
+ S + GT ++APE + ++S GI+ +E+ P
Sbjct: 163 ----AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVI--NLEQKGGSKSFAA-ECEA--LRSIRHRNLIKI 763
+G+G+FG VY + G +AVK + + E SK A ECE L+++ H +++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
+ + ++ E+M GS+++ L G ++ ++ I V
Sbjct: 70 YGCLRDPMERTL---SIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQI--LEGVS 120
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
YLH + IVH D+K +N+L D + DFG +K L L + V GT
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSG-----TGMKSVTGT 172
Query: 884 IGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
+++PE G + ++S G ++E+ T + P
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 32/220 (14%)
Query: 709 IGRGSFGFVYKGVLHENGML--------VAVKVINLEQKG-GSKSFAAECEALRSIRHRN 759
+G+G+F +YKGVL L V+V + L S +F + + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLH-QRDDQLGICNLSLIQRLNIVIDV 818
L+K+ +C D +V EY++ G L+ +LH ++++ L + ++L
Sbjct: 63 LVKLYGVCVR------DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL------ 110
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
ASA+ YL +VHG++ N+L+ + + G F+ S G + S
Sbjct: 111 ASALHYLEDK---KLVHGNVCGKNILV----ARYGLNEGYVPFIKLSDPGIPITVLSREE 163
Query: 879 GVKGTIGYVAPEYGLGGEASMR--GGVYSYGILLLEIFTR 916
V+ I ++APE G+AS+ +S+G LLEI +
Sbjct: 164 RVE-RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 709 IGRGSFGFVYKGVL---HENGMLVAVKVINLEQKGGSKSFAA--ECEALRSIRHRNLIKI 763
IG GSFG K +L E+G +K IN+ + + + E L +++H N I
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN---I 61
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
V S + G + +V +Y + G L + ++ Q G+ Q L+ + + A++
Sbjct: 62 VQYQESFEENGNLY--IVMDYCEGGDLYKKINA---QRGVL-FPEDQILDWFVQICLALK 115
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
++H I+H D+K N+ L D + DFG+A+ L+ + VE + I GT
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-----STVELARTCI---GT 164
Query: 884 IGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922
Y++PE + + +++ G +L E+ T + E+
Sbjct: 165 PYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 42/157 (26%), Positives = 64/157 (40%), Gaps = 26/157 (16%)
Query: 709 IGRGSFG--FVYKGVLHENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIV 764
IG+ V+ LVAVK INL+ K E R ++H N++ V
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWL--HQRD--DQLGICNLSLIQRLNIVIDVAS 820
T S I + +V M GS E+ L H + +L I I+ DV +
Sbjct: 66 T--SFIVDSEL---YVVSPLMAYGSCEDLLKTHFPEGLPELAIAF--------ILKDVLN 112
Query: 821 AVEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856
A++Y+H +H +K S++LL D +S
Sbjct: 113 ALDYIHSKGF----IHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 32/225 (14%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN-LEQKGGSKSFAAECEALRSIRHRNL 760
+ + + IG G++G V G+ VA+K I+ E + + E + LR +H N+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQ--RDDQLG---ICNLSLIQRLNIV 815
I I+ I F+ + +V E M E L++ + L I L Q L
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIKTQHLSNDHIQYF-LYQILR-- 117
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
++Y+H ++H DLKPSN+LL+ + + DFGLA+ A P E
Sbjct: 118 -----GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR--IADP-----EHDH 162
Query: 876 SSIGVK--GTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRR 917
+ + T Y APE L + ++S G +L E+ + R
Sbjct: 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 36/223 (16%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRNLIKIVT 765
+G+GSFG V L E+G L AVKV+ + Q + E L R+ + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQ--RDDQLGICNLSLIQRLNIVIDVASAVE 823
C F+ D V E++ G L + + R D+ + ++ SA+
Sbjct: 63 CC----FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA--------AEITSALM 110
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
+LH I++ DLK NVLLDH+ ++DFG+ K + N T + GT
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFC----GT 159
Query: 884 IGYVAPEYGLGGEASMRGGV----YSYGILLLEIFTRRRPTES 922
Y+APE M G ++ G+LL E+ P E+
Sbjct: 160 PDYIAPEI----LQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 53/195 (27%), Positives = 86/195 (44%), Gaps = 34/195 (17%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA----ECEALRSIRHR 758
++S +G G++G V + G VA+K L + S+ FA E L+ ++H
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIK--KLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 759 NLIKIVTI-CSSIDFKGVDFKALVYEYMQNGSLEE--WLHQRDDQLGICNLSLIQRLNIV 815
N+I ++ + S++ LV YMQ L++ +D+ +Q L V
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDK--------VQYL--V 123
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
+ ++Y+H I+H DLKP N+ ++ D + DFGLA+ A G VV
Sbjct: 124 YQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV---- 176
Query: 876 SSIGVKGTIGYVAPE 890
T Y APE
Sbjct: 177 -------TRWYRAPE 184
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLI 761
+F IG G++G VYK G L A+KVI LE E ++ +H N++
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
+ D + E+ GSL++ H LS Q + +
Sbjct: 70 AYFG-----SYLRRDKLWICMEFCGGGSLQDIYHVTGP------LSESQIAYVSRETLQG 118
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
+ YLH + +H D+K +N+LL + ++DFG++ ++A T +
Sbjct: 119 LYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA--------TIAKRKSFI 167
Query: 882 GTIGYVAPEYGLGGEASMRGG------VYSYGILLLEIFTRRRPTESMFN 925
GT ++APE +GG +++ GI +E+ + P MF+
Sbjct: 168 GTPYWMAPEV---AAVERKGGYNQLCDIWAVGITAIELAELQPP---MFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 35/121 (28%), Positives = 60/121 (49%), Gaps = 11/121 (9%)
Query: 796 QRDDQLGICNLSLIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854
+ D+L L+L ++ VA +E+L C +H DL N+LL + V +
Sbjct: 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKIC 215
Query: 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIF 914
DFGLA+ + P + V + + +K ++APE + + V+S+G+LL EIF
Sbjct: 216 DFGLARDIYKDP--DYVRKGDARLPLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIF 269
Query: 915 T 915
+
Sbjct: 270 S 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 48/211 (22%), Positives = 88/211 (41%), Gaps = 35/211 (16%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVK-VINLEQKGGSKS-----------FAA--ECEAL 752
+G G++G V K G +VA+K V +E F E + +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 753 RSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRL 812
I+H N++ +V + + DF LV + M L++ + ++ L+ Q
Sbjct: 75 NEIKHENIMGLVDV-----YVEGDFINLVMDIMA-SDLKKVVDRK------IRLTESQVK 122
Query: 813 NIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVV- 871
I++ + + + LH +H DL P+N+ ++ + ++DFGLA+ P + +
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 872 --ETPSSSIGVKG---TIGYVAPEYGLGGEA 897
ET + T+ Y APE +G E
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEK 210
|
Length = 335 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 53/204 (25%), Positives = 83/204 (40%), Gaps = 47/204 (23%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA----ECEALRSIR 756
+ + + + +G G++G V + G VA+K L + S A E L+ +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHMD 72
Query: 757 HRN---LIKIVTICSSI-DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRL 812
H N L+ + T SS+ DF+ V LV M L N+ Q+L
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDV---YLVTHLM------------GADLN--NIVKCQKL 115
Query: 813 N------IVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP 866
+ +V + ++Y+H I+H DLKPSN+ ++ D + DFGLA+
Sbjct: 116 SDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM 172
Query: 867 LGNVVETPSSSIGVKGTIGYVAPE 890
G V T Y APE
Sbjct: 173 TGYVA-----------TRWYRAPE 185
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 55/236 (23%), Positives = 104/236 (44%), Gaps = 26/236 (11%)
Query: 684 MEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSK 743
ME+ +VS + K +++ IG+G+ G V+ + G VA+K INL+++ +
Sbjct: 5 MEKLRTIVSIGDPKK---KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKE 61
Query: 744 SFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGI 803
E ++ +++ N++ + F D +V EY+ GSL + + +
Sbjct: 62 LIINEILVMKELKNPNIVNFLD-----SFLVGDELFVVMEYLAGGSLTDVVTE------T 110
Query: 804 CNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863
C + Q + + A+E+LH + ++H D+K NVLL D ++DFG
Sbjct: 111 C-MDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFC---- 162
Query: 864 ASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
+ S + GT ++APE + ++S GI+ +E+ P
Sbjct: 163 ----AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 23/211 (10%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
IG GS G V +G VAVK+++L ++ + E +R +H+N++++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY- 87
Query: 769 SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH 828
G + L+ E++Q G+L + + Q L+ Q + V A+ YLH
Sbjct: 88 ---LVGEELWVLM-EFLQGGALTDIVSQ-------TRLNEEQIATVCESVLQALCYLHSQ 136
Query: 829 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVA 888
++H D+K ++LL D +SDFG +S + P V GT ++A
Sbjct: 137 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-------DVPKRKSLV-GTPYWMA 185
Query: 889 PEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
PE ++S GI+++E+ P
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-06
Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 36/219 (16%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRH 757
+F +G+G +G V+ + G +VA+K + L + + E + L + +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQ----RLN 813
L+K++ F+ ++ L EY+ G L NL ++ R
Sbjct: 61 EWLVKLL-----YAFQDDEYLYLAMEYVPGGDFRTLL---------NNLGVLSEDHARFY 106
Query: 814 IVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVET 873
+ ++ AV+ LH + +H DLKP N L+D ++DFGL+K +V
Sbjct: 107 M-AEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK--------GIVTY 154
Query: 874 PSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLE 912
+S V G+ Y+APE G +S G +L E
Sbjct: 155 ANS---VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYE 190
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 3e-06
Identities = 22/43 (51%), Positives = 25/43 (58%), Gaps = 3/43 (6%)
Query: 24 NETDCLSLLAIKSQL-HDPLGVTSSWNRSACVNLCQHWTGVTC 65
D +LLA KS L DP G SSWN S+ + C WTGVTC
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSS-SDPCS-WTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 49/214 (22%), Positives = 94/214 (43%), Gaps = 18/214 (8%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
+GRG++G VYK + + +E G S S E LR ++H N+I + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 769 SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRL--NIVIDVASAVEYLH 826
S + V L+++Y ++ R + + L + + +++ + + YLH
Sbjct: 69 SHSDRKV---WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 827 HHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
+ ++H DLKP+N+L+ ++D G A+ + SPL + + +
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVV---- 177
Query: 883 TIGYVAPEYGLGGEASMRG-GVYSYGILLLEIFT 915
T Y APE LG + +++ G + E+ T
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 21/164 (12%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
+G GS G V+ V + VAVK I L K E + +R + H N++K+ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 769 SI---------DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
++ +V EYM+ L L Q L + Q L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLR------ 125
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFL 862
++Y+H ++H DLKP+NV ++ D+V + DFGLA+ +
Sbjct: 126 -GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 46/171 (26%), Positives = 69/171 (40%), Gaps = 33/171 (19%)
Query: 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVI--NLEQKGGSKSFAAECEALRSIRH 757
TN + +G G+FG V G VA+K I +K E + L+ +RH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 758 RNLIKIVTICSS--------IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLI 809
N+I + I S + G D L + + LE Q L I
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRL----LTSRPLE-------KQFIQYFLYQI 117
Query: 810 QRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
R ++Y+H +VH DLKPSN+L++ + + DFGLA+
Sbjct: 118 LR---------GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 40/219 (18%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIK 762
FS T G+ GF + + +N V VI Q+GG+ A E LR+I H ++I+
Sbjct: 94 FSILETFTPGAEGFAFACI--DNKTCEHV-VIKAGQRGGT---ATEAHILRAINHPSIIQ 147
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
+ F F L+ + L +L + + IC++ I+R V A+
Sbjct: 148 LKGT-----FTYNKFTCLILPRYKT-DLYCYLAAKR-NIAICDILAIER-----SVLRAI 195
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
+YLH + I+H D+K N+ ++H + DFG A F V + G G
Sbjct: 196 QYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF-------PVDINANKYYGWAG 245
Query: 883 TIGYVAPE------YGLGGEASMRGGVYSYGILLLEIFT 915
TI APE YG + ++S GI+L E+ T
Sbjct: 246 TIATNAPELLARDPYGPAVD------IWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 11/105 (10%)
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
++ +++LH I++ DLK NVLLD + ++DFG+ K + V T +
Sbjct: 104 EIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK----EGILGGVTTSTF 156
Query: 877 SIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTE 921
GT Y+APE ++ G+LL E+ + P E
Sbjct: 157 C----GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 22/182 (12%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
+G G++G VYK G L AVK+I LE E ++ +H N++
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG--- 73
Query: 769 SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH 828
+ + + EY GSL++ H L ++ + R + + YLH
Sbjct: 74 --SYLSREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCR-----ETLQGLAYLHSK 125
Query: 829 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVA 888
+ +H D+K +N+LL + ++DFG+A ++A+ + S I GT ++A
Sbjct: 126 GK---MHRDIKGANILLTDNGDVKLADFGVAAKITAT-----IAKRKSFI---GTPYWMA 174
Query: 889 PE 890
PE
Sbjct: 175 PE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 37/119 (31%), Positives = 57/119 (47%), Gaps = 14/119 (11%)
Query: 798 DDQLGICNLSLIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856
+D+L L L+ VA + +L +C +H DL N+LL H + + DF
Sbjct: 206 EDELA---LDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDF 258
Query: 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
GLA+ + N V ++ + VK ++APE + V+SYGILL EIF+
Sbjct: 259 GLARDIRND--SNYVVKGNARLPVK----WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 71/267 (26%), Positives = 114/267 (42%), Gaps = 48/267 (17%)
Query: 676 HKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFV----YKGVLHENGMLVAV 731
HK ++ ++ ++ +F+ T+G GSFG V YK +E+ VA+
Sbjct: 10 HKKKDSDSTKE-----PKRKNKMKYEDFNFIRTLGTGSFGRVILATYK---NEDFPPVAI 61
Query: 732 KVIN----LEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSI--DFKGVDFKALVYEYM 785
K ++QK F+ E + L I H C ++ FK + LV E++
Sbjct: 62 KRFEKSKIIKQKQVDHVFS-ERKILNYINH-------PFCVNLYGSFKDESYLYLVLEFV 113
Query: 786 QNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL 845
G +L R ++ ++ IV+ EYL IV+ DLKP N+LL
Sbjct: 114 IGGEFFTFL--RRNKRFPNDVGCFYAAQIVL----IFEYLQ---SLNIVYRDLKPENLLL 164
Query: 846 DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYS 905
D D ++DFG AK VV+T + ++ GT Y+APE L ++
Sbjct: 165 DKDGFIKMTDFGFAK---------VVDTRTYTLC--GTPEYIAPEILLNVGHGKAADWWT 213
Query: 906 YGILLLEIFTRRRPTESMFNEGLTLHE 932
GI + EI P + NE L +++
Sbjct: 214 LGIFIYEILVGCPPFYA--NEPLLIYQ 238
|
Length = 340 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 29/225 (12%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFA---AECEALRSIRHRNLIKIVT 765
+G+G+FG V +G A+K++ E A E L++ RH L +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-- 60
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
F+ D V EY+ G L + H +++ + + IV SA++YL
Sbjct: 61 ---KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIV----SALDYL 111
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK--FLSASPLGNVVETPSSSIGVKGT 883
H IV+ DLK N++LD D ++DFGL K A+ + TP
Sbjct: 112 H---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE-------- 160
Query: 884 IGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGL 928
Y+APE + + G+++ E+ R P + +E L
Sbjct: 161 --YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 26/186 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVIN----LEQKGGSKSFAAECEALRSIRHRNLIKIV 764
IG+GSFG V +G AVKV+ L +K A L++++H L+ +
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
F+ + V +++ G L + H + ++ + + ++ASA+ Y
Sbjct: 62 ----HYSFQTTEKLYFVLDFVNGGEL--FFHLQRER----SFPEPRARFYAAEIASALGY 111
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
LH IV+ DLKP N+LLD ++DFGL K + ++ GT
Sbjct: 112 LH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--------EGIAQSDTTTTFCGTP 160
Query: 885 GYVAPE 890
Y+APE
Sbjct: 161 EYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 9e-06
Identities = 31/110 (28%), Positives = 53/110 (48%), Gaps = 15/110 (13%)
Query: 814 IVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVET 873
+ + + A+ YL ++H D+KPSN+LLD + DFG++ L V++
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL--------VDS 168
Query: 874 PSSSIGVKGTIGYVAPEY----GLGGEASMRGGVYSYGILLLEIFTRRRP 919
+ + G Y+APE + +R V+S GI L+E+ T + P
Sbjct: 169 KAKTRS-AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 30/82 (36%), Positives = 45/82 (54%), Gaps = 6/82 (7%)
Query: 834 VHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL 893
+H D+ NVLL VA + DFGLA+ + N V ++ + VK ++APE
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMND--SNYVVKGNARLPVK----WMAPESIF 287
Query: 894 GGEASMRGGVYSYGILLLEIFT 915
+++ V+SYGILL EIF+
Sbjct: 288 DCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 51/199 (25%), Positives = 83/199 (41%), Gaps = 32/199 (16%)
Query: 729 VAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNG 788
V K + L + + +E L + H ++K DFK D L+ EY G
Sbjct: 96 VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFD-----DFKSDDKLLLIMEYGSGG 150
Query: 789 SLEEWLHQRDDQLGICNLSLIQRLN--------IVIDVASAVEYLHHHCQPPIVHGDLKP 840
L + + QR L + L + + A++ +H ++H DLK
Sbjct: 151 DLNKQIKQR----------LKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKS 197
Query: 841 SNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMR 900
+N+ L + + DFG +K S S +V +SS GT Y+APE S +
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDV----ASSFC--GTPYYLAPELWERKRYSKK 251
Query: 901 GGVYSYGILLLEIFTRRRP 919
++S G++L E+ T RP
Sbjct: 252 ADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 8/194 (4%)
Query: 426 NFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQIL 485
+ +PSSL L L LS + + +L N L N+L + L
Sbjct: 56 SNTLLLLPSSLSRLLSLDLLSPSGISS-LDGSENLLNLLPLPSLDLNLNRLRSNIS--EL 112
Query: 486 EITTLSLSLDLSDNLLNGSLPLGVGNLKS-LVRLGIARNQFSGQIPVTLGACTSLEYVEL 544
T SLDL +N + +P +G LKS L L ++ N+ +P L +L+ ++L
Sbjct: 113 LELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDL 170
Query: 545 QGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK 604
N S +P+ LS+L+++ LDLS N S +P +E LS L+ L+LS N + +
Sbjct: 171 SFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSL 228
Query: 605 GIFKNKTGFSIVGN 618
KN +G + N
Sbjct: 229 SNLKNLSGLELSNN 242
|
Length = 394 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
+GRG++G VYK + + +E G S S E LR ++H N+I +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISL----Q 64
Query: 769 SIDFKGVDFKA-LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRL--NIVIDVASAVEYL 825
+ D K L+++Y ++ R + + L + + +++ + + YL
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 826 HHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
H + ++H DLKP+N+L+ ++D G A+ + SPL + + +
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVV--- 177
Query: 882 GTIGYVAPEYGLGGEASMRG-GVYSYGILLLEIFT 915
T Y APE LG + +++ G + E+ T
Sbjct: 178 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS------KSFAAECEALRSIRHRNLIK 762
+G G+F Y+ + G L+AVK + + S ++ E + + H ++I+
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 763 IV-TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDD-QLGICNLSLIQRLNIVIDVAS 820
++ C F L E+M GS+ L + + + Q +
Sbjct: 68 MLGATCEDSHFN------LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ-------LLR 114
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
+ YLH + I+H D+K +N+L+D + ++DFG A L+A G
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTG----AGEFQ 165
Query: 878 IGVKGTIGYVAPEYGLGGEASMRG-GVYSYGILLLEIFTRRRP 919
+ GTI ++APE L GE R V+S G +++E+ T + P
Sbjct: 166 GQLLGTIAFMAPEV-LRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 26/215 (12%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALR----SIRHRNLIKIV 764
+G+GSFG V L G AVK L++ EC + ++ N
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
C+ F+ + V E++ G L H +D L + ++ +++
Sbjct: 61 LYCT---FQTKEHLFFVMEFLNGGDL--MFHIQDKG----RFDLYRATFYAAEIVCGLQF 111
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
LH I++ DLK NV+LD D ++DFG+ K NV +S GT
Sbjct: 112 LHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK-------ENVFGDNRAST-FCGTP 160
Query: 885 GYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
Y+APE G + + +S+G+LL E+ + P
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 41/165 (24%), Positives = 74/165 (44%), Gaps = 17/165 (10%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVI---NLEQKGGSKSFAAECEALRSIRH 757
++F S IGRG+FG V + G + A+K + + +K AE + L +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
++K+ S F+ ++ L+ EY+ G + L ++D + + + +
Sbjct: 61 PWVVKLY--YS---FQDENYLYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAE 109
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862
A++ +H +H D+KP N+LLD +SDFGL L
Sbjct: 110 TILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 56/193 (29%), Positives = 82/193 (42%), Gaps = 28/193 (14%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEAL--RSIRHR-N 759
F +G+G FG V + G + A K LE+K K E AL + I + N
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKR-KGEAMALNEKQILEKVN 58
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
+V++ + + K D LV M G L+ ++ +G + + ++
Sbjct: 59 SRFVVSLAYAYETK--DALCLVLTLMNGGDLKFHIYN----MGNPGFDEERAVFYAAEIT 112
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI- 878
+E LH IV+ DLKP N+LLD +SD GLA VE P
Sbjct: 113 CGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA-----------VEIPEGETI 158
Query: 879 -GVKGTIGYVAPE 890
G GT+GY+APE
Sbjct: 159 RGRVGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 33/221 (14%)
Query: 709 IGRGSFGFVYKGVLHENG-MLVAVKVINLEQKGGSKSFAA------ECEALRSIRHRNLI 761
+G GSFG V H N A+K I L KS +A E L ++H N
Sbjct: 8 VGEGSFGRALL-VQHVNSDQKYAMKEIRL-----PKSSSAVEDSRKEAVLLAKMKHPN-- 59
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
IV S F+ +V EY G L + + + +L L + +
Sbjct: 60 -IVAFKES--FEADGHLYIVMEYCDGGDLMQKIKLQRGKL----FPEDTILQWFVQMCLG 112
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
V+++H + ++H D+K N+ L + + DFG A+ L+ SP + +
Sbjct: 113 VQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT-SPG-------AYACTYV 161
Query: 882 GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922
GT YV PE + + ++S G +L E+ T + P ++
Sbjct: 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA----ECEALRSIRHRNLIKIV 764
+G G++G V + G VA+K L + S+ FA E L+ ++H N+I ++
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 765 TICS---SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
+ + S+D + DF LV +M + H++ + IQ L V +
Sbjct: 81 DVFTPDLSLD-RFHDF-YLVMPFMGTDLGKLMKHEKLSE------DRIQFL--VYQMLKG 130
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
++Y+H I+H DLKP N+ ++ D + DFGLA+ + G VV
Sbjct: 131 LKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV---------- 177
Query: 882 GTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRR 917
T Y APE L + ++S G ++ E+ T +
Sbjct: 178 -TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 52/190 (27%), Positives = 88/190 (46%), Gaps = 31/190 (16%)
Query: 709 IGRGSFGFVY---KGVLHENGMLVAVKV-----INLEQKGGSKSFAAECEALRSIRHRNL 760
+G+G +G V+ K + G + A+KV I QK + + AE L +++H +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHT-KAERNILEAVKHPFI 62
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
+ ++ F+ L+ EY+ G L ++H + + + + + I +
Sbjct: 63 VDLIYA-----FQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISL---- 111
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
A+E+LH I++ DLKP N+LLD ++DFGL K + G V T
Sbjct: 112 ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHT------F 160
Query: 881 KGTIGYVAPE 890
GTI Y+APE
Sbjct: 161 CGTIEYMAPE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 39/184 (21%), Positives = 78/184 (42%), Gaps = 32/184 (17%)
Query: 733 VINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV---DFKALVYEYMQNGS 789
V+ + QKG + E L+++ H ++I++ S + + + +Y Y+
Sbjct: 95 VLKIGQKG---TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTK-- 149
Query: 790 LEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM 849
R L I +I++ + + YLH I+H D+K N+ ++
Sbjct: 150 -------RSRPLPIDQALIIEK-----QILEGLRYLHAQ---RIIHRDVKTENIFINDVD 194
Query: 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGIL 909
+ D G A+F +P + +G+ GT+ APE + + + ++S GI+
Sbjct: 195 QVCIGDLGAAQFPVVAP---------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIV 245
Query: 910 LLEI 913
L E+
Sbjct: 246 LFEM 249
|
Length = 357 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 52/198 (26%), Positives = 78/198 (39%), Gaps = 38/198 (19%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRN 759
F +G+G FG V + G + A K + ++++ G E L + R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
++ + + ++ D LV M G L + I N+ N D
Sbjct: 62 VVSL-----AYAYETKDALCLVLTIMNGGDL---------KFHIYNMG-----NPGFDEQ 102
Query: 820 SAVEYLHHHC-------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVE 872
A+ Y C + IV+ DLKP N+LLD +SD GLA + P G V
Sbjct: 103 RAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI---PEGETVR 159
Query: 873 TPSSSIGVKGTIGYVAPE 890
G GT+GY+APE
Sbjct: 160 ------GRVGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 32/218 (14%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALR----SIRHRNLIKIV 764
+G+GSFG V+ L A+K L++ EC + S+ +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLE---EWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
C+ F+ + V EY+ G L + H+ D L + ++
Sbjct: 61 LYCT---FQTKENLFFVMEYLNGGDLMFHIQSCHKFD---------LPRATFYAAEIICG 108
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
+++LH IV+ DLK N+LLD D ++DFG+ K + LG+ + +
Sbjct: 109 LQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGD-----AKTCTFC 157
Query: 882 GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
GT Y+APE LG + + +S+G+LL E+ + P
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 32/231 (13%)
Query: 694 KELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALR 753
K + + + + + +G G++G V + G+ VAVK + S+ F + A R
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQSIIHAKR 62
Query: 754 SIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLN 813
+ R L+K + + I V A E + L L D + N+ Q+L
Sbjct: 63 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD----LNNIVKCQKLT 118
Query: 814 ------IVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPL 867
++ + ++Y+H I+H DLKPSN+ ++ D + DFGLA+
Sbjct: 119 DDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------- 168
Query: 868 GNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRR 917
T G T Y APE L + ++S G ++ E+ T R
Sbjct: 169 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 31/226 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRNLIKIVT 765
+G+G+FG V G A+K++ E K E L++ RH L +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-- 60
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
F+ D V EY G L + H +++ + IV SA+EYL
Sbjct: 61 ---KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIV----SALEYL 111
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK---G 882
H +V+ D+K N++LD D ++DFGL K E S +K G
Sbjct: 112 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKTFCG 157
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGL 928
T Y+APE + + G+++ E+ R P + +E L
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 11/103 (10%)
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
++ +++LH I++ DLK NVLLD D ++DFG+ K E +S
Sbjct: 104 EIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK------ENMNGEGKAS 154
Query: 877 SIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
+ GT Y+APE G + + +S+G+LL E+ + P
Sbjct: 155 TFC--GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVTI 766
TIG+G++G V+K + +NG AVK+++ + AE L+++ H N++K +
Sbjct: 25 TIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLH---QRDDQLGICNLSLIQRLNIVIDVASAVE 823
D K D LV E GS+ + + +R +++ + I + A+
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM--------EEPIIAYILHEALM 135
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
L H +H D+K +N+LL + + DFG++ L+++ L ++S+ GT
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR-----NTSV---GT 187
Query: 884 IGYVAPEY-----GLGGEASMRGGVYSYGILLLEI 913
++APE L R V+S GI +E+
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-05
Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 34/226 (15%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEAL--RSIRHRN 759
+F+ +G+GSFG V L A+K+ L++ + EC + R + ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
+T S F+ VD V EY+ G L + Q + Q + +++
Sbjct: 59 KPPFLTQLHSC-FQTVDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPQAVFYAAEIS 111
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
+ +LH + I++ DLK NV+LD + ++DFG+ K ++V+ ++
Sbjct: 112 VGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMVDGVTTRT- 160
Query: 880 VKGTIGYVAPE------YGLGGEASMRGGVYSYGILLLEIFTRRRP 919
GT Y+APE YG + ++YG+LL E+ + P
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDW------WAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-05
Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 11/99 (11%)
Query: 818 VASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
VA +E+L C +H DL N+LL + V + DFGLA+ + P + V S+
Sbjct: 183 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDP--DYVRKGSA 236
Query: 877 SIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ +K ++APE + + V+S+G+LL EIF+
Sbjct: 237 RLPLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLI 761
F +G G++G VYKG + G L A+KV+++ + + E L+ HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIA 76
Query: 762 KIVTICSSIDFKGVDFKA-LVYEYMQNGSLEEWLHQ-RDDQLGICNLSLIQRLNIVIDVA 819
G D + LV E+ GS+ + + + + L ++ I R ++
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR-----EIL 131
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
+ +LH H ++H D+K NVLL + + DFG+ ++ L V ++ I
Sbjct: 132 RGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGV-----SAQLDRTVGRRNTFI- 182
Query: 880 VKGTIGYVAPEYGLGGEA-----SMRGGVYSYGILLLEI 913
GT ++APE E R ++S GI +E+
Sbjct: 183 --GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 51/185 (27%), Positives = 77/185 (41%), Gaps = 25/185 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRNLIKIVT 765
+G+G+FG V G A+K++ E K E L++ RH L +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-- 60
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
F+ D V EY G L + H +++ + + IV SA+ YL
Sbjct: 61 ---KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIV----SALGYL 111
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H +V+ DLK N++LD D ++DFGL K G ++T GT
Sbjct: 112 H---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT------FCGTPE 160
Query: 886 YVAPE 890
Y+APE
Sbjct: 161 YLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-04
Identities = 46/174 (26%), Positives = 76/174 (43%), Gaps = 27/174 (15%)
Query: 748 ECEALRSIRHRNLIKIVTICSSIDF-----KGVDFKALVYEYMQNGSLEEWLHQRDDQLG 802
E AL + H N++KI I S + DF +Y +M + + + W +D L
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFMYDEAFD-W---KDRPL- 265
Query: 803 ICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862
L Q I+ + AVEY+H ++H D+K N+ L+ D + DFG
Sbjct: 266 -----LKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFG----- 312
Query: 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR 916
+A P E + G GT+ +PE G ++S G++LL++ +
Sbjct: 313 TAMPFEK--EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364
|
Length = 501 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 11/99 (11%)
Query: 818 VASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
VA +E+L C +H DL N+LL + V + DFGLA+ + P + V +
Sbjct: 188 VAKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDP--DYVRKGDA 241
Query: 877 SIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ +K ++APE +++ V+S+G+LL EIF+
Sbjct: 242 RLPLK----WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-04
Identities = 53/209 (25%), Positives = 83/209 (39%), Gaps = 36/209 (17%)
Query: 724 ENGMLVAVKVINLEQKGGSKSFA------AECEALRSIRHRNLIKIVTICSSIDFKGV-- 775
G VA+K++ + A A C L H N++ + +D G
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLY---HPNIVAL------LD-SGEAP 50
Query: 776 -DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIV 834
V+EY+ +L E L D L + +++ V A+ H+ IV
Sbjct: 51 PGLLFAVFEYVPGRTLREVL-AADGAL-----PAGETGRLMLQVLDALACAHNQ---GIV 101
Query: 835 HGDLKPSNVLL---DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG-VKGTIGYVAPE 890
H DLKP N+++ A V DFG+ L + + V GT Y APE
Sbjct: 102 HRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGV--RDADVATLTRTTEVLGTPTYCAPE 159
Query: 891 YGLGGEA-SMRGGVYSYGILLLEIFTRRR 918
L GE + +Y++G++ LE T +R
Sbjct: 160 Q-LRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 18/60 (30%), Positives = 31/60 (51%)
Query: 538 SLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHF 597
+L+ ++L N + + L ++K LDLS NN + P+ L L+ L+LS N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 37/215 (17%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRH 757
++F IGRG+FG V + + A+K++N + ++ + F E
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE--------- 51
Query: 758 RNLIKIVTICSSID-----FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRL 812
RN++ + C I F+ ++ LV +Y G L L + +D+L + R
Sbjct: 52 RNVL-VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLP----EDMARF 106
Query: 813 NIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVE 872
I ++ A+ +H Q VH D+KP NVLLD + ++DFG L + G V
Sbjct: 107 YIA-EMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTV-- 158
Query: 873 TPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYG 907
SS+ V GT Y++PE +M G+ YG
Sbjct: 159 --QSSVAV-GTPDYISPEI----LQAMEDGMGKYG 186
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 27/242 (11%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSF---AAECEALRSIRHRNLIKIVT 765
IGRGS+ V L +N + A+KV+ E + E + +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLH-QRDDQLGICNLSLIQRLNIVIDVASAVEY 824
C F+ LV EY+ G L H QR +L + ++ A+ +
Sbjct: 63 SC----FQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFY-----AAEICIALNF 111
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
LH + I++ DLK NVLLD D ++D+G+ K G+ T GT
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTST------FCGTP 160
Query: 885 GYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMF-NEGLTLHEFAKRALPEKVM 943
Y+APE G E ++ G+L+ E+ R P + + N + ++ + + EK +
Sbjct: 161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI 220
Query: 944 EI 945
I
Sbjct: 221 RI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 20/191 (10%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLI 761
F +G G++G VYKG + G L A+KV+++ + E L+ HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIA 66
Query: 762 KIVTICSSIDFKGVDFKA-LVYEYMQNGSLEEWL-HQRDDQLGICNLSLIQRLNIVIDVA 819
+ G+D + LV E+ GS+ + + + + + L ++ I R ++
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-----EIL 121
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
+ +LH H ++H D+K NVLL + + DFG+ ++ L V ++ I
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV-----SAQLDRTVGRRNTFI- 172
Query: 880 VKGTIGYVAPE 890
GT ++APE
Sbjct: 173 --GTPYWMAPE 181
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 47/162 (29%), Positives = 66/162 (40%), Gaps = 29/162 (17%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRS----------IRHR 758
+GRG FG V + G L A+K + K G E E+L RH
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKAL----KKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
L+ + C F+ D V EY G L +H D S + + V
Sbjct: 63 FLVNLFA-C----FQTEDHVCFVMEYAAGGDL--MMHIHTDVF-----SEPRAVFYAACV 110
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
++YLH + IV+ DLK N+LLD + ++DFGL K
Sbjct: 111 VLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK 149
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 42/217 (19%)
Query: 712 GSFGFVYKGVLH--ENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIV----- 764
GS G V+ H E V VK + G K+ E + L++I HR +I ++
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAYRW 157
Query: 765 --TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
T+C + +K ++ Y+ L L Q + I + A+
Sbjct: 158 KSTVCMVMP----KYKCDLFTYVD---------------RSGPLPLEQAITIQRRLLEAL 198
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
YLH I+H D+K N+ LD A + DFG A L A P +TP G G
Sbjct: 199 AYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP-----DTP-QCYGWSG 249
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
T+ +PE + ++S G++L E+ +
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 11/111 (9%)
Query: 806 LSLIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSA 864
LS + + VA+ +E+L +C VH DL NVL+ + + DFGLA+ +
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMR 291
Query: 865 SPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
N + S+ + +K ++APE + V+S+GILL EIFT
Sbjct: 292 D--SNYISKGSTFLPLK----WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 709 IGRGSFGFV---YKGVLHENGMLVAVKVIN--LEQKGGSKSFAAECEALRSIRHRNLIKI 763
IG G+ G V Y VL N VA+K ++ + + +K E ++ + H+N+I +
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 764 VTICSSI----DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI-DV 818
+ + + +F+ V LV E M + +L + + D +R++ ++ +
Sbjct: 82 LNVFTPQKSLEEFQDV---YLVMELM-DANLCQVIQMELDH---------ERMSYLLYQM 128
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
+++LH I+H DLKPSN+++ D + DFGLA+ S + TP
Sbjct: 129 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVV- 180
Query: 879 GVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEI 913
T Y APE LG ++S G ++ E+
Sbjct: 181 ----TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 47/228 (20%)
Query: 709 IGRGSFGFV----YKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-------- 756
+G+G++G V E VA+K I + F+ + A R++R
Sbjct: 8 LGQGAYGIVCSARNAETSEEET--VAIKKI-------TNVFSKKILAKRALRELKLLRHF 58
Query: 757 --HRNLIKIVTICSSIDFKGVDFKAL--VYEYMQNGSLEEWLHQ--RDDQLGICNLSLIQ 810
H+N I + D V +Y Y + +E LHQ R Q L+
Sbjct: 59 RGHKN---ITCL---YDMDIVFPGNFNELYLYEE--LMEADLHQIIRSGQ----PLTDAH 106
Query: 811 RLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNV 870
+ + + ++Y+H ++H DLKP N+L++ D + DFGLA+ S +P
Sbjct: 107 FQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP---- 159
Query: 871 VETPSSSIGVKGTIGYVAPEYGLGGEASMRG-GVYSYGILLLEIFTRR 917
E T Y APE L ++ + V+S G +L E+ R+
Sbjct: 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 23/192 (11%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHR 758
+F IGRG+FG V L + A+K++N + ++ + F E + L + ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
+ + F+ + LV +Y G L L + +D+L +++ +VI +
Sbjct: 62 WITTL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPE-DMARFYLAEMVIAI 115
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
S V LH+ VH D+KP N+L+D + ++DFG L T SS+
Sbjct: 116 DS-VHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMED------GTVQSSV 162
Query: 879 GVKGTIGYVAPE 890
V GT Y++PE
Sbjct: 163 AV-GTPDYISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 24/223 (10%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFA---AECEALRSIRHRNLIKIVT 765
+G+G+FG V G A+K++ E A E L++ RH L +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-- 60
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
F+ D V EY G L + H +++ + + IV SA++YL
Sbjct: 61 ---KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIV----SALDYL 111
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H + +V+ DLK N++LD D ++DFGL K G ++T GT
Sbjct: 112 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKT------FCGTPE 161
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGL 928
Y+APE + + G+++ E+ R P + +E L
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 31/212 (14%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRH 757
++F IGRG+FG V + G + A+K++N + ++ + F E + L +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
R + + F+ + LV +Y G L L + +D+L + R + +
Sbjct: 61 RWITNL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP----EDMARFYLA-E 110
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPS 875
+ A++ +H Q VH D+KP NVLL D H+ +DFG L G V
Sbjct: 111 MVLAIDSVH---QLGYVHRDIKPDNVLL--DKNGHIRLADFG--SCLRLLADGTV----Q 159
Query: 876 SSIGVKGTIGYVAPEYGLGGEASMRGGVYSYG 907
S++ V GT Y++PE +M G YG
Sbjct: 160 SNVAV-GTPDYISPEI----LQAMEDGKGRYG 186
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 34/152 (22%), Positives = 74/152 (48%), Gaps = 25/152 (16%)
Query: 709 IGRGSFGFVYKGVL------------HENGMLVAVKVINLEQKGGSKSFAAECEALRSIR 756
+GRG+ +Y G+L +E + V +KV++ + S +F +R +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 757 HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI 816
H++++ + +C D + + +V E+++ G L+ ++H++ D L+ + +
Sbjct: 63 HKHIVLLYGVCVR-DVENI----MVEEFVEFGPLDLFMHRKSDV-----LTTPWKFKVAK 112
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD 848
+ASA+ YL +VHG++ N+LL +
Sbjct: 113 QLASALSYLE---DKDLVHGNVCTKNILLARE 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-04
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 25/165 (15%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRN 759
++F S IGRG+FG V + G + A+K++ K+ E E + IR R+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERD 53
Query: 760 LIK------IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLN 813
++ +V + S F+ L+ E++ G + L ++D LS
Sbjct: 54 ILVEADGAWVVKMFYS--FQDKRNLYLIMEFLPGGDMMTLLMKKD------TLSEEATQF 105
Query: 814 IVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858
+ + A++ +H Q +H D+KP N+LLD +SDFGL
Sbjct: 106 YIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 19/51 (37%), Positives = 28/51 (54%), Gaps = 4/51 (7%)
Query: 811 RLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861
R +++ +V V LH IVHGDL SN++L + + DFGL +F
Sbjct: 94 RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGRI-YFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-04
Identities = 29/102 (28%), Positives = 45/102 (44%), Gaps = 25/102 (24%)
Query: 204 LWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKN 263
L G IP +S+L L +++ N G IPPS+ +I+SL + L N F GS
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS-------- 481
Query: 264 LPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQV 305
+P+S ++L +L+L N G+V
Sbjct: 482 -----------------IPESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 8e-04
Identities = 28/103 (27%), Positives = 50/103 (48%), Gaps = 11/103 (10%)
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
+++ A+ YLH + I++ DLK NVLLD + ++D+G+ K + +
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--------EGLRPGDT 152
Query: 877 SIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
+ GT Y+APE G + ++ G+L+ E+ R P
Sbjct: 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-04
Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 31/225 (13%)
Query: 678 SSNTSQMEQQFPMVSYKELSKATNE-FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINL 736
++N + E + M+ +++++ N+ + N IG GSFG VY+ + + VA+K +
Sbjct: 43 NNNAGEDEDEEKMID-NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ 101
Query: 737 EQKGGSKSFAAECEALRSIRHRNLIKI----VTICSSIDFKGVDFKALVYEYMQNGSLEE 792
+ + ++ E ++++ H N+I + T C + K + F +V E++ ++ +
Sbjct: 102 DPQYKNR----ELLIMKNLNHINIIFLKDYYYTECFKKNEKNI-FLNVVMEFIPQ-TVHK 155
Query: 793 WL--HQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD-HDM 849
++ + R++ L L + A+ Y+H I H DLKP N+L+D +
Sbjct: 156 YMKHYARNNH----ALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTH 208
Query: 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG 894
+ DFG AK L A S+ + Y APE LG
Sbjct: 209 TLKLCDFGSAKNLLAG---------QRSVSYICSRFYRAPELMLG 244
|
Length = 440 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 9e-04
Identities = 49/168 (29%), Positives = 76/168 (45%), Gaps = 41/168 (24%)
Query: 709 IGRGSFGFV---YKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR--------- 756
IG G+ G V Y V +N VA+K + S+ F A R+ R
Sbjct: 24 IGSGAQGIVCAAYDTVTGQN---VAIKKL-------SRPFQNVTHAKRAYRELVLMKLVN 73
Query: 757 HRNLIKIV---TICSSI-DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRL 812
H+N+I ++ T S+ +F+ V LV E M + +L + + D + L L Q L
Sbjct: 74 HKNIIGLLNVFTPQKSLEEFQDV---YLVMELM-DANLCQVIQMDLDHERMSYL-LYQML 128
Query: 813 NIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
+++LH I+H DLKPSN+++ D + DFGLA+
Sbjct: 129 -------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.001
Identities = 24/72 (33%), Positives = 40/72 (55%), Gaps = 1/72 (1%)
Query: 254 GSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLK 313
G +P +I K L +L++ + N+ G++P S + ++LEVL L+ N F G + + L
Sbjct: 432 GFIPNDISK-LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490
Query: 314 DLSMLGLATNFL 325
L +L L N L
Sbjct: 491 SLRILNLNGNSL 502
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 22/60 (36%), Positives = 26/60 (43%)
Query: 393 NLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNL 452
NL SL + NRLT L NL++L L N L P + L L L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 0.001
Identities = 62/227 (27%), Positives = 93/227 (40%), Gaps = 50/227 (22%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVK-VINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTI 766
IG G+FG V+ +G VA+K + N+ Q K E + L +H N++ + I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 767 CSSIDFKGVDFKALVY---EYMQNGSLEEWLHQ--------RDDQLGICNLSLIQRLNIV 815
+D +Y E MQ+ LH+ D + + L Q L
Sbjct: 68 LQPPH---IDPFEEIYVVTELMQSD-----LHKIIVSPQPLSSDHV---KVFLYQILR-- 114
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
++YLH I+H D+KP N+L++ + V + DFGLA+ VE P
Sbjct: 115 -----GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR----------VEEPD 156
Query: 876 SSIGVKG---TIGYVAPEYGLGGEASMRGGV--YSYGILLLEIFTRR 917
S + T Y APE L G V +S G + E+ RR
Sbjct: 157 ESKHMTQEVVTQYYRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
A+E LH + +++ DLKP N+LLD+ + DFGL K N+ + ++
Sbjct: 105 ALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL-------NMKDDDKTNT-F 153
Query: 881 KGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
GT Y+APE LG + ++ G+LL E+ T P
Sbjct: 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 29/77 (37%), Positives = 39/77 (50%), Gaps = 10/77 (12%)
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVE-------T 873
A+EYLH++ IVH DLKP N+L+ ++DFGL+K S N+ E
Sbjct: 113 ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 874 PSSSIGVKGTIGYVAPE 890
V GT Y+APE
Sbjct: 170 EFLDKQVCGTPEYIAPE 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 29/103 (28%), Positives = 50/103 (48%), Gaps = 11/103 (10%)
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
+++ A+ +LH + I++ DLK NVLLD + ++D+G+ K G+ T
Sbjct: 104 EISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTST--- 155
Query: 877 SIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
GT Y+APE G + ++ G+L+ E+ R P
Sbjct: 156 ---FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|225714 COG3173, COG3173, Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 21/82 (25%), Positives = 33/82 (40%), Gaps = 14/82 (17%)
Query: 786 QNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE-YLHHHC-----QPPIVHGDLK 839
+ L W DD+ L R I +A + +L + P +VHGD +
Sbjct: 155 RGRQLARW----DDEYRRAKKELGGR----IPLADRLIKWLEANRPPWAGPPVLVHGDYR 206
Query: 840 PSNVLLDHDMVAHVSDFGLAKF 861
P N+++D V D+ LA
Sbjct: 207 PGNLIIDPGRPTGVLDWELATL 228
|
Length = 321 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 709 IGRGSFGFV---YKGVLHENGMLVAVKVIN--LEQKGGSKSFAAECEALRSIRHRNLIKI 763
IG G+ G V Y +L N VA+K ++ + + +K E ++ + H+N+I +
Sbjct: 32 IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 764 VTIC----SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI-DV 818
+ + S +F+ V +V E M + +L + + D +R++ ++ +
Sbjct: 89 LNVFTPQKSLEEFQDV---YIVMELM-DANLCQVIQMELDH---------ERMSYLLYQM 135
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
+++LH I+H DLKPSN+++ D + DFGLA+ S + TP
Sbjct: 136 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVV- 187
Query: 879 GVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEI 913
T Y APE LG ++S G ++ E+
Sbjct: 188 ----TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 11/106 (10%)
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
+V A+ +LH H +++ DLK N+LLD + ++DFG+ K L V T
Sbjct: 104 EVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFC 157
Query: 877 SIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922
GT Y+APE E ++ G+L+ E+ + P E+
Sbjct: 158 -----GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 21/162 (12%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNL 760
+F S IGRG+FG V + G + A+K++ K+ E E + IR R++
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-------KADMLEKEQVGHIRAERDI 54
Query: 761 I----KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI 816
+ + + F+ L+ E++ G + L ++D L+ + +
Sbjct: 55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIA 108
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858
+ A++ +H Q +H D+KP N+LLD +SDFGL
Sbjct: 109 ETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 43/174 (24%), Positives = 78/174 (44%), Gaps = 33/174 (18%)
Query: 693 YKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN-----LEQKGGSKSFAA 747
YK L K IG G+F V K + G A+K + LEQ
Sbjct: 1 YKILGK----------IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL----R 46
Query: 748 ECEALRSIR-HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNL 806
E +ALR + H N+++++ + + ALV+E M + +L E + R L +
Sbjct: 47 EIQALRRLSPHPNILRLIEVLFDRKTGRL---ALVFELM-DMNLYELIKGRKRPLPEKRV 102
Query: 807 SLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
+ + + +++++H + I H D+KP N+L+ D++ ++DFG +
Sbjct: 103 -----KSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKDDIL-KLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 17/60 (28%), Positives = 32/60 (53%)
Query: 514 SLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNF 573
+L L ++ N+ + +L+ ++L GN+ + P++ S L S++ LDLS NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.003
Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 23/162 (14%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVK------VINLEQKGGSKSFAAECEALRSIR 756
F TIG G+FG V + L A+K V+ Q K AE + L
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVK---AERDILAEAD 59
Query: 757 HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI 816
+ ++K+ F+ D V +Y+ G + L +LGI L R I
Sbjct: 60 NEWVVKLY-----YSFQDKDNLYFVMDYIPGGDMMSLL----IRLGIFEEDL-ARFYIA- 108
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858
++ A+E +H + +H D+KP N+L+D D ++DFGL
Sbjct: 109 ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.004
Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 9/107 (8%)
Query: 806 LSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865
L L Q + + SA++Y+H + I+H D+K NVL++ + DFG A F S
Sbjct: 257 LGLAQVTAVARQLLSAIDYIH--GEG-IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313
Query: 866 PLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLE 912
TP G+ GT+ APE G + ++S G+++ E
Sbjct: 314 -----WSTP-FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.004
Identities = 29/145 (20%), Positives = 55/145 (37%), Gaps = 20/145 (13%)
Query: 717 VYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776
VY L +K+ +KG E L+ + + L + S
Sbjct: 14 VYL--LGTKDEDYVLKINPSREKG--ADREREVAILQLLARKGLPVPKVLASGESDGWS- 68
Query: 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHG 836
L+ E+++ +L+E +S ++ +I +A + LH + HG
Sbjct: 69 --YLLMEWIEGETLDE-------------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113
Query: 837 DLKPSNVLLDHDMVAHVSDFGLAKF 861
DL P N+L+D + + D+ A +
Sbjct: 114 DLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.004
Identities = 67/289 (23%), Positives = 107/289 (37%), Gaps = 62/289 (21%)
Query: 191 LSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGN 250
L+ LR ID+R ++ +IP LS T+L L + D +P S+ ++ L ++ +
Sbjct: 633 LTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC 691
Query: 251 RFTGSLPIEIGKNLPNLRNFVIYTNNFTG-----SLPDSFSNASNLEVLHLAENQFRGQV 305
LP G NL +L Y N +G S PD +N S L++ A +F
Sbjct: 692 ENLEILPT--GINLKSL-----YRLNLSGCSRLKSFPDISTNISWLDLDETAIEEF--PS 742
Query: 306 SINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIAN 365
++ L +L + + + L + V LT + L S+
Sbjct: 743 NLRLENLDELILCEMKSEKL-------WERVQPLTPLMTM-------------LSPSLTR 782
Query: 366 LSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIG--ELKNLQLLH- 422
L L +P I NL L L +E T+P I L++L L
Sbjct: 783 LF-------LSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGC 835
Query: 423 ------------LHANFLQGT----IPSSLGNLTLLTYLSF-GANNLQG 454
+ L T +P + + L++L G NNLQ
Sbjct: 836 SRLRTFPDISTNISDLNLSRTGIEEVPWWIEKFSNLSFLDMNGCNNLQR 884
|
syringae 6; Provisional. Length = 1153 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1009 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.59 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.55 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.54 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.48 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.38 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.13 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.11 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.07 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.06 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.05 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.03 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.01 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.96 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.94 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.89 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.88 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.88 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.86 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.86 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.83 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.81 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.81 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.77 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.77 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.69 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.64 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.53 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.47 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.47 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.4 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.4 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.37 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-117 Score=1135.19 Aligned_cols=919 Identities=31% Similarity=0.527 Sum_probs=782.3
Q ss_pred CChhhHHHHHHHHHhcCCCCCCCCCCccCCCCCCCCCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeec
Q 047768 23 SNETDCLSLLAIKSQLHDPLGVTSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIA 102 (1009)
Q Consensus 23 ~~~~d~~aLl~~k~~~~~~~~~~~sW~~~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~ 102 (1009)
..++|+.||++||+++.||.+.+.+|+.. .+|| .|+||+|++ .++|+.|||++++++|.+++.+..+++|++|+|+
T Consensus 26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~~--~~~c-~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls 101 (968)
T PLN00113 26 LHAEELELLLSFKSSINDPLKYLSNWNSS--ADVC-LWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLS 101 (968)
T ss_pred CCHHHHHHHHHHHHhCCCCcccCCCCCCC--CCCC-cCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECC
Confidence 36789999999999998898888999754 3555 899999986 4699999999999999999999999999999999
Q ss_pred CCcCCccCCcccc-CccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCC
Q 047768 103 DNDFHGEIPDRIG-NLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLT 181 (1009)
Q Consensus 103 ~n~~~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~ 181 (1009)
+|+++|.+|..+. ++++|++|||++|.++|.+|. +.+++|++|++++|.+++.+|..+ ..+.+|++|+|++|.+.
T Consensus 102 ~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~--~~l~~L~~L~L~~n~l~ 177 (968)
T PLN00113 102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDI--GSFSSLKVLDLGGNVLV 177 (968)
T ss_pred CCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHH--hcCCCCCEEECccCccc
Confidence 9999999998765 999999999999999999886 568999999999999999999987 67999999999999999
Q ss_pred CCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhc
Q 047768 182 GQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIG 261 (1009)
Q Consensus 182 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~ 261 (1009)
+.+|..|+++++|++|+|++|++.+.+|..|+++++|++|+|++|++++.+|..+.++++|++|++++|++++.+|..+
T Consensus 178 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l- 256 (968)
T PLN00113 178 GKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL- 256 (968)
T ss_pred ccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhH-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998888776
Q ss_pred cCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhccc
Q 047768 262 KNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTN 341 (1009)
Q Consensus 262 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~ 341 (1009)
.++++|++|+|++|++++.+|..+.++++|++|+|++|++.+..+..|..+++|+.|++++|.+.... +..+..
T Consensus 257 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~------~~~~~~ 330 (968)
T PLN00113 257 GNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI------PVALTS 330 (968)
T ss_pred hCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcC------ChhHhc
Confidence 46999999999999999999999999999999999999999999999999999999999999987533 356788
Q ss_pred ccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccce
Q 047768 342 CTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLL 421 (1009)
Q Consensus 342 l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 421 (1009)
+++|+.|++++|.+.+.+|..+..+ ..|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|
T Consensus 331 l~~L~~L~L~~n~l~~~~p~~l~~~-~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L 409 (968)
T PLN00113 331 LPRLQVLQLWSNKFSGEIPKNLGKH-NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRV 409 (968)
T ss_pred CCCCCEEECcCCCCcCcCChHHhCC-CCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEE
Confidence 9999999999999999999999888 689999999999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCcc
Q 047768 422 HLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLL 501 (1009)
Q Consensus 422 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l 501 (1009)
+|++|++++.+|..|.+++.|++|++++|++++.+|..+..+++|+.|++++|++.+.+|..+. . .....||+++|++
T Consensus 410 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~-~~L~~L~ls~n~l 487 (968)
T PLN00113 410 RLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-S-KRLENLDLSRNQF 487 (968)
T ss_pred ECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-c-ccceEEECcCCcc
Confidence 9999999999999999999999999999999999999999999999999999999998887543 2 3345699999999
Q ss_pred CCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCccccccccccc
Q 047768 502 NGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYL 581 (1009)
Q Consensus 502 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 581 (1009)
++.+|..+.++++|+.|+|++|++++.+|..++.+++|++|+|++|+++|.+|..|+.+++|+.|||++|+++|.+|..+
T Consensus 488 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 567 (968)
T PLN00113 488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567 (968)
T ss_pred CCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCceecccccCcccCCCCCcccCccccccccCCCcCCCCCCCCCCCCCcCCCCCCCcceeeeehhhhHHHHHHHH
Q 047768 582 ENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDELHLPSCQARGSRKPNVNLVKVVIPVIGGSCLILS 661 (1009)
Q Consensus 582 ~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (1009)
..+++|++|++++|+++|.+|..+++.++....+.||+.+||+......+.|.... .... ...+++.++++++++++
T Consensus 568 ~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~--~~~~-~~~~~~~~~~~~~~~~~ 644 (968)
T PLN00113 568 GNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR--KTPS-WWFYITCTLGAFLVLAL 644 (968)
T ss_pred hcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc--ccce-eeeehhHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999976554445453221 1111 22222223333333333
Q ss_pred hhheeeeeeeccccC-cCCCC--cccccc-C-----CccCHHHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEE
Q 047768 662 VCIFIFYARRRRSAH-KSSNT--SQMEQQ-F-----PMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVK 732 (1009)
Q Consensus 662 v~~~~~~~~~~~~~~-~~~~~--~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK 732 (1009)
++++++++++|+... +.... ...+.. + ..+++++ ....|...+.||+|+||+||+|+++.+++.||||
T Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK 721 (968)
T PLN00113 645 VAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVK 721 (968)
T ss_pred HHHHHHHHHhhhcccccccccccccccccccccccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEE
Confidence 333333323222111 11000 000000 0 1122222 3346777889999999999999998899999999
Q ss_pred EeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHH
Q 047768 733 VINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRL 812 (1009)
Q Consensus 733 ~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~ 812 (1009)
+++.... ...+|++++++++||||++++|+|... ...++||||+++|+|.++++. ++|.++.
T Consensus 722 ~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~---------l~~~~~~ 783 (968)
T PLN00113 722 EINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYIEGKNLSEVLRN---------LSWERRR 783 (968)
T ss_pred EccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCCCCCcHHHHHhc---------CCHHHHH
Confidence 9853322 223568899999999999999998653 567999999999999999963 7899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCcccc
Q 047768 813 NIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYG 892 (1009)
Q Consensus 813 ~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 892 (1009)
.++.|+|+|++|||..+.++|+||||||+||+++.++.+++. ||.+..... .....||+.|||||++
T Consensus 784 ~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------------~~~~~~t~~y~aPE~~ 850 (968)
T PLN00113 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------------DTKCFISSAYVAPETR 850 (968)
T ss_pred HHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------------CCCccccccccCcccc
Confidence 999999999999997766799999999999999999988876 665543221 1123578999999999
Q ss_pred CCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccch-hhhccCCCCCChhhhhhhccccccHHHHHH
Q 047768 893 LGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEK-VMEIVDPSLLPLEEERTNSRRVRNEECLVA 971 (1009)
Q Consensus 893 ~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~ 971 (1009)
.+..++.++|||||||++|||+||+.||...........+|........ ...++|+.+.... ....+++.+
T Consensus 851 ~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 922 (968)
T PLN00113 851 ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV--------SVNQNEIVE 922 (968)
T ss_pred cCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC--------CccHHHHHH
Confidence 9999999999999999999999999999755444555666655443322 4444554443221 122356678
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 972 VIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 972 l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
+.+++.+||+.||++||||+||+++|+++.+..
T Consensus 923 ~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 923 VMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 899999999999999999999999999987744
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-62 Score=625.93 Aligned_cols=515 Identities=34% Similarity=0.535 Sum_probs=482.4
Q ss_pred CCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCc-CCCcCcEEecccccccCCCchHHhhhccCCcCe
Q 047768 94 SFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLS-HCSKLITFSAHRNNLVGEIPEELISRRLFNLQG 172 (1009)
Q Consensus 94 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~ 172 (1009)
.+++.|||++|+++|.+|..|..+++|++|||++|+++|.+|..+. ++++|++|++++|++++.+|.. .+.+|++
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~----~l~~L~~ 144 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG----SIPNLET 144 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCcc----ccCCCCE
Confidence 4689999999999999999999999999999999999999998765 9999999999999999999874 4789999
Q ss_pred EeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCcc
Q 047768 173 LSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRF 252 (1009)
Q Consensus 173 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 252 (1009)
|+|++|.+++.+|..++++++|++|+|++|.+.+.+|..|.++++|++|+|++|++++.+|..+.++++|++|+|++|++
T Consensus 145 L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 224 (968)
T PLN00113 145 LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224 (968)
T ss_pred EECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCCCCCCC
Q 047768 253 TGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAAND 332 (1009)
Q Consensus 253 ~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~ 332 (1009)
++.+|..+. ++++|++|++++|++++.+|..|+++++|++|+|++|++.+..+..+..+++|+.|++++|.+...
T Consensus 225 ~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~---- 299 (968)
T PLN00113 225 SGEIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE---- 299 (968)
T ss_pred CCcCChhHh-cCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccC----
Confidence 989998775 699999999999999999999999999999999999999999999999999999999999998653
Q ss_pred cchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCc
Q 047768 333 LDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVI 412 (1009)
Q Consensus 333 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 412 (1009)
++..+.++++|++|++++|.+++..|..+..+ ..|+.|++++|.+++.+|..+..+++|+.|++++|++++.+|..+
T Consensus 300 --~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l-~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~ 376 (968)
T PLN00113 300 --IPELVIQLQNLEILHLFSNNFTGKIPVALTSL-PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL 376 (968)
T ss_pred --CChhHcCCCCCcEEECCCCccCCcCChhHhcC-CCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhH
Confidence 34678899999999999999999999999888 679999999999999999999999999999999999999999999
Q ss_pred CCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhcccee
Q 047768 413 GELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSL 492 (1009)
Q Consensus 413 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~ 492 (1009)
..+++|+.|++++|++.+.+|..+..+++|+.|++++|++++.+|..+.++++|+.+++++|.+++.+|..+.....+.
T Consensus 377 ~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~- 455 (968)
T PLN00113 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ- 455 (968)
T ss_pred hCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999988777665554
Q ss_pred eEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcc
Q 047768 493 SLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNN 572 (1009)
Q Consensus 493 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 572 (1009)
.|++++|++.+.+|..+ ..++|+.||+++|++++.+|..+..+++|+.|+|++|++++.+|..++++++|++|+|++|.
T Consensus 456 ~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 534 (968)
T PLN00113 456 MLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534 (968)
T ss_pred EEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCc
Confidence 59999999999999876 45899999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccCceecccccCcccCCCC-CcccCccccccccCCCcC
Q 047768 573 FSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK-GIFKNKTGFSIVGNGKLC 622 (1009)
Q Consensus 573 l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~lc 622 (1009)
++|.+|..|..+++|+.|||++|+++|.+|.. ..+..+....+.+|+..+
T Consensus 535 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred ccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 99999999999999999999999999999974 345556666777777544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=426.32 Aligned_cols=289 Identities=42% Similarity=0.671 Sum_probs=244.3
Q ss_pred cCCccCHHHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEee
Q 047768 687 QFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTI 766 (1009)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 766 (1009)
....++++++..++++|...+.||+|+||.||+|... +++.||||+++.......++|.+|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 4567899999999999999999999999999999996 568999998865443214669999999999999999999999
Q ss_pred eeccccCCCc-eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee
Q 047768 767 CSSIDFKGVD-FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL 845 (1009)
Q Consensus 767 ~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill 845 (1009)
|.+. + ..++|||||++|+|.++++..... +++|.+|.+||.++|+||+|||+.++|+||||||||+|||+
T Consensus 140 C~e~-----~~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL 210 (361)
T KOG1187|consen 140 CLEG-----GEHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL 210 (361)
T ss_pred EecC-----CceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence 9864 3 589999999999999999986642 58999999999999999999999999999999999999999
Q ss_pred CCCCceEEeccccccccCCCCCCCccccCCccccc-cccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccc
Q 047768 846 DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV-KGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMF 924 (1009)
Q Consensus 846 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~ 924 (1009)
|+++++||+|||+|+...... ...... .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+...
T Consensus 211 D~~~~aKlsDFGLa~~~~~~~--------~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 211 DEDFNAKLSDFGLAKLGPEGD--------TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR 282 (361)
T ss_pred CCCCCEEccCccCcccCCccc--------cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC
Confidence 999999999999996544200 111111 79999999999999999999999999999999999999877543
Q ss_pred -cCCccHHHHHHHhccc-hhhhccCCCCCC-hhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 925 -NEGLTLHEFAKRALPE-KVMEIVDPSLLP-LEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 925 -~~~~~~~~~~~~~~~~-~~~~~~d~~l~~-~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
.....+..|....+.. .+.+++|+.+.. .+. ..++..++..++.+|++.+|..||+|.||++.|+.+.
T Consensus 283 ~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~---------~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 283 PRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYP---------DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcccccHHHHHHHHHHCcchhheeCCCccCCCCC---------hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 3344577887666555 599999999863 211 1156778999999999999999999999999997665
Q ss_pred H
Q 047768 1002 Q 1002 (1009)
Q Consensus 1002 ~ 1002 (1009)
.
T Consensus 354 ~ 354 (361)
T KOG1187|consen 354 S 354 (361)
T ss_pred c
Confidence 4
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=403.42 Aligned_cols=260 Identities=33% Similarity=0.487 Sum_probs=212.0
Q ss_pred cCccCCcccccCCceEEEEEEecCCeE-EEEEEeecccccc--hHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGML-VAVKVINLEQKGG--SKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
+..+.+.+|+|+||+||+|.|+ |+. ||||++....... .+.|.+|+.+|++++|||||+++|+|.... ...
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~ 115 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSL 115 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----Cce
Confidence 3344566999999999999996 666 9999997544332 458999999999999999999999998641 168
Q ss_pred EEEEeccCCCCHHHHHhcc-CCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCC-ceecCCCCCceeeCCCC-ceEEec
Q 047768 779 ALVYEYMQNGSLEEWLHQR-DDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPP-IVHGDLKPSNVLLDHDM-VAHVSD 855 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivHrdlk~~Nill~~~~-~~kl~D 855 (1009)
++||||+++|+|.++++.. .. .+++..+..+|.|||+||.|||++ + ||||||||+|||++.++ ++||+|
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~~~-----~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKRKR-----KLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcccC-----CCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECC
Confidence 9999999999999999884 32 499999999999999999999999 7 99999999999999997 999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccC--CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL--GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
||+++...... ...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||...... ......
T Consensus 188 FGlsr~~~~~~--------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~~~~~v 258 (362)
T KOG0192|consen 188 FGLSREKVISK--------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-QVASAV 258 (362)
T ss_pred Cccceeecccc--------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHH
Confidence 99998765431 2223367999999999999 569999999999999999999999999865431 111111
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLG 1006 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~ 1006 (1009)
+.....+ ..+..++..+..++..||+.||+.||++.|++..|+.+...+..
T Consensus 259 ------------~~~~~Rp----------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 259 ------------VVGGLRP----------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ------------HhcCCCC----------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 1111111 11123666788999999999999999999999999999887764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=400.04 Aligned_cols=258 Identities=33% Similarity=0.493 Sum_probs=214.1
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALV 781 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 781 (1009)
.+...+.||+|-||+||.|.|. ....||+|.++.. ....+.|.+|+++|++++|++||+++|+|... +..+||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyIV 279 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYIV 279 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEc-CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEEE
Confidence 4455688999999999999996 4458999999754 33467899999999999999999999999864 468999
Q ss_pred EeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccc
Q 047768 782 YEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861 (1009)
Q Consensus 782 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~ 861 (1009)
||||+.|+|.+|++.... ..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..|||+|||+|+.
T Consensus 280 tE~m~~GsLl~yLr~~~~----~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREG----GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred EEecccCcHHHHhhhcCC----CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccc
Confidence 999999999999998332 2488999999999999999999999 999999999999999999999999999995
Q ss_pred cCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccc
Q 047768 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPE 940 (1009)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
..+..+ ....+..-+..|.|||.+..+.|+.|||||||||+||||+| |+.||+.+... +.+
T Consensus 353 ~~d~~Y-------~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-----ev~------ 414 (468)
T KOG0197|consen 353 IGDDEY-------TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-----EVL------ 414 (468)
T ss_pred cCCCce-------eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-----HHH------
Confidence 544322 12233445789999999999999999999999999999999 99999866433 222
Q ss_pred hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 941 ~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
+.++.- .+..++..|+.+++++|..||+.+|++|||++.+...++.+....
T Consensus 415 ---~~le~G----------yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 415 ---ELLERG----------YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred ---HHHhcc----------CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 112211 122345578899999999999999999999999999988877644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=375.37 Aligned_cols=254 Identities=27% Similarity=0.342 Sum_probs=208.0
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc-eEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD-FKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~-~~~ 779 (1009)
+.+..+.||+|..|+||+++++.+++.+|+|++....+ ...+++.+|++++++.+||+||.++|.+... . ...
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~-----~~~is 154 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN-----GEEIS 154 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC-----CceEE
Confidence 44556889999999999999999999999999954432 3457899999999999999999999997653 3 689
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
++||||++|||++++...+. +++....+|+.++++||.|||+.+ +||||||||+|||++..|+|||||||.+
T Consensus 155 I~mEYMDgGSLd~~~k~~g~------i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGR------IPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred eehhhcCCCCHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEecccccc
Confidence 99999999999999987643 899999999999999999999632 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
+.+..+ ...+++||..|||||.+.+..|+.++||||||++++|+++|+.||...........+...
T Consensus 227 ~~lvnS----------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~---- 292 (364)
T KOG0581|consen 227 GILVNS----------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC---- 292 (364)
T ss_pred HHhhhh----------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH----
Confidence 877643 334578999999999999999999999999999999999999999754222222222211
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.+++..--..| ...+.+++.+++..|++.||.+||+++|+++.
T Consensus 293 ----~Iv~~ppP~lP----------~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 293 ----AIVDEPPPRLP----------EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ----HHhcCCCCCCC----------cccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11111100001 11466778999999999999999999999764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=411.36 Aligned_cols=267 Identities=29% Similarity=0.459 Sum_probs=223.1
Q ss_pred ccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
.+....+.||+|+||+||+|+.. .+...||||.++..... ...+|++|++++..++|||||+++|+|...
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~---- 561 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG---- 561 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC----
Confidence 44556788999999999999875 24468999999866655 568999999999999999999999999865
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCC--------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLG--------ICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD 846 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 846 (1009)
+.+++|+|||.+|||.+||..+..... ..+++..+.+.||.|||.||+||.++ .+|||||.++|+||+
T Consensus 562 -~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 562 -DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred -CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 789999999999999999987654321 23489999999999999999999999 999999999999999
Q ss_pred CCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCccccc
Q 047768 847 HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFN 925 (1009)
Q Consensus 847 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~ 925 (1009)
++..|||+|||++|.+...+|+.... ...-+++|||||.+..++||+++||||||||+||+++ |+.||..+.+
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~------~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn 711 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRG------NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN 711 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccC------CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence 99999999999999998887765331 1234689999999999999999999999999999999 9999986654
Q ss_pred CCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 047768 926 EGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFL 1005 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~ 1005 (1009)
+ +.+ ..+-+..+. ..++.|+.+++.+|..||+..|++||+++||-..|+...+..+
T Consensus 712 ~-----EVI--------e~i~~g~lL-----------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 712 Q-----EVI--------ECIRAGQLL-----------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred H-----HHH--------HHHHcCCcc-----------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 4 111 111222222 2345788999999999999999999999999999988766543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=373.55 Aligned_cols=202 Identities=31% Similarity=0.540 Sum_probs=182.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc--cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE--QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
..+|...+.||+|+||+||+|+++.++..||||.+... .....+.+..|+++++.++|||||++++++... +.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-----~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-----DF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-----Ce
Confidence 46788889999999999999999999999999999655 333456788999999999999999999997654 78
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC------Cce
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD------MVA 851 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~------~~~ 851 (1009)
.++|||||.+|+|.+|++.++. +++...+.++.|+|.|+++||++ +||||||||.|||++.. -.+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~------l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~L 154 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGR------LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVL 154 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceE
Confidence 9999999999999999999864 99999999999999999999999 99999999999999765 568
Q ss_pred EEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccc
Q 047768 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMF 924 (1009)
Q Consensus 852 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~ 924 (1009)
||+|||+|+.+.+. ......+|++-|||||++..++|+.|+|+||.|+++|++++|+.||....
T Consensus 155 KIADFGfAR~L~~~---------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 155 KIADFGFARFLQPG---------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred EecccchhhhCCch---------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 99999999988754 33345789999999999999999999999999999999999999998543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=368.96 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=203.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc-------chHHHHHHHHHHHhcCCCCcceEEeeeeccccC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-------GSKSFAAECEALRSIRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 773 (1009)
+.|.+.+.||+|+||.|-+|..+.+|+.||||+++..... .....++|+++|++++|||||++.+++..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~---- 247 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV---- 247 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec----
Confidence 4678889999999999999999999999999999754321 12345799999999999999999999654
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC---Cc
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD---MV 850 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~ 850 (1009)
++..|+||||++||+|.+++-.++. +.+...+.+++|++.|+.|||++ ||+||||||+|||+..+ ..
T Consensus 248 -~ds~YmVlE~v~GGeLfd~vv~nk~------l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~l 317 (475)
T KOG0615|consen 248 -PDSSYMVLEYVEGGELFDKVVANKY------LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCL 317 (475)
T ss_pred -CCceEEEEEEecCccHHHHHHhccc------cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceE
Confidence 4778999999999999999988764 77888899999999999999999 99999999999999766 78
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCC---CCcccchHHHHHHHHHHhCCCCCcccccCC
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA---SMRGGVYSYGILLLEIFTRRRPTESMFNEG 927 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwS~Gvvl~elltg~~p~~~~~~~~ 927 (1009)
+||+|||+|+..... ....+.+||+.|.|||++.+..+ ..+.|+||+||++|-+++|.+||.....+.
T Consensus 318 lKItDFGlAK~~g~~---------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 318 LKITDFGLAKVSGEG---------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred EEecccchhhccccc---------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 999999999987643 34456899999999999888654 347899999999999999999998643331
Q ss_pred ccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 928 LTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.+.+.+ ....+...| ....+.-++..+++.+++..||++|||++|+++.
T Consensus 389 -sl~eQI-----------~~G~y~f~p--------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 389 -SLKEQI-----------LKGRYAFGP--------LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -cHHHHH-----------hcCcccccC--------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 112111 111111111 1111334567899999999999999999999863
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=399.14 Aligned_cols=271 Identities=29% Similarity=0.494 Sum_probs=225.8
Q ss_pred cCHHHHHHHhccC---------ccCCcccccCCceEEEEEEecCC---eEEEEEEeecccc-cchHHHHHHHHHHHhcCC
Q 047768 691 VSYKELSKATNEF---------SSSNTIGRGSFGFVYKGVLHENG---MLVAVKVINLEQK-GGSKSFAAECEALRSIRH 757 (1009)
Q Consensus 691 ~~~~~~~~~~~~~---------~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h 757 (1009)
.+++|-.++..+| .+.++||.|.||+||+|+.+..| ..||||.++..-. +...+|..|+.+|.+++|
T Consensus 610 ~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH 689 (996)
T KOG0196|consen 610 HTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 689 (996)
T ss_pred ccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC
Confidence 4566655555444 45789999999999999998655 4699999986543 345689999999999999
Q ss_pred CCcceEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecC
Q 047768 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGD 837 (1009)
Q Consensus 758 ~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrd 837 (1009)
|||+++.|+.+.. ...++|+|||++|+|..||++++.+ +++.+...+.++||.||.||.+. ++||||
T Consensus 690 PNIIrLEGVVTks-----~PvMIiTEyMENGsLDsFLR~~DGq-----ftviQLVgMLrGIAsGMkYLsdm---~YVHRD 756 (996)
T KOG0196|consen 690 PNIIRLEGVVTKS-----KPVMIITEYMENGSLDSFLRQNDGQ-----FTVIQLVGMLRGIASGMKYLSDM---NYVHRD 756 (996)
T ss_pred CcEEEEEEEEecC-----ceeEEEhhhhhCCcHHHHHhhcCCc-----eEeehHHHHHHHHHHHhHHHhhc---Cchhhh
Confidence 9999999997653 7889999999999999999999875 99999999999999999999999 999999
Q ss_pred CCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-C
Q 047768 838 LKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-R 916 (1009)
Q Consensus 838 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g 916 (1009)
|.++||||+.+..+|++|||++|.+.+.+ +......+-.-+.+|.|||.+....+|.++||||||||+||.++ |
T Consensus 757 LAARNILVNsnLvCKVsDFGLSRvledd~-----~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyG 831 (996)
T KOG0196|consen 757 LAARNILVNSNLVCKVSDFGLSRVLEDDP-----EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 831 (996)
T ss_pred hhhhheeeccceEEEeccccceeecccCC-----CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccC
Confidence 99999999999999999999999886653 12233334445789999999999999999999999999999998 9
Q ss_pred CCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 917 RRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 917 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.+||++|.+.+ +...++..+ +.+.+.+|+.++.++|..||+.|-.+||+++|++..
T Consensus 832 ERPYWdmSNQd--------------VIkaIe~gy----------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 832 ERPYWDMSNQD--------------VIKAIEQGY----------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CCcccccchHH--------------HHHHHHhcc----------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 99999886552 111111111 123445899999999999999999999999999999
Q ss_pred HHHHHHh
Q 047768 997 LCHARQN 1003 (1009)
Q Consensus 997 L~~i~~~ 1003 (1009)
|.++.++
T Consensus 888 lDklIrn 894 (996)
T KOG0196|consen 888 LDKLIRN 894 (996)
T ss_pred HHHHhcC
Confidence 9887653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=380.10 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=208.1
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.+|...+.||+|||+.||++++..+|..||+|++... .....+.+.+||++.++++|||||+++++ |++..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence 5799999999999999999999889999999999643 23345778999999999999999999999 455689
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.|+|+|+|++++|..+++.+. ++++.++..+.+||+.|+.|||++ +|+|||||..|++++++.+|||+|||
T Consensus 93 VYivLELC~~~sL~el~Krrk------~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRK------PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred eEEEEEecCCccHHHHHHhcC------CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence 999999999999999999655 399999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+|..+.... .+..+.+|||.|+|||++....++..+||||+|||+|-|+.|++||+.. .+.+.....
T Consensus 164 LAt~le~~~--------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~vkety~~I 230 (592)
T KOG0575|consen 164 LATQLEYDG--------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----TVKETYNKI 230 (592)
T ss_pred eeeeecCcc--------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----hHHHHHHHH
Confidence 999876431 3455689999999999999999999999999999999999999999742 122222111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. ..+..-+. ....+..+++.+.++.+|.+|||+++|++
T Consensus 231 k---~~~Y~~P~-----------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 231 K---LNEYSMPS-----------------HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred H---hcCccccc-----------------ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 01111000 11224569999999999999999999975
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=383.11 Aligned_cols=475 Identities=28% Similarity=0.411 Sum_probs=342.8
Q ss_pred eEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecc
Q 047768 71 RVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAH 150 (1009)
Q Consensus 71 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~ 150 (1009)
....+++++|.+.. +.+.+.+|..|.+|++++|+++ ..|++++.+..++.|+.|+|+++ .+|..++.+.+|+.|+++
T Consensus 46 ~l~~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLEV-LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchhh-ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 34556666666643 3345666777777777777777 67777777777777777777776 566666666666555555
Q ss_pred cccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCC
Q 047768 151 RNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSG 230 (1009)
Q Consensus 151 ~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 230 (1009)
+|.+ . .+|+.++.+..|..|+..+|+++ ..|+.+..+.+|..|++.+|++.
T Consensus 123 ~n~~--------------------------~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~- 173 (565)
T KOG0472|consen 123 SNEL--------------------------K-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK- 173 (565)
T ss_pred ccce--------------------------e-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-
Confidence 5444 3 56667777788888888888884 66777778888888888888887
Q ss_pred CCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccc
Q 047768 231 TIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFN 310 (1009)
Q Consensus 231 ~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~ 310 (1009)
.+|+..-++..|++||+..|-++ .+|.+++ ++.+|..|+|.+|+|. ..| .|.+++.|++|+++.|+|+.++.....
T Consensus 174 ~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg-~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~ 249 (565)
T KOG0472|consen 174 ALPENHIAMKRLKHLDCNSNLLE-TLPPELG-GLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLK 249 (565)
T ss_pred hCCHHHHHHHHHHhcccchhhhh-cCChhhc-chhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhc
Confidence 45555555888888888888887 8888776 4888888888888887 455 788888888888888888877777777
Q ss_pred cccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccC
Q 047768 311 GLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIAN 390 (1009)
Q Consensus 311 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~ 390 (1009)
.+.+|..|||..|.+...+ +.+..+.+|++||+|+|.|+ .+|.+++++ .|+.|.+.+|.+.. +...+-+
T Consensus 250 ~L~~l~vLDLRdNklke~P-------de~clLrsL~rLDlSNN~is-~Lp~sLgnl--hL~~L~leGNPlrT-iRr~ii~ 318 (565)
T KOG0472|consen 250 HLNSLLVLDLRDNKLKEVP-------DEICLLRSLERLDLSNNDIS-SLPYSLGNL--HLKFLALEGNPLRT-IRREIIS 318 (565)
T ss_pred ccccceeeeccccccccCc-------hHHHHhhhhhhhcccCCccc-cCCcccccc--eeeehhhcCCchHH-HHHHHHc
Confidence 7777777777777776543 44566677777777777776 556666666 56777777776642 1111110
Q ss_pred ------cCccCE----EEccCCCC----CCCCCC----CcCCcccccceecccccccCCCCcccccccc---cccccccC
Q 047768 391 ------LVNLNS----LRMEANRL----TGTIPH----VIGELKNLQLLHLHANFLQGTIPSSLGNLTL---LTYLSFGA 449 (1009)
Q Consensus 391 ------l~~L~~----L~L~~N~l----~~~~p~----~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~ 449 (1009)
++.|+. =.++.-+= ++..|. ....+.+.++|++++=+++ .+|+....-.. .+..+++.
T Consensus 319 ~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~Vnfsk 397 (565)
T KOG0472|consen 319 KGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSK 397 (565)
T ss_pred ccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEeccc
Confidence 111111 00111000 001111 1224567888888888888 56665444333 77888999
Q ss_pred cccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCc
Q 047768 450 NNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQI 529 (1009)
Q Consensus 450 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 529 (1009)
|++. ++|..+..+..+.+.-+.+|+..+-+|..+..+..+.. |+|++|-+. .+|.+++.+..|+.||+|.|+|. .+
T Consensus 398 NqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~-L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~l 473 (565)
T KOG0472|consen 398 NQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTF-LDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-ML 473 (565)
T ss_pred chHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhccee-eecccchhh-hcchhhhhhhhhheecccccccc-cc
Confidence 9998 78888888887766554444444477777777666664 999999888 79999999999999999999998 89
Q ss_pred cccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceecccccCc
Q 047768 530 PVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFE 598 (1009)
Q Consensus 530 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 598 (1009)
|..+..+..||.+-.++|++....|+.+.++.+|++|||.+|.+. .+|+.++++++|++|++++|+|.
T Consensus 474 P~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 474 PECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 999999899999999999999777777999999999999999998 89999999999999999999997
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=349.98 Aligned_cols=263 Identities=24% Similarity=0.352 Sum_probs=210.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
..+|.+.++||+|.||+||+++...+|..||.|.++.... .....+..|+.+|++++|||||+++++-. .++...
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchh
Confidence 3468888999999999999999999999999999975433 23457889999999999999999998532 223345
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCceeeCCCCceEEec
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPP--IVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
.++|||||.+|+|..+++..+.+. ..+++..+|+++.|++.||.++|++. ++ |+||||||.||+++++|.||++|
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qk--r~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQK--RLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhcc--ccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeecc
Confidence 889999999999999998755442 34899999999999999999999942 24 89999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++.+.... ......+|||.||+||.+.+..|+.++||||+||++|||..-+.||..- .+.....
T Consensus 172 fGL~r~l~s~~--------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~ 238 (375)
T KOG0591|consen 172 FGLGRFLSSKT--------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCK 238 (375)
T ss_pred chhHhHhcchh--------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHH
Confidence 99999887542 3445689999999999999999999999999999999999999999742 2332222
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
+.- .....+. ..+.+...+.+++..|+..||+.||+...++..+..
T Consensus 239 KI~--------qgd~~~~----------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 239 KIE--------QGDYPPL----------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHH--------cCCCCCC----------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111 1111111 123455678899999999999999986555555443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=345.03 Aligned_cols=271 Identities=21% Similarity=0.300 Sum_probs=204.7
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
+.|+...++|+|+||+||+++++++|+.||||+|....+ .-.+-..+|++++++++|+|+|.++.+|.. ....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-----krkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-----KRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-----ccee
Confidence 357777899999999999999999999999999954332 224667899999999999999999998544 4788
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++|+|||+. ++.+-+++...+ ++...++++++|++.|+.|+|++ ++|||||||+||||+.+|.+|+||||+
T Consensus 77 hLVFE~~dh-TvL~eLe~~p~G-----~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYPNG-----VPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred EEEeeecch-HHHHHHHhccCC-----CCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchh
Confidence 999999977 555556666554 89999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH-
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR- 936 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~- 936 (1009)
|+.+... ....+.++.|.+|+|||.+.+ .+|+..+||||.||++.||++|.+-|...++- +.+..+...
T Consensus 148 AR~L~~p--------gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi-DQLy~I~ktL 218 (396)
T KOG0593|consen 148 ARTLSAP--------GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI-DQLYLIRKTL 218 (396)
T ss_pred hHhhcCC--------cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH-HHHHHHHHHH
Confidence 9988732 123345678999999999888 78999999999999999999999887653322 222222211
Q ss_pred -hccchhhhccCCC------CCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 -ALPEKVMEIVDPS------LLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 -~~~~~~~~~~d~~------l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.+.+.-.+++... ..+.++.+...+ ..-......+++++..|++.||++|++.+|++.
T Consensus 219 G~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe-~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 219 GNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLE-RKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cccCHHHHHHhccCCceeeeecCCCCCccchh-hhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1222222222221 111111111100 000112235789999999999999999999874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=372.99 Aligned_cols=267 Identities=25% Similarity=0.392 Sum_probs=213.5
Q ss_pred HHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccc
Q 047768 694 KELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSID 771 (1009)
Q Consensus 694 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 771 (1009)
+++....+++.+.++||+|+||+||+|+|.. .||||+++..... ..+.|+.|+.++++-+|.||+-+.|||...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p- 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP- 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC-
Confidence 5555666778888999999999999999973 4999999766433 346899999999999999999999998763
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCce
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 851 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 851 (1009)
...+|+.+|+|-+|+.+++-.+.. ++..+.+.||+|||+||.|||.+ +|||||||..||++.+++.|
T Consensus 461 -----~~AIiTqwCeGsSLY~hlHv~etk-----fdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kV 527 (678)
T KOG0193|consen 461 -----PLAIITQWCEGSSLYTHLHVQETK-----FDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKV 527 (678)
T ss_pred -----ceeeeehhccCchhhhhccchhhh-----hhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcE
Confidence 348999999999999999977654 89999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCCCccccCCccccccccccccCccccCC---CCCCCcccchHHHHHHHHHHhCCCCCcccccCCc
Q 047768 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG---GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGL 928 (1009)
Q Consensus 852 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~ 928 (1009)
||+|||++..-......... ....|...|||||++.. .+|++++||||||+|+|||+||..||... ..+
T Consensus 528 kIgDFGLatvk~~w~g~~q~------~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~d- 599 (678)
T KOG0193|consen 528 KIGDFGLATVKTRWSGEQQL------EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRD- 599 (678)
T ss_pred EEecccceeeeeeecccccc------CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-Chh-
Confidence 99999999865543221111 12347789999999765 46899999999999999999999999722 111
Q ss_pred cHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 929 TLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
.++....+. .+.++.. .....|++++.+++..||..++++||.+.+++.+|+++...
T Consensus 600 ---qIifmVGrG--------~l~pd~s-------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 600 ---QIIFMVGRG--------YLMPDLS-------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ---heEEEeccc--------ccCccch-------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 111111111 1111110 11236788899999999999999999999999999887664
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=372.57 Aligned_cols=366 Identities=21% Similarity=0.236 Sum_probs=316.6
Q ss_pred CCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEee
Q 047768 96 LRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSV 175 (1009)
Q Consensus 96 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L 175 (1009)
-+.||+|+|.++..-+..|.++++|+.++|..|.++ .||...+...+|+.|+|.+|.++..-.+.+ ..+..|+.|||
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L--~~l~alrslDL 156 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEEL--SALPALRSLDL 156 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHH--HhHhhhhhhhh
Confidence 467899999988777888889999999999999888 788877777779999999998886666666 56788899999
Q ss_pred cCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCC
Q 047768 176 GDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGS 255 (1009)
Q Consensus 176 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 255 (1009)
|.|.|+.+.-.+|..-.++++|+|++|+|+...-+.|..+.+|..|.|++|+++...+..|.+|++|+.|+|..|+|. .
T Consensus 157 SrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ir-i 235 (873)
T KOG4194|consen 157 SRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIR-I 235 (873)
T ss_pred hhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhcccccee-e
Confidence 999998666667877788999999999998888889999999999999999998544556777999999999999987 7
Q ss_pred CChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCCCCCCCcch
Q 047768 256 LPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDF 335 (1009)
Q Consensus 256 ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~ 335 (1009)
+....|.+|++|+.|.|..|.|.......|..+.++++|+|+.|+++....+.+-+|+.|+.|+||+|.|..+....
T Consensus 236 ve~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~--- 312 (873)
T KOG4194|consen 236 VEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDS--- 312 (873)
T ss_pred ehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecch---
Confidence 77778889999999999999999888899999999999999999999998889999999999999999998887744
Q ss_pred hhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCC---Cc
Q 047768 336 VDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPH---VI 412 (1009)
Q Consensus 336 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~---~~ 412 (1009)
+..+++|+.|+|++|+|+...+.+|..+ ..|++|+|++|.|+..-...|..+++|+.|||++|.|+..+.+ .|
T Consensus 313 ---WsftqkL~~LdLs~N~i~~l~~~sf~~L-~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f 388 (873)
T KOG4194|consen 313 ---WSFTQKLKELDLSSNRITRLDEGSFRVL-SQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAF 388 (873)
T ss_pred ---hhhcccceeEeccccccccCChhHHHHH-HHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhh
Confidence 4456899999999999998888888888 6799999999999988888899999999999999999877655 57
Q ss_pred CCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCC
Q 047768 413 GELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPR 473 (1009)
Q Consensus 413 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~ 473 (1009)
.+|++|+.|+|.+|+|..+...+|.+++.|++|||.+|.|..+-|.+|..+ .|+.|.+..
T Consensus 389 ~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 389 NGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred ccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence 889999999999999997777799999999999999999998999999988 888776654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=395.84 Aligned_cols=267 Identities=25% Similarity=0.394 Sum_probs=217.7
Q ss_pred cCccCCcccccCCceEEEEEEecCC-----eEEEEEEeecc-cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENG-----MLVAVKVINLE-QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
..+..+.||+|+||+||.|...+.. ..||||.++.. +.+...+|.+|..+|++++|||||+++|+|.. .
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-----~ 767 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-----S 767 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----C
Confidence 4455678999999999999987432 34899988544 34456789999999999999999999999865 3
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCC-CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQ-LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
...++++|||++|+|.+||++.+.. .....++..+...++.|||+|+.||+++ ++|||||.++|+|+++..+|||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence 6779999999999999999986322 2234699999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 933 (1009)
|||+|+++....+++.... ..-+..|||||.+.++.|+.|+|||||||++||++| |..||....+.+ .
T Consensus 845 DFGlArDiy~~~yyr~~~~------a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-----v 913 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGE------AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-----V 913 (1025)
T ss_pred ccchhHhhhhchheeccCc------cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-----H
Confidence 9999998877665443221 123578999999999999999999999999999999 999998654331 1
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLG 1006 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~ 1006 (1009)
... +.... +...+..|++.++++|.+||+.+|++||++..+++.+..+...+..
T Consensus 914 ~~~--------~~~gg-----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 914 LLD--------VLEGG-----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred HHH--------HHhCC-----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 110 11111 1223347888999999999999999999999999999998877654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=372.16 Aligned_cols=460 Identities=26% Similarity=0.370 Sum_probs=333.6
Q ss_pred CeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEec
Q 047768 70 QRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSA 149 (1009)
Q Consensus 70 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l 149 (1009)
...+.|++.+|.++ ..|++++.+..++.|+.|+|+++ ++|++++.+.+|+.||.++|.+. .+|++++.+..|..++.
T Consensus 68 ~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~ 144 (565)
T KOG0472|consen 68 ACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDA 144 (565)
T ss_pred cceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhc
Confidence 35788999999885 57889999999999999999999 99999999999999999999998 78889988888888888
Q ss_pred ccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCC
Q 047768 150 HRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFS 229 (1009)
Q Consensus 150 ~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 229 (1009)
.+|+++ ..|+.++ .+.+|..|++.+|.++...|+.+ +++.|+.||...|-+ +.+|..++.+.+|..|+|.+|+|.
T Consensus 145 ~~N~i~-slp~~~~--~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L-~tlP~~lg~l~~L~~LyL~~Nki~ 219 (565)
T KOG0472|consen 145 TNNQIS-SLPEDMV--NLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLL-ETLPPELGGLESLELLYLRRNKIR 219 (565)
T ss_pred cccccc-cCchHHH--HHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhh-hcCChhhcchhhhHHHHhhhcccc
Confidence 777776 3343332 23444455555555553222222 255555555555544 344444555555555555555554
Q ss_pred CCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccccccccc
Q 047768 230 GTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINF 309 (1009)
Q Consensus 230 ~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f 309 (1009)
.+| .|.+++.|++|+++.|+|. .+|++ ...++++|.+|||.+|+++. .|..+
T Consensus 220 -~lP-ef~gcs~L~Elh~g~N~i~-~lpae------------------------~~~~L~~l~vLDLRdNklke-~Pde~ 271 (565)
T KOG0472|consen 220 -FLP-EFPGCSLLKELHVGENQIE-MLPAE------------------------HLKHLNSLLVLDLRDNKLKE-VPDEI 271 (565)
T ss_pred -cCC-CCCccHHHHHHHhcccHHH-hhHHH------------------------Hhcccccceeeecccccccc-CchHH
Confidence 344 4444555555555555444 34433 33478899999999999985 45567
Q ss_pred ccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhc--ccceEE-------EcCCCcc
Q 047768 310 NGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLS--TALIDF-------NLGKNQI 380 (1009)
Q Consensus 310 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~~L~~L-------~L~~N~l 380 (1009)
.-+++|..||+|+|.|+..+. .++++ .|+.|-+.+|.+..+ -..+-+-. .-|++| .++.-+=
T Consensus 272 clLrsL~rLDlSNN~is~Lp~-------sLgnl-hL~~L~leGNPlrTi-Rr~ii~~gT~~vLKyLrs~~~~dglS~se~ 342 (565)
T KOG0472|consen 272 CLLRSLERLDLSNNDISSLPY-------SLGNL-HLKFLALEGNPLRTI-RREIISKGTQEVLKYLRSKIKDDGLSQSEG 342 (565)
T ss_pred HHhhhhhhhcccCCccccCCc-------ccccc-eeeehhhcCCchHHH-HHHHHcccHHHHHHHHHHhhccCCCCCCcc
Confidence 889999999999999997664 57888 899999999998732 22211110 011111 1111110
Q ss_pred ----ccC----CCccccCcCccCEEEccCCCCCCCCCCCcCCccc---ccceecccccccCCCCcccccccccccccccC
Q 047768 381 ----YGT----IPPGIANLVNLNSLRMEANRLTGTIPHVIGELKN---LQLLHLHANFLQGTIPSSLGNLTLLTYLSFGA 449 (1009)
Q Consensus 381 ----~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 449 (1009)
++. .......+.+.+.|+++.-+++ .+|+..+.-.+ ....+++.|++. ++|..+..+..+.+.-+.+
T Consensus 343 ~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~ls 420 (565)
T KOG0472|consen 343 GTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLS 420 (565)
T ss_pred cccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhh
Confidence 001 1122344677899999999999 66665544444 788999999999 8898888888766654444
Q ss_pred cccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCc
Q 047768 450 NNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQI 529 (1009)
Q Consensus 450 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 529 (1009)
|+..+.+|..++.+++|..|++++|.+- .+|..++....+ ..||+|.|+|. .+|..+..+..|+.+-.++|++....
T Consensus 421 nn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~L-q~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd 497 (565)
T KOG0472|consen 421 NNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRL-QTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVD 497 (565)
T ss_pred cCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhh-heecccccccc-cchHHHhhHHHHHHHHhccccccccC
Confidence 4444589999999999999999999887 889888887774 46999999998 78988888888988888889998666
Q ss_pred cccccCCCCccEEEecCcccccccccccccccccceEcCCCccccccccccc
Q 047768 530 PVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYL 581 (1009)
Q Consensus 530 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 581 (1009)
|..+.+|.+|..|||.+|.+. .+|..++++++|++|+|++|.|. ..|..+
T Consensus 498 ~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~i 547 (565)
T KOG0472|consen 498 PSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPRHQI 547 (565)
T ss_pred hHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCHHHH
Confidence 666999999999999999999 89999999999999999999998 444433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=355.33 Aligned_cols=273 Identities=25% Similarity=0.328 Sum_probs=210.1
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
+.|+..++||+|+||.||+|++..+|+.||+|++..+. .+......+||.+|++++||||+++.+..++. .....
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCceE
Confidence 45677789999999999999999999999999997664 44567788999999999999999999997753 34678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
|+|+|||++ ||.-++....- .+++.+++.++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||+
T Consensus 194 YlVFeYMdh-DL~GLl~~p~v-----kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGL 264 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGV-----KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGL 264 (560)
T ss_pred EEEEecccc-hhhhhhcCCCc-----ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccc
Confidence 999999977 89888877543 399999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
|+++..... ...+..+-|..|+|||.+.+. .|+.+.|+||.|||+.||++|++.|..- .+..++..+..-.
T Consensus 265 Ar~y~~~~~-------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~-tEveQl~kIfklc 336 (560)
T KOG0600|consen 265 ARFYTPSGS-------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR-TEVEQLHKIFKLC 336 (560)
T ss_pred eeeccCCCC-------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc-cHHHHHHHHHHHh
Confidence 998876432 224456789999999998885 6899999999999999999999987642 1222233332222
Q ss_pred ccc--hhhh---ccCC-CCCC-hhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPE--KVME---IVDP-SLLP-LEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~--~~~~---~~d~-~l~~-~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... +... +... .+.+ .+..|...+. ........++++..++..||++|.||.++++
T Consensus 337 GSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~--~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 337 GSPTEDYWPVSKLPHATIFKPQQPYKRRLRET--FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCCChhccccccCCcccccCCCCcccchHHHH--hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 1111 1100 0111 1111111111 2233356789999999999999999999875
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=372.71 Aligned_cols=366 Identities=20% Similarity=0.207 Sum_probs=205.4
Q ss_pred CeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCC
Q 047768 171 QGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGN 250 (1009)
Q Consensus 171 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 250 (1009)
+.|++++|.++.+-+..|.++++|+.++|.+|.++ .+|.......+|+.|+|.+|.|+..-.+++..++.|+.||||.|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 34555555555444555555555555555555552 44444444444555555555555444455555555666666666
Q ss_pred ccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCCCCC
Q 047768 251 RFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAA 330 (1009)
Q Consensus 251 ~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~ 330 (1009)
.|+ .||..-|..-.++++|+|++|.|+.+-...|.++.+|.+|.|++|+++.++...|..|++|+.|+|..|+|.....
T Consensus 160 ~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ 238 (873)
T KOG4194|consen 160 LIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEG 238 (873)
T ss_pred hhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehh
Confidence 655 5555555545556666666666666656666666666666666666666666666666666666666666554432
Q ss_pred CCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCC
Q 047768 331 NDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPH 410 (1009)
Q Consensus 331 ~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 410 (1009)
-.|.++++|+.|.|..|+|...-...|..+ ..+++|+|+.|+++..-..++.+|+.|+.|+||+|.|..+-++
T Consensus 239 ------ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l-~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d 311 (873)
T KOG4194|consen 239 ------LTFQGLPSLQNLKLQRNDISKLDDGAFYGL-EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHID 311 (873)
T ss_pred ------hhhcCchhhhhhhhhhcCcccccCcceeee-cccceeecccchhhhhhcccccccchhhhhccchhhhheeecc
Confidence 234556666666666666654444444444 4455566666666555566677777777777777777777777
Q ss_pred CcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccc
Q 047768 411 VIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTL 490 (1009)
Q Consensus 411 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~ 490 (1009)
.+.-.++|++|+|++|+|+...+.+|..|..|++|+|++|.+...-...|..+++|+.|++++|.++..+.+..
T Consensus 312 ~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa------ 385 (873)
T KOG4194|consen 312 SWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAA------ 385 (873)
T ss_pred hhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecch------
Confidence 77777777777777777776666677777777777777777764333344444444443333333332211100
Q ss_pred eeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcC
Q 047768 491 SLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDL 568 (1009)
Q Consensus 491 ~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 568 (1009)
..|..|++|+.|+|.+|+|..+.-.+|.++.+||.|||.+|.|..+-|.+|..+ .|++|-+
T Consensus 386 ----------------~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~ 446 (873)
T KOG4194|consen 386 ----------------VAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVM 446 (873)
T ss_pred ----------------hhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhh
Confidence 113334445555555555543333344444444444444444444444444444 4444444
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=343.96 Aligned_cols=272 Identities=24% Similarity=0.376 Sum_probs=218.8
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc--CCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI--RHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++....+.||+|+||+||+|.|+ |..||||+|...+ .+.+.+|.++.+.+ +|+||+.+++.-... -....++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~TQL 284 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWTQL 284 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccC-CCceEEE
Confidence 56677889999999999999997 8899999996443 46778889988875 999999999874332 2345678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCceecCCCCCceeeCCCCceEE
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH-----CQPPIVHGDLKPSNVLLDHDMVAHV 853 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivHrdlk~~Nill~~~~~~kl 853 (1009)
++|++|.+.|||+|||.+.. ++....++++..+|.||+|||.. .+|.|.|||||+.||||..++.+.|
T Consensus 285 wLvTdYHe~GSL~DyL~r~t-------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRNT-------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEeeecccCCcHHHHHhhcc-------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 99999999999999999865 89999999999999999999964 5789999999999999999999999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCCC----CC--CCcccchHHHHHHHHHHhCC----------
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG----EA--SMRGGVYSYGILLLEIFTRR---------- 917 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~--~~~~DvwS~Gvvl~elltg~---------- 917 (1009)
+|+|+|....... ...+ ......+||.+|||||++... .+ -..+||||||.|+||+..+.
T Consensus 358 ADLGLAv~h~~~t--~~id--i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 358 ADLGLAVRHDSDT--DTID--IPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred eeceeeEEecccC--Cccc--CCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 9999998776542 1112 334457899999999987653 12 35689999999999998753
Q ss_pred CCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 918 RPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 918 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
.||......+.+..+......-+.++..+. ..+...+++..+.++|+.||..+|..|-|+-.+.+.|
T Consensus 434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ip-------------nrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIP-------------NRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred CCcccCCCCCCCHHHHhcceeecccCCCCC-------------cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 477777666666665544433333332222 3456678889999999999999999999999999999
Q ss_pred HHHHH
Q 047768 998 CHARQ 1002 (1009)
Q Consensus 998 ~~i~~ 1002 (1009)
.++.+
T Consensus 501 ~~l~~ 505 (513)
T KOG2052|consen 501 AKLSN 505 (513)
T ss_pred HHHhc
Confidence 98875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=343.42 Aligned_cols=202 Identities=30% Similarity=0.433 Sum_probs=181.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|++.+.||+|+||+||.++.+++++.+|+|+++... ....+...+|..++.+++||.||++.-. |+..+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccCC
Confidence 467999999999999999999999999999999996442 2345678899999999999999999865 56668
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
.+|+|+||+.||.|...+++.+. +++..+.-++.+|+.||.|||++ +||||||||+|||+|++|+++|+||
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~------F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDF 169 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGR------FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDF 169 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCC------cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecc
Confidence 99999999999999999997664 89999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
|+++..-.. .....+++||+.|||||++.+..|+.++|.||+||++|||++|.+||...
T Consensus 170 gL~k~~~~~--------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 170 GLCKEDLKD--------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred ccchhcccC--------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 999854322 23445589999999999999999999999999999999999999999743
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=350.77 Aligned_cols=261 Identities=28% Similarity=0.387 Sum_probs=204.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
..+|...+.||+|+||+||++..+.+|...|||.+........+.+.+|+++|++++|||||+++|.....+ . ..++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-eeeE
Confidence 346777899999999999999999889999999997664333567899999999999999999999743321 1 3689
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC-CCceEEecccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGL 858 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~DfGl 858 (1009)
+.|||+++|+|.+++.+.+.. +++..+..+++|+++||+|||++ +||||||||+|||++. ++.+||+|||+
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~-----l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGK-----LPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCC-----CCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcc
Confidence 999999999999999987632 99999999999999999999999 9999999999999999 79999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++...... ..........||+.|||||++.++ ....++||||+||++.||+||+.||.... ....+.-..
T Consensus 165 a~~~~~~~-----~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~----~~~~~~~~i 235 (313)
T KOG0198|consen 165 AKKLESKG-----TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF----EEAEALLLI 235 (313)
T ss_pred cccccccc-----ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc----chHHHHHHH
Confidence 98766311 111233457899999999999964 34469999999999999999999987531 111111111
Q ss_pred ccch-hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 938 LPEK-VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 938 ~~~~-~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
.... ... .+.....+..+++..|+..||+.||||.|+++.---
T Consensus 236 g~~~~~P~-------------------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 236 GREDSLPE-------------------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred hccCCCCC-------------------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1000 000 011223356799999999999999999999886543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=348.45 Aligned_cols=281 Identities=27% Similarity=0.354 Sum_probs=213.3
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHh--cCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRS--IRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
......+.+|+|+||.||+|+.. ++.||||+|... +...|+.|-++.+- ++|+||++++++....... ...+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccce
Confidence 34555688999999999999995 799999999644 35778888888775 5899999999986554322 4578
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcC------CCCceecCCCCCceeeCCCCceE
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHC------QPPIVHGDLKPSNVLLDHDMVAH 852 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivHrdlk~~Nill~~~~~~k 852 (1009)
++|+||.+.|+|.+||+.+. ++|.+..+|+..+++||+|||+.. +|+|+|||||++||||.+|+++.
T Consensus 284 wLVt~fh~kGsL~dyL~~nt-------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKANT-------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred eEEeeeccCCcHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 99999999999999999876 899999999999999999999864 68999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccCCccccccccccccCccccCCCC------CCCcccchHHHHHHHHHHhCCCCCcc-ccc
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE------ASMRGGVYSYGILLLEIFTRRRPTES-MFN 925 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwS~Gvvl~elltg~~p~~~-~~~ 925 (1009)
|+|||+|..+.++. ......+.+||.+|||||++.+.. .-.+.||||+|.|+|||+++..-+.. ...
T Consensus 357 IaDFGLAl~~~p~~------~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp 430 (534)
T KOG3653|consen 357 IADFGLALRLEPGK------PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP 430 (534)
T ss_pred eeccceeEEecCCC------CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence 99999999887542 224445689999999999987642 23578999999999999998764421 111
Q ss_pred C-CccHHHHHHHh-ccchhhhccCCCCCChhhhhhh-ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 047768 926 E-GLTLHEFAKRA-LPEKVMEIVDPSLLPLEEERTN-SRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQ 1002 (1009)
Q Consensus 926 ~-~~~~~~~~~~~-~~~~~~~~~d~~l~~~~~~r~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~ 1002 (1009)
+ .......+... .-+++.+.+- ..+.||. ...+..+..+..+.+.+..||+.||+.|.|+.=|.+++.++..
T Consensus 431 ~Yqlpfe~evG~hPt~e~mq~~VV-----~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 431 EYQLPFEAEVGNHPTLEEMQELVV-----RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cccCchhHHhcCCCCHHHHHHHHH-----hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1 11122111111 1111222111 1111222 1235666778889999999999999999999999999988766
Q ss_pred hhh
Q 047768 1003 NFL 1005 (1009)
Q Consensus 1003 ~~~ 1005 (1009)
-.+
T Consensus 506 ~~~ 508 (534)
T KOG3653|consen 506 LWE 508 (534)
T ss_pred cCC
Confidence 554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=321.47 Aligned_cols=273 Identities=21% Similarity=0.274 Sum_probs=208.1
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.+|...+++|+|.||.||+|++..+|+.||||+++..... ......+||+.++.++|+||+.+++++ ...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence 4688889999999999999999999999999999765432 345788999999999999999999984 445788
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
.+|+|||+. +|+..++.... .++..+++.++.++++|++|+|++ .|+||||||.|+|++++|.+||+|||+
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~i-----~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKNI-----ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred EEEEEeccc-cHHHHhccccc-----ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence 999999964 99999988764 499999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
|+.+.... ......+-|..|+|||.+.+ ..|+...||||.||++.||+-|.+-|.. ..+..++..+.+..
T Consensus 148 Ar~f~~p~--------~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG-~sDidQL~~If~~L 218 (318)
T KOG0659|consen 148 ARFFGSPN--------RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG-DSDIDQLSKIFRAL 218 (318)
T ss_pred hhccCCCC--------cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC-CchHHHHHHHHHHc
Confidence 99887542 12223367899999998887 5689999999999999999987665543 22323333333322
Q ss_pred ccchhhhccCCCCCChhhhhh----hccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERT----NSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~----~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
..+.-.++-+-.-.+++.+-. .........+.....+++..++..+|.+|+|++|++++
T Consensus 219 GTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 219 GTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 222111111111111111100 01111222344556899999999999999999999764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=355.53 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=210.1
Q ss_pred HHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhc-CCCCcceEEeeeecccc
Q 047768 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 772 (1009)
.....+|.+++.||+|+|++|++|+.+.++++||||++... .....+-+.+|-++|.++ .||.|++++..+
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF----- 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF----- 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----
Confidence 34457899999999999999999999999999999999533 233346678899999999 899999999774
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceE
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 852 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 852 (1009)
++....|.|+||+++|+|.+++++.+. +++...+.+|.+|+.|++|||++ |||||||||+|||+|.||++|
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~Gs------fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik 214 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKYGS------FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK 214 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHhCc------chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence 455789999999999999999998864 99999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCCcc---c--cCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCC
Q 047768 853 VSDFGLAKFLSASPLGNVV---E--TPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEG 927 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~---~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~ 927 (1009)
|+|||-|+.+.+....... + .......++||..|.+||++.++..++++|+|+|||++|.|+.|++||.... +.
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-ey 293 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-EY 293 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-HH
Confidence 9999999998765433111 1 1112256899999999999999999999999999999999999999997432 11
Q ss_pred ccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 928 LTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
....+ +++-.+.. + ...++.+.+++.+-+..||.+|+|.+|+.+
T Consensus 294 liFqk------------I~~l~y~f-p-----------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 294 LIFQK------------IQALDYEF-P-----------EGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHH------------HHHhcccC-C-----------CCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 11111 11111110 0 122245678888999999999999988765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=354.70 Aligned_cols=274 Identities=20% Similarity=0.268 Sum_probs=210.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccc-hHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG-SKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.++||.|+||.||+|+.++++..||||+++..-... ...-.||++.+++++ ||||+++..++.+. ...
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~----~~~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN----DRI 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc----Cce
Confidence 468889999999999999999999999999999986443322 234468999999998 99999999986543 238
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++|||||+ .+|++.++.+.. .+++.++..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||
T Consensus 85 L~fVfE~Md-~NLYqLmK~R~r-----~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 85 LYFVFEFMD-CNLYQLMKDRNR-----LFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred EeeeHHhhh-hhHHHHHhhcCC-----cCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccc
Confidence 999999995 599999998865 499999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccC-CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+||.+...+ ..+.++.|..|+|||++. .+.|+.+.||||+|||++|+.+-++-|..... .+.+.++...
T Consensus 156 LARev~Skp---------PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-~Dqi~KIc~V 225 (538)
T KOG0661|consen 156 LAREVRSKP---------PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-IDQIYKICEV 225 (538)
T ss_pred cccccccCC---------CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-HHHHHHHHHH
Confidence 999876542 334567899999999865 46789999999999999999998888875432 2223333322
Q ss_pred hccchh------hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 937 ALPEKV------MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 937 ~~~~~~------~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
...... ..+...+=...|...+.........+..+.++++.+|+++||++||||+|+++.
T Consensus 226 LGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 226 LGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 211111 111111111122221222222223366788899999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=358.66 Aligned_cols=249 Identities=22% Similarity=0.300 Sum_probs=209.4
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
..|....+||+|+.|.||.|....+++.||||++........+-+.+|+.+|+..+|+|||++++.+... +..++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeEE
Confidence 4566778999999999999999999999999999888777778899999999999999999999876543 78999
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
|||||++|+|.|.+.... +++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++.
T Consensus 348 VMEym~ggsLTDvVt~~~-------~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKTR-------MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred EEeecCCCchhhhhhccc-------ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeee
Confidence 999999999999998765 89999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH--HHhc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA--KRAL 938 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~--~~~~ 938 (1009)
.+.... ......+||+.|||||+.....|+++.||||||++++||+.|++||-... .+.... ....
T Consensus 418 qi~~~~--------~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~----PlrAlyLIa~ng 485 (550)
T KOG0578|consen 418 QISEEQ--------SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN----PLRALYLIATNG 485 (550)
T ss_pred cccccc--------CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC----hHHHHHHHhhcC
Confidence 776432 34556889999999999999999999999999999999999999986311 111111 1111
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
..++ ...+..-.++.++..+|+..|+++|+++.|+++.
T Consensus 486 ~P~l--------------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 486 TPKL--------------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCCc--------------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1111 1111223457899999999999999999999863
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.91 Aligned_cols=266 Identities=21% Similarity=0.314 Sum_probs=210.2
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccch-HHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS-KSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
..++|...+.||.|..++||+|+....+..||||+++.+.-... +.+.+|+..|+.++||||++++..+... ..
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-----~~ 98 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD-----SE 98 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-----ce
Confidence 34688899999999999999999999999999999987765444 8899999999999999999999876543 78
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.|+||.||.+||+.+.++..-.. .+++..+..|.+++++||.|||.+ |.||||||+.||||+.+|.|||+|||
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~----Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFg 171 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPD----GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFG 171 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccc----cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCce
Confidence 99999999999999999875432 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCC--CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG--GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
.+-.+........ .....+.||+.|||||++.. ..|+.|+||||||+...|+.+|..||..+..-..-+... +
T Consensus 172 vsa~l~~~G~R~~----~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-q 246 (516)
T KOG0582|consen 172 VSASLFDSGDRQV----TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-Q 246 (516)
T ss_pred eeeeecccCceee----EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-c
Confidence 8877766442111 11156789999999999544 468999999999999999999999998653221111111 1
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...+...... + ..+ ........+.+++..|+..||.+|||+++++.
T Consensus 247 n~pp~~~t~~----~---~~d-------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 247 NDPPTLLTSG----L---DKD-------EDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCCCccccc----C---ChH-------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111111111 1 111 01123346889999999999999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=352.47 Aligned_cols=241 Identities=27% Similarity=0.396 Sum_probs=201.3
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEecc
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYM 785 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 785 (1009)
.+-||.|+.|.||.|+.+ ++.||||+++.- -..+|+.|++++||||+.|.|+|+.. ..+|+|||||
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiMEfC 194 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIMEFC 194 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCC-----ceeEEeeecc
Confidence 356999999999999996 889999987422 24589999999999999999999864 7889999999
Q ss_pred CCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCC
Q 047768 786 QNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865 (1009)
Q Consensus 786 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 865 (1009)
..|-|+..|+.... ++......|..+||.||.|||.+ .|||||||.-||||+.+..|||+|||-++.....
T Consensus 195 a~GqL~~VLka~~~------itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRP------ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred ccccHHHHHhccCc------cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 99999999998764 77888899999999999999999 9999999999999999999999999999876542
Q ss_pred CCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhc
Q 047768 866 PLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEI 945 (1009)
Q Consensus 866 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1009)
.....++||..|||||++.+.+.++|+||||||||||||+||..||...... .+++.+.
T Consensus 266 ---------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----AIIwGVG------- 324 (904)
T KOG4721|consen 266 ---------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----AIIWGVG------- 324 (904)
T ss_pred ---------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----eeEEecc-------
Confidence 3445689999999999999999999999999999999999999999743221 1111000
Q ss_pred cCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 946 VDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 946 ~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
.-.+ ....+..|++.+.-++++||+-.|..||++.+++..|+-..
T Consensus 325 -sNsL----------~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 325 -SNSL----------HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred -CCcc----------cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 0000 11233478888999999999999999999999999886443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=357.27 Aligned_cols=264 Identities=28% Similarity=0.405 Sum_probs=210.3
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCC----eEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeecc
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENG----MLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSI 770 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 770 (1009)
..-++....++||+|+||+||+|+.+..+ ..||||..+... ....+++.+|+++|++++|||||+++|++...
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 33445566689999999999999998532 238999987532 33457899999999999999999999998764
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV 850 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 850 (1009)
...++|||+|.||+|.+|+++.... ++..++..++.++|.||+|||++ ++|||||.++|+|++.++.
T Consensus 234 -----~Pl~ivmEl~~gGsL~~~L~k~~~~-----v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~ 300 (474)
T KOG0194|consen 234 -----EPLMLVMELCNGGSLDDYLKKNKKS-----LPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGV 300 (474)
T ss_pred -----CccEEEEEecCCCcHHHHHHhCCCC-----CCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCe
Confidence 6789999999999999999988753 99999999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCcc
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLT 929 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~ 929 (1009)
+||+|||+++.-.... ... ....-+..|+|||.+..+.|+.++|||||||++||+++ |..||..+...
T Consensus 301 vKISDFGLs~~~~~~~---~~~-----~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--- 369 (474)
T KOG0194|consen 301 VKISDFGLSRAGSQYV---MKK-----FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--- 369 (474)
T ss_pred EEeCccccccCCccee---ecc-----ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---
Confidence 9999999987543111 000 01134679999999999999999999999999999999 88899865322
Q ss_pred HHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 047768 930 LHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFL 1005 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~ 1005 (1009)
+..........+ .+ .+...+.++..++.+||..+|+.||+|.++.+.++.+.+...
T Consensus 370 --~v~~kI~~~~~r-------~~-----------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 370 --EVKAKIVKNGYR-------MP-----------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --HHHHHHHhcCcc-------CC-----------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 111111111111 00 111345567888999999999999999999999998877644
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=349.47 Aligned_cols=263 Identities=25% Similarity=0.430 Sum_probs=220.5
Q ss_pred HHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 695 ELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 695 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
+++....+...-++||-|-||.||.|.|+...-.||||.++.+ .....+|.+|+.+|+.++|||+|+++|+|+..
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E---- 335 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE---- 335 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccC----
Confidence 3444445667778999999999999999998999999999744 34578999999999999999999999999864
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
...|+|+|||..|+|.+|+++.... .++..-.+.+|.||+.||+||..+ .+|||||.++|+|++++..|||+
T Consensus 336 -pPFYIiTEfM~yGNLLdYLRecnr~----ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvA 407 (1157)
T KOG4278|consen 336 -PPFYIITEFMCYGNLLDYLRECNRS----EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVA 407 (1157)
T ss_pred -CCeEEEEecccCccHHHHHHHhchh----hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEee
Confidence 5679999999999999999987653 477778899999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 933 (1009)
|||+++.+....+ ....+..-++.|.|||-+....++.|+|||+|||++||+.| |-.||.... +.
T Consensus 408 DFGLsRlMtgDTY-------TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----lS-- 473 (1157)
T KOG4278|consen 408 DFGLSRLMTGDTY-------TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LS-- 473 (1157)
T ss_pred ccchhhhhcCCce-------ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----HH--
Confidence 9999999876533 22223445789999999999999999999999999999999 888987432 11
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
.++++++..++ ...++.|++.++++|++||++.|.+||+++|+-+.++.+-
T Consensus 474 -------qVY~LLEkgyR----------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 474 -------QVYGLLEKGYR----------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred -------HHHHHHhcccc----------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 23344433322 2334578899999999999999999999999999998754
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.91 Aligned_cols=264 Identities=23% Similarity=0.367 Sum_probs=214.8
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccch-HHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS-KSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+...+.++||+|-||+|..++.. .+..||||+++.....+. .+|.+|+++|.+++||||++++|+|... +..+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePic 611 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPLC 611 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----CchH
Confidence 34567799999999999999985 569999999987765544 7899999999999999999999999864 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+|||++|+|.+|+.++... ........+|+.|||.||+||.+. ++||||+.++|+|+|.++++||+|||++
T Consensus 612 mI~EYmEnGDLnqFl~aheap----t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELP----TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCc----ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccc
Confidence 999999999999999987543 245566778999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh--CCCCCcccccCCccHHHHHHHh
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT--RRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
|-+..++++... ...+-+++|||||.+..++++.++|||+||+++||+++ ...||+.+.+++ ..
T Consensus 685 R~lysg~yy~vq------gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vv------ 750 (807)
T KOG1094|consen 685 RNLYSGDYYRVQ------GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VV------ 750 (807)
T ss_pred cccccCCceeee------cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HH------
Confidence 988776554322 12345789999999999999999999999999999988 788988665431 11
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
+...++++..-.... ...+.-|+.++++++.+||..|.++||+++++...|++-
T Consensus 751 --en~~~~~~~~~~~~~-------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 751 --ENAGEFFRDQGRQVV-------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred --HhhhhhcCCCCccee-------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 112222221111111 123346788899999999999999999999999988764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=323.02 Aligned_cols=272 Identities=21% Similarity=0.259 Sum_probs=207.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|++.++|++|+||.||+|+++.+++.||+|+++.+... -.-.-.+||.++.+++|||||.+-.+.... .-+.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~---~~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS---NMDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc---ccce
Confidence 46788899999999999999999999999999999765432 234567999999999999999998886654 2356
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.|+|||||++ +|.+.++.... ++...+++.+..|+++|++|||.. .|+|||||++|+|++..|.+||+|||
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q-----~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQ-----PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccc
Confidence 8999999977 99999998874 489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+||.+... ....+..+-|..|+|||.+.+. .|+++.|+||+|||+.||+++++-|..... ...+..+...
T Consensus 223 LAR~ygsp--------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE-~dQl~~If~l 293 (419)
T KOG0663|consen 223 LAREYGSP--------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE-IDQLDKIFKL 293 (419)
T ss_pred hhhhhcCC--------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch-HHHHHHHHHH
Confidence 99987653 1334557789999999998774 689999999999999999999988864322 1223332221
Q ss_pred hc-cc-h-hhhccCCC------CCChh--hhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 AL-PE-K-VMEIVDPS------LLPLE--EERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~-~~-~-~~~~~d~~------l~~~~--~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. |. . +..+...- +...+ .-|....... --+.-++++...+.+||.+|.||.|.++
T Consensus 294 lGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~---lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 294 LGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALS---LSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hCCCccccCCCccccchhhccccCCCCchhhhhhccccc---cchhHHHHHHHHhccCccccccHHHhhc
Confidence 11 10 0 11111000 00000 0111111110 1134578999999999999999999875
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=340.67 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=207.3
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
..|+..+.||+|.||.||+|.+..+++.||+|++..+... ....+++|+.++.+++++||.+++|.+... ..++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----TKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----ccHH
Confidence 4677778999999999999999999999999999876543 357899999999999999999999986543 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
++||||.+|++.+.++.... +++..+.-+.+++..|+.|||++ +.+|||||+.||++..+|.||++|||.+
T Consensus 88 iiMey~~gGsv~~lL~~~~~------~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa 158 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGNI------LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVA 158 (467)
T ss_pred HHHHHhcCcchhhhhccCCC------CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEeccee
Confidence 99999999999999987652 57788888999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
-.+.... .....++||+.|||||++.+..|+.|+||||+|++.+||++|.+|+......
T Consensus 159 ~ql~~~~--------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm------------- 217 (467)
T KOG0201|consen 159 GQLTNTV--------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM------------- 217 (467)
T ss_pred eeeechh--------hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-------------
Confidence 8776532 3335689999999999999999999999999999999999999998743221
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.+.-++.+.--+ .....+-..+.+++..|+..+|+.||+|.+++..
T Consensus 218 -rvlflIpk~~PP----------~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 218 -RVLFLIPKSAPP----------RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -eEEEeccCCCCC----------ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 111111111111 0111444568899999999999999999999763
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=344.37 Aligned_cols=199 Identities=32% Similarity=0.465 Sum_probs=179.1
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|.+.+.||+|.||.||||+.+.+.+.||+|.+....+. ..+.+.+|++++++++||||+.+++++ +...+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 5788889999999999999999999999999999644332 346789999999999999999999984 556899
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++|+||+.+ +|..++...+. ++++.+..++.+++.||.|||+. +|.|||+||.|||++.++++|+||||+
T Consensus 77 ~vVte~a~g-~L~~il~~d~~------lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQDGK------LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred EEEehhhhh-hHHHHHHhccC------CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence 999999976 99999988764 99999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
|+-+.... ...+...||+-|||||...+++|+..+|+||+||++||+++|++||..
T Consensus 147 Ar~m~~~t--------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 147 ARAMSTNT--------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred hhhcccCc--------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 99776532 344567899999999999999999999999999999999999999963
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=354.45 Aligned_cols=269 Identities=23% Similarity=0.364 Sum_probs=205.4
Q ss_pred HhccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeeccc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSSID 771 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 771 (1009)
..++|.+.++||+|+||.||+|.+. .+++.||||+++.... ...+.+.+|+++++++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 3468999999999999999999863 3456899999864322 2245788999999999 899999999987532
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCCC--------------------------------------------------
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQL-------------------------------------------------- 801 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------------- 801 (1009)
....++||||+++|+|.+++.......
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 346789999999999999997643110
Q ss_pred ------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCC
Q 047768 802 ------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875 (1009)
Q Consensus 802 ------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 875 (1009)
....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++........ .
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~------~ 231 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------V 231 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcch------h
Confidence 012478889999999999999999999 9999999999999999999999999999865432110 1
Q ss_pred ccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChh
Q 047768 876 SSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLE 954 (1009)
Q Consensus 876 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 954 (1009)
......+++.|+|||++.+..++.++|||||||++|||++ |..||....... ...... .+......
T Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~~~~~--------~~~~~~~~- 298 (338)
T cd05102 232 RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EFCQRL--------KDGTRMRA- 298 (338)
T ss_pred cccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HHHHHH--------hcCCCCCC-
Confidence 1122346788999999999999999999999999999997 999987432111 111100 00000000
Q ss_pred hhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 955 EERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 955 ~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
+..+..++.+++.+||+.||++|||+.|+++.|+.+.++
T Consensus 299 ----------~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 299 ----------PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred ----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 012334678999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=346.21 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=203.9
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc----cc-cchHHHHHHHHHHHhcC-CCCcceEEeeeeccc
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE----QK-GGSKSFAAECEALRSIR-HRNLIKIVTICSSID 771 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 771 (1009)
...+.|.+.+.||+|.||.|+.|.+..++..||+|+++.. .. ...+.+.+|+.++++++ ||||++++.+....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~- 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP- 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence 3456899999999999999999999999999999987543 11 23456778999999998 99999999996543
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC-Cc
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD-MV 850 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~ 850 (1009)
...++||||+.+|+|.+++.+... +.+.++..+++|++.|++|+|++ +|+||||||+||+++.+ ++
T Consensus 93 ----~~~~ivmEy~~gGdL~~~i~~~g~------l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 93 ----TKIYIVMEYCSGGDLFDYIVNKGR------LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGN 159 (370)
T ss_pred ----CeEEEEEEecCCccHHHHHHHcCC------CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCC
Confidence 569999999999999999998443 88999999999999999999999 99999999999999999 99
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCC-C-CCcccchHHHHHHHHHHhCCCCCcccccCCc
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE-A-SMRGGVYSYGILLLEIFTRRRPTESMFNEGL 928 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~ 928 (1009)
+||+|||++...... .......+||+.|+|||++.+.. | +.++||||+||++|.|++|+.||...
T Consensus 160 ~Kl~DFG~s~~~~~~--------~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~----- 226 (370)
T KOG0583|consen 160 LKLSDFGLSAISPGE--------DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS----- 226 (370)
T ss_pred EEEeccccccccCCC--------CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----
Confidence 999999999877311 13345678999999999999977 7 58999999999999999999999852
Q ss_pred cHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 047768 929 TLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVV 994 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl 994 (1009)
............. ...|. +.. -.++..++.+|+..||.+|+|+.|++
T Consensus 227 ~~~~l~~ki~~~~---------~~~p~-------~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 227 NVPNLYRKIRKGE---------FKIPS-------YLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred cHHHHHHHHhcCC---------ccCCC-------CcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 2222222111110 00110 000 23467999999999999999999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=345.64 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=210.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
..-|..++.||.|+-|.|-.|++.++|+.+|||++..... .....+.+|+-+|+-+.||||+++++++.. ..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-----~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-----KQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-----Cc
Confidence 3467888999999999999999999999999999965522 224578899999999999999999999654 48
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
++|+|.||+++|-|.+|+-.++. +++.++.++++||+.|+.|+|.. +|+|||+||+|+|+|..+++||+||
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~------l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADF 156 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGP------LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADF 156 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeecc
Confidence 89999999999999999988774 89999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+|..-.++ ......+|+++|.|||++.+.+| +.++||||+|||+|.|+||+.||+ +..++....
T Consensus 157 GMAsLe~~g---------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-----DdNir~LLl 222 (786)
T KOG0588|consen 157 GMASLEVPG---------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-----DDNIRVLLL 222 (786)
T ss_pred ceeecccCC---------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-----CccHHHHHH
Confidence 999865543 23345789999999999999998 789999999999999999999997 334554444
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
++....+ ++ ++....+..+++.+|+..||++|.|++||.+.
T Consensus 223 KV~~G~f-~M-------------------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 223 KVQRGVF-EM-------------------PSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHcCcc-cC-------------------CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 3322221 11 11333457899999999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=314.88 Aligned_cols=232 Identities=24% Similarity=0.314 Sum_probs=195.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|+..+.||.|+||.|..++.+.+|..+|+|+++.... ...+....|..+++.+.||.++++++.+.+ ..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-----~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-----NS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-----CC
Confidence 3578888999999999999999999999999999975532 223456789999999999999999987544 48
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||++||-|.+++++.+. +++..++-+|.+|+.|++|||+. +|++||+||+|||+|.+|.+||+||
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~r------F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGR------FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCC------CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence 89999999999999999998764 99999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+|+.... .....+||+.|+|||+++...|..++|-|||||++|||+.|.+||..... ...+.++...
T Consensus 189 GFAK~v~~-----------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~ 256 (355)
T KOG0616|consen 189 GFAKRVSG-----------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEG 256 (355)
T ss_pred cceEEecC-----------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhC
Confidence 99997653 34568999999999999999999999999999999999999999975432 2233333332
Q ss_pred ------hccchhhhccCCCCCChhhhh
Q 047768 937 ------ALPEKVMEIVDPSLLPLEEER 957 (1009)
Q Consensus 937 ------~~~~~~~~~~d~~l~~~~~~r 957 (1009)
.+..++.+++...+..+...|
T Consensus 257 ~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 KVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 234556666666666655555
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=339.55 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=214.9
Q ss_pred cCccCCcccccCCceEEEEEEecC----CeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHEN----GMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
..+..++||+|-||.||+|.+... .-.||||..+.+. .+..+.|..|..+|++++||||++++|+|.+ .
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~ 463 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------Q 463 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec------c
Confidence 444567899999999999998632 2358999987643 3346789999999999999999999999986 5
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++|||.++-|-|..|++.++.. ++......++.|++.||+|||++ .+|||||.++|||+.....||++||
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~s-----L~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDS-----LPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred ceeEEEecccchhHHHHHHhcccc-----chHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeeccc
Confidence 689999999999999999988764 99999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 935 (1009)
|++|.+....++.. ....-+..|||||.+.-..++.++|||.|||.+||++. |..||....+.+..
T Consensus 536 GLSR~~ed~~yYka-------S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI------ 602 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKA-------SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI------ 602 (974)
T ss_pred chhhhccccchhhc-------cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE------
Confidence 99999887655321 12334678999999999999999999999999999999 99999754333211
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
..+-.. .+.+.+..|+..++.++.+||++||.+||++.|+...|+.+.++
T Consensus 603 -------~~iEnG-----------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 603 -------GHIENG-----------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred -------EEecCC-----------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 111111 11234457889999999999999999999999999999998874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=337.85 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=200.7
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeecccccc---hHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEE
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG---SKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
...+|+|++|.||+|.+ +|+.||||+++...... .+.+.+|+++|++++||||++++|++... ..+....++||
T Consensus 25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~ 101 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLIL 101 (283)
T ss_pred CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEE
Confidence 36799999999999998 58999999997554333 36678999999999999999999997642 12335679999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++.+.. .+++.....++.+++.|+.|||+.. +++||||||+||++++++.+||+|||+++..
T Consensus 102 Ey~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 102 EYCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKIL 173 (283)
T ss_pred EeCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence 9999999999998754 3889999999999999999999742 7889999999999999999999999999865
Q ss_pred CCCCCCCccccCCccccccccccccCccccCC--CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccc
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLG--GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
.... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ........
T Consensus 174 ~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~~~~i~-- 235 (283)
T PHA02988 174 SSPP-----------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEIYDLII-- 235 (283)
T ss_pred cccc-----------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHH--
Confidence 4321 12457899999999876 6889999999999999999999999974321 11111110
Q ss_pred hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 047768 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQ 1002 (1009)
Q Consensus 941 ~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~ 1002 (1009)
...... ..+..++.++.+++.+||+.||++|||++|+++.|+..+.
T Consensus 236 ------~~~~~~----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 236 ------NKNNSL----------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ------hcCCCC----------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 000000 0011345568899999999999999999999999998764
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.81 Aligned_cols=275 Identities=23% Similarity=0.285 Sum_probs=208.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEee--cccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN--LEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
...|...+.||+|+||.|+.|.++.+|+.||||++. .......++..+|++.++.++|+||+.+.++........-..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345655789999999999999999999999999986 334445678889999999999999999999987755556678
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.|+|+|+| +-+|.+.++.... ++...+..+..|+++|+.|+|+. +|+|||+||.|++++.+...||+|||
T Consensus 101 vYiV~elM-etDL~~iik~~~~------L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQD------LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCcc------ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 89999999 5699999988653 88999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH--
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA-- 934 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~-- 934 (1009)
+||..... ......+..+.|..|+|||++.. ..|+.+.||||.||++.||++|+.-|.....- .++..+.
T Consensus 171 LAR~~~~~------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v-~Ql~lI~~~ 243 (359)
T KOG0660|consen 171 LARYLDKF------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV-HQLQLILEL 243 (359)
T ss_pred ceeecccc------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH-HHHHHHHHh
Confidence 99987643 11234456788999999998654 68999999999999999999999988642211 0111111
Q ss_pred ---------HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 935 ---------KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 935 ---------~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.....+.++..+...-.. +. ..........-...++++.+++..||.+|+|++|+++
T Consensus 244 lGtP~~e~l~~i~s~~ar~yi~slp~~-p~---~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 244 LGTPSEEDLQKIRSEKARPYIKSLPQI-PK---QPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred cCCCCHHHHHHhccHHHHHHHHhCCCC-CC---CCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111112222222111110 00 0000000122235679999999999999999999976
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=307.69 Aligned_cols=279 Identities=21% Similarity=0.251 Sum_probs=220.0
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
...++|.+.+.+|+|||+-||.++.-.+++.+|+|++.....++.+...+|++..++++|||++++++++.....+....
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 34578999999999999999999988899999999998877677788999999999999999999999987765556778
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.|+++.|...|+|.+.++....+ ...+++.++++|+.++++||.+||+. .++++||||||.||++++++.+++.|||
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~k--g~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIK--GNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhc--CCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 99999999999999999876654 23599999999999999999999998 3469999999999999999999999999
Q ss_pred cccccCCCCCCCc-cccCCccccccccccccCccccC---CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 858 LAKFLSASPLGNV-VETPSSSIGVKGTIGYVAPEYGL---GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 858 la~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
.++...-.-.+.. ...-........|..|+|||.+. +...++++|||||||++|+|+.|..||+.....+.++.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla-- 252 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA-- 252 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE--
Confidence 9876542211000 00001112245789999999754 45679999999999999999999999975433221111
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
..+....+. -+......+.+.+++.+|++.||..||++.|++.++...
T Consensus 253 ---------LAv~n~q~s----------~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 ---------LAVQNAQIS----------IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ---------Eeeeccccc----------cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111111111 112223566789999999999999999999999988754
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=302.46 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=209.9
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
+.++|++++.||+|.||.||.|+.+.++-.||+|++... ..+...++.+|+++-..++||||+++++++. +.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh-----d~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH-----DS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee-----cc
Confidence 456899999999999999999999999999999998533 2334578999999999999999999999954 44
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...|+++||..+|.+...++..... .+++.....+..|+|.|+.|+|.+ +|+||||||+|+|++..+..|++|
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~----~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMK----RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccc----cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccC
Confidence 7899999999999999999854432 488888999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||.+..-. .......+||..|.+||...+..++...|+|++|++.||++.|.+||+++. .+..+.++..
T Consensus 168 fGwsV~~p----------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k 236 (281)
T KOG0580|consen 168 FGWSVHAP----------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRK 236 (281)
T ss_pred CCceeecC----------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHH
Confidence 99886432 244556899999999999999999999999999999999999999998765 3233333322
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.. +..+. ....+..+++.+|+..+|.+|.+..|+++.
T Consensus 237 ~~-------~~~p~-----------------~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 VD-------LKFPS-----------------TISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cc-------ccCCc-----------------ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 21 11111 112346799999999999999999999864
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=325.22 Aligned_cols=269 Identities=24% Similarity=0.305 Sum_probs=202.1
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALV 781 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 781 (1009)
.|...+.+|.|+||.||+|...++++.||||++-.+. +--.+|+++|+.++|||||++.-++......+.-...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5666789999999999999999999999999874322 233579999999999999999988776422223456789
Q ss_pred EeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC-CceEEecccccc
Q 047768 782 YEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAK 860 (1009)
Q Consensus 782 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~DfGla~ 860 (1009)
||||+. +|.++++..... ...++...++-+.+|+.+|++|||+. +|+||||||.|+|+|.+ |.+||||||.|+
T Consensus 101 leymP~-tL~~~~r~~~~~--~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRA--NQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHhchH-HHHHHHHHHhhc--CCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 999965 999998853111 12388888999999999999999998 99999999999999977 899999999999
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
.+..+ ........|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|... +....+.++.+....
T Consensus 175 ~L~~~---------epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 175 VLVKG---------EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIKVLGT 244 (364)
T ss_pred eeccC---------CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHHHhCC
Confidence 88654 223456778999999998884 7899999999999999999999988753 222334444433222
Q ss_pred chhhhc----------cCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 940 EKVMEI----------VDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 940 ~~~~~~----------~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
+...++ ..+.+...+-. .........+.++++.++++++|.+|.++.|++.
T Consensus 245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~-----~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 245 PTREDIKSMNPNYTEFKFPQIKAHPWH-----KVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CCHHHHhhcCcccccccCcccccccce-----eecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 111111 11111111110 0122233456789999999999999999999875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.78 Aligned_cols=256 Identities=23% Similarity=0.311 Sum_probs=199.8
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
...++|+....||+|+||+||.|+-+.+|..+|+|+++... ....+.+..|-++|...++|.||+++-. |++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecC
Confidence 34578999999999999999999999999999999997543 3345678899999999999999999876 566
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
.++.|+||||++||++..+|.+.+. +++..+..++.+++-|+..+|.. |||||||||+|+|||..|++||+
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~~~------L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLS 283 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRKDT------LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLS 283 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhcCc------CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeec
Confidence 6899999999999999999988764 99999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCC----------------ccccC-----------------------CccccccccccccCccccCCC
Q 047768 855 DFGLAKFLSASPLGN----------------VVETP-----------------------SSSIGVKGTIGYVAPEYGLGG 895 (1009)
Q Consensus 855 DfGla~~~~~~~~~~----------------~~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~ 895 (1009)
|||++.-+....... ..+.+ ......+|||.|||||++.+.
T Consensus 284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k 363 (550)
T KOG0605|consen 284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK 363 (550)
T ss_pred cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence 999996432210000 00000 001134699999999999999
Q ss_pred CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHH
Q 047768 896 EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKT 975 (1009)
Q Consensus 896 ~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l 975 (1009)
.|+..+|.||+|||+|||+.|.+||.+.... ....++..- ...+.. |. ..++..+..++
T Consensus 364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~-~T~rkI~nw----------r~~l~f-P~---------~~~~s~eA~DL 422 (550)
T KOG0605|consen 364 GYGKECDWWSLGCIMYEMLVGYPPFCSETPQ-ETYRKIVNW----------RETLKF-PE---------EVDLSDEAKDL 422 (550)
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH----------hhhccC-CC---------cCcccHHHHHH
Confidence 9999999999999999999999999754322 111111110 001111 11 11122456689
Q ss_pred HhhccCCCCCCCCC
Q 047768 976 GVACSIESPFDRME 989 (1009)
Q Consensus 976 ~~~cl~~dp~~Rpt 989 (1009)
+.+|+. ||+.|.-
T Consensus 423 I~rll~-d~~~RLG 435 (550)
T KOG0605|consen 423 ITRLLC-DPENRLG 435 (550)
T ss_pred HHHHhc-CHHHhcC
Confidence 999999 9999986
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.56 Aligned_cols=262 Identities=25% Similarity=0.336 Sum_probs=201.8
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--------------cchHHHHHHHHHHHhcCCCCcceE
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--------------GGSKSFAAECEALRSIRHRNLIKI 763 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l 763 (1009)
...++|++.+.||+|.||.|-+|....+++.||||++..... ...+...+||.+|+++.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 446789999999999999999999999999999999953211 112578899999999999999999
Q ss_pred EeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCce
Q 047768 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNV 843 (1009)
Q Consensus 764 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Ni 843 (1009)
+.+-.+ +..+..|+|+|||..|.+...-... ..+++.+++++++++..||+|||.+ +||||||||+|+
T Consensus 174 iEvLDD---P~s~~~YlVley~s~G~v~w~p~d~------~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNL 241 (576)
T KOG0585|consen 174 IEVLDD---PESDKLYLVLEYCSKGEVKWCPPDK------PELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNL 241 (576)
T ss_pred EEeecC---cccCceEEEEEeccCCccccCCCCc------ccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhhe
Confidence 998765 4567899999999988774432211 1289999999999999999999999 999999999999
Q ss_pred eeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCC----CCCcccchHHHHHHHHHHhCCCC
Q 047768 844 LLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE----ASMRGGVYSYGILLLEIFTRRRP 919 (1009)
Q Consensus 844 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~elltg~~p 919 (1009)
|++++|+|||+|||.+.....+...... .......||+.|||||...++. .+.+.||||+||+||.|+.|+.|
T Consensus 242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d---~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 242 LLSSDGTVKISDFGVSNEFPQGSDEGSD---DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred EEcCCCcEEeeccceeeecccCCccccH---HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 9999999999999999877544221111 1222367999999999877732 37889999999999999999999
Q ss_pred CcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 920 TESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
|...+ ..+... .++..-+.. |. ..+.-+++.+++.++++.||+.|.+..+|....
T Consensus 319 F~~~~-----~~~l~~--------KIvn~pL~f-P~---------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 319 FFDDF-----ELELFD--------KIVNDPLEF-PE---------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred cccch-----HHHHHH--------HHhcCcccC-CC---------cccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 96421 111111 111111111 10 012334677999999999999999999987654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=317.49 Aligned_cols=280 Identities=23% Similarity=0.354 Sum_probs=207.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCC-cceEEeeeeccc-cCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRN-LIKIVTICSSID-FKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-~~~~ 775 (1009)
...|...++||+|+||+||+|+.+.+|+.||+|++....+ +......+|+.+++.++|+| |+++++++.... +...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3456667889999999999999999999999999976644 35667889999999999999 999999987642 2334
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++|+||++ -+|.+|+....... ..++...++.+++|++.|++|||++ +|+||||||.||+|+++|.+||+|
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence 47889999995 59999998866321 2367788999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
||+|+...... ...+..++|..|+|||++.+. .|+...||||+||+++||++++.-|....+. ..+..+.
T Consensus 164 FGlAra~~ip~--------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~If 234 (323)
T KOG0594|consen 164 FGLARAFSIPM--------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFRIF 234 (323)
T ss_pred cchHHHhcCCc--------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHHHH
Confidence 99999654221 223456789999999999887 7899999999999999999998888754431 1222222
Q ss_pred HHh-cc--ch---hhhccCCCCCChhhhhhhccccccH--HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 935 KRA-LP--EK---VMEIVDPSLLPLEEERTNSRRVRNE--ECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 935 ~~~-~~--~~---~~~~~d~~l~~~~~~r~~~~~~~~~--~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
+.. .| +. +..+.+-.. ..+ .+......... .-.....+++.+|++++|+.|.|++.+++.
T Consensus 235 ~~lGtP~e~~Wp~v~~~~~~k~-~f~-~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 235 RLLGTPNEKDWPGVSSLPDYKA-PFP-KWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHcCCCCccCCCCccccccccc-cCc-CCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 211 11 11 111111111 000 00000000000 001356799999999999999999999875
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=353.94 Aligned_cols=271 Identities=22% Similarity=0.275 Sum_probs=214.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-CCCcceEEe-eeeccccCC-Cce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVT-ICSSIDFKG-VDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~~~~~~-~~~ 777 (1009)
.++++.+.|.+|||+.||.|++...|..||+|++-..++..-..+.+||++|++++ |+|||.+++ ......... ..+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 35667789999999999999998777999999987776666788999999999996 999999999 333222222 467
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
+++.||||++|+|-|++..+... .+++.++++|+.|+++|+++||.. +|+|||||||.+||||+.++..||||||
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~----~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQT----RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhc----cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 89999999999999999877653 399999999999999999999985 7789999999999999999999999999
Q ss_pred cccccCCCCC-CCccccCCccccccccccccCccc---cCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 858 LAKFLSASPL-GNVVETPSSSIGVKGTIGYVAPEY---GLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 858 la~~~~~~~~-~~~~~~~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
.|.-...... ......-.......-|+.|+|||. ..+..+++|+|||++||+||.|+....||+....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------- 263 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------- 263 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------
Confidence 9975433221 000000011112346899999996 4667889999999999999999999999984311
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
..+++..+...+ ...+...+..++..|++.+|.+||++.+|+..+.++...
T Consensus 264 ---------laIlng~Y~~P~----------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 ---------LAILNGNYSFPP----------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ---------eeEEeccccCCC----------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 122332222111 125567789999999999999999999999999887653
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.30 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=197.7
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
|...+.||+|+||+||+|.+..+++.||||++..... .....+.+|++++++++|++|+++.+++.. ....+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-----~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-----KDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-----CCeEE
Confidence 6678899999999999999998999999999864322 223467889999999999999999988654 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++
T Consensus 77 lv~e~~~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred EEEEecCCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999988865432 1388999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
+...... ......||..|+|||++.+..++.++|||||||++|||++|+.||....... ..... .....
T Consensus 150 ~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~-~~~~~ 218 (285)
T cd05631 150 VQIPEGE---------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEV-DRRVK 218 (285)
T ss_pred EEcCCCC---------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHHH-HHHhh
Confidence 8654321 1123568999999999999999999999999999999999999997532211 01111 11000
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME-----MTDVVV 995 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt-----~~evl~ 995 (1009)
..... ........+.+++.+|++.||++||+ ++|+++
T Consensus 219 ~~~~~-------------------~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 219 EDQEE-------------------YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccccc-------------------CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00000 00112345779999999999999997 777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.86 Aligned_cols=267 Identities=23% Similarity=0.375 Sum_probs=200.4
Q ss_pred ccCccCCcccccCCceEEEEEEec----------------CCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHE----------------NGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKI 763 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l 763 (1009)
++|.+.++||+|+||.||+|.+.. ++..||+|++...... ....+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999998642 3457999998654322 24578899999999999999999
Q ss_pred EeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCC-------------CCccCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 047768 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQ-------------LGICNLSLIQRLNIVIDVASAVEYLHHHCQ 830 (1009)
Q Consensus 764 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ 830 (1009)
++++... ...++||||+++|+|.+++...... .....+++.++..++.|++.|++|||+.
T Consensus 85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-- 157 (304)
T cd05096 85 LGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-- 157 (304)
T ss_pred EEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence 9997643 5689999999999999998654211 0113478889999999999999999999
Q ss_pred CCceecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHH
Q 047768 831 PPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILL 910 (1009)
Q Consensus 831 ~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl 910 (1009)
+|+||||||+||+++.++.+||+|||+++........ .......++..|+|||++.++.++.++||||||+++
T Consensus 158 -~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l 230 (304)
T cd05096 158 -NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY------RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL 230 (304)
T ss_pred -CccccCcchhheEEcCCccEEECCCccceecccCcee------EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHH
Confidence 9999999999999999999999999999865432210 111223457899999999989999999999999999
Q ss_pred HHHHh--CCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC
Q 047768 911 LEIFT--RRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM 988 (1009)
Q Consensus 911 ~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp 988 (1009)
|||++ +..||...... .................. ......++..+.+++.+||+.||++||
T Consensus 231 ~el~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~li~~cl~~~p~~RP 293 (304)
T cd05096 231 WEILMLCKEQPYGELTDE--QVIENAGEFFRDQGRQVY---------------LFRPPPCPQGLYELMLQCWSRDCRERP 293 (304)
T ss_pred HHHHHccCCCCCCcCCHH--HHHHHHHHHhhhcccccc---------------ccCCCCCCHHHHHHHHHHccCCchhCc
Confidence 99997 55677643221 111111111100000000 001113445788999999999999999
Q ss_pred CHHHHHHHHH
Q 047768 989 EMTDVVVKLC 998 (1009)
Q Consensus 989 t~~evl~~L~ 998 (1009)
|++||.+.|+
T Consensus 294 s~~~i~~~l~ 303 (304)
T cd05096 294 SFSDIHAFLT 303 (304)
T ss_pred CHHHHHHHHh
Confidence 9999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=337.61 Aligned_cols=200 Identities=26% Similarity=0.372 Sum_probs=174.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|++.+.||+|+||.||+|+++.++..||+|+++.... .....+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEE
Confidence 4689999999999999999999999999999999875432 2245789999999999999999999987543 678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++|+|.+++.... .+++..+..++.|++.|+.|||++. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 150 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGV 150 (331)
T ss_pred EEEeecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcc
Confidence 99999999999999998754 2889999999999999999999852 699999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
++..... ......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 151 ~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 151 SGQLIDS----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccccccc----------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 8765332 11234689999999999999999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=347.22 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=209.4
Q ss_pred CccCCcccccCCceEEEEEEecCCe----EEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGM----LVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
....++||+|+||+||+|.|...|+ +||+|++.... .+..+++.+|+-+|.+++|||+++++|+|.. ..
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~------s~ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML------ST 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc------ch
Confidence 3446789999999999999986654 68999885432 3346789999999999999999999999975 34
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
+.+|++|++.|+|.+|++.++.. +.....+.|..|||+||.|||++ ++|||||.++||||.+-..+||.|||
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~-----igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfg 843 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDN-----IGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFG 843 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhcc-----ccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecc
Confidence 78999999999999999998764 88899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+|+........ ....+..-.+.|||=|.+....|+.++|||||||++||++| |..|+..+..+ +
T Consensus 844 la~ll~~d~~e------y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----e---- 908 (1177)
T KOG1025|consen 844 LAKLLAPDEKE------YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----E---- 908 (1177)
T ss_pred hhhccCccccc------ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----H----
Confidence 99988764321 11222334678999999999999999999999999999999 99998754322 1
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQ 1002 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~ 1002 (1009)
+.+++..-- +...+.-|...++.++.+||..|++.||+++++...+.+..+
T Consensus 909 -----I~dlle~ge----------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 909 -----IPDLLEKGE----------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred -----hhHHHhccc----------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 222221111 112334577789999999999999999999999999887654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=345.16 Aligned_cols=264 Identities=23% Similarity=0.358 Sum_probs=202.4
Q ss_pred hccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeecccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 772 (1009)
.++|++.+.||+|+||.||+|++. .++..||||+++.... ...+.+.+|+++++.+ +||||++++++|...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-- 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG-- 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence 457889999999999999999752 4567899999864332 2345788999999999 899999999997653
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCC----------------------------------------------------
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQ---------------------------------------------------- 800 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 800 (1009)
...++||||+++|+|.++++.....
T Consensus 112 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 112 ---GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ---CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 6789999999999999999754310
Q ss_pred -----------------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccC
Q 047768 801 -----------------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863 (1009)
Q Consensus 801 -----------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~ 863 (1009)
.....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 0012478899999999999999999998 99999999999999999999999999998664
Q ss_pred CCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccchh
Q 047768 864 ASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
..... .......++..|+|||++.+..++.++|||||||++|||++ |..||....... ...+..
T Consensus 266 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~-------- 330 (375)
T cd05104 266 NDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMI-------- 330 (375)
T ss_pred Ccccc------cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHH--------
Confidence 32110 01112335678999999999999999999999999999998 888886432211 111111
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
....... .+...+.++.+++.+||+.||++||++.||++.|++.
T Consensus 331 ----~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 331 ----KEGYRML----------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----HhCccCC----------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1000000 0001234678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=332.62 Aligned_cols=274 Identities=21% Similarity=0.319 Sum_probs=200.4
Q ss_pred ccCccCCcccccCCceEEEEEEec-CCeEEEEEEeecccc--cchHHHHHHHHHHHhc---CCCCcceEEeeeeccccCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHE-NGMLVAVKVINLEQK--GGSKSFAAECEALRSI---RHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~ 774 (1009)
++|++.+.||+|+||+||+|++.. +++.||||+++.... .....+.+|+.+++.+ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368899999999999999999853 578899999865432 2234566788877766 6999999999986543444
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
....++||||++ ++|.+++...... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence 567899999996 6999999764422 388999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+....
T Consensus 153 Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~ 222 (290)
T cd07862 153 DFGLARIYSFQ---------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKIL 222 (290)
T ss_pred cccceEeccCC---------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHH
Confidence 99999865432 12224568999999999999999999999999999999999999997533211 111111
Q ss_pred HHh---ccchhhh---ccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 935 KRA---LPEKVME---IVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 935 ~~~---~~~~~~~---~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... .++.... .....+...+..... . ........+.+++.+|++.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 223 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIE--K-FVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHhCCCChhhchhhhcccchhccCCCCCCHH--H-HccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 111 0111100 000001000000000 0 00112345679999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=315.68 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=205.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.+|++.+.||+|.||.|-+|..+..|+.||||.++..... +--.+.+||++|..++||||++++.+ |+..+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCce
Confidence 4788889999999999999999889999999998654332 33467899999999999999999988 455688
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
..+||||..+|.|+||+.+++. +++.+..++++||..|+.|+|.+ ++||||||.+|||+|.++++||+|||
T Consensus 128 IvivMEYaS~GeLYDYiSer~~------LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGS------LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred EEEEEEecCCccHHHHHHHhcc------ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccc
Confidence 9999999999999999998875 99999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
++-.+... ...+.++|++-|.+||++.+.+| ++..|-||+||++|-++.|.+||+..+ ....+++
T Consensus 199 LSNly~~~---------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----hk~lvrQ 264 (668)
T KOG0611|consen 199 LSNLYADK---------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----HKRLVRQ 264 (668)
T ss_pred hhhhhccc---------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----HHHHHHH
Confidence 99877653 34456899999999999999998 789999999999999999999997532 2222222
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.-....++ | +.+....-++++++..+|++|-|+.+|...
T Consensus 265 Is~GaYrE---------P------------~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 265 ISRGAYRE---------P------------ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred hhcccccC---------C------------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 11111111 1 112234578889999999999999998754
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.05 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=202.4
Q ss_pred hccCccCCcccccCCceEEEEEEe---cCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLH---ENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|++.+.||+|+||.||+|.++ ..+..||+|+++.... .....+.+|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----G 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----C
Confidence 357888999999999999999875 3467899999875432 223578899999999999999999998754 3
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++|+|.+++..... .+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~d 150 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISG 150 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECC
Confidence 678999999999999999986543 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 934 (1009)
||.+........ .......++..|+|||++.+..++.++|||||||++||+++ |+.||...... ...
T Consensus 151 fg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-----~~~ 218 (266)
T cd05064 151 FRRLQEDKSEAI-------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-----DVI 218 (266)
T ss_pred Ccccccccccch-------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHH
Confidence 998765322110 11112345678999999999999999999999999999775 99999754211 111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
.. +.+....+ .+..++..+.+++.+||+.+|++||++.|+.+.|+++
T Consensus 219 ~~--------~~~~~~~~-----------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 219 KA--------VEDGFRLP-----------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HH--------HHCCCCCC-----------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11 01100000 1123455688999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=304.61 Aligned_cols=252 Identities=21% Similarity=0.335 Sum_probs=200.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|++-+.||+|+|+.||++....+|+.+|+|+++... ....+.+.+|+++.+.++||||+++.... .+...
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccce
Confidence 356777889999999999999999999999999986442 23567899999999999999999999874 44578
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC---CCCceEEe
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHVS 854 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~---~~~~~kl~ 854 (1009)
.++|+|+|+|++|..=+-.+. -+++..+-.+.+||++++.|+|.+ +|||||+||+|+++. ..--+|++
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~------~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred eEEEEecccchHHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeec
Confidence 999999999999975554442 278889999999999999999999 999999999999994 34579999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+|..+..+ ....++.|||+|||||++...+|+..+|||+.||++|-++.|+.||+..... ...
T Consensus 156 ~FGvAi~l~~g---------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-----rly 221 (355)
T KOG0033|consen 156 DFGLAIEVNDG---------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLY 221 (355)
T ss_pred ccceEEEeCCc---------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-----HHH
Confidence 99999987732 4556789999999999999999999999999999999999999999853322 111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
++.. ...+++-.+.+. ...++..+++++|+..||++|.|+.|++.
T Consensus 222 e~I~-~g~yd~~~~~w~---------------~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 222 EQIK-AGAYDYPSPEWD---------------TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHh-ccccCCCCcccC---------------cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1111 111111111111 11134568899999999999999998875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=342.69 Aligned_cols=266 Identities=21% Similarity=0.334 Sum_probs=203.1
Q ss_pred HhccCccCCcccccCCceEEEEEEecC-----CeEEEEEEeeccccc-chHHHHHHHHHHHhc-CCCCcceEEeeeeccc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHEN-----GMLVAVKVINLEQKG-GSKSFAAECEALRSI-RHRNLIKIVTICSSID 771 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 771 (1009)
..++|++.+.||+|+||.||+|++... +..||||+++..... ....+.+|+++++.+ +|+||++++++|...
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~- 114 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG- 114 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-
Confidence 345789999999999999999987533 357999999644322 235688999999999 899999999987543
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCC---------------------------------------------------
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQ--------------------------------------------------- 800 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------- 800 (1009)
...++||||+++|+|.++++.....
T Consensus 115 ----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 115 ----GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ----CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 6789999999999999998653210
Q ss_pred -------------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCCCC
Q 047768 801 -------------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPL 867 (1009)
Q Consensus 801 -------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 867 (1009)
.....+++.++.+++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 0112478889999999999999999999 999999999999999999999999999986543211
Q ss_pred CCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccchhhhcc
Q 047768 868 GNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPEKVMEIV 946 (1009)
Q Consensus 868 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 946 (1009)
. .......++..|||||++.+..++.++|||||||++|||++ |+.||....... .......
T Consensus 268 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~----------- 329 (374)
T cd05106 268 Y------VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVK----------- 329 (374)
T ss_pred e------eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHH-----------
Confidence 0 11112335678999999999999999999999999999998 999997543211 1111110
Q ss_pred CCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 947 DPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 947 d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
....... +...+.++.+++.+||+.||++||++.||++.|+++.
T Consensus 330 -~~~~~~~----------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 330 -RGYQMSR----------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -cccCccC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0000000 0011245789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=366.54 Aligned_cols=480 Identities=29% Similarity=0.391 Sum_probs=266.4
Q ss_pred EEeecCCcccccCccccCCCCCCeeeecCCcCCccCC-ccccCccccccccccccccCCCCCCCCcCCCcCcEEeccccc
Q 047768 75 LDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIP-DRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNN 153 (1009)
Q Consensus 75 l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~ 153 (1009)
+|+++..+. .||..+..-..++.|+++.|-+- ..| +.+.+.-+|+.||||+|+++ ..|..+..+.+|+.|.++.|.
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 344444443 23333333344677777777665 223 23444455777777777776 667777777777777777776
Q ss_pred ccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCC
Q 047768 154 LVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIP 233 (1009)
Q Consensus 154 l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 233 (1009)
+. ..|... ..+.+|++|.|.+|.+. ..|.++..+.+|++|+++.|++ +.+|..+..++.++.+..++|.....++
T Consensus 80 i~-~vp~s~--~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f-~~~Pl~i~~lt~~~~~~~s~N~~~~~lg 154 (1081)
T KOG0618|consen 80 IR-SVPSSC--SNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHF-GPIPLVIEVLTAEEELAASNNEKIQRLG 154 (1081)
T ss_pred Hh-hCchhh--hhhhcchhheeccchhh-cCchhHHhhhcccccccchhcc-CCCchhHHhhhHHHHHhhhcchhhhhhc
Confidence 65 445443 45566666666666666 5666666666666666666666 4666666666666666666662221222
Q ss_pred CcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccccccccccccc
Q 047768 234 PSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLK 313 (1009)
Q Consensus 234 ~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~ 313 (1009)
... ++.++|..|.+.+.++.++. .+.+ .|+|++|.+. -..+.++.+|++|+.+.|++....- ..+
T Consensus 155 ~~~-----ik~~~l~~n~l~~~~~~~i~-~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~~----~g~ 219 (1081)
T KOG0618|consen 155 QTS-----IKKLDLRLNVLGGSFLIDIY-NLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELEI----SGP 219 (1081)
T ss_pred ccc-----chhhhhhhhhcccchhcchh-hhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEEe----cCc
Confidence 211 56666666666655555443 1222 3666666665 1234555666666666666654322 234
Q ss_pred ccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCc
Q 047768 314 DLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVN 393 (1009)
Q Consensus 314 ~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~ 393 (1009)
+|+.|+-++|.+..... -.--.+|+++++++|+++ .+|+++..+ .+|+.++..+|+|+ .+|..+...++
T Consensus 220 ~l~~L~a~~n~l~~~~~--------~p~p~nl~~~dis~n~l~-~lp~wi~~~-~nle~l~~n~N~l~-~lp~ri~~~~~ 288 (1081)
T KOG0618|consen 220 SLTALYADHNPLTTLDV--------HPVPLNLQYLDISHNNLS-NLPEWIGAC-ANLEALNANHNRLV-ALPLRISRITS 288 (1081)
T ss_pred chheeeeccCcceeecc--------ccccccceeeecchhhhh-cchHHHHhc-ccceEecccchhHH-hhHHHHhhhhh
Confidence 55555555555542221 011235566666666665 334444444 45666666666664 55555555666
Q ss_pred cCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcc-cccccc-cccccccCcccccccCCCCCCCCCcccccc
Q 047768 394 LNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSS-LGNLTL-LTYLSFGANNLQGNIPFSLGNCKNLMFFFA 471 (1009)
Q Consensus 394 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l 471 (1009)
|+.|.+.+|.+. -+|....+++.|++|+|..|+|. ..|+. +.-+.. |..|+.+.|.+....-..=..++.|+.|++
T Consensus 289 L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Lyl 366 (1081)
T KOG0618|consen 289 LVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYL 366 (1081)
T ss_pred HHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHH
Confidence 666666666665 45555555666666666666665 33332 222222 555555555555222112233455666666
Q ss_pred CCCCccCCCchhhhhhccceeeEecCCCccCCCCCC-CccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccc
Q 047768 472 PRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPL-GVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFS 550 (1009)
Q Consensus 472 ~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 550 (1009)
.+|.++...-+.+.....+. .|+|++|++. ++|. .+.++..|+.|+||+|+|+ .+|.++..+..|+.|...+|+|.
T Consensus 367 anN~Ltd~c~p~l~~~~hLK-VLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~ 443 (1081)
T KOG0618|consen 367 ANNHLTDSCFPVLVNFKHLK-VLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL 443 (1081)
T ss_pred hcCcccccchhhhcccccee-eeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee
Confidence 66666644333333333333 3666666666 3333 3556666666666666666 56666666666666666666666
Q ss_pred cccccccccccccceEcCCCccccccc-ccccccccccCceeccccc
Q 047768 551 GTIPQSLSSLTSIKELDLSQNNFSGQI-PKYLENLSFLQYLNLSYNH 596 (1009)
Q Consensus 551 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~ 596 (1009)
..| .+.+++.|+.+|+|.|+|+... |.... -++|++|||++|.
T Consensus 444 -~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 444 -SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP-SPNLKYLDLSGNT 487 (1081)
T ss_pred -ech-hhhhcCcceEEecccchhhhhhhhhhCC-CcccceeeccCCc
Confidence 555 5666666666666666666322 32222 2566666666665
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=337.25 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=204.3
Q ss_pred ccCccCCcccccCCceEEEEEEecCCe----EEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGM----LVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.+|+..+.||+|+||.||+|++..++. .||||+++.... ...+.+.+|+.+++.++||||++++|+|..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------ 80 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 80 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence 478899999999999999999875554 489999864322 234678899999999999999999999864
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++|+||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~D 152 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITD 152 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcc
Confidence 346799999999999999987653 388999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 934 (1009)
||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .++.
T Consensus 153 fG~a~~~~~~~~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-----~~~~ 221 (316)
T cd05108 153 FGLAKLLGADEKE------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEIS 221 (316)
T ss_pred ccccccccCCCcc------eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHH
Confidence 9999876532110 11112334678999999999999999999999999999998 9999864321 1111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
. ++...... + ....+...+.+++.+||..+|++||++.+++..+..+.++.
T Consensus 222 ~---------~~~~~~~~-~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 222 S---------ILEKGERL-P---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred H---------HHhCCCCC-C---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 1 11000000 0 00122345789999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=334.13 Aligned_cols=274 Identities=22% Similarity=0.309 Sum_probs=199.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|.+.+.||+|+||+||+|+.+.+++.||||+++.... .....+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-----KETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-----CCeE
Confidence 4689999999999999999999998899999999864432 223567889999999999999999998654 3678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||++ ++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHPG-----GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred EEEEECCC-cCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence 99999995 788888876543 388899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....+............
T Consensus 150 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 221 (303)
T cd07869 150 ARAKSVPS--------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL 221 (303)
T ss_pred ceeccCCC--------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence 97543211 11223567999999998765 4578899999999999999999999975432111111111110
Q ss_pred ccch---hhhccC-CCCCCh----hhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEK---VMEIVD-PSLLPL----EEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~---~~~~~d-~~l~~~----~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... ...... +...+. ..................+.+++.+|++.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 222 GTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 000000 000000 000000000000112245679999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=334.93 Aligned_cols=246 Identities=24% Similarity=0.300 Sum_probs=198.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||.||+|.++.+++.||+|+++.... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-----QRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-----CCe
Confidence 368889999999999999999998999999999965422 234568899999999999999999987543 468
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg 146 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGR------FSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG 146 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence 8999999999999999987543 88999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......
T Consensus 147 ~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~i 210 (291)
T cd05612 147 FAKKLRDR-----------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEKI 210 (291)
T ss_pred cchhccCC-----------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH
Confidence 99865321 1134689999999999999999999999999999999999999974321 1111111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME-----MTDVVVK 996 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt-----~~evl~~ 996 (1009)
... .. ..+ ......+.+++.+|++.||.+||+ ++|+++.
T Consensus 211 ~~~--------~~-~~~-----------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 211 LAG--------KL-EFP-----------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HhC--------Cc-CCC-----------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 110 00 000 011235679999999999999995 7777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=339.38 Aligned_cols=274 Identities=20% Similarity=0.243 Sum_probs=200.6
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|++.+.||+|+||.||+|+++.+++.||||+++... ......+.+|++++++++||||+++++++...........+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999999899999999986432 22345688999999999999999999987654333445689
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+. ++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~~-~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 81 VVFELME-SDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred EEEecCC-CCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence 9999995 79999987654 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCC--CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG--GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .........
T Consensus 151 ~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~ 223 (338)
T cd07859 151 RVAFNDTPT-----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDL 223 (338)
T ss_pred cccccccCc-----cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHH
Confidence 865332110 011234568999999999866 67899999999999999999999999643211 000000000
Q ss_pred c------------cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 938 L------------PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 938 ~------------~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
. .......++......+. ............+.+++.+|++.||++|||++|+++.
T Consensus 224 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 224 LGTPSPETISRVRNEKARRYLSSMRKKQPV----PFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hCCCCHHHHHHhhhhhHHHHHHhhcccCCC----chHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 00011111100000000 0000000123457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=338.56 Aligned_cols=242 Identities=22% Similarity=0.257 Sum_probs=194.0
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEe
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYE 783 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 783 (1009)
+.||+|+||.||+|+.+.+|+.||||+++.... .....+.+|++++++++||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-----CCEEEEEEe
Confidence 469999999999999998999999999975421 223567789999999999999999988654 368899999
Q ss_pred ccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccC
Q 047768 784 YMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863 (1009)
Q Consensus 784 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~ 863 (1009)
|+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 999999999997654 389999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhh
Q 047768 864 ASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVM 943 (1009)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1009)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .............
T Consensus 147 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~~~~~~~~~~~- 212 (323)
T cd05571 147 SDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILMEEI- 212 (323)
T ss_pred cCC--------CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcCCC-
Confidence 211 12234579999999999999999999999999999999999999996422 1111111111100
Q ss_pred hccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 047768 944 EIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVV 995 (1009)
Q Consensus 944 ~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~ 995 (1009)
..+ .....++.+++.+|++.||++|| ++.|+++
T Consensus 213 --------~~p-----------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 213 --------RFP-----------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred --------CCC-----------CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 000 11234577999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=331.27 Aligned_cols=271 Identities=23% Similarity=0.313 Sum_probs=198.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|.+.+.||+|+||+||+|..+.+++.||+|+++.... .....+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-----ERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-----CCeE
Confidence 3578999999999999999999998999999999865432 234567899999999999999999998653 3678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||++ |+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 79 ~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~ 149 (288)
T cd07871 79 TLVFEYLD-SDLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGL 149 (288)
T ss_pred EEEEeCCC-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcc
Confidence 99999997 599999876543 378899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++...... .......|++.|+|||++.+ ..++.++||||+||++|||++|+.||....... .........
T Consensus 150 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~ 220 (288)
T cd07871 150 ARAKSVPT--------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLL 220 (288)
T ss_pred eeeccCCC--------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 97543221 11223467899999998865 568999999999999999999999996432111 111111100
Q ss_pred ---ccchhhhccCC-----CCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 ---LPEKVMEIVDP-----SLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ---~~~~~~~~~d~-----~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.++....+.+. ...+.....+... .......+..+++.+|++.||.+|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 221 GTPTEETWPGITSNEEFRSYLFPQYRAQPLIN--HAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CCCChHHhhccccchhhhccccCccCCCchHH--hCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00111111100 0000000000000 00011235679999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=330.77 Aligned_cols=273 Identities=22% Similarity=0.295 Sum_probs=200.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|.+.+.||+|+||+||+|+++.+++.||||+++.... ...+.+.+|++++++++||||+++++++.. .+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-----RGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-----CCEE
Confidence 368899999999999999999998999999999865422 234678899999999999999999988654 3678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||++++.+..+.... . .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~-~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMP-N-----GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGF 146 (287)
T ss_pred EEEEecCCCCHHHHHHhcC-C-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccC
Confidence 9999999987776554332 2 388999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH--
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR-- 936 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~-- 936 (1009)
++....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ........
T Consensus 147 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~ 218 (287)
T cd07848 147 ARNLSEGSN-------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLG 218 (287)
T ss_pred ccccccccc-------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhC
Confidence 987643211 11223568999999999999999999999999999999999999997533211 01111100
Q ss_pred hccchhhhcc--CCCCC----ChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPEKVMEIV--DPSLL----PLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~--d~~l~----~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..+....... ++... +....+.............++.+++.+|++.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 219 PLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0111100000 00000 00000000000000113356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=338.22 Aligned_cols=244 Identities=23% Similarity=0.293 Sum_probs=198.1
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 774 (1009)
..++|...++||+|.||.|++|+.+.+++.+|||+++... .++.+..+.|.+++... +||.+++++.+ ++.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence 3568999999999999999999999999999999997653 34567788899998877 59999999987 455
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
.++.|.||||+.||++..+.+.. .+++..+.-+|..++.||.|||++ +|||||||.+|||+|.+|.+||+
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~~-------~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHTD-------VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEecc-------cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEec
Confidence 68999999999999944333322 299999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+++.--. ......+++||+.|||||++.+..|+.++|-|||||++|||+.|..||.....+
T Consensus 511 DFGlcKe~m~--------~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------- 574 (694)
T KOG0694|consen 511 DFGLCKEGMG--------QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------- 574 (694)
T ss_pred ccccccccCC--------CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------
Confidence 9999985321 224556799999999999999999999999999999999999999999843222
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~ 990 (1009)
+++|..+..++. .+.-...+...++.+.+..+|++|.-+
T Consensus 575 ---------e~FdsI~~d~~~--------yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 ---------EVFDSIVNDEVR--------YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---------HHHHHHhcCCCC--------CCCcccHHHHHHHHHHhccCcccccCC
Confidence 111211111110 011223456788889999999999866
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=337.25 Aligned_cols=200 Identities=26% Similarity=0.385 Sum_probs=174.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|++.++||+|+||.||+|.+..++..||+|+++.... .....+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CEE
Confidence 4689999999999999999999998999999999875432 2245788999999999999999999997653 678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++|+|.+++.... .+++..+..++.+++.|+.|||+.. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred EEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCc
Confidence 99999999999999997654 2788999999999999999999742 799999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
+...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 151 ~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 151 SGQLIDS----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred chhhhhh----------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9755321 11234689999999999998999999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=340.26 Aligned_cols=254 Identities=21% Similarity=0.260 Sum_probs=201.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|+++++.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-----DEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-----CCE
Confidence 36888999999999999999999889999999997542 2234568889999999999999999998654 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++.... .+++.++..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg 146 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG 146 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence 899999999999999997654 388999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.....
T Consensus 147 ~a~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i 210 (333)
T cd05600 147 LSKGIVT-----------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-----NETWENL 210 (333)
T ss_pred CCccccc-----------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-----HHHHHHH
Confidence 9975432 12235689999999999999999999999999999999999999964321 1111100
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.. ....+.. +... ........++.+++.+|+..+|.+||++.|+++.
T Consensus 211 ~~--~~~~~~~---~~~~-------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 211 KY--WKETLQR---PVYD-------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred Hh--ccccccC---CCCC-------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 0000000 0000 0001233457789999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.80 Aligned_cols=251 Identities=31% Similarity=0.509 Sum_probs=191.6
Q ss_pred cCCcccccCCceEEEEEEe----cCCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 705 SSNTIGRGSFGFVYKGVLH----ENGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 705 ~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+.+.||.|.||.||+|.++ ..+..|+||+++..... ..+.+.+|++.+++++||||++++|+|... ...+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc-----cccc
Confidence 3578999999999999998 34678999999653322 357899999999999999999999998732 4589
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+++|+|.+++..... ..+++.++..|+.|+++||+|||++ +++|+||+++||++++++.+||+|||++
T Consensus 78 lv~e~~~~g~L~~~L~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~ 150 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNK----EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLS 150 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCT----TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred cccccccccccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 99999999999999998721 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+........ .......+...|+|||.+.+..++.++||||||+++||+++ |+.||.... ...+.....
T Consensus 151 ~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-----~~~~~~~~~ 219 (259)
T PF07714_consen 151 RPISEKSKY------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-----NEEIIEKLK 219 (259)
T ss_dssp EETTTSSSE------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-----HHHHHHHHH
T ss_pred ccccccccc------ccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccc
Confidence 876322110 11222446789999999999999999999999999999999 788876442 122221110
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
..... .....++..+.+++.+||+.+|++||++.|++++|
T Consensus 220 ~~~~~-------------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 QGQRL-------------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTEET-------------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccc-------------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00000 01112345688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=326.01 Aligned_cols=259 Identities=24% Similarity=0.369 Sum_probs=200.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCe----EEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGM----LVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
++|.+.+.||+|+||+||+|.+..++. .||+|.+..... .....+..|+..+++++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------ 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence 468888999999999999999976665 477777743221 123567788888999999999999998642
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++++||+++|+|.+++..... .+++..+..++.|++.|++|||++ +++||||||+||++++++.+|++|
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~D 152 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIAD 152 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcC
Confidence 346789999999999999986543 389999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 934 (1009)
||+++....... ........++..|+|||++.++.++.++|||||||++||+++ |+.||...... ..
T Consensus 153 fg~~~~~~~~~~------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~- 220 (279)
T cd05111 153 FGVADLLYPDDK------KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-----EV- 220 (279)
T ss_pred CccceeccCCCc------ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HH-
Confidence 999986543211 111223457789999999999999999999999999999998 99998643211 11
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
.+++....... ....+...+.+++.+||..+|+.|||+.|+++.+..+.++
T Consensus 221 --------~~~~~~~~~~~----------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 221 --------PDLLEKGERLA----------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred --------HHHHHCCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 11111100000 0011234567899999999999999999999999887664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.48 Aligned_cols=246 Identities=22% Similarity=0.261 Sum_probs=198.7
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|+++.+++.||||+++... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-----EN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-----CC
Confidence 357889999999999999999999899999999996432 1234568899999999999999999998654 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGR------FPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeec
Confidence 78999999999999999987542 78889999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....
T Consensus 163 g~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~~~~~~ 226 (329)
T PTZ00263 163 GFAKKVPDR-----------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-----PFRIYEK 226 (329)
T ss_pred cCceEcCCC-----------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC-----HHHHHHH
Confidence 999865432 113468999999999999999999999999999999999999996421 1111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME-----MTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt-----~~evl~ 995 (1009)
... ... ..+. ....++.+++.+|++.||.+||+ ++|++.
T Consensus 227 i~~--------~~~-~~p~-----------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 227 ILA--------GRL-KFPN-----------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred Hhc--------CCc-CCCC-----------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111 000 0000 01234679999999999999997 566653
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=323.34 Aligned_cols=256 Identities=25% Similarity=0.439 Sum_probs=204.3
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
.+|.+.+.||+|+||.||+|.++.+++.||+|+++... ...+.+.+|++++++++|+||+++++++... ...++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCC-----CCcEE
Confidence 46788899999999999999999889999999986432 2346788999999999999999999987543 56799
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
||||+++++|.+++..... ..+++..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||+++
T Consensus 80 v~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred EEEeCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 9999999999999976432 2488999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhcc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.... ..+.....
T Consensus 153 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~-- 218 (263)
T cd05052 153 LMTGDTY-------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELL-- 218 (263)
T ss_pred cccccee-------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH--
Confidence 6643211 11112334678999999999999999999999999999998 899986432 11111111
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
....... ....++.++.+++.+|++.+|++||++.|++++|+.+
T Consensus 219 -------~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 219 -------EKGYRME----------RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -------HCCCCCC----------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0000000 0112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.71 Aligned_cols=342 Identities=23% Similarity=0.377 Sum_probs=227.1
Q ss_pred CeEEEEEeecCCcc-cccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEe
Q 047768 70 QRVTKLDLRNQSIG-GILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFS 148 (1009)
Q Consensus 70 ~~v~~l~l~~~~l~-~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 148 (1009)
.-|..+|+++|.++ +..|..+..++++++|.|...++. .+|+.++.|.+|++|.+++|++. .+-.+++.|+.|+.++
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 46888999999998 578889999999999999999998 99999999999999999999998 6777899999999999
Q ss_pred ccccccc-CCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCcc
Q 047768 149 AHRNNLV-GEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNH 227 (1009)
Q Consensus 149 l~~n~l~-~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 227 (1009)
+.+|++. +.||..+| ++..|+.||||+|+++ ..|..+..-+++-+|+||+|+|..+....|.+|+.|-+||||+|+
T Consensus 85 ~R~N~LKnsGiP~diF--~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~Nr 161 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIF--RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNR 161 (1255)
T ss_pred hhccccccCCCCchhc--ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccch
Confidence 9999985 45777775 5888888999999988 778888888888889999998876666677888888888888888
Q ss_pred CCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccc-ccc
Q 047768 228 FSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRG-QVS 306 (1009)
Q Consensus 228 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~ 306 (1009)
+. .+|+.+..|..|++|+|++|.+. ...- ..+..+++|++|++++.+-+- -+|
T Consensus 162 Le-~LPPQ~RRL~~LqtL~Ls~NPL~-hfQL------------------------rQLPsmtsL~vLhms~TqRTl~N~P 215 (1255)
T KOG0444|consen 162 LE-MLPPQIRRLSMLQTLKLSNNPLN-HFQL------------------------RQLPSMTSLSVLHMSNTQRTLDNIP 215 (1255)
T ss_pred hh-hcCHHHHHHhhhhhhhcCCChhh-HHHH------------------------hcCccchhhhhhhcccccchhhcCC
Confidence 87 78888888888888888888765 2111 112234555666665554321 122
Q ss_pred cccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCc
Q 047768 307 INFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPP 386 (1009)
Q Consensus 307 ~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~ 386 (1009)
.++.++.+|..+|||.|.+.. .|+.+.++++|+.|+||+|+|+ .+.-
T Consensus 216 tsld~l~NL~dvDlS~N~Lp~-------vPecly~l~~LrrLNLS~N~it--------------------------eL~~ 262 (1255)
T KOG0444|consen 216 TSLDDLHNLRDVDLSENNLPI-------VPECLYKLRNLRRLNLSGNKIT--------------------------ELNM 262 (1255)
T ss_pred CchhhhhhhhhccccccCCCc-------chHHHhhhhhhheeccCcCcee--------------------------eeec
Confidence 222222222222222222221 1223334444444444444443 2222
Q ss_pred cccCcCccCEEEccCCCCCCCCCCCcCCcccccceeccccccc-CCCCcccccccccccccccCcccccccCCCCCCCCC
Q 047768 387 GIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQ-GTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKN 465 (1009)
Q Consensus 387 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 465 (1009)
......+|+.|+||.|+++ .+|.+++++++|+.|++.+|+++ .-+|+.++.|..|+.+..++|.+. .+|++++.|..
T Consensus 263 ~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~k 340 (1255)
T KOG0444|consen 263 TEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVK 340 (1255)
T ss_pred cHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHH
Confidence 2233344555555555555 55555555555555555555554 234555555555555555555555 45555555555
Q ss_pred ccccccCCCCcc
Q 047768 466 LMFFFAPRNKLT 477 (1009)
Q Consensus 466 L~~l~l~~N~l~ 477 (1009)
|+.|.++.|++.
T Consensus 341 L~kL~L~~NrLi 352 (1255)
T KOG0444|consen 341 LQKLKLDHNRLI 352 (1255)
T ss_pred HHHhccccccee
Confidence 554444444443
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=310.01 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=208.8
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALV 781 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 781 (1009)
-|.++.+||+|+||.||+|.++++|+.||||.+..+ .+-.++.+|+.+|++++.|+||+++|.+.. ....++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-----~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFK-----HSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhcc-----CCceEee
Confidence 467788999999999999999999999999988543 346788999999999999999999997543 3678999
Q ss_pred EeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccc
Q 047768 782 YEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861 (1009)
Q Consensus 782 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~ 861 (1009)
||||..|+..+.++.+.. ++++.++..++++.++||+|||.. .-||||||+.|||++.+|.+|++|||.|..
T Consensus 107 MEYCGAGSiSDI~R~R~K-----~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRK-----PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred hhhcCCCcHHHHHHHhcC-----CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccch
Confidence 999999999999987765 499999999999999999999998 889999999999999999999999999987
Q ss_pred cCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccch
Q 047768 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEK 941 (1009)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
+.+ +......+.||+.|||||+++.-.|..++||||+|+...||..|++||.....
T Consensus 179 LTD--------TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---------------- 234 (502)
T KOG0574|consen 179 LTD--------TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP---------------- 234 (502)
T ss_pred hhh--------hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc----------------
Confidence 653 33556678999999999999999999999999999999999999999974321
Q ss_pred hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 942 VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 942 ~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
++.++---.. +...--.+++|..++-++++.|+-..|++|-|+-++++.
T Consensus 235 MRAIFMIPT~------PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 235 MRAIFMIPTK------PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred cceeEeccCC------CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1111100000 011112334677889999999999999999999988764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=327.00 Aligned_cols=261 Identities=27% Similarity=0.463 Sum_probs=204.7
Q ss_pred ccCccCCcccccCCceEEEEEEecCC-----eEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENG-----MLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
++|++.+.||+|+||.||+|.....+ ..||+|.++.... .....+.+|++++++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---- 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE---- 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC----
Confidence 46888999999999999999986544 6899999864432 2235688999999999999999999987543
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCC----------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCcee
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQL----------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVL 844 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nil 844 (1009)
...+++|||+++|+|.+++....... ....+++.++..++.|++.|++|||+. +++||||||+||+
T Consensus 81 -~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil 156 (283)
T cd05048 81 -QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL 156 (283)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence 56899999999999999997653211 013488899999999999999999999 9999999999999
Q ss_pred eCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCccc
Q 047768 845 LDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESM 923 (1009)
Q Consensus 845 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~ 923 (1009)
+++++.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYY------RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred EcCCCcEEECCCcceeeccccccc------cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999865432211 11123456789999999999999999999999999999998 99998743
Q ss_pred ccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 924 FNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
... +.... +....... .+..++.++.+++.+||+.||++||+++||++.|++
T Consensus 231 ~~~-----~~~~~--------i~~~~~~~-----------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 231 SNQ-----EVIEM--------IRSRQLLP-----------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CHH-----HHHHH--------HHcCCcCC-----------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 221 11110 00000000 112445678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=333.66 Aligned_cols=238 Identities=24% Similarity=0.307 Sum_probs=190.0
Q ss_pred ccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEecc
Q 047768 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYM 785 (1009)
Q Consensus 709 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 785 (1009)
||+|+||.||+|.+..+++.||+|+++... ......+.+|++++++++||||+++++++.. ....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-----PEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-----CCeEEEEEcCC
Confidence 699999999999999899999999986432 2234567889999999999999999988654 36789999999
Q ss_pred CCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCC
Q 047768 786 QNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865 (1009)
Q Consensus 786 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 865 (1009)
++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 76 ~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 76 NGGELFHHLQREG------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 9999999997654 288999999999999999999999 9999999999999999999999999999754321
Q ss_pred CCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhc
Q 047768 866 PLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEI 945 (1009)
Q Consensus 866 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1009)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+.........
T Consensus 147 ~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~~---- 209 (312)
T cd05585 147 D--------DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQEP---- 209 (312)
T ss_pred C--------CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcCC----
Confidence 1 12234568999999999999999999999999999999999999996421 222222111110
Q ss_pred cCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 047768 946 VDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDV 993 (1009)
Q Consensus 946 ~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~ev 993 (1009)
.. . +.....++.+++.+|++.||++||++.++
T Consensus 210 ----~~-~-----------~~~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 210 ----LR-F-----------PDGFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred ----CC-C-----------CCcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 00 0 01123457799999999999999864333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=326.09 Aligned_cols=271 Identities=24% Similarity=0.316 Sum_probs=204.0
Q ss_pred CccCCcccccCCceEEEEEE----ecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 703 FSSSNTIGRGSFGFVYKGVL----HENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
|.+.+.||+|+||+||.+.. ..++..||+|+++.... ...+.+.+|++++++++||||+++++++... ....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CCce
Confidence 37889999999999988764 34678999999865432 2346788999999999999999999987542 3356
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++++|.+++.... +++.++..++.|++.|+.|||++ +|+||||||+||++++++.+|++|||
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~-------l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHK-------LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence 789999999999999997643 89999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH-H
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK-R 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~ 936 (1009)
+++......... .......++..|+|||.+.+..++.++||||||+++|||+||+.||............... .
T Consensus 153 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05080 153 LAKAVPEGHEYY-----RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQ 227 (283)
T ss_pred cccccCCcchhh-----ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccc
Confidence 998665322100 0111233567799999999889999999999999999999999998643221100000000 0
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
.....+.+.++.... ...+..++.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 228 MTVVRLIELLERGMR----------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cchhhhhhhhhcCCC----------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000011111111110 0111234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.61 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=198.8
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
++|++.+.||+|+||.||+|.++ ++..+|+|.++... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-----KPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccC-----CCEEE
Confidence 56888899999999999999886 56689999876332 2356788999999999999999999987543 56899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
||||+++|+|.++++.... .+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.++
T Consensus 77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcc
Confidence 9999999999999976543 388999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhcc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.......
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~~~~~~i~~ 216 (256)
T cd05114 149 YVLDDEY-------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----YEVVEMISR 216 (256)
T ss_pred ccCCCce-------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHC
Confidence 6543211 11122345678999999998899999999999999999999 8999864321 111111100
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
. .....+ .....++.+++.+||+.+|++||+++|+++.|
T Consensus 217 ~--------~~~~~~-----------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 217 G--------FRLYRP-----------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred C--------CCCCCC-----------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0 000000 01224678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=333.42 Aligned_cols=242 Identities=22% Similarity=0.270 Sum_probs=193.1
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEe
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYE 783 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 783 (1009)
+.||+|+||.||+|+.+.+|+.||+|+++.... .....+.+|++++++++||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCEEEEEEe
Confidence 469999999999999998999999999975422 223567789999999999999999988654 367899999
Q ss_pred ccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccC
Q 047768 784 YMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863 (1009)
Q Consensus 784 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~ 863 (1009)
|+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 76 YANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 999999999887654 388999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhh
Q 047768 864 ASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVM 943 (1009)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1009)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 147 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~~~~~~-- 211 (323)
T cd05595 147 SDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILMEE-- 211 (323)
T ss_pred CCC--------CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCC--
Confidence 211 112235689999999999999999999999999999999999999964321 11111111110
Q ss_pred hccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 047768 944 EIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVV 995 (1009)
Q Consensus 944 ~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~ 995 (1009)
. ..+ .....++.+++.+|++.||++|| ++.++++
T Consensus 212 ------~-~~p-----------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 212 ------I-RFP-----------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ------C-CCC-----------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 0 000 01234567999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=361.15 Aligned_cols=485 Identities=26% Similarity=0.348 Sum_probs=367.3
Q ss_pred eeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecC
Q 047768 98 YINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGD 177 (1009)
Q Consensus 98 ~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~ 177 (1009)
.+|++..++. .||..+..-..|+.|++++|.+-...-+...+.-+|+.||+++|.++ ..|..+ ..+..|+.|.++.
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~i--t~l~~L~~ln~s~ 77 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQI--TLLSHLRQLNLSR 77 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchh--hhHHHHhhcccch
Confidence 3567777777 78887776666888888888776333334455666888899888875 777776 4577888889998
Q ss_pred ccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCC
Q 047768 178 NQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLP 257 (1009)
Q Consensus 178 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip 257 (1009)
|.|. ..|.+.+++.+|++|.|.+|++ ...|..+..+.+|++|+++.|++. .+|..+..++.++.+..++|.....++
T Consensus 78 n~i~-~vp~s~~~~~~l~~lnL~~n~l-~~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg 154 (1081)
T KOG0618|consen 78 NYIR-SVPSSCSNMRNLQYLNLKNNRL-QSLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLG 154 (1081)
T ss_pred hhHh-hCchhhhhhhcchhheeccchh-hcCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhc
Confidence 8888 6778888888899999988888 478888888889999999998887 888888888888888888883221232
Q ss_pred hhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCCCCCCCcchhh
Q 047768 258 IEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVD 337 (1009)
Q Consensus 258 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 337 (1009)
. ..++.++|..|.+.+.++..+..++. .|||.+|.+. ......+.+|+.|....|.+..+..
T Consensus 155 ~------~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~~------- 216 (1081)
T KOG0618|consen 155 Q------TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELEI------- 216 (1081)
T ss_pred c------ccchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEEe-------
Confidence 2 22778888888888888888877776 7888888887 2345567778888888888876443
Q ss_pred hcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCccc
Q 047768 338 LLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKN 417 (1009)
Q Consensus 338 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 417 (1009)
..++|+.|+.++|.++...+... +.+|+++++++|+++ .+|+++..+.+|+.|+..+|+|+ .+|..+....+
T Consensus 217 ---~g~~l~~L~a~~n~l~~~~~~p~---p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~ 288 (1081)
T KOG0618|consen 217 ---SGPSLTALYADHNPLTTLDVHPV---PLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITS 288 (1081)
T ss_pred ---cCcchheeeeccCcceeeccccc---cccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhh
Confidence 23688888888888884333322 346888889999888 55688888889999999999886 78888888888
Q ss_pred ccceecccccccCCCCcccccccccccccccCcccccccCCC-CCCCCC-ccccccCCCCccCCCchhhhhhccceeeEe
Q 047768 418 LQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFS-LGNCKN-LMFFFAPRNKLTGALPQQILEITTLSLSLD 495 (1009)
Q Consensus 418 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~-L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~ 495 (1009)
|+.|+..+|.+. .+|.....++.|++|+|..|+|. ..|.. +.-... |..+..+.|++. ..|..-......+..|.
T Consensus 289 L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~Ly 365 (1081)
T KOG0618|consen 289 LVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELY 365 (1081)
T ss_pred HHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHH
Confidence 888999899888 67777778888889999999888 45543 333333 677778888877 34422222222333588
Q ss_pred cCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCccccc
Q 047768 496 LSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSG 575 (1009)
Q Consensus 496 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 575 (1009)
+.+|.|+...-..+.+.+.|+.|+|++|+|.......+.++..|+.|+||+|+|+ .+|..+.++..|++|...+|+|.
T Consensus 366 lanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~- 443 (1081)
T KOG0618|consen 366 LANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL- 443 (1081)
T ss_pred HhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-
Confidence 8888888777667888888899999999887544556788888889999999988 78888888888999998888887
Q ss_pred ccccccccccccCceecccccCcc-cCCCCCcccCccccccccCCCc
Q 047768 576 QIPKYLENLSFLQYLNLSYNHFEG-EVPTKGIFKNKTGFSIVGNGKL 621 (1009)
Q Consensus 576 ~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~~~~~~~~~~~n~~l 621 (1009)
..| ++..+++|+.+|||.|+|+- .+|......++.-+.+.||.++
T Consensus 444 ~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 444 SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 677 78888889999999888863 3444333345566677788763
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=335.80 Aligned_cols=247 Identities=21% Similarity=0.250 Sum_probs=197.7
Q ss_pred hccCccCCcccccCCceEEEEEEecCC-eEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENG-MLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|.+.+.||+|+||.||+|+++.++ ..||+|++.... ....+.+.+|+++++.++||||+++++++...
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~----- 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE----- 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-----
Confidence 457899999999999999999977554 689999986432 22345688899999999999999999987543
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++|+|.+++..... +++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKR------FPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEec
Confidence 678999999999999999987543 88999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 175 FG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~ 238 (340)
T PTZ00426 175 FGFAKVVDTR-----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-----LLIYQ 238 (340)
T ss_pred CCCCeecCCC-----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-----HHHHH
Confidence 9999865321 1235689999999999998999999999999999999999999974321 11111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVVK 996 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~~ 996 (1009)
.. ..... ..+ ......+.+++.+|++.||++|+ +++|+++.
T Consensus 239 ~i--------~~~~~-~~p-----------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 239 KI--------LEGII-YFP-----------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HH--------hcCCC-CCC-----------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11 11000 000 01123467899999999999995 78887653
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=296.74 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=202.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccc--------hHHHHHHHHHHHhc-CCCCcceEEeeeecc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG--------SKSFAAECEALRSI-RHRNLIKIVTICSSI 770 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 770 (1009)
...|...+.+|+|..++|.++.++.+|+.+|+|++....... .+.-.+|+.+++++ .||+|+.+.+++.
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye-- 93 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE-- 93 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc--
Confidence 345666788999999999999999999999999996443211 13456799999998 7999999999854
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV 850 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 850 (1009)
...+.++|+|.|+.|.|.||+.+.- .+++++..+|++|+..|++|||.+ .||||||||+|||++++.+
T Consensus 94 ---s~sF~FlVFdl~prGELFDyLts~V------tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~ 161 (411)
T KOG0599|consen 94 ---SDAFVFLVFDLMPRGELFDYLTSKV------TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMN 161 (411)
T ss_pred ---CcchhhhhhhhcccchHHHHhhhhe------eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccc
Confidence 4478899999999999999998754 499999999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCC------CCCCCcccchHHHHHHHHHHhCCCCCcccc
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG------GEASMRGGVYSYGILLLEIFTRRRPTESMF 924 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~Gvvl~elltg~~p~~~~~ 924 (1009)
+||+|||+|+.+.++ ......+||++|.|||.+.- ..|+...|+||+||++|-++.|++||+.-.
T Consensus 162 i~isDFGFa~~l~~G---------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk 232 (411)
T KOG0599|consen 162 IKISDFGFACQLEPG---------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK 232 (411)
T ss_pred eEEeccceeeccCCc---------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH
Confidence 999999999988764 34456899999999997643 357889999999999999999999997421
Q ss_pred cCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 925 NEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
+ -.....+-+.-.++-++.+. +......+++.+|++.||..|.|++|+++.
T Consensus 233 Q------mlMLR~ImeGkyqF~speWa---------------dis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 233 Q------MLMLRMIMEGKYQFRSPEWA---------------DISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred H------HHHHHHHHhcccccCCcchh---------------hccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 0 00111111222222222221 222356789999999999999999999863
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=326.20 Aligned_cols=254 Identities=23% Similarity=0.320 Sum_probs=211.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccc--hHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG--SKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|...+.+|+|+||.++.++++.+++.||+|.+....... .+....|+.++++++|||||.+.+.+.. ++..
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~----~~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE----DGQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc----CCce
Confidence 357888999999999999999999999999999997664332 3467889999999999999999987533 3445
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||+|++||++.+.+.+.+. ..++++++..|+.|++.|+.|||++ .|+|||||+.||+++.++.||++|||
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~----~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKG----VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchh
Confidence 8999999999999999988763 3599999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+|+.+.... .......||+.||.||.+.+.+|..|+||||+||++|||++-+++|.... +...+.+.
T Consensus 152 laK~l~~~~--------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-----m~~Li~ki 218 (426)
T KOG0589|consen 152 LAKILNPED--------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-----MSELILKI 218 (426)
T ss_pred hhhhcCCch--------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-----hHHHHHHH
Confidence 999887542 23345789999999999999999999999999999999999999997432 22222222
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
......+. +..+..++..++..|++.+|..||++.+++.+
T Consensus 219 --------~~~~~~Pl-----------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 219 --------NRGLYSPL-----------PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --------hhccCCCC-----------CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11112221 22344568899999999999999999999987
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=332.24 Aligned_cols=243 Identities=23% Similarity=0.287 Sum_probs=194.0
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEe
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYE 783 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 783 (1009)
+.||+|+||.||+|+.+.+++.||||+++... ......+.+|+++++.++||||+++.+++.. .+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-----KDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCEEEEEEe
Confidence 46999999999999999899999999997442 2234567889999999999999999988654 367899999
Q ss_pred ccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccC
Q 047768 784 YMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863 (1009)
Q Consensus 784 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~ 863 (1009)
|+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 y~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 76 YVNGGELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 999999999987654 389999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhh
Q 047768 864 ASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVM 943 (1009)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1009)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+..........
T Consensus 147 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-----~~~~~~~~~~~~~- 212 (328)
T cd05593 147 TDA--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILMEDI- 212 (328)
T ss_pred Ccc--------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-----HHHHHHHhccCCc-
Confidence 211 11223568999999999999999999999999999999999999996422 1111111111000
Q ss_pred hccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 047768 944 EIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVVK 996 (1009)
Q Consensus 944 ~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~~ 996 (1009)
..+ .....++.+++.+|++.||++|| ++.|+++.
T Consensus 213 --------~~p-----------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 --------KFP-----------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --------cCC-----------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 000 01223567899999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=333.31 Aligned_cols=267 Identities=23% Similarity=0.339 Sum_probs=204.3
Q ss_pred hccCccCCcccccCCceEEEEEEec-----CCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeecccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHE-----NGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 772 (1009)
.++|.+.+.||+|+||.||+|.+.. +++.||+|+++.... ...+.+.+|+++++++ +|+||++++++|...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC--
Confidence 4579999999999999999997543 357899999864322 2235677899999999 899999999987542
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCC---------------------------------------------------
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQL--------------------------------------------------- 801 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 801 (1009)
....++++||+++++|.+++.......
T Consensus 84 --~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 84 --GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred --CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 356789999999999999986532110
Q ss_pred ----CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCcc
Q 047768 802 ----GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877 (1009)
Q Consensus 802 ----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~ 877 (1009)
....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.+...... ...
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~------~~~ 232 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------VRK 232 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcch------hhc
Confidence 012589999999999999999999999 9999999999999999999999999999876432110 111
Q ss_pred ccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhh
Q 047768 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEE 956 (1009)
Q Consensus 878 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 956 (1009)
....++..|+|||++.+..++.++|||||||++|||++ |+.||....... ...... ...... ..
T Consensus 233 ~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~----~~~~~~-------~~--- 297 (337)
T cd05054 233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRL----KEGTRM-------RA--- 297 (337)
T ss_pred cCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHH----hccCCC-------CC---
Confidence 12346778999999999999999999999999999998 999986422111 111110 000000 00
Q ss_pred hhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 047768 957 RTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQ 1002 (1009)
Q Consensus 957 r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~ 1002 (1009)
...+..++.+++.+||+.+|++||++.|+++.|+.+.+
T Consensus 298 --------~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 298 --------PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred --------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 01223467899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=337.58 Aligned_cols=266 Identities=22% Similarity=0.241 Sum_probs=198.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
..+|.+.+.||+|+||.||+|.+..+++.||+|+.. ...+.+|++++++++||||+++++++.. ....+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY-----NKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeE
Confidence 357999999999999999999999999999999753 2456889999999999999999998654 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+|++. ++|.+++.... .+++.+++.++.|++.||+|||++ +||||||||+||+++.++.+||+|||+|
T Consensus 160 lv~e~~~-~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a 229 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229 (391)
T ss_pred EEEecCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence 9999994 79999887654 288999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCC------ccHHHH
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEG------LTLHEF 933 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~------~~~~~~ 933 (1009)
+...... ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ..+...
T Consensus 230 ~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i 302 (391)
T PHA03212 230 CFPVDIN-------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI 302 (391)
T ss_pred ccccccc-------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHH
Confidence 7543211 112234679999999999999999999999999999999999998875322110 111111
Q ss_pred HHHhc--cch--------hhhcc---CCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 934 AKRAL--PEK--------VMEIV---DPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 934 ~~~~~--~~~--------~~~~~---d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..... +.+ +.... .......+..++.. ....+.+.++.+++.+|++.||++|||+.|+++
T Consensus 303 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 303 IRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLW--TNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCH--HHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 11110 000 00000 00000001111100 001123457889999999999999999999985
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=326.42 Aligned_cols=272 Identities=24% Similarity=0.361 Sum_probs=204.2
Q ss_pred ccCccCCcccccCCceEEEEEEe----cCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLH----ENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.+|.+.+.||+|+||.||+|..+ .++..||+|+++.......+.+.+|++++++++||||+++++++... +..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence 47888899999999999999853 46789999998755444456789999999999999999999987532 335
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++|+||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~df 152 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRE-----RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDF 152 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCC
Confidence 67999999999999999976543 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++......... .......++..|+|||+..+..++.++|||||||++|||++|..|+...... ..+....
T Consensus 153 g~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~ 224 (284)
T cd05081 153 GLTKVLPQDKEYY-----KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGN 224 (284)
T ss_pred cccccccCCCcce-----eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhccc
Confidence 9998765422100 0011122445699999999889999999999999999999988775432111 0000000
Q ss_pred hcc-----chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 937 ALP-----EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 937 ~~~-----~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
... ..+.+.+..... ......++.++.+++.+||+.+|++||||.||++.|+.++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 225 DKQGQMIVYHLIELLKNNGR----------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred ccccccchHHHHHHHhcCCc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 000 001111111000 0111234456889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=318.51 Aligned_cols=265 Identities=25% Similarity=0.378 Sum_probs=203.8
Q ss_pred CccCCcccccCCceEEEEEEecC---CeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeecccc-CCCc
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHEN---GMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDF-KGVD 776 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 776 (1009)
|.+.+.||+|+||.||+|....+ +..||||+++..... ....+.+|++.++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999998643 378999998754322 23578899999999999999999998765432 2334
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++|+||+++|+|.+++...........+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 5799999999999999986543222233589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 158 g~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-----~~~~~ 226 (273)
T cd05035 158 GLSKKIYSGDYY------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-----HEIYD 226 (273)
T ss_pred cceeeccccccc------cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence 999876543211 11112335678999999998999999999999999999999 8888864321 11111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
.. .+...... +..+..++.+++.+|++.||++||++.|+++.|+.+
T Consensus 227 ~~--------~~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 YL--------RHGNRLKQ-----------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HH--------HcCCCCCC-----------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 01000000 112345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=335.34 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=191.2
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
++|+..+.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++|+||+++++++.. ....+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-----NGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-----CCeEE
Confidence 456677899999999999999998999999999864332 224578899999999999999999998644 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++|+|.+.. ..++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 149 lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~ 215 (353)
T PLN00034 149 VLLEFMDGGSLEGTH----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVS 215 (353)
T ss_pred EEEecCCCCcccccc----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccc
Confidence 999999999986431 256777889999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCC-----CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-----GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
+...... .......||..|+|||++.. ...+.++|||||||++|||++|+.||...... ......
T Consensus 216 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~ 285 (353)
T PLN00034 216 RILAQTM--------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLM 285 (353)
T ss_pred eeccccc--------ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHH
Confidence 8664321 11223568999999998743 23456899999999999999999999732211 111111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
....... . ......+..++.+++.+||+.||++||++.|+++.
T Consensus 286 ~~~~~~~-----~--------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 286 CAICMSQ-----P--------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHhccC-----C--------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1000000 0 00011233467899999999999999999999864
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.93 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=201.9
Q ss_pred cccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEeccCC
Q 047768 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQN 787 (1009)
Q Consensus 708 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~ 787 (1009)
+||+|.||+||.|++..+...+|||.+..........+..||..-++++|.|||+++|.|.. .++.-+.||.++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-----nGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-----NGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-----CCeEEEEeecCCC
Confidence 69999999999999999999999999976666667789999999999999999999999654 3678899999999
Q ss_pred CCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC-CCCceEEeccccccccCCCC
Q 047768 788 GSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLSASP 866 (1009)
Q Consensus 788 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~DfGla~~~~~~~ 866 (1009)
|||.+.++..... ..-.+.++-.+.+||++||.|||+. .|||||||-+||||+ -.|.+||+|||-++.+..-
T Consensus 657 GSLSsLLrskWGP---lKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi- 729 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGP---LKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI- 729 (1226)
T ss_pred CcHHHHHHhccCC---CccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-
Confidence 9999999876542 2236778889999999999999999 999999999999995 5799999999999876532
Q ss_pred CCCccccCCccccccccccccCccccCCC--CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhh
Q 047768 867 LGNVVETPSSSIGVKGTIGYVAPEYGLGG--EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVME 944 (1009)
Q Consensus 867 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1009)
......+.||..|||||++..+ .|+.++|||||||++.||.||++||..+......+-+.
T Consensus 730 -------nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV----------- 791 (1226)
T KOG4279|consen 730 -------NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV----------- 791 (1226)
T ss_pred -------CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-----------
Confidence 1334457899999999998876 57899999999999999999999997654332111111
Q ss_pred ccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 945 IVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 945 ~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.+.+..| ..+.+...+...++.+|..+||.+||+|.++++
T Consensus 792 ---GmyKvHP--------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 792 ---GMYKVHP--------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ---cceecCC--------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1111111 223345556788999999999999999999874
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.39 Aligned_cols=261 Identities=23% Similarity=0.384 Sum_probs=205.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCe----EEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGM----LVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
.++|++.++||+|+||+||+|++..+++ .||+|+++..... ....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 4578889999999999999999876665 4899998644322 34578899999999999999999998753
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
...++++||+++|+|.++++.... .+++.++..++.|++.|++|||+. +|+||||||+||++++++.+||+
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~ 151 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKIT 151 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEEC
Confidence 346799999999999999987543 389999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 933 (1009)
|||+++........ .......++..|+|||...+..++.++|||||||++|||++ |..||...... ....+
T Consensus 152 dfG~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~ 223 (279)
T cd05109 152 DFGLARLLDIDETE------YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDL 223 (279)
T ss_pred CCCceeecccccce------eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH
Confidence 99999876532110 11112335678999999999999999999999999999998 88998643211 11111
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
. ....... ....+...+.+++.+||+.||+.||++.|+++.++.+.++.
T Consensus 224 ~------------~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 224 L------------EKGERLP----------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred H------------HCCCcCC----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1 1100000 01123446789999999999999999999999999887665
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=319.55 Aligned_cols=262 Identities=22% Similarity=0.317 Sum_probs=206.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||.||+|+++.+++.||||.++.... .....+.+|++++++++|||++++++++... ..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence 578899999999999999999998999999998864322 2235688999999999999999999986543 67
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++|+||+++|+|.+++...... ...+++..+..++.|++.|++|||++ +++||||||+||+++.++.++++|||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g 151 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence 89999999999999988643221 12478899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++....... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ....+....
T Consensus 152 ~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~ 220 (267)
T cd08228 152 LGRFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQKI 220 (267)
T ss_pred cceeccchh--------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHHH
Confidence 998654321 111234578899999999988899999999999999999999999853221 111111110
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
... ...+. ........+.+++.+||+.+|++||++.||++.+++++
T Consensus 221 -----~~~---~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 221 -----EQC---DYPPL----------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -----hcC---CCCCC----------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 000 00000 01123456889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=337.43 Aligned_cols=266 Identities=24% Similarity=0.346 Sum_probs=204.6
Q ss_pred HhccCccCCcccccCCceEEEEEEec-----CCeEEEEEEeeccccc-chHHHHHHHHHHHhcC-CCCcceEEeeeeccc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHE-----NGMLVAVKVINLEQKG-GSKSFAAECEALRSIR-HRNLIKIVTICSSID 771 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 771 (1009)
..++|.+.+.||+|+||.||+|++.. .+..||||+++..... ..+.+.+|+++++++. ||||++++++|...
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~- 113 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS- 113 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-
Confidence 35688899999999999999998742 2357999999644322 2457889999999996 99999999997543
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCCC--------------------------------------------------
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQL-------------------------------------------------- 801 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------------- 801 (1009)
...++||||+++|+|.+++.......
T Consensus 114 ----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 114 ----GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred ----CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 67899999999999999987542100
Q ss_pred ----------------------------------------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 047768 802 ----------------------------------------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPS 841 (1009)
Q Consensus 802 ----------------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~ 841 (1009)
....+++.++..++.|++.|++|||+. +|+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChH
Confidence 012478888999999999999999998 9999999999
Q ss_pred ceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCC
Q 047768 842 NVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPT 920 (1009)
Q Consensus 842 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~ 920 (1009)
||+++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~ 340 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNY------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY 340 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccc------cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999865432110 11122346788999999999999999999999999999997 99998
Q ss_pred cccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 921 ESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
.......... .. .... ... .....++.++.+++.+||+.||++||++.+|.+.|+++
T Consensus 341 ~~~~~~~~~~-~~----~~~~--------~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 341 PGMIVDSTFY-NK----IKSG--------YRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred cccchhHHHH-HH----HhcC--------CCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 7542211100 00 0000 000 00113445688999999999999999999999999876
Q ss_pred H
Q 047768 1001 R 1001 (1009)
Q Consensus 1001 ~ 1001 (1009)
.
T Consensus 398 ~ 398 (400)
T cd05105 398 L 398 (400)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=319.38 Aligned_cols=258 Identities=27% Similarity=0.427 Sum_probs=203.9
Q ss_pred hccCccCCcccccCCceEEEEEEecC---CeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHEN---GMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|++.+.||+|+||+||+|.++.. ...||||+++.... .....+.+|+.++++++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-----S 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----C
Confidence 35788999999999999999998643 45899999864432 234578899999999999999999998654 3
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++++|.+++..... .+++.++..++.|++.|++|||+. +|+||||||+||++++++.+|++|
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~d 149 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSD 149 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECc
Confidence 668999999999999999987543 389999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 934 (1009)
||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||...... +..
T Consensus 150 fg~~~~~~~~~~------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-----~~~ 218 (266)
T cd05033 150 FGLSRRLEDSEA------TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-----DVI 218 (266)
T ss_pred cchhhccccccc------ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-----HHH
Confidence 999987752111 011112345678999999999999999999999999999998 99998643211 111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
... .+....+. ...++..+.+++.+|++.+|++||++.|+++.|+++
T Consensus 219 ~~~--------~~~~~~~~-----------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 219 KAV--------EDGYRLPP-----------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHH--------HcCCCCCC-----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 00000000 112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=330.54 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=204.3
Q ss_pred ccCCcccccCCceEEEEEEecC-C--eEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 704 SSSNTIGRGSFGFVYKGVLHEN-G--MLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 704 ~~~~~lg~G~~g~V~~~~~~~~-~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
...+.||+|.||+|++|.|+.. | ..||||.++..... .-+.|.+|+.+|.+++|+|+++++|+... ....
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~m 186 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPAM 186 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chhh
Confidence 3457899999999999999732 2 46999999765543 45789999999999999999999999654 4578
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+|.++.|||.+.|++... ..+-......++.|||.||.||.++ ++|||||.++|+++-....|||+|||+.
T Consensus 187 MV~ELaplGSLldrLrka~~----~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLm 259 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKK----AILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLM 259 (1039)
T ss_pred HHhhhcccchHHHHHhhccc----cceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccce
Confidence 99999999999999998322 2488888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
|-+........+.. ...-...|+|||.+....|+-++|||+|||++|||+| |+.||-... ...+
T Consensus 260 RaLg~ned~Yvm~p-----~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-----g~qI----- 324 (1039)
T KOG0199|consen 260 RALGENEDMYVMAP-----QRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-----GIQI----- 324 (1039)
T ss_pred eccCCCCcceEecC-----CCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----HHHH-----
Confidence 98876543222211 1334678999999999999999999999999999999 888986421 1121
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
.+.+|.. ....++..|.+++++++++||...|++|||+..+.+.+-
T Consensus 325 ----L~~iD~~----------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 325 ----LKNIDAG----------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ----HHhcccc----------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 1222200 112234478899999999999999999999999986543
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=324.45 Aligned_cols=273 Identities=22% Similarity=0.306 Sum_probs=199.9
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhc---CCCCcceEEeeeeccccCCCc
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSI---RHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~ 776 (1009)
+|++.+.||+|+||+||+|+++.+++.||+|.++.... .....+.+|+++++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47888999999999999999999999999999865432 2234566788877765 699999999987654444456
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++|+||+. ++|.+++..... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence 7899999997 589998876442 2389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++..... .......||..|+|||++.+..++.++||||+||++|||++|+.||...... ....+....
T Consensus 153 g~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~ 222 (288)
T cd07863 153 GLARIYSCQ---------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDL 222 (288)
T ss_pred CccccccCc---------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHH
Confidence 999865432 1112346789999999999999999999999999999999999998643221 111111111
Q ss_pred hc-c--chhhhcc---CCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 AL-P--EKVMEIV---DPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~-~--~~~~~~~---d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. + ....... ........ .+. ......+...++.+++.+|++.||++|||+.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 223 IGLPPEDDWPRDVTLPRGAFSPRG-PRP--VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCCCChhhCcccccccccccCCCC-CCc--hHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 10 0 0000000 00000000 000 00001123356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=321.91 Aligned_cols=265 Identities=24% Similarity=0.407 Sum_probs=206.6
Q ss_pred ccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
++|.+.+.||+|+||.||++... .++..||+|.++.......+.+.+|++++++++|||++++++++...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG----- 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----
Confidence 57888999999999999999853 34567999998654444456789999999999999999999997643
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCC-------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQ-------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD 848 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 848 (1009)
...++|+||+++++|.+++...... .....+++.+++.++.|++.|++|||++ +++||||||+||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 6789999999999999999754321 1122489999999999999999999998 99999999999999999
Q ss_pred CceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCC
Q 047768 849 MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEG 927 (1009)
Q Consensus 849 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~ 927 (1009)
+.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 157 ~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-- 228 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDY------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-- 228 (288)
T ss_pred CcEEeccCCccccccCCce------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999986543211 011112345788999999999999999999999999999999 8999864321
Q ss_pred ccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 928 LTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
........... ....+ ..+..++.+++.+|++.+|.+|||+.|+.+.|+.+.+.
T Consensus 229 ---~~~~~~i~~~~--------~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 229 ---NEVIECITQGR--------VLQRP-----------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ---HHHHHHHHcCC--------cCCCC-----------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11111110100 00000 01234588999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=346.30 Aligned_cols=254 Identities=20% Similarity=0.225 Sum_probs=201.6
Q ss_pred cCccCCcccccCCceEEEEEEecC-CeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHEN-GMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
.|.+.+.||+|+||.||+|....+ +..||+|.+..........+.+|+++++.++||||+++++++... +..++
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----DKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CEEEE
Confidence 488899999999999999998766 788999987555444456788899999999999999999987643 68899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
||||+++|+|.++++..... ..++++.++..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 143 v~E~~~gg~L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKE--HLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred EEECCCCCCHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 99999999999988653211 12488999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........
T Consensus 218 ~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----~~~~~~~~~~~ 286 (478)
T PTZ00267 218 QYSDSVS------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----QREIMQQVLYG 286 (478)
T ss_pred ecCCccc------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhC
Confidence 7643211 112234569999999999999999999999999999999999999986421 11111111110
Q ss_pred hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 941 ~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...+.+ ..+..++.+++.+|++.||+.||++.+++.
T Consensus 287 --------~~~~~~-----------~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 287 --------KYDPFP-----------CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --------CCCCCC-----------ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 000000 112345789999999999999999999875
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=319.07 Aligned_cols=265 Identities=23% Similarity=0.365 Sum_probs=201.1
Q ss_pred CccCCcccccCCceEEEEEEecCCe--EEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeecccc-CCCce
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGM--LVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDF-KGVDF 777 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~ 777 (1009)
|.+.+.||+|+||.||+|++..++. .||+|.++... ....+.+.+|++++++++|+||++++++|..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999876654 69999886542 2234678899999999999999999998754311 22345
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++|+||+++|+|.+++...........+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 789999999999999885433222223489999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+++........ .......+++.|+|||+..+..++.++||||||+++|||++ |+.||..... .+....
T Consensus 158 ~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~~ 226 (272)
T cd05075 158 LSKKIYNGDYY------RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----SEIYDY 226 (272)
T ss_pred cccccCcccce------ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Confidence 99876543210 01112345678999999999999999999999999999999 7888864221 111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
..... .... ...+...+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 227 ~~~~~--------~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 227 LRQGN--------RLKQ-----------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHcCC--------CCCC-----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 10000 0000 012334578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=322.00 Aligned_cols=256 Identities=29% Similarity=0.488 Sum_probs=206.5
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
...+|++.+.||+|+||.||+|.++. +..||+|+++.........+.+|+++++.++|+||+++++++... ...
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 77 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-----EPV 77 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC-----CCe
Confidence 34578899999999999999999985 889999999766554567889999999999999999999987543 678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++++|.++++.... ..+++.++..++.|++.|+.|||+. +|+||||+|+||++++++.+||+|||.
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~ 150 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGL 150 (261)
T ss_pred EEEEeecccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccc
Confidence 999999999999999986442 2488999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+....... .......++..|+|||+..+..++.++||||||+++|+|++ |+.||..... .+.....
T Consensus 151 ~~~~~~~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-----~~~~~~~ 217 (261)
T cd05148 151 ARLIKEDV--------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-----HEVYDQI 217 (261)
T ss_pred hhhcCCcc--------ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHH
Confidence 98664321 11113346778999999999999999999999999999998 8999864321 1111110
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
....... .+..++..+.+++.+|++.||++|||++++++.|+.
T Consensus 218 --------~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 218 --------TAGYRMP-----------CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --------HhCCcCC-----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0000000 011334567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=321.66 Aligned_cols=267 Identities=25% Similarity=0.408 Sum_probs=208.4
Q ss_pred ccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.+|.+.+.||+|+||.||+|++. .++..||+|.++.......+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG----- 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-----
Confidence 46888899999999999999864 24567999998655444456799999999999999999999997543
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCC----------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQ----------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL 845 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill 845 (1009)
...++||||+++++|.+++...... .....+++..++.++.|++.|++|||++ +|+||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence 6789999999999999999764321 0112488999999999999999999999 99999999999999
Q ss_pred CCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccc
Q 047768 846 DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMF 924 (1009)
Q Consensus 846 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~ 924 (1009)
+.++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDY------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred ccCCcEEECCCCcccccCCCce------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999976543211 011123456788999999999999999999999999999999 999986432
Q ss_pred cCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 925 NEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
.. +..... ........ ...++..+.+++.+||+.+|++||++.+|++.|+++.+..
T Consensus 231 ~~-----~~~~~~--------~~~~~~~~-----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 231 NT-----EVIECI--------TQGRVLER-----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred HH-----HHHHHH--------hCCCCCCC-----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 11 111110 00000000 0123456889999999999999999999999999997654
Q ss_pred h
Q 047768 1005 L 1005 (1009)
Q Consensus 1005 ~ 1005 (1009)
+
T Consensus 287 ~ 287 (291)
T cd05094 287 P 287 (291)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=321.51 Aligned_cols=261 Identities=28% Similarity=0.458 Sum_probs=204.1
Q ss_pred hccCccCCcccccCCceEEEEEEec-----CCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHE-----NGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 773 (1009)
.++|.+.+.||+|+||.||+|.+.. +++.||||+++..... ..+.+.+|++++++++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG--- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence 3568888999999999999998753 3578999998654333 346899999999999999999999997643
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCC--------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQ--------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL 845 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill 845 (1009)
...++||||+++++|.+++...... .....+++.++..++.|++.|+.|||++ +++||||||+||++
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili 155 (280)
T cd05049 81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV 155 (280)
T ss_pred --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence 6789999999999999999865421 1223488999999999999999999999 99999999999999
Q ss_pred CCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccc
Q 047768 846 DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMF 924 (1009)
Q Consensus 846 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~ 924 (1009)
+.++.+|++|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred cCCCeEEECCcccceecccCcce------ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999765432110 11112345788999999999999999999999999999999 999986432
Q ss_pred cCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 925 NEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
.. ....... ....... .......+.+++.+||+.||++||++.||++.|+
T Consensus 230 ~~-----~~~~~~~--------~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 230 NE-----EVIECIT--------QGRLLQR-----------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HH-----HHHHHHH--------cCCcCCC-----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 21 1111110 0000000 0123356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=345.25 Aligned_cols=263 Identities=24% Similarity=0.299 Sum_probs=205.3
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeecccc---C
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDF---K 773 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~ 773 (1009)
..++|.+.+.||+|+||+||+|++..+++.||||+++.... .....+.+|+..+..++|+|++++...+...+. .
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 45689999999999999999999998999999999965432 223567889999999999999998876543211 1
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEE
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 853 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 853 (1009)
.....++||||+++|+|.++++.+... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~--~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKT--NRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 112468999999999999999764321 23488999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.
T Consensus 185 ~DFGls~~~~~~~~------~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~~~ 253 (496)
T PTZ00283 185 GDFGFSKMYAATVS------DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NMEEV 253 (496)
T ss_pred EecccCeecccccc------ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHHHH
Confidence 99999987643211 11123457999999999999999999999999999999999999999642 22222
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
....... ...+. +.....++.+++.+||+.||++||++.++++.
T Consensus 254 ~~~~~~~--------~~~~~-----------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 254 MHKTLAG--------RYDPL-----------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHhcC--------CCCCC-----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 2211111 01000 11233467899999999999999999999864
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.29 Aligned_cols=256 Identities=21% Similarity=0.307 Sum_probs=201.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|++.+.||+|+||.||+|+...+++.||+|+++.......+.+.+|+.++++++||||+++++++... ...+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----EKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----CEEE
Confidence 35799999999999999999999889999999999765444556788999999999999999999987543 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+++++|.++++... .+++.++..++.|++.|+.|||+. +|+|||++|+||+++.++.+||+|||++
T Consensus 83 iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~ 153 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVA 153 (267)
T ss_pred EEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccc
Confidence 9999999999999987644 388999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccC---CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL---GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+...... .......|+..|+|||.+. ...++.++|||||||++|||++|+.||....... .
T Consensus 154 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~----~---- 217 (267)
T cd06646 154 AKITATI--------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR----A---- 217 (267)
T ss_pred eeecccc--------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh----h----
Confidence 8654221 1122346889999999874 3457889999999999999999999985332110 0
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
........... +. . .....+..++.+++.+|++.+|++||+++++++.+
T Consensus 218 -----~~~~~~~~~~~-~~--~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 218 -----LFLMSKSNFQP-PK--L----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -----heeeecCCCCC-CC--C----ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000000000 00 0 00112345688999999999999999999998653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=333.51 Aligned_cols=208 Identities=24% Similarity=0.339 Sum_probs=175.1
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||+||+|..+.+++.||||+++... ......+.+|++++.+++|++|+++++++.. ...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-----~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-----KLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CCe
Confidence 46888999999999999999999899999999996432 1223567889999999999999999998654 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++.+.. .+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG 146 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG 146 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence 899999999999999998654 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCcc---------------------------ccCCccccccccccccCccccCCCCCCCcccchHHHHHH
Q 047768 858 LAKFLSASPLGNVV---------------------------ETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILL 910 (1009)
Q Consensus 858 la~~~~~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl 910 (1009)
+++........... ..........||+.|+|||++.+..++.++|||||||++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 99865432100000 000011245799999999999999999999999999999
Q ss_pred HHHHhCCCCCcc
Q 047768 911 LEIFTRRRPTES 922 (1009)
Q Consensus 911 ~elltg~~p~~~ 922 (1009)
|||++|+.||..
T Consensus 227 ~ell~G~~Pf~~ 238 (363)
T cd05628 227 YEMLIGYPPFCS 238 (363)
T ss_pred HHHHhCCCCCCC
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=334.50 Aligned_cols=207 Identities=22% Similarity=0.323 Sum_probs=173.3
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.|.+.+.||+|+||+||+|+++.+++.||||+++... ......+.+|++++++++||||+++++++.. ....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-----CCEE
Confidence 5788899999999999999999999999999996542 2224568899999999999999999998754 3678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++++||+|||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 99999999999999997654 288899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCcc---------------------------------------ccCCccccccccccccCccccCCCCCCC
Q 047768 859 AKFLSASPLGNVV---------------------------------------ETPSSSIGVKGTIGYVAPEYGLGGEASM 899 (1009)
Q Consensus 859 a~~~~~~~~~~~~---------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 899 (1009)
++........... ..........||+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 8644211000000 0000112357999999999999999999
Q ss_pred cccchHHHHHHHHHHhCCCCCcc
Q 047768 900 RGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 900 ~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
++|||||||++|||++|+.||..
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~ 250 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLA 250 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcC
Confidence 99999999999999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=321.58 Aligned_cols=262 Identities=21% Similarity=0.370 Sum_probs=201.1
Q ss_pred HhccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeecccc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 772 (1009)
..++|++.+.||+|+||.||+|.++ .++..||||+++.... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--- 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence 4567999999999999999999875 2357899999854322 234568899999999999999999998754
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCC----CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQL----GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD 848 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 848 (1009)
....++||||+++|+|.+++....... ....+++..+..++.|++.|++|||+. +++||||||+||+++++
T Consensus 81 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 81 --GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155 (277)
T ss_pred --CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence 357899999999999999997643211 122467889999999999999999998 99999999999999999
Q ss_pred CceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCC
Q 047768 849 MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEG 927 (1009)
Q Consensus 849 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~ 927 (1009)
+.+|++|||+++......... ......+++.|+|||++.++.++.++|||||||++|||++ |+.||....
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--- 226 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--- 226 (277)
T ss_pred CCEEECCCCCccccCCcceee------cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---
Confidence 999999999998654322110 1111345788999999999999999999999999999999 788886432
Q ss_pred ccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 928 LTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
..+...... .......+ ..++..+.+++.+|++.+|++|||+.|+++.|+
T Consensus 227 --~~~~~~~~~--------~~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 227 --NEQVLRFVM--------EGGLLDKP-----------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --HHHHHHHHH--------cCCcCCCC-----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 112111111 11110001 123346889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=335.78 Aligned_cols=259 Identities=21% Similarity=0.285 Sum_probs=197.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||+||+|++..+++.||||+++... ......+.+|+++++.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-----ENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCe
Confidence 46889999999999999999999899999999997542 2233567889999999999999999998654 378
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 146 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG 146 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence 899999999999999997654 289999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCcccc------------------------------CCccccccccccccCccccCCCCCCCcccchHHH
Q 047768 858 LAKFLSASPLGNVVET------------------------------PSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYG 907 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G 907 (1009)
+++.+........... ........||+.|+|||++.+..++.++||||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 226 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence 9976533211000000 0011134699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCC
Q 047768 908 ILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDR 987 (1009)
Q Consensus 908 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R 987 (1009)
|++|||++|+.||..... .+....... .. ..+ ..+. .....+++.+++.+|+. +|.+|
T Consensus 227 ~il~el~~G~~Pf~~~~~-----~~~~~~i~~-----~~-~~~-~~~~---------~~~~s~~~~~li~~ll~-~p~~R 284 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNP-----QETYRKIIN-----WK-ETL-QFPD---------EVPLSPEAKDLIKRLCC-EAERR 284 (364)
T ss_pred hHHHHhhcCCCCCCCCCH-----HHHHHHHHc-----CC-Ccc-CCCC---------CCCCCHHHHHHHHHHcc-CHhhc
Confidence 999999999999974321 111111100 00 000 0000 00112346678888886 89999
Q ss_pred CC---HHHHHH
Q 047768 988 ME---MTDVVV 995 (1009)
Q Consensus 988 pt---~~evl~ 995 (1009)
++ +.|+++
T Consensus 285 ~~~~~~~~ll~ 295 (364)
T cd05599 285 LGNNGVNEIKS 295 (364)
T ss_pred CCCCCHHHHhc
Confidence 98 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=328.47 Aligned_cols=243 Identities=21% Similarity=0.297 Sum_probs=189.1
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||.||+|+++.+++.||+|+++.... ...+.+.+|+.++.++ +||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence 469999999999999998999999999975422 2235677899888877 89999999998654 36789999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 76 EYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 9999999999887654 389999999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCC---ccHHHHHHHhcc
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEG---LTLHEFAKRALP 939 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~ 939 (1009)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+.....
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i- 217 (329)
T cd05618 147 LRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI- 217 (329)
T ss_pred cCCC--------CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-
Confidence 2211 11224578999999999999999999999999999999999999996422111 11111111110
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~ 990 (1009)
..... ..+ .....++.+++.+|++.||++||++
T Consensus 218 ------~~~~~-~~p-----------~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 218 ------LEKQI-RIP-----------RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ------hcCCC-CCC-----------CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 00000 001 1122356799999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=315.20 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=194.8
Q ss_pred cccccCCceEEEEEEe--cCCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEec
Q 047768 708 TIGRGSFGFVYKGVLH--ENGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEY 784 (1009)
Q Consensus 708 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 784 (1009)
.||+|+||.||+|.++ ..+..||+|++...... ..+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence 3899999999999875 44567999998654322 24568899999999999999999998642 457899999
Q ss_pred cCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCC
Q 047768 785 MQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSA 864 (1009)
Q Consensus 785 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 864 (1009)
+++++|.+++..... .+++.++..++.|++.|++|||++ +++||||||+||+++.++.+|++|||+++....
T Consensus 76 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 76 ASGGPLNKFLSGKKD-----EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred CCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence 999999999976443 389999999999999999999998 999999999999999999999999999975543
Q ss_pred CCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccchhh
Q 047768 865 SPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPEKVM 943 (1009)
Q Consensus 865 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1009)
..... .......++..|+|||++....++.++|||||||++||+++ |+.||...... .+..
T Consensus 148 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~-------- 209 (257)
T cd05115 148 DDSYY-----KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----EVMS-------- 209 (257)
T ss_pred Cccce-----eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHH--------
Confidence 21100 11112234678999999988889999999999999999997 99998754221 1111
Q ss_pred hccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 944 EIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 944 ~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
.+...... ..+..+..++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 210 -~~~~~~~~----------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 210 -FIEQGKRL----------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -HHHCCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11110000 00112345678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=334.50 Aligned_cols=255 Identities=20% Similarity=0.255 Sum_probs=198.7
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
..++|++.+.||+|+||.||+|+.+.+++.||+|+++... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-----~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-----D 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-----C
Confidence 4568999999999999999999999899999999996432 2233557889999999999999999988654 3
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++|+|.+++.... +++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~~-------l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNYD-------IPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEe
Confidence 67899999999999999987643 77888899999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCC----CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG----EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLH 931 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~ 931 (1009)
||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .
T Consensus 186 fG~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~ 253 (370)
T cd05596 186 FGTCMKMDANGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----V 253 (370)
T ss_pred ccceeeccCCCc-------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----H
Confidence 999986543211 112235699999999988653 478999999999999999999999974321 1
Q ss_pred HHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 047768 932 EFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFD--RMEMTDVVVK 996 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--Rpt~~evl~~ 996 (1009)
.......... . .+. .+. ......++.+++.+|++.+|++ ||++.|+++.
T Consensus 254 ~~~~~i~~~~-----~-~~~-~~~---------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 254 GTYSKIMDHK-----N-SLT-FPD---------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHHHcCC-----C-cCC-CCC---------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111111000 0 000 000 0012345678999999999987 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=315.36 Aligned_cols=249 Identities=27% Similarity=0.383 Sum_probs=195.2
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEecc
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYM 785 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 785 (1009)
+.||+|+||.||+|.++.+++.||+|.+..... .....+.+|++++++++||||+++++++... ...++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEeec
Confidence 469999999999999998999999998753322 2345789999999999999999999997543 5689999999
Q ss_pred CCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCC
Q 047768 786 QNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865 (1009)
Q Consensus 786 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 865 (1009)
++++|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 76 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 76 QGGDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147 (252)
T ss_pred cCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccc
Confidence 99999999976543 388999999999999999999999 9999999999999999999999999998764432
Q ss_pred CCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccchhhh
Q 047768 866 PLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPEKVME 944 (1009)
Q Consensus 866 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1009)
... .......++..|+|||.+.++.++.++|||||||++|||++ |..||...... .. ..
T Consensus 148 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-----~~---------~~ 207 (252)
T cd05084 148 VYA------STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-----QT---------RE 207 (252)
T ss_pred ccc------ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-----HH---------HH
Confidence 110 00111223567999999999999999999999999999998 88888643211 00 01
Q ss_pred ccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 945 IVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 945 ~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
.+...... .....++..+.+++.+|++.+|++|||+.|+.++|.
T Consensus 208 ~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 208 AIEQGVRL----------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHcCCCC----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11110000 001123456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=317.41 Aligned_cols=255 Identities=24% Similarity=0.420 Sum_probs=201.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|++.++||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK-----EEPIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCCcE
Confidence 457889999999999999999975 66789999876432 235688999999999999999999988654 36679
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++|+|.++++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++
T Consensus 78 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~ 150 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLA 150 (261)
T ss_pred EEEecCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccc
Confidence 99999999999999976432 2478889999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... .......++..|+|||+.....++.++|||||||++|||+| |+.||...... ......
T Consensus 151 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~~- 217 (261)
T cd05072 151 RVIEDNEY-------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-----DVMSAL- 217 (261)
T ss_pred eecCCCce-------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-----HHHHHH-
Confidence 87643211 11122345778999999998899999999999999999999 99998643211 111110
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
.. .... + ....++.++.+++.+|+..+|++||+++++.+.|+.
T Consensus 218 ~~--------~~~~-~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 218 QR--------GYRM-P---------RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred Hc--------CCCC-C---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00 0000 0 001233467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=326.23 Aligned_cols=241 Identities=22% Similarity=0.294 Sum_probs=188.4
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||+||+|++..+++.||||+++... ....+.+..|..++... +||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 46999999999999999899999999997542 22234556677777654 89999999988654 36789999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~gg~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 76 EYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 9999999999997654 288999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchh
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~-- 211 (316)
T cd05592 147 MNGE--------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILND-- 211 (316)
T ss_pred CCCC--------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcC--
Confidence 3221 122345689999999999999999999999999999999999999974321 1111111000
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMT-DVV 994 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~-evl 994 (1009)
....+ .....++.+++.+|++.||++||++. ++.
T Consensus 212 -------~~~~~-----------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 212 -------RPHFP-----------RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -------CCCCC-----------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00000 01223467899999999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=328.57 Aligned_cols=240 Identities=24% Similarity=0.292 Sum_probs=188.6
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHH---HhcCCCCcceEEeeeeccccCCCc
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEAL---RSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
|.+.+.||+|+||.||+|.++.+++.||||+++... ....+.+.+|++++ ++++||||+++++++.. ..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-----~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-----ED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-----CC
Confidence 567889999999999999999899999999997442 22235566776665 45689999999998654 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|..+++.. .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHTD-------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence 889999999999999888653 289999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 146 g~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-----~~~~~~ 212 (324)
T cd05589 146 GLCKEGMGFG--------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-----EEVFDS 212 (324)
T ss_pred cCCccCCCCC--------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence 9987532211 122346789999999999999999999999999999999999999974321 111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~ 990 (1009)
. ...... .+ ......+.+++.+|++.||.+||++
T Consensus 213 i--------~~~~~~-~p-----------~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 213 I--------VNDEVR-YP-----------RFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred H--------HhCCCC-CC-----------CCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 1 000000 00 0123456799999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=327.60 Aligned_cols=243 Identities=21% Similarity=0.285 Sum_probs=189.6
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||.||+|+++.+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-----CCEEEEEE
Confidence 469999999999999998999999999975422 2235678899999998 79999999998654 36789999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 76 EFVSGGDLMFHMQRQR------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 9999999999887654 389999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCC---ccHHHHHHHhcc
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEG---LTLHEFAKRALP 939 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~ 939 (1009)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+.....
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~- 217 (329)
T cd05588 147 IRP--------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI- 217 (329)
T ss_pred ccC--------CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH-
Confidence 211 112234578999999999999999999999999999999999999996422111 11111111111
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~ 990 (1009)
..... ..+ .....++.+++.+|++.||.+||++
T Consensus 218 ------~~~~~-~~p-----------~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 218 ------LEKQI-RIP-----------RSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred ------HcCCC-CCC-----------CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 01000 000 0122357799999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=320.35 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=198.0
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.|++.+.||+|+||+||+|.+..+++.||||++..... .....+.+|++++++++||||+++++++.. ....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-----CCeE
Confidence 37788999999999999999988899999999864321 123457789999999999999999988654 3678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++|+|.+++..... ..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999988865432 2489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
++...... ......|++.|+|||++.+..++.++||||+||++|||++|+.||...... .....+ ...
T Consensus 149 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~-~~~- 216 (285)
T cd05605 149 AVEIPEGE---------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEV-ERR- 216 (285)
T ss_pred ceecCCCC---------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHH-HHH-
Confidence 98654221 112346899999999999999999999999999999999999999742211 001111 100
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVVK 996 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~~ 996 (1009)
+....... .......+.+++.+|++.||++|| +++++++.
T Consensus 217 -------~~~~~~~~-----------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 217 -------VKEDQEEY-----------SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -------hhhccccc-----------CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00000000 012234578999999999999999 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=331.08 Aligned_cols=243 Identities=22% Similarity=0.260 Sum_probs=192.7
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEe
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYE 783 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 783 (1009)
+.||+|+||.||+|....+++.||+|+++.... .....+.+|+++++.++||||+++.+++.. ....++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-----~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-----CCEEEEEEe
Confidence 469999999999999988999999999975422 223567789999999999999999988654 367899999
Q ss_pred ccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 784 YMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 784 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
|+++|+|.+++.... .+++.++..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 999999999887654 38999999999999999999997 6 9999999999999999999999999998753
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchh
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~i~~~~- 212 (325)
T cd05594 147 IKDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEE- 212 (325)
T ss_pred CCCC--------cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHHHhcCC-
Confidence 2211 112235689999999999999999999999999999999999999964321 11111110000
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVVK 996 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~~ 996 (1009)
. ..+ .....++.+++.+|++.||++|+ ++.|+++.
T Consensus 213 -------~-~~p-----------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 213 -------I-RFP-----------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -------C-CCC-----------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0 000 01223567899999999999997 89888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=316.35 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=199.1
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
++|.+.+.||+|+||+||+|.+. ++..||||.++... ...+.+.+|+.++++++||||+++++++... ...++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CCcEE
Confidence 46888899999999999999886 45679999886432 2356789999999999999999999997543 56799
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
||||+++|+|.+++..... .+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.++
T Consensus 77 v~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~ 148 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148 (256)
T ss_pred EEEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccce
Confidence 9999999999999976543 389999999999999999999999 99999999999999999999999999988
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhcc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....... .......++..|+|||+..+..++.++|||||||++|||++ |+.||...... ......
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~-- 214 (256)
T cd05113 149 YVLDDEY-------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ETVEKV-- 214 (256)
T ss_pred ecCCCce-------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHH--
Confidence 6543211 11122346678999999988889999999999999999999 99998643211 111110
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
........+ ......+.+++.+||+.+|++||++.++++.++
T Consensus 215 ------~~~~~~~~~-----------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 215 ------SQGLRLYRP-----------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ------hcCCCCCCC-----------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000000000 012346789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=315.10 Aligned_cols=255 Identities=31% Similarity=0.463 Sum_probs=202.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|++.+.||+|+||.||+|.+. +++.||||.++... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 77 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-----EPIY 77 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecC-----CCee
Confidence 356888999999999999999975 56789999986433 2356789999999999999999999986543 5689
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++..... ..+++.++..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 78 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~ 150 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAG----RALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLA 150 (261)
T ss_pred eeeecccCCcHHHHHhccCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceE
Confidence 99999999999999976541 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... ....+...+..|+|||+..+..++.++||||||+++|||++ |+.||..... ......
T Consensus 151 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~-- 216 (261)
T cd05068 151 RVIKEDIY-------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----AEVLQQ-- 216 (261)
T ss_pred EEccCCcc-------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH--
Confidence 87653211 11112234568999999999999999999999999999999 9999864321 111111
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
++..... .....+...+.+++.+|++.+|++||++.++.+.|+.
T Consensus 217 -------~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 217 -------VDQGYRM----------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -------HHcCCCC----------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0000000 0001233568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=317.43 Aligned_cols=259 Identities=29% Similarity=0.481 Sum_probs=202.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCe---EEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGM---LVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|+..+.||+|+||.||+|..+.++. .||+|.++... ....+.+..|++++++++|||++++.+++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF----- 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-----
Confidence 3578888999999999999999875543 79999886442 22345788999999999999999999987543
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
+..++||||+++++|.+++..... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d 150 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSD 150 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECC
Confidence 668999999999999999976543 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 934 (1009)
||++.......... ........+..|+|||++.+..++.++|||||||++|||++ |+.||..... .+..
T Consensus 151 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~ 220 (268)
T cd05063 151 FGLSRVLEDDPEGT-----YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVM 220 (268)
T ss_pred Cccceecccccccc-----eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHH
Confidence 99998664322100 11112233567999999998899999999999999999998 9999864321 1111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
... ......+ ...+++.++.+++.+|++.+|++||++.+|++.|+++
T Consensus 221 ~~i--------~~~~~~~-----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 221 KAI--------NDGFRLP-----------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHH--------hcCCCCC-----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 0000000 0113345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=326.91 Aligned_cols=238 Identities=24% Similarity=0.290 Sum_probs=189.4
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||+||+|+++.+++.||||+++... ....+.+..|++++... +||||+++++++.. ....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-----~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-----PDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-----CCEEEEEE
Confidence 46999999999999999899999999996432 22345677888888876 69999999998654 36789999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 Ey~~~g~L~~~i~~~~~------l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 76 EFVNGGDLMFHIQKSRR------FDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred cCCCCchHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 99999999999876543 88999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchh
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~~~~~~~i~~~~~ 213 (320)
T cd05590 147 IFNG--------KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-----EDDLFEAILNDEV 213 (320)
T ss_pred CcCC--------CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----HHHHHHHHhcCCC
Confidence 2211 12233568999999999999999999999999999999999999997432 1122111111100
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHH
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMT 991 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~ 991 (1009)
..+ .....++.+++.+|++.||++||++.
T Consensus 214 ---------~~~-----------~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 214 ---------VYP-----------TWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred ---------CCC-----------CCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 000 01223567999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=336.11 Aligned_cols=362 Identities=24% Similarity=0.378 Sum_probs=215.5
Q ss_pred cCeEeecCccCC-CCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhh
Q 047768 170 LQGLSVGDNQLT-GQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLY 248 (1009)
Q Consensus 170 L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 248 (1009)
.+-.|+++|.++ +..|.....+++++.|.|...++ ..+|..++.+.+|++|.+++|++. .+-..+..|+.|+.+.+.
T Consensus 9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L-~~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R 86 (1255)
T KOG0444|consen 9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKL-EQVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVR 86 (1255)
T ss_pred eecccccCCcCCCCcCchhHHHhhheeEEEechhhh-hhChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhh
Confidence 344566666666 35577777777777777777777 467777888888888888888777 566677778888888888
Q ss_pred CCccCC-CCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCC
Q 047768 249 GNRFTG-SLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGN 327 (1009)
Q Consensus 249 ~N~l~~-~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~ 327 (1009)
.|++.. -||..+|. +..|+.||||+|+++ ..|..+...+++-+|+||+|+|..++...|.+|..|-.||||+|++..
T Consensus 87 ~N~LKnsGiP~diF~-l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~ 164 (1255)
T KOG0444|consen 87 DNNLKNSGIPTDIFR-LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEM 164 (1255)
T ss_pred ccccccCCCCchhcc-cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhh
Confidence 887753 47777775 788888888888887 567777777888888888888887777666666666666666666654
Q ss_pred CCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCC-C
Q 047768 328 GAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLT-G 406 (1009)
Q Consensus 328 ~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~ 406 (1009)
+++ -...+..|+.|+|++|.+. ...-..+..+++|++|.+++.+=+ .
T Consensus 165 LPP-------Q~RRL~~LqtL~Ls~NPL~-------------------------hfQLrQLPsmtsL~vLhms~TqRTl~ 212 (1255)
T KOG0444|consen 165 LPP-------QIRRLSMLQTLKLSNNPLN-------------------------HFQLRQLPSMTSLSVLHMSNTQRTLD 212 (1255)
T ss_pred cCH-------HHHHHhhhhhhhcCCChhh-------------------------HHHHhcCccchhhhhhhcccccchhh
Confidence 433 2344555555555555543 222223334445555555544322 2
Q ss_pred CCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhh
Q 047768 407 TIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILE 486 (1009)
Q Consensus 407 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~ 486 (1009)
-+|.++.++.+|..+|||.|.+. ..|+.+.++.+|+.|+||+|+|+ .+....+...+|++|++++|+++
T Consensus 213 N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt--------- 281 (1255)
T KOG0444|consen 213 NIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT--------- 281 (1255)
T ss_pred cCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc---------
Confidence 34555555555555555555555 45555555555555555555555 33333333344443333333333
Q ss_pred hccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCC-CccccccCCCCccEEEecCcccccccccccccccccce
Q 047768 487 ITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSG-QIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKE 565 (1009)
Q Consensus 487 ~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 565 (1009)
.+|..++.|++|+.|++.+|+++- -||..+|++.+|+.+..++|++. .+|+.++.+.+|+.
T Consensus 282 -----------------~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~k 343 (1255)
T KOG0444|consen 282 -----------------VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQK 343 (1255)
T ss_pred -----------------cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHH
Confidence 344444445555555555555431 24555555555555555555554 55555555555555
Q ss_pred EcCCCcccccccccccccccccCceecccccC
Q 047768 566 LDLSQNNFSGQIPKYLENLSFLQYLNLSYNHF 597 (1009)
Q Consensus 566 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 597 (1009)
|.|++|++- ++|+.+.-|+.|+.|||..|+=
T Consensus 344 L~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 344 LKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred hccccccee-echhhhhhcCCcceeeccCCcC
Confidence 555555554 4555555555555555555543
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=335.22 Aligned_cols=260 Identities=23% Similarity=0.313 Sum_probs=202.4
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|.+.+.||+|+||+||+|++..+++.||||+++... ......+.+|+++++.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-----EEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-----CCe
Confidence 36889999999999999999999899999999997542 2334678899999999999999999987643 467
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg 146 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG 146 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence 899999999999999998763 388999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCCc---------------------cccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhC
Q 047768 858 LAKFLSASPLGNV---------------------VETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR 916 (1009)
Q Consensus 858 la~~~~~~~~~~~---------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg 916 (1009)
+++.......... ...........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence 9987654320000 0001122345689999999999999999999999999999999999
Q ss_pred CCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 047768 917 RRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME-MTDVVV 995 (1009)
Q Consensus 917 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt-~~evl~ 995 (1009)
+.||..... ........ ... ..+. .+.. .....++.+++.+|++ ||.+||+ +.|+++
T Consensus 227 ~~Pf~~~~~-----~~~~~~i~-----~~~-~~~~-~p~~---------~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 227 FPPFYSDTL-----QETYNKII-----NWK-ESLR-FPPD---------PPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CCCCCCCCH-----HHHHHHHh-----ccC-Cccc-CCCC---------CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 999974321 11111110 000 0000 0000 0123457788999997 9999999 999986
Q ss_pred H
Q 047768 996 K 996 (1009)
Q Consensus 996 ~ 996 (1009)
.
T Consensus 285 h 285 (350)
T cd05573 285 H 285 (350)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=340.08 Aligned_cols=277 Identities=21% Similarity=0.282 Sum_probs=196.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeecccc---CCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDF---KGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~~ 776 (1009)
..+|.+.+.||+|+||+||+|....+++.||||++... .....+|+.+++.++||||+++++++....+ ....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45799999999999999999999888999999988432 2345679999999999999999887643222 1223
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC-ceEEec
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSD 855 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~D 855 (1009)
..++||||++ +++.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARN--NHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 5679999996 5787777542211 12488999999999999999999999 999999999999998665 799999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
||+|+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+....
T Consensus 215 FGla~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~ 284 (440)
T PTZ00036 215 FGSAKNLLAG---------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRII 284 (440)
T ss_pred cccchhccCC---------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence 9999865432 112235689999999998764 6899999999999999999999999753221 1111111
Q ss_pred HHhccc--hhhhccCCCCCC--hhhh-hhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 935 KRALPE--KVMEIVDPSLLP--LEEE-RTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 935 ~~~~~~--~~~~~~d~~l~~--~~~~-r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
...... +......+.... .+.. ........+.....++.+++.+|++.||.+|||+.|+++.
T Consensus 285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 111100 000000100000 0000 0000000111233568899999999999999999999843
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=321.57 Aligned_cols=264 Identities=23% Similarity=0.380 Sum_probs=202.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCe--EEEEEEeeccc-ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGM--LVAVKVINLEQ-KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 776 (1009)
++|++.+.||+|+||.||+|..+.++. .+|+|.++... ....+.+.+|+++++++ +||||+++++++... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-----G 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-----C
Confidence 578899999999999999999876664 47888876322 22345788999999999 799999999986543 5
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCC----------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQL----------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD 846 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 846 (1009)
..++|+||+++|+|.+++....... ....+++..+..++.|++.|++|||++ +|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 6899999999999999997643110 112488999999999999999999998 999999999999999
Q ss_pred CCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCccccc
Q 047768 847 HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFN 925 (1009)
Q Consensus 847 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~ 925 (1009)
+++.+||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||.....
T Consensus 154 ~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 154 ENLASKIADFGLSRGEEVY---------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred CCCeEEECCcCCCccccce---------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999998643211 00111223567999999999999999999999999999998 9999864321
Q ss_pred CCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 047768 926 EGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFL 1005 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~ 1005 (1009)
....... ....... ....+...+.+++.+|++.+|.+||+++++++.|+.+.+.+.
T Consensus 225 -----~~~~~~~---------~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 225 -----AELYEKL---------PQGYRME----------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred -----HHHHHHH---------hcCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1111111 0000000 001233467899999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=326.11 Aligned_cols=242 Identities=22% Similarity=0.300 Sum_probs=191.0
Q ss_pred CcccccCCceEEEEEEe---cCCeEEEEEEeeccc----ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 707 NTIGRGSFGFVYKGVLH---ENGMLVAVKVINLEQ----KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+.||+|+||.||+|+.. .+++.||||+++... ......+.+|+++++.++||||+++++++.. ....+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeEE
Confidence 67999999999999864 468899999996432 1223467789999999999999999988654 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++|+|.+++..... +.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 77 lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (323)
T cd05584 77 LILEYLSGGELFMHLEREGI------FMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLC 147 (323)
T ss_pred EEEeCCCCchHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCC
Confidence 99999999999999976542 78888999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........
T Consensus 148 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~~~~- 213 (323)
T cd05584 148 KESIHEG--------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTIDKIL- 213 (323)
T ss_pred eecccCC--------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHHHHH-
Confidence 7543211 112235689999999999999999999999999999999999999974321 11111111
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVV 995 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~ 995 (1009)
..... .+ ......+.+++.+|++.||++|| ++.++++
T Consensus 214 -------~~~~~-~~-----------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 214 -------KGKLN-LP-----------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -------cCCCC-CC-----------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11100 00 01223567999999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=331.99 Aligned_cols=204 Identities=24% Similarity=0.308 Sum_probs=171.1
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccc-cCCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSID-FKGV 775 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~ 775 (1009)
..++|.+.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.++||||+++++++.... ....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999998899999999986432 223457789999999999999999999875432 1223
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++ ++.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEec
Confidence 457999999964 67666643 278888999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 167 fg~a~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 167 FGLARTACTN---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred CCCccccccC---------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999754321 1122356899999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=326.75 Aligned_cols=242 Identities=22% Similarity=0.275 Sum_probs=191.5
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||.||+|+++.+++.||||+++... ......+..|.+++..+ +||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-----KDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCeEEEEE
Confidence 46999999999999999889999999997542 22335577888888876 79999999998654 36789999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++..... +++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 76 EYVNGGDLMFQIQRSRK------FDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred eCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 99999999999876542 88999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchh
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...........
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-----~~~~~~i~~~~- 212 (321)
T cd05591 147 ILNG--------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-----DDLFESILHDD- 212 (321)
T ss_pred ccCC--------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC-
Confidence 3211 122345689999999999999999999999999999999999999974321 11111111110
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHH
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-------EMTDVVV 995 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-------t~~evl~ 995 (1009)
.. .+ .....++.+++.+|++.||++|| +++++++
T Consensus 213 -------~~-~p-----------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 213 -------VL-YP-----------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred -------CC-CC-----------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 00 00 01123567999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=317.01 Aligned_cols=248 Identities=23% Similarity=0.288 Sum_probs=192.5
Q ss_pred ccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEecc
Q 047768 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYM 785 (1009)
Q Consensus 709 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 785 (1009)
||+|+||+||+++.+.+|+.||+|++..... ...+.+..|++++++++||||+++++++.. ....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-----KTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-----CCeEEEEEecC
Confidence 6999999999999998999999999864321 123456679999999999999999988643 36789999999
Q ss_pred CCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCC
Q 047768 786 QNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865 (1009)
Q Consensus 786 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 865 (1009)
++++|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 76 ~g~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 76 NGGDLKYHIYNVGE----RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred CCCCHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 99999988865432 2388999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhc
Q 047768 866 PLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEI 945 (1009)
Q Consensus 866 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1009)
. ......|+..|+|||++.+..++.++||||+||++|||++|+.||...... .............
T Consensus 149 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~----- 213 (277)
T cd05607 149 K---------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLED----- 213 (277)
T ss_pred c---------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhcc-----
Confidence 1 112346899999999999999999999999999999999999998643221 1111111111111
Q ss_pred cCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 946 VDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 946 ~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
..... ......++.+++.+|++.||++||++.|+++..
T Consensus 214 ---~~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 214 ---EVKFE-----------HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ---ccccc-----------cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 00000 001233578999999999999999998776443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=331.14 Aligned_cols=203 Identities=21% Similarity=0.312 Sum_probs=173.7
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
...++|++.+.||+|+||.||+|+++.+++.||+|+++... ....+.+.+|+++++.++||||+++++++..
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~----- 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD----- 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----
Confidence 34578999999999999999999999899999999986422 2234568899999999999999999998654
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
....++||||+++|+|.+++.... +++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~~-------~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~ 184 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNYD-------VPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLA 184 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEE
Confidence 378899999999999999997543 78889999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCC----CCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG----EASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
|||+|+....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 185 DFG~a~~~~~~~~-------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 185 DFGTCMKMDETGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred ecccceecccCCc-------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 9999987643211 112245799999999998764 378899999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=327.14 Aligned_cols=242 Identities=20% Similarity=0.273 Sum_probs=190.6
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCC-CcceEEeeeeccccCCCce
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHR-NLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~~ 777 (1009)
+|++.+.||+|+||.||+|+++.+++.||||+++... ....+.+..|+++++.++|+ +|+++++++.. .+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----MDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-----CCE
Confidence 4788899999999999999999889999999997542 22345678899999999765 57778777543 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~------~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGK------FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence 8999999999999999976542 88999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+++...... .......||+.|+|||++.+..++.++||||+||++|||+||+.||..... .......
T Consensus 147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~i 213 (324)
T cd05587 147 MCKENIFGG--------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DELFQSI 213 (324)
T ss_pred cceecCCCC--------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHH
Confidence 987432111 122245689999999999999999999999999999999999999964321 1111111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~ 990 (1009)
..... ..+ .....++.+++.+|++.||.+|++.
T Consensus 214 --------~~~~~-~~~-----------~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 214 --------MEHNV-SYP-----------KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --------HcCCC-CCC-----------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00000 000 0112356789999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.58 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=201.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.++||+|+||+||+|++.. ...||+|+++... ...+.+.+|++++++++||||+++++++.. ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 76 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC-CceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC------CCcE
Confidence 3568999999999999999998864 4569999986432 234678999999999999999999987532 4568
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.+
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred EEEEcCCCCcHHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCce
Confidence 99999999999999976432 2378999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... .......++..|+|||+..+..++.++||||||+++|||+| |+.||...... ......
T Consensus 150 ~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----~~~~~~- 216 (262)
T cd05071 150 RLIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQV- 216 (262)
T ss_pred eecccccc-------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----HHHHHH-
Confidence 86654321 11112346778999999998999999999999999999999 78888643211 111100
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
...... ....+++..+.+++.+|++.+|++||+++++.+.|+..
T Consensus 217 -------~~~~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 217 -------ERGYRM-----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -------hcCCCC-----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 000000 00113445688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=319.94 Aligned_cols=261 Identities=25% Similarity=0.418 Sum_probs=200.3
Q ss_pred ccCccCCcccccCCceEEEEEEe----cCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLH----ENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
++|++.+.||+|+||.||+|.+. .++..||+|.++.... .....+.+|++++++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE----- 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----
Confidence 46788899999999999999863 3567899999864332 2235788999999999999999999986543
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCC-----------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCcee
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQ-----------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVL 844 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nil 844 (1009)
...++||||+++++|.+++...... .....+++.+...++.|++.|++|||++ +|+||||||+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 6689999999999999998643211 0112478899999999999999999999 9999999999999
Q ss_pred eCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCccc
Q 047768 845 LDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESM 923 (1009)
Q Consensus 845 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~ 923 (1009)
+++++.+|++|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYY------RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred EcCCCcEEeccccccccccCCcce------ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999876432210 11122345778999999998899999999999999999999 88898643
Q ss_pred ccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 924 FNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
.. ........... .... ...++.++.+++.+|++.||++||++.++.+.|.+
T Consensus 231 ~~-----~~~~~~~~~~~--------~~~~-----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 231 SN-----QEVIEMVRKRQ--------LLPC-----------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CH-----HHHHHHHHcCC--------cCCC-----------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 21 11111110000 0000 01233467889999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=347.44 Aligned_cols=272 Identities=22% Similarity=0.269 Sum_probs=204.7
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|.+.++||+|+||.||+|.+..+++.||||+++..... ..+.+.+|++++++++||||+++++++... +.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-----~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-----DP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-----CE
Confidence 5789999999999999999999989999999998643222 245788999999999999999999987643 67
Q ss_pred EEEEEeccCCCCHHHHHhccCCC-----CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceE
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQ-----LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 852 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 852 (1009)
.++||||+++|+|.+++...... .....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence 89999999999999998753211 0112367788899999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCCc----------cccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 853 VSDFGLAKFLSASPLGNV----------VETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
|+|||+++.......... ...........||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999987632110000 0000111235699999999999999999999999999999999999999964
Q ss_pred cccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHH
Q 047768 923 MFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-EMTDVVVKLCHAR 1001 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-t~~evl~~L~~i~ 1001 (1009)
........ .. ... .+... ....+.+..+.+++.+|++.||++|| +++++.+.|+...
T Consensus 234 ~~~~ki~~----~~-------~i~------~P~~~-----~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 234 KKGRKISY----RD-------VIL------SPIEV-----APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred cchhhhhh----hh-------hcc------Chhhc-----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 21110000 00 000 00000 00012334678999999999999996 6777777777654
Q ss_pred H
Q 047768 1002 Q 1002 (1009)
Q Consensus 1002 ~ 1002 (1009)
+
T Consensus 292 q 292 (932)
T PRK13184 292 Q 292 (932)
T ss_pred h
Confidence 4
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=313.83 Aligned_cols=251 Identities=29% Similarity=0.451 Sum_probs=198.2
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
.+|++.+.||+|+||.||+|.++ ++..+|+|++.... .....+.+|++++++++||||+++++++... ...++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----RPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----CceEE
Confidence 45788899999999999999886 56789999985332 2345788999999999999999999986543 57899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
|+||+++++|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+|++|||+++
T Consensus 77 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 77 VTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred EEecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccce
Confidence 9999999999999986543 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhcc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....... ....+..++..|+|||...+..++.++||||||+++|||++ |+.||...... +.....
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~-- 214 (256)
T cd05059 149 YVLDDQY-------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----EVVESV-- 214 (256)
T ss_pred ecccccc-------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----HHHHHH--
Confidence 6543211 11112234568999999999999999999999999999999 88998643211 111110
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
.. .... ..+..++.++.+++.+|++.+|++|||+.|+++.|
T Consensus 215 ---~~----~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 215 ---SA----GYRL----------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---Hc----CCcC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00 0000 00112345688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=316.80 Aligned_cols=248 Identities=26% Similarity=0.332 Sum_probs=192.1
Q ss_pred ccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEecc
Q 047768 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYM 785 (1009)
Q Consensus 709 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 785 (1009)
||+|+||+||+|.++.+++.||||++...... ..+.+..|++++++++|+||+++.+++.. ....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-----KTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-----CCeEEEEEeCC
Confidence 69999999999999989999999998643221 23467789999999999999999887543 36789999999
Q ss_pred CCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCC
Q 047768 786 QNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865 (1009)
Q Consensus 786 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 865 (1009)
++|+|.+++...... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 76 ~~g~L~~~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 76 NGGDLRYHIYNVDEE--NPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 999999887543211 12489999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhc
Q 047768 866 PLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEI 945 (1009)
Q Consensus 866 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1009)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 151 ~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~------- 214 (280)
T cd05608 151 Q--------SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRIL------- 214 (280)
T ss_pred C--------ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhc-------
Confidence 1 11223568999999999999999999999999999999999999997432110 1111111110
Q ss_pred cCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 047768 946 VDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVV 995 (1009)
Q Consensus 946 ~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~ 995 (1009)
.... . ........+.+++.+|++.||++|| +++|+++
T Consensus 215 -~~~~-~-----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 215 -NDSV-T-----------YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred -ccCC-C-----------CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 0000 0 0112334578999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.37 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=202.1
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|++.+.||+|++|.||+|.++.+++.||+|.+.... ....+.+.+|++++++++|||++++++++... ...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEE
Confidence 4777899999999999999999899999999986432 23356788999999999999999999986543 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++..... ..+++.+++.++.+++.|+.|||+. +++||||||+||+++.++.+|++|||++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence 99999999999999987532 2488999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
+...... .......|++.|+|||+..+..++.++|||||||++|||++|+.||..... .......
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~-- 213 (256)
T cd08529 149 KLLSDNT--------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALILKI-- 213 (256)
T ss_pred eeccCcc--------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH--
Confidence 8665421 111234578899999999999999999999999999999999999974321 1111111
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
........ .......+.+++.+||+.+|++||++.|+++.
T Consensus 214 ------~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 214 ------IRGVFPPV-----------SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ------HcCCCCCC-----------ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11000000 01233468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=313.50 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=197.7
Q ss_pred CcccccCCceEEEEEEecCC---eEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHENG---MLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
++||+|+||.||+|.+...+ ..||+|.++.... ...+.+.+|++++++++|+|++++++++.. ...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEEE
Confidence 46999999999999886544 7899999864433 234678899999999999999999998642 4578999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++..
T Consensus 75 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 75 ELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred EeCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccccccee
Confidence 9999999999998755 388999999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccch
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPEK 941 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
...... ........++..|+|||...+..++.++|||||||++|||++ |+.||...... ..........+
T Consensus 146 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~~~~~~-- 216 (257)
T cd05060 146 GAGSDY-----YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAMLESGER-- 216 (257)
T ss_pred ecCCcc-----cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCCc--
Confidence 432210 011112234578999999999999999999999999999998 99998643211 11111111000
Q ss_pred hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 942 VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 942 ~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
.. ....+...+.+++.+|+..+|++||++.++++.|+++.
T Consensus 217 ---------~~-----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 ---------LP-----------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---------CC-----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 00 01123356889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=319.63 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=202.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
..+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|+|++++++++... ...+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-----~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-----CEEE
Confidence 35788899999999999999999888999999999766555567888999999999999999999987543 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++.+.. +++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 94 lv~e~~~~~~L~~~~~~~~-------~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 94 VVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred EeecccCCCCHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccc
Confidence 9999999999999986532 78899999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+.... .
T Consensus 164 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~----~~~~~~~-~ 230 (296)
T cd06654 164 AQITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYLIA-T 230 (296)
T ss_pred hhccccc--------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH----HhHHHHh-c
Confidence 7654321 1112345889999999999888999999999999999999999999643211 1110000 0
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.. .+.+ .. .......+.+++.+|+..+|++||++.|+++.
T Consensus 231 ~~-----~~~~-~~-----------~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 231 NG-----TPEL-QN-----------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CC-----CCCC-CC-----------ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00 0000 00 01223457789999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=319.40 Aligned_cols=263 Identities=22% Similarity=0.327 Sum_probs=202.2
Q ss_pred cCccCCcccccCCceEEEEEEec-----CCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHE-----NGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
+|++.+.||+|+||.||+|.... ....||+|.+..... .....+.+|+.++++++||||+++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD----- 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----
Confidence 46788999999999999998752 235789998864432 2235788999999999999999999987543
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCC------------------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecC
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQ------------------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGD 837 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrd 837 (1009)
...++|+||+.+|+|.+++...... .....+++.+++.++.|++.|++|||+. +|+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 5679999999999999998753211 0113488999999999999999999998 999999
Q ss_pred CCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-C
Q 047768 838 LKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-R 916 (1009)
Q Consensus 838 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g 916 (1009)
|||+||++++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g 226 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSY------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 226 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccch------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcC
Confidence 9999999999999999999999865432110 01122345678999999998999999999999999999999 9
Q ss_pred CCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 917 RRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 917 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
+.||.... ..+.. +.+....... ....+..++.+++.+|++.+|++||+++|+++.
T Consensus 227 ~~p~~~~~-----~~~~~---------~~~~~~~~~~----------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~ 282 (290)
T cd05045 227 GNPYPGIA-----PERLF---------NLLKTGYRME----------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282 (290)
T ss_pred CCCCCCCC-----HHHHH---------HHHhCCCCCC----------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 99986432 11111 1111111110 011233468899999999999999999999999
Q ss_pred HHHHHH
Q 047768 997 LCHARQ 1002 (1009)
Q Consensus 997 L~~i~~ 1002 (1009)
|+++..
T Consensus 283 l~~~~~ 288 (290)
T cd05045 283 LEKMMV 288 (290)
T ss_pred HHHHHh
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=313.37 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=194.8
Q ss_pred cccccCCceEEEEEEe--cCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEe
Q 047768 708 TIGRGSFGFVYKGVLH--ENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYE 783 (1009)
Q Consensus 708 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 783 (1009)
.||+|+||.||+|.++ .++..||+|+++..... ..+.+.+|+.+++.++||||+++++++.. +..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 5899999999999764 56789999998644322 24578899999999999999999998643 45689999
Q ss_pred ccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccC
Q 047768 784 YMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863 (1009)
Q Consensus 784 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~ 863 (1009)
|+++|+|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 76 LAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG 146 (257)
T ss_pred cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccC
Confidence 999999999997654 388999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccchh
Q 047768 864 ASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
...... .......++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+...
T Consensus 147 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~------ 210 (257)
T cd05116 147 ADENYY-----KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----NEVTQM------ 210 (257)
T ss_pred CCCCee-----eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH------
Confidence 332100 11112334678999999988889999999999999999998 9999874321 111111
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
+....... .+..+..++.+++.+||+.||++||++++|++.|+..
T Consensus 211 ---i~~~~~~~----------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 211 ---IESGERME----------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ---HHCCCCCC----------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 11100000 0112345678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=321.49 Aligned_cols=265 Identities=24% Similarity=0.375 Sum_probs=204.6
Q ss_pred HhccCccCCcccccCCceEEEEEEecC-----CeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeeccc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHEN-----GMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSSID 771 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 771 (1009)
..++|++.+.||+|+||.||+|.++.. ...||+|+++.... .....+.+|+++++++ +|+||+++++++...
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~- 88 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE- 88 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC-
Confidence 446788899999999999999998643 37899999864322 2235688999999999 899999999987543
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCC----------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQ----------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPS 841 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~ 841 (1009)
...+++|||+++|+|.++++.+... .....+++..++.++.|++.|++|||+. +|+||||||+
T Consensus 89 ----~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~ 161 (293)
T cd05053 89 ----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAAR 161 (293)
T ss_pred ----CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccccee
Confidence 5689999999999999999764311 1123588999999999999999999998 9999999999
Q ss_pred ceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCC
Q 047768 842 NVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPT 920 (1009)
Q Consensus 842 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~ 920 (1009)
||+++.++.+|++|||+++........ .......++..|+|||++.+..++.++|||||||++||+++ |..||
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 235 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYY------RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccce------eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCC
Confidence 999999999999999999876543211 11112335678999999999999999999999999999998 99998
Q ss_pred cccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 921 ESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
.... ..+.... +...... .....+...+.+++.+|++.+|++||||.|+++.|+.+
T Consensus 236 ~~~~-----~~~~~~~---------~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 236 PGIP-----VEELFKL---------LKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred CCCC-----HHHHHHH---------HHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 6432 1111111 0000000 00112344688999999999999999999999999876
Q ss_pred H
Q 047768 1001 R 1001 (1009)
Q Consensus 1001 ~ 1001 (1009)
.
T Consensus 292 ~ 292 (293)
T cd05053 292 L 292 (293)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=323.65 Aligned_cols=241 Identities=23% Similarity=0.331 Sum_probs=189.6
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||+||+|++..+++.||||+++... ......+..|..++... +||||+++++++.. .+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-----KENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-----CCEEEEEE
Confidence 46999999999999999889999999997542 22345566788888764 89999999998654 36789999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++.... .+++.++..++.|++.|+.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ey~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 76 EYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 9999999999997653 288999999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchh
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+......
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~i~---- 209 (316)
T cd05619 147 MLGD--------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EELFQSIR---- 209 (316)
T ss_pred CCCC--------CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH----
Confidence 2211 122345689999999999999999999999999999999999999964321 11111100
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMT-DVV 994 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~-evl 994 (1009)
...+.. + .....++.+++.+|++.||++||++. ++.
T Consensus 210 --~~~~~~---~-----------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 210 --MDNPCY---P-----------RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred --hCCCCC---C-----------ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 000000 0 01123467899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=329.97 Aligned_cols=268 Identities=22% Similarity=0.322 Sum_probs=204.5
Q ss_pred HHHhccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeeccccc-chHHHHHHHHHHHhcC-CCCcceEEeeeec
Q 047768 697 SKATNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKG-GSKSFAAECEALRSIR-HRNLIKIVTICSS 769 (1009)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 769 (1009)
....++|.+.+.||+|+||.||+|+++ ..++.||||+++..... ..+.+.+|++++.++. ||||++++++|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344567888999999999999999974 24568999999754322 2346889999999997 9999999999765
Q ss_pred cccCCCceEEEEEeccCCCCHHHHHhccCCC-------------------------------------------------
Q 047768 770 IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQ------------------------------------------------- 800 (1009)
Q Consensus 770 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------- 800 (1009)
. ...++|+||+++|+|.++++.....
T Consensus 113 ~-----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 113 G-----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred C-----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 3 5689999999999999999754310
Q ss_pred -------------------------------------------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecC
Q 047768 801 -------------------------------------------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGD 837 (1009)
Q Consensus 801 -------------------------------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrd 837 (1009)
.....+++.++..++.|++.|++|||+. +|+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrd 264 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRD 264 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCccc
Confidence 0112477888999999999999999998 999999
Q ss_pred CCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-C
Q 047768 838 LKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-R 916 (1009)
Q Consensus 838 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g 916 (1009)
|||+||++++++.+|++|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |
T Consensus 265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g 338 (401)
T cd05107 265 LAARNVLICEGKLVKICDFGLARDIMRDSNY------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLG 338 (401)
T ss_pred CCcceEEEeCCCEEEEEecCcceeccccccc------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcC
Confidence 9999999999999999999999865332110 11112356789999999999999999999999999999998 8
Q ss_pred CCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 917 RRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 917 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
+.||....... ... ..+....... .+..+..++.+++.+||..+|.+||+++|+++.
T Consensus 339 ~~P~~~~~~~~----~~~---------~~~~~~~~~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 339 GTPYPELPMNE----QFY---------NAIKRGYRMA----------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCCCCCCchH----HHH---------HHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 89986432111 110 0000000000 001223568899999999999999999999999
Q ss_pred HHHHH
Q 047768 997 LCHAR 1001 (1009)
Q Consensus 997 L~~i~ 1001 (1009)
|+.+.
T Consensus 396 L~~~~ 400 (401)
T cd05107 396 VGDLL 400 (401)
T ss_pred HHHHh
Confidence 98764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=316.34 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=199.3
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
++|.+.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++... +..++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-----~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-----DKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEEEE
Confidence 4788889999999999999999889999999998765544456788999999999999999999986543 67899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
|+||+++++|.+++.... .+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 84 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred EEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeee
Confidence 999999999999987654 389999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccC---CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL---GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
...... .......|+..|+|||++. ...++.++||||+||++|||++|+.||....... .......
T Consensus 155 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~~~-- 223 (267)
T cd06645 155 QITATI--------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMTK-- 223 (267)
T ss_pred EccCcc--------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhhhc--
Confidence 654321 1122356899999999874 4568899999999999999999999986432110 0000000
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. ....+... ....+...+.+++.+|++.+|++||+++++++
T Consensus 224 --~---~~~~~~~~------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 224 --S---NFQPPKLK------------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --c---CCCCCccc------------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0 00000000 00012345779999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.30 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=206.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||.||+|+.+.+++.||||.+..... .....+.+|+++++.++||||+++++++.. ...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence 468888999999999999999988999999998864322 223578899999999999999999998654 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.+++|||+++++|.+++...... ...+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg 151 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQ--KRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence 89999999999999998753221 12488999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++....... .......|+..|+|||++.+..++.++||||||+++|||++|..||.....+ .......
T Consensus 152 ~~~~~~~~~--------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~- 219 (267)
T cd08229 152 LGRFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKK- 219 (267)
T ss_pred hhhccccCC--------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhh-
Confidence 987654321 1112346889999999999989999999999999999999999998632211 1111110
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
+... ...+. .......++.+++.+||+.+|.+||||.+|++.+++..
T Consensus 220 ----~~~~---~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 220 ----IEQC---DYPPL----------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ----hhcC---CCCCC----------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0000 00000 01123456889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=329.18 Aligned_cols=253 Identities=22% Similarity=0.269 Sum_probs=198.4
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|.+.+.||+|+||+||+|+.+.+++.||||+++.... ...+.+.+|+.+++.++|+||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-----~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-----KDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCe
Confidence 468889999999999999999999999999999975432 234568899999999999999999988654 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg 147 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG 147 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence 8999999999999999987643 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccC------CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL------GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLH 931 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~ 931 (1009)
+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .
T Consensus 148 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~ 215 (330)
T cd05601 148 SAARLTANKM-------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----A 215 (330)
T ss_pred CCeECCCCCc-------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----H
Confidence 9987643211 1122346899999999986 45678999999999999999999999964321 1
Q ss_pred HHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 932 EFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
......... .. ....+. .......+.+++..|++ +|++||++.+++.
T Consensus 216 ~~~~~i~~~------~~-~~~~~~---------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 216 KTYNNIMNF------QR-FLKFPE---------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHcC------CC-ccCCCC---------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 111111100 00 000010 00122456788889998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=323.56 Aligned_cols=241 Identities=22% Similarity=0.303 Sum_probs=189.2
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||.||+|+++.+|+.||||+++... .........|.+++... +||||+++++++.. ....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-----CCEEEEEE
Confidence 46999999999999999999999999997542 22344567788888765 89999999998654 36889999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 76 EFLNGGDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 9999999999987654 288999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchh
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+....... .
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~~~~~-~- 211 (316)
T cd05620 147 VFGD--------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFESIRV-D- 211 (316)
T ss_pred ccCC--------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHh-C-
Confidence 2211 122345689999999999999999999999999999999999999964321 111111100 0
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMT-DVV 994 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~-evl 994 (1009)
.+.. + . ....++.+++.+|++.||++||++. ++.
T Consensus 212 ----~~~~---~-------~----~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 ----TPHY---P-------R----WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ----CCCC---C-------C----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0000 0 0 1123467899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=332.58 Aligned_cols=208 Identities=23% Similarity=0.312 Sum_probs=173.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|.+.+.||+|+||+||+|..+.+++.||||++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-----AQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCe
Confidence 36888999999999999999999999999999986432 2223567889999999999999999998654 468
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG 146 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG 146 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence 899999999999999997654 388899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCc---------ccc------------------------------CCccccccccccccCccccCCCCCC
Q 047768 858 LAKFLSASPLGNV---------VET------------------------------PSSSIGVKGTIGYVAPEYGLGGEAS 898 (1009)
Q Consensus 858 la~~~~~~~~~~~---------~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 898 (1009)
+++.......... ... ........||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 226 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence 9974322100000 000 0001124699999999999999999
Q ss_pred CcccchHHHHHHHHHHhCCCCCcc
Q 047768 899 MRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 899 ~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
.++|||||||++|||++|+.||..
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCC
Confidence 999999999999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=331.36 Aligned_cols=276 Identities=18% Similarity=0.209 Sum_probs=201.1
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccc-cCCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSID-FKGV 775 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~ 775 (1009)
..++|.+.+.||+|+||.||+|.+...++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999998899999999986432 223457788999999999999999999865432 2233
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||++ ++|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence 46799999996 578777753 278889999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||....... .......
T Consensus 170 fG~a~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~ 239 (364)
T cd07875 170 FGLARTAGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIE 239 (364)
T ss_pred CCCccccCCC---------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 9999865432 11223568999999999999999999999999999999999999997432211 1111111
Q ss_pred Hhc--cchhhhccCCCCCChhhhhhhcc----------------ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 936 RAL--PEKVMEIVDPSLLPLEEERTNSR----------------RVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 936 ~~~--~~~~~~~~d~~l~~~~~~r~~~~----------------~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
... ..+....+.+........++... .........++.+++.+|++.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 240 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 00010111000000000000000 00001122457899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=321.06 Aligned_cols=272 Identities=21% Similarity=0.295 Sum_probs=198.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
++|.+.+.||+|+||.||+|+++.+++.||+|+++.... .....+.+|++++++++||||+++++++... ...+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-----KSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-----CeEE
Confidence 578899999999999999999998899999999875432 2345678899999999999999999987543 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||++ ++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 151 (309)
T cd07872 81 LVFEYLD-KDLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA 151 (309)
T ss_pred EEEeCCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence 9999997 489888876543 378899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh-
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA- 937 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~- 937 (1009)
+...... .......+|+.|+|||++.+ ..++.++||||+||++|||+||+.||......+ .........
T Consensus 152 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~ 222 (309)
T cd07872 152 RAKSVPT--------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLG 222 (309)
T ss_pred eecCCCc--------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhC
Confidence 7543221 11123457899999998765 467999999999999999999999997532211 111111100
Q ss_pred --ccchhhhccCCCC---CChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 --LPEKVMEIVDPSL---LPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 --~~~~~~~~~d~~l---~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..+....+.+..- ...+...+............++.+++.+|++.||.+|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 223 TPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000111100000 000000000000000112345679999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=333.43 Aligned_cols=209 Identities=22% Similarity=0.298 Sum_probs=173.8
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||+||+|+.+.+++.||||++.... ......+.+|++++++++|+||+++++++.. .+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-----KDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCE
Confidence 36889999999999999999999899999999986432 2234568899999999999999999988654 478
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG 146 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 146 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence 899999999999999997754 278888999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCc-----------------------------------cccCCccccccccccccCccccCCCCCCCccc
Q 047768 858 LAKFLSASPLGNV-----------------------------------VETPSSSIGVKGTIGYVAPEYGLGGEASMRGG 902 (1009)
Q Consensus 858 la~~~~~~~~~~~-----------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 902 (1009)
+|........... ...........||+.|||||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 9854321000000 00001112357999999999999999999999
Q ss_pred chHHHHHHHHHHhCCCCCccc
Q 047768 903 VYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 903 vwS~Gvvl~elltg~~p~~~~ 923 (1009)
||||||++|||++|+.||...
T Consensus 227 iwSlGvilyell~G~~Pf~~~ 247 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLAD 247 (376)
T ss_pred eeeccceeeehhhCCCCCCCC
Confidence 999999999999999999743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.96 Aligned_cols=262 Identities=23% Similarity=0.346 Sum_probs=207.2
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||.||+|....+|+.||+|.++... ....+.+.+|++++++++|+|++++++++.. ...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence 57889999999999999999998899999999886432 2234678899999999999999999998654 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++...... ...+++.+++.++.++++|++|||+. +|+||||+|+||+++.++.++++|||
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~ 151 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQ--KRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhccc--CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence 89999999999999998753221 12488999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+++...... .......++..|+|||.+.+..++.++|||||||++|||++|+.||.... ..........
T Consensus 152 ~~~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~ 220 (267)
T cd08224 152 LGRFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKI 220 (267)
T ss_pred eeeeccCCC--------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhh
Confidence 987654321 11123457889999999999899999999999999999999999985321 1111111110
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
. .....+.+ .......+.+++.+|+..+|++||++.+|++++++++
T Consensus 221 ~--------~~~~~~~~----------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 221 E--------KCDYPPLP----------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred h--------cCCCCCCC----------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 00010111 1133446789999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=316.17 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=201.5
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCC-Cc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKG-VD 776 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~-~~ 776 (1009)
+.+.|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.+++++ +|+|++++++++......+ ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888999999999999999999899999999986543 3356788999999998 7999999999986542221 24
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++++|.+++..... ..+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 68899999999999999986432 2488999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccC-----CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-----GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLH 931 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~ 931 (1009)
|+++...... .......|+..|+|||++. +..++.++|||||||++|||++|+.||...... .
T Consensus 156 g~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~ 223 (272)
T cd06637 156 GVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----R 223 (272)
T ss_pred CCceeccccc--------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----H
Confidence 9998653321 1223356899999999876 346788999999999999999999998643211 1
Q ss_pred HHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 932 EFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... ..... .... ....+..++.+++.+||..+|.+|||+.|+++
T Consensus 224 ~~~~-~~~~~-----~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 224 ALFL-IPRNP-----APRL-------------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHH-HhcCC-----CCCC-------------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1100 00000 0000 01123346789999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.68 Aligned_cols=263 Identities=27% Similarity=0.406 Sum_probs=200.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeE--EEEEEeeccc-ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGML--VAVKVINLEQ-KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|++.+.||+|+||.||+|.++.++.. +|+|.++... ....+.+.+|++++.++ +|+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-----~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-----C
Confidence 35788889999999999999998777654 5777665322 22345788999999999 89999999998754 3
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCC----------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQL----------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL 845 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill 845 (1009)
...++|+||+++|+|.++++...... ....+++.+++.++.|++.|++|||+. +|+||||||+||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili 157 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 157 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence 67899999999999999997643210 112488999999999999999999998 99999999999999
Q ss_pred CCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccc
Q 047768 846 DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMF 924 (1009)
Q Consensus 846 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~ 924 (1009)
++++.+||+|||+++..... .......++..|+|||++.+..++.++|||||||++|||+| |..||....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred cCCCcEEeCccccCcccchh---------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 99999999999998643211 00111234678999999988889999999999999999998 999986432
Q ss_pred cCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 925 NEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
. .+..... +.. ..... .......+.+++.+|++.+|++||+++++++.+..+.+.
T Consensus 229 ~-----~~~~~~~-~~~-------~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 229 C-----AELYEKL-PQG-------YRLEK-----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred h-----HHHHHHH-hcC-------CcCCC-----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 1111110 000 00000 011234578999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.44 Aligned_cols=261 Identities=24% Similarity=0.371 Sum_probs=200.3
Q ss_pred ccCccCCcccccCCceEEEEEEec-----CCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHE-----NGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
.+|.+.+.||+|+||.||+|.+.. .+..||||+++..... ....+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~---- 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE---- 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC----
Confidence 356777899999999999998753 3578999999744332 235688999999999999999999987543
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCC----------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCcee
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQ----------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVL 844 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nil 844 (1009)
...++++||+.+++|.+++...... .....+++..+..++.|++.|++|+|++ +|+||||||+||+
T Consensus 81 -~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil 156 (283)
T cd05091 81 -QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL 156 (283)
T ss_pred -CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence 5678999999999999998643211 0112478889999999999999999999 9999999999999
Q ss_pred eCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCccc
Q 047768 845 LDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESM 923 (1009)
Q Consensus 845 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~ 923 (1009)
+++++.+||+|||+++........ .......+++.|+|||++.++.++.++|||||||++|||++ |..||...
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYY------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred ecCCCceEecccccccccccchhe------eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999998866432210 11122345789999999988899999999999999999998 78887642
Q ss_pred ccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 924 FNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
. ...+........ ... ....++..+.+++.+|++.+|++||++.|+++.|+.
T Consensus 231 ~-----~~~~~~~i~~~~--------~~~-----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 231 S-----NQDVIEMIRNRQ--------VLP-----------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred C-----HHHHHHHHHcCC--------cCC-----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2 112211111111 000 011344568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.19 Aligned_cols=254 Identities=26% Similarity=0.473 Sum_probs=200.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|++.+.||+|+||.||+|.+. ++..||+|.++.... ..+.+.+|+.++++++|+|++++++++.. ...+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIY 76 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcE
Confidence 357888999999999999999876 567799999865433 35678999999999999999999987532 4468
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.++++.... ..+++.++..++.+++.|++|||+. +|+||||||+||++++++.+|++|||++
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~ 149 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLA 149 (260)
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceee
Confidence 99999999999999976432 2488999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
........ .......++..|+|||+..+..++.++||||||+++|||++ |+.||..... .+.....
T Consensus 150 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~~- 216 (260)
T cd05070 150 RLIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----REVLEQV- 216 (260)
T ss_pred eeccCccc-------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHH-
Confidence 86543211 11112345678999999988899999999999999999999 8889864321 1111110
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
...... .........+.+++.+|++.+|++|||++++.+.|+.
T Consensus 217 --------~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 --------ERGYRM----------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --------HcCCCC----------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000000 0011233468899999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=316.93 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=201.3
Q ss_pred hccCccCCcccccCCceEEEEEEec-----CCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHE-----NGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 773 (1009)
.++|.+.+.||+|+||.||+|.+.. .+..||+|.+...... ....+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--- 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence 4678899999999999999999986 6788999988644322 245688999999999999999999986543
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCC-CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC---
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQL-GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM--- 849 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~--- 849 (1009)
...++||||+++++|.+++....... ....+++.++..++.|++.|++|||+. +++||||||+||+++.++
T Consensus 82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~ 156 (277)
T cd05036 82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGR 156 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCc
Confidence 56789999999999999997654221 123589999999999999999999999 999999999999998754
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGL 928 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~ 928 (1009)
.+|++|||+++........ ........+..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 157 ~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-- 228 (277)
T cd05036 157 VAKIADFGMARDIYRASYY------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-- 228 (277)
T ss_pred ceEeccCccccccCCccce------ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence 6999999999876432211 01111233568999999999999999999999999999997 99998743221
Q ss_pred cHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 929 TLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
+... .+....... ....++..+.+++.+|++.+|++||++.||++.|.
T Consensus 229 ---~~~~---------~~~~~~~~~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 ---EVME---------FVTGGGRLD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---HHHH---------HHHcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111 111000000 01123356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=325.81 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=202.5
Q ss_pred ccCCcccccCCceEEEEEEecCCeEEEEEEeeccc----ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 704 SSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ----KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 704 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.....||+|+|-+||+|.+..+|..||=-.++..+ ......|..|+.+|+.++||||++++.++.+. .....-
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~---~n~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT---DNKTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC---CCceee
Confidence 34578999999999999999999988843332221 22236899999999999999999999998764 225677
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC-CCceEEecccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGL 858 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~DfGl 858 (1009)
+|+|.+..|+|..|+++.+. ++...++.|++||++||.|||++ .|+|||||||.+||+|+. -|.|||+|.|+
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~~------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHRR------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred eeeecccCCcHHHHHHHhcc------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence 89999999999999999875 88899999999999999999997 789999999999999965 58999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
|.....+ ....++|||.|||||... ..|.+.+||||||++++||+|+..||.........+.+......
T Consensus 193 Atl~r~s----------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 193 ATLLRKS----------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK 261 (632)
T ss_pred HHHhhcc----------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC
Confidence 9977543 223378999999999866 89999999999999999999999999876555444444433334
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
|+.+..+-| .++.+++.+|+.. .++|||+.|++.
T Consensus 262 P~sl~kV~d----------------------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 262 PAALSKVKD----------------------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHhhccCC----------------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 444444433 2467899999999 999999999975
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=325.17 Aligned_cols=242 Identities=21% Similarity=0.267 Sum_probs=191.2
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCce
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
+|.+.+.||+|+||+||+|+++.+++.||||+++.... .....+..|..++... +|++|+++++++.. .+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-----MDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-----CCE
Confidence 47888999999999999999998899999999975422 2234566788888877 58999999888654 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++..... +++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGR------FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence 8999999999999999876542 88999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......
T Consensus 147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~~~~~i 213 (323)
T cd05616 147 MCKENMWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSI 213 (323)
T ss_pred CceecCCCC--------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HHHHHHH
Confidence 997543211 122245689999999999999999999999999999999999999974321 1111111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~ 990 (1009)
..... ..+ .....++.+++.+|++.||.+|++.
T Consensus 214 --------~~~~~-~~p-----------~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 214 --------MEHNV-AYP-----------KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --------HhCCC-CCC-----------CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11000 000 0122356789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.09 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=201.7
Q ss_pred ccCccCCcccccCCceEEEEEEecCCe---EEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGM---LVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.+|.+.+.||+|+||.||+|.++.+++ .||||+++... ......+..|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----SR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-----CC
Confidence 457888999999999999999876554 69999986442 2234679999999999999999999998643 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++++|.+++..... .+++.+++.++.|++.|++|||++ +++||||||+||+++.++.+|++||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~df 150 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF 150 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCC
Confidence 78999999999999999986543 388999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++........... ....+...+..|+|||++.+..++.++|||||||++||+++ |..||...... .......
T Consensus 151 g~~~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~ 225 (269)
T cd05065 151 GLSRFLEDDTSDPTY---TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIE 225 (269)
T ss_pred ccccccccCcccccc---ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHH
Confidence 998866443211000 01111122467999999999999999999999999999887 99998643211 1111110
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
.... . ....+++..+.+++.+||+.+|++||++.+++..|+++
T Consensus 226 ------------~~~~-~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 ------------QDYR-L---------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------------cCCc-C---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 0 00113345678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=323.73 Aligned_cols=242 Identities=22% Similarity=0.263 Sum_probs=192.4
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||+||+|.++.+++.||||+++... ......+.+|+++++.+ +||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-----~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-----KDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 46999999999999999889999999997542 22345677888999888 79999999998654 36789999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 76 EYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 9999999999987654 289999999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchh
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .........
T Consensus 147 ~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~~~~~~~i~---- 209 (318)
T cd05570 147 ILGG--------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----EDELFQSIL---- 209 (318)
T ss_pred CcCC--------CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----HHHHHHHHH----
Confidence 2211 11223568999999999999999999999999999999999999996432 111111110
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM-----TDVVV 995 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~-----~evl~ 995 (1009)
..... .+ ......+.+++.+|++.||++||++ .++++
T Consensus 210 ----~~~~~-~~-----------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 210 ----EDEVR-YP-----------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ----cCCCC-CC-----------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 00000 00 1123457899999999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.77 Aligned_cols=252 Identities=25% Similarity=0.324 Sum_probs=206.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~ 775 (1009)
...|.+.+.||+|.||+||+++.+.+|+.+|+|+++..... ....+.+|+++|+++. ||||+.+.+++.. .
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-----~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-----P 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-----C
Confidence 35788889999999999999999999999999999655433 2358999999999998 9999999999654 4
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC----Cce
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD----MVA 851 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~----~~~ 851 (1009)
...++|||++.||.|.+.+... .+++.++..++.|++.++.|||+. +|||||+||+|+|+... +.+
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcE
Confidence 6899999999999999999876 189999999999999999999998 99999999999999543 579
Q ss_pred EEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHH
Q 047768 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLH 931 (1009)
Q Consensus 852 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~ 931 (1009)
|++|||++...... ......+||+.|+|||++....|+.++||||+||++|.|+.|..||..........
T Consensus 179 k~~DFGla~~~~~~---------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~- 248 (382)
T KOG0032|consen 179 KLIDFGLAKFIKPG---------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL- 248 (382)
T ss_pred EEeeCCCceEccCC---------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-
Confidence 99999999977641 34556899999999999999999999999999999999999999998654321111
Q ss_pred HHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 932 EFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.... .+. ++-++.+. ......-+++..++..||..|+|+.++++.
T Consensus 249 ~i~~----~~~-~f~~~~w~---------------~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 AILR----GDF-DFTSEPWD---------------DISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHc----CCC-CCCCCCcc---------------ccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1111 111 11111111 223456789999999999999999999884
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=330.10 Aligned_cols=277 Identities=19% Similarity=0.212 Sum_probs=201.2
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccc-cCC
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSID-FKG 774 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~ 774 (1009)
...++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.... ...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 345789999999999999999999988899999999864322 23456788999999999999999999875432 123
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
....++||||+++ ++.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence 3467999999964 77777653 278889999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||....... ......
T Consensus 162 Dfg~~~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~ 231 (355)
T cd07874 162 DFGLARTAGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVI 231 (355)
T ss_pred eCcccccCCCc---------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence 99999865432 11223568999999999999999999999999999999999999996432110 011111
Q ss_pred HHh----------ccchhhhccCCCCC----Chhhhhhh----ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 935 KRA----------LPEKVMEIVDPSLL----PLEEERTN----SRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 935 ~~~----------~~~~~~~~~d~~l~----~~~~~r~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
... ........++..-. ..+...+. ...........++.+++.+|++.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 100 00011111110000 00000000 0000111123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=324.21 Aligned_cols=196 Identities=28% Similarity=0.374 Sum_probs=169.6
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC------CCCcceEEeeeeccccCCC
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR------HRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~~~~ 775 (1009)
+|.+.+.||+|+||.|.+|.+..+++.||||+++.... -..+-..|+.+|..++ --|+|++++++.. .
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-----r 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-----R 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-----c
Confidence 88999999999999999999999999999999964432 3455677999999986 3689999998654 3
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC--ceEE
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM--VAHV 853 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~--~~kl 853 (1009)
.+.|+|+|.+ .-+|+++++.+... .++...++.|+.||+.||.+||+. +|||+||||+|||+.+.. .|||
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~----Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFR----GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeE
Confidence 7899999998 55999999987653 489999999999999999999999 999999999999997554 7999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
+|||.|++.....+ ...-+..|+|||++.+.+|+.+.||||||||++||++|.+-|..
T Consensus 333 IDFGSSc~~~q~vy-----------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY-----------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred EecccccccCCcce-----------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 99999997664321 35567889999999999999999999999999999999776653
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=325.43 Aligned_cols=252 Identities=24% Similarity=0.291 Sum_probs=193.6
Q ss_pred cCccCCcccccCCceEEEEEEe---cCCeEEEEEEeeccc----ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccC
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLH---ENGMLVAVKVINLEQ----KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 773 (1009)
+|++.+.||+|+||.||+|+.. .+++.||+|+++... ....+.+.+|+++++.+ +|++|+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT---- 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec----
Confidence 4788899999999999998874 468899999986432 12235678899999999 59999999987543
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEE
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 853 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 853 (1009)
....++||||+++|+|.+++..+.. +++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 77 -~~~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl 146 (332)
T cd05614 77 -EAKLHLILDYVSGGEMFTHLYQRDN------FSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVL 146 (332)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEE
Confidence 3678999999999999999976543 88999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHH
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHE 932 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~ 932 (1009)
+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....
T Consensus 147 ~DfG~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~ 218 (332)
T cd05614 147 TDFGLSKEFLSEEK-------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSE 218 (332)
T ss_pred eeCcCCccccccCC-------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHH
Confidence 99999986533211 122245789999999998875 47899999999999999999999996432211 1111
Q ss_pred HHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 047768 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVV 995 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~ 995 (1009)
....... .++.+ .......+.+++.+|++.||++|| +++++++
T Consensus 219 ~~~~~~~------~~~~~--------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 219 VSRRILK------CDPPF--------------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHHhc------CCCCC--------------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111100 00000 001223567899999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=318.25 Aligned_cols=266 Identities=23% Similarity=0.368 Sum_probs=205.4
Q ss_pred HhccCccCCcccccCCceEEEEEEe-------cCCeEEEEEEeeccc-ccchHHHHHHHHHHHhc-CCCCcceEEeeeec
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLH-------ENGMLVAVKVINLEQ-KGGSKSFAAECEALRSI-RHRNLIKIVTICSS 769 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 769 (1009)
..++|.+.+.||+|+||.||+|++. .++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567889999999999999999853 234579999886432 22346788999999999 89999999998764
Q ss_pred cccCCCceEEEEEeccCCCCHHHHHhccCCCC----------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCC
Q 047768 770 IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQL----------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLK 839 (1009)
Q Consensus 770 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk 839 (1009)
. ...++||||+++|+|.+++....... ....+++.++..++.|++.|+.|||++ +|+|||||
T Consensus 93 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlk 164 (304)
T cd05101 93 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLA 164 (304)
T ss_pred C-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence 3 67899999999999999998653211 112478899999999999999999999 99999999
Q ss_pred CCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCC
Q 047768 840 PSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRR 918 (1009)
Q Consensus 840 ~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~ 918 (1009)
|+||+++.++.+||+|||.++........ .......++..|+|||++.+..++.++||||||+++|||++ |..
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 238 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 238 (304)
T ss_pred cceEEEcCCCcEEECCCccceeccccccc------ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999876432211 11122345678999999999999999999999999999999 788
Q ss_pred CCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 919 PTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 919 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
||... ...+.......... .. ....+...+.+++.+||+.+|++||++.|+++.|+
T Consensus 239 p~~~~-----~~~~~~~~~~~~~~--------~~-----------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~ 294 (304)
T cd05101 239 PYPGI-----PVEELFKLLKEGHR--------MD-----------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294 (304)
T ss_pred CcccC-----CHHHHHHHHHcCCc--------CC-----------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 87532 12222211100000 00 01133456889999999999999999999999998
Q ss_pred HHHH
Q 047768 999 HARQ 1002 (1009)
Q Consensus 999 ~i~~ 1002 (1009)
++..
T Consensus 295 ~~~~ 298 (304)
T cd05101 295 RILT 298 (304)
T ss_pred HHHH
Confidence 8765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=319.52 Aligned_cols=245 Identities=28% Similarity=0.368 Sum_probs=200.1
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeecccccch---HHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS---KSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
|.-.+-||.|+||.||-|.+..+...||||++....++.. ..+.+|++.+++++|||.+.+-||+... ...+
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-----~TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-----HTAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-----chHH
Confidence 4445779999999999999999999999999976655443 3578899999999999999999997542 5568
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||| -||-.|.+.-++. ++.+.++..|+.+.+.||+|||+. +.||||||+.|||+++.|.||++|||.|
T Consensus 103 LVMEYC-lGSAsDlleVhkK-----plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSA 173 (948)
T KOG0577|consen 103 LVMEYC-LGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSA 173 (948)
T ss_pred HHHHHH-hccHHHHHHHHhc-----cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccch
Confidence 999999 5688888876664 388999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCC---CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG---GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
....+. ..++|||.|||||++.. +.|+-++||||+||+..|+..+++|+..|..- ..+..++.
T Consensus 174 si~~PA------------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-SALYHIAQ- 239 (948)
T KOG0577|consen 174 SIMAPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQ- 239 (948)
T ss_pred hhcCch------------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-HHHHHHHh-
Confidence 876543 34789999999998644 78999999999999999999999997654211 01111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
--.+.+ ...+|...+..++..|++.-|.+|||.+++++.
T Consensus 240 --------NesPtL-------------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 240 --------NESPTL-------------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred --------cCCCCC-------------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111111 133677788999999999999999999988753
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=320.09 Aligned_cols=272 Identities=23% Similarity=0.312 Sum_probs=202.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
++|++.+.||+|+||.||+|.+..++..||+|.++..... ....+.+|++++++++||||+++++++... +..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-----GEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEEE
Confidence 3688999999999999999999989999999998654322 235688999999999999999999987543 6889
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+++++|.++++... .+++..+..++.|+++||+|||+.+ +++||||||+||+++.++.+||+|||++
T Consensus 76 lv~ey~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred EEeeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCc
Confidence 9999999999999998654 3889999999999999999999732 8999999999999999999999999998
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ....+......
T Consensus 148 ~~~~~~----------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~ 215 (308)
T cd06615 148 GQLIDS----------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVS 215 (308)
T ss_pred cccccc----------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccc
Confidence 754321 112356889999999998888999999999999999999999998643211 11111110000
Q ss_pred ch-hhhccCC-CCCChhhhh----------hh---ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 940 EK-VMEIVDP-SLLPLEEER----------TN---SRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 940 ~~-~~~~~d~-~l~~~~~~r----------~~---~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
.. ....... ........+ .. ...........++.+++.+|++.+|++||++.|+++.-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 216 EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00 0000000 000000000 00 00000011344688999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.66 Aligned_cols=251 Identities=32% Similarity=0.418 Sum_probs=199.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||.||+|... |..||+|.++.. ...+.+.+|+.++++++|+|++++++++.. .....+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY 76 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceE
Confidence 357888999999999999999874 788999998533 235678999999999999999999997543 235679
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+++++|.+++++... ..+++..+..++.|++.|++|||++ +|+||||||+||++++++.+|++|||++
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred EEEECCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccc
Confidence 99999999999999986543 2478999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||.... .........
T Consensus 150 ~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~~~ 213 (256)
T cd05082 150 KEASSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRVE 213 (256)
T ss_pred eeccccC-----------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHh
Confidence 7543211 12234568999999999999999999999999999998 999986321 111111110
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
..... .....++..+.+++.+|++.+|++|||++++++.|+++
T Consensus 214 ---------~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 214 ---------KGYKM----------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---------cCCCC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00000 00112345688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.32 Aligned_cols=257 Identities=22% Similarity=0.295 Sum_probs=197.8
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.+++.+.....||+|+||.||+|.+..++..||+|.+........+.+.+|++++++++|+||+++++++... ..
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 79 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-----GF 79 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-----CE
Confidence 3455566667899999999999999888999999998655444556889999999999999999999987643 67
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC-CCceEEecc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDF 856 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Df 856 (1009)
.++|+||+++++|.+++...... ...++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWGP---LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhccc---CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecc
Confidence 89999999999999999864321 0127888899999999999999998 9999999999999976 679999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCC--CCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE--ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|.+....... .......|+..|+|||++.... ++.++||||||+++|||++|+.||.......... +.
T Consensus 154 g~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--~~ 223 (268)
T cd06624 154 GTSKRLAGIN--------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--FK 223 (268)
T ss_pred hhheecccCC--------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH--hh
Confidence 9987654321 1112245789999999986644 7899999999999999999999986432111000 00
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. . ... .. ...+.....++.+++.+|++.+|.+|||+.|+++
T Consensus 224 ~-~----~~~----~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 224 V-G----MFK----IH-----------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred h-h----hhc----cC-----------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0 0 000 00 0011123345789999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=329.73 Aligned_cols=207 Identities=22% Similarity=0.306 Sum_probs=173.0
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.|++.+.||+|+||+||+|+.+.+++.||||++.... ......+.+|++++++++||||+++++++.. ....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-----~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-----KDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-----CCEE
Confidence 5888999999999999999999899999999986432 1224568899999999999999999998654 3678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++|+|.+++.+.. .+++..+..++.|++.||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence 99999999999999997654 278889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCc---------------------------------------cccCCccccccccccccCccccCCCCCCC
Q 047768 859 AKFLSASPLGNV---------------------------------------VETPSSSIGVKGTIGYVAPEYGLGGEASM 899 (1009)
Q Consensus 859 a~~~~~~~~~~~---------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 899 (1009)
++.......... ...........||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 864321100000 00001112357999999999999999999
Q ss_pred cccchHHHHHHHHHHhCCCCCcc
Q 047768 900 RGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 900 ~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
++||||+||++|||++|+.||..
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCC
Confidence 99999999999999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=325.32 Aligned_cols=238 Identities=25% Similarity=0.276 Sum_probs=186.7
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHH-HHHhcCCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECE-ALRSIRHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||+||+|+++.+|+.||||++..... .....+..|.. +++.++||||+++++++.. ....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence 469999999999999998999999999964321 12234455554 4678899999999988654 36789999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 76 DYVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred cCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 9999999999997654 388999999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchh
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.......
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~--- 210 (323)
T cd05575 147 IEHS--------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDNILN--- 210 (323)
T ss_pred ccCC--------CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHHHHc---
Confidence 2211 12234568999999999999999999999999999999999999997432 1122111111
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHH
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMT 991 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~ 991 (1009)
...... ......+.+++.+|++.||++||++.
T Consensus 211 -----~~~~~~------------~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 211 -----KPLRLK------------PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -----CCCCCC------------CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 100000 01134577999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.74 Aligned_cols=261 Identities=25% Similarity=0.418 Sum_probs=202.7
Q ss_pred hccCccCCcccccCCceEEEEEEecCCe----EEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGM----LVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
.++|...+.||+|+||.||+|.+..++. .||+|.+..... .....+.+|+.++++++||||++++++|..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS----- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence 3567888999999999999999876665 578888754322 123468899999999999999999998753
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
...++++||+++|+|.+++..... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~ 151 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKIT 151 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEc
Confidence 235789999999999999987543 388999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 933 (1009)
|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... ....+
T Consensus 152 Dfg~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~ 223 (303)
T cd05110 152 DFGLARLLEGDEK------EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDL 223 (303)
T ss_pred cccccccccCccc------ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH
Confidence 9999986643211 011222345778999999999999999999999999999998 89998643211 11111
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
.. ..... + ....+...+.+++..||..+|++||+++|+++.++++.++.
T Consensus 224 ~~------------~~~~~-~---------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 224 LE------------KGERL-P---------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HH------------CCCCC-C---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 11 00000 0 00112345789999999999999999999999999876553
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=316.54 Aligned_cols=268 Identities=25% Similarity=0.376 Sum_probs=199.0
Q ss_pred hccCccCCcccccCCceEEEEEEecC--------------CeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHEN--------------GMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIV 764 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~--------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~ 764 (1009)
.++|.+.+.||+|+||.||+|..... ...||+|+++.... .....+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 35789999999999999999987532 23589999864422 2235688999999999999999999
Q ss_pred eeeeccccCCCceEEEEEeccCCCCHHHHHhccCCC------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCC
Q 047768 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQ------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDL 838 (1009)
Q Consensus 765 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdl 838 (1009)
+++... ...++||||+++++|.+++...... .....+++..+..++.|++.|++|||+. +++||||
T Consensus 84 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dl 155 (295)
T cd05097 84 GVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDL 155 (295)
T ss_pred EEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 997543 6789999999999999999654311 1123478899999999999999999999 9999999
Q ss_pred CCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh--C
Q 047768 839 KPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT--R 916 (1009)
Q Consensus 839 k~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--g 916 (1009)
||+||++++++.+|++|||+++........ .......++..|+|||+..++.++.++|||||||++|||++ |
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~ 229 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYY------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK 229 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCcce------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCC
Confidence 999999999999999999999865432110 11122345778999999999999999999999999999998 5
Q ss_pred CCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 917 RRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 917 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
..||...... ................. .. ......+..+.+++.+|++.||++||++++|++.
T Consensus 230 ~~p~~~~~~~--~~~~~~~~~~~~~~~~~----~~-----------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 292 (295)
T cd05097 230 EQPYSLLSDE--QVIENTGEFFRNQGRQI----YL-----------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHF 292 (295)
T ss_pred CCCCcccChH--HHHHHHHHhhhhccccc----cC-----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 5676543211 01110000000000000 00 0011223568899999999999999999999998
Q ss_pred HH
Q 047768 997 LC 998 (1009)
Q Consensus 997 L~ 998 (1009)
|+
T Consensus 293 l~ 294 (295)
T cd05097 293 LR 294 (295)
T ss_pred Hh
Confidence 85
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=320.26 Aligned_cols=268 Identities=24% Similarity=0.364 Sum_probs=202.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCC----------------eEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENG----------------MLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIK 762 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 762 (1009)
.++|.+.+.||+|+||.||+|.+...+ ..||+|++..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357889999999999999999876433 5689999865432 23467889999999999999999
Q ss_pred EEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCC-----CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecC
Q 047768 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQL-----GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGD 837 (1009)
Q Consensus 763 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrd 837 (1009)
+++++... ...++|+||+++++|.+++....... ....+++..++.++.|++.|++|||+. +|+|||
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d 155 (296)
T cd05051 84 LLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155 (296)
T ss_pred EEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence 99987543 67899999999999999997654211 112489999999999999999999998 999999
Q ss_pred CCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh--
Q 047768 838 LKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-- 915 (1009)
Q Consensus 838 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-- 915 (1009)
|||+||+++.++.++++|||+++........ .......++..|+|||++.+..++.++|||||||++|||++
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 229 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYY------RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcce------eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence 9999999999999999999999865432211 11123446788999999998899999999999999999998
Q ss_pred CCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 916 RRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 916 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
|..||....... ............ +... . ......++.++.+++.+|++.||++|||+.|+++
T Consensus 230 ~~~p~~~~~~~~--~~~~~~~~~~~~-----~~~~---~-------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 230 REQPYEHLTDQQ--VIENAGHFFRDD-----GRQI---Y-------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCCCCCcChHH--HHHHHHhccccc-----cccc---c-------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 677775432110 001000000000 0000 0 0001123356899999999999999999999998
Q ss_pred HHH
Q 047768 996 KLC 998 (1009)
Q Consensus 996 ~L~ 998 (1009)
.|+
T Consensus 293 ~L~ 295 (296)
T cd05051 293 FLQ 295 (296)
T ss_pred Hhc
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=312.97 Aligned_cols=258 Identities=28% Similarity=0.446 Sum_probs=201.6
Q ss_pred ccCccCCcccccCCceEEEEEEecCC---eEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENG---MLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.+|.+.+.||+|+||.||+|.++.++ ..||+|.++.... ...+.+.+|+.++++++||||+++++++.. .+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----SK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CC
Confidence 57888999999999999999986433 4799998864322 234678999999999999999999998754 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++++|.+++..... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++||
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~df 150 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDG-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDF 150 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCC
Confidence 78999999999999999986543 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++........ ........++..|+|||++.+..++.++||||||+++||+++ |+.||...... +...
T Consensus 151 g~~~~~~~~~~~-----~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----~~~~ 220 (267)
T cd05066 151 GLSRVLEDDPEA-----AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----DVIK 220 (267)
T ss_pred Ccccccccccce-----eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----HHHH
Confidence 999876542210 011112234568999999999999999999999999999887 99998643211 1111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
.. .+. .. .+ ....++..+.+++.+|++.+|.+||+|.++++.|.++
T Consensus 221 ~~--------~~~-~~-~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 221 AI--------EEG-YR-LP---------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HH--------hCC-Cc-CC---------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 000 00 00 0112344678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=324.21 Aligned_cols=268 Identities=24% Similarity=0.374 Sum_probs=202.7
Q ss_pred hccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeeccccc-chHHHHHHHHHHHhc-CCCCcceEEeeeecccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKG-GSKSFAAECEALRSI-RHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 772 (1009)
.++|.+.+.||+|+||+||+|.+. .+++.||||+++..... ....+.+|+.++.++ +||||++++++|...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence 357999999999999999999853 35789999999654322 235688899999999 689999999987542
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCC---------------------------------------------------
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQL--------------------------------------------------- 801 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 801 (1009)
....++||||+++|+|.+++.......
T Consensus 84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 346789999999999999987532100
Q ss_pred ----------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCCCCCCcc
Q 047768 802 ----------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVV 871 (1009)
Q Consensus 802 ----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 871 (1009)
....+++.++..++.|+++|++|||++ +|+||||||+||++++++.+|++|||+++........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--- 235 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--- 235 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcch---
Confidence 012368888999999999999999999 9999999999999999999999999999865332110
Q ss_pred ccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccchhhhccCCCC
Q 047768 872 ETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSL 950 (1009)
Q Consensus 872 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 950 (1009)
.......++..|+|||++.+..++.++||||||+++|||++ |..||...... ...... .... ..
T Consensus 236 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~-~~~~-------~~ 300 (343)
T cd05103 236 ---VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCRR-LKEG-------TR 300 (343)
T ss_pred ---hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc----HHHHHH-Hhcc-------CC
Confidence 11112345678999999999999999999999999999997 89998643211 011110 0000 00
Q ss_pred CChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 951 LPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 951 ~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
...+ .....++.+++.+||+.+|++|||+.|+++.|+.+.++
T Consensus 301 ~~~~-----------~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 301 MRAP-----------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCC-----------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0000 01123578999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=318.03 Aligned_cols=270 Identities=24% Similarity=0.339 Sum_probs=206.7
Q ss_pred hccCccCCcccccCCceEEEEEEec-------CCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeecc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHE-------NGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSSI 770 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 770 (1009)
.++|.+.+.||+|+||.||+|++.. ++..||+|.++.... .....+.+|+++++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3579999999999999999998743 235799999875422 2345688899999999 799999999997643
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCC----------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCC
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQL----------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKP 840 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~ 840 (1009)
...++||||+++|+|.+++....... ....+++.++..++.|++.|++|||+. +++||||||
T Consensus 97 -----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 168 (307)
T cd05098 97 -----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168 (307)
T ss_pred -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence 57899999999999999998653211 112488999999999999999999998 999999999
Q ss_pred CceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCC
Q 047768 841 SNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRP 919 (1009)
Q Consensus 841 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p 919 (1009)
+||+++.++.+||+|||.++........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p 242 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYY------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchh------hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999765432110 11112234578999999999999999999999999999998 8888
Q ss_pred CcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 920 TESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
|... ......... ...... .....+..++.+++.+|++.+|++||++.||++.|.+
T Consensus 243 ~~~~-----~~~~~~~~~---------~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 243 YPGV-----PVEELFKLL---------KEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred CCcC-----CHHHHHHHH---------HcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 8532 112211111 000000 0011233567899999999999999999999999999
Q ss_pred HHHhhhcC
Q 047768 1000 ARQNFLGQ 1007 (1009)
Q Consensus 1000 i~~~~~~~ 1007 (1009)
+.+....+
T Consensus 299 ~~~~~~~~ 306 (307)
T cd05098 299 ILALTSNQ 306 (307)
T ss_pred HHHHhhcC
Confidence 88765443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=315.58 Aligned_cols=268 Identities=21% Similarity=0.318 Sum_probs=207.9
Q ss_pred HhccCccCCcccccCCceEEEEEEec----CCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHE----NGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 773 (1009)
..++|.+.+.||+|+||.||+|.+.. .+..||+|++..... .....+.+|+.++++++|+||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED--- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence 34688899999999999999999875 268899998864322 2345688999999999999999999987542
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCC--CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCce
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQL--GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 851 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 851 (1009)
....++++||+++|+|.+++....... ....+++.+++.++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQV 156 (280)
T ss_pred -CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcE
Confidence 356789999999999999997643210 113589999999999999999999998 99999999999999999999
Q ss_pred EEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccH
Q 047768 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTL 930 (1009)
Q Consensus 852 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~ 930 (1009)
|++|||+++.+...... .......++..|+|||++.+..++.++|||||||++||+++ |+.||.....
T Consensus 157 kl~d~g~~~~~~~~~~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 225 (280)
T cd05043 157 KITDNALSRDLFPMDYH------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP----- 225 (280)
T ss_pred EECCCCCcccccCCceE------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-----
Confidence 99999999866443211 01112345778999999999999999999999999999999 9999864311
Q ss_pred HHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 931 HEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
..+... +...... .....++.++.+++.+||+.||++|||+.|+++.|+.+.++
T Consensus 226 ~~~~~~---------~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 226 FEMAAY---------LKDGYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHHHHH---------HHcCCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 111110 0000000 00112345688999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=327.30 Aligned_cols=208 Identities=21% Similarity=0.306 Sum_probs=176.7
Q ss_pred HHHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeec
Q 047768 693 YKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSS 769 (1009)
Q Consensus 693 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 769 (1009)
..+.....++|++.+.||+|+||.||+|+++.+++.||+|+++... ......+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4445556689999999999999999999999999999999986432 2223567889999999999999999988654
Q ss_pred cccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC
Q 047768 770 IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM 849 (1009)
Q Consensus 770 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 849 (1009)
....++||||+++|+|.+++.... +++..+..++.|++.||.|||++ +|+||||||+||+++.++
T Consensus 115 -----~~~~~lv~Ey~~gg~L~~~~~~~~-------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 115 -----DRYLYMVMEYMPGGDLVNLMSNYD-------VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG 179 (371)
T ss_pred -----CCEEEEEEcCCCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCC
Confidence 377899999999999999997643 78888999999999999999999 999999999999999999
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCC----CCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG----EASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 180 ~ikL~DfG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 180 HLKLADFGTCMKMNKEGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CEEEEeCCceeEcCcCCc-------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 999999999987643211 112245799999999998754 378999999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.17 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=196.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|++++++++||||+++++++... ...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEE
Confidence 367888999999999999999988999999999865422 2245788999999999999999999987653 6778
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+++++|..+. .+++..+..++.|++.|+.|||+. +|+|+||||+||+++.++.+||+|||++
T Consensus 76 lv~e~~~~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~ 142 (279)
T cd06619 76 ICTEFMDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVS 142 (279)
T ss_pred EEEecCCCCChHHhh----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 999999999997652 267888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccH--HHHHHHh
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL--HEFAKRA 937 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~--~~~~~~~ 937 (1009)
...... ......||..|+|||++.+..++.++||||||+++|||++|+.||.......... ......
T Consensus 143 ~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~- 211 (279)
T cd06619 143 TQLVNS----------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC- 211 (279)
T ss_pred eecccc----------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-
Confidence 765322 1223568999999999999999999999999999999999999997533221110 111100
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
+.+......+ ......++.+++.+|++.+|++||++.|+++.
T Consensus 212 -------~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 212 -------IVDEDPPVLP----------VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -------HhccCCCCCC----------CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000000000 01122357899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=314.19 Aligned_cols=270 Identities=23% Similarity=0.366 Sum_probs=202.9
Q ss_pred ccCccCCcccccCCceEEEEEEe----cCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLH----ENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
+.|++.+.||+|+||.||.|++. .++..||+|.++... ....+.+.+|++++++++|||++++++++... +.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence 35788899999999999999853 467899999986443 22346789999999999999999999987542 23
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++++|.+++.+... .+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~d 152 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD 152 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECC
Confidence 567899999999999999976532 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++........ ........++..|+|||++.+..++.++|||||||++|||+|++.|+...... ..+...
T Consensus 153 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~ 224 (284)
T cd05079 153 FGLTKAIETDKEY-----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIG 224 (284)
T ss_pred CccccccccCccc-----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhcc
Confidence 9999876432210 01112345677899999999889999999999999999999988765421110 000000
Q ss_pred Hhc----cchhhhcc-CCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 936 RAL----PEKVMEIV-DPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 936 ~~~----~~~~~~~~-d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
... .......+ +.... .....+...+.+++.+|++.+|++||++.++++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 225 PTHGQMTVTRLVRVLEEGKRL-----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccccccHHHHHHHHHcCccC-----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000 00000000 00000 01112445789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=329.14 Aligned_cols=275 Identities=20% Similarity=0.219 Sum_probs=199.2
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|++.+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+++++.++|+||+++++++...........+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999998899999999985432 22346788999999999999999999987654322223689
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+. ++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred EEeeccc-cCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence 9999996 68888886543 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||....... ..........
T Consensus 151 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g 222 (372)
T cd07853 151 RVEEPDES-------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLG 222 (372)
T ss_pred eecccCcc-------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcC
Confidence 86543211 112234578999999998774 47899999999999999999999997432210 1111111000
Q ss_pred c----------chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 939 P----------EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 939 ~----------~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
. +.....+.......+. .... .....+..+++.+++.+|++.||++|||+.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 223 TPSLEAMRSACEGARAHILRGPHKPPS-LPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCCHHHHHHhhHHHHHHHHhCCCCCCc-hHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 0000001000000000 0000 00011123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=309.14 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=194.0
Q ss_pred CcccccCCceEEEEEEec---CCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHE---NGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||.||+|.+.. .+..||+|.+.... ....+.+.+|+.+++.++|||++++++++... ....++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence 468999999999998753 34679999885322 22346788999999999999999999987532 24578999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+.+|+|.+++..... ..++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||+++..
T Consensus 77 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 77 PYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred ecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccc
Confidence 99999999999976543 267788899999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhC-CCCCcccccCCccHHHHHHHhccch
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNEGLTLHEFAKRALPEK 941 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
....... ........++..|+|||++.+..++.++|||||||++|||++| ..||.... ........
T Consensus 149 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~~~~~---- 215 (262)
T cd05058 149 YDKEYYS----VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SFDITVYL---- 215 (262)
T ss_pred cCCccee----ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH----
Confidence 4321100 0111234467789999999888999999999999999999995 55554321 11111111
Q ss_pred hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 047768 942 VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQ 1002 (1009)
Q Consensus 942 ~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~ 1002 (1009)
........ ....+..+.+++.+||+.+|++||++.|+++.++++..
T Consensus 216 ----~~~~~~~~-----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 216 ----LQGRRLLQ-----------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----hcCCCCCC-----------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00000000 01123468899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.37 Aligned_cols=267 Identities=22% Similarity=0.382 Sum_probs=200.2
Q ss_pred ccCccCCcccccCCceEEEEEEec----------------CCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHE----------------NGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKI 763 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l 763 (1009)
++|++.++||+|+||.||+|.+.. ++..||+|+++.... .....+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 468999999999999999986532 345799999865432 234678999999999999999999
Q ss_pred EeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCC-----CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCC
Q 047768 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQL-----GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDL 838 (1009)
Q Consensus 764 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdl 838 (1009)
++++... +..++||||+++|+|.+++....... ....+++.++..++.|++.|++|||+. +++||||
T Consensus 85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl 156 (296)
T cd05095 85 LAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL 156 (296)
T ss_pred EEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence 9987543 56799999999999999997654221 113478889999999999999999999 9999999
Q ss_pred CCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh--C
Q 047768 839 KPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT--R 916 (1009)
Q Consensus 839 k~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--g 916 (1009)
||+||+++.++.+|++|||+++.+...... .......++..|+|||...++.++.++|||||||++|||++ |
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~ 230 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYY------RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK 230 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcce------eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCC
Confidence 999999999999999999999865432211 11112334678999999888899999999999999999998 6
Q ss_pred CCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 917 RRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 917 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
..||...... +...... +...........+ ....++..+.+++.+||+.||++||++.||.+.
T Consensus 231 ~~p~~~~~~~-----~~~~~~~-~~~~~~~~~~~~~-----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 293 (296)
T cd05095 231 EQPYSQLSDE-----QVIENTG-EFFRDQGRQVYLP-----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHAT 293 (296)
T ss_pred CCCccccChH-----HHHHHHH-HHHhhccccccCC-----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 7787643221 1111100 0000000000000 011234578899999999999999999999998
Q ss_pred HH
Q 047768 997 LC 998 (1009)
Q Consensus 997 L~ 998 (1009)
|+
T Consensus 294 l~ 295 (296)
T cd05095 294 LL 295 (296)
T ss_pred Hh
Confidence 86
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.88 Aligned_cols=244 Identities=22% Similarity=0.306 Sum_probs=190.1
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||+||+|+.+.+++.||||+++.... ...+.+.+|+.++.++ +||+|+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEEEEEE
Confidence 469999999999999998999999999975422 2235678899999888 69999999998654 36789999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 76 EYVNGGDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 9999999999887654 389999999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccC-CccHHHHHHHhccch
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNE-GLTLHEFAKRALPEK 941 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~ 941 (1009)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..............
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~- 217 (327)
T cd05617 147 LGPG--------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE- 217 (327)
T ss_pred cCCC--------CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-
Confidence 2211 1223457899999999999999999999999999999999999999643221 11111111111100
Q ss_pred hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHH
Q 047768 942 VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMT 991 (1009)
Q Consensus 942 ~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~ 991 (1009)
... ..+ ......+.+++.+|++.||++|++++
T Consensus 218 ------~~~-~~p-----------~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 218 ------KPI-RIP-----------RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred ------CCC-CCC-----------CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 000 000 01123467899999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=317.54 Aligned_cols=260 Identities=24% Similarity=0.388 Sum_probs=201.8
Q ss_pred hccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeecccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 772 (1009)
.++|.+.+.||+|+||.||+|.+. .++..||||+++.... ...+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-- 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence 457899999999999999999863 3456899999864432 2245788999999999 799999999987643
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceE
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 852 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 852 (1009)
+..++||||+++|+|.++++.... ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+|
T Consensus 112 ---~~~~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 112 ---GPILVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred ---CceEEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEE
Confidence 568999999999999999976432 1389999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHH
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLH 931 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~ 931 (1009)
++|||+++........ .......++..|+|||++.+..++.++||||+||++|||++ |+.||...... .
T Consensus 182 l~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~----~ 251 (302)
T cd05055 182 ICDFGLARDIMNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD----S 251 (302)
T ss_pred ECCCcccccccCCCce------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch----H
Confidence 9999999865432100 01112345788999999999999999999999999999998 99998643211 0
Q ss_pred HHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 932 EFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
.. ...++....... ......++.+++.+|+..+|++|||+.|+++.|++.
T Consensus 252 ~~---------~~~~~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 252 KF---------YKLIKEGYRMAQ----------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HH---------HHHHHcCCcCCC----------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11 011111000000 001124578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=314.54 Aligned_cols=275 Identities=27% Similarity=0.396 Sum_probs=207.4
Q ss_pred ccCccCCcccccCCceEEEEEEec----CCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHE----NGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
++|.+.+.||+|+||.||+|++.. +++.||||+++..... ..+.+.+|++++++++|+||+++++++... +.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CC
Confidence 467778999999999999999753 4789999999755432 356899999999999999999999987542 34
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence 578999999999999999987653 389999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||.+.......... .......++..|+|||...+..++.++||||||+++|||++|+.|+...............
T Consensus 153 fg~~~~~~~~~~~~-----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 227 (284)
T cd05038 153 FGLAKVLPEDKDYY-----YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ 227 (284)
T ss_pred cccccccccCCcce-----eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccc
Confidence 99998765321100 1111234566799999999889999999999999999999999997643221111000000
Q ss_pred -HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 936 -RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 936 -~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
......+.+.+..... ......++.++.+++.+|++.+|++||||.||+++|+.++
T Consensus 228 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 228 GQMIVTRLLELLKEGER----------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred ccccHHHHHHHHHcCCc----------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 0000011111111110 0111234467899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=313.24 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=201.5
Q ss_pred ccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
++|...++||+|+||.||+|... .++..||+|.+..........+.+|++++++++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG----- 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-----
Confidence 46778899999999999999753 34678999988654444456899999999999999999999986543
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCC---------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQ---------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD 846 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 846 (1009)
...++|+||+++++|.+++...... .....+++..+..++.|++.|++|||+. +++||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence 5679999999999999999765421 1113488999999999999999999998 999999999999999
Q ss_pred CCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCccccc
Q 047768 847 HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFN 925 (1009)
Q Consensus 847 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~ 925 (1009)
+++.+||+|||+++........ .......+++.|+|||+..+..++.++|||||||++|||++ |+.||.....
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 230 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYY------RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230 (280)
T ss_pred CCCCEEECCCCceeEcCCCcee------ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence 9999999999999765432110 11112345788999999999999999999999999999999 8999864321
Q ss_pred CCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 926 EGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
. ..... .....-.. ....++..+.+++.+||+.||.+||++.||.+.|+
T Consensus 231 ~-----~~~~~--------~~~~~~~~-----------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 231 T-----EAIEC--------ITQGRELE-----------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-----HHHHH--------HHcCccCC-----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1 11100 00000000 00123456789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.34 Aligned_cols=251 Identities=20% Similarity=0.270 Sum_probs=200.4
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
+|++.+.||+|+||.||++++..+++.||+|.++... ....+.+.+|+.++++++|+|++++.+++.. ....++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-----DGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEE
Confidence 4778899999999999999999899999999986433 2234678889999999999999999998654 368899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
|+||+++|+|.+++..... ..+++..++.++.|++.|+.|||+. +|+|+||||+||++++++.++++|||.++
T Consensus 76 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEeeCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence 9999999999999875432 1378899999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
...... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... ...........
T Consensus 149 ~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~~~~ 215 (255)
T cd08219 149 LLTSPG--------AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKVCQG 215 (255)
T ss_pred eecccc--------cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHHhcC
Confidence 654321 11223568899999999999899999999999999999999999996421 11111111000
Q ss_pred hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 941 ~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.....+ ......+.+++.+||+.||++||++.|++..
T Consensus 216 --------~~~~~~-----------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 --------SYKPLP-----------SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --------CCCCCC-----------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 000000 1123357799999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=313.49 Aligned_cols=261 Identities=23% Similarity=0.398 Sum_probs=202.4
Q ss_pred hccCccCCcccccCCceEEEEEEecC-----CeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHEN-----GMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 773 (1009)
.++|.+.+.||+|+||.||+|.++.. +..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC---
Confidence 45788899999999999999998643 37899999854432 2245788999999999999999999986543
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCC----CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQL----GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM 849 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 849 (1009)
...++||||+++|+|.+++....... ....+++..+..++.|++.|+.|||+. +|+||||||+||+++.++
T Consensus 82 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~ 156 (277)
T cd05032 82 --QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL 156 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence 67899999999999999997643211 112478889999999999999999998 999999999999999999
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGL 928 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~ 928 (1009)
.+||+|||+++........ .......++..|+|||.+.++.++.++|||||||++||+++ |+.||.....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--- 227 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYY------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--- 227 (277)
T ss_pred CEEECCcccchhhccCccc------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---
Confidence 9999999999866443211 11122346789999999998899999999999999999998 8999864221
Q ss_pred cHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 929 TLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
....... .+......+ ..+..++.+++.+|++.+|++|||+.|+++.|+
T Consensus 228 --~~~~~~~--------~~~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 228 --EEVLKFV--------IDGGHLDLP-----------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --HHHHHHH--------hcCCCCCCC-----------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111110 011000111 122456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=324.44 Aligned_cols=242 Identities=25% Similarity=0.262 Sum_probs=187.4
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHH-HHHhcCCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECE-ALRSIRHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||+||+|+++.+++.||+|++.... ......+..|.. +++.++||||+++++++.. .+..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----ADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-----CCeEEEEE
Confidence 46999999999999999899999999996432 112234444444 5677899999999988654 36789999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++..... +++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~~------~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 76 DYINGGELFYHLQRERC------FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred eCCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 99999999999976542 77888899999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchh
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+.......
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~--- 210 (325)
T cd05602 147 IEHN--------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNILN--- 210 (325)
T ss_pred ccCC--------CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHHHHh---
Confidence 3211 122345689999999999999999999999999999999999999974321 111111110
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...... ......+.+++.+|++.||.+||++.+.+.
T Consensus 211 -----~~~~~~------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 211 -----KPLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred -----CCcCCC------------CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 000000 012235678999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=314.76 Aligned_cols=264 Identities=22% Similarity=0.363 Sum_probs=202.1
Q ss_pred HhccCccCCcccccCCceEEEEEEec-----CCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeecccc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHE-----NGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 772 (1009)
..++|++.+.||+|+||.||+|..+. .+..||+|.++.... .....+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-- 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 45689999999999999999997652 356899998854332 1234678899999999999999999986543
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCC----CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQ----LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD 848 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 848 (1009)
...++||||+++|+|.+++...... .+....++..+..++.|++.|++|||++ +|+||||||+||+++++
T Consensus 82 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~ 155 (288)
T cd05061 82 ---QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 155 (288)
T ss_pred ---CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence 5679999999999999999764321 1123467788899999999999999999 99999999999999999
Q ss_pred CceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCC
Q 047768 849 MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEG 927 (1009)
Q Consensus 849 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~ 927 (1009)
+.+|++|||+++........ .......++..|+|||.+.++.++.++|||||||++|||++ |+.||.....
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-- 227 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYY------RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-- 227 (288)
T ss_pred CcEEECcCCccccccccccc------cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999865432210 11111235678999999999999999999999999999999 7888864221
Q ss_pred ccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 928 LTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
.+..... .+......+ ..+...+.+++.+|++.||++|||+.|+++.+.+.
T Consensus 228 ---~~~~~~~--------~~~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 228 ---EQVLKFV--------MDGGYLDQP-----------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ---HHHHHHH--------HcCCCCCCC-----------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111111 111111111 12235688999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.31 Aligned_cols=268 Identities=22% Similarity=0.285 Sum_probs=205.8
Q ss_pred HHHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccc
Q 047768 693 YKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSID 771 (1009)
Q Consensus 693 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 771 (1009)
++++....++|++.+.||+|+||.||+|.++.+++.||+|+++... .....+.+|+.+++++ +||||+++++++....
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3445566789999999999999999999999899999999875422 2346788899999999 6999999999886544
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCce
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 851 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 851 (1009)
.......++||||+++++|.+++...... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKR--GERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhcc--CccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 45557789999999999999988643211 12478899999999999999999998 99999999999999999999
Q ss_pred EEeccccccccCCCCCCCccccCCccccccccccccCccccCC-----CCCCCcccchHHHHHHHHHHhCCCCCcccccC
Q 047768 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-----GEASMRGGVYSYGILLLEIFTRRRPTESMFNE 926 (1009)
Q Consensus 852 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~ 926 (1009)
|++|||+++...... .......|++.|+|||++.. ..++.++||||+||++|||++|+.||......
T Consensus 164 kl~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~ 235 (286)
T cd06638 164 KLVDFGVSAQLTSTR--------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235 (286)
T ss_pred EEccCCceeecccCC--------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence 999999998664321 11123468999999998753 45788999999999999999999998643211
Q ss_pred CccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 927 GLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
..... .. ....... .....+..++.+++.+|++.||++|||+.|+++.
T Consensus 236 ----~~~~~--~~----~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 236 ----RALFK--IP----RNPPPTL------------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ----HHHhh--cc----ccCCCcc------------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11100 00 0000000 0001123457899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=325.23 Aligned_cols=242 Identities=24% Similarity=0.263 Sum_probs=188.2
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHH-HHHhcCCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECE-ALRSIRHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||+||+|+.+.+|+.||||++..... .....+..|.. +++.++||||+++++++.. .+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----TEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-----CCEEEEEE
Confidence 469999999999999998999999999964421 22344555555 4677899999999988654 36789999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 76 DFVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 9999999999887654 388999999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchh
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.......
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~~~~--- 210 (325)
T cd05604 147 IAQS--------DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----VAEMYDNILH--- 210 (325)
T ss_pred CCCC--------CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----HHHHHHHHHc---
Confidence 2211 12234568999999999999999999999999999999999999996432 1122111111
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..+...+ .....+.+++.+|++.+|.+||++.+.++
T Consensus 211 -----~~~~~~~------------~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 211 -----KPLVLRP------------GASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred -----CCccCCC------------CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 1110000 11234678999999999999999864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=319.31 Aligned_cols=202 Identities=26% Similarity=0.346 Sum_probs=172.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|.+.+.||+|+||+||+|+.+.+++.||||+++... ....+.+.+|+.++..++|+||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-----ENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-----CCe
Confidence 46889999999999999999999899999999996422 2234568889999999999999999998654 378
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++.+... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg 147 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG 147 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence 8999999999999999976433 388999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCC-----CCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-----GEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
++........ .......||+.|+|||++.. ..++.++||||+||++|||++|+.||..
T Consensus 148 ~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 148 SCLRLLADGT-------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ceeecCCCCC-------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 9976543211 11122468999999999863 4578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=338.23 Aligned_cols=274 Identities=19% Similarity=0.253 Sum_probs=195.7
Q ss_pred HHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCC------CcceEEeeee
Q 047768 695 ELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHR------NLIKIVTICS 768 (1009)
Q Consensus 695 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~ 768 (1009)
++....++|.+.+.||+|+||+||+|.+..+++.||||+++... ...+....|+++++.++|. +++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 33445678999999999999999999998889999999986432 2234566788888877554 5788888764
Q ss_pred ccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC
Q 047768 769 SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD 848 (1009)
Q Consensus 769 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 848 (1009)
. .....++|||++ +++|.+++.+.. .+++..+..|+.|++.||+|||+++ +||||||||+|||++.+
T Consensus 202 ~----~~~~~~iv~~~~-g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~ 268 (467)
T PTZ00284 202 N----ETGHMCIVMPKY-GPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETS 268 (467)
T ss_pred c----CCceEEEEEecc-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecC
Confidence 3 235789999988 789999887654 3899999999999999999999732 89999999999999876
Q ss_pred C----------------ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHH
Q 047768 849 M----------------VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLE 912 (1009)
Q Consensus 849 ~----------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~e 912 (1009)
+ .+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++||
T Consensus 269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~e 337 (467)
T PTZ00284 269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYE 337 (467)
T ss_pred CcccccccccccCCCCceEEECCCCccccCcc-----------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHH
Confidence 5 499999998764321 1224678999999999999999999999999999999
Q ss_pred HHhCCCCCcccccCCccHHHHHHHh---ccchh---------hhccCC------CCCChhhhhhhc-cccccHHHHHHHH
Q 047768 913 IFTRRRPTESMFNEGLTLHEFAKRA---LPEKV---------MEIVDP------SLLPLEEERTNS-RRVRNEECLVAVI 973 (1009)
Q Consensus 913 lltg~~p~~~~~~~~~~~~~~~~~~---~~~~~---------~~~~d~------~l~~~~~~r~~~-~~~~~~~~~~~l~ 973 (1009)
|++|+.||...... ......... ++..+ .++++. ...+..-.+... ...........+.
T Consensus 338 lltG~~pf~~~~~~--~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (467)
T PTZ00284 338 LYTGKLLYDTHDNL--EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLC 415 (467)
T ss_pred HHhCCCCCCCCChH--HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHH
Confidence 99999999753221 111111111 11111 111111 000000000000 0000011124577
Q ss_pred HHHhhccCCCCCCCCCHHHHHH
Q 047768 974 KTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 974 ~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
+++.+|+++||++|||+.|+++
T Consensus 416 dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 416 DLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHHHhCCcChhhCCCHHHHhc
Confidence 9999999999999999999986
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=310.16 Aligned_cols=258 Identities=23% Similarity=0.362 Sum_probs=202.8
Q ss_pred ccCccCCcccccCCceEEEEEEecC---CeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHEN---GMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
++|++.+.||+|+||.||+|.+... ...||||...... ....+.+.+|+.++++++||||+++++++.. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence 4688889999999999999998643 3468999886544 2334678999999999999999999998753 3
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|.+++..... .+++.++..++.+++.|++|||+. +++||||||+||+++.++.+|++||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~ 151 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDF 151 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccC
Confidence 46899999999999999976543 389999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++....... .......++..|+|||.+....++.++||||||+++||+++ |+.||...... +...
T Consensus 152 g~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~ 219 (270)
T cd05056 152 GLSRYLEDESY-------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----DVIG 219 (270)
T ss_pred ceeeecccccc-------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHH
Confidence 99986644311 11112234578999999988889999999999999999996 99998643221 1111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
.. ....... ....++.++.+++.+|+..+|++|||+.|+++.|++++++
T Consensus 220 ~~--------~~~~~~~-----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 220 RI--------ENGERLP-----------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HH--------HcCCcCC-----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 0000000 0112345688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=325.92 Aligned_cols=239 Identities=23% Similarity=0.290 Sum_probs=189.6
Q ss_pred CcccccCCceEEEEEEe---cCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEE
Q 047768 707 NTIGRGSFGFVYKGVLH---ENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALV 781 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 781 (1009)
+.||+|+||.||+++.. .+|+.||+|+++.... .....+.+|++++++++||||+++++++.. ....++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-----EGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCEEEEE
Confidence 57999999999998863 5689999999975432 123457789999999999999999998654 3678999
Q ss_pred EeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccc
Q 047768 782 YEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861 (1009)
Q Consensus 782 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~ 861 (1009)
|||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 77 ~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred EcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 99999999999997654 389999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccch
Q 047768 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEK 941 (1009)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..........
T Consensus 148 ~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~i~~~- 213 (318)
T cd05582 148 SIDHE--------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTMILKA- 213 (318)
T ss_pred cCCCC--------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHHHHcC-
Confidence 53321 122245689999999999998999999999999999999999999964321 1111111110
Q ss_pred hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 047768 942 VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTD 992 (1009)
Q Consensus 942 ~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~e 992 (1009)
.. ..+ ......+.+++.+|++.||++||++.+
T Consensus 214 -------~~-~~p-----------~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 214 -------KL-GMP-----------QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -------CC-CCC-----------CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 00 000 012235678999999999999999666
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=318.21 Aligned_cols=204 Identities=24% Similarity=0.323 Sum_probs=163.5
Q ss_pred CCcccccCCceEEEEEEe--cCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEe
Q 047768 706 SNTIGRGSFGFVYKGVLH--ENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYE 783 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 783 (1009)
.++||+|+||+||+|+.+ .+++.||+|+++.. .....+.+|++++++++||||+++++++... .....++|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEe
Confidence 468999999999999975 36689999998543 2345678899999999999999999986532 2356889999
Q ss_pred ccCCCCHHHHHhccCCC---CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee----CCCCceEEecc
Q 047768 784 YMQNGSLEEWLHQRDDQ---LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDF 856 (1009)
Q Consensus 784 ~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~~~kl~Df 856 (1009)
|+. ++|.+++...... .....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 985 5898887643211 1123488999999999999999999999 99999999999999 46679999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCccc
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
|+++....... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 157 G~a~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 157 GFARLFNSPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CceeccCCCCc-----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99987643211 1112234678999999999877 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=315.93 Aligned_cols=268 Identities=24% Similarity=0.370 Sum_probs=204.6
Q ss_pred hccCccCCcccccCCceEEEEEEe-------cCCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeecc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLH-------ENGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSSI 770 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 770 (1009)
.++|.+.+.||+|+||.||+|+.. .....||+|.++.... .....+.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457889999999999999999863 2345799999864322 2235688899999999 699999999987543
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCC----------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCC
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQ----------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKP 840 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~ 840 (1009)
...++|+||+++|+|.+++...... .....+++.++..++.|++.|+.|||++ +|+||||||
T Consensus 91 -----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 162 (314)
T cd05099 91 -----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA 162 (314)
T ss_pred -----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 5689999999999999999764321 0113488999999999999999999998 999999999
Q ss_pred CceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCC
Q 047768 841 SNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRP 919 (1009)
Q Consensus 841 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p 919 (1009)
+||+++.++.+|++|||.++......... ......++..|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p 236 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYK------KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236 (314)
T ss_pred eeEEEcCCCcEEEcccccccccccccccc------ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCC
Confidence 99999999999999999998664322110 0111234567999999999999999999999999999999 8888
Q ss_pred CcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 920 TESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
|.... ............. .. ....+..++.+++.+|+..+|++||++.|+++.|++
T Consensus 237 ~~~~~-----~~~~~~~~~~~~~--------~~-----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 237 YPGIP-----VEELFKLLREGHR--------MD-----------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred CCCCC-----HHHHHHHHHcCCC--------CC-----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 86432 1111111100000 00 011233467799999999999999999999999999
Q ss_pred HHHhhh
Q 047768 1000 ARQNFL 1005 (1009)
Q Consensus 1000 i~~~~~ 1005 (1009)
+.....
T Consensus 293 ~~~~~~ 298 (314)
T cd05099 293 VLAAVS 298 (314)
T ss_pred HHHHhc
Confidence 876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.34 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=197.4
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALV 781 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 781 (1009)
.|++.+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++|||++++++++... ...++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEEE
Confidence 367788999999999999999988999999998654444456788999999999999999999987543 678999
Q ss_pred EeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccc
Q 047768 782 YEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861 (1009)
Q Consensus 782 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~ 861 (1009)
+||+++++|.+++..... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+|++|||++..
T Consensus 81 ~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 81 IEFCAGGAVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred EEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccc
Confidence 999999999998875432 389999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCCCccccCCccccccccccccCccccC-----CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-----GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
..... .......|+..|+|||++. +..++.++|||||||++|||++|+.||...... +....
T Consensus 153 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~ 219 (282)
T cd06643 153 NTRTI--------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-----RVLLK 219 (282)
T ss_pred ccccc--------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-----HHHHH
Confidence 43211 1122346889999999874 455788999999999999999999998643211 11110
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
..... .+.. . .+..+..++.+++.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~-----~~~~-~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 220 IAKSE-----PPTL-A-----------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HhhcC-----CCCC-C-----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0000 0 001223467899999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=308.84 Aligned_cols=254 Identities=21% Similarity=0.291 Sum_probs=200.1
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc-----chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-----GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
+.|.+.+.||+|++|.||+|....+++.||+|.+...... ..+.+.+|++++++++||||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD----- 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----
Confidence 4688899999999999999999888999999998643211 235688899999999999999999997543
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++|+||+++++|.+++.... .+++..+..++.|++.|+.|||+. +|+||||+|+||++++++.++|+|
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d 147 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD 147 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 68899999999999999997654 378899999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++....... .........|+..|+|||++.+..++.++||||+|+++|||++|+.||..... ......
T Consensus 148 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~ 218 (263)
T cd06625 148 FGASKRLQTICS-----SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFK 218 (263)
T ss_pred cccceecccccc-----ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHHH
Confidence 999976543210 00111234578899999999999999999999999999999999999864311 111111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
...... ... .+......+.+++.+|+..+|.+|||+.|+++.
T Consensus 219 ~~~~~~--------~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 219 IATQPT--------NPQ-----------LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HhccCC--------CCC-----------CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000000 000 011233457899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=316.35 Aligned_cols=251 Identities=21% Similarity=0.271 Sum_probs=201.7
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
..+|++.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.+++.++|+|++++++++.. ....+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCEEE
Confidence 3689999999999999999999988999999999976555556778899999999999999999998754 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++.+.. +++.++..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 93 lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 93 VVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred EeecccCCCCHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccc
Confidence 9999999999999987532 78899999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....... .......+++.|+|||...+..++.++|||||||++|++++|+.||....... ..
T Consensus 163 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~----~~------ 224 (297)
T cd06656 163 AQITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----AL------ 224 (297)
T ss_pred eEccCCc--------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch----he------
Confidence 7654321 11123457889999999999999999999999999999999999996422110 00
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..... ...+ .. .........+.+++.+|++.+|++||++.++++
T Consensus 225 ---~~~~~---~~~~----~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 225 ---YLIAT---NGTP----EL--QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ---eeecc---CCCC----CC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0000 00 001122345678999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=309.18 Aligned_cols=254 Identities=24% Similarity=0.447 Sum_probs=200.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.++||+|+||.||+|..+ +++.||+|.+.... .....+.+|+.++++++|+|++++++++.. ...+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~ 76 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIY 76 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CCcE
Confidence 457888999999999999999875 67889999986433 235678999999999999999999987532 4579
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.++++|||++
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 149 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEG----IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLA 149 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcce
Confidence 99999999999999876432 2488999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
........ .......++..|+|||++....++.++||||||+++||+++ |+.||..... .+.....
T Consensus 150 ~~~~~~~~-------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~- 216 (260)
T cd05067 150 RLIEDNEY-------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----PEVIQNL- 216 (260)
T ss_pred eecCCCCc-------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHHH-
Confidence 76653211 11122345778999999999999999999999999999999 9999974321 1111110
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
...... + .....+.++.+++.+|++.+|++||+++++...|+.
T Consensus 217 --------~~~~~~-~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 217 --------ERGYRM-P---------RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --------HcCCCC-C---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 000000 0 001123468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=312.09 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=203.8
Q ss_pred ccCccCCcccccCCceEEEEEEecCCe----EEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGM----LVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.+|.+.+.||+|+||+||+|.++.+|. .||+|.++.... .....+.+|+.++++++|||+++++++|..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 578888999999999999999876554 689998764432 234578899999999999999999998753
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++|+||+++|+|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~d 152 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITD 152 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECC
Confidence 567899999999999999987543 289999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 934 (1009)
||.++........ .......++..|+|||......++.++||||||+++||+++ |+.||.... ..++.
T Consensus 153 fg~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~ 221 (279)
T cd05057 153 FGLAKLLDVDEKE------YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-----AVEIP 221 (279)
T ss_pred CcccccccCcccc------eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-----HHHHH
Confidence 9999876532110 11112234678999999988899999999999999999999 999986432 11111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
.... .......+ ..+...+.+++.+||..+|.+||++.++++.+.++.++
T Consensus 222 ~~~~--------~~~~~~~~-----------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 222 DLLE--------KGERLPQP-----------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHh--------CCCCCCCC-----------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 1110 00000000 01223577999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=299.24 Aligned_cols=260 Identities=27% Similarity=0.318 Sum_probs=202.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.+.|...+.||+|.-|+||+++.+.++..+|+|++....- ....+.+.|.+||+.++||.+..+++.+ +...
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccc
Confidence 3456777899999999999999998889999999965432 2235677899999999999999999974 4558
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
+.|+|||||+||+|...+++.... .+++..++-+|.+++-||+|||-. |||+|||||+||||.++|++-++||
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~----~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDF 223 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGK----RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDF 223 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCC----ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeec
Confidence 899999999999999999887654 599999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCC------------------------------C-C---------------c--cccCCccccccccccccC
Q 047768 857 GLAKFLSASPL------------------------------G-N---------------V--VETPSSSIGVKGTIGYVA 888 (1009)
Q Consensus 857 Gla~~~~~~~~------------------------------~-~---------------~--~~~~~~~~~~~gt~~y~a 888 (1009)
.++......+. . . . ..+..++..++||-.|.|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 99866432110 0 0 0 112234456789999999
Q ss_pred ccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHH
Q 047768 889 PEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEEC 968 (1009)
Q Consensus 889 PE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~ 968 (1009)
||++.+...+.++|-|+|||++|||+.|+.||....+.. . +..++...+... +. .+.
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-T------------l~NIv~~~l~Fp-~~---------~~v 360 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-T------------LRNIVGQPLKFP-EE---------PEV 360 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-h------------HHHHhcCCCcCC-CC---------Ccc
Confidence 999999999999999999999999999999997543331 1 222222222111 00 022
Q ss_pred HHHHHHHHhhccCCCCCCCCC----HHHHH
Q 047768 969 LVAVIKTGVACSIESPFDRME----MTDVV 994 (1009)
Q Consensus 969 ~~~l~~l~~~cl~~dp~~Rpt----~~evl 994 (1009)
..++.+++++-+..||.+|.- |.||-
T Consensus 361 s~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 361 SSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred hhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 335667788888888888876 55553
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=312.64 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=196.0
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
|+..+.||+|+||+||+|.+..+++.||+|+++.... .....+.+|++++++++|++++++.+++.. .+..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-----KDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-----CCEEE
Confidence 5667889999999999999998999999999864422 223457889999999999999999887654 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++..... ..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred EEEEeccCccHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 99999999999988865432 1489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....... ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....... ...
T Consensus 150 ~~~~~~~---------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~-~~~ 218 (285)
T cd05632 150 VKIPEGE---------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDR-RVL 218 (285)
T ss_pred eecCCCC---------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-hhh
Confidence 7653221 1123468999999999999999999999999999999999999997432110 0111111 000
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME-----MTDVVVK 996 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt-----~~evl~~ 996 (1009)
..... . ......++.+++..|++.||++||+ +.|++..
T Consensus 219 ~~~~~-----~--------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 219 ETEEV-----Y--------------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccccc-----c--------------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00000 0 0112335678999999999999999 5666553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=313.65 Aligned_cols=261 Identities=27% Similarity=0.426 Sum_probs=202.1
Q ss_pred hccCccCCcccccCCceEEEEEEec-----CCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHE-----NGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 773 (1009)
.++|++.+.||+|+||.||+|.+.. ++..||+|+++.... ...+.+.+|+.++++++|||++++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~--- 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG--- 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC---
Confidence 4678999999999999999998752 578999999864432 2245788999999999999999999987643
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCC----------------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecC
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQ----------------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGD 837 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrd 837 (1009)
...++|+||+++|+|.+++...... .....+++.+++.++.|++.|++|||+. +++|||
T Consensus 81 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d 155 (288)
T cd05050 81 --KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD 155 (288)
T ss_pred --CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 5679999999999999999754321 1123478899999999999999999998 999999
Q ss_pred CCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-C
Q 047768 838 LKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-R 916 (1009)
Q Consensus 838 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g 916 (1009)
|||+||+++.++.+|++|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~ 229 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYY------KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 229 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCccc------cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCC
Confidence 9999999999999999999998765432110 11112234678999999999999999999999999999998 8
Q ss_pred CCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 917 RRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 917 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
..||..... .+..... .+...... ...++.++.+++.+|++.+|++|||+.|+++.
T Consensus 230 ~~p~~~~~~-----~~~~~~~--------~~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~ 285 (288)
T cd05050 230 MQPYYGMAH-----EEVIYYV--------RDGNVLSC-----------PDNCPLELYNLMRLCWSKLPSDRPSFASINRI 285 (288)
T ss_pred CCCCCCCCH-----HHHHHHH--------hcCCCCCC-----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 888864321 1111111 11111100 01233568899999999999999999999998
Q ss_pred HH
Q 047768 997 LC 998 (1009)
Q Consensus 997 L~ 998 (1009)
|+
T Consensus 286 l~ 287 (288)
T cd05050 286 LQ 287 (288)
T ss_pred hh
Confidence 86
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=312.58 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=196.9
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
|+..+.||+|+||+||+|.+..+++.||||.+...... ..+.+.+|+.++++++|++++++++.+.. ....+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-----KDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-----CCEEE
Confidence 66778899999999999999999999999998643221 23457789999999999999999988654 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++..... ..+++.++..++.|++.|+.|||+. +|+||||||+||+++.++.++++|||++
T Consensus 77 lv~e~~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred EEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 99999999999999865432 2488999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....... ......|+..|+|||++.+..++.++||||+||++|||++|+.||....... .........
T Consensus 150 ~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~~~~~~~~~- 217 (285)
T cd05630 150 VHVPEGQ---------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLV- 217 (285)
T ss_pred eecCCCc---------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc--hHHHHHhhh-
Confidence 7543221 1123468999999999999999999999999999999999999997432210 000000000
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME-----MTDVVV 995 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt-----~~evl~ 995 (1009)
..... .. .......+.+++.+|++.||++||| +.|+++
T Consensus 218 ~~~~~----~~--------------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 218 KEVQE----EY--------------SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhhh----hc--------------CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00000 00 0112335679999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=322.13 Aligned_cols=273 Identities=19% Similarity=0.237 Sum_probs=198.6
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccc-cCC
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSID-FKG 774 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~ 774 (1009)
...++|.+.+.||+|+||+||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++.... ...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 345789999999999999999999988999999999864322 22356778999999999999999998865321 122
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
....++++|++ +++|.++++.. .+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 34578999988 78999888643 289999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+
T Consensus 161 Dfg~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~ 228 (343)
T cd07878 161 DFGLARQADDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRI 228 (343)
T ss_pred CCccceecCCC-----------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHH
Confidence 99999865321 223568999999999877 56899999999999999999999999643211 011111
Q ss_pred HHHhc--cch-hhhccC-------CCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 934 AKRAL--PEK-VMEIVD-------PSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 934 ~~~~~--~~~-~~~~~d-------~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
..... ... ...+.. ..+...+...... ........+.+++.+|++.||++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 229 MEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKK---IFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHH---hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11000 000 000000 0000000000000 000112346799999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=308.49 Aligned_cols=250 Identities=32% Similarity=0.467 Sum_probs=201.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||.||+|... |+.||||.++.... ..+.+.+|+.++++++|+|++++++++.. ....+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeE
Confidence 457888999999999999999874 88999999975543 45788999999999999999999998654 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++...... .+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRA----VITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccc
Confidence 999999999999999865421 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+...... ....++..|+|||++.++.++.++||||||+++||+++ |+.||...... ......
T Consensus 150 ~~~~~~~-----------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~- 212 (256)
T cd05039 150 KEASQGQ-----------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPHV- 212 (256)
T ss_pred ccccccc-----------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHH-
Confidence 8663221 01234668999999998899999999999999999998 99998643211 111100
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
....... ....++.++.+++.+|+..+|++||++.|++++|+.
T Consensus 213 --------~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 213 --------EKGYRME----------APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --------hcCCCCC----------CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0000000 001234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=320.37 Aligned_cols=243 Identities=21% Similarity=0.286 Sum_probs=190.7
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCce
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 777 (1009)
+|+..+.||+|+||+||+|+++.+|+.||||+++... ....+.+..|+++++.+. |++|+++.+++.. .+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-----VDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-----CCE
Confidence 4677899999999999999999899999999997442 223356778889988885 5777788877543 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++.... .+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg 146 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence 899999999999999987654 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......
T Consensus 147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~i 213 (323)
T cd05615 147 MCKEHMVDG--------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DELFQSI 213 (323)
T ss_pred cccccCCCC--------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHH
Confidence 987543211 112235689999999999999999999999999999999999999974321 1111111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMT 991 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~ 991 (1009)
. .... ..+ .....++.+++.+|++.+|.+|++..
T Consensus 214 ~--------~~~~-~~p-----------~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 214 M--------EHNV-SYP-----------KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred H--------hCCC-CCC-----------ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 1 1000 000 01223567899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=308.96 Aligned_cols=254 Identities=27% Similarity=0.413 Sum_probs=194.5
Q ss_pred CcccccCCceEEEEEEecCCe--EEEEEEeeccc-ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHENGM--LVAVKVINLEQ-KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||.||+|+++.++. .+|+|.++... ......+.+|+++++++ +||||+++++++... ...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEEE
Confidence 368999999999999987665 46888876322 22345788999999999 899999999997643 5679999
Q ss_pred eccCCCCHHHHHhccCCC----------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceE
Q 047768 783 EYMQNGSLEEWLHQRDDQ----------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 852 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 852 (1009)
||+++|+|.+++...... .....+++.++..++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 999999999999764321 0112478999999999999999999998 999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHH
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLH 931 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~ 931 (1009)
++|||+++..... ........+..|+|||++....++.++|||||||++|||++ |..||..... .
T Consensus 153 l~dfgl~~~~~~~---------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~ 218 (270)
T cd05047 153 IADFGLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----A 218 (270)
T ss_pred ECCCCCccccchh---------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----H
Confidence 9999998632211 00111234567999999988899999999999999999997 9999864321 1
Q ss_pred HHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 932 EFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
...... +. ..... ....+..++.+++.+|++.+|.+|||+.|++..|..+.
T Consensus 219 ~~~~~~-~~--------~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 219 ELYEKL-PQ--------GYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHHH-hC--------CCCCC----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111111 00 00000 00122345789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=308.59 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=203.3
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
++|.+.+.+|+|+||.||+|....+++.+|+|++........+.+.+|++++++++||||+++++++.. ....++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEEE
Confidence 578889999999999999999988899999999976655556789999999999999999999998654 367899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
+|||+++++|.+++..... .+++.++..++.|++.|++|||+. +|+||||+|+||++++++.+||+|||.+.
T Consensus 78 ~~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred EEeCCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence 9999999999999877532 388999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCC---CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG---EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... .... ..
T Consensus 150 ~~~~~~--------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~----~~~~-~~ 216 (262)
T cd06613 150 QLTATI--------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM----RALF-LI 216 (262)
T ss_pred hhhhhh--------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHHH-HH
Confidence 654321 112234678899999998777 8899999999999999999999998643211 1000 00
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... ......+ ........++.+++.+||+.+|..|||+++++.
T Consensus 217 ~~~---~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 217 SKS---NFPPPKL------------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred Hhc---cCCCccc------------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0000000 011233456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=318.85 Aligned_cols=273 Identities=19% Similarity=0.165 Sum_probs=196.1
Q ss_pred cCCccccc--CCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 705 SSNTIGRG--SFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 705 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
+.++||+| +|++||++..+.+|+.||||+++.... ...+.+.+|+++++.++||||+++++++... ...++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence 45789999 678999999999999999999965432 2235678899999999999999999997653 67899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
|+||+++|+|.+++..+... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.++++||+.+.
T Consensus 77 v~e~~~~~~l~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMD----GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEeccCCCcHHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence 99999999999999764321 388999999999999999999999 99999999999999999999999998765
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCC--CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG--GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
.......... ..........++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... ...
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~---- 223 (327)
T cd08227 150 SMINHGQRLR-VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKL---- 223 (327)
T ss_pred cccccccccc-ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH-HHh----
Confidence 4322110000 00011122356788999999876 468999999999999999999999997543221111 111
Q ss_pred cchhhhccCCC-------------------CCC-------hhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 047768 939 PEKVMEIVDPS-------------------LLP-------LEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTD 992 (1009)
Q Consensus 939 ~~~~~~~~d~~-------------------l~~-------~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~e 992 (1009)
........+.. ... .+................++.+++.+|++.||++|||++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e 303 (327)
T cd08227 224 NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAST 303 (327)
T ss_pred cCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHH
Confidence 01110000000 000 0000000000111233457889999999999999999999
Q ss_pred HHH
Q 047768 993 VVV 995 (1009)
Q Consensus 993 vl~ 995 (1009)
+++
T Consensus 304 ll~ 306 (327)
T cd08227 304 LLN 306 (327)
T ss_pred Hhc
Confidence 986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=329.68 Aligned_cols=196 Identities=24% Similarity=0.299 Sum_probs=168.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|++++++++|+||+++++++... ...+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVG-----GLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEE
Confidence 457899999999999999999999889999999642 23467899999999999999999987543 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|||++ .++|.+++..... .+++.+++.++.|++.||.|||++ +||||||||+|||++.++.+||+|||++
T Consensus 237 lv~e~~-~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla 307 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGARLR-----PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA 307 (461)
T ss_pred EEEEcc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCc
Confidence 999999 5799999876543 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTE 921 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~ 921 (1009)
+....... ........||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 308 ~~~~~~~~------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 308 CFARGSWS------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred eecccccc------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 86543211 112234579999999999999999999999999999999999887654
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=313.84 Aligned_cols=263 Identities=21% Similarity=0.273 Sum_probs=203.7
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+++++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEE
Confidence 3578888999999999999999988899999999865432 2346789999999999999999999997643 678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++++|.+++.... .+++..+..++.+++.|+.|||+.. +++||||+|+||+++.++.++|+|||+
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl 150 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGV 150 (284)
T ss_pred EEEEecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCc
Confidence 99999999999999987654 3889999999999999999999732 899999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... .....|+..|+|||++.+..++.++|||||||++||+++|+.||.......... ......
T Consensus 151 ~~~~~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~--~~~~~~ 218 (284)
T cd06620 151 SGELINSI----------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ--DDPMGI 218 (284)
T ss_pred ccchhhhc----------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh--hhhhHH
Confidence 86543211 113468999999999988899999999999999999999999997543221000 000000
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
.+.....+...... ....+.+..+.+++.+|++.||++|||+.|+++..
T Consensus 219 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 219 LDLLQQIVQEPPPR----------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHHhhccCCC----------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00011111100000 00112445688999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=316.06 Aligned_cols=272 Identities=21% Similarity=0.299 Sum_probs=199.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|.+.+.||+|+||.||+|.++.+++.||+|.++.... .....+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-----~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-----CCeE
Confidence 3578899999999999999999988899999999865432 234567889999999999999999999654 3678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++|+||++ ++|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 150 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGL 150 (301)
T ss_pred EEEEeccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcc
Confidence 99999996 699999876543 378999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+....... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||....... ........
T Consensus 151 ~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~--~~~~~~~~ 220 (301)
T cd07873 151 ARAKSIPT--------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE--QLHFIFRI 220 (301)
T ss_pred hhccCCCC--------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHH
Confidence 97543211 111234568899999987654 57889999999999999999999997432210 01111111
Q ss_pred ccc----hhhhccCCCCCC---hhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPE----KVMEIVDPSLLP---LEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~----~~~~~~d~~l~~---~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... ....+.+..... .+.................+.+++.+|++.||.+|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 221 LGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111 111111100000 0000000000001122345779999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=308.99 Aligned_cols=240 Identities=21% Similarity=0.354 Sum_probs=186.1
Q ss_pred CcccccCCceEEEEEEec------------CCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 707 NTIGRGSFGFVYKGVLHE------------NGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
+.||+|+||.||+|.+.. ....||+|+++.........+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~---- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD---- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 468999999999998642 2336899988655444456788999999999999999999997643
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc----
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV---- 850 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---- 850 (1009)
...++||||+++|+|..++..... .+++..++.++.|+++|++|||++ +|+||||||+||+++.++.
T Consensus 77 -~~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~ 147 (262)
T cd05077 77 -VENIMVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGEC 147 (262)
T ss_pred -CCCEEEEecccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCC
Confidence 567899999999999999876543 389999999999999999999999 9999999999999987664
Q ss_pred ---eEEeccccccccCCCCCCCccccCCccccccccccccCccccC-CCCCCCcccchHHHHHHHHHH-hCCCCCccccc
Q 047768 851 ---AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-GGEASMRGGVYSYGILLLEIF-TRRRPTESMFN 925 (1009)
Q Consensus 851 ---~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~ell-tg~~p~~~~~~ 925 (1009)
+|++|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|+.||.....
T Consensus 148 ~~~~~l~d~g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 148 GPFIKLSDPGIPITVLSR------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred CceeEeCCCCCCccccCc------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 899999998754321 1245788999999886 467899999999999999998 58888753211
Q ss_pred CCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 926 EGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
.+... +....... ..+....+.+++.+||+.||.+||++.|+++.+
T Consensus 216 -----~~~~~---------~~~~~~~~------------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 216 -----AEKER---------FYEGQCML------------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -----hHHHH---------HHhcCccC------------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 11100 00000000 001234578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=318.55 Aligned_cols=267 Identities=24% Similarity=0.356 Sum_probs=205.1
Q ss_pred hccCccCCcccccCCceEEEEEEec-------CCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeecc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHE-------NGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSSI 770 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 770 (1009)
..+|.+.+.||+|+||.||+|.+.. .+..||+|.++.... ...+.+.+|+++++++ +||||++++++|...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3478999999999999999998642 224799998864322 2246788999999999 899999999997643
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCC----------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCC
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQ----------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKP 840 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~ 840 (1009)
...++++||+++|+|.+++...... .....+++.++..++.|++.|++|||++ +|+||||||
T Consensus 91 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp 162 (334)
T cd05100 91 -----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAA 162 (334)
T ss_pred -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccccc
Confidence 5689999999999999999764321 1123488899999999999999999998 999999999
Q ss_pred CceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCC
Q 047768 841 SNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRP 919 (1009)
Q Consensus 841 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p 919 (1009)
+||+++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 236 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236 (334)
T ss_pred ceEEEcCCCcEEECCcccceeccccccc------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999866432111 11112334578999999999999999999999999999999 8888
Q ss_pred CcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 920 TESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
|.... ..+........ ..... ...+..++.+++.+|++.+|++||++.|+++.|++
T Consensus 237 ~~~~~-----~~~~~~~~~~~--------~~~~~-----------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~ 292 (334)
T cd05100 237 YPGIP-----VEELFKLLKEG--------HRMDK-----------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDR 292 (334)
T ss_pred CCCCC-----HHHHHHHHHcC--------CCCCC-----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 86432 22222111100 00000 11233468899999999999999999999999998
Q ss_pred HHHhh
Q 047768 1000 ARQNF 1004 (1009)
Q Consensus 1000 i~~~~ 1004 (1009)
+....
T Consensus 293 ~~~~~ 297 (334)
T cd05100 293 VLTVT 297 (334)
T ss_pred Hhhhc
Confidence 87543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=326.08 Aligned_cols=208 Identities=25% Similarity=0.343 Sum_probs=174.8
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||+||+|+.+.+++.||||+++... ......+.+|++++..++||+|+++++++.. ...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-----~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-----KRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCE
Confidence 36888999999999999999999899999999996432 2234567889999999999999999988653 478
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++.+... +++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG 146 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDT------LSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG 146 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence 8999999999999999976542 88999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCcc---------------------------ccCCccccccccccccCccccCCCCCCCcccchHHHHHH
Q 047768 858 LAKFLSASPLGNVV---------------------------ETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILL 910 (1009)
Q Consensus 858 la~~~~~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl 910 (1009)
+++........... ..........||+.|+|||++.+..++.++|||||||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 98755321100000 000111245799999999999999999999999999999
Q ss_pred HHHHhCCCCCcc
Q 047768 911 LEIFTRRRPTES 922 (1009)
Q Consensus 911 ~elltg~~p~~~ 922 (1009)
|||++|+.||..
T Consensus 227 yel~tG~~Pf~~ 238 (360)
T cd05627 227 YEMLIGYPPFCS 238 (360)
T ss_pred eecccCCCCCCC
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.52 Aligned_cols=257 Identities=21% Similarity=0.320 Sum_probs=188.9
Q ss_pred CcccccCCceEEEEEEec--CCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEe
Q 047768 707 NTIGRGSFGFVYKGVLHE--NGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYE 783 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 783 (1009)
+.||+|+||.||+|.+.. ++..+|+|.++.... .....+.+|+.++++++||||+++++++... ...++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEEE
Confidence 358999999999998753 456799998865432 2235788899999999999999999987543 56799999
Q ss_pred ccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccC
Q 047768 784 YMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863 (1009)
Q Consensus 784 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~ 863 (1009)
|+++|+|.+++...... .....++..+..++.|++.|++|||+. +++||||||+||+++.++++|++|||.++...
T Consensus 76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 76 FCPLGDLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred CCCCCcHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999999764321 112367778889999999999999999 99999999999999999999999999997543
Q ss_pred CCCCCCccccCCccccccccccccCccccCCC-------CCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHH
Q 047768 864 ASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-------EASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 935 (1009)
.... ........|+..|+|||++.+. .++.++||||||+++|||++ |+.||....... ...
T Consensus 152 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-----~~~ 220 (269)
T cd05087 152 KEDY------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-----VLT 220 (269)
T ss_pred Ccce------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-----HHH
Confidence 2211 0112234578899999987642 35789999999999999997 999996432221 111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
...........++.+. ....+.+.+++..|| .+|++|||++||++.|+
T Consensus 221 ~~~~~~~~~~~~~~~~--------------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 221 YTVREQQLKLPKPRLK--------------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHhhcccCCCCCCccC--------------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0111111111111111 012234678888999 58999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.78 Aligned_cols=248 Identities=21% Similarity=0.339 Sum_probs=205.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.-|...+.||+|.|++|-.|++..+|..||||+++...-+ ....+.+|++.|+-++|||||+++.+.... ...
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ-----TKl 92 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-----TKL 92 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc-----ceE
Confidence 4577788999999999999999999999999999654322 345788899999999999999999985543 678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee-CCCCceEEeccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHVSDFG 857 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill-~~~~~~kl~DfG 857 (1009)
|+|+|.-++|+|++|+-++..+ +.+.-..+++.||+.|+.|+|.. .+|||||||+||.+ ..-|-||++|||
T Consensus 93 yLiLELGD~GDl~DyImKHe~G-----l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEG-----LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred EEEEEecCCchHHHHHHhhhcc-----ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecc
Confidence 9999999999999999988775 89999999999999999999998 89999999999876 567899999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
++-.+.++ ......+|+..|-|||++.+..| .++.||||+||++|-++.|+.||....+.
T Consensus 165 FSNkf~PG---------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------- 225 (864)
T KOG4717|consen 165 FSNKFQPG---------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------- 225 (864)
T ss_pred ccccCCCc---------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----------
Confidence 99776654 34456789999999999999988 57899999999999999999999865433
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
+.+.-++|-.+.. +.....++.+++..|+..||.+|.+.+|++.
T Consensus 226 ---ETLTmImDCKYtv------------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 226 ---ETLTMIMDCKYTV------------PSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ---hhhhhhhcccccC------------chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2223333322211 1123345678889999999999999998864
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=313.56 Aligned_cols=250 Identities=21% Similarity=0.301 Sum_probs=201.3
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
.+|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+++++.++|||++++++++.. ....++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----CceEEE
Confidence 468899999999999999999988999999999976555556788899999999999999999998754 367899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
|+||+++++|.+++.... +++.++..++.+++.|++|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 94 v~e~~~~~~L~~~~~~~~-------l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 94 VMEYLAGGSLTDVVTETC-------MDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred EEEecCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccch
Confidence 999999999999987542 88999999999999999999999 99999999999999999999999999988
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ..... ....
T Consensus 164 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~----~~~~~-~~~~ 230 (296)
T cd06655 164 QITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----RALYL-IATN 230 (296)
T ss_pred hccccc--------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH-HHhc
Confidence 654321 1112345788999999999989999999999999999999999998643211 11100 0000
Q ss_pred hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 941 ~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. .+.+. ........+.+++.+||..||.+||++.+++.
T Consensus 231 ~-----~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 231 G-----TPELQ------------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred C-----CcccC------------CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0 00000 00122345778999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=307.99 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=199.6
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccc---------hHHHHHHHHHHHhcCCCCcceEEeeeecccc
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG---------SKSFAAECEALRSIRHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 772 (1009)
+|.+...||+|+||.||+|.+..+++.||+|.+....... .+.+.+|++++++++||||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 4778899999999999999998889999999886443221 2468889999999999999999998654
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceE
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 852 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 852 (1009)
....++|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence 367889999999999999997654 378889999999999999999998 999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHH
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHE 932 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~ 932 (1009)
|+|||.++.......... .........|+..|+|||.+.+..++.++||||+||++|||++|+.||...... ..
T Consensus 147 l~dfg~~~~~~~~~~~~~--~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~ 220 (267)
T cd06628 147 ISDFGISKKLEANSLSTK--TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QA 220 (267)
T ss_pred ecccCCCcccccccccCC--ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HH
Confidence 999999987653211110 011112345889999999999999999999999999999999999999743211 11
Q ss_pred HHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. ......... ........+.+++.+||+.||.+||++.|+++
T Consensus 221 ~~---------~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 221 IF---------KIGENASPE-----------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HH---------HHhccCCCc-----------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 10 000000000 01123456789999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=306.81 Aligned_cols=253 Identities=26% Similarity=0.468 Sum_probs=198.4
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
++|.+.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|++++++++|+|++++++++.. ...++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EPIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC-CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CCcEE
Confidence 468888999999999999998864 4569999875432 234678899999999999999999987632 45689
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
||||+++++|.++++.... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++
T Consensus 78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred EEEcCCCCCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccce
Confidence 9999999999999976432 2378999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhcc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....... .......++..|+|||+..+..++.++||||||+++|||++ |+.||...... ..........
T Consensus 151 ~~~~~~~-------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~- 220 (260)
T cd05069 151 LIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERGY- 220 (260)
T ss_pred EccCCcc-------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC-
Confidence 6643211 11112346778999999998999999999999999999999 89998643211 0111100000
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
. .. .....+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 221 -------~---~~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 -------R---MP-----------CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -------C---CC-----------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 00 011234568899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=307.29 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=201.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .+.+.+|++++++++|+||+++++++... ...++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcEEE
Confidence 578899999999999999999988889999999865433 67899999999999999999999987543 67899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
++||+++++|.+++..... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||++.
T Consensus 76 ~~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~ 147 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNK-----TLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSG 147 (256)
T ss_pred EEecCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccch
Confidence 9999999999999976443 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
...... .......|+..|+|||++.+..++.++||||||+++|||++|+.||....... ... .
T Consensus 148 ~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----~~~-~---- 210 (256)
T cd06612 148 QLTDTM--------AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----AIF-M---- 210 (256)
T ss_pred hcccCc--------cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----hhh-h----
Confidence 665321 11122447889999999999999999999999999999999999987432110 000 0
Q ss_pred hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 941 ~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
........+ .........+.+++.+|++.+|++|||+.|+++
T Consensus 211 -~~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 211 -IPNKPPPTL------------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -hccCCCCCC------------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000000000 001123346789999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=321.25 Aligned_cols=238 Identities=26% Similarity=0.294 Sum_probs=185.5
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHH-HHHhcCCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECE-ALRSIRHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||.||+|++..+++.||+|++.... ......+.+|.. +++.++||||+++++++.. ....++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-----AEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCEEEEEE
Confidence 46999999999999999899999999986432 122334555554 5788899999999988654 36789999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 76 DYVNGGELFFHLQRER------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 9999999999887644 278889999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchh
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .........
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~---- 209 (321)
T cd05603 147 VEPE--------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNIL---- 209 (321)
T ss_pred CCCC--------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHHh----
Confidence 2211 12234568999999999999999999999999999999999999996431 112211111
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHH
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMT 991 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~ 991 (1009)
..... .+ .....++.+++.+|++.||.+||++.
T Consensus 210 ----~~~~~-~~-----------~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 210 ----HKPLQ-LP-----------GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ----cCCCC-CC-----------CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 10000 00 01223577999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=322.05 Aligned_cols=194 Identities=23% Similarity=0.332 Sum_probs=165.8
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
....+|.+.+.||+|+||.||+|.+..+++.||+|+... .....|+.++++++||||+++++++... ..
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 131 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSG-----AI 131 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeC-----Ce
Confidence 344679999999999999999999998889999997532 2335699999999999999999987643 67
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++|+||+ .++|.+++..... .+++.++..++.|++.||.|||++ +||||||||+||+++.++.+||+|||
T Consensus 132 ~~lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG 202 (357)
T PHA03209 132 TCMVLPHY-SSDLYTYLTKRSR-----PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLG 202 (357)
T ss_pred eEEEEEcc-CCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCc
Confidence 89999999 5699999876543 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCC
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPT 920 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~ 920 (1009)
+++..... ....+..||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 203 ~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 203 AAQFPVVA---------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccC---------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 99753221 1223456899999999999999999999999999999999965554
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.61 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=199.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
+.|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++|||++++++++... ...++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----CeEEE
Confidence 5688899999999999999999988999999998755444456788999999999999999999986543 57899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
||||+++++|..++.+... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 87 v~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDR-----GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred EEecCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999988866443 389999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccC-----CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-----GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
...... .......++..|+|||++. ...++.++|||||||++|||++|+.||..... .+...
T Consensus 159 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~ 225 (292)
T cd06644 159 KNVKTL--------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLL 225 (292)
T ss_pred eccccc--------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHH
Confidence 543211 1122345788999999874 44578899999999999999999999864321 11111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...... .+.. .....+..++.+++.+||+.+|++||++.|+++
T Consensus 226 ~~~~~~-----~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 226 KIAKSE-----PPTL------------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHhcCC-----CccC------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 100000 0000 001123345778999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=309.29 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=201.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
++|++.+.||.|+||.||+|.+..+++.||+|++.... ......+.+|+++++.++|+|++++++++... ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEE
Confidence 36888899999999999999999899999999987543 23346788999999999999999999986543 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+++++|.+++... .+++..++.++.|++.|+.|||+. +++||||+|+||++++++.++++|||++
T Consensus 76 ~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred EEEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 999999999999999765 288999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
+...... .......|+..|+|||++.+..++.++||||||+++|||+||+.||...... ..... ..
T Consensus 146 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~~~-~~ 211 (274)
T cd06609 146 GQLTSTM--------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVLFL-IP 211 (274)
T ss_pred eeecccc--------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHHHH-hh
Confidence 8775431 1122345788999999999988999999999999999999999999643211 11100 00
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. ..+.+. ...+...+.+++.+|+..+|++|||++++++
T Consensus 212 ~~----~~~~~~-------------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 212 KN----NPPSLE-------------GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred hc----CCCCCc-------------ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 00 000000 0013345778999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=308.93 Aligned_cols=253 Identities=28% Similarity=0.423 Sum_probs=198.4
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeecccccch--HHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
|++.+.||+|+||+||+|+...+++.||+|++........ ....+|+.++++++||||+++++++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 5677899999999999999999999999999976543322 234569999999999999999999765 377889
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
||||+++++|.+++.... .+++.++..++.|+++||+|||+. +|+||||||+||++++++.++|+|||.+.
T Consensus 76 v~~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNK------PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEETTEBHHHHHHHHS------SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred cccccccccccccccccc------cccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 999999999999998433 389999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccC-CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
..... ........++..|+|||++. +..++.++||||+|+++|+|++|+.||...... ...........
T Consensus 147 ~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~~~~ 216 (260)
T PF00069_consen 147 KLSEN--------NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEKILK 216 (260)
T ss_dssp ESTST--------TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHHHHH
T ss_pred ccccc--------ccccccccccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhhccc
Confidence 64111 12233456899999999998 888999999999999999999999999754100 11111111110
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
....... ........++.+++.+|++.||++||++.|+++
T Consensus 217 ~~~~~~~----------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 217 RPLPSSS----------------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp THHHHHT----------------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccc----------------cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 000011257889999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=344.06 Aligned_cols=261 Identities=18% Similarity=0.261 Sum_probs=199.9
Q ss_pred HHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
....++|.+.+.||+|+||+||+|.+..++..||+|++..... .....+..|+.++++++||||+++++++... .
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~ 85 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---A 85 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---C
Confidence 3445789999999999999999999999999999999865422 2346788999999999999999999986432 2
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCC----CCceecCCCCCceeeCC---
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQ----PPIVHGDLKPSNVLLDH--- 847 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~ivHrdlk~~Nill~~--- 847 (1009)
....++||||+++|+|.+++...... ...+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 35689999999999999999764221 1248999999999999999999998521 25999999999999964
Q ss_pred --------------CCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCC--CCCCCcccchHHHHHHH
Q 047768 848 --------------DMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG--GEASMRGGVYSYGILLL 911 (1009)
Q Consensus 848 --------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~ 911 (1009)
.+.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY 234 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccc---------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence 2359999999998654321 1223568999999999854 45889999999999999
Q ss_pred HHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHH
Q 047768 912 EIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMT 991 (1009)
Q Consensus 912 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~ 991 (1009)
||++|+.||.... ............ +.+ + .......+.+++..||+.+|.+||++.
T Consensus 235 ELLTGk~PF~~~~----~~~qli~~lk~~-------p~l---p----------i~~~S~eL~dLI~~~L~~dPeeRPSa~ 290 (1021)
T PTZ00266 235 ELCSGKTPFHKAN----NFSQLISELKRG-------PDL---P----------IKGKSKELNILIKNLLNLSAKERPSAL 290 (1021)
T ss_pred HHHHCCCCCCcCC----cHHHHHHHHhcC-------CCC---C----------cCCCCHHHHHHHHHHhcCChhHCcCHH
Confidence 9999999996422 111111110000 000 0 001234578999999999999999999
Q ss_pred HHHH
Q 047768 992 DVVV 995 (1009)
Q Consensus 992 evl~ 995 (1009)
|++.
T Consensus 291 QlL~ 294 (1021)
T PTZ00266 291 QCLG 294 (1021)
T ss_pred HHhc
Confidence 9984
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=310.61 Aligned_cols=239 Identities=21% Similarity=0.329 Sum_probs=184.0
Q ss_pred cccccCCceEEEEEEecC------------------------CeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceE
Q 047768 708 TIGRGSFGFVYKGVLHEN------------------------GMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKI 763 (1009)
Q Consensus 708 ~lg~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 763 (1009)
.||+|+||.||+|....+ +..||+|+++.........+.+|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 599999999999986421 24689998865444344678889999999999999999
Q ss_pred EeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCce
Q 047768 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNV 843 (1009)
Q Consensus 764 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Ni 843 (1009)
+++|... ...++||||+++|+|.+++..... .+++..+..++.|+++||+|||++ +|+||||||+||
T Consensus 82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Ni 148 (274)
T cd05076 82 HGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKG-----RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNI 148 (274)
T ss_pred EEEEEeC-----CceEEEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccE
Confidence 9998653 577999999999999999876443 378999999999999999999998 999999999999
Q ss_pred eeCCCC-------ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHH-
Q 047768 844 LLDHDM-------VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIF- 914 (1009)
Q Consensus 844 ll~~~~-------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~ell- 914 (1009)
+++..+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++
T Consensus 149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~ 216 (274)
T cd05076 149 LLARLGLAEGTSPFIKLSDPGVSFTALSR------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF 216 (274)
T ss_pred EEeccCcccCccceeeecCCccccccccc------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 997654 4899999988643221 11346788999998865 56899999999999999995
Q ss_pred hCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 047768 915 TRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVV 994 (1009)
Q Consensus 915 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl 994 (1009)
+|+.||....... ..... ..... .+ .+....+.+++.+||+.+|++||++.+++
T Consensus 217 ~g~~p~~~~~~~~--~~~~~------------~~~~~-~~-----------~~~~~~~~~li~~cl~~~p~~Rps~~~il 270 (274)
T cd05076 217 DGEVPLKERTPSE--KERFY------------EKKHR-LP-----------EPSCKELATLISQCLTYEPTQRPSFRTIL 270 (274)
T ss_pred CCCCCccccChHH--HHHHH------------HhccC-CC-----------CCCChHHHHHHHHHcccChhhCcCHHHHH
Confidence 6899986432111 01110 00000 00 01123578999999999999999999999
Q ss_pred HHH
Q 047768 995 VKL 997 (1009)
Q Consensus 995 ~~L 997 (1009)
+.|
T Consensus 271 ~~L 273 (274)
T cd05076 271 RDL 273 (274)
T ss_pred Hhh
Confidence 876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=317.90 Aligned_cols=202 Identities=24% Similarity=0.334 Sum_probs=172.2
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|.+.+.||+|+||+||+|+++.+++.||+|+++... ......+.+|+.++..++|++|+++++++.. ...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-----~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-----ENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCE
Confidence 47889999999999999999999899999999986422 2223457889999999999999999998654 378
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence 8999999999999999987433 388999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCC-----CCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-----GEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
+++....... .......||+.|+|||++.+ +.++.++|||||||++|||++|+.||..
T Consensus 148 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 148 SCLKMNQDGT-------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ceeeccCCCc-------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 9986543211 11123568999999999876 5678999999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.23 Aligned_cols=254 Identities=22% Similarity=0.355 Sum_probs=201.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|++.+.||+|+||.||+|.+..++..||+|+++.......+.+.+|++++++++|||++++++++.. ....+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCeEE
Confidence 3578899999999999999999988899999999976554455678899999999999999999998654 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++..... .+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++
T Consensus 79 lv~e~~~~~~L~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 79 ILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred EEeeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccc
Confidence 99999999999999877543 389999999999999999999999 9999999999999999999999999988
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccC-----CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-----GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
....... .......|++.|+|||.+. ...++.++||||||+++|||++|+.||...... +..
T Consensus 151 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----~~~ 217 (280)
T cd06611 151 AKNKSTL--------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----RVL 217 (280)
T ss_pred hhhcccc--------cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----HHH
Confidence 7543221 1122346889999999874 345688999999999999999999998743211 111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
...... ..+.+. .+..+..++.+++.+|++.+|++||++.++++.
T Consensus 218 ~~~~~~-----~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 218 LKILKS-----EPPTLD------------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHhcC-----CCCCcC------------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 110000 000000 011233457789999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=317.00 Aligned_cols=202 Identities=24% Similarity=0.322 Sum_probs=171.3
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|.+.++||+|+||+||+++++.+++.||+|++.... ......+.+|+.++..++|++|+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-----ENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----CCE
Confidence 36888999999999999999999889999999985422 2223458889999999999999999988654 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++.+... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence 8999999999999999987433 388999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccC-----CCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-----GGEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 148 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 148 SCLKLMEDGT-------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred hheecccCCc-------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 9975532211 1112356899999999986 34678999999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.84 Aligned_cols=241 Identities=22% Similarity=0.354 Sum_probs=186.8
Q ss_pred CcccccCCceEEEEEEecCCe-------EEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 707 NTIGRGSFGFVYKGVLHENGM-------LVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+.||+|+||.||+|..+..+. .||+|.+........+.+.+|+.+++.++|||++++++++... ...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcE
Confidence 469999999999999865443 4888988654444456788999999999999999999997643 5678
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc--------e
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV--------A 851 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~--------~ 851 (1009)
+||||+++|+|.++++.... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++. +
T Consensus 76 lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~ 147 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFI 147 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceE
Confidence 99999999999999987653 388999999999999999999999 9999999999999987765 6
Q ss_pred EEeccccccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCC-CCCcccccCCcc
Q 047768 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRR-RPTESMFNEGLT 929 (1009)
Q Consensus 852 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~-~p~~~~~~~~~~ 929 (1009)
+++|||.+...... ....++..|+|||++.+. .++.++|||||||++|||++|. .||.....
T Consensus 148 ~l~d~g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~---- 211 (258)
T cd05078 148 KLSDPGISITVLPK------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS---- 211 (258)
T ss_pred EecccccccccCCc------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH----
Confidence 99999988654321 124578899999998874 5799999999999999999985 55442111
Q ss_pred HHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 930 LHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
..... +..... ..+ .....++.+++.+||+.||++|||++|+++.|+
T Consensus 212 -~~~~~---------~~~~~~-~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 212 -QKKLQ---------FYEDRH-QLP-----------APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -HHHHH---------HHHccc-cCC-----------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11000 000000 000 012245789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=313.97 Aligned_cols=271 Identities=20% Similarity=0.303 Sum_probs=195.9
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|++.+.||+|+||.||+|.++.+|+.||+|+++.... .....+.+|++++++++|||++++++++.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-----DKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-----CCceE
Confidence 47788999999999999999998999999999865422 223567889999999999999999998543 46789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||++ ++|.+++..... .+++..++.++.|+++|+.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence 9999996 588888876433 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+...... .......++..|+|||++.+. .++.++|||||||++|||+||+.|+..................
T Consensus 147 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
T cd07839 147 RAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 218 (284)
T ss_pred hccCCCC--------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhC
Confidence 7653321 111234578899999988764 4689999999999999999999986532221111111111000
Q ss_pred c--ch----hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 P--EK----VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 ~--~~----~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. +. ..+..+............. .........++.+++.+|++.||.+|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 219 TPTEESWPGVSKLPDYKPYPMYPATTSL-VNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCChHHhHHhhhcccccccCCCCCcchh-hhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 00 0011110000000000000 0000112346779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.51 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=199.8
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|++.+.||+|++|.||+|.++.+++.||+|.+..... ...+.+.+|++++++++|+|++++++.+.. .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 47888999999999999999998899999999865432 234578899999999999999999887532 234678
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++..... ..+++.+++.++.+++.|++|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 77 lv~e~~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred EEecccCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence 99999999999999986432 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....... .......|++.|+|||+..+..++.++||||+|+++|||++|+.||.... ..........
T Consensus 150 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~~~ 216 (257)
T cd08223 150 RVLENQC--------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRIIE 216 (257)
T ss_pred EEecccC--------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHh
Confidence 8664321 11223467899999999999999999999999999999999999986321 1111111111
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..+... ......++.+++.+|++.+|++||++.|+++
T Consensus 217 --------~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 217 --------GKLPPM-----------PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred --------cCCCCC-----------ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 001000 1123346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=311.95 Aligned_cols=248 Identities=23% Similarity=0.322 Sum_probs=198.3
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
.|+..+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCceEE
Confidence 4666788999999999999998889999999986443 2234578899999999999999999998654 367899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
|+||+++++|.+++... .+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.+|++|||++.
T Consensus 80 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 80 IMEYLGGGSALDLLKPG-------PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred EEEccCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccc
Confidence 99999999999998653 278999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
...... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 150 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~----- 211 (277)
T cd06642 150 QLTDTQ--------IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----RVLF----- 211 (277)
T ss_pred cccCcc--------hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----hHHh-----
Confidence 654321 1112245788999999999999999999999999999999999998643211 0000
Q ss_pred hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 941 ~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.+...... .....+...+.+++.+|++.+|++||++.|+++.
T Consensus 212 ----~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 212 ----LIPKNSPP----------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----hhhcCCCC----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00000000 0011234467899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.97 Aligned_cols=254 Identities=30% Similarity=0.481 Sum_probs=200.9
Q ss_pred CcccccCCceEEEEEEecC---CeEEEEEEeecccccc-hHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHEN---GMLVAVKVINLEQKGG-SKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||.||+|.+... +..||+|+++...... .+.+.+|++.++.++|+|++++++++.. ....++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence 4699999999999999865 8899999997554333 5788999999999999999999998754 36789999
Q ss_pred eccCCCCHHHHHhccCCC---CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQ---LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
||+++++|.+++...... .....+++.+++.++.|++.|++|||++ +|+||||+|+||++++++.+|++|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence 999999999999876210 0012489999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... ........++..|+|||.+....++.++||||+|+++|||++ |+.||.... .........
T Consensus 153 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~ 221 (262)
T cd00192 153 RDVYDDDY------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-----NEEVLEYLR 221 (262)
T ss_pred cccccccc------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHH
Confidence 87654321 011223557889999999988899999999999999999999 699987542 111111111
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
+..... ....+..++.+++.+|++.+|++||++.|+++.|+
T Consensus 222 --------~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 --------KGYRLP-----------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --------cCCCCC-----------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000000 01122456889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=305.28 Aligned_cols=251 Identities=26% Similarity=0.460 Sum_probs=198.4
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
.+|++.+.||+|+||.||+|.+. +++.+|+|+++... .....+.+|++++++++|||++++++++... ...++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccC-----CceEE
Confidence 46888899999999999999886 57789999886432 2346789999999999999999999986543 57899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
|+||+++++|.+++..... .+++..++.++.+++.|++|||+. +++||||||+||+++.++.+||+|||.++
T Consensus 77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 148 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRG-----KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTR 148 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCccee
Confidence 9999999999999976543 378999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhcc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....... ....+..++.+|+|||+..++.++.++||||||+++|||++ |+.||.... ........ .
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~-~ 215 (256)
T cd05112 149 FVLDDQY-------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-----NSEVVETI-N 215 (256)
T ss_pred ecccCcc-------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-----HHHHHHHH-h
Confidence 6543211 11122345678999999998899999999999999999998 999986422 11111111 0
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
... ....+ .....++.+++.+||+.+|++||++.|+++.|
T Consensus 216 ~~~-~~~~~-----------------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 216 AGF-RLYKP-----------------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCC-CCCCC-----------------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 000 00000 01234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.63 Aligned_cols=251 Identities=21% Similarity=0.300 Sum_probs=202.3
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|+..+.||+|+||.||.++...+++.||+|.+.... ....+.+.+|++++++++|+||+++++++.. ....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence 4788899999999999999999999999999986543 2334678899999999999999999999754 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKG----QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred EEEEecCCCcHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence 99999999999999986532 2488999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
+....... ......|++.|+|||+..+..++.++||||||+++|||++|+.||.... ..+......
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~- 214 (256)
T cd08221 149 KILGSEYS--------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLVVKIV- 214 (256)
T ss_pred EEcccccc--------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHH-
Confidence 86643221 1223568899999999988889999999999999999999999986321 111111111
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
....... ......++.+++.+|++.+|++||++.|+++.
T Consensus 215 -------~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 215 -------QGNYTPV-----------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -------cCCCCCC-----------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1111100 01233457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.46 Aligned_cols=247 Identities=28% Similarity=0.402 Sum_probs=193.3
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEecc
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYM 785 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 785 (1009)
+.||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++... ...++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEECC
Confidence 36999999999999865 688999999864432 2234688999999999999999999997643 5679999999
Q ss_pred CCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCC
Q 047768 786 QNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865 (1009)
Q Consensus 786 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 865 (1009)
++++|.+++..... .+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.+|++|||++......
T Consensus 75 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 75 PGGDFLSFLRKKKD-----ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccc
Confidence 99999999876543 378999999999999999999998 9999999999999999999999999999754332
Q ss_pred CCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccchhhh
Q 047768 866 PLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPEKVME 944 (1009)
Q Consensus 866 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1009)
.. .......++..|+|||+..+..++.++||||||+++||+++ |..||...... .........
T Consensus 147 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----~~~~~~~~~---- 210 (250)
T cd05085 147 IY-------SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----QAREQVEKG---- 210 (250)
T ss_pred cc-------ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHHHHcC----
Confidence 11 01111234678999999998999999999999999999999 99998643211 111111000
Q ss_pred ccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 945 IVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 945 ~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
... .....++..+.+++.+|++.+|++||++.|+++.|.
T Consensus 211 -----~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 211 -----YRM----------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -----CCC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 000 000123356889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=346.10 Aligned_cols=255 Identities=27% Similarity=0.361 Sum_probs=207.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
-+|....+||.|.||.||.|...++|...|+|-++..+.. ..+...+|..++..++|||+|+++|+... .+..
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-----Rekv 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-----REKV 1309 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-----HHHH
Confidence 4677788999999999999999999999999988765433 34678899999999999999999998543 3677
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++.||||++|+|.+.++..+. .++.....+..|++.|++|||++ |||||||||.||+++.+|.+|.+|||.
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri------~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRI------EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcch------hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccc
Confidence 899999999999999987653 66777778999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCC---CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG---EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|..+... ..+.+....+..||+.|||||++.+. ....++||||+|||+.||+||++||..++.+...+.+...
T Consensus 1381 a~ki~~~----~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~ 1456 (1509)
T KOG4645|consen 1381 AVKIKNN----AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA 1456 (1509)
T ss_pred eeEecCc----hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc
Confidence 9988654 11233455678899999999998774 3577999999999999999999999877666444444332
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
...|+- | ...-.+=.+++.+|+..||+.|.++.|+++.
T Consensus 1457 gh~Pq~------------P-----------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 GHKPQI------------P-----------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred cCCCCC------------c-----------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 221111 0 0112234588899999999999999887653
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=306.75 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=200.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
..|+..+.||+|+||.||+|.+..++..||+|+++... ......+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-----TKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEE
Confidence 35777889999999999999998889999999987543 22346788999999999999999999987643 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++|+|.+++... .+++.+...++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++
T Consensus 79 lv~e~~~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 79 IIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EEEecCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence 999999999999998753 278889999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....... .......++..|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~---- 211 (277)
T cd06640 149 GQLTDTQ--------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----RVLF---- 211 (277)
T ss_pred eeccCCc--------cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----hHhh----
Confidence 7654321 1112245788999999999889999999999999999999999998643211 1000
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.+..... ......++..+.+++.+||+.+|++||++.|++..
T Consensus 212 -----~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 212 -----LIPKNNP----------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -----hhhcCCC----------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0000000 01112345678899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=312.65 Aligned_cols=269 Identities=25% Similarity=0.280 Sum_probs=205.7
Q ss_pred cCHHHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeec
Q 047768 691 VSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSS 769 (1009)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 769 (1009)
+...++..+.++|.+.+.||+|+||.||+|..+.+++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 334455556789999999999999999999998899999999985432 2346778899999999 89999999999875
Q ss_pred cccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC
Q 047768 770 IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM 849 (1009)
Q Consensus 770 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 849 (1009)
.+.......++|+||+++++|.++++..... ...+++..++.++.|++.|+.|||+. +++||||||+||+++.++
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLIC--GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 4333345789999999999999988642211 12488999999999999999999998 999999999999999999
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCC-----CCCCcccchHHHHHHHHHHhCCCCCcccc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-----EASMRGGVYSYGILLLEIFTRRRPTESMF 924 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~Gvvl~elltg~~p~~~~~ 924 (1009)
.+||+|||+++....... ......|+..|+|||++... .++.++|||||||++|||++|+.||....
T Consensus 166 ~~kl~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL--------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred CEEEeecccchhcccccc--------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 999999999986543211 11234578899999987543 36899999999999999999999987432
Q ss_pred cCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 925 NEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. .... ....... +.+. ........+.+++.+|++.+|++||++.|+++
T Consensus 238 ~~----~~~~-~~~~~~~-----~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 238 PV----KTLF-KIPRNPP-----PTLL------------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HH----HHHH-HHhcCCC-----CCCC------------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 1110 0000000 0000 01123345889999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=305.35 Aligned_cols=265 Identities=24% Similarity=0.364 Sum_probs=200.1
Q ss_pred CccCCcccccCCceEEEEEEec---CCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC-Cc
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHE---NGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG-VD 776 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-~~ 776 (1009)
|.+.+.||+|+||+||+|.+.. ++..||||+++.... ...+.+.+|++++++++||||+++++++......+ ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5677899999999999998753 468999999865432 23457889999999999999999999875432111 12
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++++||+.+|+|.+++...........+++.....++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 3578999999999999876432221223478999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 935 (1009)
|.++........ .......++..|++||.+.+..++.++|||||||++|||++ |+.||..... .....
T Consensus 158 g~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-----~~~~~ 226 (273)
T cd05074 158 GLSKKIYSGDYY------RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-----SEIYN 226 (273)
T ss_pred cccccccCCcce------ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----HHHHH
Confidence 999866432110 11112345678999999999999999999999999999999 8888864321 11111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
... ....... ...+...+.+++.+|++.+|++||++.|+++.|+++
T Consensus 227 ~~~--------~~~~~~~-----------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 227 YLI--------KGNRLKQ-----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHH--------cCCcCCC-----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 0000000 012335688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.65 Aligned_cols=254 Identities=20% Similarity=0.311 Sum_probs=194.8
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-----cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-----GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.+|...+.||+|+||.||+|....+++.||+|+++.... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 368889999999999999999988899999999864321 1234688899999999999999999986532 23
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++++||+++++|.+++.... .+++...+.++.|++.|++|||+. +|+||||+|+||+++.++.+||+|
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 56789999999999999997654 278899999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++....... .........++..|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 150 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~~~- 219 (266)
T cd06651 150 FGASKRLQTICM-----SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIF- 219 (266)
T ss_pred CCCccccccccc-----cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHHHH-
Confidence 999986543210 00111234578999999999998999999999999999999999999874311 11111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...... ..+.+ +....+.+.+++ +||..+|++||+++||++
T Consensus 220 ~~~~~~----~~~~~--------------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 220 KIATQP----TNPQL--------------PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHhcCC----CCCCC--------------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000000 00000 011122344554 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.45 Aligned_cols=266 Identities=21% Similarity=0.286 Sum_probs=196.5
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|++.+.||+|++|.||+|..+.++..||||+++.... ...+.+.+|+.++++++|||++++++++.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence 47788999999999999999988899999999865432 234678899999999999999999999754 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||++ ++|.+++...... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKG---QYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCC---CcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccce
Confidence 9999997 6899988754321 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
....... .......+++.|+|||++.+. .++.++|||||||++|||+||+.||....... ..........
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~ 219 (285)
T cd07861 149 RAFGIPV--------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILG 219 (285)
T ss_pred eecCCCc--------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhC
Confidence 7543211 111223568899999987654 57899999999999999999999986432111 0000000000
Q ss_pred c--c----------hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 P--E----------KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 ~--~----------~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. + .....++........ ........++.+++.+|++.||++|||+.||+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 220 TPTEDVWPGVTSLPDYKNTFPKWKKGSLR-------SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CCChhhhhcchhhHHHHhhccccCcchhH-------HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0 000000000000000 000112345679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=312.93 Aligned_cols=203 Identities=23% Similarity=0.321 Sum_probs=162.5
Q ss_pred CCcccccCCceEEEEEEec--CCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEe
Q 047768 706 SNTIGRGSFGFVYKGVLHE--NGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYE 783 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 783 (1009)
..+||+|+||+||+|+.+. ++..||+|.++... ....+.+|++++++++||||+++++++... .....++|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEe
Confidence 3679999999999999763 56789999885432 345678999999999999999999987542 3356799999
Q ss_pred ccCCCCHHHHHhccCCC---CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee----CCCCceEEecc
Q 047768 784 YMQNGSLEEWLHQRDDQ---LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDF 856 (1009)
Q Consensus 784 ~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~~~kl~Df 856 (1009)
|++ ++|.+++...... .....+++..++.++.|++.||.|||+. +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 986 5888887543211 1123488999999999999999999999 99999999999999 56789999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
|+++....... .........||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 157 G~a~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 157 GFARLFNSPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cceeccCCCcc-----cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 99987653211 1112234568999999999876 4579999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.93 Aligned_cols=255 Identities=27% Similarity=0.465 Sum_probs=201.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||.||+|... +++.||||.++... ...+.+.+|+.++++++|+|++++++++.. ....+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 77 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EEPIY 77 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CCceE
Confidence 468999999999999999999976 56789999986433 245679999999999999999999998654 25689
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++..... ..+++.++..++.+++.|+.|||+. +++||||||+||++++++.+|++|||.+
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred EEEeccCCCCHHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccc
Confidence 99999999999999987542 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... .......++..|+|||.+.+..++.++||||+|+++||+++ |+.||..... .......
T Consensus 151 ~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~~~- 217 (261)
T cd05034 151 RLIEDDEY-------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-----REVLEQV- 217 (261)
T ss_pred eeccchhh-------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH-
Confidence 86643210 11112334678999999999899999999999999999999 9999864321 1111110
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
....-...+ ...+.++.+++.+|++.+|++||+++|+.+.|+.
T Consensus 218 -------~~~~~~~~~-----------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 218 -------ERGYRMPRP-----------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -------HcCCCCCCC-----------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 000000000 1123467899999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.53 Aligned_cols=248 Identities=28% Similarity=0.426 Sum_probs=195.1
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEecc
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYM 785 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 785 (1009)
++||+|+||.||+|.+.. ++.||+|+++..... ..+.+.+|++++++++|+||+++++++... ...++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEcC
Confidence 469999999999999876 999999998654333 346789999999999999999999986543 6789999999
Q ss_pred CCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCC
Q 047768 786 QNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865 (1009)
Q Consensus 786 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 865 (1009)
++++|.+++..... .+++..+..++.+++.|++|||++ +++||||+|+||+++.++.+||+|||+++.....
T Consensus 75 ~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 75 PGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 99999999976443 378999999999999999999999 9999999999999999999999999999865422
Q ss_pred CCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccchhhh
Q 047768 866 PLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPEKVME 944 (1009)
Q Consensus 866 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1009)
... .......++..|+|||++.++.++.++|||||||++|||+| |..||...... ....
T Consensus 147 ~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-----~~~~--------- 206 (251)
T cd05041 147 IYT------VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-----QTRE--------- 206 (251)
T ss_pred cce------eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-----HHHH---------
Confidence 110 01111234667999999998999999999999999999999 88888643211 1110
Q ss_pred ccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 945 IVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 945 ~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
.+....... .....+.++.+++.+|+..+|++|||+.|+++.|.
T Consensus 207 ~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 207 RIESGYRMP----------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHhcCCCCC----------CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 010000000 01123446889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=303.74 Aligned_cols=257 Identities=22% Similarity=0.305 Sum_probs=186.6
Q ss_pred CcccccCCceEEEEEEec--CCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEe
Q 047768 707 NTIGRGSFGFVYKGVLHE--NGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYE 783 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 783 (1009)
+.||+|+||+||+|.... ....+|+|.+..... .....+.+|++.++.++|+||+++++++... ...++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEEE
Confidence 359999999999997642 345788888754322 2235688999999999999999999987543 67899999
Q ss_pred ccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccC
Q 047768 784 YMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863 (1009)
Q Consensus 784 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~ 863 (1009)
|+++|+|.+++....... ....++.....++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 76 ~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred eCCCCcHHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccc
Confidence 999999999997754321 12256778889999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCCccccCCccccccccccccCccccC-------CCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHH
Q 047768 864 ASPLGNVVETPSSSIGVKGTIGYVAPEYGL-------GGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 935 (1009)
..... .......++..|+|||+.. ...++.++|||||||++|||++ |..||...... ....
T Consensus 152 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~~~ 220 (269)
T cd05042 152 PEDYY------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-----QVLK 220 (269)
T ss_pred cchhe------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHH
Confidence 32110 0112234677899999864 3456889999999999999999 77888643211 1111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
.........+.++.+ ...+...+.+++..|| .||++|||++||++.|.
T Consensus 221 ~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 221 QVVREQDIKLPKPQL--------------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHhhccCccCCCCcc--------------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111111111111 1123345667888898 49999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=305.91 Aligned_cols=264 Identities=24% Similarity=0.262 Sum_probs=202.6
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
++|...+.||.|++|.||+|.+..+++.||+|.+..... .....+.+|++++++++||||+++++++... .....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEE
Confidence 367788999999999999999988899999999864432 2346789999999999999999999987542 235679
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++...... ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKR--GGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccc
Confidence 999999999999987643221 12478899999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....... .....++..|+|||.+.+..++.++||||+||++|||++|+.||...........+.......
T Consensus 153 ~~~~~~~----------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd06621 153 GELVNSL----------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN 222 (287)
T ss_pred ccccccc----------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc
Confidence 7553221 112356889999999999999999999999999999999999997542211111111111100
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... +.+...+ .....+..++.+++.+|++.+|++|||+.|+++
T Consensus 223 ~~~-----~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 223 MPN-----PELKDEP--------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCc-----hhhccCC--------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 0000000 001124457889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=323.52 Aligned_cols=268 Identities=21% Similarity=0.222 Sum_probs=196.6
Q ss_pred hccCccCCcccccCCceEEEEEEe--cCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLH--ENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
..+|.+.+.||+|+||.||+|... ..++.||||.+... +...+|++++++++||||+++++++.. ...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW-----KST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee-----CCE
Confidence 357999999999999999999864 34678999987432 345689999999999999999988654 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++|||++. ++|.+++.... .+++.+++.++.|++.||.|||++ +||||||||+||+++.++.+||+|||
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG 230 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG 230 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence 899999995 68999985433 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCC--ccHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEG--LTLHEFAK 935 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~ 935 (1009)
+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.....
T Consensus 231 ~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~ 304 (392)
T PHA03207 231 AACKLDAHPD------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304 (392)
T ss_pred cccccCcccc------cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH
Confidence 9986654321 112234679999999999999999999999999999999999999986533221 11111111
Q ss_pred Hhc--cchh--------hhccCCCCCChhhhhhhc---cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 936 RAL--PEKV--------MEIVDPSLLPLEEERTNS---RRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 936 ~~~--~~~~--------~~~~d~~l~~~~~~r~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
... +... ...+.... ...|+.. ..........++.+++.+|+..||++|||+.|++..
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 305 CMQVHPLEFPQNGSTNLCKHFKQYA---IVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HhccCccccCCccchhHHHHHHhhc---ccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 110 0000 00000000 0000000 000001123456788999999999999999999864
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.23 Aligned_cols=254 Identities=27% Similarity=0.423 Sum_probs=195.1
Q ss_pred CcccccCCceEEEEEEecCC------eEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 707 NTIGRGSFGFVYKGVLHENG------MLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+.||+|+||.||+|+++... +.||||.+.... ......+.+|++++++++||||+++++++... ...+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCeE
Confidence 36999999999999986433 689999885432 23356788999999999999999999987543 5689
Q ss_pred EEEeccCCCCHHHHHhccCCCC-CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC-----ceEE
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQL-GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM-----VAHV 853 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-----~~kl 853 (1009)
+||||+++++|.+++....... ....+++.++..++.|++.|++|||+. +++|+||||+||+++.++ .+|+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence 9999999999999997643221 223478999999999999999999998 999999999999999887 8999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHH
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHE 932 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 932 (1009)
+|||+++........ .......++..|+|||++.++.++.++|||||||++|||++ |+.||...... .
T Consensus 153 ~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-----~ 221 (269)
T cd05044 153 GDFGLARDIYKSDYY------RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-----E 221 (269)
T ss_pred CCccccccccccccc------ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-----H
Confidence 999999765432111 11112345778999999999999999999999999999998 99998643211 1
Q ss_pred HHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
....... ..... .....+..+.+++.+|+..+|.+||++.++.+.|+
T Consensus 222 ~~~~~~~--------~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 222 VLQHVTA--------GGRLQ-----------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHHHhc--------CCccC-----------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1110000 00000 01123456789999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.27 Aligned_cols=247 Identities=32% Similarity=0.457 Sum_probs=196.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
++|++.+.||+|+||.||+|.. +++.||+|+++... ....+.+|+.++++++|||++++++++.. ...++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence 4688899999999999999975 58889999986432 34678899999999999999999998643 34689
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
||||+++++|.+++..... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 76 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred EEECCCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccce
Confidence 9999999999999976542 2478999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhcc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
...... .....+..|+|||++.+..++.++|||||||++|||++ |+.||..... .+....
T Consensus 149 ~~~~~~-----------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~--- 209 (254)
T cd05083 149 VGSMGV-----------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEVKEC--- 209 (254)
T ss_pred eccccC-----------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHHHHH---
Confidence 543211 11234568999999998999999999999999999998 8999864321 111111
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
+.......+ ...++..+.+++.+|++.+|+.||+++++++.|++
T Consensus 210 ------~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 210 ------VEKGYRMEP----------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ------HhCCCCCCC----------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111110000 11234567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.38 Aligned_cols=265 Identities=22% Similarity=0.315 Sum_probs=204.3
Q ss_pred CHHHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeecc
Q 047768 692 SYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSI 770 (1009)
Q Consensus 692 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 770 (1009)
+..+.....+.|++.+.+|+|+||.||+|.+..+++.||+|++..... ....+..|+.+++++ +|+|++++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 344555567889999999999999999999998999999999865432 345688899999998 799999999987542
Q ss_pred cc-CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC
Q 047768 771 DF-KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM 849 (1009)
Q Consensus 771 ~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 849 (1009)
.. ......+++|||+++|+|.+++...... .+++..+..++.|++.|++|||+. +|+||||+|+||++++++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN----ALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA 158 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 21 1246789999999999999999764422 378888999999999999999999 999999999999999999
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccC-----CCCCCCcccchHHHHHHHHHHhCCCCCcccc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-----GGEASMRGGVYSYGILLLEIFTRRRPTESMF 924 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~ 924 (1009)
.++|+|||+++...... .......|+..|+|||.+. +..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 159 EVKLVDFGVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred CEEEeeCcchhhhhccc--------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 99999999987553211 1122356889999999875 3567889999999999999999999986432
Q ss_pred cCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 925 NEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. ..... ....... ......+...+.+++.+||+.||.+||++.|+++
T Consensus 231 ~~----~~~~~------~~~~~~~-------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 231 PM----RALFL------IPRNPPP-------------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HH----hhhhh------HhhCCCC-------------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 11 10000 0000000 0011123456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=306.22 Aligned_cols=270 Identities=22% Similarity=0.321 Sum_probs=198.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|++.+.||+|+||.||+|+++.+++.||+|++..... ...+.+.+|++++++++|+|++++++++.. ....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-----KRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEE
Confidence 368889999999999999999998899999999864322 223568899999999999999999998654 3678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||++++++..+..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPR------GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred EEEEeccCccHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence 99999999988888765433 289999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+........ ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+ ..... ...
T Consensus 147 ~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~-~~~ 216 (286)
T cd07847 147 ARILTGPGD--------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLI-RKT 216 (286)
T ss_pred ceecCCCcc--------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHH-HHH
Confidence 987644211 1122457889999999876 557899999999999999999999997433211 11111 111
Q ss_pred cc---chhhhccCC------CCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LP---EKVMEIVDP------SLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~---~~~~~~~d~------~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. ....+..+. ...+.+....... .........+.+++.+|++.+|++||++.|++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 217 LGDLIPRHQQIFSTNQFFKGLSIPEPETREPLE-SKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred hCCCChHHhhhcccccccccccCCCcccccCHH-HHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 000011100 0000000000000 000112356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=301.24 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=185.8
Q ss_pred CcccccCCceEEEEEEecC--CeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEe
Q 047768 707 NTIGRGSFGFVYKGVLHEN--GMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYE 783 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 783 (1009)
+.||+|+||.||+|+...+ ...+++|.++.... ...+.+.+|+.+++.++||||++++++|... ...++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEEe
Confidence 3599999999999986532 23566777654322 2356889999999999999999999987643 56799999
Q ss_pred ccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccC
Q 047768 784 YMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863 (1009)
Q Consensus 784 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~ 863 (1009)
|+++|+|.+++++.... ....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~ 150 (268)
T cd05086 76 YCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY 150 (268)
T ss_pred cCCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccC
Confidence 99999999999864321 12367778889999999999999998 99999999999999999999999999986432
Q ss_pred CCCCCCccccCCccccccccccccCccccCC-------CCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHH
Q 047768 864 ASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-------GEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 935 (1009)
.... ........|+..|+|||++.. ..++.++|||||||++|||++ |..||..... .+...
T Consensus 151 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~ 219 (268)
T cd05086 151 KEDY------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLN 219 (268)
T ss_pred cchh------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence 2110 011123467889999998753 345789999999999999997 5667753321 11222
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
....+....+.++.+.. .....+.+++..|| .+|++||+++||++.|
T Consensus 220 ~~~~~~~~~~~~~~~~~--------------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 220 HVIKDQQVKLFKPQLEL--------------PYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred HHHhhcccccCCCccCC--------------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 11112222222222211 12234667888999 5799999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=293.74 Aligned_cols=273 Identities=20% Similarity=0.304 Sum_probs=216.4
Q ss_pred HHHHHHhccCccCCcccccCCceEEEEEEecCC-----eEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeee
Q 047768 694 KELSKATNEFSSSNTIGRGSFGFVYKGVLHENG-----MLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTIC 767 (1009)
Q Consensus 694 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~ 767 (1009)
+++.....+++....+.+|.||.||.|.|++.+ +.|-||.++....+ ....+..|.-.+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 344455566777788999999999999987543 34566766433222 235677888889999999999999998
Q ss_pred eccccCCCceEEEEEeccCCCCHHHHHhccC--CCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee
Q 047768 768 SSIDFKGVDFKALVYEYMQNGSLEEWLHQRD--DQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL 845 (1009)
Q Consensus 768 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill 845 (1009)
.+ +...+++++.++.-|+|..|+...+ +......++..+...++.|++.|++|||++ +|||.||.++|++|
T Consensus 357 ie----~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 357 IE----DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVI 429 (563)
T ss_pred ee----ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhccee
Confidence 65 3467799999999999999998433 222345688899999999999999999999 99999999999999
Q ss_pred CCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccc
Q 047768 846 DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMF 924 (1009)
Q Consensus 846 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~ 924 (1009)
|+..+||++|=.++|.+.+.++....+. ...+..||+||.+.+..|+.++|||||||++|||+| |+.|+...+
T Consensus 430 dd~LqVkltDsaLSRDLFP~DYhcLGDn------EnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID 503 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPGDYHCLGDN------ENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID 503 (563)
T ss_pred hhheeEEeccchhccccCcccccccCCC------CCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC
Confidence 9999999999999999998876544333 335789999999999999999999999999999999 999987542
Q ss_pred cCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 925 NEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
.. .+..+ +.|. .+...+..|+++++.+|..||..+|++||+++|++.-|.+....
T Consensus 504 Pf--Em~~y-----------lkdG-----------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 504 PF--EMEHY-----------LKDG-----------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HH--HHHHH-----------Hhcc-----------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 21 11111 1111 11234457899999999999999999999999999988876644
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=308.93 Aligned_cols=274 Identities=22% Similarity=0.322 Sum_probs=197.7
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|++.+.||+|++|.||+|..+.+++.||||.+...... ....+.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-----KKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-----CCeE
Confidence 35788999999999999999999888999999998654322 23567789999999999999999998654 3678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+. ++|.+++..... .+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 149 (291)
T cd07844 79 TLVFEYLD-TDLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGL 149 (291)
T ss_pred EEEEecCC-CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccc
Confidence 99999997 599999876543 388999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++...... .......++..|+|||+..+ ..++.++||||+|+++|||++|+.||.................
T Consensus 150 ~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~ 221 (291)
T cd07844 150 ARAKSVPS--------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL 221 (291)
T ss_pred ccccCCCC--------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhc
Confidence 87543211 11112346789999998765 4578999999999999999999999964321111111111100
Q ss_pred ---ccchhhhccCC-----CCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 ---LPEKVMEIVDP-----SLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ---~~~~~~~~~d~-----~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.++......+. ........+..............+.+++.+|++.+|++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 222 GTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred CCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000000 00000000000000001111245679999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=316.99 Aligned_cols=285 Identities=25% Similarity=0.287 Sum_probs=206.7
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccc-cCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSID-FKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~~ 779 (1009)
.|...+.||+|+||.||+|+++++|+.||||.++... ....+...+|+++|++++|+|||+++++-.... ........
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3455678999999999999999999999999997543 233567789999999999999999999854431 11145678
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC--CCC--ceEEec
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD--HDM--VAHVSD 855 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~--~~~--~~kl~D 855 (1009)
+|||||.+|||+..+.+-... ..+++.+.+.+..+++.||.|||++ +||||||||.||++- ++| .-||+|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~---~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENA---YGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred EEEeecCCCcHHHHhcCcccc---cCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeec
Confidence 999999999999999865432 3499999999999999999999999 999999999999983 434 579999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccC-CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
||.|+.+++. .......||..|.+||... .+.|+..+|.|||||++||.+||..||....... ...+..
T Consensus 168 fG~Arel~d~---------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk-~~~~~~ 237 (732)
T KOG4250|consen 168 FGAARELDDN---------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK-NNKEIM 237 (732)
T ss_pred ccccccCCCC---------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc-ccchhh
Confidence 9999988764 2445688999999999988 4888999999999999999999999997544332 111111
Q ss_pred HH---hccchhhhccCCCCCChhhhh--hhccccccHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHHHHHH
Q 047768 935 KR---ALPEKVMEIVDPSLLPLEEER--TNSRRVRNEECLVAVIKTGVACSIESPFDRM--EMTDVVVKLCHARQ 1002 (1009)
Q Consensus 935 ~~---~~~~~~~~~~d~~l~~~~~~r--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp--t~~evl~~L~~i~~ 1002 (1009)
.. ..+..+....++...+..+.. .+............+-+....++..+|++|- ...+....+..|..
T Consensus 238 ~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 238 WHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred hhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 11 112222222221111100000 0001112223334455666677778888888 66676666666654
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=308.04 Aligned_cols=255 Identities=22% Similarity=0.292 Sum_probs=197.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|++++++++||||+++++++.. ....+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEE
Confidence 368889999999999999999988999999999865422 224578899999999999999999998654 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+++++|.+++..... ...+++..+..++.+++.|+.|||+.+ +|+||||||+||+++.++.+|++|||++
T Consensus 76 lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred EEEeecCCCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 99999999999999876421 124899999999999999999999632 8999999999999999999999999998
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCC------CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG------EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
...... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||...... .....
T Consensus 151 ~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~ 218 (286)
T cd06622 151 GNLVAS----------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQ 218 (286)
T ss_pred ccccCC----------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHH
Confidence 765321 11123578899999987554 3588999999999999999999999643211 00000
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
...+.+..... ....+..++.+++.+|++.+|++||++++++..
T Consensus 219 --------~~~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 219 --------LSAIVDGDPPT-----------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --------HHHHhhcCCCC-----------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11111110000 111244567899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=302.96 Aligned_cols=255 Identities=23% Similarity=0.370 Sum_probs=197.8
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc------chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG------GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
+|.+.+.||+|+||+||+|... +++.+|||+++..... ....+.+|++++++++|+||+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD----- 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-----
Confidence 4788899999999999999874 7889999998644321 124688999999999999999999997643
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++|+||+++++|.+++.+.. .+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.+|++|
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 145 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID 145 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence 78899999999999999997654 278999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||++.......... ..........|+..|+|||+..+..++.++|||||||++|||++|+.||...... .....
T Consensus 146 fg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~ 219 (265)
T cd06631 146 FGCARRLAWVGLHG--THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----AAMFY 219 (265)
T ss_pred chhhHhhhhccccc--cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----HHHHH
Confidence 99998654321110 0111122356899999999999989999999999999999999999999643211 11100
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..... .. .+.+ ......++.+++.+|++.+|++||++.|++.
T Consensus 220 ~~~~~---~~-~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 220 IGAHR---GL-MPRL--------------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hhhcc---CC-CCCC--------------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00 0000 0123345789999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.54 Aligned_cols=238 Identities=26% Similarity=0.459 Sum_probs=188.6
Q ss_pred CcccccCCceEEEEEEecCC----------eEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 707 NTIGRGSFGFVYKGVLHENG----------MLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
+.||+|+||.||+|.++.++ ..||+|++...... ...+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 46999999999999998665 45888887644333 6788999999999999999999998753 3
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC-------
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM------- 849 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~------- 849 (1009)
..++|+||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~ 145 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVP 145 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCce
Confidence 46899999999999999987653 388999999999999999999998 999999999999999888
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCC--CCCCcccchHHHHHHHHHHh-CCCCCcccccC
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG--EASMRGGVYSYGILLLEIFT-RRRPTESMFNE 926 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~ 926 (1009)
.+|++|||+++..... ....++..|+|||++.+. .++.++|||||||++|||++ |..||......
T Consensus 146 ~~kl~Dfg~a~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~ 213 (259)
T cd05037 146 FIKLSDPGIPITVLSR------------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS 213 (259)
T ss_pred eEEeCCCCcccccccc------------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch
Confidence 7999999999865431 123466789999998876 78999999999999999999 57777543211
Q ss_pred CccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 927 GLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
....+.. .....+. +....+.+++.+|+..+|.+|||+.|+++.|
T Consensus 214 --~~~~~~~-----------~~~~~~~-------------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 214 --EKERFYQ-----------DQHRLPM-------------PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred --hHHHHHh-----------cCCCCCC-------------CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0011100 0000000 0114678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=308.52 Aligned_cols=274 Identities=22% Similarity=0.335 Sum_probs=197.5
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
+.++|.+.+.||+|+||.||+|..+.+++.||+|++..... .....+.+|+++++.++|+||+++++++.. ...
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-----KET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-----CCe
Confidence 35689999999999999999999988899999999865432 223467889999999999999999998654 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++|+||+. +++.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg 148 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPG-----GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFG 148 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccc
Confidence 899999995 788887765432 277888999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+++...... .......++..|+|||++.+. .++.++|||||||++|||++|+.||.........+.+....
T Consensus 149 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~ 220 (291)
T cd07870 149 LARAKSIPS--------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220 (291)
T ss_pred cccccCCCC--------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHH
Confidence 997543211 111224568899999998764 57889999999999999999999997543221111111110
Q ss_pred h-ccch-h----h---hccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 A-LPEK-V----M---EIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~-~~~~-~----~---~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. .+.. . . +............ .....+........+.+++.+|+..||++|||+.|++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 221 LGVPTEDTWPGVSKLPNYKPEWFLPCKPQ-QLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cCCCChhhhhhhhhcccccchhccccCCc-chhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 0000 0 0 0000000000000 00000011112346779999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=300.45 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=196.9
Q ss_pred CcccccCCceEEEEEEec-CC--eEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHE-NG--MLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|++|.||+|.+.. .+ ..||||.++.... ...+.+.+|++++++++||||+++++++.. ...++|+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 468999999999999864 33 3699999976544 445688999999999999999999998643 5679999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++..
T Consensus 75 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred EecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccc
Confidence 99999999999987542 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccch
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPEK 941 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+.......
T Consensus 148 ~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~-- 215 (257)
T cd05040 148 PQNEDHY-----VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-----SQILKKIDK-- 215 (257)
T ss_pred cccccce-----ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHh--
Confidence 5422100 01112456789999999999999999999999999999999 9999863321 111111100
Q ss_pred hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 942 VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 942 ~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
....... ....+..+.+++.+|++.+|++||+++|+++.|.
T Consensus 216 -----~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 -----EGERLER-----------PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----cCCcCCC-----------CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0000000 0123356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.22 Aligned_cols=251 Identities=20% Similarity=0.315 Sum_probs=200.5
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|++.+.||+|+||.||++....+++.||+|.+.... ....+.+.+|++++++++||||+++++++.. ....+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-----NGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-----CCeEE
Confidence 4788899999999999999999899999999986542 2234578899999999999999999998643 46889
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++
T Consensus 76 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 99999999999999976432 1378899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....... .......|++.|+|||+..+..++.++|||||||++|||++|+.||.... ........
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~-- 213 (256)
T cd08218 149 RVLNSTV--------ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLVLKI-- 213 (256)
T ss_pred eecCcch--------hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHHHHH--
Confidence 7654321 11122457889999999999999999999999999999999999986321 11111111
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
........ .......+.+++.+|++.+|++||++.||++.
T Consensus 214 ------~~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 214 ------IRGSYPPV-----------SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ------hcCCCCCC-----------cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11111000 11233467899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=315.69 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=204.6
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
+-|.++--||.|+||.||+|+.++++...|-|++.......-..|.-||++|..++||+||++++.|... ...++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----nkLwi 106 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----NKLWI 106 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----CceEE
Confidence 3466677799999999999999988888899999776666678899999999999999999999976532 67899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
+.|||.||-...++-+-+.. +++.++..++++++.||.|||++ .|||||||+.|||++-+|.++++|||.+-
T Consensus 107 liEFC~GGAVDaimlEL~r~-----LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGRV-----LTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred EEeecCCchHhHHHHHhccc-----cchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccc
Confidence 99999999999988876654 99999999999999999999999 99999999999999999999999999875
Q ss_pred ccCCCCCCCccccCCccccccccccccCccc-----cCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEY-----GLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
.... +......+.||+.|||||+ +.+.+|+.++||||||+.+.||..+.+|-.... ..+...
T Consensus 179 Kn~~--------t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-----pMRVll 245 (1187)
T KOG0579|consen 179 KNKS--------TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-----PMRVLL 245 (1187)
T ss_pred cchh--------HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-----hHHHHH
Confidence 4322 1234446899999999997 456789999999999999999999999965321 111111
Q ss_pred H-hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 R-ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~-~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. ..++ . +....+..|...+.++...|+..+|..||+++++++
T Consensus 246 KiaKSe------P------------PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 246 KIAKSE------P------------PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHhhcC------C------------CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1 0000 0 011223456677889999999999999999999875
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=317.86 Aligned_cols=279 Identities=21% Similarity=0.253 Sum_probs=203.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|.+.+.||+|+||.||+|.+..+|+.||||+++... ......+.+|+.++++++|+||+++++++....+......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999999899999999986432 2234567889999999999999999998776555555678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++|+||+. +++.+++.... +++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~-------l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQH-------LSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred EEEehhcc-cCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence 99999996 58888876532 89999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++....... .........||..|+|||++.+ ..++.++||||+||++|||++|+.||...... .........
T Consensus 153 ~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~--~~~~~~~~~ 225 (336)
T cd07849 153 ARIADPEHD-----HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL--HQLNLILGV 225 (336)
T ss_pred eeecccccc-----ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHH
Confidence 986643221 1112233568999999998655 56899999999999999999999999643211 000001111
Q ss_pred c----cchhhhccCCCCCChhhhhhhcccc----ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 938 L----PEKVMEIVDPSLLPLEEERTNSRRV----RNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 938 ~----~~~~~~~~d~~l~~~~~~r~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
. ++....+.+..........+..... .......++.+++.+|++.||++|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred cCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 1111111111110000000000000 000123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.75 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=202.6
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
++|++.+.||+|+||.||+|.++.+++.||+|++..... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEE
Confidence 367788999999999999999998899999999865432 3346788999999999999999999986543 7789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
+|+||+++++|.+++..... .+++..+..++.|++.|++|||+ . +++||||||+||++++++.+||+|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQG-----RIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred EEEEecCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999987542 38899999999999999999999 7 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... .....++..|+|||+..+..++.++||||||+++|+|++|+.||..................
T Consensus 148 ~~~~~~~~----------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 217 (265)
T cd06605 148 SGQLVNSL----------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV 217 (265)
T ss_pred chhhHHHH----------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh
Confidence 87553211 11156788999999999999999999999999999999999999754322222222211111
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.......+ ......++.+++.+|+..+|++|||+.|++..
T Consensus 218 --------~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 218 --------NEPPPRLP----------SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred --------cCCCCCCC----------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 10000000 01134567899999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=319.01 Aligned_cols=236 Identities=23% Similarity=0.243 Sum_probs=180.8
Q ss_pred ccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhc---CCCCcceEEeeeeccccCCCceEEEEE
Q 047768 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSI---RHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 709 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
||+|+||+||+|+++.+++.||||++..... ........|..++... +||||+++++++.. ....++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-----~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-----DSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-----CCeEEEEE
Confidence 6999999999999998999999999864321 1223445566666655 69999999988654 36789999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++.... .+++..+..++.|+++|++|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 76 DYMSGGELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred cCCCCChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 9999999999987654 388999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccch
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEK 941 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
.... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..+.........
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~ 213 (330)
T cd05586 147 LTDN--------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-----TQQMYRNIAFGK 213 (330)
T ss_pred CCCC--------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-----HHHHHHHHHcCC
Confidence 3211 112345689999999998764 47999999999999999999999986421 111111111000
Q ss_pred hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 047768 942 VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990 (1009)
Q Consensus 942 ~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~ 990 (1009)
. ..+. ......+.+++.+|++.||.+||++
T Consensus 214 --------~-~~~~----------~~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 214 --------V-RFPK----------NVLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred --------C-CCCC----------ccCCHHHHHHHHHHcCCCHHHCCCC
Confidence 0 0000 0112346789999999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=299.90 Aligned_cols=249 Identities=25% Similarity=0.408 Sum_probs=198.1
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|+..+.||+|+||.||+|....+++.+|||.+.... ......+.+|++++++++|||++++++.+.. ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-----DKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-----CCEEE
Confidence 4778899999999999999998899999999986542 2234678899999999999999999987543 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC-CceEEecccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGL 858 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~DfGl 858 (1009)
+|+||+++++|.+++..... ..+++..+..++.+++.|++|||++ +|+||||+|+||+++++ +.+|++|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred EEEecCCCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 99999999999999986532 2488999999999999999999999 99999999999999865 4689999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ........
T Consensus 149 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~ 214 (256)
T cd08220 149 SKILSSKS---------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLKIM 214 (256)
T ss_pred ceecCCCc---------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHHHH
Confidence 98664321 11234578899999999988899999999999999999999999864321 11111110
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...... ........+.+++.+||+.+|++|||+.|+++
T Consensus 215 --------~~~~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 215 --------SGTFAP-----------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --------hcCCCC-----------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000000 01123345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=334.04 Aligned_cols=267 Identities=23% Similarity=0.290 Sum_probs=197.4
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccc-----
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSID----- 771 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 771 (1009)
+-..+|+..+.||+||||.||+++.+-+|+.||||++.... ......+.+|+..+++++|||||+++..+.+..
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34457788899999999999999999999999999997654 223456889999999999999999985431000
Q ss_pred --------------------------------------------------------------------------------
Q 047768 772 -------------------------------------------------------------------------------- 771 (1009)
Q Consensus 772 -------------------------------------------------------------------------------- 771 (1009)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ----------------------cC-------CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHH
Q 047768 772 ----------------------FK-------GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822 (1009)
Q Consensus 772 ----------------------~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l 822 (1009)
.. .....|+-||||+.-.+.++++.+... -.....|+++++|+.||
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEGL 710 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHHH
Confidence 00 013567899999998888888876531 14667899999999999
Q ss_pred HHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccC---------CCCCCCccc-cCCccccccccccccCcccc
Q 047768 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS---------ASPLGNVVE-TPSSSIGVKGTIGYVAPEYG 892 (1009)
Q Consensus 823 ~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~---------~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~ 892 (1009)
+|+|++ |||||||||.||+++++..|||+|||+|+... ......... .....++.+||.-|+|||++
T Consensus 711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999999 99999999999999999999999999999832 011111111 11245678999999999998
Q ss_pred CCCC---CCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHH
Q 047768 893 LGGE---ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECL 969 (1009)
Q Consensus 893 ~~~~---~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~ 969 (1009)
.+.. |+.|+|+||+|||++||+. ||...+.....+.......+|.+ .++.+ +..
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~-------------------~~~ 844 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFD-------------------PEH 844 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-ccccc-------------------ccc
Confidence 7755 9999999999999999985 56543322111111111112222 22222 222
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 970 VAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 970 ~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..-.+++.++++.||.+||||.|++.
T Consensus 845 ~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 845 PEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred hHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 33468999999999999999999975
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.82 Aligned_cols=250 Identities=21% Similarity=0.298 Sum_probs=197.1
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALV 781 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 781 (1009)
.|.....||+|+||.||+|....++..||||.++.......+.+.+|+..++.++|+|++++++.+.. .+..++|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCeEEEE
Confidence 34445679999999999999988899999999865544445678899999999999999999998654 3678999
Q ss_pred EeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccc
Q 047768 782 YEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861 (1009)
Q Consensus 782 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~ 861 (1009)
|||+++++|.+++... .+++.++..++.|++.|++|||++ +|+||||||+||++++++.+||+|||++..
T Consensus 98 ~e~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 98 MEFLEGGALTDIVTHT-------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167 (292)
T ss_pred EeCCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence 9999999999988543 278999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccch
Q 047768 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEK 941 (1009)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
..... .......|+..|+|||...+..++.++||||||+++|||++|+.||...... .....
T Consensus 168 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~----- 229 (292)
T cd06658 168 VSKEV--------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-----QAMRR----- 229 (292)
T ss_pred ccccc--------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH-----
Confidence 43211 1112356889999999998889999999999999999999999998642211 11000
Q ss_pred hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 942 VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 942 ~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
+.......... .......+.+++.+|+..||.+|||+.|+++.
T Consensus 230 ~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 230 IRDNLPPRVKD------------SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHhcCCCcccc------------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01111111110 00122356788999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=300.39 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=197.5
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-----cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-----GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
+|+..+.||+|+||+||+|....+++.||+|.+..... ...+.+.+|++++++++|+||+++++++... .
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-----D 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-----C
Confidence 46778899999999999999988899999999865432 2346788999999999999999999986543 6
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.+||+||
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~ 146 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF 146 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence 7899999999999999997654 378999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCC-CCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE-ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|.+....... ......|+..|+|||.+.... ++.++|+||||+++|||++|+.||..... ......
T Consensus 147 ~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~~~ 213 (258)
T cd06632 147 GMAKQVVEFS---------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAVFK 213 (258)
T ss_pred ccceeccccc---------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHHHH
Confidence 9987654321 112356889999999987776 89999999999999999999999874321 111100
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
......... ........+.+++.+|++.+|++||++.|++.
T Consensus 214 ~~~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 214 IGRSKELPP-------------------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHhcccCCC-------------------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 000000000 00112345678999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=308.05 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=201.7
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.++++++|||++++++++... ...+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----CcEE
Confidence 36888999999999999999998888999999998755544557788999999999999999999987543 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+++++|.+++.+.. +++.++..++.|++.|+.|||++ +++||||+|+||+++.++.+||+|||++
T Consensus 93 lv~e~~~~~~L~~~~~~~~-------l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~ 162 (293)
T cd06647 93 VVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (293)
T ss_pred EEEecCCCCcHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcce
Confidence 9999999999999997643 78889999999999999999999 9999999999999999999999999988
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....... .......|++.|+|||.+....++.++|||||||++||+++|+.||......... ..
T Consensus 163 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~~------- 226 (293)
T cd06647 163 AQITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YL------- 226 (293)
T ss_pred ecccccc--------cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-ee-------
Confidence 7554321 1112345888999999998888999999999999999999999999743221100 00
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
... ...+ . ..........+.+++.+||..+|++||++.+++..
T Consensus 227 -----~~~---~~~~----~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 227 -----IAT---NGTP----E--LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -----hhc---CCCC----C--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0000 0 00011123457789999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=335.10 Aligned_cols=266 Identities=26% Similarity=0.418 Sum_probs=209.0
Q ss_pred ccCccCCcccccCCceEEEEEEec-------CCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeeccc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHE-------NGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSSID 771 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 771 (1009)
++..+.+.+|+|.||.||+|..+. ....||||.++.... ...+.+..|+++|+.+ +|+||+.++|+|+.
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 344556799999999999998651 145799999875433 3457899999999999 69999999999986
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccC--CCCCc--------cCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRD--DQLGI--------CNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPS 841 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~--------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~ 841 (1009)
....++|+||+.+|+|.+|++.++ ..... ..++..+.+.++.|||.|++||+++ ++||||+.++
T Consensus 374 ---~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 374 ---DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred ---CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 367899999999999999999877 11111 2388999999999999999999999 9999999999
Q ss_pred ceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCC
Q 047768 842 NVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPT 920 (1009)
Q Consensus 842 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~ 920 (1009)
|||++++..+||+|||+|+......++..... .+. -+..|||||.+....|+.++|||||||++||++| |..||
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~----~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSS----AGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCC----CCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence 99999999999999999997766543221110 001 2456999999999999999999999999999999 99999
Q ss_pred cccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 921 ESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
...... .. +.+.+. ...+...+..|..+++++|..||+.+|++||++.|+++.+...
T Consensus 523 p~~~~~----~~---------l~~~l~----------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 523 PGIPPT----EE---------LLEFLK----------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCCCcH----HH---------HHHHHh----------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 752111 11 111111 1111223345677899999999999999999999999999985
Q ss_pred HH
Q 047768 1001 RQ 1002 (1009)
Q Consensus 1001 ~~ 1002 (1009)
..
T Consensus 580 l~ 581 (609)
T KOG0200|consen 580 LQ 581 (609)
T ss_pred HH
Confidence 43
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=301.66 Aligned_cols=254 Identities=20% Similarity=0.274 Sum_probs=196.3
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc-----chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-----GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.+|++.+.||+|+||.||.|.+..+++.||||.+...... ..+.+.+|++++++++||||+++++++... ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 4788899999999999999999989999999998643211 134688899999999999999999986432 23
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++++|.+++.... .+++.....++.|++.||+|||+. +|+|+||||+||+++.++.+||+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence 46789999999999999997654 278888999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++....... .........|+..|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 150 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~ 220 (265)
T cd06652 150 FGASKRLQTICL-----SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAAIFK 220 (265)
T ss_pred Cccccccccccc-----cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHHHHH
Confidence 999986543211 01112234588999999999888899999999999999999999999863211 111110
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..... ..+ ..+......+.+++.+|+. +|+.||+++|+++
T Consensus 221 -~~~~~----~~~--------------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 221 -IATQP----TNP--------------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -HhcCC----CCC--------------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00000 000 0111223456788888885 8999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=306.88 Aligned_cols=254 Identities=22% Similarity=0.275 Sum_probs=197.1
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc--cccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE--QKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 775 (1009)
...+|++.++||+||.+.||++... +.+.+|+|++... +.+....|..|+..|.++ .|.+||++++|... .
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d 432 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-----D 432 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----C
Confidence 4568999999999999999999875 5567888776433 333457899999999999 59999999999543 4
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
++.|+||||- ..+|.++|+++... ++...++.+..|++.|+.++|.+ ||||.||||.|+|+- .|.+||+|
T Consensus 433 ~~lYmvmE~G-d~DL~kiL~k~~~~-----~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLID 502 (677)
T KOG0596|consen 433 GYLYMVMECG-DIDLNKILKKKKSI-----DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLID 502 (677)
T ss_pred ceEEEEeecc-cccHHHHHHhccCC-----CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeee
Confidence 7899999986 56999999987753 33237889999999999999999 999999999999984 57999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCC-----------CCCcccchHHHHHHHHHHhCCCCCcccc
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE-----------ASMRGGVYSYGILLLEIFTRRRPTESMF 924 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwS~Gvvl~elltg~~p~~~~~ 924 (1009)
||+|.-+..... .......+||+.||+||.+.... .++++||||+||++|+|+.|+.||+...
T Consensus 503 FGIA~aI~~DTT------sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 503 FGIANAIQPDTT------SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred echhcccCcccc------ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 999988765432 22334578999999999876542 5689999999999999999999997432
Q ss_pred cCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 925 NEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. | .++..+.++.-.-...+ ++...+++++|..|++.||++|||+.|+++
T Consensus 577 n~------~------aKl~aI~~P~~~Iefp~---------~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 577 NQ------I------AKLHAITDPNHEIEFPD---------IPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HH------H------HHHHhhcCCCccccccC---------CCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11 1 23344455432211110 011123889999999999999999999986
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=301.06 Aligned_cols=254 Identities=25% Similarity=0.453 Sum_probs=199.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||.||+|.+. .+..||+|.++... ...+.+.+|++++++++|+||+++++++.. ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY 76 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence 457889999999999999999865 56679999886432 234678899999999999999999988643 4578
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
++|||+++++|.+++..... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.+|++|||.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 149 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA 149 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCc----cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcce
Confidence 99999999999999976432 2478889999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
........ .......++..|+|||++....++.++|||||||++||+++ |+.||...... ..........
T Consensus 150 ~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~ 220 (260)
T cd05073 150 RVIEDNEY-------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGY 220 (260)
T ss_pred eeccCCCc-------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCC
Confidence 76543211 11112345678999999998899999999999999999999 89998643211 1111111000
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
. . . .....+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 221 ~----------~-~-----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 R----------M-P-----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred C----------C-C-----------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 0 0 001233468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=301.29 Aligned_cols=255 Identities=23% Similarity=0.368 Sum_probs=196.4
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc----------chHHHHHHHHHHHhcCCCCcceEEeeeeccc
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG----------GSKSFAAECEALRSIRHRNLIKIVTICSSID 771 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 771 (1009)
+|.+.+.||+|+||.||+|....+++.||+|.++..... ..+.+.+|++++++++|||++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 467788999999999999999888999999988643111 124578899999999999999999987543
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCce
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 851 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 851 (1009)
...++|+||+++++|.+++.... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+
T Consensus 81 ----~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 81 ----EYLSIFLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC 147 (272)
T ss_pred ----CceEEEEecCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence 67899999999999999998753 388899999999999999999998 99999999999999999999
Q ss_pred EEeccccccccCCCCCCCccccCCccccccccccccCccccCCCC--CCCcccchHHHHHHHHHHhCCCCCcccccCCcc
Q 047768 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE--ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLT 929 (1009)
Q Consensus 852 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~ 929 (1009)
+++|||+++...... .........|+..|+|||...... ++.++||||||+++||+++|..||.....
T Consensus 148 ~l~d~~~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---- 217 (272)
T cd06629 148 KISDFGISKKSDDIY------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---- 217 (272)
T ss_pred EEeeccccccccccc------cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----
Confidence 999999997653211 001122345889999999987654 78999999999999999999999853211
Q ss_pred HHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 930 LHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
........ .......+.. .........+.+++.+|+..+|+.||++.||++
T Consensus 218 ~~~~~~~~-~~~~~~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 218 IAAMFKLG-NKRSAPPIPP--------------DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHHHHhh-ccccCCcCCc--------------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 11111100 0000000000 000123456789999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.75 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=201.2
Q ss_pred ccCccCCcccccCCceEEEEEEec-----CCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHE-----NGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
++|++.+.||+|+||+||+|+.+. +.+.||+|.+...... ..+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA---- 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC----
Confidence 568888999999999999999763 3467999988644332 346789999999999999999999987543
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCC---ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCce
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLG---ICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 851 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 851 (1009)
...++||||+++|+|.+++........ ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+
T Consensus 81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 81 -EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred -CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence 567999999999999999986542210 12489999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccH
Q 047768 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTL 930 (1009)
Q Consensus 852 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~ 930 (1009)
+++|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 157 ~l~~~~~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---- 225 (275)
T cd05046 157 KVSLLSLSKDVYNSEY-------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---- 225 (275)
T ss_pred EEcccccccccCcccc-------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH----
Confidence 9999999875433211 11223456788999999988889999999999999999999 78888643211
Q ss_pred HHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 931 HEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
............ . . ....++..+.+++.+|++.+|++||++.|+++.|.
T Consensus 226 -~~~~~~~~~~~~-~------~-----------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 226 -EVLNRLQAGKLE-L------P-----------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -HHHHHHHcCCcC-C------C-----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111111000000 0 0 01123456889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=306.57 Aligned_cols=273 Identities=22% Similarity=0.277 Sum_probs=200.4
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.++++++|||++++++++.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence 4788899999999999999998889999999997544 2234678999999999999999999998654 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+ +++|.+++..... .+++.+++.++.|+++|++|||+. +++|+||||+||+++.++.++++|||++
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEER-----PLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred EEeccc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 999999 9999999876543 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
........ .......|+..|+|||++.+. .++.++||||+|+++|||++|+.||...... ...........
T Consensus 147 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~ 218 (286)
T cd07832 147 RLFSEEEP-------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLG 218 (286)
T ss_pred ccccCCCC-------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcC
Confidence 86653211 112234688999999987654 4689999999999999999998777542211 11111111000
Q ss_pred ---cchhhh---ccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 939 ---PEKVME---IVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 939 ---~~~~~~---~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
+....+ ..+......+............+...++.+++.+|++.+|.+||+++++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 219 TPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 0000000000000000000001223678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=306.43 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=197.5
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
|.....||+|+||.||+|....+++.||+|+++.......+.+.+|+.+++.++|||++++++++.. ....++|+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEEE
Confidence 3445679999999999999988899999999976555556778899999999999999999998654 36789999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++++|.+++.... +++..++.++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++...
T Consensus 98 e~~~~~~L~~~~~~~~-------~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 98 EFLQGGALTDIVSQTR-------LNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred ecCCCCCHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 9999999999886532 88999999999999999999999 9999999999999999999999999998755
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchh
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
.... .......|+..|+|||++.+..++.++|||||||++|||++|+.||..... .. ..... ...
T Consensus 168 ~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~-~~~~~-~~~- 232 (297)
T cd06659 168 SKDV--------PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----VQ-AMKRL-RDS- 232 (297)
T ss_pred cccc--------ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HH-HHHHH-hcc-
Confidence 4321 111235688999999999998999999999999999999999999863221 11 11100 000
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
....... .......+.+++.+|++.+|.+||++.|+++.
T Consensus 233 ---~~~~~~~------------~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 233 ---PPPKLKN------------AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ---CCCCccc------------cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000 00122357789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.82 Aligned_cols=271 Identities=24% Similarity=0.329 Sum_probs=198.4
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|++.+.||+|+||.||+|.++.+++.||+|++...... ..+.+.+|+++++.++||||+++++++.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-----KKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-----CCeE
Confidence 3688899999999999999999888999999988543222 24578899999999999999999998643 4678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++|+||+++++|.++..... .+++.+++.++.|++.|++|||+. +++||||+|+||++++++.+|++|||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPN------GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred EEEEecCCccHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeee
Confidence 99999999999888765433 288999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH--
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK-- 935 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-- 935 (1009)
+....... .......++..|+|||+..+ ..++.++||||||+++|||++|+.||...... ........
T Consensus 147 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~ 217 (286)
T cd07846 147 ARTLAAPG--------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCL 217 (286)
T ss_pred eeeccCCc--------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHh
Confidence 98654321 11123457889999998775 45688999999999999999999988632211 00011100
Q ss_pred HhccchhhhccC------CCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVD------PSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d------~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
....+......+ ....+....... ...........+.+++.+||+.+|++||++.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 218 GNLIPRHQEIFQKNPLFAGMRLPEVKEIEP-LEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CCCchhhHHHhccchHhhccccccccCcch-HHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 001111111110 000000000000 00001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=300.23 Aligned_cols=255 Identities=21% Similarity=0.282 Sum_probs=201.3
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|++.+.||.|+||.||+|.+..+++.||+|+++.... ...+.+..|++++++++|||++++++++.. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 47788999999999999999998999999999864322 234568889999999999999999987643 2335678
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH-----HHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-----~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
+++||+++++|.+++...... ...+++..++.++.+++.|++||| +. +++||||+|+||+++.++.+|++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKE--RKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred EEehhccCCCHHHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEe
Confidence 999999999999999764221 124899999999999999999999 66 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... .....
T Consensus 153 d~g~~~~~~~~~--------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~ 219 (265)
T cd08217 153 DFGLAKILGHDS--------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLA 219 (265)
T ss_pred cccccccccCCc--------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHH
Confidence 999998765421 11123468899999999999999999999999999999999999987432 11111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.... ...... ........+.+++.+|++.+|++||++.||++.
T Consensus 220 ~~~~--------~~~~~~-----------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 220 SKIK--------EGKFRR-----------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHh--------cCCCCC-----------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1110 000000 111234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=310.29 Aligned_cols=260 Identities=25% Similarity=0.298 Sum_probs=200.8
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|+..+.||+|+||.||+|....+++.||+|.+...... ..+.+.+|+++++.++|+||+++++.+.. ...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-----ETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-----CCE
Confidence 3688889999999999999999888999999999654322 34568899999999999999999998654 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+.+++|.+++..... ..+++..+..++.|+++|++|||+. +++||||||+||+++.++.++|+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecc
Confidence 8999999999999999875432 2489999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCCcc---------------------ccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhC
Q 047768 858 LAKFLSASPLGNVV---------------------ETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR 916 (1009)
Q Consensus 858 la~~~~~~~~~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg 916 (1009)
++............ ..........||..|+|||++.+..++.++||||||+++|||++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 98765432110000 000111234688999999999999999999999999999999999
Q ss_pred CCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC----HHH
Q 047768 917 RRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME----MTD 992 (1009)
Q Consensus 917 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt----~~e 992 (1009)
+.||...... ..+ ..+.+..... + ........+.+++.+|++.||++||+ ++|
T Consensus 229 ~~pf~~~~~~----~~~---------~~~~~~~~~~-~---------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ 285 (316)
T cd05574 229 TTPFKGSNRD----ETF---------SNILKKEVTF-P---------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAE 285 (316)
T ss_pred CCCCCCCchH----HHH---------HHHhcCCccC-C---------CccccCHHHHHHHHHHccCCHhHCCCchhhHHH
Confidence 9998643221 111 1111111000 0 00013456889999999999999999 666
Q ss_pred HHH
Q 047768 993 VVV 995 (1009)
Q Consensus 993 vl~ 995 (1009)
++.
T Consensus 286 ll~ 288 (316)
T cd05574 286 IKQ 288 (316)
T ss_pred HHc
Confidence 655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=304.48 Aligned_cols=261 Identities=23% Similarity=0.300 Sum_probs=202.9
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeecccc-CCCc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDF-KGVD 776 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-~~~~ 776 (1009)
+.++|++.+.||+|+||.||+|.++.+++.||+|+++.... ..+.+.+|+++++++ +|+||+++++++..... ....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 46789999999999999999999988899999999865433 346789999999999 79999999999865422 2346
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++++|.+++...... ...+++..+..++.|++.|+.|||+. +++||||+|+||++++++.+|++||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 789999999999999998753311 12488999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCC-----CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-----GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLH 931 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~ 931 (1009)
|++....... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...... .
T Consensus 158 ~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~ 225 (275)
T cd06608 158 GVSAQLDSTL--------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM----R 225 (275)
T ss_pred ccceecccch--------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH----H
Confidence 9987654321 11223458899999998754 34678999999999999999999999642111 1
Q ss_pred HHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 932 EFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. ....... .+.+ .....+..++.+++.+|+..||++|||+.|+++
T Consensus 226 ~~-~~~~~~~-----~~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 226 AL-FKIPRNP-----PPTL------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HH-HHhhccC-----CCCC------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 1000000 0000 011234557889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=304.65 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=192.6
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHH-HHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEA-LRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|++.+.||+|+||.||+|+++.+|+.||+|+++.... .....+..|+.. ++..+|||++++++++.. ....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcE
Confidence 468889999999999999999998999999999865432 223455566665 566689999999998754 3568
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||++ |+|.+++...... ...+++..++.++.|++.|++|||+++ +++||||||+||+++.++.+||+|||+
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~ 150 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI 150 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999996 7898888653221 134899999999999999999999853 799999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCC----CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG----GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
++..... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 151 ~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~ 218 (283)
T cd06617 151 SGYLVDS---------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---FQQLK 218 (283)
T ss_pred ccccccc---------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---HHHHH
Confidence 9865322 11122457889999998765 45688999999999999999999998643211 11111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..........+. ..+..++.+++.+|+..+|++||+++++++
T Consensus 219 ---------~~~~~~~~~~~~----------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 219 ---------QVVEEPSPQLPA----------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---------HHHhcCCCCCCc----------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111100000000 013346789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=301.77 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=197.0
Q ss_pred cCccCCcccccCCceEEEEEEec-CCeEEEEEEeecccc----------cchHHHHHHHHHHHh-cCCCCcceEEeeeec
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHE-NGMLVAVKVINLEQK----------GGSKSFAAECEALRS-IRHRNLIKIVTICSS 769 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 769 (1009)
+|++.+.||+|+||.||+|.+.. .++.+|+|.+..... .....+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999986 678999998853321 112456778888875 699999999998754
Q ss_pred cccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC
Q 047768 770 IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM 849 (1009)
Q Consensus 770 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 849 (1009)
....++||||+++++|.+++...... ...+++..++.++.|++.|+.|||+.. +++||||+|+||+++.++
T Consensus 81 -----~~~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~ 151 (269)
T cd08528 81 -----NDRLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDD 151 (269)
T ss_pred -----CCeEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCC
Confidence 36789999999999999988642211 124889999999999999999999631 899999999999999999
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCcc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLT 929 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~ 929 (1009)
.+|++|||.+....... ......|+..|+|||...+..++.++||||||+++|||++|+.||....
T Consensus 152 ~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~----- 217 (269)
T cd08528 152 KVTITDFGLAKQKQPES---------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN----- 217 (269)
T ss_pred cEEEecccceeeccccc---------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----
Confidence 99999999998654321 1223568899999999999889999999999999999999999986321
Q ss_pred HHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 930 LHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
....... +.+....+.+. ......+.+++.+|++.||++||++.|+.++++
T Consensus 218 ~~~~~~~--------~~~~~~~~~~~----------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 218 MLSLATK--------IVEAVYEPLPE----------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHH--------HhhccCCcCCc----------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111 11111111000 012345789999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=304.38 Aligned_cols=263 Identities=22% Similarity=0.251 Sum_probs=200.2
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... ...+.+.+|+++++.++||||+++++.+.. ...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-----KRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-----CCE
Confidence 368889999999999999999998999999999865432 223567899999999999999999988654 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg 146 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG 146 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence 899999999999999997654 388999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCCcc-------ccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccH
Q 047768 858 LAKFLSASPLGNVV-------ETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL 930 (1009)
Q Consensus 858 la~~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~ 930 (1009)
+++........... ..........|+..|+|||++.+..++.++|||||||++|||++|+.||.... .
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-----~ 221 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-----P 221 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H
Confidence 98743211100000 00011112457889999999998899999999999999999999999986321 1
Q ss_pred HHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 931 HEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
.+........... .+.. .......+.+++.+|++.+|++||++.++.+.++.
T Consensus 222 ~~~~~~~~~~~~~---~~~~--------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 222 EELFGQVISDDIE---WPEG--------------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHHHhcccC---CCCc--------------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1221111111000 0000 00223457899999999999999997666655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=298.68 Aligned_cols=255 Identities=28% Similarity=0.410 Sum_probs=199.9
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|.+.+.||+|+||.||+|....+++.||+|+++..... ..+.+.+|++++++++|+||+++++++.. ....+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-----REKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-----CCEEE
Confidence 578889999999999999999888999999999765443 45688999999999999999999998643 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+++++|.+++.... .+++..+..++.+++.|++|||+. +|+|+||+|+||++++++.+||+|||.+
T Consensus 76 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred EEEecCCCCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 9999999999999998653 278889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCC---CCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE---ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
.......... ........++..|+|||++.+.. ++.++||||||+++||+++|+.||...... ......
T Consensus 147 ~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~----~~~~~~ 218 (264)
T cd06626 147 VKLKNNTTTM----GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE----FQIMFH 218 (264)
T ss_pred cccCCCCCcc----cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch----HHHHHH
Confidence 8765432110 01012356788999999988766 899999999999999999999999643211 111000
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... ..+.+ +. .......+.+++.+|++.+|.+||++.|++.
T Consensus 219 ~~~~-----~~~~~---~~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 219 VGAG-----HKPPI---PD---------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HhcC-----CCCCC---Cc---------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 00000 00 0012345678999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=313.90 Aligned_cols=276 Identities=20% Similarity=0.233 Sum_probs=201.8
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccc-cCCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSID-FKGV 775 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~ 775 (1009)
..++|++.+.||+|+||.||+|....+++.||||++.... ....+.+.+|++++++++||||+++++++.... +.+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3578999999999999999999999899999999985332 223456778999999999999999999875432 2233
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+. ++|.+++... +++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~--------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD--------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc--------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 46799999995 5888887542 77888999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ........
T Consensus 162 fg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~ 231 (353)
T cd07850 162 FGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIE 231 (353)
T ss_pred CccceeCCCCC---------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Confidence 99998654321 122345788999999999999999999999999999999999998643211 00111111
Q ss_pred Hh--ccchhhhccCCCCCChhhhhhhcc-----------------ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 936 RA--LPEKVMEIVDPSLLPLEEERTNSR-----------------RVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 936 ~~--~~~~~~~~~d~~l~~~~~~r~~~~-----------------~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.. .++++.+.++.........++... .........++.+++.+|++.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 011111111111111000000000 00011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.09 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=204.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
++|++.+.||+|++|.||+|+...+++.||||++..... ...+.+.+|++++++++|+|++++++++.. ....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-----EGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-----CCeEE
Confidence 368888999999999999999998899999999865543 335689999999999999999999998654 37889
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
+|+||+++++|.+++.... .+++..++.++.|+++|++|||+ . +++||||+|+||+++.++.++++|||.
T Consensus 76 lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVG------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcc
Confidence 9999999999999998753 38999999999999999999999 8 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+......
T Consensus 147 ~~~~~~~~~--------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~ 216 (264)
T cd06623 147 SKVLENTLD--------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAIC 216 (264)
T ss_pred ceecccCCC--------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHh
Confidence 986653221 112345788999999999999999999999999999999999998754321 1111111111
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEE-CLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~-~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
....... ... +...+.+++.+|++.+|++||++.|+++.
T Consensus 217 --------~~~~~~~-----------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 217 --------DGPPPSL-----------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --------cCCCCCC-----------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1000000 011 34568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=304.18 Aligned_cols=269 Identities=19% Similarity=0.228 Sum_probs=189.5
Q ss_pred hccCccCCcccccCCceEEEEEEecC---CeEEEEEEeecccccch-----------HHHHHHHHHHHhcCCCCcceEEe
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHEN---GMLVAVKVINLEQKGGS-----------KSFAAECEALRSIRHRNLIKIVT 765 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 765 (1009)
.++|.+.+.||+|+||+||+|.+..+ +..+|+|+......... .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35899999999999999999998866 56777776543322110 11122334455678999999998
Q ss_pred eeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee
Q 047768 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL 845 (1009)
Q Consensus 766 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill 845 (1009)
++... .......++++|++. .++.+.+..... .++..+..++.|++.|++|||+. +|+||||||+||++
T Consensus 91 ~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill 159 (294)
T PHA02882 91 CGSFK-RCRMYYRFILLEKLV-ENTKEIFKRIKC------KNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV 159 (294)
T ss_pred eeeEe-cCCceEEEEEEehhc-cCHHHHHHhhcc------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 76543 112235578888873 467777655332 56788899999999999999999 99999999999999
Q ss_pred CCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCccccc
Q 047768 846 DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFN 925 (1009)
Q Consensus 846 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~ 925 (1009)
+.++.++|+|||+|+.......... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~-~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIE-YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccc-cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999987643211100 011112235699999999999999999999999999999999999999975422
Q ss_pred CCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 926 EGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
...... .....+ ...+..... ....++..+.+++..|++.+|++||+++++.+.+
T Consensus 239 ~~~~~~-~~~~~~---~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 239 NGNLIH-AAKCDF---IKRLHEGKI-------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred chHHHH-HhHHHH---HHHhhhhhh-------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 211111 111000 011111000 0112345688999999999999999999998865
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=281.60 Aligned_cols=258 Identities=23% Similarity=0.272 Sum_probs=202.9
Q ss_pred hccCccC-CcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSS-NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
+++|++. ++||-|-.|.|-.+..+.+|+.+|+|++.. ....++|++.--.. .|||||.+++++... +.+...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENS-YQGRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCcee
Confidence 4456554 679999999999999999999999999842 24457788875444 799999999998775 677788
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC---CCceEEe
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVS 854 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~ 854 (1009)
..+|||.|+||.|.+.++.++.+ .+++.++..|++||+.|+.|||+. .|.||||||+|+|.+. +-.+|++
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~----afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQ----AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred eEeeeecccchHHHHHHHHcccc----cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence 89999999999999999988764 599999999999999999999999 9999999999999964 5589999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+|+..... ......+-|+.|.|||++....|+..+|+||+||++|-|+.|.+||.+.....
T Consensus 207 DfGFAK~t~~~---------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a------- 270 (400)
T KOG0604|consen 207 DFGFAKETQEP---------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------- 270 (400)
T ss_pred ccccccccCCC---------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-------
Confidence 99999975532 22334567999999999999999999999999999999999999998754321
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
++..++.-+......+|.+.| ....++..++++..++.+|.+|.|+.|+++.
T Consensus 271 ---ispgMk~rI~~gqy~FP~pEW-------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 271 ---ISPGMKRRIRTGQYEFPEPEW-------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ---CChhHHhHhhccCccCCChhH-------hHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 112222111111112222111 1222456688888899999999999998753
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.83 Aligned_cols=252 Identities=31% Similarity=0.514 Sum_probs=199.3
Q ss_pred CccCCcccccCCceEEEEEEecCC----eEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENG----MLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
+++.+.||+|+||.||+|.+...+ ..||+|+++..... ..+.+..|++++++++|+||+++++++... ..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Ce
Confidence 356788999999999999998655 88999999654432 456889999999999999999999987543 67
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.+++|||+++++|.+++...... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg 148 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFG 148 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhc----cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccC
Confidence 89999999999999999865421 189999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+++......... .....++..|+|||.+.+..++.++||||+|+++|||++ |+.||.... .......
T Consensus 149 ~~~~~~~~~~~~-------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~ 216 (258)
T smart00219 149 LSRDLYDDDYYK-------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS-----NEEVLEY 216 (258)
T ss_pred Cceecccccccc-------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHH
Confidence 998765432111 112336789999999988889999999999999999999 788876421 1111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
..... .... ......++.+++.+|+..+|++|||+.|+++.|
T Consensus 217 ~~~~~--------~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 LKKGY--------RLPK-----------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HhcCC--------CCCC-----------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 10000 0000 011345688999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=304.68 Aligned_cols=269 Identities=21% Similarity=0.266 Sum_probs=197.5
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc-----chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-----GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
+|++.+.||+|+||.||+|.+..+++.||||+++..... ....+..|++++++++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 477888999999999999999888999999999754322 23457789999999999999999998754 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+ +|+|.+++..... .+++..+..++.|+++||+|||++ +|+||||+|+||+++.++.+||+||
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSI-----VLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence 789999999 9999999976542 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++...... .......++..|+|||.+.+ ..++.++|||||||++|||++|..||...... ........
T Consensus 147 g~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~ 217 (298)
T cd07841 147 GLARSFGSPN--------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFE 217 (298)
T ss_pred eeeeeccCCC--------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHH
Confidence 9998764321 11122346788999998755 46789999999999999999997776532211 11111111
Q ss_pred Hhccc---hhhh---ccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPE---KVME---IVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~---~~~~---~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..... ...+ ..+........ ..............+.+++.+|++.||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 218 ALGTPTEENWPGVTSLPDYVEFKPFP--PTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred HcCCCchhhhhhcccccccccccccC--CcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000 0000 00000000000 00000011123456889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.81 Aligned_cols=256 Identities=22% Similarity=0.328 Sum_probs=199.1
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc------chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG------GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
+|+..+.||+|+||.||+|....+++.||+|+++..... ..+.+.+|++++++++|+|++++++++.. .
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-----D 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-----C
Confidence 477889999999999999999889999999998643311 23578899999999999999999998654 3
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC-ceEEe
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVS 854 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~ 854 (1009)
+..++|+||+++++|.+++.+.. .+++..+..++.|++.|+.|||++ +++||||+|+||+++.++ .+||+
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~ 146 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA 146 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 67899999999999999997654 388999999999999999999999 999999999999998776 69999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||.+......... .........|+..|+|||.+.+..++.++||||+|+++|||++|+.||...... ......
T Consensus 147 dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~ 220 (268)
T cd06630 147 DFGAAARLAAKGTG----AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALI 220 (268)
T ss_pred cccccccccccccc----CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHH
Confidence 99999876543110 011122346889999999998888999999999999999999999998632211 111111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... ......+ ..+.....++.+++.+|+..+|++||++.|++.
T Consensus 221 ~~~--------~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 FKI--------ASATTAP----------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHH--------hccCCCC----------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 100 0000000 011123356788999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.07 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=196.8
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcC---CCCcceEEeeeeccccCCCce
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIR---HRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.|+..+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++ |||++++++++.. ...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CCE
Confidence 4677889999999999999998899999999986542 223467889999999996 9999999998654 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++++|.++++.. .+++..+..++.+++.|+.|||+. +|+||||+|+||+++.++.++++|||
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence 89999999999999998654 288999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
++....... .......|+..|+|||.+.++ .++.++|||||||++|||++|+.||..... ......
T Consensus 147 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~ 213 (277)
T cd06917 147 VAALLNQNS--------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMML 213 (277)
T ss_pred ceeecCCCc--------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhc
Confidence 998765432 112234688899999987654 468999999999999999999999864321 111000
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
......+.+ .......++.+++.+|++.||++||++.|++..
T Consensus 214 -----~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 214 -----IPKSKPPRL-------------EDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -----cccCCCCCC-------------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 000000000 000134568899999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=303.97 Aligned_cols=247 Identities=26% Similarity=0.322 Sum_probs=195.4
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
+.|...+.||+|+||+||+|....+++.||+|++...... ..+.+.+|+++++.++|||+++++++|... ..
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----Ce
Confidence 4688889999999999999999888999999998643322 234688999999999999999999997653 56
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++|+||+. |++.+++..... .+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence 899999996 688887765433 389999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccC---CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL---GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
++...... ....++..|+|||++. ...++.++||||||+++|||++|+.||...... ...
T Consensus 161 ~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~~ 223 (307)
T cd06607 161 SASLVSPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SAL 223 (307)
T ss_pred cceecCCC------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HHH
Confidence 98754322 1245788999999874 456889999999999999999999998643211 100
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.. +..... + ......+...+.+++.+||+.+|++||++.+++..
T Consensus 224 ~~--------~~~~~~---~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 224 YH--------IAQNDS---P-------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HH--------HhcCCC---C-------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 000000 0 00112345578899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=281.97 Aligned_cols=215 Identities=23% Similarity=0.357 Sum_probs=177.6
Q ss_pred CHHHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeecc
Q 047768 692 SYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSI 770 (1009)
Q Consensus 692 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 770 (1009)
.++|+.+.++ +.||+|+|+.|-.++...+|.++|||+++........+..+|++++.+. .|+||++++.|+
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF--- 145 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF--- 145 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh---
Confidence 3566666654 5699999999999999999999999999877555667889999999999 599999999984
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC-
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM- 849 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~- 849 (1009)
++....|+|||-|.||+|.+.++++.. +++.++..+..+||.||.|||.+ ||.|||+||+|||-....
T Consensus 146 --Edd~~FYLVfEKm~GGplLshI~~~~~------F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~ 214 (463)
T KOG0607|consen 146 --EDDTRFYLVFEKMRGGPLLSHIQKRKH------FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNK 214 (463)
T ss_pred --cccceEEEEEecccCchHHHHHHHhhh------ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCC
Confidence 455788999999999999999998774 99999999999999999999999 999999999999996654
Q ss_pred --ceEEeccccccccCCCCCCCccccCCccccccccccccCccccC-----CCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 850 --VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-----GGEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 850 --~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
-||||||.++.-+.....-.. .+.......+|+..|||||+.. ...|+.++|.||+|||+|-|+.|..||-.
T Consensus 215 vsPvKiCDfDLgSg~k~~~~~sp-astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 215 VSPVKICDFDLGSGIKLNNDCSP-ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred cCceeeeccccccccccCCCCCC-CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 589999998865443221111 1122334567999999999732 24578999999999999999999999976
Q ss_pred cccC
Q 047768 923 MFNE 926 (1009)
Q Consensus 923 ~~~~ 926 (1009)
...+
T Consensus 294 ~Cg~ 297 (463)
T KOG0607|consen 294 HCGA 297 (463)
T ss_pred ccCC
Confidence 5444
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=299.14 Aligned_cols=249 Identities=21% Similarity=0.284 Sum_probs=198.0
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALV 781 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 781 (1009)
+|...+.||+|++|.||+|....+++.||+|+++.......+.+.+|+.+++.++|||++++++++.. ....++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence 34555799999999999999988899999999875544445678899999999999999999998654 3678999
Q ss_pred EeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccc
Q 047768 782 YEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861 (1009)
Q Consensus 782 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~ 861 (1009)
+||+++++|.+++... .+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+..
T Consensus 95 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 95 MEFLEGGALTDIVTHT-------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred EeccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 9999999999998773 278999999999999999999999 999999999999999999999999998875
Q ss_pred cCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccch
Q 047768 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEK 941 (1009)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
..... .......|+..|+|||...+..++.++|||||||++|||++|+.||.... .........
T Consensus 165 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-----~~~~~~~~~--- 228 (285)
T cd06648 165 VSKEV--------PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-----PLQAMKRIR--- 228 (285)
T ss_pred hccCC--------cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-----HHHHHHHHH---
Confidence 43211 11123458899999999998899999999999999999999999986321 111111100
Q ss_pred hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 942 VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 942 ~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
....+.... .......+.+++.+|++.+|++||++.|+++
T Consensus 229 --~~~~~~~~~------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 229 --DNLPPKLKN------------LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --hcCCCCCcc------------cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 000000000 0012346889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.43 Aligned_cols=261 Identities=23% Similarity=0.304 Sum_probs=203.1
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
++|++.+.||.|+||+||+|....++..||+|++.... ....+.+.+|++.++.++|+|++++++.+.. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEE
Confidence 47889999999999999999998889999999986433 2245678999999999999999999988654 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+++++|.++++..... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.+|++|||++
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPR---GGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred EEEeccCCCcHHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 999999999999999764321 1388999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
.......... ........|+..|+|||++... .++.++|||||||++|||++|+.||....... .......
T Consensus 150 ~~~~~~~~~~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~--- 221 (267)
T cd06610 150 ASLADGGDRT----RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQ--- 221 (267)
T ss_pred HHhccCcccc----ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhc---
Confidence 8765432110 0112335688999999998877 78999999999999999999999997432211 1111110
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. .+.+... ........++.+++.+|++.||++||++.|+++
T Consensus 222 -~~-----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 222 -ND-----PPSLETG---------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -CC-----CCCcCCc---------cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 0000000 001123456789999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=304.67 Aligned_cols=272 Identities=22% Similarity=0.298 Sum_probs=195.2
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|+..+.||+|++|.||+|+++.+++.||||+++.... ...+.+.+|++++++++||||+++++++.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-----CCcEE
Confidence 47788999999999999999988999999999864432 223578899999999999999999998643 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+. ++|.+++..... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||++
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred EEeeccc-cCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence 9999995 689998876432 2489999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCC-CCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE-ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+...... .......++..|+|||+..+.. ++.++|||||||++|||+||+.||...... ....+......
T Consensus 148 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~ 218 (284)
T cd07860 148 RAFGVPV--------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLG 218 (284)
T ss_pred hhcccCc--------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhC
Confidence 7654321 1112234688999999876644 588999999999999999999998642211 11111111100
Q ss_pred -cc-hhhhccCCC---CCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 -PE-KVMEIVDPS---LLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 -~~-~~~~~~d~~---l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
+. .....+... ....+................++.+++.+|++.||++|||++|++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 219 TPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred CCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00 000000000 0000000000000000012245678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=300.19 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=198.2
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
-|+..+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-----CeEEE
Confidence 4677889999999999999998889999999986433 22345788999999999999999999987543 67899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
|+||+++++|.+++... .+++..+..++.+++.|+.|||+. +++|+||+|+||+++.++.++++|||++.
T Consensus 80 v~e~~~~~~l~~~i~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 80 IMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred EEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccce
Confidence 99999999999998753 278999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
...... .......++..|+|||.+.+..++.++|||||||++|||++|..||..... ....... ..
T Consensus 150 ~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~-~~ 215 (277)
T cd06641 150 QLTDTQ--------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFLI-PK 215 (277)
T ss_pred ecccch--------hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHHH-hc
Confidence 654321 111224578899999999888899999999999999999999999864221 1111110 00
Q ss_pred hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 941 ~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
. .. + ........++.+++.+|++.+|..||++.++++.
T Consensus 216 ~-------~~-~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 216 N-------NP-P----------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred C-------CC-C----------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 00 0 0011233457799999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.89 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=198.6
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|.+.+.||+|+||.||+|..+.+|..||+|.+..... ...+.+.+|++++++++|+|++++++++.. ....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-----NGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-----CCeEE
Confidence 47788999999999999999998999999999865421 234678899999999999999999998654 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC-ceEEecccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGL 858 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~DfGl 858 (1009)
+|+||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||||+||++++++ .+|++|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence 99999999999999976442 2378999999999999999999998 999999999999999886 569999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... .......|++.|+|||+..+..++.++||||||+++|||++|+.||.... ..+......
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~ 215 (257)
T cd08225 149 ARQLNDSM--------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKIC 215 (257)
T ss_pred chhccCCc--------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHh
Confidence 97654321 11122458899999999988899999999999999999999999986321 222222111
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... ..... ......+.+++.+|+..+|++|||+.|+++
T Consensus 216 ~~~--------~~~~~-----------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 216 QGY--------FAPIS-----------PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ccc--------CCCCC-----------CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111 10000 012235789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=302.85 Aligned_cols=273 Identities=23% Similarity=0.336 Sum_probs=200.1
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|++.+.||+|+||.||+|.++.+++.||||+++... ....+.+.+|++++++++|+||+++++++.. .+..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 36888999999999999999999889999999986432 2234678999999999999999999999754 3678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++|+||++++.+..+..... .+++.+++.++.+++.|++|||+. +++||||+|+||++++++.+||+|||+
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 76 YLVFEYVERTLLELLEASPG------GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred EEEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeec
Confidence 99999998877766554432 288999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH--
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK-- 935 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-- 935 (1009)
+........ .......++..|+|||++.+. .++.++||||||+++|||++|+.||......+ .......
T Consensus 147 ~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~ 218 (288)
T cd07833 147 ARALRARPA-------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCL 218 (288)
T ss_pred ccccCCCcc-------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 987654321 112234678899999999888 88999999999999999999999986432110 0000000
Q ss_pred HhccchhhhccC--CCCCC----hhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVD--PSLLP----LEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d--~~l~~----~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...+........ +.... ..................++.+++.+|+..+|++||++++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 219 GPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 001111000000 00000 0000000000011123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=303.64 Aligned_cols=281 Identities=20% Similarity=0.328 Sum_probs=199.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeecccc---CC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDF---KG 774 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~ 774 (1009)
.++|++.+.||+|+||.||+|....+++.||||++...... ....+.+|++++++++||||++++++|..... ..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45799999999999999999999989999999998644322 23456789999999999999999999865422 12
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
....++||||+. +++.+++..... .+++.+++.++.|++.|+.|||++ +++||||||+||+++.++.+||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNV-----KFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEEC
Confidence 345699999996 588888876542 389999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
|||++.......... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||...... .....
T Consensus 162 dfg~~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~ 235 (310)
T cd07865 162 DFGLARAFSLSKNSK----PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTL 235 (310)
T ss_pred cCCCcccccCCcccC----CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 999998765432110 1112234578899999987664 4688999999999999999999998643211 11111
Q ss_pred HHH---hccchhh-h-----ccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 934 AKR---ALPEKVM-E-----IVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 934 ~~~---~~~~~~~-~-----~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... ..+.+.. + ..+....+....+.........-....+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 111 1111110 0 000000000000000000000011235678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=301.14 Aligned_cols=245 Identities=25% Similarity=0.285 Sum_probs=197.4
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-----DSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCe
Confidence 36888999999999999999999889999999986432 1234568899999999999999999998654 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++++|.+++.... .+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg 146 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG 146 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence 899999999999999998764 388999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+++..... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ........
T Consensus 147 ~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~ 210 (290)
T cd05580 147 FAKRVKGR-----------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PIQIYEKI 210 (290)
T ss_pred CccccCCC-----------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHH
Confidence 99865432 123457899999999988889999999999999999999999986432 11111111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~ 995 (1009)
. .... ..+ ......+.+++.+|+..+|.+|| +++|+++
T Consensus 211 ~--------~~~~-~~~-----------~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 211 L--------EGKV-RFP-----------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred h--------cCCc-cCC-----------ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1 0000 000 01123567899999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=303.04 Aligned_cols=281 Identities=20% Similarity=0.243 Sum_probs=198.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||.||+|.+..+++.||||+++.... .....+.+|++++++++ ||||+++++++...+..+...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 368889999999999999999998999999999865432 23467888999999995 699999999876653333345
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC-CCceEEecc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDF 856 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Df 856 (1009)
.++||||+++ +|.+++...... ....+++..++.++.|++.||.|||++ +|+||||+|+||+++. ++.+||+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 7999999975 899988754321 113489999999999999999999999 9999999999999998 899999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++...... .......+++.|+|||++.+ ..++.++||||||+++|||++|+.||....... .......
T Consensus 156 g~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~ 226 (295)
T cd07837 156 GLGRAFSIPV--------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFK 226 (295)
T ss_pred ccceecCCCc--------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHH
Confidence 9998653321 11112346788999998765 457899999999999999999999987432111 0111110
Q ss_pred Hhc-cch--hhhccCCC-CCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RAL-PEK--VMEIVDPS-LLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~-~~~--~~~~~d~~-l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... +.. .....+.. ....+..++............++.+++.+|+..+|++||++.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 000 00000000 0000000000000001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=304.46 Aligned_cols=274 Identities=24% Similarity=0.301 Sum_probs=198.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|++.+.||+|+||.||+|.++.+|+.||+|+++..... ....+.+|++++++++|+|++++++++... ....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence 46899999999999999999999989999999998754322 234567899999999999999999986532 2246
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||++ ++|.+++..... .+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|||
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMPT-----PFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred EEEEEecCC-CCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence 799999996 589888876442 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+++...... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||....... ...... .
T Consensus 154 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~-~ 223 (309)
T cd07845 154 LARTYGLPA--------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLII-Q 223 (309)
T ss_pred eeeecCCcc--------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-H
Confidence 998664321 11122345788999998865 457899999999999999999999997432211 111111 1
Q ss_pred hccchhhhcc----CCCC---CChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPEKVMEIV----DPSL---LPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~----d~~l---~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.......... +... .....................+.+++.+|++.||++|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 224 LLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1110000000 0000 000000000000000112345678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=301.51 Aligned_cols=273 Identities=21% Similarity=0.280 Sum_probs=198.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|++.+.||+|+||.||+|.++.+++.||+|.++..... ....+.+|++++++++||||+++++++... .....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence 5788899999999999999999988999999999754322 234567899999999999999999987542 23678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++|+||++ ++|.+++..... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~ 152 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGL 152 (293)
T ss_pred EEEehhcC-cCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCc
Confidence 99999996 599999876543 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++...... .......++..|+|||.+.+. .++.++||||+|+++|||++|+.||....... ...+.....
T Consensus 153 ~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~ 223 (293)
T cd07843 153 AREYGSPL--------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLL 223 (293)
T ss_pred eeeccCCc--------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHh
Confidence 98665421 111234578899999988764 46899999999999999999999987432210 011111000
Q ss_pred ---ccchhhhccC------CCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 ---LPEKVMEIVD------PSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ---~~~~~~~~~d------~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.+.....+.+ .........+. ..........+.+.+++.+|++.+|++|||+.|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 224 GTPTEKIWPGFSELPGAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred CCCchHHHHHhhccchhcccccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000000 00000000000 000000002455789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.36 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=199.2
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
+|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++. +....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ-----DEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc-----CCCeE
Confidence 47888999999999999999988899999999964432 23568899999999999999999998754 34788
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++|+||+++++|.+++.... .+++.++..++.|+++|+.|||+. +++|+||+|+||++++++.++++|||.
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKV------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 99999999999999997753 388999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ........
T Consensus 147 ~~~~~~~~---------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~-- 213 (258)
T cd05578 147 ATKVTPDT---------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAK-- 213 (258)
T ss_pred ccccCCCc---------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHH--
Confidence 88654321 112345788999999999888999999999999999999999998754322 11111110
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM--TDVV 994 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~--~evl 994 (1009)
........ +...+..+.+++.+|++.||.+||++ +|++
T Consensus 214 -------~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 214 -------QETADVLY-----------PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -------hccccccC-----------cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 00000000 11233567899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=299.35 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=203.5
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
..+.|++.+.+|+|+||.||+|.+..+++.||+|+++.... ..+.+.+|++++++++|+|++++++++... ...
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG-----DEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEE
Confidence 45678888999999999999999988899999999975543 456788999999999999999999987653 678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++|+||+++++|.+++..+.. .+++..+..++.+++.|++|||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~ 162 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFV-----RMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGF 162 (286)
T ss_pred EEEEeccCCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccch
Confidence 999999999999999988652 389999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... .......++..|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 163 ~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-----~~~~~~- 228 (286)
T cd06614 163 AAQLTKEK--------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----RALFLI- 228 (286)
T ss_pred hhhhccch--------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH-
Confidence 87554321 1112345788999999999889999999999999999999999998632211 111000
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
......... ....+...+.+++.+|++.+|.+||++.++++.
T Consensus 229 -------~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 229 -------TTKGIPPLK---------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -------HhcCCCCCc---------chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 000000000 011234568899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=301.90 Aligned_cols=271 Identities=22% Similarity=0.320 Sum_probs=196.1
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
|++.+.||+|++|.||+|.++.+|+.||+|++..... ...+.+.+|++++++++|||++++++++.. ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-----~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-----ENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-----CCeEEE
Confidence 5678899999999999999988999999999875432 233578889999999999999999998754 377899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
|+||++ ++|.+++..... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||+++
T Consensus 76 v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred EEeccC-cCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 999994 699999876542 2389999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc-
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL- 938 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~- 938 (1009)
...... .......++..|+|||++.+. .++.++||||||+++|||++|+.||....... ...+......
T Consensus 148 ~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~ 218 (283)
T cd07835 148 AFGVPV--------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGT 218 (283)
T ss_pred ccCCCc--------cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCC
Confidence 553211 111123468899999987664 56889999999999999999999986432111 1111111100
Q ss_pred cch-hhhccCC--C-CCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 PEK-VMEIVDP--S-LLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 ~~~-~~~~~d~--~-l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
+.. ....... . ....+.................+.+++.+|++.||++|||+.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 219 PDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0000000 0 0000000000000001112246789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=296.90 Aligned_cols=243 Identities=23% Similarity=0.275 Sum_probs=184.8
Q ss_pred cccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHh---cCCCCcceEEeeeeccccCCCceEEEE
Q 047768 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRS---IRHRNLIKIVTICSSIDFKGVDFKALV 781 (1009)
Q Consensus 708 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~~~~~~lv 781 (1009)
.||+|+||.||+|....+++.||+|.+...... ....+.+|..+++. .+||+++.+.+++.. .+..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence 489999999999999888999999998643221 12334445444433 479999999888654 3678999
Q ss_pred EeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccc
Q 047768 782 YEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861 (1009)
Q Consensus 782 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~ 861 (1009)
|||+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+|++|||++..
T Consensus 76 ~e~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 76 LDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred EecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 99999999999987654 389999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccc
Q 047768 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940 (1009)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
..... .....|+..|+|||...+ ..++.++||||+||++|||++|+.||....... ..........
T Consensus 147 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~- 213 (279)
T cd05633 147 FSKKK----------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLT- 213 (279)
T ss_pred ccccC----------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--HHHHHHHhhc-
Confidence 53221 112458999999998864 567999999999999999999999997432221 1111110000
Q ss_pred hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 047768 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVVK 996 (1009)
Q Consensus 941 ~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~~ 996 (1009)
....+ ......++.+++.+|++.||++|| +++|+++.
T Consensus 214 -----~~~~~--------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 214 -----VNVEL--------------PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -----CCcCC--------------ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 00000 112334678999999999999999 59888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=308.83 Aligned_cols=277 Identities=22% Similarity=0.242 Sum_probs=201.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc--cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE--QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||+||+|....+++.||||.++.. .....+.+.+|+.+++.++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35788999999999999999999989999999998643 2223456778999999999999999999876543333356
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++|+||+. ++|.+++.... .+++..+..++.|++.|+.|||++ +++||||||+||+++.++.+||+|||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence 899999995 78999887654 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+++...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...... ........
T Consensus 154 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~ 223 (337)
T cd07858 154 LARTTSEKG--------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV--HQLKLITE 223 (337)
T ss_pred cccccCCCc--------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHH
Confidence 998654321 11123457889999998765 46899999999999999999999998643110 00000000
Q ss_pred h----ccchhhhccCCCCCChhhhhhhc----cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 937 A----LPEKVMEIVDPSLLPLEEERTNS----RRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 937 ~----~~~~~~~~~d~~l~~~~~~r~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
. .++....+.+..........+.. .......+..++.+++.+|++.+|++|||+.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 224 LLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 00011011111000000000000 000011234567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=302.06 Aligned_cols=247 Identities=26% Similarity=0.333 Sum_probs=193.9
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.|...+.||+|+||.||+|++..++..||+|++...... ....+.+|++++++++|||++++++++... ...
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CeE
Confidence 366778899999999999999888999999998643222 234688899999999999999999987643 578
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+. |++.+++..... .+++.++..++.+++.|+.|||+. +|+||||+|+||+++.++.+||+|||+
T Consensus 101 ~lv~e~~~-g~l~~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 101 WLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred EEEEeCCC-CCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCC
Confidence 99999996 588888765443 389999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccC---CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL---GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
+...... ....|+..|+|||++. .+.++.++|||||||++|||++|+.||....... ....+.
T Consensus 172 ~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~- 237 (317)
T cd06635 172 ASIASPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIA- 237 (317)
T ss_pred ccccCCc------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHH-
Confidence 8754321 1245788999999874 4578999999999999999999999986431110 001110
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
...... .....+...+.+++.+|++.+|.+||++.|+++..
T Consensus 238 -----------~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 238 -----------QNESPT----------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred -----------hccCCC----------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 000000 00112344678999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=303.32 Aligned_cols=210 Identities=25% Similarity=0.365 Sum_probs=171.0
Q ss_pred cCccCCcccccCCceEEEEEEec--CCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHE--NGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
+|.+.+.||+|+||.||+|.++. +++.||+|.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 47788899999999999999987 78999999997533 33346778899999999999999999997642 236
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC----CCceE
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH----DMVAH 852 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~----~~~~k 852 (1009)
..++||||++ +++.+++....... ...+++..++.++.|++.|+.|||+. +|+||||||+||+++. ++.+|
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 78 SVYLLFDYAE-HDLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred eEEEEEeCCC-cCHHHHHHhhccCC-CcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEE
Confidence 7899999996 47777775433211 12488999999999999999999999 9999999999999999 99999
Q ss_pred EeccccccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccc
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMF 924 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~ 924 (1009)
++|||+++....... .........++..|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 153 l~Dfg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 153 IGDLGLARLFNAPLK-----PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ECCCccccccCCCcc-----cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 999999987644321 01122345678999999987664 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=306.89 Aligned_cols=280 Identities=21% Similarity=0.261 Sum_probs=202.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|++.+.||+|+||.||+|..+.+++.||+|++..... ...+.+.+|+.++++++||||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 3689999999999999999999998999999999864422 23456788999999999999999998765432 33457
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++|+||+. ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg 152 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG 152 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence 899999995 69999887543 289999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+++........ .........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 153 ~~~~~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~ 226 (334)
T cd07855 153 MARGLSSSPTE----HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILS 226 (334)
T ss_pred cceeecccCcC----CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHH
Confidence 99866442211 1112234568899999998766 46899999999999999999999999643211 00011111
Q ss_pred hccchhhhccCCCCCC--------hhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLP--------LEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~--------~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.......++.+..... .+......-.........++.+++.+|++.+|++||++++++..
T Consensus 227 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 227 VLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1000000000000000 00000000000001234568899999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.83 Aligned_cols=202 Identities=26% Similarity=0.384 Sum_probs=176.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.+.|..-++||+|+||+||-++.+.+|+.+|.|.+... ..........|-.++.+++.+.||.+--. ++..+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCC
Confidence 46788889999999999999999999999999988533 23344567789999999999988776433 45668
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..|+|+..|.||+|.-.+.+... ..+++..+..+|.+|+.||++||.. +||+||+||+|||+|+.|+|+|+|.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~----~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGN----PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCC----CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeecc
Confidence 99999999999999888877654 3499999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
|+|..+..+ ....+.+||.+|||||++.++.|+...|-||+||++|||+.|+.||..
T Consensus 332 GLAvei~~g---------~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 332 GLAVEIPEG---------KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred ceEEecCCC---------CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 999987654 233346899999999999999999999999999999999999999964
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=297.92 Aligned_cols=273 Identities=21% Similarity=0.295 Sum_probs=198.5
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
+|++.++||+|++|.||+|++..+|+.||||+++.... ...+.+.+|++++++++|+||+++++++... +..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEE
Confidence 47888999999999999999998999999999975533 2346678899999999999999999987643 67899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
||||++ ++|.+++...... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.+|++|||+++
T Consensus 76 v~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 76 VFEYMD-KDLKKYMDTHGVR---GALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred EEecCC-ccHHHHHHhcCCC---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 999997 5899988765421 2489999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh--
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA-- 937 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-- 937 (1009)
...... .......++..|+|||++.+. .++.++|||||||++|||++|+.||....... .........
T Consensus 149 ~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~ 219 (284)
T cd07836 149 AFGIPV--------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGT 219 (284)
T ss_pred hhcCCc--------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCC
Confidence 553321 111224568899999987664 56889999999999999999999987532211 111111100
Q ss_pred -ccchhhhccC--CCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 -LPEKVMEIVD--PSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 -~~~~~~~~~d--~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.......+.+ ......+.................+.+++.+|++.||.+||+++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 220 PTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000111100 000000000000000001122456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=304.55 Aligned_cols=276 Identities=20% Similarity=0.245 Sum_probs=192.7
Q ss_pred Cccccc--CCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRG--SFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
..||+| +||+||+|++..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.. .+..++|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEE
Confidence 346666 8999999999889999999998654322 24678899999999999999999999764 36789999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+.++++.+++...... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++||+.+...
T Consensus 79 e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 79 PFMAYGSANSLLKTYFPE----GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred ecccCCCHHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 999999999998875421 388999999999999999999998 9999999999999999999999999866443
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCC--CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccc
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG--EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
.......... ........++..|+|||++.+. .++.++|||||||++|||++|+.||....................
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd08226 152 VRNGQKAKVV-YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP 230 (328)
T ss_pred hccCcccccc-ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCC
Confidence 2211100000 0011112356779999998764 478999999999999999999999975432211000000000000
Q ss_pred --------hhhh-----------ccCCCCC----ChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 941 --------KVME-----------IVDPSLL----PLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 941 --------~~~~-----------~~d~~l~----~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.... +.+.... ..... ..........+...+.+++.+|++.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTS-ERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhcccccccccc-ccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000 0000000 00000 000011123455678999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=307.37 Aligned_cols=275 Identities=21% Similarity=0.283 Sum_probs=200.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc--cccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE--QKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---NDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CCc
Confidence 46788899999999999999999888999999988532 122335677899999999 999999999987542 235
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||++ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~ 151 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADF 151 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeec
Confidence 6799999996 5999998764 278899999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++......... .........|+..|+|||++.+ ..++.++||||||+++|||++|+.||....... ...+...
T Consensus 152 g~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~ 227 (337)
T cd07852 152 GLARSLSELEENP---ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIE 227 (337)
T ss_pred cchhccccccccc---cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH
Confidence 9998765432110 0112233568999999998765 457899999999999999999999986432211 0111111
Q ss_pred Hh--cc-c--------hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 936 RA--LP-E--------KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 936 ~~--~~-~--------~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.. .. + ...++++. ..... . ... .........++.+++.+|++.||++|||+.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~-~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 228 VIGPPSAEDIESIKSPFAATMLDS-LPSRP-R-KPL-DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhCCCCHHHHHHHHhhhHHHhhhh-ccccc-c-cch-hhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 00 0 00011110 00000 0 000 00011134578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=299.26 Aligned_cols=255 Identities=23% Similarity=0.286 Sum_probs=191.6
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|...+.||+|+||+||++.+..+++.||+|++..... .....+.+|+.++.++. |+||+++++++.. ....+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence 45566789999999999999998999999999864432 23457889999999996 9999999998653 35678
Q ss_pred EEEeccCCCCHHHHHh---ccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 780 LVYEYMQNGSLEEWLH---QRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~---~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
++|||+. +++.++.. .... ..+++..+..++.+++.|++|||+.. +|+||||||+||+++.++.+||+||
T Consensus 80 ~~~e~~~-~~l~~l~~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 80 ICMELMD-ISLDKFYKYVYEVLK----SVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred EEEeccc-CCHHHHHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeec
Confidence 9999985 46655432 2111 24899999999999999999999742 8999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCC---CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG---EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
|+++...... ......|+..|+|||++.+. .++.++|||||||++|||++|+.||.... .....
T Consensus 153 g~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~ 219 (288)
T cd06616 153 GISGQLVDSI---------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQ 219 (288)
T ss_pred chhHHhccCC---------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHH
Confidence 9997654321 11223578899999998776 68999999999999999999999986432 11111
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
........ .+.+.. .....+..++.+++.+|++.+|++|||+.||++.
T Consensus 220 ~~~~~~~~-----~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 220 LTQVVKGD-----PPILSN----------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HhhhcCCC-----CCcCCC----------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11110000 000000 0011244568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=300.52 Aligned_cols=281 Identities=23% Similarity=0.306 Sum_probs=201.4
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccc----
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSID---- 771 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 771 (1009)
...++|++.+.||+|+||.||+|.++.+++.||||+++.... .....+.+|++++++++|||++++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 356789999999999999999999998899999999975432 23356788999999999999999999876532
Q ss_pred -cCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc
Q 047768 772 -FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV 850 (1009)
Q Consensus 772 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 850 (1009)
..+....++|+||+++ ++.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLV-----HFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence 1123478999999975 78887776432 389999999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCcc
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLT 929 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~ 929 (1009)
+||+|||.+........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...
T Consensus 155 ~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~ 226 (302)
T cd07864 155 IKLADFGLARLYNSEES-------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQ 226 (302)
T ss_pred EEeCcccccccccCCcc-------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHH
Confidence 99999999986654221 11112345788999998765 4578999999999999999999999864221 111
Q ss_pred HHHHHHHh---ccchhhhccCCCCCChhhhhhhc-cc--cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 930 LHEFAKRA---LPEKVMEIVDPSLLPLEEERTNS-RR--VRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 930 ~~~~~~~~---~~~~~~~~~d~~l~~~~~~r~~~-~~--~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
+....... .+....++............... .. ......+..+.+++.+|++.+|.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 227 LELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111111 11111111110000000000000 00 000112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=291.44 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=192.8
Q ss_pred HHHHHHhccCccCCcc--cccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeecc
Q 047768 694 KELSKATNEFSSSNTI--GRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSI 770 (1009)
Q Consensus 694 ~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 770 (1009)
.+.....++|.+.+.+ |+|+||.||++..+.++..+|+|++...... . .|+.....+ +|||++++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~--~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---A--IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---h--hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444455677777776 9999999999999999999999998643221 1 122222222 799999999987643
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC-
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM- 849 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~- 849 (1009)
...++||||+++++|.+++.... .+++.++..++.|+++|+.|||+. +++||||||+||+++.++
T Consensus 82 -----~~~~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~ 147 (267)
T PHA03390 82 -----KGHVLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKD 147 (267)
T ss_pred -----CeeEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCC
Confidence 57899999999999999998754 389999999999999999999999 999999999999999998
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCcc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLT 929 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~ 929 (1009)
.++++|||+++..... ....|+..|+|||++.+..++.++||||+|+++|||++|+.||.........
T Consensus 148 ~~~l~dfg~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~ 215 (267)
T PHA03390 148 RIYLCDYGLCKIIGTP------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD 215 (267)
T ss_pred eEEEecCccceecCCC------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh
Confidence 9999999998765422 1235789999999999999999999999999999999999999754333322
Q ss_pred HHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 047768 930 LHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME-MTDVVV 995 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt-~~evl~ 995 (1009)
...+.... .. ... ........+.+++.+|++.+|.+||+ ++|+++
T Consensus 216 ~~~~~~~~-~~--------~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 216 LESLLKRQ-QK--------KLP------------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHhh-cc--------cCC------------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 22222111 00 000 00023345789999999999999996 588863
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=297.86 Aligned_cols=273 Identities=24% Similarity=0.313 Sum_probs=199.2
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|++++++++|+|++++++++... .....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 567789999999999999999889999999997653 33346788999999999999999999997643 1367899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
|+||++ ++|.+++..... .+++.+++.++.|+++|++|||+. +++|+||+|+||++++++.+|++|||++.
T Consensus 78 v~e~~~-~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 78 VFEYMD-HDLTGLLDSPEV-----KFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred Eecccc-ccHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence 999997 589998876532 389999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc-
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL- 938 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~- 938 (1009)
....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...........
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~ 220 (287)
T cd07840 149 PYTKRNS-------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGS 220 (287)
T ss_pred eccCCCc-------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence 7654321 11223456788999997765 45789999999999999999999998743321 11111111100
Q ss_pred --cchhhhccCC----CCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 --PEKVMEIVDP----SLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 --~~~~~~~~d~----~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
........+. ...................+..++.+++.+|++.+|.+||++.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 221 PTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred CchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0001000000 00000000000000111112567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=296.17 Aligned_cols=269 Identities=20% Similarity=0.244 Sum_probs=193.4
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCceEEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
|.+.+.||+|+||.||+|..+.+++.||+|+++.... .......+|+.+++++. |+|++++++++... ..+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 5677899999999999999988999999999864422 22234457889999885 99999999987642 2256899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
|+||++ |++.+++..... .+++.++..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||+++
T Consensus 78 v~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 78 VFELMD-MNLYELIKGRKR-----PLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred EEecCC-ccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence 999996 688888876442 389999999999999999999999 9999999999999999 999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc-
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL- 938 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~- 938 (1009)
...... ......++..|+|||++.. ..++.++||||+||++|||++|+.||......+ .........
T Consensus 148 ~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~ 216 (282)
T cd07831 148 GIYSKP---------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLG 216 (282)
T ss_pred ccccCC---------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcC
Confidence 654321 1122457889999997644 557899999999999999999999996432111 111111111
Q ss_pred --cchhhhccCCCCC---ChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 --PEKVMEIVDPSLL---PLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 --~~~~~~~~d~~l~---~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
++.+.......-. ..+................++.+++.+|++.+|++||++.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 217 TPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1111000000000 00000000000011133567899999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=277.71 Aligned_cols=209 Identities=28% Similarity=0.382 Sum_probs=173.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCC----eEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENG----MLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 773 (1009)
...|+....||+|.||.||+|.-+.+. +.+|+|+|+.+.. +-.....+|+..++.++|||++.++.++..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~---- 98 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS---- 98 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc----
Confidence 347888999999999999999665332 3799999976543 234678899999999999999999987643
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC----C
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD----M 849 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~----~ 849 (1009)
.....++++||.++ +|++.++-++.... ..++...++.|++||+.|+.|||++ -|+||||||.||||..+ |
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG 173 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERG 173 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccC
Confidence 24778999999977 99999987655443 4689999999999999999999999 89999999999999877 8
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
.|||+|||+||.+... ..+-.....++-|..|+|||.+.+. .||.+.||||.||++.||+|-++-|..
T Consensus 174 ~VKIaDlGlaR~~~~p-----lkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 174 RVKIADLGLARLFNNP-----LKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred eeEeecccHHHHhhcc-----ccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999999999987643 1222334457789999999998885 689999999999999999998877653
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=295.67 Aligned_cols=275 Identities=23% Similarity=0.286 Sum_probs=198.0
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhc---CCCCcceEEeeeeccccCCCce
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSI---RHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
|++.+.||+|+||.||+|+++.+++.||+|+++..... ....+.+|+.+++++ +|+|++++++++...+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 56778999999999999999888999999999644322 234566788877666 5999999999987654334445
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.+++|||+. ++|.+++..... ..+++..++.++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg 152 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG 152 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence 899999996 589998876442 1489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
.+....... ......++..|+|||++.+..++.++|||||||++|||++|+.||...... .....+....
T Consensus 153 ~~~~~~~~~---------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~ 222 (287)
T cd07838 153 LARIYSFEM---------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVI 222 (287)
T ss_pred cceeccCCc---------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHc
Confidence 997664321 112234788999999999999999999999999999999999988643211 1122221111
Q ss_pred ccchhhhcc-CCCCCC--hhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEKVMEIV-DPSLLP--LEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~-d~~l~~--~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
......... ...... .+............+....+.+++.+|++.||++||++.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 000000 0000000000011123356779999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=290.47 Aligned_cols=254 Identities=20% Similarity=0.268 Sum_probs=197.3
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-----ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-----KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.+|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|++++++++|+||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence 46888999999999999999998899999999875332 12235788999999999999999999986542 23
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++|+||+++++|.+++.... .+++.....++.|++.|+.|||+. +++||||||+||+++.++.++|+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence 46789999999999999997654 278889999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++....... .........|+..|+|||++.+..++.++|||||||++||+++|+.||..... .... .
T Consensus 150 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~-~ 219 (264)
T cd06653 150 FGASKRIQTICM-----SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAI-F 219 (264)
T ss_pred cccccccccccc-----cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHH-H
Confidence 999986543110 00112235688999999999988899999999999999999999999864211 1111 1
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
........ +. .+....+++.+++.+|+. +|.+||++.+++.
T Consensus 220 ~~~~~~~~----~~--------------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 220 KIATQPTK----PM--------------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHcCCCC----CC--------------CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11000000 00 011223457899999999 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=288.02 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=202.1
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALV 781 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 781 (1009)
+|+..+.||+|++|.||+|.+..+++.||+|++........+.+.+|++++++++|++++++++++... ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence 477889999999999999999888999999999765544567899999999999999999999986543 678999
Q ss_pred EeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccc
Q 047768 782 YEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861 (1009)
Q Consensus 782 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~ 861 (1009)
+||+++++|.+++..... .+++.++..++.+++.|+.|||+. +++||||+|+||++++++.++|+|||.+..
T Consensus 76 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQ-----TLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred EecCCCCcHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 999999999999987642 389999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccch
Q 047768 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEK 941 (1009)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
...... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...........
T Consensus 148 ~~~~~~---------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~ 213 (253)
T cd05122 148 LSDTKA---------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-----MKALFKIATNG 213 (253)
T ss_pred cccccc---------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-----HHHHHHHHhcC
Confidence 654311 2235678899999999988899999999999999999999999864321 11111000000
Q ss_pred hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 942 VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 942 ~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..... ....+...+.+++.+|++.||++|||+.|+++
T Consensus 214 ~~~~~-----------------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 214 PPGLR-----------------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CCCcC-----------------cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000 00112346889999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=297.99 Aligned_cols=244 Identities=23% Similarity=0.321 Sum_probs=194.0
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEeccC
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQ 786 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~ 786 (1009)
.+||+|+||.||+|..+.++..||||++........+.+.+|+.+++.++|+|++++++++.. .+..++||||++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~ 100 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVMEFLE 100 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEEecCC
Confidence 679999999999999988999999999865444445678899999999999999999998654 368899999999
Q ss_pred CCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCCC
Q 047768 787 NGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP 866 (1009)
Q Consensus 787 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 866 (1009)
+++|.+++.... +++.....++.|++.|++|||+. +++||||+|+||++++++.++++|||++.......
T Consensus 101 ~~~L~~~~~~~~-------~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 101 GGALTDIVTHTR-------MNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170 (292)
T ss_pred CCcHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence 999999876532 78899999999999999999999 99999999999999999999999999887553211
Q ss_pred CCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhcc
Q 047768 867 LGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIV 946 (1009)
Q Consensus 867 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 946 (1009)
.......|+..|+|||+..+..++.++||||+|+++|||++|+.||...... ..........+..
T Consensus 171 --------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~----- 235 (292)
T cd06657 171 --------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPK----- 235 (292)
T ss_pred --------ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCCcc-----
Confidence 1112345789999999998888999999999999999999999998632111 1111111111110
Q ss_pred CCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 947 DPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 947 d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
+... ......+.+++.+|++.+|.+||++.|+++
T Consensus 236 ---~~~~------------~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 236 ---LKNL------------HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ---cCCc------------ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0000 012234678899999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=273.33 Aligned_cols=252 Identities=20% Similarity=0.263 Sum_probs=191.9
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+.....-||.|..|+||+++.+.+|..+|||.+..... ..-+++...++++..- ..|.||+.+||+... ...+
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TDVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----chHH
Confidence 33445679999999999999999999999999964432 2235566677766655 489999999997542 4567
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+.||.|. ..+...++.-.. ++++.-.-++...+.+||.||.+++ +|+|||+||+|||+|+.|++|+||||++
T Consensus 168 IcMelMs-~C~ekLlkrik~-----piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 168 ICMELMS-TCAEKLLKRIKG-----PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred HHHHHHH-HHHHHHHHHhcC-----CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccc
Confidence 8899883 355566655443 4888888899999999999999886 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCC---CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG---GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
.++.++. +.+...|.+.|||||.+.- ..|+.++||||||+.++|+.||+.||.....+-..+.+...
T Consensus 240 GrlvdSk---------AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln- 309 (391)
T KOG0983|consen 240 GRLVDSK---------AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN- 309 (391)
T ss_pred ceeeccc---------ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-
Confidence 8776542 3334678999999998754 46899999999999999999999999865433222222221
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
..| +++... ......+.+++..|++.|+.+||...++++.
T Consensus 310 ~eP--------P~L~~~------------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 310 EEP--------PLLPGH------------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cCC--------CCCCcc------------cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 111 111110 0133457899999999999999999988753
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=298.77 Aligned_cols=266 Identities=21% Similarity=0.214 Sum_probs=189.1
Q ss_pred CCceEEEEEEecCCeEEEEEEeecc--cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEeccCCCCH
Q 047768 713 SFGFVYKGVLHENGMLVAVKVINLE--QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSL 790 (1009)
Q Consensus 713 ~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL 790 (1009)
++|.||.++...+++.||||+++.. .....+.+.+|++++++++|+||+++++++.. ....+++|||+++|+|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEEEEeccCCCCH
Confidence 4455666666668999999999754 22344689999999999999999999998654 3678999999999999
Q ss_pred HHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCCCCCCc
Q 047768 791 EEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNV 870 (1009)
Q Consensus 791 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 870 (1009)
.+++...... .+++.....++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.+..........
T Consensus 87 ~~~l~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~- 158 (314)
T cd08216 87 EDLLKTHFPE----GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ- 158 (314)
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc-
Confidence 9999865321 378899999999999999999999 99999999999999999999999999987654322110
Q ss_pred cccCCccccccccccccCccccCCC--CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCC
Q 047768 871 VETPSSSIGVKGTIGYVAPEYGLGG--EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDP 948 (1009)
Q Consensus 871 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 948 (1009)
...........++..|+|||++... .++.++|||||||++|||++|+.||............ ........++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-----~~~~~~~~~~~ 233 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-----VRGTVPCLLDK 233 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----HhccCcccccc
Confidence 0011122335578899999998763 5789999999999999999999999753221111111 11111111110
Q ss_pred CCCC--------------hhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 949 SLLP--------------LEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 949 ~l~~--------------~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.... .+................++.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000000111122233568899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=301.61 Aligned_cols=203 Identities=27% Similarity=0.418 Sum_probs=179.7
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccc--hHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG--SKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.....|.+...||+|.|++|.+|.+..++..||||+++...-.. ...+.+|+++|+.++|||||+++.+... .
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-----~ 127 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-----E 127 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-----c
Confidence 34567889999999999999999999999999999996543222 2348899999999999999999998543 4
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...|+||||+.+|.+++|+.++.. +.+..+..++.|+.+|++|+|++ .|||||||++||+++.+.++||+|
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~gr------~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaD 198 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHGR------MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIAD 198 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhccc------chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeec
Confidence 789999999999999999998875 66688999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCccc
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
||++..+... ......+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||+..
T Consensus 199 fgfS~~~~~~---------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 199 FGFSTFFDYG---------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred cccceeeccc---------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 9999887643 34456889999999999999887 78999999999999999999999853
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=305.36 Aligned_cols=276 Identities=21% Similarity=0.283 Sum_probs=196.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccc---------
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSID--------- 771 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------- 771 (1009)
.+|.+.+.||+|+||+||+|..+.+++.||+|++........+.+.+|++++++++||||+++++++....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57899999999999999999999899999999997665555677889999999999999999998755321
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC-CCCc
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD-HDMV 850 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~ 850 (1009)
..+....++|+||++ ++|.+++... .+++..++.++.|++.|+.|||+. +|+||||||+||+++ +++.
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence 111245789999996 5998888643 288999999999999999999999 999999999999997 4567
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCcc
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLT 929 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~ 929 (1009)
+|++|||.++....... .........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .
T Consensus 154 ~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~ 227 (342)
T cd07854 154 LKIGDFGLARIVDPHYS-----HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-Q 227 (342)
T ss_pred EEECCcccceecCCccc-----cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 89999999986543211 0011122357889999997654 567889999999999999999999996432211 0
Q ss_pred HHHHHHHhccc----hhhhccC---CCCC-ChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 930 LHEFAKRALPE----KVMEIVD---PSLL-PLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 930 ~~~~~~~~~~~----~~~~~~d---~~l~-~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
....... .+. ....... .... .....+.... ........++.+++.+|++.||++|||+.|++.
T Consensus 228 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 228 MQLILES-VPVVREEDRNELLNVIPSFVRNDGGEPRRPLR-DLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHHh-cCCCChHHhhhhhhhhhhhhhhcccccCCCHH-HHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0111000 000 0000000 0000 0000000000 000012245779999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=298.79 Aligned_cols=272 Identities=22% Similarity=0.282 Sum_probs=194.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|++.+.||+|++|+||+|.++.+++.||+|++..... ...+.+.+|++++++++||||+++++++.. ....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-----CCeE
Confidence 478889999999999999999988899999999864422 224578899999999999999999999754 3688
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC-CCceEEeccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFG 857 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~DfG 857 (1009)
++||||++ +++.+++..... ..+++..+..++.|++.||+|||++ +++||||+|+||+++. ++.+||+|||
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence 99999995 588888765432 1367888889999999999999999 9999999999999985 5679999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
++....... .......+++.|+|||++.+ ..++.++||||+||++|||+||+.||......+ ...+.. .
T Consensus 149 ~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~-~ 218 (294)
T PLN00009 149 LARAFGIPV--------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIF-R 218 (294)
T ss_pred cccccCCCc--------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-H
Confidence 997553211 11122456889999998766 457899999999999999999999997532211 011110 0
Q ss_pred hccchhhhccCCCC------CChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPEKVMEIVDPSL------LPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l------~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.........++... ...+..+.............++.+++.+|++.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 219 ILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred HhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000011000000 000000000000001112345779999999999999999999986
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=292.38 Aligned_cols=245 Identities=24% Similarity=0.333 Sum_probs=190.3
Q ss_pred ccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEecc
Q 047768 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYM 785 (1009)
Q Consensus 709 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 785 (1009)
||+|+||+||+|....+|+.||+|++.... ......+..|++++++++||||+++++++.. .+..++||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-----KDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-----CCeEEEEEecC
Confidence 689999999999998899999999986432 2224456789999999999999999988654 36789999999
Q ss_pred CCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCC
Q 047768 786 QNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865 (1009)
Q Consensus 786 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 865 (1009)
++++|.+++..... ..+++.++..++.|++.|+.|||+. +++||||+|+||++++++.+|++|||.+......
T Consensus 76 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 76 NGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred CCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 99999999976542 2489999999999999999999999 9999999999999999999999999998765431
Q ss_pred CCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhc
Q 047768 866 PLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEI 945 (1009)
Q Consensus 866 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1009)
.......++..|+|||++.+..++.++||||+||++|+|++|+.||...... ........... ..
T Consensus 149 ---------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~---- 213 (277)
T cd05577 149 ---------KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTL-EM---- 213 (277)
T ss_pred ---------CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhccc-cc----
Confidence 1112345788999999998888999999999999999999999998643221 01111111000 00
Q ss_pred cCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 047768 946 VDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVV 995 (1009)
Q Consensus 946 ~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~ 995 (1009)
... ........+.+++.+|++.+|++|| ++.+++.
T Consensus 214 ----~~~-----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 214 ----AVE-----------YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ----ccc-----------CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 000 0011234577999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=288.67 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=202.3
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|.+.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|++++++++|||++++.+.+.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence 47788999999999999999988899999999975533 345678899999999999999999998654 27789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+++++|.+++...... ...+++.++..++.+++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~ 150 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKE--GKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGIS 150 (258)
T ss_pred EEEEecCCCcHHHHHHHhhcc--CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccce
Confidence 999999999999999875311 12489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....... .......|++.|+|||...+..++.++||||+|+++|+|++|+.||.... ..........
T Consensus 151 ~~~~~~~--------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~ 217 (258)
T cd08215 151 KVLSSTV--------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILK 217 (258)
T ss_pred eecccCc--------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhc
Confidence 8654321 11123467889999999999899999999999999999999999986432 1122111111
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. .....+ ..+...+.+++.+|+..+|++|||+.|+++
T Consensus 218 ~--------~~~~~~-----------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 218 G--------QYPPIP-----------SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred C--------CCCCCC-----------CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1 111111 123346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=287.52 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=200.3
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|++.+.||+|++|.||+|....+++.||+|.+..... ...+.+.+|++++++++|+|++++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-----DSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEEE
Confidence 47788999999999999999988899999999965543 2346789999999999999999999986543 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+++++|.+++.... .+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 76 IILEYAENGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred EEEecCCCCcHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence 9999999999999998763 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
........ ......++..|+|||...+..++.++||||+|+++|+|++|+.||..... ..... ....
T Consensus 147 ~~~~~~~~--------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~-~~~~ 213 (254)
T cd06627 147 TKLNDVSK--------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALF-RIVQ 213 (254)
T ss_pred eecCCCcc--------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHH-HHhc
Confidence 87654321 12234678899999998888889999999999999999999999864321 11111 0000
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... . ........+.+++.+|+..+|++||++.|++.
T Consensus 214 ~~~~--------~-----------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 214 DDHP--------P-----------LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred cCCC--------C-----------CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0000 0 00122345779999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=297.69 Aligned_cols=283 Identities=21% Similarity=0.280 Sum_probs=199.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeecccc---CC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDF---KG 774 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~ 774 (1009)
.++|++.+.||+|+||.||+|+++.+++.||||++...... ....+.+|++++++++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46899999999999999999999989999999998644322 23467889999999999999999987654321 22
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
....++|+||+. +++.+.+..... .+++.++..++.|+++||+|||++ +|+||||||+||++++++.+|++
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSV-----KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence 346799999996 478777765432 389999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccc---cCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccH
Q 047768 855 DFGLAKFLSASPLGNVVE---TPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL 930 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~ 930 (1009)
|||+++............ .........|++.|+|||++.+. .++.++|||||||++|||++|+.||....... ..
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~ 236 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QL 236 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 999998665432111100 11122335678899999987654 57899999999999999999999986432210 11
Q ss_pred HHHHHHh--ccch-------hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 931 HEFAKRA--LPEK-------VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 931 ~~~~~~~--~~~~-------~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
....... .++. +....+......... .... ........+.+++.+|++.||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPR-TLEE--RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCc-cHHH--HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1111100 0000 000000000000000 0000 00112256789999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=295.34 Aligned_cols=270 Identities=23% Similarity=0.312 Sum_probs=199.7
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
|.+.+.||+|++|.||+|....+++.+|+|+++..... ....+.+|++++++++|+||+++++++.. ....++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence 56778999999999999999888999999998654322 34678889999999999999999998654 377899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
|+||+++ ++.+++..... .+++.++..++.+++.|+.|||+. +|+|+||+|+||+++.++.+||+|||.+.
T Consensus 76 v~e~~~~-~l~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQR-----GLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred EEeccCC-CHHHHHHhhcc-----cCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 9999964 89888877542 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh--
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA-- 937 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-- 937 (1009)
...... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+ .........
T Consensus 147 ~~~~~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~ 217 (283)
T cd05118 147 SFGSPV--------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGT 217 (283)
T ss_pred ecCCCc--------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCC
Confidence 665432 011124578899999998776 78999999999999999999999986432211 111111110
Q ss_pred -ccchhhhccC---CCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 -LPEKVMEIVD---PSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 -~~~~~~~~~d---~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.+.....+.+ ......+................++.+++.+|++.||.+||++.|++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 218 PDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000111110 000000100000001111234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=290.19 Aligned_cols=242 Identities=26% Similarity=0.319 Sum_probs=192.6
Q ss_pred ccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEecc
Q 047768 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYM 785 (1009)
Q Consensus 709 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 785 (1009)
||.|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++.. ....++|+||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-----KKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-----CCccEEEEecC
Confidence 6999999999999988899999999864332 234678999999999999999999998654 36789999999
Q ss_pred CCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCC
Q 047768 786 QNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865 (1009)
Q Consensus 786 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 865 (1009)
++++|.+++.+... +++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||.++.....
T Consensus 76 ~~~~L~~~l~~~~~------l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 76 LGGELWTILRDRGL------FDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred CCCcHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 99999999987542 88999999999999999999998 9999999999999999999999999999866432
Q ss_pred CCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhc
Q 047768 866 PLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEI 945 (1009)
Q Consensus 866 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1009)
. ......|+..|+|||.+.+..++.++|+||+|+++|||++|+.||.....+ ..+.... +
T Consensus 147 ~---------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~--------~ 206 (262)
T cd05572 147 Q---------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---PMEIYND--------I 206 (262)
T ss_pred c---------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---HHHHHHH--------H
Confidence 1 112245788999999998888999999999999999999999999754321 1111111 1
Q ss_pred cC-CCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 047768 946 VD-PSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME-----MTDVVV 995 (1009)
Q Consensus 946 ~d-~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt-----~~evl~ 995 (1009)
.+ ......+ ......+.+++.+||+.+|++||+ ++|+++
T Consensus 207 ~~~~~~~~~~-----------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 207 LKGNGKLEFP-----------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred hccCCCCCCC-----------cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 10 0000000 112346889999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=301.16 Aligned_cols=277 Identities=19% Similarity=0.251 Sum_probs=201.3
Q ss_pred HHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccc
Q 047768 694 KELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSID 771 (1009)
Q Consensus 694 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 771 (1009)
.++....++|.+.+.||+|+||.||+|....+++.||+|+++.... ...+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 4455677899999999999999999999988999999999864321 22456788999999999999999999875432
Q ss_pred -cCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc
Q 047768 772 -FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV 850 (1009)
Q Consensus 772 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 850 (1009)
+......+++++++ +++|.+++.... +++..+..++.|+++|++|||+. +|+||||||+||++++++.
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~-------l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQK-------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 12234567888877 789998886532 88999999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCcc
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLT 929 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~ 929 (1009)
+||+|||+++.... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..
T Consensus 159 ~kl~dfg~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~ 226 (345)
T cd07877 159 LKILDFGLARHTDD-----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQ 226 (345)
T ss_pred EEEecccccccccc-----------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 99999999875432 1123467889999998766 56789999999999999999999998643211 11
Q ss_pred HHHHHHHh--ccchhhhccCCC--------CCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 930 LHEFAKRA--LPEKVMEIVDPS--------LLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 930 ~~~~~~~~--~~~~~~~~~d~~--------l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
........ .+.....-+... +...+..+. .........++.+++.+|++.||.+||++.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF---ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcch---hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 11111100 001111000000 000000000 00000123457899999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=292.41 Aligned_cols=253 Identities=24% Similarity=0.308 Sum_probs=194.4
Q ss_pred ccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEecc
Q 047768 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYM 785 (1009)
Q Consensus 709 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 785 (1009)
||+|+||.||+|++..+|+.||+|++..... ...+.+.+|++++++++|||++++++.+.. ....++|+||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-----KKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-----CcEEEEEEecC
Confidence 6899999999999988899999999864432 234678899999999999999999887543 47789999999
Q ss_pred CCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCC
Q 047768 786 QNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865 (1009)
Q Consensus 786 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 865 (1009)
++++|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||++++++.+|++|||++......
T Consensus 76 ~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 76 PGGDLASLLENVG------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred CCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 9999999998654 389999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhc
Q 047768 866 PLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEI 945 (1009)
Q Consensus 866 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1009)
................++..|+|||......++.++||||||+++||+++|+.||..... .......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~-------- 213 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQNI-------- 213 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH--------
Confidence 110000001122235578899999999888899999999999999999999999864321 1111111
Q ss_pred cCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 946 VDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 946 ~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
...... .+. .......+.+++.+|++.+|++|||+.++.+.++
T Consensus 214 ~~~~~~-~~~---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 214 LNGKIE-WPE---------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred hcCCcC-CCc---------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 000000 000 0002356789999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=300.64 Aligned_cols=271 Identities=23% Similarity=0.296 Sum_probs=198.3
Q ss_pred HHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
...+++|++.+.||+|+||.||+|..+.+++.||||++.... ....+.+.+|++++++++|||++++.+++...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 81 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP---- 81 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----
Confidence 446778999999999999999999999899999999885432 22346788999999999999999999986432
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
....++|+||+ +++|.++++... +++.....++.|+++|++|||+. +|+||||+|+||++++++.+|++
T Consensus 82 ~~~~~lv~e~~-~~~L~~~~~~~~-------~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~ 150 (328)
T cd07856 82 LEDIYFVTELL-GTDLHRLLTSRP-------LEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKIC 150 (328)
T ss_pred CCcEEEEeehh-ccCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeC
Confidence 24678999998 569998887532 77888889999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
|||.++..... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||...... .....
T Consensus 151 dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~--~~~~~ 217 (328)
T cd07856 151 DFGLARIQDPQ-----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV--NQFSI 217 (328)
T ss_pred ccccccccCCC-----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 99998754321 123457889999998766 56899999999999999999999999643211 00000
Q ss_pred HHHh---ccchhh-hccCCCCCChhhhhhhcccc-----ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 934 AKRA---LPEKVM-EIVDPSLLPLEEERTNSRRV-----RNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 934 ~~~~---~~~~~~-~~~d~~l~~~~~~r~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.... .++++. .+.+......... ...... .......++.+++.+|++.+|++||+++|++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 218 ITDLLGTPPDDVINTICSENTLRFVQS-LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhCCCCHHHHHhccchhhHHHHhh-ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 111111 1111000000000 000000 000123568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=296.32 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=192.7
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|++.+.||+|+||+||+|.++.+++.||||+++.... .....+.+|+.++.+. .||||+++++++... ..
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD-----SD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC-----Ce
Confidence 4578889999999999999999988899999999964432 2234566777777766 499999999997653 67
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+. +++.+++..... .+++..+..++.|++.|++|||+.. +|+||||+|+||++++++.+||+|||
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccc
Confidence 899999984 578777765432 4899999999999999999999732 89999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCC----CCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE----ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
++....... ......++..|+|||++.+.. ++.++||||||+++|||++|+.||...... .+.
T Consensus 161 ~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~ 227 (296)
T cd06618 161 ISGRLVDSK---------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----FEV 227 (296)
T ss_pred cchhccCCC---------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----HHH
Confidence 987654321 111234788999999987654 789999999999999999999998642211 111
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.... .+......+. ...+..++.+++.+|++.||++||++.++++.
T Consensus 228 ~~~~--------~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 228 LTKI--------LQEEPPSLPP---------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHH--------hcCCCCCCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 1110000000 00233467899999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=286.59 Aligned_cols=254 Identities=26% Similarity=0.357 Sum_probs=202.8
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|...+.||+|++|.||+|....+++.|++|+++.... ...+.+.+|++++++++|+||+++++++.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 46778999999999999999988899999999865542 33578899999999999999999999865421 25789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+++++|.+++.... .+++.+++.++.+++.|++|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 78 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence 9999999999999998764 389999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
......... .......++..|+|||...+..++.++||||||+++|+|++|+.||..... ......
T Consensus 149 ~~~~~~~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~---- 214 (260)
T cd06606 149 KRLGDIETG------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALY---- 214 (260)
T ss_pred Eeccccccc------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHH----
Confidence 876553210 012235678899999999888899999999999999999999999875331 111111
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.+....... ..+......+.+++.+|++.+|++||++.|++.
T Consensus 215 ----~~~~~~~~~----------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 215 ----KIGSSGEPP----------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ----hccccCCCc----------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111000000 011122456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=300.29 Aligned_cols=279 Identities=21% Similarity=0.239 Sum_probs=197.7
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccc-cCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSID-FKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|++..+|+.||||+++... ......+.+|++++++++||||+++++++.... .....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999998889999999986432 222356789999999999999999999875432 12234
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++|+||+. .++.++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMGH--------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred eEEEEecccc-cCHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence 5689999995 477766531 288999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++.... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .......
T Consensus 162 g~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~ 229 (342)
T cd07879 162 GLARHADA-----------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK 229 (342)
T ss_pred CCCcCCCC-----------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 99875432 1123467889999999876 468899999999999999999999997422110 0111110
Q ss_pred Hh-c-cchhhhccCCCC-CChhhhhhhccc----cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHH
Q 047768 936 RA-L-PEKVMEIVDPSL-LPLEEERTNSRR----VRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK--LCHARQ 1002 (1009)
Q Consensus 936 ~~-~-~~~~~~~~d~~l-~~~~~~r~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~--L~~i~~ 1002 (1009)
.. . .....+...... .......+.... .........+.+++.+|++.||++||+++|++.. ++..++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 230 VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00 0 000111110000 000000000000 0000123457799999999999999999999854 555543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=296.19 Aligned_cols=248 Identities=26% Similarity=0.326 Sum_probs=193.1
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
+.|+..+.||+|+||.||+|+++.++..||+|.+..... ...+.+.+|+++++.++|+|++++.+++... ..
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----Ce
Confidence 347777889999999999999988899999999864322 2234677899999999999999999987643 67
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++|+||+. |++.+++..... .+++.++..++.+++.|+.|||+. +++||||+|+||+++.++.+|++|||
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~~~-----~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 160 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (308)
T ss_pred eEEEEEccC-CCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcc
Confidence 899999996 688888765443 388999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccC---CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL---GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
++...... ....|+..|+|||++. ...++.++|||||||++|||++|+.||....... ....+.
T Consensus 161 ~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~ 227 (308)
T cd06634 161 SASIMAPA------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIA 227 (308)
T ss_pred cceeecCc------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHh
Confidence 98765321 1245788999999874 3567889999999999999999999986431110 000000
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
. ..... .....+...+.+++.+||+.+|++||++.+++..-
T Consensus 228 ~------------~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 228 Q------------NESPA----------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred h------------cCCCC----------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0 00000 00112334578999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=288.85 Aligned_cols=242 Identities=23% Similarity=0.281 Sum_probs=183.8
Q ss_pred cccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHH---HHhcCCCCcceEEeeeeccccCCCceEEEE
Q 047768 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEA---LRSIRHRNLIKIVTICSSIDFKGVDFKALV 781 (1009)
Q Consensus 708 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 781 (1009)
.||+|+||.||+|....+++.||+|.+...... ....+..|..+ ++...||+|+++.+++.. .+..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----PDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCEEEEE
Confidence 489999999999999888999999998643211 12233444433 444579999999987654 3678999
Q ss_pred EeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccc
Q 047768 782 YEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861 (1009)
Q Consensus 782 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~ 861 (1009)
|||+.+|+|.+++.... .+++.++..++.|+++|+.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 76 ~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 76 LDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred EecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 99999999999887643 389999999999999999999998 999999999999999999999999999875
Q ss_pred cCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccc
Q 047768 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940 (1009)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
.... ......|+..|+|||++.++ .++.++||||+||++|||++|+.||....... .........
T Consensus 147 ~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~-- 212 (278)
T cd05606 147 FSKK----------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTL-- 212 (278)
T ss_pred cCcc----------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc--hHHHHHHhh--
Confidence 5321 11234689999999998754 68999999999999999999999997532211 111110000
Q ss_pred hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 047768 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVV 995 (1009)
Q Consensus 941 ~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~ 995 (1009)
..+..+ ......++.+++.+|+..+|.+|| ++.|+++
T Consensus 213 ----~~~~~~--------------~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 213 ----TMAVEL--------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ----ccCCCC--------------CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 000000 011234578999999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=287.58 Aligned_cols=250 Identities=23% Similarity=0.289 Sum_probs=200.3
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|++.+.||+|+||.||+|+++.+++.+|+|.+.... ......+.+|++++++++|+||+++.+++.. ....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence 4778899999999999999998899999999986543 2234567889999999999999999988543 37789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+||+++++|.+++...... ...+++..++.++.+++.|++|||+. +++||||+|+||++++++.+|++|||++
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKK--RKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccch
Confidence 999999999999998763321 12488999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
+..... ......++..|+|||...+..++.++|+||+|+++|||++|+.||..... .+.......
T Consensus 151 ~~~~~~----------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~ 215 (256)
T cd08530 151 KVLKKN----------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----QDLRYKVQR 215 (256)
T ss_pred hhhccC----------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhc
Confidence 876542 11123578899999999999999999999999999999999999864321 111111100
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... .....+..++.+++.+|++.+|++||++.|+++
T Consensus 216 --------~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 216 --------GKYP-----------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --------CCCC-----------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 011134456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=302.67 Aligned_cols=285 Identities=21% Similarity=0.234 Sum_probs=206.7
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|.+.+.||+|+||.||+|+...+++.||||++.... ....+.+.+|++++++++|+||+++.+++...........+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999998889999999986543 33456789999999999999999999987654323334689
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||++ ++|.+++.... .+++..++.++.+++.|++|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 81 lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred EEecchh-hhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence 9999997 58999887654 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh-
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA- 937 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~- 937 (1009)
......... ........++..|+|||++.+. .++.++||||+|+++|+|++|+.||....... .........
T Consensus 151 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~ 224 (330)
T cd07834 151 RGVDPDEDE-----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIVEVLG 224 (330)
T ss_pred Eeecccccc-----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHhcC
Confidence 876543210 0112234578899999999888 78999999999999999999999997543210 001110000
Q ss_pred -ccch-hhhccCCCCCChhhh----hhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHH
Q 047768 938 -LPEK-VMEIVDPSLLPLEEE----RTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK--LCHARQ 1002 (1009)
Q Consensus 938 -~~~~-~~~~~d~~l~~~~~~----r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~--L~~i~~ 1002 (1009)
.+.. ............... ...............+.+++.+||+.+|++||++.++++. ++.+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000 000000000000000 0000000011134567899999999999999999999874 554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-33 Score=273.97 Aligned_cols=282 Identities=22% Similarity=0.349 Sum_probs=203.8
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeec--ccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC---C
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINL--EQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG---V 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~---~ 775 (1009)
+.|....++|+|.||+||+|+.+.+|+.||+|++-. +..+-.....+|++++..++|+|++.++..|...+... .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345566889999999999999999999999987633 23344567788999999999999999999987643222 3
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++|+.+|++ +|.-.+...... ++..++.+++.++..||.|+|.. .|+|||+||+|+||+.+|.+||+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr-----~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVR-----FSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcccc-----ccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence 357899999976 899998876543 88999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
||+|+.+..+.. ......+..+-|..|++||.+.+ ..|+++.|||..||++.||+||.+-+..... ...+..+.
T Consensus 168 FGlar~fs~~~n----~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte-qqql~~Is 242 (376)
T KOG0669|consen 168 FGLARAFSTSKN----VVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE-QQQLHLIS 242 (376)
T ss_pred cccccceecccc----cCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH-HHHHHHHH
Confidence 999987765432 11223345667999999998776 5789999999999999999999876653221 11111111
Q ss_pred H---H----hccc----hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 935 K---R----ALPE----KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 935 ~---~----~~~~----~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
. . ..|+ ++++-++..-.+....|.......+.---.+.++++...+..||.+|+++++++..
T Consensus 243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1 0 0111 01111111101111111111111111111256789999999999999999998754
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-33 Score=276.51 Aligned_cols=203 Identities=27% Similarity=0.323 Sum_probs=176.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccch---HHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS---KSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|...+.||+|.||.|..++.+.+|+.+|+|+++.+..-.. ..-..|-++++..+||.+..+-- .|+..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKY-----sFQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKY-----SFQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhh-----hhccCc
Confidence 4678889999999999999999999999999999976643332 34456889999999999877643 356668
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..|.||||..||.|.-.+.+.+. +++.....+..+|..||.|||++ +||.||+|.+|.++|.+|++||+||
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~------FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERV------FSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhc------ccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeec
Confidence 99999999999999888876543 88888899999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccc
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMF 924 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~ 924 (1009)
|+++.-- ........++||+.|.|||++.+..|+.+.|-|.+|||+|||+.|+.||....
T Consensus 313 GLCKE~I--------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 313 GLCKEEI--------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred ccchhcc--------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 9998432 22345567999999999999999999999999999999999999999997543
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=299.71 Aligned_cols=279 Identities=18% Similarity=0.289 Sum_probs=195.5
Q ss_pred ccCc-cCCcccccCCceEEEEEEecCCeEEEEEEeecccccc--------------hHHHHHHHHHHHhcCCCCcceEEe
Q 047768 701 NEFS-SSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG--------------SKSFAAECEALRSIRHRNLIKIVT 765 (1009)
Q Consensus 701 ~~~~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 765 (1009)
++|. +.+.||+|+||+||+|.++.+++.||||+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3554 4577999999999999998889999999986432211 125778999999999999999999
Q ss_pred eeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee
Q 047768 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL 845 (1009)
Q Consensus 766 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill 845 (1009)
++... ...++||||+. |+|.+++.... .+++.....++.|++.|+.|||+. +|+||||+|+||++
T Consensus 88 ~~~~~-----~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill 152 (335)
T PTZ00024 88 VYVEG-----DFINLVMDIMA-SDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFI 152 (335)
T ss_pred EEecC-----CcEEEEEeccc-cCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEE
Confidence 87543 67899999996 69999987644 388999999999999999999998 99999999999999
Q ss_pred CCCCceEEeccccccccCCCCCCCcc------ccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCC
Q 047768 846 DHDMVAHVSDFGLAKFLSASPLGNVV------ETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRR 918 (1009)
Q Consensus 846 ~~~~~~kl~DfGla~~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~ 918 (1009)
+.++.+|++|||+++........... ..........++..|+|||.+.+. .++.++||||+||++|||++|+.
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999876522111000 001112234568899999998764 46899999999999999999999
Q ss_pred CCcccccCCccHHHHHHHhc---cchhhhccC-CCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 047768 919 PTESMFNEGLTLHEFAKRAL---PEKVMEIVD-PSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVV 994 (1009)
Q Consensus 919 p~~~~~~~~~~~~~~~~~~~---~~~~~~~~d-~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl 994 (1009)
||....... .+........ ...+.+..+ +.........+.........+..++.+++.+|++.+|++||+++|++
T Consensus 233 p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 233 LFPGENEID-QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred CCCCCCHHH-HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 987433211 1111111000 000000000 00000000000000000012235678999999999999999999998
Q ss_pred H
Q 047768 995 V 995 (1009)
Q Consensus 995 ~ 995 (1009)
.
T Consensus 312 ~ 312 (335)
T PTZ00024 312 K 312 (335)
T ss_pred c
Confidence 5
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=316.93 Aligned_cols=278 Identities=19% Similarity=0.223 Sum_probs=186.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCC-eEEEEEEee--------------c---ccccchHHHHHHHHHHHhcCCCCcc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENG-MLVAVKVIN--------------L---EQKGGSKSFAAECEALRSIRHRNLI 761 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~--------------~---~~~~~~~~~~~E~~~l~~l~h~niv 761 (1009)
.++|.+.+.||+|+||+||+|..+... ..+++|.+. . ........+.+|++++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999999875322 222222110 0 0111234678999999999999999
Q ss_pred eEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 047768 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPS 841 (1009)
Q Consensus 762 ~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~ 841 (1009)
++++++... +..++|+|++ .+++.+++........ ......++..++.|++.||.|||++ +||||||||+
T Consensus 227 ~l~~~~~~~-----~~~~lv~e~~-~~~l~~~l~~~~~~~~-~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~ 296 (501)
T PHA03210 227 KIEEILRSE-----ANTYMITQKY-DFDLYSFMYDEAFDWK-DRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLE 296 (501)
T ss_pred cEeEEEEEC-----CeeEEEEecc-ccCHHHHHhhcccccc-ccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 999997643 6778999998 4688888765332111 1234566788999999999999999 9999999999
Q ss_pred ceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCC-C
Q 047768 842 NVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP-T 920 (1009)
Q Consensus 842 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p-~ 920 (1009)
|||++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.+ +
T Consensus 297 NILl~~~~~vkL~DFGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 297 NIFLNCDGKIVLGDFGTAMPFEKERE-------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred HEEECCCCCEEEEeCCCceecCcccc-------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 99999999999999999987643211 122346799999999999999999999999999999999998754 4
Q ss_pred cccccC-CccHHHHHHH------hccch---hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 047768 921 ESMFNE-GLTLHEFAKR------ALPEK---VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990 (1009)
Q Consensus 921 ~~~~~~-~~~~~~~~~~------~~~~~---~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~ 990 (1009)
...... ...+.+.... .++.. +.+.++......... ..............+.+++.+|++.||++|||+
T Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa 448 (501)
T PHA03210 370 GDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGH-SVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA 448 (501)
T ss_pred cCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCcc-chhhHHHhcCCChHHHHHHHHHhccCcccCcCH
Confidence 322111 1111111110 01111 111111100000000 000000000122346677889999999999999
Q ss_pred HHHHH
Q 047768 991 TDVVV 995 (1009)
Q Consensus 991 ~evl~ 995 (1009)
.|++.
T Consensus 449 ~elL~ 453 (501)
T PHA03210 449 AELLA 453 (501)
T ss_pred HHHhh
Confidence 99986
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=293.53 Aligned_cols=245 Identities=26% Similarity=0.334 Sum_probs=191.4
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
|...+.||+|+||+||+|+...+++.||+|++...... ....+.+|++++++++|||++++++++... ...+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEE
Confidence 55567899999999999999889999999998644322 234678899999999999999999997653 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+. |++.+++..... .+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||++
T Consensus 98 lv~e~~~-~~l~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence 9999995 688888866443 388999999999999999999999 9999999999999999999999999988
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccC---CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL---GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
..... .....|+..|+|||++. ...++.++|||||||++|||++|..||..... ......
T Consensus 169 ~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~~~~ 231 (313)
T cd06633 169 SKSSP------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYH 231 (313)
T ss_pred cccCC------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHH
Confidence 64321 11346788999999974 46688999999999999999999999864321 111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
...... +.. ....+...+.+++.+|++.+|.+||++.+++..
T Consensus 232 ~~~~~~-----~~~-------------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 232 IAQNDS-----PTL-------------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHhcCC-----CCC-------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 000 001223457789999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=297.48 Aligned_cols=275 Identities=20% Similarity=0.237 Sum_probs=195.5
Q ss_pred cCccCCcccccCCceEEEEEEecC--CeEEEEEEeecccc--cchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCc
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHEN--GMLVAVKVINLEQK--GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 776 (1009)
+|.+.+.||+|+||.||+|.+..+ +..||+|++..... ...+.+.+|+++++++ +||||+++++++... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence 477888999999999999999877 88999999864322 2245678899999999 599999999875432 12335
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++++||+. ++|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df 149 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF 149 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence 6788899885 69999987544 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++........ .........||..|+|||+..+ ..++.++||||+||++|+|++|+.||....... .......
T Consensus 150 g~a~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~ 224 (332)
T cd07857 150 GLARGFSENPGE----NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQ 224 (332)
T ss_pred CCceeccccccc----ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHH
Confidence 999876542211 1112234568999999998765 468999999999999999999999986432110 0000000
Q ss_pred Hh--ccch-hhhccCCC-------CCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RA--LPEK-VMEIVDPS-------LLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~--~~~~-~~~~~d~~-------l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. .+++ ...+.+.. ....+..+. ..........+.+++.+|++.||++|||+.|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPF---ESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhCCCCHHHHHhhhhhhHHHHHHhccccCCcch---HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 0000 11110000 000000000 0000011346889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=246.87 Aligned_cols=199 Identities=23% Similarity=0.406 Sum_probs=169.1
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+|...++||+|.||+||+|+.+++++.||+|.++.++. +-.....+|+-+++.++|+|||+++++.. .....-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-----sdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-----cCceeE
Confidence 46667899999999999999999999999999976543 34578889999999999999999999843 447788
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+|+|||. .+|..|....... ++.+.+..++.|+++|+.|+|++ .+.|||+||.|.+|+.+|+.|++|||+|
T Consensus 78 lvfe~cd-qdlkkyfdslng~-----~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 78 LVFEFCD-QDLKKYFDSLNGD-----LDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred EeHHHhh-HHHHHHHHhcCCc-----CCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchh
Confidence 9999994 5999999876553 89999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCC-CCCcccchHHHHHHHHHHh-CCCCCcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE-ASMRGGVYSYGILLLEIFT-RRRPTES 922 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~ellt-g~~p~~~ 922 (1009)
+-....- ......+-|..|.+|.++.+.. |+...|+||.||++.|+.. |++-|..
T Consensus 149 rafgipv--------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 149 RAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred hhcCCce--------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 9765321 1122345789999999988864 6899999999999999998 5544543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=289.97 Aligned_cols=266 Identities=23% Similarity=0.305 Sum_probs=194.3
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc-chHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCceEEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-GSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
|.+.+.||+|+||+||+|....+++.||||++...... ......+|+..+++++ |+|++++++++.. ....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence 56788999999999999999888999999998644321 2234567999999998 9999999998654 477899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
||||+ +|+|.+++..... ..+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||.++
T Consensus 76 v~e~~-~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKG----KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred EEecC-CCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence 99999 8899999876541 1389999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
...... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+ ....... ...
T Consensus 148 ~~~~~~---------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~-~~~ 216 (283)
T cd07830 148 EIRSRP---------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICS-VLG 216 (283)
T ss_pred eccCCC---------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHH-hcC
Confidence 654321 1123457889999998744 557899999999999999999999986432110 0111000 000
Q ss_pred ch----------hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 940 EK----------VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 940 ~~----------~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. ....++..+...... ....... .....+.+++.+|++.+|++|||+.|++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 217 TPTKQDWPEGYKLASKLGFRFPQFAPT--SLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred CCChhhhhhHhhhhccccccccccccc--cHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00 000000000000000 0000000 11356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=286.23 Aligned_cols=245 Identities=22% Similarity=0.263 Sum_probs=187.1
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHH-hcCCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALR-SIRHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||.||+|....+++.||||+++..... ....+..|..++. ..+|+|++++++++.. ....++|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-----KDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-----CCeEEEEE
Confidence 5699999999999999888999999998643211 1223445555443 4589999999998754 36789999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.+|++|||+++..
T Consensus 77 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 77 EYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred eccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 9999999999997654 378999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchh
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
.. .....|+..|+|||...+..++.++||||||+++|||++|..||..... ..........
T Consensus 148 ~~------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~-- 208 (260)
T cd05611 148 LE------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILSR-- 208 (260)
T ss_pred cc------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhc--
Confidence 32 1124578899999999888899999999999999999999999964321 1111110000
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
.... + ......+...+.+++.+|++.+|++||++.++.+.+.
T Consensus 209 ------~~~~-~-------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 209 ------RINW-P-------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ------ccCC-C-------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 0000 0 0001123456889999999999999998876655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=299.87 Aligned_cols=274 Identities=19% Similarity=0.233 Sum_probs=197.6
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeecccc-CCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDF-KGV 775 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~ 775 (1009)
..++|++.+.||+|+||.||+|....+++.||||+++.... ...+.+.+|++++++++||||+++++++..... ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 45689999999999999999999988999999999854322 123567899999999999999999998754311 122
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++|+||+ +++|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 3568999999 77999888643 288999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
||++...... .....+++.|+|||.+.+ ..++.++||||+||++|++++|+.||....... ......
T Consensus 162 fg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~ 229 (343)
T cd07880 162 FGLARQTDSE-----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIM 229 (343)
T ss_pred cccccccccC-----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence 9999754321 123457889999998876 457899999999999999999999987432110 011111
Q ss_pred HHh--ccchhhhccCCCCCCh-----hhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 935 KRA--LPEKVMEIVDPSLLPL-----EEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 935 ~~~--~~~~~~~~~d~~l~~~-----~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... .+..+.+.+...-... +..+..............+.+++.+|++.||++|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 230 KVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 100 0111111111000000 000000000000122345789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=291.45 Aligned_cols=256 Identities=24% Similarity=0.329 Sum_probs=201.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 776 (1009)
++|.+.+.||+|+||.||+|....+++.||+|++.... ....+.+.+|++++++++ ||||+++++++. ...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ-----DEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc-----CCc
Confidence 36888999999999999999999899999999986432 223467888999999998 999999998754 346
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++++|.+++.... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df 146 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF 146 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence 7899999999999999998754 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCcc------------ccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccc
Q 047768 857 GLAKFLSASPLGNVV------------ETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMF 924 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~ 924 (1009)
|++............ ..........|+..|+|||+.....++.++||||+|+++|++++|+.||....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 999876543211000 00122234567899999999988889999999999999999999999987432
Q ss_pred cCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 047768 925 NEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM----TDVVV 995 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~----~evl~ 995 (1009)
. ...... ....... .+....+.+.+++.+|++.+|.+||++ .|++.
T Consensus 227 ~-----~~~~~~--------~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 227 E-----YLTFQK--------ILKLEYS------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H-----HHHHHH--------HHhcCCC------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1 010110 0000000 001223457899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=289.97 Aligned_cols=267 Identities=24% Similarity=0.335 Sum_probs=197.4
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
|+..+.||+|+||.||+|+...+++.||+|+++... ....+.+..|++++++++|+|++++++++... ...++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence 556788999999999999999889999999997553 33346788899999999999999999986543 67899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
|+||++ ++|.+++..... .+++.++..++.+++.|++|||+. +|+||||+|+||++++++.+||+|||.++
T Consensus 76 v~e~~~-~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRPG-----PLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred EecCcC-cCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence 999997 599999987642 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh--
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA-- 937 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-- 937 (1009)
...... .......++..|+|||.+.+. .++.++|||||||++||+++|+.||...... ..........
T Consensus 147 ~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~ 217 (282)
T cd07829 147 AFGIPL--------RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGT 217 (282)
T ss_pred ccCCCc--------cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCC
Confidence 654321 111123457789999998776 7899999999999999999999998643211 0011111000
Q ss_pred -ccchhhhcc-----CCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 -LPEKVMEIV-----DPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 -~~~~~~~~~-----d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.+....... +......... .. ..........+.+++.+|+..+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 218 PTEESWPGVTKLPDYKPTFPKFPPK-DL--EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred CcHHHHHhhcccccccccccccCcc-ch--HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000011110 0000000000 00 0000011456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=284.89 Aligned_cols=251 Identities=21% Similarity=0.258 Sum_probs=192.9
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-----ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-----KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
+|.+.+.||+|+||.||+|.+...+..+++|+++... ......+.+|+.++++++||||+++++++.. ..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence 4788899999999999999998776667777764321 1223457789999999999999999998643 35
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++|+||+++++|.+++...... ...+++.+++.++.|++.|+.|||+. +++|+||+|+||+++. +.+|++||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~ 149 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDF 149 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeeccc
Confidence 689999999999999998753221 12489999999999999999999998 9999999999999975 56999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|.++...... .......|+..|+|||...+..++.++||||||+++|+|++|..||.... .......
T Consensus 150 g~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~ 216 (260)
T cd08222 150 GVSRLLMGSC--------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLR 216 (260)
T ss_pred CceeecCCCc--------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHH
Confidence 9997664321 11123457889999999988888999999999999999999999986321 1111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..... .+. ....+..++.+++.+|++.+|++||++.|+++
T Consensus 217 ~~~~~-----~~~--------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 217 IVEGP-----TPS--------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHcCC-----CCC--------------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11000 000 01133456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=281.20 Aligned_cols=271 Identities=21% Similarity=0.256 Sum_probs=199.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-C-C----CcceEEeeeeccccC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-H-R----NLIKIVTICSSIDFK 773 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~ 773 (1009)
..+|.+...+|+|.||.|-++.+.+++..||||+++.-. ...+...-|+++++++. + | -++++.+|+ +
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----d 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----D 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----h
Confidence 678999999999999999999999899999999986332 22345667999999993 2 2 255555553 3
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC------
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH------ 847 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~------ 847 (1009)
-.++.|+|+|.+ |-|+.+++.++.. .+++...+..|+.|++++++|||+. +++|-||||+|||+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y----~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNY----IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCc----cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence 347889999988 7799999998664 4699999999999999999999999 9999999999999842
Q ss_pred --------------CCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHH
Q 047768 848 --------------DMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEI 913 (1009)
Q Consensus 848 --------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el 913 (1009)
+..+||+|||.|+..... ....+.|..|+|||++.+-.++.++||||+||||.|+
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El 302 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL 302 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccC-----------cceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence 335899999999875532 1346789999999999999999999999999999999
Q ss_pred HhCCCCCcccccC-CccHHHHHHHhccchhhhcc------CCC-C-------------CChhhhhhhccccccHHHHHHH
Q 047768 914 FTRRRPTESMFNE-GLTLHEFAKRALPEKVMEIV------DPS-L-------------LPLEEERTNSRRVRNEECLVAV 972 (1009)
Q Consensus 914 ltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~------d~~-l-------------~~~~~~r~~~~~~~~~~~~~~l 972 (1009)
.||..-|....+. ...+.+-+...+|..+..-. ... + ...+............++..++
T Consensus 303 ytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L 382 (415)
T KOG0671|consen 303 YTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL 382 (415)
T ss_pred eccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence 9999988654321 11122222222222211100 000 0 0000011111122333455679
Q ss_pred HHHHhhccCCCCCCCCCHHHHHH
Q 047768 973 IKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 973 ~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
++++.+++..||.+|+|+.|++.
T Consensus 383 fDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 383 FDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHHccCccccccHHHHhc
Confidence 99999999999999999999875
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=288.44 Aligned_cols=257 Identities=23% Similarity=0.298 Sum_probs=196.3
Q ss_pred cCccCCcccccCCceEEEEEEe---cCCeEEEEEEeeccc----ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccC
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLH---ENGMLVAVKVINLEQ----KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 773 (1009)
+|++.+.||+|+||.||+|+.. .+++.||||+++... ....+.+.+|+++++++ +||||+++.+++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~---- 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT---- 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence 4777899999999999999864 357889999986432 12345688999999999 59999999987543
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEE
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 853 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 853 (1009)
....++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+++
T Consensus 77 -~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l 146 (288)
T cd05583 77 -DTKLHLILDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVL 146 (288)
T ss_pred -CCEEEEEEecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence 367899999999999999987643 388999999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCCCC--CCCcccchHHHHHHHHHHhCCCCCcccccCCccHH
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE--ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLH 931 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~ 931 (1009)
+|||+++....... .......|+..|+|||...+.. .+.++||||||+++|||++|+.||...... ....
T Consensus 147 ~dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~ 218 (288)
T cd05583 147 TDFGLSKEFLAEEE-------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQS 218 (288)
T ss_pred EECccccccccccc-------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHH
Confidence 99999876543211 1112345789999999987765 788999999999999999999998632111 1111
Q ss_pred HHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 932 EFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
+...... ... ... .......+.+++.+|++.+|++|||+.++.+.|+..
T Consensus 219 ~~~~~~~--------~~~-~~~-----------~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 219 EISRRIL--------KSK-PPF-----------PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHHHH--------ccC-CCC-----------CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1111110 000 000 011234577899999999999999999888777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=298.19 Aligned_cols=270 Identities=20% Similarity=0.243 Sum_probs=197.0
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeecccc-CCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDF-KGV 775 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~ 775 (1009)
..++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++|||++++.+++...+. ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3568999999999999999999999889999999986432 2233567789999999999999999887543321 222
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++|+||+ +++|.+++... .+++.++..++.|+++|++|||+. +|+||||||+||++++++.+||+|
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence 3479999998 67999998753 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
||++...... .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||...... ..+....
T Consensus 162 fg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~ 229 (343)
T cd07851 162 FGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIM 229 (343)
T ss_pred cccccccccc-----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence 9999865321 123457889999998765 36789999999999999999999999643211 0011110
Q ss_pred HHh--ccch---------hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 935 KRA--LPEK---------VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 935 ~~~--~~~~---------~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... .++. ...++....... .. .. .........++.+++.+|++.+|++|||+.||+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~-~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 230 NLVGTPDEELLQKISSESARNYIQSLPQMP-KK--DF-KEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhcCCCCHHHHhhccchhHHHHHHhccccC-CC--CH-HHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000 0000 011100000000 00 00 0000012456889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=286.87 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=192.2
Q ss_pred cCccCCcccccCCceEEEEEEe---cCCeEEEEEEeeccc----ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccC
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLH---ENGMLVAVKVINLEQ----KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 773 (1009)
+|++.+.||+|+||.||.|... .+|+.||+|+++... ....+.+.+|+++++++ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---- 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence 4778899999999999999875 478899999986432 12346688899999999 59999999987543
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEE
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 853 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 853 (1009)
....++|+||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 146 (290)
T cd05613 77 -DTKLHLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL 146 (290)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEE
Confidence 367889999999999999997654 278899999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCCC--CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHH
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG--EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLH 931 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~ 931 (1009)
+|||+++....... .......|+..|+|||.+... .++.++||||||+++|||++|+.||..... .....
T Consensus 147 ~dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~ 218 (290)
T cd05613 147 TDFGLSKEFHEDEV-------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQA 218 (290)
T ss_pred eeCccceecccccc-------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHH
Confidence 99999986543211 111234588999999998753 468899999999999999999999863211 11112
Q ss_pred HHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 047768 932 EFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVV 995 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~ 995 (1009)
......... ..+. +......+.+++.+|++.||++|| ++.+++.
T Consensus 219 ~~~~~~~~~---------~~~~-----------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 219 EISRRILKS---------EPPY-----------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHHhhcc---------CCCC-----------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 221111000 0000 011234577999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=288.06 Aligned_cols=195 Identities=27% Similarity=0.408 Sum_probs=168.6
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEe
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYE 783 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 783 (1009)
.+.||.|-||+||-|+++.+|+.||||+++... .....++++|+.+++++.||.||.+...|. ..+..++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~E-----T~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFE-----TPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeec-----CCceEEEEeh
Confidence 478999999999999999999999999996432 234578999999999999999999988754 4478999999
Q ss_pred ccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC---CceEEecccccc
Q 047768 784 YMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHVSDFGLAK 860 (1009)
Q Consensus 784 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~DfGla~ 860 (1009)
.+ +|+..+++-....+ .+++...+.+..||+.||.|||.+ +|||+||||+|||+.+. ..+|+||||+||
T Consensus 644 Kl-~GDMLEMILSsEkg----RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 644 KL-HGDMLEMILSSEKG----RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred hh-cchHHHHHHHhhcc----cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence 99 56766666544332 388888899999999999999999 99999999999999654 479999999999
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
++... ......+||+.|.|||++..+.|...-|+||.||++|--++|..||..
T Consensus 716 iIgEk---------sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 716 IIGEK---------SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred ecchh---------hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 98764 334457899999999999999999999999999999999999999963
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=298.12 Aligned_cols=265 Identities=21% Similarity=0.289 Sum_probs=218.4
Q ss_pred HHHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccc
Q 047768 693 YKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSID 771 (1009)
Q Consensus 693 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 771 (1009)
++.+...++-|.+.+.||+|.+|.||+++.+.+++.+|||+..... ...++...|..+++.. .|||++.++|++....
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3344445678999999999999999999999999999999986543 3467788899999888 6999999999988776
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCce
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 851 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 851 (1009)
-..++..++|||||.+||..|+++.... ..+.|+.+..|++.++.|+.+||.. .++|||||-.|||++.++.|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g----~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKG----NRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcc----cchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence 6778999999999999999999987653 2489999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCCCccccCCccccccccccccCccccCC-----CCCCCcccchHHHHHHHHHHhCCCCCcccccC
Q 047768 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-----GEASMRGGVYSYGILLLEIFTRRRPTESMFNE 926 (1009)
Q Consensus 852 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~ 926 (1009)
|++|||.+..+.... .......||+.|||||++.- ..|+..+|+||+|++..||.-|.+|+.++..-
T Consensus 163 KLvDFGvSaQldsT~--------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm 234 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTV--------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM 234 (953)
T ss_pred EEeeeeeeeeeeccc--------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh
Confidence 999999998776432 44556789999999998644 35678999999999999999999998755321
Q ss_pred CccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 927 GLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
+.++. .+. .|......+..|.+++.+++..|+..|.+.||++.++++
T Consensus 235 ----------------raLF~-----IpR-NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 ----------------RALFL-----IPR-NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ----------------hhhcc-----CCC-CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11110 000 011122345578889999999999999999999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=312.77 Aligned_cols=148 Identities=32% Similarity=0.472 Sum_probs=130.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.++||+|+||+||+|.+..+++.||||+++..... ....+.+|+.+++.++||||+++++++.. ..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-----AN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-----CC
Confidence 35789999999999999999999988999999999644321 23578899999999999999999987654 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+.+++|.+++.... .+++..++.++.|++.||+|||+. +||||||||+|||++.++.+||+||
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeC
Confidence 7899999999999999997654 278889999999999999999998 9999999999999999999999999
Q ss_pred ccccc
Q 047768 857 GLAKF 861 (1009)
Q Consensus 857 Gla~~ 861 (1009)
|+++.
T Consensus 149 Gls~~ 153 (669)
T cd05610 149 GLSKV 153 (669)
T ss_pred CCCcc
Confidence 99873
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=267.11 Aligned_cols=253 Identities=25% Similarity=0.258 Sum_probs=188.3
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHh-cCCCCcceEEeeeeccccCCCceEEEEEec
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRS-IRHRNLIKIVTICSSIDFKGVDFKALVYEY 784 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 784 (1009)
..||.|+||+|++-.+++.|+..|||+++.... ...+++..|.+...+ -+.||||+++|.+... +..++.||.
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E-----GdcWiCMEL 144 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-----GDCWICMEL 144 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----CceeeeHHH
Confidence 569999999999999999999999999976544 445778888886544 4799999999987542 567999999
Q ss_pred cCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCC
Q 047768 785 MQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSA 864 (1009)
Q Consensus 785 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 864 (1009)
| ..|+..+.+.--. .....+++.-.-+|+...+.||.||.+.. .|||||+||+|||++..|.+|+||||.+..+..
T Consensus 145 M-d~SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 145 M-DISLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred H-hhhHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9 4576554331000 00123888888899999999999999875 899999999999999999999999999987654
Q ss_pred CCCCCccccCCccccccccccccCccccCCC--CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchh
Q 047768 865 SPLGNVVETPSSSIGVKGTIGYVAPEYGLGG--EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 865 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
+ .+.+...|...|||||.+... .|+.++||||+|+++||+.||+.||..+.+- -+...+....+.
T Consensus 221 S---------iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv----feql~~Vv~gdp 287 (361)
T KOG1006|consen 221 S---------IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV----FEQLCQVVIGDP 287 (361)
T ss_pred H---------HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH----HHHHHHHHcCCC
Confidence 3 222335688899999987653 4889999999999999999999998755431 111111111111
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..+ ... ....+....+..++..|+..|-..||...++..
T Consensus 288 p~l-----~~~---------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 288 PIL-----LFD---------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred Cee-----cCc---------ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111 000 011223346889999999999999999998865
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=289.24 Aligned_cols=240 Identities=24% Similarity=0.242 Sum_probs=191.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.+.|.....+|.|+|+.|-.+.+..+++..|||++... .....+|+.++... +|||++++.+.+.+ ..+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~-----~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYED-----GKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecC-----Ccee
Confidence 34667777799999999999999999999999999644 23445677676666 79999999998654 4789
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee-CCCCceEEeccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHVSDFG 857 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill-~~~~~~kl~DfG 857 (1009)
++|||.+.++-+.+.+..... .. .++..|+.+++.|+.|||++ ||||||+||+|||+ ++.++++|+|||
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~------~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG 461 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPE------FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFG 461 (612)
T ss_pred eeeehhccccHHHHHHHhcch------hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEec
Confidence 999999999988777766542 23 67778999999999999998 99999999999999 699999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
.++...+. ....+-|..|.|||+.....|++++|+||+|+++|+|++|+.||.....+ .+...+.
T Consensus 462 ~a~~~~~~-----------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i 526 (612)
T KOG0603|consen 462 FWSELERS-----------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRI 526 (612)
T ss_pred hhhhCchh-----------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhh
Confidence 99876543 11234588999999999999999999999999999999999999865433 2222222
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...+..+ ....+..+++.+|++.||.+||+|+|+..
T Consensus 527 ~~~~~s~----------------------~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 527 QMPKFSE----------------------CVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cCCcccc----------------------ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1221111 11124568999999999999999999865
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=307.20 Aligned_cols=209 Identities=26% Similarity=0.347 Sum_probs=181.6
Q ss_pred HHHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhcCCCCcceEEeeeec
Q 047768 693 YKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRNLIKIVTICSS 769 (1009)
Q Consensus 693 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 769 (1009)
..++....++|.+.+.||+|+||.|..++++.+++.||+|+++.. ......-|..|-++|..-+.+-|++++-.
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA--- 143 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA--- 143 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH---
Confidence 345556678999999999999999999999999999999999653 23445779999999999899999988754
Q ss_pred cccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC
Q 047768 770 IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM 849 (1009)
Q Consensus 770 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 849 (1009)
|++..+.|+|||||+||+|-..+.+... +++..++.++..|+-||.-+|+. |+|||||||+|||+|..|
T Consensus 144 --FQD~~~LYlVMdY~pGGDlltLlSk~~~------~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~G 212 (1317)
T KOG0612|consen 144 --FQDERYLYLVMDYMPGGDLLTLLSKFDR------LPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSG 212 (1317)
T ss_pred --hcCccceEEEEecccCchHHHHHhhcCC------ChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccC
Confidence 6677999999999999999999988762 88999999999999999999999 999999999999999999
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCC-----CCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-----GEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
++|++|||-+-.+...+. -.+...+|||.|++||+++. +.|++.+|-||+||++|||+.|..||..
T Consensus 213 HikLADFGsClkm~~dG~-------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 213 HIKLADFGSCLKMDADGT-------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred cEeeccchhHHhcCCCCc-------EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 999999998877764321 23334679999999998654 5789999999999999999999999973
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=274.01 Aligned_cols=237 Identities=29% Similarity=0.331 Sum_probs=190.2
Q ss_pred ccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEecc
Q 047768 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYM 785 (1009)
Q Consensus 709 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 785 (1009)
||+|+||.||+|.+..+++.||+|+++..... ..+.+..|++++++++|+|++++++.+. .....++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-----TEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-----cCCeeEEEEecC
Confidence 69999999999999888999999998654322 3457889999999999999999998754 347889999999
Q ss_pred CCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCC
Q 047768 786 QNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865 (1009)
Q Consensus 786 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 865 (1009)
++++|.+++.... .+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||.+......
T Consensus 76 ~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 76 PGGELFSHLSKEG------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 9999999998754 389999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhc
Q 047768 866 PLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEI 945 (1009)
Q Consensus 866 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1009)
. .......++..|+|||...+..++.++|+||||+++||+++|+.||..... .+.......
T Consensus 147 ~--------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~------ 207 (250)
T cd05123 147 G--------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILK------ 207 (250)
T ss_pred C--------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhc------
Confidence 1 112235678899999999888899999999999999999999999964321 111111111
Q ss_pred cCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 047768 946 VDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTD 992 (1009)
Q Consensus 946 ~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~e 992 (1009)
... ..+ ......+.+++.+|+..||++||++++
T Consensus 208 --~~~-~~~-----------~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 208 --DPL-RFP-----------EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --CCC-CCC-----------CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 000 000 011345789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=276.01 Aligned_cols=264 Identities=24% Similarity=0.358 Sum_probs=200.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--c-----chHHHHHHHHHHHhcCCCCcceEEeeeecccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--G-----GSKSFAAECEALRSIRHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 772 (1009)
.++|-..+.||+|+|++||+|.+....+.||||+-..... + -.+...+|.++-+.++||.||++++|+.-
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl--- 538 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL--- 538 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee---
Confidence 4577788899999999999999998899999998743321 1 12456789999999999999999999764
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC---CCC
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD---HDM 849 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~---~~~ 849 (1009)
+.+..|-|+|||+|-+|.-|++.++. +++.++..|+.||+.||.||.+. .|+|||-||||.|||+. ..|
T Consensus 539 -DtdsFCTVLEYceGNDLDFYLKQhkl------mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 539 -DTDSFCTVLEYCEGNDLDFYLKQHKL------MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred -ccccceeeeeecCCCchhHHHHhhhh------hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence 34677999999999999999998874 89999999999999999999986 67999999999999994 457
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCC----CCCCcccchHHHHHHHHHHhCCCCCccccc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG----EASMRGGVYSYGILLLEIFTRRRPTESMFN 925 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltg~~p~~~~~~ 925 (1009)
.+||+|||+++++....+... +.........||.+|.+||.+.-+ .++.|+||||.||++|..+.|+.||+....
T Consensus 611 eIKITDFGLSKIMdddSy~~v-dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSV-DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred eeEeeecchhhhccCCccCcc-cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 899999999999987654322 222334456799999999976543 468899999999999999999999985432
Q ss_pred CCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 047768 926 EGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVV 994 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl 994 (1009)
....+.+ . .++...-..+|.+ . ....+...++++|+++--++|....++.
T Consensus 690 QQdILqe----N------TIlkAtEVqFP~K-----P----vVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 690 QQDILQE----N------TILKATEVQFPPK-----P----VVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHHHHhh----h------chhcceeccCCCC-----C----ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 2111110 0 0111111111111 0 1112345788899998888888777664
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=271.57 Aligned_cols=204 Identities=23% Similarity=0.300 Sum_probs=172.2
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 774 (1009)
...+|....+||+|+||.|-.|..+.+.+.+|||+++.+.. ++.+--..|-++|.-- +-|.++++..++..
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT----- 421 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT----- 421 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh-----
Confidence 34579999999999999999999999999999999975532 1222234566666655 67888888887544
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
.+..|.||||+.+|+|--.+++.+. +.+..+..+|.+||-||-|||++ +||+||||.+||++|.+|++||+
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~Gk------FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~ 492 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVGK------FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIA 492 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhcc------cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEee
Confidence 4789999999999999888887654 77788899999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccc
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMF 924 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~ 924 (1009)
|||+++.--- .......++||+.|+|||++...+|+.++|-|||||++|||+.|+.||+...
T Consensus 493 DFGmcKEni~--------~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD 554 (683)
T KOG0696|consen 493 DFGMCKENIF--------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 554 (683)
T ss_pred eccccccccc--------CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999985321 1234456899999999999999999999999999999999999999998543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=270.62 Aligned_cols=223 Identities=19% Similarity=0.137 Sum_probs=175.8
Q ss_pred cCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEeccCCCCHH
Q 047768 712 GSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLE 791 (1009)
Q Consensus 712 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 791 (1009)
|.+|.||+++++.+++.||+|+++... .+.+|...+....|||++++++++.. ....++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVS-----EDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheec-----CCeEEEEEecCCCCCHH
Confidence 889999999999999999999986432 33455556666689999999998643 36789999999999999
Q ss_pred HHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCCCCCCcc
Q 047768 792 EWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVV 871 (1009)
Q Consensus 792 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 871 (1009)
+++.+.. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++|||.+......
T Consensus 74 ~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------ 138 (237)
T cd05576 74 SHISKFL------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------ 138 (237)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc------
Confidence 9997654 289999999999999999999998 9999999999999999999999999988655432
Q ss_pred ccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCC
Q 047768 872 ETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLL 951 (1009)
Q Consensus 872 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 951 (1009)
..+..++..|+|||+..+..++.++||||+|+++|||++|+.|+...... ...... +
T Consensus 139 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~~~~~~--~- 195 (237)
T cd05576 139 -----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------INTHTT--L- 195 (237)
T ss_pred -----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------cccccc--c-
Confidence 11234567899999998888999999999999999999999886521100 000000 0
Q ss_pred ChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 047768 952 PLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDV 993 (1009)
Q Consensus 952 ~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~ev 993 (1009)
..+ ......+.+++.+|++.||++||++.+.
T Consensus 196 ~~~-----------~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 196 NIP-----------EWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred CCc-----------ccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 000 0122457789999999999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=296.93 Aligned_cols=277 Identities=19% Similarity=0.177 Sum_probs=172.1
Q ss_pred HhccCccCCcccccCCceEEEEEEecC----CeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEee-eeccccC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHEN----GMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTI-CSSIDFK 773 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~~ 773 (1009)
..++|.+.+.||+|+||.||+|++..+ +..||||++..... .+....| .++...+.++..++.. .......
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 467899999999999999999999888 89999998753221 1111111 1122222222222211 1111113
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCC--------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCC
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLG--------------ICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLK 839 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk 839 (1009)
.....++|+||+.+++|.+++........ ........+..++.|++.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 44678999999999999999876432100 00112344668999999999999999 99999999
Q ss_pred CCceeeCC-CCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCC----------------------C
Q 047768 840 PSNVLLDH-DMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG----------------------E 896 (1009)
Q Consensus 840 ~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~ 896 (1009)
|+|||++. ++.+||+|||+|+....... .......+|+.|||||.+... .
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-------cCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 99999986 58999999999986543211 122345789999999965332 2
Q ss_pred CCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh-cc-chhhhccCCCCCChhhhhhhccccccHHHHHHHHH
Q 047768 897 ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA-LP-EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIK 974 (1009)
Q Consensus 897 ~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~ 974 (1009)
++.++|||||||++|||+++..|+.... .......... .. ..+...+.+..... .+.... . ......+..+
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~-~-~d~~~~~~~d 428 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSDSNL---IQFNRQLKRNDYDLVAWRKLVEPRASPD--LRRGFE-V-LDLDGGAGWE 428 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCchHH---HHHHHHHHhcCCcHHHHHHhhccccchh--hhhhhh-h-ccccchHHHH
Confidence 3456799999999999999776654210 0011111000 00 00111111110000 000000 0 0001123458
Q ss_pred HHhhccCCCCCCCCCHHHHHHH
Q 047768 975 TGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 975 l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
++.+|++.||++|||+.|+++.
T Consensus 429 Li~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 429 LLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHccCCcccCCCHHHHhCC
Confidence 9999999999999999999863
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=248.88 Aligned_cols=270 Identities=19% Similarity=0.280 Sum_probs=206.1
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCce
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 777 (1009)
..++|++.+++|+|.|++||.|....+...++||+++.-. .+.+.+|+++++.+. ||||++++++..+. .+..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccC
Confidence 4578999999999999999999988889999999997443 478899999999996 99999999987654 4466
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC-CceEEecc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDF 856 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Df 856 (1009)
+.+|+||+.+.+....... ++..++..+..++++||.|+|+. ||+|||+||.|++||.. -..+++|+
T Consensus 110 paLiFE~v~n~Dfk~ly~t---------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYPT---------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred chhHhhhhccccHHHHhhh---------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeec
Confidence 7899999999887776543 66778899999999999999999 99999999999999865 47999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+|.++.++...+. .+.+..|--||.+.+ ..|+..-|+|||||++..|+..+.||....+...++.+++.
T Consensus 178 GLAEFYHp~~eYnV---------RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak 248 (338)
T KOG0668|consen 178 GLAEFYHPGKEYNV---------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK 248 (338)
T ss_pred chHhhcCCCceeee---------eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence 99999887643221 234566788998776 45788999999999999999999999766555556666655
Q ss_pred HhccchhhhccCCCCCC-----------hhhhhhhccc--cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLP-----------LEEERTNSRR--VRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~-----------~~~~r~~~~~--~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
....+++...+.+.-.. ....++.... ...+-...+.++++.+.+.+|-.+|+|+.|.++
T Consensus 249 VLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 249 VLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 44444333322221111 1111111110 011111246779999999999999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=243.38 Aligned_cols=207 Identities=24% Similarity=0.310 Sum_probs=166.4
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.......||+|+||.|-+-++..+|+..|||.+..... +..++...|+++..+. ..|.+|.++|.... ....+
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-----egdvw 121 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-----EGDVW 121 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-----cccEE
Confidence 34445679999999999999999999999999965533 2346677788876554 79999999996432 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+.||.| ..||..+-++--.+ ...+++.-.-+||..+.+||.|||++. .++|||+||+|||++.+|+||+||||.+
T Consensus 122 IcME~M-~tSldkfy~~v~~~--g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 122 ICMELM-DTSLDKFYRKVLKK--GGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EeHHHh-hhhHHHHHHHHHhc--CCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence 999999 45887776542221 124888899999999999999999986 8999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCC----CCCCCcccchHHHHHHHHHHhCCCCCcccccCC
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG----GEASMRGGVYSYGILLLEIFTRRRPTESMFNEG 927 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~ 927 (1009)
-.+.++- ..+-..|...|||||.+.. ..|+.++||||+|+.+.||.+++.||+.+...-
T Consensus 197 G~L~dSi---------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF 259 (282)
T KOG0984|consen 197 GYLVDSI---------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF 259 (282)
T ss_pred eeehhhh---------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence 8776531 1222457889999998644 478999999999999999999999998765543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=254.98 Aligned_cols=201 Identities=24% Similarity=0.340 Sum_probs=175.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|...++||+|+|+.|..++++.+.+.+|+|+++.+ +..+.+..+.|-.++.+. +||.+|-+..++ +.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----qte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----QTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----ccc
Confidence 46788999999999999999999999999999999754 334557788899998887 799999998874 445
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...+.|.||+++|+|--.+++.+. ++++.+..+..+|+-||.|||++ |||.||+|.+|||+|..|++|++|
T Consensus 324 srlffvieyv~ggdlmfhmqrqrk------lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltd 394 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRK------LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTD 394 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhc------CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecc
Confidence 788999999999999666655443 99999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
||+++.--. .......++||+.|+|||++.+..|+...|-|++||+++||+.|+.||+-
T Consensus 395 ygmcke~l~--------~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 395 YGMCKEGLG--------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred cchhhcCCC--------CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 999985322 22445568999999999999999999999999999999999999999974
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=274.82 Aligned_cols=200 Identities=26% Similarity=0.363 Sum_probs=175.1
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++..+..||-|+||.|-.++.+.....+|+|+++.. +....+.+..|-.+|...+.|.||+++-. |.+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchh
Confidence 3455567899999999999998755555888888533 23334567789999999999999999976 455689
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.|+.||-|-||.++..++.+.. ++......++..+++|++|||++ +||+|||||+|.+++.+|-+|+.|||
T Consensus 495 vYmLmEaClGGElWTiLrdRg~------Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGS------FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCC------cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehh
Confidence 9999999999999999998875 88888999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
+|+.+..+ ....+++||+.|.|||++.+...+.++|.||+|+++||+++|.+||...
T Consensus 566 FAKki~~g---------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 566 FAKKIGSG---------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred hHHHhccC---------CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99988654 4556799999999999999999999999999999999999999999753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=263.46 Aligned_cols=239 Identities=30% Similarity=0.386 Sum_probs=191.6
Q ss_pred CCceEEEEEEecCCeEEEEEEeecccccc-hHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEeccCCCCHH
Q 047768 713 SFGFVYKGVLHENGMLVAVKVINLEQKGG-SKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLE 791 (1009)
Q Consensus 713 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 791 (1009)
+||.||+|.+..+++.||+|++....... .+.+.+|++.+++++|+|++++++++... ...++++||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHH
Confidence 58999999998889999999997654444 67899999999999999999999987643 6789999999999999
Q ss_pred HHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCCCCCCcc
Q 047768 792 EWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVV 871 (1009)
Q Consensus 792 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 871 (1009)
+++..... +++..++.++.+++.++.|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 76 ~~~~~~~~------~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----- 141 (244)
T smart00220 76 DLLKKRGR------LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----- 141 (244)
T ss_pred HHHHhccC------CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----
Confidence 99976542 78899999999999999999999 99999999999999999999999999998765431
Q ss_pred ccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCC
Q 047768 872 ETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLL 951 (1009)
Q Consensus 872 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 951 (1009)
......++..|+|||......++.++||||+|+++|++++|..||..... ......... .....
T Consensus 142 ----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~----~~~~~~~~~--------~~~~~ 205 (244)
T smart00220 142 ----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ----LLELFKKIG--------KPKPP 205 (244)
T ss_pred ----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHh--------ccCCC
Confidence 22235678899999999888899999999999999999999999864211 111111100 00000
Q ss_pred ChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 952 PLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 952 ~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... ......++.+++.+|+..+|++||++.++++
T Consensus 206 ~~~~---------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 206 FPPP---------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred Cccc---------cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0000 0003356889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=280.26 Aligned_cols=213 Identities=19% Similarity=0.270 Sum_probs=156.6
Q ss_pred HhccCccCCcccccCCceEEEEEEe----------------cCCeEEEEEEeecccccch--------------HHHHHH
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLH----------------ENGMLVAVKVINLEQKGGS--------------KSFAAE 748 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~--------------~~~~~E 748 (1009)
..++|.+.++||+|+||+||+|.+. ..++.||||+++....... +....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 2456799999865432222 233457
Q ss_pred HHHHHhcCCCCc-----ceEEeeeecccc---CCCceEEEEEeccCCCCHHHHHhccCCCC------------------C
Q 047768 749 CEALRSIRHRNL-----IKIVTICSSIDF---KGVDFKALVYEYMQNGSLEEWLHQRDDQL------------------G 802 (1009)
Q Consensus 749 ~~~l~~l~h~ni-----v~l~~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~ 802 (1009)
+.++.+++|.++ ++++++|..... ......++||||+++++|.++++...... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677787764211 12346799999999999999997532110 1
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccc
Q 047768 803 ICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882 (1009)
Q Consensus 803 ~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~g 882 (1009)
...+++..++.++.|++.|+.|+|+. +|+||||||+||+++.++.+||+|||+++....... .......+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-------~~~~~g~~ 372 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-------FNPLYGML 372 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-------cCccccCC
Confidence 12356788899999999999999998 999999999999999999999999999976543211 11112234
Q ss_pred cccccCccccCCCCC----------------------CCcccchHHHHHHHHHHhCCC-CCc
Q 047768 883 TIGYVAPEYGLGGEA----------------------SMRGGVYSYGILLLEIFTRRR-PTE 921 (1009)
Q Consensus 883 t~~y~aPE~~~~~~~----------------------~~~~DvwS~Gvvl~elltg~~-p~~ 921 (1009)
|+.|+|||.+..... ..+.||||+||+++||++|.. ||.
T Consensus 373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 789999998754321 134699999999999999875 664
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=282.08 Aligned_cols=245 Identities=27% Similarity=0.333 Sum_probs=184.5
Q ss_pred CCcccccCCc-eEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceEEEEEe
Q 047768 706 SNTIGRGSFG-FVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVYE 783 (1009)
Q Consensus 706 ~~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e 783 (1009)
.+.+|.|+.| .||+|.. .|+.||||++-. +..+..++||+.++.- +|||||++++... +..+.|++.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~-----d~qF~YIalE 583 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQ-----DRQFLYIALE 583 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeecc-----CCceEEEEeh
Confidence 3568899887 5799998 489999998732 2345678999999888 6999999998743 4478999999
Q ss_pred ccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC---C--CceEEecccc
Q 047768 784 YMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH---D--MVAHVSDFGL 858 (1009)
Q Consensus 784 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~--~~~kl~DfGl 858 (1009)
.| ..+|.++++..... .........+.+..|+++|+++||+. +||||||||.||||+. + ..++|+|||+
T Consensus 584 LC-~~sL~dlie~~~~d--~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLD--VEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred Hh-hhhHHHHHhccccc--hhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccc
Confidence 99 56999999884111 11111145678899999999999997 9999999999999976 3 4799999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhC-CCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++.+..+.. .-....+..||-+|+|||++....-+.++||||+|||+|+.++| ..||+.....+ ....
T Consensus 658 sKkl~~~~s-----S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~------~NIl 726 (903)
T KOG1027|consen 658 SKKLAGGKS-----SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ------ANIL 726 (903)
T ss_pred ccccCCCcc-----hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh------hhhh
Confidence 998876532 11234567899999999999999889999999999999999994 99998532211 1100
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.....+.. +.+ ..+| +..+++.++++.||..||+|.+|+.
T Consensus 727 --~~~~~L~~--L~~------------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 727 --TGNYTLVH--LEP------------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --cCccceee--ecc------------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00111110 000 1122 5679999999999999999999973
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=251.44 Aligned_cols=203 Identities=24% Similarity=0.336 Sum_probs=164.4
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeecc--cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE--QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
.+-.+.||.|+||+||.+.+..+|+.||+|++..- .-...+.+-+|++++..++|.|++..+++-......--.+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457899999999999999999999999988422 1224578889999999999999999987744321111235678
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
++|.| ..+|.+.+-.-. .++...++-+..||++||.|||+. +|.||||||.|.|++.+...||||||+|+
T Consensus 135 ~TELm-QSDLHKIIVSPQ------~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSPQ------ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHH-HhhhhheeccCC------CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccc
Confidence 88888 457877775533 488888999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
...... ....+..+-|..|+|||.+.+. .|+.+.||||.||++.|++.++.-|..
T Consensus 205 vee~d~-------~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 205 TWDQRD-------RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred ccchhh-------hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 765432 1233345678899999998885 689999999999999999998887754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=268.63 Aligned_cols=199 Identities=25% Similarity=0.394 Sum_probs=173.0
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--------cchHHHHHHHHHHHhcC---CCCcceEEeee
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--------GGSKSFAAECEALRSIR---HRNLIKIVTIC 767 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~~~~ 767 (1009)
...+|+..+.+|+|+||.|+.|.++++...|+||.+..+.- ..-....-||++|..++ |+||+++++++
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 34578999999999999999999999999999999854321 11124667999999997 99999999995
Q ss_pred eccccCCCceEEEEEeccC-CCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC
Q 047768 768 SSIDFKGVDFKALVYEYMQ-NGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD 846 (1009)
Q Consensus 768 ~~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 846 (1009)
++.+++|++||-.. +.+|.+++..++. +++.+++.|++|++.|+++||+. +|||||||-+||.++
T Consensus 639 -----Eddd~yyl~te~hg~gIDLFd~IE~kp~------m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd 704 (772)
T KOG1152|consen 639 -----EDDDYYYLETEVHGEGIDLFDFIEFKPR------MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVD 704 (772)
T ss_pred -----ecCCeeEEEecCCCCCcchhhhhhccCc------cchHHHHHHHHHHHhcccccccc---CceecccccccEEEe
Confidence 44588999999874 4599999988764 99999999999999999999999 999999999999999
Q ss_pred CCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCc
Q 047768 847 HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTE 921 (1009)
Q Consensus 847 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~ 921 (1009)
.+|-+|++|||.|.....++. ..++||..|.|||++.+..| +..-|||++|+++|-++....||.
T Consensus 705 ~~g~~klidfgsaa~~ksgpf----------d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 705 SNGFVKLIDFGSAAYTKSGPF----------DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cCCeEEEeeccchhhhcCCCc----------ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999987765432 24789999999999999988 777899999999999999999985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=255.80 Aligned_cols=137 Identities=25% Similarity=0.394 Sum_probs=117.6
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC--------CCCcceEEeeeecccc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR--------HRNLIKIVTICSSIDF 772 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~~~~ 772 (1009)
.+|.+.++||-|.|++||+|.+..+.+.||+|+.+... .-.+....||++|++++ ..+||++++.+... -
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs-G 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS-G 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec-C
Confidence 68999999999999999999999999999999986442 23456678999999983 35789999887654 4
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD 846 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 846 (1009)
..+.+.|||+|++ |.+|..++.....+ .++...++.|++|++.||.|||.+| +|||-||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Yr----Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYR----GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCC----CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 5678999999999 77999999876543 4999999999999999999999998 999999999999994
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=263.71 Aligned_cols=212 Identities=23% Similarity=0.291 Sum_probs=174.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.-|..++.||-|+||+|.+++..++...+|.|.++..+ .......++|-+||...+.+-||+++-. |.+.+.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence 34667789999999999999998888999999986443 2234567889999999999999999865 556689
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
+|.||+|++||++-++|-+.+- +.+.-+..++.++..|+++.|.. |+|||||||+|||||.+|++||+|||
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgI------FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFG 774 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGI------FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 774 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhcc------CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecc
Confidence 9999999999999999988763 78888888999999999999999 99999999999999999999999999
Q ss_pred cccccC---CCCCCCcc--------c-----------------------cCCccccccccccccCccccCCCCCCCcccc
Q 047768 858 LAKFLS---ASPLGNVV--------E-----------------------TPSSSIGVKGTIGYVAPEYGLGGEASMRGGV 903 (1009)
Q Consensus 858 la~~~~---~~~~~~~~--------~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 903 (1009)
++.-+. .++++... + ........+||+.|+|||++....|+..+|.
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw 854 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW 854 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence 986431 11111100 0 0011123569999999999999999999999
Q ss_pred hHHHHHHHHHHhCCCCCcccccC
Q 047768 904 YSYGILLLEIFTRRRPTESMFNE 926 (1009)
Q Consensus 904 wS~Gvvl~elltg~~p~~~~~~~ 926 (1009)
||.|||||||+.|+.||......
T Consensus 855 ws~gvil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 855 WSVGVILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred hHhhHHHHHHhhCCCCccCCCCC
Confidence 99999999999999999764443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-29 Score=257.67 Aligned_cols=404 Identities=21% Similarity=0.260 Sum_probs=254.5
Q ss_pred CcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccC-ccCCCCCCCcccCCChHHHHHh
Q 047768 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGD-NHFSGTIPPSVYNISSLVEIYL 247 (1009)
Q Consensus 169 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L 247 (1009)
+-.+++|..|+|+.+.|.+|+.+++|++||||+|+|+.+-|++|.+|.+|..|-+-+ |+|+..-...|.+|.+|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 447789999999977788999999999999999999999999999999988776655 9999655567899999999999
Q ss_pred hCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccc------------ccccccccccccccc
Q 047768 248 YGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQ------------FRGQVSINFNGLKDL 315 (1009)
Q Consensus 248 ~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~------------l~~~~~~~f~~l~~L 315 (1009)
.-|++. .++...+..+++|..|.+..|.+..+--.+|..+.+++.+++..|. +....+..|++..-.
T Consensus 148 Nan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~ 226 (498)
T KOG4237|consen 148 NANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV 226 (498)
T ss_pred Chhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence 999999 9999999999999999999999996666699999999999999998 333445556666666
Q ss_pred ccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCch-hhhhhcccceEEEcCCCccccCCCccccCcCcc
Q 047768 316 SMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPH-SIANLSTALIDFNLGKNQIYGTIPPGIANLVNL 394 (1009)
Q Consensus 316 ~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L 394 (1009)
....+.++++....+..+. ..+..+..-..+.....++.|. .|..+ .+|+.|+|++|+|+++-+.+|.++..+
T Consensus 227 ~p~rl~~~Ri~q~~a~kf~-----c~~esl~s~~~~~d~~d~~cP~~cf~~L-~~L~~lnlsnN~i~~i~~~aFe~~a~l 300 (498)
T KOG4237|consen 227 SPYRLYYKRINQEDARKFL-----CSLESLPSRLSSEDFPDSICPAKCFKKL-PNLRKLNLSNNKITRIEDGAFEGAAEL 300 (498)
T ss_pred chHHHHHHHhcccchhhhh-----hhHHhHHHhhccccCcCCcChHHHHhhc-ccceEeccCCCccchhhhhhhcchhhh
Confidence 6666677776665553221 1111221111222222223333 23333 455555555555555555555555555
Q ss_pred CEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCC
Q 047768 395 NSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRN 474 (1009)
Q Consensus 395 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N 474 (1009)
+.|.|..|+|...-...|.++..|+.|+|.+|+|+...|..|..+..|.+|+|-.|.+.-. +.+..|.. ++..+
T Consensus 301 ~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~Cn-----C~l~wl~~-Wlr~~ 374 (498)
T KOG4237|consen 301 QELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCN-----CRLAWLGE-WLRKK 374 (498)
T ss_pred hhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCc-----cchHHHHH-HHhhC
Confidence 5555555555544455555555555555555555555555555555555555555544310 00000000 12222
Q ss_pred CccCCCchhhhhhccceeeEecCCCccCC---CCCCCcc---------CCCCCCe-eeccccccCCCccccccCCCCccE
Q 047768 475 KLTGALPQQILEITTLSLSLDLSDNLLNG---SLPLGVG---------NLKSLVR-LGIARNQFSGQIPVTLGACTSLEY 541 (1009)
Q Consensus 475 ~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~---~~p~~~~---------~l~~L~~-L~ls~N~l~~~~p~~~~~l~~L~~ 541 (1009)
.-+|..|-+- ......++++++.+.. .-|++.+ ..+-+.+ ..-|++.++ .+|.-+. ..-..
T Consensus 375 ~~~~~~~Cq~---p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~te 448 (498)
T KOG4237|consen 375 SVVGNPRCQS---PGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTE 448 (498)
T ss_pred CCCCCCCCCC---CchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHH
Confidence 2222222110 0111124555544431 1222211 1222322 233444443 4554442 24567
Q ss_pred EEecCcccccccccccccccccceEcCCCcccccccccccccccccCceecccc
Q 047768 542 VELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYN 595 (1009)
Q Consensus 542 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 595 (1009)
|+|.+|.++ .+|.. .+..| .+|||+|+++..---.|.++++|.+|-+|+|
T Consensus 449 lyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 449 LYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred Hhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 888888888 67766 66777 8899999888665667888888888888876
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=246.69 Aligned_cols=280 Identities=26% Similarity=0.341 Sum_probs=205.2
Q ss_pred HHhccCccCCcccccCCceEEEEEEec---CCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccC
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHE---NGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 773 (1009)
...+.|..+++||+|.|++||+|.+.. .++.||+|.+... .....+..|+++|..+ .+.||+++.++ +.
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~-----~r 105 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGC-----FR 105 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhh-----hc
Confidence 345678899999999999999999986 6789999988543 3467899999999999 59999999988 44
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC-CceE
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAH 852 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~k 852 (1009)
..+...+|+||+++..-.++... ++..++..+.+.+..||+++|.. |||||||||.|++.+.. +.-.
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~~---------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~ 173 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYRS---------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGV 173 (418)
T ss_pred cCCeeEEEecccCccCHHHHHhc---------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCce
Confidence 55889999999999999888765 77889999999999999999999 99999999999999754 6788
Q ss_pred EeccccccccCCCC------C----------C------------------C--ccccCCccccccccccccCccccCCC-
Q 047768 853 VSDFGLAKFLSASP------L----------G------------------N--VVETPSSSIGVKGTIGYVAPEYGLGG- 895 (1009)
Q Consensus 853 l~DfGla~~~~~~~------~----------~------------------~--~~~~~~~~~~~~gt~~y~aPE~~~~~- 895 (1009)
|+|||+|....... . + . ....+.......||++|.|||++...
T Consensus 174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence 99999998321100 0 0 0 00011122235699999999998775
Q ss_pred CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhh---ccCC--CCC-----Chhhh---------
Q 047768 896 EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVME---IVDP--SLL-----PLEEE--------- 956 (1009)
Q Consensus 896 ~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~d~--~l~-----~~~~~--------- 956 (1009)
.-+++.||||.||++.-+++++.||....++...+.+.+.-..+..++. ..+. .+. ..++.
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~ 333 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI 333 (418)
T ss_pred CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence 4589999999999999999999999876666555555543222211111 1111 000 00110
Q ss_pred ------hh--hccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 957 ------RT--NSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 957 ------r~--~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
+. ..........+..++++..+|+..||.+|.|++|++..
T Consensus 334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00 01111111223368899999999999999999998753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-28 Score=267.15 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=203.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|...+++|.|.||.||+|+++.+++..|||+++.+.....+..++|+-+++..+||||+.++|.+.. .+..+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-----~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-----RDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-----hcCcE
Confidence 3578889999999999999999999999999999999888888889999999999999999999997654 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
++||||.+|+|.+.-+-.. ++++.++..++++..+|++|||+. +=+|||||-.||++++.|.+|++|||.+
T Consensus 89 icMEycgggslQdiy~~Tg------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred EEEEecCCCcccceeeecc------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCch
Confidence 9999999999999876654 389999999999999999999999 8899999999999999999999999998
Q ss_pred cccCCCCCCCccccCCccccccccccccCcccc---CCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYG---LGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
-.+... -..+..+.||+.|||||+. ..+.|...+|||+.|+...|+---+.|...... ++.
T Consensus 160 aqitat--------i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp----mr~---- 223 (829)
T KOG0576|consen 160 AQITAT--------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----MRA---- 223 (829)
T ss_pred hhhhhh--------hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch----HHH----
Confidence 766542 2455668999999999974 456789999999999999998776666432110 000
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.-+..+.....+.. -....|.+.+-++++.|+..+|++||++..++.
T Consensus 224 ------l~LmTkS~~qpp~l------kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 224 ------LFLMTKSGFQPPTL------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ------HHHhhccCCCCCcc------cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 01111111111100 011234556778999999999999999987654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=238.86 Aligned_cols=268 Identities=21% Similarity=0.227 Sum_probs=198.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc--cccchHHHHHHHHHHHhcCCCCcceEEeeeecccc-CCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE--QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDF-KGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 776 (1009)
..+|.-.+.+|.|.- .|..|.+.-.+++||+|+...+ ...+.++..+|...+..++|+|+++++.+++.... ....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777788999988 7888888888999999988543 23345778899999999999999999998775432 2234
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..|+|||+| .++|...++.. ++-..+..+..|++.|+.|||+. +|+||||||+||++..+..+||.||
T Consensus 95 e~y~v~e~m-~~nl~~vi~~e--------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~df 162 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILME--------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDF 162 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHHh--------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccc
Confidence 678999999 56999988842 67788999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+|+.-... -..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.. ...+..|.+.
T Consensus 163 g~ar~e~~~---------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g----~d~idQ~~ki 229 (369)
T KOG0665|consen 163 GLARTEDTD---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG----KDHIDQWNKI 229 (369)
T ss_pred hhhcccCcc---------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC----chHHHHHHHH
Confidence 999854432 234457789999999999999999999999999999999999987763 2233333221
Q ss_pred h-------------ccchhhhccC----------CCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 047768 937 A-------------LPEKVMEIVD----------PSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDV 993 (1009)
Q Consensus 937 ~-------------~~~~~~~~~d----------~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~ev 993 (1009)
. +.+-.+..+. ....++-.-+...+.. .-......+++.+++-.+|++|.+++++
T Consensus 230 ~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~--~~~~~~ardll~~MLvi~pe~Risv~da 307 (369)
T KOG0665|consen 230 IEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGS--KLDCSLARDLLSKMLVIDPEKRISVDDA 307 (369)
T ss_pred HHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCC--ccchHHHHHHHHHhhccChhhcccHHHH
Confidence 1 0011111111 0000000000001111 1122345688999999999999999999
Q ss_pred HH
Q 047768 994 VV 995 (1009)
Q Consensus 994 l~ 995 (1009)
++
T Consensus 308 L~ 309 (369)
T KOG0665|consen 308 LR 309 (369)
T ss_pred hc
Confidence 75
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=231.01 Aligned_cols=253 Identities=17% Similarity=0.243 Sum_probs=186.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.+.|++.+.+|+|.||.+-.++++.+.+.+|+|.+..+. ...++|.+|...--.+ .|.||+.-+++ .|+..+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~v----aFqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEV----AFQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHH----HhhcCceE
Confidence 347899999999999999999999999999999986443 2467888887654444 58999887765 36667888
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC--CCCceEEecc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD--HDMVAHVSDF 856 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~--~~~~~kl~Df 856 (1009)
+.++||++.|+|.+-+...+ +.+.-.+.++.|+++|+.|||++ .+||||||.+||||- +...||+|||
T Consensus 98 vF~qE~aP~gdL~snv~~~G-------igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG-------IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred EEeeccCccchhhhhcCccc-------ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeec
Confidence 99999999999999887654 77888999999999999999999 999999999999993 3348999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCC---C--CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG---G--EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLH 931 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~ 931 (1009)
|..+..+.. .....-+..|.|||.... + ...+.+|||.||+++|..+||+.||......+..+.
T Consensus 168 G~t~k~g~t-----------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~ 236 (378)
T KOG1345|consen 168 GLTRKVGTT-----------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW 236 (378)
T ss_pred ccccccCce-----------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH
Confidence 998855431 112233567999996433 2 347889999999999999999999986555566666
Q ss_pred HHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 932 EFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
+|..-..+... .+-+ .. ....+..+++.++-+..+|++|=..-++.+
T Consensus 237 ~~~~w~~rk~~-~~P~-~F---------------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 237 EWEQWLKRKNP-ALPK-KF---------------NPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred HHHHHhcccCc-cCch-hh---------------cccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 65432111100 0000 00 011234556677778888888844444433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=233.04 Aligned_cols=211 Identities=31% Similarity=0.497 Sum_probs=181.6
Q ss_pred ccccCCceEEEEEEecCCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEeccCC
Q 047768 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQN 787 (1009)
Q Consensus 709 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~ 787 (1009)
||+|.+|.||++....+++.+++|++...... ..+.+.+|++.++.++|++++++++++... ...++++||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence 68999999999999877999999999654332 246799999999999999999999987543 678999999999
Q ss_pred CCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC-CCceEEeccccccccCCCC
Q 047768 788 GSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLAKFLSASP 866 (1009)
Q Consensus 788 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~DfGla~~~~~~~ 866 (1009)
++|.+++..... .+++..+..++.++++++.|||+. +++|+||+|.||+++. ++.++++|||.+.......
T Consensus 76 ~~l~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 76 GSLKDLLKENEG-----KLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred CcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 999999987532 388999999999999999999999 9999999999999999 8999999999998665431
Q ss_pred CCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhc
Q 047768 867 LGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEI 945 (1009)
Q Consensus 867 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1009)
. ......+...|++||..... .++.++|+|++|++++++
T Consensus 148 ~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------- 187 (215)
T cd00180 148 S--------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------- 187 (215)
T ss_pred c--------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------
Confidence 1 12234567889999998887 888999999999999998
Q ss_pred cCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 946 VDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 946 ~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.++.+++..|++.+|++||++.++++.
T Consensus 188 ------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 246799999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=246.59 Aligned_cols=298 Identities=23% Similarity=0.254 Sum_probs=197.9
Q ss_pred CCCCCCC-CCc-cc--eeeCCCC---------CeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCc
Q 047768 51 SACVNLC-QHW-TG--VTCGRRN---------QRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNL 117 (1009)
Q Consensus 51 ~~~~~~c-~~w-~g--v~C~~~~---------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l 117 (1009)
..|+..| |+= .| |+|+..+ ...+.++|..|+|+.+.+.+|+.+.+||.||||+|+|+-+-|++|.+|
T Consensus 35 ~~CP~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL 114 (498)
T KOG4237|consen 35 SACPAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGL 114 (498)
T ss_pred ccCCCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhh
Confidence 3566666 222 22 7887543 356777777777777777777777777777777777776777777777
Q ss_pred cccccccccc-cccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccce
Q 047768 118 FRLETLVLAN-NSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRV 196 (1009)
Q Consensus 118 ~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 196 (1009)
.+|.+|-|-+ |+|+...-..|++|..|+.|.+..|++.-...+.+ ..+++|..|.+.+|.+..+-..+|..+..++.
T Consensus 115 ~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al--~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~t 192 (498)
T KOG4237|consen 115 ASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDAL--RDLPSLSLLSLYDNKIQSICKGTFQGLAAIKT 192 (498)
T ss_pred HhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHH--HHhhhcchhcccchhhhhhccccccchhccch
Confidence 7766665544 77775545567777777777777777764333333 45777777777777777333346777777777
Q ss_pred eecccCc------------ccCCCCcccccccccccccccCccCCCCCCCcccC-CChHHHHHhhCCccCCCCChhhccC
Q 047768 197 IDIRTNR------------LWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYN-ISSLVEIYLYGNRFTGSLPIEIGKN 263 (1009)
Q Consensus 197 L~L~~N~------------l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~ip~~~~~~ 263 (1009)
+.+..|. +....|..++...-..-..+.++++...-+..|.. +.++.+=..+.+...+..|..-|+.
T Consensus 193 lhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~ 272 (498)
T KOG4237|consen 193 LHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKK 272 (498)
T ss_pred HhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhh
Confidence 7777776 22334455555555555555555555333333321 2233333334444555777777888
Q ss_pred CCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhccccc
Q 047768 264 LPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCT 343 (1009)
Q Consensus 264 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~ 343 (1009)
|++|+.|+|++|+|+++-+.+|.++..++.|.|..|+|..+....|.++..|+.|+|..|+|+.+.. .+|..+.
T Consensus 273 L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~------~aF~~~~ 346 (498)
T KOG4237|consen 273 LPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAP------GAFQTLF 346 (498)
T ss_pred cccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEec------ccccccc
Confidence 8888888888888888888888888888888888888888877777777777777777777776554 4455666
Q ss_pred ccceEEccCCCCC
Q 047768 344 KLQYLYLADNGFG 356 (1009)
Q Consensus 344 ~L~~L~L~~N~l~ 356 (1009)
.|..|.|-.|.+.
T Consensus 347 ~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 347 SLSTLNLLSNPFN 359 (498)
T ss_pred eeeeeehccCccc
Confidence 6777777666654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=246.99 Aligned_cols=204 Identities=23% Similarity=0.310 Sum_probs=170.0
Q ss_pred HHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC------CCCcceEEeeeecc
Q 047768 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR------HRNLIKIVTICSSI 770 (1009)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~ 770 (1009)
+....+|.+.-..|+|-|++|..|.+...|..||||++...... .+.=.+|+++|++++ ..|+++++..
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~---- 502 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRH---- 502 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHH----
Confidence 34567899999999999999999999988899999999644332 344567999999984 4567777765
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC-
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM- 849 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~- 849 (1009)
|....++|+|+|-+ .-+|.+++++.+... .+....+..++.|+.-||..|... +|+|.||||+||||++..
T Consensus 503 -F~hknHLClVFE~L-slNLRevLKKyG~nv---GL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 503 -FKHKNHLCLVFEPL-SLNLREVLKKYGRNV---GLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred -hhhcceeEEEehhh-hchHHHHHHHhCccc---ceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 44458999999988 679999999877653 388889999999999999999987 999999999999998764
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
.+||||||.|........ +.+.-+..|.|||++.+-+|+...|+||.||.|||+.||+..|+..
T Consensus 575 iLKLCDfGSA~~~~enei----------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEI----------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred eeeeccCccccccccccc----------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 689999999987765322 1233456799999999999999999999999999999999988753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-25 Score=232.22 Aligned_cols=200 Identities=33% Similarity=0.497 Sum_probs=171.8
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALV 781 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 781 (1009)
|.+.+.||+|++|.||+|....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++... ...+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence 55678899999999999999877899999999755443 467889999999999999999999986543 678899
Q ss_pred EeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccc
Q 047768 782 YEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861 (1009)
Q Consensus 782 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~ 861 (1009)
+||+++++|.+++...... +++.....++.+++.++.|||+. +++|+|++|+||+++.++.++++|||.+..
T Consensus 76 ~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGGK-----LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred EeccCCCCHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 9999999999999875432 78899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCCccccCCccccccccccccCcccc-CCCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYG-LGGEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
...... .......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 148 ~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 148 IHRDLA-------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ecCccc-------ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 654320 012234577889999998 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=266.41 Aligned_cols=363 Identities=19% Similarity=0.266 Sum_probs=225.5
Q ss_pred CCeEEEEEeecCCccc--ccCccccCCCCCCeeeecCCc------CCccCCccccCcc-ccccccccccccCCCCCCCCc
Q 047768 69 NQRVTKLDLRNQSIGG--ILSPYVGNLSFLRYINIADND------FHGEIPDRIGNLF-RLETLVLANNSFSGRIPTNLS 139 (1009)
Q Consensus 69 ~~~v~~l~l~~~~l~~--~~~~~~~~l~~L~~L~L~~n~------~~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~ 139 (1009)
+.+|..+.|.-..+.. ..+.+|..+.+|++|.+..+. +...+|+.|..++ +|+.|++++|.+. .+|..|
T Consensus 531 ~~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f- 608 (1153)
T PLN03210 531 TKKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF- 608 (1153)
T ss_pred cceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-
Confidence 3456665554333322 223457889999999887653 3445777777764 5888888888876 677776
Q ss_pred CCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccc
Q 047768 140 HCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLA 219 (1009)
Q Consensus 140 ~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 219 (1009)
...+|+.|++++|++. .+|..+ ..+.+|+.|+|++|...+.+|. ++.+++|++|+|++|.....+|..+..+++|+
T Consensus 609 ~~~~L~~L~L~~s~l~-~L~~~~--~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~ 684 (1153)
T PLN03210 609 RPENLVKLQMQGSKLE-KLWDGV--HSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLE 684 (1153)
T ss_pred CccCCcEEECcCcccc-cccccc--ccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCC
Confidence 4677888888877765 455544 4566777777776654445553 66677777777777665566677777777777
Q ss_pred cccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccc
Q 047768 220 YLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAEN 299 (1009)
Q Consensus 220 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 299 (1009)
.|++++|...+.+|..+ ++++|+.|++++|...+.+|.. ..+|+.|+|++|.+. .+|..+ .+++|++|++.++
T Consensus 685 ~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~ 757 (1153)
T PLN03210 685 DLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSNL-RLENLDELILCEM 757 (1153)
T ss_pred EEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc----cCCcCeeecCCCccc-cccccc-ccccccccccccc
Confidence 77777654434555544 5666666666666544344421 345556666666554 233333 3455555555443
Q ss_pred ccccccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCc
Q 047768 300 QFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQ 379 (1009)
Q Consensus 300 ~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~ 379 (1009)
....... .+.... +......++|+.|+|++|...+.+|..+.++ +.|+.|++++|.
T Consensus 758 ~~~~l~~-----------------~~~~l~------~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L-~~L~~L~Ls~C~ 813 (1153)
T PLN03210 758 KSEKLWE-----------------RVQPLT------PLMTMLSPSLTRLFLSDIPSLVELPSSIQNL-HKLEHLEIENCI 813 (1153)
T ss_pred chhhccc-----------------cccccc------hhhhhccccchheeCCCCCCccccChhhhCC-CCCCEEECCCCC
Confidence 3211100 000000 0011234677888888887776777777776 567888887765
Q ss_pred cccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccC-cccccccCC
Q 047768 380 IYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGA-NNLQGNIPF 458 (1009)
Q Consensus 380 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~ 458 (1009)
..+.+|..+ ++++|+.|+|++|..-..+|.. ..+|++|+|++|.++ .+|.++..+++|++|++++ |++. .+|.
T Consensus 814 ~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~ 887 (1153)
T PLN03210 814 NLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSL 887 (1153)
T ss_pred CcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCc
Confidence 444666655 6778888888877654455543 356777888888877 5677777788888888877 4444 5666
Q ss_pred CCCCCCCccccccCCC
Q 047768 459 SLGNCKNLMFFFAPRN 474 (1009)
Q Consensus 459 ~~~~l~~L~~l~l~~N 474 (1009)
.+..+++|+.++++++
T Consensus 888 ~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 888 NISKLKHLETVDFSDC 903 (1153)
T ss_pred ccccccCCCeeecCCC
Confidence 6777777776666555
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=267.36 Aligned_cols=344 Identities=20% Similarity=0.240 Sum_probs=165.3
Q ss_pred CcccCCccccceeecccCc------ccCCCCccccccc-ccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCC
Q 047768 185 PASIGNLSALRVIDIRTNR------LWGKIPITLSQLT-SLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLP 257 (1009)
Q Consensus 185 p~~~~~l~~L~~L~L~~N~------l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip 257 (1009)
+.+|.++++|+.|.+..+. +...+|..|..++ +|+.|++.+|.+. .+|..| .+.+|++|+|.+|++. .+|
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence 3456667777777765543 2234555555553 4777777776665 556655 3566666777776666 555
Q ss_pred hhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccccccccccccccccccccccc-ccCCCCCCCcchh
Q 047768 258 IEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATN-FLGNGAANDLDFV 336 (1009)
Q Consensus 258 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N-~l~~~~~~~~~~~ 336 (1009)
..+ ..+++|+.|+|++|...+.+|. ++.+++|++|+|++|......|..+..+++|+.|++++| .+..++..
T Consensus 628 ~~~-~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~----- 700 (1153)
T PLN03210 628 DGV-HSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTG----- 700 (1153)
T ss_pred ccc-ccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCc-----
Confidence 554 3466666777666554444453 566666666666666544444444555555555555442 22222210
Q ss_pred hhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcc
Q 047768 337 DLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELK 416 (1009)
Q Consensus 337 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 416 (1009)
.++++|+.|++++|...+.+|.. ..+|+.|++++|.+. .+|..+ .+++|+.|++.++.... ++
T Consensus 701 ---i~l~sL~~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~-l~------- 763 (1153)
T PLN03210 701 ---INLKSLYRLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEK-LW------- 763 (1153)
T ss_pred ---CCCCCCCEEeCCCCCCccccccc----cCCcCeeecCCCccc-cccccc-cccccccccccccchhh-cc-------
Confidence 13445555555555433222221 123344444444443 223222 23334444333322110 00
Q ss_pred cccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEec
Q 047768 417 NLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDL 496 (1009)
Q Consensus 417 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~L 496 (1009)
+.+....|..+...++|+.|+|++|...+.+|.+++++++|+.|++++|...
T Consensus 764 ---------~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L------------------- 815 (1153)
T PLN03210 764 ---------ERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINL------------------- 815 (1153)
T ss_pred ---------ccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCc-------------------
Confidence 0011011111122244555555555544455555555555554444433221
Q ss_pred CCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCC-ccccc
Q 047768 497 SDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQ-NNFSG 575 (1009)
Q Consensus 497 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~ 575 (1009)
+.+|..+ ++++|+.|++++|.....+|.. .++|+.|+|++|.++ .+|.++..+++|+.|+|++ |++.
T Consensus 816 ------~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~- 883 (1153)
T PLN03210 816 ------ETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ- 883 (1153)
T ss_pred ------CeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-
Confidence 1233332 3455555555554333233322 234555555555555 4555555555555555555 3333
Q ss_pred ccccccccccccCceecccc
Q 047768 576 QIPKYLENLSFLQYLNLSYN 595 (1009)
Q Consensus 576 ~~p~~~~~l~~L~~L~ls~N 595 (1009)
.+|..+..+++|+.++++++
T Consensus 884 ~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 884 RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred ccCcccccccCCCeeecCCC
Confidence 35555555555555555555
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=212.24 Aligned_cols=171 Identities=19% Similarity=0.181 Sum_probs=129.2
Q ss_pred CCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCCCC
Q 047768 788 GSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPL 867 (1009)
Q Consensus 788 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 867 (1009)
|+|.++++.+.. .+++.+++.++.|++.||.|||++ + ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~-- 62 (176)
T smart00750 1 VSLADILEVRGR-----PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE-- 62 (176)
T ss_pred CcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc--
Confidence 789999987543 399999999999999999999998 5 999999999999999 9999865432
Q ss_pred CCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccC
Q 047768 868 GNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVD 947 (1009)
Q Consensus 868 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 947 (1009)
...||+.|||||++.+..++.++|||||||++|||+||+.||............+...
T Consensus 63 -----------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~----------- 120 (176)
T smart00750 63 -----------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG----------- 120 (176)
T ss_pred -----------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH-----------
Confidence 1257899999999999999999999999999999999999986432211111111111
Q ss_pred CCCCChhhhhhhccccccHHHH--HHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 948 PSLLPLEEERTNSRRVRNEECL--VAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 948 ~~l~~~~~~r~~~~~~~~~~~~--~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
.....+..+. ...... .++.+++.+|+..+|++||++.|+++.+..+..+.
T Consensus 121 -~~~~~~~~~~-----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 121 -MPADDPRDRS-----NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred -hccCCccccc-----cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 0000011000 001112 25889999999999999999999999998776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-24 Score=209.63 Aligned_cols=246 Identities=23% Similarity=0.306 Sum_probs=185.6
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEe
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYE 783 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 783 (1009)
.-+|.+...|+.|+|+|. |..+++|+++..+.. ..+.|..|.-.++.+.||||+.++|.|... ....++..
T Consensus 195 ~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~isq 267 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVIISQ 267 (448)
T ss_pred hhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEeee
Confidence 456888999999999997 556777888654332 346899999999999999999999999764 67889999
Q ss_pred ccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe--ccccccc
Q 047768 784 YMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS--DFGLAKF 861 (1009)
Q Consensus 784 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~--DfGla~~ 861 (1009)
||+.|||+..+++.... ..+..++.++|.++|+|++|||+. .|-|.---+.++.|++|++.+++|+ |--++..
T Consensus 268 ~mp~gslynvlhe~t~v----vvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq 342 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSV----VVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ 342 (448)
T ss_pred eccchHHHHHHhcCccE----EEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee
Confidence 99999999999987643 477788999999999999999996 3344455788999999999998884 3222221
Q ss_pred cCCCCCCCccccCCccccccccccccCccccCCCCC---CCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA---SMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
. .+..-.+.||+||.++..+. -.++|+|||++++||+.|+..||.....-...+.-.
T Consensus 343 e---------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia----- 402 (448)
T KOG0195|consen 343 E---------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA----- 402 (448)
T ss_pred c---------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-----
Confidence 1 11223678999999988765 357999999999999999999998654332111111
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
-+.++--+.+ .....+.+++.-|+.+||.+||.++.++-.|+++.
T Consensus 403 leglrv~ipp------------------gis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 LEGLRVHIPP------------------GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hccccccCCC------------------CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1111111111 12235778999999999999999999999988764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=246.24 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=165.1
Q ss_pred HhhcCChhhHHHHHHHHHhcCCCCCCCCC----CccCCCCCCCCC---------------ccceeeCCCCCeEEEEEeec
Q 047768 19 ALALSNETDCLSLLAIKSQLHDPLGVTSS----WNRSACVNLCQH---------------WTGVTCGRRNQRVTKLDLRN 79 (1009)
Q Consensus 19 ~~~~~~~~d~~aLl~~k~~~~~~~~~~~s----W~~~~~~~~c~~---------------w~gv~C~~~~~~v~~l~l~~ 79 (1009)
+.+..+++|.+++++..+.+.-|. ..++ |++. +++|-. =.-|.|.. +.|+.+..-+
T Consensus 56 ~~~~~~~~~~~~~~~~~~~l~~p~-~~~~~~~~~~~~--~~fc~~~~~~~~~l~~~~~~~~~tv~~~~--~~vt~l~~~g 130 (754)
T PRK15370 56 PPETASPEEIKSKFECLRMLAFPA-YADNIQYSRGGA--DQYCILSENSQEILSIVFNTEGYTVEGGG--KSVTYTRVTE 130 (754)
T ss_pred CCCCCCHHHHHHHHHHHHHhcCCc-hhhccccccCCC--CcccccCCcchhhheeeecCCceEEecCC--Cccccccccc
Confidence 344567899999999999986663 4555 9876 577821 11277864 4677766654
Q ss_pred CCccccc--------------------Cc--------cc-----cCCCCCCeeeecCCcCCccCCccccCcccccccccc
Q 047768 80 QSIGGIL--------------------SP--------YV-----GNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLA 126 (1009)
Q Consensus 80 ~~l~~~~--------------------~~--------~~-----~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls 126 (1009)
....... ++ .+ +-..+...|++++++++ .+|..+. ++|+.|+|+
T Consensus 131 ~~~~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls 207 (754)
T PRK15370 131 SEQASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILD 207 (754)
T ss_pred ccccccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEec
Confidence 2211100 00 00 11245678888888888 6777664 478888888
Q ss_pred ccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccC
Q 047768 127 NNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWG 206 (1009)
Q Consensus 127 ~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 206 (1009)
+|.|+ .+|..+. ++|++|++++|+++ .+|..+. .+|+.|+|++|++. .+|..+. ++|+.|+|++|+|+
T Consensus 208 ~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~----~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~- 275 (754)
T PRK15370 208 NNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP----DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS- 275 (754)
T ss_pred CCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh----ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-
Confidence 88888 5666554 47888888888877 5676553 36888888888887 5666653 47888888888886
Q ss_pred CCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcC
Q 047768 207 KIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFS 286 (1009)
Q Consensus 207 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 286 (1009)
.+|..+. ++|++|+|++|+|+ .+|..+. ++|+.|++++|+++ .+|..++ ++|+.|++++|.+++ +|..+.
T Consensus 276 ~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~Lt~-LP~~l~ 345 (754)
T PRK15370 276 CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-ALPETLP---PGLKTLEAGENALTS-LPASLP 345 (754)
T ss_pred ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cCCcccc---ccceeccccCCcccc-CChhhc
Confidence 4566554 47888888888887 4565443 46888888888887 5665443 466666677776664 344332
Q ss_pred cccccccccccccccc
Q 047768 287 NASNLEVLHLAENQFR 302 (1009)
Q Consensus 287 ~l~~L~~L~Ls~N~l~ 302 (1009)
++|+.|+|++|+|+
T Consensus 346 --~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 346 --PELQVLDVSKNQIT 359 (754)
T ss_pred --CcccEEECCCCCCC
Confidence 45666666666554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-24 Score=264.96 Aligned_cols=207 Identities=18% Similarity=0.224 Sum_probs=139.4
Q ss_pred hcCC-CCcceEEeeeecccc--CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 047768 754 SIRH-RNLIKIVTICSSIDF--KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQ 830 (1009)
Q Consensus 754 ~l~h-~niv~l~~~~~~~~~--~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ 830 (1009)
.++| +||+++++++..... ......+.++||+ +++|.+++..... .+++.+++.++.||++||+|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~-- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDR-----SVDAFECFHVFRQIVEIVNAAHSQ-- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccc-----cccHHHHHHHHHHHHHHHHHHHhC--
Confidence 4455 588888887633221 1223567788887 6699999975432 389999999999999999999999
Q ss_pred CCceecCCCCCceeeCCCC-------------------ceEEeccccccccCCCCCC------Cccc--cCCcccccccc
Q 047768 831 PPIVHGDLKPSNVLLDHDM-------------------VAHVSDFGLAKFLSASPLG------NVVE--TPSSSIGVKGT 883 (1009)
Q Consensus 831 ~~ivHrdlk~~Nill~~~~-------------------~~kl~DfGla~~~~~~~~~------~~~~--~~~~~~~~~gt 883 (1009)
+||||||||+|||++..+ .+|++|||+++........ .... .+.......||
T Consensus 100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 999999999999996544 4555566665532110000 0000 00111224689
Q ss_pred ccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhcccc
Q 047768 884 IGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRV 963 (1009)
Q Consensus 884 ~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~ 963 (1009)
+.|||||++.+..++.++|||||||++|||++|..|+..... ........ ...+ ..
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~--------~~~~----~~--------- 234 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHR--------VLPP----QI--------- 234 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHh--------hcCh----hh---------
Confidence 999999999999999999999999999999999888652110 01111000 0000 00
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 964 RNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 964 ~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.....+...++.+|++.+|.+||+|.|+++
T Consensus 235 --~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 235 --LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred --hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 011223457788999999999999999975
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=246.02 Aligned_cols=259 Identities=25% Similarity=0.317 Sum_probs=153.8
Q ss_pred HHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccccccccccccccccccccccc
Q 047768 244 EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATN 323 (1009)
Q Consensus 244 ~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N 323 (1009)
.|+|++|.|+ .+|..+. ++|+.|++++|+++. +|. .+++|++|+|++|+|+.++..
T Consensus 205 ~LdLs~~~Lt-sLP~~l~---~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsLP~l---------------- 260 (788)
T PRK15387 205 VLNVGESGLT-TLPDCLP---AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLPVL---------------- 260 (788)
T ss_pred EEEcCCCCCC-cCCcchh---cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcccCc----------------
Confidence 4566666666 5665543 245666666666663 232 134555555555555533210
Q ss_pred ccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCC
Q 047768 324 FLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANR 403 (1009)
Q Consensus 324 ~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 403 (1009)
.++|+.|+|++|.++ .+|. +...|..|++++|+|+ .+|.. +++|+.|+|++|+
T Consensus 261 ------------------p~sL~~L~Ls~N~L~-~Lp~----lp~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~ 313 (788)
T PRK15387 261 ------------------PPGLLELSIFSNPLT-HLPA----LPSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQ 313 (788)
T ss_pred ------------------ccccceeeccCCchh-hhhh----chhhcCEEECcCCccc-ccccc---ccccceeECCCCc
Confidence 134555555555554 2222 2234555666666665 23332 3456666666666
Q ss_pred CCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchh
Q 047768 404 LTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQ 483 (1009)
Q Consensus 404 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 483 (1009)
|++ +|... .+|+.|++++|+|++ +|.. ..+|++|+|++|+|+ .+|... .+|..
T Consensus 314 L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~lp---~~L~~--------------- 366 (788)
T PRK15387 314 LAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTLP---SELYK--------------- 366 (788)
T ss_pred ccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccC-CCCCCC---cccce---------------
Confidence 663 33322 345566666666663 4431 135666666666666 344322 22222
Q ss_pred hhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccccccccccccccccc
Q 047768 484 ILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSI 563 (1009)
Q Consensus 484 ~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 563 (1009)
|++++|+|+ .+|... .+|+.|++++|+|++ +|... ++|+.|++++|+|+ .+|..+ .+|
T Consensus 367 ----------L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L 424 (788)
T PRK15387 367 ----------LWAYNNRLT-SLPALP---SGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLT-SLPMLP---SGL 424 (788)
T ss_pred ----------ehhhccccc-cCcccc---cccceEEecCCcccC-CCCcc---cCCCEEEccCCcCC-CCCcch---hhh
Confidence 555555555 244332 467888888888874 55433 57888888888888 466543 467
Q ss_pred ceEcCCCcccccccccccccccccCceecccccCcccCCC
Q 047768 564 KELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPT 603 (1009)
Q Consensus 564 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 603 (1009)
+.|+|++|+|+ .+|..+.++++|+.|+|++|+|+|.+|.
T Consensus 425 ~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 425 LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred hhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 88899999987 7888888889999999999999887775
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=249.10 Aligned_cols=146 Identities=27% Similarity=0.328 Sum_probs=94.8
Q ss_pred ccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccC
Q 047768 393 NLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAP 472 (1009)
Q Consensus 393 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~ 472 (1009)
+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|... .+|+.|++++|+|+ .+|... .+|+.
T Consensus 323 ~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~-~LP~l~---~~L~~---- 386 (788)
T PRK15387 323 ELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLT-SLPALP---SGLKE---- 386 (788)
T ss_pred cccccccccCcccc-cccc---ccccceEecCCCccCC-CCCCC---cccceehhhccccc-cCcccc---cccce----
Confidence 35555666666653 3321 1356666666666663 44322 34666677777776 345322 22332
Q ss_pred CCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccc
Q 047768 473 RNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGT 552 (1009)
Q Consensus 473 ~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 552 (1009)
|++++|+|++ +|.. .++|+.|++++|+|++ +|... .+|+.|+|++|+|+ .
T Consensus 387 ---------------------LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~ 436 (788)
T PRK15387 387 ---------------------LIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-R 436 (788)
T ss_pred ---------------------EEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-c
Confidence 5555555553 4432 2468888888888884 66543 46788999999998 7
Q ss_pred cccccccccccceEcCCCcccccccccccccc
Q 047768 553 IPQSLSSLTSIKELDLSQNNFSGQIPKYLENL 584 (1009)
Q Consensus 553 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 584 (1009)
+|..++++++|+.|+|++|+|++.+|..+..+
T Consensus 437 LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 437 LPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred cChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 88889999999999999999998888776444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=224.73 Aligned_cols=173 Identities=21% Similarity=0.168 Sum_probs=131.7
Q ss_pred HhccCccCCcccccCCceEEEEEEec-CCeEEEEEEeeccc-----ccchHHHHHHHHHHHhcCCCCcceEEeeeecccc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHE-NGMLVAVKVINLEQ-----KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 772 (1009)
...+|.+.+.||+|+||+||+|.++. +++.||||++.... ......+.+|++++++++|+|++..+..+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 35689999999999999999999875 67888999875321 11245689999999999999998533221
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCC-CCCceeeCCCCce
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDL-KPSNVLLDHDMVA 851 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdl-k~~Nill~~~~~~ 851 (1009)
...++||||+++++|... .. .. ...++.++++||+|||+. +|+|||| ||+||+++.++.+
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~~---------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-RP---------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-Cc---------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCE
Confidence 346899999999999632 11 11 145788999999999999 9999999 9999999999999
Q ss_pred EEeccccccccCCCCCCCccccCCccccccccccccCccccCCC
Q 047768 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG 895 (1009)
Q Consensus 852 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 895 (1009)
||+|||+|+.....................+++.|+|||++...
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999999987654322111111222356788999999987554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-21 Score=214.94 Aligned_cols=270 Identities=22% Similarity=0.246 Sum_probs=197.6
Q ss_pred cCccCCcccccCCceEEEEEEecCC-eEEEEEEeecccccchHHHHHHHHHHHhcCC----CCcceEEeeeeccccCCCc
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENG-MLVAVKVINLEQKGGSKSFAAECEALRSIRH----RNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~~~~~~~~~~ 776 (1009)
+|.+.+.||+|+||.||.|....++ ..+|+|............+..|+.++..+.+ +++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 7999999999999999999987554 6789998765433333378889999998863 57778877642 2346
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC-----Cce
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD-----MVA 851 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-----~~~ 851 (1009)
+.++||+.+ |.+|.++...... ..++..+...|+.|++.+|.++|+. |++||||||.|++++.. ..+
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~----~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPP----GRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCC----CCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence 789999987 8899998876652 2489999999999999999999999 99999999999999865 469
Q ss_pred EEeccccccccC--CCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCcc
Q 047768 852 HVSDFGLAKFLS--ASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLT 929 (1009)
Q Consensus 852 kl~DfGla~~~~--~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~ 929 (1009)
.+.|||+|+... .................+||..|+++.+..+.+.+++.|+||++.++.|+..|..||........
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~- 245 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL- 245 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-
Confidence 999999999432 22111101111113457799999999999999999999999999999999999999864432211
Q ss_pred HHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 930 LHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
..+..... ....... . ....+.++.+++..+-..+..++|....+...+......
T Consensus 246 ~~~~~~~~----~~~~~~~-~--------------~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 246 KSKFEKDP----RKLLTDR-F--------------GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHHHHHHh----hhhcccc-c--------------cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 11111100 0000000 0 011223456666666678999999999999998776654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-21 Score=195.64 Aligned_cols=265 Identities=18% Similarity=0.252 Sum_probs=199.6
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
-.|.++++||+|.||+++.|+.--+++.||||.-.. +....++..|.+..+.+. .++|..++-+. +++.+-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhh
Confidence 379999999999999999999988999999997432 234567888999998884 68888877653 3346678
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC-----ceEEe
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM-----VAHVS 854 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-----~~kl~ 854 (1009)
+|+|.+ |-||.|.+.-++.. ++..++..+|.|+..-++|+|++ .+|.|||||+|+||+..+ .+.++
T Consensus 101 LVidLL-GPSLEDLFD~CgR~-----FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRR-----FSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCc-----ccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEE
Confidence 999988 88999999887764 99999999999999999999999 999999999999997544 68999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccC--CccHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNE--GLTLHE 932 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~--~~~~~~ 932 (1009)
|||+|+.+-+.....-.+. .......||.+||+-....+.+-+.+-|+=|+|=|++..+.|..||.....+ ...+.+
T Consensus 172 DFGmAK~YrDp~TkqHIPY-rE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK 250 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPY-REHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK 250 (449)
T ss_pred eccchhhhcCccccccCcc-ccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH
Confidence 9999998876544332222 3334577999999999999999999999999999999999999999754222 111111
Q ss_pred HHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
+... +|.+.........++++..-+.-.-..+-++-|..+-+..-+..+.
T Consensus 251 IGe~-------------------Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 251 IGET-------------------KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred hccc-------------------cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 1111 1111111222234455666666666677777777766555544443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-21 Score=185.68 Aligned_cols=263 Identities=19% Similarity=0.251 Sum_probs=192.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCC-CCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRH-RNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~ 778 (1009)
...|.++++||.|+||.+|.|....+|..||||+-+... ...++..|.++.+.++| ..|..+..|.. +..+-
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~-----e~~yn 86 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGT-----EKDYN 86 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcc-----ccccc
Confidence 467899999999999999999999999999999864332 24567789999998865 45555554433 33566
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC---CceEEec
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHVSD 855 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~D 855 (1009)
.+||+.. |.||.+.+.-.... ++..+++-.|-|++.-++|+|.+ ++|||||||+|+|++-+ ..+.++|
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~-----ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRR-----FTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhh-----hhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEe
Confidence 8999988 88999998766543 88999999999999999999999 99999999999999754 4689999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccC--CccHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNE--GLTLHEF 933 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~--~~~~~~~ 933 (1009)
||+|+.+.+......... .......||.+|.+-....+.+-+.+-|+=|+|.++..+-.|..||...... ...+.++
T Consensus 158 FGLaKky~d~~t~~HIpy-re~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPY-REDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred ccchhhhccccccccCcc-ccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 999998766543322222 2334567999999999988888899999999999999999999999764322 1222222
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
.+......+..+ ....+.++.-.+.-|-...-++-|...-+.+...
T Consensus 237 ~EkK~s~~ie~L-------------------C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 237 SEKKMSTPIEVL-------------------CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred HHhhcCCCHHHH-------------------hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 222222221111 1122334555566677766677776655544443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-21 Score=232.32 Aligned_cols=215 Identities=21% Similarity=0.389 Sum_probs=173.7
Q ss_pred ccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCc
Q 047768 60 WTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLS 139 (1009)
Q Consensus 60 w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 139 (1009)
|.-..|... +.+.|++++++++. +|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+.
T Consensus 170 ~r~~~Cl~~--~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~ 240 (754)
T PRK15370 170 QRMRDCLKN--NKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP 240 (754)
T ss_pred HHHHhhccc--CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh
Confidence 333467543 57889999999875 455453 57999999999999 7887665 58999999999998 6777664
Q ss_pred CCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccc
Q 047768 140 HCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLA 219 (1009)
Q Consensus 140 ~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 219 (1009)
.+|+.|++++|++. .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|++++|+|++ +|..+. ++|+
T Consensus 241 --~~L~~L~Ls~N~L~-~LP~~l~----s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~ 307 (754)
T PRK15370 241 --DTIQEMELSINRIT-ELPERLP----SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGIT 307 (754)
T ss_pred --ccccEEECcCCccC-cCChhHh----CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHH
Confidence 47999999999998 7888763 58999999999999 5787664 589999999999974 555543 5799
Q ss_pred cccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccc
Q 047768 220 YLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAEN 299 (1009)
Q Consensus 220 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 299 (1009)
.|++++|+++ .+|..+. ++|+.|++++|.++ .+|..+. ++|+.|++++|+|+. +|..+. ++|++|+|++|
T Consensus 308 ~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~L~~-LP~~lp--~~L~~LdLs~N 377 (754)
T PRK15370 308 HLNVQSNSLT-ALPETLP--PGLKTLEAGENALT-SLPASLP---PELQVLDVSKNQITV-LPETLP--PTITTLDVSRN 377 (754)
T ss_pred HHHhcCCccc-cCCcccc--ccceeccccCCccc-cCChhhc---CcccEEECCCCCCCc-CChhhc--CCcCEEECCCC
Confidence 9999999999 5676553 68999999999999 7887663 689999999999984 666553 68999999999
Q ss_pred ccccccc
Q 047768 300 QFRGQVS 306 (1009)
Q Consensus 300 ~l~~~~~ 306 (1009)
+++.+++
T Consensus 378 ~Lt~LP~ 384 (754)
T PRK15370 378 ALTNLPE 384 (754)
T ss_pred cCCCCCH
Confidence 9886543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-18 Score=196.08 Aligned_cols=264 Identities=31% Similarity=0.394 Sum_probs=194.2
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcCCC-CcceEEeeeeccccCCCceE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIRHR-NLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~~~ 778 (1009)
|.+.+.||.|+||.||++.+. ..+|+|.+...... ....+.+|+.+++.+.|+ +++++.++... ....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-----EGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-----CCEE
Confidence 567788999999999999986 78999998655433 256799999999999988 79999998633 2447
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC-ceEEeccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFG 857 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~DfG 857 (1009)
+++++|+.++++.+++...... ..+.......+..+++.++.|+|+. +++|||+||+||+++..+ .++++|||
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg 147 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFG 147 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccC
Confidence 9999999999999777765421 2388899999999999999999999 999999999999999998 79999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCC---CCCCCcccchHHHHHHHHHHhCCCCCcccccC--CccHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG---GEASMRGGVYSYGILLLEIFTRRRPTESMFNE--GLTLHE 932 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~--~~~~~~ 932 (1009)
.++............ .......||..|+|||...+ ..+....|+||+|++++++++|..||...... ......
T Consensus 148 ~~~~~~~~~~~~~~~--~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~ 225 (384)
T COG0515 148 LAKLLPDPGSTSSIP--ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK 225 (384)
T ss_pred cceecCCCCcccccc--ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH
Confidence 998554432110000 12345779999999999888 57889999999999999999999996543321 011111
Q ss_pred HHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
........ ......... ........+.+++..|+..+|..|.++.+....
T Consensus 226 ~~~~~~~~--------~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 226 IILELPTP--------SLASPLSPS------NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHhcCCc--------ccccccCcc------ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111100 000000000 001223457788889999999999999987764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=221.12 Aligned_cols=256 Identities=19% Similarity=0.205 Sum_probs=184.3
Q ss_pred cCCcccccCCceEEEEEEecCCeEEEEEEeecc--cccc----hHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 705 SSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE--QKGG----SKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 705 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
..+.+|.|++|.|+.+.........+.|.+... .... ...+..|.-+-..+.|+|++..+..+... ...
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-----~~~ 396 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-----DGI 396 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-----ccc
Confidence 457899999998888887766666666654321 1111 12255677777788999998877665433 233
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
.-+||||++ +|..++..... +...++-.++.|+..|+.|+|+. ||.|||+|++|++++.+|.+||+|||.
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~------~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGK------LTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGA 466 (601)
T ss_pred hhhhhcccH-HHHHHHhcccc------cchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCc
Confidence 344999999 99999987632 77788889999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCC-CcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEAS-MRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+....-... .......+.+|+..|+|||++.+..|. ...||||.|+++..|++|+.||......+..... ..
T Consensus 467 ~~vf~~~~e----~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~---~~ 539 (601)
T KOG0590|consen 467 ASVFRYPWE----KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT---NN 539 (601)
T ss_pred ceeeccCcc----hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh---hc
Confidence 875543211 111345578899999999999999985 5689999999999999999998765444333200 00
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...... + .... ......-+.+...++.++++.||.+|.|+++|++
T Consensus 540 ~~~~~~-~------~~~~------~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 540 YSDQRN-I------FEGP------NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccc-c------ccCh------HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000000 0 0000 0111233455678899999999999999999975
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-20 Score=216.12 Aligned_cols=250 Identities=21% Similarity=0.223 Sum_probs=175.9
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHH--HHhcCCCCcceEEeeeeccccCCCceE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEA--LRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++...+.+|+++|=.|.+|++. .|. |+||++-..+. -.-+.|.++++- ....+|||++++.-+- ......
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~-----~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVL-----VTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHH-----HhhHHH
Confidence 6777899999999999999986 454 99999954432 233444444333 4455899999987652 223556
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
|+|-+|+.+ +|+|.+..+.- +...+.+.|++|++.|+..+|.. +|+|||||.+||||+.-..+.|+||..
T Consensus 97 ylvRqyvkh-nLyDRlSTRPF------L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRLSTRPF------LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred HHHHHHHhh-hhhhhhccchH------HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccc
Confidence 788888855 99999987764 78889999999999999999999 999999999999999999999999976
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCC----------C-CCCcccchHHHHHHHHHHh-CCCCCcccccC
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG----------E-ASMRGGVYSYGILLLEIFT-RRRPTESMFNE 926 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~ 926 (1009)
-+...-... +..+......+...-..|+|||.+... . .+++.||||+|||++|+++ |++||.-
T Consensus 167 FKPtYLPeD-NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---- 241 (1431)
T KOG1240|consen 167 FKPTYLPED-NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---- 241 (1431)
T ss_pred cCCccCCCC-CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----
Confidence 543322110 101111111112233579999975441 2 5788999999999999999 7888752
Q ss_pred CccHHHHHHHh-----ccch-hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 927 GLTLHEFAKRA-----LPEK-VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 927 ~~~~~~~~~~~-----~~~~-~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
.+..... .++. +..+-| ..+..++..|++.||+.|.+|+++++.-++
T Consensus 242 ----SQL~aYr~~~~~~~e~~Le~Ied----------------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 242 ----SQLLAYRSGNADDPEQLLEKIED----------------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred ----HHHHhHhccCccCHHHHHHhCcC----------------------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 1111110 1111 111111 135688899999999999999999988554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-19 Score=180.72 Aligned_cols=140 Identities=19% Similarity=0.159 Sum_probs=108.1
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeeccccc--c-------h-----------------HHHHHHHHHHHhcCCCC
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--G-------S-----------------KSFAAECEALRSIRHRN 759 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~n 759 (1009)
...||+|+||.||+|... +|+.||||+++..... . . .....|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 8999999999754211 0 0 12234999999998877
Q ss_pred cceEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHH-hhcCCCCceecCC
Q 047768 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL-HHHCQPPIVHGDL 838 (1009)
Q Consensus 760 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivHrdl 838 (1009)
+.....+.. ...++||||++++++........ .+++.+...++.|++.++.|+ |+. +|+||||
T Consensus 81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~------~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl 144 (190)
T cd05147 81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDA------PLSESKARELYLQVIQIMRILYQDC---RLVHADL 144 (190)
T ss_pred CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 644333211 22379999999887765433222 388899999999999999999 687 9999999
Q ss_pred CCCceeeCCCCceEEeccccccccC
Q 047768 839 KPSNVLLDHDMVAHVSDFGLAKFLS 863 (1009)
Q Consensus 839 k~~Nill~~~~~~kl~DfGla~~~~ 863 (1009)
||+||+++ ++.++++|||+|....
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CHHHEEEE-CCcEEEEEccccccCC
Confidence 99999998 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3e-21 Score=177.24 Aligned_cols=184 Identities=29% Similarity=0.507 Sum_probs=141.4
Q ss_pred ccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCcc
Q 047768 388 IANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLM 467 (1009)
Q Consensus 388 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 467 (1009)
+.++.+.+.|.||+|+++ .+|..++.+.+|+.|++++|+++ ..|.+++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 445666777777788777 66667777888888888888887 67777788888888888888877 7777788777777
Q ss_pred ccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCc
Q 047768 468 FFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGN 547 (1009)
Q Consensus 468 ~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N 547 (1009)
.|++..|.+.. ..+|..|..++.|+-|+|+.|.+. .+|..++++++|+.|.+..|
T Consensus 106 vldltynnl~e------------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdn 160 (264)
T KOG0617|consen 106 VLDLTYNNLNE------------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDN 160 (264)
T ss_pred hhhcccccccc------------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccC
Confidence 65555444431 256777888888999999999997 89999999999999999999
Q ss_pred ccccccccccccccccceEcCCCccccccccccccccccc---CceecccccCcccC
Q 047768 548 SFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFL---QYLNLSYNHFEGEV 601 (1009)
Q Consensus 548 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L---~~L~ls~N~l~g~~ 601 (1009)
.+- .+|..++.|+.|++|.+.+|+++ .+|++++++.-+ +.+.+.+|++..+|
T Consensus 161 dll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pI 215 (264)
T KOG0617|consen 161 DLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPI 215 (264)
T ss_pred chh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCChH
Confidence 987 88999999999999999999998 788887776432 34445555554333
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.3e-19 Score=198.50 Aligned_cols=218 Identities=27% Similarity=0.414 Sum_probs=163.2
Q ss_pred HHhcCCCCcceEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 047768 752 LRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQP 831 (1009)
Q Consensus 752 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~ 831 (1009)
|+.+.|.|+.+++|.+... ...++|.+||..|+|.|.+.....+ +++.....+.++++.||.|+|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~-----~d~~F~~s~~rdi~~Gl~ylh~s--- 67 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIK-----LDYFFILSFIRDISKGLAYLHNS--- 67 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccC-----ccHHHHHHHHHHHHHHHHHHhcC---
Confidence 3568999999999998764 6789999999999999999986543 99999999999999999999987
Q ss_pred Cc-eecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCC-------CCCCcccc
Q 047768 832 PI-VHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-------EASMRGGV 903 (1009)
Q Consensus 832 ~i-vHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv 903 (1009)
+| .|+.++++|++++....+|++|||+........ .........-..-|.|||.+... ..+.++||
T Consensus 68 ~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~------~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdi 141 (484)
T KOG1023|consen 68 PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETA------EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDI 141 (484)
T ss_pred cceeeeeeccccceeeeeEEEEechhhhcccccccc------cccccchhHHHHhccCHHHhcccccccccccccccCCe
Confidence 55 999999999999999999999999988765310 00111122245679999987764 14678999
Q ss_pred hHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCC
Q 047768 904 YSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIES 983 (1009)
Q Consensus 904 wS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~d 983 (1009)
||||++++|+++++.||......... .+.+... .+.-..-. ||..... .+...++..++.+||..+
T Consensus 142 Ys~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~-----~~~~~~~~------rP~i~~~--~e~~~~l~~l~~~cw~e~ 207 (484)
T KOG1023|consen 142 YSFGIIMYEILFRSGPFDLRNLVEDP-DEIILRV-----KKGGSNPF------RPSIELL--NELPPELLLLVARCWEEI 207 (484)
T ss_pred ehHHHHHHHHHhccCccccccccCCh-HHHHHHH-----HhcCCCCc------Ccchhhh--hhcchHHHHHHHHhcccC
Confidence 99999999999999999864333222 2222221 11001111 1111111 033446889999999999
Q ss_pred CCCCCCHHHHHHHHHHHHH
Q 047768 984 PFDRMEMTDVVVKLCHARQ 1002 (1009)
Q Consensus 984 p~~Rpt~~evl~~L~~i~~ 1002 (1009)
|+.||++++|-..++.+..
T Consensus 208 P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 208 PEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred hhhCccHHHHHhhhhhhcc
Confidence 9999999999998887665
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-19 Score=183.38 Aligned_cols=175 Identities=13% Similarity=0.133 Sum_probs=134.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHH---------HHHHHHHHHhcCCCCcceEEeeeecc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS---------FAAECEALRSIRHRNLIKIVTICSSI 770 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~ 770 (1009)
..+|...+.+|.|+||.||.+.. ++..+|||+++.......+. +.+|++.+.++.|++|..+.++....
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 57899999999999999999755 46689999997554333322 68999999999999999998875432
Q ss_pred cc---CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC
Q 047768 771 DF---KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH 847 (1009)
Q Consensus 771 ~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~ 847 (1009)
.. .-....++||||++|.+|.++.. ++. ....+++.++..+|.. +++|||++|+||+++.
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 11 11245789999999999988731 222 2456899999999999 9999999999999999
Q ss_pred CCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHH
Q 047768 848 DMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIF 914 (1009)
Q Consensus 848 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ell 914 (1009)
++ ++++|||..+....... ...+.....+..++|+||||+.+.-+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a--------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKA--------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhh--------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 98 99999998875432110 011445556778999999999887654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8e-19 Score=181.84 Aligned_cols=207 Identities=23% Similarity=0.233 Sum_probs=145.2
Q ss_pred CCCCcceEEeeeecc----------------------ccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHH
Q 047768 756 RHRNLIKIVTICSSI----------------------DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLN 813 (1009)
Q Consensus 756 ~h~niv~l~~~~~~~----------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~ 813 (1009)
+|||||++.+++.+. ...+....|+||...+. +|.+|+..+. .+.....-
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-------~s~r~~~~ 345 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-------RSYRTGRV 345 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-------CchHHHHH
Confidence 599999998876432 12335678899988754 9999998765 56667778
Q ss_pred HHHHHHHHHHHHhhcCCCCceecCCCCCceee--CCCC--ceEEeccccccccCCCCCCCccccCCccccccccccccCc
Q 047768 814 IVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL--DHDM--VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAP 889 (1009)
Q Consensus 814 i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill--~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 889 (1009)
+..|+++|+.|||.+ ||.|||+|++|||+ |+|+ ...|+|||++---+... -..+.........|...-|||
T Consensus 346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hG--lqlpy~S~~Vd~GGNa~lmAP 420 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHG--LQLPYESDEVDLGGNAKLMAP 420 (598)
T ss_pred HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccc--cccccccccccCCCcceecch
Confidence 999999999999999 99999999999999 3443 57889999875332211 112222333345678889999
Q ss_pred cccCCCCC------CCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhcccc
Q 047768 890 EYGLGGEA------SMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRV 963 (1009)
Q Consensus 890 E~~~~~~~------~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~ 963 (1009)
|+....+- ..|+|.|+.|.+.||+++...||............+.+ ..+- .
T Consensus 421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe------------~qLP-----------a 477 (598)
T KOG4158|consen 421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE------------SQLP-----------A 477 (598)
T ss_pred hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh------------hhCC-----------C
Confidence 98655321 45899999999999999999999752211111111111 1111 1
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 964 RNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 964 ~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
.+..++..+.+++...++.||.+|+++.-....|.
T Consensus 478 lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 478 LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred CcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 12244556789999999999999999877666653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=175.19 Aligned_cols=140 Identities=21% Similarity=0.175 Sum_probs=110.5
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeecccccc--------------------------hHHHHHHHHHHHhcCCCC
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG--------------------------SKSFAAECEALRSIRHRN 759 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~n 759 (1009)
...||+|++|.||+|.+. +|+.||||+++...... ...+.+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999987 89999999997542110 112457899999999998
Q ss_pred cceEEeeeeccccCCCceEEEEEeccCCCCHHHH-HhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCceecC
Q 047768 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEW-LHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH-HCQPPIVHGD 837 (1009)
Q Consensus 760 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrd 837 (1009)
+.....+.. ...++||||++++++... +... .++..+...++.+++.++.|+|+ . +|+|||
T Consensus 81 i~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~---givHrD 143 (190)
T cd05145 81 VPVPEPILL-------KKNVLVMEFIGDDGSPAPRLKDV-------PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGD 143 (190)
T ss_pred CCCceEEEe-------cCCEEEEEEecCCCchhhhhhhc-------cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence 755444322 124799999988865433 3322 26788899999999999999999 8 999999
Q ss_pred CCCCceeeCCCCceEEeccccccccCC
Q 047768 838 LKPSNVLLDHDMVAHVSDFGLAKFLSA 864 (1009)
Q Consensus 838 lk~~Nill~~~~~~kl~DfGla~~~~~ 864 (1009)
|||+||+++ ++.++++|||+|+....
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecCC
Confidence 999999999 88999999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-20 Score=173.16 Aligned_cols=157 Identities=34% Similarity=0.522 Sum_probs=82.4
Q ss_pred ccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCC
Q 047768 90 VGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFN 169 (1009)
Q Consensus 90 ~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~ 169 (1009)
+.++++.+.|-||+|+++ .+|+.+..|.+|+.|++++|+++ .+|.+++.+++|+.|+++-|++.
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-------------- 92 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-------------- 92 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh--------------
Confidence 445566666777777777 66666777777777777777776 56666666666666666655543
Q ss_pred cCeEeecCccCCCCCCcccCCccccceeecccCccc-CCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhh
Q 047768 170 LQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLW-GKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLY 248 (1009)
Q Consensus 170 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 248 (1009)
..|..|+.++.|++|||++|++. ..+|+.|..++.|+.|+|++|.+. .+|..++++++|+.|.+.
T Consensus 93 -------------~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lr 158 (264)
T KOG0617|consen 93 -------------ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLR 158 (264)
T ss_pred -------------cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeec
Confidence 34444444444555555444443 233444444444444444444443 444444444444444444
Q ss_pred CCccCCCCChhhccCCCcccceeccccccC
Q 047768 249 GNRFTGSLPIEIGKNLPNLRNFVIYTNNFT 278 (1009)
Q Consensus 249 ~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~ 278 (1009)
.|.+. ++|.+++. +..|++|.+.+|+++
T Consensus 159 dndll-~lpkeig~-lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 159 DNDLL-SLPKEIGD-LTRLRELHIQGNRLT 186 (264)
T ss_pred cCchh-hCcHHHHH-HHHHHHHhcccceee
Confidence 44443 34443332 333333333333333
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.6e-18 Score=169.44 Aligned_cols=192 Identities=16% Similarity=0.084 Sum_probs=137.9
Q ss_pred ccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc----chHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCceE
Q 047768 704 SSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG----GSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 704 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.+...|++|+||+||.+.. .+.+++.+.++....- ....+.+|+++|+++. |+++.+++++ ...
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence 4567899999999997765 5778887777543321 1125789999999995 5889999886 345
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCC-CCCceeeCCCCceEEeccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDL-KPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdl-k~~Nill~~~~~~kl~DfG 857 (1009)
+++|||+.|.+|.+.... ....++.+++.++.++|+. ||||||| ||+||+++.++.++|+|||
T Consensus 74 ~lvmeyI~G~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG 137 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR-------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ 137 (218)
T ss_pred EEEEeeecCccHHhhhhh-------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence 899999999998654321 1134778999999999999 9999999 7999999999999999999
Q ss_pred cccccCCCCCC-Ccc---ccCCc-cccccccccccCccccCCC-CCC-CcccchHHHHHHHHHHhCCCCCcc
Q 047768 858 LAKFLSASPLG-NVV---ETPSS-SIGVKGTIGYVAPEYGLGG-EAS-MRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 858 la~~~~~~~~~-~~~---~~~~~-~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
+|........- ... +.... ......++.|++|+...-- ..+ .+.+-++-|.-+|.++||+.|..+
T Consensus 138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 99865432200 000 00000 0112357778888742221 222 556888999999999999998764
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.6e-20 Score=206.52 Aligned_cols=220 Identities=25% Similarity=0.277 Sum_probs=119.7
Q ss_pred hhcccccccceEEccCCCCCCcCchhhhhhcc--cceEEEcCCCcccc----CCCccccCc-CccCEEEccCCCCCCCCC
Q 047768 337 DLLTNCTKLQYLYLADNGFGGVLPHSIANLST--ALIDFNLGKNQIYG----TIPPGIANL-VNLNSLRMEANRLTGTIP 409 (1009)
Q Consensus 337 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--~L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~~p 409 (1009)
..+..+++|++|++++|.+.+..+..+..+.. .|++|++++|++++ .+...+..+ ++|+.|++++|.+++..+
T Consensus 75 ~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~ 154 (319)
T cd00116 75 QGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASC 154 (319)
T ss_pred HHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHH
Confidence 44556677777777777776555555544422 15555555555542 112223333 455555555555542111
Q ss_pred CCcCCcccccceecccccccCCCCcccccccccccccccCcccccc----cCCCCCCCCCccccccCCCCccCCCchhhh
Q 047768 410 HVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGN----IPFSLGNCKNLMFFFAPRNKLTGALPQQIL 485 (1009)
Q Consensus 410 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~ 485 (1009)
. .++..+..++.|++|++++|.+++. ++..+..+++|+.|++++|.+++....
T Consensus 155 ~--------------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~--- 211 (319)
T cd00116 155 E--------------------ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS--- 211 (319)
T ss_pred H--------------------HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH---
Confidence 1 1122233334455555555544421 112222233444444444433311111
Q ss_pred hhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccC-----CCCccEEEecCcccc----cccccc
Q 047768 486 EITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGA-----CTSLEYVELQGNSFS----GTIPQS 556 (1009)
Q Consensus 486 ~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~----~~~p~~ 556 (1009)
.++..+..+++|++|++++|.+++.....+.. .+.|+.|++++|.++ ..+...
T Consensus 212 ------------------~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~ 273 (319)
T cd00116 212 ------------------ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEV 273 (319)
T ss_pred ------------------HHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHH
Confidence 11223455678888888888887533333322 378888888888886 234455
Q ss_pred cccccccceEcCCCcccccc----cccccccc-cccCceecccccC
Q 047768 557 LSSLTSIKELDLSQNNFSGQ----IPKYLENL-SFLQYLNLSYNHF 597 (1009)
Q Consensus 557 ~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~ls~N~l 597 (1009)
+..+++|+++|+++|.++.. +...+... +.|+.+|+.+|++
T Consensus 274 ~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 274 LAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 66678899999999999844 45555555 7888888888864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.9e-18 Score=202.00 Aligned_cols=157 Identities=31% Similarity=0.518 Sum_probs=132.6
Q ss_pred hcCChhhHHHHHHHHHhcCCCCCCCCCCccCCCCCCCCCccceeeCCC--C--CeEEEEEeecCCcccccCccccCCCCC
Q 047768 21 ALSNETDCLSLLAIKSQLHDPLGVTSSWNRSACVNLCQHWTGVTCGRR--N--QRVTKLDLRNQSIGGILSPYVGNLSFL 96 (1009)
Q Consensus 21 ~~~~~~d~~aLl~~k~~~~~~~~~~~sW~~~~~~~~c~~w~gv~C~~~--~--~~v~~l~l~~~~l~~~~~~~~~~l~~L 96 (1009)
..+.++|..||++||+++.+|.. .+|+++.|.+.++.|.||.|+.. . .+|+.|+|+++++.|.+|+.++.+++|
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L 444 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR--FGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL 444 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc--CCCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence 34567899999999999877643 48988777655558999999532 2 369999999999999999999999999
Q ss_pred CeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeec
Q 047768 97 RYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVG 176 (1009)
Q Consensus 97 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~ 176 (1009)
++|+|++|.++|.+|..++.+++|+.|||++|+++|.+|..++++++|++|+|++|+++|.+|..+. ..+.++..+++.
T Consensus 445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~-~~~~~~~~l~~~ 523 (623)
T PLN03150 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG-GRLLHRASFNFT 523 (623)
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHh-hccccCceEEec
Confidence 9999999999999999999999999999999999999999999999999999999999999888764 223455566666
Q ss_pred CccC
Q 047768 177 DNQL 180 (1009)
Q Consensus 177 ~n~l 180 (1009)
+|..
T Consensus 524 ~N~~ 527 (623)
T PLN03150 524 DNAG 527 (623)
T ss_pred CCcc
Confidence 6653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.2e-18 Score=179.45 Aligned_cols=240 Identities=21% Similarity=0.250 Sum_probs=149.1
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcC----------CCCcceEEeeee
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIR----------HRNLIKIVTICS 768 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~----------h~niv~l~~~~~ 768 (1009)
.+...+.||.|+++.||.+++.++++++|||++...... ..+.+++|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 445567899999999999999999999999999655422 2345666554443321 222222222221
Q ss_pred ccc-------cCCCc-----eEEEEEeccCCCCHHHHHhc---cCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 047768 769 SID-------FKGVD-----FKALVYEYMQNGSLEEWLHQ---RDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPI 833 (1009)
Q Consensus 769 ~~~-------~~~~~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 833 (1009)
... ..+.. ..+++|+-+ .+||.+++.. .... ...+....+..+..|+.+.+++||+. |+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~---Gl 166 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSY---GL 166 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhc---ce
Confidence 110 00001 235677777 6688887653 2211 11234455677889999999999999 99
Q ss_pred eecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCC--------CCCCCcccchH
Q 047768 834 VHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG--------GEASMRGGVYS 905 (1009)
Q Consensus 834 vHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwS 905 (1009)
||+||+|+|++++.+|.++++||+.....+... .....+..|.+||.... -.++.+.|.|+
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCcee-----------eccCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 999999999999999999999999877554311 11234578999997533 25788999999
Q ss_pred HHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCC
Q 047768 906 YGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPF 985 (1009)
Q Consensus 906 ~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~ 985 (1009)
+|+++|.|+.|+.||+.......... .++.| . +.++.+..++...++.+|.
T Consensus 236 LG~~ly~lWC~~lPf~~~~~~~~~~~-------------~f~~C---------------~-~~Pe~v~~LI~~lL~~~~~ 286 (288)
T PF14531_consen 236 LGITLYSLWCGRLPFGLSSPEADPEW-------------DFSRC---------------R-DMPEPVQFLIRGLLQRNPE 286 (288)
T ss_dssp HHHHHHHHHHSS-STCCCGGGSTSGG-------------GGTTS---------------S----HHHHHHHHHHT-SSGG
T ss_pred HHHHHHHHHHccCCCCCCCccccccc-------------cchhc---------------C-CcCHHHHHHHHHHccCCcc
Confidence 99999999999999985432211100 11111 1 4456688999999999999
Q ss_pred CC
Q 047768 986 DR 987 (1009)
Q Consensus 986 ~R 987 (1009)
+|
T Consensus 287 ~R 288 (288)
T PF14531_consen 287 DR 288 (288)
T ss_dssp GS
T ss_pred cC
Confidence 88
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.2e-17 Score=166.94 Aligned_cols=139 Identities=18% Similarity=0.272 Sum_probs=107.6
Q ss_pred ccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-----CCCCcceEEeeeeccccCCCce-
Q 047768 704 SSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-----RHRNLIKIVTICSSIDFKGVDF- 777 (1009)
Q Consensus 704 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~~~~~~~- 777 (1009)
.-.+.||+|+||.||. +..++.. +||++........+.+.+|+++++.+ .||||++++|++... .+.+.
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~--~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD--CGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC--CCCeEE
Confidence 3457899999999995 5555555 69998765444567899999999999 579999999997653 12233
Q ss_pred EEEEEec--cCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHH-HHHhhcCCCCceecCCCCCceeeCC----CCc
Q 047768 778 KALVYEY--MQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV-EYLHHHCQPPIVHGDLKPSNVLLDH----DMV 850 (1009)
Q Consensus 778 ~~lv~e~--~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~ivHrdlk~~Nill~~----~~~ 850 (1009)
..+|+|| +.+|+|.+++++.. +++. ..++.+++.++ +|||++ +||||||||+||+++. ++.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~-------~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~ 147 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCR-------YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVI 147 (210)
T ss_pred EEEEecCCCCcchhHHHHHHccc-------ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCc
Confidence 3478999 55799999997632 4444 35677888777 999999 9999999999999974 348
Q ss_pred eEEeccccc
Q 047768 851 AHVSDFGLA 859 (1009)
Q Consensus 851 ~kl~DfGla 859 (1009)
++|+||+.+
T Consensus 148 ~~LiDg~G~ 156 (210)
T PRK10345 148 PVVCDNIGE 156 (210)
T ss_pred EEEEECCCC
Confidence 999995544
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.5e-19 Score=201.43 Aligned_cols=284 Identities=21% Similarity=0.247 Sum_probs=131.1
Q ss_pred cccccccccC-CCCCCCCcCCCcCcEEecccccccCCCchHHh--hhccCCcCeEeecCccCCC------CCCcccCCcc
Q 047768 122 TLVLANNSFS-GRIPTNLSHCSKLITFSAHRNNLVGEIPEELI--SRRLFNLQGLSVGDNQLTG------QLPASIGNLS 192 (1009)
Q Consensus 122 ~L~Ls~N~l~-~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~--~~~l~~L~~L~L~~n~l~~------~~p~~~~~l~ 192 (1009)
.|+|+.+.++ ...+..+..+.+|+.|+++.+.++..-...+. ....++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4667777776 33444555566666666666666432111111 0233445566666555541 1223344455
Q ss_pred ccceeecccCcccCCCCcccccccc---cccccccCccCCCC----CCCcccCCChHHHHHhhCCccCCCCChhhccCCC
Q 047768 193 ALRVIDIRTNRLWGKIPITLSQLTS---LAYLHVGDNHFSGT----IPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLP 265 (1009)
Q Consensus 193 ~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~ 265 (1009)
+|+.|++++|.+.+..+..+..+.+ |++|++++|++++. +...+..+ .+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~------------------------~~ 137 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDL------------------------PP 137 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhC------------------------CC
Confidence 5555555555554444444444333 55555555554420 11111222 14
Q ss_pred cccceeccccccCCC----CCCCcCccccccccccccccccccc----ccccccccccccccccccccCCCCCCCcchhh
Q 047768 266 NLRNFVIYTNNFTGS----LPDSFSNASNLEVLHLAENQFRGQV----SINFNGLKDLSMLGLATNFLGNGAANDLDFVD 337 (1009)
Q Consensus 266 ~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 337 (1009)
+|+.|++++|.+++. ++..+..+++|++|++++|.+++.. ...+...++|+.|++++|.+..... ..+..
T Consensus 138 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~--~~l~~ 215 (319)
T cd00116 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA--SALAE 215 (319)
T ss_pred CceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH--HHHHH
Confidence 555555555555521 2233445556666666666655311 1122233345555555554432211 11223
Q ss_pred hcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCC----CCCCCcC
Q 047768 338 LLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTG----TIPHVIG 413 (1009)
Q Consensus 338 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~ 413 (1009)
.+..+++|++|++++|.+++.....+.... ....+.|+.|++++|.++. .+...+.
T Consensus 216 ~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~--------------------~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~ 275 (319)
T cd00116 216 TLASLKSLEVLNLGDNNLTDAGAAALASAL--------------------LSPNISLLTLSLSCNDITDDGAKDLAEVLA 275 (319)
T ss_pred HhcccCCCCEEecCCCcCchHHHHHHHHHH--------------------hccCCCceEEEccCCCCCcHHHHHHHHHHh
Confidence 445556666666666666543222222211 0012455555555555541 1222333
Q ss_pred CcccccceecccccccCC----CCcccccc-cccccccccCcc
Q 047768 414 ELKNLQLLHLHANFLQGT----IPSSLGNL-TLLTYLSFGANN 451 (1009)
Q Consensus 414 ~l~~L~~L~L~~N~l~~~----~p~~~~~l-~~L~~L~L~~N~ 451 (1009)
.+++|+++++++|.++.. ....+... +.|++|++.+|.
T Consensus 276 ~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 276 EKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred cCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence 445566666666666532 22222333 456666666554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5e-17 Score=193.44 Aligned_cols=198 Identities=23% Similarity=0.283 Sum_probs=155.3
Q ss_pred HHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC---CCCcceEEeeeeccccC
Q 047768 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR---HRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~ 773 (1009)
......|.+.+.+|+|+||.||+|.... |+.||+|+-+.. ...+|.--.+++.+++ -+.|..+..++. +.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~---~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~---~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPP---NPWEFYICLQVMERLKPQMLPSIMHISSAHV---FQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCC---CceeeeehHHHHHhhchhhhcchHHHHHHHc---cC
Confidence 3445678888999999999999999874 999999986433 2344444445556665 122333332221 22
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC------
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH------ 847 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~------ 847 (1009)
+.-++|+||.+.|+|.+++...+ .++|.-+..+..|+++.+++||.. +|||+||||+|+++..
T Consensus 767 --~~S~lv~ey~~~Gtlld~~N~~~------~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~ 835 (974)
T KOG1166|consen 767 --NASVLVSEYSPYGTLLDLINTNK------VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADS 835 (974)
T ss_pred --CcceeeeeccccccHHHhhccCC------CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCC
Confidence 44579999999999999998544 389999999999999999999999 9999999999999942
Q ss_pred -CCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCC
Q 047768 848 -DMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR 918 (1009)
Q Consensus 848 -~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~ 918 (1009)
...++|+|||.+.++..-+. .....+.++|-.+-.+|...+..++.++|.|.++.+++-|+.|+.
T Consensus 836 ~~~~l~lIDfG~siDm~lfp~------~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 836 DSKGLYLIDFGRSIDMKLFPD------GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceEEEecccceeeeEcCC------CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 34699999999987754321 124456788999999999999999999999999999999999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=9e-17 Score=168.19 Aligned_cols=145 Identities=19% Similarity=0.162 Sum_probs=112.8
Q ss_pred hccCccCCcccccCCceEEEEE-EecCCeEEEEEEeeccccc------------------------chHHHHHHHHHHHh
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGV-LHENGMLVAVKVINLEQKG------------------------GSKSFAAECEALRS 754 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~ 754 (1009)
..-|.+.+.||+|+||.||+|. ...+|+.||||+++..... ....+.+|++.+.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458889999999999999998 5568999999998643210 01235689999999
Q ss_pred cCCC--CcceEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 047768 755 IRHR--NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPP 832 (1009)
Q Consensus 755 l~h~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ 832 (1009)
+.+. .+.+++++ ...++||||++++++..+..... .....+...++.|++.++.|||+. +
T Consensus 107 L~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---g 168 (237)
T smart00090 107 LYEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDV------EPEEEEEFELYDDILEEMRKLYKE---G 168 (237)
T ss_pred HHhcCCCCCeeeEe---------cCceEEEEEecCCcccccccccC------CcchHHHHHHHHHHHHHHHHHHhc---C
Confidence 9753 34444443 22479999999988876543322 255666789999999999999999 8
Q ss_pred -ceecCCCCCceeeCCCCceEEeccccccccC
Q 047768 833 -IVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863 (1009)
Q Consensus 833 -ivHrdlk~~Nill~~~~~~kl~DfGla~~~~ 863 (1009)
|+||||||+||+++ ++.++++|||.|....
T Consensus 169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999999999 8899999999987543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-17 Score=185.63 Aligned_cols=187 Identities=25% Similarity=0.306 Sum_probs=152.6
Q ss_pred cccccCCceEEEEEE---ecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCceEEEE
Q 047768 708 TIGRGSFGFVYKGVL---HENGMLVAVKVINLEQKG--GSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDFKALV 781 (1009)
Q Consensus 708 ~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv 781 (1009)
.+|+|+||.|+.+.- .+.|..+|+|+.+..... .......|..++..++ ||.++++.-. ++.....+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence 379999999997543 245778899888543221 1124456777888886 9999998765 3444678899
Q ss_pred EeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccc
Q 047768 782 YEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861 (1009)
Q Consensus 782 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~ 861 (1009)
++|..+|++...+..... ++......+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+.+.
T Consensus 76 ld~~rgg~lft~l~~~~~------f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske 146 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVM------FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKE 146 (612)
T ss_pred hhhcccchhhhccccCCc------hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhH
Confidence 999999999988877664 77888888999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
.-.... .+||..|||||++. ....++|-||||++++||+||..||..
T Consensus 147 ~v~~~~------------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 147 AVKEKI------------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hHhhhh------------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 643211 27999999999988 567789999999999999999999975
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.6e-17 Score=180.70 Aligned_cols=129 Identities=30% Similarity=0.500 Sum_probs=111.0
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
.+.++.|++|+..+|.+++..++.. ..-++.....++.|++.|++| + +.+|||+||.||+...+..+||.|
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~---e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTG---EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcc---cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhh
Confidence 3578999999999999999865542 347788899999999999999 6 899999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt 915 (1009)
||+........ ...+.....+...||..||+||.+.+..|+.++||||+|++++|+++
T Consensus 400 Fgl~ts~~~~~--~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 400 FGLVTSQDKDE--TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhheeecccCC--cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99998776543 22223345566789999999999999999999999999999999997
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-15 Score=155.93 Aligned_cols=144 Identities=24% Similarity=0.236 Sum_probs=111.1
Q ss_pred HHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc----------------------chHHHHHHHHHH
Q 047768 695 ELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG----------------------GSKSFAAECEAL 752 (1009)
Q Consensus 695 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l 752 (1009)
++......|.+.+.||+|+||.||+|... +|+.||||+++..... ......+|..++
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 33344445888899999999999999885 7999999987643210 012367788999
Q ss_pred HhcCCCC--cceEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 047768 753 RSIRHRN--LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQ 830 (1009)
Q Consensus 753 ~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ 830 (1009)
.++.|++ +...++. ...++||||+++++|.+.... .....++.+++.++.++|+.
T Consensus 88 ~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~~-- 144 (198)
T cd05144 88 KALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYKH-- 144 (198)
T ss_pred HHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHHC--
Confidence 9998774 4444432 345899999999998765321 23456889999999999998
Q ss_pred CCceecCCCCCceeeCCCCceEEeccccccccC
Q 047768 831 PPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863 (1009)
Q Consensus 831 ~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~ 863 (1009)
+|+||||||+||++++++.++|+|||++....
T Consensus 145 -gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 145 -GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred -CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.7e-15 Score=156.11 Aligned_cols=134 Identities=23% Similarity=0.345 Sum_probs=109.8
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeeccccc--------chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--------GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
+.||+|++|.||+|.+ .|..|+||+....... ....+.+|++++..++|+++.....++... ...
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence 5799999999999987 5778999986533211 123577899999999999887666654322 456
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++++|.+++.... . ++..++.+++.++.++|+. +++|||++|+||+++ ++.++++|||.
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~---------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNG---------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred EEEEEEeCCcCHHHHHHhcc---------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence 89999999999999986532 2 7788999999999999999 999999999999999 78999999998
Q ss_pred ccc
Q 047768 859 AKF 861 (1009)
Q Consensus 859 a~~ 861 (1009)
++.
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.2e-16 Score=183.45 Aligned_cols=172 Identities=30% Similarity=0.375 Sum_probs=127.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
..+|..++.+..|+||.||..+++.+.+++|+|+=+ + .- +++ ||..+.+ ..+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q-----~l------ilR-----nilt~a~-----------npf 133 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-Q-----NL------ILR-----NILTFAG-----------NPF 133 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-c-----ch------hhh-----ccccccC-----------Ccc
Confidence 357888999999999999999999899999995421 1 11 111 2333322 223
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+| |+..+.++..+. ++. +++.+++|+|+. +|||||+||+|.+|+.-|++|++|||+.
T Consensus 134 vv------gDc~tllk~~g~------lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 134 VV------GDCATLLKNIGP------LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLS 190 (1205)
T ss_pred ee------chhhhhcccCCC------Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhh
Confidence 33 666666665442 332 237889999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCc-------cccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 860 KFLSASPLGNV-------VETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 860 ~~~~~~~~~~~-------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
+..--...... ....-.....+||+.|+|||++....|+..+|.|++|+++||.+.|+.||..
T Consensus 191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG 260 (1205)
T KOG0606|consen 191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 260 (1205)
T ss_pred hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC
Confidence 76432111000 0011122356899999999999999999999999999999999999999874
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.2e-15 Score=176.10 Aligned_cols=137 Identities=27% Similarity=0.325 Sum_probs=108.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc--cc------cchHHHHHHHHHHHhcCCCCcceEEeeeeccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE--QK------GGSKSFAAECEALRSIRHRNLIKIVTICSSID 771 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 771 (1009)
...|...+.||+|+||+||+|.+. +..+++|+.... .. ...+.+.+|++++++++|++++....++...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~- 408 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP- 408 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-
Confidence 345566789999999999999885 334555543211 11 1124688999999999999998877665432
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCce
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 851 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 851 (1009)
...++||||+++++|.+++. ....++.++++++.|||+. +++|||+||+||++ .++.+
T Consensus 409 ----~~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~ 466 (535)
T PRK09605 409 ----EEKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRL 466 (535)
T ss_pred ----CCCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcE
Confidence 34689999999999999875 2356899999999999999 99999999999999 67899
Q ss_pred EEeccccccc
Q 047768 852 HVSDFGLAKF 861 (1009)
Q Consensus 852 kl~DfGla~~ 861 (1009)
+|+|||+++.
T Consensus 467 ~liDFGla~~ 476 (535)
T PRK09605 467 YLIDFGLGKY 476 (535)
T ss_pred EEEeCccccc
Confidence 9999999974
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.59 E-value=8e-15 Score=151.03 Aligned_cols=130 Identities=25% Similarity=0.382 Sum_probs=102.7
Q ss_pred cccccCCceEEEEEEecCCeEEEEEEeeccccc--------chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--------GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 708 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.||+|+||.||+|.+ ++..|++|+....... ....+.+|+++++.++|+++.....++.. ....+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-----PDNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-----CCCCE
Confidence 389999999999986 5788999986432211 12457789999999988765444433322 13458
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++.... . .++.+++.++.++|+. +++|||++|+||+++ ++.++++|||.+
T Consensus 74 lv~e~~~g~~l~~~~~~~~-------~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN-------D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred EEEEEECCccHHHHHhhcH-------H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 9999999999998875421 1 7899999999999999 999999999999999 899999999988
Q ss_pred cc
Q 047768 860 KF 861 (1009)
Q Consensus 860 ~~ 861 (1009)
+.
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 64
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.5e-15 Score=176.00 Aligned_cols=112 Identities=38% Similarity=0.639 Sum_probs=84.5
Q ss_pred CCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceeccc
Q 047768 515 LVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSY 594 (1009)
Q Consensus 515 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 594 (1009)
++.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..++.+++|+.|||++|+++|.+|..++++++|++|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 56777777777777777777788888888888888777887788888888888888888887888888888888888888
Q ss_pred ccCcccCCCC--CcccCccccccccCCCcCCCCC
Q 047768 595 NHFEGEVPTK--GIFKNKTGFSIVGNGKLCGGLD 626 (1009)
Q Consensus 595 N~l~g~~p~~--~~~~~~~~~~~~~n~~lc~~~~ 626 (1009)
|+++|.+|.. ..+.......+.+|+.+||.+.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCCC
Confidence 8888887763 1122334566788889998653
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.54 E-value=4e-16 Score=169.34 Aligned_cols=176 Identities=28% Similarity=0.429 Sum_probs=130.0
Q ss_pred ccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEe
Q 047768 416 KNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLD 495 (1009)
Q Consensus 416 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~ 495 (1009)
..-...||+.|++. .+|..++.+..|+.+.|.+|.+. .+|..++++..|++++++.|+++ .+|..++.+.-. .|-
T Consensus 75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLk--vli 149 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLK--VLI 149 (722)
T ss_pred cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcce--eEE
Confidence 33344555555555 45555555555555555555555 45555555555555555555555 455544443211 277
Q ss_pred cCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCccccc
Q 047768 496 LSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSG 575 (1009)
Q Consensus 496 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 575 (1009)
+++|+++ .+|..++.+..|..||.+.|++. .+|..++++.+|+.|++..|++. .+|..++.| .|..||+|.|+++
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis- 224 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS- 224 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-
Confidence 7888887 78999999999999999999998 78999999999999999999998 778888865 4899999999998
Q ss_pred ccccccccccccCceecccccCcccC
Q 047768 576 QIPKYLENLSFLQYLNLSYNHFEGEV 601 (1009)
Q Consensus 576 ~~p~~~~~l~~L~~L~ls~N~l~g~~ 601 (1009)
.||-.|.+|+.|++|-|.+|+|+.+.
T Consensus 225 ~iPv~fr~m~~Lq~l~LenNPLqSPP 250 (722)
T KOG0532|consen 225 YLPVDFRKMRHLQVLQLENNPLQSPP 250 (722)
T ss_pred ecchhhhhhhhheeeeeccCCCCCCh
Confidence 89999999999999999999998543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.7e-14 Score=143.67 Aligned_cols=136 Identities=23% Similarity=0.265 Sum_probs=97.7
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeecccccc--hHH----------------------HHHHHHHHHhcCCC--C
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG--SKS----------------------FAAECEALRSIRHR--N 759 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~--n 759 (1009)
.+.||+|+||+||+|... +|+.||||+++...... ... ...|.+.+.++.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999986 78999999986432211 111 13455566666433 2
Q ss_pred cceEEeeeeccccCCCceEEEEEeccCCCCHHH-HHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCceecC
Q 047768 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEE-WLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH-HCQPPIVHGD 837 (1009)
Q Consensus 760 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrd 837 (1009)
+.+.+++ ...++||||++++++.. .+.... .. .+...++.+++.++.++|. . +|+|||
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D 140 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-------LL-EDPEELYDQILELMRKLYREA---GLVHGD 140 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence 4444443 23589999999854321 111111 11 4567899999999999999 7 999999
Q ss_pred CCCCceeeCCCCceEEeccccccccC
Q 047768 838 LKPSNVLLDHDMVAHVSDFGLAKFLS 863 (1009)
Q Consensus 838 lk~~Nill~~~~~~kl~DfGla~~~~ 863 (1009)
|||+||+++ ++.++++|||.+....
T Consensus 141 l~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 141 LSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred CChhhEEEE-CCcEEEEECccccccc
Confidence 999999999 9999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.6e-13 Score=141.45 Aligned_cols=139 Identities=17% Similarity=0.136 Sum_probs=105.6
Q ss_pred CCccc-ccCCceEEEEEEecCCeEEEEEEeeccc-------------ccchHHHHHHHHHHHhcCCCCc--ceEEeeeec
Q 047768 706 SNTIG-RGSFGFVYKGVLHENGMLVAVKVINLEQ-------------KGGSKSFAAECEALRSIRHRNL--IKIVTICSS 769 (1009)
Q Consensus 706 ~~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~ 769 (1009)
...+| .|+.|+||.+... +..+|||.+.... ......+.+|++++.+++|+++ ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35687 8999999999774 7789999885311 1123567889999999998775 667766432
Q ss_pred cccCCCceEEEEEeccCC-CCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC
Q 047768 770 IDFKGVDFKALVYEYMQN-GSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD 848 (1009)
Q Consensus 770 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 848 (1009)
. .......++|+||+++ .+|.+++.... ++.. .+.+++.++.+||+. ||+||||||+|||++.+
T Consensus 114 ~-~~~~~~~~lV~e~l~G~~~L~~~l~~~~-------l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~ 178 (239)
T PRK01723 114 R-HGLFYRADILIERIEGARDLVALLQEAP-------LSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPD 178 (239)
T ss_pred e-cCcceeeeEEEEecCCCCCHHHHHhcCC-------CCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCC
Confidence 1 1111234699999997 69999886532 4443 356899999999999 99999999999999999
Q ss_pred CceEEeccccccc
Q 047768 849 MVAHVSDFGLAKF 861 (1009)
Q Consensus 849 ~~~kl~DfGla~~ 861 (1009)
+.++++|||.++.
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 9999999998874
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-15 Score=165.18 Aligned_cols=178 Identities=29% Similarity=0.452 Sum_probs=116.8
Q ss_pred EEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcc
Q 047768 372 DFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANN 451 (1009)
Q Consensus 372 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 451 (1009)
..||+.|++. .+|..+..+..|+.+.|.+|.|. .+|..++++..|++|||+.|+++ ..|..++.|+ |+.|-+++|+
T Consensus 79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNk 154 (722)
T KOG0532|consen 79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNK 154 (722)
T ss_pred hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCc
Confidence 3455555555 55666666666666666666666 66666666666666666666666 5566666555 6666666666
Q ss_pred cccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccc
Q 047768 452 LQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPV 531 (1009)
Q Consensus 452 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 531 (1009)
++ .+|..++.+..|.. ||.+.|++. .+|..++++.+|+.|.+..|++. .+|+
T Consensus 155 l~-~lp~~ig~~~tl~~-------------------------ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~ 206 (722)
T KOG0532|consen 155 LT-SLPEEIGLLPTLAH-------------------------LDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPE 206 (722)
T ss_pred cc-cCCcccccchhHHH-------------------------hhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCH
Confidence 66 55665655555444 445555554 56667777777777777777776 5666
Q ss_pred cccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccc
Q 047768 532 TLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENL 584 (1009)
Q Consensus 532 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 584 (1009)
++. .-.|..||+|.|+++ .+|-.|.+|+.|++|-|.+|.|. ..|..++..
T Consensus 207 El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~k 256 (722)
T KOG0532|consen 207 ELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEK 256 (722)
T ss_pred HHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhc
Confidence 666 345777777777777 77777777777777777777776 556555433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.8e-13 Score=131.86 Aligned_cols=136 Identities=21% Similarity=0.252 Sum_probs=110.9
Q ss_pred cCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCC--CCcceEEeeeeccccCCCceEEEEE
Q 047768 705 SSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRH--RNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 705 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.+.+|+|.++.||++... +..+++|....... ...+.+|+..++.++| ..+.+++++... .+..++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-----~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGES-----DGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCccEEEE
Confidence 3577999999999999985 47899999854332 4678999999999976 588888877543 25689999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||++++.+..+ +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.++..
T Consensus 73 e~~~g~~~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 73 EWIEGETLDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred EecCCeecccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 99988766543 34566778999999999999864457999999999999999999999999998743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=8.3e-15 Score=172.16 Aligned_cols=257 Identities=22% Similarity=0.244 Sum_probs=183.9
Q ss_pred hccCccCCcccccCCceEEEEEEe-cCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLH-ENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~ 775 (1009)
...|...+.||+|+|+.|-.+... .....+|+|.+.... ....+....|..+=+.+. |+|++++++... ..
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~-----~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS-----SP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC-----CC
Confidence 346777788999999999888764 334567777765443 122344455777666675 999999998754 34
Q ss_pred ceEEEEEeccCCCCHHHHH-hccCCCCCccCCCHHHHHHHHHHHHHHHHHHh-hcCCCCceecCCCCCceeeCCCC-ceE
Q 047768 776 DFKALVYEYMQNGSLEEWL-HQRDDQLGICNLSLIQRLNIVIDVASAVEYLH-HHCQPPIVHGDLKPSNVLLDHDM-VAH 852 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l-~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivHrdlk~~Nill~~~~-~~k 852 (1009)
...+++.||..++++.+.+ +.... ..+......+..|+..++.|+| .. ++.|||+||+|.+++..+ ..+
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~-----~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~ 165 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDST-----GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALK 165 (601)
T ss_pred cccccccCcccccccccccccCCcc-----CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCccc
Confidence 7789999999999998888 43321 2566677789999999999999 77 999999999999999999 999
Q ss_pred EeccccccccCCCCCCCccccCCccccccc-cccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccH
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKG-TIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL 930 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~ 930 (1009)
++|||+|..+.... .........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......+...
T Consensus 166 ~~df~~At~~~~~~-----g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~ 240 (601)
T KOG0590|consen 166 IADFGLATAYRNKN-----GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY 240 (601)
T ss_pred CCCchhhccccccC-----CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc
Confidence 99999998776511 11233344667 9999999998884 44788999999999999999999988665554343
Q ss_pred HHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 047768 931 HEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVV 994 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl 994 (1009)
..|........ . ..+. .......++...++..+|..|.+..++.
T Consensus 241 ~~~~~~~~~~~--------~----------~~~~--~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 241 SSWKSNKGRFT--------Q----------LPWN--SISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred eeecccccccc--------c----------Cccc--cCChhhhhcccccccCCchhcccccccc
Confidence 33332210000 0 0000 0111244666677778888888877764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=5e-13 Score=136.28 Aligned_cols=162 Identities=22% Similarity=0.379 Sum_probs=123.0
Q ss_pred HHHhcCCCCcceEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 047768 751 ALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQ 830 (1009)
Q Consensus 751 ~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ 830 (1009)
-+-++.|.|+++++.|+++..+.+......+.|||..|++.++|++.... ...+......+|+-||..||.|||+ |.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~--~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN--QKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh--hhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 34455799999999999887676667778899999999999999875432 3347778888999999999999998 58
Q ss_pred CCceecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHH
Q 047768 831 PPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILL 910 (1009)
Q Consensus 831 ~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl 910 (1009)
|+|+|+++..+-|++..+|-+|+.---......... .. .........+-++|.|||+-.....+.++|||+||+..
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~--~~--~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVN--ST--REAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhh--hh--hHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 899999999999999999999984211111110000 00 00111123467899999997777788899999999999
Q ss_pred HHHHhCCCC
Q 047768 911 LEIFTRRRP 919 (1009)
Q Consensus 911 ~elltg~~p 919 (1009)
.||..+..-
T Consensus 273 lemailEiq 281 (458)
T KOG1266|consen 273 LEMAILEIQ 281 (458)
T ss_pred HHHHHheec
Confidence 999988663
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.3e-13 Score=154.77 Aligned_cols=181 Identities=35% Similarity=0.516 Sum_probs=103.7
Q ss_pred cCccCEEEccCCCCCCCCCCCcCCcc-cccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCcccc
Q 047768 391 LVNLNSLRMEANRLTGTIPHVIGELK-NLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFF 469 (1009)
Q Consensus 391 l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l 469 (1009)
++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+..++|+.|
T Consensus 115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L 191 (394)
T COG4886 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL 191 (394)
T ss_pred ccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence 345555555555555 4444444443 5666666666665 44445556666666666666665 344444344444444
Q ss_pred ccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccc
Q 047768 470 FAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSF 549 (1009)
Q Consensus 470 ~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 549 (1009)
++++|+++ .+|..+..+..|++|++++|.+. .++..+.++.++..|.+++|++
T Consensus 192 ~ls~N~i~--------------------------~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~ 244 (394)
T COG4886 192 DLSGNKIS--------------------------DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL 244 (394)
T ss_pred eccCCccc--------------------------cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCcee
Confidence 44444433 33433344445666666666433 4556666666666666666666
Q ss_pred ccccccccccccccceEcCCCcccccccccccccccccCceecccccCcccCCCC
Q 047768 550 SGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK 604 (1009)
Q Consensus 550 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 604 (1009)
. .++..++.+++|++|++++|+++ .++. ++.+.+|+.|++++|.+....|..
T Consensus 245 ~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 245 E-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred e-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhh
Confidence 5 33566666677777777777776 3333 666777777777777776655543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.6e-12 Score=149.17 Aligned_cols=177 Identities=31% Similarity=0.468 Sum_probs=77.2
Q ss_pred cCeEeecCccCCCCCCcccCCcc-ccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhh
Q 047768 170 LQGLSVGDNQLTGQLPASIGNLS-ALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLY 248 (1009)
Q Consensus 170 L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 248 (1009)
++.|++.+|.++ .+|...+.++ +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|+++
T Consensus 118 l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls 194 (394)
T COG4886 118 LTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLS 194 (394)
T ss_pred eeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheecc
Confidence 333444444444 3333333332 4444444444442 33333444444444444444444 333333344444444444
Q ss_pred CCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCCC
Q 047768 249 GNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNG 328 (1009)
Q Consensus 249 ~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~ 328 (1009)
+|+++ .+|..+. ....|++|.+++|.+. ..+..+.++.++..|.+.+|++... +..+..+.+++.|+++.|.+..+
T Consensus 195 ~N~i~-~l~~~~~-~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~~i 270 (394)
T COG4886 195 GNKIS-DLPPEIE-LLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQISSI 270 (394)
T ss_pred CCccc-cCchhhh-hhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-cchhccccccceecccccccccc
Confidence 44444 4444321 1223444444444322 2334444555555555555554432 22233333344444444444332
Q ss_pred CCCCcchhhhcccccccceEEccCCCCCCcCch
Q 047768 329 AANDLDFVDLLTNCTKLQYLYLADNGFGGVLPH 361 (1009)
Q Consensus 329 ~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~ 361 (1009)
.. +..+.+++.|++++|.+....|.
T Consensus 271 ~~--------~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 271 SS--------LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred cc--------ccccCccCEEeccCccccccchh
Confidence 21 34455666666666666544443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.29 E-value=9e-12 Score=142.41 Aligned_cols=143 Identities=19% Similarity=0.237 Sum_probs=100.5
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeecccccc----------------------------------------hHHH
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG----------------------------------------SKSF 745 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~ 745 (1009)
.+.||.|++|.||+|+.+ +|+.||||+.+...... .-.|
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999986 79999999985431100 0024
Q ss_pred HHHHHHHHhcC----CCCcceEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHH-
Q 047768 746 AAECEALRSIR----HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS- 820 (1009)
Q Consensus 746 ~~E~~~l~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~- 820 (1009)
.+|++.+.+++ |.+-+.+-.++... ....++||||++|++|.++....... . .+..++..++.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~----~~~~vLvmE~i~G~~L~~~~~~~~~~-----~---~~~~ia~~~~~~ 268 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDR----TSERVLTMEWIDGIPLSDIAALDEAG-----L---DRKALAENLARS 268 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhh----cCCceEEEEeECCcccccHHHHHhcC-----C---CHHHHHHHHHHH
Confidence 45666665552 33333333333221 23468999999999998886543211 2 23456666665
Q ss_pred HHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCC
Q 047768 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSA 864 (1009)
Q Consensus 821 ~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 864 (1009)
.+..+|.. |++|+|++|.||+++.++.++++|||++..+..
T Consensus 269 ~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 269 FLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 46788888 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.2e-12 Score=142.81 Aligned_cols=201 Identities=28% Similarity=0.326 Sum_probs=158.8
Q ss_pred cCccCCcccc--cCCceEEEEEE--ecCCeEEEEEEeecccc--cchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCC
Q 047768 702 EFSSSNTIGR--GSFGFVYKGVL--HENGMLVAVKVINLEQK--GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 702 ~~~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 774 (1009)
.|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.... .....=.+|+...+++ .|++.++.... +.+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----ccc
Confidence 5666788999 99999999998 78899999998543332 2334445677777777 49999996554 445
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHH----HHHHHhhcCCCCceecCCCCCceeeCCC-C
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS----AVEYLHHHCQPPIVHGDLKPSNVLLDHD-M 849 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~ivHrdlk~~Nill~~~-~ 849 (1009)
.+..++-+|++ +.+|.++.+..... ++....+.+..+..+ |+.++|+. .++|-|+||.||++..+ .
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~~~-----~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPCNF-----LPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWT 260 (524)
T ss_pred CCcceeeeccc-cchhHHhhhccccc-----CCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccc
Confidence 67889999998 57898888775542 777788888888888 99999999 99999999999999999 8
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCC
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPT 920 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~ 920 (1009)
.++++|||+...+......... .......|...|++||.. .+-++.+.||||+|.++.|..++-.+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~---~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVF---KVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred eeecCCcceeEEccCCccccce---eeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccc
Confidence 9999999999988776533322 222333678899999984 457788999999999999999986654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.6e-11 Score=135.29 Aligned_cols=172 Identities=19% Similarity=0.220 Sum_probs=132.0
Q ss_pred EEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccC
Q 047768 719 KGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRD 798 (1009)
Q Consensus 719 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 798 (1009)
.|..+.++.+|.|+..+...........+.++.|+.+|||||++++.... ..+..|+|+|.+. .|..++++
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-----~~~~~ylvTErV~--Pl~~~lk~-- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE-----EEGTLYLVTERVR--PLETVLKE-- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc-----ccCceEEEeeccc--cHHHHHHH--
Confidence 46667789999999887655544566788899999999999999998743 3468899999985 57777776
Q ss_pred CCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccc
Q 047768 799 DQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878 (1009)
Q Consensus 799 ~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~ 878 (1009)
+........++||+.||.|||+.| +++|+++....|+|++.|..||++|.++........ ...
T Consensus 101 -------l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--------~~~ 163 (690)
T KOG1243|consen 101 -------LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--------PAK 163 (690)
T ss_pred -------hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--------ccc
Confidence 335667788999999999999776 899999999999999999999999998875543211 011
Q ss_pred cccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCC
Q 047768 879 GVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR 918 (1009)
Q Consensus 879 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~ 918 (1009)
...---.|..|+.+.... ...|.|-||+++||++.|..
T Consensus 164 ~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 164 SLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred cchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence 111223466777554433 35699999999999999933
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.1e-12 Score=134.07 Aligned_cols=211 Identities=22% Similarity=0.245 Sum_probs=138.6
Q ss_pred cCccccccccccccccCCCCC--CCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcc-cCCc
Q 047768 115 GNLFRLETLVLANNSFSGRIP--TNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPAS-IGNL 191 (1009)
Q Consensus 115 ~~l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l 191 (1009)
+++.+|+...|.+.... ..+ .....|++++.||||+|-+..-.|..-+...|++|+.|+|+.|++.-..... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 56778888888888775 333 3667788888888888888766666556678888888888888887433322 2367
Q ss_pred cccceeecccCcccCC-CCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCCh-hhccCCCcccc
Q 047768 192 SALRVIDIRTNRLWGK-IPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPI-EIGKNLPNLRN 269 (1009)
Q Consensus 192 ~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~-~~~~~l~~L~~ 269 (1009)
++|+.|.|+.|.++-. +-..+..+++|+.|+|..|..-+.-......+..|++|||++|++. ..+. ..-..++.|+.
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhh
Confidence 7888888888888622 2223455688888888888533344444556777888888888876 4442 12235777888
Q ss_pred eeccccccCCCC-CCC-----cCcccccccccccccccccccc-cccccccccccccccccccCC
Q 047768 270 FVIYTNNFTGSL-PDS-----FSNASNLEVLHLAENQFRGQVS-INFNGLKDLSMLGLATNFLGN 327 (1009)
Q Consensus 270 L~L~~N~l~~~~-p~~-----~~~l~~L~~L~Ls~N~l~~~~~-~~f~~l~~L~~L~L~~N~l~~ 327 (1009)
|.++.+.+..+- |+. -..+++|++|+++.|+|..... ..+..+++|+.|....|.++.
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 888888776432 222 3556778888888887764322 223344555555555555544
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.6e-11 Score=135.93 Aligned_cols=149 Identities=18% Similarity=0.217 Sum_probs=95.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc----------------------------------chH---
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG----------------------------------GSK--- 743 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------------------~~~--- 743 (1009)
.+|+. +.+|+|++|.||+|+.+.+|+.||||+.+..... -.+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 7899999999999999877999999999643100 001
Q ss_pred ---HHHHHHHHHHhcC----CCCcceEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHH
Q 047768 744 ---SFAAECEALRSIR----HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI 816 (1009)
Q Consensus 744 ---~~~~E~~~l~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~ 816 (1009)
++.+|+..+.+++ +...+.+-.++.+. ....++||||++|+.+.++-.-...+.....+.......++.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 2444555555542 43333333332211 245689999999999987532111110001122222222333
Q ss_pred HHHHHHHHHhhcCCCCceecCCCCCceeeCCCC----ceEEeccccccccCC
Q 047768 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAHVSDFGLAKFLSA 864 (1009)
Q Consensus 817 ~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~----~~kl~DfGla~~~~~ 864 (1009)
| ++.. |++|+|++|.||+++.++ .++++|||++..++.
T Consensus 275 Q-------if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 Q-------VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 3345 999999999999999988 999999999987754
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.5e-12 Score=132.97 Aligned_cols=248 Identities=19% Similarity=0.260 Sum_probs=139.4
Q ss_pred CcCeEeecCccCCC----CCCcccCCccccceeecccC---cccCCCC-------cccccccccccccccCccCCCCCCC
Q 047768 169 NLQGLSVGDNQLTG----QLPASIGNLSALRVIDIRTN---RLWGKIP-------ITLSQLTSLAYLHVGDNHFSGTIPP 234 (1009)
Q Consensus 169 ~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N---~l~~~~p-------~~~~~l~~L~~L~L~~N~l~~~~p~ 234 (1009)
.++.|+|++|.+.. .+...+.+.++|+..++|+= ++...+| .++...++|++||||+|.|.-.-+.
T Consensus 31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~ 110 (382)
T KOG1909|consen 31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIR 110 (382)
T ss_pred ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchH
Confidence 44444444444431 12234455556666666652 2222333 3445567888899999888744443
Q ss_pred c----ccCCChHHHHHhhCCccCCCCCh-hhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccc---
Q 047768 235 S----VYNISSLVEIYLYGNRFTGSLPI-EIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVS--- 306 (1009)
Q Consensus 235 ~----~~~l~~L~~L~L~~N~l~~~ip~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~--- 306 (1009)
. +..+.+|++|+|.+|.+. .... .+++ .|..|. .|+. ...-++|++++.++|++..-..
T Consensus 111 ~l~~ll~s~~~L~eL~L~N~Glg-~~ag~~l~~---al~~l~--~~kk-------~~~~~~Lrv~i~~rNrlen~ga~~~ 177 (382)
T KOG1909|consen 111 GLEELLSSCTDLEELYLNNCGLG-PEAGGRLGR---ALFELA--VNKK-------AASKPKLRVFICGRNRLENGGATAL 177 (382)
T ss_pred HHHHHHHhccCHHHHhhhcCCCC-hhHHHHHHH---HHHHHH--HHhc-------cCCCcceEEEEeeccccccccHHHH
Confidence 3 345778999999999886 2221 1111 233332 2222 2234678888888888875433
Q ss_pred -cccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCC
Q 047768 307 -INFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIP 385 (1009)
Q Consensus 307 -~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p 385 (1009)
..|...+.|+.+.++.|.|..-+. ......|..+++|+.|||.+|-|+......+ .
T Consensus 178 A~~~~~~~~leevr~~qN~I~~eG~--~al~eal~~~~~LevLdl~DNtft~egs~~L---------------------a 234 (382)
T KOG1909|consen 178 AEAFQSHPTLEEVRLSQNGIRPEGV--TALAEALEHCPHLEVLDLRDNTFTLEGSVAL---------------------A 234 (382)
T ss_pred HHHHHhccccceEEEecccccCchh--HHHHHHHHhCCcceeeecccchhhhHHHHHH---------------------H
Confidence 345666777888888887765444 2334567788888888888888773322211 2
Q ss_pred ccccCcCccCEEEccCCCCCCCCCCCc-----CCcccccceecccccccC----CCCcccccccccccccccCccc
Q 047768 386 PGIANLVNLNSLRMEANRLTGTIPHVI-----GELKNLQLLHLHANFLQG----TIPSSLGNLTLLTYLSFGANNL 452 (1009)
Q Consensus 386 ~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l 452 (1009)
..++.+++|+.|+++++.+...-..+| ...++|+.|.|.+|.++. .+...+...+.|..|+|++|++
T Consensus 235 kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 235 KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 233444556666666666553333222 134566666666666652 1122233455566666666666
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.5e-10 Score=111.07 Aligned_cols=137 Identities=19% Similarity=0.174 Sum_probs=99.5
Q ss_pred CcccccCCceEEEEEEec------CCeEEEEEEeeccc------------c----------cchHHH----HHHHHHHHh
Q 047768 707 NTIGRGSFGFVYKGVLHE------NGMLVAVKVINLEQ------------K----------GGSKSF----AAECEALRS 754 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~------------~----------~~~~~~----~~E~~~l~~ 754 (1009)
..||.|.-+.||.|.... .+..+|||+.+... . ...+.+ .+|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997643 35799999985211 0 001223 389999999
Q ss_pred cC--CCCcceEEeeeeccccCCCceEEEEEeccCCCCHHH-HHhccCCCCCccCCCHHHHHHHHHHHHHHHHHH-hhcCC
Q 047768 755 IR--HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEE-WLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL-HHHCQ 830 (1009)
Q Consensus 755 l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~ 830 (1009)
+. .-++.+.+++ ...++||||+.+..+.. .++.. .++..+...+..+++.++.++ |..
T Consensus 83 l~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd~-------~~~~~~~~~i~~~i~~~l~~l~H~~-- 144 (197)
T cd05146 83 MQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKDA-------KLNDEEMKNAYYQVLSMMKQLYKEC-- 144 (197)
T ss_pred HHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhcc-------ccCHHHHHHHHHHHHHHHHHHHHhC--
Confidence 84 3566777765 34589999997654421 22221 245556677889999999999 777
Q ss_pred CCceecCCCCCceeeCCCCceEEeccccccccC
Q 047768 831 PPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863 (1009)
Q Consensus 831 ~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~ 863 (1009)
++||||+++.||+++ ++.+.++|||.|....
T Consensus 145 -glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 145 -NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred -CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999999999997 4689999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.4e-12 Score=133.28 Aligned_cols=189 Identities=21% Similarity=0.225 Sum_probs=95.9
Q ss_pred ccCCcCeEeecCccCCCCCC--cccCCccccceeecccCcccC--CCCcccccccccccccccCccCCCCCCCc-ccCCC
Q 047768 166 RLFNLQGLSVGDNQLTGQLP--ASIGNLSALRVIDIRTNRLWG--KIPITLSQLTSLAYLHVGDNHFSGTIPPS-VYNIS 240 (1009)
Q Consensus 166 ~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~ 240 (1009)
.+.+|++..|.+.... ..+ .....|++++.||||.|-+.. .+-.-...|++|+.|+|+.|++.-..... -..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 4555666666666555 222 245566777777777776642 22233455677777777777665222111 12345
Q ss_pred hHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccc-ccccccccccccc
Q 047768 241 SLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVS-INFNGLKDLSMLG 319 (1009)
Q Consensus 241 ~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~f~~l~~L~~L~ 319 (1009)
+|+.|.|++|.|+-.--..+....|+|+.|+|+.|....+-......+..|+.|||++|++-.... .....++.|..|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 566666666666521111223345666666666664333444445556667777777766654321 2233444555555
Q ss_pred ccccccCCCCCCCcchhhhcccccccceEEccCCCC
Q 047768 320 LATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGF 355 (1009)
Q Consensus 320 L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 355 (1009)
++.+.|..+..-+....+-....++|++|+++.|++
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I 313 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNI 313 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCcc
Confidence 555555444333322222233344444444444444
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.6e-10 Score=114.07 Aligned_cols=130 Identities=18% Similarity=0.167 Sum_probs=95.4
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcc-eEEeeeeccccCCCceEEEEEec
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLI-KIVTICSSIDFKGVDFKALVYEY 784 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~~~~~lv~e~ 784 (1009)
.+.++.|.++.||+++.. +..|++|+...... ....+.+|+++++.+.+.+++ +++.+.. ...++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-------~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP-------ETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC-------CCCeEEEEe
Confidence 356899999999999874 78899998753321 234568899999998655543 4444321 224799999
Q ss_pred cCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcC--CCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 785 MQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHC--QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 785 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
+++.++.+. . . ....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 73 i~G~~l~~~----~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 73 IEGSELLTE----D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cCCCccccc----c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 999877543 0 0 11345678999999999982 12359999999999999 6789999999886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.2e-11 Score=139.76 Aligned_cols=129 Identities=22% Similarity=0.291 Sum_probs=67.0
Q ss_pred ccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHH
Q 047768 166 RLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEI 245 (1009)
Q Consensus 166 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 245 (1009)
.+..++.+.+..|.+.. +-..+..+++|+.|++.+|+|... ...+..+++|++|+|++|+|+... .+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhh
Confidence 35566666677776663 233356666677777777777432 222556666666777766666332 24445556666
Q ss_pred HhhCCccCCCCChhhccCCCcccceeccccccCCCCC-CCcCcccccccccccccccc
Q 047768 246 YLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLP-DSFSNASNLEVLHLAENQFR 302 (1009)
Q Consensus 246 ~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 302 (1009)
++++|.|+ .++.. ..+++|+.+++++|.+..+.+ . ...+.+++.+++..|.+.
T Consensus 146 ~l~~N~i~-~~~~~--~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 146 NLSGNLIS-DISGL--ESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR 199 (414)
T ss_pred eeccCcch-hccCC--ccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence 66666665 33321 124444444444444443322 1 233344444444444433
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=5e-11 Score=136.79 Aligned_cols=219 Identities=26% Similarity=0.323 Sum_probs=136.0
Q ss_pred cCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCc
Q 047768 91 GNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNL 170 (1009)
Q Consensus 91 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L 170 (1009)
..+..+..+++..|.+. .+-..+..+++|+.|+|.+|+|. .+...+..+++|++|++++|.|+...+-. .+..|
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~l~----~l~~L 142 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEGLS----TLTLL 142 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccchh----hccch
Confidence 35666777777788777 44455777888888888888887 34444777788888888888777544443 34557
Q ss_pred CeEeecCccCCCCCCcccCCccccceeecccCcccCCCC-cccccccccccccccCccCCCCCCCcccCCChHHHHHhhC
Q 047768 171 QGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIP-ITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYG 249 (1009)
Q Consensus 171 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 249 (1009)
+.|++++|.|+. + ..+..+++|+.+++++|++....+ . ...+.+|+.+++.+|.+. ....+..+..+..+++..
T Consensus 143 ~~L~l~~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~ 217 (414)
T KOG0531|consen 143 KELNLSGNLISD-I-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLD 217 (414)
T ss_pred hhheeccCcchh-c-cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhccc
Confidence 777888887773 2 335557777888888887764444 2 466777777777777775 233444455566667777
Q ss_pred CccCCCCChhhccCCCc--ccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccC
Q 047768 250 NRFTGSLPIEIGKNLPN--LRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLG 326 (1009)
Q Consensus 250 N~l~~~ip~~~~~~l~~--L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~ 326 (1009)
|+++ .+-.-. .+.. |+.+++++|.+... +..+..+.++..|++.+|++..... +.....+..+.+..|.+.
T Consensus 218 n~i~-~~~~l~--~~~~~~L~~l~l~~n~i~~~-~~~~~~~~~l~~l~~~~n~~~~~~~--~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 218 NKIS-KLEGLN--ELVMLHLRELYLSGNRISRS-PEGLENLKNLPVLDLSSNRISNLEG--LERLPKLSELWLNDNKLA 290 (414)
T ss_pred ccce-eccCcc--cchhHHHHHHhcccCccccc-cccccccccccccchhhcccccccc--ccccchHHHhccCcchhc
Confidence 7776 222111 1222 67777777777632 2455566677777777776654332 233344444444444443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.7e-11 Score=120.96 Aligned_cols=93 Identities=25% Similarity=0.322 Sum_probs=61.7
Q ss_pred CCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccccccccc
Q 047768 230 GTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINF 309 (1009)
Q Consensus 230 ~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f 309 (1009)
|..-..+.....|++||||+|.|+ .+...+ +-+|+++.|++|+|.|+.+ +.++.+++|+.||||+|.++.... .-
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESv-KL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~G-wh 348 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESV-KLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECVG-WH 348 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhh-hhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhhh-hH
Confidence 333334444567889999999888 777665 3478888888888888744 237788888888888888775432 22
Q ss_pred ccccccccccccccccCC
Q 047768 310 NGLKDLSMLGLATNFLGN 327 (1009)
Q Consensus 310 ~~l~~L~~L~L~~N~l~~ 327 (1009)
..+.+++.|.|+.|.|..
T Consensus 349 ~KLGNIKtL~La~N~iE~ 366 (490)
T KOG1259|consen 349 LKLGNIKTLKLAQNKIET 366 (490)
T ss_pred hhhcCEeeeehhhhhHhh
Confidence 234455555555555443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.03 E-value=8.6e-11 Score=118.35 Aligned_cols=133 Identities=25% Similarity=0.231 Sum_probs=97.7
Q ss_pred ccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCee
Q 047768 439 LTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRL 518 (1009)
Q Consensus 439 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L 518 (1009)
...|++||||+|.|+ .+.++..-.+.++. |++|+|.+.. + ..+..|.+|+.|
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~-------------------------L~lS~N~i~~-v-~nLa~L~~L~~L 334 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRR-------------------------LILSQNRIRT-V-QNLAELPQLQLL 334 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeE-------------------------Eeccccceee-e-hhhhhcccceEe
Confidence 355666666666666 45555554444444 5555555542 2 236678899999
Q ss_pred eccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCccccccc-ccccccccccCceecccccC
Q 047768 519 GIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQI-PKYLENLSFLQYLNLSYNHF 597 (1009)
Q Consensus 519 ~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l 597 (1009)
|||+|.++ .+..+-.++.+.+.|.|++|.|... ..++.|-+|..||+++|+|.... -..+++|+-|+++.|.+|++
T Consensus 335 DLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl 411 (490)
T KOG1259|consen 335 DLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL 411 (490)
T ss_pred ecccchhH-hhhhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence 99999998 5666777788999999999998732 46788889999999999998422 24689999999999999999
Q ss_pred cccCC
Q 047768 598 EGEVP 602 (1009)
Q Consensus 598 ~g~~p 602 (1009)
.+.+-
T Consensus 412 ~~~vd 416 (490)
T KOG1259|consen 412 AGSVD 416 (490)
T ss_pred cccch
Confidence 87554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.4e-10 Score=111.85 Aligned_cols=129 Identities=29% Similarity=0.384 Sum_probs=46.7
Q ss_pred ccCCCCCCeeeecCCcCCccCCcccc-CccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccC
Q 047768 90 VGNLSFLRYINIADNDFHGEIPDRIG-NLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLF 168 (1009)
Q Consensus 90 ~~~l~~L~~L~L~~n~~~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~ 168 (1009)
+.+...+++|+|++|.|+ .|. .++ .+.+|+.||||+|.|+. + +.+..+++|++|++++|.++. +++.+. ..++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l-~~l~~L~~L~~L~L~~N~I~~-i~~~l~-~~lp 88 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-L-EGLPGLPRLKTLDLSNNRISS-ISEGLD-KNLP 88 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHH-HH-T
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-c-cCccChhhhhhcccCCCCCCc-cccchH-HhCC
Confidence 455667888999999988 453 466 57889999999999884 3 357788888888888888874 443332 3577
Q ss_pred CcCeEeecCccCCCCCC-cccCCccccceeecccCcccCCCC---ccccccccccccccc
Q 047768 169 NLQGLSVGDNQLTGQLP-ASIGNLSALRVIDIRTNRLWGKIP---ITLSQLTSLAYLHVG 224 (1009)
Q Consensus 169 ~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~ 224 (1009)
+|++|+|++|+|...-- ..++.+++|++|+|.+|.+....- ..+..+++|+.||-.
T Consensus 89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence 88888888888874322 456777888888888888753311 135567777777643
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.5e-11 Score=127.26 Aligned_cols=142 Identities=21% Similarity=0.270 Sum_probs=68.6
Q ss_pred ChHHHHHhhCCccCCCCCh----hhccCCCcccceeccccccCC----CCCCCcCccccccccccccccccccccccccc
Q 047768 240 SSLVEIYLYGNRFTGSLPI----EIGKNLPNLRNFVIYTNNFTG----SLPDSFSNASNLEVLHLAENQFRGQVSINFNG 311 (1009)
Q Consensus 240 ~~L~~L~L~~N~l~~~ip~----~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~ 311 (1009)
+.|+.+...+|++. .-+. ..++..+.|+.+.++.|.|.. .+...|..+++|++|||.+|-++.
T Consensus 157 ~~Lrv~i~~rNrle-n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~-------- 227 (382)
T KOG1909|consen 157 PKLRVFICGRNRLE-NGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTL-------- 227 (382)
T ss_pred cceEEEEeeccccc-cccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhh--------
Confidence 34555555555554 2222 233344555555555555531 112234455555555555555443
Q ss_pred ccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCc
Q 047768 312 LKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANL 391 (1009)
Q Consensus 312 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l 391 (1009)
.+. ......+..+++|+.|+++++.+...-...+.+-.. ...
T Consensus 228 ----------------egs--~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~--------------------~~~ 269 (382)
T KOG1909|consen 228 ----------------EGS--VALAKALSSWPHLRELNLGDCLLENEGAIAFVDALK--------------------ESA 269 (382)
T ss_pred ----------------HHH--HHHHHHhcccchheeecccccccccccHHHHHHHHh--------------------ccC
Confidence 221 122345556667777777777766544443332210 113
Q ss_pred CccCEEEccCCCCCCC----CCCCcCCcccccceecccccc
Q 047768 392 VNLNSLRMEANRLTGT----IPHVIGELKNLQLLHLHANFL 428 (1009)
Q Consensus 392 ~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l 428 (1009)
++|++|.|.+|.|+.. +...+...+.|..|+|++|.+
T Consensus 270 p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 270 PSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred CCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 4555555555555421 112233456666666666666
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=8.3e-10 Score=123.77 Aligned_cols=248 Identities=18% Similarity=0.123 Sum_probs=168.6
Q ss_pred HHhccCccCCcccccCCceEEEEEEe-cCCeEEEEEEeecccccchH--HHHHHHHHHHhc-CCCCcceEEeeeeccccC
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLH-ENGMLVAVKVINLEQKGGSK--SFAAECEALRSI-RHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 773 (1009)
....+|..+..||.|.|+.|+..... .++..+++|........... .-..|+.+...+ .|.+++++...+...
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~--- 338 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL--- 338 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc---
Confidence 34567888899999999999998866 67889999987533322221 123455555555 577777766543322
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC-CceE
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAH 852 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~k 852 (1009)
...++-.|||+++++.....-.. .+++..++.+..+++.++.++|+. .++|+|+||+||++..+ +..+
T Consensus 339 --r~~~ip~e~~~~~s~~l~~~~~~------~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~ 407 (524)
T KOG0601|consen 339 --RQGYIPLEFCEGGSSSLRSVTSQ------MLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSK 407 (524)
T ss_pred --ccccCchhhhcCcchhhhhHHHH------hcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhh
Confidence 45568889999998877663222 377888899999999999999998 99999999999999886 8899
Q ss_pred EeccccccccCCCCCCCccccCCcccccccccccc--CccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccH
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYV--APEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL 930 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~ 930 (1009)
+.|||.+..+.-.. . .....-+++ +|+......+..++|+||||.-+.|.++|..--+...
T Consensus 408 ~~~~~~~t~~~~~~----------~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------ 470 (524)
T KOG0601|consen 408 LGDFGCWTRLAFSS----------G-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------ 470 (524)
T ss_pred ccccccccccceec----------c-cccccccccccchhhccccccccccccccccccccccccCcccCcccc------
Confidence 99999987432110 0 011223334 6666777888999999999999999999865322110
Q ss_pred HHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 931 HEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
.| ..+....+...+ .....+..++..+...++..||.+.+......
T Consensus 471 -~~---------~~i~~~~~p~~~------------~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 471 -QS---------LTIRSGDTPNLP------------GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -cc---------eeeecccccCCC------------chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 00 011111010000 11134556777788899999999888765544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.6e-10 Score=108.78 Aligned_cols=111 Identities=23% Similarity=0.296 Sum_probs=36.6
Q ss_pred cCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccc
Q 047768 237 YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLS 316 (1009)
Q Consensus 237 ~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~ 316 (1009)
.+..++++|+|++|+|+ .|. .....+.+|+.|+|++|.|+.+ +.+..+++|++|++++|+|+.+.......+++|+
T Consensus 16 ~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQ 91 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--
T ss_pred ccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCC
Confidence 34445666666666666 443 3333466777777777777754 2466677777788888877765443234567777
Q ss_pred cccccccccCCCCCCCcchhhhcccccccceEEccCCCCC
Q 047768 317 MLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFG 356 (1009)
Q Consensus 317 ~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 356 (1009)
.|+|++|.|.+... ...+..+++|+.|+|.+|.++
T Consensus 92 ~L~L~~N~I~~l~~-----l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 92 ELYLSNNKISDLNE-----LEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp EEE-TTS---SCCC-----CGGGGG-TT--EEE-TT-GGG
T ss_pred EEECcCCcCCChHH-----hHHHHcCCCcceeeccCCccc
Confidence 77777777766543 245667788888888888776
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=9e-08 Score=101.83 Aligned_cols=275 Identities=14% Similarity=0.102 Sum_probs=164.7
Q ss_pred ccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeecc--ccCCCceEEE
Q 047768 704 SSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSI--DFKGVDFKAL 780 (1009)
Q Consensus 704 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~~~~~~l 780 (1009)
...+.||+|+.+.+|-.-.. + ..+-|+.......... +.+..|.+. .||-+-.-+.|=... .-......-+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh--h-chhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34678999999999965332 2 2345777544332222 223344444 566543322221100 0111222445
Q ss_pred EEeccCCC-CHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 781 VYEYMQNG-SLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 781 v~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
.|..+.+. -...+.............+|....+.++.+|.+.+-||+. |.+-+|+.++|+|+++++.|.+.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 66665543 3444444333333456789999999999999999999999 9999999999999999999999875432
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccC-----CCCCCCcccchHHHHHHHHHHhC-CCCCcccccCCccHHHH
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-----GGEASMRGGVYSYGILLLEIFTR-RRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg-~~p~~~~~~~~~~~~~~ 933 (1009)
.....+ ......+|...|.+||.-. +...+...|-|.+||++++++.| +.||.........
T Consensus 165 qi~~ng---------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a---- 231 (637)
T COG4248 165 QINANG---------TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA---- 231 (637)
T ss_pred eeccCC---------ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC----
Confidence 222111 2223456889999999633 34457789999999999999995 9999754221100
Q ss_pred HHHhccchhh-hccCCCCCChhh----hhhhccccccHHHHHHHHHHHhhccCCC--CCCCCCHHHHHHHHHHHHHhhh
Q 047768 934 AKRALPEKVM-EIVDPSLLPLEE----ERTNSRRVRNEECLVAVIKTGVACSIES--PFDRMEMTDVVVKLCHARQNFL 1005 (1009)
Q Consensus 934 ~~~~~~~~~~-~~~d~~l~~~~~----~r~~~~~~~~~~~~~~l~~l~~~cl~~d--p~~Rpt~~evl~~L~~i~~~~~ 1005 (1009)
+.... ++....+....+ .++....+.-.--+..+..+..+|.... +.-|||++..+..|.+..++..
T Consensus 232 -----p~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 232 -----PNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred -----CCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 00000 111111111111 1111122222223345666677887653 6789999999999988877654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.3e-08 Score=95.83 Aligned_cols=129 Identities=26% Similarity=0.360 Sum_probs=94.9
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeeccccc--------chHHHHHHHHHHHhcCCC--CcceEEeeeeccccCCCc
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--------GSKSFAAECEALRSIRHR--NLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~~~ 776 (1009)
..+++|+-+.+|.+.+. |..+++|.=..+.-. ......+|++++.+++-. ++..++++ +++
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD 72 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence 35789999999999885 555667743211111 123567899999988533 33344443 225
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
...++|||+++..|.+++.... ..++..+=.-+.-||.. +|||+|+.++||.+..+. +.++||
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~~-------------~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDf 135 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEAR-------------PDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDF 135 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhcc-------------hHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEEC
Confidence 5679999999999998987642 34667777778899999 999999999999998775 899999
Q ss_pred ccccc
Q 047768 857 GLAKF 861 (1009)
Q Consensus 857 Gla~~ 861 (1009)
|++..
T Consensus 136 GLg~~ 140 (204)
T COG3642 136 GLGEF 140 (204)
T ss_pred Ccccc
Confidence 99974
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.7e-09 Score=87.05 Aligned_cols=60 Identities=38% Similarity=0.617 Sum_probs=37.7
Q ss_pred CccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceecccccC
Q 047768 538 SLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHF 597 (1009)
Q Consensus 538 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 597 (1009)
+|+.|++++|+|+...+.+|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 556666666666655555666666666666666666655555666666666666666654
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.1e-09 Score=128.68 Aligned_cols=211 Identities=24% Similarity=0.296 Sum_probs=146.0
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
..+.+.+.+.+.+|.++.++.+.-...|...+.|+...... ...+....+-.+.-..+||-++....- +...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCC
Confidence 44567777888899999999887766665555555432211 111222222222222234544443322 3344
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++|++|..++++..-++.... .+..-.......+..+.+|||+. .++|||++|.|.+...++..+++|
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~------~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~ 947 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGC------LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTD 947 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCC------cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCc
Confidence 677899999999999999988663 44444455666788999999998 799999999999999999999999
Q ss_pred cccccccCCC----------------CCCC-----cccc--CCccccccccccccCccccCCCCCCCcccchHHHHHHHH
Q 047768 856 FGLAKFLSAS----------------PLGN-----VVET--PSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLE 912 (1009)
Q Consensus 856 fGla~~~~~~----------------~~~~-----~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~e 912 (1009)
||........ .... .... ........||+.|.|||...+.....++|.|+.|++++|
T Consensus 948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen 948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhh
Confidence 9844332211 0000 0000 012344679999999999999999999999999999999
Q ss_pred HHhCCCCCccc
Q 047768 913 IFTRRRPTESM 923 (1009)
Q Consensus 913 lltg~~p~~~~ 923 (1009)
.++|..||...
T Consensus 1028 ~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 1028 VLTGIPPFNAE 1038 (1205)
T ss_pred hhcCCCCCCCc
Confidence 99999999754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.8e-08 Score=105.75 Aligned_cols=145 Identities=22% Similarity=0.292 Sum_probs=108.4
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCC--CCcceEEeeeeccccCCCceEEEEEe
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRH--RNLIKIVTICSSIDFKGVDFKALVYE 783 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e 783 (1009)
+.++.|..+.||++... +|+.+++|+...... .....+.+|+++++.+++ ..+.+++.++.... ..+..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence 56899999999999875 468899998754332 134678999999999965 44577777754321 1124589999
Q ss_pred ccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 047768 784 YMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHC---------------------------------- 829 (1009)
Q Consensus 784 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------------- 829 (1009)
|+++.++.+.+... .++..+...++.++++++.+||+..
T Consensus 81 ~i~G~~l~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 81 RVDGRVLRDRLLRP-------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred EeCCEecCCCCCCC-------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 99998887654321 2677777888888888888888521
Q ss_pred -------------------CCCceecCCCCCceeeCC--CCceEEeccccccc
Q 047768 830 -------------------QPPIVHGDLKPSNVLLDH--DMVAHVSDFGLAKF 861 (1009)
Q Consensus 830 -------------------~~~ivHrdlk~~Nill~~--~~~~kl~DfGla~~ 861 (1009)
...++|+|+.+.||+++. ++.+.++||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 67789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=4e-09 Score=128.96 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=158.6
Q ss_pred CCCCCeEEEEEeecCC--cccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCc
Q 047768 66 GRRNQRVTKLDLRNQS--IGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSK 143 (1009)
Q Consensus 66 ~~~~~~v~~l~l~~~~--l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 143 (1009)
+.....+++|-+.+|. +.......|..++.|++||||+|.=-+.+|..+++|-+|++|+|++..++ .+|..+++|++
T Consensus 541 ~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~ 619 (889)
T KOG4658|consen 541 SSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKK 619 (889)
T ss_pred CCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHh
Confidence 3334568888888886 44444455888999999999998766799999999999999999999998 89999999999
Q ss_pred CcEEecccccccCCCchHHhhhccCCcCeEeecCccCC--CCCCcccCCccccceeecccCcc-----------------
Q 047768 144 LITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLT--GQLPASIGNLSALRVIDIRTNRL----------------- 204 (1009)
Q Consensus 144 L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~L~~N~l----------------- 204 (1009)
|.+|++.++.-...+|... ..+.+|++|.+..-... ...-..+.+|.+|+.+.......
T Consensus 620 L~~Lnl~~~~~l~~~~~i~--~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~~~~e~l~~~~~L~~~~~ 697 (889)
T KOG4658|consen 620 LIYLNLEVTGRLESIPGIL--LELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSVLLLEDLLGMTRLRSLLQ 697 (889)
T ss_pred hheeccccccccccccchh--hhcccccEEEeeccccccchhhHHhhhcccchhhheeecchhHhHhhhhhhHHHHHHhH
Confidence 9999999988766665555 56999999998876532 22233445555555555433322
Q ss_pred --------cCCCCcccccccccccccccCccCCCCCCCcccC------CChHHHHHhhCCccCCCCChhhccCCCcccce
Q 047768 205 --------WGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYN------ISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNF 270 (1009)
Q Consensus 205 --------~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L 270 (1009)
....+.++..+.+|+.|.+.++.++......... ++++..+...++..-..+-... ..++|+.|
T Consensus 698 ~l~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~r~l~~~~--f~~~L~~l 775 (889)
T KOG4658|consen 698 SLSIEGCSKRTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHMLRDLTWLL--FAPHLTSL 775 (889)
T ss_pred hhhhcccccceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccccccchhh--ccCcccEE
Confidence 0123345556667777777776665322222111 2233333333332221111112 25677777
Q ss_pred eccccccCCCCCCCcCcccccccccccccccccc-cccccccccccccccc
Q 047768 271 VIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQ-VSINFNGLKDLSMLGL 320 (1009)
Q Consensus 271 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~f~~l~~L~~L~L 320 (1009)
.+..+.....+.+....+..++.+-+..+.+.+. .-....+++++..+.+
T Consensus 776 ~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l 826 (889)
T KOG4658|consen 776 SLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPL 826 (889)
T ss_pred EEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEeccc
Confidence 7777666555555555555555555666665555 2344444444444433
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.2e-09 Score=85.37 Aligned_cols=61 Identities=28% Similarity=0.491 Sum_probs=53.3
Q ss_pred CCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCccc
Q 047768 513 KSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNF 573 (1009)
Q Consensus 513 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 573 (1009)
++|++|++++|+|+...+..|.++++|++|++++|+++...|.+|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4688899999999866667889999999999999999988888999999999999999975
|
... |
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.81 E-value=4.8e-09 Score=76.98 Aligned_cols=41 Identities=51% Similarity=0.922 Sum_probs=29.7
Q ss_pred hhhHHHHHHHHHhcC-CCCCCCCCCccCCCCCCCCCccceeeC
Q 047768 25 ETDCLSLLAIKSQLH-DPLGVTSSWNRSACVNLCQHWTGVTCG 66 (1009)
Q Consensus 25 ~~d~~aLl~~k~~~~-~~~~~~~sW~~~~~~~~c~~w~gv~C~ 66 (1009)
++|++||++||+++. +|.+.+.+|+.+...++| +|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C-~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC-SWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC-CSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe-eeccEEeC
Confidence 579999999999998 577899999976323556 89999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.77 E-value=8.7e-08 Score=104.80 Aligned_cols=178 Identities=16% Similarity=0.187 Sum_probs=136.8
Q ss_pred CCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEeccCC-CCHH
Q 047768 713 SFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQN-GSLE 791 (1009)
Q Consensus 713 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-gsL~ 791 (1009)
...+.|++....+|..|++|+++............-+++++++.|+|+|++..++....|. ....++||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~-D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFG-DLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccC-cceEEEEEecCCCCchHH
Confidence 3468899999999999999999665555554556678899999999999999887644343 3577899999976 4787
Q ss_pred HHHhccCCCC---------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 792 EWLHQRDDQL---------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 792 ~~l~~~~~~~---------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
++--...... .....++...|.++.|+..||.++|+. |..-+-+.+++|+++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 7654332221 123477889999999999999999999 9999999999999999999999988877655
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCC
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p 919 (1009)
...+. |.+.+ -.+-|.=.+|.+++.+.||..-
T Consensus 444 ~~d~~----------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPT----------------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCC----------------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 43310 11111 2356888999999999999654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.5e-09 Score=128.50 Aligned_cols=129 Identities=23% Similarity=0.347 Sum_probs=74.0
Q ss_pred CCCCeeeecCCcCCccCCccccCccccccccccccc--cCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcC
Q 047768 94 SFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNS--FSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQ 171 (1009)
Q Consensus 94 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~ 171 (1009)
...+...+-+|.+. .++..... ++|++|-+..|. +.-..+..|..++.|+.|||++|.-.+.+|..+ +.|-+|+
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I--~~Li~Lr 598 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSI--GELVHLR 598 (889)
T ss_pred hheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHH--hhhhhhh
Confidence 44555556566554 44433322 256666666664 331222235556666666666665555666665 4566666
Q ss_pred eEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCcc
Q 047768 172 GLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNH 227 (1009)
Q Consensus 172 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 227 (1009)
+|+|++..++ .+|..+++|..|.+|++..+.-...+|.....|++|++|.+....
T Consensus 599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 6666666666 566666666666666666665544555666666666666665443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=8.5e-08 Score=91.29 Aligned_cols=140 Identities=21% Similarity=0.293 Sum_probs=98.1
Q ss_pred cCCcccccCCceEEEEEEecCCeEEEEEEeeccc--------ccchHHHHHHHHHHHhcCCCCc--ceEEeeeeccccCC
Q 047768 705 SSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--------KGGSKSFAAECEALRSIRHRNL--IKIVTICSSIDFKG 774 (1009)
Q Consensus 705 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~ 774 (1009)
....+-+|+-+.|+++.+. |+.+.||.=-... .-..++..+|++.+.+++--.| .+++.+ +
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~--D----- 81 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI--D----- 81 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE--e-----
Confidence 4567889999999999985 7777777431111 1113567789999998852222 223322 1
Q ss_pred CceEEEEEeccCC-CCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC---c
Q 047768 775 VDFKALVYEYMQN-GSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM---V 850 (1009)
Q Consensus 775 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---~ 850 (1009)
...-.++|||+++ .++.+++...... .....-...++..|-+.+.-||.. +|||+||..+||++..++ .
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~~~----~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~ 154 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTMED----ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQIT 154 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHccC----cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCc
Confidence 1334799999966 3788888765432 122222367888999999999999 999999999999996655 4
Q ss_pred eEEecccccc
Q 047768 851 AHVSDFGLAK 860 (1009)
Q Consensus 851 ~kl~DfGla~ 860 (1009)
+.++|||++.
T Consensus 155 ~~lIdfgls~ 164 (229)
T KOG3087|consen 155 PILIDFGLSS 164 (229)
T ss_pred eEEEeecchh
Confidence 6899999985
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.7e-08 Score=96.42 Aligned_cols=126 Identities=25% Similarity=0.288 Sum_probs=82.0
Q ss_pred eEEEEEEecCCeEEEEEEeeccc--------------c--------c----chHHHHHHHHHHHhcCCC--CcceEEeee
Q 047768 716 FVYKGVLHENGMLVAVKVINLEQ--------------K--------G----GSKSFAAECEALRSIRHR--NLIKIVTIC 767 (1009)
Q Consensus 716 ~V~~~~~~~~~~~vavK~~~~~~--------------~--------~----~~~~~~~E~~~l~~l~h~--niv~l~~~~ 767 (1009)
.||.|... +|..||||+.+... . . ......+|.+.|.++... ++.+.+++
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 38999874 78899999985321 0 0 013567899999999655 56777765
Q ss_pred eccccCCCceEEEEEeccC--CCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHH-hhcCCCCceecCCCCCcee
Q 047768 768 SSIDFKGVDFKALVYEYMQ--NGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVL 844 (1009)
Q Consensus 768 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivHrdlk~~Nil 844 (1009)
....+||||++ +..+....... ++......++.+++..+..+ |.. ||||+|+.+.||+
T Consensus 79 --------~~~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIl 139 (188)
T PF01163_consen 79 --------NRNVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNIL 139 (188)
T ss_dssp --------ETTEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEE
T ss_pred --------eCCEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEE
Confidence 23479999998 54454433221 11233456777888866664 677 9999999999999
Q ss_pred eCCCCceEEeccccccccC
Q 047768 845 LDHDMVAHVSDFGLAKFLS 863 (1009)
Q Consensus 845 l~~~~~~kl~DfGla~~~~ 863 (1009)
++++ .+.++|||.+....
T Consensus 140 v~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 140 VDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp EETT-CEEE--GTTEEETT
T ss_pred eecc-eEEEEecCcceecC
Confidence 9988 99999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.8e-07 Score=96.83 Aligned_cols=144 Identities=16% Similarity=0.037 Sum_probs=99.5
Q ss_pred ccccCCceEEEEEEecCCeEEEEEEeecccc-----------cchHHHHHHHHHHHhcC--CCCcceEEeeeeccccCCC
Q 047768 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQK-----------GGSKSFAAECEALRSIR--HRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 709 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~ 775 (1009)
+-+.....|++..+ +|+.|.||....... .....+.+|.+.+.++. .-.+.+.+++.........
T Consensus 30 v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 30 FRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 33333345667665 588999997743221 11124788999988884 3333444555432111112
Q ss_pred ceEEEEEeccCCC-CHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC-------
Q 047768 776 DFKALVYEYMQNG-SLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH------- 847 (1009)
Q Consensus 776 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~------- 847 (1009)
...++|+|++++. +|.+++..... .+.+...+..++.+++..+.-||.. ||+|+|++++|||++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCC
Confidence 3568999999876 89999864321 1245667788999999999999999 9999999999999975
Q ss_pred CCceEEeccccccc
Q 047768 848 DMVAHVSDFGLAKF 861 (1009)
Q Consensus 848 ~~~~kl~DfGla~~ 861 (1009)
+..+.++||+.++.
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46899999998864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.4e-07 Score=96.03 Aligned_cols=142 Identities=27% Similarity=0.250 Sum_probs=103.5
Q ss_pred HHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---------------c-------chHHHHHHHHHH
Q 047768 695 ELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---------------G-------GSKSFAAECEAL 752 (1009)
Q Consensus 695 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------~-------~~~~~~~E~~~l 752 (1009)
.+.....-..++.+||-|.-+.||.|... .|.++|||.=+.... . .....++|.++|
T Consensus 85 ~l~~r~~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L 163 (304)
T COG0478 85 ALVKRGIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEAL 163 (304)
T ss_pred HHHHcChHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHH
Confidence 33333334556789999999999999986 789999996542210 0 113467899999
Q ss_pred HhcCCC--CcceEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 047768 753 RSIRHR--NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQ 830 (1009)
Q Consensus 753 ~~l~h~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ 830 (1009)
.++... .|.+.+++ ....+||||+++--|...- ++......++..|+.-+.-.-..
T Consensus 164 ~~L~~~G~~VP~P~~~---------nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~~~-- 221 (304)
T COG0478 164 QRLYPEGVKVPKPIAW---------NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAYRR-- 221 (304)
T ss_pred HHhhhcCCCCCCcccc---------ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHHHc--
Confidence 999644 77777776 5678999999886664432 12333445666666666666666
Q ss_pred CCceecCCCCCceeeCCCCceEEecccccc
Q 047768 831 PPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 831 ~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
||||+|+.+-||+++++|.+.++||--+.
T Consensus 222 -GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 222 -GIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred -CccccCCchheEEEecCCCEEEEeCcccc
Confidence 99999999999999999999999997554
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.1e-08 Score=100.38 Aligned_cols=161 Identities=20% Similarity=0.274 Sum_probs=83.8
Q ss_pred cccccccccccccCC--CCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCC-CcccCCcccc
Q 047768 118 FRLETLVLANNSFSG--RIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQL-PASIGNLSAL 194 (1009)
Q Consensus 118 ~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L 194 (1009)
++++.|||.+|.|+. .|-.-+.+++.|++|+++.|.+...|...- ..+.+|+.|-|++..+.-.. ...+..++.+
T Consensus 71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp--~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v 148 (418)
T KOG2982|consen 71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLP--LPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV 148 (418)
T ss_pred hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCc--ccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence 344444444444442 122223344444444444444433322110 13456666666666665332 3456677778
Q ss_pred ceeecccCcccCCCCcccccccccccccccCccCCCCCCC--cccCCChHHHHHhhCCccCCCCChhhccCCCcccceec
Q 047768 195 RVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPP--SVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVI 272 (1009)
Q Consensus 195 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L 272 (1009)
+.|.+|.|.+ +.+++.+|.++..-|. .+..++.+..++++-|++. +-+|++..+.+
T Consensus 149 telHmS~N~~--------------rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~--------r~Fpnv~sv~v 206 (418)
T KOG2982|consen 149 TELHMSDNSL--------------RQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLS--------RIFPNVNSVFV 206 (418)
T ss_pred hhhhhccchh--------------hhhccccccccccchhhhhhhcCCcHHHHHHHHHhHH--------hhcccchheee
Confidence 8888877744 4455666666532221 2445567778888888776 23566666777
Q ss_pred cccccCCCC-CCCcCcccccccccccccccc
Q 047768 273 YTNNFTGSL-PDSFSNASNLEVLHLAENQFR 302 (1009)
Q Consensus 273 ~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 302 (1009)
..|.+...- -..+..++.+--|+|+.|+|.
T Consensus 207 ~e~PlK~~s~ek~se~~p~~~~LnL~~~~id 237 (418)
T KOG2982|consen 207 CEGPLKTESSEKGSEPFPSLSCLNLGANNID 237 (418)
T ss_pred ecCcccchhhcccCCCCCcchhhhhcccccc
Confidence 777665322 223444444445555555544
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.4e-08 Score=91.18 Aligned_cols=107 Identities=24% Similarity=0.345 Sum_probs=68.8
Q ss_pred EecCCCccCCCCCCCcc-CCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcc
Q 047768 494 LDLSDNLLNGSLPLGVG-NLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNN 572 (1009)
Q Consensus 494 L~Ls~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 572 (1009)
.+|++|.|. ..|..|. ..+.++.|+|++|+|+ .+|.++..++.|+.|++++|.|. ..|..+..|.+|..||..+|.
T Consensus 58 i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na 134 (177)
T KOG4579|consen 58 ISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENA 134 (177)
T ss_pred Eecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCc
Confidence 666777666 3444443 3456777777777777 56777777777777777777776 666667677777777777777
Q ss_pred cccccccccccccccCceecccccCcccCCCC
Q 047768 573 FSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK 604 (1009)
Q Consensus 573 l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 604 (1009)
+. .+|-.+-.-+.....++.+|++.+..|.+
T Consensus 135 ~~-eid~dl~~s~~~al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 135 RA-EIDVDLFYSSLPALIKLGNEPLGDETKKK 165 (177)
T ss_pred cc-cCcHHHhccccHHHHHhcCCcccccCccc
Confidence 76 44444333333344455677777766654
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.47 E-value=6e-08 Score=98.32 Aligned_cols=185 Identities=20% Similarity=0.273 Sum_probs=122.6
Q ss_pred HHhhhccCCcCeEeecCccCCCC--CCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCC-CCCccc
Q 047768 161 ELISRRLFNLQGLSVGDNQLTGQ--LPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGT-IPPSVY 237 (1009)
Q Consensus 161 ~~~~~~l~~L~~L~L~~n~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~ 237 (1009)
..+....+.+++|||.+|+|+.. +..-+.+|+.|++|+|+.|.+...+...-..+.+|+.|-|.+..+.-. ....+.
T Consensus 64 ~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~ 143 (418)
T KOG2982|consen 64 MLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLD 143 (418)
T ss_pred HHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhh
Confidence 33445566777788888887742 234467888888888888888633322214667888888888777632 334456
Q ss_pred CCChHHHHHhhCCccCC---------CCChhh--ccCCCcccceeccccccCCCCCCCcCccccccccccccccccccc-
Q 047768 238 NISSLVEIYLYGNRFTG---------SLPIEI--GKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQV- 305 (1009)
Q Consensus 238 ~l~~L~~L~L~~N~l~~---------~ip~~~--~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~- 305 (1009)
.++.+++|.++.|.+.. .+...+ ...++.+..+.++-|++..+. +++..+-+..|.+....
T Consensus 144 ~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~F-------pnv~sv~v~e~PlK~~s~ 216 (418)
T KOG2982|consen 144 DLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIF-------PNVNSVFVCEGPLKTESS 216 (418)
T ss_pred cchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhc-------ccchheeeecCcccchhh
Confidence 67788888888884330 111011 122455556666667766543 46777888888777643
Q ss_pred ccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCC
Q 047768 306 SINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGG 357 (1009)
Q Consensus 306 ~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 357 (1009)
...+..++.+..|+|+.|+|...+ -.+.+.++++|..|.+++|.+..
T Consensus 217 ek~se~~p~~~~LnL~~~~idswa-----svD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 217 EKGSEPFPSLSCLNLGANNIDSWA-----SVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred cccCCCCCcchhhhhcccccccHH-----HHHHHcCCchhheeeccCCcccc
Confidence 345777888889999999987644 35788888999999999988764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=5.5e-06 Score=83.00 Aligned_cols=159 Identities=18% Similarity=0.151 Sum_probs=113.0
Q ss_pred HHHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc------ccchHHHHHHHHHHHhcC--CCCcceEE
Q 047768 693 YKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ------KGGSKSFAAECEALRSIR--HRNLIKIV 764 (1009)
Q Consensus 693 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~--h~niv~l~ 764 (1009)
++.+-....++...---|+||-+-|+.-... |+.+-+|.-...- .-....|.+|...+.++. .-.+.+.+
T Consensus 10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv 87 (216)
T PRK09902 10 FNHWWATEGDWVEEPNYRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV 87 (216)
T ss_pred HHHHHhCCCceecCCCcCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc
Confidence 3444444444544445677999999997764 5578888764111 224578999999999984 33355555
Q ss_pred eeeeccccCCCceEEEEEeccCC-CCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCce
Q 047768 765 TICSSIDFKGVDFKALVYEYMQN-GSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNV 843 (1009)
Q Consensus 765 ~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Ni 843 (1009)
++...........++|+|-+++ -||.+++.+... .+.+..++..+..+++..++-||.. |+.|+|+.+.||
T Consensus 88 -f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khI 159 (216)
T PRK09902 88 -FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHI 159 (216)
T ss_pred -eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhhe
Confidence 3322222334456899998764 489999866432 1367778889999999999999999 999999999999
Q ss_pred eeCCCCc--eEEeccccccc
Q 047768 844 LLDHDMV--AHVSDFGLAKF 861 (1009)
Q Consensus 844 ll~~~~~--~kl~DfGla~~ 861 (1009)
+++.++. ++++||.-++.
T Consensus 160 ll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 160 YVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eecCCCCeeEEEEEhhccch
Confidence 9986666 99999987764
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.40 E-value=6.9e-09 Score=116.62 Aligned_cols=128 Identities=27% Similarity=0.289 Sum_probs=90.4
Q ss_pred ccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccc-cccCCCCccEEEe
Q 047768 466 LMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPV-TLGACTSLEYVEL 544 (1009)
Q Consensus 466 L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~L 544 (1009)
|...+.+.|.++ .-+..+.+.+....||||+|+++..- .+..++.|++|||+.|.|. .+|. ...++. |..|+|
T Consensus 166 L~~a~fsyN~L~--~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 166 LATASFSYNRLV--LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred HhhhhcchhhHH--hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 444455555554 22223444444556889999987432 6778899999999999998 4443 344454 999999
Q ss_pred cCcccccccccccccccccceEcCCCcccccccc-cccccccccCceecccccCcccC
Q 047768 545 QGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIP-KYLENLSFLQYLNLSYNHFEGEV 601 (1009)
Q Consensus 545 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~g~~ 601 (1009)
++|.++.. ..+.+|.+|+.|||++|-|++.-- .-+..|.+|+.|+|.+|++.+..
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 99998733 357889999999999999986332 23567788899999999987643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.2e-07 Score=107.92 Aligned_cols=101 Identities=22% Similarity=0.467 Sum_probs=77.1
Q ss_pred HHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCCCCCCcccc-CCccccccccccccCccccCCC
Q 047768 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVET-PSSSIGVKGTIGYVAPEYGLGG 895 (1009)
Q Consensus 817 ~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 895 (1009)
+++.|+.|+|... ++||++|.|++|.+++.+.+|++.|+++............+. +....-......|.|||++...
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4558999999764 899999999999999999999999998876554221111111 1111122345689999999998
Q ss_pred CCCCcccchHHHHHHHHHHhCCCC
Q 047768 896 EASMRGGVYSYGILLLEIFTRRRP 919 (1009)
Q Consensus 896 ~~~~~~DvwS~Gvvl~elltg~~p 919 (1009)
..+.++|+||+||++|.+..|..+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred cccccccceeeeeEEEEEecCCcc
Confidence 889999999999999999965554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.6e-06 Score=85.77 Aligned_cols=111 Identities=25% Similarity=0.267 Sum_probs=85.7
Q ss_pred hHHHHHHHHHHHhcC--CCCcceEEeeeeccccCCCceEEEEEeccCCC-CHHHHHhccCCCCCccCCCHHHHHHHHHHH
Q 047768 742 SKSFAAECEALRSIR--HRNLIKIVTICSSIDFKGVDFKALVYEYMQNG-SLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818 (1009)
Q Consensus 742 ~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i 818 (1009)
.....+|...+..+. .-.+.+.+++....... ....++|+|++++. +|.+++..... .+......++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~-~~~s~lite~l~~~~~L~~~~~~~~~------~~~~~~~~ll~~l 127 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGG-GYRSYLITEALPGAQDLRDLLQQWEQ------LDPSQRRELLRAL 127 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC-ceeEEEEEEeCCCcccHHHHHHhhcc------cchhhHHHHHHHH
Confidence 346778888888774 44455666665443211 24558999999874 89999886432 4556778899999
Q ss_pred HHHHHHHhhcCCCCceecCCCCCceeeCCCC---ceEEecccccccc
Q 047768 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHVSDFGLAKFL 862 (1009)
Q Consensus 819 a~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---~~kl~DfGla~~~ 862 (1009)
+..++-||.. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 128 ~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 128 ARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999 999999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1009 | ||||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-46 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-10 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-46 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-39 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-32 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-21 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-10 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 5e-10 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-09 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 1e-09 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 1e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-09 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 3e-09 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 6e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-08 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 3e-08 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 3e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-08 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 6e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-08 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 7e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-07 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 5e-07 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 4e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 1xku_A | 330 | Crystal Structure Of The Dimeric Protein Core Of De | 3e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 1xcd_A | 329 | Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo | 3e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 3e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-05 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 1e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-04 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 2e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-04 | ||
| 2wfh_A | 193 | The Human Slit 2 Dimerization Domain D4 Length = 19 | 6e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 7e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 7e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-04 | ||
| 4fcg_A | 328 | Structure Of The Leucine-Rich Repeat Domain Of The | 8e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 8e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-04 |
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FCG|A Chain A, Structure Of The Leucine-Rich Repeat Domain Of The Type Iii Effector Xcv3220 (Xopl) Length = 328 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 500 bits (1289), Expect = e-164
Identities = 161/575 (28%), Positives = 260/575 (45%), Gaps = 25/575 (4%)
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG 132
LD+ + + + P++G+ S L++++I+ N G+ I L+ L +++N F G
Sbjct: 203 EFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 133 RIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLS 192
IP L S N GEIP+ L L GL + N G +P G+ S
Sbjct: 262 PIPP--LPLKSLQYLSLAENKFTGEIPDFLSGA-CDTLTGLDLSGNHFYGAVPPFFGSCS 318
Query: 193 ALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNHFSGTIPPSVYNIS-SLVEIYLYGN 250
L + + +N G++P+ TL ++ L L + N FSG +P S+ N+S SL+ + L N
Sbjct: 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN 378
Query: 251 RFTGSLPIEIGKN-LPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINF 309
F+G + + +N L+ + N FTG +P + SN S L LHL+ N G + +
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 310 NGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTA 369
L L L L N L G + L L+ L L N G +P ++N T
Sbjct: 439 GSLSKLRDLKLWLNML-EG-----EIPQELMYVKTLETLILDFNDLTGEIPSGLSNC-TN 491
Query: 370 LIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQ 429
L +L N++ G IP I L NL L++ N +G IP +G+ ++L L L+ N
Sbjct: 492 LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFN 551
Query: 430 GTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRN--KLTGALPQQILEI 487
GTIP+++ + AN + G + N N + G +Q+ +
Sbjct: 552 GTIPAAMFKQSGKI----AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607
Query: 488 TTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGN 547
+T + +++ + G N S++ L ++ N SG IP +G+ L + L N
Sbjct: 608 STRN-PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666
Query: 548 SFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIF 607
SG+IP + L + LDLS N G+IP+ + L+ L ++LS N+ G +P G F
Sbjct: 667 DISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQF 726
Query: 608 KNKTGFSIVGNGKLCGGLDELHLPSCQARGSRKPN 642
+ + N LCG LP C +
Sbjct: 727 ETFPPAKFLNNPGLCG----YPLPRCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 441 bits (1137), Expect = e-141
Identities = 152/595 (25%), Positives = 254/595 (42%), Gaps = 79/595 (13%)
Query: 19 ALALSNETDCLSLLAIKSQLHDPLGVTSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLR 78
+ + S + L++ K L D + W+ + N C + GVTC R+ +VT +DL
Sbjct: 5 SPSQSLYREIHQLISFKDVLPDK-NLLPDWSSNK--NPC-TFDGVTC--RDDKVTSIDLS 58
Query: 79 NQSI---GGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIP 135
++ + +S + +L+ L + ++++ +G + L +L L+ NS SG
Sbjct: 59 SKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSG--- 114
Query: 136 TNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIG-NLSAL 194
+ L+ L+V N L S G L++L
Sbjct: 115 ---------------------PVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSL 153
Query: 195 RVIDIRTNRLWGKIPITL---SQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNR 251
V+D+ N + G + L +L + N SG + S +L + + N
Sbjct: 154 EVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVS--RCVNLEFLDVSSNN 211
Query: 252 FTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNG 311
F+ +P +G + L++ I N +G + S + L++L+++ NQF G +
Sbjct: 212 FSTGIP-FLG-DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP----- 264
Query: 312 LKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALI 371
LQYL LA+N F G +P ++ L
Sbjct: 265 ---------------------------PLPLKSLQYLSLAENKFTGEIPDFLSGACDTLT 297
Query: 372 DFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIP-HVIGELKNLQLLHLHANFLQG 430
+L N YG +PP + L SL + +N +G +P + +++ L++L L N G
Sbjct: 298 GLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG 357
Query: 431 TIPSSLGNLTL-LTYLSFGANNLQGNIPFSLGNC--KNLMFFFAPRNKLTGALPQQILEI 487
+P SL NL+ L L +NN G I +L L + N TG +P +
Sbjct: 358 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNC 417
Query: 488 TTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGN 547
+ L SL LS N L+G++P +G+L L L + N G+IP L +LE + L N
Sbjct: 418 SELV-SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476
Query: 548 SFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVP 602
+G IP LS+ T++ + LS N +G+IPK++ L L L LS N F G +P
Sbjct: 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 7e-20
Identities = 31/114 (27%), Positives = 53/114 (46%), Gaps = 2/114 (1%)
Query: 72 VTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFS 131
++ ++ GG SP N + +++++ N G IP IG++ L L L +N S
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 132 GRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLP 185
G IP + L N L G IP+ + + L L + + +N L+G +P
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA--LTMLTEIDLSNNNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-04
Identities = 12/54 (22%), Positives = 21/54 (38%), Gaps = 3/54 (5%)
Query: 559 SLTSIKELDLSQNNFS---GQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKN 609
+ +DLS + + L +L+ L+ L LS +H G V +
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSAS 101
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 330 bits (847), Expect = e-101
Identities = 93/590 (15%), Positives = 183/590 (31%), Gaps = 62/590 (10%)
Query: 45 TSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADN 104
++WN + +++ GV+ N RVT L L G + +G L+ L + + +
Sbjct: 57 GANWNFNKELDMWGAQPGVSLNS-NGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSH 115
Query: 105 DFHG----EIPDRIGNLFRLETLVLANNSFSGRIPTNLS--HCSKLITFSAHRNNLVGEI 158
P I E + S LI + + I
Sbjct: 116 GEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSI 175
Query: 159 PEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSL 218
+ R + N +T + ++ L+ LR + + + + +
Sbjct: 176 KKSS--RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS 232
Query: 219 AYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFT 278
Y T N+ L ++ +Y LP + LP ++ + N
Sbjct: 233 EY-----AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACNRGI 286
Query: 279 --------GSLPDSFSNASNLEVLHLAENQFR-GQVSINFNGLKDLSMLGLATNFLGNGA 329
++++++ N + V + +K L ML N L
Sbjct: 287 SGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQL---- 342
Query: 330 ANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPP--G 387
+ + KL L LA N +P + + + + + N++ IP
Sbjct: 343 ---EGKLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKL-KYIPNIFD 397
Query: 388 IANLVNLNSLRMEANRLTG-------TIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLT 440
++ ++++ N + + + N+ ++L N + +
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
Query: 441 LLTYLSFGANNLQG-------NIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLS 493
L+ ++ N L + + N L NKLT L T L
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLV 516
Query: 494 -LDLSDNLLNGSLPLGVGNLKSLVRLGI------ARNQFSGQIPVTLGACTSLEYVELQG 546
+DLS N + P N +L GI N+ + P + C SL +++
Sbjct: 517 GIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGS 575
Query: 547 NSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNH 596
N + + + +I LD+ N Y+ L Y+
Sbjct: 576 NDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 6e-64
Identities = 67/422 (15%), Positives = 136/422 (32%), Gaps = 44/422 (10%)
Query: 204 LWGKIP-ITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGK 262
+WG P ++L+ + L + SG +P ++ ++ L + L + + + K
Sbjct: 68 MWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPK 127
Query: 263 NLPN---LRNFVIYTNNFTGSLPDSFSNA--SNLEVLHLAENQFRGQVSINFNGLKDLSM 317
+ ++ + D S+L + + + + + +
Sbjct: 128 GISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187
Query: 318 LGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGK 377
+G +N + + + TKL+ Y+ ++ F N
Sbjct: 188 IGQLSNNITFVSKA-------VMRLTKLRQFYMGNSPFVAENICEAWENE------NSEY 234
Query: 378 NQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFL--------Q 429
Q Y T NL +L + + +P + L +QL+++ N
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294
Query: 430 GTIPSSLGNLTLLTYLSFGANNLQ-GNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEIT 488
+ + + G NNL+ + SL K L N+L G LP
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP----AFG 350
Query: 489 TLS--LSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGA--CTSLEYVEL 544
+ SL+L+ N + G + + L A N+ IP A + + ++
Sbjct: 351 SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDF 409
Query: 545 QGNSFSGTIPQSLSS-------LTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHF 597
N ++ ++ ++LS N S + S L +NL N
Sbjct: 410 SYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469
Query: 598 EG 599
Sbjct: 470 TE 471
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-57
Identities = 66/409 (16%), Positives = 122/409 (29%), Gaps = 44/409 (10%)
Query: 75 LDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSF---- 130
+ NL L + + + ++P + L ++ + +A N
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289
Query: 131 ----SGRIPTNLSHCSKLITFSAHRNNL-VGEIPEELISRRLFNLQGLSVGDNQLTGQLP 185
+ + K+ NNL + L +++ L L NQL G
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL--QKMKKLGMLECLYNQLEG-KL 346
Query: 186 ASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPP--SVYNISSLV 243
+ G+ L +++ N++ + L N IP ++S +
Sbjct: 347 PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMS 405
Query: 244 EIYLYGNRFTG-------SLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHL 296
I N L N+ + + N + + FS S L ++L
Sbjct: 406 AIDFSYNEIGSVDGKNFDPLDPTPF-KGINVSSINLSNNQISKFPKELFSTGSPLSSINL 464
Query: 297 AENQFRG-------QVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLY 349
N + NF L+ + L N L ++D T L +
Sbjct: 465 MGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL-TKLSDDFRA----TTLPYLVGID 519
Query: 350 LADNGFGGVLPHSIANLST-----ALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRL 404
L+ N F P N ST + N+ P GI +L L++ +N +
Sbjct: 520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578
Query: 405 TGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453
+ I N+ +L + N S + + Q
Sbjct: 579 R-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-36
Identities = 33/241 (13%), Positives = 80/241 (33%), Gaps = 15/241 (6%)
Query: 386 PGIA--NLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQG----TIPSSLGNL 439
PG++ + + L +E +G +P IG+L L++L L ++ + P +
Sbjct: 73 PGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISAN 132
Query: 440 TLLTYLSFGANNLQGNIPFSLG--NCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLS 497
+ Q + +L+ + ++ + IT +
Sbjct: 133 MSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR-ITLKDTQIGQL 191
Query: 498 DNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSL 557
N + + V L L + + + F + + EY T
Sbjct: 192 SNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKW 245
Query: 558 SSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVG 617
+L + ++++ ++P +L+ L +Q +N++ N K ++ +
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305
Query: 618 N 618
Sbjct: 306 K 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-07
Identities = 12/57 (21%), Positives = 23/57 (40%)
Query: 547 NSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPT 603
+ + SL+S + L L SG++P + L+ L+ L L + +
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERL 123
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = 6e-98
Identities = 87/308 (28%), Positives = 136/308 (44%), Gaps = 14/308 (4%)
Query: 333 LDFVDLLTNCTKLQ----YLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGT--IPP 386
L L N T L + + GVL + + + + +L + IP
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPS 70
Query: 387 GIANLVNLNSLRM-EANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYL 445
+ANL LN L + N L G IP I +L L L++ + G IP L + L L
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 446 SFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSL 505
F N L G +P S+ + NL+ N+++GA+P + L S+ +S N L G +
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190
Query: 506 PLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKE 565
P NL +L + ++RN G V G+ + + + L NS + + + ++
Sbjct: 191 PPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNG 248
Query: 566 LDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGL 625
LDL N G +P+ L L FL LN+S+N+ GE+P G + + N LCG
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS- 307
Query: 626 DELHLPSC 633
LP+C
Sbjct: 308 ---PLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 3e-68
Identities = 79/309 (25%), Positives = 124/309 (40%), Gaps = 40/309 (12%)
Query: 22 LSNETDCLSLLAIKSQLHDPLGVTSSWNRSACVNLCQ-HWTGVTCGRRNQ--RVTKLDLR 78
L N D +LL IK L +P SSW + + C W GV C Q RV LDL
Sbjct: 2 LCNPQDKQALLQIKKDLGNP-TTLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLS 58
Query: 79 NQSIGGILS---------------------------PYVGNLSFLRYINIADNDFHGEIP 111
++ P + L+ L Y+ I + G IP
Sbjct: 59 GLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118
Query: 112 DRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNL- 170
D + + L TL + N+ SG +P ++S L+ + N + G IP+ S L
Sbjct: 119 DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS--FSKLF 176
Query: 171 QGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSG 230
+++ N+LTG++P + NL+ L +D+ N L G + + +H+ N +
Sbjct: 177 TSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 231 TIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASN 290
+ V +L + L NR G+LP + L L + + NN G +P N
Sbjct: 236 DL-GKVGLSKNLNGLDLRNNRIYGTLPQGLT-QLKFLHSLNVSFNNLCGEIPQG-GNLQR 292
Query: 291 LEVLHLAEN 299
+V A N
Sbjct: 293 FDVSAYANN 301
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 1e-87
Identities = 109/312 (34%), Positives = 166/312 (53%), Gaps = 32/312 (10%)
Query: 692 SYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE-QKGGSKSFAAECE 750
S +EL A++ FS+ N +GRG FG VYKG L +G LVAVK + E +GG F E E
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 751 ALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQ 810
+ HRNL+++ C + + LVY YM NGS+ L +R + L +
Sbjct: 80 MISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPE--SQPPLDWPK 132
Query: 811 RLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNV 870
R I + A + YLH HC P I+H D+K +N+LLD + A V DFGLAK + +
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDT 189
Query: 871 -VETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMF---NE 926
V T V+GTIG++APEY G++S + V+ YG++LLE+ T +R + ++
Sbjct: 190 HVTT-----AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 927 GLTLHEFAKRALPE-KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPF 985
+ L ++ K L E K+ +VD L + +E + +I+ + C+ SP
Sbjct: 245 DVMLLDWVKGLLKEKKLEALVDVDL----------QGNYKDEEVEQLIQVALLCTQSSPM 294
Query: 986 DRMEMTDVVVKL 997
+R +M++VV L
Sbjct: 295 ERPKMSEVVRML 306
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 6e-87
Identities = 111/575 (19%), Positives = 202/575 (35%), Gaps = 48/575 (8%)
Query: 53 CVNLCQHWTGVTCGRRN---------QRVTKLDLRNQSIGGILSPYVGNLSFLRYINIAD 103
CV + + T C N LDL + + S + L+ ++++
Sbjct: 3 CVEVVPNIT-YQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 104 NDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELI 163
+ +L L TL+L N S S L A NL +
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI- 120
Query: 164 SRRLFNLQGLSVGDNQLTG-QLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAY-- 220
L L+ L+V N + +LP NL+ L +D+ +N++ L L +
Sbjct: 121 -GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179
Query: 221 --LHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFT 278
L + N + I P + L ++ L N + ++ + L L + F
Sbjct: 180 LSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 279 GSL------PDSFSNASNLEVLHLAENQ---FRGQVSINFNGLKDLSMLGLATNFLGNGA 329
+ NL + + + FN L ++S L +
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSV------ 292
Query: 330 ANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIA 389
++ V + Q+L L + FG + +L L G
Sbjct: 293 --TIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK------RLTFTSNKGGNAFSEV 344
Query: 390 NLVNLNSLRMEANRLT--GTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSF 447
+L +L L + N L+ G +L+ L L N + T+ S+ L L +L F
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 403
Query: 448 GANNLQGNIPFS-LGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLP 506
+NL+ FS + +NL++ A +++L L ++ N +
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE-VLKMAGNSFQENFL 462
Query: 507 LGV-GNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKE 565
+ L++L L +++ Q P + +SL+ + + N+F L S++
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 522
Query: 566 LDLSQNNFSGQIPKYLENL-SFLQYLNLSYNHFEG 599
LD S N+ + L++ S L +LNL+ N F
Sbjct: 523 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 4e-70
Identities = 84/507 (16%), Positives = 145/507 (28%), Gaps = 53/507 (10%)
Query: 109 EIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLF 168
+IPD + + L L+ N + +L R + + L
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY--QSLS 76
Query: 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHF 228
+L L + N + + LS+L+ + L + L +L L+V N
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 229 -SGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIY----TNNFTGSLPD 283
S +P N+++L + L N+ ++ L + + N P
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR-VLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 284 SFSNASNLEVLHLAENQFRGQVSIN-FNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNC 342
+F L L L N V GL L + L N + L
Sbjct: 196 AFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 254
Query: 343 TKLQYLYLADN---GFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRM 399
L + + L T + F+L I + L +
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCL-TNVSSFSLVSVTI--ERVKDFSYNFGWQHLEL 311
Query: 400 EANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ--GNIP 457
+ + LK L +G S +L L +L N L G
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTSN-----KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCS 366
Query: 458 FSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVR 517
S +L LDLS N + + L+ L
Sbjct: 367 QSDFGTTSL-------------------------KYLDLSFNGVIT-MSSNFLGLEQLEH 400
Query: 518 LGIARNQFSGQIPV-TLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQ 576
L + + +L Y+++ + L+S++ L ++ N+F
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460
Query: 577 IPKY-LENLSFLQYLNLSYNHFEGEVP 602
L L +L+LS E P
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSP 487
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 3e-58
Identities = 83/497 (16%), Positives = 162/497 (32%), Gaps = 46/497 (9%)
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHG-EIPDRIGNLFRLETLVLANNSFS 131
KL ++ + + +G+L L+ +N+A N ++P+ NL LE L L++N
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 132 GRIPTNLSHCSKLITFSAH----RNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPA- 186
T+L ++ + N + P + L L++ +N + +
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF---KEIRLHKLTLRNNFDSLNVMKT 219
Query: 187 SIGNLSALRVIDIRTNRLWGKIPIT---LSQLTSLAYLHVGDNHFS------GTIPPSVY 237
I L+ L V + + + S L L L + + + I
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 238 NISSLVEIYLYGNRFTGSLPIEIGKNLPNLR----------------NFVIYTNNFTGSL 281
++++ L +L + + G
Sbjct: 280 CLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 339
Query: 282 PDSFSNASNLEVLHLAENQ--FRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLL 339
S + +LE L L+ N F+G S + G L L L+ N + +
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-------ITMSSNF 392
Query: 340 TNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRM 399
+L++L + + S+ LI ++ L +L L+M
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 400 EANRLTGTI-PHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPF 458
N P + EL+NL L L L+ P++ +L+ L L+ NN F
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512
Query: 459 SLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLG--VGNLKSLV 516
+L N + + Q++ + L+L+ N + + +K
Sbjct: 513 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQR 572
Query: 517 RLGIARNQFSGQIPVTL 533
+L + + P
Sbjct: 573 QLLVEVERMECATPSDK 589
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-46
Identities = 74/485 (15%), Positives = 144/485 (29%), Gaps = 73/485 (15%)
Query: 73 TKLDL-RNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLE----TLVLAN 127
+L++ N L Y NL+ L +++++ N + L ++ +L L+
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 128 NSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISR---------------------- 165
N + P L + N + + I
Sbjct: 187 NPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
Query: 166 ----RLFNLQGLSVGDNQLT------GQLPASIGNLSALRVIDIRTNRLWGKIPITLSQL 215
L L L++ + +L + L+ + + + + S
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYN 303
Query: 216 TSLAYLHVGDNHFS-------------------GTIPPSVYNISSLVEIYLYGNR--FTG 254
+L + + F G S ++ SL + L N F G
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG 363
Query: 255 SLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSIN-FNGLK 313
+L+ + N + +F LE L + + + F L+
Sbjct: 364 CCSQSDF-GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 314 DLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDF 373
+L L ++ F + + L+ L +A N F I L
Sbjct: 422 NLIYLDISHTHTRV------AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475
Query: 374 NLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIP 433
+L + Q+ P +L +L L M N L +LQ+L N + +
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535
Query: 434 SSLGNL-TLLTYLSFGANNLQGNIPFS--LGNCKNLMFFFAPRNKLTGALPQQILEITTL 490
L + + L +L+ N+ L K+ ++ A P + L
Sbjct: 536 QELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVL 595
Query: 491 SLSLD 495
SL++
Sbjct: 596 SLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-37
Identities = 58/360 (16%), Positives = 115/360 (31%), Gaps = 48/360 (13%)
Query: 70 QRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNS 129
V+ L + +I + +++ + + F ++ +L L S
Sbjct: 282 TNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSL-----KRLTFTS 334
Query: 130 FSGRIPTNLSHCSKLITFSAHRNNL--VGEIPEELISRRLFNLQGLSVGDNQLTGQLPAS 187
G + L RN L G + +L+ L + N + + ++
Sbjct: 335 NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD--FGTTSLKYLDLSFNGVIT-MSSN 391
Query: 188 IGNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIY 246
L L +D + + L L +L YL + H +SSL +
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 247 LYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVS 306
+ GN F + +I L NL + P +F++ S+L+VL+++ N F +
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 307 INFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANL 366
LQ L + N + +
Sbjct: 512 ------------------------------FPYKCLNSLQVLDYSLNHIMTSKKQELQHF 541
Query: 367 STALIDFNLGKNQIYGTIPPG--IANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLH 424
++L NL +N T + + + L +E R+ P + + + +L L+
Sbjct: 542 PSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP---SDKQGMPVLSLN 598
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 2e-86
Identities = 111/557 (19%), Positives = 188/557 (33%), Gaps = 43/557 (7%)
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG 132
T+L L + SI I + L ++++ N L L+ L+L+NN
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 133 RIPTNLS--HCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIG- 189
L S L N + P + L GL + + QL L +
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCF--HAIGRLFGLFLNNVQLGPSLTEKLCL 217
Query: 190 --NLSALRVIDIRTNRLWGKIPITLSQL--TSLAYLHVGDNHFSGTIPPSVYNISSLVEI 245
+++R + + ++L T L T+L L + N+ + S + L
Sbjct: 218 ELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYF 277
Query: 246 YLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSL---------PDSFSNASNLEVLHL 296
+L N + L N+R + + S+ SF LE L++
Sbjct: 278 FLEYNNIQHLFSHSLH-GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNM 336
Query: 297 AENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFG 356
+N G S F GL +L L L+ +F + FV L + L L L N
Sbjct: 337 EDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL--AHSPLHILNLTKNKIS 394
Query: 357 GVLPHSIANLSTALIDFNLGKNQIYGTIPPG-IANLVNLNSLRMEANRLTGTIPHVIGEL 415
+ + + L L +LG N+I + L N+ + + N+ + +
Sbjct: 395 KIESDAFSWL-GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALV 453
Query: 416 KNLQLLHLHANFLQG--TIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPR 473
+LQ L L L+ + PS L LT L NN+ L + L
Sbjct: 454 PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQH 513
Query: 474 NKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTL 533
N L L + G + L L L + N F
Sbjct: 514 NNLA-----------------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVF 556
Query: 534 GACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLE-NLSFLQYLNL 592
L+ ++L N+ + ++ S+K L+L +N + K L L++
Sbjct: 557 KDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDM 616
Query: 593 SYNHFEGEVPTKGIFKN 609
+N F+ + F N
Sbjct: 617 RFNPFDCTCESIAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 1e-81
Identities = 94/540 (17%), Positives = 183/540 (33%), Gaps = 62/540 (11%)
Query: 72 VTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFS 131
+T L+L + + + + S L +++ N P+ L L+ L L +N S
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 132 GRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNL 191
+ C+ L N++ + NL L + N L+ + L
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPF--VKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 192 SALRVIDIRTNRLWGKIPITLS--QLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYG 249
L+ + + N++ L +SL L + N P + I L ++L
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204
Query: 250 NRFTGSLPIEIGK--NLPNLRNFVIYTNNFTGSLPDSFSN--ASNLEVLHLAENQFRGQV 305
+ SL ++ ++RN + + + + +F +NL +L L+ N
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264
Query: 306 SINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIAN 365
+ +F L L L N + + ++ L ++YL L +
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHS------LHGLFNVRYLNLKRS------------ 306
Query: 366 LSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHA 425
++ + L L L ME N + G ++ L NL+ L L
Sbjct: 307 ----FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSN 362
Query: 426 NFLQGTIPSSLG----NLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALP 481
+F ++ + L L+ N + + +L
Sbjct: 363 SFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHL--------------- 407
Query: 482 QQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGIARNQFSGQIPVTLGACTSLE 540
LDL N + L L+++ + ++ N++ + SL+
Sbjct: 408 ----------EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQ 457
Query: 541 YVELQGNSFSG--TIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFE 598
+ L+ + + P L ++ LDLS NN + LE L L+ L+L +N+
Sbjct: 458 RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 1e-80
Identities = 87/521 (16%), Positives = 169/521 (32%), Gaps = 49/521 (9%)
Query: 96 LRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLV 155
+ + ++PD + + L L +N N + S+L + N +
Sbjct: 6 HEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 156 GEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQL 215
PE ++L L+ L++ N+L+ + + L + + +N + +
Sbjct: 63 KLEPELC--QKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 216 TSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGK-NLPNLRNFVIYT 274
+L L + N S T + + +L E+ L N+ E+ +L+ + +
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 275 NNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLD 334
N P F L L L Q ++
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC------------------------ 216
Query: 335 FVDLLTNCTKLQYLYLADNGFGGVLPHSIANLS-TALIDFNLGKNQIYGTIPPGIANLVN 393
L T ++ L L+++ + L T L +L N + A L
Sbjct: 217 ---LELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQ 273
Query: 394 LNSLRMEANRLTGTIPHVIGELKNLQLLHLHANF---------LQGTIPSSLGNLTLLTY 444
L +E N + H + L N++ L+L +F L S L L +
Sbjct: 274 LEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEH 333
Query: 445 LSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLT-GALPQQILEITTLSL--SLDLSDNLL 501
L+ N++ G NL + + + L + S L+L+ N +
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393
Query: 502 NGSLPLGVGNLKSLVRLGIARNQFSGQIPV-TLGACTSLEYVELQGNSFSGTIPQSLSSL 560
+ L L L + N+ ++ ++ + L N + S + +
Sbjct: 394 SKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALV 453
Query: 561 TSIKELDLSQNNFSG--QIPKYLENLSFLQYLNLSYNHFEG 599
S++ L L + P + L L L+LS N+
Sbjct: 454 PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-51
Identities = 74/407 (18%), Positives = 133/407 (32%), Gaps = 39/407 (9%)
Query: 66 GRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVL 125
G + +T LDL ++ + + L L Y + N+ + LF + L L
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 126 ANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLP 185
+ I +L + L L+ L++ DN + G
Sbjct: 304 KRSFTKQSIS---------------LASLPKIDDFSF--QWLKCLEHLNMEDNDIPGIKS 346
Query: 186 ASIGNLSALRVIDIRTNRLWGKIPITLS----QLTSLAYLHVGDNHFSGTIPPSVYNISS 241
L L+ + + + + + + L L++ N S + +
Sbjct: 347 NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGH 406
Query: 242 LVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQF 301
L + L N L + + L N+ + N + +SF+ +L+ L L
Sbjct: 407 LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL 466
Query: 302 RGQVSI--NFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADN------ 353
+ S F L++L++L L+ N + +++ D+L KL+ L L N
Sbjct: 467 KNVDSSPSPFQPLRNLTILDLSNNNI-----ANIN-DDMLEGLEKLEILDLQHNNLARLW 520
Query: 354 --GFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHV 411
G + + LS L NL N +L L + + N L V
Sbjct: 521 KHANPGGPIYFLKGLS-HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
Query: 412 IGELKNLQLLHLHANFLQGTIPSSLG-NLTLLTYLSFGANNLQGNIP 457
+L+ L+L N + G LT L N
Sbjct: 580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-44
Identities = 63/272 (23%), Positives = 96/272 (35%), Gaps = 10/272 (3%)
Query: 337 DLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNS 396
DL TN + L L N + + + L ++G N I P L L
Sbjct: 22 DLPTN---ITVLNLTHNQLRRLPAANFTRY-SQLTSLDVGFNTISKLEPELCQKLPMLKV 77
Query: 397 LRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNI 456
L ++ N L+ NL LHL +N +Q + L L N L
Sbjct: 78 LNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTK 137
Query: 457 PFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSL-SLDLSDNLLNGSLPLGVGNLKSL 515
+ +NL NK+ +++ SL L+LS N + P + L
Sbjct: 138 LGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRL 197
Query: 516 VRLGIARNQFSGQIPVTLG---ACTSLEYVELQGNSFSGTIPQSLSSL--TSIKELDLSQ 570
L + Q + L A TS+ + L + S T + L T++ LDLS
Sbjct: 198 FGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSY 257
Query: 571 NNFSGQIPKYLENLSFLQYLNLSYNHFEGEVP 602
NN + L L+Y L YN+ +
Sbjct: 258 NNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFS 289
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-29
Identities = 44/243 (18%), Positives = 79/243 (32%), Gaps = 18/243 (7%)
Query: 73 TKLDLRNQSIGGILSPYV-GNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFS 131
LDL IG L+ L + I ++ N + + + L+ L+L +
Sbjct: 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467
Query: 132 G--RIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLT-------- 181
P+ L NN+ + L L L+ L + N L
Sbjct: 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG--LEKLEILDLQHNNLARLWKHANP 525
Query: 182 GQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISS 241
G + LS L ++++ +N L L + +G N+ + N S
Sbjct: 526 GGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVS 585
Query: 242 LVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPD-----SFSNASNLEVLHL 296
L + L N T G NL + N F + ++ N ++ + L
Sbjct: 586 LKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPEL 645
Query: 297 AEN 299
+ +
Sbjct: 646 SSH 648
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-22
Identities = 39/183 (21%), Positives = 57/183 (31%), Gaps = 28/183 (15%)
Query: 417 NLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKL 476
+ ++ L +P L T +T L+ N L+ + L
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQL---------- 51
Query: 477 TGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGAC 536
SLD+ N ++ P L L L + N+ S T C
Sbjct: 52 ---------------TSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFC 96
Query: 537 TSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNH 596
T+L + L NS ++ LDLS N S L LQ L LS N
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156
Query: 597 FEG 599
+
Sbjct: 157 IQA 159
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 6e-08
Identities = 16/68 (23%), Positives = 25/68 (36%), Gaps = 4/68 (5%)
Query: 536 CT-SLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSY 594
CT S E + + +P L T+I L+L+ N S L L++ +
Sbjct: 2 CTVSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58
Query: 595 NHFEGEVP 602
N P
Sbjct: 59 NTISKLEP 66
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 2e-80
Identities = 89/623 (14%), Positives = 186/623 (29%), Gaps = 101/623 (16%)
Query: 24 NETDCLSLLAIKSQLH-----------DPLGVTSSWNRSACVNLCQHWTGVTCGRRNQRV 72
D +L AI L + + +WN + +++ GV N RV
Sbjct: 267 YIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRV 325
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG 132
T L L G + +G L+ L+ ++ + + +
Sbjct: 326 TGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRM 385
Query: 133 RIPTNLSHCSKLITFSAHRNNLVGEIPE--ELISRRLFNLQGLSVGD--NQLTGQLPASI 188
+ + S + + PE + +L+ +G+ N++T + +I
Sbjct: 386 HYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAI 444
Query: 189 GNLSALRVIDIRTNRL-------------------WGKIPITLSQLTSLAYLHVGDNHFS 229
L+ L++I + + ++ S L L + + +
Sbjct: 445 QRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNM 504
Query: 230 GTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNAS 289
+P +Y++ L + + NR L D
Sbjct: 505 TQLPDFLYDLPELQSLNIACNRGIS----------------AAQLKADWTRLADDEDTGP 548
Query: 290 NLEVLHLAENQFRG-QVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYL 348
+++ ++ N S + + L +L N + ++ KL L
Sbjct: 549 KIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVH--------NKVRHLEAFGTNVKLTDL 600
Query: 349 YLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPP--GIANLVNLNSLRMEANRLTG 406
L N +P + + N++ IP ++ + S+ N++
Sbjct: 601 KLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS 658
Query: 407 TIPHV-----IGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ-------G 454
++ + N + L N +Q + ++ + N +
Sbjct: 659 EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLK 718
Query: 455 NIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSL-SLDLSDNLLNGSLPLGVGNLK 513
+ N L NKLT L T L ++D+S N + S P N
Sbjct: 719 PKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSS 776
Query: 514 SLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNF 573
L GI + +GN P +++ S+ +L + N+
Sbjct: 777 QLKAFGIRHQRD------------------AEGNRILRQWPTGITTCPSLIQLQIGSNDI 818
Query: 574 SGQIPKYLENLSFLQYLNLSYNH 596
+ + L L L+++ N
Sbjct: 819 RK-VDEKL--TPQLYILDIADNP 838
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 8e-53
Identities = 69/417 (16%), Positives = 125/417 (29%), Gaps = 38/417 (9%)
Query: 204 LWGKIP-ITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGK 262
+WG P + L + L + G +P ++ ++ L + + T S + +
Sbjct: 310 MWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE 369
Query: 263 NLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLAT 322
L + L + L ++ + +K S + L
Sbjct: 370 ELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR--NPEMKPIKKDSRISLKD 427
Query: 323 NFLGNGAANDLDFV-DLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIY 381
+GN N + F+ + TKLQ +Y A++ F + D N + Y
Sbjct: 428 TQIGN-LTNRITFISKAIQRLTKLQIIYFANSPFTYDNI------AVDWEDANSDYAKQY 480
Query: 382 GTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQG---------TI 432
+NL +L + + +P + +L LQ L++ N +
Sbjct: 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540
Query: 433 PSSLGNLTLLTYLSFGANNLQG-NIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLS 491
+ G NNL+ SL L NK+ L T
Sbjct: 541 ADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE----AFGTNV 595
Query: 492 --LSLDLSDNLLNGSLPLGVG-NLKSLVRLGIARNQFSGQIP--VTLGACTSLEYVELQG 546
L L N + +P + LG + N+ IP + + V+
Sbjct: 596 KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSY 653
Query: 547 NSFSGTIPQSLSSL-----TSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFE 598
N S+ + + LS N + S + + LS N
Sbjct: 654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 1e-28
Identities = 35/243 (14%), Positives = 74/243 (30%), Gaps = 11/243 (4%)
Query: 372 DFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGT 431
+FN + + N + L + G +P IG+L L++L + +
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 432 IPSSLGNLTLLTYLSFGANNLQGNIP-FSLGNCKNLMFFFAPRNKLTG---ALPQQILEI 487
+ ++ + L + L ++ + P +
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422
Query: 488 TTLS-LSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQG 546
+L + N + + + L L + A + F+ E
Sbjct: 423 ISLKDTQIGNLTNRI-TFISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDY 476
Query: 547 NSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGI 606
S S+L + +++L Q+P +L +L LQ LN++ N K
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536
Query: 607 FKN 609
+
Sbjct: 537 WTR 539
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 12/88 (13%), Positives = 29/88 (32%)
Query: 547 NSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGI 606
+ + L + + L L+ G++P + L+ L+ L+ + G
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 607 FKNKTGFSIVGNGKLCGGLDELHLPSCQ 634
+ S ++ ++ L Q
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQ 396
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 2e-77
Identities = 105/333 (31%), Positives = 157/333 (47%), Gaps = 30/333 (9%)
Query: 668 YARRRRSAHKSSNTSQMEQQFPMV-SYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENG 726
Y++ S + + ++S + +L +ATN F IG G FG VYKGVL +G
Sbjct: 5 YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDG 63
Query: 727 MLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQ 786
VA+K E G + F E E L RH +L+ ++ C + L+Y+YM+
Sbjct: 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILIYKYME 118
Query: 787 NGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD 846
NG+L+ L+ D +S QRL I I A + YLH I+H D+K N+LLD
Sbjct: 119 NGNLKRHLYGSDLPTMS--MSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLD 173
Query: 847 HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSY 906
+ V ++DFG++K G ++ S VKGT+GY+ PEY + G + + VYS+
Sbjct: 174 ENFVPKITDFGISK------KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227
Query: 907 GILLLEIFTRRRPTESMFNEG-LTLHEFAKRALPE-KVMEIVDPSLLPLEEERTNSRRVR 964
G++L E+ R + L E+A + ++ +IVDP+L
Sbjct: 228 GVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL----------ADKI 277
Query: 965 NEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997
E L T V C S DR M DV+ KL
Sbjct: 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 4e-71
Identities = 100/540 (18%), Positives = 180/540 (33%), Gaps = 25/540 (4%)
Query: 72 VTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFS 131
L+ + I + L L ++++ + D + RL+TLVL N
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 132 GRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNL 191
T LS L + + L L+ L +G N ++
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPL--HNQKTLESLYLGSNHISSIKLPKGFPT 152
Query: 192 SALRVIDIRTNRLWGKIPITLSQLTSLA--YLHVGDNHFSGTIPPSVYNISSLVEIYLYG 249
L+V+D + N + +S L L++ N + I P ++ + + G
Sbjct: 153 EKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGG 211
Query: 250 NRFTGSLPIEI-GKNLPNLRNFVIYTNNFTGSLPDSFSN--ASNLEVLHLAENQFRGQVS 306
+ + + + +L + P F ++E ++L ++ F S
Sbjct: 212 TQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271
Query: 307 INFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANL 366
F+ L L L L L + L+ L L+ N F + S +N
Sbjct: 272 NTFHCFSGLQELDLTATHLSE-------LPSGLVGLSTLKKLVLSANKFENLCQISASNF 324
Query: 367 STALIDFNLGKNQIYGTIPPG-IANLVNLNSLRMEANRLT--GTIPHVIGELKNLQLLHL 423
+L ++ N + G + NL NL L + + + + L +LQ L+L
Sbjct: 325 -PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNL 383
Query: 424 HANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFS-LGNCKNLMFFFAPRNKLTGALPQ 482
N + L L L+ S N L + L + Q
Sbjct: 384 SYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ 443
Query: 483 QILEITTLSLSLDLSDNLLNGSLPLGVG---NLKSLVRLGIARNQFSGQIPVTLGACTSL 539
+ L L+L N L L L ++ S + +
Sbjct: 444 LFDGLPAL-QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM 502
Query: 540 EYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEG 599
+V+L N + + ++LS L I L+L+ N+ S +P L LS + +NL N +
Sbjct: 503 NHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 1e-69
Identities = 88/514 (17%), Positives = 166/514 (32%), Gaps = 26/514 (5%)
Query: 109 EIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLF 168
EIP + N E L + N T S L R + + +
Sbjct: 26 EIPGTLPNS--TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTF--QSQH 81
Query: 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHF 228
L L + N L ++ AL+ + + I L +L L++G NH
Sbjct: 82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI 141
Query: 229 SGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIY-TNNFTGSLPDSFSN 287
S P + L + N ++ +L N + N + +
Sbjct: 142 SSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMS-SLQQATNLSLNLNGNDIAGIEPGAFD 200
Query: 288 ASNLEVLHLAENQFRGQV--SINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNC-TK 344
++ + L+ Q + + + ++ L + D+ C
Sbjct: 201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD-----EDISPAVFEGLCEMS 255
Query: 345 LQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRL 404
++ + L + F + ++ S L + +L + +P G+ L L L + AN+
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSG-LQELDLTATHL-SELPSGLVGLSTLKKLVLSANKF 313
Query: 405 TGTIPHVIGELKNLQLLHLHANFLQGTIPS-SLGNLTLLTYLSFGANNLQ--GNIPFSLG 461
+L L + N + + + L NL L L ++++ L
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
Query: 462 NCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGI 520
N +L N+ + E L LDL+ L NL L L +
Sbjct: 374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLE-LLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432
Query: 521 ARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQ---SLSSLTSIKELDLSQNNFSGQI 577
+ + +L+++ LQGN F Q SL +L ++ L LS + S
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID 492
Query: 578 PKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKT 611
+L + +++LS+N +
Sbjct: 493 QHAFTSLKMMNHVDLSHNRLTSSSI--EALSHLK 524
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 4e-55
Identities = 89/491 (18%), Positives = 160/491 (32%), Gaps = 47/491 (9%)
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG 132
L I I + N L + + N + +L+ L NN+
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
Query: 133 RIPTNLSHCSKL--ITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGN 190
++S + ++ + + N++ I Q L+ G Q + + N
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAF--DSAVFQSLNFGGTQNLLVIFKGLKN 224
Query: 191 --LSALRVIDIRTNRLWGKIPITLSQL--TSLAYLHVGDNHFSGTIPPSVYNISSLVEIY 246
+ +L + P L S+ +++ ++F + + S L E+
Sbjct: 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELD 284
Query: 247 LYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVS 306
L + LP + L L+ V+ N F S SN +L L + N R ++
Sbjct: 285 LTATHLS-ELPSGLV-GLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342
Query: 307 IN-FNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIAN 365
L++L L L+ + + +L N + LQ L L+ N + +
Sbjct: 343 TGCLENLENLRELDLSHDDIETSDCCNLQL----RNLSHLQSLNLSYNEPLSLKTEAFKE 398
Query: 366 LSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLH 424
L +L ++ NL L L + + L + + L LQ L+L
Sbjct: 399 C-PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457
Query: 425 ANFLQGTI---PSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALP 481
N +SL L L L +L + + K +
Sbjct: 458 GNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM--------------- 502
Query: 482 QQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEY 541
+DLS N L S + +LK + L +A N S +P L +
Sbjct: 503 ----------NHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRT 551
Query: 542 VELQGNSFSGT 552
+ L+ N T
Sbjct: 552 INLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-37
Identities = 60/367 (16%), Positives = 117/367 (31%), Gaps = 37/367 (10%)
Query: 70 QRVTKLDLRNQSIGGILSPYVGNLSF--LRYINIADNDFHGEIPDRIGNLFRLETLVLAN 127
Q + + I L + IN+ + F + L+ L L
Sbjct: 228 QSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTA 287
Query: 128 NSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQL-PA 186
S +P+ L S L N +L LS+ N +L
Sbjct: 288 THLS-ELPSGLVGLSTLKKLVLSANKFENLCQISA--SNFPSLTHLSIKGNTKRLELGTG 344
Query: 187 SIGNLSALRVIDIRTNRLW--GKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVE 244
+ NL LR +D+ + + + L L+ L L++ N + L
Sbjct: 345 CLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLEL 404
Query: 245 IYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQ 304
+ L R +NL L+ + + S F L+ L+L N F
Sbjct: 405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK- 463
Query: 305 VSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIA 364
++ + L +L+ L L+ + H+
Sbjct: 464 --------------------------GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFT 497
Query: 365 NLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLH 424
+L + +L N++ + +++L + L + +N ++ +P ++ L + ++L
Sbjct: 498 SL-KMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLR 555
Query: 425 ANFLQGT 431
N L T
Sbjct: 556 QNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-22
Identities = 40/238 (16%), Positives = 65/238 (27%), Gaps = 33/238 (13%)
Query: 402 NRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLG 461
L IP + + + L N L ++ L LT+L + +
Sbjct: 22 LGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQ 78
Query: 462 NCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIA 521
+ L +L L+ N L + K+L L
Sbjct: 79 SQHRLD-------------------------TLVLTANPLIFMAETALSGPKALKHLFFI 113
Query: 522 RNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYL 581
+ S + L +LE + L N S +K LD N + +
Sbjct: 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173
Query: 582 ENLSFLQ--YLNLSYNHFEGEVPTKGIFKNKTGFSIVGN---GKLCGGLDELHLPSCQ 634
+L LNL+ N G P + G + GL + S
Sbjct: 174 SSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLW 231
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-17
Identities = 27/179 (15%), Positives = 45/179 (25%), Gaps = 28/179 (15%)
Query: 421 LHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGAL 480
+ L IP +L L F N L + NL
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINL-------------- 59
Query: 481 PQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLE 540
LDL+ + + L L + N L +L+
Sbjct: 60 -----------TFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALK 108
Query: 541 YVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEG 599
++ S L + +++ L L N+ S L+ L+ N
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 7e-04
Identities = 23/129 (17%), Positives = 48/129 (37%), Gaps = 19/129 (14%)
Query: 71 RVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSF 130
R+ L L + I +L + +++++ N + + +L + L LA+N
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI 535
Query: 131 SGRIPTNLSHCSKLITFSAHRNNLVGEI------------------PEELISRRLFNLQG 172
S +P+ L S+ T + +N L E+ + L+G
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRG 595
Query: 173 LSVGDNQLT 181
+ + D L+
Sbjct: 596 VRLSDVTLS 604
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 1e-69
Identities = 85/318 (26%), Positives = 134/318 (42%), Gaps = 44/318 (13%)
Query: 692 SYKELSKATNEFSS------SNTIGRGSFGFVYKGVLHENGMLVAVK----VINLEQKGG 741
S+ EL TN F N +G G FG VYKG + N VAVK ++++ +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEEL 73
Query: 742 SKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQL 801
+ F E + + +H NL++++ S D LVY YM NGSL + L D
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 802 GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861
LS R I A+ + +LH + +H D+K +N+LLD A +SDFGLA+
Sbjct: 129 ---PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR- 181
Query: 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTE 921
+ + GT Y+APE L GE + + +YS+G++LLEI T +
Sbjct: 182 -----ASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 922 SMFNEGLTLHEFAKRALPEK--VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVAC 979
L + + E+ + + +D + + + A+ C
Sbjct: 236 EHREPQ-LLLDIKEEIEDEEKTIEDYIDKKM-----------NDADSTSVEAMYSVASQC 283
Query: 980 SIESPFDRMEMTDVVVKL 997
E R ++ V L
Sbjct: 284 LHEKKNKRPDIKKVQQLL 301
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 1e-68
Identities = 97/542 (17%), Positives = 181/542 (33%), Gaps = 34/542 (6%)
Query: 72 VTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFS 131
+DL + + S N S L++++++ + L L L+L N
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 132 GRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTG-QLPASIGN 190
P + S + L A L + +L L+ L+V N + +LPA N
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPI--GQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 191 LSALRVIDIRTNRLWGKIPITLSQLTSLA----YLHVGDNHFSGTIPPSVYNISSLVEIY 246
L+ L +D+ N + L L L + N I + L E+
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELT 210
Query: 247 LYGNRFTGSLPIEIGKNLPNLR------NFVIYTNNFTGSLPDSFSNASNL--EVLHLAE 298
L GN + ++ +NL L N P ++ + L
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270
Query: 299 NQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGV 358
+ F+ L ++S + LA + +++ + K Q L +
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLA--------GVSIKYLEDVPKHFKWQSLSIIRCQLKQF 322
Query: 359 LPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNL 418
+ L + L N+ +I L +L+ L + N L+ + +L
Sbjct: 323 PTLDLPFLKS----LTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376
Query: 419 QLLHLHANFLQ-GTIPSSLGNLTLLTYLSFGANNLQGNIPFS-LGNCKNLMFFFAPRNKL 476
L HL +F + ++ L L +L F + L+ FS + + L++
Sbjct: 377 SLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436
Query: 477 TGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGIARNQFSGQIPVTLGA 535
L +T+L+ +L ++ N + V N +L L +++ Q
Sbjct: 437 KIDFDGIFLGLTSLN-TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDT 495
Query: 536 CTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYN 595
L+ + + N+ + L S+ LD S N L + NL+ N
Sbjct: 496 LHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
Query: 596 HF 597
Sbjct: 556 SV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 1e-60
Identities = 86/525 (16%), Positives = 168/525 (32%), Gaps = 32/525 (6%)
Query: 94 SFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNN 153
S + I+++ N N L+ L L+ L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 154 LVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWG-KIPITL 212
+ P L +L+ L + +L IG L L+ +++ N + K+P
Sbjct: 92 IQSFSPGSF--SGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYF 149
Query: 213 SQLTSLAYLHVGDNHFSGTIPPSVYNIS----SLVEIYLYGNRFTGSLPIEIGKNLPNLR 268
S LT+L ++ + N+ + + + + + N + + + + L
Sbjct: 150 SNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGI-KLH 207
Query: 269 NFVIYTNNFTGSLP-DSFSNASNLEVLHLAENQFRGQVSIN------FNGLKDLSMLGLA 321
+ N + ++ N + L V L +F+ + ++ GL D+++
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 322 TNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIY 381
+ + + + + F + + LA + ++ + Q+
Sbjct: 268 LTYTNDFSDDIVKF----HCLANVSAMSLAGVSIKYLEDVP---KHFKWQSLSIIRCQL- 319
Query: 382 GTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTL 441
P +L L SL + N+ +I L +L L L N L + S +L
Sbjct: 320 KQFPT--LDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGT 375
Query: 442 --LTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDN 499
L +L N + + + L + L L LD+S
Sbjct: 376 NSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 500 LLNGSLPLGVGNLKSLVRLGIARNQFSGQIPV-TLGACTSLEYVELQGNSFSGTIPQSLS 558
L SL L +A N F T+L +++L
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
Query: 559 SLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPT 603
+L ++ L++S NN + L L L+ S+N E
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-51
Identities = 90/491 (18%), Positives = 162/491 (32%), Gaps = 34/491 (6%)
Query: 132 GRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNL 191
G + + + T+ L ++P+++ + + + + N L S N
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDI----PSSTKNIDLSFNPLKILKSYSFSNF 55
Query: 192 SALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNR 251
S L+ +D+ + L L+ L + N P S ++SL + +
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 252 FTGSLPIEIGKNLPNLRNFVIYTNNFTG-SLPDSFSNASNLEVLHLAENQFRGQVSINFN 310
IG L L+ + N LP FSN +NL + L+ N + +
Sbjct: 116 LASLESFPIG-QLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174
Query: 311 GLKDLSMLGLATNFLGNGAANDLDFVDLLT-NCTKLQYLYLADNGFGGVLPHSIANLSTA 369
L++ + L+ + N +DF+ KL L L N + +
Sbjct: 175 FLRENPQVNLSLDMSLN----PIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAG 230
Query: 370 LIDFNLGKNQIYG-----TIPPGI-ANLVNL--NSLRMEANRLTGTIPHVIGELKNLQLL 421
L L + P I L ++ + R+ L N+ +
Sbjct: 231 LHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAM 290
Query: 422 HLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALP 481
L + + LS L+ L K+L NK + +
Sbjct: 291 SLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTL---TMNKGSISFK 345
Query: 482 QQILEITTLSLSLDLSDNLLN--GSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSL 539
+ L +LS LDLS N L+ G SL L ++ N + L
Sbjct: 346 KVAL--PSLS-YLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEEL 401
Query: 540 EYVELQGNSFSGTIPQS-LSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFE 598
++++ Q ++ S SL + LD+S N L+ L L ++ N F+
Sbjct: 402 QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFK 461
Query: 599 GEVPTKGIFKN 609
+ +F N
Sbjct: 462 DNTLS-NVFAN 471
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-51
Identities = 88/502 (17%), Positives = 153/502 (30%), Gaps = 35/502 (6%)
Query: 122 TLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLT 181
T + S ++P ++ S N L LQ L + ++
Sbjct: 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSF--SNFSELQWLDLSRCEIE 69
Query: 182 GQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISS 241
+ L L + + N + P + S LTSL L + + + + +
Sbjct: 70 TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT 129
Query: 242 LVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNL----EVLHLA 297
L ++ + N NL NL + + N + L ++
Sbjct: 130 LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189
Query: 298 ENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGG 357
N F G+K L L L NF + L N L L F
Sbjct: 190 LNPIDFIQDQAFQGIK-LHELTLRGNFN-----SSNIMKTCLQNLAGLHVHRLILGEFKD 243
Query: 358 VLPHSIANLST-------ALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPH 410
I S + +F L + L N++++ + +
Sbjct: 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDV 303
Query: 411 VIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFF 470
+ Q L + L+ L L L L+ +G+I F +L +
Sbjct: 304 P--KHFKWQSLSIIRCQLKQFPTLDLPFLKSL-TLT----MNKGSISFKKVALPSLSYLD 356
Query: 471 APRNKLTGALPQQILEITTLSL-SLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQI 529
RN L+ + ++ T SL LDLS N + L+ L L +
Sbjct: 357 LSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVT 415
Query: 530 PV-TLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKY-LENLSFL 587
+ L Y+++ + LTS+ L ++ N+F N + L
Sbjct: 416 EFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL 475
Query: 588 QYLNLSYNHFEGEVPTKGIFKN 609
+L+LS E G+F
Sbjct: 476 TFLDLSKCQLEQISW--GVFDT 495
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-40
Identities = 78/419 (18%), Positives = 136/419 (32%), Gaps = 30/419 (7%)
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLR----YINIADNDFHGEIPDRIGNLFRLETLVLANN 128
+DL I I + L ++++ N I D+ +L L L N
Sbjct: 156 VHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGN 214
Query: 129 SFSGRIPTN-LSHCSKLITFSAHRNNLVGEIPEELISRRLF-NLQGLSVGD-----NQLT 181
S I L + + L E E+ + L +++ +
Sbjct: 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDF 274
Query: 182 GQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISS 241
L+ + + + + K + + L + P ++
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLK-QFPTL--DLPF 329
Query: 242 LVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSN--ASNLEVLHLAEN 299
L + L N+ + S LP+L + N + S S+S+ ++L L L+ N
Sbjct: 330 LKSLTLTMNKGSISFKKV---ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFN 386
Query: 300 QFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVL 359
+S NF GL++L L + L + + KL YL ++
Sbjct: 387 GAII-MSANFMGLEELQHLDFQHSTL-----KRVTEFSAFLSLEKLLYLDISYTNTKIDF 440
Query: 360 PHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGELKNL 418
L T+L + N + AN NL L + +L V L L
Sbjct: 441 DGIFLGL-TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499
Query: 419 QLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLT 477
QLL++ N L S L L+ L N ++ + K+L FF N +
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-30
Identities = 49/358 (13%), Positives = 102/358 (28%), Gaps = 66/358 (18%)
Query: 71 RVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSF 130
+ + L + L+ + +++A + + + F+ ++L +
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQL 319
Query: 131 SGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGN 190
+L L+ L++ N+ + +
Sbjct: 320 KQFPTLDLP-----------------------------FLKSLTLTMNKGS--ISFKKVA 348
Query: 191 LSALRVIDIRTNRLWGKIPITLSQL--TSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLY 248
L +L +D+ N L + S L SL +L + N + + + L +
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQ 407
Query: 249 GNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSIN 308
+ +L L I N F ++L L +A N F+
Sbjct: 408 HSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNT--- 464
Query: 309 FNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLST 368
++ N T L +L L+ + L
Sbjct: 465 --------------------------LSNVFANTTNLTFLDLSKCQLEQISWGVFDTL-H 497
Query: 369 ALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHAN 426
L N+ N + L +L++L NR+ + + K+L +L N
Sbjct: 498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-61
Identities = 74/336 (22%), Positives = 131/336 (38%), Gaps = 40/336 (11%)
Query: 676 HKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN 735
H ++S ++ + + L + RG FG V+K L VAVK+
Sbjct: 4 HHHHHSSGVD-----LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFP 56
Query: 736 LEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLH 795
Q S E +L ++H N+++ + VD L+ + + GSL ++L
Sbjct: 57 -IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLK 114
Query: 796 QRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH-------CQPPIVHGDLKPSNVLLDHD 848
+S + +I +A + YLH +P I H D+K NVLL ++
Sbjct: 115 AN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167
Query: 849 MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-----EASMRGGV 903
+ A ++DFGLA A ++ + G GT Y+APE G +A +R +
Sbjct: 168 LTACIADFGLALKFEAG------KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM 221
Query: 904 YSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP--EKVMEIVDPSLLPLEEERTNSR 961
Y+ G++L E+ +R + +E + E P E + E+V
Sbjct: 222 YAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR----D 277
Query: 962 RVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997
+ + + +T C R+ V ++
Sbjct: 278 YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 8e-57
Identities = 78/326 (23%), Positives = 125/326 (38%), Gaps = 36/326 (11%)
Query: 692 SYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECE- 750
+ E S + IGRG +G VYKG L VAVKV + + ++F E
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANR---QNFINEKNI 58
Query: 751 -ALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLI 809
+ + H N+ + + + G LV EY NGSL ++L +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-------TSDWV 111
Query: 810 QRLNIVIDVASAVEYLH------HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863
+ V + YLH H +P I H DL NVL+ +D +SDFGL+ L+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 864 ASPLGNVVETPSSSIGVKGTIGYVAPEY-------GLGGEASMRGGVYSYGILLLEIFTR 916
+ L E +++I GTI Y+APE A + +Y+ G++ EIF R
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 917 ---RRPTESMFNEGLTLHEFAKRALPEKVME--IVDPSLLPLEEERTNSRRVRNEECLVA 971
P ES+ + + M+ + P E N + +
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE----NSLAVRS 287
Query: 972 VIKTGVACSIESPFDRMEMTDVVVKL 997
+ +T C + R+ ++
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERM 313
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 4e-52
Identities = 103/543 (18%), Positives = 182/543 (33%), Gaps = 59/543 (10%)
Query: 72 VTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFS 131
LDL + + S + L+ ++++ + +L L TL+L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 132 GRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLT-GQLPASIGN 190
S S L A NL + L L+ L+V N + +LP N
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPI--GHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 191 LSALRVIDIRTNRLWGKIPITLSQLTSLAY----LHVGDNHFSGTIPPSVYNISSLVEIY 246
L+ L +D+ +N++ L L + L + N + I P + L ++
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLT 206
Query: 247 LYGNRFTGSLPIEIGKNLPNLR------NFVIYTNNFTGSLPDSFSNASNLEVLHLAENQ 300
L N + ++ + L L N + NL +
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 301 ---FRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGG 357
+ + FN L ++S L + ++ V + Q+L L + FG
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSV--------TIERVKDFSYNFGWQHLELVNCKFGQ 318
Query: 358 VLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLT--GTIPHVIGEL 415
+ +L N+ G + +L +L L + N L+ G
Sbjct: 319 FPTLKLKSLKR----LTFTSNKG-GNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 416 KNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNK 475
+L+ L L N + T+ S+ L L +L F +NL+ FS F
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFS---------VFLSLRN 422
Query: 476 LTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQI-PVTLG 534
L LD+S + L SL L +A N F P
Sbjct: 423 LI---------------YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 535 ACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSY 594
+L +++L P + +SL+S++ L+++ N + L+ LQ + L
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHT 527
Query: 595 NHF 597
N +
Sbjct: 528 NPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-41
Identities = 100/480 (20%), Positives = 173/480 (36%), Gaps = 36/480 (7%)
Query: 145 ITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRL 204
IT+ N +IP+ L + + L + N L S + L+V+D+ +
Sbjct: 10 ITYQCMELNFY-KIPDNLPF----STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI 64
Query: 205 WGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNL 264
L+ L+ L + N + +SSL ++ SL +L
Sbjct: 65 QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHL 123
Query: 265 PNLRNFVIYTNNFT-GSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATN 323
L+ + N LP+ FSN +NLE L L+ N+ + + L + +L L+ +
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 324 FLGNGAANDLDFVDLLT-NCTKLQYLYLADNGFGG-VLPHSIANLS-TALIDFNLGKNQI 380
+ N ++F+ +L L L +N V+ I L+ + LG+ +
Sbjct: 184 L----SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
Query: 381 YGTIPPGIAN-LVNLNSLRMEANRLTG------TIPHVIGELKNLQLLHLHANFLQGTIP 433
G + + L L +L +E RL I + L N+ L + ++
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
Query: 434 SS-LGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSL 492
S L ++ L + K L F NK A + L +L
Sbjct: 300 FSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTF---TSNKGGNAFSEVDL--PSLE- 350
Query: 493 SLDLSDNLLN--GSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFS 550
LDLS N L+ G SL L ++ N + LE+++ Q ++
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 409
Query: 551 GTIPQS-LSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKN 609
S SL ++ LD+S + LS L+ L ++ N F+ IF
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-29
Identities = 72/415 (17%), Positives = 133/415 (32%), Gaps = 40/415 (9%)
Query: 71 RVTKLDLRNQSIGGILSPYVGNLSFLRY----INIADNDFHGEIPDRIGNLFRLETLVLA 126
+ LDL + I I + L + ++++ N + I RL L L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLR 208
Query: 127 NNSFSGRIPTN-LSHCSKLITFSAHRNNLVGEIPEELISRRLF-NLQGLSVGDNQLTG-- 182
NN S + + + L E E + L L++ + +L
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 183 ----QLPASIGNLSALRVIDIRTNRLWGKIPIT-LSQLTSLAYLHVGDNHFSGTIPPSVY 237
+ L+ + + + + + L ++ F S
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS-- 326
Query: 238 NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFT--GSLPDSFSNASNLEVLH 295
L + N+ + +LP+L + N + G S ++L+ L
Sbjct: 327 ----LKRLTFTSNKGGNAFS---EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 296 LAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGF 355
L+ N +S NF GL+ L L + L + + + L YL ++
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-----KQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 356 GGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGE 414
L ++L + N P I L NL L + +L P
Sbjct: 434 RVAFNGIFNGL-SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 415 LKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFF 469
L +LQ+L++ +N L+ LT L + L N P+ +C + +
Sbjct: 493 LSSLQVLNMASNQLKSVPDGIFDRLTSLQKI-----WLHTN-PWD-CSCPRIDYL 540
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-19
Identities = 52/258 (20%), Positives = 91/258 (35%), Gaps = 15/258 (5%)
Query: 70 QRVTKLDLRNQSIGGILS-PYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANN 128
V+ L + +I + Y L +N F L L+ L +N
Sbjct: 282 TNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSN 335
Query: 129 SFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASI 188
L RN L + +L+ L + N + + ++
Sbjct: 336 KGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF 392
Query: 189 GNLSALRVIDIRTNRLWGKIP--ITLSQLTSLAYLHVGDNHFSGTIPPSV-YNISSLVEI 245
L L +D + + L ++ L +L YL + H + +SSL +
Sbjct: 393 LGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVL 450
Query: 246 YLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQV 305
+ GN F + +I L NL + P +F++ S+L+VL++A NQ +
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVP 510
Query: 306 SINFNGLKDLSMLGLATN 323
F+ L L + L TN
Sbjct: 511 DGIFDRLTSLQKIWLHTN 528
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-51
Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 30/228 (13%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNL 760
E +GRG+FG V K VA+K I E + K+F E L + H N+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNI 63
Query: 761 IKIVTICSSIDFKGVDFKAL--VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
+K G + V EY + GSL LH + + + ++ +
Sbjct: 64 VK---------LYGACLNPVCLVMEYAEGGSLYNVLHGAE---PLPYYTAAHAMSWCLQC 111
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
+ V YLH ++H DLKP N+LL V + DFG A + +
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-----------THM 160
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFN 925
KG+ ++APE G S + V+S+GI+L E+ TRR+P + +
Sbjct: 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG 208
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-51
Identities = 114/530 (21%), Positives = 187/530 (35%), Gaps = 73/530 (13%)
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG 132
+ ++ I I + L+ + + + +L ++ TL
Sbjct: 5 SATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK- 59
Query: 133 RIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLS 192
+ + + L + N L P + L L + + +NQ+ + NL+
Sbjct: 60 -SIDGVEYLNNLTQINFSNNQLTDITP---LKN-LTKLVDILMNNNQIAD--ITPLANLT 112
Query: 193 ALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRF 252
L + + N++ L LT+L L + N S ++ ++SL ++ GN+
Sbjct: 113 NLTGLTLFNNQI--TDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQV 167
Query: 253 TGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGL 312
T P+ NL L I +N + + +NLE L NQ L
Sbjct: 168 TDLKPLA---NLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD--ITPLGIL 220
Query: 313 KDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALID 372
+L L L N L + + L + T L L LA+N + P ++ L T L +
Sbjct: 221 TNLDELSLNGNQLKD--------IGTLASLTNLTDLDLANNQISNLAP--LSGL-TKLTE 269
Query: 373 FNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTI 432
LG NQI P +A L L +L + N+L P I LKNL L L+ N +
Sbjct: 270 LKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS 325
Query: 433 PSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSL 492
P + +LT L L F N + SL N N+
Sbjct: 326 P--VSSLTKLQRLFFYNNKVSD--VSSLANLTNI-------------------------N 356
Query: 493 SLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGT 552
L N ++ PL NL + +LG+ ++ PV A S+
Sbjct: 357 WLSAGHNQISDLTPLA--NLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKNVTGAL-I 412
Query: 553 IPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVP 602
P ++S S E D++ N S + S + F G V
Sbjct: 413 APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-51
Identities = 102/434 (23%), Positives = 170/434 (39%), Gaps = 48/434 (11%)
Query: 187 SIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIY 246
+ L+ + + ++ + L + L V +++L +I
Sbjct: 19 TDTALAEKMKTVLGKTNV--TDTVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQIN 74
Query: 247 LYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVS 306
N+ T P+ KNL L + ++ N +N +NL L L NQ
Sbjct: 75 FSNNQLTDITPL---KNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD--I 127
Query: 307 INFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANL 366
L +L+ L L++N + + + L+ T LQ L N + P +ANL
Sbjct: 128 DPLKNLTNLNRLELSSNTISD--------ISALSGLTSLQQLSF-GNQVTDLKP--LANL 176
Query: 367 STALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHAN 426
T L ++ N++ + +A L NL SL N+++ P +G L NL L L+ N
Sbjct: 177 -TTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGN 231
Query: 427 FLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILE 486
L +L +LT LT L N + P L L N+++ I
Sbjct: 232 QL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-----ISP 282
Query: 487 ITTLS--LSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVEL 544
+ L+ +L+L++N L P+ NLK+L L + N S P + + T L+ +
Sbjct: 283 LAGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338
Query: 545 QGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK 604
N S SL++LT+I L N S P L NL+ + L L+ +
Sbjct: 339 YNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVN- 393
Query: 605 GIFKNKTGFSIVGN 618
N + + V N
Sbjct: 394 -YKANVSIPNTVKN 406
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 6e-49
Identities = 113/488 (23%), Positives = 196/488 (40%), Gaps = 51/488 (10%)
Query: 72 VTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFS 131
K L ++ +L + + + D + L L + +NN +
Sbjct: 26 KMKTVLGKTNVTDT--VSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLT 81
Query: 132 GRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNL 191
P L + +KL+ + N + P ++ L NL GL++ +NQ+T + NL
Sbjct: 82 DITP--LKNLTKLVDILMNNNQIADITP---LAN-LTNLTGLTLFNNQITD--IDPLKNL 133
Query: 192 SALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNR 251
+ L +++ +N + LS LTSL L G+ T + N+++L + + N+
Sbjct: 134 TNLNRLELSSNTI--SDISALSGLTSLQQLSFGNQV---TDLKPLANLTTLERLDISSNK 188
Query: 252 FTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNG 311
+ I + L NL + + N + P +NL+ L L NQ +
Sbjct: 189 VSD---ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLAS 241
Query: 312 LKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALI 371
L +L+ L LA N + N + L+ TKL L L N + P +A L TAL
Sbjct: 242 LTNLTDLDLANNQISN--------LAPLSGLTKLTELKLGANQISNISP--LAGL-TALT 290
Query: 372 DFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGT 431
+ L +NQ+ I+NL NL L + N ++ P + L LQ L + N + +
Sbjct: 291 NLELNENQL--EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--S 344
Query: 432 IPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLS 491
SSL NLT + +LS G N + P L N + T A ++ +
Sbjct: 345 DVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPN 402
Query: 492 LSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQ--FSGQIPVTLGACTSLEYVELQGNSF 549
+++ L+ P + + S I N ++ ++ T + + +F
Sbjct: 403 TVKNVTGALI---APATISDGGSYTEPDITWNLPSYTNEVSYTF---SQPVTIGKGTTTF 456
Query: 550 SGTIPQSL 557
SGT+ Q L
Sbjct: 457 SGTVTQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 80/333 (24%), Positives = 128/333 (38%), Gaps = 56/333 (16%)
Query: 267 LRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLG 326
L + I + + + + + L + +++ L ++ L +
Sbjct: 3 LGSATITQDTPINQIF-TDTALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK 59
Query: 327 NGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPP 386
+ +D + L + ++N + P + NL T L+D + NQI
Sbjct: 60 S--------IDGVEYLNNLTQINFSNNQLTDITP--LKNL-TKLVDILMNNNQI--ADIT 106
Query: 387 GIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLS 446
+ANL NL L + N++T P + L NL L L +N + + S+L LT L LS
Sbjct: 107 PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLS 162
Query: 447 FGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLP 506
FG N + P L N L LD+S N ++
Sbjct: 163 FG-NQVTDLKP--LANLTTLE-------------------------RLDISSNKVSD--I 192
Query: 507 LGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKEL 566
+ L +L L NQ S P LG T+L+ + L GN +L+SLT++ +L
Sbjct: 193 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDL 248
Query: 567 DLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEG 599
DL+ N S P L L+ L L L N
Sbjct: 249 DLANNQISNLAP--LSGLTKLTELKLGANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-09
Identities = 13/111 (11%), Positives = 36/111 (32%), Gaps = 8/111 (7%)
Query: 489 TLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNS 548
L + D +N L ++ + + + + + ++
Sbjct: 2 PLGSATITQDTPINQIFTDT--ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57
Query: 549 FSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEG 599
+ L ++ +++ S N + P L+NL+ L + ++ N
Sbjct: 58 I--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 104
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 6e-51
Identities = 62/258 (24%), Positives = 109/258 (42%), Gaps = 44/258 (17%)
Query: 682 SQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG 741
+ +FP L+ NE IG+G FG V+KG L ++ +VA+K + L G
Sbjct: 2 AMGGSEFPKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG 59
Query: 742 S-------KSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA--LVYEYMQNGSLEE 792
+ F E + ++ H N++K G+ +V E++ G L
Sbjct: 60 ETEMIEKFQEFQREVFIMSNLNHPNIVK---------LYGLMHNPPRMVMEFVPCGDLYH 110
Query: 793 WLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD-----H 847
L + + +L +++D+A +EY+ + PPIVH DL+ N+ L
Sbjct: 111 RLLDKAHP-----IKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENA 164
Query: 848 DMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE--YGLGGEASMRGGVYS 905
+ A V+DFGL++ ++ S G+ G ++APE + + YS
Sbjct: 165 PVCAKVADFGLSQ-----------QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYS 213
Query: 906 YGILLLEIFTRRRPTESM 923
+ ++L I T P +
Sbjct: 214 FAMILYTILTGEGPFDEY 231
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 6e-51
Identities = 69/260 (26%), Positives = 117/260 (45%), Gaps = 29/260 (11%)
Query: 670 RRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLV 729
+ T++ + ++ + + IG GSFG V++ H G V
Sbjct: 6 HHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDV 63
Query: 730 AVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK----ALVYE 783
AVK++ + F E ++ +RH N++ F G + ++V E
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL---------FMGAVTQPPNLSIVTE 114
Query: 784 YMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNV 843
Y+ GSL LH+ + L +RL++ DVA + YLH+ PPIVH +LK N+
Sbjct: 115 YLSRGSLYRLLHKSGARE---QLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNL 170
Query: 844 LLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGV 903
L+D V DFGL++ + T SS GT ++APE ++ + V
Sbjct: 171 LVDKKYTVKVCDFGLSRLKA--------STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDV 222
Query: 904 YSYGILLLEIFTRRRPTESM 923
YS+G++L E+ T ++P ++
Sbjct: 223 YSFGVILWELATLQQPWGNL 242
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-49
Identities = 50/231 (21%), Positives = 89/231 (38%), Gaps = 34/231 (14%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG--SKSFAAECEALRSIRHR 758
+ + + G ++KG G + VKV+ + S+ F EC LR H
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
N++ ++ C S L+ +M GSL LH+ + + Q + +D+
Sbjct: 68 NVLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHEGTNF----VVDQSQAVKFALDM 120
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
A + +LH +P I L +V++D DM A +S + +
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP------------- 166
Query: 879 GVKGTIGYVAPE------YGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923
G +VAPE ++ ++S+ +LL E+ TR P +
Sbjct: 167 GRMYAPAWVAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVPFADL 214
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 58/231 (25%), Positives = 92/231 (39%), Gaps = 44/231 (19%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINL----EQKGGSKSFAAECEALRSIRHRNLIKIV 764
IG G FG VY+ G VAVK + ++ E + ++H N+I
Sbjct: 15 IGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA-- 70
Query: 765 TICSSIDFKGVDFK----ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
+GV K LV E+ + G L L + + +N + +A
Sbjct: 71 -------LRGVCLKEPNLCLVMEFARGGPLNRVLSGK-------RIPPDILVNWAVQIAR 116
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLD--------HDMVAHVSDFGLAKFLSASPLGNVVE 872
+ YLH PI+H DLK SN+L+ + + ++DFGLA+
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----------EW 166
Query: 873 TPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923
++ + G ++APE S V+SYG+LL E+ T P +
Sbjct: 167 HRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-46
Identities = 103/526 (19%), Positives = 180/526 (34%), Gaps = 44/526 (8%)
Query: 100 NIADNDFHG--EIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGE 157
IA F ++P L E L+L+ N ++ +L
Sbjct: 7 RIAFYRFCNLTQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 158 IPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKI--PITLSQL 215
I +E R L NL+ L +G +++ P + L L + + L + L
Sbjct: 64 IDKEAF-RNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122
Query: 216 TSLAYLHVGDNHFSG-TIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNL--PNLRNFVI 272
+L L + N + PS ++SL I N+ + + L L F +
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSL 181
Query: 273 YTNNFTGSLPDSFSNASN------LEVLHLAENQFRGQVSINF----NGLKDLSMLGLAT 322
N+ + + N LE+L ++ N + ++ NF + + S++
Sbjct: 182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH 241
Query: 323 NFLGNGAANDLDFVDLLT----NCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKN 378
+++ D T + +++L L+ + L L NL N
Sbjct: 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL-KDLKVLNLAYN 300
Query: 379 QIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLG 437
+I I L NL L + N L L + + L N + +
Sbjct: 301 KI-NKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFK 359
Query: 438 NLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLS 497
L L L N L ++ ++ F NKL LP+ L + LS +
Sbjct: 360 FLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVT-LPKINLTANLIHLSENRL 413
Query: 498 DNLLNGSLPLGVGNLKSLVRLGIARNQFSG-QIPVTLGACTSLEYVELQGNSFSGTIPQS 556
+NL L + L L + +N+FS T SLE + L N
Sbjct: 414 ENLDILYFLL---RVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETE 470
Query: 557 L-----SSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHF 597
L L+ ++ L L+ N + P +L+ L+ L+L+ N
Sbjct: 471 LCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-35
Identities = 70/382 (18%), Positives = 130/382 (34%), Gaps = 24/382 (6%)
Query: 225 DNHFSG--TIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSL- 281
F +P +++ + L N ++ L L+ + + ++
Sbjct: 10 FYRFCNLTQVPQ---VLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTID 65
Query: 282 PDSFSNASNLEVLHLAENQFRGQVSIN-FNGLKDLSMLGLATNFLGNGAANDLDFVDLLT 340
++F N NL +L L ++ + + F GL L L L L + D F +L
Sbjct: 66 KEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL-- 122
Query: 341 NCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANL--VNLNSLR 398
L L L+ N + H +L + NQI+ + L L+
Sbjct: 123 --KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFS 180
Query: 399 MEANRLTGTIPHVIGELKN-LQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIP 457
+ AN L + G+ N + + L + G N + +N + +
Sbjct: 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQA 233
Query: 458 FSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSL-SLDLSDNLLNGSLPLGVGNLKSLV 516
FSL ++M + + + S+ LDLS + LK L
Sbjct: 234 FSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLK 293
Query: 517 RLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQ 576
L +A N+ + +L+ + L N + L + +DL +N+ +
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAII 353
Query: 577 IPKYLENLSFLQYLNLSYNHFE 598
+ + L LQ L+L N
Sbjct: 354 QDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-23
Identities = 60/378 (15%), Positives = 126/378 (33%), Gaps = 33/378 (8%)
Query: 91 GNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSH--CSKLITFS 148
GN + N + + ++ + S +
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272
Query: 149 AHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKI 208
+ + + L +L+ L++ N++ + L L+V+++ N L
Sbjct: 273 LSHGFVF-SLNSRVFET-LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY 330
Query: 209 PITLSQLTSLAYLHVGDNHFSGTIPPSVY-NISSLVEIYLYGNRFTGSLPIEIGKNLPNL 267
L +AY+ + NH + I + + L + L N T ++ +P++
Sbjct: 331 SSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT-TIH-----FIPSI 383
Query: 268 RNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRG-QVSINFNGLKDLSMLGLATNFLG 326
+ + N + + ++HL+EN+ + + L +L L N
Sbjct: 384 PDIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS 439
Query: 327 NGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLS----TALIDFNLGKNQIYG 382
+ + L+ L+L +N + + L L N +
Sbjct: 440 S-----CSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN- 493
Query: 383 TIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTL 441
++PPG+ ++L L L + +NRLT + + NL++L + N L P +
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVFVS--- 548
Query: 442 LTYLSFGANNLQGNIPFS 459
L+ L N S
Sbjct: 549 LSVLDITHNKFICECELS 566
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 4e-09
Identities = 22/100 (22%), Positives = 38/100 (38%), Gaps = 1/100 (1%)
Query: 511 NLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTI-PQSLSSLTSIKELDLS 569
L + RL ++ N + L+ +EL TI ++ +L +++ LDL
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 570 QNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKN 609
+ P + L L L L + V G F+N
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-46
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 28/222 (12%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIVTI 766
IG GSFG VYKG H + VAVK++N+ ++F E LR RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
++ A+V ++ + SL LH + + + + ++I A ++YLH
Sbjct: 89 STAPQL------AIVTQWCEGSSLYHHLHASETKF-----EMKKLIDIARQTARGMDYLH 137
Query: 827 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGY 886
I+H DLK +N+ L D + DFGLA S + E G+I +
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL------SGSILW 188
Query: 887 VAPE---YGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFN 925
+APE S + VY++GI+L E+ T + P ++ N
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-46
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 30/228 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECE--ALRSIRHRNLIKIVTI 766
+G+G +G V++G G VAVK+ + + KS+ E E +RH N++ +
Sbjct: 16 VGKGRYGEVWRGSWQ--GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 70
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
+ L+ Y + GSL ++L L + L IV+ +AS + +LH
Sbjct: 71 DMTSRHSSTQL-WLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLH 122
Query: 827 -----HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
+P I H DLK N+L+ + ++D GLA S S + +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST----NQLDVGNNPRV 178
Query: 882 GTIGYVAPE------YGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923
GT Y+APE ++ R ++++G++L E+ R +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-45
Identities = 63/255 (24%), Positives = 102/255 (40%), Gaps = 27/255 (10%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
+G+G FG K E G ++ +K + + ++F E + +R + H N++K + +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 769 SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH 828
K + EY++ G+L + D Q QR++ D+AS + YLH
Sbjct: 78 ----KDKRL-NFITEYIKGGTLRGIIKSMDSQ-----YPWSQRVSFAKDIASGMAYLHSM 127
Query: 829 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL------SASPLGNVVETPSSSIGVKG 882
I+H DL N L+ + V+DFGLA+ + V G
Sbjct: 128 ---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTE--SMFNE--GLTLHEFAKRAL 938
++APE G + V+S+GI+L EI R GL + F R
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244
Query: 939 PEKVMEIVDPSLLPL 953
P PS P+
Sbjct: 245 PPN----CPPSFFPI 255
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-45
Identities = 89/405 (21%), Positives = 149/405 (36%), Gaps = 60/405 (14%)
Query: 170 LQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFS 229
L+ + P +L+ ++ + +T +L S+ L V
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASV--TDVVTQEELESITKLVVAGEKV- 56
Query: 230 GTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNAS 289
+ +++L + L GN+ T P+ NL L N I TN T + N +
Sbjct: 57 -ASIQGIEYLTNLEYLNLNGNQITDISPLS---NLVKLTNLYIGTNKITD--ISALQNLT 110
Query: 290 NLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLY 349
NL L+L E+ L + L L N + + L+N T L YL
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP-------LSNMTGLNYLT 161
Query: 350 LADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIP 409
+ ++ V P IANL T L +L NQI +A+L +L+ N++T P
Sbjct: 162 VTESKVKDVTP--IANL-TDLYSLSLNYNQI--EDISPLASLTSLHYFTAYVNQITDITP 216
Query: 410 HVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFF 469
+ + L L + N + P L NL+ LT+L G N + +I ++ + L
Sbjct: 217 --VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DIN-AVKDLTKLK-- 268
Query: 470 FAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQI 529
L++ N ++ L NL L L + NQ +
Sbjct: 269 -----------------------MLNVGSNQISDISVLN--NLSQLNSLFLNNNQLGNED 303
Query: 530 PVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFS 574
+G T+L + L N + P L+SL+ + D +
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 8e-43
Identities = 68/405 (16%), Positives = 136/405 (33%), Gaps = 61/405 (15%)
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG 132
L I I +L+ + + L + LV+A +
Sbjct: 3 ATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS 58
Query: 133 RIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLS 192
+ + + L + + N + P L L L +G N++T +++ NL+
Sbjct: 59 --IQGIEYLTNLEYLNLNGNQITDISPLS----NLVKLTNLYIGTNKITD--ISALQNLT 110
Query: 193 ALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRF 252
LR + + + + P L+ LT + L++G NH + + N++ L + + ++
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKV 167
Query: 253 TGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGL 312
PI NL +L + + N ++ ++L NQ +
Sbjct: 168 KDVTPIA---NLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITD--ITPVANM 220
Query: 313 KDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALID 372
L+ L + N + DL L N ++L +L + N
Sbjct: 221 TRLNSLKIGNNKI-----TDLSP---LANLSQLTWLEIGTNQI----------------- 255
Query: 373 FNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTI 432
+ + +L L L + +N+++ + L L L L+ N L
Sbjct: 256 ----------SDINAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNED 303
Query: 433 PSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLT 477
+G LT LT L N++ P + + + +
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-41
Identities = 85/362 (23%), Positives = 140/362 (38%), Gaps = 56/362 (15%)
Query: 238 NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLA 297
+++ + L T + E L ++ V+ S+ +NLE L+L
Sbjct: 20 DLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLN 74
Query: 298 ENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGG 357
NQ + L L+ L + TN + + + L N T L+ LYL ++
Sbjct: 75 GNQITD--ISPLSNLVKLTNLYIGTNKITD--------ISALQNLTNLRELYLNEDNISD 124
Query: 358 VLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKN 417
+ P +ANL T + NLG N + ++N+ LN L + +++ P I L +
Sbjct: 125 ISP--LANL-TKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTD 178
Query: 418 LQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLT 477
L L L+ N ++ P L +LT L Y + N + P + N L
Sbjct: 179 LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLN---------- 224
Query: 478 GALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACT 537
SL + +N + PL NL L L I NQ S I + T
Sbjct: 225 ---------------SLKIGNNKITDLSPLA--NLSQLTWLEIGTNQISD-IN-AVKDLT 265
Query: 538 SLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHF 597
L+ + + N S L++L+ + L L+ N + + + L+ L L LS NH
Sbjct: 266 KLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323
Query: 598 EG 599
Sbjct: 324 TD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 70/319 (21%), Positives = 125/319 (39%), Gaps = 35/319 (10%)
Query: 286 SNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKL 345
++ + L + + L+ ++ L +A + + + + T L
Sbjct: 19 ADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVAS--------IQGIEYLTNL 68
Query: 346 QYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLT 405
+YL L N + P ++NL L + +G N+I T + NL NL L + + ++
Sbjct: 69 EYLNLNGNQITDISP--LSNL-VKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNIS 123
Query: 406 GTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKN 465
P + L + L+L AN + S L N+T L YL+ + ++ P N +
Sbjct: 124 DISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTPI--ANLTD 178
Query: 466 LMFFFAPRNKLTGALPQQILEITTLSL--SLDLSDNLLNGSLPLGVGNLKSLVRLGIARN 523
L N++ I + +L+ N + P+ N+ L L I N
Sbjct: 179 LYSLSLNYNQIED-----ISPLASLTSLHYFTAYVNQITDITPVA--NMTRLNSLKIGNN 231
Query: 524 QFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLEN 583
+ + P L + L ++E+ N S ++ LT +K L++ N S L N
Sbjct: 232 KITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNN 285
Query: 584 LSFLQYLNLSYNHFEGEVP 602
LS L L L+ N E
Sbjct: 286 LSQLNSLFLNNNQLGNEDM 304
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-45
Identities = 54/228 (23%), Positives = 102/228 (44%), Gaps = 30/228 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECE--ALRSIRHRNLIKIVTI 766
IG+G FG V++G G VAVK+ + ++ +S+ E E +RH N++ +
Sbjct: 50 IGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 104
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
+ + LV +Y ++GSL ++L++ +++ + + + AS + +LH
Sbjct: 105 DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLH 156
Query: 827 -----HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
+P I H DLK N+L+ + ++D GLA ++ + ++ +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT--DTIDIAPN--HRV 212
Query: 882 GTIGYVAPE------YGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923
GT Y+APE E+ R +Y+ G++ EI R
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-44
Identities = 72/310 (23%), Positives = 112/310 (36%), Gaps = 49/310 (15%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECE--ALRSIRHRNLIKIVTI 766
IG+G +G V+ G G VAVKV ++ S+ E E +RH N++ +
Sbjct: 45 IGKGRYGEVWMGKWR--GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAA 99
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
L+ +Y +NGSL ++L L L + S + +LH
Sbjct: 100 DIKGTGSWTQL-YLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLH 151
Query: 827 -----HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
+P I H DLK N+L+ + ++D GLA + E
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT----NEVDIPPNTRV 207
Query: 882 GTIGYVAPEYGLGGEASMRGG-------VYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934
GT Y+ PE L + +YS+G++L E+ R
Sbjct: 208 GTKRYMPPEV-LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG----------IVE 256
Query: 935 KRALPEKVMEIVDPSLLPLEEE--RTNSR-----RVRNEECLVAVIKTGVACSIESPFDR 987
+ LP + DPS + E R R ++ECL + K C +P R
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316
Query: 988 MEMTDVVVKL 997
+ V L
Sbjct: 317 LTALRVKKTL 326
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 53/231 (22%), Positives = 89/231 (38%), Gaps = 41/231 (17%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIVTI 766
IG+G FG VY G H VA+++I++E+ K+F E A R RH N++
Sbjct: 41 IGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL---- 93
Query: 767 CSSIDFKGVDFK----ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
F G A++ + +L + L + + I ++ +
Sbjct: 94 -----FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVL-----DVNKTRQIAQEIVKGM 143
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
YLH I+H DLK NV D+ V ++DFGL G + G
Sbjct: 144 GYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLR---IQNG 196
Query: 883 TIGYVAPEYGLGGEASMRGG----------VYSYGILLLEIFTRRRPTESM 923
+ ++APE + + V++ G + E+ R P ++
Sbjct: 197 WLCHLAPEI-IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-42
Identities = 89/510 (17%), Positives = 177/510 (34%), Gaps = 36/510 (7%)
Query: 72 VTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFS 131
+ LDL I I + + L+ + + + + D +L LE L L++N S
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 132 GRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPA-SIGN 190
+ S L + N + + L NLQ L +G+ + ++
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146
Query: 191 LSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGN 250
L++L ++I+ L +L + + +L + + + + +SS+ + L
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 251 RFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFN 310
+ +SF+ L R + ++
Sbjct: 207 NLA-RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL---------LRYILELSEV 256
Query: 311 GLKDLSMLGLAT-NFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTA 369
D ++ GL N + ++L V+ +T ++ L++ L + L
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVT----IRRLHIPQFYLFYDLSTVYSLL-EK 311
Query: 370 LIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPH---VIGELKNLQLLHLHA 425
+ + ++++ +P +L +L L + N + G +LQ L L
Sbjct: 312 VKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 426 NFLQ--GTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQ 483
N L+ L L LT L N +P S + + F + +
Sbjct: 371 NHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTC 428
Query: 484 ILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVE 543
I + + LD+S+N L+ S L L L L I+RN+ +P L ++
Sbjct: 429 IPQTLEV---LDVSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDA-SLFPVLLVMK 479
Query: 544 LQGNSFSGTIPQSLSSLTSIKELDLSQNNF 573
+ N LTS++++ L N +
Sbjct: 480 ISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-40
Identities = 88/502 (17%), Positives = 174/502 (34%), Gaps = 35/502 (6%)
Query: 125 LANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQL 184
+ SF+ IP+ L+ + + + N + I + NLQ L + +++
Sbjct: 12 GRSRSFT-SIPSGLT--AAMKSLDLSFNKIT-YIGHGDLRA-CANLQVLILKSSRINTIE 66
Query: 185 PASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSV-YNISSLV 243
+ +L +L +D+ N L L+SL YL++ N + S+ N+++L
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126
Query: 244 EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRG 303
+ + + L +L I + S + ++ L L ++
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186
Query: 304 QVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKL--QYLYLADNGFGGV--L 359
+ I + L + L L L + L ++ + KL + L D F + L
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246
Query: 360 PHSIANLSTALIDFN-------LGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVI 412
I LS D ++ G V + L + L + V
Sbjct: 247 LRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306
Query: 413 GELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFS---LGNCKNLMFF 469
L+ ++ + + + + S +L L +L N + + G +L
Sbjct: 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366
Query: 470 FAPRNKLTGALPQQILEITTLS--LSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSG 527
+N L ++ + + TL SLD+S N + +P + + L ++
Sbjct: 367 VLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV 424
Query: 528 QIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFL 587
V +LE +++ N+ + L L EL +S+N +P L
Sbjct: 425 ---VKTCIPQTLEVLDVSNNNLD-SFSLFLPRLQ---ELYISRNKLK-TLPDAS-LFPVL 475
Query: 588 QYLNLSYNHFEGEVPTKGIFKN 609
+ +S N + GIF
Sbjct: 476 LVMKISRNQL--KSVPDGIFDR 495
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 63/422 (14%), Positives = 123/422 (29%), Gaps = 53/422 (12%)
Query: 73 TKLDLRNQSIGGILSPYV-GNLSFLRYINIADNDFHGEIPDR-IGNLFRLETLVLANNSF 130
L+L + + NL+ L+ + I + + EI L L L + S
Sbjct: 101 KYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160
Query: 131 SGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGN 190
+L + + H + E+ + L +++ L + D L + +
Sbjct: 161 RNYQSQSLKSIRDIHHLTLHLSES--AFLLEIFADILSSVRYLELRDTNLARFQFSPLPV 218
Query: 191 LSALRVIDIRTNRL-------WGKIPITLSQLTSLAYLHVGDN------HFSGTIPPSVY 237
+ R + ++ L + L+ + D F+ + V
Sbjct: 219 DEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVS 278
Query: 238 NISSLVEIYLYGNRFTG----SLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEV 293
+ + + + + L ++ + + + +LE
Sbjct: 279 ELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEF 338
Query: 294 LHLAENQFRGQVSIN---FNGLKDLSMLGLATNFLGNGAANDLDFV-DLLTNCTKLQYLY 349
L L+EN + N L L L+ N L + ++L L L
Sbjct: 339 LDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL-----RSMQKTGEILLTLKNLTSLD 393
Query: 350 LADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI------------------ANL 391
++ N F +P S + NL I + I L
Sbjct: 394 ISRNTFH-PMPDSCQWPEK-MRFLNLSSTGI-RVVKTCIPQTLEVLDVSNNNLDSFSLFL 450
Query: 392 VNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANN 451
L L + N+L T+P L ++ + N L+ LT L + N
Sbjct: 451 PRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNP 508
Query: 452 LQ 453
Sbjct: 509 WD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 6e-13
Identities = 37/234 (15%), Positives = 81/234 (34%), Gaps = 38/234 (16%)
Query: 71 RVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDR---IGNLFRLETLVLAN 127
+V ++ + N + + + +L L ++++++N E G L+TLVL+
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 128 NSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPAS 187
N ++ +++ L NL L + N +P S
Sbjct: 371 NHL-----RSMQKTGEILL-------------------TLKNLTSLDISRNTFH-PMPDS 405
Query: 188 IGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYL 247
+R +++ + + + +L L V +N+ + + L E+Y+
Sbjct: 406 CQWPEKMRFLNLSSTGI---RVVKTCIPQTLEVLDVSNNNLD-SFSL---FLPRLQELYI 458
Query: 248 YGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQF 301
N+ + P L I N F ++L+ + L N +
Sbjct: 459 SRNKLKT---LPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 6e-09
Identities = 30/117 (25%), Positives = 54/117 (46%), Gaps = 4/117 (3%)
Query: 493 SLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGT 552
D S+P G+ ++ L ++ N+ + L AC +L+ + L+ + +
Sbjct: 9 VCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65
Query: 553 IPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKN 609
+ SL S++ LDLS N+ S + LS L+YLNL N ++ + +F N
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPN 121
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-42
Identities = 58/327 (17%), Positives = 108/327 (33%), Gaps = 27/327 (8%)
Query: 279 GSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDL 338
GS ++S E L+ + + + L A N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGST---ALRPYHDVLSQWQRHYNADR-------NRWHSAWR 51
Query: 339 LTNCTKLQYLYLADNGFGGVLPHSIANL-STALIDFNLGKNQIYGTIPPGIANLVNLNSL 397
N Q + + + L + P L +L +
Sbjct: 52 QANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHM 109
Query: 398 RMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIP 457
++A L +P + + L+ L L N L+ +P+S+ +L L LS A +P
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
Query: 458 FSLGNC---------KNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLG 508
L + NL + +LP I + L SL + ++ L+ +L
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK-SLKIRNSPLS-ALGPA 224
Query: 509 VGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDL 568
+ +L L L + P G L+ + L+ S T+P + LT +++LDL
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDL 284
Query: 569 SQNNFSGQIPKYLENLSFLQYLNLSYN 595
++P + L + + +
Sbjct: 285 RGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 56/354 (15%), Positives = 102/354 (28%), Gaps = 51/354 (14%)
Query: 84 GILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSK 143
G + + S + + D + R ++ +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 144 LITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNR 203
+ L + L L + L Q P LS L+ + I
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 204 LWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGK- 262
L ++P T+ Q L L + N +P S+ +++ L E+ + LP +
Sbjct: 116 L-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 263 -------NLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDL 315
L NL++ + SLP S +N NL+ L + + L L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP-----------LSAL 221
Query: 316 SMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNL 375
+ + KL+ L L P L L
Sbjct: 222 G--------------------PAIHHLPKLEELDLRGCTALRNYPPIFGGR-APLKRLIL 260
Query: 376 -GKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFL 428
+ + T+P I L L L + +P +I +L ++ + +
Sbjct: 261 KDCSNL-LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 59/428 (13%), Positives = 107/428 (25%), Gaps = 110/428 (25%)
Query: 137 NLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRV 196
+ H S + + + L Q D N + ++
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVL-----SQWQRHYNADRNRW-HSAWRQANSNNPQI 60
Query: 197 IDIRTNRLWGKIPITLSQLTS--LAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTG 254
L L T L + P + +S L + +
Sbjct: 61 ETRTGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM- 117
Query: 255 SLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKD 314
LP + L + N +LP S ++ + L L +
Sbjct: 118 ELPDTMQ-QFAGLETLTLARNPLR-ALPASIASLNRLRELSIR----------------- 158
Query: 315 LSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFN 374
C +L L P +A+
Sbjct: 159 --------------------------ACPELTEL-----------PEPLASTD------- 174
Query: 375 LGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPS 434
LVNL SLR+E + ++P I L+NL+ L + + L +
Sbjct: 175 ---------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGP 223
Query: 435 SLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSL 494
++ +L L L N P G L L
Sbjct: 224 AIHHLPKLEELDLRGCTALRNYPPIFGGRAPL-------------------------KRL 258
Query: 495 DLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIP 554
L D +LPL + L L +L + ++P + + + + + +
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
Query: 555 QSLSSLTS 562
+ +
Sbjct: 319 HRPVARPA 326
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 39/270 (14%), Positives = 83/270 (30%), Gaps = 33/270 (12%)
Query: 337 DLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNS 396
+ + + LY + ++ + + N N+
Sbjct: 6 HHHHHSSGRENLYFQGSTALRPYHDVLSQW-QRHYNADR-------NRWHSAWRQANSNN 57
Query: 397 LRMEANRLTG--TIPHVIGELK--NLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNL 452
++E ++ + L L + L P L+ L +++ A L
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116
Query: 453 QGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNL 512
+P ++ L RN L ALP I + L L + LP + +
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR-ELSIRACPELTELPEPLAST 173
Query: 513 KSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNN 572
+L+ + L+ ++P S+++L ++K L + +
Sbjct: 174 ---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217
Query: 573 FSGQIPKYLENLSFLQYLNLSYNHFEGEVP 602
S + + +L L+ L+L P
Sbjct: 218 LS-ALGPAIHHLPKLEELDLRGCTALRNYP 246
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 40/220 (18%), Positives = 75/220 (34%), Gaps = 17/220 (7%)
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG 132
+ + + L + + L + +A N +P I +L RL L +
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT 164
Query: 133 RIPTNL---------SHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQ 183
+P L L + + +P + L NL+ L + ++ L+
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASI--ANLQNLKSLKIRNSPLS-A 220
Query: 184 LPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLV 243
L +I +L L +D+R P L L + D T+P ++ ++ L
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLE 280
Query: 244 EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPD 283
++ L G LP I LP ++ + L
Sbjct: 281 KLDLRGCVNLSRLPSLIA-QLPANCIILVP-PHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 27/146 (18%), Positives = 50/146 (34%), Gaps = 4/146 (2%)
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG 132
L L I L + NL L+ + I ++ + I +L +LE L L +
Sbjct: 186 QSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR 243
Query: 133 RIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLS 192
P + L + + +P ++ RL L+ L + +LP+ I L
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLTLPLDI--HRLTQLEKLDLRGCVNLSRLPSLIAQLP 301
Query: 193 ALRVIDIRTNRLWGKIPITLSQLTSL 218
A +I + + +
Sbjct: 302 ANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 19/194 (9%), Positives = 43/194 (22%), Gaps = 56/194 (28%)
Query: 406 GTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKN 465
G+ H + L+ + L + + + + N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNA----DRNRWHSAWRQANSNN 57
Query: 466 LMFFFAPRNKLTGALPQQILEITTLSL-SLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQ 524
L A + + T +L+L L
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP---------------------- 94
Query: 525 FSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENL 584
P L+ ++ + + ++P ++
Sbjct: 95 ---------------------------QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQF 126
Query: 585 SFLQYLNLSYNHFE 598
+ L+ L L+ N
Sbjct: 127 AGLETLTLARNPLR 140
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 8e-42
Identities = 90/524 (17%), Positives = 165/524 (31%), Gaps = 88/524 (16%)
Query: 86 LSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSH----- 140
++P + +FL+ ++ E+P N+ A + + P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 141 --------CSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLS 192
+ + L +PE +L+ L N LT +LP +L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELP-----PHLESLVASCNSLT-ELPELPQSLK 114
Query: 193 ALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRF 252
+L V + L P L YL V +N P + N S L I + N
Sbjct: 115 SLLVDNNNLKALSDLPP-------LLEYLGVSNNQL--EKLPELQNSSFLKIIDVDNNSL 165
Query: 253 TGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGL 312
LP P+L N LP+ N L ++ N + ++ L
Sbjct: 166 K-KLP----DLPPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSL 217
Query: 313 KDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALID 372
+ + N L+ + L N L +Y +N LP +L
Sbjct: 218 ESIVAGN-----------NILEELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA---- 261
Query: 373 FNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTI 432
N+ N + +P +L L+ + L+ P NL L+ +N ++ ++
Sbjct: 262 LNVRDNYL-TDLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SL 312
Query: 433 PSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSL 492
+L L+ N L +P + L A N L +P+ L
Sbjct: 313 CDLPPSLE---ELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPE---LPQNLK- 360
Query: 493 SLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGT 552
L + N L P +++ L + + + +L+ + ++ N
Sbjct: 361 QLHVEYNPLR-EFPDIPESVEDL--------RMNSHLAEVPELPQNLKQLHVETNPLR-E 410
Query: 553 IPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNH 596
P S+ +L ++ E L+ ++H
Sbjct: 411 FPDIPESVE---DLRMNSERVVDPYEFAHETTDKLEDDVFEHHH 451
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-41
Identities = 91/515 (17%), Positives = 161/515 (31%), Gaps = 116/515 (22%)
Query: 110 IPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRR--- 166
I R + L+ + +++ + +P + + + P +R
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 167 --------LFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSL 218
L + + L+ LP +L +L N L ++P L SL
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSL-TELPELPQSLKSL 116
Query: 219 AYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFT 278
+ S L + + N+ LP E+ N L+ + N+
Sbjct: 117 LVDNNNLKALSD-------LPPLLEYLGVSNNQLE-KLP-ELQ-NSSFLKIIDVDNNSLK 166
Query: 279 GSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDL 338
LPD + LE + NQ L++L L
Sbjct: 167 -KLPDLPPS---LEFIAAGNNQ-----------LEELPELQ------------------- 192
Query: 339 LTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLR 398
N L +Y +N LP +L + G N + P + NL L ++
Sbjct: 193 --NLPFLTAIYADNNSLK-KLPDLPLSLES----IVAGNNIL--EELPELQNLPFLTTIY 243
Query: 399 MEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPF 458
+ N L T+P + L+ L + + +P +LT L + L P
Sbjct: 244 ADNNLLK-TLPDLPPSLEALNVRDNYLT----DLPELPQSLTFLDVSENIFSGLSELPP- 297
Query: 459 SLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLS----------------LDLSDNLLN 502
NL + A N++ +L + L++S L S N L
Sbjct: 298 ------NLYYLNASSNEIR-SLCDLPPSLEELNVSNNKLIELPALPPRLERLIASFNHLA 350
Query: 503 GSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTS 562
+P NLK L + N + P + L NS +P+ +L
Sbjct: 351 -EVPELPQNLKQLH---VEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPELPQNL-- 398
Query: 563 IKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHF 597
K+L + N + P E++ + L ++
Sbjct: 399 -KQLHVETNPLR-EFPDIPESV---EDLRMNSERV 428
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-28
Identities = 63/373 (16%), Positives = 121/373 (32%), Gaps = 80/373 (21%)
Query: 232 IPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNL 291
I P + + L E + + T +P+E N+ + + + + + P +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAE-NVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 292 EVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLA 351
V L + + L L
Sbjct: 61 AVSRLRDC-----------------------------------------LDRQAHELELN 79
Query: 352 DNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHV 411
+ G LP +L + N + +P +L +L L+ P
Sbjct: 80 NLGLS-SLPELPPHLES----LVASCNSL-TELPELPQSLKSLLVDNNNLKALSDLPP-- 131
Query: 412 IGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFA 471
L+ L + N L+ +P L N + L + N+L+ +P + + +
Sbjct: 132 -----LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAGN- 182
Query: 472 PRNKLTGALPQQILEITTLS--LSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQI 529
N+L LP E+ L ++ +N L LP +L+S+V N ++
Sbjct: 183 --NQLE-ELP----ELQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---AGNNILE-EL 230
Query: 530 PVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQY 589
P L L + N T+P SL + L++ N + +P+ ++L+FL
Sbjct: 231 P-ELQNLPFLTTIYADNNLLK-TLPDLPPSL---EALNVRDNYLT-DLPELPQSLTFLDV 284
Query: 590 LNLSYNHFEGEVP 602
++ P
Sbjct: 285 SENIFSGLSELPP 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 6e-38
Identities = 62/491 (12%), Positives = 143/491 (29%), Gaps = 74/491 (15%)
Query: 110 IPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFN 169
I + N R + + ++S + L +N
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLK-------------------------QALASLRQ-SAWN 35
Query: 170 LQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFS 229
++ L + N L+ A + + L ++++ +N L + L L++L L + +N+
Sbjct: 36 VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ 93
Query: 230 GTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNAS 289
+ S+ ++ N + + G+ N+ + N T S
Sbjct: 94 -ELLVG----PSIETLHAANNNIS-RVSCSRGQGKKNIY---LANNKITMLRDLDEGCRS 144
Query: 290 NLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLY 349
++ L L N+ + ++F +L + L++L
Sbjct: 145 RVQYLDLKLNEI-----------------------------DTVNFAELAASSDTLEHLN 175
Query: 350 LADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIP 409
L N + + + L +L N++ + P + + + + N+L I
Sbjct: 176 LQYNFI-YDVKGQV--VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIE 230
Query: 410 HVIGELKNLQLLHLHANFLQ-GTIPSSLGNLTLLTYLSFGAN-NLQGNIPFSLGNCKNLM 467
+ +NL+ L N GT+ + ++ L G
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 468 FFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSG 527
+ L +++ + +L L N + + Q+
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT 350
Query: 528 QIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFL 587
I + +E + + + + + ++ E S L
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPL 409
Query: 588 QYLNLSYNHFE 598
Q L +E
Sbjct: 410 QLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-32
Identities = 57/469 (12%), Positives = 123/469 (26%), Gaps = 42/469 (8%)
Query: 69 NQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANN 128
R + + S+ L+ + ++ ++++ N + +LE L L++N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 129 SFSGRIP-----------------TNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQ 171
+ L + T A NN+ + R +
Sbjct: 69 VLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI-----SRVSCSRGQGKK 123
Query: 172 GLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPI--TLSQLTSLAYLHVGDNHFS 229
+ + +N++T G S ++ +D++ N + + + +L +L++ N
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI-DTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 230 GTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNAS 289
+ V + L + L N+ + E + + + N + + +
Sbjct: 183 -DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQ-SAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 290 NLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLY 349
NLE L N + L+D + L CT +
Sbjct: 238 NLEHFDLRGNG------FHCGTLRDFFSKNQRVQTVAKQTVKKLTG-QNEEECTVPTLGH 290
Query: 350 LADN---GFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTG 406
+ L G+ + N + +
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT 350
Query: 407 TIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNL 466
I V + L L + + L A + + L
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI-ELQHATEEQSPL 409
Query: 467 MFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSL 515
A + +Q D+ + L LK L
Sbjct: 410 QLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET-QLAEENARLKKL 457
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-29
Identities = 51/321 (15%), Positives = 112/321 (34%), Gaps = 26/321 (8%)
Query: 280 SLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLL 339
++ + N + ++ + ++ + ++ ++ L L+ N L +A L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA------DL 54
Query: 340 TNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRM 399
TKL+ L L+ N L + +L + L +L N + + ++ +L
Sbjct: 55 APFTKLELLNLSSNVLYETLD--LESL-STLRTLDLNNNYV-----QELLVGPSIETLHA 106
Query: 400 EANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQG-NIPF 458
N ++ + + + ++L N + G + + YL N + N
Sbjct: 107 ANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 459 SLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRL 518
+ L N + + Q++ L +LDLS N L + + + +
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLK-TLDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 519 GIARNQFSGQIPVTLGACTSLEYVELQGNSFS-GTIPQSLSSLTSIKELDLSQNNFSGQI 577
+ N+ I L +LE+ +L+GN F GT+ S ++ +
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLT 276
Query: 578 PKYLENLSFLQYLNLSYNHFE 598
+ E + + E
Sbjct: 277 GQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 47/283 (16%), Positives = 96/283 (33%), Gaps = 17/283 (6%)
Query: 337 DLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNS 396
++ N + + + D+ L + + + +L N + +A L
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSA-WNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 397 LRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNI 456
L + +N L T+ + L L+ L L+ N++ L + L NN+ +
Sbjct: 63 LNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RV 114
Query: 457 PFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNG-SLPLGVGNLKSL 515
S G + + NK+T + + LDL N ++ + + +L
Sbjct: 115 SCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQ-YLDLKLNEIDTVNFAELAASSDTL 171
Query: 516 VRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSG 575
L + N + + L+ ++L N + + S + + L N
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 576 QIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGN 618
I K L L++ +L N F KN+ ++
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-36
Identities = 65/370 (17%), Positives = 134/370 (36%), Gaps = 31/370 (8%)
Query: 134 IPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSA 193
I +NL + + + H + ++ L N + ++ ++ + A + +
Sbjct: 13 IDSNLQY--DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 194 LRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSV-YNISSLVEIYLYGNRF 252
+ ++++ ++ + ++ L++G N +PP V N+ L + L N
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 253 TGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGL 312
+ SLP I N P L + NN D+F ++L+ L L+ N+ ++ + +
Sbjct: 130 S-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLI 185
Query: 313 KDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALID 372
L ++ N L L ++ L + N V L+
Sbjct: 186 PSLFHANVSYNLLST-----------LAIPIAVEELDASHNSINVVRGPVNVELTI---- 230
Query: 373 FNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTI 432
L N + T + N L + + N L + H +++ L+ L++ N L +
Sbjct: 231 LKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 287
Query: 433 PSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSL 492
+ L L N+L ++ + L + N + L TL
Sbjct: 288 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTH--HTLK- 342
Query: 493 SLDLSDNLLN 502
+L LS N +
Sbjct: 343 NLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-34
Identities = 62/392 (15%), Positives = 129/392 (32%), Gaps = 53/392 (13%)
Query: 208 IPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNL 267
I L +H+ +++ + + LP + + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 268 RNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGN 327
+ +F+ A ++ L++ N R F + L++L L N L
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-- 129
Query: 328 GAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPG 387
+ L + N KL L +++N + + T+L + L N++ +
Sbjct: 130 ---SSLP-RGIFHNTPKLTTLSMSNNNLERIEDDTFQAT-TSLQNLQLSSNRL-THVDLS 183
Query: 388 IANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSF 447
+ +L + N L+ + ++ L N + + + LT L
Sbjct: 184 --LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKL 233
Query: 448 GANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPL 507
NNL + L N L + +DLS N L +
Sbjct: 234 QHNNLT-DTA-WLLNYPGL-------------------------VEVDLSYNELE-KIMY 265
Query: 508 GV-GNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKEL 566
++ L RL I+ N+ + + +L+ ++L N + ++ ++ L
Sbjct: 266 HPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323
Query: 567 DLSQNNFSGQIPKYLENLSFLQYLNLSYNHFE 598
L N+ + L L+ L LS+N ++
Sbjct: 324 YLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 61/344 (17%), Positives = 121/344 (35%), Gaps = 36/344 (10%)
Query: 116 NLFRLETLVLANNSFSGRIPTN-LSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLS 174
L + + N++ ++P L ++ + + + EI + +Q L
Sbjct: 43 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFA-YAHTIQKLY 99
Query: 175 VGDNQLTGQLPASI-GNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNHFSGTI 232
+G N + LP + N+ L V+ + N L +P L L + +N+ I
Sbjct: 100 MGFNAIR-YLPPHVFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLE-RI 156
Query: 233 PPSV-YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNL 291
+SL + L NR T + + +P+L + + N + + + +
Sbjct: 157 EDDTFQATTSLQNLQLSSNRLT-HVDLS---LIPSLFHANVSYNLLS-----TLAIPIAV 207
Query: 292 EVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLA 351
E L + N + +L++L L N L + L N L + L+
Sbjct: 208 EELDASHNSIN---VVRGPVNVELTILKLQHNNLTD--------TAWLLNYPGLVEVDLS 256
Query: 352 DNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHV 411
N ++ H + L + N++ + + L L + N L +
Sbjct: 257 YNELEKIMYHPFVKM-QRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERN 313
Query: 412 IGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGN 455
+ L+ L+L N + T+ L L L+ N+ N
Sbjct: 314 QPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN 354
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 56/295 (18%), Positives = 100/295 (33%), Gaps = 23/295 (7%)
Query: 306 SINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIAN 365
I+ N D + + + + L + + ++ + + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITL----NNQKIVTFKNSTMRKLPAALLDS 67
Query: 366 LSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLH 424
+ NL QI I A + L M N + PHV + L +L L
Sbjct: 68 F-RQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125
Query: 425 ANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQI 484
N L N LT LS NNL+ + +L N+LT + +
Sbjct: 126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL 184
Query: 485 LEITTLSL-SLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVE 543
+ SL ++S NLL+ +L ++ L + N + + L ++
Sbjct: 185 IP----SLFHANVSYNLLS-TLA----IPIAVEELDASHNSIN-VVRG--PVNVELTILK 232
Query: 544 LQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFE 598
LQ N+ + L + + E+DLS N + + L+ L +S N
Sbjct: 233 LQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 39/260 (15%), Positives = 79/260 (30%), Gaps = 47/260 (18%)
Query: 67 RRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLA 126
++T L + N ++ I + L+ + ++ N + + L ++
Sbjct: 138 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVS 194
Query: 127 NNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPA 186
N + L+ + A N++ + + L L + N LT
Sbjct: 195 YNLL-----STLAIPIAVEELDASHNSIN-VVRGPV----NVELTILKLQHNNLT-DTAW 243
Query: 187 SIGNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEI 245
+ N L +D+ N L KI ++ L L++ +N + I +L +
Sbjct: 244 -LLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300
Query: 246 YLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQV 305
L N + + LE L+L N
Sbjct: 301 DLSHNHLL--------------------------HVERNQPQFDRLENLYLDHNSIV--- 331
Query: 306 SINFNGLKDLSMLGLATNFL 325
++ + L L L+ N
Sbjct: 332 TLKLSTHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 32/200 (16%), Positives = 65/200 (32%), Gaps = 36/200 (18%)
Query: 69 NQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANN 128
V +LD + SI + L + + N+ + + N L + L+ N
Sbjct: 204 PIAVEELDASHNSINVVRG---PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYN 258
Query: 129 SFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASI 188
+I ++ L+ L + +N+L L
Sbjct: 259 ELE-------------------------KIMYHPF-VKMQRLERLYISNNRLV-ALNLYG 291
Query: 189 GNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLY 248
+ L+V+D+ N L + Q L L++ N T+ S + +L + L
Sbjct: 292 QPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV-TLKLSTH--HTLKNLTLS 347
Query: 249 GNRFTGSLPIEIGKNLPNLR 268
N + + + +N+
Sbjct: 348 HNDWDCNSLRALFRNVARPA 367
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-34
Identities = 84/491 (17%), Positives = 167/491 (34%), Gaps = 46/491 (9%)
Query: 120 LETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQ 179
L ++ N S +++ SKL N + + + L+ L + N+
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRI-QYLDISVFKF-NQELEYLDLSHNK 80
Query: 180 LTGQLPASIGNLSALRVIDIRTNRLWGKIPIT--LSQLTSLAYLHVGDNHFSGTIPPSVY 237
L S L+ +D+ N +PI ++ L +L + H + +
Sbjct: 81 LVK---ISCHPTVNLKHLDLSFNAF-DALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 238 NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNN--FTGSLPDSFSNASNLEVLH 295
+++ + + G + E ++ +++ N F L S +NLE+ +
Sbjct: 137 HLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196
Query: 296 LAENQFRGQVSINFNGLKDLSMLGLATNF-LGNGAANDLDFVDLLT--NCTKLQYLYLAD 352
+ + S + L L +N L N F+ +L T + Y +++
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256
Query: 353 NGFGGVLPHSIANLS----TALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTI 408
G L + S AL + + N+N +
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVH 316
Query: 409 PHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMF 468
++ L N L T+ + G+LT L L N L+ + +
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELS-------KIAE 368
Query: 469 FFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGIARNQFSG 527
L LD+S N ++ G KSL+ L ++ N +
Sbjct: 369 MTTQMKSLQ---------------QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413
Query: 528 QIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKY-LENLSF 586
I L ++ ++L N +IP+ + L +++EL+++ N +P + L+
Sbjct: 414 TIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTS 469
Query: 587 LQYLNLSYNHF 597
LQ + L N +
Sbjct: 470 LQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-31
Identities = 88/460 (19%), Positives = 160/460 (34%), Gaps = 34/460 (7%)
Query: 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHF 228
L++ N ++ + I +LS LR++ I NR+ L YL + N
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 229 SGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNA 288
I +L + L N F + N+ L+ + T + S ++
Sbjct: 82 V-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138
Query: 289 SNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYL 348
+ +VL + + + GL+D + L F N + + V + T L+
Sbjct: 139 NISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT-VANLELS 195
Query: 349 YLADNGFGGVLPHSIANLSTALI-----DFNLGKNQIYGTIPPGIANLV--------NLN 395
+ + ++ L+ + L + I LV +++
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSIS 255
Query: 396 SLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGN 455
+++++ + LK L + + ++ + + +F + +
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315
Query: 456 IPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVG---NL 512
+ N LT + + +T L +L L N L L +
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELE-TLILQMNQLK-ELSKIAEMTTQM 373
Query: 513 KSLVRLGIARNQFSGQIPVTLGAC---TSLEYVELQGNSFSGTIPQSLSSLTSIKELDLS 569
KSL +L I++N S G C SL + + N + TI + L IK LDL
Sbjct: 374 KSLQQLDISQNSVSYDEKK--GDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLH 429
Query: 570 QNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKN 609
N IPK + L LQ LN++ N + VP GIF
Sbjct: 430 SNKIK-SIPKQVVKLEALQELNVASNQLK-SVP-DGIFDR 466
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 57/370 (15%), Positives = 116/370 (31%), Gaps = 18/370 (4%)
Query: 240 SSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAEN 299
+ + N + L +L LR +I N F LE L L+ N
Sbjct: 21 QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79
Query: 300 QFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVL 359
+ I+ + +L L L+ N + L N ++L++L L+
Sbjct: 80 KLV---KISCHPTVNLKHLDLSFNAF-----DALPICKEFGNMSQLKFLGLSTTHLEKSS 131
Query: 360 PHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQ 419
IA+L+ + + LG+ L + N+ + T H I ++
Sbjct: 132 VLPIAHLNISKVLLVLGETYGE---KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT 188
Query: 420 LLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGA 479
+ +L + ++ + + + L N N+ + F +L
Sbjct: 189 VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL--QLVWH 246
Query: 480 LPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSL 539
I+ + L L + S +LK+L + + F +++
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGT----SLKALSIHQVVSDVFGFPQSYIYEIFSNM 302
Query: 540 EYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEG 599
+ S ++ LD S N + + + +L+ L+ L L N +
Sbjct: 303 NIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE 362
Query: 600 EVPTKGIFKN 609
+
Sbjct: 363 LSKIAEMTTQ 372
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 69/427 (16%), Positives = 138/427 (32%), Gaps = 53/427 (12%)
Query: 68 RNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPD--RIGNLFRLETLVL 125
NQ + LDL + + I L++++++ N F +P GN+ +L+ L L
Sbjct: 67 FNQELEYLDLSHNKLVKISC---HPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGL 122
Query: 126 ANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISR-RLFNLQGLSVGDNQLTGQL 184
+ ++H + + E + +L + + + L
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFIL 182
Query: 185 PASIGNLSALRVIDIRTNRLWGKIPITLSQL----------------------------- 215
S+ ++ L + +I+ K LS L
Sbjct: 183 DVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ 242
Query: 216 ----TSLAYLHVGDNHFSGTIPPSVYNIS-----SLVEIYLYGNRFTGSLPIEIGKNLPN 266
T++ Y + + G + ++ S +L + + F I + N
Sbjct: 243 LVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-FPQSYIYEIFSN 301
Query: 267 LRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLG 326
+ + S S L + N V N L +L L L N L
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 327 NGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPP 386
+ + LQ L ++ N + + +L+ N+ N + TI
Sbjct: 362 ELSKIAEMTTQM----KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR 417
Query: 387 GIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLS 446
+ + L + +N++ +IP + +L+ LQ L++ +N L+ LT L +
Sbjct: 418 CL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIW 474
Query: 447 FGANNLQ 453
N
Sbjct: 475 LHTNPWD 481
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-34
Identities = 76/480 (15%), Positives = 164/480 (34%), Gaps = 43/480 (8%)
Query: 134 IPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSA 193
I +NL + + + H + ++ L N + ++ ++ + A + +
Sbjct: 19 IDSNLQY--DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76
Query: 194 LRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSV-YNISSLVEIYLYGNRF 252
+ ++++ ++ + ++ L++G N +PP V N+ L + L N
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
Query: 253 TGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGL 312
+ SLP I N P L + NN D+F ++L+ L L+ N+ ++ + +
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLI 191
Query: 313 KDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALID 372
L ++ N L L ++ L + N V L+
Sbjct: 192 PSLFHANVSYNLLST-----------LAIPIAVEELDASHNSINVVRGPVNVELTI---- 236
Query: 373 FNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTI 432
L N + T + N L + + N L + H +++ L+ L++ N L +
Sbjct: 237 LKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 293
Query: 433 PSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSL 492
+ L L N+L ++ + L + N + L TL
Sbjct: 294 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTH--HTLK- 348
Query: 493 SLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLG---ACTSLEY-------V 542
+L LS N + + + +++ R + +I L C +
Sbjct: 349 NLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQ 406
Query: 543 ELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVP 602
+ S + ++ ++ ++ Q+ + L + L N EV
Sbjct: 407 YIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQ 466
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 77/482 (15%), Positives = 154/482 (31%), Gaps = 54/482 (11%)
Query: 116 NLFRLETLVLANNSFSGRIPTN-LSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLS 174
L + + N++ ++P L ++ + + + EI + +Q L
Sbjct: 49 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFA-YAHTIQKLY 105
Query: 175 VGDNQLTGQLPASI-GNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNHFSGTI 232
+G N + LP + N+ L V+ + N L +P L L + +N+ I
Sbjct: 106 MGFNAIR-YLPPHVFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLE-RI 162
Query: 233 PPSV-YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNL 291
+SL + L NR T + + +P+L + + N + + + +
Sbjct: 163 EDDTFQATTSLQNLQLSSNRLT-HVDL---SLIPSLFHANVSYNLLS-----TLAIPIAV 213
Query: 292 EVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLA 351
E L + N + +L++L L N L + L N L + L+
Sbjct: 214 EELDASHNSIN---VVRGPVNVELTILKLQHNNLTD--------TAWLLNYPGLVEVDLS 262
Query: 352 DNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHV 411
N ++ H + L + N++ + + L L + N L +
Sbjct: 263 YNELEKIMYHPFVKM-QRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERN 319
Query: 412 IGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFA 471
+ L+ L+L N + T+ L L L+ N+ C +L F
Sbjct: 320 QPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD---------CNSLRALFR 367
Query: 472 PRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPV 531
+ Q +I + IA ++
Sbjct: 368 NVARPAVDDADQHCKIDYQLEHGLCCKESDK--------PYLDRLLQYIALTSVVEKVQR 419
Query: 532 TLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLN 591
G C++ + + + Q L ++L+ N ++ + L N Q
Sbjct: 420 AQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQ-LTNEQIQQEQL 478
Query: 592 LS 593
L
Sbjct: 479 LQ 480
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-24
Identities = 57/293 (19%), Positives = 100/293 (34%), Gaps = 23/293 (7%)
Query: 306 SINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIAN 365
I+ N D + + + + L + + ++ + + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITL----NNQKIVTFKNSTMRKLPAALLDS 73
Query: 366 LSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLH 424
+ NL QI I A + L M N + PHV + L +L L
Sbjct: 74 F-RQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131
Query: 425 ANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQI 484
N L N LT LS NNL+ + +L N+LT + +
Sbjct: 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL 190
Query: 485 LEITTLSL-SLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVE 543
+ SL ++S NLL+ +L ++ L + N + V L ++
Sbjct: 191 IP----SLFHANVSYNLLS-TLA----IPIAVEELDASHNSINV---VRGPVNVELTILK 238
Query: 544 LQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNH 596
LQ N+ + L + + E+DLS N + + L+ L +S N
Sbjct: 239 LQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 289
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-17
Identities = 67/462 (14%), Positives = 131/462 (28%), Gaps = 37/462 (8%)
Query: 67 RRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLA 126
++T L + N ++ I + L+ + ++ N + + L ++
Sbjct: 144 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVS 200
Query: 127 NNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPA 186
N + L+ + A N++ + + L L + N LT
Sbjct: 201 YNLL-----STLAIPIAVEELDASHNSIN-VVRGPV----NVELTILKLQHNNLT-DTAW 249
Query: 187 SIGNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEI 245
+ N L +D+ N L KI ++ L L++ +N + I +L +
Sbjct: 250 -LLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 306
Query: 246 YLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRG-Q 304
L N + L N + N+ +L S L+ L L+ N +
Sbjct: 307 DLSHNHLL-HVERNQP-QFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNS 361
Query: 305 VSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIA 364
+ F + ++ + + + L
Sbjct: 362 LRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQ 421
Query: 365 NLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGEL--KNLQLLH 422
+A N ++ + G L L E N L + + E + L
Sbjct: 422 GRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQG 481
Query: 423 LHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQ 482
LHA NL G N+ + K F + + T A
Sbjct: 482 LHAE--------IDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAF---KLRETQARRT 530
Query: 483 QILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQ 524
+ + L+ + L L L + + Q
Sbjct: 531 EADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQ 572
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 5e-15
Identities = 39/217 (17%), Positives = 79/217 (36%), Gaps = 11/217 (5%)
Query: 381 YGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLT 440
Y I + + ++ L N +++ + ++ + L +
Sbjct: 16 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75
Query: 441 LLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNL 500
+ L+ ++ ++ + + N + LP + + L L L N
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134
Query: 501 LNGSLPLGV-GNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSS 559
L+ SLP G+ N L L ++ N T A TSL+ ++L N + + LS
Sbjct: 135 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSL 190
Query: 560 LTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNH 596
+ S+ ++S N S L ++ L+ S+N
Sbjct: 191 IPSLFHANVSYNLLST-----LAIPIAVEELDASHNS 222
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 20/138 (14%), Positives = 41/138 (29%), Gaps = 3/138 (2%)
Query: 472 PRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPV 531
PR + + + + + L + + +
Sbjct: 11 PRQPEYKCIDSNLQYDCVF-YDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA 69
Query: 532 TLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLN 591
L + +E + L + + +I++L + N P +N+ L L
Sbjct: 70 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129
Query: 592 LSYNHFEGEVPTKGIFKN 609
L N +P +GIF N
Sbjct: 130 LERNDLS-SLP-RGIFHN 145
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-33
Identities = 79/467 (16%), Positives = 149/467 (31%), Gaps = 63/467 (13%)
Query: 120 LETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQ 179
+ V A + + L + H +++ ++ I + L L L N
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG--IEK-LTGLTKLICTSNN 75
Query: 180 LTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNI 239
+T L + + L + +N+L + ++ LT L YL+ N + + S
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT-KLDVS--QN 126
Query: 240 SSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAEN 299
L + N T + + + L + N L + + L L + N
Sbjct: 127 PLLTYLNCARNTLT-EIDV---SHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFN 180
Query: 300 QFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVL 359
+ ++ + K L+ L TN + LD +L +L + N +
Sbjct: 181 KIT---ELDVSQNKLLNRLNCDTNNI-----TKLDL----NQNIQLTFLDCSSNKLTEI- 227
Query: 360 PHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQ 419
+ L T L F+ N + + L L +L L I N Q
Sbjct: 228 --DVTPL-TQLTYFDCSVNPL-TELDVS--TLSKLTTLHCIQTDLL-----EIDLTHNTQ 276
Query: 420 LLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGA 479
L++ A + + + T L L A + + S L++ + +LT
Sbjct: 277 LIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELDLS--QNPKLVYLYLNNTELT-- 331
Query: 480 LPQQILEITTLSL--SLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGA-- 535
L+++ + SL + + VG + +L A Q TL
Sbjct: 332 ----ELDVSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNS 385
Query: 536 ---CTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPK 579
S + ++ GN I + ++ N S P
Sbjct: 386 LTIAVSPDLLDQFGNPM--NIEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-32
Identities = 67/429 (15%), Positives = 129/429 (30%), Gaps = 74/429 (17%)
Query: 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHF 228
N ++ S L+ L +D + +T +
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNS-----------SITDM---------- 57
Query: 229 SGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNA 288
+ ++ L ++ N T +L + NL +N T +L +
Sbjct: 58 -----TGIEKLTGLTKLICTSNNIT-TLDL---SQNTNLTYLACDSNKLT-NLD--VTPL 105
Query: 289 SNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYL 348
+ L L+ N+ ++ + L+ L A N L ++D +++ T+L L
Sbjct: 106 TKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTL-----TEID----VSHNTQLTEL 153
Query: 349 YLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTI 408
N L + T L + N+I + ++ LN L + N +T +
Sbjct: 154 DCHLNKKITKLD--VTPQ-TQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KL 206
Query: 409 PHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMF 468
+ + L L +N L I + LT LTY N L + S L
Sbjct: 207 D--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTT 258
Query: 469 FFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQ 528
+ L +++T + + L V + L L +
Sbjct: 259 LHCIQTDLL------EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-- 310
Query: 529 IPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQ 588
+ L L Y+ L + + +S T +K L + + + L
Sbjct: 311 -ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALN 364
Query: 589 YLNLSYNHF 597
+
Sbjct: 365 NNFEAEGQT 373
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-31
Identities = 71/434 (16%), Positives = 139/434 (32%), Gaps = 62/434 (14%)
Query: 68 RNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLAN 127
+ +T LD N SI + + L+ L + N+ + + L L +
Sbjct: 40 QLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDS 94
Query: 128 NSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPAS 187
N + +++ +KL + N L +L + L L+ N LT ++
Sbjct: 95 NKLTN---LDVTPLTKLTYLNCDTNKL-----TKLDVSQNPLLTYLNCARNTLT-EID-- 143
Query: 188 IGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYL 247
+ + + L +D N+ + ++ T L L N + + S L +
Sbjct: 144 VSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKIT-ELDVS--QNKLLNRLNC 198
Query: 248 YGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSI 307
N T L + L +N T + + + L + N +
Sbjct: 199 DTNNIT-KLDLN---QNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---EL 248
Query: 308 NFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLS 367
+ + L L+ L L ++D LT+ T+L Y L + +
Sbjct: 249 DVSTLSKLTTLHCIQTDL-----LEID----LTHNTQLIYFQAEGCRKIKELD--VTHN- 296
Query: 368 TALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANF 427
T L + I + ++ L L + LT + + L+ L
Sbjct: 297 TQLYLLDCQAAGI-TELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAH 350
Query: 428 LQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEI 487
+Q S+G + L +L N N LT A+ +L+
Sbjct: 351 IQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTN-----------NSLTIAVSPDLLDQ 397
Query: 488 TTLSLSLDLSDNLL 501
++++ D +
Sbjct: 398 FGNPMNIEPGDGGV 411
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 69/364 (18%), Positives = 131/364 (35%), Gaps = 48/364 (13%)
Query: 235 SVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVL 294
S +++L + + + T IE L L + +NN T +L S +NL L
Sbjct: 37 SEEQLATLTSLDCHNSSITDMTGIE---KLTGLTKLICTSNNIT-TLD--LSQNTNLTYL 90
Query: 295 HLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNG 354
N+ +++ L L+ L TN L LD + L YL A N
Sbjct: 91 ACDSNKLT---NLDVTPLTKLTYLNCDTNKL-----TKLDV----SQNPLLTYLNCARNT 138
Query: 355 FGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGE 414
+ +++ T L + + N+ + L +L N++T + + +
Sbjct: 139 LTEI---DVSHN-TQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQ 189
Query: 415 LKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRN 474
K L L+ N + + L LT+L +N L I + L +F N
Sbjct: 190 NKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EIDVT--PLTQLTYFDCSVN 243
Query: 475 KLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLG 534
LT L L + L+ +L L + L + L+ + ++ +
Sbjct: 244 PLT-ELDVSTL--SKLT-TLHCIQTDLL-EIDLT--HNTQLIYFQAEGCRKIKELD--VT 294
Query: 535 ACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSY 594
T L ++ Q + + LS + L L+ + ++ + + + L+ L+
Sbjct: 295 HNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVN 348
Query: 595 NHFE 598
H +
Sbjct: 349 AHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-25
Identities = 55/334 (16%), Positives = 95/334 (28%), Gaps = 47/334 (14%)
Query: 265 PNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSI-NFNGLKDLSMLGLATN 323
N + V + S + L L + + L L+ L +N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT---DMTGIEKLTGLTKLICTSN 74
Query: 324 FLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGT 383
+ LD + T L YL N + + L T L N N++
Sbjct: 75 NI-----TTLDL----SQNTNLTYLACDSNKLTNL---DVTPL-TKLTYLNCDTNKL-TK 120
Query: 384 IPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLT 443
+ ++ L L N LT I + L L H N + + T LT
Sbjct: 121 LD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLN--KKITKLDVTPQTQLT 173
Query: 444 YLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSL--SLDLSDNLL 501
L N + + K L N +T L++ LD S N L
Sbjct: 174 TLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK------LDLNQNIQLTFLDCSSNKL 224
Query: 502 NGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLT 561
+ + L L + N + + + + L + I L+ T
Sbjct: 225 T-EIDV--TPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EID--LTHNT 275
Query: 562 SIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYN 595
+ ++ + + + L L+
Sbjct: 276 QLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAA 307
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 8e-21
Identities = 57/281 (20%), Positives = 94/281 (33%), Gaps = 35/281 (12%)
Query: 320 LATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLS--TALIDFNLGK 377
A+ D + L L ++ + + T L
Sbjct: 20 FASEVAAAFEMQATDTISE-EQLATLTSLDCHNSSI-----TDMTGIEKLTGLTKLICTS 73
Query: 378 NQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLG 437
N I T+ ++ NL L ++N+LT + + L L L+ N L +
Sbjct: 74 NNI-TTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVS 124
Query: 438 NLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLS 497
LLTYL+ N L + + L NK L + T L+ +LD S
Sbjct: 125 QNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLT-TLDCS 178
Query: 498 DNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSL 557
N + L V K L RL N + + L L +++ N + I +
Sbjct: 179 FNKITE---LDVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID--V 229
Query: 558 SSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFE 598
+ LT + D S N + ++ + LS L L+
Sbjct: 230 TPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 8e-12
Identities = 42/286 (14%), Positives = 100/286 (34%), Gaps = 35/286 (12%)
Query: 69 NQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANN 128
N+ + +L+ +I + + L +++ + N EI + L +L + N
Sbjct: 190 NKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVN 243
Query: 129 SFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASI 188
+ + +S SKL T + +L E+ L + +L +
Sbjct: 244 PLT-ELD--VSTLSKLTTLHCIQTDL-----LEIDLTHNTQLIYFQAEGCRKIKELD--V 293
Query: 189 GNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLY 248
+ + L ++D + + + LSQ L YL++ + + + S + + L +
Sbjct: 294 THNTQLYLLDCQAAGI---TELDLSQNPKLVYLYLNNTELT-ELDVS--HNTKLKSLSCV 347
Query: 249 GNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSIN 308
+P L N ++ +N N + ++ + N
Sbjct: 348 NAHIQD---FSSVGKIPALNNNFEAEGQTITMPKETLTN--NSLTIAVSPDLL--DQFGN 400
Query: 309 FNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNG 354
++ + + A N + + +L T+ + Y + ++NG
Sbjct: 401 PMNIEPGD------GGVYDQATNTITWENLSTDNPAVTYTFTSENG 440
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-32
Identities = 58/230 (25%), Positives = 114/230 (49%), Gaps = 27/230 (11%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS---FAAECEALRSIRH 757
+ + + +G G +G VY+GV + + VAVK + K + F E ++ I+H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 275
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
NL++++ +C+ + F ++ E+M G+L ++L + + Q +S + L +
Sbjct: 276 PNLVQLLGVCT----REPPFY-IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQ 326
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
++SA+EYL +H +L N L+ + + V+DFGL++ ++ +T ++
Sbjct: 327 ISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTAH 376
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
G K I + APE + S++ V+++G+LL EI T P +
Sbjct: 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 426
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-32
Identities = 82/355 (23%), Positives = 133/355 (37%), Gaps = 53/355 (14%)
Query: 240 SSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAEN 299
+ + + + T +LP + ++ L I NN T SLP L L ++ N
Sbjct: 40 NGNAVLNVGESGLT-TLPDCLPAHITTLV---IPDNNLT-SLPALPPE---LRTLEVSGN 91
Query: 300 QFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVL 359
Q + + GL +LS+ L L + L L++ N L
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHL----------PALPSG---LCKLWIFGNQLT-SL 136
Query: 360 PHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQ 419
P L ++ NQ+ ++P + L L + N+LT ++P + LQ
Sbjct: 137 PVLPPGLQE----LSVSDNQL-ASLPALPSELCKLWAYN---NQLT-SLPMLPS---GLQ 184
Query: 420 LLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGA 479
L + N L ++P+ L L + N L ++P K L+ N+LT +
Sbjct: 185 ELSVSDNQLA-SLPTLPSELYKLWAYN---NRLT-SLPALPSGLKELIVSG---NRLT-S 235
Query: 480 LPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSL 539
LP + L L +S N L SLP+ L SL + RNQ + ++P +L +S
Sbjct: 236 LPV---LPSELK-ELMVSGNRLT-SLPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSE 286
Query: 540 EYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSY 594
V L+GN S Q+L +TS F L +
Sbjct: 287 TTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW 341
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-31
Identities = 76/412 (18%), Positives = 136/412 (33%), Gaps = 85/412 (20%)
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG 132
L++ + + P + + + I DN+ +P L TL ++ N +
Sbjct: 43 AVLNVGESGLTTL--P-DCLPAHITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLT- 94
Query: 133 RIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLS 192
+P +L FS +L L L + NQLT LP L
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLPALPS---------GLCKLWIFGNQLT-SLPVLPPGLQ 144
Query: 193 ALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRF 252
L + N+L +P S+L L +N + ++P S L E+ + N+
Sbjct: 145 EL---SVSDNQL-ASLPALPSELCKL---WAYNNQLT-SLPML---PSGLQELSVSDNQL 193
Query: 253 TGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGL 312
SLP L Y N T SLP S L+ L ++ N+ L
Sbjct: 194 A-SLPTLPS----ELYKLWAYNNRLT-SLPALPSG---LKELIVSGNR-----------L 233
Query: 313 KDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALID 372
L +L ++L+ L ++ N LP + L +
Sbjct: 234 TSLPVL-----------------------PSELKELMVSGNRLTS-LPMLPSGLLS---- 265
Query: 373 FNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLH---LHANFLQ 429
++ +NQ+ +P + +L + ++ +E N L+ + E+ + + +
Sbjct: 266 LSVYRNQL-TRLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAG 324
Query: 430 GTIPSSLGNLTLLTYLSFGANNLQGNIPF----SLGNCKNLMFFFAPRNKLT 477
+ P L L P G N F ++L+
Sbjct: 325 ASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 79/379 (20%), Positives = 140/379 (36%), Gaps = 57/379 (15%)
Query: 141 CSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIR 200
+ + + L +P+ L + ++ L + DN LT LPA L R +++
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLPA----HITTLVIPDNNLT-SLPALPPEL---RTLEVS 89
Query: 201 TNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEI 260
N+L +P+ L L+ H S L +++++GN+ T SLP+
Sbjct: 90 GNQL-TSLPVLPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGNQLT-SLPVLP 140
Query: 261 GKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGL 320
L+ + N SLP S L L NQ + + +GL++LS +
Sbjct: 141 P----GLQELSVSDNQLA-SLPALPSE---LCKLWAYNNQLT-SLPMLPSGLQELS---V 188
Query: 321 ATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQI 380
+ N L L T ++L L+ +N LP + L + N++
Sbjct: 189 SDNQL----------ASLPTLPSELYKLWAYNNRLT-SLPALPSGLKE----LIVSGNRL 233
Query: 381 YGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLT 440
++P + L L + NRLT ++P + L L ++ N L +P SL +L+
Sbjct: 234 -TSLPVLPSELKELM---VSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLS 284
Query: 441 LLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNL 500
T ++ N L +L + + P + A E L L+ +
Sbjct: 285 SETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAA---ADW 341
Query: 501 LNGSLPLGVGNLKSLVRLG 519
L + G
Sbjct: 342 LVPAREGEPAPADRWHMFG 360
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 82/435 (18%), Positives = 139/435 (31%), Gaps = 60/435 (13%)
Query: 152 NNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPIT 211
+ + +++ + L+VG++ LT LP + + + I N L +P
Sbjct: 24 SRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNL-TSLPAL 79
Query: 212 LSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFV 271
+L + L V N + ++P + L L
Sbjct: 80 PPELRT---LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL--------PSGLCKLW 127
Query: 272 IYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAAN 331
I+ N T SLP L+ L +++NQ + + L L N
Sbjct: 128 IFGNQLT-SLPVLP---PGLQELSVSDNQLA-SLPALPSELCKLWAYN-----------N 171
Query: 332 DLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANL 391
L L + LQ L ++DN LP + L L N++ ++P + L
Sbjct: 172 QL--TSLPMLPSGLQELSVSDNQL-ASLPTLPSEL-YKL---WAYNNRLT-SLPALPSGL 223
Query: 392 VNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANN 451
L + NRLT ++P + ELK L + N L ++P L L + N
Sbjct: 224 KELI---VSGNRLT-SLPVLPSELKE---LMVSGNRLT-SLPMLPSGLLSL-SVYR--NQ 272
Query: 452 LQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGN 511
L +P SL + + N L+ Q L T S + G
Sbjct: 273 LT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREIT---SAPGYSGPIIRFDMAGASA 327
Query: 512 LKSLVRLGIARNQ-FSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQ 570
+ L +A + N + L L+ + +
Sbjct: 328 PRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDN--ADAFSLFLDRLSETEN-FIKD 384
Query: 571 NNFSGQIPKYLENLS 585
F QI +L L+
Sbjct: 385 AGFKAQISSWLAQLA 399
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-23
Identities = 54/257 (21%), Positives = 92/257 (35%), Gaps = 41/257 (15%)
Query: 342 CTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEA 401
L + ++G LP + T L + N + ++P L L +
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPAHITTL---VIPDNNL-TSLPALPPELRTLE---VSG 90
Query: 402 NRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLG 461
N+LT ++P + L L + L +PS L L + N ++P
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIF-------GNQLTSLPVLPP 141
Query: 462 NCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIA 521
+ L N+L +LP E+ L +N L SLP+ L+ L ++
Sbjct: 142 GLQEL---SVSDNQLA-SLPALPSELC----KLWAYNNQLT-SLPMLPSGLQEL---SVS 189
Query: 522 RNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYL 581
NQ + +P L + N + ++P S L EL +S N + +P
Sbjct: 190 DNQLA-SLPTLPS---ELYKLWAYNNRLT-SLPALPSGLK---ELIVSGNRLT-SLPVLP 240
Query: 582 ENLSFLQYLNLSYNHFE 598
L + L +S N
Sbjct: 241 SEL---KELMVSGNRLT 254
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 8e-21
Identities = 53/233 (22%), Positives = 91/233 (39%), Gaps = 36/233 (15%)
Query: 366 LSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHA 425
L+ N+G++ + T+P + ++ +L + N LT ++P + EL+ L++
Sbjct: 38 LNNGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTLEVSG--- 90
Query: 426 NFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQIL 485
N L ++P L L+ S +L P L F N+LT +LP
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKLWIF---GNQLT-SLPVLPP 141
Query: 486 EITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQ 545
+ L +SDN L SLP L L NQ + +P+ L+ + +
Sbjct: 142 GLQ----ELSVSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPS---GLQELSVS 189
Query: 546 GNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFE 598
N + ++P S L L N + +P L + L +S N
Sbjct: 190 DNQLA-SLPTLPSELYK---LWAYNNRLT-SLPALPSGL---KELIVSGNRLT 234
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-32
Identities = 70/334 (20%), Positives = 120/334 (35%), Gaps = 18/334 (5%)
Query: 244 EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRG 303
+ + RF ++P I R + N D F++ +LE L L EN
Sbjct: 15 AVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA 70
Query: 304 QVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSI 363
FN L +L LGL +N L + T + L L +++N +L +
Sbjct: 71 VEPGAFNNLFNLRTLGLRSNRLKLIPL------GVFTGLSNLTKLDISENKIVILLDYMF 124
Query: 364 ANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLH 422
+L L +G N + I + L +L L +E LT + L L +L
Sbjct: 125 QDL-YNLKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLR 182
Query: 423 LHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQ 482
L + S L L L + + NL LT A+P
Sbjct: 183 LRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPY 241
Query: 483 QILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGIARNQFSGQIPVTLGACTSLEY 541
+ L+LS N ++ ++ + L L + + Q + P L
Sbjct: 242 LAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRV 300
Query: 542 VELQGNSFSGTIPQSL-SSLTSIKELDLSQNNFS 574
+ + GN + T+ +S+ S+ +++ L L N +
Sbjct: 301 LNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 57/306 (18%), Positives = 114/306 (37%), Gaps = 17/306 (5%)
Query: 150 HRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIP 209
HR V +PE + + + L +G N++ + L +++ N + P
Sbjct: 19 HRKRFV-AVPEGIPT----ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEP 73
Query: 210 ITLSQLTSLAYLHVGDNHFSGTIPPSV-YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLR 268
+ L +L L + N IP V +S+L ++ + N+ L + ++L NL+
Sbjct: 74 GAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLK 131
Query: 269 NFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNG 328
+ + N+ +FS ++LE L L + + + L L +L L +
Sbjct: 132 SLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAI 191
Query: 329 AANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPG- 387
+L+ L ++ + + + L ++ + +P
Sbjct: 192 RD------YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN-LTSLSITHCNL-TAVPYLA 243
Query: 388 IANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSF 447
+ +LV L L + N ++ ++ EL LQ + L L P + L L L+
Sbjct: 244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNV 303
Query: 448 GANNLQ 453
N L
Sbjct: 304 SGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 72/396 (18%), Positives = 127/396 (32%), Gaps = 80/396 (20%)
Query: 51 SACVNLCQ---HWTGVTCGRRN---------QRVTKLDLRNQSIGGILSPYVGNLSFLRY 98
+ C C+ V C R+ LDL I + + L
Sbjct: 1 TGCPPRCECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEE 60
Query: 99 INIADNDFHGEIPDRI-GNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGE 157
+ + +N + NLF L TL L +N
Sbjct: 61 LELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-------------------------L 94
Query: 158 IPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPI-TLSQLT 216
IP + L NL L + +N++ L +L L+ +++ N L I S L
Sbjct: 95 IPLGVF-TGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL-VYISHRAFSGLN 152
Query: 217 SLAYLHVGDNHFSGTIPPSV-YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTN 275
SL L + + + +IP ++ L+ + L ++ K L L+ I
Sbjct: 153 SLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHW 210
Query: 276 NFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDF 335
+ ++ + NL L + ++ + ++ L
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLT---AVPYLAVRHL-------------------- 247
Query: 336 VDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNL 394
L++L L+ N + + L L + L Q+ + P L L
Sbjct: 248 -------VYLRFLNLSYNPISTIEGSMLHEL-LRLQEIQLVGGQL-AVVEPYAFRGLNYL 298
Query: 395 NSLRMEANRLTGTIPH-VIGELKNLQLLHLHANFLQ 429
L + N+LT T+ V + NL+ L L +N L
Sbjct: 299 RVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-19
Identities = 49/270 (18%), Positives = 87/270 (32%), Gaps = 58/270 (21%)
Query: 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEA 401
T+ + L L N + A+ L + L +N + + PG NL NL +L + +
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASF-PHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRS 89
Query: 402 NRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLG 461
NRL V L NL L + N + + +L L
Sbjct: 90 NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLK------------------ 131
Query: 462 NCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGI 520
SL++ DN L + L SL +L +
Sbjct: 132 -------------------------------SLEVGDNDLV-YISHRAFSGLNSLEQLTL 159
Query: 521 ARNQFSGQIPV-TLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPK 579
+ + IP L L + L+ + + S L +K L++S + +
Sbjct: 160 EKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP 218
Query: 580 YLENLSFLQYLNLSYNHFEGEVPTKGIFKN 609
L L++++ + VP ++
Sbjct: 219 NCLYGLNLTSLSITHCNLT-AVPY-LAVRH 246
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 56/224 (25%), Positives = 86/224 (38%), Gaps = 26/224 (11%)
Query: 709 IGRGSFGFVYKGVLH---ENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIK 762
+G GSFG V +G + VAVK + L Q F E A+ S+ HRNLI+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
+ + + K +V E GSL + L + + L + VA +
Sbjct: 86 LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTL-----SRYAVQVAEGM 134
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
YL +H DL N+LL + + DFGL + L + + K
Sbjct: 135 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-----DHYVMQEHRKV 186
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFN 925
+ APE S + +G+ L E+FT + P +
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 74/247 (29%), Positives = 110/247 (44%), Gaps = 38/247 (15%)
Query: 689 PMVSYKELSKATNEFSSS-----NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS- 742
+ + E ++ + TIG+G FG V G G VAVK I K +
Sbjct: 4 SVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI----KNDAT 57
Query: 743 -KSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQL 801
++F AE + +RH NL++++ + + +V EYM GSL ++L R
Sbjct: 58 AQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRS- 112
Query: 802 GICNLSLIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
L L +DV A+EYL ++ VH DL NVL+ D VA VSDFGL K
Sbjct: 113 ---VLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK 165
Query: 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRP 919
E S+ K + + APE + S + V+S+GILL EI++ R P
Sbjct: 166 -----------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
Query: 920 TESMFNE 926
+ +
Sbjct: 215 YPRIPLK 221
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 46/290 (15%), Positives = 99/290 (34%), Gaps = 22/290 (7%)
Query: 163 ISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLH 222
I + + V D+ L L + + ++ +D+ N L L+ T L L+
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 223 VGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLP 282
+ N + ++S+L + L N L P++ NN +
Sbjct: 65 LSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNISRVSC 116
Query: 283 DSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNC 342
+ ++LA N+ ++ + L L N + + ++F +L +
Sbjct: 117 SRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI-----DTVNFAELAASS 168
Query: 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEAN 402
L++L L N + + L +L N++ + P + + + + N
Sbjct: 169 DTLEHLNLQYNFI-YDVKGQVVF--AKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNN 224
Query: 403 RLTGTIPHVIGELKNLQLLHLHANFLQ-GTIPSSLGNLTLLTYLSFGANN 451
+L I + +NL+ L N GT+ + ++
Sbjct: 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 51/345 (14%), Positives = 109/345 (31%), Gaps = 50/345 (14%)
Query: 110 IPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFN 169
I + N R + + ++S + L +N
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLK-------------------------QALASLRQ-SAWN 35
Query: 170 LQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFS 229
++ L + N L+ A + + L ++++ +N L + L L++L L + +N+
Sbjct: 36 VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ 93
Query: 230 GTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNAS 289
+ S+ ++ N + + G+ N+ + N T S
Sbjct: 94 -ELLVG----PSIETLHAANNNIS-RVSCSRGQGKKNIY---LANNKITMLRDLDEGCRS 144
Query: 290 NLEVLHLAENQFRG-QVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYL 348
++ L L N+ + L L L NF+ + V KL+ L
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD--------VKGQVVFAKLKTL 196
Query: 349 YLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTI 408
L+ N + + + +L N++ I + NL + N
Sbjct: 197 DLSSNKL-AFMGPEFQSA-AGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFH-CG 252
Query: 409 PHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453
KN ++ + ++ + T+ T +GA +
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 49/314 (15%), Positives = 111/314 (35%), Gaps = 24/314 (7%)
Query: 280 SLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLL 339
++ + N + ++ + ++ + ++ ++ L L+ N L + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL-----SQISA-ADL 54
Query: 340 TNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRM 399
TKL+ L L+ N L + +L + L +L N + + ++ +L
Sbjct: 55 APFTKLELLNLSSNVLYETLD--LESL-STLRTLDLNNNYV-QELLV----GPSIETLHA 106
Query: 400 EANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQG-NIPF 458
N ++ + + + ++L N + G + + YL N + N
Sbjct: 107 ANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 459 SLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRL 518
+ L N + + Q++ L +LDLS N L + + + +
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLK-TLDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 519 GIARNQFSGQIPVTLGACTSLEYVELQGNSFS-GTIPQSLSSLTSIKELDLSQNNFSGQI 577
+ N+ I L +LE+ +L+GN F GT+ S ++ +
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278
Query: 578 PKYLENLSFLQYLN 591
+ + L +
Sbjct: 279 NEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 50/299 (16%), Positives = 99/299 (33%), Gaps = 20/299 (6%)
Query: 337 DLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPG-IANLVNLN 395
++ N + + + D+ L + + + +L N + I +A L
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSA-WNVKELDLSGNPL-SQISAADLAPFTKLE 61
Query: 396 SLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGN 455
L + +N L + L L+ L L+ N++ L + L NN+
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113
Query: 456 IPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNG-SLPLGVGNLKS 514
+ S G + + NK+T + + LDL N ++ + + +
Sbjct: 114 VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQ-YLDLKLNEIDTVNFAELAASSDT 170
Query: 515 LVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFS 574
L L + N + + L+ ++L N + + S + + L N
Sbjct: 171 LEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 575 GQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNG-KLCGGLDELHLPS 632
I K L L++ +L N F KN+ ++ K G +E
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 35/252 (13%), Positives = 83/252 (32%), Gaps = 30/252 (11%)
Query: 70 QRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNS 129
R + + S+ L+ + ++ ++++ N + +LE L L++N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 130 FSGRIP-----------------TNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQG 172
+ L + T A NN+ + +
Sbjct: 70 LYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI-SRVSCSR----GQGKKN 124
Query: 173 LSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPI--TLSQLTSLAYLHVGDNHFSG 230
+ + +N++T G S ++ +D++ N + + + +L +L++ N
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEI-DTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 231 TIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASN 290
+ V + L + L N+ + E + + + N + + + N
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQ-SAAGVTWISLRNNKLV-LIEKALRFSQN 238
Query: 291 LEVLHLAENQFR 302
LE L N F
Sbjct: 239 LEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 19/95 (20%), Positives = 41/95 (43%), Gaps = 2/95 (2%)
Query: 504 SLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSI 563
++ N + + + + +++ ++L GN S L+ T +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 564 KELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFE 598
+ L+LS N + LE+LS L+ L+L+ N+ +
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ 93
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 28/233 (12%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENG----MLVAVKVINLEQKGGSKS-FAAECEALRSI 755
EF +G G+FG VYKG+ G + VA+K + + E + S+
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 756 RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
+ ++ +++ IC + + L+ + M G L +++ + D +G L LN
Sbjct: 75 DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 816 IDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETP 874
+ +A + YL VH DL NVL+ ++DFGLAK L A E
Sbjct: 124 VQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKE 173
Query: 875 SSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
+ G K I ++A E L + + V+SYG+ + E+ T +P + +
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTIC 767
IGRG+FG V+ G L + LVAVK F E L+ H N+++++ +C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 768 SS-----IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
+ I V E +Q G +L + L + L +V D A+ +
Sbjct: 182 TQKQPIYI----------VMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAGM 226
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
EYL +H DL N L+ V +SDFG+++ + + VK
Sbjct: 227 EYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY--AASGGLRQVPVKW 281
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
T APE G S V+S+GILL E F+ P ++ N+
Sbjct: 282 T----APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ 322
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 60/267 (22%), Positives = 109/267 (40%), Gaps = 39/267 (14%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIVTI 766
IGRGSF VYKG+ E + VA + + S + F E E L+ ++H N+++
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF--Y 91
Query: 767 CSSIDFKGVDFKALVY-EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
S ++ E M +G+L+ +L + + + +++ + +++L
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRS--WCRQILKGLQFL 145
Query: 826 HHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
H PPI+H DLK N+ + + D GLA AS + V GT
Sbjct: 146 HTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-------FAKA---VIGTP 194
Query: 885 GYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVME 944
++APE VY++G+ +LE+ T P +++ ++
Sbjct: 195 EFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYP-------------YSECQNAAQIYR 240
Query: 945 IVDPSLLPLEEERTNSRRVRN--EECL 969
V + P ++ V+ E C+
Sbjct: 241 RVTSGVKPASFDKVAIPEVKEIIEGCI 267
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSI 755
S + + + S+ +G+G+ V++G + G L A+KV N E E L+ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 756 RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
H+N++K+ I + K L+ E+ GSL L + + G L + L ++
Sbjct: 65 NHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG---LPESEFLIVL 118
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLAKFLSASPLGNVV 871
DV + +L + IVH ++KP N++ D V ++DFG A+ L
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQF 172
Query: 872 ETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYG 907
+ + GT Y+ P+ + YG
Sbjct: 173 VS------LYGTEEYLHPDM-YERAVLRKDHQKKYG 201
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-31
Identities = 74/229 (32%), Positives = 104/229 (45%), Gaps = 31/229 (13%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHR 758
E TIG+G FG V G G VAVK I K + ++F AE + +RH
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHS 246
Query: 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
NL++++ + + +V EYM GSL ++L R L L +DV
Sbjct: 247 NLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDV 298
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
A+EYL + VH DL NVL+ D VA VSDFGL K E S+
Sbjct: 299 CEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQD 344
Query: 879 GVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
K + + APE + S + V+S+GILL EI++ R P + +
Sbjct: 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 393
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 49/231 (21%), Positives = 96/231 (41%), Gaps = 18/231 (7%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTIC 767
+G G F +V +G A+K I ++ + E + R H N++++ +
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRL--VA 93
Query: 768 SSIDFKGVDFKA-LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
+ +G +A L+ + + G+L + + D+ L+ Q L +++ + +E +H
Sbjct: 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN--FLTEDQILWLLLGICRGLEAIH 151
Query: 827 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNV-VETPSSSIGVKGTIG 885
H DLKP+N+LL + + D G G+ T + TI
Sbjct: 152 ---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 886 YVAPE------YGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL 930
Y APE + + E + V+S G +L + P + +F +G ++
Sbjct: 209 YRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 22/227 (9%)
Query: 709 IGRGSFGFVYKGVLH----ENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIV 764
+G+G+FG V G +VAVK + + + F E E L+S++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
+C S + + L+ EY+ GSL ++L + +++ L L + +EY
Sbjct: 78 GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 129
Query: 825 LH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
L +H DL N+L++++ + DFGL K L V+ P +
Sbjct: 130 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG-----ESP 180
Query: 884 IGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL 930
I + APE + S+ V+S+G++L E+FT ++S E + +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 53/237 (22%), Positives = 97/237 (40%), Gaps = 27/237 (11%)
Query: 676 HKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN 735
H ++S ++ + ++ +S +S IG G V++ VL+E + A+K +N
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVN 61
Query: 736 LEQKGGS--KSFAAECEALRSIRHRNLIKIVTICSSID-FKGVDFKALVYEYMQNGSLEE 792
LE+ S+ E L ++ + KI+ + D + +V E N L
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRL---YDYEITDQYIYMVMECG-NIDLNS 116
Query: 793 WLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 852
WL ++ ++ +R + ++ AV +H H IVH DLKP+N L+ M+
Sbjct: 117 WLKKKK------SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGML-K 166
Query: 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE--YGLGGEASMRGGVYSYG 907
+ DFG+A + V ++ GT+ Y+ PE +
Sbjct: 167 LIDFGIANQMQPDTTSVVKDS------QVGTVNYMPPEAIKDMSSSRENGKSKSKIS 217
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 47/208 (22%), Positives = 87/208 (41%), Gaps = 23/208 (11%)
Query: 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR 756
+ ++F +G+G+FG V K + A+K I ++ + +E L S+
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLN 60
Query: 757 HRNLIK-----IVTICSSIDFKGVDFKALVY---EYMQNGSLEEWLHQRDDQLGICNLSL 808
H+ +++ + V K+ ++ EY +NG+L + +H + N
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQR 115
Query: 809 IQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLG 868
+ + + A+ Y+H I+H DLKP N+ +D + DFGLAK + S
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 869 NVVETPSSSIGVK------GTIGYVAPE 890
+++ + GT YVA E
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATE 200
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 63/277 (22%), Positives = 113/277 (40%), Gaps = 48/277 (17%)
Query: 674 SAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSN-----TIGRGSFGFVYKGVLH---EN 725
S H ++S + + +L + +G G FG V +G L
Sbjct: 4 SHHHHHHSSGLVPRGSEELQNKLEDV--VIDRNLLILGKILGEGEFGSVMEGNLKQEDGT 61
Query: 726 GMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYE 783
+ VAVK + L+ + F +E ++ H N+I+++ +C + +G+ ++
Sbjct: 62 SLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP 121
Query: 784 YMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSN 842
+M+ G L +L + G ++ L L ++D+A +EYL + + +H DL N
Sbjct: 122 FMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF----LHRDLAARN 177
Query: 843 VLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYV-----APEYGLGGEA 897
+L DM V+DFGL+K + S +G I + A E
Sbjct: 178 CMLRDDMTVCVADFGLSKKIY-----------SGDYYRQGRIAKMPVKWIAIE------- 219
Query: 898 SMRGGVY-------SYGILLLEIFTR-RRPTESMFNE 926
S+ VY ++G+ + EI TR P + N
Sbjct: 220 SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 29/230 (12%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS---FAAECEALRSIRH 757
+G+G FG V+ G + VA+K + K G+ S F E + ++ +RH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTL----KPGTMSPEAFLQEAQVMKKLRH 238
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
L+++ + S +V EYM GSL ++L + L L Q +++
Sbjct: 239 EKLVQLYAVVSEEPI------YIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQ 288
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
+AS + Y+ VH DL+ +N+L+ ++V V+DFGLA+ + +
Sbjct: 289 IASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAK 342
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
+K T APE L G +++ V+S+GILL E+ T+ R P M N
Sbjct: 343 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 388
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 22/227 (9%)
Query: 709 IGRGSFGFVYKGVLH----ENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIV 764
+G+G+FG V G +VAVK + + + F E E L+S++H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
+C S + + L+ EY+ GSL ++L + +++ L L + +EY
Sbjct: 109 GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 160
Query: 825 LH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
L +H DL N+L++++ + DFGL K L V+ P +
Sbjct: 161 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG-----ESP 211
Query: 884 IGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL 930
I + APE + S+ V+S+G++L E+FT ++S E + +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 258
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 53/222 (23%), Positives = 100/222 (45%), Gaps = 25/222 (11%)
Query: 709 IGRGSFGFVYKGVLHENG--MLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNLIKIVT 765
+G G+FG V +GV + VA+KV+ + E + + + + +++++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+C + LV E G L ++L + +++ + N+ ++ V+ ++YL
Sbjct: 78 VCQAEALM------LVMEMAGGGPLHKFLVGKREEIPVSNV-----AELLHQVSMGMKYL 126
Query: 826 -HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
+ VH DL NVLL + A +SDFGL+K L A ++ K +
Sbjct: 127 EEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPL 177
Query: 885 GYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFN 925
+ APE + S R V+SYG+ + E + ++P + M
Sbjct: 178 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 57/247 (23%), Positives = 101/247 (40%), Gaps = 33/247 (13%)
Query: 691 VSYKELSKATNEFSSSN------TIGRGSFGFVYKGVLHENG--MLVAVKVI--NLEQKG 740
++ +E+ +G G+FG V KG VAVK++
Sbjct: 1 MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60
Query: 741 GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQ 800
AE ++ + + +++++ IC + + LV E + G L ++L Q
Sbjct: 61 LKDELLAEANVMQQLDNPYIVRMIGICEAESWM------LVMEMAELGPLNKYLQQNR-- 112
Query: 801 LGICNLSLIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859
++ + +V V+ ++YL + VH DL NVLL A +SDFGL+
Sbjct: 113 ----HVKDKNIIELVHQVSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLS 164
Query: 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RR 918
K L A + K + + APE + S + V+S+G+L+ E F+ ++
Sbjct: 165 KALRADE-----NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
Query: 919 PTESMFN 925
P M
Sbjct: 220 PYRGMKG 226
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-30
Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 43/233 (18%)
Query: 709 IGRGSFGFVYKGVLHENG---MLVAVKVINLEQKGGS-----KSFAAECEALRSIRHRNL 760
+G G FG V G L + VA+K + K G + F E + H N+
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTL----KVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 761 IKIVTICSS-----IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
I++ + + I V EYM+NGSL+ +L + D Q ++IQ + ++
Sbjct: 109 IRLEGVVTKSKPVMI----------VTEYMENGSLDSFLRKHDAQF-----TVIQLVGML 153
Query: 816 IDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETP 874
+AS ++YL VH DL N+L++ ++V VSDFGL + L P E
Sbjct: 154 RGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----EAA 204
Query: 875 SSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
++ G K I + +PE + + V+SYGI+L E+ + RP M N+
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 22/212 (10%)
Query: 709 IGRGSFGFVYKGVLH----ENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIV 764
+G+G+FG V G LVAVK + + F E + L+++ ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
+ + + LV EY+ +G L ++L + +L L L + +EY
Sbjct: 91 GVSYGPGRQSL---RLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEY 142
Query: 825 LH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
L C VH DL N+L++ + ++DFGLAK L + +
Sbjct: 143 LGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK-----DYYVVREPGQSP 193
Query: 884 IGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
I + APE S + V+S+G++L E+FT
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 5e-30
Identities = 33/312 (10%), Positives = 74/312 (23%), Gaps = 46/312 (14%)
Query: 668 YARRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGM 727
+ + ++ + Q LS+ + + G V+ E
Sbjct: 29 ALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLE 88
Query: 728 LVAVKVINLEQKGGS---KSFAAECEALRSIRHRNLI---------------------KI 763
A+KV + + + A + +
Sbjct: 89 DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQL-GICNLSLIQRLNIVIDVASAV 822
+ D V L+ LE D + ++ + +
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLA 207
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
L +VHG P N+ + D + D +G S
Sbjct: 208 ANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW-----KVGTRGPASS------V 253
Query: 883 TIGYVAPEYGLGGEASMRGGV--YSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940
+ Y E+ A+ + + G+ + ++ P F + + +
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FGLVTPGIKGSWKRPSL 309
Query: 941 KVMEIVDPSLLP 952
+V +
Sbjct: 310 RVPGTDSLAFGS 321
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 69/272 (25%), Positives = 115/272 (42%), Gaps = 49/272 (18%)
Query: 672 RRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENG---ML 728
+ +T + + +E+ + IG G G V G L G +
Sbjct: 22 EPQFYAEPHTYEEPGRAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVP 79
Query: 729 VAVKVINLEQKGGS-----KSFAAECEALRSIRHRNLIKIVTICSS-----IDFKGVDFK 778
VA+K + K G + F +E + H N+I++ + + I
Sbjct: 80 VAIKAL----KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI-------- 127
Query: 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDL 838
V EYM+NGSL+ +L D Q +++Q + ++ V + + YL VH DL
Sbjct: 128 --VTEYMENGSLDTFLRTHDGQF-----TIMQLVGMLRGVGAGMRYLSDLG---YVHRDL 177
Query: 839 KPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE---YGLGG 895
NVL+D ++V VSDFGL++ L P + ++ G K I + APE +
Sbjct: 178 AARNVLVDSNLVCKVSDFGLSRVLEDDP-----DAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 896 EASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
AS V+S+G+++ E+ RP +M N
Sbjct: 233 SAS---DVWSFGVVMWEVLAYGERPYWNMTNR 261
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 709 IGRGSFGFVYKGVLH----ENGMLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNLIKI 763
+G G FG V G VAVK + E G + E E LR++ H N++K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
IC+ G+ L+ E++ +GSL+E+L + +++ + L + + ++
Sbjct: 89 KGICTEDGGNGI---KLIMEFLPSGSLKEYLPKNKNKINLKQQ-----LKYAVQICKGMD 140
Query: 824 YLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
YL VH DL NVL++ + + DFGL K + E +
Sbjct: 141 YLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-----EYYTVKDDRDS 191
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ + APE + + + V+S+G+ L E+ T
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 49/240 (20%), Positives = 89/240 (37%), Gaps = 31/240 (12%)
Query: 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR 756
+ +F IG G FG V+K +G +K + ++ E +AL +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLD 62
Query: 757 HRNLIK--------IVTICSSIDFKGVDFKALVY---EYMQNGSLEEWLHQRDDQLGICN 805
H N++ +S ++ E+ G+LE+W+ +R +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK---- 118
Query: 806 LSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865
L + L + + V+Y+H +++ DLKPSN+ L + DFGL L
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 866 PLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFN 925
KGT+ Y++PE + +Y+ G++L E+
Sbjct: 176 GKRT---------RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK 226
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-30
Identities = 62/302 (20%), Positives = 110/302 (36%), Gaps = 44/302 (14%)
Query: 671 RRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSN--------TIGRGSFGFVYKGVL 722
+ +A K + S + NE S IG G V++ VL
Sbjct: 18 KETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQ-VL 76
Query: 723 HENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIVTICSSID-FKGVDFKA 779
+E + A+K +NLE+ S+ E L ++ + KI+ + D +
Sbjct: 77 NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRL---YDYEITDQYIY 132
Query: 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLK 839
+V E N L WL ++ ++ +R + ++ AV +H H IVH DLK
Sbjct: 133 MVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLK 182
Query: 840 PSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE--YGLGGEA 897
P+N L+ M+ + DFG+A + V ++ G + Y+ PE +
Sbjct: 183 PANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QVGAVNYMPPEAIKDMSSSR 235
Query: 898 SMRGGVYSY---------GILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDP 948
G +L + + P + + N+ LH + +I +
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 295
Query: 949 SL 950
L
Sbjct: 296 DL 297
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 59/230 (25%), Positives = 111/230 (48%), Gaps = 39/230 (16%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS---FAAECEALRSIRHRNLIKI 763
+ +G G +G VY+GV + + VAVK + K + F E ++ I+H NL+++
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 764 VTICSS-----IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
+ +C+ I + E+M G+L ++L + + Q +S + L + +
Sbjct: 75 LGVCTREPPFYI----------ITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQI 120
Query: 819 ASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
+SA+EYL + +H DL N L+ + + V+DFGL++ ++ +T ++
Sbjct: 121 SSAMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTAH 169
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
G K I + APE + S++ V+++G+LL EI T P +
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 219
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-30
Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 29/230 (12%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS---FAAECEALRSIRH 757
+G+G FG V+ G + VA+K + K G+ S F E + ++ +RH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTL----KPGTMSPEAFLQEAQVMKKLRH 321
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
L+++ + S +V EYM GSL ++L + L L Q +++
Sbjct: 322 EKLVQLYAVVSEEPI------YIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQ 371
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
+AS + Y+ VH DL+ +N+L+ ++V V+DFGLA+ + +
Sbjct: 372 IASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAK 425
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
+K T APE L G +++ V+S+GILL E+ T+ R P M N
Sbjct: 426 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 471
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 57/227 (25%), Positives = 100/227 (44%), Gaps = 18/227 (7%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA-ECEALRSIRHRN 759
+F +GRG FG V++ + A+K I L + ++ E +AL + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 760 LIK----IVTICSSIDFKGVDFKALVY---EYMQNGSLEEWLHQRDDQLGICNLSLIQRL 812
+++ + ++ + K +Y + + +L++W++ R I L
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC---TIEERERSVCL 121
Query: 813 NIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVE 872
+I + +A AVE+LH ++H DLKPSN+ D V V DFGL + V
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 873 TPSSSIGVK----GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
TP + GT Y++PE G S + ++S G++L E+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-30
Identities = 70/406 (17%), Positives = 126/406 (31%), Gaps = 54/406 (13%)
Query: 216 TSLAYLHVGDNHFSGTIPPSV-YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYT 274
+ Y+ + N + + + + L + + + + L +L +
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 275 NNFTGSLPDSFSNASNLEVLHLAENQFRGQV--SINFNGLKDLSMLGLATNFLGNGAAND 332
N F +F+ +NLEVL L + G V F L L ML L N +
Sbjct: 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI-----KK 143
Query: 333 LDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANL-STALIDFNLGKNQIYGTIPPGIANL 391
+ N + L L N + + N L +
Sbjct: 144 IQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITL----------- 192
Query: 392 VNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANN 451
M L + ++ L L N + ++ + T + +
Sbjct: 193 -----QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS 247
Query: 452 LQGNIPFSLG-----NCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLP 506
N+ S G + N F + + + DLS + + +L
Sbjct: 248 NSYNMGSSFGHTNFKDPDNFTFKGLEASGVK---------------TCDLSKSKIF-ALL 291
Query: 507 LGV-GNLKSLVRLGIARNQFSGQIPV-TLGACTSLEYVELQGNSFSGTIPQSLSSLTSIK 564
V + L +L +A+N+ + +I T L + L N + +L ++
Sbjct: 292 KSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLE 350
Query: 565 ELDLSQNNFSGQIPKYL-ENLSFLQYLNLSYNHFEGEVPTKGIFKN 609
LDLS N+ + L L+ L L N + VP GIF
Sbjct: 351 VLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVP-DGIFDR 393
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 76/420 (18%), Positives = 140/420 (33%), Gaps = 58/420 (13%)
Query: 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNH 227
++ + + N + S L L+ + + I T L+SL L + N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 228 FSGTIPPSVY-NISSLVEIYLYGNRFTGS-LPIEIGKNLPNLRNFVIYTNNFTGSLPDS- 284
F + + +++L + L G+ L K L +L V+ NN P S
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 285 FSNASNLEVLHLAENQFRGQVSINFNGL--KDLSMLGLATNFLGNGAANDLDFV--DLLT 340
F N VL L N+ + + K ++L L++ L + L +
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209
Query: 341 NCTKLQYLYLADNGFGGVLP----HSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNS 396
T + L L+ NGF + +IA + + N + N
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
Query: 397 LRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNI 456
+EA+ ++ L + + + S + T L L+ N +
Sbjct: 270 KGLEAS--------------GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKID 315
Query: 457 PFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSL 515
+ +L L L+LS N L GS+ + NL L
Sbjct: 316 DNAFWGLTHL-------------------------LKLNLSQNFL-GSIDSRMFENLDKL 349
Query: 516 VRLGIARNQFSGQIPV-TLGACTSLEYVELQGNSFSGTIPQS-LSSLTSIKELDLSQNNF 573
L ++ N + + +L+ + L N ++P LTS++++ L N +
Sbjct: 350 EVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 78/384 (20%), Positives = 128/384 (33%), Gaps = 57/384 (14%)
Query: 120 LETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQ 179
+ + L+ NS + T+ S L + I R L +L L + NQ
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTF-RGLSSLIILKLDYNQ 90
Query: 180 LTGQLPASI-GNLSALRVIDIRTNRLWGKI--PITLSQLTSLAYLHVGDNHFSGTIPPSV 236
QL L+ L V+ + L G + LTSL L + DN+ P S
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 237 -YNISSLVEIYLYGNRFTGSLPIEI-----GKNLPNLRNFVIY-----TNNFTGSLPDSF 285
N+ + L N+ S+ E GK+ LR I +
Sbjct: 150 FLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 286 SNASNLEVLHLAENQFRGQVSINFNGLKDLSML---------------------GLATNF 324
+++ L L+ N F+ ++ F + +
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268
Query: 325 LGNGAANDLDFVDL------------LTNCTKLQYLYLADNGFGGVLPHSIANLSTALID 372
A+ + DL ++ T L+ L LA N + ++ L T L+
Sbjct: 269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGL-THLLK 327
Query: 373 FNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPH-VIGELKNLQLLHLHANFLQG 430
NL +N + G+I + NL L L + N + + L NL+ L L N L+
Sbjct: 328 LNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK- 384
Query: 431 TIPSS-LGNLTLLTYLSFGANNLQ 453
++P LT L + N
Sbjct: 385 SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 42/228 (18%), Positives = 80/228 (35%), Gaps = 22/228 (9%)
Query: 92 NLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG-------------RIPTNL 138
LS + ++ + E + TL L+ N F +I + +
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 139 SHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASI-GNLSALRVI 197
S + S N ++ + +++ L S+ + + L +
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQL 304
Query: 198 DIRTNRLWGKIPI-TLSQLTSLAYLHVGDNHFSGTIPPSV-YNISSLVEIYLYGNRFTGS 255
+ N + KI LT L L++ N +I + N+ L + L N +
Sbjct: 305 TLAQNEI-NKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-A 361
Query: 256 LPIEIGKNLPNLRNFVIYTNNFTGSLPDS-FSNASNLEVLHLAENQFR 302
L + LPNL+ + TN S+PD F ++L+ + L N +
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 26/232 (11%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENG----MLVAVKVINLEQKGGSKS-FAAECEALRSI 755
EF +G G+FG VYKG+ G + VA+K + + E + S+
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 756 RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
+ ++ +++ IC + + L+ + M G L +++ + D +G L LN
Sbjct: 75 DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
+ +A + YL +VH DL NVL+ ++DFGLAK L A E
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 174
Query: 876 SSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
+ G K I ++A E L + + V+SYG+ + E+ T +P + +
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSI 755
S + + + S+ +G+G+ V++G + G L A+KV N E E L+ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 756 RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
H+N++K+ I + K L+ E+ GSL L + + G L + L ++
Sbjct: 65 NHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG---LPESEFLIVL 118
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLAKFLSASPLGNVV 871
DV + +L + IVH ++KP N++ D V ++DFG A+ L
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQF 172
Query: 872 ETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYG 907
+ + GT Y+ P+ + YG
Sbjct: 173 VS------LYGTEEYLHPDM-YERAVLRKDHQKKYG 201
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 35/225 (15%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS---FAAECEALRSIRHRNLIKIVT 765
IG G FG V+ G N VA+K I + G+ S F E E + + H L+++
Sbjct: 16 IGSGQFGLVHLGYWL-NKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 766 ICSSID--FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
+C LV E+M++G L ++L + + L + +DV +
Sbjct: 71 VCLEQAPIC-------LVTEFMEHGCLSDYLRTQRGLF-----AAETLLGMCLDVCEGMA 118
Query: 824 YL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
YL +H DL N L+ + V VSDFG+ +F+ + +SS G K
Sbjct: 119 YLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKF 167
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
+ + +PE S + V+S+G+L+ E+F+ + P E+ N
Sbjct: 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 212
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 1e-29
Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 20/223 (8%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSK-SFAAECEALRSIRHRNLIKIV-T 765
+G G FG+V + + + G VA+K E ++ + E + ++ + H N++
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
D L EY + G L ++L+Q ++ C L ++ D++SA+ YL
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC---CGLKEGPIRTLLSDISSALRYL 137
Query: 826 HHHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
H + I+H DLKP N++L ++ + D G AK L G + G
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTE------FVG 185
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFN 925
T+ Y+APE + ++ +S+G L E T RP +
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 30/234 (12%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENG----MLVAVKVINLEQKGGSKS---FAAECEALR 753
E +G G FG V+KGV G + V +KV +E K G +S A+
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIG 70
Query: 754 SIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLN 813
S+ H ++++++ +C + LV +Y+ GSL + + Q LG L LN
Sbjct: 71 SLDHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGALGPQLL-----LN 119
Query: 814 IVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVET 873
+ +A + YL H +VH +L NVLL V+DFG+A L +
Sbjct: 120 WGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD------DK 170
Query: 874 PSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
K I ++A E G+ + + V+SYG+ + E+ T P +
Sbjct: 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA 224
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-29
Identities = 58/230 (25%), Positives = 106/230 (46%), Gaps = 29/230 (12%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS---FAAECEALRSIRH 757
+G G FG V+ +++ VAVK + K GS S F AE +++++H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHT-KVAVKTM----KPGSMSVEAFLAEANVMKTLQH 242
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
L+K+ + + + ++ E+M GSL ++L + L + ++
Sbjct: 243 DKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQ 292
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
+A + ++ +H DL+ +N+L+ +V ++DFGLA+ + ++
Sbjct: 293 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED-------NEYTAR 342
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
G K I + APE G +++ V+S+GILL+EI T R P M N
Sbjct: 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 27/206 (13%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIV 764
IG G V++ L+E + A+K +NLE+ S+ E L ++ + KI+
Sbjct: 15 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKII 72
Query: 765 TICSSID-FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
+ D + +V E N L WL ++ ++ +R + ++ AV
Sbjct: 73 RL---YDYEITDQYIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVH 122
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
+H H IVH DLKP+N L+ M+ + DFG+A + V ++ GT
Sbjct: 123 TIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QVGT 172
Query: 884 IGYVAPE--YGLGGEASMRGGVYSYG 907
+ Y+ PE +
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKIS 198
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 41/228 (17%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS---FAAECEALRSIRHRNLIKIVT 765
+G G FG V G VA+K+I K GS S F E + + ++ H L+++
Sbjct: 32 LGTGQFGVVKYGKWRGQ-YDVAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 766 ICSS-----IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
+C+ I + EYM NG L +L + + Q L + DV
Sbjct: 87 VCTKQRPIFI----------ITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCE 131
Query: 821 AVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
A+EYL +H DL N L++ V VSDFGL++++ + +SS+G
Sbjct: 132 AMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-------DEYTSSVG 180
Query: 880 VKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
K + + PE + + S + ++++G+L+ EI++ + P E N
Sbjct: 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 4e-29
Identities = 52/222 (23%), Positives = 100/222 (45%), Gaps = 25/222 (11%)
Query: 709 IGRGSFGFVYKGVLHENG--MLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNLIKIVT 765
+G G+FG V +GV + VA+KV+ + E + + + + +++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+C + LV E G L ++L + +++ + N+ ++ V+ ++YL
Sbjct: 404 VCQAEALM------LVMEMAGGGPLHKFLVGKREEIPVSNV-----AELLHQVSMGMKYL 452
Query: 826 -HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
+ VH +L NVLL + A +SDFGL+K L A ++ K +
Sbjct: 453 EEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPL 503
Query: 885 GYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFN 925
+ APE + S R V+SYG+ + E + ++P + M
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 67/271 (24%), Positives = 122/271 (45%), Gaps = 46/271 (16%)
Query: 672 RRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENG----M 727
+ + Q + E+ + + IG G FG VYKG+L + +
Sbjct: 17 TENLYFQGAMGSDPNQAVLKFTTEIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEV 74
Query: 728 LVAVKVINLEQKGGS-----KSFAAECEALRSIRHRNLIKIVTICSS-----IDFKGVDF 777
VA+K + K G F E + H N+I++ + S I
Sbjct: 75 PVAIKTL----KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI------- 123
Query: 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL-HHHCQPPIVHG 836
+ EYM+NG+L+++L ++D + S++Q + ++ +A+ ++YL + + VH
Sbjct: 124 ---ITEYMENGALDKFLREKDGEF-----SVLQLVGMLRGIAAGMKYLANMNY----VHR 171
Query: 837 DLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE 896
DL N+L++ ++V VSDFGL++ L + E ++ G K I + APE +
Sbjct: 172 DLAARNILVNSNLVCKVSDFGLSRV-----LEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 897 ASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
+ V+S+GI++ E+ T RP + N
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERPYWELSNH 257
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 6e-29
Identities = 46/213 (21%), Positives = 90/213 (42%), Gaps = 27/213 (12%)
Query: 709 IGRGSFGFVYKGV-LHENGMLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNLIKIVTI 766
I G G++Y + + NG V +K + +++ AE + L + H ++++I
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
D G +V EY+ SL+ Q+ L + + + ++++ A+ YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--------LPVAEAIAYLLEILPALSYLH 199
Query: 827 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGY 886
+V+ DLKP N++L + + + D G +++ G + GT G+
Sbjct: 200 SI---GLVYNDLKPENIMLTEEQLK-LIDLGAVSRINSF--GYLY----------GTPGF 243
Query: 887 VAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
APE G ++ +Y+ G L +
Sbjct: 244 QAPEIVRTG-PTVATDIYTVGRTLAALTLDLPT 275
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 39/227 (17%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS---FAAECEALRSIRHRNLIKIVT 765
+G G FG V+ G VAVK + K GS S F AE ++ ++H+ L+++
Sbjct: 21 LGAGQFGEVWMGYY-NGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 766 ICSS----IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
+ + I + EYM+NGSL ++L L++ + L++ +A
Sbjct: 76 VVTQEPIYI----------ITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEG 121
Query: 822 VEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
+ ++ + +H DL+ +N+L+ + ++DFGLA+ + + ++ G
Sbjct: 122 MAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLIEDN-------EYTAREGA 170
Query: 881 KGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
K I + APE G +++ V+S+GILL EI T R P M N
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS---KSFAAECEALRSIRHRNLIKIVT 765
+G G VY + VA+K I + + K F E + H+N IV+
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN---IVS 75
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ + + LV EY++ +L E++ LS+ +N + +++
Sbjct: 76 MIDVDEEDDCYY--LVMEYIEGPTLSEYIESHGP------LSVDTAINFTNQILDGIKHA 127
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H IVH D+KP N+L+D + + DFG+AK LS + L T ++ V GT+
Sbjct: 128 HDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-----TQTNH--VLGTVQ 177
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
Y +PE G +YS GI+L E+ P
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-29
Identities = 63/313 (20%), Positives = 113/313 (36%), Gaps = 48/313 (15%)
Query: 638 SRKPNVNLVKVVIPV----IGGSCLILSVCIFIFYARRRRSAHKSSNTSQMEQQFPMVS- 692
R+ +++P + G C I + ++ + + + +
Sbjct: 15 GRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPE 74
Query: 693 -YKELSKATNEFSSSN-----TIGRGSFGFVYKGVLHENG---MLVAVKVINLEQKGGS- 742
+ + SS IGRG FG VY G L +N + AVK + +
Sbjct: 75 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL----NRITD 130
Query: 743 ----KSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRD 798
F E ++ H N++ ++ IC + + +V YM++G L ++
Sbjct: 131 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNET 186
Query: 799 DQLGICNLSLIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857
++ + + VA +++L VH DL N +LD V+DFG
Sbjct: 187 HNP-----TVKDLIGFGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFG 237
Query: 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE---YGLGGEASMRGGVYSYGILLLEIF 914
LA+ + +V + + VK A E S V+S+G+LL E+
Sbjct: 238 LARDMYDKEFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKS---DVWSFGVLLWELM 290
Query: 915 TR-RRPTESMFNE 926
TR P +
Sbjct: 291 TRGAPPYPDVNTF 303
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 41/228 (17%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS---FAAECEALRSIRHRNLIKIVT 765
+G G FG V G VAVK+I K GS S F E + + + H L+K
Sbjct: 16 LGSGQFGVVKLGKWKGQ-YDVAVKMI----KEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 766 ICSS-----IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
+CS I V EY+ NG L +L L Q L + DV
Sbjct: 71 VCSKEYPIYI----------VTEYISNGCLLNYLRSHGKGL-----EPSQLLEMCYDVCE 115
Query: 821 AVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
+ +L H +H DL N L+D D+ VSDFG+ +++ + SS+G
Sbjct: 116 GMAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-------DQYVSSVG 164
Query: 880 VKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
K + + APE + S + V+++GIL+ E+F+ + P + N
Sbjct: 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS 212
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 57/233 (24%), Positives = 92/233 (39%), Gaps = 37/233 (15%)
Query: 707 NTIGRGSFGFVYKGVLHENG---MLVAVKVINLEQKGGS-----KSFAAECEALRSIRHR 758
IGRG FG VY G L +N + AVK + + F E ++ H
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL----NRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
N++ ++ IC + + +V YM++G L ++ ++ + + V
Sbjct: 87 NVLSLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNP-----TVKDLIGFGLQV 137
Query: 819 ASAVEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
A ++YL VH DL N +LD V+DFGLA+ + +V +
Sbjct: 138 AKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 878 IGVKGTIGYVAPE---YGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
+ VK A E S V+S+G+LL E+ TR P +
Sbjct: 194 LPVKWM----ALESLQTQKFTTKS---DVWSFGVLLWELMTRGAPPYPDVNTF 239
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 27/222 (12%)
Query: 707 NTIGRGSFGFVYKGVLHENG---MLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLI 761
+G+G FG V + L + + VAVK++ + S + F E ++ H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 762 KIVTICSSIDFKGVDFKAL-VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
K+V + KG + + +M++G L +L NL L + ++D+A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 821 AVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
+EYL + +H DL N +L DM V+DFGL++ + S
Sbjct: 149 GMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKIY-----------SGDYY 193
Query: 880 VKGTIGYV-----APEYGLGGEASMRGGVYSYGILLLEIFTR 916
+G + A E ++ V+++G+ + EI TR
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 36/229 (15%)
Query: 702 EFSSSNTIGRGSFG-FVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALR-SIRHRN 759
F + +G G+ G VY+G+ + VAVK I E + E + LR S H N
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADR---EVQLLRESDEHPN 79
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
+I+ C+ K F+ + E +L+E++ Q+D ++ + ++
Sbjct: 80 VIRY--FCT---EKDRQFQYIAIELCA-ATLQEYVEQKDF-----AHLGLEPITLLQQTT 128
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLL-----DHDMVAHVSDFGLAKFLSASPLGNVVETP 874
S + +LH IVH DLKP N+L+ + A +SDFGL K L+ +
Sbjct: 129 SGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR-----HSF 180
Query: 875 SSSIGVKGTIGYVAPEYGLGGEASMRGG----VYSYGILLLEIFTRRRP 919
S GV GT G++APE L + ++S G + + +
Sbjct: 181 SRRSGVPGTEGWIAPEM-LSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 30/217 (13%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS---KSFAAECEALRSIRHRNLIKIVT 765
+GRG G VY+ +VA+K+++ E ++ + +V
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH---VVP 98
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
I + G + + + L L ++ L+ + + IV + SA++
Sbjct: 99 IHDFGEIDGQLY--VDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAA 150
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPL---GNVVETPSSSIGVKG 882
H H D+KP N+L+ D A++ DFG+A + L GN V G
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV----------G 197
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
T+ Y+APE A+ R +Y+ +L E T P
Sbjct: 198 TLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 25/213 (11%)
Query: 709 IGRGSFGFVYKGVLH----ENGMLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNLIKI 763
+G G FG V G +VAVK + + +S + E + LR++ H ++IK
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
C + LV EY+ GSL ++L + ++ L Q L + +
Sbjct: 99 KGCCEDAGAASL---QLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMA 148
Query: 824 YLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
YLH H +H DL NVLLD+D + + DFGLAK + V
Sbjct: 149 YLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE-----DGDS 199
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ + APE + V+S+G+ L E+ T
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 49/231 (21%), Positives = 89/231 (38%), Gaps = 42/231 (18%)
Query: 709 IGRGSFGFVYKGVLHENG---MLVAVKVINLE-QKGGSKSFAAECEALRSIRHRNLIKIV 764
IG G FG V++G+ + VA+K + F E +R H +++K++
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 765 TICSS----IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
+ + I + E G L +L R L L + +++
Sbjct: 83 GVITENPVWI----------IMELCTLGELRSFLQVRKYSL-----DLASLILYAYQLST 127
Query: 821 AVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
A+ YL VH D+ NVL+ + + DFGL++++ S + +
Sbjct: 128 ALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLP 180
Query: 880 VKGTIGYVAPE---YGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
+K APE + AS V+ +G+ + EI +P + + N
Sbjct: 181 IKWM----APESINFRRFTSAS---DVWMFGVCMWEILMHGVKPFQGVKNN 224
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-28
Identities = 78/474 (16%), Positives = 151/474 (31%), Gaps = 78/474 (16%)
Query: 165 RRLFNLQGLSVGDNQLTGQLPASI-GNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHV 223
L L+ L + N++ L + L +D+ NRL I + SL +L +
Sbjct: 73 SFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDL 128
Query: 224 GDNHFSGTIPPSVY--NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSL 281
N F +P N++ L + L +F L + +L + +
Sbjct: 129 SFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGG 186
Query: 282 PDSFSNASNLEVLHLAENQ---FRGQVSINFNGLKDLSMLGLATNF-------------- 324
N VLHL + F QV+++ N L L + + N
Sbjct: 187 ETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELT 246
Query: 325 ---------LGNGAANDLDFVDLLTN--CTKLQYLYLADNGFGGVLPHSIANLSTALIDF 373
L + V L ++YL + + + S +
Sbjct: 247 RGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKS 306
Query: 374 ----NLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQ 429
++ + + +N + + + L+ N
Sbjct: 307 LMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT 366
Query: 430 GTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITT 489
++ L L L N L+ + L
Sbjct: 367 DSVFQGCSTLKRLQTLILQRNGLK-------------------------NFFKVALMTKN 401
Query: 490 LSLSLDLSDNLLNGSLPLGV-----GNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVEL 544
+S SL+ D LN SL +S++ L ++ N +G + L ++ ++L
Sbjct: 402 MS-SLETLDVSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDL 457
Query: 545 QGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPK-YLENLSFLQYLNLSYNHF 597
N +IP+ ++ L +++EL+++ N +P + L+ LQY+ L N +
Sbjct: 458 HNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-27
Identities = 80/459 (17%), Positives = 141/459 (30%), Gaps = 34/459 (7%)
Query: 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNH 227
+ LS+ N ++ I LS LRV+ + NR+ + L YL V N
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNR 111
Query: 228 FSGTIPPSVYNISSLVEIYLYGNRFTGSLPI-EIGKNLPNLRNFVIYTNNFTGSLPDSFS 286
I ++SL + L N F LP+ + NL L + F +
Sbjct: 112 LQ-NISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVA 167
Query: 287 N------ASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLT 340
+ +L H+ + N L L N L + N
Sbjct: 168 HLHLSCILLDLVSYHIKGGETESLQIPNTTVLH----LVFHPNSLFSVQVNMSVNALGHL 223
Query: 341 NCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIP-PGIANLVNLNSLRM 399
+ ++ L + + + ++ + L +
Sbjct: 224 QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283
Query: 400 EANRLTGTIPHVIG-----ELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQG 454
+T I LK+L + H+ + + + ++
Sbjct: 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343
Query: 455 NIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKS 514
+ + F +N T ++ Q + L L L N L + K+
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQT-LILQRNGLK-NFFKVALMTKN 401
Query: 515 LVRLGIARNQF----SGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQ 570
+ L S T S+ + L N +G++ + L +K LDL
Sbjct: 402 MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHN 459
Query: 571 NNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKN 609
N IPK + +L LQ LN++ N + VP G+F
Sbjct: 460 NRIM-SIPKDVTHLQALQELNVASNQLK-SVP-DGVFDR 495
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-19
Identities = 67/375 (17%), Positives = 116/375 (30%), Gaps = 24/375 (6%)
Query: 246 YLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDS-FSNASNLEVLHLAENQFRGQ 304
L N + L + L LR + N SL F +LE L ++ N+ +
Sbjct: 58 SLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-- 113
Query: 305 VSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIA 364
+I+ + L L L+ N + L N TKL +L L+ F + +A
Sbjct: 114 -NISCCPMASLRHLDLSFNDF-----DVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVA 167
Query: 365 NLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLH 424
+L + I +L I G + N L + + + V + L L L
Sbjct: 168 HLHLSCILLDLVSYHIKG-GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLS 226
Query: 425 ANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQI 484
L L N+ + C +F F
Sbjct: 227 NIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF-----------FWP 275
Query: 485 LEITTLSLS-LDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVE 543
+ L++ L +++ + LKSL+ + F +
Sbjct: 276 RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM 335
Query: 544 LQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPT 603
L + S +S L+ +QN F+ + + L LQ L L N +
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKV 395
Query: 604 KGIFKNKTGFSIVGN 618
+ KN + +
Sbjct: 396 ALMTKNMSSLETLDV 410
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-19
Identities = 75/425 (17%), Positives = 152/425 (35%), Gaps = 55/425 (12%)
Query: 68 RNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPD--RIGNLFRLETLVL 125
NQ + LD+ + + I ++ LR+++++ NDF +P GNL +L L L
Sbjct: 98 FNQDLEYLDVSHNRLQNISC---CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGL 153
Query: 126 ANNSFSGRIPTNLSHCSKLITFSA-HRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQL 184
+ F ++H ++ G E L L + ++ + Q+
Sbjct: 154 SAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQV 213
Query: 185 PASIGNLSALRVIDIRTNRLWGKIPITLS------------------------------- 213
S+ L L++ +I+ N + +T
Sbjct: 214 NMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273
Query: 214 QLTSLAYLHVGDNHFSGTIPPSVYNIS-----SLVEIYLYGNRFTGSLPIEIGKNLPNLR 268
+ YL++ + + I + S SL+ ++ F + +
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMN 332
Query: 269 NFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNG 328
++ ++ + S+ L+ +N F V + LK L L L N L
Sbjct: 333 IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL--- 389
Query: 329 AANDLDFV-DLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPG 387
+ V + N + L+ L ++ N + +++ NL N + G++
Sbjct: 390 --KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRC 447
Query: 388 IANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIP-SSLGNLTLLTYLS 446
+ + L + NR+ +IP + L+ LQ L++ +N L+ ++P LT L Y+
Sbjct: 448 LP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIW 503
Query: 447 FGANN 451
N
Sbjct: 504 LHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 51/239 (21%), Positives = 86/239 (35%), Gaps = 40/239 (16%)
Query: 384 IPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSL-GNLTLL 442
+P + +L + N ++ I L L++L L N ++ ++ + L
Sbjct: 46 VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDL 102
Query: 443 TYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLN 502
YL N LQ NI +L LDLS N +
Sbjct: 103 EYLDVSHNRLQ-NISC--CPMASLRH-------------------------LDLSFNDFD 134
Query: 503 GSLPLGV--GNLKSLVRLGIARNQFSGQIPVTLGACTSLEYV--ELQGNSFSGTIPQSLS 558
LP+ GNL L LG++ +F Q+ + A L + +L G +SL
Sbjct: 135 -VLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQ 192
Query: 559 SL-TSIKELDLSQNN-FSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSI 615
T++ L N+ FS Q+ + L LQ N+ N + + + G ++
Sbjct: 193 IPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTL 251
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 34/207 (16%), Positives = 74/207 (35%), Gaps = 11/207 (5%)
Query: 75 LDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRI 134
++NQ + + ++ +D + L N F+ +
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369
Query: 135 PTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLT----GQLPASIGN 190
S +L T RN L + ++ N+ L D L +
Sbjct: 370 FQGCSTLKRLQTLILQRNGLK-NFFK--VALMTKNMSSLETLDVSLNSLNSHAYDRTCAW 426
Query: 191 LSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGN 250
++ V+++ +N L G + L + L + +N +IP V ++ +L E+ + N
Sbjct: 427 AESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASN 483
Query: 251 RFTGSLPIEIGKNLPNLRNFVIYTNNF 277
+ S+P + L +L+ ++ N +
Sbjct: 484 QLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 58/251 (23%), Positives = 101/251 (40%), Gaps = 37/251 (14%)
Query: 689 PMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLH---ENGMLVAVKVINLEQKGGSKS- 744
V + S IG+G FG VY G +N + A+K ++ +
Sbjct: 9 AEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA 68
Query: 745 FAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGIC 804
F E +R + H N++ ++ I +G+ ++ YM +G L +++
Sbjct: 69 FLREGLLMRGLNHPNVLALIGIML--PPEGLPH--VLLPYMCHGDLLQFIRSPQR----- 119
Query: 805 NLSLIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863
N ++ ++ + VA +EYL VH DL N +LD V+DFGLA+ +
Sbjct: 120 NPTVKDLISFGLQVARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDIL 175
Query: 864 ASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVY-------SYGILLLEIFTR 916
+V + + + VK T A E S++ + S+G+LL E+ TR
Sbjct: 176 DREYYSVQQHRHARLPVKWT----ALE-------SLQTYRFTTKSDVWSFGVLLWELLTR 224
Query: 917 -RRPTESMFNE 926
P +
Sbjct: 225 GAPPYRHIDPF 235
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 58/257 (22%), Positives = 95/257 (36%), Gaps = 32/257 (12%)
Query: 669 ARRRRSAHKSSNTSQMEQQFPMVSYKELSKATNE-FSSSNTIGRGSFGFVYKGVLHENGM 727
A+ +R ++ + + + + + +GRGSFG V++ + G
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGF 84
Query: 728 LVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA----LVYE 783
AVK + LE E A + IV G + + E
Sbjct: 85 QCAVKKVRLE-----VFRVEELVACAGLSSPR---IVP------LYGAVREGPWVNIFME 130
Query: 784 YMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNV 843
++ GSL + + Q G + +EYLH I+HGD+K NV
Sbjct: 131 LLEGGSLGQLIKQM----GCLPEDRAL--YYLGQALEGLEYLHTRR---ILHGDVKADNV 181
Query: 844 LLDHD-MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGG 902
LL D A + DFG A L LG + T + GT ++APE +G +
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY---IPGTETHMAPEVVMGKPCDAKVD 238
Query: 903 VYSYGILLLEIFTRRRP 919
++S ++L + P
Sbjct: 239 IWSSCCMMLHMLNGCHP 255
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 46/227 (20%), Positives = 99/227 (43%), Gaps = 34/227 (14%)
Query: 709 IGRGSFGFVYKGVLHENG---MLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNLIKIV 764
+G G FG VY+GV + + VAVK + +K F +E ++++ H +++K++
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
I + ++ E G L +L + + L ++ + + + A+ Y
Sbjct: 80 GIIEE------EPTWIIMELYPYGELGHYLERNKNSL-----KVLTLVLYSLQICKAMAY 128
Query: 825 L-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
L +C VH D+ N+L+ + DFGL++++ + + + + +K
Sbjct: 129 LESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDE---DYYKASVTRLPIKWM 181
Query: 884 IGYVAPE---YGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
+PE + AS V+ + + + EI + ++P + N+
Sbjct: 182 ----SPESINFRRFTTAS---DVWMFAVCMWEILSFGKQPFFWLENK 221
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 46/288 (15%), Positives = 83/288 (28%), Gaps = 55/288 (19%)
Query: 670 RRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLV 729
+ +A +TS P EL + +G+ + E G
Sbjct: 42 YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 101
Query: 730 AVKVINLEQKGGS---KSFAAECEALRSIR----------------------HRNLIKIV 764
V V ++ S K E LR +R K++
Sbjct: 102 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 161
Query: 765 TICSSIDFKGVDFKALVYEYMQ--NGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
+ V + +Y MQ + E L +L RL + + V +
Sbjct: 162 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK--SLVHHARLQLTLQVIRLL 219
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
LHH+ +VH L+P +++LD ++ F G V +
Sbjct: 220 ASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGARVVSS-------V 264
Query: 883 TIGYVAPEYGLGGEASMRGG-----------VYSYGILLLEIFTRRRP 919
+ G+ PE ++ G+++ I+ P
Sbjct: 265 SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-27
Identities = 46/285 (16%), Positives = 80/285 (28%), Gaps = 50/285 (17%)
Query: 670 RRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLV 729
+ +A +TS P EL + +G+ + E G
Sbjct: 47 YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 106
Query: 730 AVKVINLEQKGGS---KSFAAECEALRSIRH----------------RNLIKIVTICSSI 770
V V ++ S K E LR +R +L+K I
Sbjct: 107 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 166
Query: 771 DFKGVD--------FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
+ + F + E L +L RL + + V +
Sbjct: 167 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK--SLVHHARLQLTLQVIRLL 224
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPL---GNVVETPSSSIG 879
LHH+ +VH L+P +++LD ++ F AS + G P
Sbjct: 225 ASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPE---- 277
Query: 880 VKGTIGYVAPEYGLGGEASMRGG-----VYSYGILLLEIFTRRRP 919
A G+ ++ G+ + I+ P
Sbjct: 278 ------TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 44/190 (23%), Positives = 79/190 (41%), Gaps = 11/190 (5%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIV-- 764
+ G F FVY+ +G A+K + ++ +++ E ++ + H N+++
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
+ + L+ + G L E+L + + + LS L I AV++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG---PLSCDTVLKIFYQTCRAVQH 151
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS----IGV 880
+H +PPI+H DLK N+LL + + DFG A +S P + + I
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 881 KGTIGYVAPE 890
T Y PE
Sbjct: 211 NTTPMYRTPE 220
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 47/236 (19%), Positives = 104/236 (44%), Gaps = 44/236 (18%)
Query: 709 IGRGSFGFVYKGVLHENG-------MLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLI 761
+G+G+F ++KGV E G V +KV++ + S+SF + + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
+C G + LV E+++ GSL+ +L + + ++++ +L + +A+A
Sbjct: 76 LNYGVCV----CGDEN-ILVQEFVKFGSLDTYLKKNKNC-----INILWKLEVAKQLAAA 125
Query: 822 VEYL-HHHCQPPIVHGDLKPSNVLLDHD--------MVAHVSDFGLAKFLSASPLGNVVE 872
+ +L + +HG++ N+LL + +SD G++ +
Sbjct: 126 MHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV---------- 171
Query: 873 TPSSSIGVKGTIGYVAPE-YGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNE 926
++ I +V PE ++ +S+G L EI + +P ++ ++
Sbjct: 172 --LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ 225
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 21/218 (9%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIVT 765
TIG GS+G K +G ++ K ++ + + +E LR ++H N IV
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN---IVR 69
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWL--HQRDDQLGICNLSLIQRLNIVIDVASAVE 823
I + +V EY + G L + ++ Q L L ++ + A++
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY----LDEEFVLRVMTQLTLALK 125
Query: 824 YLH--HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
H ++H DLKP+NV LD + DFGLA+ L+ + +T
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKT------FV 177
Query: 882 GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
GT Y++PE + + ++S G LL E+ P
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 8e-27
Identities = 56/320 (17%), Positives = 113/320 (35%), Gaps = 56/320 (17%)
Query: 641 PNVNLVKVVIPVIGGSCLILSVCIFIFYARRRRSAHKSSNTSQMEQQFPMVS-------- 692
P++ + + + +I G C +++ F R ++ ++ +
Sbjct: 302 PSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSV 361
Query: 693 ---------------YKELSKATNEFSSSN-----TIGRGSFGFVYKGVLHENG---MLV 729
Y S E IG G FG V++G+ M V
Sbjct: 362 SETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAV 421
Query: 730 AVKVINLEQKGGSKS-FAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNG 788
A+K + F E +R H +++K++ + + + ++ E G
Sbjct: 422 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------NPVWIIMELCTLG 475
Query: 789 SLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH-HHCQPPIVHGDLKPSNVLLDH 847
L +L R L + +L + +++A+ YL VH D+ NVL+
Sbjct: 476 ELRSFLQVRKFSLDLASL-----ILYAYQLSTALAYLESKRF----VHRDIAARNVLVSS 526
Query: 848 DMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYG 907
+ + DFGL++++ S + + +K APE + V+ +G
Sbjct: 527 NDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWM----APESINFRRFTSASDVWMFG 579
Query: 908 ILLLEIFTR-RRPTESMFNE 926
+ + EI +P + + N
Sbjct: 580 VCMWEILMHGVKPFQGVKNN 599
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 26/218 (11%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS---KSFAAECEALRSIRHRNLIKIVT 765
+G G V+ + VAVKV+ + F E + ++ H IV
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA---IVA 76
Query: 766 I----CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
+ + + + +V EY+ +L + +H ++ + + ++ D A
Sbjct: 77 VYDTGEAETPAGPLPY--IVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQA 128
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
+ + H + I+H D+KP+N+++ V DFG+A+ ++ S + + + V
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS-----GNSVTQTAAVI 180
Query: 882 GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
GT Y++PE G R VYS G +L E+ T P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 38/222 (17%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
+G+G++G VY G N + +A+K I S+ E + ++H+N IV
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN---IVQ--- 83
Query: 769 SIDFKGVDFKA----LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
+ G + + E + GSL L + L N I + ++Y
Sbjct: 84 ---YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD-NEQTIG--FYTKQILEGLKY 137
Query: 825 LHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
LH + IVH D+K NVL++ + V +SDFG +K L+ + GT
Sbjct: 138 LHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA--------GINPCTETFTGT 186
Query: 884 IGYVAPE------YGLGGEASMRGGVYSYGILLLEIFTRRRP 919
+ Y+APE G G A ++S G ++E+ T + P
Sbjct: 187 LQYMAPEIIDKGPRGYGKAAD----IWSLGCTIIEMATGKPP 224
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 53/260 (20%), Positives = 96/260 (36%), Gaps = 39/260 (15%)
Query: 667 FYARRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENG 726
+ +++ K IGRG F VY+ +G
Sbjct: 8 MQGPPVPQFQPQKALRPDMGYNTLANFRIEKK----------IGRGQFSEVYRAACLLDG 57
Query: 727 MLVAVKVINLEQKGGSK---SFAAECEALRSIRHRNLIKIVTICSSIDFKG--VDFKAL- 780
+ VA+K + + +K E + L+ + H N+IK + ++ L
Sbjct: 58 VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK---------YYASFIEDNELN 108
Query: 781 -VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLK 839
V E G L + Q + + + + SA+E++H ++H D+K
Sbjct: 109 IVLELADAGDLSRMIKHFKKQKRLIPERTV--WKYFVQLCSALEHMHSRR---VMHRDIK 163
Query: 840 PSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASM 899
P+NV + V + D GL +F S+ S + GT Y++PE +
Sbjct: 164 PANVFITATGVVKLGDLGLGRFFSSK-----TTAAHS---LVGTPYYMSPERIHENGYNF 215
Query: 900 RGGVYSYGILLLEIFTRRRP 919
+ ++S G LL E+ + P
Sbjct: 216 KSDIWSLGCLLYEMAALQSP 235
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 49/250 (19%), Positives = 106/250 (42%), Gaps = 34/250 (13%)
Query: 676 HKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN 735
H ++S ++ + ++ + K + IG GSFG E+G +K IN
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN 58
Query: 736 LEQKGGS--KSFAAECEALRSIRHRNLIKIVTICSSIDFKG--VDFKAL--VYEYMQNGS 789
+ + + E L +++H N+++ ++ + +L V +Y + G
Sbjct: 59 ISRMSSKEREESRREVAVLANMKHPNIVQ---------YRESFEENGSLYIVMDYCEGGD 109
Query: 790 LEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM 849
L + ++ + L Q L+ + + A++++H I+H D+K N+ L D
Sbjct: 110 LFKRINAQKGVL----FQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDG 162
Query: 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGIL 909
+ DFG+A+ L+++ + GT Y++PE + + +++ G +
Sbjct: 163 TVQLGDFGIARVLNST--VELARA------CIGTPYYLSPEICENKPYNNKSDIWALGCV 214
Query: 910 LLEIFTRRRP 919
L E+ T +
Sbjct: 215 LYELCTLKHA 224
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 62/275 (22%), Positives = 98/275 (35%), Gaps = 21/275 (7%)
Query: 345 LQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANR 403
L L +N + NL L L N+I I PG A LV L L + N+
Sbjct: 54 TALLDLQNNKITEIKDGDFKNL-KNLHTLILINNKI-SKISPGAFAPLVKLERLYLSKNQ 111
Query: 404 LTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNI--PFSLG 461
L +P K LQ L +H N + S L + + G N L+ + +
Sbjct: 112 LK-ELP--EKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
Query: 462 NCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGI 520
K L + +T +PQ + +L+ L L N + + L +L +LG+
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQGLP--PSLT-ELHLDGNKIT-KVDAASLKGLNNLAKLGL 223
Query: 521 ARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSG----- 575
+ N S +L L + L N +P L+ I+ + L NN S
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 282
Query: 576 -QIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKN 609
P Y + ++L N + F+
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 71/362 (19%), Positives = 110/362 (30%), Gaps = 71/362 (19%)
Query: 241 SLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQ 300
L + +P ++ P+ + N T F N NL L L N+
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 87
Query: 301 FRGQVSIN---FNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGG 357
I+ F L L L L+ N L + LQ L + +N
Sbjct: 88 IS---KISPGAFAPLVKLERLYLSKNQLKELPEK------MPKT---LQELRVHENEITK 135
Query: 358 VLPHSIANLSTALIDFNLGKNQIY-GTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGEL 415
V L +I LG N + I G + L+ +R+ +T TIP G
Sbjct: 136 VRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLP 191
Query: 416 KNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNK 475
+L LHL N + +SL L L L N++ SL N +L
Sbjct: 192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL--------- 242
Query: 476 LTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGA 535
L L++N L +P G+ + K + + + N S
Sbjct: 243 ----------------RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS--------- 276
Query: 536 CTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFS-GQIPKYL-ENLSFLQYLNLS 593
+ N F P + S + L N +I + + L
Sbjct: 277 -------AIGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLG 327
Query: 594 YN 595
Sbjct: 328 NY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 67/287 (23%), Positives = 114/287 (39%), Gaps = 15/287 (5%)
Query: 96 LRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLV 155
+++ +N NL L TL+L NN S P + KL +N L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 156 GEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRL-WGKIPI-TLS 213
E+PE++ LQ L V +N++T + L+ + V+++ TN L I
Sbjct: 114 -ELPEKMPK----TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
Query: 214 QLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIY 273
+ L+Y+ + D + + TIP + SL E++L GN+ T + K L NL +
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLS 224
Query: 274 TNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDL 333
N+ + S +N +L LHL N+ +V K + ++ L N + +ND
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 283
Query: 334 DFVDLLTNCTKLQYLYLADN--GFGGVLPHSIANLSTALIDFNLGKN 378
T + L N + + P + + LG
Sbjct: 284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV-YVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 32/213 (15%), Positives = 70/213 (32%), Gaps = 40/213 (18%)
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFH-GEIPDRI-GNLFRLETLVLANNSF 130
+L + I + L+ + + + N I + + +L + +A+ +
Sbjct: 124 QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183
Query: 131 SGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGN 190
+ IP L L N + ++ + L NL L + N ++ S+ N
Sbjct: 184 T-TIPQGL--PPSLTELHLDGNKI-TKVDAASLKG-LNNLAKLGLSFNSISAVDNGSLAN 238
Query: 191 LSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFS--------------------- 229
LR + + N+L K+P L+ + +++ +N+ S
Sbjct: 239 TPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 297
Query: 230 ----------GTIPPSVY-NISSLVEIYLYGNR 251
I PS + + + L +
Sbjct: 298 VSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 18/73 (24%), Positives = 28/73 (38%), Gaps = 2/73 (2%)
Query: 537 TSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNH 596
++LQ N + +L ++ L L N S P L L+ L LS N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 597 FEGEVPTKGIFKN 609
+ E+P + K
Sbjct: 112 LK-ELPE-KMPKT 122
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 60/285 (21%), Positives = 99/285 (34%), Gaps = 42/285 (14%)
Query: 667 FYARRRRSAHKSSNTSQMEQQFPMVSYKELSKAT---NEFSSSNTIGRGSFGFVYKGVLH 723
F + + + S + + Y + F + +G GS+G V+K
Sbjct: 20 FQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSK 79
Query: 724 ENGMLVAVKVINLEQKGGS--KSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKA- 779
E+G L AVK +G AE + + +H ++ + +
Sbjct: 80 EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR---------LEQAWEEGG 130
Query: 780 ---LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHG 836
L E SL++ L Q + D A+ +LH +VH
Sbjct: 131 ILYLQTELCG-PSLQQHCEAWGASL-----PEAQVWGYLRDTLLALAHLHSQ---GLVHL 181
Query: 837 DLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE 896
D+KP+N+ L + DFGL L + G V E G Y+APE L G
Sbjct: 182 DVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---------GDPRYMAPEL-LQGS 231
Query: 897 ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEK 941
V+S G+ +LE+ + G + + LP +
Sbjct: 232 YGTAADVFSLGLTILEVACNMEL----PHGGEGWQQLRQGYLPPE 272
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-26
Identities = 67/395 (16%), Positives = 108/395 (27%), Gaps = 93/395 (23%)
Query: 114 IGNLFRLETLVLANN--SFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQ 171
I N F L N + K +RN V + E LI+
Sbjct: 7 INNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN----QFS 62
Query: 172 GLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGT 231
L + L+ LP ++ + V++I N L +P + L YL DN S T
Sbjct: 63 ELQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPASLE---YLDACDNRLS-T 114
Query: 232 IPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNL 291
+P +SL + + N+ T LP L
Sbjct: 115 LPEL---PASLKHLDVDNNQLT-MLPELPA----------------------------LL 142
Query: 292 EVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLA 351
E ++ NQ L T L+ L +
Sbjct: 143 EYINADNNQLT----------------------------------MLPELPTSLEVLSVR 168
Query: 352 DNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNS----LRMEANRLTGT 407
+N LP +L ++ N + ++P + R NR+T
Sbjct: 169 NNQL-TFLPELPESLEA----LDVSTNLL-ESLPAVPVRNHHSEETEIFFRCRENRIT-H 221
Query: 408 IPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLM 467
IP I L + L N L I SL T + ++ N +
Sbjct: 222 IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYH--GPRIYFSMSDGQQNTLHRP 279
Query: 468 FFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLN 502
A + +I + ++
Sbjct: 280 LADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSA 314
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 1e-21
Identities = 58/326 (17%), Positives = 109/326 (33%), Gaps = 39/326 (11%)
Query: 263 NLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVS-INFNGLKDLSMLGLA 321
N +L Y N +G+ D FS E L VS + + S L L
Sbjct: 9 NNFSLSQNSFY-NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLN 67
Query: 322 TNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIY 381
L + N ++ L + N LP A+L + N++
Sbjct: 68 RLNLSSLPDNL---------PPQITVLEITQNALI-SLPELPASLEY----LDACDNRL- 112
Query: 382 GTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTL 441
T+P A+L +L+ ++ N+LT +P + L+ ++ N L +P +L +
Sbjct: 113 STLPELPASLKHLD---VDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTSLEV 164
Query: 442 LTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEIT---TLSLSLDLSD 498
L + NN +P + + L N L +LP + + +
Sbjct: 165 L-SVR---NNQLTFLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRE 216
Query: 499 NLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLS 558
N + +P + +L + + N S +I +L T+ + G ++
Sbjct: 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQP--DYHGPRIYFSMSDGQQ 273
Query: 559 SLTSIKELDLSQNNFSGQIPKYLENL 584
+ D F + +
Sbjct: 274 NTLHRPLADAVTAWFPENKQSDVSQI 299
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 96.2 bits (239), Expect = 1e-20
Identities = 49/266 (18%), Positives = 92/266 (34%), Gaps = 30/266 (11%)
Query: 337 DLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNS 396
D + K + L + L + L + + ++P + +
Sbjct: 28 DYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNL-SSLPDNLPP--QITV 84
Query: 397 LRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNI 456
L + N L ++P + L+ L N L T+P +L +L N L +
Sbjct: 85 LEITQNALI-SLPELPASLEYLDACD---NRLS-TLPELPASLK---HLDVDNNQLT-ML 135
Query: 457 PFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLV 516
P + + N+LT LP+ T+L L + +N L LP +L+
Sbjct: 136 PELPALLEYINADN---NQLT-MLPELP---TSLE-VLSVRNNQLT-FLPELPESLE--- 183
Query: 517 RLGIARNQFSGQIPVTLGACTSLE----YVELQGNSFSGTIPQSLSSLTSIKELDLSQNN 572
L ++ N +P E + + N + IP+++ SL + L N
Sbjct: 184 ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNP 241
Query: 573 FSGQIPKYLENLSFLQYLNLSYNHFE 598
S +I + L + + +F
Sbjct: 242 LSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 6e-10
Identities = 52/281 (18%), Positives = 93/281 (33%), Gaps = 37/281 (13%)
Query: 96 LRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLV 155
L YIN +N +P+ +L E L + NN + +P L N L
Sbjct: 142 LEYINADNNQLT-MLPELPTSL---EVLSVRNNQLT-FLPELPESLEAL---DVSTNLLE 193
Query: 156 GEIPEELISRRLFNLQ----GLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPIT 211
+P R + + +N++T +P +I +L I + N L +I +
Sbjct: 194 -SLPAVP--VRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRES 249
Query: 212 LSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFV 271
LSQ T+ H +FS + L + T P ++ + +
Sbjct: 250 LSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADA------VTAWFPENKQSDVSQIWHAF 303
Query: 272 IYTNNFTGSLPDSFSNASNLEVLHLAEN-----QFRGQVSINFNGLKDLSMLGLATN-FL 325
+ + ++ L+ L + FR QV+ L + L +
Sbjct: 304 -------EHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVA 356
Query: 326 GNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANL 366
+ + D V L N L+ L G+ + L
Sbjct: 357 ADATESCEDRVALTWN--NLRKTLLVHQASEGLFDNDTGAL 395
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 51/222 (22%), Positives = 84/222 (37%), Gaps = 34/222 (15%)
Query: 701 NEFSSSNTIGRGSFG-FVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALR-SIRHR 758
N S +G GS G V++G G VAVK + ++ E + L S H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQG--SFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHP 69
Query: 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDD-QLGICNLSLIQRLNIVID 817
N+I+ CS F + E N +L++ + ++ + ++++
Sbjct: 70 NVIRY--YCS---ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDH-------------DMVAHVSDFGLAKFLSA 864
+AS V +LH I+H DLKP N+L+ ++ +SDFGL K L
Sbjct: 124 IASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD- 179
Query: 865 SPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSY 906
++ GT G+ APE +
Sbjct: 180 ---SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTR 218
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 58/276 (21%), Positives = 101/276 (36%), Gaps = 63/276 (22%)
Query: 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS-KSFAAECEALRSI 755
S+ +F +GRG FG V++ + A+K I L + + + E +AL +
Sbjct: 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 756 RHRNLIKIVTICSSIDFKGVDF-------------------------------------- 777
H +++ +
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 778 -----------KALVY---EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
K +Y + + +L++W+++R + + L+I I +A AVE
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR---CSLEDREHGVCLHIFIQIAEAVE 178
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK-- 881
+LH ++H DLKPSN+ D V V DFGL + V TP +
Sbjct: 179 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235
Query: 882 --GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
GT Y++PE G S + ++S G++L E+
Sbjct: 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 42/307 (13%), Positives = 85/307 (27%), Gaps = 49/307 (15%)
Query: 677 KSSNTSQMEQQFPMVS-YKELSKATNEFSSSNTIGRGSFGFVYKGV-----LHENGMLVA 730
NT + + + P + E + + +G G+F VY+ +N
Sbjct: 40 SYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFV 99
Query: 731 VKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSL 790
+KV E L+ + S+ F+ + LV E G+L
Sbjct: 100 LKVQKPANPWEFYIGTQLMERLKPSMQHM---FMKFYSAHLFQ--NGSVLVGELYSYGTL 154
Query: 791 EEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV 850
++ + + ++ + + +E +H I+HGD+KP N +L + +
Sbjct: 155 LNAINLYKNTPEKV-MPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFL 210
Query: 851 AH-----------VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASM 899
+ D G + + P G + T G+ E M
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA------KCETSGFQCVE--------M 256
Query: 900 RGG--------VYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVM-EIVDPSL 950
+ + + +R + E L
Sbjct: 257 LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVML 316
Query: 951 LPLEEER 957
+
Sbjct: 317 NIPDCHH 323
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 50/186 (26%), Positives = 78/186 (41%), Gaps = 27/186 (14%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTIC 767
+G G+F V+ G L A+K I S E L+ I+H N++ + I
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI- 74
Query: 768 SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH 827
++ LV + + G L + + +R + ++ V SAV+YLH
Sbjct: 75 ----YESTTHYYLVMQLVSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHE 124
Query: 828 HCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
+ IVH DLKP N+L + + ++DFGL+K + GT
Sbjct: 125 NG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC----------GTP 171
Query: 885 GYVAPE 890
GYVAPE
Sbjct: 172 GYVAPE 177
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 55/275 (20%), Positives = 93/275 (33%), Gaps = 22/275 (8%)
Query: 345 LQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANR 403
L L +N + L L L N+I I + L L L + N
Sbjct: 56 TTLLDLQNNDISELRKDDFKGL-QHLYALVLVNNKI-SKIHEKAFSPLRKLQKLYISKNH 113
Query: 404 LTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ-GNIPFSLGN 462
L IP +L L +H N ++ L + + G N L+ +
Sbjct: 114 LV-EIP--PNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 463 CKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGIA 521
L + KLT +P+ + TL+ L L N + ++ L L RLG+
Sbjct: 171 GLKLNYLRISEAKLT-GIPKDLP--ETLN-ELHLDHNKIQ-AIELEDLLRYSKLYRLGLG 225
Query: 522 RNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIP--- 578
NQ +L +L + L N S +P L L ++ + L NN + ++
Sbjct: 226 HNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVND 283
Query: 579 ----KYLENLSFLQYLNLSYNHFEGEVPTKGIFKN 609
+ ++ ++L N F+
Sbjct: 284 FCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-22
Identities = 66/288 (22%), Positives = 104/288 (36%), Gaps = 16/288 (5%)
Query: 96 LRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTN-LSHCSKLITFSAHRNNL 154
+++ +ND D L L LVL NN S +I S KL +N+L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHL 114
Query: 155 VGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRL-WGKIPITLS 213
V EIP L S +L L + DN++ L + I++ N L
Sbjct: 115 V-EIPPNLPS----SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169
Query: 214 QLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIY 273
L YL + + + IP + +L E++L N+ ++ +E L +
Sbjct: 170 DGLKLNYLRISEAKLT-GIPKDLP--ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLG 225
Query: 274 TNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDL 333
N S S L LHL N+ +V LK L ++ L TN + ND
Sbjct: 226 HNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDF 284
Query: 334 DFVDLLTNCTKLQYLYLADN--GFGGVLPHSIANLSTALIDFNLGKNQ 379
V + L +N + V P + + T + G +
Sbjct: 285 CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV-TDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 61/359 (16%), Positives = 109/359 (30%), Gaps = 85/359 (23%)
Query: 240 SSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAEN 299
+ L N + L + K L +L V+ N + +FS L+ L++++N
Sbjct: 54 PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112
Query: 300 QFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVL 359
L ++ +L ++ L L + DN V
Sbjct: 113 H-----------LVEIPP-------------------NLPSS---LVELRIHDNRIRKVP 139
Query: 360 PHSIANLSTALIDFNLGKNQIYGT-IPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNL 418
+ L + +G N + + PG + + LN LR+ +LT IP + L
Sbjct: 140 KGVFSGL-RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETL 195
Query: 419 QLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTG 478
LHL N +Q L + L L G N ++ SL L
Sbjct: 196 NELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLR----------- 244
Query: 479 ALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTS 538
L L +N L+ +P G+ +LK L + + N +
Sbjct: 245 --------------ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT------------ 277
Query: 539 LEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFS-GQIPKYL-ENLSFLQYLNLSYN 595
++ N F + L N ++ ++ +
Sbjct: 278 ----KVGVNDFCPVGF--GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 39/225 (17%), Positives = 68/225 (30%), Gaps = 29/225 (12%)
Query: 393 NLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNL 452
+L ++ L +P I + LL L N + L L L N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 453 QGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILE-ITTLSLS------------------ 493
+ + L + +N L +P + + L +
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNM 149
Query: 494 --LDLSDNLL-NGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFS 550
+++ N L N G + L L I+ + + IP +L + L N
Sbjct: 150 NCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ 206
Query: 551 GTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYN 595
+ L + + L L N L L L+ L+L N
Sbjct: 207 AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNN 251
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 36/236 (15%), Positives = 74/236 (31%), Gaps = 38/236 (16%)
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDF-HGEIPDRIGNLFRLETLVLANNSFS 131
+L + + I + L + I + N + + +L L ++ +
Sbjct: 126 VELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185
Query: 132 GRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNL 191
IP +L L N + I E + R L L +G NQ+ S+ L
Sbjct: 186 -GIPKDLP--ETLNELHLDHNKIQ-AIELEDLLR-YSKLYRLGLGHNQIRMIENGSLSFL 240
Query: 192 SALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSV-------YNISSLVE 244
LR + + N+L ++P L L L +++ N+ + + + +
Sbjct: 241 PTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNG 298
Query: 245 IYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQ 300
I L+ N + P +F ++ + +
Sbjct: 299 ISLFNNPVPYW-------EVQ----------------PATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 19/73 (26%), Positives = 26/73 (35%), Gaps = 2/73 (2%)
Query: 537 TSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNH 596
++LQ N S L + L L N S K L LQ L +S NH
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 597 FEGEVPTKGIFKN 609
E+P + +
Sbjct: 114 LV-EIPP-NLPSS 124
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 43/197 (21%), Positives = 75/197 (38%), Gaps = 47/197 (23%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIV 764
+G+G F ++ + + A K++ L + + + E RS+ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG-- 79
Query: 765 TICSSIDFKGV-DFKALVY---EYMQNGSLEEWLHQRDDQLGICNLSLIQRLN------I 814
F G + V+ E + SL E +R + L
Sbjct: 80 -------FHGFFEDNDFVFVVLELCRRRSLLELHKRR------------KALTEPEARYY 120
Query: 815 VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETP 874
+ + +YLH + ++H DLK N+ L+ D+ + DFGLA VE
Sbjct: 121 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYD 168
Query: 875 SSSIGVK-GTIGYVAPE 890
V GT Y+APE
Sbjct: 169 GERKKVLCGTPNYIAPE 185
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 48/232 (20%), Positives = 87/232 (37%), Gaps = 41/232 (17%)
Query: 669 ARRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGML 728
+A + + ++ P V S+ + +G+G F ++ + +
Sbjct: 11 GVPGVAAPGAPAAAPPAKEIPEVLVDPRSR--RRYVRGRFLGKGGFAKCFEISDADTKEV 68
Query: 729 VAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYM 785
A K++ L + + + E RS+ H++++ F+ DF +V E
Sbjct: 69 FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF-----FEDNDFVFVVLELC 123
Query: 786 QNGSLEEWLHQRDDQLGICNLSLIQRLN------IVIDVASAVEYLHHHCQPPIVHGDLK 839
+ SL E +R + L + + +YLH + ++H DLK
Sbjct: 124 RRRSLLELHKRR------------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLK 168
Query: 840 PSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK-GTIGYVAPE 890
N+ L+ D+ + DFGLA VE V GT Y+APE
Sbjct: 169 LGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKVLCGTPNYIAPE 211
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 48/236 (20%), Positives = 96/236 (40%), Gaps = 46/236 (19%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA-----------------ECE 750
T+ +G F + ++ A+K + F E +
Sbjct: 38 TLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 751 ALRSIRHRNLIKIVTICSSID--FKGVDFKALVYEYMQNGSLEEWL--HQRDDQLGICNL 806
+ I++ + I ++ D + ++YEYM+N S+ ++ D+ C +
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVY-------IIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 807 SLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP 866
+ I+ V ++ Y+H+ I H D+KPSN+L+D + +SDFG ++++
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV--- 203
Query: 867 LGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGG---VYSYGILLLEIFTRRRP 919
++ +GT ++ PE+ E+S G ++S GI L +F P
Sbjct: 204 -DKKIKG------SRGTYEFMPPEF-FSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 54/249 (21%), Positives = 101/249 (40%), Gaps = 61/249 (24%)
Query: 707 NTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSKS----FAAECEALRSIRH 757
+G+GSFG VY+GV E VA+K +N + S F E ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNC 87
Query: 758 RNLIKIVTICSSID--FKGVDFKALVYEYMQNGSLEEWLHQR----DDQLGICNLSLIQR 811
++++++ + S ++ E M G L+ +L + + SL +
Sbjct: 88 HHVVRLLGVVSQGQPTL-------VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 812 LNIVIDVASAVEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNV 870
+ + ++A + YL+ + VH DL N ++ D + DFG+ + +
Sbjct: 141 IQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIY------- 189
Query: 871 VETPSSSIGVKGTIGYV-----APEYGLGGEASMRGGVY-------SYGILLLEIFTR-R 917
+ KG G + +PE S++ GV+ S+G++L EI T
Sbjct: 190 ----ETDYYRKGGKGLLPVRWMSPE-------SLKDGVFTTYSDVWSFGVVLWEIATLAE 238
Query: 918 RPTESMFNE 926
+P + + NE
Sbjct: 239 QPYQGLSNE 247
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 55/214 (25%), Positives = 87/214 (40%), Gaps = 34/214 (15%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTI 766
+G G+FG V+ +G+ +K IN ++ + + AE E L+S+ H N+IKI +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
F+ +V E + G L E + + LS ++ + +A+ Y H
Sbjct: 89 -----FEDYHNMYIVMETCEGGELLERIVSAQARGK--ALSEGYVAELMKQMMNALAYFH 141
Query: 827 HHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLSA-SPLGNVVETPSSSIGVKG 882
+VH DLKP N+L + DFGLA+ + N T
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTA-------- 190
Query: 883 TIGYVAPE---YGLGGEA---SMRGGVYSYGILL 910
Y+APE + + S GV Y LL
Sbjct: 191 --LYMAPEVFKRDVTFKCDIWSA--GVVMY-FLL 219
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 37/208 (17%)
Query: 697 SKATNEFSS----SNTIGRGSFGFVYKGVLHENGMLVAVKVIN---------LEQKGGSK 743
S +T+ F +GRG V + + AVK+I+ E + +
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 744 SFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLG 802
+ E + LR + H N+I++ ++ F LV++ M+ G L ++L ++
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYLTEKV---- 119
Query: 803 ICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862
LS + I+ + + LH IVH DLKP N+LLD DM ++DFG + L
Sbjct: 120 --TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 174
Query: 863 SASPLGNVVETPSSSIGVKGTIGYVAPE 890
G + V GT Y+APE
Sbjct: 175 DP---GEKLRE------VCGTPSYLAPE 193
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 66/252 (26%), Positives = 103/252 (40%), Gaps = 66/252 (26%)
Query: 707 NTIGRGSFGFVYKGVLHENG--MLVAVKVINLEQKGGS-----KSFAAECEALRSI-RHR 758
+ IG G+FG V K + ++G M A+K + K + + FA E E L + H
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRM----KEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQR----------DDQLGICNLSL 808
N+I ++ C +G + L EY +G+L ++L + LS
Sbjct: 87 NIINLLGACEH---RGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 809 IQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPL 867
Q L+ DVA ++YL +H DL N+L+ + VA ++DFGL++
Sbjct: 142 QQLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR------- 190
Query: 868 GNVVETPSSSIGVKGTIGYV-----APEYGLGGEASMRGGVY-------SYGILLLEIFT 915
+ VK T+G + A E S+ VY SYG+LL EI +
Sbjct: 191 -------GQEVYVKKTMGRLPVRWMAIE-------SLNYSVYTTNSDVWSYGVLLWEIVS 236
Query: 916 R-RRPTESMFNE 926
P M
Sbjct: 237 LGGTPYCGMTCA 248
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 56/245 (22%), Positives = 102/245 (41%), Gaps = 53/245 (21%)
Query: 707 NTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGS-----KSFAAECEALRSIR 756
+G G+FG VY+G + + + VAVK + F E +
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL----PEVCSEQDELDFLMEALIISKFN 91
Query: 757 HRNLIKIVTICSSIDFKGVDFKA----LVYEYMQNGSLEEWLHQRDDQLGI-CNLSLIQR 811
H+N+++ + GV ++ ++ E M G L+ +L + + +L+++
Sbjct: 92 HQNIVRCI---------GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 812 LNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLAKFLSASPL 867
L++ D+A +YL +H +H D+ N LL VA + DFG+A+
Sbjct: 143 LHVARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR------- 191
Query: 868 GNVVETPSSSIGVKGTIGYV-----APEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTE 921
+ +S KG + PE + G + + +S+G+LL EIF+ P
Sbjct: 192 ----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247
Query: 922 SMFNE 926
S N+
Sbjct: 248 SKSNQ 252
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 19/187 (10%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVTI 766
+G G+ V + AVK+I + E E L + HRN+++++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
F+ D LV+E M+ GS+ +H+R + + ++ +V DVASA+++LH
Sbjct: 80 -----FEEEDRFYLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLH 128
Query: 827 HHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
+ I H DLKP N+L + + DF L + + + + TP G+
Sbjct: 129 NKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GS 184
Query: 884 IGYVAPE 890
Y+APE
Sbjct: 185 AEYMAPE 191
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-24
Identities = 52/279 (18%), Positives = 95/279 (34%), Gaps = 40/279 (14%)
Query: 177 DNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSV 236
L ++P I + R++++ N++ + L L L + NH TI
Sbjct: 52 RKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGA 107
Query: 237 -YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLH 295
+++L + L+ NR T ++P L L+ + N +F+ +L L
Sbjct: 108 FNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLD 166
Query: 296 LAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGF 355
L E L +S + L+YL LA
Sbjct: 167 LGEL----------KRLSYIS-------------------EGAFEGLSNLRYLNLAMCNL 197
Query: 356 GGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGE 414
+ ++ L L + +L N + I PG L++L L M +++ +
Sbjct: 198 REI--PNLTPL-IKLDELDLSGNHL-SAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN 253
Query: 415 LKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453
L++L ++L N L L L + N
Sbjct: 254 LQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 8e-20
Identities = 57/256 (22%), Positives = 93/256 (36%), Gaps = 33/256 (12%)
Query: 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEA 401
T + L L +N + +S +L L L +N I TI G L NLN+L +
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHL-RHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFD 121
Query: 402 NRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSL-GNLTLLTYLSFGANNLQGNIP-FS 459
NRLT L L+ L L N ++ +IPS + L L G I +
Sbjct: 122 NRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180
Query: 460 LGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLG 519
NL L+L+ L +P + L L L
Sbjct: 181 FEGLSNLR-------------------------YLNLAMCNLR-EIP-NLTPLIKLDELD 213
Query: 520 IARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPK 579
++ N S P + L+ + + + + +L S+ E++L+ NN +
Sbjct: 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHD 273
Query: 580 YLENLSFLQYLNLSYN 595
L L+ ++L +N
Sbjct: 274 LFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 7e-18
Identities = 58/294 (19%), Positives = 102/294 (34%), Gaps = 44/294 (14%)
Query: 44 VTSSWNRSACVNLCQ---HWTGVTCGRRN---------QRVTKLDLRNQSIGGILSPYVG 91
V + + C ++C ++ V C R+N L+L I
Sbjct: 26 VAETGSAQTCPSVCSCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQ-------- 77
Query: 92 NLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTN-LSHCSKLITFSAH 150
I N F +L LE L L+ N I + + L T
Sbjct: 78 --------IIKVNSFK--------HLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELF 120
Query: 151 RNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDI-RTNRLWGKIP 209
N L IP L L+ L + +N + + + +LR +D+ RL
Sbjct: 121 DNRLT-TIPNGAFV-YLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISE 178
Query: 210 ITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRN 269
L++L YL++ + P++ + L E+ L GN + ++ + L +L+
Sbjct: 179 GAFEGLSNLRYLNLAMCNL--REIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQK 235
Query: 270 FVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATN 323
+ + ++F N +L ++LA N F L L + L N
Sbjct: 236 LWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 8e-17
Identities = 55/238 (23%), Positives = 90/238 (37%), Gaps = 16/238 (6%)
Query: 119 RLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDN 178
L L N + H L RN++ I + L NL L + DN
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNG-LANLNTLELFDN 122
Query: 179 QLTGQLPASIGNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNHFSGTIPPSV- 236
+LT + LS L+ + +R N + IP +++ SL L +G+ I
Sbjct: 123 RLTTIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAF 181
Query: 237 YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHL 296
+S+L + L I L L + N+ + P SF +L+ L +
Sbjct: 182 EGLSNLRYLNLAMCNLRE---IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238
Query: 297 AENQFRGQVSIN-FNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADN 353
++Q + + N F+ L+ L + LA N L DL T L+ ++L N
Sbjct: 239 IQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPH------DLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-14
Identities = 50/206 (24%), Positives = 82/206 (39%), Gaps = 9/206 (4%)
Query: 393 NLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNL 452
+ + L +P I N +LL+LH N +Q +S +L L L N++
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 453 QGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GN 511
+ + NL N+LT +P + L L +N + S+P
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNR 158
Query: 512 LKSLVRLGIAR-NQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQ 570
+ SL RL + + S ++L Y+ L + IP +L+ L + ELDLS
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSG 216
Query: 571 NNFSGQIPKYLENLSFLQYLNLSYNH 596
N+ S P + L LQ L + +
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQ 242
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 26/143 (18%), Positives = 43/143 (30%), Gaps = 17/143 (11%)
Query: 491 SLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFS 550
+ L +P G+ + L + NQ + LE ++L N
Sbjct: 45 FSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101
Query: 551 GTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNK 610
+ + L ++ L+L N + LS L+ L L N E +P+ F
Sbjct: 102 TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPS-YAFNR- 158
Query: 611 TGFSIVGNGKLCGGLDELHLPSC 633
L L L
Sbjct: 159 -----------IPSLRRLDLGEL 170
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 62/243 (25%), Positives = 110/243 (45%), Gaps = 48/243 (19%)
Query: 709 IGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSKS----FAAECEALRSIRHRN 759
+G G+FG V+ + ++ MLVAVK + K + + F E E L +++H +
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL----KDPTLAARKDFQREAELLTNLQHEH 78
Query: 760 LIKIVTICSSID--FKGVDFKALVYEYMQNGSLEEWLHQR----------DDQLGICNLS 807
++K +C D +V+EYM++G L ++L + L
Sbjct: 79 IVKFYGVCGDGDPLI-------MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 808 LIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP 866
L Q L+I +AS + YL H VH DL N L+ +++ + DFG+++
Sbjct: 132 LSQMLHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSR------ 181
Query: 867 LGNVVETPSSSIGVKGT--IGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESM 923
+V T +G I ++ PE + + + V+S+G++L EIFT ++P +
Sbjct: 182 --DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 239
Query: 924 FNE 926
N
Sbjct: 240 SNT 242
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 53/279 (18%), Positives = 88/279 (31%), Gaps = 40/279 (14%)
Query: 177 DNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSV 236
L+ ++P I S R +++ N + T L L L +G N I
Sbjct: 63 RRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGA 118
Query: 237 -YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLH 295
++SL + L+ N T +P + L LR + N +F+ +L L
Sbjct: 119 FNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLD 177
Query: 296 LAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGF 355
L E L+ +S L+YL L
Sbjct: 178 LGEL----------KKLEYIS-------------------EGAFEGLFNLKYLNLGMCNI 208
Query: 356 GGVLPHSIANLSTALIDFNLGKNQIYGTIPPG-IANLVNLNSLRMEANRLTGTIPHVIGE 414
+ ++ L L + + N I PG L +L L + ++++ +
Sbjct: 209 KDM--PNLTPL-VGLEELEMSGNHF-PEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDG 264
Query: 415 LKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453
L +L L+L N L L L L N
Sbjct: 265 LASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 55/255 (21%), Positives = 90/255 (35%), Gaps = 31/255 (12%)
Query: 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEA 401
+ +YL L +N + + +L L LG+N I I G L +LN+L +
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHL-HHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFD 132
Query: 402 NRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIP-FSL 460
N LT L L+ L L N ++ + + L L G I +
Sbjct: 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192
Query: 461 GNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGI 520
NL L+L + +P + L L L +
Sbjct: 193 EGLFNL-------------------------KYLNLGMCNIK-DMP-NLTPLVGLEELEM 225
Query: 521 ARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKY 580
+ N F P + +SL+ + + + S + L S+ EL+L+ NN S
Sbjct: 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDL 285
Query: 581 LENLSFLQYLNLSYN 595
L +L L+L +N
Sbjct: 286 FTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-18
Identities = 52/310 (16%), Positives = 98/310 (31%), Gaps = 66/310 (21%)
Query: 119 RLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDN 178
+ +V S +P + ++ + N + I + L +L+ L +G N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIPSNTRYLNLM---ENNIQMIQADTFRH-LHHLEVLQLGRN 109
Query: 179 QLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYN 238
+ + L++L +++ N L L+ L L + +N +IP
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYA-- 166
Query: 239 ISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLP-DSFSNASNLEVLHLA 297
F +P+L + + +F NL+ L+L
Sbjct: 167 -------------FNR---------VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204
Query: 298 ENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGG 357
+ + LT L+ L ++ N F
Sbjct: 205 MCN--------------------------------IKDMPNLTPLVGLEELEMSGNHFPE 232
Query: 358 VLPHSIANLSTALIDFNLGKNQIYGTIPPG-IANLVNLNSLRMEANRLTGTIPHVIGELK 416
+ P S L ++L + +Q+ I L +L L + N L+ + L+
Sbjct: 233 IRPGSFHGL-SSLKKLWVMNSQV-SLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290
Query: 417 NLQLLHLHAN 426
L LHLH N
Sbjct: 291 YLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 4e-18
Identities = 53/255 (20%), Positives = 90/255 (35%), Gaps = 36/255 (14%)
Query: 344 KLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEAN 402
+ + G V P + + NL +N I I +L +L L++ N
Sbjct: 55 QFSKVVCTRRGLSEV-P---QGIPSNTRYLNLMENNI-QMIQADTFRHLHHLEVLQLGRN 109
Query: 403 RLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIP-FSLG 461
+ L +L L L N+L + L+ L L N ++ +IP ++
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168
Query: 462 NCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGI 520
+L + LDL + + G L +L L +
Sbjct: 169 RVPSL-------------------------MRLDLGELKKLEYISEGAFEGLFNLKYLNL 203
Query: 521 ARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKY 580
+P L LE +E+ GN F P S L+S+K+L + + S
Sbjct: 204 GMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNA 261
Query: 581 LENLSFLQYLNLSYN 595
+ L+ L LNL++N
Sbjct: 262 FDGLASLVELNLAHN 276
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 59/297 (19%), Positives = 104/297 (35%), Gaps = 46/297 (15%)
Query: 42 LGVTSSWNRSACVNLCQ---HWTGVTCGRRN---------QRVTKLDLRNQSIGGILSPY 89
+ +S C ++C ++ V C RR L+L +I
Sbjct: 35 IAAAASAGPQNCPSVCSCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQ------ 88
Query: 90 VGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTN-LSHCSKLITFS 148
I + F +L LE L L NS +I + + L T
Sbjct: 89 ----------MIQADTFR--------HLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLE 129
Query: 149 AHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASI-GNLSALRVIDI-RTNRLWG 206
N L IP L L+ L + +N + +P+ + +L +D+ +L
Sbjct: 130 LFDNWLT-VIPSGAF-EYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEY 186
Query: 207 KIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPN 266
L +L YL++G + P++ + L E+ + GN F + L +
Sbjct: 187 ISEGAFEGLFNLKYLNLGMCNI--KDMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSS 243
Query: 267 LRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATN 323
L+ + + + ++F ++L L+LA N F L+ L L L N
Sbjct: 244 LKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 48/220 (21%), Positives = 76/220 (34%), Gaps = 37/220 (16%)
Query: 393 NLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNL 452
+ + L+ +P I N + L+L N +Q + +L L L G N++
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 453 QGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GN 511
+ + +L +L+L DN L +P G
Sbjct: 112 RQIEVGAFNGLASLN-------------------------TLELFDNWLT-VIPSGAFEY 145
Query: 512 LKSLVRLGIARNQFSGQIPV-TLGACTSLEYVELQGNSFSGTIP-QSLSSLTSIKELDLS 569
L L L + N IP SL ++L I + L ++K L+L
Sbjct: 146 LSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204
Query: 570 QNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKN 609
N +P L L L+ L +S NHF E+ G F
Sbjct: 205 MCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRP-GSFHG 240
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 52/200 (26%), Positives = 85/200 (42%), Gaps = 47/200 (23%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVIN--------LEQKGGSKSFAAECEALRSIRHRN 759
T+G G+ G V + VA+K+I+ + + + E E L+ + H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRL------N 813
+IKI + D+ +V E M+ G L + + +RL
Sbjct: 77 IIKIKNFFDAEDY------YIVLELMEGGELFDKVVGN------------KRLKEATCKL 118
Query: 814 IVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLSASPLGNV 870
+ AV+YLH + I+H DLKP NVLL + D + ++DFG +K L ++
Sbjct: 119 YFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSL 172
Query: 871 VETPSSSIGVKGTIGYVAPE 890
+ T + GT Y+APE
Sbjct: 173 MRT------LCGTPTYLAPE 186
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 55/351 (15%), Positives = 109/351 (31%), Gaps = 61/351 (17%)
Query: 228 FSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSN 287
+ + + S+P + +++ + N T
Sbjct: 19 KEESSNQASLSCDRNGICKGSSGSLN-SIPSGL---TEAVKSLDLSNNRITYISNSDLQR 74
Query: 288 ASNLEVLHLAENQFRGQVSIN---FNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTK 344
NL+ L L N +I F+ L L L L+ N+L N ++ +
Sbjct: 75 CVNLQALVLTSNGIN---TIEEDSFSSLGSLEHLDLSYNYLSNLSS------SWFKPLSS 125
Query: 345 LQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANR 403
L +L L N + + S+ + T L +G + I A L L L ++A+
Sbjct: 126 LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185
Query: 404 LTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNC 463
L P + ++N+ L LH + + + + L +L
Sbjct: 186 LQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTF-------- 237
Query: 464 KNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARN 523
E++T +++L+ + + I
Sbjct: 238 -------------------HFSELSTGE-----TNSLI---------KKFTFRNVKITDE 264
Query: 524 QFSGQIPVTLGACTSLEYVELQGNSFSGTIPQS-LSSLTSIKELDLSQNNF 573
Q+ L + L +E N ++P LTS++++ L N +
Sbjct: 265 SLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 50/337 (14%), Positives = 110/337 (32%), Gaps = 40/337 (11%)
Query: 123 LVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTG 182
V+ + S C + +L IP L ++ L + +N++T
Sbjct: 12 GVIISLSKEESSNQASLSCDRNGICKGSSGSL-NSIPSGLTE----AVKSLDLSNNRITY 66
Query: 183 QLPASIGNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNHFSGTIPPSVY-NIS 240
+ + L+ + + +N + I + S L SL +L + N+ S + S + +S
Sbjct: 67 ISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLS 124
Query: 241 SLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPD-SFSNASNLEVLHLAEN 299
SL + L GN + + +L L+ + + + F+ + LE L + +
Sbjct: 125 SLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184
Query: 300 QFRGQVSINFNGLKDLSMLGLATN---FLGNGAANDLDFVDLLTNCTKLQYLYLADNGFG 356
+ + ++++S L L L + + ++ L L D
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVT---------SSVECLELRDTDLD 235
Query: 357 GVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELK 416
++ T + ++++ L + ++ ++
Sbjct: 236 TFHFSELSTGETN-----------------SLIKKFTFRNVKITDESLF-QVMKLLNQIS 277
Query: 417 NLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453
L L N L+ LT L + N
Sbjct: 278 GLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 55/266 (20%), Positives = 100/266 (37%), Gaps = 27/266 (10%)
Query: 337 DLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLN 395
L C LQ L L NG + S ++L +L +L N + + L +L
Sbjct: 70 SDLQRCVNLQALVLTSNGINTIEEDSFSSL-GSLEHLDLSYNYL-SNLSSSWFKPLSSLT 127
Query: 396 SLRMEANRLTGTIPH--VIGELKNLQLLHLHANFLQGTIPS-SLGNLTLLTYLSFGANNL 452
L + N T+ + L LQ+L + I LT L L A++L
Sbjct: 128 FLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186
Query: 453 QGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNL 512
Q P SL + +N+ + L + +++T+ L+L D L+
Sbjct: 187 QSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDT--------- 236
Query: 513 KSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNN 572
++ S +L + V++ S + + L+ ++ + EL+ S+N
Sbjct: 237 -------FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQ 288
Query: 573 FSGQIPKY-LENLSFLQYLNLSYNHF 597
+P + L+ LQ + L N +
Sbjct: 289 LKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 53/262 (20%), Positives = 93/262 (35%), Gaps = 14/262 (5%)
Query: 72 VTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRI-GNLFRLETLVLANNSF 130
V LDL N I I + + L+ + + N + I + +L LE L L+ N
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112
Query: 131 SGRIPTNL-SHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASI- 188
S + ++ S L + N + E + L LQ L VG+ ++
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 189 GNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVY-NISSLVEIYL 247
L+ L ++I + L P +L + ++++L + + SS+ + L
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLEL 229
Query: 248 YGNRFTG----SLPIEIGKNLPNLRNF--VIYTNNFTGSLPDSFSNASNLEVLHLAENQF 301
L +L F V T+ + + S L L + NQ
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQL 289
Query: 302 RGQVSINFNGLKDLSMLGLATN 323
+ F+ L L + L TN
Sbjct: 290 KSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 46/282 (16%), Positives = 87/282 (30%), Gaps = 52/282 (18%)
Query: 364 ANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLH 422
+ L+ A+ +L N+I I VNL +L + +N + L +L+ L
Sbjct: 48 SGLTEAVKSLDLSNNRI-TYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106
Query: 423 LHANFLQGTIPSSL-GNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALP 481
L N+L + SS L+ LT+L+ N + S F+ KL
Sbjct: 107 LSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETS---------LFSHLTKLQ---- 152
Query: 482 QQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGIARNQFSGQIPVTLGACTSLE 540
L + + + L L L I + P +L + ++
Sbjct: 153 -----------ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVS 201
Query: 541 YVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSF--------LQYLNL 592
++ L + + +S++ L+L + L + + +
Sbjct: 202 HLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 593 SYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDELHLPSCQ 634
+ F ++ GL EL Q
Sbjct: 262 TDESL---------------FQVMKLLNQISGLLELEFSRNQ 288
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 33/193 (17%), Positives = 72/193 (37%), Gaps = 17/193 (8%)
Query: 73 TKLDLRNQSIGGILSPYV-GNLSFLRYINIADNDFHGEIPDRI-GNLFRLETLVLANNSF 130
T L+L + + +L+ L+ + + + D +I + L LE L + +
Sbjct: 127 TFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186
Query: 131 SGRIPTN-LSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTG----QLP 185
L + H + + E + +++ L + D L +L
Sbjct: 187 Q-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD-VTSSVECLELRDTDLDTFHFSELS 243
Query: 186 A----SIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVY-NIS 240
S+ R + I L ++ L+Q++ L L N ++P ++ ++
Sbjct: 244 TGETNSLIKKFTFRNVKITDESL-FQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLT 301
Query: 241 SLVEIYLYGNRFT 253
SL +I+L+ N +
Sbjct: 302 SLQKIWLHTNPWD 314
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 61/242 (25%), Positives = 93/242 (38%), Gaps = 50/242 (20%)
Query: 669 ARRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSS----SNTIGRGSFGFVYKGVLHE 724
A++ A + Q A EF + IGRG V + V
Sbjct: 58 AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117
Query: 725 NGMLVAVKVINLEQKGGSKSFAA--------ECEALRSIR-HRNLIKIVTICSSIDFKGV 775
G AVK++ + + S E LR + H ++I ++ S
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-----S 172
Query: 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRL------NIVIDVASAVEYLHHHC 829
F LV++ M+ G L ++L ++ L +I+ + AV +LH +
Sbjct: 173 SFMFLVFDLMRKGELFDYLTEK------------VALSEKETRSIMRSLLEAVSFLHANN 220
Query: 830 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSA-SPLGNVVETPSSSIGVKGTIGYVA 888
IVH DLKP N+LLD +M +SDFG + L L + GT GY+A
Sbjct: 221 ---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC----------GTPGYLA 267
Query: 889 PE 890
PE
Sbjct: 268 PE 269
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 50/256 (19%), Positives = 89/256 (34%), Gaps = 56/256 (21%)
Query: 676 HKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN 735
H ++ + F S EL ++ IG+GS+G V + ++ + A+K++N
Sbjct: 4 HHHHSSGRENLYFQGGSLLEL---QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 736 LEQ-----KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSL 790
+ + E ++ + H N+ ++ + ++ + LV E G L
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV-----YEDEQYICLVMELCHGGHL 115
Query: 791 EEWLHQRDDQLGICNLSLIQRL----------------------------------NIVI 816
+ L+ D + + NI+
Sbjct: 116 LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETP 874
+ SA+ YLH+ I H D+KP N L + + DFGL+K G
Sbjct: 176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232
Query: 875 SSSIGVKGTIGYVAPE 890
GT +VAPE
Sbjct: 233 ----TKAGTPYFVAPE 244
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 58/262 (22%), Positives = 96/262 (36%), Gaps = 20/262 (7%)
Query: 244 EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQ--F 301
EI T S+P I + + +N F + L L L+ N F
Sbjct: 11 EIRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 302 RGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPH 361
+G S + G L L L+ N + ++N +L++L + +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVITMSSN-------FLGLEQLEHLDFQHSNLKQMSEF 119
Query: 362 SI-ANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTI-PHVIGELKNL 418
S+ +L LI ++ GI L +L L+M N P + EL+NL
Sbjct: 120 SVFLSL-RNLIYLDISHTHT-RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 177
Query: 419 QLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTG 478
L L L+ P++ +L+ L L+ NN F +L N +
Sbjct: 178 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM- 236
Query: 479 ALPQQILEITTLSLS-LDLSDN 499
+Q L+ SL+ L+L+ N
Sbjct: 237 TSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 51/265 (19%), Positives = 99/265 (37%), Gaps = 19/265 (7%)
Query: 121 ETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQL 180
+ + + +PT + + + +N + +P + + L L LS+ N L
Sbjct: 10 TEIRCNSKGLT-SVPTGIPSSATRLELE---SNKLQSLPHGVFDK-LTQLTKLSLSSNGL 64
Query: 181 TGQ--LPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSV-Y 237
+ + S ++L+ +D+ N + + L L +L ++ SV
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123
Query: 238 NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSL-PDSFSNASNLEVLHL 296
++ +L+ + + I L +L + N+F + PD F+ NL L L
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 297 AENQFRGQVSIN-FNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGF 355
++ Q Q+S FN L L +L ++ N LD LQ L + N
Sbjct: 183 SQCQLE-QLSPTAFNSLSSLQVLNMSHNNF-----FSLDT-FPYKCLNSLQVLDYSLNHI 235
Query: 356 GGVLPHSIANLSTALIDFNLGKNQI 380
+ + ++L NL +N
Sbjct: 236 MTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 47/247 (19%), Positives = 88/247 (35%), Gaps = 11/247 (4%)
Query: 109 EIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLF 168
+P I L L +N ++L S N L +
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNH 227
+L+ L + N + + ++ L L +D + + L L +L YL + H
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 228 FSGTIPPSV-YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFS 286
+ +SSL + + GN F + +I L NL + P +F+
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 196
Query: 287 NASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQ 346
+ S+L+VL+++ N F + + L L +L + N + + ++ L
Sbjct: 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ--ELQHFPSS---LA 251
Query: 347 YLYLADN 353
+L L N
Sbjct: 252 FLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 50/282 (17%), Positives = 90/282 (31%), Gaps = 43/282 (15%)
Query: 150 HRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRL--WGK 207
+ L +P + + L + N+L L+ L + + +N L G
Sbjct: 15 NSKGLT-SVPTGI----PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC 69
Query: 208 IPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNL 267
+ TSL YL + N T+ + + L + + + +L NL
Sbjct: 70 CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 128
Query: 268 RNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGN 327
I + + F+ S+LEVL +A N F+
Sbjct: 129 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL--------------------- 167
Query: 328 GAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPG 387
D+ T L +L L+ + P + +L ++L N+ N ++
Sbjct: 168 --------PDIFTELRNLTFLDLSQCQLEQLSPTAFNSL-SSLQVLNMSHNNF-FSLDTF 217
Query: 388 I-ANLVNLNSLRMEANRLTGTIPHVI--GELKNLQLLHLHAN 426
L +L L N + T +L L+L N
Sbjct: 218 PYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 56/241 (23%), Positives = 95/241 (39%), Gaps = 34/241 (14%)
Query: 364 ANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLT--GTIPHVIGELKNLQL 420
+ ++ L N++ ++P G+ L L L + +N L+ G +L+
Sbjct: 24 TGIPSSATRLELESNKL-QSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82
Query: 421 LHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGAL 480
L L N + T+ S+ L L +L F +NL+ FS+ F L
Sbjct: 83 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV---------FLSLRNLI--- 129
Query: 481 PQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGIARNQFSGQI-PVTLGACTS 538
LD+S G+ L SL L +A N F P +
Sbjct: 130 ------------YLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 176
Query: 539 LEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKY-LENLSFLQYLNLSYNHF 597
L +++L P + +SL+S++ L++S NNF + + + L+ LQ L+ S NH
Sbjct: 177 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHI 235
Query: 598 E 598
Sbjct: 236 M 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 47/217 (21%), Positives = 77/217 (35%), Gaps = 11/217 (5%)
Query: 240 SSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFT--GSLPDSFSNASNLEVLHLA 297
SS + L N+ SLP + L L + +N + G S ++L+ L L+
Sbjct: 28 SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86
Query: 298 ENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGG 357
N +S NF GL+ L L + L + + + L YL ++
Sbjct: 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-----MSEFSVFLSLRNLIYLDISHTHTRV 140
Query: 358 VLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGELK 416
L ++L + N P I L NL L + +L P L
Sbjct: 141 AFNGIFNGL-SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 199
Query: 417 NLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453
+LQ+L++ N L L L + N++
Sbjct: 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 46/236 (19%), Positives = 76/236 (32%), Gaps = 10/236 (4%)
Query: 345 LQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIA--NLVNLNSLRMEAN 402
L L N + L T L +L N + + +L L + N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKL-TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 403 RLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSL-GNLTLLTYLSFGANNLQGNIPFSLG 461
+ T+ L+ L+ L + L+ S+ +L L YL + +
Sbjct: 89 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147
Query: 462 NCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGI 520
+L N I LDLS L L +L SL L +
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNM 206
Query: 521 ARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSL--SSLTSIKELDLSQNNFS 574
+ N F SL+ ++ N T + +S+ L+L+QN+F+
Sbjct: 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 50/237 (21%), Positives = 91/237 (38%), Gaps = 11/237 (4%)
Query: 72 VTKLDLRNQSIGGILSPYVGNLSFLRYINIADND--FHGEIPDRIGNLFRLETLVLANNS 129
T+L+L + + + L+ L ++++ N F G L+ L L+ N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 130 FSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASI- 188
+ +N +L +NL ++ E + L NL L + I
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIF 146
Query: 189 GNLSALRVIDIRTNRLWGKI-PITLSQLTSLAYLHVGDNHFSGTIPPSV-YNISSLVEIY 246
LS+L V+ + N P ++L +L +L + + P+ ++SSL +
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLN 205
Query: 247 LYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSN-ASNLEVLHLAENQFR 302
+ N F SL K L +L+ N+ S + S+L L+L +N F
Sbjct: 206 MSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 56/252 (22%), Positives = 100/252 (39%), Gaps = 67/252 (26%)
Query: 707 NTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGS-----KSFAAECEALRSIR 756
+G G+FG VY+G + + + VAVK + F E +
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL----PEVCSEQDELDFLMEALIISKFN 132
Query: 757 HRNLIKIVTICSSIDFKGVDFKA----LVYEYMQNGSLEEWLHQ-RDDQLGICNLSLIQR 811
H+N+++ + GV ++ ++ E M G L+ +L + R +L+++
Sbjct: 133 HQNIVRCI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 812 LNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLAKFLSASPL 867
L++ D+A +YL +H +H D+ N LL VA + DFG+A+
Sbjct: 184 LHVARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR------- 232
Query: 868 GNVVETPSSSIGVKGTIGYV-----APEYGLGGEASMRGGVY-------SYGILLLEIFT 915
+ + KG + PE + G++ S+G+LL EIF+
Sbjct: 233 ----DIYRAGYYRKGGCAMLPVKWMPPE-------AFMEGIFTSKTDTWSFGVLLWEIFS 281
Query: 916 R-RRPTESMFNE 926
P S N+
Sbjct: 282 LGYMPYPSKSNQ 293
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 53/218 (24%), Positives = 89/218 (40%), Gaps = 39/218 (17%)
Query: 688 FPMVSYKELSKATNEFSS----SNTIGRGSFGFVYKGVLHENGMLVAVKVIN-------- 735
F ++ + S S T+G G+ G V + VA+++I+
Sbjct: 118 FFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS 177
Query: 736 LEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLH 795
+ + + E E L+ + H +IKI + D+ +V E M+ G L + +
Sbjct: 178 AREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVV 231
Query: 796 QRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAH 852
L + AV+YLH + I+H DLKP NVLL + D +
Sbjct: 232 GNK------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 282
Query: 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE 890
++DFG +K L +++ T + GT Y+APE
Sbjct: 283 ITDFGHSKILGE---TSLMRT------LCGTPTYLAPE 311
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 48/186 (25%), Positives = 85/186 (45%), Gaps = 24/186 (12%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIV 764
+G+GSF VY+ G+ VA+K+I+ + + G + E + ++H +++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
F+ ++ LV E NG + +L R S + + + + + + Y
Sbjct: 78 NY-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPF-----SENEARHFMHQIITGMLY 127
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
LH H I+H DL SN+LL +M ++DFGLA L T + GT
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--HEKHYT------LCGTP 176
Query: 885 GYVAPE 890
Y++PE
Sbjct: 177 NYISPE 182
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 50/263 (19%), Positives = 96/263 (36%), Gaps = 41/263 (15%)
Query: 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA--ECEALRS 754
S+ T EF IG G FG V+K V +G + A+K G A E A
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 755 I-RHRNLIKIVTICSSIDFKGVDFKA----LVYEYMQNGSLEEWLHQRDDQLGICNLSLI 809
+ +H ++++ + + + EY GSL + + + + + +
Sbjct: 67 LGQHSHVVR---------YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 810 QRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGN 869
+ ++++ V + Y+H +VH D+KPSN+ + + + + + AS
Sbjct: 118 K--DLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
Query: 870 V-------VETPSSSIGVKGTIGYVAPE-----YGLGGEASMRGGVYSYGILLLEIFTRR 917
V SS +G ++A E Y +A +++ + ++
Sbjct: 173 FKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKAD----IFALALTVVCAAGAE 228
Query: 918 RPTESMFNEGLTLHEFAKRALPE 940
G HE + LP
Sbjct: 229 PL----PRNGDQWHEIRQGRLPR 247
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 65/297 (21%), Positives = 115/297 (38%), Gaps = 77/297 (25%)
Query: 674 SAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSN-----TIGRGSFGFVYKGVLH----- 723
S+H + SQ + Y+ EF +G G+FG V
Sbjct: 3 SSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKD 62
Query: 724 --ENGMLVAVKVINLEQKGGSKS-----FAAECEALRSI-RHRNLIKIVTICSSID--FK 773
+ + VAVK++ K + +E E ++ I +H+N+I ++ C+ +
Sbjct: 63 KPKEAVTVAVKML----KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY- 117
Query: 774 GVDFKALVYEYMQNGSLEEWLHQR----------DDQLGICNLSLIQRLNIVIDVASAVE 823
++ EY G+L E+L R +++ ++ ++ +A +E
Sbjct: 118 ------VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGME 171
Query: 824 YL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
YL C +H DL NVL+ + V ++DFGLA+ ++ + K
Sbjct: 172 YLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDIN-----------NIDYYKKT 216
Query: 883 TIGYV-----APEYGLGGEASMRGGVY-------SYGILLLEIFTR-RRPTESMFNE 926
T G + APE ++ VY S+G+L+ EIFT P + E
Sbjct: 217 TNGRLPVKWMAPE-------ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-23
Identities = 62/250 (24%), Positives = 106/250 (42%), Gaps = 63/250 (25%)
Query: 709 IGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSKS----FAAECEALRSIRHRN 759
+G G+FG V+ H ++ MLVAVK + K S+S F E E L ++H++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL----KEASESARQDFQREAELLTMLQHQH 104
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQR---------DDQLGICNLSLIQ 810
+++ +C+ +G +V+EYM++G L +L + + L L Q
Sbjct: 105 IVRFFGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 811 RLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGN 869
L + VA+ + YL H VH DL N L+ +V + DFG+++
Sbjct: 160 LLAVASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSR--------- 206
Query: 870 VVETPSSSIGVKGTIGYV-----APEYGLGGEASMRGGVY-------SYGILLLEIFTR- 916
+ S+ G + PE S+ + S+G++L EIFT
Sbjct: 207 --DIYSTDYYRVGGRTMLPIRWMPPE-------SILYRKFTTESDVWSFGVVLWEIFTYG 257
Query: 917 RRPTESMFNE 926
++P + N
Sbjct: 258 KQPWYQLSNT 267
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-23
Identities = 63/297 (21%), Positives = 114/297 (38%), Gaps = 75/297 (25%)
Query: 673 RSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSN-----TIGRGSFGFVYKGVLH---- 723
R + S+T+ + Y+ EF +G G FG V
Sbjct: 48 RITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDK 107
Query: 724 ---ENGMLVAVKVINLEQKGGSKS----FAAECEALRSI-RHRNLIKIVTICSSID--FK 773
+ + VAVK++ ++ +E E ++ I +H+N+I ++ C+ +
Sbjct: 108 DKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY- 163
Query: 774 GVDFKALVYEYMQNGSLEEWLHQR----------DDQLGICNLSLIQRLNIVIDVASAVE 823
++ EY G+L E+L R +++ ++ ++ +A +E
Sbjct: 164 ------VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGME 217
Query: 824 YL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
YL C +H DL NVL+ + V ++DFGLA+ ++ + K
Sbjct: 218 YLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDIN-----------NIDYYKKT 262
Query: 883 TIGYV-----APEYGLGGEASMRGGVY-------SYGILLLEIFTR-RRPTESMFNE 926
T G + APE ++ VY S+G+L+ EIFT P + E
Sbjct: 263 TNGRLPVKWMAPE-------ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-23
Identities = 50/212 (23%), Positives = 83/212 (39%), Gaps = 34/212 (16%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTIC 767
+G G+FG V++ V G + K IN + E + + H LI +
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 116
Query: 768 SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH 827
F+ L+ E++ G L + + D +S + +N + ++++H
Sbjct: 117 ----FEDKYEMVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHE 167
Query: 828 HCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H IVH D+KP N++ + + V DFGLA L+ +V+ T
Sbjct: 168 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKV------TTATAE 215
Query: 886 YVAPE------YGLGGEASM-RGGVYSYGILL 910
+ APE G M GV Y +LL
Sbjct: 216 FAAPEIVDREPVGF--YTDMWAIGVLGY-VLL 244
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 46/192 (23%), Positives = 78/192 (40%), Gaps = 26/192 (13%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLI 761
S + +G G FG V+K G+ +A K+I + E + + H NLI
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
++ F+ + LV EY+ G L + + NL+ + + + +
Sbjct: 150 QLYDA-----FESKNDIVLVMEYVDGGELFDRIIDES-----YNLTELDTILFMKQICEG 199
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPSSSIG 879
+ ++H I+H DLKP N+L + + DFGLA+ P +
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK----------PREKLK 246
Query: 880 VK-GTIGYVAPE 890
V GT ++APE
Sbjct: 247 VNFGTPEFLAPE 258
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 52/189 (27%), Positives = 77/189 (40%), Gaps = 30/189 (15%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIVT 765
+G+GSFG V K AVKVIN + E E L+ + H N++K+
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
I + +V E G L + + +R S I+ V S + Y+
Sbjct: 89 I-----LEDSSSFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYM 137
Query: 826 HHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLSA-SPLGNVVETPSSSIGVK 881
H H IVH DLKP N+LL + D + DFGL+ + + + + T
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA------- 187
Query: 882 GTIGYVAPE 890
Y+APE
Sbjct: 188 ---YYIAPE 193
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 63/214 (29%), Positives = 82/214 (38%), Gaps = 39/214 (18%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTIC 767
TIGRGS+G V V + A K I F E E ++S+ H N+I++
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET- 74
Query: 768 SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH 827
F+ LV E G L E + + I+ DV SAV Y H
Sbjct: 75 ----FEDNTDIYLVMELCTGGELFERVVHKR------VFRESDAARIMKDVLSAVAYCHK 124
Query: 828 HCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
+ H DLKP N L D + DFGLA G ++ T GT
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---GKMMRT------KVGTP 172
Query: 885 GYVAPE-----YGLGGEA---SMRGGVYSYGILL 910
YV+P+ YG E S GV Y +LL
Sbjct: 173 YYVSPQVLEGLYGP--ECDEWSA--GVMMY-VLL 201
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 55/241 (22%), Positives = 94/241 (39%), Gaps = 64/241 (26%)
Query: 709 IGRGSFGFVYKGVL-----HENGMLVAVKVINLEQKGGS-----KSFAAECEALRSI-RH 757
+GRG+FG V + VAVK++ K G+ ++ +E + L I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKML----KEGATHSEHRALMSELKILIHIGHH 90
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQR----------DDQLGICNLS 807
N++ ++ C+ ++ E+ + G+L +L + + L L+
Sbjct: 91 LNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 808 LIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP 866
L + VA +E+L C +H DL N+LL V + DFGLA+ +
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIY--- 199
Query: 867 LGNVVETPSSSIGVKGTIGYV-----APEYGLGGEASMRGGVY-------SYGILLLEIF 914
V+ + APE ++ VY S+G+LL EIF
Sbjct: 200 --------KDPDYVRKGDARLPLKWMAPE-------TIFDRVYTIQSDVWSFGVLLWEIF 244
Query: 915 T 915
+
Sbjct: 245 S 245
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 62/321 (19%), Positives = 111/321 (34%), Gaps = 32/321 (9%)
Query: 238 NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLA 297
+++ ++I + T ++ +L + + T ++ +NL L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELK 71
Query: 298 ENQFRGQVSI-NFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFG 356
+NQ + L ++ L L+ N L N V + ++ L L
Sbjct: 72 DNQIT---DLAPLKNLTKITELELSGNPLKN--------VSAIAGLQSIKTLDLTSTQIT 120
Query: 357 GVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELK 416
V P +A L + L L NQI T +A L NL L + +++ P + L
Sbjct: 121 DVTP--LAGL-SNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVSDLTP--LANLS 173
Query: 417 NLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKL 476
L L N + + S L +L L + N + ++ L N NL +
Sbjct: 174 KLTTLKADDNKI--SDISPLASLPNLIEVHLKNNQIS-DVS-PLANTSNLFIVTLTNQTI 229
Query: 477 TGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGAC 536
T Q + L + + P + + + + N S V+
Sbjct: 230 TN---QPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFN 286
Query: 537 TSLEYVELQGNSFSGTIPQSL 557
S+ + FSGT+ Q L
Sbjct: 287 QSVTFKNTTVP-FSGTVTQPL 306
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 61/295 (20%), Positives = 117/295 (39%), Gaps = 35/295 (11%)
Query: 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHF 228
N ++ G + +T + +L + + + I + L +L L + DN
Sbjct: 20 NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKDNQI 75
Query: 229 SGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNA 288
+ + P + N++ + E+ L GN + L +++ + + T +
Sbjct: 76 T-DLAP-LKNLTKITELELSGNPLKN---VSAIAGLQSIKTLDLTSTQITD--VTPLAGL 128
Query: 289 SNLEVLHLAENQFRGQVSI-NFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQY 347
SNL+VL+L NQ +I GL +L L + + + + L N +KL
Sbjct: 129 SNLQVLYLDLNQIT---NISPLAGLTNLQYLSIGNAQVSD--------LTPLANLSKLTT 177
Query: 348 LYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGT 407
L DN + P +A+L LI+ +L NQI + +AN NL + + +T
Sbjct: 178 LKADDNKISDISP--LASL-PNLIEVHLKNNQI--SDVSPLANTSNLFIVTLTNQTITNQ 232
Query: 408 IPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGN 462
NL + N ++G + + T+ ++ + NL N+ + N
Sbjct: 233 PV---FYNNNLVVP----NVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINN 280
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 60/228 (26%), Positives = 91/228 (39%), Gaps = 19/228 (8%)
Query: 368 TALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANF 427
I GK+ + T A+L + +L +T TI + L NL L L N
Sbjct: 19 ANAIKIAAGKSNV--TDTVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ 74
Query: 428 LQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEI 487
+ T + L NLT +T L N L+ N+ ++ +++ ++T P L
Sbjct: 75 I--TDLAPLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGL-- 128
Query: 488 TTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGN 547
+ L L L N + PL L +L L I Q S P L + L ++ N
Sbjct: 129 SNLQ-VLYLDLNQITNISPLA--GLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDN 183
Query: 548 SFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYN 595
S I L+SL ++ E+ L N S P L N S L + L+
Sbjct: 184 KIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQ 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 49/255 (19%), Positives = 91/255 (35%), Gaps = 24/255 (9%)
Query: 339 LTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLR 398
+ + + A+L + + + T G+ L NL L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADL-DGITTLSAFGTGV--TTIEGVQYLNNLIGLE 69
Query: 399 MEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPF 458
++ N++T P + L + L L N L S++ L + L + + P
Sbjct: 70 LKDNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTPL 125
Query: 459 SLGNCKNLMFFFAPRNKLTGALPQQILEITTLS--LSLDLSDNLLNGSLPLGVGNLKSLV 516
+ NL + N++T I + L+ L + + ++ PL NL L
Sbjct: 126 A--GLSNLQVLYLDLNQIT-----NISPLAGLTNLQYLSIGNAQVSDLTPL--ANLSKLT 176
Query: 517 RLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQ 576
L N+ S P L + +L V L+ N S P L++ +++ + L+ + Q
Sbjct: 177 TLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232
Query: 577 IPKYLENLSFLQYLN 591
Y NL +
Sbjct: 233 PVFYNNNLVVPNVVK 247
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 45/212 (21%), Positives = 75/212 (35%), Gaps = 21/212 (9%)
Query: 387 GIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLS 446
L N + + +T T+ +L + L + T + L L L
Sbjct: 14 PDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLE 69
Query: 447 FGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLS--LSLDLSDNLLNGS 504
N + ++ L N + N L + I L +LDL+ +
Sbjct: 70 LKDNQIT-DLA-PLKNLTKITELELSGNPLK-----NVSAIAGLQSIKTLDLTSTQITDV 122
Query: 505 LPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIK 564
PL L +L L + NQ + P L T+L+Y+ + S P L++L+ +
Sbjct: 123 TPLA--GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLT 176
Query: 565 ELDLSQNNFSGQIPKYLENLSFLQYLNLSYNH 596
L N S I L +L L ++L N
Sbjct: 177 TLKADDNKIS-DIS-PLASLPNLIEVHLKNNQ 206
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 49/242 (20%), Positives = 92/242 (38%), Gaps = 19/242 (7%)
Query: 70 QRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNS 129
+T L + I V L+ L + + DN ++ + NL ++ L L+ N
Sbjct: 41 DGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNP 96
Query: 130 FSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIG 189
+ ++ + T + P L NLQ L + NQ+T + +
Sbjct: 97 LK--NVSAIAGLQSIKTLDLTSTQITDVTPLA----GLSNLQVLYLDLNQIT-NISP-LA 148
Query: 190 NLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYG 249
L+ L+ + I ++ + L+ L+ L L DN S I P + ++ +L+E++L
Sbjct: 149 GLTNLQYLSIGNAQV-SDLT-PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKN 204
Query: 250 NRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINF 309
N+ + P+ N NL + T +N V+ +I+
Sbjct: 205 NQISDVSPLA---NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISD 261
Query: 310 NG 311
NG
Sbjct: 262 NG 263
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 23/121 (19%), Positives = 44/121 (36%), Gaps = 13/121 (10%)
Query: 481 PQQILEITTLS-----LSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGA 535
P I I + + + + ++ +L + L + I +
Sbjct: 6 PTAINVIFPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQY 61
Query: 536 CTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYN 595
+L +EL+ N + P L +LT I EL+LS N + L ++ L+L+
Sbjct: 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTST 117
Query: 596 H 596
Sbjct: 118 Q 118
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 44/187 (23%), Positives = 79/187 (42%), Gaps = 27/187 (14%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEAL-RSIRHRNLIKIVTI 766
+G G G V + G A+K++ S E + ++ +++ I+ +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY---D--SPKARQEVDHHWQASGGPHIVCILDV 90
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
++ ++ E M+ G L + +R DQ + + I+ D+ +A+++LH
Sbjct: 91 YENMHHGKRCL-LIIMECMEGGELFSRIQERGDQ----AFTEREAAEIMRDIGTAIQFLH 145
Query: 827 HHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
H I H D+KP N+L + D V ++DFG AK + + L T
Sbjct: 146 SHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----------YT 192
Query: 884 IGYVAPE 890
YVAPE
Sbjct: 193 PYYVAPE 199
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 56/238 (23%), Positives = 100/238 (42%), Gaps = 57/238 (23%)
Query: 707 NTIGRGSFGFVYKGVL-----HENGMLVAVKVINLEQKGGS-----KSFAAECEALRSI- 755
T+G G+FG V + + + VAVK++ K + ++ +E + + +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML----KSTAHADEKEALMSELKIMSHLG 107
Query: 756 RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQL--------GICNLS 807
+H N++ ++ C+ G ++ EY G L +L ++ L S
Sbjct: 108 QHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 808 LIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP 866
L+ VA + +L +C +H D+ NVLL + VA + DFGLA+
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLAR------ 212
Query: 867 LGNVVETPSSSIGVKG--TIGYVAPEYGLGGEASMRGGVY-------SYGILLLEIFT 915
+++ + + + ++APE S+ VY SYGILL EIF+
Sbjct: 213 --DIMNDSNYIVKGNARLPVKWMAPE-------SIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 57/248 (22%), Positives = 92/248 (37%), Gaps = 29/248 (11%)
Query: 677 KSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINL 736
++ M + + + +G G++G V + A+K+I
Sbjct: 13 NLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRK 72
Query: 737 EQKGGSK--SFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWL 794
S E L+ + H N++K+ D + LV E + G L + +
Sbjct: 73 TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE--DKRNY---YLVMECYKGGELFDEI 127
Query: 795 HQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL---DHDMVA 851
R + + I+ V S V YLH H IVH DLKP N+LL + D +
Sbjct: 128 IHRM------KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALI 178
Query: 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLL 911
+ DFGL+ E GT Y+APE L + + V+S G++L
Sbjct: 179 KIVDFGLSAV---------FENQKKMKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILF 228
Query: 912 EIFTRRRP 919
+ P
Sbjct: 229 ILLAGYPP 236
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-22
Identities = 59/244 (24%), Positives = 94/244 (38%), Gaps = 65/244 (26%)
Query: 707 NTIGRGSFGFVYKGVLH-------ENGMLVAVKVINLEQKGGSKS----FAAECEALRSI 755
+G G+FG V VAVK++ ++ +E E ++ I
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMI 131
Query: 756 -RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQR----------DDQLGIC 804
+H+N+I ++ C+ + ++ EY G+L E+L R
Sbjct: 132 GKHKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 805 NLSLIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863
LS ++ VA +EYL C +H DL NVL+ D V ++DFGLA+ +
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 864 ASPLGNVVETPSSSIGVKGTIGYV-----APEYGLGGEASMRGGVY-------SYGILLL 911
K T G + APE ++ +Y S+G+LL
Sbjct: 243 -----------HIDYYKKTTNGRLPVKWMAPE-------ALFDRIYTHQSDVWSFGVLLW 284
Query: 912 EIFT 915
EIFT
Sbjct: 285 EIFT 288
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 57/219 (26%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 678 SSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN-- 735
S + M + ++ + +G+GSFG V G AVKVI+
Sbjct: 3 GSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62
Query: 736 -LEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWL 794
++QK +S E + L+ + H N++K+ F+ + LV E G L + +
Sbjct: 63 QVKQKTDKESLLREVQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEI 117
Query: 795 HQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL---DHDMVA 851
R S + I+ V S + Y+H + IVH DLKP N+LL D
Sbjct: 118 ISRK------RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANI 168
Query: 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE 890
+ DFGL+ E GT Y+APE
Sbjct: 169 RIIDFGLSTH---------FEASKKMKDKIGTAYYIAPE 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-22
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 35/206 (16%)
Query: 694 KELSKATNEFSS----SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAEC 749
++L + + +F+ IG GS+ + + M AVK+I+ ++ ++ E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EI 66
Query: 750 EAL-RSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSL 808
E L R +H N+I + + + + +V E M+ G L + + ++ S
Sbjct: 67 EILLRYGQHPNIITLKDV-----YDDGKYVYVVTELMKGGELLDKILRQK------FFSE 115
Query: 809 IQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLAKFLSA 864
+ ++ + VEYLH +VH DLKPSN+L + + DFG AK L A
Sbjct: 116 REASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 865 SPLGNVVETPSSSIGVKGTIGYVAPE 890
++ TP T +VAPE
Sbjct: 173 E--NGLLMTPC------YTANFVAPE 190
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 6e-22
Identities = 58/262 (22%), Positives = 94/262 (35%), Gaps = 77/262 (29%)
Query: 709 IGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGS-----KSFAAECEALRSIRHR 758
+G G FG V K VAVK++ K + + +E L+ + H
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKML----KENASPSELRDLLSEFNVLKQVNHP 86
Query: 759 NLIKIVTICSSID--FKGVDFKALVYEYMQNGSLEEWLHQR------------------D 798
++IK+ CS L+ EY + GSL +L +
Sbjct: 87 HVIKLYGACSQDGPLL-------LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 799 DQLGICNLSLIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857
D L++ ++ ++ ++YL VH DL N+L+ +SDFG
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFG 195
Query: 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYV-----APEYGLGGEASMRGGVY-------S 905
L++ +V E VK + G + A E S+ +Y S
Sbjct: 196 LSR--------DVYEE---DSYVKRSQGRIPVKWMAIE-------SLFDHIYTTQSDVWS 237
Query: 906 YGILLLEIFTR-RRPTESMFNE 926
+G+LL EI T P + E
Sbjct: 238 FGVLLWEIVTLGGNPYPGIPPE 259
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 6e-22
Identities = 56/246 (22%), Positives = 98/246 (39%), Gaps = 53/246 (21%)
Query: 709 IGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSKS----FAAECEALRSIRHRN 759
+G FG VYKG L E VA+K + F E ++H N
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARLQHPN 73
Query: 760 LIKIVTICSSID--FKGVDFKALVYEYMQNGSLEEWLHQR----------DDQLGICNLS 807
++ ++ + + +++ Y +G L E+L R DD+ L
Sbjct: 74 VVCLLGVVTKDQPLS-------MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 808 LIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP 866
+++V +A+ +EYL HH VH DL NVL+ + +SD GL + +
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVY--- 179
Query: 867 LGNVVETPSSSIGVKGTIGYV-----APEYGLGGEASMRGGVYSYGILLLEIFTR-RRPT 920
++ + APE + G+ S+ ++SYG++L E+F+ +P
Sbjct: 180 --------AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231
Query: 921 ESMFNE 926
N+
Sbjct: 232 CGYSNQ 237
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 7e-22
Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 36/218 (16%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA-----ECEALRSIRHRNLIK 762
IG+G F V + + E G AVK++++ + S + E ++H ++++
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
++ SS +V+E+M L + +R D S + + + A+
Sbjct: 91 LLETYSS-----DGMLYMVFEFMDGADLCFEIVKRADAGF--VYSEAVASHYMRQILEAL 143
Query: 823 EYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
Y H + I+H D+KP VLL ++ + FG+A L E+ + G
Sbjct: 144 RYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--------ESGLVAGG 192
Query: 880 VKGTIGYVAPE------YGLGGEASMRG-GVYSYGILL 910
GT ++APE YG + G GV + ILL
Sbjct: 193 RVGTPHFMAPEVVKREPYGK--PVDVWGCGVILF-ILL 227
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 9e-22
Identities = 51/218 (23%), Positives = 87/218 (39%), Gaps = 44/218 (20%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIVT 765
+G+G+F V + V G+ A K+IN ++ + E R ++H N++++
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ F LV++ + G L E + R+ S + + + ++ Y
Sbjct: 73 S-----IQEESFHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYC 121
Query: 826 HHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLSA-SPLGNVVETPSSSIGVK 881
H + IVH +LKP N+LL ++DFGLA ++
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---------- 168
Query: 882 GTIGYVAPE------YGLGGEA---SMRGGVYSYGILL 910
GT GY++PE Y + GV Y ILL
Sbjct: 169 GTPGYLSPEVLKKDPYSK--PVDIWAC--GVILY-ILL 201
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 1e-21
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 40/228 (17%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS-KSFAAECEALRSIRHRN 759
++F + +G G+ G V+K +G+++A K+I+LE K E + L
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 760 LIKIVTICSSIDFKGVDFKA----LVYEYMQNGSLEEWLHQRD----DQLGICNLSLIQR 811
++ F G + + E+M GSL++ L + LG
Sbjct: 93 IVG---------FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-------- 135
Query: 812 LNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVV 871
+ I V + YL + I+H D+KPSN+L++ + DFG++ L S + V
Sbjct: 136 --VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 191
Query: 872 ETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
GT Y++PE G S++ ++S G+ L+E+ R P
Sbjct: 192 ----------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 57/238 (23%), Positives = 93/238 (39%), Gaps = 53/238 (22%)
Query: 707 NTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSKS-FAAECEALRSI-RHRN 759
T+G G+FG V + + + M VAVK++ + +E + L + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 760 LIKIVTICSSID--FKGVDFKALVYEYMQNGSLEEWL------------HQRDDQLGICN 805
++ ++ C+ ++ EY G L +L +
Sbjct: 89 IVNLLGACTIGGPTL-------VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 806 LSLIQRLNIVIDVASAVEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSA 864
L L L+ VA + +L +C +H DL N+LL H + + DFGLA+ +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 865 SPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVY-------SYGILLLEIFT 915
N V ++ + VK APE S+ VY SYGI L E+F+
Sbjct: 198 D--SNYVVKGNARLPVKWM----APE-------SIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 46/190 (24%), Positives = 75/190 (39%), Gaps = 27/190 (14%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVIN----LEQKGGSKSFAAECEALRSIRHRNLIKI 763
+G GS+G V + + E AVK++ G + E + LR +RH+N+I++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLE---EWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
V + + + +V EY G E +R + Q +
Sbjct: 72 VDV---LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--------FPVCQAHGYFCQLID 120
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
+EYLH IVH D+KP N+LL +S G+A+ L + T
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ----- 172
Query: 881 KGTIGYVAPE 890
G+ + PE
Sbjct: 173 -GSPAFQPPE 181
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 63/238 (26%), Positives = 96/238 (40%), Gaps = 44/238 (18%)
Query: 690 MVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA-- 747
M ++K+ K + + +G G F V K G+ A K I Q S+
Sbjct: 2 METFKQ-QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCRE 60
Query: 748 ----ECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGI 803
E LR + H N+I + + ++ L+ E + G L ++L Q++
Sbjct: 61 EIEREVSILRQVLHPNIITLHDV-----YENRTDVVLILELVSGGELFDFLAQKE----- 110
Query: 804 CNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLA 859
+LS + + + + V YLH I H DLKP N++L + DFGLA
Sbjct: 111 -SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
Query: 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPE------YGLGGEASM-RGGVYSYGILL 910
+ G + + GT +VAPE GL EA M GV +Y ILL
Sbjct: 167 HEIED---GVEFKN------IFGTPEFVAPEIVNYEPLGL--EADMWSIGVITY-ILL 212
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 48/215 (22%), Positives = 89/215 (41%), Gaps = 39/215 (18%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKI 763
+G+G FG VY ++ ++A+KV+ LE+ G E E +RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLN------IVID 817
F L+ EY G++ L + + + + +
Sbjct: 75 YGY-----FHDATRVYLILEYAPLGTVYRELQKL------------SKFDEQRTATYITE 117
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
+A+A+ Y H ++H D+KP N+LL ++DFG + +S ++
Sbjct: 118 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------ 168
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLE 912
GT+ Y+ PE G + ++S G+L E
Sbjct: 169 ----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 199
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-21
Identities = 53/256 (20%), Positives = 95/256 (37%), Gaps = 40/256 (15%)
Query: 669 ARRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSS----SNTIGRGSFGFVYKGVLHE 724
R + S+ + + + + + + +G G+FG V++
Sbjct: 121 IVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA 180
Query: 725 NGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEY 784
G A K + + ++ E + + +RH L+ + F+ + ++YE+
Sbjct: 181 TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEF 235
Query: 785 MQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVL 844
M G L E + ++ +S + + + V + ++H + VH DLKP N++
Sbjct: 236 MSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIM 287
Query: 845 LDHDMVAHV--SDFGLAKFLSASPLGNVVETPSSSIGVK-GTIGYVAPE------YGLGG 895
+ DFGL L P S+ V GT + APE G
Sbjct: 288 FTTKRSNELKLIDFGLTAHLD----------PKQSVKVTTGTAEFAAPEVAEGKPVGY-- 335
Query: 896 EASM-RGGVYSYGILL 910
M GV SY ILL
Sbjct: 336 YTDMWSVGVLSY-ILL 350
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-21
Identities = 56/237 (23%), Positives = 86/237 (36%), Gaps = 39/237 (16%)
Query: 670 RRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLV 729
S ++ + M K+ K + +G G++G V
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64
Query: 730 AVKVIN-------------LEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776
A+KVI + + E L+S+ H N+IK+ + D K
Sbjct: 65 AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE--DKKYF- 121
Query: 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHG 836
LV E+ + G L E + R NI+ + S + YLH H IVH
Sbjct: 122 --YLVTEFYEGGELFEQIINRH------KFDECDAANIMKQILSGICYLHKHN---IVHR 170
Query: 837 DLKPSNVLL---DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE 890
D+KP N+LL + + + DFGL+ F S + GT Y+APE
Sbjct: 171 DIKPENILLENKNSLLNIKIVDFGLSSFFSKD------YKLRDRL---GTAYYIAPE 218
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 57/249 (22%), Positives = 92/249 (36%), Gaps = 70/249 (28%)
Query: 707 NTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSKS----FAAECEALRSIRH 757
IG G+FG V++ E +VAVK++ + S F E + +
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDN 109
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICN------------ 805
N++K++ +C+ G L++EYM G L E+L
Sbjct: 110 PNIVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 806 ------LSLIQRLNIVIDVASAVEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858
LS ++L I VA+ + YL VH DL N L+ +MV ++DFGL
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGL 220
Query: 859 AKFLSASPLGNVVETPSSSIGVKGTIGYV-----APEYGLGGEASMRGGVY-------SY 906
++ S+ + PE S+ Y +Y
Sbjct: 221 SR-----------NIYSADYYKADGNDAIPIRWMPPE-------SIFYNRYTTESDVWAY 262
Query: 907 GILLLEIFT 915
G++L EIF+
Sbjct: 263 GVVLWEIFS 271
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-21
Identities = 47/220 (21%), Positives = 87/220 (39%), Gaps = 30/220 (13%)
Query: 677 KSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINL 736
S Q + +K ++ + +G+G+F V + V G+ A K+IN
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 737 EQKGGS--KSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWL 794
++ + E R ++H N++++ + F LV++ + G L E +
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDI 119
Query: 795 HQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL---DHDMVA 851
R+ S + + + ++ Y H + IVH +LKP N+LL
Sbjct: 120 VARE------FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAV 170
Query: 852 HVSDFGLAKFLSA-SPLGNVVETPSSSIGVKGTIGYVAPE 890
++DFGLA ++ GT GY++PE
Sbjct: 171 KLADFGLAIEVNDSEAWHGFA----------GTPGYLSPE 200
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-21
Identities = 54/190 (28%), Positives = 78/190 (41%), Gaps = 30/190 (15%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIV 764
+G+GSFG V K AVKVIN + E E L+ + H N++K+
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
I D +V E G L + + +R S I+ V S + Y
Sbjct: 88 EILE--DSSSF---YIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITY 136
Query: 825 LHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLSAS-PLGNVVETPSSSIGV 880
+H H IVH DLKP N+LL + D + DFGL+ + + + +
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--------- 184
Query: 881 KGTIGYVAPE 890
GT Y+APE
Sbjct: 185 -GTAYYIAPE 193
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 46/192 (23%), Positives = 72/192 (37%), Gaps = 37/192 (19%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNLIKIVTI 766
T+G G++G V V VAVK++++++ E + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA------- 819
+ + L EY G L + + + A
Sbjct: 74 RRE---GNIQY--LFLEYCSGGELFDRIEPD------------IGMPE--PDAQRFFHQL 114
Query: 820 -SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
+ V YLH I H D+KP N+LLD +SDFGLA + ++
Sbjct: 115 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--- 168
Query: 879 GVKGTIGYVAPE 890
GT+ YVAPE
Sbjct: 169 ---GTLPYVAPE 177
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 49/214 (22%), Positives = 87/214 (40%), Gaps = 39/214 (18%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIV 764
+G+G FG VY +N ++A+KV+ LE++G E E +RH N++++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLN------IVIDV 818
F L+ E+ G L + L + R + + ++
Sbjct: 81 NY-----FHDRKRIYLMLEFAPRGELYKELQKH------------GRFDEQRSATFMEEL 123
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
A A+ Y H ++H D+KP N+L+ + ++DFG S T
Sbjct: 124 ADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRT----- 171
Query: 879 GVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLE 912
+ GT+ Y+ PE G + ++ G+L E
Sbjct: 172 -MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYE 204
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 7e-21
Identities = 61/247 (24%), Positives = 112/247 (45%), Gaps = 34/247 (13%)
Query: 684 MEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGS 742
M +Q+ V + +++ IG+G+FG V+K + G VA+K + +E K G
Sbjct: 1 MAKQYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 59
Query: 743 KSFAA-ECEALRSIRHRNLIKIVTICSSIDFKGVDFKA---LVYEYMQNGSLEEWLHQRD 798
A E + L+ ++H N++ ++ IC + K LV+++ ++ L L
Sbjct: 60 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL 118
Query: 799 DQLGICNL-SLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857
+ + + ++Q L + + Y+H + I+H D+K +NVL+ D V ++DFG
Sbjct: 119 VKFTLSEIKRVMQMLL------NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169
Query: 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGI-------LL 910
LA+ S + N ++ V T+ Y PE LG Y I ++
Sbjct: 170 LARAFSLAK--NSQPNRYTNRVV--TLWYRPPELLLGERD------YGPPIDLWGAGCIM 219
Query: 911 LEIFTRR 917
E++TR
Sbjct: 220 AEMWTRS 226
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-21
Identities = 50/191 (26%), Positives = 81/191 (42%), Gaps = 29/191 (15%)
Query: 704 SSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIK 762
+G GSF K V ++ AVK+I+ K + E AL+ H N++K
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVK 70
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
+ + F LV E + G L E + ++ + S + I+ + SAV
Sbjct: 71 LHEV-----FHDQLHTFLVMELLNGGELFERIKKKK------HFSETEASYIMRKLVSAV 119
Query: 823 EYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
++H +VH DLKP N+L + ++ + DFG A+ P ++TP
Sbjct: 120 SHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK--PPDNQPLKTPC---- 170
Query: 880 VKGTIGYVAPE 890
T+ Y APE
Sbjct: 171 --FTLHYAAPE 179
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 8e-21
Identities = 51/196 (26%), Positives = 69/196 (35%), Gaps = 48/196 (24%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTIC 767
IG G+FG LVAVK I E RS+RH N+++ +
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVI 85
Query: 768 SS---IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA----- 819
+ + A++ EY G L E + R + D A
Sbjct: 86 LTPTHL--------AIIMEYASGGELYERICNA------------GRFS--EDEARFFFQ 123
Query: 820 ---SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH--VSDFGLAKFLSASPLGNVVETP 874
S V Y H I H DLK N LLD + DFG +K S L + ++
Sbjct: 124 QLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKST 177
Query: 875 SSSIGVKGTIGYVAPE 890
GT Y+APE
Sbjct: 178 V------GTPAYIAPE 187
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-21
Identities = 46/192 (23%), Positives = 72/192 (37%), Gaps = 37/192 (19%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNLIKIVTI 766
T+G G++G V V VAVK++++++ E + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA------- 819
+ + L EY G L + + + A
Sbjct: 74 RRE---GNIQY--LFLEYCSGGELFDRIEPD------------IGMPE--PDAQRFFHQL 114
Query: 820 -SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
+ V YLH I H D+KP N+LLD +SDFGLA + ++
Sbjct: 115 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--- 168
Query: 879 GVKGTIGYVAPE 890
GT+ YVAPE
Sbjct: 169 ---GTLPYVAPE 177
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 9e-21
Identities = 59/252 (23%), Positives = 97/252 (38%), Gaps = 76/252 (30%)
Query: 707 NTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGS-----KSFAAECEALRSI- 755
+G G+FG V + + VAVK++ K + ++ +E + + +
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKML----KEKADSSEREALMSELKMMTQLG 106
Query: 756 RHRNLIKIVTICSSID--FKGVDFKALVYEYMQNGSLEEWLHQR---------------- 797
H N++ ++ C+ + L++EY G L +L +
Sbjct: 107 SHENIVNLLGACTLSGPIY-------LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 798 -DDQLGICNLSLIQRLNIVIDVASAVEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855
+++ + L+ L VA +E+L C VH DL NVL+ H V + D
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICD 215
Query: 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYV-----APEYGLGGEASMRGGVY------ 904
FGLA+ + S S V + APE S+ G+Y
Sbjct: 216 FGLARDIM-----------SDSNYVVRGNARLPVKWMAPE-------SLFEGIYTIKSDV 257
Query: 905 -SYGILLLEIFT 915
SYGILL EIF+
Sbjct: 258 WSYGILLWEIFS 269
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 43/212 (20%), Positives = 82/212 (38%), Gaps = 35/212 (16%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTIC 767
+GRG FG V++ V + K + + + E L RHRN++ +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHES- 69
Query: 768 SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH 827
F+ ++ +++E++ + E ++ L+ + ++ V V A+++LH
Sbjct: 70 ----FESMEELVMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHS 120
Query: 828 HCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H I H D++P N++ + + +FG A+ L G+ +
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRL------LFTAPE 168
Query: 886 YVAPE------YGLGGEASM-RGGVYSYGILL 910
Y APE M G Y +LL
Sbjct: 169 YYAPEVHQHDVVST--ATDMWSLGTLVY-VLL 197
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 63/220 (28%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA------ECEALRSIRHRNLI 761
+G G F V K G A K I + S+ + E LR IRH N+I
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
+ I F+ L+ E + G L ++L +++ +L+ + + +
Sbjct: 72 TLHDI-----FENKTDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDG 120
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH----VSDFGLAKFLSASPLGNVVETPSSS 877
V YLH I H DLKP N++L V + + DFG+A + A GN +
Sbjct: 121 VHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA---GNEFKN---- 170
Query: 878 IGVKGTIGYVAPE------YGLGGEASM-RGGVYSYGILL 910
+ GT +VAPE GL EA M GV +Y ILL
Sbjct: 171 --IFGTPEFVAPEIVNYEPLGL--EADMWSIGVITY-ILL 205
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 54/192 (28%), Positives = 76/192 (39%), Gaps = 32/192 (16%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA--------ECEALRSIRHRN 759
+G G+FGFV+ V E V VK I E+ E L + H N
Sbjct: 31 PLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGS-LEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
+IK++ I F+ F LV E +G L ++ + L I +
Sbjct: 91 IIKVLDI-----FENQGFFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQL 139
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
SAV YL I+H D+K N+++ D + DFG A +L G + T
Sbjct: 140 VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER---GKLFYT----- 188
Query: 879 GVKGTIGYVAPE 890
GTI Y APE
Sbjct: 189 -FCGTIEYCAPE 199
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 63/239 (26%), Positives = 95/239 (39%), Gaps = 46/239 (19%)
Query: 690 MVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA-- 747
M +K+ K + + +G G F V K G+ A K I Q S+ +
Sbjct: 2 MEPFKQ-QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 748 ----ECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGI 803
E LR + H N+I + + ++ L+ E + G L ++L Q++
Sbjct: 61 EIEREVSILRQVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFLAQKE----- 110
Query: 804 CNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLA 859
+LS + + + + V YLH I H DLKP N++L + DFGLA
Sbjct: 111 -SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
Query: 860 KFLS-ASPLGNVVETPSSSIGVKGTIGYVAPE------YGLGGEASM-RGGVYSYGILL 910
+ N+ TP +VAPE GL EA M GV +Y ILL
Sbjct: 167 HEIEDGVEFKNIFGTP----------EFVAPEIVNYEPLGL--EADMWSIGVITY-ILL 212
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-20
Identities = 56/234 (23%), Positives = 101/234 (43%), Gaps = 45/234 (19%)
Query: 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA-ECEALRSIRH 757
++++F +G G++ VYKG+ G+ VA+K + L+ + G+ S A E ++ ++H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 758 RN---LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNI 814
N L ++ + + LV+E+M N L++++ R L L
Sbjct: 63 ENIVRLYDVIHTENKL--------TLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYF 113
Query: 815 VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLG----NV 870
+ + + H + I+H DLKP N+L++ + DFGLA+ P+ V
Sbjct: 114 QWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEV 169
Query: 871 VETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGI-------LLLEIFTRR 917
V T+ Y AP+ +G YS I +L E+ T +
Sbjct: 170 V-----------TLWYRAPDVLMGSRT------YSTSIDIWSCGCILAEMITGK 206
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 58/216 (26%), Positives = 87/216 (40%), Gaps = 11/216 (5%)
Query: 240 SSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAEN 299
++ I+L+GNR + +P + NL +++N +F+ + LE L L++N
Sbjct: 32 AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 300 QFRGQVSIN-FNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGV 358
V F+GL L L L L L LQYLYL DN +
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGP------GLFRGLAALQYLYLQDNALQAL 144
Query: 359 LPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGELKN 417
+ +L L L N+I ++P L +L+ L + NR+ PH +L
Sbjct: 145 PDDTFRDL-GNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 418 LQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453
L L+L AN L +L L L YL N
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 52/220 (23%), Positives = 76/220 (34%), Gaps = 23/220 (10%)
Query: 244 EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRG 303
++P+ I + ++ N + SF NL +L L N
Sbjct: 15 TTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA- 69
Query: 304 QVSIN---FNGLKDLSMLGLATNFLGNGAANDLDFV--DLLTNCTKLQYLYLADNGFGGV 358
I+ F GL L L L+ N L V +L L+L G +
Sbjct: 70 --RIDAAAFTGLALLEQLDLSDN-------AQLRSVDPATFHGLGRLHTLHLDRCGLQEL 120
Query: 359 LPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGELKN 417
P L AL L N + +P +L NL L + NR++ L +
Sbjct: 121 GPGLFRGL-AALQYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178
Query: 418 LQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIP 457
L L LH N + P + +L L L ANNL +P
Sbjct: 179 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALP 217
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 48/226 (21%), Positives = 83/226 (36%), Gaps = 23/226 (10%)
Query: 208 IPITLSQLTSLAYLHVGDNHFSGTIPPSV-YNISSLVEIYLYGNRFTGSLPIEIGKNLPN 266
+P+ + + + + N S +P + +L ++L+ N + L
Sbjct: 26 VPVGIP--AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81
Query: 267 LRNFVIYTNNFTGSLP-DSFSNASNLEVLHLAENQFRGQVSIN---FNGLKDLSMLGLAT 322
L + N S+ +F L LHL + + F GL L L L
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ---ELGPGLFRGLAALQYLYLQD 138
Query: 323 NFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYG 382
N L D + L +L+L N V + L +L L +N++
Sbjct: 139 NALQALPD------DTFRDLGNLTHLFLHGNRISSVPERAFRGL-HSLDRLLLHQNRV-A 190
Query: 383 TIPPGI-ANLVNLNSLRMEANRLTGTIPH-VIGELKNLQLLHLHAN 426
+ P +L L +L + AN L+ +P + L+ LQ L L+ N
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 47/213 (22%), Positives = 79/213 (37%), Gaps = 13/213 (6%)
Query: 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNH 227
Q + + N+++ AS L ++ + +N L +I + L L L + DN
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNA 91
Query: 228 FSGTIPPSV-YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPD-SF 285
++ P+ + + L ++L L + + L L+ + N +LPD +F
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTF 149
Query: 286 SNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKL 345
+ NL L L N+ F GL L L L N + + + + +L
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH------AFRDLGRL 203
Query: 346 QYLYLADNGFGGVLPHSIANLSTALIDFNLGKN 378
LYL N LP AL L N
Sbjct: 204 MTLYLFANNL-SALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 52/237 (21%), Positives = 78/237 (32%), Gaps = 37/237 (15%)
Query: 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEA 401
Q ++L N V S L L N + I L L L +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRAC-RNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSD 89
Query: 402 NRLTGTIP-HVIGELKNLQLLHLHANFLQGTIPS-SLGNLTLLTYLSFGANNLQGNIPF- 458
N ++ L L LHL LQ + L L YL N LQ +P
Sbjct: 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDD 147
Query: 459 SLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVR 517
+ + NL L L N ++ S+P L SL R
Sbjct: 148 TFRDLGNLTH-------------------------LFLHGNRIS-SVPERAFRGLHSLDR 181
Query: 518 LGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQS-LSSLTSIKELDLSQNNF 573
L + +N+ + P L + L N+ S +P L+ L +++ L L+ N +
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 47/215 (21%), Positives = 74/215 (34%), Gaps = 30/215 (13%)
Query: 383 TIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLL 442
+P GI + + NR++ +NL +L LH+N L ++ L LL
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 443 TYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLN 502
L N ++ + F +L +L L L
Sbjct: 83 EQLDLSDNAQLRSVDPAT---------FHGLGRLH---------------TLHLDRCGLQ 118
Query: 503 GSLPLGV-GNLKSLVRLGIARNQFSGQIPV-TLGACTSLEYVELQGNSFSGTIPQSLSSL 560
L G+ L +L L + N +P T +L ++ L GN S ++ L
Sbjct: 119 -ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176
Query: 561 TSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYN 595
S+ L L QN + P +L L L L N
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 45/207 (21%), Positives = 79/207 (38%), Gaps = 8/207 (3%)
Query: 120 LETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQ 179
+ + L N S + C L H N L I + L L+ L + DN
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFT-GLALLEQLDLSDNA 91
Query: 180 LTGQLPASI-GNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNHFSGTIPPSV- 236
+ + L L + + L ++ L +L YL++ DN +P
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQ-ALPDDTF 149
Query: 237 YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHL 296
++ +L ++L+GNR + S+P + L +L +++ N P +F + L L+L
Sbjct: 150 RDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 297 AENQFRGQVSINFNGLKDLSMLGLATN 323
N + L+ L L L N
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 43/212 (20%), Positives = 81/212 (38%), Gaps = 12/212 (5%)
Query: 96 LRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTN-LSHCSKLITFSAHRNNL 154
+ I + N L L L +N + RI + + L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92
Query: 155 VGEIPEELISRRLFNLQGLSVGDNQLTGQLPASI-GNLSALRVIDIRTNRLWGKIPI-TL 212
+ + L L L + L +L + L+AL+ + ++ N L +P T
Sbjct: 93 LRSVDPATF-HGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL-QALPDDTF 149
Query: 213 SQLTSLAYLHVGDNHFSGTIPPSV-YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFV 271
L +L +L + N S ++P + SL + L+ NR + ++L L
Sbjct: 150 RDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLY 207
Query: 272 IYTNNFTGSLP-DSFSNASNLEVLHLAENQFR 302
++ NN + +LP ++ + L+ L L +N +
Sbjct: 208 LFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 38/183 (20%), Positives = 69/183 (37%), Gaps = 7/183 (3%)
Query: 71 RVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRI-GNLFRLETLVLANNS 129
+T L L + + I + L+ L ++++DN + L RL TL L
Sbjct: 57 NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116
Query: 130 FSGRIPTN-LSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASI 188
+ + L N L +P++ R L NL L + N+++ +
Sbjct: 117 LQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTF-RDLGNLTHLFLHGNRISSVPERAF 173
Query: 189 GNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVY-NISSLVEIYL 247
L +L + + NR+ P L L L++ N+ S +P + +L + L
Sbjct: 174 RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRL 232
Query: 248 YGN 250
N
Sbjct: 233 NDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 22/98 (22%), Positives = 32/98 (32%), Gaps = 13/98 (13%)
Query: 537 TSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNH 596
+ + + L GN S S + ++ L L N + L+ L+ L+LS N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 597 FEGEVPTKGIFKNKTGFSIVGNGKLCGGLDELHLPSCQ 634
V F G L LHL C
Sbjct: 92 QLRSVDP-ATFHG------------LGRLHTLHLDRCG 116
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 29/187 (15%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIVT 765
TIG+G+F V G VA+K+I+ Q + + E ++ + H N++K+
Sbjct: 22 TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWL--HQRDDQLGICNLSLIQRLNIVIDVASAVE 823
+ I+ + + L+ EY G + ++L H R + + + + SAV+
Sbjct: 82 V---IETEKTLY--LIMEYASGGEVFDYLVAHGR--------MKEKEARSKFRQIVSAVQ 128
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
Y H IVH DLK N+LLD DM ++DFG + + G ++ G
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV---GGKLDAFC------GA 176
Query: 884 IGYVAPE 890
Y APE
Sbjct: 177 PPYAAPE 183
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 49/210 (23%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAA----------------- 747
IG+GS+G V + A+KV++ L ++ G
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 748 ------ECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWL-HQRDDQ 800
E L+ + H N++K+V + +D D +V+E + G + E +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVPTLKP--- 133
Query: 801 LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860
LS Q D+ +EYLH+ I+H D+KPSN+L+ D ++DFG
Sbjct: 134 -----LSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFG--- 182
Query: 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPE 890
+S G+ ++ GT ++APE
Sbjct: 183 -VSNEFKGSDALLSNTV----GTPAFMAPE 207
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 61/234 (26%), Positives = 96/234 (41%), Gaps = 54/234 (23%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA-ECEALRSIRHRN 759
+ + +G G++ VYKG LVA+K I LE + G+ A E L+ ++H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 760 ---LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLS--LIQRLNI 814
L I+ S+ LV+EY+ L+++L + + + N+ L Q L
Sbjct: 62 IVTLHDIIHTEKSL--------TLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL-- 110
Query: 815 VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGN----V 870
+ Y H ++H DLKP N+L++ ++DFGLA+ S P V
Sbjct: 111 -----RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEV 161
Query: 871 VETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGI-------LLLEIFTRR 917
V T+ Y P+ LG YS I + E+ T R
Sbjct: 162 V-----------TLWYRPPDILLGSTD------YSTQIDMWGVGCIFYEMATGR 198
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 64/248 (25%), Positives = 103/248 (41%), Gaps = 39/248 (15%)
Query: 673 RSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVK 732
+A + T+ + + + ++ F + +GRG+ VY+ A+K
Sbjct: 26 VTASAAPGTASLVPDYW-IDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK 84
Query: 733 VINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEE 792
V+ + K E L + H N+IK+ I F+ +LV E + G L +
Sbjct: 85 VLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEI-----FETPTEISLVLELVTGGELFD 137
Query: 793 WLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL---DHDM 849
+ ++ S + V + AV YLH + IVH DLKP N+L D
Sbjct: 138 RIVEKG------YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDA 188
Query: 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE----YGLGGEA---SMRGG 902
++DFGL+K + +++T V GT GY APE G E S+ G
Sbjct: 189 PLKIADFGLSKIVEH---QVLMKT------VCGTPGYCAPEILRGCAYGPEVDMWSV--G 237
Query: 903 VYSYGILL 910
+ +Y ILL
Sbjct: 238 IITY-ILL 244
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-20
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 43/218 (19%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHRNLIKIVT 765
+G+G+F V + V G A +IN ++ + E R ++H N++++
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
S L+++ + G L E + R+ S + + + AV +
Sbjct: 78 SISE-----EGHHYLIFDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHC 126
Query: 826 HHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI-GVK 881
H +VH +LKP N+LL ++DFGLA VE + G
Sbjct: 127 HQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE---------VEGEQQAWFGFA 174
Query: 882 GTIGYVAPE------YGLGGEA---SMRGGVYSYGILL 910
GT GY++PE YG + GV Y ILL
Sbjct: 175 GTPGYLSPEVLRKDPYGK--PVDLWAC--GVILY-ILL 207
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-20
Identities = 53/231 (22%), Positives = 89/231 (38%), Gaps = 33/231 (14%)
Query: 669 ARRRRSAHKSSNTSQMEQQFPMVSYKELSKATNE---FSSSNTIGRGSFGFVYKGVLHEN 725
A A Q QF + S ++ K +S +G G G V +
Sbjct: 27 ALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRT 86
Query: 726 GMLVAVKVINLEQKGGSKSFAAECEA---LRSIRHRNLIKIVTICSSIDFKGVDFKALVY 782
A+K++ A E R+ + ++++IV + + + G +V
Sbjct: 87 QEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVYEN-LYAGRKCLLIVM 138
Query: 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSN 842
E + G L + R DQ + + I+ + A++YLH I H D+KP N
Sbjct: 139 ECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 191
Query: 843 VLL---DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE 890
+L + + ++DFG AK ++ N + TP T YVAPE
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPC------YTPYYVAPE 233
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-20
Identities = 59/220 (26%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA------ECEALRSIRHRNLI 761
+G G F V K G+ A K I + S+ + E L+ I+H N+I
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
+ + ++ L+ E + G L ++L +++ +L+ + + + +
Sbjct: 78 TLHEV-----YENKTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNG 126
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH----VSDFGLAKFLSASPLGNVVETPSSS 877
V YLH I H DLKP N++L V + DFGLA + GN +
Sbjct: 127 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFKN---- 176
Query: 878 IGVKGTIGYVAPE------YGLGGEASM-RGGVYSYGILL 910
+ GT +VAPE GL EA M GV +Y ILL
Sbjct: 177 --IFGTPEFVAPEIVNYEPLGL--EADMWSIGVITY-ILL 211
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 7e-20
Identities = 50/229 (21%), Positives = 93/229 (40%), Gaps = 51/229 (22%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAA-ECEALRSIRHRN---LI 761
IG G++G V+K E +VA+K + L+ G S A E L+ ++H+N L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
++ + LV+E+ L+++ D G + +++ + +
Sbjct: 68 DVLHSDKKL--------TLVFEFCDQ-DLKKYF---DSCNGDLDPEIVKSF--LFQLLKG 113
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLG----NVVETPSSS 877
+ + H ++H DLKP N+L++ + +++FGLA+ P+ VV
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV------ 163
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGI-------LLLEIFTRRRP 919
T+ Y P+ G + YS I + E+ RP
Sbjct: 164 -----TLWYRPPDVLFGAKL------YSTSIDMWSAGCIFAELANAGRP 201
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 59/194 (30%), Positives = 85/194 (43%), Gaps = 42/194 (21%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIV 764
T+G G+FG V G G VAVK++N + E + L+ RH ++IK+
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA----- 819
+ I F +V EY+ G L +++ + R+ A
Sbjct: 78 QV---ISTPTDFF--MVMEYVSGGELFDYICKH------------GRVEE--MEARRLFQ 118
Query: 820 ---SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
SAV+Y H H +VH DLKP NVLLD M A ++DFGL+ +S G + T
Sbjct: 119 QILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---GEFLRTSC- 171
Query: 877 SIGVKGTIGYVAPE 890
G+ Y APE
Sbjct: 172 -----GSPNYAAPE 180
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 52/235 (22%), Positives = 100/235 (42%), Gaps = 33/235 (14%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS-KSFAAECE-ALRSIRHR 758
++ +GRG++G V K +G ++AVK I K + + ++R++
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 759 NLIKIVTICSSIDFKGVDFK----ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNI 814
+ F G F+ + E M + SL+++ Q D+ ++ + I
Sbjct: 67 FTVT---------FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--I 114
Query: 815 VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETP 874
+ + A+E+LH ++H D+KPSNVL++ + DFG++ +L +
Sbjct: 115 AVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD----- 167
Query: 875 SSSIGVKGTIGYVAPE----YGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFN 925
G Y+APE S++ ++S GI ++E+ R P +S
Sbjct: 168 -IDA---GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 9e-20
Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 35/234 (14%)
Query: 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSI 755
S AT+ + IG G++G VYK +G VA+K + + GG +R +
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLP--ISTVREV 62
Query: 756 ---------RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNL 806
H N+++++ +C++ LV+E++ L +L D+ L
Sbjct: 63 ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGL 117
Query: 807 SLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP 866
+++ +++LH +C IVH DLKP N+L+ ++DFGLA+ S
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS-YQ 173
Query: 867 LG---NVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRR 917
+ VV T+ Y APE L + ++S G + E+F R+
Sbjct: 174 MALTPVVV-----------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 50/263 (19%), Positives = 89/263 (33%), Gaps = 48/263 (18%)
Query: 668 YARRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSN-----TIGRGSFGFVYKGVL 722
+ S+ S M + + K E S +G G FG VY G+
Sbjct: 5 HHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIR 64
Query: 723 HENGMLVAVKVINLEQKGGSKSFAA------ECEALRSIRHR--NLIKIVTICSSIDFKG 774
+ + VA+K + ++ E L+ + +I+++ +
Sbjct: 65 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW---FERPD 121
Query: 775 VDFKALVYEYMQN-GSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPI 833
L+ E + L +++ +R L + V AV + H+ +
Sbjct: 122 SFV--LILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNCG---V 170
Query: 834 VHGDLKPSNVLLDHD-MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYG 892
+H D+K N+L+D + + DFG L + GT Y PE+
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFD------GTRVYSPPEWI 220
Query: 893 LGG-----EASMRGGVYSYGILL 910
A+ V+S GILL
Sbjct: 221 RYHRYHGRSAA----VWSLGILL 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 3e-19
Identities = 58/194 (29%), Positives = 85/194 (43%), Gaps = 42/194 (21%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIV 764
T+G G+FG V G G VAVK++N + E + L+ RH ++IK+
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA----- 819
+ I F +V EY+ G L +++ + RL+ +
Sbjct: 83 QV---ISTPSDIF--MVMEYVSGGELFDYICKN------------GRLDE--KESRRLFQ 123
Query: 820 ---SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
S V+Y H H +VH DLKP NVLLD M A ++DFGL+ +S G + T
Sbjct: 124 QILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---GEFLRTSC- 176
Query: 877 SIGVKGTIGYVAPE 890
G+ Y APE
Sbjct: 177 -----GSPNYAAPE 185
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 53/255 (20%), Positives = 98/255 (38%), Gaps = 41/255 (16%)
Query: 672 RRSAHKSSNTSQMEQQFPMVSYKELSKATNE----------FSSSNTIGRGSFGFVYKGV 721
S+ T + Q +V++++ A S IG GS G V
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65
Query: 722 LHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA-- 779
+G VAVK+++L ++ + E +R +H N+++
Sbjct: 66 EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE---------MYKSYLVGEE 116
Query: 780 --LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGD 837
++ E++Q G+L D + L+ Q + V A+ YLH ++H D
Sbjct: 117 LWVLMEFLQGGAL-------TDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRD 166
Query: 838 LKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA 897
+K ++LL D +SDFG + + + GT ++APE
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFC--------AQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 898 SMRGGVYSYGILLLE 912
+ ++S GI+++E
Sbjct: 219 ATEVDIWSLGIMVIE 233
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 47/202 (23%), Positives = 81/202 (40%), Gaps = 23/202 (11%)
Query: 684 MEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSK 743
M + + + S +++ IG G+ V VA+K INLE+ S
Sbjct: 1 MSEDSSALPW---SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM 57
Query: 744 S-FAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA-LVYEYMQNGSLEEWLHQRDDQL 801
E +A+ H N++ S + V + LV + + GS+ + + +
Sbjct: 58 DELLKEIQAMSQCHHPNIVSY--YTSFV----VKDELWLVMKLLSGGSVLDIIKHIVAKG 111
Query: 802 GICNLSL--IQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859
+ L I+ +V +EYLH + Q +H D+K N+LL D ++DFG++
Sbjct: 112 EHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS 168
Query: 860 KFLSASPLGN-------VVETP 874
FL+ V TP
Sbjct: 169 AFLATGGDITRNKVRKTFVGTP 190
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 47/197 (23%), Positives = 86/197 (43%), Gaps = 27/197 (13%)
Query: 670 RRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLV 729
S+ T + Q M Y+ L +G GS+G V K + G +V
Sbjct: 5 HHHHSSGVDLGTENLYFQ-SMEKYENLGL----------VGEGSYGMVMKCRNKDTGRIV 53
Query: 730 AVKVINLEQ-KGGSKSFAA-ECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQN 787
A+K K A E + L+ +RH NL+ ++ +C K + LV+E++ +
Sbjct: 54 AIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK---KKRWY--LVFEFVDH 108
Query: 788 GSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH 847
++ + L + + ++Q + + + + + H H I+H D+KP N+L+
Sbjct: 109 -TILDDL---ELFPNGLDYQVVQ--KYLFQIINGIGFCHSHN---IIHRDIKPENILVSQ 159
Query: 848 DMVAHVSDFGLAKFLSA 864
V + DFG A+ L+A
Sbjct: 160 SGVVKLCDFGFARTLAA 176
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 66/259 (25%), Positives = 109/259 (42%), Gaps = 56/259 (21%)
Query: 672 RRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAV 731
H SS + Q M Y++L K +G G++G VYK G +VA+
Sbjct: 2 HHHHHHSSGRENLYFQGLMEKYQKLEK----------VGEGTYGVVYKA-KDSQGRIVAL 50
Query: 732 KVINLEQ-KGGSKSFAA-ECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGS 789
K I L+ G S A E L+ + H N++ ++ + S + LV+E+M+
Sbjct: 51 KRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS---ERCLT--LVFEFMEK-D 104
Query: 790 LEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM 849
L++ L D+ S I+ + + V + H H I+H DLKP N+L++ D
Sbjct: 105 LKKVL---DENKTGLQDSQIKIY--LYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDG 156
Query: 850 VAHVSDFGLAKFLSASPLG----NVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYS 905
++DFGLA+ P+ VV T+ Y AP+ +G + YS
Sbjct: 157 ALKLADFGLARAFG-IPVRSYTHEVV-----------TLWYRAPDVLMGSKK------YS 198
Query: 906 YGI-------LLLEIFTRR 917
+ + E+ T +
Sbjct: 199 TSVDIWSIGCIFAEMITGK 217
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 9e-19
Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 16/157 (10%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAA-ECEALRSIRHRNLIKIVTI 766
IG GS+G V+K + G +VA+K + K A E L+ ++H NL+ ++ +
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
K LV+EY + ++ L D L++ +I AV + H
Sbjct: 71 FRR---KRRLH--LVFEYCDH-TVLHEL---DRYQRGVPEHLVK--SITWQTLQAVNFCH 119
Query: 827 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863
H +H D+KP N+L+ V + DFG A+ L+
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 45/215 (20%), Positives = 78/215 (36%), Gaps = 37/215 (17%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS--KSFAAECEALRSIRHR-NLIKIVT 765
+GRG F V + + G A K + ++G E L + +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ ++ L+ EY G + + +S + ++ + V YL
Sbjct: 97 V-----YENTSEIILILEYAAGGEIFSLCLPELAE----MVSENDVIRLIKQILEGVYYL 147
Query: 826 HHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
H + IVH DLKP N+LL + DFG+++ + + + G
Sbjct: 148 HQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH---ACELRE------IMG 195
Query: 883 TIGYVAPE------YGLGGEASM-RGGVYSYGILL 910
T Y+APE M G+ +Y +LL
Sbjct: 196 TPEYLAPEILNYDPITT--ATDMWNIGIIAY-MLL 227
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 34/224 (15%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS-KSFAAECE-ALRSIRHR 758
+ IGRG++G V K V +G ++AVK I K + + +RS
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 759 NLIKIVTICSSIDFKGVDFKA----LVYEYMQNGSLEEWLHQ-RDDQLGICNLSLIQRLN 813
+++ F G F+ + E M + S +++ + ++ +
Sbjct: 82 YIVQ---------FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK-- 129
Query: 814 IVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVET 873
I + A+ +L + + I+H D+KPSN+LLD + DFG++ G +V++
Sbjct: 130 ITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGIS--------GQLVDS 179
Query: 874 PSSSIGVKGTIGYVAPE----YGLGGEASMRGGVYSYGILLLEI 913
+ + G Y+APE +R V+S GI L E+
Sbjct: 180 IAKTRDA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 39/167 (23%), Positives = 72/167 (43%), Gaps = 21/167 (12%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIK 762
+ +G G+FG VYK E G L A KVI + + + + E E L + H ++K
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 763 IVTICSSIDFKGVDFKA----LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
G + ++ E+ G+++ + + D L + ++ R +
Sbjct: 81 ---------LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR-----QM 126
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865
A+ +LH I+H DLK NVL+ + ++DFG++ +
Sbjct: 127 LEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 56/333 (16%), Positives = 98/333 (29%), Gaps = 47/333 (14%)
Query: 276 NFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDF 335
NF+ PD S L A+ + G G + L L + A+ F
Sbjct: 16 NFSDPKPDWSSA---FNCLGAADVELYG-------GGRSLEYLLKRVDTE----ADLGQF 61
Query: 336 VDLLTNCTKLQYLYLADNGF-GGVLPHSIANLS-TALIDFNLGKNQIYGTIPPGIANLV- 392
D++ L+ L + +L ++ L + L + L ++ GT PP +
Sbjct: 62 TDII-KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATG 120
Query: 393 -NLNSLRMEANRLTGTIPHV----IGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSF 447
+LN L + + L++L + + L+ L
Sbjct: 121 PDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL 180
Query: 448 GANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPL 507
N G C P + + L+L + +G
Sbjct: 181 SDNPELGERGLISALC-----------------PLKFPTLQVLALR-NAGMETPSGVCSA 222
Query: 508 GVGNLKSLVRLGIARNQFSGQIPVTLGA-CTSLEYVELQGNSFSGTIPQSLSSLTSIKEL 566
L L ++ N + L + L +P+ L + + L
Sbjct: 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVL 279
Query: 567 DLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEG 599
DLS N P + L + L+L N F
Sbjct: 280 DLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 5e-17
Identities = 45/264 (17%), Positives = 81/264 (30%), Gaps = 23/264 (8%)
Query: 365 NLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLH 424
N S D++ N + +L L + +K+L L L
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLG-QFTDIIKSLSLKRLT 74
Query: 425 ANFLQGTIPSSLGNLTL-----LTYLSFGANNLQGNIPFSLGNC--KNLMFFFAPRNKLT 477
+ G L + L L+ + G P L +L
Sbjct: 75 VRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134
Query: 478 GALPQQILEITTLSL----SLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTL 533
+ E+ L ++ V +L L ++ N G+ +
Sbjct: 135 T-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193
Query: 534 GAC----TSLEYVELQGN---SFSGTIPQSLSSLTSIKELDLSQNNFSGQIPK-YLENLS 585
C +L+ + L+ + SG ++ ++ LDLS N+ + S
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253
Query: 586 FLQYLNLSYNHFEGEVPTKGIFKN 609
L LNLS+ + +VP KG+
Sbjct: 254 QLNSLNLSFTGLK-QVP-KGLPAK 275
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 40/244 (16%), Positives = 71/244 (29%), Gaps = 19/244 (7%)
Query: 96 LRYINIADNDFHGEIPD---RIGNLFRLETLVLANNSFSGRIPTNLS--HCSKLITFSAH 150
L+ + + I R+ + L+ L L N +G P L L +
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 151 RNNLVGEIPE--ELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKI 208
+ EL L+ LS+ + AL +D+ N G+
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 209 PITLS----QLTSLAYLHVGDNHF---SGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIG 261
+ + + +L L + + SG L + L N +
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 262 KNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLA 321
L + + +P + L VL L+ N+ S + L + L L
Sbjct: 250 DWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPSP--DELPQVGNLSLK 304
Query: 322 TNFL 325
N
Sbjct: 305 GNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 46/293 (15%), Positives = 86/293 (29%), Gaps = 31/293 (10%)
Query: 253 TGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDS-FSNASNLEVLHLAENQFRGQVS----- 306
G+ +E+ +L + + + + +L+ L + + ++
Sbjct: 31 LGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALR 90
Query: 307 -INFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADN---GFGGVLPHS 362
+ +GL++L++ L G L+ L L L + L
Sbjct: 91 VLGISGLQELTLENL--EVTGTAPPPLLEATGP-----DLNILNLRNVSWATRDAWLAEL 143
Query: 363 IANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTI-------PHVIGEL 415
L L ++ + + L++L + N G P L
Sbjct: 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTL 203
Query: 416 KNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSL-GNCKNLMFFFAPRN 474
+ L L + G + L L N+L+ L
Sbjct: 204 QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT 263
Query: 475 KLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSG 527
L +P+ + LS LDLS N L+ P L + L + N F
Sbjct: 264 GLK-QVPKGLP--AKLS-VLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 49/278 (17%), Positives = 77/278 (27%), Gaps = 44/278 (15%)
Query: 189 GNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPS---VYNISSLVEI 245
G S ++ + + SL L V I V IS L E+
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 246 YLYGNRFTGSLPIEIGKN-----------------------------LPNLRNFVIYTNN 276
L TG+ P + + P L+ I +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 277 FTGSLPDSFSNASNLEVLHLAENQFRGQV----SINFNGLKDLSMLGLATNFLGNGAAND 332
+ L L L++N G+ ++ L +L L +
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM---ETPS 217
Query: 333 LDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLV 392
L +LQ L L+ N + + L NL + +P G+
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PA 274
Query: 393 NLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQG 430
L+ L + NRL P EL + L L N
Sbjct: 275 KLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 40/223 (17%), Positives = 72/223 (32%), Gaps = 20/223 (8%)
Query: 71 RVTKLDLRNQSIGGILSPYVGNLSF--LRYINIADNDFHGEIPDRIGNLF-----RLETL 123
+ +L L N + G P + + L +N+ + + + L L+ L
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVL 154
Query: 124 VLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIP--EELISRRLFNLQGLSVGDNQLT 181
+A + L T N +GE L + LQ L++ + +
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214
Query: 182 ---GQLPASIGNLSALRVIDIRTNRLWGKIP-ITLSQLTSLAYLHVGDNHFSGTIPPSVY 237
G A L+ +D+ N L + + L L++ +P +
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273
Query: 238 NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGS 280
+ L + L NR P LP + N + N F S
Sbjct: 274 --AKLSVLDLSYNRLD-RNPSPDE--LPQVGNLSLKGNPFLDS 311
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 48/237 (20%), Positives = 89/237 (37%), Gaps = 37/237 (15%)
Query: 694 KELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS-KSFAAECEAL 752
+ N+ + +G G+ G V+K + G ++AVK + K + + +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 753 -RSIRHRNLIKIVTICSSIDFKGVDFKA----LVYEYMQNGSLEEWLHQRDDQLGICNLS 807
+S +++ G + E M E+ + + L
Sbjct: 78 LKSHDCPYIVQ---------CFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILG 127
Query: 808 LIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPL 867
+ + A+ YL ++H D+KPSN+LLD + DFG++
Sbjct: 128 KMTV-----AIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS-------- 172
Query: 868 GNVVETPSSSIGVKGTIGYVAPE-----YGLGGEASMRGGVYSYGILLLEIFTRRRP 919
G +V+ + G Y+APE + +R V+S GI L+E+ T + P
Sbjct: 173 GRLVDDKAKDRSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 20/216 (9%)
Query: 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEA 401
+ L L+ N + +S + L +L + +I TI G +L +L++L +
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSF-PELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTG 85
Query: 402 NRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSL-GNLTLLTYLSFGANNLQGNIPF-- 458
N + L +LQ L L ++ + G+L L L+ N +Q +
Sbjct: 86 NPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPE 143
Query: 459 ---SLGNCKNLMFFFAPRNKLTGALPQQIL----EITTLSLSLDLSDNLLNGSLPLGVGN 511
+L N ++L NK+ ++ L ++ L+LSLDLS N +N + G
Sbjct: 144 YFSNLTNLEHLDLS---SNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198
Query: 512 LKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGN 547
L L + NQ TSL+ + L N
Sbjct: 199 EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 46/225 (20%), Positives = 79/225 (35%), Gaps = 42/225 (18%)
Query: 209 PITLSQLTSLAYLHVGDNHFSGTIPPSVY-NISSLVEIYLYGNRFTGSLPIEIGKNLPNL 267
+ L L + TI Y ++S L + L GN SL + L +L
Sbjct: 45 SYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSL 102
Query: 268 RNFVIYTNNFTGSLPD-SFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLG 326
+ V N SL + + L+ L++A N + S
Sbjct: 103 QKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ---SFKLPEY-------------- 144
Query: 327 NGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSI----ANLSTALIDFNLGKNQIYG 382
F +L T L++L L+ N + + + + +L N +
Sbjct: 145 --------FSNL----TNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPM-N 190
Query: 383 TIPPGIANLVNLNSLRMEANRLTGTIPH-VIGELKNLQLLHLHAN 426
I PG + L L ++ N+L ++P + L +LQ + LH N
Sbjct: 191 FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 44/203 (21%), Positives = 70/203 (34%), Gaps = 42/203 (20%)
Query: 417 NLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIP---FS-LGNCKNLMFFFAP 472
+ + L L N L+ S + L L +Q I + L + L+
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILT--- 84
Query: 473 RNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGIARNQFSGQIPV 531
N + +L + L + L SL G+LK+L L +A N
Sbjct: 85 GNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI------ 136
Query: 532 TLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIP----KYLENLSFL 587
S + +P+ S+LT+++ LDLS N I + L + L
Sbjct: 137 -----QSFK------------LPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLL 178
Query: 588 QY-LNLSYNHFEGEVPTKGIFKN 609
L+LS N + G FK
Sbjct: 179 NLSLDLSLNPMN-FIQP-GAFKE 199
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 35/192 (18%), Positives = 66/192 (34%), Gaps = 15/192 (7%)
Query: 116 NLFRLETLVLANNSFSGRIPTNL-SHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLS 174
+ L+ L L+ I S L T N + + L +LQ L
Sbjct: 50 SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI-QSLALG-AFSGLSSLQKLV 106
Query: 175 VGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPI--TLSQLTSLAYLHVGDNHFSGTI 232
+ L IG+L L+ +++ N + + S LT+L +L + N +I
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLI-QSFKLPEYFSNLTNLEHLDLSSNKIQ-SI 164
Query: 233 PPSVY-NISSL----VEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSN 287
+ + + + + L N + K + L+ + TN F
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI-RLKELALDTNQLKSVPDGIFDR 222
Query: 288 ASNLEVLHLAEN 299
++L+ + L N
Sbjct: 223 LTSLQKIWLHTN 234
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 59/247 (23%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 678 SSNTSQMEQQFPMVSYKELSKATNE------FSSSNTIGRGSFGFVYKGVLHENGMLVAV 731
S T Q+ + P K+L + + F +G GS+G VYK + E G +VA+
Sbjct: 1 SLETVQL-RNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAI 59
Query: 732 KVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA----LVYEYMQN 787
K + +E + E ++ +++K + G FK +V EY
Sbjct: 60 KQVPVESD--LQEIIKEISIMQQCDSPHVVK---------YYGSYFKNTDLWIVMEYCGA 108
Query: 788 GSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH 847
GS+ + + R+ L ++ I + +EYLH +H D+K N+LL+
Sbjct: 109 GSVSDIIRLRNKTLTEDEIATILQ-----STLKGLEYLHFM---RKIHRDIKAGNILLNT 160
Query: 848 DMVAHVSDFGLAKFLSA--SPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYS 905
+ A ++DFG+A L+ + V+ TP ++APE + ++S
Sbjct: 161 EGHAKLADFGVAGQLTDTMAKRNTVIGTPF----------WMAPEVIQEIGYNCVADIWS 210
Query: 906 YGILLLE 912
GI +E
Sbjct: 211 LGITAIE 217
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 46/217 (21%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIK 762
++ IG+G+ G VY + G VA++ +NL+Q+ + E +R ++ N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 763 IVTICSSIDFKGVDFKA----LVYEYMQNGSLEEWLHQR---DDQLGICNLSLIQRLNIV 815
+ +V EY+ GSL + + + + Q+ +
Sbjct: 82 ---------YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA----------VC 122
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
+ A+E+LH + ++H D+K N+LL D ++DFG ++ S
Sbjct: 123 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--------PEQS 171
Query: 876 SSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLE 912
+ GT ++APE + ++S GI+ +E
Sbjct: 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 5e-18
Identities = 50/249 (20%), Positives = 93/249 (37%), Gaps = 26/249 (10%)
Query: 212 LSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFV 271
++ + + + ++S+ +I + I+ LPN+
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ---YLPNVTKLF 71
Query: 272 IYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSI-NFNGLKDLSMLGLATNFLGNGAA 330
+ N T P +N NL L L EN+ + + + LK L L L N + +
Sbjct: 72 LNGNKLTDIKP--LTNLKNLGWLFLDENKIK---DLSSLKDLKKLKSLSLEHNGISD--- 123
Query: 331 NDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIAN 390
++ L + +L+ LYL +N + ++ L T L +L NQI + +A
Sbjct: 124 -----INGLVHLPQLESLYLGNNKITDITV--LSRL-TKLDTLSLEDNQI--SDIVPLAG 173
Query: 391 LVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGAN 450
L L +L + N ++ + LKNL +L L + + NL + +
Sbjct: 174 LTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231
Query: 451 NLQGNIPFS 459
+L S
Sbjct: 232 SLVTPEIIS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 81.3 bits (200), Expect = 6e-16
Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 19/219 (8%)
Query: 378 NQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLG 437
I I P ++ +T + EL ++ + + + ++ ++ +
Sbjct: 9 TPI-KQIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQ 62
Query: 438 NLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLS 497
L +T L N L +I L N KNL + F NK+ + L L SL L
Sbjct: 63 YLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSSLKDL--KKLK-SLSLE 117
Query: 498 DNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSL 557
N ++ + G+ +L L L + N+ + I L T L+ + L+ N S I L
Sbjct: 118 HNGIS-DIN-GLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQIS-DIV-PL 171
Query: 558 SSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNH 596
+ LT ++ L LS+N+ S + L L L L L
Sbjct: 172 AGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQE 208
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 70.5 bits (172), Expect = 2e-12
Identities = 43/239 (17%), Positives = 89/239 (37%), Gaps = 27/239 (11%)
Query: 116 NLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSV 175
L S + + + + + A+ +++ + + + L N+ L +
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQY--LPNVTKLFL 72
Query: 176 GDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPS 235
N+LT P + NL L + + N++ + +L L L L + N S I
Sbjct: 73 NGNKLTDIKP--LTNLKNLGWLFLDENKI-KDLS-SLKDLKKLKSLSLEHNGIS-DING- 126
Query: 236 VYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLH 295
+ ++ L +YL N+ T I + L L + N + + + + L+ L+
Sbjct: 127 LVHLPQLESLYLGNNKITD---ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLY 181
Query: 296 LAENQFRGQVSI-NFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADN 353
L++N + GLK+L +L L + N ++ +N + D
Sbjct: 182 LSKNHIS---DLRALAGLKNLDVLELFSQECLN------KPINHQSNLVVPNTVKNTDG 231
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 42/227 (18%), Positives = 82/227 (36%), Gaps = 12/227 (5%)
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG 132
L L I + + +L L+ +++ N +I + +L +LE+L L NN +
Sbjct: 90 GWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT- 144
Query: 133 RIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLS 192
T LS +KL T S N + +I L LQ L + N ++ L A + L
Sbjct: 145 -DITVLSRLTKLDTLSLEDNQIS-DIVPL---AGLTKLQNLYLSKNHIS-DLRA-LAGLK 197
Query: 193 ALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRF 252
L V+++ + K S L + D S + + F
Sbjct: 198 NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEF 257
Query: 253 TGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAEN 299
T + + + + + T L + ++ + +++ +
Sbjct: 258 TNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTK 304
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 6e-18
Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 45/195 (23%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIV 764
T+G GSFG V ++ VA+K I+ L++ E L+ +RH ++IK+
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 765 TICSSIDFKGVDFKALVYEY---------MQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
+ I +V EY ++ + E +R Q++
Sbjct: 76 DV---ITTPTDIV--MVIEYAGGELFDYIVEKKRMTEDEGRR----------FFQQI--- 117
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
A+EY H H IVH DLKP N+LLD ++ ++DFGL+ ++ GN ++T
Sbjct: 118 ---ICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD---GNFLKTSC 168
Query: 876 SSIGVKGTIGYVAPE 890
G+ Y APE
Sbjct: 169 ------GSPNYAAPE 177
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 30/171 (17%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNLI 761
F+ IG+GSFG V+KG+ + +VA+K+I+LE+ E L +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 762 KIVTICSSIDFKGVDFKA----LVYEYMQNGSLEEWLHQR---DDQLGICNLSLIQRLNI 814
K + G K ++ EY+ GS + L + Q+ I
Sbjct: 84 K---------YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT----------I 124
Query: 815 VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865
+ ++ ++YLH +H D+K +NVLL ++DFG+A L+ +
Sbjct: 125 LREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 7e-18
Identities = 48/255 (18%), Positives = 85/255 (33%), Gaps = 42/255 (16%)
Query: 675 AHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRG--SFGFVYKGVLHENGMLVAVK 732
AH + + M S+ + IG+G V G V V+
Sbjct: 2 AHHHHHHMENLYFQGMSSFLP---EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR 58
Query: 733 VINLEQKGGS--KSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSL 790
INLE E + H N++ + F + +V +M GS
Sbjct: 59 RINLEACSNEMVTFLQGELHVSKLFNHPNIVPY--RAT---FIADNELWVVTSFMAYGSA 113
Query: 791 EEWLHQRDDQLGICNLSLIQRLN------IVIDVASAVEYLHHHCQPPIVHGDLKPSNVL 844
+D + + +N I+ V A++Y+HH VH +K S++L
Sbjct: 114 ------KD----LICTHFMDGMNELAIAYILQGVLKALDYIHHMGY---VHRSVKASHIL 160
Query: 845 LDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE------YGLGGEAS 898
+ D ++S + + V V + +++PE G ++
Sbjct: 161 ISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV-KVLPWLSPEVLQQNLQGYDAKSD 219
Query: 899 MRGGVYSYGILLLEI 913
+YS GI E+
Sbjct: 220 ----IYSVGITACEL 230
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 47/239 (19%)
Query: 697 SKATNEFSSSNTIGRGSFGFVYKGV-LHENGMLVAVKVINLEQKGGSKSFAAECE----- 750
+A ++ IG G++G V+K L G VA+K + ++ E
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---------GEEGMPLS 57
Query: 751 ALRSI---------RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQL 801
+R + H N++++ +C+ LV+E++ L +L D++
Sbjct: 58 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL----DKV 112
Query: 802 GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861
+ +++ + +++LH H +VH DLKP N+L+ ++DFGLA+
Sbjct: 113 PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 169
Query: 862 LSASPLG---NVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRR 917
S + VV T+ Y APE L + ++S G + E+F R+
Sbjct: 170 YS-FQMALTSVVV-----------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 58/263 (22%), Positives = 107/263 (40%), Gaps = 54/263 (20%)
Query: 676 HKSSNTSQMEQQFPM---VSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVK 732
H T + + Q P VS + + + + +G G++G VYK + VA+K
Sbjct: 6 HHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK 65
Query: 733 VINLEQ-KGGSKSFAA-ECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSL 790
I LE + G A E L+ ++HRN+I++ ++ L++EY +N L
Sbjct: 66 RIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH---NHRLH--LIFEYAEN-DL 119
Query: 791 EEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV 850
++++ D+ ++ +I+ + + + V + H +H DLKP N+LL
Sbjct: 120 KKYM----DKNPDVSMRVIKSF--LYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDA 170
Query: 851 AH-----VSDFGLAKFLSASPLG----NVVETPSSSIGVKGTIGYVAPEYGLGGEASMRG 901
+ + DFGLA+ P+ ++ T+ Y PE LG
Sbjct: 171 SETPVLKIGDFGLARAFG-IPIRQFTHEII-----------TLWYRPPEILLGSRH---- 214
Query: 902 GVYSYGI-------LLLEIFTRR 917
YS + + E+ +
Sbjct: 215 --YSTSVDIWSIACIWAEMLMKT 235
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 65/243 (26%), Positives = 97/243 (39%), Gaps = 56/243 (23%)
Query: 695 ELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINL----EQKGGSKSFAA-EC 749
++ + + +G G F VYK +VA+K I L E K G A E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 750 EALRSIRHRNLIK---IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNL 806
+ L+ + H N+I S+I +LV+++M+ LE + L ++
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNI--------SLVFDFMET-DLEVIIKDNSLVLTPSHI 114
Query: 807 -SLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865
+ + +EYLH H I+H DLKP+N+LLD + V ++DFGLAK S
Sbjct: 115 KAYMLMT------LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-S 164
Query: 866 PLG----NVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGI-------LLLEIF 914
P VV T Y APE G Y G+ +L E+
Sbjct: 165 PNRAYTHQVV-----------TRWYRAPELLFGARM------YGVGVDMWAVGCILAELL 207
Query: 915 TRR 917
R
Sbjct: 208 LRV 210
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 51/231 (22%), Positives = 86/231 (37%), Gaps = 47/231 (20%)
Query: 674 SAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKV 733
+A ++ P ++ +F +G GSF V A+K+
Sbjct: 5 AAEPRPGAGSLQHAQPPPQPRKKR--PEDFKFGKILGEGSFSTVVLARELATSREYAIKI 62
Query: 734 IN---LEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSL 790
+ + ++ E + + + H +K+ + F+ + Y +NG L
Sbjct: 63 LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL--YFT---FQDDEKLYFGLSYAKNGEL 117
Query: 791 EEWLHQRDDQLGICNLSLIQRLNIVID---------VASAVEYLHHHCQPPIVHGDLKPS 841
L I+++ + + SA+EYLH I+H DLKP
Sbjct: 118 ---------------LKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPE 159
Query: 842 NVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE 890
N+LL+ DM H+ +DFG AK LS + GT YV+PE
Sbjct: 160 NILLNEDM--HIQITDFGTAKVLSPESKQARANS------FVGTAQYVSPE 202
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 41/177 (23%), Positives = 69/177 (38%), Gaps = 28/177 (15%)
Query: 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHR 758
F +G G++G VYKG + G L A+KV+++ + E L+ HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHR 81
Query: 759 NLIKIVTICSSIDFKGVDFKA----------LVYEYMQNGSLEEWLHQRDDQLGICNLSL 808
N+ + G K LV E+ GS+ + + L
Sbjct: 82 NIAT---------YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT----LKE 128
Query: 809 IQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSAS 865
I ++ + +LH H ++H D+K NVLL + + DFG++ L +
Sbjct: 129 EWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 16/171 (9%)
Query: 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRN 759
++ + IG GSFG VY+ L ++G LVA+K + +++ ++ E + +R + H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108
Query: 760 LIKIV-TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQ--RDDQLGICNLSLIQRLNIVI 816
++++ SS + K + LV +Y+ E +++ R L +I +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLAKFLSASP 866
+ ++ Y+H I H D+KP N+LLD D V + DFG AK L
Sbjct: 164 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 49/220 (22%), Positives = 81/220 (36%), Gaps = 45/220 (20%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA------ECEALRSIR----H 757
+G+G FG V+ G + + VA+KVI + G + E L + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGS-LEEWLHQRDDQLGICNLSLIQRLNIVI 816
+I+++ + + LV E L +++ ++ L
Sbjct: 98 PGVIRLLDW---FETQEGFM--LVLERPLPAQDLFDYITEKG------PLGEGPSRCFFG 146
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLAKFLSASPLGNVVETPS 875
V +A+++ H +VH D+K N+L+D A + DFG L P
Sbjct: 147 QVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFD 199
Query: 876 SSIGVKGTIGYVAPEYGLGG-----EASMRGGVYSYGILL 910
GT Y PE+ A+ V+S GILL
Sbjct: 200 ------GTRVYSPPEWISRHQYHALPAT----VWSLGILL 229
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-17
Identities = 58/266 (21%), Positives = 99/266 (37%), Gaps = 56/266 (21%)
Query: 672 RRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAV 731
+ + + E + L + ++F IGRG+F V + + G + A+
Sbjct: 34 AQDKYVADFLQWAEPIVVRLKEVRLQR--DDFEILKVIGRGAFSEVAVVKMKQTGQVYAM 91
Query: 732 KVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNG 788
K++N + ++G F E + L + R I + + F+ ++ LV EY G
Sbjct: 92 KIMNKWDMLKRGEVSCFREERDVLVNGDRR---WITQLHFA--FQDENYLYLVMEYYVGG 146
Query: 789 SLEEWLHQRDDQLGICNLSLIQRLNIVID----------VASAVEYLHHHCQPPIVHGDL 838
L L+L+ + I + A++ +H VH D+
Sbjct: 147 DL---------------LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDI 188
Query: 839 KPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE 896
KP N+LLD H+ +DFG L T S + V GT Y++PE
Sbjct: 189 KPDNILLDRC--GHIRLADFGSCLKL------RADGTVRSLVAV-GTPDYLSPEILQAVG 239
Query: 897 ASMRGGVY-------SYGILLLEIFT 915
G Y + G+ E+F
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-17
Identities = 42/200 (21%), Positives = 75/200 (37%), Gaps = 38/200 (19%)
Query: 682 SQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG 741
S M + + K + F G+G+FG V G GM VA+K + +
Sbjct: 4 SMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD---- 59
Query: 742 SKSFA----AECEALRSIRHRNLIKIVTICSSIDFKGVD--FKALVYEYMQNGSLEEWLH 795
F + L + H N++++ + ++ + + +V EY+ + LH
Sbjct: 60 -PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLH 113
Query: 796 QRDDQLGICNLSL-----------IQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVL 844
+ ++ + R ++ LH + H D+KP NVL
Sbjct: 114 RCCRNYYRRQVAPPPILIKVFLFQLIR---------SIGCLHLPSV-NVCHRDIKPHNVL 163
Query: 845 LD-HDMVAHVSDFGLAKFLS 863
++ D + DFG AK LS
Sbjct: 164 VNEADGTLKLCDFGSAKKLS 183
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 7e-17
Identities = 52/226 (23%), Positives = 93/226 (41%), Gaps = 50/226 (22%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAA-ECEALRSIRHRNLIKIV 764
IG G++G VYK + G A+K I LE+ G S E L+ ++H N++K+
Sbjct: 8 EKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 765 TICSSID--FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
+ + LV+E++ L++ L D G + ++ + + +
Sbjct: 67 DVIHTKKRLV-------LVFEHLDQ-DLKKLL---DVCEGGLESVTAKSF--LLQLLNGI 113
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLG----NVVETPSSSI 878
Y H ++H DLKP N+L++ + ++DFGLA+ P+ +V
Sbjct: 114 AYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV------- 162
Query: 879 GVKGTIGYVAPEYGLGGEASMRGGVYSYGI-------LLLEIFTRR 917
T+ Y AP+ +G + YS I + E+
Sbjct: 163 ----TLWYRAPDVLMGSKK------YSTTIDIWSVGCIFAEMVNGT 198
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-16
Identities = 69/336 (20%), Positives = 124/336 (36%), Gaps = 58/336 (17%)
Query: 620 KLCGGLDELHLPSCQARGSRKPNVNLVKVVIPVIGGSCLILSVCIFIFYARRRRSAHKSS 679
L + + +C R + P +L + + + LSV F Y S
Sbjct: 116 DLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEY---LSVAPFADY--------LDS 164
Query: 680 NTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN---L 736
Q+ + + ++K N F +G+G FG V + G + A K + +
Sbjct: 165 IYFNRFLQWKWLERQPVTK--NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI 222
Query: 737 EQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQ 796
+++ G E + L + R +V++ + ++ D LV M G L+ ++
Sbjct: 223 KKRKGEAMALNEKQILEKVNSRF---VVSLAYA--YETKDALCLVLTLMNGGDLKFHIYH 277
Query: 797 RDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--S 854
+G + + ++ +E LH IV+ DLKP N+LLD H+ S
Sbjct: 278 ----MGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDH--GHIRIS 328
Query: 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE------YGLGGEASMRGGV--YSY 906
D GLA + +T + GT+GY+APE Y ++
Sbjct: 329 DLGLAVHVPEG------QTIKGRV---GTVGYMAPEVVKNERYTF--------SPDWWAL 371
Query: 907 GILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942
G LL E+ + P + + + E +
Sbjct: 372 GCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPE 406
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 49/212 (23%), Positives = 84/212 (39%), Gaps = 21/212 (9%)
Query: 244 EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRG 303
+ + T ++P I + L + +N + +F + L +L+L +N+ +
Sbjct: 20 SVDCSSKKLT-AIPSNIPADTKKLD---LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT 75
Query: 304 QVSINFNGLKDLSMLGLATNFLG---NGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLP 360
+ F LK+L L + N L G + L L L L N LP
Sbjct: 76 LPAGIFKELKNLETLWVTDNKLQALPIGVFDQL---------VNLAELRLDRNQLKS-LP 125
Query: 361 HSI-ANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGELKNL 418
+ +L T L +LG N++ ++P G+ L +L LR+ N+L +L L
Sbjct: 126 PRVFDSL-TKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTEL 183
Query: 419 QLLHLHANFLQGTIPSSLGNLTLLTYLSFGAN 450
+ L L N L+ + +L L L N
Sbjct: 184 KTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 51/189 (26%), Positives = 84/189 (44%), Gaps = 15/189 (7%)
Query: 169 NLQGLSVGDNQLTGQLPASI-GNLSALRVIDIRTNRLWGKIPITL-SQLTSLAYLHVGDN 226
+ + L + N+L+ LP+ L+ LR++ + N+L +P + +L +L L V DN
Sbjct: 38 DTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDN 95
Query: 227 HFSGTIPPSVY-NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPD-S 284
+P V+ + +L E+ L N+ SLP + +L L + N SLP
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152
Query: 285 FSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTK 344
F ++L+ L L NQ + F+ L +L L L N L D + K
Sbjct: 153 FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD------SLEK 206
Query: 345 LQYLYLADN 353
L+ L L +N
Sbjct: 207 LKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 50/163 (30%), Positives = 77/163 (47%), Gaps = 9/163 (5%)
Query: 165 RRLFNLQGLSVGDNQLTGQLPASI-GNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLH 222
RL L+ L + DN+L LPA I L L + + N+L +PI QL +LA L
Sbjct: 58 HRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELR 115
Query: 223 VGDNHFSGTIPPSVY-NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSL 281
+ N ++PP V+ +++ L + L N SLP + L +L+ +Y N +
Sbjct: 116 LDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RV 172
Query: 282 PDS-FSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATN 323
P+ F + L+ L L NQ + F+ L+ L ML L N
Sbjct: 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 45/174 (25%), Positives = 75/174 (43%), Gaps = 18/174 (10%)
Query: 289 SNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATN---FLGNGAANDLDFVDLLTNCTKL 345
++ + L L N+ S F+ L L +L L N L G +L L
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKEL---------KNL 87
Query: 346 QYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRL 404
+ L++ DN LP + + L + L +NQ+ ++PP + +L L L + N L
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNEL 145
Query: 405 TGTIPH-VIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIP 457
++P V +L +L+ L L+ N L+ + LT L L N L+ +P
Sbjct: 146 Q-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVP 197
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 62/257 (24%), Positives = 86/257 (33%), Gaps = 82/257 (31%)
Query: 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEA 401
+ L L N + + L T L L N++ T+P GI L NL +L +
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRL-TKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTD 94
Query: 402 NRLTGTIPH-VIGELKNLQLLHLHANFLQGTIPSSL-GNLTLLTYLSFGANNLQGNIPFS 459
N+L +P V +L NL L L N L+ ++P + +LT LTYLS
Sbjct: 95 NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLS------------- 139
Query: 460 LGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRL 518
LG N+L SLP GV L SL L
Sbjct: 140 LGY-----------NELQ--------------------------SLPKGVFDKLTSLKEL 162
Query: 519 GIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIP 578
+ NQ + +F LT +K L L N
Sbjct: 163 RLYNNQLK----------------RVPEGAFDK--------LTELKTLKLDNNQLKRVPE 198
Query: 579 KYLENLSFLQYLNLSYN 595
++L L+ L L N
Sbjct: 199 GAFDSLEKLKMLQLQEN 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 45/273 (16%), Positives = 86/273 (31%), Gaps = 41/273 (15%)
Query: 177 DNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSV 236
++++T ++P+ + + +L S L + + N I V
Sbjct: 18 ESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 74
Query: 237 -YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPD-SFSNASNLEVL 294
N+ L EI + + E +NLPNL+ +I LPD ++ +L
Sbjct: 75 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLL 133
Query: 295 HLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNG 354
+ +N + + FV L + L+L NG
Sbjct: 134 DIQDN----------INIHTIE---------------RNSFVGL---SFESVILWLNKNG 165
Query: 355 FGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIG 413
+ +S N + N + +P + L + R+ + +
Sbjct: 166 I-QEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLE 223
Query: 414 ELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLS 446
LK L+ + +P +L L L S
Sbjct: 224 NLKKLRARSTYNLK---KLP-TLEKLVALMEAS 252
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 6e-16
Identities = 40/255 (15%), Positives = 80/255 (31%), Gaps = 18/255 (7%)
Query: 244 EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRG 303
++ T +P ++ N +FS +LE + +++N
Sbjct: 13 VFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 304 QVSIN-FNGLKDLSMLGLATNFLGNGAANDLDFV--DLLTNCTKLQYLYLADNGFGGVLP 360
+ + F+ L L + + N+L ++ + N LQYL +++ G LP
Sbjct: 69 VIEADVFSNLPKLHEIRIEKA-------NNLLYINPEAFQNLPNLQYLLISNTGIK-HLP 120
Query: 361 HSIANLSTALIDFNLGKNQIYGTIPPG-IANL-VNLNSLRMEANRLTGTIPHVIGELKNL 418
S + ++ N TI L L + N + +
Sbjct: 121 DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLD 180
Query: 419 QLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTG 478
+L N L+ + L + + L N K L K
Sbjct: 181 ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLP 240
Query: 479 ALPQQILEITTLSLS 493
L ++++ + SL+
Sbjct: 241 TL-EKLVALMEASLT 254
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 43/255 (16%), Positives = 80/255 (31%), Gaps = 34/255 (13%)
Query: 345 LQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRME-AN 402
L + + + L + +N + I + +NL L+ +R+E AN
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGF-GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 403 RLTGTIPHVIGELKNLQLLHLHANFLQGTIPS-SLGNLTLLTYLSFGANNLQGNIPFSLG 461
L P L NLQ L + ++ +P + L N I
Sbjct: 91 NLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIE---- 145
Query: 462 NCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIA 521
RN G ++ S+ L L+ N + + N L L ++
Sbjct: 146 -----------RNSFVG--------LSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLS 185
Query: 522 RNQFSGQIPV-TLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKY 580
N ++P + +++ L +L ++ ++P
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-T 241
Query: 581 LENLSFLQYLNLSYN 595
LE L L +L+Y
Sbjct: 242 LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 48/267 (17%), Positives = 87/267 (32%), Gaps = 28/267 (10%)
Query: 140 HCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDI 199
HCS F + + EIP +L N L +L + L I+I
Sbjct: 8 HCSNR-VFLCQESKVT-EIPSDLPR----NAIELRFVLTKLRVIQKGAFSGFGDLEKIEI 61
Query: 200 RTNRLWGKIPI-TLSQLTSLAYLHV-GDNHFSGTIPPSV-YNISSLVEIYLYGNRFTGSL 256
N + I S L L + + N+ I P N+ +L + + L
Sbjct: 62 SQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HL 119
Query: 257 PIEIGKNLPNLRNFVIYTNNFTGSLPD-SFSN-ASNLEVLHLAENQFRGQVSINFNGLKD 314
P + I N ++ SF + +L L +N + + FNG +
Sbjct: 120 PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQL 179
Query: 315 LSMLGLATNFLGNGAANDLDFV--DLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALID 372
+ N N+L+ + D+ + L ++ + + + NL L
Sbjct: 180 DELN-----LSDN---NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL-KKLRA 230
Query: 373 FNLGKNQIYGTIPPGIANLVNLNSLRM 399
+ + +P + LV L +
Sbjct: 231 RSTYNLK---KLPT-LEKLVALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 42/218 (19%), Positives = 69/218 (31%), Gaps = 9/218 (4%)
Query: 383 TIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSS-LGNLTL 441
IP + N LR +L +L+ + + N + I + NL
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 442 LTYLSF-GANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNL 500
L + ANNL P + N NL + + LP + + LD+ DN+
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139
Query: 501 LNGSLPLGV--GNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLS 558
++ G V L + +N E N+
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199
Query: 559 SLTSIKELDLSQNNFSGQIPKY-LENLSFLQYLNLSYN 595
+ LD+S+ +P Y LENL L+ +
Sbjct: 200 GASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 40/214 (18%), Positives = 68/214 (31%), Gaps = 16/214 (7%)
Query: 393 NLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNL 452
+ + +++T IP + +N L L+ + L + N++
Sbjct: 10 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 453 QGNIP---FS-LGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLG 508
I FS L + A N L + + + L +S+ + LP
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKA--NNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDV 122
Query: 509 V-GNLKSLVRLGIARNQFSGQIPVTL--GACTSLEYVELQGNSFSGTIPQSLSSLTSIKE 565
+ V L I N I G + L N I S + T + E
Sbjct: 123 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDE 181
Query: 566 LDLSQNNFSGQIPKY-LENLSFLQYLNLSYNHFE 598
L+LS NN ++P S L++S
Sbjct: 182 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 42/263 (15%), Positives = 86/263 (32%), Gaps = 18/263 (6%)
Query: 67 RRNQRVTKLDLRNQSIGGILSPYV-GNLSFLRYINIADNDFHGEIPDRI-GNLFRLETLV 124
+ K+++ + ++ V NL L I I + I NL L+ L+
Sbjct: 51 SGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 110
Query: 125 LANNSFSGRIPTNL-SHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQ 183
++N +P H + + N + I F L + N + +
Sbjct: 111 ISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-E 168
Query: 184 LPASIGNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNHFSGTIPPSV-YNISS 241
+ S N + L +++ N ++P + L + ++P N+
Sbjct: 169 IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKK 227
Query: 242 LVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSN-ASNLEVLHLAENQ 300
L Y + +L + L L + T S +F+N + LH N+
Sbjct: 228 LRARSTYNLKKLPTL-----EKLVALMEASL-TYP---SHCCAFANWRRQISELHPICNK 278
Query: 301 FRGQVSINFNGLKDLSMLGLATN 323
+ +++ LA +
Sbjct: 279 SILRQEVDYMTQARGQRSSLAED 301
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 55/245 (22%), Positives = 96/245 (39%), Gaps = 69/245 (28%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRH--- 757
+ F IG+GSFG V ++ + A+K +N K +C +R+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN-------K---QKCVERNEVRNVFK 64
Query: 758 -RNLIK------IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQ 810
+++ +V + S F+ + +V + + G L +Q
Sbjct: 65 ELQIMQGLEHPFLVNLWYS--FQDEEDMFMVVDLLLGGDL---------------RYHLQ 107
Query: 811 RLNI---------VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861
+ + ++ A++YL + I+H D+KP N+LLD H++DF +A
Sbjct: 108 QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAM 164
Query: 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVY-------SYGILLLEIF 914
L ET ++ + GT Y+APE S +G Y S G+ E+
Sbjct: 165 LPR-------ETQITT--MAGTKPYMAPEMFS----SRKGAGYSFAVDWWSLGVTAYELL 211
Query: 915 TRRRP 919
RRP
Sbjct: 212 RGRRP 216
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-16
Identities = 69/278 (24%), Positives = 109/278 (39%), Gaps = 49/278 (17%)
Query: 682 SQMEQQFPMVSYKELSKAT-NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN---LE 737
S +F + E + F +GRG FG V+ + G L A K +N L+
Sbjct: 165 SLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224
Query: 738 QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQR 797
++ G + E + L + R IV++ + F+ LV M G + ++
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRF---IVSLAYA--FETKTDLCLVMTIMNGGDIRYHIYNV 279
Query: 798 DDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SD 855
D+ + + + S +E+LH I++ DLKP NVLLD D +V SD
Sbjct: 280 DEDNPG--FQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDD--GNVRISD 332
Query: 856 FGLAKFLSASPLGNVVETPSSSIGVK---GTIGYVAPE------YGLGGEASMRGGV--Y 904
GLA E + K GT G++APE Y V +
Sbjct: 333 LGLAV-----------ELKAGQTKTKGYAGTPGFMAPELLLGEEYDF--------SVDYF 373
Query: 905 SYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942
+ G+ L E+ R P + E + E +R L + V
Sbjct: 374 ALGVTLYEMIAARGPFRA-RGEKVENKELKQRVLEQAV 410
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 34/233 (14%), Positives = 69/233 (29%), Gaps = 41/233 (17%)
Query: 297 AENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFG 356
A Q + S + + D + LG + ++ + L Y+ LA+
Sbjct: 2 AAEQTGLKASQDNVNIPDSTFKAYLNGLLGQSSTANITEAQM----NSLTYITLANINV- 56
Query: 357 GVLPHSIANLS--TALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGE 414
+ + + D + T I+ L NL LR+ +T +
Sbjct: 57 ----TDLTGIEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSG 110
Query: 415 LKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRN 474
L +L LL + + +I + + L + + N +I L L
Sbjct: 111 LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELK------- 162
Query: 475 KLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSG 527
SL++ + ++ + + L +L G
Sbjct: 163 ------------------SLNIQFDGVHDYRGI--EDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 25/194 (12%), Positives = 66/194 (34%), Gaps = 22/194 (11%)
Query: 265 PNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATN- 323
+ ++ + + + + ++L + L + DL+ + A N
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITL-----------ANINVTDLTGIEYAHNI 68
Query: 324 ---FLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQI 380
+ N + ++ + L+ L + +++ L T+L ++ +
Sbjct: 69 KDLTINN---IHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGL-TSLTLLDISHSAH 124
Query: 381 YGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLT 440
+I I L +NS+ + N I + L L+ L++ + + + +
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGV--HDYRGIEDFP 181
Query: 441 LLTYLSFGANNLQG 454
L L + + G
Sbjct: 182 KLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 27/212 (12%), Positives = 65/212 (30%), Gaps = 36/212 (16%)
Query: 364 ANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHL 423
+ A ++ LG++ A + +L + + +T I N++ L +
Sbjct: 20 STF-KAYLNGLLGQSST---ANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTI 73
Query: 424 HANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQ 483
+ T + + L+ L L ++ + +L +L
Sbjct: 74 NNI--HATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT---------------- 115
Query: 484 ILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVE 543
LD+S + + S+ + L + + ++ N I L L+ +
Sbjct: 116 ---------LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLN 165
Query: 544 LQGNSFSGTIPQSLSSLTSIKELDLSQNNFSG 575
+Q + + + +L G
Sbjct: 166 IQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 28/172 (16%), Positives = 61/172 (35%), Gaps = 15/172 (8%)
Query: 209 PITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLR 268
IT +Q+ SL Y+ + + + + + ++ ++ + T PI L NL
Sbjct: 37 NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNPI---SGLSNLE 91
Query: 269 NFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNG 328
I + T + S ++L +L ++ + + N L ++ + L+ N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN----- 146
Query: 329 AANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQI 380
+ + L +L+ L + +G I + L I
Sbjct: 147 --GAITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDF-PKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 33/210 (15%), Positives = 66/210 (31%), Gaps = 37/210 (17%)
Query: 70 QRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNS 129
+ L S I ++ L YI +A+ + I ++ L + N
Sbjct: 23 KAYLNGLLGQSSTANI---TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIH 77
Query: 130 FSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIG 189
TN + S L NL+ L + +T ++
Sbjct: 78 A-----TNYNPISGLS-----------------------NLERLRIMGKDVTSDKIPNLS 109
Query: 190 NLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYG 249
L++L ++DI + I ++ L + + + N I P + + L + +
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQF 168
Query: 250 NRFTGSLPIEIGKNLPNLRNFVIYTNNFTG 279
+ IE + P L ++ G
Sbjct: 169 DGVHDYRGIE---DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 25/117 (21%), Positives = 48/117 (41%), Gaps = 8/117 (6%)
Query: 483 QILEITTLSL----SLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTS 538
IT + + L++ + L G+ ++ L I + P + ++
Sbjct: 34 STANITEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNYNP--ISGLSN 89
Query: 539 LEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYN 595
LE + + G + +LS LTS+ LD+S + I + L + ++LSYN
Sbjct: 90 LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN 146
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 14/103 (13%), Positives = 43/103 (41%), Gaps = 4/103 (3%)
Query: 502 NGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLT 561
+ + + + SL + +A + + +++ + + + P +S L+
Sbjct: 33 SSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLS 88
Query: 562 SIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK 604
+++ L + + + L L+ L L++S++ + + TK
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-16
Identities = 49/261 (18%), Positives = 98/261 (37%), Gaps = 51/261 (19%)
Query: 672 RRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAV 731
R++ + + S+ + + + ++ IGRG+FG V + A+
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKA--EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99
Query: 732 KVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNG 788
K+++ + ++ S F E + + +V + + F+ + +V EYM G
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSP---WVVQLFYA--FQDDRYLYMVMEYMPGG 154
Query: 789 SLEEWLHQRDDQLGICNLSLIQRLNIVIDVA--------SAVEYLHHHCQPPIVHGDLKP 840
L ++L+ ++ A A++ +H +H D+KP
Sbjct: 155 DL---------------VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKP 196
Query: 841 SNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEAS 898
N+LLD H+ +DFG + +V ++ GT Y++PE
Sbjct: 197 DNMLLDKS--GHLKLADFGTCMKM---NKEGMVRCDTAV----GTPDYISPEVLKSQGGD 247
Query: 899 MRGGV----YSYGILLLEIFT 915
G +S G+ L E+
Sbjct: 248 GYYGRECDWWSVGVFLYEMLV 268
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 6e-16
Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 48/231 (20%)
Query: 709 IGRGSFGFVYKGVLHE--NGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTI 766
+GRG++G VYK + + A+K I G S S E LR ++H N+I + +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKV 86
Query: 767 CSSIDFKGVDFKALVYEYMQN--GSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
S + V L+++Y ++ + ++ L +++ + + Y
Sbjct: 87 FLSHADRKV---WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAH----VSDFGLAKFLSASPL-------GNVVET 873
LH + ++H DLKP+N+L+ + ++D G A+ + SPL VV
Sbjct: 144 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVV-- 197
Query: 874 PSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGI-------LLLEIFTRR 917
T Y APE LG Y+ I + E+ T
Sbjct: 198 ---------TFWYRAPELLLGAR------HYTKAIDIWAIGCIFAELLTSE 233
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 47/182 (25%), Positives = 72/182 (39%), Gaps = 11/182 (6%)
Query: 120 LETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQ 179
L L+ N L ++L + R L ++ + L L L + NQ
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQ---VDGTLPVLGTLDLSHNQ 88
Query: 180 LTGQLPASIGNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNHFSGTIPPSVY- 237
L LP L AL V+D+ NRL +P+ L L L L++ N T+PP +
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRL-TSLPLGALRGLGELQELYLKGNELK-TLPPGLLT 145
Query: 238 NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLA 297
L ++ L N T LP + L NL ++ N+ ++P F + L L
Sbjct: 146 PTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLH 203
Query: 298 EN 299
N
Sbjct: 204 GN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 46/174 (26%), Positives = 69/174 (39%), Gaps = 10/174 (5%)
Query: 152 NNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPIT 211
NL+ + L L++ +LT +L G L L +D+ N+L +P+
Sbjct: 40 ENLLYTFSLATLMP-YTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQL-QSLPLL 95
Query: 212 LSQLTSLAYLHVGDNHFSGTIPPSVY-NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNF 270
L +L L V N + ++P + L E+YL GN +LP + P L
Sbjct: 96 GQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKL 153
Query: 271 VIYTNNFTGSLPDS-FSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATN 323
+ NN T LP + NL+ L L EN + F G L L N
Sbjct: 154 SLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 60/260 (23%), Positives = 89/260 (34%), Gaps = 67/260 (25%)
Query: 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHF 228
+ ++ LT LP + ++ + N L+ TL T L L++
Sbjct: 11 SHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 229 SGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLP-DSFSN 287
T + L + L N+ SLP +G+ LP L + N T SLP +
Sbjct: 68 --TKLQVDGTLPVLGTLDLSHNQLQ-SLP-LLGQTLPALTVLDVSFNRLT-SLPLGALRG 122
Query: 288 ASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQY 347
L+ L+L N+ LK L LLT KL+
Sbjct: 123 LGELQELYLKGNE-----------LKTLP-------------------PGLLTPTPKLEK 152
Query: 348 LYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTG 406
L LA+N NL+ +P G+ L NL++L ++ N L
Sbjct: 153 LSLANN-----------NLT---------------ELPAGLLNGLENLDTLLLQENSLY- 185
Query: 407 TIPHVIGELKNLQLLHLHAN 426
TIP L LH N
Sbjct: 186 TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 55/223 (24%), Positives = 85/223 (38%), Gaps = 37/223 (16%)
Query: 390 NLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGA 449
+ + + + LT +P + K+ +LHL N L ++L T LT L+
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 450 NNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV 509
L G L N+L +LP + L+ LD+S N L SLPLG
Sbjct: 65 AELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALT-VLDVSFNRLT-SLPLGA 119
Query: 510 GNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSL-SSLTSIKELDL 568
G L+ + L+GN T+P L + +++L L
Sbjct: 120 ---------------LRG--------LGELQELYLKGNELK-TLPPGLLTPTPKLEKLSL 155
Query: 569 SQNNFSGQIPKYL-ENLSFLQYLNLSYNHFEGEVPTKGIFKNK 610
+ NN + ++P L L L L L N +P KG F +
Sbjct: 156 ANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IP-KGFFGSH 195
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 52/288 (18%), Positives = 83/288 (28%), Gaps = 92/288 (31%)
Query: 238 NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLA 297
++S +E+ T +LP ++ + + N + + L L+L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 298 ENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGG 357
+ L+ L + L L L L+ N
Sbjct: 64 RAE--------------LTKLQV--------------DGTL----PVLGTLDLSHNQLQ- 90
Query: 358 VLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPH-VIGELK 416
++P L L L + NRLT ++P + L
Sbjct: 91 -------------------------SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG 124
Query: 417 NLQLLHLHANFLQGTIPSSL-GNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNK 475
LQ L+L N L+ T+P L L LS NNL +P L
Sbjct: 125 ELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGL---------LNGLEN 173
Query: 476 LTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARN 523
L +L L +N L ++P G L + N
Sbjct: 174 LD---------------TLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 37/180 (20%), Positives = 65/180 (36%), Gaps = 34/180 (18%)
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG 132
T+L+L + + G L L ++++ N +P L L L ++ N +
Sbjct: 58 TQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT- 113
Query: 133 RIPTNL-SHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASI-GN 190
+P +L N L +P L+ L+ LS+ +N LT +LPA +
Sbjct: 114 SLPLGALRGLGELQELYLKGNELK-TLPPGLL-TPTPKLEKLSLANNNLT-ELPAGLLNG 170
Query: 191 LSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGN 250
L L + ++ N L + IP + L +L+GN
Sbjct: 171 LENLDTLLLQEN-----------SLYT--------------IPKGFFGSHLLPFAFLHGN 205
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 57/266 (21%), Positives = 98/266 (36%), Gaps = 58/266 (21%)
Query: 672 RRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAV 731
RR + + V L + +F IGRG+FG V L + A+
Sbjct: 47 RREKNILEYLEWAKPFTSKVKQMRLHR--EDFEILKVIGRGAFGEVAVVKLKNADKVFAM 104
Query: 732 KVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNG 788
K++N + ++ + F E + L + + I T+ + F+ + LV +Y G
Sbjct: 105 KILNKWEMLKRAETACFREERDVLVNGDSK---WITTLHYA--FQDDNNLYLVMDYYVGG 159
Query: 789 SLEEWLHQRDDQLGICNLSLIQRLNIVID----------VASAVEYLHHHCQPPIVHGDL 838
L L+L+ + + + A++ +H VH D+
Sbjct: 160 DL---------------LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDI 201
Query: 839 KPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE 896
KP N+L+D + H+ +DFG T SS+ V GT Y++PE E
Sbjct: 202 KPDNILMDMN--GHIRLADFGSCL------KLMEDGTVQSSVAV-GTPDYISPEILQAME 252
Query: 897 ASMRGGVY-------SYGILLLEIFT 915
Y S G+ + E+
Sbjct: 253 GGKGR--YGPECDWWSLGVCMYEMLY 276
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 35/159 (22%), Positives = 64/159 (40%), Gaps = 21/159 (13%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEA---LRSIRHRNLIKIV 764
+G G G V + A+K++ A E R+ + ++++IV
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIV 77
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
+ + + G +V E + G L + R G + + I+ + A++Y
Sbjct: 78 DVYEN-LYAGRKCLLIVMECLDGGELFSRIQDR----GDQAFTEREASEIMKSIGEAIQY 132
Query: 825 LHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAK 860
LH I H D+KP N+L + + ++DFG AK
Sbjct: 133 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 44/170 (25%), Positives = 80/170 (47%), Gaps = 21/170 (12%)
Query: 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRN 759
+++ IG GSFG V++ L E+ VA+K + +++ ++ E + +R ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR----ELQIMRIVKHPN 93
Query: 760 LIKIV-TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSL----IQRLNI 814
++ + S+ D K F LV EY+ E +++ ++ I+
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPMLLIK--LY 146
Query: 815 VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLAKFLS 863
+ + ++ Y+H I H D+KP N+LLD V + DFG AK L
Sbjct: 147 MYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 46/224 (20%), Positives = 90/224 (40%), Gaps = 35/224 (15%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR--------HRN 759
+G G F V+ N VA+K++ K +++ E + L+ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 760 LIKIVTICSSIDFKGVDFK--ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
I+ + + KG + +V+E + +L + + + + GI L +++ I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR-GI-PLIYVKQ--ISKQ 139
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH------VSDFGLAKFLSASPLGNVV 871
+ ++Y+H C I+H D+KP NVL++ ++D G A + N +
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD-EHYTNSI 196
Query: 872 ETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+T Y +PE LG ++S L+ E+ T
Sbjct: 197 QTRE----------YRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 36/213 (16%), Positives = 70/213 (32%), Gaps = 14/213 (6%)
Query: 240 SSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLP-DSFSNASNLEVLHLAE 298
S + L ++P NLPN+ + + L SF N S + + +
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 299 NQFRGQVSIN-FNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGG 357
+ + + L L LG+ L + + + L + DN +
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGL-----KMFPDLTKVYSTDIFFILEITDNPYMT 144
Query: 358 VLP-HSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVI--GE 414
+P ++ L + L N ++ N L+++ + N+ I G
Sbjct: 145 SIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV 203
Query: 415 LKNLQLLHLHANFLQGTIPS-SLGNLTLLTYLS 446
LL + + +PS L +L L +
Sbjct: 204 YSGPSLLDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 28/197 (14%), Positives = 68/197 (34%), Gaps = 15/197 (7%)
Query: 264 LPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSIN-FNGLKDLSMLGLAT 322
P+ + + + +FSN N+ ++++ + Q+ + F L ++ + +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 323 NFLGNGAANDLDFV--DLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQI 380
+L ++ D L L++L + + G + + + N
Sbjct: 90 T-------RNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPY 142
Query: 381 YGTIPPGI-ANLVN-LNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSL-- 436
+IP L N +L++ N T ++ L ++L+ N I
Sbjct: 143 MTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFG 201
Query: 437 GNLTLLTYLSFGANNLQ 453
G + + L ++
Sbjct: 202 GVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 39/240 (16%), Positives = 85/240 (35%), Gaps = 26/240 (10%)
Query: 168 FNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNH 227
+ V + ++P + + + + L S L +++ ++V +
Sbjct: 11 HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 228 FSGTIPPSV-YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPD--S 284
+ YN+S + I + R + + K LP L+ I+ PD
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK 125
Query: 285 FSNASNLEVLHLAENQFRGQVSIN-FNGLKDLSM-LGLATN---FLGNGAANDLDFVDLL 339
+ +L + +N + + +N F GL + ++ L L N + A N
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG------- 178
Query: 340 TNCTKLQYLYLADNGFGGVLP-HSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSL 397
TKL +YL N + V+ + + + ++ + + +P +L L +
Sbjct: 179 ---TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV-TALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 33/232 (14%), Positives = 71/232 (30%), Gaps = 32/232 (13%)
Query: 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEA 401
Q L L + + H+ +NL + + + + NL + + +
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNL-PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 402 NRLTGTIPH-VIGELKNLQLLHLHANFLQGTIP--SSLGNLTLLTYLSFGANNLQGNIPF 458
R I + EL L+ L + L+ P + + + + L N +IP
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP- 147
Query: 459 SLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRL 518
+ +L+L L +N S+ N L +
Sbjct: 148 ----------------------VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184
Query: 519 GIARNQFSGQIPVTL--GACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDL 568
+ +N++ I G + +++ S + + L L + +
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 39/222 (17%), Positives = 68/222 (30%), Gaps = 20/222 (9%)
Query: 213 SQLTSLAYLHVGDNHFSGTIPPSV-YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFV 271
S S L + + H TIP N+ ++ IY+ + L NL + +
Sbjct: 28 SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86
Query: 272 IYTNNFTGSLP-DSFSNASNLEVLHLAENQFRG-QVSINFNGLKDLSMLGLATN----FL 325
I + D+ L+ L + + +L + N +
Sbjct: 87 IRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 326 GNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIP 385
A F L C + L L +NGF V ++ L L KN+ I
Sbjct: 147 PVNA-----FQGL---CNETLTLKLYNNGFTSVQGYAFNGTK--LDAVYLNKNKYLTVID 196
Query: 386 PGI-ANLVN-LNSLRMEANRLTGTIPHVIGELKNLQLLHLHA 425
+ + + L + +T + LK L +
Sbjct: 197 KDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 37/228 (16%), Positives = 78/228 (34%), Gaps = 31/228 (13%)
Query: 386 PGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPS-SLGNLTLLTY 444
P + + +L++ L H L N+ +++ + + S S NL+ +T+
Sbjct: 27 PSL--PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTH 84
Query: 445 LSFGANNLQGNIP-FSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNG 503
+ I +L L F L + T + L+++DN
Sbjct: 85 IEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMT 144
Query: 504 SLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSI 563
S+P+ F G C ++L N F+ ++ + T +
Sbjct: 145 SIPVNA---------------FQGL-------CNETLTLKLYNNGFT-SVQGYAFNGTKL 181
Query: 564 KELDLSQNNFSGQIPKY-LENL-SFLQYLNLSYNHFEGEVPTKGIFKN 609
+ L++N + I K + S L++S +P+ ++
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPS-KGLEH 227
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 34/212 (16%), Positives = 66/212 (31%), Gaps = 33/212 (15%)
Query: 71 RVTKLDL-RNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRI-GNLFRLETLVLANN 128
++++ + + ++ + S NLS + +I I + I L L+ L + N
Sbjct: 56 NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115
Query: 129 SFSGRIP--TNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPA 186
P T + N + IP L + +N T +
Sbjct: 116 GLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQG 173
Query: 187 SIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIY 246
N + L + + N+ LT + + F G S +
Sbjct: 174 YAFNGTKLDAVYLNKNK----------YLTVID-----KDAFGGV-------YSGPSLLD 211
Query: 247 LYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFT 278
+ T +LP + ++L L N +T
Sbjct: 212 VSQTSVT-ALPSKGLEHLKELIA----RNTWT 238
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 54/270 (20%), Positives = 96/270 (35%), Gaps = 30/270 (11%)
Query: 331 NDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIAN 390
+ + + L + L ++ + I GI
Sbjct: 12 TPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNEL-NSIDQIIANNSDI--KSVQGIQY 66
Query: 391 LVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGAN 450
L N+ L + N+LT P + LKNL L L N + SSL +L L LS N
Sbjct: 67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSLEHN 122
Query: 451 NLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSL-----SLDLSDNLLNGSL 505
+ +I L + L + NK+T +IT LS +L L DN ++ +
Sbjct: 123 GIS-DIN-GLVHLPQLESLYLGNNKIT--------DITVLSRLTKLDTLSLEDNQIS-DI 171
Query: 506 PLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKE 565
+ L L L +++N S + L +L+ +EL S+L
Sbjct: 172 V-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 228
Query: 566 LDLSQNNFSGQIPKYLENLSFLQYLNLSYN 595
+ + + P+ + + + N+ ++
Sbjct: 229 VKNTDGSLVT--PEIISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 47/266 (17%), Positives = 101/266 (37%), Gaps = 26/266 (9%)
Query: 166 RLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGD 225
++ +T + L+++ I + + + + L ++ L +
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-KSVQ-GIQYLPNVTKLFLNG 77
Query: 226 NHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSF 285
N + I P + N+ +L ++L N+ + K+L L++ + N + + +
Sbjct: 78 NKLT-DIKP-LANLKNLGWLFLDENKVKD---LSSLKDLKKLKSLSLEHNGIS-DI-NGL 130
Query: 286 SNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKL 345
+ LE L+L N+ ++ + L L L L N + + + L TKL
Sbjct: 131 VHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQISD--------IVPLAGLTKL 180
Query: 346 QYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLT 405
Q LYL+ N + +A L L L + +NLV N+++ L
Sbjct: 181 QNLYLSKNHISDLRA--LAGL-KNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
Query: 406 GTIPHVIGELKNLQLLHLHANFLQGT 431
P +I + + + ++ + + T
Sbjct: 238 T--PEIISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 50/210 (23%), Positives = 75/210 (35%), Gaps = 39/210 (18%)
Query: 387 GIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLS 446
++ +T + EL ++ + + + ++ ++ + L +T L
Sbjct: 19 SDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLF 74
Query: 447 FGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLP 506
N L +I L N KNL + F NK + LS
Sbjct: 75 LNGNKLT-DI-KPLANLKNLGWLFLDENK-----------VKDLS--------------- 106
Query: 507 LGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKEL 566
+ +LK L L + N S I L LE + L N T LS LT + L
Sbjct: 107 -SLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTL 161
Query: 567 DLSQNNFSGQIPKYLENLSFLQYLNLSYNH 596
L N S +P L L+ LQ L LS NH
Sbjct: 162 SLEDNQISDIVP--LAGLTKLQNLYLSKNH 189
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 27/214 (12%), Positives = 58/214 (27%), Gaps = 54/214 (25%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS---FAAECEALRSIRHRNLIKIVT 765
G ++ + VA+ ++ + + L I +
Sbjct: 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG---VAR 95
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ + + +V E+++ GSL+E S + + + +A+A +
Sbjct: 96 VLDVVHTRAGGL--VVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAA 145
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H + PS V + D G+V V
Sbjct: 146 HRA---GVALSIDHPSRVRVSID-------------------GDV---------VLAYPA 174
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
+ A+ + + G L + R P
Sbjct: 175 TMPD-------ANPQDDIRGIGASLYALLVNRWP 201
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 44/164 (26%), Positives = 67/164 (40%), Gaps = 25/164 (15%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS---KSFAAECEALRSIRHRN 759
FS IG GSFG VY N +VA+K ++ K + + E L+ +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 760 LIKIVTICSSIDFKGVDFKA----LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
I+ ++G + LV EY GS + L L ++ +
Sbjct: 116 TIQ---------YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTH---- 161
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859
+ YLH H ++H D+K N+LL + + DFG A
Sbjct: 162 -GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 49/235 (20%), Positives = 85/235 (36%), Gaps = 72/235 (30%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-------HRNLI 761
+GRG + V++ + N V VK++ +K + R I+ N+I
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---------KIKREIKILENLRGGPNII 94
Query: 762 KIV-TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
+ + + LV+E++ N Q L Q L D+
Sbjct: 95 TLADIVKDPVSRTPA----LVFEHVNNTD----FKQ-----------LYQTLTD-YDIRF 134
Query: 821 -------AVEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAKFLSASPLGNV-V 871
A++Y H I+H D+KP NV++DH+ + D+GLA+F NV V
Sbjct: 135 YMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 191
Query: 872 ETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGI-------LLLEIFTRRRP 919
+ + PE + + Y Y + +L + R+ P
Sbjct: 192 ----------ASRYFKGPELLVDYQM------YDYSLDMWSLGCMLASMIFRKEP 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 56/287 (19%), Positives = 102/287 (35%), Gaps = 87/287 (30%)
Query: 702 EFSSSN-----TIGRGSFGFVYKGVL-----HENGMLVAVKVINLEQKGGS-----KSFA 746
EF +GRG+FG V + VAVK++ K G+ ++
Sbjct: 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML----KEGATHSEHRALM 73
Query: 747 AECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQR-------- 797
+E + L I H N++ ++ C+ + ++ E+ + G+L +L +
Sbjct: 74 SELKILIHIGHHLNVVNLLGACTKPGGPLM----VIVEFCKFGNLSTYLRSKRNEFVPYK 129
Query: 798 ---------DDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPP---------------- 832
D +G + L +RL+ + S+ +
Sbjct: 130 TKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF 189
Query: 833 ------------------------IVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLG 868
+H DL N+LL V + DFGLA+ + P
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-- 247
Query: 869 NVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ V + + +K APE +++ V+S+G+LL EIF+
Sbjct: 248 DYVRKGDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-14
Identities = 64/405 (15%), Positives = 123/405 (30%), Gaps = 66/405 (16%)
Query: 240 SSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFT----GSLPDSFSNASNLEVLH 295
+ + + + + E+ L + + T + + L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 296 LAENQFRGQ-VSINFNGLKD----LSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYL 350
L N+ V GL+ + L L L L L LQ L+L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL--SSTLRTLPTLQELHL 120
Query: 351 ADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGT--- 407
+DN G + L L+D L L++E L+
Sbjct: 121 SDNLLGDA---GLQLLCEGLLDPQC-----------------RLEKLQLEYCSLSAASCE 160
Query: 408 -IPHVIGELKNLQLLHLHANFLQGT----IPSSLGNLTL-LTYLSFGANNLQ----GNIP 457
+ V+ + + L + N + + L + L L + + ++
Sbjct: 161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC 220
Query: 458 FSLGNCKNLMFFFAPRNKLTG----ALPQQILEITTLSLSLDLSDNLLN----GSLPLGV 509
+ + +L NKL L +L ++ +L + + + G L +
Sbjct: 221 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVL 280
Query: 510 GNLKSLVRLGIARNQFSGQIPVTLGA-----CTSLEYVELQGNSFSGT----IPQSLSSL 560
+SL L +A N+ + L LE + ++ SF+ L+
Sbjct: 281 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 340
Query: 561 TSIKELDLSQNNFSGQIPKYL-----ENLSFLQYLNLSYNHFEGE 600
+ EL +S N + L + S L+ L L+
Sbjct: 341 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 65/354 (18%), Positives = 116/354 (32%), Gaps = 64/354 (18%)
Query: 67 RRNQRVTKLDLRNQSIG--GILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLV 124
R + +L L + +G G+ G L RLE L
Sbjct: 110 RTLPTLQELHLSDNLLGDAGLQLLCEGLLD---------------------PQCRLEKLQ 148
Query: 125 LANNSFSGR----IPTNLSHCSKLITFSAHRNNL----VGEIPEELISRRLFNLQGLSVG 176
L S S + + L + N++ V + + L L+ L +
Sbjct: 149 LEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPC-QLEALKLE 207
Query: 177 DNQLTGQ----LPASIGNLSALRVIDIRTNRLWGK-----IPITLSQLTSLAYLHVGDNH 227
+T L + + ++LR + + +N+L P L + L L + +
Sbjct: 208 SCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG 267
Query: 228 FS----GTIPPSVYNISSLVEIYLYGNRFTGS----LPIEIGKNLPNLRNFVIYTNNFTG 279
+ G + + SL E+ L GN L + + L + + + +FT
Sbjct: 268 ITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTA 327
Query: 280 SLPDSFSNA----SNLEVLHLAENQFRGQ-VSINFNGLKD----LSMLGLATNFLGNGAA 330
+ FS+ L L ++ N+ V GL L +L LA + + +
Sbjct: 328 ACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSC 387
Query: 331 NDLDFVDLLTNCTKLQYLYLADNGFG--GV--LPHSIANLSTALIDFNLGKNQI 380
+ L L L+ L L++N G G+ L S+ L L
Sbjct: 388 SSL--AATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 93/572 (16%), Positives = 163/572 (28%), Gaps = 171/572 (29%)
Query: 69 NQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANN 128
+ + LD++ + + L + + + + L +
Sbjct: 2 SLDIQSLDIQCEELSDA-----RWAELLPLLQ------------------QCQVVRLDDC 38
Query: 129 SFSGR----IPTNLSHCSKLITFSAHRNNLVGEIPEELISRRL----FNLQGLSVGDNQL 180
+ I + L L + N L G++ + + L +Q LS+ + L
Sbjct: 39 GLTEARCKDISSALRVNPALAELNLRSNEL-GDVGVHCVLQGLQTPSCKIQKLSLQNCCL 97
Query: 181 TGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNIS 240
T A G LS+ L L +L LH+ DN + +
Sbjct: 98 T---GAGCGVLSST-----------------LRTLPTLQELHLSDNLLG---DAGLQLLC 134
Query: 241 SLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFT----GSLPDSFSNASNLEVLHL 296
+ L + + + L + + L +
Sbjct: 135 EGLL-----------------DPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTV 177
Query: 297 AENQFRGQ-VSINFNGLKD----LSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLA 351
+ N V + GLKD L L L + + + DL ++ + L+ L L
Sbjct: 178 SNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL--CGIVASKASLRELALG 235
Query: 352 DNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLT----GT 407
N G V +A L L+ + L +L + +T G
Sbjct: 236 SNKLGDV---GMAELCPGLLHPSS-----------------RLRTLWIWECGITAKGCGD 275
Query: 408 IPHVIGELKNLQLLHLHANFLQGTIPSSLGNL-----TLLTYLSFGANNLQG----NIPF 458
+ V+ ++L+ L L N L L L L + + +
Sbjct: 276 LCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335
Query: 459 SLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLL--NGSLPLGVG---NLK 513
L + L L L +S+N L G L G
Sbjct: 336 VLAQNRFL-------------------------LELQISNNRLEDAGVRELCQGLGQPGS 370
Query: 514 SLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNF 573
L L +A S +C+SL +L + S++ELDLS N
Sbjct: 371 VLRVLWLADCDVSDS------SCSSLA--------------ATLLANHSLRELDLSNNCL 410
Query: 574 SGQIPKYL-----ENLSFLQYLNLSYNHFEGE 600
L + L+ L L ++ E
Sbjct: 411 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 44/239 (18%), Positives = 85/239 (35%), Gaps = 34/239 (14%)
Query: 669 ARRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGML 728
+ ++ + + M + + + + IG GS+G V + +
Sbjct: 21 SGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRV 80
Query: 729 VAVKVINLEQKGGSKSFAAECEALRSIR---------HRNLIKIVTICSSIDFKGVDFKA 779
VA+K I F + R +R H +++K++ I D + F
Sbjct: 81 VAIKKILRV-------FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE--KFDE 131
Query: 780 --LVYEYMQNGSLEEWLHQ--RDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVH 835
+V E + + R L+ + ++ ++ V+Y+H I+H
Sbjct: 132 LYVVLEIA-----DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILH 179
Query: 836 GDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG 894
DLKP+N L++ D V DFGLA+ + GN S + + +
Sbjct: 180 RDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 2e-14
Identities = 67/257 (26%), Positives = 103/257 (40%), Gaps = 33/257 (12%)
Query: 672 RRSAHKSSNTSQMEQQFPMVSYKELSKAT--NEFSSSNTIGRGSFGFVYKGVLHENGMLV 729
R + S +F EL+ N+FS IGRG FG VY + G +
Sbjct: 158 RGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMY 217
Query: 730 AVKVIN---LEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQ 786
A+K ++ ++ K G E L + + IV + + F D + + + M
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA--FHTPDKLSFILDLMN 275
Query: 787 NGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD 846
G L L Q S ++ +E++H+ +V+ DLKP+N+LLD
Sbjct: 276 GGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLD 326
Query: 847 HDMVAHV--SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGV- 903
HV SD GLA S + P +S+ GT GY+APE G A
Sbjct: 327 EH--GHVRISDLGLACDFSK-------KKPHASV---GTHGYMAPEVLQKGVAYDS-SAD 373
Query: 904 -YSYGILLLEIFTRRRP 919
+S G +L ++ P
Sbjct: 374 WFSLGCMLFKLLRGHSP 390
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-14
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 33/216 (15%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA---ECEALRSIRHR---NLI 761
IG+GSFG V K H+ VA+K++ + + E L +R + N +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV----RNEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
++ + + F+ + +E + +L E + + Q G +L L+++ +
Sbjct: 160 NVIHMLENFTFRN--HICMTFELLSM-NLYELIKKNKFQ-GF-SLPLVRK--FAHSILQC 212
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH--VSDFGLAKFLSASPLGNVVETPSSSIG 879
++ LH + I+H DLKP N+LL + V DFG + + + + I
Sbjct: 213 LDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--------QRVYTYI- 260
Query: 880 VKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ Y APE LG M ++S G +L E+ T
Sbjct: 261 --QSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 57/233 (24%), Positives = 92/233 (39%), Gaps = 48/233 (20%)
Query: 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR--- 756
+ + IG G+ G V VA+K + S+ F + A R+ R
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-------SRPFQNQTHAKRAYRELV 76
Query: 757 ------HRNLIKIVTI----CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNL 806
H+N+I ++ + S +F+ V +V E M +L + + D + L
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDV---YIVMELMDA-NLCQVIQMELDHERMSYL 132
Query: 807 SLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASP 866
L Q L +++LH I+H DLKPSN+++ D + DFGLA+ S
Sbjct: 133 -LYQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 867 L--GNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRR 917
+ VV T Y APE LG ++S G ++ E+
Sbjct: 182 MMTPYVV-----------TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 37/168 (22%), Positives = 68/168 (40%), Gaps = 27/168 (16%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSF--------AAECEALRSIRHRNL 760
IG G FG +Y A V+ +E + F A+ + ++ R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 761 IKIVTI-----CSSIDFKGVDFKALVYEYMQNG-SLEEWLHQRDDQLGICNLSLIQRLNI 814
+ + I +FKG ++ +V E + G L++ Q L +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNG------TFKKSTVLQL 156
Query: 815 VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD--HDMVAHVSDFGLAK 860
I + +EY+H + VHGD+K +N+LL + +++D+GL+
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 44/210 (20%), Positives = 79/210 (37%), Gaps = 50/210 (23%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR---------HRN 759
IGRGS+G+VY VA+K + ++ F + R +R
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKV-------NRMFEDLIDCKRILREITILNRLKSDY 86
Query: 760 LIKIVTIC---SSIDFKGVDFKALVYEYMQNGSLEEWLHQ--RDDQLGICNLSLIQRLNI 814
+I++ + + F + +V E + L + + L+ I
Sbjct: 87 IIRLYDLIIPDDLLKFDEL---YIVLEIA-----DSDLKKLFKTPI----FLTEEHIKTI 134
Query: 815 VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETP 874
+ ++ ++H + I+H DLKP+N LL+ D V DFGLA+ +++ N+V
Sbjct: 135 LYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 875 SSSIGVKGTI--------GYV------APE 890
+ +V APE
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPE 221
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 53/297 (17%), Positives = 96/297 (32%), Gaps = 61/297 (20%)
Query: 238 NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLA 297
+++ V+ L T + + L ++NF +N SL +NL+ LHL+
Sbjct: 17 GLANAVKQNLGKQSVTDLVSQK---ELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLS 71
Query: 298 ENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGG 357
NQ + DLS L + TKL+ L + N
Sbjct: 72 HNQ-----------ISDLSPLK---------------------DLTKLEELSVNRNRL-- 97
Query: 358 VLPHSIANLS-TALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELK 416
++ + L L N++ + +L NL L + N+L +I +G L
Sbjct: 98 ---KNLNGIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIVM-LGFLS 150
Query: 417 NLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKL 476
L++L LH N + T L L + ++ N +
Sbjct: 151 KLEVLDLHGNEI--TNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYIT-------NTV 201
Query: 477 TGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNL----KSLVRLGIARNQFSGQI 529
+ + +S D + LP+ + + +G F G +
Sbjct: 202 K-DPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVSYKFSEYINVGETEAIFDGTV 257
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 45/226 (19%), Positives = 79/226 (34%), Gaps = 21/226 (9%)
Query: 387 GIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLS 446
L N + +T + EL +Q + + + + + T L L
Sbjct: 14 PDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELH 69
Query: 447 FGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSL-SLDLSDNLLNGSL 505
N + ++ L + L RN+L + I + L L L +N L +
Sbjct: 70 LSHNQIS-DLS-PLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELRDTD 122
Query: 506 PLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKE 565
L +LK+L L I N+ + LG + LE ++L GN + T L+ L +
Sbjct: 123 SLI--HLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNW 176
Query: 566 LDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKT 611
+DL+ + KY L N + + I +
Sbjct: 177 IDLTGQKCVNEPVKYQPE---LYITNTVKDPDGRWISPYYISNGGS 219
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 44/248 (17%), Positives = 86/248 (34%), Gaps = 36/248 (14%)
Query: 331 NDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLS--TALIDFNLGKNQIYGTIPPGI 388
+ + + +Q ++ S+A + T L + +L NQI + +
Sbjct: 29 QSVTDLVSQKELSGVQNFNGDNSNI-----QSLAGMQFFTNLKELHLSHNQI--SDLSPL 81
Query: 389 ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFG 448
+L L L + NRL + + + L L + + SL +L L LS
Sbjct: 82 KDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIR 136
Query: 449 ANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALP-QQILEITTLSLS-------------- 493
N L+ +I LG L N++T ++ ++ + L+
Sbjct: 137 NNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPE 194
Query: 494 LDLSDNL--LNGSL--PLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSF 549
L +++ + +G P + N S V + V+ + E + F
Sbjct: 195 LYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVSYKFSEYINVGETEAI-F 253
Query: 550 SGTIPQSL 557
GT+ Q +
Sbjct: 254 DGTVTQPI 261
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 37/186 (19%), Positives = 70/186 (37%), Gaps = 24/186 (12%)
Query: 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHF 228
N ++G +T + LS ++ + + + + + T+L LH+ N
Sbjct: 20 NAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI-QSLA-GMQFFTNLKELHLSHNQI 75
Query: 229 SGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNA 288
S + P + +++ L E+ + NR + + L + N DS +
Sbjct: 76 S-DLSP-LKDLTKLEELSVNRNRLKN---LNGIPSA-CLSRLFLDNNELRD--TDSLIHL 127
Query: 289 SNLEVLHLAENQFRGQVSI-NFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQY 347
NLE+L + N+ + SI L L +L L N + N LT K+ +
Sbjct: 128 KNLEILSIRNNKLK---SIVMLGFLSKLEVLDLHGNEITN--------TGGLTRLKKVNW 176
Query: 348 LYLADN 353
+ L
Sbjct: 177 IDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 42/239 (17%), Positives = 84/239 (35%), Gaps = 36/239 (15%)
Query: 72 VTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFS 131
K +L QS+ ++S LS ++ N +++ + + L+ L L++N S
Sbjct: 21 AVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQIS 76
Query: 132 GRIPTNLSHCSKLITFSAHRNNLVGEIPEELIS-----------------RRLFNLQGLS 174
+ + L +KL S +RN L L NL+ LS
Sbjct: 77 -DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILS 134
Query: 175 VGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPP 234
+ +N+L +G LS L V+D+ N + L++L + ++ +
Sbjct: 135 IRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVK 190
Query: 235 SVYNISSLVEIYLYGNRFTGSLPI---------EIGKNLPNLRNFVIYTNNFTGSLPDS 284
+ + R+ I + LP + V Y + ++ ++
Sbjct: 191 YQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVSYKFSEYINVGET 249
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 4e-13
Identities = 61/261 (23%), Positives = 105/261 (40%), Gaps = 55/261 (21%)
Query: 676 HKSSNTSQMEQQFPMVSYKELSKATNE----FSSSNTIGRGSFGFVYKGVLHENGMLVAV 731
H + + S+++ QF S E+ +T + + IG G+ G V VA+
Sbjct: 36 HYNMSKSKVDNQF--YSV-EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAI 92
Query: 732 KVINLEQKGGSKSFAAECEALRSIR---------HRNLIKIVTI----CSSIDFKGVDFK 778
K + S+ F + A R+ R H+N+I ++ + + +F+ V
Sbjct: 93 KKL-------SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV--- 142
Query: 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDL 838
LV E M + L Q L + ++ + +++LH I+H DL
Sbjct: 143 YLVMELM-----DANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 190
Query: 839 KPSNVLLDHDMVAHVSDFGLAKFLSASPL--GNVVETPSSSIGVKGTIGYVAPEYGLGGE 896
KPSN+++ D + DFGLA+ S + VV T Y APE LG
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-----------TRYYRAPEVILGMG 239
Query: 897 ASMRGGVYSYGILLLEIFTRR 917
++S G ++ E+ +
Sbjct: 240 YKENVDIWSVGCIMGEMVRHK 260
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-13
Identities = 59/244 (24%), Positives = 100/244 (40%), Gaps = 67/244 (27%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR----------HR 758
+G+G++G V+K + G +VAVK I +F +A R+ R H
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQ--RDDQLG---ICNLSLIQRLN 813
N++ ++ + + + + V LV++YM E LH R + L + + Q +
Sbjct: 70 NIVNLLNVLRADNDRDV---YLVFDYM-----ETDLHAVIRANILEPVHKQYV-VYQLIK 120
Query: 814 IVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVET 873
++YLH ++H D+KPSN+LL+ + V+DFGL++
Sbjct: 121 -------VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 874 PSSSIGVKGTI-------GYV------APEYGLGGEASMRGGVYSYGI-------LLLEI 913
S + + YV APE LG S + Y+ GI +L EI
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLG---STK---YTKGIDMWSLGCILGEI 224
Query: 914 FTRR 917
+
Sbjct: 225 LCGK 228
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 66/231 (28%), Positives = 96/231 (41%), Gaps = 51/231 (22%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA----ECEALRSIRHRNLIKIV 764
+G G++G V G +VA+K I K FA E + L+ +H N+I I
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDK---PLFALRTLREIKILKHFKHENIITIF 75
Query: 765 TIC---SSIDFKGVDFKALVYEYMQNGSLEEWLHQ--RDDQLG---ICNLSLIQRLNIVI 816
I S +F V ++ E M + LH+ L I + Q L
Sbjct: 76 NIQRPDSFENFNEV---YIIQELM-----QTDLHRVISTQMLSDDHIQYF-IYQTLR--- 123
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
AV+ LH ++H DLKPSN+L++ + V DFGLA+ + S N T
Sbjct: 124 ----AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 877 SIGVKGTIGYV------APEYGLGGEASMRGG----VYSYGILLLEIFTRR 917
S + +V APE L S + V+S G +L E+F RR
Sbjct: 177 SG----MVEFVATRWYRAPEVMLT---SAKYSRAMDVWSCGCILAELFLRR 220
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 39/166 (23%), Positives = 74/166 (44%), Gaps = 13/166 (7%)
Query: 194 LRVIDIRTNRLWGKIP--ITLSQLTSLAYLHVGDNHFSGTIPPSV-YNISSLVEIYLYGN 250
++D+ N L ++ T ++LT+L L + NH + I + +L + L N
Sbjct: 41 TALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 251 RFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQ---FRGQVSI 307
+L + +L L ++Y N+ ++F + + L+ L+L++NQ F ++
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIK 157
Query: 308 NFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADN 353
+ N L L +L L++N L DL + LYL +N
Sbjct: 158 DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV----KNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 38/177 (21%), Positives = 70/177 (39%), Gaps = 15/177 (8%)
Query: 134 IPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASI-GNLS 192
+P +L + L+ S +N + + E RL NL L + N L + + +
Sbjct: 33 VPQSLPSYTALLDLS---HNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 193 ALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNHFSGTIPPSV-YNISSLVEIYLYGN 250
LR +D+ +N L + S L +L L + +NH + + +++ L ++YL N
Sbjct: 89 NLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146
Query: 251 RFTGSLPIEI---GKNLPNLRNFVIYTNNFTGSLPDSFSNASNL--EVLHLAENQFR 302
+ + P+E+ G LP L + +N L+L N
Sbjct: 147 QIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 41/185 (22%), Positives = 67/185 (36%), Gaps = 26/185 (14%)
Query: 280 SLPDSFSNASNLEVLHLAENQFRG-QVSINFNGLKDLSMLGLATN---FLGNGAANDLDF 335
++P S S +L L+ N + L +L L L+ N F+ + A F
Sbjct: 32 NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEA-----F 84
Query: 336 VDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNL 394
V + L+YL L+ N + ++L AL L N I + ++ L
Sbjct: 85 VPV----PNLRYLDLSSNHLHTLDEFLFSDL-QALEVLLLYNNHI-VVVDRNAFEDMAQL 138
Query: 395 NSLRMEANRLTGTIP----HVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGAN 450
L + N+++ P +L L LL L +N L+ + L L
Sbjct: 139 QKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL--- 194
Query: 451 NLQGN 455
L N
Sbjct: 195 YLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 30/161 (18%), Positives = 52/161 (32%), Gaps = 8/161 (4%)
Query: 345 LQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANR 403
L L+ N + T L L N + I + NL L + +N
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNH 99
Query: 404 LTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPF----S 459
L + +L+ L++L L+ N + ++ ++ L L N + P
Sbjct: 100 LHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKD 158
Query: 460 LGNCKNLMFFFAPRNKLTGALPQQILEITTLS-LSLDLSDN 499
LM NKL + ++ L L +N
Sbjct: 159 GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 39/189 (20%), Positives = 61/189 (32%), Gaps = 39/189 (20%)
Query: 417 NLQLLHLHANFLQGTIPS--SLGNLTLLTYLSFGANNLQGNIP-FSLGNCKNLMFFFAPR 473
LL L N L + + + LT L L N+L I + NL +
Sbjct: 40 YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRY----- 92
Query: 474 NKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGIARNQFSGQIPV- 531
LDLS N L+ +L + +L++L L + N +
Sbjct: 93 --------------------LDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRN 130
Query: 532 TLGACTSLEYVELQGNSFSGTIP----QSLSSLTSIKELDLSQNNFSGQIPKYLENLSFL 587
L+ + L N S P + + L + LDLS N L+ L
Sbjct: 131 AFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAW 189
Query: 588 QYLNLSYNH 596
L ++
Sbjct: 190 VKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 27/126 (21%), Positives = 44/126 (34%), Gaps = 31/126 (24%)
Query: 473 RNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV--GNLKSLVRLGIARNQFSGQIP 530
+ +L +PQ + T LDLS N L L L +L L ++ N +
Sbjct: 27 KQQLP-NVPQSLPSYTA---LLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN---- 77
Query: 531 VTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYL 590
+ +F + +++ LDLS N+ +L L+ L
Sbjct: 78 ------------FISSEAFVP--------VPNLRYLDLSSNHLHTLDEFLFSDLQALEVL 117
Query: 591 NLSYNH 596
L NH
Sbjct: 118 LLYNNH 123
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 51/199 (25%), Positives = 83/199 (41%), Gaps = 40/199 (20%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFA---AECEALRSIRH 757
++F T+G GSFG V E+G A+K+++ ++ K E L+++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLN---- 813
L+K+ S FK +V EY+ G + + H R I R +
Sbjct: 101 PFLVKL--EFS---FKDNSNLYMVMEYVAGGEM--FSHLRR----------IGRFSEPHA 143
Query: 814 --IVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVV 871
+ EYLH +++ DLKP N+L+D V+DFG AK V
Sbjct: 144 RFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---------RV 191
Query: 872 ETPSSSIGVKGTIGYVAPE 890
+ + ++ GT +APE
Sbjct: 192 KGRTWTLC--GTPEALAPE 208
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 50/164 (30%), Positives = 67/164 (40%), Gaps = 17/164 (10%)
Query: 292 EVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLG---NGAANDLDFVDLLTNCTKLQYL 348
E L L F GL L+ L L N L G +DL T+L L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDL---------TELGTL 88
Query: 349 YLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGT 407
LA+N LP + + T L LG NQ+ ++P G+ L L LR+ N+L +
Sbjct: 89 GLANNQL-ASLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-S 145
Query: 408 IPH-VIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGAN 450
IP +L NLQ L L N LQ + L L ++ N
Sbjct: 146 IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 7/156 (4%)
Query: 171 QGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNHFS 229
+ L + L A+ L+ L +++ N+L + LT L L + +N +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 230 GTIPPSVY-NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDS-FSN 287
++P V+ +++ L ++YL GN+ SLP + L L+ + TN S+P F
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153
Query: 288 ASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATN 323
+NL+ L L+ NQ + F+ L L + L N
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 42/170 (24%), Positives = 65/170 (38%), Gaps = 13/170 (7%)
Query: 383 TIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSL-GNLTL 441
++P GI + L +++ L L L L+L N LQ T+ + + +LT
Sbjct: 28 SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 442 LTYLSFGANNLQ---GNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSD 498
L L N L + L L N+L +LP + + T L L+
Sbjct: 85 LGTLGLANNQLASLPLGVFDHLTQLDKLYLG---GNQLK-SLPSGVFDRLTKLKELRLNT 140
Query: 499 NLLNGSLPLGV-GNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGN 547
N L S+P G L +L L ++ NQ L+ + L GN
Sbjct: 141 NQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 7/140 (5%)
Query: 165 RRLFNLQGLSVGDNQLTGQLPASI-GNLSALRVIDIRTNRLWGKIPITL-SQLTSLAYLH 222
R L L L++ NQL L A + +L+ L + + N+L +P+ + LT L L+
Sbjct: 56 RGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQL-ASLPLGVFDHLTQLDKLY 113
Query: 223 VGDNHFSGTIPPSVY-NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSL 281
+G N ++P V+ ++ L E+ L N+ S+P L NL+ + TN
Sbjct: 114 LGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVP 171
Query: 282 PDSFSNASNLEVLHLAENQF 301
+F L+ + L NQF
Sbjct: 172 HGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 36/160 (22%), Positives = 66/160 (41%), Gaps = 9/160 (5%)
Query: 121 ETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQL 180
E L L + + +KL + N L + + L L L + +NQL
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAG-VFDDLTELGTLGLANNQL 95
Query: 181 TGQLPASI-GNLSALRVIDIRTNRLWGKIPITL-SQLTSLAYLHVGDNHFSGTIPPSVYN 238
LP + +L+ L + + N+L +P + +LT L L + N +IP ++
Sbjct: 96 A-SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152
Query: 239 -ISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNF 277
+++L + L N+ S+P L L+ ++ N F
Sbjct: 153 KLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 43/157 (27%), Positives = 62/157 (39%), Gaps = 13/157 (8%)
Query: 375 LGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPS 434
L + L L L ++ N+L V +L L L L N L ++P
Sbjct: 42 LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPL 100
Query: 435 SL-GNLTLLTYLSFGANNLQGNIP---F-SLGNCKNLMFFFAPRNKLTGALPQQILEITT 489
+ +LT L L G N L+ +P F L K L N+L ++P + T
Sbjct: 101 GVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLN---TNQLQ-SIPAGAFDKLT 155
Query: 490 LSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGIARNQF 525
+L LS N L S+P G L L + + NQF
Sbjct: 156 NLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 42/163 (25%), Positives = 62/163 (38%), Gaps = 16/163 (9%)
Query: 221 LHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGS 280
L + + + ++ L + L N+ +L + +L L + N S
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 281 LPDS-FSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLG---NGAANDLDFV 336
LP F + + L+ L+L NQ + S F+ L L L L TN L GA + L
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKL--- 154
Query: 337 DLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQ 379
T LQ L L+ N V PH + L L NQ
Sbjct: 155 ------TNLQTLSLSTNQLQSV-PHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 44/162 (27%), Positives = 63/162 (38%), Gaps = 15/162 (9%)
Query: 419 QLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ---GNIPFSLGNCKNLMFFFAPRNK 475
+ L L + L ++ LT LT+L+ N LQ + L L N+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA---NNQ 94
Query: 476 LTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGIARNQFSGQIPVTLG 534
L +LP + + T L L N L SLP GV L L L + NQ IP G
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPA--G 149
Query: 535 A---CTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNF 573
A T+L+ + L N + L ++ + L N F
Sbjct: 150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 45/180 (25%), Positives = 78/180 (43%), Gaps = 17/180 (9%)
Query: 280 SLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLL 339
+ + ++++ + + + L ++ L L N L + + + L
Sbjct: 33 DAV-TQNELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLHD-----ISALKEL 84
Query: 340 TNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIAN-LVNLNSLR 398
TN L YL L N LP+ + + T L + L +NQ+ ++P G+ + L NL L
Sbjct: 85 TN---LTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYLN 139
Query: 399 MEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSL-GNLTLLTYLSFGANNLQGNIP 457
+ N+L V +L NL L L N LQ ++P + LT L L N L+ ++P
Sbjct: 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVP 197
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 50/212 (23%), Positives = 88/212 (41%), Gaps = 27/212 (12%)
Query: 121 ETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQL 180
L S + + N + I + V I L N++ L++G N+L
Sbjct: 22 IKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQ------YLPNVRYLALGGNKL 75
Query: 181 TGQLPASIG---NLSALRVIDIRTNRLWGKIPITL-SQLTSLAYLHVGDNHFSGTIPPSV 236
I L+ L + + N+L +P + +LT+L L + +N ++P V
Sbjct: 76 H-----DISALKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQ-SLPDGV 128
Query: 237 YN-ISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDS-FSNASNLEVL 294
++ +++L + L N+ SLP + L NL + N SLP+ F + L+ L
Sbjct: 129 FDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDL 186
Query: 295 HLAENQFRGQVSI---NFNGLKDLSMLGLATN 323
L +NQ + S+ F+ L L + L N
Sbjct: 187 RLYQNQLK---SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 53/194 (27%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 165 RRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVG 224
L ++ + ++ + + I L +R + + N+L I L +LT+L YL +
Sbjct: 38 NELNSIDQIIANNSDIKS-VQG-IQYLPNVRYLALGGNKL-HDISA-LKELTNLTYLILT 93
Query: 225 DNHFSGTIPPSVYN-ISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPD 283
N ++P V++ +++L E+ L N+ SLP + L NL + N SLP
Sbjct: 94 GNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPK 150
Query: 284 S-FSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLG---NGAANDLDFVDLL 339
F +NL L L+ NQ + F+ L L L L N L +G + L
Sbjct: 151 GVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL------ 204
Query: 340 TNCTKLQYLYLADN 353
T LQY++L DN
Sbjct: 205 ---TSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 59/251 (23%), Positives = 88/251 (35%), Gaps = 67/251 (26%)
Query: 364 ANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHL 423
+ I NL K + L +++ + + + ++ I L N++ L L
Sbjct: 15 DDAFAETIKANLKKKSV-TDAVTQN-ELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLAL 70
Query: 424 HANFLQGTIPSSLG---NLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGAL 480
N L + LT LTYL N LQ +L
Sbjct: 71 GGNKLH-----DISALKELTNLTYLILTGNQLQ-------------------------SL 100
Query: 481 PQQILEITTLSLSLDLSDNLLNGSLPLGVGN-LKSLVRLGIARNQFSGQIPVTLGACTSL 539
P + + T L L +N L SLP GV + L +L L +A NQ SL
Sbjct: 101 PNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQL-----------QSL 148
Query: 540 EYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPK-YLENLSFLQYLNLSYNHFE 598
LT++ ELDLS N +P+ + L+ L+ L L N +
Sbjct: 149 P-------------KGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK 194
Query: 599 GEVPTKGIFKN 609
VP G+F
Sbjct: 195 S-VP-DGVFDR 203
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 47/185 (25%), Positives = 78/185 (42%), Gaps = 21/185 (11%)
Query: 173 LSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTI 232
++ +T L+++ I + + I L ++ YL +G N
Sbjct: 24 ANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQGI--QYLPNVRYLALGGNKL--HD 77
Query: 233 PPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDS-FSNASNL 291
++ +++L + L GN+ SLP + L NL+ V+ N SLPD F +NL
Sbjct: 78 ISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNL 135
Query: 292 EVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLG---NGAANDLDFVDLLTNCTKLQYL 348
L+LA NQ + F+ L +L+ L L+ N L G + L T+L+ L
Sbjct: 136 TYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKL---------TQLKDL 186
Query: 349 YLADN 353
L N
Sbjct: 187 RLYQN 191
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 49/231 (21%), Positives = 80/231 (34%), Gaps = 51/231 (22%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVIN--LEQKGGSKSFAAECEALRSIR---------H 757
I GS+G V GV G+ VA+K + + + R +R H
Sbjct: 30 ISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 758 RNLIKIVTI---CSSIDFKGVDFKALVYEYMQNGSLEEWLHQ--RDDQLGICNLSLIQRL 812
N++ + I + LV E M L Q D ++ +S
Sbjct: 89 PNILGLRDIFVHFEEPAMHKL---YLVTELM-----RTDLAQVIHDQRI---VISPQHIQ 137
Query: 813 NIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPL--GNV 870
+ + + LH + +VH DL P N+LL + + DF LA+ +A V
Sbjct: 138 YFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV 194
Query: 871 VETPSSSIGVKGTIGYVAPEYGLGGEASMRGG----VYSYGILLLEIFTRR 917
Y APE + ++S G ++ E+F R+
Sbjct: 195 T-----------HRWYRAPELVMQ---FKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.4 bits (169), Expect = 3e-12
Identities = 39/219 (17%), Positives = 67/219 (30%), Gaps = 11/219 (5%)
Query: 378 NQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLG 437
A L + + T + + K LQ L + TI +
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMR 393
Query: 438 NLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLS 497
L L Y + + R+K +E L L+
Sbjct: 394 ALDPLLYEKETLQYFST---LKAVDPMRAAYLDDLRSKFLLENSVLKMEYAD-VRVLHLA 449
Query: 498 DNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSL 557
L L + L + L ++ N+ +P L A LE ++ N+ + +
Sbjct: 450 HKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GV 504
Query: 558 SSLTSIKELDLSQNNFSG-QIPKYLENLSFLQYLNLSYN 595
++L ++EL L N + L + L LNL N
Sbjct: 505 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.5 bits (151), Expect = 5e-10
Identities = 52/369 (14%), Positives = 99/369 (26%), Gaps = 55/369 (14%)
Query: 74 KLDLRNQSIG----GILSPYVG-NLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANN 128
D +QS +L ++ +++ + + R+ TL+L +
Sbjct: 220 FTDPNDQSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVD 279
Query: 129 SFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQL------TG 182
+ + + + ++L + S +
Sbjct: 280 EAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE 339
Query: 183 QLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSL 242
L ++ + + L L L + TI + + L
Sbjct: 340 CWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPL 398
Query: 243 VEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFR 302
E + L+ L ++F
Sbjct: 399 ------------LYEKETLQYFSTLKAVDP----------------MRAAYLDDLRSKFL 430
Query: 303 GQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHS 362
+ S+ D+ +L LA L + L + +L L+ N LP +
Sbjct: 431 LENSVLKMEYADVRVLHLAHKDLTV--------LCHLEQLLLVTHLDLSHNRL-RALPPA 481
Query: 363 IANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHV--IGELKNLQL 420
+A L L N + G+ANL L L + NRL + + L L
Sbjct: 482 LAAL-RCLEVLQASDNAL--ENVDGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVL 537
Query: 421 LHLHANFLQ 429
L+L N L
Sbjct: 538 LNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 1e-09
Identities = 49/332 (14%), Positives = 97/332 (29%), Gaps = 33/332 (9%)
Query: 32 LAIKSQLHDPLGVTSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVG 91
L +++ HD L AC+++C R + +D S+
Sbjct: 235 LLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRN 294
Query: 92 NLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRI----PTNLSHCSKLITF 147
S + ++ + ++P + + + + +L
Sbjct: 295 RPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRC 354
Query: 148 SAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGK 207
+ EL S LQ L + + I + AL + L
Sbjct: 355 ELSVEKST-VLQSELES--CKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQ-- 406
Query: 208 IPITLSQLTSLAYLHVGD-----NHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGK 262
S L ++ + + F + + ++L T + +
Sbjct: 407 ---YFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV---LCHLE 460
Query: 263 NLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSI-NFNGLKDLSMLGLA 321
L + + + N +LP + + LEVL ++N ++ L L L L
Sbjct: 461 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE---NVDGVANLPRLQELLLC 516
Query: 322 TNFLGNGAANDLDFVDLLTNCTKLQYLYLADN 353
N L + L +C +L L L N
Sbjct: 517 NNRL-----QQSAAIQPLVSCPRLVLLNLQGN 543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 37/192 (19%), Positives = 69/192 (35%), Gaps = 50/192 (26%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA-ECEALRSIRHRNLIKIVTIC 767
+G GSFG V + E+G A+K + + + + E + ++ + H N+IK+V
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYF 69
Query: 768 SSIDFKGVDFKA---------------------------------LVYEYMQNGSLEEWL 794
+ + ++ EY+ + L
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-----PDTL 124
Query: 795 HQRDDQLGICN--LSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD-HDMVA 851
H+ + + + + AV ++H I H D+KP N+L++ D
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTL 181
Query: 852 HVSDFGLAKFLS 863
+ DFG AK L
Sbjct: 182 KLCDFGSAKKLI 193
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 31/217 (14%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA---ECEALRSIRHR---NL 760
+ IG+GSFG V K VA+K+I K E L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKII----KNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
IV + F+ LV+E + +L + L + + G+ +L+L ++ + +
Sbjct: 116 YYIVHLKRHFMFRN--HLCLVFEMLSY-NLYDLLRNTNFR-GV-SLNLTRK--FAQQMCT 168
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH--VSDFGLAKFLSASPLGNVVETPSSSI 878
A+ +L + I+H DLKP N+LL + + + DFG S+ LG + S
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG-----SSCQLGQRIYQYIQS- 221
Query: 879 GVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
Y +PE LG + ++S G +L+E+ T
Sbjct: 222 -----RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 57/237 (24%), Positives = 97/237 (40%), Gaps = 57/237 (24%)
Query: 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR--- 756
+ S +G G++G V + +G VA+K + S+ F +E A R+ R
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEIFAKRAYRELL 75
Query: 757 ------HRNLIKIVTI----CSSIDFKGVDFKALVYEYMQNGSLEEWLHQR--DDQLGIC 804
H N+I ++ + S +F LV +MQ L++ + + +++
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDF---YLVMPFMQT-DLQKIMGLKFSEEK---I 128
Query: 805 NLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSA 864
+ Q L ++Y+H +VH DLKP N+ ++ D + DFGLA+ A
Sbjct: 129 QYLVYQMLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178
Query: 865 SPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGG----VYSYGILLLEIFTRR 917
G VV T Y APE L M ++S G ++ E+ T +
Sbjct: 179 EMTGYVV-----------TRWYRAPEVILS---WMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 41/212 (19%), Positives = 80/212 (37%), Gaps = 33/212 (15%)
Query: 669 ARRRRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLH----- 723
+ ++ +SS + +QF + A + IG+G FG +Y ++
Sbjct: 4 VKAAQAGRQSSAKRHLAEQFAVGEIITDMAA-AAWKVGLPIGQGGFGCIYLADMNSSESV 62
Query: 724 ENGMLVAVKVINLEQKG---GSKSF--AAECEALRSIRHRNLIKIVTICSSIDF-----K 773
+ VKV + K + AA+ E ++ +K + +
Sbjct: 63 GSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKN 122
Query: 774 GVDFKALVYEYMQNG-SLEEWLHQRDDQLGICN--LSLIQRLNIVIDVASAVEYLHHHCQ 830
G ++ ++ + G L+ S L + + + +EY+H H
Sbjct: 123 GKSYRFMIMDRF--GSDLQ-------KIYEANAKRFSRKTVLQLSLRILDILEYIHEHE- 172
Query: 831 PPIVHGDLKPSNVLLD--HDMVAHVSDFGLAK 860
VHGD+K SN+LL+ + ++ D+GLA
Sbjct: 173 --YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 31/135 (22%), Positives = 58/135 (42%), Gaps = 5/135 (3%)
Query: 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNH 227
+ + + N + P + LR ID+ N++ ++ L SL L + N
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNK 91
Query: 228 FSGTIPPSV-YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFS 286
+ +P S+ + SL + L N+ L ++ ++L NL +Y N +FS
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 287 NASNLEVLHLAENQF 301
++ +HLA+N F
Sbjct: 150 PLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 33/131 (25%), Positives = 58/131 (44%), Gaps = 5/131 (3%)
Query: 195 RVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSV-YNISSLVEIYLYGNRFT 253
I + N + P S L + + +N S + P + SL + LYGN+ T
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 254 GSLPIEIGKNLPNLRNFVIYTNNFTGSLP-DSFSNASNLEVLHLAENQFRGQVSINFNGL 312
LP + + L +L+ ++ N L D+F + NL +L L +N+ + F+ L
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 313 KDLSMLGLATN 323
+ + + LA N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 31/109 (28%), Positives = 47/109 (43%), Gaps = 3/109 (2%)
Query: 346 QYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRL 404
+ L N + P + + L +L NQI + P L +LNSL + N++
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPY-KKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKI 92
Query: 405 TGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453
T + L +LQLL L+AN + + +L L LS N LQ
Sbjct: 93 TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 26/110 (23%), Positives = 44/110 (40%), Gaps = 5/110 (4%)
Query: 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEA 401
KL+ + L++N L +L L N+I +P + L +L L + A
Sbjct: 56 KKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNA 113
Query: 402 NRLTGTIPH-VIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGAN 450
N++ + +L NL LL L+ N LQ + L + + N
Sbjct: 114 NKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 38/167 (22%), Positives = 56/167 (33%), Gaps = 36/167 (21%)
Query: 263 NLP-NLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLA 321
NLP + + N P +FS L + L+ NQ F GL+ L+ L L
Sbjct: 29 NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLY 88
Query: 322 TNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIY 381
N + + + LQ L L N+I
Sbjct: 89 GNKITELPKSLFE------GLFSLQLLLLNA-------------------------NKI- 116
Query: 382 GTIPPGI-ANLVNLNSLRMEANRLTGTIPH-VIGELKNLQLLHLHAN 426
+ +L NLN L + N+L TI L+ +Q +HL N
Sbjct: 117 NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 27/138 (19%), Positives = 53/138 (38%), Gaps = 11/138 (7%)
Query: 417 NLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIP---F-SLGNCKNLMFFFAP 472
+ + L N ++ P + L + N + + F L + +L+ +
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLY--- 88
Query: 473 RNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGIARNQFSGQIPV 531
NK+T LP+ + E L L+ N +N L + +L +L L + N+
Sbjct: 89 GNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKG 146
Query: 532 TLGACTSLEYVELQGNSF 549
T +++ + L N F
Sbjct: 147 TFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 23/106 (21%), Positives = 41/106 (38%), Gaps = 2/106 (1%)
Query: 494 LDLSDNLLNGSLPLGV-GNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGT 552
+DLS+N ++ L L+SL L + N+ + SL+ + L N +
Sbjct: 61 IDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCL 119
Query: 553 IPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFE 598
+ L ++ L L N L +Q ++L+ N F
Sbjct: 120 RVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 30/133 (22%), Positives = 55/133 (41%), Gaps = 6/133 (4%)
Query: 72 VTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRI-GNLFRLETLVLANNSF 130
+T++ L +I I LR I++++N E+ L L +LVL N
Sbjct: 34 ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92
Query: 131 SGRIPTNL-SHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIG 189
+ +P +L L + N + + + + L NL LS+ DN+L +
Sbjct: 93 T-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAF-QDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 190 NLSALRVIDIRTN 202
L A++ + + N
Sbjct: 150 PLRAIQTMHLAQN 162
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 1e-11
Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 50/204 (24%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFA---AECEALRSIRH 757
+F T+G GSFG V+ NG A+KV+ E K E L + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
+I++ + F+ ++ +Y++ G L SL+++ +
Sbjct: 66 PFIIRM--WGT---FQDAQQIFMIMDYIEGGEL---------------FSLLRKSQRFPN 105
Query: 818 ---------VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASP 866
V A+EYLH I++ DLKP N+LLD + H+ +DFG AK
Sbjct: 106 PVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFGFAK------ 154
Query: 867 LGNVVETPSSSIGVKGTIGYVAPE 890
V + ++ GT Y+APE
Sbjct: 155 ---YVPDVTYTLC--GTPDYIAPE 173
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 58/239 (24%), Positives = 95/239 (39%), Gaps = 56/239 (23%)
Query: 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA----ECEALRSI 755
+++ + IG G++G V + N + VA+K I+ + +++ E + L
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRF 82
Query: 756 RHRNLIKIVTICSSIDFKGVDFKA--LVYEYMQNGSLEEWLHQ--RDDQLG---ICNLSL 808
RH N+I I I + + K +V + M E L++ + L IC L
Sbjct: 83 RHENIIGINDIIRAPTIE--QMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYF-L 134
Query: 809 IQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLG 868
Q L ++Y+H ++H DLKPSN+LL+ + DFGLA+
Sbjct: 135 YQILR-------GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 869 NVVETPSSSIGVKGTIGYV------APEYGLGGEASMRGG----VYSYGILLLEIFTRR 917
T YV APE L S ++S G +L E+ + R
Sbjct: 185 TGFLT-----------EYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 57/239 (23%), Positives = 93/239 (38%), Gaps = 60/239 (25%)
Query: 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR--- 756
+ +G G++G V V G VA+K + + F +E A R+ R
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-------YRPFQSELFAKRAYRELR 76
Query: 757 ------HRNLIKIVTI----CSSIDFKGVDFKALVYEYMQNGSLEEWLHQ--RDDQLGIC 804
H N+I ++ + + DF LV +M L + + ++LG
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDF---YLVMPFM-----GTDLGKLMKHEKLGED 128
Query: 805 NLSLI--QRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862
+ + Q L + Y+H I+H DLKP N+ ++ D + DFGLA+
Sbjct: 129 RIQFLVYQMLK-------GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178
Query: 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGG----VYSYGILLLEIFTRR 917
+ G VV T Y APE L MR ++S G ++ E+ T +
Sbjct: 179 DSEMTGYVV-----------TRWYRAPEVILN---WMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 43/162 (26%), Positives = 66/162 (40%), Gaps = 30/162 (18%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
IG G+FG + G VA+K+ ++ + ++ L I
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-------YKQLGSGDGIPQ 69
Query: 769 SIDFKGV--DFKALVYEYMQNG-SLEEWLHQRDDQLGICN--LSLIQRLNIVIDVASAVE 823
F G + A+V E + G SLE D +C+ SL L I I + S +E
Sbjct: 70 VYYF-GPCGKYNAMVLELL--GPSLE-------DLFDLCDRTFSLKTVLMIAIQLISRME 119
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHDM-----VAHVSDFGLAK 860
Y+H +++ D+KP N L+ V H+ DF LAK
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 27/137 (19%), Positives = 51/137 (37%), Gaps = 8/137 (5%)
Query: 169 NLQGLSVGDNQLTGQLP-ASIGNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDN 226
L + +N+ T L LR I+ N++ I + + + + N
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSN 91
Query: 227 HFSGTIPPSV-YNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPD-S 284
+ + + SL + L NR T + + L ++R +Y N T ++ +
Sbjct: 92 RLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148
Query: 285 FSNASNLEVLHLAENQF 301
F +L L+L N F
Sbjct: 149 FDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 25/109 (22%), Positives = 41/109 (37%), Gaps = 2/109 (1%)
Query: 346 QYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRL 404
L L +N F + I L N N+I I G +N + + +NRL
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRL 93
Query: 405 TGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453
+ L++L+ L L +N + S L+ + LS N +
Sbjct: 94 ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 22/125 (17%), Positives = 52/125 (41%), Gaps = 8/125 (6%)
Query: 324 FLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGT 383
L N L+ + +L+ + ++N + + + + + L N++
Sbjct: 38 RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGA-SGVNEILLTSNRL-EN 95
Query: 384 IPPGI-ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIP----SSLGN 438
+ + L +L +L + +NR+T L +++LL L+ N + T+ +L +
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHS 154
Query: 439 LTLLT 443
L+ L
Sbjct: 155 LSTLN 159
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 39/197 (19%), Positives = 59/197 (29%), Gaps = 65/197 (32%)
Query: 232 IPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNL 291
IP E+ L N FT I K LP LR N T +F AS +
Sbjct: 30 IPQYT------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 292 EVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLA 351
+ L N+ L+++ + F L L+ L L
Sbjct: 84 NEILLTSNR-----------LENVQ----------HKM-----FKGL----ESLKTLMLR 113
Query: 352 DNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPH 410
N+I + L ++ L + N++T T+
Sbjct: 114 S-------------------------NRI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVAP 146
Query: 411 -VIGELKNLQLLHLHAN 426
L +L L+L AN
Sbjct: 147 GAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 25/125 (20%), Positives = 45/125 (36%), Gaps = 2/125 (1%)
Query: 474 NKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGIARNQFSGQIPVT 532
N+ T I + ++ S+N + + G + + + N+
Sbjct: 42 NEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKM 100
Query: 533 LGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNL 592
SL+ + L+ N + S L+S++ L L N + P + L L LNL
Sbjct: 101 FKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNL 160
Query: 593 SYNHF 597
N F
Sbjct: 161 LANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 27/161 (16%), Positives = 56/161 (34%), Gaps = 32/161 (19%)
Query: 417 NLQLLHLHANFLQGTIPSSL-GNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNK 475
L L+ N + + L L ++F N + +I F +
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGA---------FEGASG 82
Query: 476 LTGALPQQILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGIARNQFSGQIPV-TL 533
+ + L+ N L ++ + L+SL L + N+ + + +
Sbjct: 83 VN---------------EILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSF 125
Query: 534 GACTSLEYVELQGNSFSGTIPQ-SLSSLTSIKELDLSQNNF 573
+S+ + L N + T+ + +L S+ L+L N F
Sbjct: 126 IGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 57/239 (23%), Positives = 92/239 (38%), Gaps = 60/239 (25%)
Query: 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR--- 756
+ + + +G G++G V + G+ VAVK + S+ F + A R+ R
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQSIIHAKRTYRELR 80
Query: 757 ------HRNLIKIVTI----CSSIDFKGVDFKALVYEYMQNGSLEEWLHQ-------RDD 799
H N+I ++ + S +F V LV M L+ DD
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLM-----GADLNNIVKCQKLTDD 132
Query: 800 QLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859
+ Q L ++Y+H I+H DLKPSN+ ++ D + DFGLA
Sbjct: 133 H---VQFLIYQILR-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 179
Query: 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRR 917
+ + G V T Y APE L + ++S G ++ E+ T R
Sbjct: 180 RHTADEMTGYVA-----------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 8e-11
Identities = 36/147 (24%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-----HRNLIKI 763
+G G F V+ + VA+KV+ + + E L+S+R N +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 764 VTICSSIDFKGVDFK--ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
V + GV+ +V+E + + L +W+ + + Q L +++ I+ V
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQG--LPLPCVKK--IIQQVLQG 158
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHD 848
++YLH C+ I+H D+KP N+LL +
Sbjct: 159 LDYLHTKCR--IIHTDIKPENILLSVN 183
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 58/239 (24%), Positives = 90/239 (37%), Gaps = 57/239 (23%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVI---NLEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
+G+G+FG V G A+K++ + K E L++ RH L +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-- 213
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNI---------VI 816
S F+ D V EY G L + H + R +
Sbjct: 214 KYS---FQTHDRLCFVMEYANGGEL--FFH-------------LSRERVFSEDRARFYGA 255
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
++ SA++YLH +V+ DLK N++LD D ++DFGL K G
Sbjct: 256 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK------EGIKDGATMK 307
Query: 877 SIGVKGTIGYVAPEYGLG---GEASMRGGV--YSYGILLLEIFTRRRP-----TESMFN 925
+ GT Y+APE G A V + G+++ E+ R P E +F
Sbjct: 308 TFC--GTPEYLAPEVLEDNDYGRA-----VDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 47/233 (20%), Positives = 85/233 (36%), Gaps = 53/233 (22%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTI-- 766
+G G G V+ V ++ VA+K I L K E + +R + H N++K+ I
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 767 -----CSSIDFKGVDFKA--LVYEYMQNGSLEEWLHQ--RDDQLGI--CNLSLIQRLNIV 815
+ + + +V EYM E L L L + Q L
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLFMYQLLR-- 131
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLSASPLGNVVETP 874
++Y+H ++H DLKP+N+ ++ D+V + DFGLA+ + +
Sbjct: 132 -----GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS- 182
Query: 875 SSSIGVKGTIGYV------APEYGLGGEASMRGG----VYSYGILLLEIFTRR 917
+ +P L +++ G + E+ T +
Sbjct: 183 ----------EGLVTKWYRSPRLLLS---PNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 31/172 (18%), Positives = 63/172 (36%), Gaps = 32/172 (18%)
Query: 709 IGRGSFGFVYKGV--------LHENGMLVAVKV------INLEQKGGSKSFAAECEALRS 754
R + G +Y+ ++K+ + EQ + AA+ +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQR--AAKPLQVNK 107
Query: 755 IRHRNLIKIVTICSSIDF--KGVDFKALVYEYMQNG-SLEEWLHQRDDQLGICNLSLIQR 811
+ ++ I + + F ++ LV + G SL+ L + LS
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHV----LSERSV 161
Query: 812 LNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAK 860
L + + A+E+LH + VHG++ N+ + D V ++ +G A
Sbjct: 162 LQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 2e-10
Identities = 33/197 (16%), Positives = 58/197 (29%), Gaps = 39/197 (19%)
Query: 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVI--------NLEQKGGSKSFAAECE 750
T + IG G FG V++ + + VA+K+I N + + E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 751 ALR---SIRHRNLIKIVTICSSIDF---KGVDFKALVYEYMQ----NGSLEEWLHQR-DD 799
+ + + +G L+ + GS + DD
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 800 QLGIC----------------NLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNV 843
QL I SL +I+ + +++ + H DL NV
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNV 193
Query: 844 LLDHDMVAHVSDFGLAK 860
LL + + K
Sbjct: 194 LLKKTSLKKLHYTLNGK 210
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 36/112 (32%), Positives = 53/112 (47%), Gaps = 4/112 (3%)
Query: 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEA 401
T Q LYL DN L + + L + LG NQ+ G +P G+ +L L L +
Sbjct: 40 TNAQILYLHDNQITK-LEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGT 97
Query: 402 NRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453
N+LT V L +L+ L + N L +P + LT LT+L+ N L+
Sbjct: 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK 148
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 34/104 (32%), Positives = 49/104 (47%), Gaps = 4/104 (3%)
Query: 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEA 401
L+ LYL N G LP + + T L +LG NQ+ +P + LV+L L M
Sbjct: 64 INLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL-TVLPSAVFDRLVHLKELFMCC 121
Query: 402 NRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYL 445
N+LT +P I L +L L L N L+ + L+ LT+
Sbjct: 122 NKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA 164
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 31/130 (23%), Positives = 57/130 (43%), Gaps = 4/130 (3%)
Query: 195 RVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYN-ISSLVEIYLYGNRFT 253
+++ + N++ P L +L L++G N +P V++ ++ L + L N+ T
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 254 GSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLK 313
LP + L +L+ + N T LP ++L L L +NQ + F+ L
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 314 DLSMLGLATN 323
L+ L N
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 38/135 (28%), Positives = 54/135 (40%), Gaps = 14/135 (10%)
Query: 419 QLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ---GNIPFSLGNCKNLMFFFAPRNK 475
Q+L+LH N + P +L L L G+N L + SL L N+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG---TNQ 99
Query: 476 LTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGA 535
LT LP + + L + N L LP G+ L L L + +NQ + GA
Sbjct: 100 LT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS---IPHGA 154
Query: 536 ---CTSLEYVELQGN 547
+SL + L GN
Sbjct: 155 FDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 37/132 (28%), Positives = 60/132 (45%), Gaps = 7/132 (5%)
Query: 121 ETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQL 180
+ L L +N + P L N L +P + L L L +G NQL
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVG-VFDSLTQLTVLDLGTNQL 100
Query: 181 TGQLPASI-GNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVY-N 238
T LP+++ L L+ + + N+L ++P + +LT L +L + N +IP +
Sbjct: 101 T-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIPHGAFDR 157
Query: 239 ISSLVEIYLYGN 250
+SSL YL+GN
Sbjct: 158 LSSLTHAYLFGN 169
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 26/159 (16%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
IG GSFG +Y G G VA+K+ ++ K E + + + V I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIY-----KMMQGGVGIP- 68
Query: 769 SIDFKGV--DFKALVYEYMQNGSLEEWLHQRDDQLGICN--LSLIQRLNIVIDVASAVEY 824
+I + G D+ +V E + SLE D C+ SL L + + S +EY
Sbjct: 69 TIRWCGAEGDYNVMVME-LLGPSLE-------DLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 825 LHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAK 860
+H +H D+KP N L+ + ++ DFGLAK
Sbjct: 121 IHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 6/107 (5%)
Query: 346 QYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRL 404
LYL N F ++P ++N L +L N+I T+ +N+ L +L + NRL
Sbjct: 34 TELYLDGNQFT-LVPKELSNY-KHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRL 90
Query: 405 TGTIPHVIGELKNLQLLHLHANFLQGTIP-SSLGNLTLLTYLSFGAN 450
P LK+L+LL LH N + +P + +L+ L++L+ GAN
Sbjct: 91 RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 38/114 (33%), Positives = 56/114 (49%), Gaps = 16/114 (14%)
Query: 244 EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPD-SFSNASNLEVLHLAENQFR 302
E+YL GN+FT +P E+ N +L + N + +L + SFSN + L L L+ N+ R
Sbjct: 35 ELYLDGNQFT-LVPKEL-SNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 303 GQVSINFNGLKDLSMLGLATNFLG---NGAANDLDFVDLLTNCTKLQYLYLADN 353
F+GLK L +L L N + GA NDL + L +L + N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDL---------SALSHLAIGAN 136
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 55/339 (16%), Positives = 101/339 (29%), Gaps = 71/339 (20%)
Query: 313 KDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANL---STA 369
+ L + + + +L ++ + L+ N G ++
Sbjct: 4 FSIEGKSLKLDAITTEDEKSV--FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 61
Query: 370 LIDFNLGKNQI---YGTIPPGIANLV-------NLNSLRMEANRLTGTIPHVIGEL---- 415
L IP + L+ L+++R+ N T + +
Sbjct: 62 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 121
Query: 416 KNLQLLHLHANFL-------------QGTIPSSLGNLTLLTYLSFGANNLQGN----IPF 458
L+ L+LH N L + + N L + G N L+
Sbjct: 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 181
Query: 459 SLGNCKNLMFFFAPRNKLT-----GALPQQILEITTLSLSLDLSDNLL--NGSLPLG--V 509
+ + + L +N + L + + L LDL DN GS L +
Sbjct: 182 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK-VLDLQDNTFTHLGSSALAIAL 240
Query: 510 GNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLS 569
+ +L LG+ S + GA ++ N ++ L L
Sbjct: 241 KSWPNLRELGLNDCLLSAR-----GAAAVVDAFSKLEN-------------IGLQTLRLQ 282
Query: 570 QNNFSGQIPKYL-----ENLSFLQYLNLSYNHF--EGEV 601
N + L E + L +L L+ N F E +V
Sbjct: 283 YNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDV 321
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 67/383 (17%), Positives = 116/383 (30%), Gaps = 86/383 (22%)
Query: 239 ISSLVEIYLYGNRFTGSLPIEIGKNL---PNLRNFVIYTNNFTG----SLPDSFSNASNL 291
S+ L + T + L +++ V+ N L ++ ++ +L
Sbjct: 3 RFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 62
Query: 292 EVLHLAENQFRGQVSINFNGLKD----------LSMLGLATNFLGNGAANDLDFVDLLTN 341
E+ ++ L+ L + L+ N G A L +D L+
Sbjct: 63 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPL--IDFLSK 120
Query: 342 CTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEA 401
T L++LYL +NG G P + A ++ AL + + K L S+
Sbjct: 121 HTPLEHLYLHNNGLG---PQAGAKIARALQELAVNKKAKNAP---------PLRSIICGR 168
Query: 402 NRLTG----TIPHVIGELKNLQLLHLHANFL-----QGTIPSSLGNLTLLTYLSFGANNL 452
NRL + L + + N + + + L L L N
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
Query: 453 --QG--NIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLL--NGSLP 506
G + +L + NL L L+D LL G+
Sbjct: 229 THLGSSALAIALKSWPNL-------------------------RELGLNDCLLSARGAAA 263
Query: 507 LG----VGNLKSLVRLGIARNQFSGQIPVTLGA-----CTSLEYVELQGNSFS------G 551
+ L L + N+ TL L ++EL GN FS
Sbjct: 264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVD 323
Query: 552 TIPQSLSSLTSIKELDLSQNNFS 574
I + S+ + +L
Sbjct: 324 EIREVFSTRGRGELDELDDMEEL 346
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 62/326 (19%), Positives = 93/326 (28%), Gaps = 74/326 (22%)
Query: 67 RRNQRVTKLDLRNQSIGG----ILSPYVGNLSFLRYINIADN---DFHGEIPDRIGNLFR 119
+ V ++ L +IG LS + + L +D EIP+ + L +
Sbjct: 29 LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQ 88
Query: 120 -------LETLVLANNSFSGR----IPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLF 168
L T+ L++N+F + LS + L H N L G I+R L
Sbjct: 89 ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL-GPQAGAKIARALQ 147
Query: 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRL-------WGKIPITLSQLTSLAYL 221
L N LR I NRL W K T L +
Sbjct: 148 ELAVNK------------KAKNAPPLRSIICGRNRLENGSMKEWAK---TFQSHRLLHTV 192
Query: 222 HVGDNHF-----SGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNN 276
+ N + + L + L N FT + L +
Sbjct: 193 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP-------- 244
Query: 277 FTGSLPDSFSNASNLEVLHLAENQFRGQ------VSINFNGLKDLSMLGLATNFLGNGAA 330
NL L L + + + + L L L N + A
Sbjct: 245 -------------NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 291
Query: 331 NDLDFVDLLTNCTKLQYLYLADNGFG 356
L V + L +L L N F
Sbjct: 292 RTLKTV-IDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 22/171 (12%), Positives = 50/171 (29%), Gaps = 24/171 (14%)
Query: 487 ITTLSL-SLDLSDNLLN--GSLPLG--VGNLKSLVRLGIARNQFSGQ----IPVTLGACT 537
+ S+ L + + + + S+ + ++ N + + + +
Sbjct: 1 MARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 60
Query: 538 SLEYVELQGNSFS----------GTIPQSLSSLTSIKELDLSQNNFSGQ----IPKYLEN 583
LE E + Q+L + + LS N F + +L
Sbjct: 61 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120
Query: 584 LSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDELHLPSCQ 634
+ L++L L N G I + ++ K L + +
Sbjct: 121 HTPLEHLYLHNNGL-GPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 51/225 (22%)
Query: 708 TIGRGSFGFVY---KGVLHENGMLVAVKVIN----LEQKGGSKSFAAECEALRSIRHRNL 760
+G G++G V+ K H+ G L A+KV+ +++ ++ E + L IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNI------ 814
+ VT+ + F+ L+ +Y+ G L + + +
Sbjct: 121 L--VTLHYA--FQTETKLHLILDYINGGEL---------------FTHLSQRERFTEHEV 161
Query: 815 ---VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGN 869
V ++ A+E+LH I++ D+K N+LLD + HV +DFGL+K
Sbjct: 162 QIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSKE-------F 209
Query: 870 VVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGV--YSYGILLLE 912
V + + GTI Y+AP+ GG++ V +S G+L+ E
Sbjct: 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 58/244 (23%), Positives = 91/244 (37%), Gaps = 68/244 (27%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVI---NLEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
+G+G+FG V G A+K++ + K E L++ RH L +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNI---------VI 816
+ F+ D V EY G L + H + R +
Sbjct: 72 -YA---FQTHDRLCFVMEYANGGEL--FFH-------------LSRERVFTEERARFYGA 112
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETP 874
++ SA+EYLH +V+ D+K N++LD D H+ +DFGL K G
Sbjct: 113 EIVSALEYLHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK------EGISDGAT 161
Query: 875 SSSIGVKGTIGYVAPE------YGLGGEASMRGGV--YSYGILLLEIFTRRRP-----TE 921
+ GT Y+APE YG V + G+++ E+ R P E
Sbjct: 162 MKTFC--GTPEYLAPEVLEDNDYGR--------AVDWWGLGVVMYEMMCGRLPFYNQDHE 211
Query: 922 SMFN 925
+F
Sbjct: 212 RLFE 215
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 38/161 (23%), Positives = 61/161 (37%), Gaps = 28/161 (17%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
IG GSFG +++G N VA+K + E + L I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKL-----LAGCTGIPN 70
Query: 769 SIDFKGV--DFKALVYEYMQNGSLEEWLHQRDDQLGICN--LSLIQRLNIVIDVASAVEY 824
F G LV + + SLE D L +C S+ + + V+
Sbjct: 71 VYYF-GQEGLHNVLVID-LLGPSLE-------DLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 825 LHHHCQPPIVHGDLKPSNVLL-----DHDMVAHVSDFGLAK 860
+H +V+ D+KP N L+ + + +V DFG+ K
Sbjct: 122 IHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 47/202 (23%), Positives = 88/202 (43%), Gaps = 57/202 (28%)
Query: 709 IGRGSFGFVY---KGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIK--- 762
+G+GSFG V+ K + L A+KV+ K+ + +R+ R+++
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDRVRTKMERDILVEVN 84
Query: 763 ---IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNI----- 814
IV + + F+ L+ ++++ G L + + + +
Sbjct: 85 HPFIVKLHYA--FQTEGKLYLILDFLRGGDL--FTR-------------LSKEVMFTEED 127
Query: 815 ----VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLG 868
+ ++A A+++LH I++ DLKP N+LLD + H+ +DFGL+K
Sbjct: 128 VKFYLAELALALDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLSK------ES 176
Query: 869 NVVETPSSSIGVKGTIGYVAPE 890
E + S GT+ Y+APE
Sbjct: 177 IDHEKKAYSFC--GTVEYMAPE 196
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 48/227 (21%), Positives = 83/227 (36%), Gaps = 33/227 (14%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA---ECEALRSIRHR--NLIK 762
+G G+FG V +N AVKV+ + K + E + L+ I++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV----RNIKKYTRSAKIEADILKKIQNDDINNNN 97
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
IV + L++E + SL E + + + G ++ I+ I++ A+
Sbjct: 98 IVKYHGKFMYYD--HMCLIFEPL-GPSLYEIITRNNYN-GF-HIEDIKL--YCIEILKAL 150
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS------- 875
YL + H DLKP N+LLD ++
Sbjct: 151 NYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
Query: 876 SSIGVKGTIG-------YVAPEYGLGGEASMRGGVYSYGILLLEIFT 915
+ G Y APE L + ++S+G +L E++T
Sbjct: 208 CATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 26/107 (24%), Positives = 47/107 (43%), Gaps = 4/107 (3%)
Query: 346 QYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRL 404
L L DN G + + L+ L +NQ+ I P ++ L++ N++
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKI 90
Query: 405 TGTIPH-VIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGAN 450
I + + L L+ L+L+ N + +P S +L LT L+ +N
Sbjct: 91 K-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 30/117 (25%), Positives = 44/117 (37%), Gaps = 20/117 (17%)
Query: 244 EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDS-FSNASNLEVLHLAENQFR 302
E+ L N + LP+L + N T + + F AS+++ L L EN+ +
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 303 GQVSIN---FNGLKDLSMLGLATNFLG---NGAANDLDFVDLLTNCTKLQYLYLADN 353
I+ F GL L L L N + G+ L L L LA N
Sbjct: 92 ---EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL---------NSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 20/82 (24%), Positives = 36/82 (43%), Gaps = 3/82 (3%)
Query: 374 NLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTI 432
L N++ G+ L +L L ++ N+LTG P+ ++Q L L N ++ I
Sbjct: 35 LLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EI 93
Query: 433 PSSL-GNLTLLTYLSFGANNLQ 453
+ + L L L+ N +
Sbjct: 94 SNKMFLGLHQLKTLNLYDNQIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 22/90 (24%), Positives = 41/90 (45%), Gaps = 5/90 (5%)
Query: 214 QLTSLAYLHVGDNHFSGTIPPSVY-NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVI 272
+L L L + N + I P+ + S + E+ L N+ + ++ L L+ +
Sbjct: 52 RLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNL 109
Query: 273 YTNNFTGSLPD-SFSNASNLEVLHLAENQF 301
Y N + + SF + ++L L+LA N F
Sbjct: 110 YDNQIS-CVMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 26/102 (25%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 152 NNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASI-GNLSALRVIDIRTNRLWGKIPI 210
+N +G I + + RL +L L + NQLTG + + S ++ + + N++ +I
Sbjct: 38 DNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKI-KEISN 95
Query: 211 -TLSQLTSLAYLHVGDNHFSGTIPPSVY-NISSLVEIYLYGN 250
L L L++ DN S + P + +++SL + L N
Sbjct: 96 KMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 9e-09
Identities = 52/235 (22%), Positives = 87/235 (37%), Gaps = 49/235 (20%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVI---NLEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
+G+GSFG V L AVK++ + Q + E L +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL--TQ 406
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYL 825
+ S F+ +D V EY+ G L + Q + ++A + +L
Sbjct: 407 LHSC--FQTMDRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFL 458
Query: 826 HHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
I++ DLK NV+LD + H+ +DFG+ K + + GT
Sbjct: 459 QSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK------ENIWDGVTTKTFC--GT 505
Query: 884 IGYVAPE------YGLGGEASMRGGV--YSYGILLLEIFTRRRP-----TESMFN 925
Y+APE YG V +++G+LL E+ + P + +F
Sbjct: 506 PDYIAPEIIAYQPYGK--------SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 9e-09
Identities = 49/200 (24%), Positives = 84/200 (42%), Gaps = 51/200 (25%)
Query: 709 IGRGSFGFVY---KGVLHENGMLVAVKVIN----LEQKGGSKSFAAECEALRSIRHRNLI 761
+G+G +G V+ K G + A+KV+ + + AE L ++H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH---P 81
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNI------- 814
IV + + F+ L+ EY+ G L ++ ++R I
Sbjct: 82 FIVDLIYA--FQTGGKLYLILEYLSGGEL--FMQ-------------LEREGIFMEDTAC 124
Query: 815 --VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNV 870
+ +++ A+ +LH I++ DLKP N++L+H HV +DFGL K
Sbjct: 125 FYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCK------ESIH 173
Query: 871 VETPSSSIGVKGTIGYVAPE 890
T + + GTI Y+APE
Sbjct: 174 DGTVTHTFC--GTIEYMAPE 191
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.3 bits (140), Expect = 1e-08
Identities = 95/629 (15%), Positives = 187/629 (29%), Gaps = 154/629 (24%)
Query: 371 IDFNLGKNQI-YGTI-----PPGIANLVNLNSLRMEANRLTGT-IPHVIGELKNLQLLHL 423
+DF G++Q Y I + N + M + L+ I H+I +
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTL- 65
Query: 424 HANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPF--------SLGNCKNLMFFFAPRNK 475
L T+ S F L+ N F + R++
Sbjct: 66 ---RLFWTLLSKQEE----MVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 476 LTGAL----------PQQILEITTLSLSLDLSDNL-LNGSLPLGVGNLKSLVRLGIARN- 523
L Q L++ L L + N+ ++G LG G K+ V L + +
Sbjct: 119 LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG--VLGSG--KTWVALDVCLSY 174
Query: 524 ----QFSGQIP-VTLGACTSLEYVELQGNSFSGTIPQSLSSLTSI-KELDLSQNNFSGQI 577
+ +I + L C S E V I + +S + + L ++ ++
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL 234
Query: 578 PKYLENLSFLQYL----NLSY----NHFEGEVPT------KGIF-----KNKTGFSIVGN 618
+ L++ + L N+ N F K + T S+ +
Sbjct: 235 RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH 294
Query: 619 GK------------LCGGLDELHLPSCQARGSRKPNVNLVKVVIPVIGGSCLILSVCIFI 666
LP + + P + +I S + + +
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQDLPR-EVL-TTNP------RRLSIIAES-IRDGLATWD 345
Query: 667 FYARRRRSAHKSSNTSQMEQQFPMV---SYKELSKATNEFSSSNTIGRGSFGFVYKGVLH 723
+ + S + P + LS F S I ++ V+
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV----FPPSAHIPTILLSLIWFDVIK 401
Query: 724 ENGMLVAVKVIN--LEQKGGSKS----------FAAECEALRSIRHRNLIKIVTICSSID 771
+ M+V K+ L +K +S + E ++ HR+++ I + D
Sbjct: 402 SDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVDHYNIPKTFD 460
Query: 772 FKG-----VD---FKALVYEYMQNGSLEE-------------WLHQ--RDDQLGICNLSL 808
+D + + + +++N E +L Q R D
Sbjct: 461 SDDLIPPYLDQYFYSHIGH-HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGS 519
Query: 809 IQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLG 868
I LN + + Y + I D K ++ + FL
Sbjct: 520 I--LNTLQQLKF---YKPY-----ICDNDPKYERLVNA-----------ILDFLP-KIEE 557
Query: 869 NVVETPSSSIGVKGTIGYVAPEYGLGGEA 897
N++ + + + ++ I +A + + EA
Sbjct: 558 NLICSKYTDL-LR--IALMAEDEAIFEEA 583
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 1e-07
Identities = 66/478 (13%), Positives = 139/478 (29%), Gaps = 117/478 (24%)
Query: 565 ELDLSQNNFSGQ--IPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLC 622
+ + ++ + + + + + F+ N + K I + I+ +
Sbjct: 8 DFETGEHQYQYKDILSVFEDA--FVD--NFDCKDVQDM--PKSILSKEEIDHIIMSKDAV 61
Query: 623 GGLDELHLPSCQARGSRKPNVNLVKVVIPVIGGSCLILSVCIFIFYARRRRSAHKSSNTS 682
G L K +V+ + L ++ F+ + S T
Sbjct: 62 SGTLRLFWTLLS-----KQE-EMVQKFV----EEVLRINYK-FLMSPIKTEQRQPSMMTR 110
Query: 683 QMEQQ----------FP--MVS----YKELSKATNEFSSSNTI---GRGSFGFVYKGVLH 723
+Q F VS Y +L +A E + + G G K +
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWV- 166
Query: 724 ENGMLVAVKVIN---LEQKGGSKSF---AAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777
A+ V ++ K K F C + ++ L + + ID ++
Sbjct: 167 ------ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETV----LEMLQKLLYQID---PNW 213
Query: 778 KALVYEYMQNGSLE-EWLHQRDDQLGICNLSLIQRLNIVIDVASA--VEYLHHHCQPPIV 834
+ ++ N L + +L + + L ++++V +A + C+ +
Sbjct: 214 TSRS-DHSSNIKLRIHSIQAELRRL-LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLT 271
Query: 835 HGDLKPSNVLLDHDMVAHVS----DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE 890
+ ++ L H+S L S L ++ + P
Sbjct: 272 TRFKQVTDFL-SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL----------PR 320
Query: 891 YGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA------KRALPEKVME 944
E + S+ ++ + K +K+
Sbjct: 321 -----EVL--------TTNPRRL--------SII--AESIRDGLATWDNWKHVNCDKLTT 357
Query: 945 IVDPSLLPLEEERTNSRRVRNEECLV----AVIKTGVACSIESPFDRMEMTDVVVKLC 998
I++ SL LE R + V A I T + I + ++ VV KL
Sbjct: 358 IIESSLNVLEPAEY---RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLH 412
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 53/228 (23%), Positives = 94/228 (41%), Gaps = 35/228 (15%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVI---NLEQKGGSKSFAAECEAL-RSIRHRNLIKIV 764
+G+GSFG V+ + A+K + + + E L + H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
C+ F+ + V EY+ G L + L + ++ +++
Sbjct: 85 --CT---FQTKENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQF 133
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPSSSIGVKG 882
LH IV+ DLK N+LLD D H+ +DFG+ K + + +++ G
Sbjct: 134 LHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCK------ENMLGDAKTNTFC--G 180
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP-----TESMFN 925
T Y+APE LG + + +S+G+LL E+ + P E +F+
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 5/113 (4%)
Query: 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIAN-LVNLNSLRMEA 401
+ YL L N LP+ + + T+L LG N++ ++P G+ N L +L L +
Sbjct: 28 AQTTYLDLETNSLKS-LPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLST 85
Query: 402 NRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSL-GNLTLLTYLSFGANNLQ 453
N+L V +L L+ L L+ N LQ ++P + LT L L N L+
Sbjct: 86 NQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK 137
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 41/142 (28%), Positives = 59/142 (41%), Gaps = 15/142 (10%)
Query: 216 TSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTN 275
YL + N ++SL ++YL GN+ SLP + L +L + TN
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 276 NFTGSLPDS-FSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLG---NGAAN 331
SLP+ F + L+ L L NQ + F+ L L L L N L +G +
Sbjct: 87 QLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFD 145
Query: 332 DLDFVDLLTNCTKLQYLYLADN 353
L T LQY++L DN
Sbjct: 146 RL---------TSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 36/153 (23%), Positives = 50/153 (32%), Gaps = 27/153 (17%)
Query: 364 ANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHL 423
+ +L N + L +L L + N+L V +L +L L+L
Sbjct: 24 TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNL 83
Query: 424 HANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQ 483
N LQ LT L L+ N LQ +LP
Sbjct: 84 STNQLQSLPNGVFDKLTQLKELALNTNQLQ-------------------------SLPDG 118
Query: 484 ILEITTLSLSLDLSDNLLNGSLPLGV-GNLKSL 515
+ + T L L N L S+P GV L SL
Sbjct: 119 VFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSL 150
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 33/133 (24%), Positives = 56/133 (42%), Gaps = 8/133 (6%)
Query: 121 ETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQL 180
L L NS + L N L + + +L +L L++ NQL
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL--QSLPNGVFNKLTSLTYLNLSTNQL 88
Query: 181 TGQLPASI-GNLSALRVIDIRTNRLWGKIPI-TLSQLTSLAYLHVGDNHFSGTIPPSVY- 237
LP + L+ L+ + + TN+L +P +LT L L + N ++P V+
Sbjct: 89 Q-SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFD 145
Query: 238 NISSLVEIYLYGN 250
++SL I+L+ N
Sbjct: 146 RLTSLQYIWLHDN 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 47/159 (29%), Positives = 71/159 (44%), Gaps = 26/159 (16%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICS 768
IG GSFG +Y G + VA+K+ N++ K E + R L I
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIY-----RILQGGTGIP- 66
Query: 769 SIDFKGV--DFKALVYEYMQNGSLEEWLHQRDDQLGICN--LSLIQRLNIVIDVASAVEY 824
++ + GV D+ LV + + SLE D C+ LSL L + + + VE+
Sbjct: 67 NVRWFGVEGDYNVLVMD-LLGPSLE-------DLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAH---VSDFGLAK 860
+H +H D+KP N L+ A+ + DFGLAK
Sbjct: 119 VHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 57/202 (28%), Positives = 84/202 (41%), Gaps = 58/202 (28%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVI---NLEQKGGSKSFAAECEALRSIRHRNLIK--- 762
IG+GSFG V + AVKV+ + +K K +E R++ L+K
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE----RNV----LLKNVK 97
Query: 763 ---IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNI----- 814
+V + S F+ D V +Y+ G L + H +QR
Sbjct: 98 HPFLVGLHFS--FQTADKLYFVLDYINGGEL--FYH-------------LQRERCFLEPR 140
Query: 815 ----VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLG 868
++ASA+ YLH IV+ DLKP N+LLD H+ +DFGL K
Sbjct: 141 ARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCK------EN 189
Query: 869 NVVETPSSSIGVKGTIGYVAPE 890
+ +S+ GT Y+APE
Sbjct: 190 IEHNSTTSTFC--GTPEYLAPE 209
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 34/148 (22%), Positives = 63/148 (42%), Gaps = 21/148 (14%)
Query: 708 TIGRGSFGFVYKGVLHE-NGMLVAVKVINLEQKGGSKSFAA---ECEALRSIRHR---NL 760
+G G+FG V + + H VA+K+I + K A E L+ I+ + N
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII----RNVGKYREAARLEINVLKKIKEKDKENK 81
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
V + +F G + +E + + E+L + + Q L ++ + +
Sbjct: 82 FLCVLMSDWFNFHG--HMCIAFELL-GKNTFEFLKENNFQ-PY-PLPHVRH--MAYQLCH 134
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHD 848
A+ +LH + + H DLKP N+L +
Sbjct: 135 ALRFLHENQ---LTHTDLKPENILFVNS 159
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 59/372 (15%), Positives = 119/372 (31%), Gaps = 29/372 (7%)
Query: 240 SSLVEIYLYGNRF---TGSLPIEIGKNLPNLR--NFVIYTNNFT-GSLPDSFSNASNLEV 293
+L E+ L + +G +L N + + +L + NL+
Sbjct: 156 RNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKS 215
Query: 294 LHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADN 353
L L +++ L LG L+ C +L+ L +
Sbjct: 216 LKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWD 275
Query: 354 GFGGVLPHSIANLSTALIDFNLGKNQIYGT-IPPGIANLVNLNSLRMEANRLTGTIPHVI 412
LP + ++ + L NL + + + L L + + +
Sbjct: 276 AVPAYLPA-VYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLA 334
Query: 413 GELKNLQLLHLHANFLQGTIPSSLGNLTL--LTYLSFGANNLQGNIPFSLGNCKN----- 465
K+L+ L + + + LT L +S G L+ L C+
Sbjct: 335 STCKDLRELRV--FPSEPFVMEPNVALTEQGLVSVSMGCPKLE----SVLYFCRQMTNAA 388
Query: 466 LMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQF 525
L+ R +T + L I L+ L+ V + K L RL +
Sbjct: 389 LITIARNRPNMT----RFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSL-SGLL 443
Query: 526 SGQIPVTLGA-CTSLEYVELQGNSFSGT-IPQSLSSLTSIKELDLSQNNFSGQ-IPKYLE 582
+ ++ +G +E + + S + LS S+++L++ F + +
Sbjct: 444 TDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANAS 503
Query: 583 NLSFLQYLNLSY 594
L ++ L +S
Sbjct: 504 KLETMRSLWMSS 515
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 82/553 (14%), Positives = 163/553 (29%), Gaps = 84/553 (15%)
Query: 42 LGVTSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQSIGGILS--PYVGNLSFLRYI 99
+ + N + V C+ W + R ++V + S ++ P V ++
Sbjct: 21 IQLDKDRNSVSLV--CKSWYEIERWCR-RKVFIGNCYAVSPATVIRRFPKVRSVELKGKP 77
Query: 100 NIADN-----DFHGEIPDRIGNLFR----LETLVLANNSFSGRIPTNLS-HCSKLITFSA 149
+ AD + G + I + LE + L + ++
Sbjct: 78 HFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVL 137
Query: 150 HRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLS----ALRVIDIRTNRLW 205
I+ NL+ L + ++ + + + +L ++I
Sbjct: 138 SSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNIS----C 193
Query: 206 GKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLP 265
++ S L L +L + L L + + P
Sbjct: 194 LASEVSFSALERLV-----------------TRCPNLKSLKLNRAVPLEKL-ATLLQRAP 235
Query: 266 NLRNFVIY------TNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLG 319
L + L + S L L + + ++ L+ L
Sbjct: 236 QLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLN 295
Query: 320 LATNFLGNGAANDLDFVDLLTNCTKLQYLYLADN-GFGGVLPHSIANLSTALIDFNLGKN 378
L+ + D V LL C KLQ L++ D G+ +A+ L + + +
Sbjct: 296 LSYATV-----QSYDLVKLLCQCPKLQRLWVLDYIEDAGL--EVLASTCKDLRELRVFPS 348
Query: 379 QIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGN 438
+ P + V L + + V L+ + + N
Sbjct: 349 E-----PFVMEPNVALTEQGLVS---------VSMGCPKLESVLYFC--------RQMTN 386
Query: 439 LTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSD 498
L+T ++ N+ F L + + L I+E L LS
Sbjct: 387 AALIT-IARNRPNMTR---FRLCIIEPKAPDYLTLEPLDIGF-GAIVEHCKDLRRLSLSG 441
Query: 499 NLLNGSLPLGVGNLKSLVRLGIARNQFSGQ-IPVTLGACTSLEYVELQGNSFSG-TIPQS 556
L + K + L +A S + L C SL +E++ F + +
Sbjct: 442 LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLAN 501
Query: 557 LSSLTSIKELDLS 569
S L +++ L +S
Sbjct: 502 ASKLETMRSLWMS 514
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 9e-08
Identities = 23/95 (24%), Positives = 35/95 (36%), Gaps = 1/95 (1%)
Query: 231 TIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASN 290
+ +L E+Y+ + L + + L LRN I + PD+F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 291 LEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFL 325
L L+L+ N GL L L L+ N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 7e-06
Identities = 22/115 (19%), Positives = 36/115 (31%), Gaps = 5/115 (4%)
Query: 140 HCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPA-SIGNLSALRVID 198
R+ + + L NL L + + Q L + L LR +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHL--PGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 199 IRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFT 253
I + L P L+ L++ N ++ SL E+ L GN
Sbjct: 63 IVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 13/72 (18%), Positives = 26/72 (36%), Gaps = 1/72 (1%)
Query: 383 TIPPGIANLVNLNSLRMEANRLTGTIP-HVIGELKNLQLLHLHANFLQGTIPSSLGNLTL 441
+ NL L +E + + + L L+ L + + L+ P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 442 LTYLSFGANNLQ 453
L+ L+ N L+
Sbjct: 82 LSRLNLSFNALE 93
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 5e-05
Identities = 18/95 (18%), Positives = 31/95 (32%), Gaps = 3/95 (3%)
Query: 360 PHSIANLSTALIDFNLGKNQIYGTIPPG-IANLVNLNSLRMEANRLTGTIPHVIGELKNL 418
H + L + + Q + + L L +L + + L P L
Sbjct: 24 LHHLPGA-ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 419 QLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453
L+L N L+ ++ L+ L L N L
Sbjct: 83 SRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 5e-05
Identities = 20/95 (21%), Positives = 32/95 (33%), Gaps = 2/95 (2%)
Query: 504 SLPLGVGNLKSLVRLGIARNQFSGQIP-VTLGACTSLEYVELQGNSFSGTIPQSLSSLTS 562
+ ++L L I Q + L L + + + P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 563 IKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHF 597
+ L+LS N K ++ LS LQ L LS N
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 2e-04
Identities = 7/48 (14%), Positives = 14/48 (29%), Gaps = 1/48 (2%)
Query: 552 TIPQSLSSLTSIKELDLSQNNFSGQIPKY-LENLSFLQYLNLSYNHFE 598
L ++ EL + + L L L+ L + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 16/102 (15%), Positives = 33/102 (32%), Gaps = 4/102 (3%)
Query: 104 NDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTN-LSHCSKLITFSAHRNNLVGEIPEEL 162
D + + L L + N + L +L + ++ L + +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 163 ISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRL 204
L L++ N L ++ LS L+ + + N L
Sbjct: 76 F-HFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 58/272 (21%), Positives = 106/272 (38%), Gaps = 73/272 (26%)
Query: 678 SSNTSQMEQQFPMVSYKELSKATNEFSSSN-----TIGRGSFGFVYKGVLHENGMLVAVK 732
+ S +E++ ++ +E KA++ + IGRGS+ V L + + A++
Sbjct: 24 GAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMR 83
Query: 733 VINLEQKGGSKSFAAECEALRSIRH-RNLIKIVTICSSIDFKGVDFKA---------LVY 782
V+ K + E + ++ +++ + + + V + V
Sbjct: 84 VV-------KKELVNDDEDIDWVQTEKHVFEQASNHPFL----VGLHSCFQTESRLFFVI 132
Query: 783 EYMQNGSL------EEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHG 836
EY+ G L + L + + +SL A+ YLH I++
Sbjct: 133 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------------ALNYLHER---GIIYR 177
Query: 837 DLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG 894
DLK NVLLD + H+ +D+G+ K G +S+ GT Y+APE
Sbjct: 178 DLKLDNVLLDSE--GHIKLTDYGMCK------EGLRPGDTTSTFC--GTPNYIAPEI--- 224
Query: 895 GEASMRGGVY-------SYGILLLEIFTRRRP 919
+RG Y + G+L+ E+ R P
Sbjct: 225 ----LRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 33/148 (22%), Positives = 63/148 (42%), Gaps = 21/148 (14%)
Query: 708 TIGRGSFGFVYKGVLHE-NGMLVAVKVINLEQKGGSKSFAA---ECEALRSIRHR---NL 760
T+G G+FG V + + H+ G VAVK++ K + A E + L + +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV----KNVDRYCEAARSEIQVLEHLNTTDPNST 76
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
+ V + + G +V+E + S +++ + L I++ + +
Sbjct: 77 FRCVQMLEWFEHHG--HICIVFELL-GLSTYDFIKENGFL-PF-RLDHIRK--MAYQICK 129
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHD 848
+V +LH + + H DLKP N+L
Sbjct: 130 SVNFLHSNK---LTHTDLKPENILFVQS 154
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 26/123 (21%), Positives = 48/123 (39%), Gaps = 13/123 (10%)
Query: 232 IPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNL 291
+ ++ + + + L N I + NLR + N + + + A L
Sbjct: 40 MDATLSTLKACKHLALSTNNIEK---ISSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95
Query: 292 EVLHLAENQFRGQVSI-NFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYL 350
E L ++ NQ S+ L +L +L ++ N + + +D L KL+ L L
Sbjct: 96 EELWISYNQIA---SLSGIEKLVNLRVLYMSNNKI-----TNWGEIDKLAALDKLEDLLL 147
Query: 351 ADN 353
A N
Sbjct: 148 AGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 33/144 (22%), Positives = 55/144 (38%), Gaps = 18/144 (12%)
Query: 287 NASNLEVLHLAENQFRG--QVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTK 344
A+ E + L ++ + LK L L+TN + + L+
Sbjct: 21 VATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNNIEK--------ISSLSGMEN 71
Query: 345 LQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRL 404
L+ L L N + ++ ++ L + + NQI GI LVNL L M N++
Sbjct: 72 LRILSLGRNLIKKI--ENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKI 127
Query: 405 TGTIPHV--IGELKNLQLLHLHAN 426
T + + L L+ L L N
Sbjct: 128 T-NWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 24/101 (23%), Positives = 36/101 (35%), Gaps = 20/101 (19%)
Query: 532 TLGACTSLEYVELQGNSFSG--TIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQY 589
T E VEL + +LS+L + K L LS NN +I L + L+
Sbjct: 18 KSVVATEAEKVELH-GMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRI 74
Query: 590 LNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDELHL 630
L+L N + I + L+EL +
Sbjct: 75 LSLGRNLIK---------------KIENLDAVADTLEELWI 100
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 17/70 (24%), Positives = 31/70 (44%), Gaps = 3/70 (4%)
Query: 529 IPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQ 588
+ TL + +++ L N+ I SLS + +++ L L +N +I L+
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 589 YLNLSYNHFE 598
L +SYN
Sbjct: 97 ELWISYNQIA 106
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 31/166 (18%), Positives = 57/166 (34%), Gaps = 32/166 (19%)
Query: 109 EIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLF 168
++ + L + L L+ N+ +I ++LS L S RN + +I E +
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KI--ENLDAVAD 93
Query: 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHF 228
L+ L + NQ+ L + I L LRV+ + N+ ++ + L
Sbjct: 94 TLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNK--------ITNWGEIDKLA------ 137
Query: 229 SGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYT 274
+ L ++ L GN R V+
Sbjct: 138 ---------ALDKLEDLLLAGNPLYNDYKEN--NATSEYRIEVVKR 172
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 4e-07
Identities = 55/230 (23%), Positives = 86/230 (37%), Gaps = 56/230 (24%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVI---NLEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
IGRGS+ V L + + A+KV+ + E + +V
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF--LVG 74
Query: 766 ICSSIDFKGVDFKALVYEYMQNGSL------EEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
+ S F+ V EY+ G L + L + + +SL
Sbjct: 75 LHSC--FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL----------- 121
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPSSS 877
A+ YLH I++ DLK NVLLD + H+ +D+G+ K G +S+
Sbjct: 122 -ALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK------EGLRPGDTTST 169
Query: 878 IGVKGTIGYVAPE------YGLGGEASMRGGV--YSYGILLLEIFTRRRP 919
GT Y+APE YG V ++ G+L+ E+ R P
Sbjct: 170 FC--GTPNYIAPEILRGEDYGF--------SVDWWALGVLMFEMMAGRSP 209
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 4e-07
Identities = 30/123 (24%), Positives = 51/123 (41%), Gaps = 36/123 (29%)
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPS 875
+A + +L I++ DLK NV+LD + H+ +DFG+ K +
Sbjct: 130 IAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK------ENIWDGVTT 178
Query: 876 SSIGVKGTIGYVAPE------YGLGGEASMRGGV--YSYGILLLEIFTRRRP-----TES 922
+ GT Y+APE YG V +++G+LL E+ + P +
Sbjct: 179 KTFC--GTPDYIAPEIIAYQPYGK--------SVDWWAFGVLLYEMLAGQAPFEGEDEDE 228
Query: 923 MFN 925
+F
Sbjct: 229 LFQ 231
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 35/123 (28%), Positives = 53/123 (43%), Gaps = 36/123 (29%)
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPS 875
+ SA+ +LH I++ DLK NVLLDH+ H +DFG+ K G +
Sbjct: 133 IISALMFLHDK---GIIYRDLKLDNVLLDHE--GHCKLADFGMCK------EGICNGVTT 181
Query: 876 SSIGVKGTIGYVAPE------YGLGGEASMRGGV--YSYGILLLEIFTRRRP-----TES 922
++ GT Y+APE YG V ++ G+LL E+ P +
Sbjct: 182 ATFC--GTPDYIAPEILQEMLYGP--------AVDWWAMGVLLYEMLCGHAPFEAENEDD 231
Query: 923 MFN 925
+F
Sbjct: 232 LFE 234
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 55/344 (15%), Positives = 96/344 (27%), Gaps = 79/344 (22%)
Query: 289 SNLEVLHLAENQF--RGQVSINFNGLKD----LSMLGLATNFLGNGAANDLDFVDLLTNC 342
+ L L+ N V + + ++ L L+ N LG +++L + L
Sbjct: 22 HGVTSLDLSLNNLYSISTVEL-IQAFANTPASVTSLNLSGNSLGFKNSDELVQI-LAAIP 79
Query: 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEAN 402
+ L L+ N S L L + L + N
Sbjct: 80 ANVTSLNLSGNFLS---YKSSDELVKTLAAIPF-----------------TITVLDLGWN 119
Query: 403 RLTGTIPHVIGEL-----KNLQLLHLHANFLQGT----IPSSLGNL-TLLTYLSFGANNL 452
+ + ++ L+L N L + L + + L+ NNL
Sbjct: 120 DFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179
Query: 453 QGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLN--GSLPLG-- 508
S C L F A ++ SLDLS NLL L
Sbjct: 180 A-----SKN-CAELAKFLASIP-------------ASV-TSLDLSANLLGLKSYAELAYI 219
Query: 509 -VGNLKSLVRLGIARNQFSGQ----IPVTLGACTSLEYVELQGNSFSGT-------IPQS 556
+V L + N G + + + L+ V L + + +
Sbjct: 220 FSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAA 279
Query: 557 LSSLTSIKELDLSQNNFSG----QIPKYLENLSF-LQYLNLSYN 595
++ I +D + I + LS +L
Sbjct: 280 FPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQ 323
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 48/331 (14%), Positives = 99/331 (29%), Gaps = 69/331 (20%)
Query: 286 SNASNLEVLHLAENQFRGQVSINF-NGLKD----LSMLGLATNFLGNGAANDLDFVDLLT 340
+ +++ L+L+ N + S L ++ L L+ NFL ++++L L
Sbjct: 48 NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT-LAA 106
Query: 341 NCTKLQYLYLADNGFG--GV--LPHSIANLSTALIDFNLGKNQIYGTIPPGIANL----- 391
+ L L N F + +NL ++ NL N + L
Sbjct: 107 IPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG---IKSSDELIQILA 163
Query: 392 ---VNLNSLRMEANRLTGTIPHVIGEL-----KNLQLLHLHANFLQGTIPSSLG-----N 438
N+NSL + N L + + ++ L L AN L + L
Sbjct: 164 AIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSI 223
Query: 439 LTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSD 498
+ L+ N L G + +NL L ++ L
Sbjct: 224 PNHVVSLNLCLNCLHGP------SLENLKLLKDSLKHLQ---------------TVYLDY 262
Query: 499 NLLNG-------SLPLGVGNLKSLVRLGIARNQFSGQIPVTLGA-----CTSLEYVELQG 546
+++ +L N++ ++ + + + + + L
Sbjct: 263 DIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLN 322
Query: 547 NSFS-----GTIPQSLSSLTSIKELDLSQNN 572
T + L+ ++E +
Sbjct: 323 QCLIFAQKHQTNIEDLNIPDELRESIQTCKP 353
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 31/110 (28%), Positives = 48/110 (43%), Gaps = 5/110 (4%)
Query: 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEA 401
+ L L N LPH + + T L +L +NQI ++P G+ L L L +
Sbjct: 28 SSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHE 85
Query: 402 NRLTGTIPH-VIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGAN 450
N+L ++P+ V +L L+ L L N L+ LT L + N
Sbjct: 86 NKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 24/82 (29%), Positives = 41/82 (50%), Gaps = 4/82 (4%)
Query: 374 NLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTI 432
L N++ ++P G+ L L L + N++ V +L L +L+LH N LQ ++
Sbjct: 34 ELESNKL-QSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SL 91
Query: 433 PSSL-GNLTLLTYLSFGANNLQ 453
P+ + LT L L+ N L+
Sbjct: 92 PNGVFDKLTQLKELALDTNQLK 113
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 8e-04
Identities = 36/134 (26%), Positives = 51/134 (38%), Gaps = 31/134 (23%)
Query: 384 IPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSL-GNLTLL 442
+P GI + L +E+N+L V +L L L L N +Q ++P + LT L
Sbjct: 22 VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78
Query: 443 TYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLN 502
T L N LQ +LP + + T L L N L
Sbjct: 79 TILYLHENKLQ-------------------------SLPNGVFDKLTQLKELALDTNQLK 113
Query: 503 GSLPLGV-GNLKSL 515
S+P G+ L SL
Sbjct: 114 -SVPDGIFDRLTSL 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 31/117 (26%), Positives = 42/117 (35%), Gaps = 13/117 (11%)
Query: 339 LTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDF---NLGKNQIYGTIPPGIANLVNLN 395
TN + + L L I NL L F + N+I G L L
Sbjct: 15 YTNAVRDRELDLRGYKI-----PVIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLK 67
Query: 396 SLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQ--GTIPSSLGNLTLLTYLSFGAN 450
+L + NR+ + L +L L L N L G + L +L LTYL N
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 15/105 (14%), Positives = 30/105 (28%), Gaps = 5/105 (4%)
Query: 494 LDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTI 553
+ L+ L+ + N L + + I + ++ N +
Sbjct: 2 VKLTAELIEQAA--QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 554 PQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFE 598
L +K L ++ N + L L L L+ N
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 30/114 (26%), Positives = 41/114 (35%), Gaps = 10/114 (8%)
Query: 71 RVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIP--DRIGNLFRLETLVLANN 128
R +LDLR I I L I+ +DN EI D L RL+TL++ NN
Sbjct: 20 RDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDN----EIRKLDGFPLLRRLKTLLVNNN 74
Query: 129 SFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELIS-RRLFNLQGLSVGDNQLT 181
L N+L +L L +L L + N +T
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLTYLCILRNPVT 126
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 44/328 (13%), Positives = 90/328 (27%), Gaps = 31/328 (9%)
Query: 66 GRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVL 125
R + + + + + I ++ + + L + +P++ NL L
Sbjct: 216 ARNCRSLVSVKVGDFEILELVGFFKA-AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCR 274
Query: 126 ANNSFSGR--IPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQ 183
S+ G +P +++ L E LI + NL+ L +
Sbjct: 275 LGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQK-CPNLEVLETRNVIGDRG 333
Query: 184 LPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLV 243
L L+ + I + ++ + + L
Sbjct: 334 LEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALA------------QGCQELE 381
Query: 244 EIYLYGNRFTGSLPIEIGKNLPNLRNFVI----YTNNFTGSLPDS-----FSNASNLEVL 294
+ +Y + T IG L NL +F + T D+ L
Sbjct: 382 YMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRF 441
Query: 295 HLAENQFRGQVSINFNGLKDLSMLG--LATNFLGNGAANDLDFVDLLTNCTKLQYLYLAD 352
+ Q + GL + + LG +D ++ C LQ L +
Sbjct: 442 AF----YLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRG 497
Query: 353 NGFGGVLPHSIANLSTALIDFNLGKNQI 380
F + +L + +
Sbjct: 498 CCFSERAIAAAVTKLPSLRYLWVQGYRA 525
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 8e-06
Identities = 68/504 (13%), Positives = 133/504 (26%), Gaps = 99/504 (19%)
Query: 162 LISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYL 221
L+ RR F + + + A+ LS R ++R+ +L GK + L +
Sbjct: 39 LVCRRWFKIDSETREHVTMALCYTATPDRLSR-RFPNLRSLKLKGKPRAAMFNLIPENWG 97
Query: 222 HVGDNHFSGTIPPSVYNISSLVEIYLYGNRFT-GSLPIEIGKNLPNLRNFVI-YTNNFTG 279
+ N+ L ++ + L +L + + FT
Sbjct: 98 GYVTPWVTEISN----NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTT 153
Query: 280 -SLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDL 338
L ++ ++ L + E+ F + L L
Sbjct: 154 DGLLSIVTHCRKIKTLLMEESSFS-----------EKDGKWLHE---------------L 187
Query: 339 LTNCTKLQYLYLADNGFGGVLPHSIANL---STALIDFNLGKNQI--YGTIPPGIANLVN 393
+ T L+ L F + P + + +L+ +G +I ANL
Sbjct: 188 AQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEE 247
Query: 394 LNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453
+ + + + L L L +P + L L+
Sbjct: 248 FCGGSLNEDIGMPEKYMNLVFPRKLCRLGLS-YMGPNEMPILFPFAAQIRKLDLLYALLE 306
Query: 454 GNIPFSL-GNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNL 512
+L C NL L+ + + + L +
Sbjct: 307 TEDHCTLIQKCPNL-------------------------EVLETRNVIGDRGLEVLAQYC 341
Query: 513 KSLVRLGIARNQFSGQIPVTLGA------------CTSLEYVELQGNSFS----GTIPQS 556
K L RL I R + G C LEY+ + + + +I
Sbjct: 342 KQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTY 401
Query: 557 LSSLTSIKELDLSQ-NNFSGQ-----IPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNK 610
L +L + + L + + + L L+
Sbjct: 402 LKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQ-----------GGL 450
Query: 611 TGFSIVGNGKLCGGLDELHLPSCQ 634
T + G+ + + L
Sbjct: 451 TDLGLSYIGQYSPNVRWMLLGYVG 474
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 8e-06
Identities = 84/588 (14%), Positives = 173/588 (29%), Gaps = 118/588 (20%)
Query: 42 LGVTSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRN-----------QSIGGILSPYV 90
+ S + LC T RR + L L+ ++ GG ++P+V
Sbjct: 45 FKIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWV 104
Query: 91 GNLSF---------LRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHC 141
+S R + ++D D R +L L L + + + + ++HC
Sbjct: 105 TEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL-KLDKCSGFTTDGLLSIVTHC 163
Query: 142 SKLITFSAHRNNLVGEIPEEL--ISRRLFNLQGLSVGDNQLTGQLPASI----GNLSALR 195
K+ T ++ + + L +++ +L+ L+ + P + N +L
Sbjct: 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV 223
Query: 196 VIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGS 255
+ + + + +L G + +P N+ ++ G + G
Sbjct: 224 SVKVGDFEILELVGF-FKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP 282
Query: 256 LPIE-IGKNLPNLRNFVI-YTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLK 313
+ + +R + Y T NLEVL N +
Sbjct: 283 NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR------------NVIG 330
Query: 314 DLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLS-TALID 372
D + LA C +L+ L + + +S LI
Sbjct: 331 DRGLEVLAQY------------------CKQLKRLRIERGADEQGMEDEEGLVSQRGLIA 372
Query: 373 FNLGKNQIYGTIPPGIANLVNLNSLRMEANRLT-GTIPHVIGELKNLQLLHLHANFLQGT 431
L + + + +T ++ + LKNL L
Sbjct: 373 L--------------AQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRL-------- 410
Query: 432 IPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLS 491
L +T L L + L CK L +
Sbjct: 411 --VLLDREERITDLP-----LDNGVRSLLIGCKKL---------------------RRFA 442
Query: 492 LSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQ-IPVTLGACTSLEYVELQGNSFS 550
L L + L ++ + + S + + C +L+ +E++G FS
Sbjct: 443 FYLR-QGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS 501
Query: 551 -GTIPQSLSSLTSIKELDLSQNNFSGQIPKYLE---NLSFLQYLNLSY 594
I +++ L S++ L + S ++ ++ +
Sbjct: 502 ERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRR 549
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 34/167 (20%), Positives = 57/167 (34%), Gaps = 41/167 (24%)
Query: 286 SNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKL 345
S +S +++ + R + +++L L N +ND L L
Sbjct: 3 SGSSGMDMKRRIHLELRNR---TPAAVREL--------VLDNCKSNDGKIEGLTAEFVNL 51
Query: 346 QYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLT 405
++L L + G S++NL L L L + NR+
Sbjct: 52 EFLSLINVGL-----ISVSNLP----------------------KLPKLKKLELSENRIF 84
Query: 406 GTIPHVIGELKNLQLLHLHANFLQ--GTIPSSLGNLTLLTYLSFGAN 450
G + + +L NL L+L N L+ T+ L L L L
Sbjct: 85 GGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 22/119 (18%), Positives = 46/119 (38%), Gaps = 3/119 (2%)
Query: 158 IPEELISRRLFNLQGLSVGDNQLT-GQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLT 216
I EL +R ++ L + + + G++ L + + L + L +L
Sbjct: 14 IHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISVSN-LPKLP 71
Query: 217 SLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTN 275
L L + +N G + + +L + L GN+ +E K L L++ ++
Sbjct: 72 KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 21/117 (17%), Positives = 46/117 (39%), Gaps = 4/117 (3%)
Query: 66 GRRNQRVTKLDLRN-QSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLV 124
R V +L L N +S G + L ++++ + + + + L +L+ L
Sbjct: 20 NRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLE 77
Query: 125 LANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLT 181
L+ N G + L + N + +I ++L L+ L + + ++T
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLS-GNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.5 bits (109), Expect = 3e-05
Identities = 30/215 (13%), Positives = 74/215 (34%), Gaps = 29/215 (13%)
Query: 400 EANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFS 459
+ + + I + + + L + S + + L L +
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLD----AMPLLNNLK 178
Query: 460 LGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLG 519
+ NL PR L + LEI + L + +++L LP NL+ L L
Sbjct: 179 IKGTNNLSIGKKPRPNL------KSLEIISGGLPDSVVEDILGSDLP----NLEKL-VLY 227
Query: 520 IARNQFSGQIPVTL-------GACTSLEYVELQGNSFSGTIPQSLSS---LTSIKELDLS 569
+ + + + +L+++ + + + L ++ +D+S
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287
Query: 570 QNNFSG----QIPKYLENLSFLQYLNLSYNHFEGE 600
+ + +++ + L+++N+ YN+ E
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 8e-05
Identities = 26/167 (15%), Positives = 53/167 (31%), Gaps = 14/167 (8%)
Query: 429 QGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFA--PRNKLTGALPQQILE 486
Q + L + LL L N N K+L P + + L +
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPN 220
Query: 487 ITTLSLSLDLSDNLLNGSLP-----LGVGNLKSLVRLGIARNQFSGQIPVTLGAC---TS 538
+ L L + + D +G + +L LGI + +
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280
Query: 539 LEYVELQGNSFSGT----IPQSLSSLTSIKELDLSQNNFSGQIPKYL 581
LE +++ + + + + +K +++ N S ++ K L
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 28/119 (23%), Positives = 48/119 (40%), Gaps = 3/119 (2%)
Query: 158 IPEELISRRLFNLQGLSVGDNQLT-GQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLT 216
I EL +R +++ L + +++ G+L L + L I L +L
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSIAN-LPKLN 64
Query: 217 SLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTN 275
L L + DN SG + +L + L GN+ IE K L NL++ ++
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 25/106 (23%), Positives = 38/106 (35%), Gaps = 4/106 (3%)
Query: 491 SLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFS 550
L LD S + G L + L L + I L L+ +EL N S
Sbjct: 21 ELVLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVS 77
Query: 551 GTIPQSLSSLTSIKELDLSQNNFSG-QIPKYLENLSFLQYLNLSYN 595
G + ++ L+LS N + L+ L L+ L+L
Sbjct: 78 GGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 29/144 (20%), Positives = 48/144 (33%), Gaps = 36/144 (25%)
Query: 308 NFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLS 367
+ +K+L L N +N+ L +L++L + G SIANL
Sbjct: 15 TPSDVKELV--------LDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLP 61
Query: 368 TALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANF 427
L L L + NR++G + + + NL L+L N
Sbjct: 62 ----------------------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNK 99
Query: 428 LQG-TIPSSLGNLTLLTYLSFGAN 450
++ + L L L L
Sbjct: 100 IKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 4/88 (4%)
Query: 511 NLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQ 570
++K LV G++ LE++ + +I +L L +K+L+LS
Sbjct: 18 DVKELVLDN--SRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 571 NNFSGQIPKYLENLSFLQYLNLSYNHFE 598
N SG + E L +LNLS N +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 26/75 (34%), Positives = 39/75 (52%), Gaps = 5/75 (6%)
Query: 384 IPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSL-GNLTLL 442
+P GI + L + N++T P V L NLQ L+ ++N L IP+ + LT L
Sbjct: 27 VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83
Query: 443 TYLSFGANNLQGNIP 457
T L N+L+ +IP
Sbjct: 84 TQLDLNDNHLK-SIP 97
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 28/76 (36%), Positives = 40/76 (52%), Gaps = 9/76 (11%)
Query: 374 NLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPH-VIGELKNLQLLHLHANFLQGT 431
L NQI + PG+ +LVNL L +N+LT IP V +L L L L+ N L+ +
Sbjct: 39 WLNNNQI-TKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK-S 95
Query: 432 IPS----SLGNLTLLT 443
IP +L +LT +
Sbjct: 96 IPRGAFDNLKSLTHIY 111
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 25/75 (33%), Positives = 34/75 (45%), Gaps = 5/75 (6%)
Query: 384 IPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSL-GNLTLL 442
+P GI L + N++T P V L L L L N L +P+ + LT L
Sbjct: 24 VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80
Query: 443 TYLSFGANNLQGNIP 457
T LS N L+ +IP
Sbjct: 81 TQLSLNDNQLK-SIP 94
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 25/76 (32%), Positives = 38/76 (50%), Gaps = 9/76 (11%)
Query: 374 NLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPH-VIGELKNLQLLHLHANFLQGT 431
L NQI + PG+ L L L ++ N+LT +P V +L L L L+ N L+ +
Sbjct: 36 YLYDNQI-TKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLK-S 92
Query: 432 IPS----SLGNLTLLT 443
IP +L +LT +
Sbjct: 93 IPRGAFDNLKSLTHIW 108
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 22/126 (17%), Positives = 39/126 (30%), Gaps = 8/126 (6%)
Query: 737 EQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQ 796
E G S E E + + + SID + + L E +
Sbjct: 91 EADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSR-----LAELDYL 145
Query: 797 RDDQLGICNLSLIQRLNIVIDVASAVEYLHHH---CQPPIVHGDLKPSNVLLDHDMVAHV 853
++ L + + D ++L + HGDL SN+ + V+
Sbjct: 146 LNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGF 205
Query: 854 SDFGLA 859
D G +
Sbjct: 206 IDLGRS 211
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 39/232 (16%), Positives = 73/232 (31%), Gaps = 24/232 (10%)
Query: 388 IANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSF 447
I NL L + + +L V+ + L L H F S L+ L L+
Sbjct: 22 IKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRF--SAEVLSSLRQLNL 79
Query: 448 GANNLQGN----IPFSLG-NCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLL- 501
+ + LG L +L A + +L + + L L N L
Sbjct: 80 AGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG 139
Query: 502 -NGSLPLGVG---NLKSLVRLGIARNQFSGQ----IPVTLGACTSLEYVELQGNSFSGT- 552
L + + L ++ N + + L TS+ ++ L
Sbjct: 140 PEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEG 199
Query: 553 ---IPQSLSSLTSIKELDLSQNNFSGQ----IPKYLENLSFLQYLNLSYNHF 597
+ L ++EL+++ N + + L+ L+L +N
Sbjct: 200 LELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 Length = 264 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 9/79 (11%), Positives = 27/79 (34%), Gaps = 6/79 (7%)
Query: 787 NGSLEEWLHQRDDQL--GICNLSLIQRLNIVIDVASAVEYLHHHCQPP----IVHGDLKP 840
+ + + + ++ G+ + + + + A L + HGD
Sbjct: 134 DHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACL 193
Query: 841 SNVLLDHDMVAHVSDFGLA 859
N+++++ + D G
Sbjct: 194 PNIMVENGRFSGFIDCGRL 212
|
| >4fev_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, PP1, protein kinase inhibitor; HET: KAN PP1; 1.89A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4ej7_A* 3r78_A* Length = 272 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 7/30 (23%), Positives = 11/30 (36%)
Query: 830 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859
+ HGD N++ D + D G
Sbjct: 192 DSVVTHGDFSLDNLIFDEGKLIGCIDVGRV 221
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1009 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.82 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.68 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.55 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.53 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.5 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.5 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.5 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.49 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.49 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.47 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.36 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.34 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.34 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.32 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.24 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.23 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.2 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.18 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.87 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.84 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.81 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.79 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.77 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.76 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.71 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.67 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.49 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.32 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.3 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.27 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.17 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.16 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.06 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.83 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.73 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.63 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.63 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.45 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.39 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.26 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.09 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.96 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.79 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.6 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.44 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.38 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.37 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.34 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.34 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.18 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.09 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.0 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.93 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.83 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.32 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.03 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.71 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.35 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.18 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 80.48 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-83 Score=798.92 Aligned_cols=597 Identities=30% Similarity=0.483 Sum_probs=455.5
Q ss_pred hhcCChhhHHHHHHHHHhcCCCCCCCCCCccCCCCCCCCCccceeeCCCCCeEEEEEeecCCcccc---cC---------
Q 047768 20 LALSNETDCLSLLAIKSQLHDPLGVTSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQSIGGI---LS--------- 87 (1009)
Q Consensus 20 ~~~~~~~d~~aLl~~k~~~~~~~~~~~sW~~~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~~~---~~--------- 87 (1009)
++.+.++|++|||+||+++.||. .+++|+.+ .+|| +|+||+|+ +++|+.|||+++++.|. ++
T Consensus 6 ~~~~~~~~~~all~~k~~~~~~~-~l~~W~~~--~~~C-~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L 79 (768)
T 3rgz_A 6 PSQSLYREIHQLISFKDVLPDKN-LLPDWSSN--KNPC-TFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGL 79 (768)
T ss_dssp --CCHHHHHHHHHHHHTTCSCTT-SSTTCCTT--SCGG-GSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTC
T ss_pred cccCCHHHHHHHHHHHhhCCCcc-cccCCCCC--CCCc-CCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcc
Confidence 34457899999999999999998 89999844 3445 89999998 68999999999999887 44
Q ss_pred --------------ccccCCCCCCeeeecCCcCCccCCc--cccCccccccccccccccCCCCCCCC-cCCCcCcEEecc
Q 047768 88 --------------PYVGNLSFLRYINIADNDFHGEIPD--RIGNLFRLETLVLANNSFSGRIPTNL-SHCSKLITFSAH 150 (1009)
Q Consensus 88 --------------~~~~~l~~L~~L~L~~n~~~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~l~ 150 (1009)
+.++.+++|++|||++|.++|.+|. .|+++++|++|||++|.+++.+|..+ +++++|++||++
T Consensus 80 ~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls 159 (768)
T 3rgz_A 80 ESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159 (768)
T ss_dssp CEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECC
T ss_pred cccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECC
Confidence 4678889999999999999999998 89999999999999999999888876 888888888888
Q ss_pred cccccCCCchHHh-h----------------------hccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCC
Q 047768 151 RNNLVGEIPEELI-S----------------------RRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGK 207 (1009)
Q Consensus 151 ~n~l~~~~p~~~~-~----------------------~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 207 (1009)
+|++++..|..+. . ..+.+|++|+|++|++++.+|. ++++++|++|+|++|++++.
T Consensus 160 ~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~ 238 (768)
T 3rgz_A 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD 238 (768)
T ss_dssp SSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSC
T ss_pred CCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCc
Confidence 8888877766521 1 3456677777777777766666 77778888888888888777
Q ss_pred CCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCc
Q 047768 208 IPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSN 287 (1009)
Q Consensus 208 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 287 (1009)
+|..|..+++|++|+|++|++++.+|.. .+++|++|+|++|+++|.+|..++..+++|++|+|++|++++.+|..|++
T Consensus 239 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~ 316 (768)
T 3rgz_A 239 FSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316 (768)
T ss_dssp HHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGG
T ss_pred ccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhc
Confidence 7777778888888888888777666654 67777778888888877888877766688888888888888888888888
Q ss_pred ccccccccccccccccccccc-cccccccccccccccccCCCCCCCcc-------------------hhhhccc--cccc
Q 047768 288 ASNLEVLHLAENQFRGQVSIN-FNGLKDLSMLGLATNFLGNGAANDLD-------------------FVDLLTN--CTKL 345 (1009)
Q Consensus 288 l~~L~~L~Ls~N~l~~~~~~~-f~~l~~L~~L~L~~N~l~~~~~~~~~-------------------~~~~l~~--l~~L 345 (1009)
+++|++|+|++|++.+..+.. |..+++|+.|++++|.+.......+. .+..+.. +++|
T Consensus 317 l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L 396 (768)
T 3rgz_A 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396 (768)
T ss_dssp CTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCC
T ss_pred CCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCc
Confidence 888888888888888655544 77888888888888877521111110 0111111 3445
Q ss_pred ceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceeccc
Q 047768 346 QYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHA 425 (1009)
Q Consensus 346 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 425 (1009)
++|++++|++++.+|..+.++ +.|+.|+|++|++++.+|..|.++++|+.|+|++|++++.+|..+..+++|++|+|++
T Consensus 397 ~~L~L~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 475 (768)
T 3rgz_A 397 QELYLQNNGFTGKIPPTLSNC-SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475 (768)
T ss_dssp CEEECCSSEEEEECCGGGGGC-TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCS
T ss_pred cEEECCCCccccccCHHHhcC-CCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecC
Confidence 555555555555555555555 4566666666666666666666666666666666666666666666666666666666
Q ss_pred ccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCC
Q 047768 426 NFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSL 505 (1009)
Q Consensus 426 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~ 505 (1009)
|++++.+|..+.++++|++|++++|++++.+|.+++.+++|++|++++|+++|.+|..+..+..+. .||+++|+++|.+
T Consensus 476 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~-~L~Ls~N~l~g~i 554 (768)
T 3rgz_A 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLI-WLDLNTNLFNGTI 554 (768)
T ss_dssp SCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCC-EEECCSSEEESBC
T ss_pred CcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCC-EEECCCCccCCcC
Confidence 666655666666666666666666666666666666666666666666666655555555444433 3666666555554
Q ss_pred C----------------------------------------------------------------------CCccCCCCC
Q 047768 506 P----------------------------------------------------------------------LGVGNLKSL 515 (1009)
Q Consensus 506 p----------------------------------------------------------------------~~~~~l~~L 515 (1009)
| ..++++++|
T Consensus 555 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L 634 (768)
T 3rgz_A 555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 634 (768)
T ss_dssp CGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCC
T ss_pred ChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccc
Confidence 4 455667889
Q ss_pred CeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceecccc
Q 047768 516 VRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYN 595 (1009)
Q Consensus 516 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 595 (1009)
+.|||++|+++|.+|.+++.+++|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+..+++|++|||++|
T Consensus 635 ~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N 714 (768)
T 3rgz_A 635 MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714 (768)
T ss_dssp CEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS
T ss_pred cEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcccCCCCCcccCccccccccCCCcCCCCCC
Q 047768 596 HFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDE 627 (1009)
Q Consensus 596 ~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~~~ 627 (1009)
+|+|.||..++|.++...+|.||+++||.|..
T Consensus 715 ~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~ 746 (768)
T 3rgz_A 715 NLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP 746 (768)
T ss_dssp EEEEECCSSSSGGGSCGGGGCSCTEEESTTSC
T ss_pred cccccCCCchhhccCCHHHhcCCchhcCCCCc
Confidence 99999999999999999999999999998754
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-65 Score=637.63 Aligned_cols=517 Identities=31% Similarity=0.490 Sum_probs=431.4
Q ss_pred CeEEEEEeecCCcccccCccc-cCCCCCCeeeecCCcCCccCCcc---cc----------------------Cccccccc
Q 047768 70 QRVTKLDLRNQSIGGILSPYV-GNLSFLRYINIADNDFHGEIPDR---IG----------------------NLFRLETL 123 (1009)
Q Consensus 70 ~~v~~l~l~~~~l~~~~~~~~-~~l~~L~~L~L~~n~~~~~~p~~---~~----------------------~l~~L~~L 123 (1009)
.+++.|+|++|.+.+.++..+ +++++|++|+|++|++++.+|.. ++ ++++|++|
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L 205 (768)
T 3rgz_A 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFL 205 (768)
T ss_dssp TTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEE
T ss_pred CCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEE
Confidence 367888888888888777665 67777777777777777666654 44 45555666
Q ss_pred cccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCc
Q 047768 124 VLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNR 203 (1009)
Q Consensus 124 ~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 203 (1009)
+|++|.+++.+|. ++++++|++|++++|++++.+|..+ ..+++|++|+|++|++++.+|.. .+++|++|+|++|+
T Consensus 206 ~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l--~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~ 280 (768)
T 3rgz_A 206 DVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAI--STCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENK 280 (768)
T ss_dssp ECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHT--TTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSE
T ss_pred ECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHH--hcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCc
Confidence 6666666655555 6666666666666666666666655 45666666666666666655554 56667777777777
Q ss_pred ccCCCCcccccc-cccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCC
Q 047768 204 LWGKIPITLSQL-TSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLP 282 (1009)
Q Consensus 204 l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p 282 (1009)
+++.+|..+..+ ++|++|+|++|++++.+|..|.++++|++|+|++|+++|.+|...+.++++|++|++++|.+++.+|
T Consensus 281 l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p 360 (768)
T 3rgz_A 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360 (768)
T ss_dssp EEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCC
T ss_pred cCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCcccc
Confidence 776777777665 8888888888888888888888888888888888888878887766778888888888888888888
Q ss_pred CCcCccc-cccccccccccccccccccccc--ccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcC
Q 047768 283 DSFSNAS-NLEVLHLAENQFRGQVSINFNG--LKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVL 359 (1009)
Q Consensus 283 ~~~~~l~-~L~~L~Ls~N~l~~~~~~~f~~--l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 359 (1009)
..+.+++ +|++|+|++|++++..+..+.. +++|+.|++++|.+... .+..+.++++|++|+|++|++++.+
T Consensus 361 ~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~------~p~~l~~l~~L~~L~Ls~N~l~~~~ 434 (768)
T 3rgz_A 361 ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK------IPPTLSNCSELVSLHLSFNYLSGTI 434 (768)
T ss_dssp TTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEE------CCGGGGGCTTCCEEECCSSEEESCC
T ss_pred HHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccc------cCHHHhcCCCCCEEECcCCcccCcc
Confidence 8888887 8888888888888777776665 77888888888887642 3467889999999999999999999
Q ss_pred chhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccc
Q 047768 360 PHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNL 439 (1009)
Q Consensus 360 p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 439 (1009)
|..+..+ +.|+.|++++|++++.+|..+..+++|+.|+|++|++++.+|..+..+++|++|+|++|++++.+|.+++++
T Consensus 435 p~~l~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 513 (768)
T 3rgz_A 435 PSSLGSL-SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513 (768)
T ss_dssp CGGGGGC-TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred cHHHhcC-CCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcC
Confidence 9999998 689999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhc-------------------------------
Q 047768 440 TLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEIT------------------------------- 488 (1009)
Q Consensus 440 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~------------------------------- 488 (1009)
++|++|++++|+++|.+|..++++++|++|++++|+++|.+|..++...
T Consensus 514 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (768)
T 3rgz_A 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNL 593 (768)
T ss_dssp TTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEE
T ss_pred CCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccc
Confidence 9999999999999999999999999999999999999999998765421
Q ss_pred --------------------------------------cceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCcc
Q 047768 489 --------------------------------------TLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIP 530 (1009)
Q Consensus 489 --------------------------------------~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 530 (1009)
.....|||++|+++|.+|..|+++++|+.|+|++|+++|.+|
T Consensus 594 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip 673 (768)
T 3rgz_A 594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIP 673 (768)
T ss_dssp EECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCC
T ss_pred cccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCC
Confidence 123469999999999999999999999999999999999999
Q ss_pred ccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceeccccc-Ccc
Q 047768 531 VTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNH-FEG 599 (1009)
Q Consensus 531 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~-l~g 599 (1009)
..++.+++|+.|||++|+++|.+|..++++++|++|||++|+++|.+|.. +.+..+....+.+|+ |+|
T Consensus 674 ~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg 742 (768)
T 3rgz_A 674 DEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCG 742 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEES
T ss_pred hHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcC
Confidence 99999999999999999999999999999999999999999999999965 556667777788886 554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-60 Score=583.47 Aligned_cols=560 Identities=19% Similarity=0.196 Sum_probs=476.5
Q ss_pred CccceeeCCC---------CCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccc
Q 047768 59 HWTGVTCGRR---------NQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNS 129 (1009)
Q Consensus 59 ~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~ 129 (1009)
.++-|.|+.. ..+++.|+|++|.+++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.
T Consensus 5 ~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 84 (680)
T 1ziw_A 5 SHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84 (680)
T ss_dssp BSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSC
T ss_pred ECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCc
Confidence 4566777642 2579999999999999888899999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCC
Q 047768 130 FSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIP 209 (1009)
Q Consensus 130 l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 209 (1009)
+++..+..|+++++|++|++++|++.+..|..+ ..+.+|++|+|++|.+++..|..++++++|++|++++|++++..+
T Consensus 85 l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 162 (680)
T 1ziw_A 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF--VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162 (680)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTT--TTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCH
T ss_pred cCccChhhhccCCCCCEEECCCCccCccChhHc--cccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCH
Confidence 996666689999999999999999986665665 679999999999999999999999999999999999999998888
Q ss_pred cccc--cccccccccccCccCCCCCCCcccCCC---------------------------hHHHHHhhCCccCCCCChhh
Q 047768 210 ITLS--QLTSLAYLHVGDNHFSGTIPPSVYNIS---------------------------SLVEIYLYGNRFTGSLPIEI 260 (1009)
Q Consensus 210 ~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~---------------------------~L~~L~L~~N~l~~~ip~~~ 260 (1009)
..+. .+++|++|++++|++++..|..|..++ +|++|++++|++++..|. .
T Consensus 163 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~-~ 241 (680)
T 1ziw_A 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT-T 241 (680)
T ss_dssp HHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTT-T
T ss_pred HHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChh-H
Confidence 7765 458999999999999988888777654 456677888888844443 4
Q ss_pred ccCCCc--ccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCCCCCCCcchh--
Q 047768 261 GKNLPN--LRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFV-- 336 (1009)
Q Consensus 261 ~~~l~~--L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~-- 336 (1009)
+.+++. |++|+|++|++++..|..|+++++|++|+|++|++.+..+..|.++++|+.|++++|....... ...++
T Consensus 242 ~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~-~~~lp~i 320 (680)
T 1ziw_A 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS-LASLPKI 320 (680)
T ss_dssp TGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC-------CCEE
T ss_pred hhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccc-ccccccc
Confidence 445644 9999999999998888999999999999999999999999999999999999998876542100 00011
Q ss_pred --hhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCcccc--CCCccccCc--CccCEEEccCCCCCCCCCC
Q 047768 337 --DLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYG--TIPPGIANL--VNLNSLRMEANRLTGTIPH 410 (1009)
Q Consensus 337 --~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~--~~p~~~~~l--~~L~~L~L~~N~l~~~~p~ 410 (1009)
..|..+++|++|++++|.+++..+..+.++ ..|++|++++|.+.. ..+..|..+ ++|+.|++++|++++..|.
T Consensus 321 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~ 399 (680)
T 1ziw_A 321 DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL-INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCCCCTTTTTTC-TTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTT
T ss_pred ChhhcccCCCCCEEECCCCccCCCChhHhccc-cCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChh
Confidence 256788999999999999999888888887 679999999998543 233345444 5899999999999999999
Q ss_pred CcCCcccccceecccccccCCCC-cccccccccccccccCcccccccCCCCCCCCCccccccCCCCcc--CCCchhhhhh
Q 047768 411 VIGELKNLQLLHLHANFLQGTIP-SSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLT--GALPQQILEI 487 (1009)
Q Consensus 411 ~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~--~~~p~~~~~~ 487 (1009)
.|..+++|++|+|++|++++.+| ..|.++++|++|++++|++++..+..+..+++|+.|++++|.++ +.+|..+...
T Consensus 400 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l 479 (680)
T 1ziw_A 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPL 479 (680)
T ss_dssp TTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTC
T ss_pred hhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccC
Confidence 99999999999999999987666 68999999999999999999999999999999999999999987 5677777666
Q ss_pred ccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCcc--------ccccCCCCccEEEecCccccccccccccc
Q 047768 488 TTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIP--------VTLGACTSLEYVELQGNSFSGTIPQSLSS 559 (1009)
Q Consensus 488 ~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p--------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 559 (1009)
..+. .|++++|++++..|..|.++++|++|++++|++++..+ ..+.++++|+.|+|++|+++...+..|++
T Consensus 480 ~~L~-~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~ 558 (680)
T 1ziw_A 480 RNLT-ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558 (680)
T ss_dssp TTCC-EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred CCCC-EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHccc
Confidence 6655 59999999998888889999999999999999986422 34789999999999999999655567999
Q ss_pred ccccceEcCCCcccccccccccccccccCceecccccCcccCCCC-C-cccCccccccccCCCcCCC
Q 047768 560 LTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK-G-IFKNKTGFSIVGNGKLCGG 624 (1009)
Q Consensus 560 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~-~~~~~~~~~~~~n~~lc~~ 624 (1009)
+++|++|||++|+|++..|..|..+++|++|+|++|++++..|.. + .+.++....+.+|++.|+-
T Consensus 559 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c 625 (680)
T 1ziw_A 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCC
T ss_pred ccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCC
Confidence 999999999999999777777899999999999999999877653 2 4567777888999999964
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-58 Score=564.82 Aligned_cols=524 Identities=20% Similarity=0.220 Sum_probs=455.7
Q ss_pred CeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEec
Q 047768 70 QRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSA 149 (1009)
Q Consensus 70 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l 149 (1009)
.+++.|+|++|.+++..|..++++++|++|+|++|.+++..+..|+++++|++|+|++|++++..|..|+++++|++|++
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 46889999999999988889999999999999999999554557999999999999999999877889999999999999
Q ss_pred ccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccC--CccccceeecccCcccCCCCcccccc------------
Q 047768 150 HRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIG--NLSALRVIDIRTNRLWGKIPITLSQL------------ 215 (1009)
Q Consensus 150 ~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l------------ 215 (1009)
++|.+++..|..+ ..+++|++|++++|.+++..+..++ .+++|++|++++|++.+..|..|..+
T Consensus 129 s~n~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~ 206 (680)
T 1ziw_A 129 SHNGLSSTKLGTQ--VQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206 (680)
T ss_dssp CSSCCSCCCCCSS--SCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCC
T ss_pred CCCcccccCchhh--cccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccc
Confidence 9999988777665 5788999999999999987777654 55899999999999988888877655
Q ss_pred ---------------cccccccccCccCCCCCCCcccCCCh--HHHHHhhCCccCCCCChhhccCCCcccceeccccccC
Q 047768 216 ---------------TSLAYLHVGDNHFSGTIPPSVYNISS--LVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFT 278 (1009)
Q Consensus 216 ---------------~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~ 278 (1009)
++|++|++++|.+++..|..|.+++. |++|+|++|+++ .++...+..+++|++|++++|+++
T Consensus 207 l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~ 285 (680)
T 1ziw_A 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN-VVGNDSFAWLPQLEYFFLEYNNIQ 285 (680)
T ss_dssp CHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCC-EECTTTTTTCTTCCEEECCSCCBS
T ss_pred cChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcC-ccCcccccCcccccEeeCCCCccC
Confidence 45778888999999888999998866 999999999999 555566678999999999999999
Q ss_pred CCCCCCcCccccccccccccccccc---------ccccccccccccccccccccccCCCCCCCcchhhhcccccccceEE
Q 047768 279 GSLPDSFSNASNLEVLHLAENQFRG---------QVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLY 349 (1009)
Q Consensus 279 ~~~p~~~~~l~~L~~L~Ls~N~l~~---------~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~ 349 (1009)
+..|..|.++++|++|++++|...+ +....|..+++|+.|++++|.+..... ..|.++++|++|+
T Consensus 286 ~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L~ 359 (680)
T 1ziw_A 286 HLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS------NMFTGLINLKYLS 359 (680)
T ss_dssp EECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCT------TTTTTCTTCCEEE
T ss_pred ccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCCh------hHhccccCCcEEE
Confidence 9999999999999999999876543 333478899999999999999987654 4678899999999
Q ss_pred ccCCCCCCc--Cchhhhhhc-ccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCC-CCcCCcccccceeccc
Q 047768 350 LADNGFGGV--LPHSIANLS-TALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIP-HVIGELKNLQLLHLHA 425 (1009)
Q Consensus 350 L~~N~l~~~--~p~~~~~l~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~ 425 (1009)
+++|.+... .+..+..+. ..|+.|++++|++++..|..|..+++|+.|+|++|++++.+| ..|.++++|++|+|++
T Consensus 360 Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~ 439 (680)
T 1ziw_A 360 LSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439 (680)
T ss_dssp CTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCS
T ss_pred CCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCC
Confidence 999986533 223343332 479999999999999999999999999999999999987666 6899999999999999
Q ss_pred ccccCCCCcccccccccccccccCcccc--cccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCC
Q 047768 426 NFLQGTIPSSLGNLTLLTYLSFGANNLQ--GNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNG 503 (1009)
Q Consensus 426 N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~ 503 (1009)
|++++..+..|..+++|++|++++|.++ +.+|..+.++++|+.|++++|++++..|..+.....+ ..|++++|++++
T Consensus 440 n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L-~~L~Ls~N~l~~ 518 (680)
T 1ziw_A 440 NKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL-EILDLQHNNLAR 518 (680)
T ss_dssp CSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCGG
T ss_pred CCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcccccc-CEEeCCCCCccc
Confidence 9999999999999999999999999997 6789999999999999999999996655555555444 469999999986
Q ss_pred CC----C----CCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCccccc
Q 047768 504 SL----P----LGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSG 575 (1009)
Q Consensus 504 ~~----p----~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 575 (1009)
.. | ..|.++++|++|+|++|+++...+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++
T Consensus 519 ~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ 598 (680)
T 1ziw_A 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS 598 (680)
T ss_dssp GGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCB
T ss_pred cchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCc
Confidence 42 2 237899999999999999995555679999999999999999998778889999999999999999999
Q ss_pred ccccccc-cccccCceecccccCcccCCC
Q 047768 576 QIPKYLE-NLSFLQYLNLSYNHFEGEVPT 603 (1009)
Q Consensus 576 ~~p~~~~-~l~~L~~L~ls~N~l~g~~p~ 603 (1009)
..|..+. .+++|++|++++|++.|.++.
T Consensus 599 ~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 599 VEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp CCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred cChhHhcccccccCEEEccCCCcccCCcc
Confidence 8888887 899999999999999999985
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-58 Score=558.58 Aligned_cols=528 Identities=20% Similarity=0.193 Sum_probs=424.3
Q ss_pred ccceeeCCC---------CCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCcccccccccccccc
Q 047768 60 WTGVTCGRR---------NQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSF 130 (1009)
Q Consensus 60 w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l 130 (1009)
+..|.|... ...++.|+|++|.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 455788643 24688899999999888888888999999999999988888888899999999999999998
Q ss_pred CCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCc
Q 047768 131 SGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPI 210 (1009)
Q Consensus 131 ~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 210 (1009)
++..|..|+++++|++|++++|.+++..|..+ ..+.+|++|+|++|++++..+..+..+++|++|++++|++.+..|.
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 171 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPL--HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCC--TTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchh--ccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChh
Confidence 88888889999999999999998886545544 5788889999999988875444445588899999999988888888
Q ss_pred ccccccccc--cccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceecccccc-----CCCCCC
Q 047768 211 TLSQLTSLA--YLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNF-----TGSLPD 283 (1009)
Q Consensus 211 ~~~~l~~L~--~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l-----~~~~p~ 283 (1009)
.|+.+++|+ .|++++|.+++..|..+. ..+|++|++++|.. ++. .+.++.++....+..+.+ ..+.+.
T Consensus 172 ~~~~l~~L~~l~L~l~~n~l~~~~~~~~~-~~~L~~L~l~~~~~---~~~-~~~~l~~~~l~~l~~~~~~~~~~~~i~~~ 246 (606)
T 3t6q_A 172 DMSSLQQATNLSLNLNGNDIAGIEPGAFD-SAVFQSLNFGGTQN---LLV-IFKGLKNSTIQSLWLGTFEDMDDEDISPA 246 (606)
T ss_dssp HHHTTTTCCSEEEECTTCCCCEECTTTTT-TCEEEEEECTTCSC---HHH-HHHHTTTCEEEEEECCCCTTSCCCCCCGG
T ss_pred hhhhhcccceeEEecCCCccCccChhHhh-hccccccccCCchh---HHH-HhhhccccchhheechhhccccccccChh
Confidence 888888888 788888988866665554 46788888888762 221 222333333322222221 223344
Q ss_pred CcCccc--ccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCch
Q 047768 284 SFSNAS--NLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPH 361 (1009)
Q Consensus 284 ~~~~l~--~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~ 361 (1009)
.|.++. +|++|++++|+++++.+..|..+++|+.|++++|.+..++ ..+.++++|++|++++|.+++..|.
T Consensus 247 ~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp-------~~l~~l~~L~~L~l~~n~l~~~~~~ 319 (606)
T 3t6q_A 247 VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELP-------SGLVGLSTLKKLVLSANKFENLCQI 319 (606)
T ss_dssp GGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCC-------SSCCSCTTCCEEECTTCCCSBGGGG
T ss_pred HhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCC-------hhhcccccCCEEECccCCcCcCchh
Confidence 455544 6888888888888888888888888888888888887544 3467788888888888888877777
Q ss_pred hhhhhcccceEEEcCCCccccCCCc-cccCcCccCEEEccCCCCCCCC--CCCcCCcccccceecccccccCCCCccccc
Q 047768 362 SIANLSTALIDFNLGKNQIYGTIPP-GIANLVNLNSLRMEANRLTGTI--PHVIGELKNLQLLHLHANFLQGTIPSSLGN 438 (1009)
Q Consensus 362 ~~~~l~~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 438 (1009)
.+..+ +.|+.|++++|.+.+.+|. .+.++++|++|++++|++++.. |..+..+++|++|++++|++++..|..|..
T Consensus 320 ~~~~l-~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 398 (606)
T 3t6q_A 320 SASNF-PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKE 398 (606)
T ss_dssp CGGGC-TTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTT
T ss_pred hhhcc-CcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcC
Confidence 77777 5788888888888866654 4888888888999888888665 778888888888999888888888888888
Q ss_pred ccccccccccCcccccccCCC-CCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCC---CCCCccCCCC
Q 047768 439 LTLLTYLSFGANNLQGNIPFS-LGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGS---LPLGVGNLKS 514 (1009)
Q Consensus 439 l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~---~p~~~~~l~~ 514 (1009)
+++|++|++++|++++..|.. +.++++|++|++++|.+++..|..+.....+. .|++++|++++. .+..+..+++
T Consensus 399 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~~~~l~~ 477 (606)
T 3t6q_A 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQ-HLNLQGNHFPKGNIQKTNSLQTLGR 477 (606)
T ss_dssp CTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCC-EEECTTCBCGGGEECSSCGGGGCTT
T ss_pred CccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCC-EEECCCCCCCccccccchhhccCCC
Confidence 888888888888888776654 88888888888888888877777666555444 599999998762 3456899999
Q ss_pred CCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceeccc
Q 047768 515 LVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSY 594 (1009)
Q Consensus 515 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 594 (1009)
|++|++++|++++.+|..|+.+++|+.|+|++|++++..|..+.++++| +|||++|++++.+|..+..+++|++|++++
T Consensus 478 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 556 (606)
T 3t6q_A 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQ 556 (606)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTT
T ss_pred ccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCC
Confidence 9999999999999889999999999999999999999999999999999 999999999998899999999999999999
Q ss_pred ccCcccCCCC
Q 047768 595 NHFEGEVPTK 604 (1009)
Q Consensus 595 N~l~g~~p~~ 604 (1009)
|++.|.++..
T Consensus 557 N~~~c~c~~~ 566 (606)
T 3t6q_A 557 NPLDCTCSNI 566 (606)
T ss_dssp CCEECSGGGH
T ss_pred CCccccCCcH
Confidence 9999988853
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-58 Score=576.72 Aligned_cols=523 Identities=20% Similarity=0.203 Sum_probs=452.1
Q ss_pred CccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccC-CccccCccccccccccccccCCCCCCC
Q 047768 59 HWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEI-PDRIGNLFRLETLVLANNSFSGRIPTN 137 (1009)
Q Consensus 59 ~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 137 (1009)
+|+.|-+ ...+++.|||++|.+++..+.+|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+++..|..
T Consensus 15 ~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 15 NLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 6888877 4568999999999999999999999999999999999877777 788999999999999999999999999
Q ss_pred CcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCC-cccCCccccceeecccCcccCCCCcccccc-
Q 047768 138 LSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLP-ASIGNLSALRVIDIRTNRLWGKIPITLSQL- 215 (1009)
Q Consensus 138 l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l- 215 (1009)
|+++++|++|+|++|.+++.+|...+...+++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..|..+
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~ 172 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHH
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccccc
Confidence 999999999999999999988876444789999999999999998765 579999999999999999999999999988
Q ss_pred -cccccccccCccCCCCCCCcccCCCh------HHHHHhhCCccCCCCChhhccCC--Ccccceecc---------cccc
Q 047768 216 -TSLAYLHVGDNHFSGTIPPSVYNISS------LVEIYLYGNRFTGSLPIEIGKNL--PNLRNFVIY---------TNNF 277 (1009)
Q Consensus 216 -~~L~~L~L~~N~l~~~~p~~~~~l~~------L~~L~L~~N~l~~~ip~~~~~~l--~~L~~L~L~---------~N~l 277 (1009)
++|+.|+|++|.+++..|..+..+++ |++|++++|++++.+|..+...+ .+++.|.++ .|++
T Consensus 173 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l 252 (844)
T 3j0a_A 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI 252 (844)
T ss_dssp HCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSS
T ss_pred CCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccccc
Confidence 89999999999999989888877766 99999999999988887776543 456777766 3445
Q ss_pred CCCCCCCcCcc--cccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCC
Q 047768 278 TGSLPDSFSNA--SNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGF 355 (1009)
Q Consensus 278 ~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 355 (1009)
.+..+..|.++ ++|++|+|++|.+.+..+..|..+++|+.|+|++|.+..... +.|.++++|++|+|++|.+
T Consensus 253 ~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~------~~~~~l~~L~~L~Ls~N~l 326 (844)
T 3j0a_A 253 KDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD------EAFYGLDNLQVLNLSYNLL 326 (844)
T ss_dssp TTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECT------TTTTTCSSCCEEEEESCCC
T ss_pred CCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCCh------HHhcCCCCCCEEECCCCCC
Confidence 55556667665 789999999999999999999999999999999999986544 4678889999999999999
Q ss_pred CCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcc
Q 047768 356 GGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSS 435 (1009)
Q Consensus 356 ~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 435 (1009)
++..|..+..+ ..|+.|++++|++.+..+..|.++++|+.|+|++|.+++. + .+++|+.|++++|+++ .+|..
T Consensus 327 ~~~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l~~N~l~-~l~~~ 399 (844)
T 3j0a_A 327 GELYSSNFYGL-PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFLSGNKLV-TLPKI 399 (844)
T ss_dssp SCCCSCSCSSC-TTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEEESCCCC-CCCCC
T ss_pred CccCHHHhcCC-CCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhccCCCCcc-ccccc
Confidence 98888888888 5799999999999988888899999999999999999843 2 3788999999999998 55654
Q ss_pred cccccccccccccCcccccccC-CCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccC-----CCCCCCc
Q 047768 436 LGNLTLLTYLSFGANNLQGNIP-FSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLN-----GSLPLGV 509 (1009)
Q Consensus 436 ~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~-----~~~p~~~ 509 (1009)
..+++.|++++|++++... ..+.++++|+.|++++|++++..+............|+|++|.++ +..|..|
T Consensus 400 ---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~ 476 (844)
T 3j0a_A 400 ---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVF 476 (844)
T ss_dssp ---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCS
T ss_pred ---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhh
Confidence 4678899999999985321 235688999999999999997655544433444556999999997 4455678
Q ss_pred cCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCc
Q 047768 510 GNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQY 589 (1009)
Q Consensus 510 ~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 589 (1009)
.++++|+.|+|++|+|++.+|..|..+++|+.|+|++|+|++..|..+. ++|+.|||++|+|++.+|..|. +|+.
T Consensus 477 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~ 551 (844)
T 3j0a_A 477 EGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SLSV 551 (844)
T ss_dssp SCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SCCE
T ss_pred cCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---CcCE
Confidence 8999999999999999999999999999999999999999987777776 8999999999999999887764 7889
Q ss_pred eecccccCcccCCCC
Q 047768 590 LNLSYNHFEGEVPTK 604 (1009)
Q Consensus 590 L~ls~N~l~g~~p~~ 604 (1009)
|++++|++.|.++..
T Consensus 552 l~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 552 LDITHNKFICECELS 566 (844)
T ss_dssp EEEEEECCCCSSSCC
T ss_pred EEecCCCcccccccH
Confidence 999999999998854
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=569.85 Aligned_cols=491 Identities=19% Similarity=0.220 Sum_probs=279.2
Q ss_pred cCChhhHHHHHHHHHhcCCCCCCCCCCccCC---CCCC-CCCc------------cceeeCCCCCeEEEEEeecCCcccc
Q 047768 22 LSNETDCLSLLAIKSQLHDPLGVTSSWNRSA---CVNL-CQHW------------TGVTCGRRNQRVTKLDLRNQSIGGI 85 (1009)
Q Consensus 22 ~~~~~d~~aLl~~k~~~~~~~~~~~sW~~~~---~~~~-c~~w------------~gv~C~~~~~~v~~l~l~~~~l~~~ 85 (1009)
++..+|++||++||+++.|| +|+.++ ..++ ||.| .||+|+. .+||+.|+|++++++|.
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ 338 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGR 338 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEE
T ss_pred ccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCc
Confidence 34578999999999999887 797654 1233 2589 9999987 58999999999999999
Q ss_pred cCccccCCCCCCeeee-cCCcCCccCCcccc-------------------------------------------------
Q 047768 86 LSPYVGNLSFLRYINI-ADNDFHGEIPDRIG------------------------------------------------- 115 (1009)
Q Consensus 86 ~~~~~~~l~~L~~L~L-~~n~~~~~~p~~~~------------------------------------------------- 115 (1009)
+|++|++|++|++|+| ++|.++|..|-...
T Consensus 339 ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~ 418 (876)
T 4ecn_A 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418 (876)
T ss_dssp ECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred CchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence 9999999999999999 88999887553311
Q ss_pred --Cccccccccccc--cccCCCCCCCCcCCCcCcEEecccccccCC-----------------CchHHhhhccCCcCeEe
Q 047768 116 --NLFRLETLVLAN--NSFSGRIPTNLSHCSKLITFSAHRNNLVGE-----------------IPEELISRRLFNLQGLS 174 (1009)
Q Consensus 116 --~l~~L~~L~Ls~--N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~-----------------~p~~~~~~~l~~L~~L~ 174 (1009)
...+++.+.++. |+++| +|..|+++++|++|+|++|++++. +|..+.+..+++|++|+
T Consensus 419 ~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~ 497 (876)
T 4ecn_A 419 KDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497 (876)
T ss_dssp CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred cccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEE
Confidence 112233333333 66665 666666666666666666666652 44443222444555555
Q ss_pred ecCccCCCCCCcccCCccccceeecccCc-ccC-CCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCcc
Q 047768 175 VGDNQLTGQLPASIGNLSALRVIDIRTNR-LWG-KIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRF 252 (1009)
Q Consensus 175 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 252 (1009)
|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..++.++ ..+..+++|++|+|++|++
T Consensus 498 Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~-----------------~~~~~l~~L~~L~Ls~N~L 560 (876)
T 4ecn_A 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA-----------------DDEDTGPKIQIFYMGYNNL 560 (876)
T ss_dssp EESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHH-----------------HCTTTTTTCCEEECCSSCC
T ss_pred CcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhh-----------------hcccccCCccEEEeeCCcC
Confidence 55555544555445555555555555554 444 4444444333 0001111444444444444
Q ss_pred CCCCCh-hhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccc-cccccccccccCCCCC
Q 047768 253 TGSLPI-EIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKD-LSMLGLATNFLGNGAA 330 (1009)
Q Consensus 253 ~~~ip~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~-L~~L~L~~N~l~~~~~ 330 (1009)
+ .+|. ..+.++++|+.|+|++|+++ .+| .|+++++|++|+|++|+++ ..+..|..+++ |+.|+|++|.+..++
T Consensus 561 ~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp- 635 (876)
T 4ecn_A 561 E-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIP- 635 (876)
T ss_dssp C-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCC-
T ss_pred C-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCc-
Confidence 4 4444 12233455555555555554 334 4555555555555555554 23333444444 444444444443222
Q ss_pred CCcchhhhcccc--cccceEEccCCCCCCcCchhh---hhh-cccceEEEcCCCccccCCCcc-ccCcCccCEEEccCCC
Q 047768 331 NDLDFVDLLTNC--TKLQYLYLADNGFGGVLPHSI---ANL-STALIDFNLGKNQIYGTIPPG-IANLVNLNSLRMEANR 403 (1009)
Q Consensus 331 ~~~~~~~~l~~l--~~L~~L~L~~N~l~~~~p~~~---~~l-~~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~ 403 (1009)
..+..+ ++|+.|+|++|++++.+|... ..+ ..+|+.|+|++|+++ .+|.. +..+++|+.|+|++|+
T Consensus 636 ------~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~ 708 (876)
T 4ecn_A 636 ------NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNL 708 (876)
T ss_dssp ------SCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCC
T ss_pred ------hhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCc
Confidence 122222 337777777777766554321 111 125667777777776 34433 3466777777777777
Q ss_pred CCCCCCCCcCC--------cccccceecccccccCCCCcccc--cccccccccccCcccccccCCCCCCCCCccccccCC
Q 047768 404 LTGTIPHVIGE--------LKNLQLLHLHANFLQGTIPSSLG--NLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPR 473 (1009)
Q Consensus 404 l~~~~p~~~~~--------l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~ 473 (1009)
|+ .+|..+.. +++|++|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+.++++|+.|++++
T Consensus 709 L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~ 785 (876)
T 4ecn_A 709 MT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRH 785 (876)
T ss_dssp CS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCC
T ss_pred CC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCC
Confidence 77 44443322 226777777777777 5666665 67777777777777765 566666666666655555
Q ss_pred CCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccccccc
Q 047768 474 NKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTI 553 (1009)
Q Consensus 474 N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 553 (1009)
|+ ++++|++.+.+|..|+++++|+.|+|++|++ +.+|..+. ++|+.|+|++|++....
T Consensus 786 N~-------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~ 843 (876)
T 4ecn_A 786 QR-------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISID 843 (876)
T ss_dssp CB-------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEE
T ss_pred CC-------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccC
Confidence 53 3445555555555555555555555555555 34554443 35555555555554444
Q ss_pred ccccccccccceEcCCCccc
Q 047768 554 PQSLSSLTSIKELDLSQNNF 573 (1009)
Q Consensus 554 p~~~~~l~~L~~L~Ls~N~l 573 (1009)
+..+.....+..+.|++|.+
T Consensus 844 ~~~~~~~~~~~~~~L~~n~~ 863 (876)
T 4ecn_A 844 VTSVCPYIEAGMYVLLYDKT 863 (876)
T ss_dssp CGGGHHHHHTTCCEEECCTT
T ss_pred hHHccccccchheeecCCCc
Confidence 44444444444444444443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-59 Score=565.72 Aligned_cols=496 Identities=19% Similarity=0.233 Sum_probs=351.7
Q ss_pred CChhhHHHHHHHHHhcCCCC--------CCCCCCccCCCCCCCCCc---cceeeCCCCCeEEEEEeecCCcccccCcccc
Q 047768 23 SNETDCLSLLAIKSQLHDPL--------GVTSSWNRSACVNLCQHW---TGVTCGRRNQRVTKLDLRNQSIGGILSPYVG 91 (1009)
Q Consensus 23 ~~~~d~~aLl~~k~~~~~~~--------~~~~sW~~~~~~~~c~~w---~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~ 91 (1009)
....|+.||.+||+++.++. ....+|+.+ .++| .| .||+|+.. +||+.|+|++++++|.+|++++
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~--~~~c-~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~ 102 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN--KELD-MWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIG 102 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS--SCGG-GTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGG
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC--CCcc-cccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHh
Confidence 34679999999999976542 123479865 4555 89 99999865 7999999999999999999999
Q ss_pred CCCCCCeeeecCCcC------Cc------cCCccccCccccccccccccccCCCCCCCCcC-CCcCcEEecccccccCCC
Q 047768 92 NLSFLRYINIADNDF------HG------EIPDRIGNLFRLETLVLANNSFSGRIPTNLSH-CSKLITFSAHRNNLVGEI 158 (1009)
Q Consensus 92 ~l~~L~~L~L~~n~~------~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~-l~~L~~L~l~~n~l~~~~ 158 (1009)
+|++|++|+|++|.+ .| .+|... +.+|+ +++++|.+.+.+|..++. +..+..+++....+..
T Consensus 103 ~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~-- 177 (636)
T 4eco_A 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK-- 177 (636)
T ss_dssp GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC--
T ss_pred cCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc--
Confidence 999999999999987 44 566655 67888 999999999988887763 2334444444332221
Q ss_pred chHHhhhccCCcCeEeec--CccCCCCCCcccCCccccceeecccCcccCC-----------------CCcccc--cccc
Q 047768 159 PEELISRRLFNLQGLSVG--DNQLTGQLPASIGNLSALRVIDIRTNRLWGK-----------------IPITLS--QLTS 217 (1009)
Q Consensus 159 p~~~~~~~l~~L~~L~L~--~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~ 217 (1009)
.....++.+.+. +|++++ +|..|+++++|++|+|++|++++. +|..++ ++++
T Consensus 178 ------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~ 250 (636)
T 4eco_A 178 ------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKD 250 (636)
T ss_dssp ------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTT
T ss_pred ------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCC
Confidence 112233333333 577887 788888888888888888888775 888887 8888
Q ss_pred cccccccCccCCCCCCCcccCCChHHHHHhhCCc-cCC-CCChhhcc-----CCCcccceeccccccCCCCCC--CcCcc
Q 047768 218 LAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNR-FTG-SLPIEIGK-----NLPNLRNFVIYTNNFTGSLPD--SFSNA 288 (1009)
Q Consensus 218 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~ip~~~~~-----~l~~L~~L~L~~N~l~~~~p~--~~~~l 288 (1009)
|++|+|++|++.+.+|..|.++++|++|+|++|+ ++| .+|..++. .+++|++|+|++|+++ .+|. .|+++
T Consensus 251 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l 329 (636)
T 4eco_A 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKM 329 (636)
T ss_dssp CCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTC
T ss_pred CCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccC
Confidence 8888888888888888888888888888888887 877 67777653 2388888888888888 6777 88888
Q ss_pred cccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhcccccc-cceEEccCCCCCCcCchhhhhhc
Q 047768 289 SNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTK-LQYLYLADNGFGGVLPHSIANLS 367 (1009)
Q Consensus 289 ~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~-L~~L~L~~N~l~~~~p~~~~~l~ 367 (1009)
++|++|+|++|+++|.++ .|..+++|+.|++++|.+..++ ..+.++++ |++|++++|.+
T Consensus 330 ~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp-------~~l~~l~~~L~~L~Ls~N~l------------ 389 (636)
T 4eco_A 330 KKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIP-------ANFCGFTEQVENLSFAHNKL------------ 389 (636)
T ss_dssp TTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEECC-------TTSEEECTTCCEEECCSSCC------------
T ss_pred CCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCcccccc-------HhhhhhcccCcEEEccCCcC------------
Confidence 888888888888886665 6555555555555555444221 22344444 44444444444
Q ss_pred ccceEEEcCCCccccCCCccccCcC--ccCEEEccCCCCCCCCCCCcC-------CcccccceecccccccCCCCccccc
Q 047768 368 TALIDFNLGKNQIYGTIPPGIANLV--NLNSLRMEANRLTGTIPHVIG-------ELKNLQLLHLHANFLQGTIPSSLGN 438 (1009)
Q Consensus 368 ~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~~~ 438 (1009)
+ .+|..+..++ +|+.|++++|++++.+|..|. .+++|++|+|++|++++..+..+..
T Consensus 390 -------------~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~ 455 (636)
T 4eco_A 390 -------------K-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFST 455 (636)
T ss_dssp -------------S-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHT
T ss_pred -------------c-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHcc
Confidence 4 3444444433 566666666666666665555 5556666666666666332223344
Q ss_pred ccccccccccCcccccccCCCCCC--------CCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCcc
Q 047768 439 LTLLTYLSFGANNLQGNIPFSLGN--------CKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVG 510 (1009)
Q Consensus 439 l~~L~~L~L~~N~l~~~~p~~~~~--------l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~ 510 (1009)
+++|++|+|++|+++ .+|..... +++|+ .|+|++|+++ .+|..+.
T Consensus 456 l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~-------------------------~L~Ls~N~l~-~lp~~~~ 508 (636)
T 4eco_A 456 GSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLT-------------------------SIDLRFNKLT-KLSDDFR 508 (636)
T ss_dssp TCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCC-------------------------EEECCSSCCC-BCCGGGS
T ss_pred CCCCCEEECCCCCCC-CcCHHHhccccccccccCCcc-------------------------EEECcCCcCC-ccChhhh
Confidence 666666666666666 44433221 11333 3666666666 5666665
Q ss_pred --CCCCCCeeeccccccCCCccccccCCCCccEEEe------cCcccccccccccccccccceEcCCCcccccccccccc
Q 047768 511 --NLKSLVRLGIARNQFSGQIPVTLGACTSLEYVEL------QGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLE 582 (1009)
Q Consensus 511 --~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L------~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 582 (1009)
.+++|++|+|++|++++ +|..+..+++|+.|+| ++|++.+.+|.+++++++|++|||++|+| +.+|..+.
T Consensus 509 ~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~ 586 (636)
T 4eco_A 509 ATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT 586 (636)
T ss_dssp TTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC
T ss_pred hccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh
Confidence 78888888888888886 7888888888888888 56888889999999999999999999999 58888766
Q ss_pred cccccCceecccccCccc
Q 047768 583 NLSFLQYLNLSYNHFEGE 600 (1009)
Q Consensus 583 ~l~~L~~L~ls~N~l~g~ 600 (1009)
++|++|||++|++...
T Consensus 587 --~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 587 --PNISVLDIKDNPNISI 602 (636)
T ss_dssp --TTCCEEECCSCTTCEE
T ss_pred --CcCCEEECcCCCCccc
Confidence 7899999999988743
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-57 Score=548.43 Aligned_cols=514 Identities=19% Similarity=0.186 Sum_probs=436.8
Q ss_pred CeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEec
Q 047768 70 QRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSA 149 (1009)
Q Consensus 70 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l 149 (1009)
.+++.|+|++|.+++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|++
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 57899999999999888888999999999999999999888888999999999999999999888999999999999999
Q ss_pred ccccccCCCchHHhhhccCCcCeEeecCccCCC-CCCcccCCccccceeecccCcccCCCCcccccccccc----ccccc
Q 047768 150 HRNNLVGEIPEELISRRLFNLQGLSVGDNQLTG-QLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLA----YLHVG 224 (1009)
Q Consensus 150 ~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~L~ 224 (1009)
++|.+.+..|..+ ..+.+|++|+|++|.+++ .+|..|+++++|++|+|++|++++..|..|+.+++|+ +|+++
T Consensus 112 ~~n~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~ 189 (606)
T 3vq2_A 112 VETKLASLESFPI--GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189 (606)
T ss_dssp TTSCCCCSSSSCC--TTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECT
T ss_pred cCCcccccccccc--CCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeecc
Confidence 9999986665654 678899999999999986 5688999999999999999999888888888888776 69999
Q ss_pred CccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCC------CCCCCcCccc--ccccccc
Q 047768 225 DNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTG------SLPDSFSNAS--NLEVLHL 296 (1009)
Q Consensus 225 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~------~~p~~~~~l~--~L~~L~L 296 (1009)
+|.+++..+..+. ..+|++|++++|.+++......+.++++|+.+++..+.+.+ ..+..+.++. +++.+++
T Consensus 190 ~n~l~~~~~~~~~-~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l 268 (606)
T 3vq2_A 190 LNPIDFIQDQAFQ-GIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268 (606)
T ss_dssp TCCCCEECTTTTT-TCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEE
T ss_pred CCCcceeCccccc-CceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheec
Confidence 9999855444444 44899999999988755555556678888888886655442 2222333333 3556666
Q ss_pred -cccccccccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEc
Q 047768 297 -AENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNL 375 (1009)
Q Consensus 297 -s~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L 375 (1009)
..|.+.+..+. |..+++|+.|++++|.+..++ .+..+++|+.|++++|.+ +.+| .+ .+ ..|+.|++
T Consensus 269 ~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~--------~l~~~~~L~~L~l~~n~l-~~lp-~~-~l-~~L~~L~l 335 (606)
T 3vq2_A 269 TYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE--------DVPKHFKWQSLSIIRCQL-KQFP-TL-DL-PFLKSLTL 335 (606)
T ss_dssp CCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC--------CCCTTCCCSEEEEESCCC-SSCC-CC-CC-SSCCEEEE
T ss_pred cccccccccccc-cccCCCCCEEEecCccchhhh--------hccccccCCEEEcccccC-cccc-cC-CC-Cccceeec
Confidence 77788887777 999999999999999987654 367788999999999999 5777 44 44 68999999
Q ss_pred CCCccccCCCccccCcCccCEEEccCCCCCCC--CCCCcCCcccccceecccccccCCCCcccccccccccccccCcccc
Q 047768 376 GKNQIYGTIPPGIANLVNLNSLRMEANRLTGT--IPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453 (1009)
Q Consensus 376 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 453 (1009)
++|+..+.. .+..+++|+.|++++|++++. .|..+..+++|++|+|++|.+++ +|..+.++++|++|++++|++.
T Consensus 336 ~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~ 412 (606)
T 3vq2_A 336 TMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLK 412 (606)
T ss_dssp ESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEE
T ss_pred cCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccC
Confidence 999665444 677899999999999999866 48888999999999999999984 6688999999999999999999
Q ss_pred cccC-CCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCC-CCCCCccCCCCCCeeeccccccCCCccc
Q 047768 454 GNIP-FSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNG-SLPLGVGNLKSLVRLGIARNQFSGQIPV 531 (1009)
Q Consensus 454 ~~~p-~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 531 (1009)
+..| ..+.++++|++|++++|++++..|..+.....+. .|++++|++++ .+|..|+.+++|++|++++|++++.+|.
T Consensus 413 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 491 (606)
T 3vq2_A 413 RVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN-TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491 (606)
T ss_dssp STTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC-EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred CccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCC-EEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChh
Confidence 8877 6899999999999999999988887776665555 59999999998 4789999999999999999999999999
Q ss_pred cccCCCCccEEEecCcccccccccccccccccceEcCCCccccccccccccccc-ccCceecccccCcccCCCC
Q 047768 532 TLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLS-FLQYLNLSYNHFEGEVPTK 604 (1009)
Q Consensus 532 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~g~~p~~ 604 (1009)
.++.+++|+.|+|++|++++.+|..|+++++|++|||++|+|+ .+|..+..++ +|++|++++|++.|.++..
T Consensus 492 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~ 564 (606)
T 3vq2_A 492 VFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQ 564 (606)
T ss_dssp TTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred hhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence 9999999999999999999999999999999999999999999 6888899997 5999999999999998864
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-56 Score=540.51 Aligned_cols=531 Identities=18% Similarity=0.158 Sum_probs=454.1
Q ss_pred EEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEeccccc
Q 047768 74 KLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNN 153 (1009)
Q Consensus 74 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~ 153 (1009)
.++.++.+++ .+|..+. .++++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|++++|+
T Consensus 16 ~~~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 16 TYNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEECCCCCcc-cCcCCCC--CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 4677887776 3555554 378999999999998889999999999999999999999999999999999999999999
Q ss_pred ccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCC
Q 047768 154 LVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIP 233 (1009)
Q Consensus 154 l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 233 (1009)
+++..|..+ ..+.+|++|+|++|++++..|..|+++++|++|+|++|++.+..+..+..+++|++|++++|++++..|
T Consensus 93 l~~~~~~~~--~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 170 (606)
T 3t6q_A 93 LIFMAETAL--SGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170 (606)
T ss_dssp CSEECTTTT--SSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECH
T ss_pred ccccChhhh--cccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccCh
Confidence 997777776 678999999999999998778889999999999999999987655556669999999999999997778
Q ss_pred CcccCCChHH--HHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccc-----ccccccc
Q 047768 234 PSVYNISSLV--EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAEN-----QFRGQVS 306 (1009)
Q Consensus 234 ~~~~~l~~L~--~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-----~l~~~~~ 306 (1009)
..|..+++|+ +|++++|+++ .++...+. ..+|+.|++++|. ..+..+.++.+++...+..+ ....+.+
T Consensus 171 ~~~~~l~~L~~l~L~l~~n~l~-~~~~~~~~-~~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~ 245 (606)
T 3t6q_A 171 EDMSSLQQATNLSLNLNGNDIA-GIEPGAFD-SAVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP 245 (606)
T ss_dssp HHHHTTTTCCSEEEECTTCCCC-EECTTTTT-TCEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCG
T ss_pred hhhhhhcccceeEEecCCCccC-ccChhHhh-hccccccccCCch---hHHHHhhhccccchhheechhhccccccccCh
Confidence 8888898888 7899999998 45555554 4689999998886 23344444444433333222 2223445
Q ss_pred ccccccc--ccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCC
Q 047768 307 INFNGLK--DLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTI 384 (1009)
Q Consensus 307 ~~f~~l~--~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~ 384 (1009)
..|.++. +|+.|++++|.+..+.. ..|.++++|++|++++|+++ .+|..+..+ ..|++|++++|++++..
T Consensus 246 ~~~~~l~~~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l-~~L~~L~l~~n~l~~~~ 317 (606)
T 3t6q_A 246 AVFEGLCEMSVESINLQKHYFFNISS------NTFHCFSGLQELDLTATHLS-ELPSGLVGL-STLKKLVLSANKFENLC 317 (606)
T ss_dssp GGGGGGGGSEEEEEECTTCCCSSCCT------TTTTTCTTCSEEECTTSCCS-CCCSSCCSC-TTCCEEECTTCCCSBGG
T ss_pred hHhchhhcCceeEEEeecCccCccCH------HHhccccCCCEEeccCCccC-CCChhhccc-ccCCEEECccCCcCcCc
Confidence 5566665 78999999999988765 45788999999999999999 778888777 68999999999999888
Q ss_pred CccccCcCccCEEEccCCCCCCCCCC-CcCCcccccceecccccccCCC--CcccccccccccccccCcccccccCCCCC
Q 047768 385 PPGIANLVNLNSLRMEANRLTGTIPH-VIGELKNLQLLHLHANFLQGTI--PSSLGNLTLLTYLSFGANNLQGNIPFSLG 461 (1009)
Q Consensus 385 p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 461 (1009)
|..+.++++|+.|++++|.+.+.+|. .+..+++|++|++++|++++.. |..+.++++|++|++++|++++..|..+.
T Consensus 318 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 397 (606)
T 3t6q_A 318 QISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFK 397 (606)
T ss_dssp GGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTT
T ss_pred hhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhc
Confidence 99999999999999999999976665 5999999999999999999766 78899999999999999999999999999
Q ss_pred CCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCC---ccccccCCCC
Q 047768 462 NCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQ---IPVTLGACTS 538 (1009)
Q Consensus 462 ~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~---~p~~~~~l~~ 538 (1009)
.+++|+.|++++|++++..|...+........|++++|.+++..|..++.+++|++|++++|++++. .+..+..+++
T Consensus 398 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~ 477 (606)
T 3t6q_A 398 ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477 (606)
T ss_dssp TCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTT
T ss_pred CCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCC
Confidence 9999999999999999887766454445555799999999999999999999999999999999873 3367999999
Q ss_pred ccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceecccccCcccCCCC-CcccCcccccccc
Q 047768 539 LEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK-GIFKNKTGFSIVG 617 (1009)
Q Consensus 539 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~~~~~~~~~~~ 617 (1009)
|+.|+|++|++++..|.+|+++++|++|||++|++++.+|..+..++.| +|++++|++++.+|.. +.+.++....+.+
T Consensus 478 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 556 (606)
T 3t6q_A 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQ 556 (606)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTT
T ss_pred ccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCC
Confidence 9999999999999999999999999999999999999999999999999 9999999999887763 4456677788899
Q ss_pred CCCcCC
Q 047768 618 NGKLCG 623 (1009)
Q Consensus 618 n~~lc~ 623 (1009)
|++.|.
T Consensus 557 N~~~c~ 562 (606)
T 3t6q_A 557 NPLDCT 562 (606)
T ss_dssp CCEECS
T ss_pred CCcccc
Confidence 998884
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=542.24 Aligned_cols=522 Identities=19% Similarity=0.180 Sum_probs=447.9
Q ss_pred EEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCC-CCCCcCCCcCcEEeccccc
Q 047768 75 LDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRI-PTNLSHCSKLITFSAHRNN 153 (1009)
Q Consensus 75 l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~l~~n~ 153 (1009)
.|.++++++.. |. ..++|++|||++|.+++..|..|+++++|++|||++|.+.+.+ |..|+++++|++|+|++|.
T Consensus 9 ~dcs~~~L~~v-P~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~ 84 (844)
T 3j0a_A 9 AFYRFCNLTQV-PQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84 (844)
T ss_dssp EEESCCCSSCC-CS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCC
T ss_pred EEccCCCCCCC-CC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCc
Confidence 34455667654 33 4588999999999999889999999999999999999777676 7899999999999999999
Q ss_pred ccCCCchHHhhhccCCcCeEeecCccCCCCCCcc--cCCccccceeecccCcccCCCC-cccccccccccccccCccCCC
Q 047768 154 LVGEIPEELISRRLFNLQGLSVGDNQLTGQLPAS--IGNLSALRVIDIRTNRLWGKIP-ITLSQLTSLAYLHVGDNHFSG 230 (1009)
Q Consensus 154 l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~ 230 (1009)
+.+..|..+ ..+.+|++|+|++|.+++.+|.. |+++++|++|+|++|.+.+..+ ..|+++++|++|+|++|.+++
T Consensus 85 l~~~~p~~~--~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~ 162 (844)
T 3j0a_A 85 IYFLHPDAF--QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162 (844)
T ss_dssp CCEECTTSS--CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred CcccCHhHc--cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence 998888877 68999999999999999877665 9999999999999999987765 689999999999999999999
Q ss_pred CCCCcccCC--ChHHHHHhhCCccCCCCChhhccCCC------cccceeccccccCCCCCCCcCcc---ccccccccc--
Q 047768 231 TIPPSVYNI--SSLVEIYLYGNRFTGSLPIEIGKNLP------NLRNFVIYTNNFTGSLPDSFSNA---SNLEVLHLA-- 297 (1009)
Q Consensus 231 ~~p~~~~~l--~~L~~L~L~~N~l~~~ip~~~~~~l~------~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls-- 297 (1009)
..|..+..+ ++|+.|+|++|.+++.+|..+.. ++ +|+.|++++|.+++..+..+... ++++.|+++
T Consensus 163 ~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~-~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~ 241 (844)
T 3j0a_A 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGK-CMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH 241 (844)
T ss_dssp CCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCS-SSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSS
T ss_pred eCHHHcccccCCccceEECCCCccccccccchhh-cCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccc
Confidence 999999888 89999999999999888766432 33 49999999999999888877654 567777776
Q ss_pred -------ccccccccccccccc--cccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcc
Q 047768 298 -------ENQFRGQVSINFNGL--KDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLST 368 (1009)
Q Consensus 298 -------~N~l~~~~~~~f~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 368 (1009)
.|.+.+.....|.++ ++|+.|++++|.+..... ..|..+++|+.|+|++|++++..|..+..+ .
T Consensus 242 ~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~------~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l-~ 314 (844)
T 3j0a_A 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS------RVFETLKDLKVLNLAYNKINKIADEAFYGL-D 314 (844)
T ss_dssp CCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECS------CCSSSCCCCCEEEEESCCCCEECTTTTTTC-S
T ss_pred cccccccccccCCCChhhhhccccCCccEEECCCCcccccCh------hhhhcCCCCCEEECCCCcCCCCChHHhcCC-C
Confidence 445555666677776 789999999999876543 567889999999999999999888888888 6
Q ss_pred cceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCccccccccccccccc
Q 047768 369 ALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFG 448 (1009)
Q Consensus 369 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 448 (1009)
.|++|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|++|+|++|.+++ ++ .+++|+.|+++
T Consensus 315 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~----~~~~L~~L~l~ 389 (844)
T 3j0a_A 315 NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IH----FIPSIPDIFLS 389 (844)
T ss_dssp SCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CS----SCCSCSEEEEE
T ss_pred CCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-cc----CCCCcchhccC
Confidence 89999999999998989999999999999999999998888899999999999999999984 33 37889999999
Q ss_pred CcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCC-CccCCCCCCeeeccccccC-
Q 047768 449 ANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPL-GVGNLKSLVRLGIARNQFS- 526 (1009)
Q Consensus 449 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~- 526 (1009)
+|+++ .+|.. ..+++.+++++|++++.-........+....|+|++|++++..+. .+..+++|+.|++++|.++
T Consensus 390 ~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~ 465 (844)
T 3j0a_A 390 GNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465 (844)
T ss_dssp SCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSS
T ss_pred CCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCcccc
Confidence 99999 56654 467889999999999643333332333445699999999975544 4667899999999999997
Q ss_pred ----CCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceecccccCcccCC
Q 047768 527 ----GQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVP 602 (1009)
Q Consensus 527 ----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p 602 (1009)
+..|..|.++++|+.|+|++|+|++.+|..|+++++|+.|||++|+|++..|..+. ++|+.|||++|+|+|.+|
T Consensus 466 ~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~ 543 (844)
T 3j0a_A 466 AWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNP 543 (844)
T ss_dssp SCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCS
T ss_pred ccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCCh
Confidence 45567799999999999999999999999999999999999999999987777766 899999999999999998
Q ss_pred CCCcccCccccccccCCCcCC
Q 047768 603 TKGIFKNKTGFSIVGNGKLCG 623 (1009)
Q Consensus 603 ~~~~~~~~~~~~~~~n~~lc~ 623 (1009)
.. |.++....+.+|++.|.
T Consensus 544 ~~--~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 544 DV--FVSLSVLDITHNKFICE 562 (844)
T ss_dssp CC--CSSCCEEEEEEECCCCS
T ss_pred hH--hCCcCEEEecCCCcccc
Confidence 64 66777888899999884
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-55 Score=528.43 Aligned_cols=527 Identities=18% Similarity=0.154 Sum_probs=447.0
Q ss_pred EEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccc
Q 047768 75 LDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNL 154 (1009)
Q Consensus 75 l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l 154 (1009)
++.++++++. +|..+. ++|++|+|++|.+++..|..|+++++|++|||++|.+++..|..|+++++|++|++++|.+
T Consensus 16 ~~c~~~~l~~-ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l 92 (606)
T 3vq2_A 16 YQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92 (606)
T ss_dssp EECTTSCCSS-CCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred eEccCCCccc-CCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcc
Confidence 4555566654 444443 7899999999999988888999999999999999999998899999999999999999999
Q ss_pred cCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccC-CCCcccccccccccccccCccCCCCCC
Q 047768 155 VGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWG-KIPITLSQLTSLAYLHVGDNHFSGTIP 233 (1009)
Q Consensus 155 ~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p 233 (1009)
++..|..+ ..+.+|++|+|++|++++..+..|+++++|++|++++|++.+ .+|..|+++++|++|+|++|++++..|
T Consensus 93 ~~~~p~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~ 170 (606)
T 3vq2_A 93 QSFSPGSF--SGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV 170 (606)
T ss_dssp CCCCTTSS--TTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECT
T ss_pred cccChhhc--CCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecCh
Confidence 98878877 679999999999999998888899999999999999999986 579999999999999999999998888
Q ss_pred CcccCCChHH----HHHhhCCccCCCCChhhccCCCcccceeccccccC-CCCCCCcCccccccccccccccccc-----
Q 047768 234 PSVYNISSLV----EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFT-GSLPDSFSNASNLEVLHLAENQFRG----- 303 (1009)
Q Consensus 234 ~~~~~l~~L~----~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~----- 303 (1009)
..|..+++|+ +|++++|+++ .+|...+... +|+.|++++|.++ +..|..+.++++|+.+++..+.+..
T Consensus 171 ~~~~~l~~L~~~l~~L~l~~n~l~-~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~ 248 (606)
T 3vq2_A 171 NDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248 (606)
T ss_dssp TTTHHHHHCTTCCCEEECTTCCCC-EECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCS
T ss_pred hhhhhhhccccccceeeccCCCcc-eeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCccc
Confidence 8888888776 6999999999 7888887655 8999999999987 5667788999999999987665543
Q ss_pred -cccccccccccc--ccccc-cccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCc
Q 047768 304 -QVSINFNGLKDL--SMLGL-ATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQ 379 (1009)
Q Consensus 304 -~~~~~f~~l~~L--~~L~L-~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~ 379 (1009)
.....+.++..+ +.+++ ..|.+.. ..+. +..+++|+.|++++|.+.. +| .+..+ ..|+.|++++|+
T Consensus 249 ~~~~~~~~~l~~l~l~~l~l~~~~~~~~------~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~-~~L~~L~l~~n~ 318 (606)
T 3vq2_A 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSD------DIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKH-FKWQSLSIIRCQ 318 (606)
T ss_dssp CCCGGGGTTGGGSEEEEEEECCCTTCCG------GGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTT-CCCSEEEEESCC
T ss_pred ccChHHhhhhhhccHhheeccccccccc------cccc-cccCCCCCEEEecCccchh-hh-hcccc-ccCCEEEccccc
Confidence 223333333332 33333 3333322 2233 7889999999999999974 55 66666 689999999999
Q ss_pred cccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCC--CCcccccccccccccccCcccccccC
Q 047768 380 IYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGT--IPSSLGNLTLLTYLSFGANNLQGNIP 457 (1009)
Q Consensus 380 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p 457 (1009)
+ +.+| .+ .+++|+.|++++|+..+.. .+..+++|++|++++|++++. .|..+..+++|++|++++|.+++ +|
T Consensus 319 l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~ 392 (606)
T 3vq2_A 319 L-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MS 392 (606)
T ss_dssp C-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-EC
T ss_pred C-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-ch
Confidence 9 5788 55 9999999999999765444 678999999999999999976 48889999999999999999995 77
Q ss_pred CCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCC-CccccccCC
Q 047768 458 FSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSG-QIPVTLGAC 536 (1009)
Q Consensus 458 ~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l 536 (1009)
..+..+++|+.|++++|++++..|...+........|++++|.+++..|..++++++|++|++++|++++ .+|..++.+
T Consensus 393 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l 472 (606)
T 3vq2_A 393 ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANT 472 (606)
T ss_dssp CCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTC
T ss_pred hhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccC
Confidence 9999999999999999999988884444334445569999999999999999999999999999999998 479999999
Q ss_pred CCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceecccccCcccCCCC-Cccc-Cccccc
Q 047768 537 TSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK-GIFK-NKTGFS 614 (1009)
Q Consensus 537 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~~-~~~~~~ 614 (1009)
++|+.|+|++|++++.+|..|+++++|++|+|++|++++.+|..|..+++|++|+|++|+++ .+|.. ..+. ++....
T Consensus 473 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~ 551 (606)
T 3vq2_A 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFN 551 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEE
T ss_pred CCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999 45543 3333 366678
Q ss_pred cccCCCcCCCC
Q 047768 615 IVGNGKLCGGL 625 (1009)
Q Consensus 615 ~~~n~~lc~~~ 625 (1009)
+.+|++.|+.+
T Consensus 552 l~~N~~~c~c~ 562 (606)
T 3vq2_A 552 LTNNSVACICE 562 (606)
T ss_dssp CCSCCCCCSST
T ss_pred ccCCCcccCCc
Confidence 89999998644
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=503.77 Aligned_cols=492 Identities=16% Similarity=0.174 Sum_probs=406.6
Q ss_pred CccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCC
Q 047768 59 HWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNL 138 (1009)
Q Consensus 59 ~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 138 (1009)
.|.|| |+. ++++++ .+|+.+. ++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|
T Consensus 5 ~~~~~-c~~----------~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~ 70 (549)
T 2z81_A 5 DASGV-CDG----------RSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF 70 (549)
T ss_dssp CTTSE-EEC----------TTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTT
T ss_pred CCCce-EEC----------CCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhc
Confidence 79998 853 345555 3455554 789999999999998889999999999999999999999889999
Q ss_pred cCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCC-CCCcccCCccccceeecccCcccCCC-Cccccccc
Q 047768 139 SHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTG-QLPASIGNLSALRVIDIRTNRLWGKI-PITLSQLT 216 (1009)
Q Consensus 139 ~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~ 216 (1009)
+++++|++|++++|++++..|..+ ..+.+|++|+|++|++++ ..|..|+++++|++|++++|++.+.+ +..|.+++
T Consensus 71 ~~l~~L~~L~Ls~n~l~~~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~ 148 (549)
T 2z81_A 71 YSLGSLEHLDLSDNHLSSLSSSWF--GPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT 148 (549)
T ss_dssp TTCTTCCEEECTTSCCCSCCHHHH--TTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred cccccCCEEECCCCccCccCHHHh--ccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccc
Confidence 999999999999999997776666 679999999999999997 35788999999999999999954444 47899999
Q ss_pred ccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCC--C-CCcCccccccc
Q 047768 217 SLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSL--P-DSFSNASNLEV 293 (1009)
Q Consensus 217 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~--p-~~~~~l~~L~~ 293 (1009)
+|++|++++|++++..|..+..+++|++|++++|.+. .+|..++..+++|++|++++|++++.. | .....+++|+.
T Consensus 149 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~ 227 (549)
T 2z81_A 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227 (549)
T ss_dssp EEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCE
T ss_pred ccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccc
Confidence 9999999999999999999999999999999999997 888888778999999999999999753 2 23456889999
Q ss_pred cccccccccccccc----ccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCc----hhhhh
Q 047768 294 LHLAENQFRGQVSI----NFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLP----HSIAN 365 (1009)
Q Consensus 294 L~Ls~N~l~~~~~~----~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~ 365 (1009)
|++++|++++..+. .+..+++|+.+++++|.+...........+.+..+++|+.|++.++.+..... ..+..
T Consensus 228 L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~ 307 (549)
T 2z81_A 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307 (549)
T ss_dssp EEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHH
T ss_pred eeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhh
Confidence 99999999875443 34667889999999998876543222223456778899999999998764210 11223
Q ss_pred hcccceEEEcCCCccccCCCccc-cCcCccCEEEccCCCCCCCCC---CCcCCcccccceecccccccCCCC--cccccc
Q 047768 366 LSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIP---HVIGELKNLQLLHLHANFLQGTIP--SSLGNL 439 (1009)
Q Consensus 366 l~~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l 439 (1009)
....|+.|++++|++. .+|..+ .++++|++|+|++|++++.+| ..++.+++|++|+|++|++++..+ ..+..+
T Consensus 308 ~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l 386 (549)
T 2z81_A 308 LLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386 (549)
T ss_dssp HSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGC
T ss_pred hcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcC
Confidence 3467899999999987 666665 579999999999999987664 447889999999999999986433 458889
Q ss_pred cccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeee
Q 047768 440 TLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLG 519 (1009)
Q Consensus 440 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 519 (1009)
++|++|++++|+++ .+|..+..+++|++|++++|+++ .+|..+ .++|++|+
T Consensus 387 ~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~--------------------------~l~~~~--~~~L~~L~ 437 (549)
T 2z81_A 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR--------------------------VVKTCI--PQTLEVLD 437 (549)
T ss_dssp TTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS--------------------------CCCTTS--CTTCSEEE
T ss_pred CCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc--------------------------cccchh--cCCceEEE
Confidence 99999999999998 68888888888887666666655 223222 25789999
Q ss_pred ccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceecccccCcc
Q 047768 520 IARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEG 599 (1009)
Q Consensus 520 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g 599 (1009)
+++|+|++.+ ..+++|++|+|++|+|+ .+|. .+.+++|++|||++|+|++.+|..+..+++|++|++++|++.|
T Consensus 438 Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 511 (549)
T 2z81_A 438 VSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 511 (549)
T ss_dssp CCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCC
T ss_pred CCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccC
Confidence 9999998643 57889999999999998 6776 5789999999999999999888889999999999999999999
Q ss_pred cCCC
Q 047768 600 EVPT 603 (1009)
Q Consensus 600 ~~p~ 603 (1009)
.+|.
T Consensus 512 ~~~~ 515 (549)
T 2z81_A 512 SCPR 515 (549)
T ss_dssp CHHH
T ss_pred CCcc
Confidence 9885
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-52 Score=499.60 Aligned_cols=495 Identities=19% Similarity=0.185 Sum_probs=320.2
Q ss_pred CeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEec
Q 047768 70 QRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSA 149 (1009)
Q Consensus 70 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l 149 (1009)
.+++.|+|++|.+++..+.+|.++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 35677777777777766667777777777777777777666666777777777777777777666677777777777777
Q ss_pred ccccccCCCchHHhhhccCCcCeEeecCccCCC-CCCcccCCccccceeecccCcccCCCCccccccccc----cccccc
Q 047768 150 HRNNLVGEIPEELISRRLFNLQGLSVGDNQLTG-QLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSL----AYLHVG 224 (1009)
Q Consensus 150 ~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~L~ 224 (1009)
++|++++..+..+ ..+.+|++|++++|.+++ .+|..|+++++|++|++++|++++..|..|+.+++| ++|+++
T Consensus 108 ~~n~l~~l~~~~~--~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~ 185 (570)
T 2z63_A 108 VETNLASLENFPI--GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185 (570)
T ss_dssp TTSCCCCSTTCSC--TTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECT
T ss_pred cccccccCCCccc--cccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccC
Confidence 7777664333232 456777777777777765 356677777777777777777766666667776666 667777
Q ss_pred CccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccC------CCCCCCcCcccc--cccccc
Q 047768 225 DNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFT------GSLPDSFSNASN--LEVLHL 296 (1009)
Q Consensus 225 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~------~~~p~~~~~l~~--L~~L~L 296 (1009)
+|.+++..|..|..+ +|++|++++|......-.....++++++.+.+..+.+. ......|.++++ ++.+++
T Consensus 186 ~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l 264 (570)
T 2z63_A 186 LNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264 (570)
T ss_dssp TCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEE
T ss_pred CCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhh
Confidence 777775555555544 66677776664432211222334555554444332221 122223333322 333444
Q ss_pred ccc-ccccccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEc
Q 047768 297 AEN-QFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNL 375 (1009)
Q Consensus 297 s~N-~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L 375 (1009)
++| .+.+..+..|..+ ++|+.|++++|.++ .+|..+..+ .|+.|++
T Consensus 265 ~~~~~~~~~~~~~~~~l------------------------------~~L~~L~l~~~~l~-~l~~~~~~~--~L~~L~l 311 (570)
T 2z63_A 265 AYLDYYLDDIIDLFNCL------------------------------TNVSSFSLVSVTIE-RVKDFSYNF--GWQHLEL 311 (570)
T ss_dssp EETTEEESCSTTTTGGG------------------------------TTCSEEEEESCEEC-SCCBCCSCC--CCSEEEE
T ss_pred hcchhhhhhchhhhcCc------------------------------CcccEEEecCccch-hhhhhhccC--CccEEee
Confidence 444 4444444444444 44555555555444 234434333 4555555
Q ss_pred CCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCC--CcccccccccccccccCcccc
Q 047768 376 GKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTI--PSSLGNLTLLTYLSFGANNLQ 453 (1009)
Q Consensus 376 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~ 453 (1009)
++|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|++++.. |..+.++++|++|++++|.++
T Consensus 312 ~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~ 386 (570)
T 2z63_A 312 VNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386 (570)
T ss_dssp ESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEE
T ss_pred ccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccc
Confidence 555554 3332 2445555555555555544433 44555555555555555332 444555555555555555555
Q ss_pred cccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccC-CCcccc
Q 047768 454 GNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFS-GQIPVT 532 (1009)
Q Consensus 454 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~ 532 (1009)
+..+. +..+++|+.|++++|.+++..|...+........|++++|.+.+..|..+.++++|++|++++|.++ +.+|..
T Consensus 387 ~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~ 465 (570)
T 2z63_A 387 TMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465 (570)
T ss_dssp EEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSC
T ss_pred ccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhh
Confidence 43332 5555555555555555554444322222233335888888888888889999999999999999998 679999
Q ss_pred ccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceecccccCcccCCCCCc
Q 047768 533 LGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGI 606 (1009)
Q Consensus 533 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~ 606 (1009)
+..+++|+.|+|++|++++..|.+|+++++|++|+|++|++++.+|..|..+++|++|++++|+++|.+|....
T Consensus 466 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~ 539 (570)
T 2z63_A 466 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 539 (570)
T ss_dssp CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHH
T ss_pred hhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHH
Confidence 99999999999999999998899999999999999999999998888899999999999999999999997543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=446.05 Aligned_cols=265 Identities=27% Similarity=0.419 Sum_probs=205.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.+++.+.++||+|+||+||+|+++ ..||||+++.... ...+.|.+|+++|++++|||||+++|+|.. +.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence 457788899999999999999875 2599999874432 234679999999999999999999999753 35
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++|||||++|+|.++++.... .+++.++..|+.|+|+||+|||++ +||||||||+|||+++++++||+|||
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~-----~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFG 177 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQET-----KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFG 177 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred EEEEEEcCCCCCHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeecc
Confidence 7899999999999999986543 399999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCC---CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG---GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
+|+....... ........||+.|||||++.+ +.|+.++|||||||++|||+||+.||....... ......
T Consensus 178 la~~~~~~~~------~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~ 250 (307)
T 3omv_A 178 LATVKSRWSG------SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMV 250 (307)
T ss_dssp SCBC------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHH
T ss_pred CceecccCCc------ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHH
Confidence 9987654221 122334679999999999864 468999999999999999999999997543221 111111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLG 1006 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~ 1006 (1009)
... ...+.+.. ....++.++.+++.+||+.||++||||+||++.|+.++..++.
T Consensus 251 ~~~-------~~~p~~~~-----------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 251 GRG-------YASPDLSK-----------LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp HTT-------CCCCCSTT-----------SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred hcC-------CCCCCccc-----------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 110 01111110 1123456788999999999999999999999999998877653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=445.71 Aligned_cols=266 Identities=24% Similarity=0.388 Sum_probs=212.6
Q ss_pred ccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
++|.+.+.||+|+||+||+|++. .+++.||||+++.......++|.+|+++|++++|||||+++|+|...
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~----- 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG----- 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----
Confidence 56888899999999999999975 35789999999765544567899999999999999999999998653
Q ss_pred ceEEEEEeccCCCCHHHHHhccCC-------CCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDD-------QLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD 848 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 848 (1009)
+..++|||||++|+|.++++.... ......++|.++..|+.|+|+||+|||++ +||||||||+|||++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence 678999999999999999986531 11123599999999999999999999999 99999999999999999
Q ss_pred CceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCC
Q 047768 849 MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEG 927 (1009)
Q Consensus 849 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~ 927 (1009)
+++||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||+| |+.||.....
T Consensus 165 ~~~Ki~DFGla~~~~~~~~------~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-- 236 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDY------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-- 236 (299)
T ss_dssp GCEEECCCSCHHHHTGGGC------EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--
T ss_pred CcEEECCcccceecCCCCc------eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 9999999999987654321 112233568999999999999999999999999999999999 8999975432
Q ss_pred ccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 928 LTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
.+...... ....... +..++.++.+++.+||+.||++||||+||++.|+.+.+.-
T Consensus 237 ---~~~~~~i~--------~~~~~~~-----------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 237 ---NEVIECIT--------QGRVLQR-----------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp ---HHHHHHHH--------HTCCCCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ---HHHHHHHH--------cCCCCCC-----------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 12211111 1011111 1234557889999999999999999999999999887653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-51 Score=446.80 Aligned_cols=265 Identities=26% Similarity=0.409 Sum_probs=206.7
Q ss_pred ccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
++|.+.++||+|+||+||+|+++ .+++.||||+++.......+.|.+|+++|++++|||||+++|+|...
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~----- 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG----- 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----
Confidence 46777889999999999999975 35789999999765544567899999999999999999999998653
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCC---------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQL---------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD 846 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 846 (1009)
...++|||||++|+|.++++...... ...+++|.++..|+.|+|+||+|||++ +||||||||+|||++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence 67899999999999999998754221 123599999999999999999999999 999999999999999
Q ss_pred CCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCccccc
Q 047768 847 HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFN 925 (1009)
Q Consensus 847 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~ 925 (1009)
+++++||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||+| |+.||.....
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~------~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~ 266 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDY------YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266 (329)
T ss_dssp TTTEEEECCCC----------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred CCCcEEEcccccceeccCCCc------ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999987654321 122234679999999999999999999999999999999999 8999975432
Q ss_pred CCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 926 EGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
.+..... ....... .+..+++++.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 267 -----~~~~~~i--------~~g~~~~-----------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 267 -----TEAIDCI--------TQGRELE-----------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -----HHHHHHH--------HHTCCCC-----------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----HHHHHHH--------HcCCCCC-----------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111111 0000000 1113455788999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=440.51 Aligned_cols=262 Identities=25% Similarity=0.378 Sum_probs=209.1
Q ss_pred ccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
.++.+.++||+|+||+||+|++. .+++.||||+++.... ...+.|.+|+.++++++|||||+++|+|...
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~---- 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD---- 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC----
Confidence 35667789999999999999974 3578999999965433 2357899999999999999999999998653
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCC----------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCcee
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQL----------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVL 844 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nil 844 (1009)
...++|||||++|+|.+++..+.... ....++|.++..|+.|||+||+|||++ +||||||||+|||
T Consensus 102 -~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL 177 (308)
T 4gt4_A 102 -QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL 177 (308)
T ss_dssp -SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred -CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence 56799999999999999997653211 123589999999999999999999999 9999999999999
Q ss_pred eCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCccc
Q 047768 845 LDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESM 923 (1009)
Q Consensus 845 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~ 923 (1009)
+++++++||+|||+|+....... ........||+.|||||++.++.|+.++|||||||++|||+| |+.||...
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~------~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADY------YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGC------BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred ECCCCCEEECCcccceeccCCCc------eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999987654321 122334679999999999999999999999999999999999 89999754
Q ss_pred ccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 924 FNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
.. .+..... .+....+. +..++.++.+++.+||+.||++||||+||++.|+..
T Consensus 252 ~~-----~~~~~~i--------~~~~~~~~-----------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 252 SN-----QDVVEMI--------RNRQVLPC-----------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp CH-----HHHHHHH--------HTTCCCCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CH-----HHHHHHH--------HcCCCCCC-----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 32 2221111 11111111 124556788999999999999999999999999753
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=478.23 Aligned_cols=497 Identities=19% Similarity=0.158 Sum_probs=372.6
Q ss_pred CCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeE
Q 047768 94 SFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGL 173 (1009)
Q Consensus 94 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L 173 (1009)
+++++|+|++|++++..|..|.++++|++|||++|++++..|..|+++++|++|++++|.+++..|..+ ..+.+|++|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~--~~l~~L~~L 105 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF--SGLSSLQKL 105 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTT--TTCTTCCEE
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhh--cCccccccc
Confidence 578999999999998778889999999999999999998778889888888888888888775444444 456777777
Q ss_pred eecCccCCCCCCcccCCccccceeecccCcccC-CCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCcc
Q 047768 174 SVGDNQLTGQLPASIGNLSALRVIDIRTNRLWG-KIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRF 252 (1009)
Q Consensus 174 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 252 (1009)
++++|++++..+..|+++++|++|++++|.+.+ .+|..|+++++|++|++++|++++..|..+..+++|..
T Consensus 106 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-------- 177 (570)
T 2z63_A 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL-------- 177 (570)
T ss_dssp ECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTT--------
T ss_pred cccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccch--------
Confidence 777777775555557777777777777777765 35666777777777777777776555555555444400
Q ss_pred CCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccc-ccccccccccccccccccccccCCCCCC
Q 047768 253 TGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRG-QVSINFNGLKDLSMLGLATNFLGNGAAN 331 (1009)
Q Consensus 253 ~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~f~~l~~L~~L~L~~N~l~~~~~~ 331 (1009)
..+.|++++|.+++..|..|..+ +|+.|++++|.... ..+..+.++++++.+.+..+.+.....-
T Consensus 178 -------------~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l 243 (570)
T 2z63_A 178 -------------LNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243 (570)
T ss_dssp -------------CCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSC
T ss_pred -------------hhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhh
Confidence 00344444454444444444443 45555555543221 1222233344443333332221111000
Q ss_pred Ccchhhhccccc--ccceEEccCC-CCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCC
Q 047768 332 DLDFVDLLTNCT--KLQYLYLADN-GFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTI 408 (1009)
Q Consensus 332 ~~~~~~~l~~l~--~L~~L~L~~N-~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 408 (1009)
..-....+..+. .++.+++++| .+.+..|..+..+ ..|+.|++++|.++ .+|..+..+ +|+.|++++|.+. .+
T Consensus 244 ~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l-~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l 319 (570)
T 2z63_A 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL-TNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QF 319 (570)
T ss_dssp EECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGG-TTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SC
T ss_pred hhcchhhhccccccchhhhhhhcchhhhhhchhhhcCc-CcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-cc
Confidence 000001122222 4678888888 7888888888887 68999999999999 688889999 9999999999999 56
Q ss_pred CCCcCCcccccceecccccccCCCCcccccccccccccccCccccccc--CCCCCCCCCccccccCCCCccCCCchhhhh
Q 047768 409 PHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNI--PFSLGNCKNLMFFFAPRNKLTGALPQQILE 486 (1009)
Q Consensus 409 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~ 486 (1009)
|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|++++.. |..+.++++|++|++++|.+++..+. +..
T Consensus 320 ~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~ 394 (570)
T 2z63_A 320 PT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLG 394 (570)
T ss_dssp CB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EET
T ss_pred Cc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccc
Confidence 65 5789999999999999877665 78999999999999998654 77888999999999999999965444 444
Q ss_pred hccceeeEecCCCccCCCCC-CCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccc-cccccccccccccc
Q 047768 487 ITTLSLSLDLSDNLLNGSLP-LGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFS-GTIPQSLSSLTSIK 564 (1009)
Q Consensus 487 ~~~~~~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~ 564 (1009)
... ...|++++|.+.+..| ..+.++++|++|++++|.+++.+|..+..+++|+.|+|++|+++ +.+|..++.+++|+
T Consensus 395 l~~-L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~ 473 (570)
T 2z63_A 395 LEQ-LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473 (570)
T ss_dssp CTT-CCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCC
T ss_pred cCC-CCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCC
Confidence 444 4469999999998776 56899999999999999999999999999999999999999998 68999999999999
Q ss_pred eEcCCCcccccccccccccccccCceecccccCcccCCCC-CcccCccccccccCCCcCCC
Q 047768 565 ELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK-GIFKNKTGFSIVGNGKLCGG 624 (1009)
Q Consensus 565 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~lc~~ 624 (1009)
+|+|++|++++..|..|..+++|++|++++|++++.+|.. ..+.++....+.+|+..|.-
T Consensus 474 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 534 (570)
T 2z63_A 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534 (570)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred EEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence 9999999999988999999999999999999999887753 45667777888899988753
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=481.26 Aligned_cols=459 Identities=18% Similarity=0.218 Sum_probs=311.5
Q ss_pred EEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccc
Q 047768 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRN 152 (1009)
Q Consensus 73 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n 152 (1009)
+.||+++++++. +|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++||+++|
T Consensus 3 ~~l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCccc-cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 368999999984 666665 89999999999999877789999999999999999999888999999999999999999
Q ss_pred cccCCCchHHhhhccCCcCeEeecCccCCC-CCCcccCCccccceeecccCcccCCCCccccccccc--ccccccCccC-
Q 047768 153 NLVGEIPEELISRRLFNLQGLSVGDNQLTG-QLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSL--AYLHVGDNHF- 228 (1009)
Q Consensus 153 ~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l- 228 (1009)
+++ .+|.. .+.+|++|+|++|++++ .+|..|+++++|++|++++|++.+ ..|..+++| ++|++++|.+
T Consensus 80 ~l~-~lp~~----~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~ 151 (520)
T 2z7x_B 80 KLV-KISCH----PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETY 151 (520)
T ss_dssp CCC-EEECC----CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTT
T ss_pred cee-ecCcc----ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccc
Confidence 998 67765 58899999999999987 468899999999999999999875 467777777 9999999998
Q ss_pred -CCCCCCcccCCC-hHHHHHhhCCccCCCCChhhccCCCcccceeccccc-------cCCCCCCCcCccccccccccccc
Q 047768 229 -SGTIPPSVYNIS-SLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNN-------FTGSLPDSFSNASNLEVLHLAEN 299 (1009)
Q Consensus 229 -~~~~p~~~~~l~-~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~-------l~~~~p~~~~~l~~L~~L~Ls~N 299 (1009)
++..|..+..+. ....+++++|++.+.++...+.++++|+.|++++|. +.+.+| .|..+++|++|++++|
T Consensus 152 ~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~ 230 (520)
T 2z7x_B 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNI 230 (520)
T ss_dssp TSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEE
T ss_pred ccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccc
Confidence 777777776655 223345566666555555555555555555555554 333333 3444444444444444
Q ss_pred ccccccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCc
Q 047768 300 QFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQ 379 (1009)
Q Consensus 300 ~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~ 379 (1009)
.+.+.....+. .. ...++ |++|++++|+
T Consensus 231 ~l~~~~~~~~~--------------------------~~-~~~~~-------------------------L~~L~l~~n~ 258 (520)
T 2z7x_B 231 ETTWNSFIRIL--------------------------QL-VWHTT-------------------------VWYFSISNVK 258 (520)
T ss_dssp EEEHHHHHHHH--------------------------HH-HHTSS-------------------------CSEEEEEEEE
T ss_pred ccCHHHHHHHH--------------------------HH-hhhCc-------------------------ccEEEeeccc
Confidence 44321110000 00 00123 3444444444
Q ss_pred cccCCCccc-----cCcCccCEEEccCCCCCCCCC-CCcCCc---ccccceecccccccCCCCcccccccccccccccCc
Q 047768 380 IYGTIPPGI-----ANLVNLNSLRMEANRLTGTIP-HVIGEL---KNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGAN 450 (1009)
Q Consensus 380 l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 450 (1009)
++|.+|..+ .++++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.+.. .+..+++|++|++++|
T Consensus 259 l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n 334 (520)
T 2z7x_B 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNN 334 (520)
T ss_dssp EESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSS
T ss_pred ccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECC
Confidence 444444444 4455555555555555 222 233322 34555555555544211 1134445555555555
Q ss_pred ccccccCCCCCCCCCccccccCCCCccC--CCchhhhhhccceeeEecCCCccCCCCCCC-ccCCCCCCeeeccccccCC
Q 047768 451 NLQGNIPFSLGNCKNLMFFFAPRNKLTG--ALPQQILEITTLSLSLDLSDNLLNGSLPLG-VGNLKSLVRLGIARNQFSG 527 (1009)
Q Consensus 451 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~--~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~~ 527 (1009)
++++.+|..++++++|++|++++|++++ .+|..+.....+. .||+++|++++.+|.. +..+++|++|++++|++++
T Consensus 335 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~-~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~ 413 (520)
T 2z7x_B 335 LLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQ-QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413 (520)
T ss_dssp CCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCC-EEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCG
T ss_pred ccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCC-EEECCCCcCCcccccchhccCccCCEEECcCCCCCc
Confidence 5554455555555555555555555553 2333333333322 3777777777655554 7788999999999999998
Q ss_pred CccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccc-cccccccCceecccccCcccCCCC
Q 047768 528 QIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKY-LENLSFLQYLNLSYNHFEGEVPTK 604 (1009)
Q Consensus 528 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~g~~p~~ 604 (1009)
.+|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|+ .+|.. +..+++|++|++++|+++|.++..
T Consensus 414 ~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~ 487 (520)
T 2z7x_B 414 TIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 487 (520)
T ss_dssp GGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHHH
T ss_pred chhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCCch
Confidence 8888775 79999999999999 88888889999999999999999 56665 999999999999999999988753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=434.87 Aligned_cols=250 Identities=22% Similarity=0.288 Sum_probs=208.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
+.|++.++||+|+||+||+|+++.+|+.||||+++.......+.+.+|+++|++++|||||++++++... +..|+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEE
Confidence 4688899999999999999999999999999999877666677899999999999999999999997653 78999
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
|||||++|+|.+++.+.. +++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 149 vmEy~~gg~L~~~l~~~~-------l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHTR-------MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp EECCCTTEEHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence 999999999999997643 89999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
.+.... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+.....
T Consensus 219 ~~~~~~--------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i--- 282 (346)
T 4fih_A 219 QVSKEV--------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMI--- 282 (346)
T ss_dssp ECCSSS--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHH---
T ss_pred ecCCCC--------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHH---
Confidence 765421 223457899999999999999999999999999999999999999974321 1111110
Q ss_pred hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 941 ~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.+-..+.+.. ......++.+++.+||+.||++|||++|+++
T Consensus 283 --~~~~~~~~~~------------~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 283 --RDNLPPRLKN------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp --HHSSCCCCSC------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --HcCCCCCCCc------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111110 0122345779999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=431.28 Aligned_cols=275 Identities=24% Similarity=0.305 Sum_probs=206.6
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
++|.+.++||+|+||+||+|++ +|+.||||+++.... ....+.+|+..+.+++|||||+++|+|... .......++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~-~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKD-NGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE-CSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEec-CCCceEEEE
Confidence 4677889999999999999988 589999999964422 122334566666788999999999998753 122346799
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCceecCCCCCceeeCCCCceEEec
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH-----CQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
|||||++|+|.++++... ++|.++..++.|+|+||+|||++ ..++||||||||+|||++.++++||+|
T Consensus 79 V~Ey~~~gsL~~~l~~~~-------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEECCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EecCCCCCcHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 999999999999998653 89999999999999999999976 245899999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCC------CCCCcccchHHHHHHHHHHhCCCCCcccccC---
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG------EASMRGGVYSYGILLLEIFTRRRPTESMFNE--- 926 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~--- 926 (1009)
||+|+....... ..........||+.|||||++.+. .++.++|||||||++|||+||+.||......
T Consensus 152 FGla~~~~~~~~----~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 152 LGLAVRHDSATD----TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp CTTCEEEETTTT----EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred CCCCccccCCCC----ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 999987654321 111122346799999999998764 4678999999999999999998876543221
Q ss_pred -------CccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 927 -------GLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 927 -------~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
.......... +.+..+.+... ......+++..+.+++.+||+.||++||||.||++.|++
T Consensus 228 ~~~~~~~~~~~~~~~~~--------~~~~~~rp~~p-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKV--------VCEQKLRPNIP-----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp TTTTSCSSCCHHHHHHH--------HTTSCCCCCCC-----GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred chhcccccchHHHHHHH--------HhcccCCCCCC-----ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1122222111 11222211110 112334677789999999999999999999999999999
Q ss_pred HHHh
Q 047768 1000 ARQN 1003 (1009)
Q Consensus 1000 i~~~ 1003 (1009)
+.++
T Consensus 295 l~~~ 298 (303)
T 3hmm_A 295 LSQQ 298 (303)
T ss_dssp HHHC
T ss_pred HHHH
Confidence 8764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=430.50 Aligned_cols=262 Identities=24% Similarity=0.294 Sum_probs=209.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.+.|.+.++||+|+||+||+|+++.+|+.||||+++.+.. ..+|++++++++|||||++++++.. ....|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~-----~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVRE-----GPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence 3567888899999999999999999999999999975432 2479999999999999999999764 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC-ceEEecccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGL 858 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~DfGl 858 (1009)
+|||||++|+|.+++++... +++.++..++.|++.||+|||++ +||||||||+|||++.++ .+||+|||+
T Consensus 127 ivmEy~~gg~L~~~l~~~~~------l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGl 197 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGC------LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGH 197 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred EEEeccCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCC
Confidence 99999999999999987653 99999999999999999999999 999999999999999988 699999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
|+......... ........+||+.|||||++.+..|+.++||||+||++|||+||+.||....... .........
T Consensus 198 a~~~~~~~~~~---~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~- 272 (336)
T 4g3f_A 198 ALCLQPDGLGK---SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASEP- 272 (336)
T ss_dssp CEEC---------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHSC-
T ss_pred CeEccCCCccc---ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcCC-
Confidence 99876432211 1112234679999999999999999999999999999999999999997543322 222222110
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFL 1005 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~ 1005 (1009)
....+ .+..+..++.+++.+||+.||++|||+.|+++.+....++..
T Consensus 273 -~~~~~-------------------~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 273 -PPIRE-------------------IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp -CGGGG-------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred -CCchh-------------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 00000 011233467899999999999999999999999988776643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=421.49 Aligned_cols=251 Identities=26% Similarity=0.388 Sum_probs=198.3
Q ss_pred ccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEE
Q 047768 704 SSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALV 781 (1009)
Q Consensus 704 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 781 (1009)
.+.+.||+|+||+||+|.++.+++.||||++..... ...+.|.+|++++++++|||||++++++... ..+....++|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEEE
Confidence 566789999999999999999999999999965432 2245789999999999999999999987643 2334668999
Q ss_pred EeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC-CCCceEEecccccc
Q 047768 782 YEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAK 860 (1009)
Q Consensus 782 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~DfGla~ 860 (1009)
||||++|+|.+++++.. .+++..+..|+.|++.||+|||++ .++||||||||+|||++ .++.+||+|||+|+
T Consensus 108 mEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 99999999999998765 389999999999999999999998 11399999999999997 47999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
.... ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||..... .........
T Consensus 181 ~~~~----------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~~i~-- 243 (290)
T 3fpq_A 181 LKRA----------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVT-- 243 (290)
T ss_dssp GCCT----------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHT--
T ss_pred eCCC----------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----HHHHHHHHH--
Confidence 5432 12335689999999998865 699999999999999999999999964321 122211111
Q ss_pred hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 941 ~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
....+.. ....+..++.+++.+||+.||++|||++|+++
T Consensus 244 -------~~~~~~~---------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 244 -------SGVKPAS---------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -------TTCCCGG---------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------cCCCCCC---------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0010000 00012235778999999999999999999975
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=435.94 Aligned_cols=252 Identities=19% Similarity=0.303 Sum_probs=201.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.. .+.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----NGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----CCE
Confidence 3689999999999999999999999999999999975432 234678999999999999999999999754 378
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.|+|||||++|+|.+++...... .+++.+++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG 170 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGV----LFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFG 170 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccc
Confidence 89999999999999999765432 478999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+|+..... .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.... ..+.....
T Consensus 171 la~~~~~~--------~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i 237 (350)
T 4b9d_A 171 IARVLNST--------VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNLVLKI 237 (350)
T ss_dssp EESCCCHH--------HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHH
T ss_pred cceeecCC--------cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHH
Confidence 99866431 112334679999999999999999999999999999999999999997432 22222211
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..... .+. ...+..++.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~--------~~~-----------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 238 ISGSF--------PPV-----------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHTCC--------CCC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HcCCC--------CCC-----------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11110 000 0122345789999999999999999999976
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=482.40 Aligned_cols=515 Identities=20% Similarity=0.188 Sum_probs=375.6
Q ss_pred eEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecc
Q 047768 71 RVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAH 150 (1009)
Q Consensus 71 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~ 150 (1009)
.++.|||++|.|++..+.+|.++++|++|||++|+|++..|++|++|++|++|+|++|+|++..|..|+++++|++|+++
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 56777777777777666677777777777777777776556667777777777777777776555667777777777777
Q ss_pred cccccCCCchHHhhhccCCcCeEeecCccCCCC-CCcccCCccccceeecccCcccCCCCcccccccccc----cccccC
Q 047768 151 RNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQ-LPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLA----YLHVGD 225 (1009)
Q Consensus 151 ~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~L~~ 225 (1009)
+|++++..+..+ ..+++|++|+|++|++++. .|..++++++|++|+|++|++++..+..|..+.+++ .++++.
T Consensus 133 ~N~l~~l~~~~~--~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~ 210 (635)
T 4g8a_A 133 ETNLASLENFPI--GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 210 (635)
T ss_dssp TSCCCCSTTCCC--TTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred CCcCCCCChhhh--hcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhccc
Confidence 777764433333 5667777777777777643 466677777777777777777777777776665554 456667
Q ss_pred ccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccc------cCCCCCCCcCccccccccccccc
Q 047768 226 NHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNN------FTGSLPDSFSNASNLEVLHLAEN 299 (1009)
Q Consensus 226 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~------l~~~~p~~~~~l~~L~~L~Ls~N 299 (1009)
|.++.. +........++.+++.+|.....++...+.++..++...+..+. +.......+..+..+..+++..+
T Consensus 211 n~l~~i-~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~ 289 (635)
T 4g8a_A 211 NPMNFI-QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 289 (635)
T ss_dssp CCCCEE-CTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEE
T ss_pred Cccccc-CcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 777633 33333344556666666665544445555556666655554332 33344455666666666666555
Q ss_pred cccc---ccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcC
Q 047768 300 QFRG---QVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLG 376 (1009)
Q Consensus 300 ~l~~---~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~ 376 (1009)
.... .....|..+.+++.+.+..|.+.... .+.....|+.|++.+|.+.+..+..+ ..++.+++.
T Consensus 290 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--------~~~~~~~L~~L~l~~~~~~~~~~~~l----~~L~~l~l~ 357 (635)
T 4g8a_A 290 YLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--------DFSYNFGWQHLELVNCKFGQFPTLKL----KSLKRLTFT 357 (635)
T ss_dssp CCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--------GGGSCCCCSEEEEESCEESSCCCCBC----TTCCEEEEE
T ss_pred hhcccccchhhhhhhhccccccccccccccccc--------ccccchhhhhhhcccccccCcCcccc----hhhhhcccc
Confidence 4332 22344566677777777777665432 24556788899999998876554433 457788888
Q ss_pred CCccccCCCccccCcCccCEEEccCCCCCC--CCCCCcCCcccccceecccccccCCCCcccccccccccccccCccccc
Q 047768 377 KNQIYGTIPPGIANLVNLNSLRMEANRLTG--TIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQG 454 (1009)
Q Consensus 377 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 454 (1009)
+|.+... .....+++|+.|++++|.+.. ..+..+..+.+|+.|+++.|.+. ..+..+..+++|+.+++++|++..
T Consensus 358 ~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~ 434 (635)
T 4g8a_A 358 SNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ 434 (635)
T ss_dssp SCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEES
T ss_pred cccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccc
Confidence 8887643 345678899999999998853 35566678889999999999887 456678889999999999888776
Q ss_pred ccC-CCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccC-CCCCCCccCCCCCCeeeccccccCCCcccc
Q 047768 455 NIP-FSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLN-GSLPLGVGNLKSLVRLGIARNQFSGQIPVT 532 (1009)
Q Consensus 455 ~~p-~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 532 (1009)
..+ ..+.++++++.++++.|.+++..|..+.....+ ..|++++|.+. +.+|..|..+++|++|||++|+|++.+|..
T Consensus 435 ~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L-~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~ 513 (635)
T 4g8a_A 435 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL-EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 513 (635)
T ss_dssp TTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC-CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred cccccccccccccccccccccccccccccccccchhh-hhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHH
Confidence 555 467888999999999999987766655554444 45999999854 457888999999999999999999988999
Q ss_pred ccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccc-cccCceecccccCcccCCCC
Q 047768 533 LGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENL-SFLQYLNLSYNHFEGEVPTK 604 (1009)
Q Consensus 533 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~ls~N~l~g~~p~~ 604 (1009)
|+++++|+.|+|++|+|++..|..|+++++|++|||++|+|++.+|..|..+ ++|++|+|++|++.|.+...
T Consensus 514 f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~ 586 (635)
T 4g8a_A 514 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 586 (635)
T ss_dssp TTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGH
T ss_pred HcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcH
Confidence 9999999999999999998889999999999999999999999999999988 68999999999999988743
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=475.57 Aligned_cols=480 Identities=16% Similarity=0.168 Sum_probs=400.2
Q ss_pred CccceeeCC--CCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCC
Q 047768 59 HWTGVTCGR--RNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPT 136 (1009)
Q Consensus 59 ~w~gv~C~~--~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 136 (1009)
++.+++.-. ...+++.|+|++|.+++..+..|+++++|++|+|++|++++..|+.|+++++|++|||++|++++..|.
T Consensus 13 ~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 92 (549)
T 2z81_A 13 RSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSS 92 (549)
T ss_dssp TTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHH
T ss_pred CCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHH
Confidence 455555422 235899999999999999999999999999999999999988889999999999999999999988888
Q ss_pred CCcCCCcCcEEecccccccC-CCchHHhhhccCCcCeEeecCccCCCCCC-cccCCccccceeecccCcccCCCCccccc
Q 047768 137 NLSHCSKLITFSAHRNNLVG-EIPEELISRRLFNLQGLSVGDNQLTGQLP-ASIGNLSALRVIDIRTNRLWGKIPITLSQ 214 (1009)
Q Consensus 137 ~l~~l~~L~~L~l~~n~l~~-~~p~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 214 (1009)
.|+++++|++|++++|.+++ .+|..+ ..+++|++|++++|++.+.+| ..|+++++|++|++++|++++..|..+..
T Consensus 93 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~--~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 170 (549)
T 2z81_A 93 WFGPLSSLKYLNLMGNPYQTLGVTSLF--PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS 170 (549)
T ss_dssp HHTTCTTCCEEECTTCCCSSSCSSCSC--TTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTT
T ss_pred HhccCCCCcEEECCCCcccccchhhhh--hccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhc
Confidence 89999999999999999986 355544 679999999999999555555 68999999999999999999999999999
Q ss_pred ccccccccccCccCCCCCCCcc-cCCChHHHHHhhCCccCCCC--ChhhccCCCcccceeccccccCCCCC----CCcCc
Q 047768 215 LTSLAYLHVGDNHFSGTIPPSV-YNISSLVEIYLYGNRFTGSL--PIEIGKNLPNLRNFVIYTNNFTGSLP----DSFSN 287 (1009)
Q Consensus 215 l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~i--p~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~ 287 (1009)
+++|++|+++.|.+. .+|..+ ..+++|++|++++|++++.. |..+...+++|+.|++++|.+++..+ ..+..
T Consensus 171 l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~ 249 (549)
T 2z81_A 171 IRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249 (549)
T ss_dssp CSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGG
T ss_pred cccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhh
Confidence 999999999999987 555544 56899999999999999532 44555678999999999999886443 34567
Q ss_pred ccccccccccccccccccc------cccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCch
Q 047768 288 ASNLEVLHLAENQFRGQVS------INFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPH 361 (1009)
Q Consensus 288 l~~L~~L~Ls~N~l~~~~~------~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~ 361 (1009)
+++|+.|++++|.+.+... ..+..+.+|+.|++..+.+..... .......+...++|+.|++++|.++ .+|.
T Consensus 250 ~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~-~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~ 327 (549)
T 2z81_A 250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL-FYDLSTVYSLLEKVKRITVENSKVF-LVPC 327 (549)
T ss_dssp CTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGG-SCCCCHHHHHSTTCCEEEEESSCCC-CCCH
T ss_pred hccccccccccccccccccccccchhhhhhhcccccccccccccchhhh-cccchhhhhhcccceEEEeccCccc-cCCH
Confidence 8899999999999887532 245678889999999988765321 0111223445678999999999998 6777
Q ss_pred hhhhhcccceEEEcCCCccccCCC---ccccCcCccCEEEccCCCCCCCCC--CCcCCcccccceecccccccCCCCccc
Q 047768 362 SIANLSTALIDFNLGKNQIYGTIP---PGIANLVNLNSLRMEANRLTGTIP--HVIGELKNLQLLHLHANFLQGTIPSSL 436 (1009)
Q Consensus 362 ~~~~l~~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~~ 436 (1009)
.+..-...|++|+|++|++++.+| ..+..+++|+.|+|++|++++..+ ..+..+++|++|+|++|+++ .+|..+
T Consensus 328 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~ 406 (549)
T 2z81_A 328 SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSC 406 (549)
T ss_dssp HHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCC
T ss_pred HHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhh
Confidence 775444789999999999998764 447899999999999999986543 56889999999999999999 688899
Q ss_pred ccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCC
Q 047768 437 GNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLV 516 (1009)
Q Consensus 437 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~ 516 (1009)
..+++|++|++++|+++ .+|..+. ++|+ .||+++|++++.+ +.+++|+
T Consensus 407 ~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~-------------------------~L~Ls~N~l~~~~----~~l~~L~ 454 (549)
T 2z81_A 407 QWPEKMRFLNLSSTGIR-VVKTCIP--QTLE-------------------------VLDVSNNNLDSFS----LFLPRLQ 454 (549)
T ss_dssp CCCTTCCEEECTTSCCS-CCCTTSC--TTCS-------------------------EEECCSSCCSCCC----CCCTTCC
T ss_pred cccccccEEECCCCCcc-cccchhc--CCce-------------------------EEECCCCChhhhc----ccCChhc
Confidence 99999999999999998 4444321 2333 3677777776532 5788999
Q ss_pred eeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccc
Q 047768 517 RLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIP 578 (1009)
Q Consensus 517 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 578 (1009)
+|+|++|+|+ .+|. ...+++|++|+|++|++++.+|..|+.+++|+.|+|++|.+++..|
T Consensus 455 ~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 455 ELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp EEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred EEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 9999999999 6776 5789999999999999999999999999999999999999998777
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=436.11 Aligned_cols=278 Identities=21% Similarity=0.313 Sum_probs=218.5
Q ss_pred CHHHHHHHhccCccCCcccccCCceEEEEEEecC-----CeEEEEEEeecccc-cchHHHHHHHHHHHhcCC-CCcceEE
Q 047768 692 SYKELSKATNEFSSSNTIGRGSFGFVYKGVLHEN-----GMLVAVKVINLEQK-GGSKSFAAECEALRSIRH-RNLIKIV 764 (1009)
Q Consensus 692 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~ 764 (1009)
...+++...++|++.+.||+|+||+||+|++... ++.||||+++.... ...+.|.+|+++|++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 3445555668899999999999999999998743 36899999965432 234679999999999965 8999999
Q ss_pred eeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCC----------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCce
Q 047768 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQL----------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIV 834 (1009)
Q Consensus 765 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 834 (1009)
|+|... ....++|||||++|+|.++++...... ....+++.++..++.|||+||+|||++ +||
T Consensus 135 g~~~~~----~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~ii 207 (353)
T 4ase_A 135 GACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI 207 (353)
T ss_dssp EEECCT----TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred EEEEec----CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Cee
Confidence 998542 356799999999999999998643210 123489999999999999999999999 999
Q ss_pred ecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHH
Q 047768 835 HGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIF 914 (1009)
Q Consensus 835 Hrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ell 914 (1009)
||||||+|||+++++++||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||+
T Consensus 208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~------~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~ 281 (353)
T 4ase_A 208 HRDLAARNILLSEKNVVKICDFGLARDIYKDPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 281 (353)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred cCccCccceeeCCCCCEEECcchhhhhcccCCC------ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHH
Confidence 999999999999999999999999997654321 11223467999999999999999999999999999999999
Q ss_pred h-CCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 047768 915 T-RRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDV 993 (1009)
Q Consensus 915 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~ev 993 (1009)
| |+.||....... .+........+ ... +..+..++.+++.+||+.||++||||+||
T Consensus 282 t~G~~Pf~~~~~~~-~~~~~i~~g~~-----------~~~-----------p~~~~~~~~~li~~c~~~dP~~RPt~~ei 338 (353)
T 4ase_A 282 SLGASPYPGVKIDE-EFCRRLKEGTR-----------MRA-----------PDYTTPEMYQTMLDCWHGEPSQRPTFSEL 338 (353)
T ss_dssp TTSCCSSTTCCCSH-HHHHHHHHTCC-----------CCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hCCCCCCCCCCHHH-HHHHHHHcCCC-----------CCC-----------CccCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence 8 999997543221 11111111000 001 11234568899999999999999999999
Q ss_pred HHHHHHHHHhhh
Q 047768 994 VVKLCHARQNFL 1005 (1009)
Q Consensus 994 l~~L~~i~~~~~ 1005 (1009)
++.|+.+.+.-.
T Consensus 339 l~~L~~llq~~~ 350 (353)
T 4ase_A 339 VEHLGNLLQANA 350 (353)
T ss_dssp HHHHHHHHHHTC
T ss_pred HHHHHHHHHHhh
Confidence 999999877543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=436.36 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=208.1
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
+.|++.++||+|+||+||+|+++.+|+.||||+++.......+.+.+|+++|++++|||||++++++... +..|+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEEE
Confidence 5699999999999999999999999999999999876666677899999999999999999999997653 78999
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
|||||++|+|.++++... +++.++..|+.|++.||+|||++ +||||||||+|||++.+|.+||+|||+|+
T Consensus 226 VmEy~~gG~L~~~i~~~~-------l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHTR-------MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp EEECCTTEEHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHhccC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccce
Confidence 999999999999997643 89999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
.+.... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||...... .....+....
T Consensus 296 ~~~~~~--------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~-- 363 (423)
T 4fie_A 296 QVSKEV--------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNL-- 363 (423)
T ss_dssp ECCSSC--------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSC--
T ss_pred ECCCCC--------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCC--
Confidence 765421 2334578999999999999999999999999999999999999999743211 1111111111
Q ss_pred hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 941 ~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.+.+... .....++.+++.+||+.||++|||++|+++
T Consensus 364 ------~~~~~~~------------~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 364 ------PPRLKNL------------HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ------CCCCSCT------------TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CCCCccc------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111000 012245779999999999999999999875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=481.72 Aligned_cols=436 Identities=19% Similarity=0.235 Sum_probs=270.9
Q ss_pred CCCCeeeecCCcCCccCCccccCccccccccc-cccccCCCCCCCCcCC----CcCc--EEe----------cccccccC
Q 047768 94 SFLRYINIADNDFHGEIPDRIGNLFRLETLVL-ANNSFSGRIPTNLSHC----SKLI--TFS----------AHRNNLVG 156 (1009)
Q Consensus 94 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L-s~N~l~~~~p~~l~~l----~~L~--~L~----------l~~n~l~~ 156 (1009)
.+++.|+|++|+++|.+|+.|++|++|++||| ++|.++|..|-..... +.++ .+. ....++.+
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57899999999999999999999999999999 9999998855432211 0000 000 00011111
Q ss_pred CCchHHh---------hhccCCcCeEeecC--ccCCCCCCcccCCccccceeecccCcccC-----------------CC
Q 047768 157 EIPEELI---------SRRLFNLQGLSVGD--NQLTGQLPASIGNLSALRVIDIRTNRLWG-----------------KI 208 (1009)
Q Consensus 157 ~~p~~~~---------~~~l~~L~~L~L~~--n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----------------~~ 208 (1009)
.++..+. ......++.+.+.. |++++ +|..|+++++|++|+|++|++++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 1111110 01123445555544 88887 88889999999999999999987 38
Q ss_pred Ccccc--cccccccccccCccCCCCCCCcccCCChHHHHHhhCCc-cCC-CCChhhc------cCCCcccceeccccccC
Q 047768 209 PITLS--QLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNR-FTG-SLPIEIG------KNLPNLRNFVIYTNNFT 278 (1009)
Q Consensus 209 p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~ip~~~~------~~l~~L~~L~L~~N~l~ 278 (1009)
|..++ ++++|++|+|++|++.+.+|..|.++++|++|+|++|+ ++| .+|..++ ..+++|++|+|++|+++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 88877 99999999999999999999999999999999999998 887 7887654 34569999999999999
Q ss_pred CCCCC--CcCcccccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhcccccc-cceEEccCCCC
Q 047768 279 GSLPD--SFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTK-LQYLYLADNGF 355 (1009)
Q Consensus 279 ~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~-L~~L~L~~N~l 355 (1009)
.+|. .|+++++|++|+|++|+++. ++ .|..+++|+.|+|++|.+..++ ..+.++++ |+.|+|++|++
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~~-lp-~~~~L~~L~~L~Ls~N~l~~lp-------~~l~~l~~~L~~L~Ls~N~L 631 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVRH-LE-AFGTNVKLTDLKLDYNQIEEIP-------EDFCAFTDQVEGLGFSHNKL 631 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCCB-CC-CCCTTSEESEEECCSSCCSCCC-------TTSCEECTTCCEEECCSSCC
T ss_pred -ccCChhhhhcCCCCCEEECCCCCccc-ch-hhcCCCcceEEECcCCccccch-------HHHhhccccCCEEECcCCCC
Confidence 7888 99999999999999999983 33 6666666666666666655322 23445555 55555555555
Q ss_pred CCcCchhhhhhcccceEEEcCCCccccCCCccccCcCc--cCEEEccCCCCCCCCCCCc---C--Ccccccceecccccc
Q 047768 356 GGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVN--LNSLRMEANRLTGTIPHVI---G--ELKNLQLLHLHANFL 428 (1009)
Q Consensus 356 ~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~p~~~---~--~l~~L~~L~L~~N~l 428 (1009)
+ .+| ..+..++. |+.|+|++|++++.+|... . .+++|+.|+|++|++
T Consensus 632 ~-~lp-------------------------~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L 685 (876)
T 4ecn_A 632 K-YIP-------------------------NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEI 685 (876)
T ss_dssp C-SCC-------------------------SCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCC
T ss_pred C-cCc-------------------------hhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcC
Confidence 5 334 44443332 5555555555554443221 1 223555566666655
Q ss_pred cCCCCcc-cccccccccccccCcccccccCCCCCCC--------CCccccccCCCCccCCCchhhhhhccceeeEecCCC
Q 047768 429 QGTIPSS-LGNLTLLTYLSFGANNLQGNIPFSLGNC--------KNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDN 499 (1009)
Q Consensus 429 ~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l--------~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N 499 (1009)
+ .+|.. +..+++|++|+|++|+|+ .+|..+... ++|+. |+|++|
T Consensus 686 ~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~-------------------------L~Ls~N 738 (876)
T 4ecn_A 686 Q-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTT-------------------------IDLRFN 738 (876)
T ss_dssp C-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCE-------------------------EECCSS
T ss_pred C-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccE-------------------------EECCCC
Confidence 5 33333 235555666666666655 444433221 13433 333333
Q ss_pred ccCCCCCCCcc--CCCCCCeeeccccccCCCccccccCCCCccEEEecC------cccccccccccccccccceEcCCCc
Q 047768 500 LLNGSLPLGVG--NLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQG------NSFSGTIPQSLSSLTSIKELDLSQN 571 (1009)
Q Consensus 500 ~l~~~~p~~~~--~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~------N~l~~~~p~~~~~l~~L~~L~Ls~N 571 (1009)
+++ .+|..+. .+++|+.|+|++|+|++ +|..++.+++|+.|+|++ |++.+.+|..|+++++|+.|+|++|
T Consensus 739 ~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N 816 (876)
T 4ecn_A 739 KLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSN 816 (876)
T ss_dssp CCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSS
T ss_pred CCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCC
Confidence 333 3344443 44455555555555543 444444555555555533 4555555555555555555555555
Q ss_pred ccccccccccccccccCceecccccCc
Q 047768 572 NFSGQIPKYLENLSFLQYLNLSYNHFE 598 (1009)
Q Consensus 572 ~l~~~~p~~~~~l~~L~~L~ls~N~l~ 598 (1009)
+| +.+|..+. ++|+.|||++|++.
T Consensus 817 ~L-~~Ip~~l~--~~L~~LdLs~N~l~ 840 (876)
T 4ecn_A 817 DI-RKVDEKLT--PQLYILDIADNPNI 840 (876)
T ss_dssp CC-CBCCSCCC--SSSCEEECCSCTTC
T ss_pred CC-CccCHhhc--CCCCEEECCCCCCC
Confidence 55 45555443 35555555555554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=419.27 Aligned_cols=249 Identities=20% Similarity=0.292 Sum_probs=206.4
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+++|++++|||||++++++.. ...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence 5799999999999999999999999999999999643 23345789999999999999999999998654 478
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.|+||||+++|+|.+++++... +++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~------l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG 177 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 177 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence 9999999999999999987653 99999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+|+.+..... .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..+.....
T Consensus 178 la~~~~~~~~------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~~i 246 (311)
T 4aw0_A 178 TAKVLSPESK------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EGLIFAKI 246 (311)
T ss_dssp TCEECCTTTT------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHH
T ss_pred CceecCCCCC------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHH
Confidence 9998754321 123345789999999999999999999999999999999999999997432 22222211
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVV 994 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl 994 (1009)
..... ..++ ....++.+++.+|++.||++|||++|+.
T Consensus 247 ~~~~~---------~~p~-----------~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 247 IKLEY---------DFPE-----------KFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHTCC---------CCCT-----------TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HcCCC---------CCCc-----------ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11110 0010 1123567999999999999999999874
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=473.21 Aligned_cols=476 Identities=18% Similarity=0.257 Sum_probs=320.9
Q ss_pred CCCCeeeecCCcCCccCCccccCccccccccccccccC------C------CCCCCCcCCCcCcEEecccccccCCCchH
Q 047768 94 SFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFS------G------RIPTNLSHCSKLITFSAHRNNLVGEIPEE 161 (1009)
Q Consensus 94 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~------~------~~p~~l~~l~~L~~L~l~~n~l~~~~p~~ 161 (1009)
.+++.|+|++|+++|.+|++|++|++|++|||++|.+. | .+|... +..|+ ++++.|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 46889999999999999999999999999999999873 2 222222 33344 444554444444433
Q ss_pred HhhhccCCcCeEeecCccCCCCCCcccCCccccceeecc--cCcccCCCCcccccccccccccccCccCCCC-CCCcccC
Q 047768 162 LISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIR--TNRLWGKIPITLSQLTSLAYLHVGDNHFSGT-IPPSVYN 238 (1009)
Q Consensus 162 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~--~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~ 238 (1009)
+. ..+..+..+++....+.. .....++.+.+. .|++++ +|..|+++++|++|+|++|++++. ++.....
T Consensus 158 ~~-~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~ 229 (636)
T 4eco_A 158 FS-DLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229 (636)
T ss_dssp SC-HHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC
T ss_pred HH-HHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccc
Confidence 21 111222222222222110 011122222222 344444 455555555555555555555432 0000000
Q ss_pred CChHHHHHhhCCccCCCCChhhc-cCCCcccceeccccccCCCCCCCcCcccccccccccccc-ccc-cccccccccccc
Q 047768 239 ISSLVEIYLYGNRFTGSLPIEIG-KNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQ-FRG-QVSINFNGLKDL 315 (1009)
Q Consensus 239 l~~L~~L~L~~N~l~~~ip~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~~~~f~~l~~L 315 (1009)
. +.+...+.+|..++ .++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ ..|..+..+.
T Consensus 230 -~-------~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~-- 299 (636)
T 4eco_A 230 -E-------NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA-- 299 (636)
T ss_dssp -T-------TSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHH--
T ss_pred -c-------ccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhh--
Confidence 0 00000011666654 247888888888888888888888888888888888887 776 5555443331
Q ss_pred ccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCch--hhhhhcccceEEEcCCCccccCCCccccCcCc
Q 047768 316 SMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPH--SIANLSTALIDFNLGKNQIYGTIPPGIANLVN 393 (1009)
Q Consensus 316 ~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~ 393 (1009)
.+..+++|++|+|++|+++ .+|. .+.++ +.|++|++++|+++|.+| .|.++++
T Consensus 300 ----------------------~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l-~~L~~L~L~~N~l~g~ip-~~~~l~~ 354 (636)
T 4eco_A 300 ----------------------DAPVGEKIQIIYIGYNNLK-TFPVETSLQKM-KKLGMLECLYNQLEGKLP-AFGSEIK 354 (636)
T ss_dssp ----------------------HSGGGGTCCEEECCSSCCS-SCCCHHHHTTC-TTCCEEECCSCCCEEECC-CCEEEEE
T ss_pred ----------------------ccccCCCCCEEECCCCcCC-ccCchhhhccC-CCCCEEeCcCCcCccchh-hhCCCCC
Confidence 1123366777777777776 5666 66666 467777777777776777 7777777
Q ss_pred cCEEEccCCCCCCCCCCCcCCccc-ccceecccccccCCCCccccccc--ccccccccCcccccccCCCCC-------CC
Q 047768 394 LNSLRMEANRLTGTIPHVIGELKN-LQLLHLHANFLQGTIPSSLGNLT--LLTYLSFGANNLQGNIPFSLG-------NC 463 (1009)
Q Consensus 394 L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~-------~l 463 (1009)
|+.|+|++|+++ .+|..+..+++ |++|+|++|+++ .+|..+..+. +|++|++++|++++.+|..+. .+
T Consensus 355 L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~ 432 (636)
T 4eco_A 355 LASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKG 432 (636)
T ss_dssp ESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCC
T ss_pred CCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccC
Confidence 777777777777 66777777777 777777777777 6666666544 677777777777777777776 66
Q ss_pred CCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccC--------CCCCCeeeccccccCCCcccccc-
Q 047768 464 KNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGN--------LKSLVRLGIARNQFSGQIPVTLG- 534 (1009)
Q Consensus 464 ~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~--------l~~L~~L~ls~N~l~~~~p~~~~- 534 (1009)
++|++|++++|+++ .+|..++...+....|+|++|+++ .+|..+.. +++|++|+|++|+++ .+|..+.
T Consensus 433 ~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 509 (636)
T 4eco_A 433 INVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRA 509 (636)
T ss_dssp CCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGST
T ss_pred CCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhh
Confidence 77777777777777 566666554444445888888888 56654332 339999999999999 7888887
Q ss_pred -CCCCccEEEecCcccccccccccccccccceEcC------CCcccccccccccccccccCceecccccCcccCCCCCcc
Q 047768 535 -ACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDL------SQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIF 607 (1009)
Q Consensus 535 -~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~ 607 (1009)
.+++|+.|+|++|+|++ +|..++++++|++|+| ++|++.+.+|..+..+++|++|+|++|++ +.+|.. .+
T Consensus 510 ~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~ 586 (636)
T 4eco_A 510 TTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-IT 586 (636)
T ss_dssp TTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CC
T ss_pred ccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-Hh
Confidence 99999999999999997 8999999999999999 56889999999999999999999999999 788875 34
Q ss_pred cCccccccccCCCcCC
Q 047768 608 KNKTGFSIVGNGKLCG 623 (1009)
Q Consensus 608 ~~~~~~~~~~n~~lc~ 623 (1009)
.++....+.+|+..|-
T Consensus 587 ~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 587 PNISVLDIKDNPNISI 602 (636)
T ss_dssp TTCCEEECCSCTTCEE
T ss_pred CcCCEEECcCCCCccc
Confidence 6677778888887763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=409.18 Aligned_cols=247 Identities=28% Similarity=0.402 Sum_probs=189.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|++++++++||||+++++++.. .+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-----KD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CC
Confidence 368999999999999999999999999999999996432 2334679999999999999999999998654 47
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+ +|+|.+++.++.. +++.++..++.|++.||+|||++ +||||||||+|||+++++.+||+||
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~~------l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DF 156 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRDK------MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADF 156 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSCS------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCS
T ss_pred EEEEEEeCC-CCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeec
Confidence 889999999 7899999987653 99999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+|+..... ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||... .......
T Consensus 157 Gla~~~~~~---------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-----~~~~~~~ 222 (275)
T 3hyh_A 157 GLSNIMTDG---------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-----SIPVLFK 222 (275)
T ss_dssp SCC------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHH
T ss_pred CCCeecCCC---------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-----CHHHHHH
Confidence 999866432 12234689999999999998876 58999999999999999999999742 1222221
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...... . ..+. ....++.+++.+|++.||++|||++|+++
T Consensus 223 ~i~~~~--------~-~~p~-----------~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 223 NISNGV--------Y-TLPK-----------FLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHHTC--------C-CCCT-----------TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHcCC--------C-CCCC-----------CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111000 0 0000 11235679999999999999999999976
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=460.70 Aligned_cols=458 Identities=16% Similarity=0.204 Sum_probs=304.8
Q ss_pred EEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccc
Q 047768 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRN 152 (1009)
Q Consensus 73 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n 152 (1009)
..+|++++++++ +|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++||+++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 678999999987 666554 89999999999999877889999999999999999999988999999999999999999
Q ss_pred cccCCCchHHhhhccCCcCeEeecCccCCCC-CCcccCCccccceeecccCcccCCCCccccccccc--ccccccCccC-
Q 047768 153 NLVGEIPEELISRRLFNLQGLSVGDNQLTGQ-LPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSL--AYLHVGDNHF- 228 (1009)
Q Consensus 153 ~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l- 228 (1009)
+++ .+|.. .+.+|++|+|++|++++. +|..|+++++|++|+|++|++.+. .+..+++| ++|++++|++
T Consensus 111 ~l~-~lp~~----~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~ 182 (562)
T 3a79_B 111 RLQ-NISCC----PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYH 182 (562)
T ss_dssp CCC-EECSC----CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCC
T ss_pred cCC-ccCcc----ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccc
Confidence 998 67765 589999999999999973 468899999999999999999763 45555555 9999999999
Q ss_pred -CCCCCCcccCCC--hHHHHHhhCCccCCCCChhhccCCCcccceecccccc-----CCCCCCCcCcccccccccccccc
Q 047768 229 -SGTIPPSVYNIS--SLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNF-----TGSLPDSFSNASNLEVLHLAENQ 300 (1009)
Q Consensus 229 -~~~~p~~~~~l~--~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l-----~~~~p~~~~~l~~L~~L~Ls~N~ 300 (1009)
++..|..+..+. .| .+++++|.+.+.++...+..+++|+.|++++|+. .+. ...|.++++|+.|+|+++.
T Consensus 183 ~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~~ 260 (562)
T 3a79_B 183 IKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHIE 260 (562)
T ss_dssp CCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEEE
T ss_pred ccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCCc
Confidence 878888887765 23 3466777777666666555566666666665531 110 1123344444444444443
Q ss_pred cccccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhh-----hhhcccceEEEc
Q 047768 301 FRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSI-----ANLSTALIDFNL 375 (1009)
Q Consensus 301 l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~~L~~L~L 375 (1009)
+.+..... .+.. ...++|++|++++|.+++.+|..+ ..+ ..|..+++
T Consensus 261 l~~~~~~~--------------------------~~~~-~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L-~~L~~~~~ 312 (562)
T 3a79_B 261 TTWKCSVK--------------------------LFQF-FWPRPVEYLNIYNLTITERIDREEFTYSETAL-KSLMIEHV 312 (562)
T ss_dssp ECHHHHHH--------------------------HHHH-HTTSSEEEEEEEEEEECSCCCCCCCCCCSCSC-CEEEEEEE
T ss_pred CcHHHHHH--------------------------HHHh-hhcccccEEEEeccEeeccccchhhhcccccc-hheehhhc
Confidence 33211000 0000 011244444444444444444333 121 22222333
Q ss_pred CCCccccCCC-ccccCc---CccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcc
Q 047768 376 GKNQIYGTIP-PGIANL---VNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANN 451 (1009)
Q Consensus 376 ~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 451 (1009)
+.|.+ .+| ..+..+ .+|+.|++++|.+.... ....+++|++|+|++|++++.+|..+.++++|++|++++|+
T Consensus 313 ~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 388 (562)
T 3a79_B 313 KNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG 388 (562)
T ss_dssp EECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSC
T ss_pred cccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCC
Confidence 33332 111 111111 23444444444443111 01334444444444444444444444444444444444444
Q ss_pred ccc--ccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCC-CccCCCCCCeeeccccccCCC
Q 047768 452 LQG--NIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPL-GVGNLKSLVRLGIARNQFSGQ 528 (1009)
Q Consensus 452 l~~--~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~ 528 (1009)
+++ .+|..+.++++|+ .|++++|++++.+|. .+..+++|++|++++|++++.
T Consensus 389 l~~~~~~~~~~~~l~~L~-------------------------~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 443 (562)
T 3a79_B 389 LKNFFKVALMTKNMSSLE-------------------------TLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443 (562)
T ss_dssp CCBTTHHHHTTTTCTTCC-------------------------EEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGG
T ss_pred cCCcccchhhhcCCCCCC-------------------------EEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcc
Confidence 443 1223344444433 366666666664554 477889999999999999988
Q ss_pred ccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccc-cccccccCceecccccCcccCCCC
Q 047768 529 IPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKY-LENLSFLQYLNLSYNHFEGEVPTK 604 (1009)
Q Consensus 529 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~g~~p~~ 604 (1009)
+|..+. ++|+.|+|++|+|+ .+|..+.++++|++|||++|+|+ .+|.. +..+++|++|++++|+++|.+|..
T Consensus 444 ~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~ 516 (562)
T 3a79_B 444 VFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPGI 516 (562)
T ss_dssp GGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHHHH
T ss_pred hhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcchH
Confidence 887765 79999999999999 78887789999999999999999 56665 999999999999999999988864
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=453.50 Aligned_cols=462 Identities=18% Similarity=0.197 Sum_probs=328.8
Q ss_pred CeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeec
Q 047768 97 RYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVG 176 (1009)
Q Consensus 97 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~ 176 (1009)
++||+++|+++ .+|..+. ++|++|||++|.+++..|..|+++++|++|++++|++++..|..+ ..+.+|++|+|+
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~--~~l~~L~~L~Ls 77 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVF--KFNQELEYLDLS 77 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGG--TTCTTCCEEECC
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHh--hcccCCCEEecC
Confidence 57888888888 6887776 788888888888887777778888888888888877776556555 456777777777
Q ss_pred CccCCCCCCcccCCccccceeecccCcccC-CCCcccccccccccccccCccCCCCCCCcccCCChH--HHHHhhCCccC
Q 047768 177 DNQLTGQLPASIGNLSALRVIDIRTNRLWG-KIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSL--VEIYLYGNRFT 253 (1009)
Q Consensus 177 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l~ 253 (1009)
+|+++ .+|.. .+++|++|+|++|++++ .+|..|+.+++|++|+|++|++++ ..+..+++| ++|++++|++.
T Consensus 78 ~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~ 151 (520)
T 2z7x_B 78 HNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETY 151 (520)
T ss_dssp SSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTT
T ss_pred CCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccc
Confidence 77777 45544 66777777777777765 356677777777777777777663 234444444 55555555540
Q ss_pred CCCChhhccCCCcccceeccccccCCCCCCCcCccc-cccccccccccccccc-ccccccccccccccccccccCCCCCC
Q 047768 254 GSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNAS-NLEVLHLAENQFRGQV-SINFNGLKDLSMLGLATNFLGNGAAN 331 (1009)
Q Consensus 254 ~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~-~~~f~~l~~L~~L~L~~N~l~~~~~~ 331 (1009)
+ .+..|..|..+. +...+++++|++.+.. ...+..+++|+.++++.|........
T Consensus 152 ~-----------------------~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 208 (520)
T 2z7x_B 152 G-----------------------EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208 (520)
T ss_dssp T-----------------------SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHH
T ss_pred c-----------------------cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccce
Confidence 0 444444444433 2223344444443322 22333344444444444321000000
Q ss_pred CcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCC
Q 047768 332 DLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHV 411 (1009)
Q Consensus 332 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 411 (1009)
.......+..+++|+.|++++|.+++..+..+.. .+ .+++|+.|++++|+++|.+|..
T Consensus 209 ~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~---------------------~~-~~~~L~~L~l~~n~l~~~~p~~ 266 (520)
T 2z7x_B 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ---------------------LV-WHTTVWYFSISNVKLQGQLDFR 266 (520)
T ss_dssp HHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHH---------------------HH-HTSSCSEEEEEEEEEESCCCCC
T ss_pred eecchhhhccccchhhccccccccCHHHHHHHHH---------------------Hh-hhCcccEEEeecccccCccccc
Confidence 0001123556667777777776665332222111 11 2358999999999999999999
Q ss_pred c-----CCcccccceecccccccCCCC-cccccc---cccccccccCcccccccCCCCCCCCCccccccCCCCccCCCch
Q 047768 412 I-----GELKNLQLLHLHANFLQGTIP-SSLGNL---TLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQ 482 (1009)
Q Consensus 412 ~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 482 (1009)
+ ..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.+. + .+..+++|++|++++|++++.+|.
T Consensus 267 ~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~Ls~n~l~~~~~~ 342 (520)
T 2z7x_B 267 DFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHM-L-CPSKISPFLHLDFSNNLLTDTVFE 342 (520)
T ss_dssp CCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCC-C-CCSSCCCCCEEECCSSCCCTTTTT
T ss_pred hhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccc-c-chhhCCcccEEEeECCccChhhhh
Confidence 8 9999999999999999 455 566665 6799999999998743 2 137889999999999999998888
Q ss_pred hhhhhccceeeEecCCCccCC--CCCCCccCCCCCCeeeccccccCCCcccc-ccCCCCccEEEecCccccccccccccc
Q 047768 483 QILEITTLSLSLDLSDNLLNG--SLPLGVGNLKSLVRLGIARNQFSGQIPVT-LGACTSLEYVELQGNSFSGTIPQSLSS 559 (1009)
Q Consensus 483 ~~~~~~~~~~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~ 559 (1009)
.+..+..+. .|++++|++++ .+|..++++++|++|++++|++++.+|.. +..+++|+.|+|++|++++.+|..+.
T Consensus 343 ~~~~l~~L~-~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~- 420 (520)
T 2z7x_B 343 NCGHLTELE-TLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP- 420 (520)
T ss_dssp TCCCCSSCC-EEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC-
T ss_pred hhccCCCCC-EEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc-
Confidence 876665555 59999999997 56778999999999999999999867764 88999999999999999988888775
Q ss_pred ccccceEcCCCcccccccccccccccccCceecccccCcccCCCC--CcccCccccccccCCCcCC
Q 047768 560 LTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK--GIFKNKTGFSIVGNGKLCG 623 (1009)
Q Consensus 560 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~--~~~~~~~~~~~~~n~~lc~ 623 (1009)
++|++|||++|+|+ .+|..+..+++|++|+|++|+++. +|.. ..+.++....+.+|+..|.
T Consensus 421 -~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 421 -PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp -TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred -ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCccc
Confidence 79999999999999 789888899999999999999994 5543 4455667778889988874
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=457.53 Aligned_cols=524 Identities=18% Similarity=0.153 Sum_probs=422.9
Q ss_pred CcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCch
Q 047768 81 SIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPE 160 (1009)
Q Consensus 81 ~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~ 160 (1009)
+++ .+|+.+- +++++|||++|+|++..|.+|.++++|++|||++|+|++..|..|+++++|++|+|++|++++..+.
T Consensus 42 ~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~ 118 (635)
T 4g8a_A 42 NFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 118 (635)
T ss_dssp CCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGG
T ss_pred CcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHH
Confidence 444 3454442 4789999999999977778999999999999999999988888999999999999999999854444
Q ss_pred HHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccC-CCCcccccccccccccccCccCCCCCCCcccCC
Q 047768 161 ELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWG-KIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNI 239 (1009)
Q Consensus 161 ~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 239 (1009)
.+ ..+.+|++|+|++|++++..+..|+++++|++|+|++|++.+ ..|..++.+++|++|+|++|++++..|..|..+
T Consensus 119 ~f--~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L 196 (635)
T 4g8a_A 119 AF--SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 196 (635)
T ss_dssp GG--TTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHH
T ss_pred Hh--cCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccch
Confidence 44 679999999999999998878889999999999999999976 468889999999999999999998888887766
Q ss_pred ChHH----HHHhhCCccCCCCChhhccCCCcccceeccccccCC-CCCCCcCcccccccccccccc------cccccccc
Q 047768 240 SSLV----EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTG-SLPDSFSNASNLEVLHLAENQ------FRGQVSIN 308 (1009)
Q Consensus 240 ~~L~----~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~------l~~~~~~~ 308 (1009)
.+++ .++++.|.++ .++...+. ...++.+++.+|.... ..+..+.++..++...+..+. +.......
T Consensus 197 ~~l~~~~~~~~ls~n~l~-~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~ 274 (635)
T 4g8a_A 197 HQMPLLNLSLDLSLNPMN-FIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 274 (635)
T ss_dssp HTCTTCCCEEECTTCCCC-EECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTT
T ss_pred hhhhhhhhhhhcccCccc-ccCccccc-chhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccc
Confidence 6554 4678889888 67766665 4567788888886552 234456667777766665443 33334445
Q ss_pred cccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccc
Q 047768 309 FNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI 388 (1009)
Q Consensus 309 f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~ 388 (1009)
+..+..+....+..+....... .....+..+.+++.+++.+|.+....+. ... ..++.|++.+|.+.+..+.
T Consensus 275 ~~~~~~l~~~~l~~~~~~~~~~---~~~~~~~~~~~l~~l~~~~~~~~~~~~~--~~~-~~L~~L~l~~~~~~~~~~~-- 346 (635)
T 4g8a_A 275 LEGLCNLTIEEFRLAYLDYYLD---GIIDLFNCLTNVSSFSLVSVTIERVKDF--SYN-FGWQHLELVNCKFGQFPTL-- 346 (635)
T ss_dssp TGGGGGSEEEEEEEECCCSCEE---ECTTTTGGGTTCSEEEEESCEEEECGGG--GSC-CCCSEEEEESCEESSCCCC--
T ss_pred cccccchhhhhhhhhhhccccc---chhhhhhhhccccccccccccccccccc--ccc-hhhhhhhcccccccCcCcc--
Confidence 5666666666665554433221 1223466778899999999988754332 222 5689999999999865543
Q ss_pred cCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccC--CCCcccccccccccccccCcccccccCCCCCCCCCc
Q 047768 389 ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQG--TIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNL 466 (1009)
Q Consensus 389 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 466 (1009)
.+..|+.++++.|.+... .....+++|+.|++++|.+.. ..+..+..+.+|++|+++.|.+. ..+..+..+++|
T Consensus 347 -~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L 422 (635)
T 4g8a_A 347 -KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQL 422 (635)
T ss_dssp -BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTC
T ss_pred -cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccc
Confidence 467889999999998743 345679999999999999863 45666778899999999999998 467788999999
Q ss_pred cccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeecccccc-CCCccccccCCCCccEEEec
Q 047768 467 MFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQF-SGQIPVTLGACTSLEYVELQ 545 (1009)
Q Consensus 467 ~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l-~~~~p~~~~~l~~L~~L~L~ 545 (1009)
+.+++..|......+...+........++++.|.+.+..|..+..++.|+.|++++|.+ .+.+|..|..+++|++|+|+
T Consensus 423 ~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls 502 (635)
T 4g8a_A 423 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 502 (635)
T ss_dssp CEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECT
T ss_pred cchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECC
Confidence 99999999998877776666666666799999999999999999999999999999985 45678899999999999999
Q ss_pred CcccccccccccccccccceEcCCCcccccccccccccccccCceecccccCcccCCCC-Ccc-cCccccccccCCCcCC
Q 047768 546 GNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK-GIF-KNKTGFSIVGNGKLCG 623 (1009)
Q Consensus 546 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~-~~~~~~~~~~n~~lc~ 623 (1009)
+|+|++.+|.+|+++++|++|+|++|+|++..|..|..+++|++|||++|+|++.+|.. ..+ .++....+.+|++.|.
T Consensus 503 ~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 503 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred CCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 99999999999999999999999999999988999999999999999999999988864 222 4566678899999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=410.10 Aligned_cols=263 Identities=23% Similarity=0.381 Sum_probs=191.3
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeecccc-------
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDF------- 772 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------- 772 (1009)
++|++.+.||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|+++|++++|||||++++++.....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4689999999999999999999999999999999754432 34678999999999999999999998764321
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceE
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 852 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 852 (1009)
......|+|||||++|+|.+++..+... ...++..++.++.|++.||+|||++ +||||||||+|||++.++.+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG---GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC---ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence 1233578999999999999999875431 2356777899999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCCcc----ccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCc
Q 047768 853 VSDFGLAKFLSASPLGNVV----ETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGL 928 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~ 928 (1009)
|+|||+|+........... .......+.+||+.|||||++.+..|+.++||||+||++|||++ ||......
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~-- 233 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER-- 233 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--
Confidence 9999999987653221111 11123345689999999999999999999999999999999996 77532110
Q ss_pred cHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 929 TLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. .. +..+......+. ..+......+++.+||+.||++|||+.|+++
T Consensus 234 -~-~~--------~~~~~~~~~p~~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 -V-RT--------LTDVRNLKFPPL-----------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -H-HH--------HHHHHTTCCCHH-----------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -H-HH--------HHHHhcCCCCCC-----------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00 011111111000 1122234568999999999999999999976
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=411.72 Aligned_cols=243 Identities=23% Similarity=0.279 Sum_probs=191.7
Q ss_pred ccCccCCcccccCCceEEEEEEe---cCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLH---ENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
++|++.+.||+|+||+||+|+.. .+++.||||+++... ......+.+|+++|++++|||||++++++.. .
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence 57999999999999999999884 467899999996442 2234578899999999999999999999754 3
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
+..|+|||||++|+|.+++.+... +++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~~------l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D 169 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEVM------FTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTD 169 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEES
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecc
Confidence 788999999999999999987653 99999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+|+...... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.... ..+...
T Consensus 170 FGla~~~~~~~--------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~ 236 (304)
T 3ubd_A 170 FGLSKESIDHE--------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD-----RKETMT 236 (304)
T ss_dssp SEEEEC-------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH
T ss_pred cccceeccCCC--------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC-----HHHHHH
Confidence 99998654321 22335789999999999999999999999999999999999999997432 122221
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~ 990 (1009)
...... . ..+. ....++.+++.+||+.||++|||+
T Consensus 237 ~i~~~~--------~-~~p~-----------~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 237 MILKAK--------L-GMPQ-----------FLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp HHHHCC--------C-CCCT-----------TSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred HHHcCC--------C-CCCC-----------cCCHHHHHHHHHHcccCHHHCCCC
Confidence 111110 0 0010 122357799999999999999995
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=405.98 Aligned_cols=280 Identities=22% Similarity=0.264 Sum_probs=204.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeecc-ccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSI-DFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~~~ 777 (1009)
++|.+.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+++|++++|||||++++++... .+.....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999999999999999964432 2245788999999999999999999987643 2344567
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.|+|||||+ |+|.+++.... .+++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEeCCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecc
Confidence 899999995 78999998754 399999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+|+.+..... .........+||+.|||||++.+. .++.++||||+||++|||++|+.||...... ..+..+...
T Consensus 204 la~~~~~~~~----~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~ 278 (398)
T 4b99_A 204 MARGLCTSPA----EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMV 278 (398)
T ss_dssp TCBCC-----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHH
T ss_pred eeeecccCcc----ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHh
Confidence 9987654321 111233457899999999998875 4699999999999999999999999743211 112222211
Q ss_pred hccc--hhhhccCCCCCChhhhhhhccccc-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPE--KVMEIVDPSLLPLEEERTNSRRVR-----NEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~--~~~~~~d~~l~~~~~~r~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... .....+.................. ......++.+++.+|+..||++|||++|+++
T Consensus 279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1111 111000000000000000000000 0011245679999999999999999999875
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=429.67 Aligned_cols=460 Identities=19% Similarity=0.219 Sum_probs=324.8
Q ss_pred CCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEee
Q 047768 96 LRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSV 175 (1009)
Q Consensus 96 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L 175 (1009)
.+++|+++|+++ .+|..+. ++|++|||++|.+++..|..|+++++|++|++++|++++..|..+ ..+++|++|+|
T Consensus 33 ~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~--~~l~~L~~L~L 107 (562)
T 3a79_B 33 ESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVF--LFNQDLEYLDV 107 (562)
T ss_dssp CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTT--TTCTTCCEEEC
T ss_pred CcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHh--CCCCCCCEEEC
Confidence 489999999999 5888765 799999999999998888899999999998888888876556555 55777777777
Q ss_pred cCccCCCCCCcccCCccccceeecccCcccC-CCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCC
Q 047768 176 GDNQLTGQLPASIGNLSALRVIDIRTNRLWG-KIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTG 254 (1009)
Q Consensus 176 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 254 (1009)
++|+++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++. .+..+++|
T Consensus 108 s~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L------------ 169 (562)
T 3a79_B 108 SHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHL------------ 169 (562)
T ss_dssp TTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTS------------
T ss_pred CCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhc------------
Confidence 777777 45554 67777777777777765 3456777777777777777777632 23333333
Q ss_pred CCChhhccCCCcccceecccccc--CCCCCCCcCccc--cccccccccccccccc-ccccccccccccccccccccCCCC
Q 047768 255 SLPIEIGKNLPNLRNFVIYTNNF--TGSLPDSFSNAS--NLEVLHLAENQFRGQV-SINFNGLKDLSMLGLATNFLGNGA 329 (1009)
Q Consensus 255 ~ip~~~~~~l~~L~~L~L~~N~l--~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~-~~~f~~l~~L~~L~L~~N~l~~~~ 329 (1009)
+|++|++++|.+ ++..|..|.++. .+ .+++++|.+.+.. ...+..+++|+.++++.|.....
T Consensus 170 -----------~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~- 236 (562)
T 3a79_B 170 -----------HLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ- 236 (562)
T ss_dssp -----------CEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH-
T ss_pred -----------eeeEEEeecccccccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccc-
Confidence 224444444444 444444444432 22 3344455444422 22344455555555555431000
Q ss_pred CCCcchhhhcccccccceEEccCCCCCCcCchhhhhh--cccceEEEcCCCccccCCCccc-----cCcCccCEEEccCC
Q 047768 330 ANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANL--STALIDFNLGKNQIYGTIPPGI-----ANLVNLNSLRMEAN 402 (1009)
Q Consensus 330 ~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N 402 (1009)
........+..+++|+.|+++++.+.+.....+... ...|++|++++|+++|.+|..+ .++++|+.++++.|
T Consensus 237 -~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~ 315 (562)
T 3a79_B 237 -RLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQ 315 (562)
T ss_dssp -HHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEEC
T ss_pred -hHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccc
Confidence 000122456677888888888887764322221111 1378999999999998888887 77888888888888
Q ss_pred CCCCCCC-CCcCCc---ccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccC
Q 047768 403 RLTGTIP-HVIGEL---KNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTG 478 (1009)
Q Consensus 403 ~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 478 (1009)
.+ .+| ..+..+ .+|++|++++|.+.... ....+++|++|++++|++++.+|..+.++++|++|++++|++++
T Consensus 316 ~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 391 (562)
T 3a79_B 316 VF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN 391 (562)
T ss_dssp CC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCB
T ss_pred ee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCC
Confidence 77 344 333322 56899999999886322 12678889999999999998888888888888776655555542
Q ss_pred CCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccc-cccCCCCccEEEecCccccccccccc
Q 047768 479 ALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPV-TLGACTSLEYVELQGNSFSGTIPQSL 557 (1009)
Q Consensus 479 ~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~ 557 (1009)
. + .+|..++++++|++|++++|++++.+|. .+..+++|+.|+|++|++++.+|..+
T Consensus 392 ~-~----------------------~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 448 (562)
T 3a79_B 392 F-F----------------------KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448 (562)
T ss_dssp T-T----------------------HHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSC
T ss_pred c-c----------------------cchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhh
Confidence 1 0 2345688899999999999999985665 58899999999999999998888776
Q ss_pred ccccccceEcCCCcccccccccccccccccCceecccccCcccCCC--CCcccCccccccccCCCcCC
Q 047768 558 SSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPT--KGIFKNKTGFSIVGNGKLCG 623 (1009)
Q Consensus 558 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~--~~~~~~~~~~~~~~n~~lc~ 623 (1009)
. ++|++|||++|+|+ .+|..+..+++|++|+|++|++++ +|. ...+..+....+.+|++.|.
T Consensus 449 ~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 449 P--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp C--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred c--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCC
Confidence 5 79999999999998 788888899999999999999995 554 34566667778889998884
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=415.23 Aligned_cols=410 Identities=21% Similarity=0.280 Sum_probs=209.2
Q ss_pred cCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhh
Q 047768 86 LSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISR 165 (1009)
Q Consensus 86 ~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~ 165 (1009)
+.|.-...++|++|++++|++ |.+|++|++|++|++|+|++|.++|.+|..++++++|+.++++.|..
T Consensus 3 ~~p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~----------- 70 (454)
T 1jl5_A 3 INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD----------- 70 (454)
T ss_dssp --------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------
T ss_pred ccccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------
Confidence 344555678999999999999 79999999999999999999999999999999999988877776532
Q ss_pred ccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHH
Q 047768 166 RLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEI 245 (1009)
Q Consensus 166 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 245 (1009)
.++++|++++|++++ +|.. .++|++|++++|++++ +|.. +++|++|++++|++++ +|.. .++|++|
T Consensus 71 --~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L 136 (454)
T 1jl5_A 71 --RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYL 136 (454)
T ss_dssp --HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEE
T ss_pred --cCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEE
Confidence 467888888888885 3442 3678888888888876 5543 3678888888888773 3321 1456666
Q ss_pred HhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccccccccccccccccccccccccc
Q 047768 246 YLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFL 325 (1009)
Q Consensus 246 ~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l 325 (1009)
++++|+++ .+|. +.++++|++|++++|++++ +|..+ .+|++|++++|++++++ .|..
T Consensus 137 ~L~~n~l~-~lp~--~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~--~~~~-------------- 193 (454)
T 1jl5_A 137 GVSNNQLE-KLPE--LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEELP--ELQN-------------- 193 (454)
T ss_dssp ECCSSCCS-SCCC--CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSCC--CCTT--------------
T ss_pred ECcCCCCC-CCcc--cCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcCc--cccC--------------
Confidence 66666666 3552 4456666666666666654 33322 35666666666655532 2344
Q ss_pred CCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCC
Q 047768 326 GNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLT 405 (1009)
Q Consensus 326 ~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 405 (1009)
+++|++|++++|++++ +|.. ...|++|++++|+++ .+| .+..+++|+.|++++|+++
T Consensus 194 ----------------l~~L~~L~l~~N~l~~-l~~~----~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~ 250 (454)
T 1jl5_A 194 ----------------LPFLTAIYADNNSLKK-LPDL----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK 250 (454)
T ss_dssp ----------------CTTCCEEECCSSCCSS-CCCC----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS
T ss_pred ----------------CCCCCEEECCCCcCCc-CCCC----cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCC
Confidence 4445555555555443 2211 124555555555555 444 2556666666666666665
Q ss_pred CCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhh
Q 047768 406 GTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQIL 485 (1009)
Q Consensus 406 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~ 485 (1009)
+ +|.. +++|++|++++|++++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++ ++.
T Consensus 251 ~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~~--- 314 (454)
T 1jl5_A 251 T-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LCD--- 314 (454)
T ss_dssp S-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-ECC---
T ss_pred c-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCc-ccC---
Confidence 3 3332 2556666666666664 3432 2456666666666664 2211 1355555555555553 111
Q ss_pred hhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccccc--cccccccccccc
Q 047768 486 EITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSG--TIPQSLSSLTSI 563 (1009)
Q Consensus 486 ~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L 563 (1009)
.......|++++|++++ +|.. +++|++|++++|+++ .+|. .+++|++|+|++|++++ .+|.+++.+
T Consensus 315 -~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--- 382 (454)
T 1jl5_A 315 -LPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--- 382 (454)
T ss_dssp -CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE---
T ss_pred -CcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh---
Confidence 11122346677777664 4543 466777777777777 3555 35677777777777776 566655543
Q ss_pred ceEcCCCcccccccccccccccccCceecccccCcc--cCCC
Q 047768 564 KELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEG--EVPT 603 (1009)
Q Consensus 564 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g--~~p~ 603 (1009)
+.|++.|.+|.. +++|++|++++|+++| .+|.
T Consensus 383 -----~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~ 416 (454)
T 1jl5_A 383 -----RMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE 416 (454)
T ss_dssp -----ECCC---------------------------------
T ss_pred -----hhcccccccccc---cCcCCEEECCCCcCCccccchh
Confidence 234455555542 3566777777777766 5553
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=393.63 Aligned_cols=208 Identities=23% Similarity=0.331 Sum_probs=171.4
Q ss_pred HhccCccCCcccccCCceEEEEEEe---cCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLH---ENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 774 (1009)
..++|++.+.||+|+||+||+|+++ .+++.||||++... .....+.+|+++++.+ +||||+++++++..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~----- 91 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK----- 91 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-----
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE-----
Confidence 3578999999999999999999886 35789999988543 3456788999999998 69999999998654
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC-CceEE
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHV 853 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl 853 (1009)
.+..++||||+++|+|.++++. +++.+++.++.|++.||+|||++ +||||||||+|||++.+ +.+||
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~~---------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl 159 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILNS---------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYAL 159 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHTT---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred CCEEEEEEeCCCcccHHHHHcC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEE
Confidence 3789999999999999999842 88999999999999999999999 99999999999999877 79999
Q ss_pred eccccccccCCCCCCCc--------------------cccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHH
Q 047768 854 SDFGLAKFLSASPLGNV--------------------VETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLE 912 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~e 912 (1009)
+|||+|+.......... ..........+||+.|||||++.+. .|+.++||||+||++||
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e 239 (361)
T 4f9c_A 160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS 239 (361)
T ss_dssp CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence 99999987654321100 0001122346799999999998876 48999999999999999
Q ss_pred HHhCCCCCccccc
Q 047768 913 IFTRRRPTESMFN 925 (1009)
Q Consensus 913 lltg~~p~~~~~~ 925 (1009)
|++|+.||....+
T Consensus 240 ll~G~~Pf~~~~~ 252 (361)
T 4f9c_A 240 LLSGRYPFYKASD 252 (361)
T ss_dssp HHHTCSSSSCCSS
T ss_pred HHHCCCCCCCCCC
Confidence 9999999965433
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=391.97 Aligned_cols=293 Identities=30% Similarity=0.484 Sum_probs=269.2
Q ss_pred cCChhhHHHHHHHHHhcCCCCCCCCCCccCCCCCCCCC--ccceeeCCCC--CeEEEEEeecCCccc--ccCccccCCCC
Q 047768 22 LSNETDCLSLLAIKSQLHDPLGVTSSWNRSACVNLCQH--WTGVTCGRRN--QRVTKLDLRNQSIGG--ILSPYVGNLSF 95 (1009)
Q Consensus 22 ~~~~~d~~aLl~~k~~~~~~~~~~~sW~~~~~~~~c~~--w~gv~C~~~~--~~v~~l~l~~~~l~~--~~~~~~~~l~~ 95 (1009)
.|.++|++||++||+++.||. .+++|+.+ .+|| . |.||+|+..+ ++|+.|+|++++++| .+|+.++++++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~--~~~C-~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~ 77 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT--TDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT--SCTT-TTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCC--CCCC-cCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCC
Confidence 589999999999999998886 78999764 3556 5 9999998765 799999999999999 99999999999
Q ss_pred CCeeeecC-CcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEe
Q 047768 96 LRYINIAD-NDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLS 174 (1009)
Q Consensus 96 L~~L~L~~-n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~ 174 (1009)
|++|+|++ |++++.+|..|+++++|++|+|++|++++.+|..|+++++|++|++++|.+++.+|..+ ..+++|++|+
T Consensus 78 L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~ 155 (313)
T 1ogq_A 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI--SSLPNLVGIT 155 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGG--GGCTTCCEEE
T ss_pred CCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHH--hcCCCCCeEE
Confidence 99999995 99999999999999999999999999999999999999999999999999999999888 6799999999
Q ss_pred ecCccCCCCCCcccCCcc-ccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccC
Q 047768 175 VGDNQLTGQLPASIGNLS-ALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFT 253 (1009)
Q Consensus 175 L~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 253 (1009)
|++|++++.+|..+++++ +|++|+|++|++++.+|..|..++ |++|+|++|++++..|..|..+++|++|+|++|+++
T Consensus 156 L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 234 (313)
T 1ogq_A 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEEC
T ss_pred CcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCcee
Confidence 999999999999999998 999999999999999999999998 999999999999999999999999999999999999
Q ss_pred CCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccc
Q 047768 254 GSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNF 324 (1009)
Q Consensus 254 ~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~ 324 (1009)
+.+|. +..+++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|.. ..+++|+.+++++|.
T Consensus 235 ~~~~~--~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 235 FDLGK--VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp CBGGG--CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred eecCc--ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 66665 456899999999999999999999999999999999999999877765 667777777776665
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=407.73 Aligned_cols=379 Identities=18% Similarity=0.191 Sum_probs=251.6
Q ss_pred CCCCeeeecCCcCCccCCccccCccccccccccccccCCCC-CCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCe
Q 047768 94 SFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRI-PTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQG 172 (1009)
Q Consensus 94 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~ 172 (1009)
++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|+++++|++|
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L------------------------- 84 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL------------------------- 84 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEE-------------------------
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEE-------------------------
Confidence 66777888887777766777777777777777777776444 3345554444444
Q ss_pred EeecCccCCCCCCcccCCccccceeecccCcccCCCCcc--cccccccccccccCccCCCCCCCcccCCChHHHHHhhCC
Q 047768 173 LSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPIT--LSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGN 250 (1009)
Q Consensus 173 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 250 (1009)
+|++|++++..|..|+++++|++|+|++|++++..|.. |..+++|++|+|++|++++..|..
T Consensus 85 -~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--------------- 148 (455)
T 3v47_A 85 -KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS--------------- 148 (455)
T ss_dssp -ECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCG---------------
T ss_pred -eCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCccc---------------
Confidence 44445555556677777788888888888777644443 777777777777777776444433
Q ss_pred ccCCCCChhhccCCCcccceeccccccCCCCCCCcCcc--cccccccccccccccccccccccccccccccccccccCCC
Q 047768 251 RFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNA--SNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNG 328 (1009)
Q Consensus 251 ~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~ 328 (1009)
++.++++|++|++++|.+++..|..+..+ .+|+.|++++|.+.+..+..+..
T Consensus 149 ---------~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~----------------- 202 (455)
T 3v47_A 149 ---------FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW----------------- 202 (455)
T ss_dssp ---------GGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH-----------------
T ss_pred ---------ccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccc-----------------
Confidence 23445566666666666666666666555 56777777777766544332210
Q ss_pred CCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhc--ccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCC
Q 047768 329 AANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLS--TALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTG 406 (1009)
Q Consensus 329 ~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 406 (1009)
.....+..+++|++|++++|++++..|..+.... ..++.|++++|.+.+.. +..+.+.+
T Consensus 203 -----~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~ 263 (455)
T 3v47_A 203 -----EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKD 263 (455)
T ss_dssp -----HHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCC
T ss_pred -----cccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------cchhhhcc
Confidence 0011233457788888888888877777665542 33444444444433210 11112221
Q ss_pred CCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhh
Q 047768 407 TIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILE 486 (1009)
Q Consensus 407 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~ 486 (1009)
..+..+..+ ..++|++|++++|++++.+|..+..+++|++
T Consensus 264 ~~~~~~~~~----------------------~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~------------------ 303 (455)
T 3v47_A 264 PDNFTFKGL----------------------EASGVKTCDLSKSKIFALLKSVFSHFTDLEQ------------------ 303 (455)
T ss_dssp CCTTTTGGG----------------------TTSCCCEEECCSSCCCEECTTTTTTCTTCCE------------------
T ss_pred Ccccccccc----------------------cccCceEEEecCccccccchhhcccCCCCCE------------------
Confidence 222222111 1245666666666666666666666666554
Q ss_pred hccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceE
Q 047768 487 ITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKEL 566 (1009)
Q Consensus 487 ~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 566 (1009)
|++++|++++..|..|+++++|++|+|++|++++..|..++.+++|+.|+|++|++++..|.+|+++++|++|
T Consensus 304 -------L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 376 (455)
T 3v47_A 304 -------LTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKEL 376 (455)
T ss_dssp -------EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred -------EECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEE
Confidence 4444444444556677788889999999999988888899999999999999999998889999999999999
Q ss_pred cCCCcccccccccccccccccCceecccccCcccCCCCC
Q 047768 567 DLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKG 605 (1009)
Q Consensus 567 ~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~ 605 (1009)
+|++|+|++..+..+..+++|++|++++|+++|.+|...
T Consensus 377 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 415 (455)
T 3v47_A 377 ALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 415 (455)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred ECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence 999999998777778999999999999999999999643
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=403.68 Aligned_cols=420 Identities=21% Similarity=0.227 Sum_probs=239.6
Q ss_pred CeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEec
Q 047768 70 QRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSA 149 (1009)
Q Consensus 70 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l 149 (1009)
.+++.|+++++.+ |.+|++++++++|++|++++|.++|.+|..++++++|+.++++.|.. .++++|++
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~l 78 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELEL 78 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEEC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEEe
Confidence 4788999999999 89999999999999999999999999999999999998887777653 45777888
Q ss_pred ccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCC
Q 047768 150 HRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFS 229 (1009)
Q Consensus 150 ~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 229 (1009)
++|.+++ +|.. ..+|++|++++|++++ +|.. +++|++|++++|++++. |.. .++|++|++++|+++
T Consensus 79 ~~~~l~~-lp~~-----~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~ 144 (454)
T 1jl5_A 79 NNLGLSS-LPEL-----PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLE 144 (454)
T ss_dssp TTSCCSC-CCSC-----CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCS
T ss_pred cCCcccc-CCCC-----cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCC
Confidence 8887764 3331 2577888888888886 5643 36788888888888642 221 157888888888888
Q ss_pred CCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccccccccc
Q 047768 230 GTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINF 309 (1009)
Q Consensus 230 ~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f 309 (1009)
+ +| .|.++++|++|++++|+++ .+|.. .++|++|++++|++++ +| .|+++++|++|++++|++++++..
T Consensus 145 ~-lp-~~~~l~~L~~L~l~~N~l~-~lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~-- 213 (454)
T 1jl5_A 145 K-LP-ELQNSSFLKIIDVDNNSLK-KLPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDL-- 213 (454)
T ss_dssp S-CC-CCTTCTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCC--
T ss_pred C-Cc-ccCCCCCCCEEECCCCcCc-ccCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCC--
Confidence 5 66 5888888888888888887 46643 3588888898888887 45 588888999999999988864432
Q ss_pred ccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCcccc
Q 047768 310 NGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIA 389 (1009)
Q Consensus 310 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~ 389 (1009)
.++|+.|++++|.+..++. +..+++|++|++++|++++ +|.. ...|+.|++++|++++ +|..
T Consensus 214 --~~~L~~L~l~~n~l~~lp~--------~~~l~~L~~L~l~~N~l~~-l~~~----~~~L~~L~l~~N~l~~-l~~~-- 275 (454)
T 1jl5_A 214 --PLSLESIVAGNNILEELPE--------LQNLPFLTTIYADNNLLKT-LPDL----PPSLEALNVRDNYLTD-LPEL-- 275 (454)
T ss_dssp --CTTCCEEECCSSCCSSCCC--------CTTCTTCCEEECCSSCCSS-CCSC----CTTCCEEECCSSCCSC-CCCC--
T ss_pred --cCcccEEECcCCcCCcccc--------cCCCCCCCEEECCCCcCCc-cccc----ccccCEEECCCCcccc-cCcc--
Confidence 2467777777776664331 4566777777777777764 3321 2456666666666664 3432
Q ss_pred CcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccc-cccccccccCcccccccCCCCCCCCCccc
Q 047768 390 NLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNL-TLLTYLSFGANNLQGNIPFSLGNCKNLMF 468 (1009)
Q Consensus 390 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 468 (1009)
+++|+.|++++|++++. |.. .++|++|++++|++++ ++ .+ ++|++|++++|++++ +|.. +++|+
T Consensus 276 -~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~- 340 (454)
T 1jl5_A 276 -PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLE- 340 (454)
T ss_dssp -CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCC-
T ss_pred -cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCC-
Confidence 25666666666666642 111 1456666666666653 22 12 356666666666664 4433 23333
Q ss_pred cccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCC--CccccccCCCCccEEEecC
Q 047768 469 FFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSG--QIPVTLGACTSLEYVELQG 546 (1009)
Q Consensus 469 l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~L~L~~ 546 (1009)
.|++++|+++ .+|. .+++|++|++++|++++ .+|..++. |+.
T Consensus 341 ------------------------~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~ 384 (454)
T 1jl5_A 341 ------------------------RLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRM 384 (454)
T ss_dssp ------------------------EEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EEC
T ss_pred ------------------------EEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhh
Confidence 4777777777 4665 47899999999999998 67776653 456
Q ss_pred cccccccccccccccccceEcCCCccccc--ccccccccccccCceecccccCcccCCCC
Q 047768 547 NSFSGTIPQSLSSLTSIKELDLSQNNFSG--QIPKYLENLSFLQYLNLSYNHFEGEVPTK 604 (1009)
Q Consensus 547 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 604 (1009)
|.+.|.+|.. +++|+.||+++|++++ .+|.+ |+.|.+++|.+.+.+|..
T Consensus 385 n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~~ 435 (454)
T 1jl5_A 385 NSHLAEVPEL---PQNLKQLHVETNPLREFPDIPES------VEDLRMNSERVVDPYEFA 435 (454)
T ss_dssp CC----------------------------------------------------------
T ss_pred cccccccccc---cCcCCEEECCCCcCCccccchhh------HhheeCcCcccCCccccC
Confidence 7888888874 5789999999999997 67754 566778999999887753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=403.80 Aligned_cols=250 Identities=24% Similarity=0.290 Sum_probs=198.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHH---HHHHHhcCCCCcceEEeeeeccccC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAE---CEALRSIRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~ 773 (1009)
.++|.+.+.||+|+||+||+|+++.+|+.||||+++... ........+| +++++.++|||||++++++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~---- 263 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---- 263 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE----
Confidence 468999999999999999999999999999999996432 2223334444 556667799999999998654
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEE
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 853 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 853 (1009)
....|+||||++||+|.+++.+... +++..++.++.||+.||+|||++ +||||||||+|||++.+|.+||
T Consensus 264 -~~~lylVmEy~~GGdL~~~l~~~~~------l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 264 -PDKLSFILDLMNGGDLHYHLSQHGV------FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEE
T ss_pred -CCEEEEEEecCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEe
Confidence 4789999999999999999987653 99999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHH
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHE 932 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~ 932 (1009)
+|||+|+..... .....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||......+ ..+
T Consensus 334 ~DFGlA~~~~~~----------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~ 401 (689)
T 3v5w_A 334 SDLGLACDFSKK----------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHE 401 (689)
T ss_dssp CCCTTCEECSSC----------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHH
T ss_pred cccceeeecCCC----------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHH
Confidence 999999876542 2234689999999999975 579999999999999999999999997543221 222
Q ss_pred HHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 047768 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME-----MTDVVV 995 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt-----~~evl~ 995 (1009)
.......... ..+ .....++.+++.+|++.||++|++ ++||.+
T Consensus 402 i~~~i~~~~~---------~~p-----------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 402 IDRMTLTMAV---------ELP-----------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHHHCCC---------CCC-----------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHhhcCCCC---------CCC-----------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 2111111100 000 011234679999999999999998 566643
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=405.61 Aligned_cols=391 Identities=18% Similarity=0.191 Sum_probs=307.0
Q ss_pred CCCCCCCCccc--eeeCCCC--------CeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccC-CccccCcccc
Q 047768 52 ACVNLCQHWTG--VTCGRRN--------QRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEI-PDRIGNLFRL 120 (1009)
Q Consensus 52 ~~~~~c~~w~g--v~C~~~~--------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~-p~~~~~l~~L 120 (1009)
+|+..| .|.+ |.|+... .+++.|+|++|.+++..+..|+++++|++|+|++|.+.+.+ |..|.++++|
T Consensus 3 p~~~~c-~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L 81 (455)
T 3v47_A 3 PGTSEC-SVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81 (455)
T ss_dssp ----CC-EEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTC
T ss_pred Ccccee-EEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccC
Confidence 355666 5666 8898643 57999999999999999999999999999999999998776 5679999999
Q ss_pred ccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcc-cCCccccceeec
Q 047768 121 ETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPAS-IGNLSALRVIDI 199 (1009)
Q Consensus 121 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~L 199 (1009)
++|||++|++++..|..|+++++|++|++++|++++.+|.......+++|++|+|++|++++..|.. ++++++|++|++
T Consensus 82 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L 161 (455)
T 3v47_A 82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDL 161 (455)
T ss_dssp CEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEEC
T ss_pred CEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeC
Confidence 9999999999999999999999999999999999887776633467889999999999999887776 889999999999
Q ss_pred ccCcccCCCCcccccc--cccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceecccccc
Q 047768 200 RTNRLWGKIPITLSQL--TSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNF 277 (1009)
Q Consensus 200 ~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l 277 (1009)
++|++.+..|..+..+ .+|+.|++++|.+.+..+..+.. .... . ...+++|++|++++|++
T Consensus 162 ~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~-------~~~~---------~-~~~~~~L~~L~Ls~n~l 224 (455)
T 3v47_A 162 TFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW-------EKCG---------N-PFKNTSITTLDLSGNGF 224 (455)
T ss_dssp TTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH-------HHHC---------C-TTTTCEEEEEECTTSCC
T ss_pred CCCcccccChhhhhccccccccccccccCcccccchhhccc-------cccc---------c-ccccceeeeEecCCCcc
Confidence 9999988888888877 78899999999888544433210 0000 0 11245666666666666
Q ss_pred CCCCCCCcCcc---cccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhcc--cccccceEEccC
Q 047768 278 TGSLPDSFSNA---SNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLT--NCTKLQYLYLAD 352 (1009)
Q Consensus 278 ~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~--~l~~L~~L~L~~ 352 (1009)
++..|..|..+ ++|+.|++++|.+.+... ..+.+..... ..+. ..++|++|++++
T Consensus 225 ~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~~~~------~~~~~~~~~~L~~L~l~~ 284 (455)
T 3v47_A 225 KESMAKRFFDAIAGTKIQSLILSNSYNMGSSF--------------GHTNFKDPDN------FTFKGLEASGVKTCDLSK 284 (455)
T ss_dssp CHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT--------------TCCSSCCCCT------TTTGGGTTSCCCEEECCS
T ss_pred cccchhhhhccccccceeeEeecccccccccc--------------chhhhccCcc------cccccccccCceEEEecC
Confidence 66555555443 677777777776554211 1111111111 0111 236889999999
Q ss_pred CCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCC
Q 047768 353 NGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTI 432 (1009)
Q Consensus 353 N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 432 (1009)
|.+++..|..+..+ +.|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..
T Consensus 285 n~l~~~~~~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 363 (455)
T 3v47_A 285 SKIFALLKSVFSHF-TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALG 363 (455)
T ss_dssp SCCCEECTTTTTTC-TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEEC
T ss_pred ccccccchhhcccC-CCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccC
Confidence 99988888888777 57999999999999888888999999999999999998888888999999999999999999888
Q ss_pred CcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCc
Q 047768 433 PSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALP 481 (1009)
Q Consensus 433 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 481 (1009)
|..|.++++|++|++++|++++..+..+..+++|++|++++|++++..|
T Consensus 364 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 364 DQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 8889999999999999999997666778889999988888888887776
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=409.22 Aligned_cols=253 Identities=19% Similarity=0.273 Sum_probs=206.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|+++|+.++||||+++++++.. ....+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-----SSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEE
Confidence 3689999999999999999999999999999999976554456788999999999999999999998654 47899
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC--CceEEeccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD--MVAHVSDFG 857 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~--~~~kl~DfG 857 (1009)
+|||||++|+|.+++..... .+++.++..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 231 iv~E~~~gg~L~~~i~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG 302 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 302 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTS-----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred EEEeecCCCcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence 99999999999999976543 389999999999999999999999 99999999999999854 899999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+|+.+... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+.....
T Consensus 303 ~a~~~~~~---------~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-----~~~~~~i 368 (573)
T 3uto_A 303 LTAHLDPK---------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETLRNV 368 (573)
T ss_dssp SCEECCTT---------SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHH
T ss_pred ceeEccCC---------CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHH
Confidence 99977543 223346799999999999999999999999999999999999999974321 1111111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
......... . .......++.+++.+|++.||++|||+.|+++
T Consensus 369 --------~~~~~~~~~-~-------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 369 --------KSCDWNMDD-S-------AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --------HTTCCCCCS-G-------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --------HhCCCCCCc-c-------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 110000000 0 00012235679999999999999999999976
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=374.91 Aligned_cols=288 Identities=38% Similarity=0.627 Sum_probs=231.2
Q ss_pred cCCccCHHHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEe
Q 047768 687 QFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVT 765 (1009)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~ 765 (1009)
....+++.++....++|.+.+.||+|+||.||+|.+. +++.||||+++.... .....+.+|++++++++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 3456788999999999999999999999999999864 689999999965432 23447899999999999999999999
Q ss_pred eeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee
Q 047768 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL 845 (1009)
Q Consensus 766 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill 845 (1009)
++... ...++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+++.++|+||||||+||++
T Consensus 95 ~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~ 167 (326)
T 3uim_A 95 FCMTP-----TERLLVYPYMANGSVASCLRERPES--QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL 167 (326)
T ss_dssp EECCS-----SCCEEEEECCTTCBHHHHHHCCSTT--CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred EEecC-----CceEEEEEeccCCCHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence 97643 5678999999999999999876432 2358999999999999999999999877799999999999999
Q ss_pred CCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCccc--
Q 047768 846 DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM-- 923 (1009)
Q Consensus 846 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~-- 923 (1009)
+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (326)
T 3uim_A 168 DEEFEAVVGDFGLAKLMDYKDT-------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240 (326)
T ss_dssp CTTCCEEECCCSSCEECCSSSS-------CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHH
T ss_pred CCCCCEEeccCccccccCcccc-------cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccc
Confidence 9999999999999987653321 2223456999999999999999999999999999999999999999632
Q ss_pred -ccCCccHHHHHHHhccch-hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 924 -FNEGLTLHEFAKRALPEK-VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 924 -~~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
.........+........ ...+.+..+.. ....++...+.+++.+|++.||++|||+.||++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQG----------NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTSCSBHHHHHTTTTSSCCSTTSSCTTCTT----------SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ccccchhHHHHHHHHhhchhhhhhcChhhcc----------ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 122334444443333222 33333332222 2334677889999999999999999999999999974
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=373.62 Aligned_cols=282 Identities=36% Similarity=0.546 Sum_probs=226.1
Q ss_pred HHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 695 ELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 695 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
++...+++|.+.+.||+|+||.||+|+++ +++.||||++........+.+.+|++++++++||||+++++++..
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 106 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE----- 106 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-----
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----
Confidence 34456789999999999999999999975 789999999876655556789999999999999999999999754
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
....++||||+++|+|.+++...... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLP--TMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCC--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEEC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCC--ccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEe
Confidence 36789999999999999999765421 23489999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccC-CccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNE-GLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~-~~~~~~~ 933 (1009)
|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+
T Consensus 182 Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~ 255 (321)
T 2qkw_B 182 DFGISKKGTELDQ------THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255 (321)
T ss_dssp CCTTCEECSSSSC------CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred ecccccccccccc------cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence 9999986543211 11223456899999999999999999999999999999999999999754432 2233333
Q ss_pred HHHh-ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 934 AKRA-LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 934 ~~~~-~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
.... ....+...+++.+.. ....+++.++.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 256 AVESHNNGQLEQIVDPNLAD----------KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp THHHHTTTCCCSSSSSSCTT----------CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hhhccccccHHHhcChhhcc----------ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 2211 122233333333221 22346778899999999999999999999999999988763
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=371.07 Aligned_cols=268 Identities=24% Similarity=0.378 Sum_probs=215.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||+||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----CeeE
Confidence 46788999999999999999999999999999998655445567899999999999999999999997653 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++|+|.++++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLA 155 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccc
Confidence 99999999999999987544 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCcc------ccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCC----cc
Q 047768 860 KFLSASPLGNVV------ETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEG----LT 929 (1009)
Q Consensus 860 ~~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~----~~ 929 (1009)
+........... ..........||+.|+|||++.+..++.++||||||+++|||++|..||....... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 235 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence 876543221100 00111224679999999999999999999999999999999999999986533221 11
Q ss_pred HHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 047768 930 LHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLG 1006 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~ 1006 (1009)
........ ....++.++.+++.+||+.||++|||+.|+++.|+++++....
T Consensus 236 ~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 236 VRGFLDRY--------------------------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp HHHHHHHT--------------------------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred hhcccccc--------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 11111110 0112234578999999999999999999999999999877543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=365.05 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=207.7
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||+||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++... ...+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEE
Confidence 46899999999999999999999889999999999877666677899999999999999999999987653 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++|+|.+++.... +++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 94 lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp EEEECCTTCBHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEECCCCCCHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999999999998653 88999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .........
T Consensus 164 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~-- 232 (297)
T 3fxz_A 164 AQITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNG-- 232 (297)
T ss_dssp EECCSTT--------CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHC--
T ss_pred eecCCcc--------cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC--
Confidence 8765432 12234679999999999999999999999999999999999999996432110 000100000
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.+... ........+.+++.+|++.||++|||++|+++
T Consensus 233 -------~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 233 -------TPELQ------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -------SCCCS------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------CCCCC------------CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00000 01122345789999999999999999999976
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=370.77 Aligned_cols=282 Identities=24% Similarity=0.328 Sum_probs=213.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|++.+.||+|+||+||+|++. ++.||||+++.... ......+|+.++++++||||+++++++.... ......+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence 468999999999999999999875 89999999964432 2345667899999999999999999987642 2234579
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcC-------CCCceecCCCCCceeeCCCCceE
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHC-------QPPIVHGDLKPSNVLLDHDMVAH 852 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------~~~ivHrdlk~~Nill~~~~~~k 852 (1009)
+||||+++|+|.++++... +++.+++.++.|++.||+|||+.+ .++|+||||||+||+++.++.+|
T Consensus 99 lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKANV-------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEECCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred EEEecCCCCCHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 9999999999999997643 899999999999999999999861 34899999999999999999999
Q ss_pred EeccccccccCCCCCCCccccCCccccccccccccCccccCC-----CCCCCcccchHHHHHHHHHHhCCCCCcccccCC
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-----GEASMRGGVYSYGILLLEIFTRRRPTESMFNEG 927 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~ 927 (1009)
|+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.......
T Consensus 172 L~DFg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 172 IADFGLALKFEAGKS------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp ECCCTTCEEECTTSC------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred EccCCcccccccccC------ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 999999987654321 122234679999999999887 356778999999999999999999997543322
Q ss_pred cc-HHHHHHHh-ccchhhhc-cCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 928 LT-LHEFAKRA-LPEKVMEI-VDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 928 ~~-~~~~~~~~-~~~~~~~~-~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
.. ........ ....+.+. ......+... .......++.++.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR-----DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCC-----GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchhhhhccCCchhhhhhhhhcccCCCCcc-----ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11 11110000 00111111 1111111110 1122345667899999999999999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=363.14 Aligned_cols=268 Identities=24% Similarity=0.380 Sum_probs=209.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHh--cCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRS--IRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||+||+|++ +++.||||++... ..+.+.+|.+++.. ++||||+++++++... ......
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence 46899999999999999999987 5899999998643 34566677777776 7999999999987653 334467
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCceecCCCCCceeeCCCC
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH--------HHCQPPIVHGDLKPSNVLLDHDM 849 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivHrdlk~~Nill~~~~ 849 (1009)
.++||||+++|+|.++++... +++..++.++.|++.||+||| +. +|+||||||+||+++.++
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLTT-------LDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTCC-------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTS
T ss_pred eEEehhhccCCCHHHHHhhcc-------cCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCC
Confidence 899999999999999996542 899999999999999999999 77 999999999999999999
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCC------CCCCcccchHHHHHHHHHHhC-------
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG------EASMRGGVYSYGILLLEIFTR------- 916 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltg------- 916 (1009)
.+||+|||+++........ .........||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 226 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQ----LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226 (301)
T ss_dssp CEEECCCTTCEEEETTTTE----EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CEEEeeCCCeeeccccccc----ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence 9999999999876543211 01112335799999999998877 556799999999999999999
Q ss_pred ---CCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 047768 917 ---RRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDV 993 (1009)
Q Consensus 917 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~ev 993 (1009)
+.||...................... .+.. + .......+..++.+++.+||+.||++|||+.||
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~---~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 293 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQ----RPNI---P------NRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCC---C------GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ccccccccccCCCCcchhhhhHHHhccCC----CCCC---C------hhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence 78887655444444433322111110 0000 0 111233567789999999999999999999999
Q ss_pred HHHHHHH
Q 047768 994 VVKLCHA 1000 (1009)
Q Consensus 994 l~~L~~i 1000 (1009)
++.|+++
T Consensus 294 ~~~L~~i 300 (301)
T 3q4u_A 294 KKTLTKI 300 (301)
T ss_dssp HHHHHHH
T ss_pred HHHHhcc
Confidence 9999876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=369.94 Aligned_cols=266 Identities=26% Similarity=0.396 Sum_probs=209.8
Q ss_pred hccCccCCcccccCCceEEEEEEecC---CeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHEN---GMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|.+.+.||+|+||+||+|++..+ +..||||+++.... ...+.+.+|++++++++||||+++++++...
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 122 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG----- 122 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG-----
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----
Confidence 35788899999999999999999744 45699999975422 2346789999999999999999999997543
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++|+|.++++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 194 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDG-----QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSD 194 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECC
Confidence 678999999999999999976543 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 934 (1009)
||+++........ ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 195 fg~a~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~ 264 (325)
T 3kul_A 195 FGLSRVLEDDPDA-----AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-----DVI 264 (325)
T ss_dssp CSSCEECC----C-----CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHH
T ss_pred CCcccccccCccc-----eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----HHH
Confidence 9999877543211 112223456889999999999999999999999999999999 99999753221 111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcC
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQ 1007 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~~ 1007 (1009)
... ....... ....+..++.+++.+||+.||++|||+.|+++.|+.+.+.....
T Consensus 265 ~~~--------~~~~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 265 SSV--------EEGYRLP-----------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp HHH--------HTTCCCC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred HHH--------HcCCCCC-----------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 111 0000000 01123456889999999999999999999999999998876544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=365.18 Aligned_cols=274 Identities=25% Similarity=0.397 Sum_probs=210.2
Q ss_pred hccCccCCcccccCCceEEEEEE----ecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVL----HENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|++.+.||+|+||+||+|++ ..+++.||||+++.......+.+.+|++++++++||||+++++++... +.
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---HH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence 46899999999999999999994 457899999999755544557899999999999999999999987542 22
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CceEEEEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEcc
Confidence 457899999999999999987653 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++........ ........+|..|+|||++.+..++.++||||||+++|||++|..|+...... +..
T Consensus 158 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~~ 226 (295)
T 3ugc_A 158 FGLTKVLPQDKEF-----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE------FMR 226 (295)
T ss_dssp CCSCC------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH------HHH
T ss_pred CcccccccCCcce-----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH------HHh
Confidence 9999876543211 11222345788899999999999999999999999999999999998643211 110
Q ss_pred Hhccc--------hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 047768 936 RALPE--------KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFL 1005 (1009)
Q Consensus 936 ~~~~~--------~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~ 1005 (1009)
..... ...+.+.... ....+..++.++.+++.+||+.||++|||+.|+++.|+++++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 227 MIGNDKQGQMIVFHLIELLKNNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHCTTCCTHHHHHHHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred hhcCccccchhHHHHHHHHhccC----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 00000 0001110000 001122345678899999999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=380.48 Aligned_cols=263 Identities=27% Similarity=0.414 Sum_probs=211.2
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
..++|.+.+.||+|+||+||+|+++.+++.||||+++.... ...+.+.+|++++++++||||+++++++... ..
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 186 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QP 186 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----SS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----CC
Confidence 34678899999999999999999988899999999864422 1234688999999999999999999997543 56
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.++++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG 258 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFG 258 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred cEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCC
Confidence 7999999999999999987543 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+++....... ........+++.|+|||++.++.++.++|||||||++|||+| |+.||...... ........
T Consensus 259 ~s~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~ 330 (377)
T 3cbl_A 259 MSREEADGVY------AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEK 330 (377)
T ss_dssp GCEECTTSEE------ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHT
T ss_pred CceecCCCce------eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc
Confidence 9986543211 011112346788999999999999999999999999999999 99999754321 11111110
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
. ...+ .+..++.++.+++.+||+.||++|||++|+++.|+++++.+
T Consensus 331 ~-----------~~~~-----------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 331 G-----------GRLP-----------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp T-----------CCCC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred C-----------CCCC-----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 0 0000 01123456889999999999999999999999999998764
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=379.21 Aligned_cols=363 Identities=18% Similarity=0.174 Sum_probs=224.0
Q ss_pred ccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHH
Q 047768 83 GGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEEL 162 (1009)
Q Consensus 83 ~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~ 162 (1009)
.+..+.+++++++|++|+|++|.+++ +| .|+.+++|++|+|++|++++. | ++++++|++|++++|++++. | +
T Consensus 31 ~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~ 102 (457)
T 3bz5_A 31 QATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--V 102 (457)
T ss_dssp CTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--C
T ss_pred CcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--c
Confidence 34445567778888888888888885 45 588888888888888888763 3 77777777777777766642 2 1
Q ss_pred hhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChH
Q 047768 163 ISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSL 242 (1009)
Q Consensus 163 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 242 (1009)
..+++|++|++++|++++ +| ++++++|++|++++|++++. .++.+++|++|++++|+..
T Consensus 103 --~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~------------- 161 (457)
T 3bz5_A 103 --TPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKI------------- 161 (457)
T ss_dssp --TTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCC-------------
T ss_pred --CCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCcc-------------
Confidence 345556666666666554 22 55555666666666655542 1455555555555555333
Q ss_pred HHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccc
Q 047768 243 VEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLAT 322 (1009)
Q Consensus 243 ~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~ 322 (1009)
+.++ +..+++|++|++++|++++. | +..+++|++|++++|++++. .|
T Consensus 162 -----------~~~~---~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l------------- 208 (457)
T 3bz5_A 162 -----------TKLD---VTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DL------------- 208 (457)
T ss_dssp -----------CCCC---CTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CC-------------
T ss_pred -----------cccc---cccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---cc-------------
Confidence 2332 23456666666666666653 3 66666777777777766643 12
Q ss_pred cccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCC
Q 047768 323 NFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEAN 402 (1009)
Q Consensus 323 N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 402 (1009)
..+++|++|++++|++++ +| +..+ ..|+.|++++|++++.. +..+++|+.|++++|
T Consensus 209 -----------------~~l~~L~~L~Ls~N~l~~-ip--~~~l-~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n 264 (457)
T 3bz5_A 209 -----------------NQNIQLTFLDCSSNKLTE-ID--VTPL-TQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT 264 (457)
T ss_dssp -----------------TTCTTCSEEECCSSCCSC-CC--CTTC-TTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC
T ss_pred -----------------ccCCCCCEEECcCCcccc-cC--cccc-CCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC
Confidence 223444444554444443 22 2222 23344444444444322 234455566665554
Q ss_pred CCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCch
Q 047768 403 RLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQ 482 (1009)
Q Consensus 403 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 482 (1009)
+|+.|++++|.+.+.+| ++.+++|++|++++|.+.+.+|... .+|+
T Consensus 265 --------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~---~~L~--------------- 310 (457)
T 3bz5_A 265 --------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQA---AGIT--------------- 310 (457)
T ss_dssp --------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTT---CCCS---------------
T ss_pred --------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCC---Ccce---------------
Confidence 24456666666655554 3455666666666666555555321 1211
Q ss_pred hhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccc
Q 047768 483 QILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTS 562 (1009)
Q Consensus 483 ~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 562 (1009)
.|++++ +++|++|++++|+|++. + ++.+++|+.|++++|+|++ ++.
T Consensus 311 ----------~L~l~~-------------~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~ 356 (457)
T 3bz5_A 311 ----------ELDLSQ-------------NPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSS 356 (457)
T ss_dssp ----------CCCCTT-------------CTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTT
T ss_pred ----------Eechhh-------------cccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccc
Confidence 133333 36889999999999974 3 8889999999999999985 356
Q ss_pred cceEcCCCcccccccccccccccccCceecccccCcccCCCC
Q 047768 563 IKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK 604 (1009)
Q Consensus 563 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 604 (1009)
|..|++++|.++|. ..+..|+.+++++|+++|.+|..
T Consensus 357 L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 357 VGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp GGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred cccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence 77888999999986 35677888999999999999964
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=370.96 Aligned_cols=268 Identities=22% Similarity=0.371 Sum_probs=212.4
Q ss_pred hccCccCCcccccCCceEEEEEEe-------cCCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeecc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLH-------ENGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSSI 770 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 770 (1009)
.++|.+.+.||+|+||.||+|++. .++..||||+++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence 468899999999999999999975 2456899999965432 2345789999999999 89999999999754
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCC----------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCC
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQ----------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKP 840 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~ 840 (1009)
....++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||++ +|+||||||
T Consensus 159 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp 231 (370)
T 2psq_A 159 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231 (370)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred ----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence 36689999999999999999875421 0112489999999999999999999999 999999999
Q ss_pred CceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCC
Q 047768 841 SNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRP 919 (1009)
Q Consensus 841 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p 919 (1009)
+||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p 305 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTT------CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred hhEEECCCCCEEEccccCCcccCcccce------ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999876543211 12223457889999999999999999999999999999999 9999
Q ss_pred CcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 920 TESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
|...... ......... .... .+..+..++.+++.+||+.||++|||+.|+++.|+.
T Consensus 306 ~~~~~~~--~~~~~~~~~-----------~~~~-----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 306 YPGIPVE--ELFKLLKEG-----------HRMD-----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp STTCCGG--GHHHHHHTT-----------CCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHH--HHHHHHhcC-----------CCCC-----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 9754222 111111110 0000 011234568899999999999999999999999999
Q ss_pred HHHhhh
Q 047768 1000 ARQNFL 1005 (1009)
Q Consensus 1000 i~~~~~ 1005 (1009)
+.+...
T Consensus 362 il~~~~ 367 (370)
T 2psq_A 362 ILTLTT 367 (370)
T ss_dssp HHHHHC
T ss_pred HHHHhc
Confidence 887554
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=360.99 Aligned_cols=262 Identities=23% Similarity=0.291 Sum_probs=211.9
Q ss_pred CccCHHHHHHHhcc----------CccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCC
Q 047768 689 PMVSYKELSKATNE----------FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHR 758 (1009)
Q Consensus 689 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 758 (1009)
+.++++++..+++. |...+.||+|+||.||+|+++.+|+.||||+++.......+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 55677777766653 66678999999999999999889999999999876666667899999999999999
Q ss_pred CcceEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCC
Q 047768 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDL 838 (1009)
Q Consensus 759 niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdl 838 (1009)
||+++++++... ...++||||+++|+|.+++.... +++.++..++.|++.||+|||+. +|+||||
T Consensus 103 niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~-------l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dl 167 (321)
T 2c30_A 103 NVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLHAQ---GVIHRDI 167 (321)
T ss_dssp TBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTTCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred CcceEEEEEEEC-----CEEEEEEecCCCCCHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCC
Confidence 999999997653 67899999999999999987542 89999999999999999999999 9999999
Q ss_pred CCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCC
Q 047768 839 KPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR 918 (1009)
Q Consensus 839 k~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~ 918 (1009)
||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 168 kp~NIll~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 239 (321)
T 2c30_A 168 KSDSILLTLDGRVKLSDFGFCAQISKDV--------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239 (321)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSSS--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEECCCCcEEEeeeeeeeecccCc--------cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999998765321 12234579999999999999999999999999999999999999
Q ss_pred CCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 919 PTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 919 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
||..... ...... +.....+.+.. ......++.+++.+|++.||++|||+.|+++
T Consensus 240 pf~~~~~-----~~~~~~-----~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 240 PYFSDSP-----VQAMKR-----LRDSPPPKLKN------------SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp TTTTSCH-----HHHHHH-----HHHSSCCCCTT------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCCH-----HHHHHH-----HhcCCCCCcCc------------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9964321 111111 11111111110 0122345789999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=364.19 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=204.2
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
..++|.+.+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+++++.++||||+++++++.. ..
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-----EK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence 35689999999999999999999988999999999965432 234568899999999999999999999754 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|.+++..... +++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~------l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DF 158 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGR------MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADF 158 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECST
T ss_pred EEEEEEECCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeec
Confidence 78999999999999999987653 89999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCC-CcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEAS-MRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++..... .......||+.|+|||++.+..+. .++||||+||++|||++|+.||.... ......
T Consensus 159 G~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~ 224 (328)
T 3fe3_A 159 GFSNEFTVG---------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRE 224 (328)
T ss_dssp TCCGGGSSS---------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH
T ss_pred cCceecCCC---------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHH
Confidence 999866532 223346799999999999888874 79999999999999999999997432 222221
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
....... ..+ .....++.+++.+|++.||.+|||++|+++
T Consensus 225 ~i~~~~~---------~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 225 RVLRGKY---------RIP-----------FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHHCCC---------CCC-----------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HHHhCCC---------CCC-----------CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111100 000 012235679999999999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=374.21 Aligned_cols=263 Identities=27% Similarity=0.447 Sum_probs=198.9
Q ss_pred hccCccCCcccccCCceEEEEEEe---cCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLH---ENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|.+.+.||+|+||+||+|+++ .++..||||+++.... ...+.+.+|++++++++||||+++++++.. .
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-----S 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----C
Confidence 358999999999999999999986 4577899999975432 234679999999999999999999999754 3
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++|+|.++++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 190 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD 190 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred CceEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECc
Confidence 678999999999999999987643 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 934 (1009)
||+++....... .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 191 fg~a~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-----~~~ 260 (373)
T 2qol_A 191 FGLGRVLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----DVI 260 (373)
T ss_dssp C---------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-----HHH
T ss_pred CccccccccCCc-----cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHH
Confidence 999987654321 0111223346788999999999999999999999999999998 99999754221 111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
... ..... ......++.++.+++.+||+.||++||++.||++.|+++.+..
T Consensus 261 ~~i---------~~~~~----------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 261 KAV---------DEGYR----------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHH---------HTTEE----------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHH---------HcCCC----------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 110 00000 0011133456889999999999999999999999999987754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=370.50 Aligned_cols=281 Identities=17% Similarity=0.232 Sum_probs=214.6
Q ss_pred HhccCccCCcccccCCceEEEEEEecC-----CeEEEEEEeeccccc-----------chHHHHHHHHHHHhcCCCCcce
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHEN-----GMLVAVKVINLEQKG-----------GSKSFAAECEALRSIRHRNLIK 762 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~ 762 (1009)
..++|.+.+.||+|+||+||+|.++.+ ++.||||++...... ....+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345899999999999999999998754 578999998643211 1123344555667778999999
Q ss_pred EEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCc
Q 047768 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSN 842 (1009)
Q Consensus 763 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~N 842 (1009)
+++++... ..+....++||||+ +++|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+|
T Consensus 113 ~~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N 182 (364)
T 3op5_A 113 YWGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEANAK-----RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN 182 (364)
T ss_dssp EEEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred EEeeeeec-cCCcceEEEEEeCC-CCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence 99998753 23345689999999 9999999987543 399999999999999999999999 99999999999
Q ss_pred eeeC--CCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCC
Q 047768 843 VLLD--HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPT 920 (1009)
Q Consensus 843 ill~--~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~ 920 (1009)
||++ .++.+||+|||+++.+......... .........||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf 261 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY-AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCS-SCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred EEEecCCCCeEEEEECCcceecccCCccccc-ccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 9999 8899999999999877543221111 111223456999999999999999999999999999999999999999
Q ss_pred cccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 921 ESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
...... ..............+.++++.++.. ..++.++.+++..||+.||++||++.++++.|+.+
T Consensus 262 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 262 EDNLKD-PKYVRDSKIRYRENIASLMDKCFPA-------------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp GGGTTC-HHHHHHHHHHHHHCHHHHHHHHSCT-------------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cccccC-HHHHHHHHHHhhhhHHHHHHHhccc-------------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 854332 1222222223333344444433321 12245688999999999999999999999999998
Q ss_pred HHhh
Q 047768 1001 RQNF 1004 (1009)
Q Consensus 1001 ~~~~ 1004 (1009)
.++.
T Consensus 328 ~~~~ 331 (364)
T 3op5_A 328 LKAI 331 (364)
T ss_dssp HHHT
T ss_pred HHHc
Confidence 8764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=352.88 Aligned_cols=283 Identities=30% Similarity=0.452 Sum_probs=224.1
Q ss_pred CCccCHHHHHHHhccCccC------CcccccCCceEEEEEEecCCeEEEEEEeeccc----ccchHHHHHHHHHHHhcCC
Q 047768 688 FPMVSYKELSKATNEFSSS------NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ----KGGSKSFAAECEALRSIRH 757 (1009)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h 757 (1009)
...+++.++..++++|... +.||+|+||.||+|.+ +++.||||++.... ....+.+.+|++++++++|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 4567889999999888876 8999999999999986 58899999986432 2234678999999999999
Q ss_pred CCcceEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecC
Q 047768 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGD 837 (1009)
Q Consensus 758 ~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrd 837 (1009)
|||+++++++.. ....++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+|||
T Consensus 90 ~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~d 158 (307)
T 2nru_A 90 ENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRD 158 (307)
T ss_dssp TTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHTGGG---CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCeEEEEEEEec-----CCceEEEEEecCCCcHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCC
Confidence 999999999754 3567999999999999999975432 12489999999999999999999999 999999
Q ss_pred CCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCC
Q 047768 838 LKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRR 917 (1009)
Q Consensus 838 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~ 917 (1009)
|||+||+++.++.+||+|||+++....... ........||+.|+|||++.+ .++.++||||||+++|||++|+
T Consensus 159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~ 231 (307)
T 2nru_A 159 IKSANILLDEAFTAKISDFGLARASEKFAQ------TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGL 231 (307)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCSCSS------CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCC
T ss_pred CCHHHEEEcCCCcEEEeecccccccccccc------cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCC
Confidence 999999999999999999999987654211 111223568999999998765 5899999999999999999999
Q ss_pred CCCcccccCCccHHHHHHH--hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 918 RPTESMFNEGLTLHEFAKR--ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 918 ~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.||........ ...+... .....+.+.++..+.. ....+...+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 232 PAVDEHREPQL-LLDIKEEIEDEEKTIEDYIDKKMND-----------ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp CSBCTTBSSSB-TTHHHHHHHTTSCCHHHHSCSSCSC-----------CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCcccCcchHH-HHHHHHHhhhhhhhhhhhccccccc-----------cchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99976443321 1112111 1122234444443322 23356778999999999999999999999999
Q ss_pred HHHHHHH
Q 047768 996 KLCHARQ 1002 (1009)
Q Consensus 996 ~L~~i~~ 1002 (1009)
.|+++.+
T Consensus 300 ~L~~l~~ 306 (307)
T 2nru_A 300 LLQEMTA 306 (307)
T ss_dssp HHHHHC-
T ss_pred HHHHHhc
Confidence 9998864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=360.56 Aligned_cols=263 Identities=26% Similarity=0.373 Sum_probs=200.6
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
...++|.+.+.||+|+||+||+|++ +++.||||++...... ..+.+.+|++++++++||||+++++++...
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----- 106 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP----- 106 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-----
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----
Confidence 3456899999999999999999987 5899999998654322 235788999999999999999999997543
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCceeeCCCCceEE
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPP--IVHGDLKPSNVLLDHDMVAHV 853 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrdlk~~Nill~~~~~~kl 853 (1009)
...++||||+++|+|.+++...... ..+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL 180 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAR---EQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKV 180 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHH---HHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEE
T ss_pred CceEEEEecCCCCcHHHHHhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEE
Confidence 5679999999999999999865421 2388999999999999999999998 7 999999999999999999999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 181 ~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-----~~ 247 (309)
T 3p86_A 181 CDFGLSRLKASTF--------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-----QV 247 (309)
T ss_dssp CCCC-------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-----HH
T ss_pred CCCCCCccccccc--------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HH
Confidence 9999998544321 1223457899999999999999999999999999999999999999743221 11
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
..... . ..... .. +..+..++.+++.+||+.||++|||++|+++.|+.+.+..
T Consensus 248 ~~~~~-----~-~~~~~-~~-----------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 248 VAAVG-----F-KCKRL-EI-----------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHHH-----H-SCCCC-CC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHHHH-----h-cCCCC-CC-----------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 11100 0 00000 00 0122345789999999999999999999999999887654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=364.93 Aligned_cols=293 Identities=25% Similarity=0.325 Sum_probs=210.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHH--HHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEA--LRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||+||+|++ +++.||||+++... ...+..|.++ +..++||||+++++++......+...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46899999999999999999976 68999999996433 3444445554 44589999999998776554555667
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcC------CCCceecCCCCCceeeCCCCce
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHC------QPPIVHGDLKPSNVLLDHDMVA 851 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivHrdlk~~Nill~~~~~~ 851 (1009)
.++||||+++|+|.+++.... .++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhhcc-------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 899999999999999997654 588999999999999999999863 3389999999999999999999
Q ss_pred EEeccccccccCCCCCCCccccCCccccccccccccCccccCC-------CCCCCcccchHHHHHHHHHHhCCCCCcccc
Q 047768 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-------GEASMRGGVYSYGILLLEIFTRRRPTESMF 924 (1009)
Q Consensus 852 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~elltg~~p~~~~~ 924 (1009)
||+|||+++.....................||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9999999987765432221112223334679999999999887 456789999999999999999987764322
Q ss_pred cCCc---cHHHHHHHh-ccchhhhccC-CCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 925 NEGL---TLHEFAKRA-LPEKVMEIVD-PSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 925 ~~~~---~~~~~~~~~-~~~~~~~~~d-~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
.... ......... ..+.....+. ....+... ........+..++.+++.+||+.||++|||++|+++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP----EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCC----TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCC----cccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 2110 000000000 0000111111 00000000 0011123456679999999999999999999999999999
Q ss_pred HHHhhhcCC
Q 047768 1000 ARQNFLGQR 1008 (1009)
Q Consensus 1000 i~~~~~~~~ 1008 (1009)
+...|..++
T Consensus 316 ll~~~~~~~ 324 (336)
T 3g2f_A 316 LMMIWERNK 324 (336)
T ss_dssp HHHCCCC--
T ss_pred HHHHHHhcc
Confidence 999987654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=360.20 Aligned_cols=270 Identities=20% Similarity=0.240 Sum_probs=212.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|.+.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|+++++++ +||||+++++++... ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG-----KYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEET-----TEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecC-----Ccc
Confidence 357999999999999999999998899999999986443 245688999999999 999999999987653 678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc-----eEE
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV-----AHV 853 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~-----~kl 853 (1009)
++||||+ +++|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++. +||
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl 151 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDR-----TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHI 151 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred EEEEEeC-CCCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEE
Confidence 9999999 9999999987533 399999999999999999999999 9999999999999999887 999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
+|||+++........... .........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.
T Consensus 152 ~DFg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~~~~~ 228 (330)
T 2izr_A 152 IDFALAKEYIDPETKKHI-PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--TLKER 228 (330)
T ss_dssp CCCTTCEESBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--SHHHH
T ss_pred EEcccceeeecCCCCccc-cccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc--cHHHH
Confidence 999999876543221111 111234567999999999999999999999999999999999999999764322 12211
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
........... ........++ ++.+++..|++.||.+||+++++.+.|+.+.+..
T Consensus 229 ~~~i~~~~~~~---------------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 229 YQKIGDTKRAT---------------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHHHHHS---------------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHhhhccC---------------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 11110000000 0000001123 6889999999999999999999999999887653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=354.95 Aligned_cols=263 Identities=22% Similarity=0.367 Sum_probs=206.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|++++++++||||+++++++.. ..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-----DD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-----SS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-----CC
Confidence 35799999999999999999999989999999998654332 23578899999999999999999999654 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df 155 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDF 155 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeC
Confidence 7899999999999999998765 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++....... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ......
T Consensus 156 g~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----~~~~~~ 223 (294)
T 4eqm_A 156 GIAKALSETSL-------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-----VSIAIK 223 (294)
T ss_dssp SSSTTC--------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-----HHHHHH
T ss_pred CCccccccccc-------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHH
Confidence 99987653221 122235689999999999999999999999999999999999999974321 111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHh
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-EMTDVVVKLCHARQN 1003 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-t~~evl~~L~~i~~~ 1003 (1009)
. +.......+. ......+..+.+++.+|++.||++|| +++++.+.|+.+..+
T Consensus 224 ~--------~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 224 H--------IQDSVPNVTT-------DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp H--------HSSCCCCHHH-------HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred H--------hhccCCCcch-------hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 1 1111111100 01112345688999999999999999 999999988876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=361.81 Aligned_cols=252 Identities=22% Similarity=0.281 Sum_probs=204.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc------chHHHHHHHHHHHhcCCCCcceEEeeeeccccC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG------GSKSFAAECEALRSIRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 773 (1009)
.++|.+.+.||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|++++++++||||+++++++..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---- 86 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN---- 86 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe----
Confidence 45799999999999999999999999999999999754322 24678999999999999999999999754
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC----
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM---- 849 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---- 849 (1009)
....++||||+++|+|.+++.... .+++.++..++.|++.||.|||+. +|+||||||+||+++.++
T Consensus 87 -~~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 87 -RTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp -SSEEEEEEECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCcc
Confidence 367899999999999999997654 389999999999999999999999 999999999999998877
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCcc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLT 929 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~ 929 (1009)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 157 ~vkl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---- 223 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGV---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---- 223 (361)
T ss_dssp CEEECCCSSCEECCTTC---------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----
T ss_pred CEEEEecCCceEcCCCC---------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 79999999998765421 22345799999999999999999999999999999999999999974321
Q ss_pred HHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 930 LHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.+.... +........+.. .......+.+++.+|+..||++|||+.|+++
T Consensus 224 -~~~~~~--------i~~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 224 -QETLAN--------ITAVSYDFDEEF--------FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -HHHHHH--------HHTTCCCCCHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHHH--------HHhcCCCCCchh--------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111 111111110000 0012245779999999999999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=350.61 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=209.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||+||+|.+. +++.||||++.... ...+.+.+|++++++++||||+++++++.. ....+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 81 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPIC 81 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCceE
Confidence 467899999999999999999986 68889999997443 235779999999999999999999999754 36689
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++..... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 82 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT 153 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred EEEEeCCCCcHHHHHHhcCc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccc
Confidence 99999999999999977554 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+...... ........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||..... .......
T Consensus 154 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-----~~~~~~~- 220 (269)
T 4hcu_A 154 RFVLDDQ-------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDI- 220 (269)
T ss_dssp GGBCCHH-------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHH-
T ss_pred ccccccc-------cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHH-
Confidence 8664321 112233557889999999999999999999999999999999 9999874321 1111111
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
........+ ......+.+++.+|++.||++|||++|+++.|+++.+.
T Consensus 221 -------~~~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 221 -------STGFRLYKP-----------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -------HTTCCCCCC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------hcCccCCCC-----------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 000000000 11234578999999999999999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=352.02 Aligned_cols=270 Identities=17% Similarity=0.199 Sum_probs=214.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|.+.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|+++++++ +|+|++++++++.. ....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC-----Ccee
Confidence 457999999999999999999998899999999985432 345688999999999 79999999998754 3678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc-----eEE
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV-----AHV 853 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~-----~kl 853 (1009)
++||||+ +++|.+++..... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++. +||
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred EEEEEec-CCCHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 9999999 9999999987643 389999999999999999999999 9999999999999987776 999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCc--cHH
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGL--TLH 931 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~--~~~ 931 (1009)
+|||+++............ ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIP-YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 231 (298)
T ss_dssp CCCTTCEESBCTTTCCBCC-CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred EECcccccccccccccccc-ccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHH
Confidence 9999998776543211111 1223456799999999999999999999999999999999999999976432211 011
Q ss_pred HHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 047768 932 EFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFL 1005 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~ 1005 (1009)
.......+....+. ...++.++.+++.+||+.||++||++++|++.|+++.++..
T Consensus 232 ~~~~~~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 232 RIGEKKQSTPLREL-------------------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHHHHHHHSCHHHH-------------------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHhhccCccHHHH-------------------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 11111100101000 01234568899999999999999999999999999987653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=357.82 Aligned_cols=249 Identities=23% Similarity=0.277 Sum_probs=204.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||+||+|+.+.+|+.||||+++.. .......+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-----CC
Confidence 46899999999999999999999999999999999754 23345678899999999999999999998754 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|.+++..... +++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF 149 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRERV------FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeec
Confidence 78999999999999999987543 89999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......
T Consensus 150 G~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~ 216 (337)
T 1o6l_A 150 GLCKEGISDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFEL 216 (337)
T ss_dssp TTCBCSCCTT--------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH
T ss_pred cchhhcccCC--------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC-----HHHHHHH
Confidence 9998543211 22334679999999999999999999999999999999999999996432 1111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~ 995 (1009)
..... .. .+ .....++.+++.+|++.||++|| +++|+++
T Consensus 217 i~~~~--------~~-~p-----------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 217 ILMEE--------IR-FP-----------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHCC--------CC-CC-----------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHcCC--------CC-CC-----------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11110 00 00 01224577999999999999999 8888865
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=363.35 Aligned_cols=260 Identities=25% Similarity=0.431 Sum_probs=202.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeE----EEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGML----VAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
.++|.+.+.||+|+||+||+|++..+++. ||+|.++... ....+.+.+|++++++++||||++++++|..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence 35799999999999999999998766654 5778775332 2345789999999999999999999999864
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
...++|+||+.+|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 89 -~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~ 159 (327)
T 3poz_A 89 -STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred -CCeEEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEc
Confidence 346899999999999999987654 389999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 933 (1009)
|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 160 Dfg~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~ 231 (327)
T 3poz_A 160 DFGLAKLLGAEEK------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSI 231 (327)
T ss_dssp CTTHHHHHTTTCC-------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH
T ss_pred cCcceeEccCCcc------cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHH
Confidence 9999987754321 122233557889999999999999999999999999999999 99999754322 11221
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
..... ... ....+...+.+++.+||+.||++||++.|+++.|+.+.++
T Consensus 232 ~~~~~-----------~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 232 LEKGE-----------RLP-----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHTTC-----------CCC-----------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHcCC-----------CCC-----------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11100 000 0112334678999999999999999999999999988653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.03 Aligned_cols=282 Identities=19% Similarity=0.234 Sum_probs=214.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|.+.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++... .....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceE
Confidence 357999999999999999999999889999999997543 23456788999999999999999999987643 33477
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee----CCCCceEEe
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVS 854 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~~~kl~ 854 (1009)
++||||+++|+|.+++...... ..+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred EEEEeCCCCCCHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEc
Confidence 9999999999999999875432 2389999999999999999999999 99999999999999 788899999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccC--------CCCCCCcccchHHHHHHHHHHhCCCCCcccccC
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL--------GGEASMRGGVYSYGILLLEIFTRRRPTESMFNE 926 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~ 926 (1009)
|||+++...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 159 Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 229 (319)
T 4euu_A 159 DFGAARELEDDE---------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (319)
T ss_dssp CCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred cCCCceecCCCC---------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 999998765431 222456899999999876 578899999999999999999999999754333
Q ss_pred CccHH---HHHHHhccchhhhccCCCCCCh-hhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 927 GLTLH---EFAKRALPEKVMEIVDPSLLPL-EEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 927 ~~~~~---~~~~~~~~~~~~~~~d~~l~~~-~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
..... .......+.....+....-... ..................+.+++.+|++.||++|||++|+++....
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp GGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred chhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 22222 1111111111111111100000 0000011112334666788999999999999999999999988764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=357.36 Aligned_cols=253 Identities=19% Similarity=0.280 Sum_probs=205.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||+||+|.++.+++.||+|+++... .....+.+|+++++.++||||+++++++... ...+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM-----EELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----CEEE
Confidence 368999999999999999999999999999999986432 2346788999999999999999999997643 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC--CCceEEeccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH--DMVAHVSDFG 857 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~--~~~~kl~DfG 857 (1009)
+||||+++|+|.+++..... .+++.+++.++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 78 lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg 149 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EEEEeCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence 99999999999999976543 389999999999999999999999 9999999999999987 7899999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......
T Consensus 150 ~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i 215 (321)
T 1tki_A 150 QARQLKPG---------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQIIENI 215 (321)
T ss_dssp TCEECCTT---------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHH
T ss_pred CCeECCCC---------CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHH
Confidence 99876542 122345689999999999998899999999999999999999999974321 1111111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
........... ......++.+++.+|++.||++|||+.|+++.
T Consensus 216 --------~~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 216 --------MNAEYTFDEEA--------FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --------HHTCCCCCHHH--------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --------HcCCCCCChhh--------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111100000 00123457899999999999999999999873
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=359.70 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=202.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|++.+.||+|+||+||+|+++.+++.||||+++.... ...+.+.+|+.+++.++||||+++++++.. ....
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CCeE
Confidence 3589999999999999999999998999999999965432 224668899999999999999999999764 3678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++|+|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~ 151 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 151 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeec
Confidence 99999999999999987654 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++....... ........||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+...
T Consensus 152 a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~- 224 (323)
T 3tki_A 152 ATVFRYNNR------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK- 224 (323)
T ss_dssp CEECEETTE------ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT-
T ss_pred cceeccCCc------ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc-
Confidence 986643211 112234679999999999988776 789999999999999999999997543332222222111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.....+ ......++.+++.+|++.||++|||+.|+++
T Consensus 225 -----------~~~~~~----------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 225 -----------KTYLNP----------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp -----------CTTSTT----------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----------cccCCc----------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000000 0112345679999999999999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=358.34 Aligned_cols=247 Identities=24% Similarity=0.369 Sum_probs=202.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||+||+|.+..+++.||||++.... ......+.+|+++++.++||||+++++++... .
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----T 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence 468999999999999999999999899999999996432 23346789999999999999999999997643 6
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+ +|+|.+++..... +++.+++.++.|++.|+.|||+. +|+||||||+||+++.++.+||+||
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~~------l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DF 152 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKKR------MTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADF 152 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCS
T ss_pred EEEEEEECC-CCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEe
Confidence 789999999 7899999977653 89999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++..... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||......
T Consensus 153 G~s~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--------- 214 (336)
T 3h4j_B 153 GLSNIMTDG---------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP--------- 214 (336)
T ss_dssp SCTBTTTTS---------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST---------
T ss_pred ccceeccCC---------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH---------
Confidence 999866442 12234579999999999988876 78999999999999999999999743211
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.....+.......+ .....++.+++.+|++.||.+|||++|+++
T Consensus 215 -----~~~~~i~~~~~~~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 215 -----NLFKKVNSCVYVMP-----------DFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp -----TCBCCCCSSCCCCC-----------TTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred -----HHHHHHHcCCCCCc-----------ccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11111111111111 112345779999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=368.20 Aligned_cols=267 Identities=22% Similarity=0.348 Sum_probs=208.4
Q ss_pred hccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 773 (1009)
.++|.+.+.||+|+||+||+|++. .+++.||||+++... ......+.+|+.++++++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---- 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 357889999999999999999953 467899999986432 2234578899999999999999999999754
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCC-CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC---
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQL-GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM--- 849 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~--- 849 (1009)
....++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 146 -SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred -CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCc
Confidence 356799999999999999998754321 123589999999999999999999999 999999999999999555
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGL 928 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~ 928 (1009)
.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 222 ~~kL~DFG~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--- 292 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGY------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--- 292 (367)
T ss_dssp CEEECCCHHHHHHHHHSS------CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred eEEECCCccccccccccc------cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 599999999986543211 112223567999999999999999999999999999999998 9999874321
Q ss_pred cHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 929 TLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
.+......... ... ....+...+.+++.+||+.||++|||+.||++.|+.+.+..
T Consensus 293 --~~~~~~i~~~~--------~~~-----------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 293 --QEVLEFVTSGG--------RMD-----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp --HHHHHHHHTTC--------CCC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred --HHHHHHHHcCC--------CCC-----------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 11111111000 000 01123345789999999999999999999999999887754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=354.94 Aligned_cols=251 Identities=21% Similarity=0.291 Sum_probs=203.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc------chHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG------GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
++|.+.+.||+|+||.||+|.++.+|+.||||+++..... ..+.+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----- 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence 5789999999999999999999989999999999754321 34679999999999999999999999754
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC----c
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM----V 850 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~----~ 850 (1009)
....++||||+++|+|.+++.... .+++.+++.++.|++.||.|||+. +|+||||||+||+++.++ .
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~ 156 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR 156 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCC
Confidence 367899999999999999997654 389999999999999999999999 999999999999999887 8
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccH
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL 930 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~ 930 (1009)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 157 ~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----- 222 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGN---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----- 222 (326)
T ss_dssp EEECCCTTCEECCTTS---------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----
T ss_pred EEEEECCCCeECCCCC---------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----
Confidence 9999999998765321 12235689999999999999999999999999999999999999964321
Q ss_pred HHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 931 HEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.+..... ........... .......+.+++.+|++.||++|||+.|+++
T Consensus 223 ~~~~~~~--------~~~~~~~~~~~--------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 223 QETLANV--------SAVNYEFEDEY--------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHH--------HHTCCCCCHHH--------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHH--------HhcCCCcCccc--------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111110 00000000000 0012345779999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=372.62 Aligned_cols=254 Identities=31% Similarity=0.414 Sum_probs=207.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+++|++++||||+++++++... ....+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~ 263 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY 263 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSCEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCceE
Confidence 467888999999999999999885 8899999996443 467899999999999999999999997542 24689
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++|+|.++++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 264 iv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 99999999999999987643 2378999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+..... .....+++.|+|||++.+..++.++|||||||++|||+| |+.||....... ........
T Consensus 337 ~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~- 402 (450)
T 1k9a_A 337 KEASST-----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKG- 402 (450)
T ss_dssp EECC-----------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTT-
T ss_pred cccccc-----------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC-
Confidence 854321 112356889999999999999999999999999999999 999997543321 11111110
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
.... .+..++.++.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 403 ----------~~~~-----------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 403 ----------YKMD-----------APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ----------CCCC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----------CCCC-----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 0000 1113445788999999999999999999999999998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=354.95 Aligned_cols=277 Identities=22% Similarity=0.288 Sum_probs=205.4
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-----cchHHHHHHHHHHHhcC---CCCcceEEeeeecc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-----GGSKSFAAECEALRSIR---HRNLIKIVTICSSI 770 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 770 (1009)
..++|++.+.||+|+||+||+|++..+++.||||+++.... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 35689999999999999999999988999999999964432 12357788888888775 99999999998765
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV 850 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 850 (1009)
........++||||+. |+|.+++...... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP----GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTT----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 3333446899999996 6999999876532 389999999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccH
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL 930 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~ 930 (1009)
+||+|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..
T Consensus 159 ~kl~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~ 228 (308)
T 3g33_A 159 VKLADFGLARIYSYQ---------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QL 228 (308)
T ss_dssp EEECSCSCTTTSTTC---------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HH
T ss_pred EEEeeCccccccCCC---------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 999999999865432 22234678999999999999999999999999999999999999997533221 11
Q ss_pred HHHHHHhccchhhhccCCCCCChhhhhhhcc-----ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 931 HEFAKRALPEKVMEIVDPSLLPLEEERTNSR-----RVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..............+. .... .+....... .....+...++.+++.+|++.||++|||+.|+++
T Consensus 229 ~~i~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 229 GKIFDLIGLPPEDDWP-RDVS-LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHCCCCTTTSC-SSCS-SCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhCCCChhhcc-chhh-ccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111111100000000 0000 000000000 0001123356789999999999999999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=349.07 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=208.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||+||+|.++ ++..||||+++... ...+.+.+|++++++++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 79 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-----EYPIY 79 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCceE
Confidence 468999999999999999999886 67889999996443 245779999999999999999999999754 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++..... .+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred EEEEccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccc
Confidence 99999999999999987643 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... ....+..+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...... ......
T Consensus 152 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~- 218 (268)
T 3sxs_A 152 RYVLDDQY-------VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----EVVLKV- 218 (268)
T ss_dssp EECCTTCE-------EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHH-
T ss_pred eecchhhh-------hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----HHHHHH-
Confidence 87654321 12234556788999999999899999999999999999999 99998643221 111110
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
........+ ......+.+++.+|++.||++|||+.|+++.|+.++++
T Consensus 219 -------~~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 219 -------SQGHRLYRP-----------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -------HTTCCCCCC-----------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -------HcCCCCCCC-----------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 000000000 01223578999999999999999999999999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=381.50 Aligned_cols=259 Identities=25% Similarity=0.435 Sum_probs=211.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||.||+|.++.++..||||+++... ...+.+.+|+++|++++||||++++++|... ...+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 292 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFY 292 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecC-----CcEE
Confidence 457888999999999999999999889999999996543 3467899999999999999999999997643 5679
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++|+|.++++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 293 lv~E~~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred EEEEccCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccc
Confidence 99999999999999986442 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... ....+..+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ...+....
T Consensus 366 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~-- 434 (495)
T 1opk_A 366 RLMTGDTY-------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEK-- 434 (495)
T ss_dssp ECCTTCCE-------ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHT--
T ss_pred eeccCCce-------eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc--
Confidence 87653211 11223456889999999999999999999999999999999 99999754322 11111111
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQ 1002 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~ 1002 (1009)
.... ..+..++.++.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 435 ----------~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 435 ----------DYRM----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ----------TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ----------CCCC----------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1000 0111344568899999999999999999999999987643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=372.58 Aligned_cols=262 Identities=20% Similarity=0.228 Sum_probs=205.3
Q ss_pred HHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeecc
Q 047768 694 KELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSI 770 (1009)
Q Consensus 694 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 770 (1009)
.++....++|.+.++||+|+||+||+|+++.+++.||||+++... ......+.+|+.++..++||||+++++++..
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~- 145 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD- 145 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 344455689999999999999999999999899999999996432 2233458899999999999999999998764
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV 850 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 850 (1009)
....++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +||||||||+|||++.++.
T Consensus 146 ----~~~~~lV~Ey~~gg~L~~~l~~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~ 213 (437)
T 4aw2_A 146 ----DNNLYLVMDYYVGGDLLTLLSKFED-----RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGH 213 (437)
T ss_dssp ----SSEEEEEECCCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred ----CCEEEEEEecCCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCC
Confidence 3778999999999999999987433 389999999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccC-----CCCCCCcccchHHHHHHHHHHhCCCCCccccc
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-----GGEASMRGGVYSYGILLLEIFTRRRPTESMFN 925 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~ 925 (1009)
+||+|||+|+....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 214 vkL~DFGla~~~~~~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~- 285 (437)
T 4aw2_A 214 IRLADFGSCLKLMEDGT-------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES- 285 (437)
T ss_dssp EEECCCTTCEECCTTSC-------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS-
T ss_pred EEEcchhhhhhcccCCC-------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC-
Confidence 99999999986643211 1223467999999999987 5678999999999999999999999997432
Q ss_pred CCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 047768 926 EGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFD--RMEMTDVVV 995 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--Rpt~~evl~ 995 (1009)
..+...........-.+.... .....++.+++.+|++.+|++ ||+++|+++
T Consensus 286 ----~~~~~~~i~~~~~~~~~p~~~---------------~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 286 ----LVETYGKIMNHKERFQFPTQV---------------TDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ----HHHHHHHHHTHHHHCCCCSSC---------------CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ----hhHHHHhhhhccccccCCccc---------------ccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 111111111100000000000 012234678999999888888 999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=366.46 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=202.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||+||+|.++.+|+.||+|++..... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-----EGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-----SSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-----CCE
Confidence 4689999999999999999999999999999999965432 234578899999999999999999998754 378
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC---CCCceEEe
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHVS 854 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~---~~~~~kl~ 854 (1009)
.++||||+++|+|.+++..... +++.++..++.|++.||.|||++ +|+||||||+||+++ .++.+||+
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~------~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREY------YSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSC------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred EEEEEEeCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEc
Confidence 8999999999999999987653 89999999999999999999999 999999999999998 56889999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....
T Consensus 156 DFG~a~~~~~~~--------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----~~~~ 222 (444)
T 3soa_A 156 DFGLAIEVEGEQ--------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----HRLY 222 (444)
T ss_dssp CCSSCBCCCTTC--------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHH
T ss_pred cCceeEEecCCC--------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----HHHH
Confidence 999998665321 222346799999999999999999999999999999999999999964321 1111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... ....+...+.+ .....++.+++.+|++.||++|||+.|+++
T Consensus 223 ~~i~-~~~~~~~~~~~---------------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 223 QQIK-AGAYDFPSPEW---------------DTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHH-HTCCCCCTTTT---------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHH-hCCCCCCcccc---------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1110 00001111111 012345779999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=349.45 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=202.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccc-------hHHHHHHHHHHHhcCCCCcceEEeeeecccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG-------SKSFAAECEALRSIRHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 772 (1009)
.++|.+.+.||+|+||+||+|++..+++.||||++....... .+.+.+|++++++++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 468999999999999999999999899999999986443222 16789999999999999999999987532
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCceeeCCCCc
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPP--IVHGDLKPSNVLLDHDMV 850 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrdlk~~Nill~~~~~ 850 (1009)
.++||||+++|+|.+++..... .+++..++.++.|++.|++|||++ + |+||||||+||+++.++.
T Consensus 96 -----~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~ 162 (287)
T 4f0f_A 96 -----PRMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDE 162 (287)
T ss_dssp -----TEEEEECCTTCBHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCT
T ss_pred -----CeEEEEecCCCCHHHHHhcccC-----CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCC
Confidence 2699999999999999876554 389999999999999999999998 7 999999999999988776
Q ss_pred -----eEEeccccccccCCCCCCCccccCCccccccccccccCcccc--CCCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 047768 851 -----AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYG--LGGEASMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 851 -----~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
+||+|||+++.... ......||+.|+|||++ ....++.++||||+||++|||++|+.||...
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 231 (287)
T 4f0f_A 163 NAPVCAKVADFGLSQQSVH-----------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231 (287)
T ss_dssp TCSCCEEECCCTTCBCCSS-----------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCceeEEeCCCCccccccc-----------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999974432 22345789999999998 4556789999999999999999999999754
Q ss_pred ccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 924 FNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
............. ... .+. ....+..++.+++.+||+.||++|||+.|+++.|++
T Consensus 232 ~~~~~~~~~~~~~---~~~----~~~--------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 232 SYGKIKFINMIRE---EGL----RPT--------------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCCHHHHHHHHHH---SCC----CCC--------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cccHHHHHHHHhc---cCC----CCC--------------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 3332111111110 000 000 011233468899999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=351.01 Aligned_cols=260 Identities=28% Similarity=0.428 Sum_probs=201.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||+||+|++. ++.||||+++.. ...+.+.+|++++++++||||+++++++. +..+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~ 75 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVC 75 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcE
Confidence 357889999999999999999884 889999998532 33578999999999999999999999864 2368
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc-eEEecccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV-AHVSDFGL 858 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~-~kl~DfGl 858 (1009)
+||||+++|+|.+++..... ...+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+
T Consensus 76 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred EEEEcCCCCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 99999999999999986543 124789999999999999999999932229999999999999998886 79999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.................
T Consensus 153 ~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~- 220 (307)
T 2eva_A 153 ACDIQTH-----------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG- 220 (307)
T ss_dssp -----------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT-
T ss_pred ccccccc-----------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC-
Confidence 9755321 1224589999999999999999999999999999999999999975432211111111000
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLG 1006 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~ 1006 (1009)
.... ....++..+.+++.+|++.||++|||++|+++.|+.+.+.+..
T Consensus 221 ----------~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 221 ----------TRPP-----------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp ----------CCCC-----------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ----------CCCC-----------cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 0000 0012234578999999999999999999999999999887754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=364.28 Aligned_cols=278 Identities=21% Similarity=0.311 Sum_probs=216.0
Q ss_pred cCHHHHHHHhccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceE
Q 047768 691 VSYKELSKATNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKI 763 (1009)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l 763 (1009)
+...++....++|.+.+.||+|+||.||+|++. .+++.||||+++.... ...+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 344555666789999999999999999999953 4568999999965432 2245789999999999 79999999
Q ss_pred EeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCC------------------------------------------
Q 047768 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQL------------------------------------------ 801 (1009)
Q Consensus 764 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------ 801 (1009)
++++... ....++||||+++|+|.++++......
T Consensus 92 ~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 92 LGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp EEEECST----TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeecC----CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 9997542 345789999999999999998754310
Q ss_pred ------------------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccC
Q 047768 802 ------------------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863 (1009)
Q Consensus 802 ------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~ 863 (1009)
....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 011288999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccchh
Q 047768 864 ASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPEKV 942 (1009)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
.... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||........ ...........
T Consensus 245 ~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~-- 315 (359)
T 3vhe_A 245 KDPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTRM-- 315 (359)
T ss_dssp SCTT------CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHHHHHTCCC--
T ss_pred cccc------chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HHHHHHcCCCC--
Confidence 4321 112234568999999999999999999999999999999999 9999975432211 11111110000
Q ss_pred hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 943 ~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
.. ...+..++.+++.+|++.||++|||++|+++.|+++.+..
T Consensus 316 ---------~~-----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 316 ---------RA-----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp ---------CC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------CC-----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 00 0112345789999999999999999999999999988753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=347.54 Aligned_cols=271 Identities=21% Similarity=0.275 Sum_probs=211.0
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
..++|.+.+.||+|+||+||+|++..+++.||||++..... ...+.+|+++++.++|++++..++++.. .....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecC----CCCce
Confidence 34689999999999999999999988999999998754432 3468899999999999888888877643 24678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee---CCCCceEEec
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSD 855 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~D 855 (1009)
++||||+ +++|.+++..... .+++.+++.++.|++.||.|||++ +|+||||||+||++ +.++.+||+|
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred EEEEEcc-CCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEec
Confidence 9999999 9999999986543 389999999999999999999999 99999999999999 7899999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCC--ccHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEG--LTLHEF 933 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~--~~~~~~ 933 (1009)
||+++............ ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......
T Consensus 152 fg~a~~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 4hgt_A 152 FGLAKKYRDARTHQHIP-YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp CTTCEECBCTTTCCBCC-CCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred CccceeccCcccCccCC-CCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence 99998776543211111 122334679999999999999999999999999999999999999998644321 112222
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
.....+...... ...++.++.+++.+|++.||++|||++|+++.|+++.++.
T Consensus 231 ~~~~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 231 SEKKMSTPIEVL-------------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHHHSCHHHH-------------------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hcccccchhhhh-------------------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 111111111000 0112356889999999999999999999999999988764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=349.23 Aligned_cols=259 Identities=24% Similarity=0.396 Sum_probs=206.8
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
..++|.+.+.||+|+||+||+|.+. ++..||||+++... ...+.+.+|++++++++||||+++++++.. ....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 94 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPI 94 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEec-----CCCe
Confidence 4568999999999999999999886 68889999997443 235779999999999999999999999754 3678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++++|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred EEEEeccCCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccc
Confidence 999999999999999987543 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++...... ........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...... ......
T Consensus 167 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~~ 234 (283)
T 3gen_A 167 SRYVLDDE-------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEHI 234 (283)
T ss_dssp GGGBCCHH-------HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHH
T ss_pred cccccccc-------cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----HHHHHH
Confidence 98664321 112223457889999999999999999999999999999999 99999753221 111110
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
........+ ......+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 235 --------~~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 235 --------AQGLRLYRP-----------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --------HTTCCCCCC-----------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------hcccCCCCC-----------CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 000000000 01124578999999999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=361.91 Aligned_cols=249 Identities=21% Similarity=0.280 Sum_probs=199.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|.+.+.||+|+||+||+|+++.+++.||||+++.... ...+.+.+|..+++++ +||||+++++++.. .
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-----S
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-----C
Confidence 4689999999999999999999999999999999975432 2345688999999887 89999999998654 3
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++|+|.+++..... +++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D 196 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRK------LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEee
Confidence 788999999999999999987653 89999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCC----ccHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEG----LTLH 931 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~----~~~~ 931 (1009)
||+|+..... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....
T Consensus 197 FGla~~~~~~--------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~ 268 (396)
T 4dc2_A 197 YGMCKEGLRP--------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 268 (396)
T ss_dssp CTTCBCCCCT--------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHH
T ss_pred cceeeecccC--------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHH
Confidence 9999853321 122345689999999999999999999999999999999999999996432211 0111
Q ss_pred HHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 047768 932 EFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~ 990 (1009)
...... ..... ..+ .....++.+++.+|++.||++||++
T Consensus 269 ~~~~~i--------~~~~~-~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 269 YLFQVI--------LEKQI-RIP-----------RSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHH--------HHCCC-CCC-----------TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHH--------hcccc-CCC-----------CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 111110 00000 000 0122357799999999999999996
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=356.62 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=202.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|+++.+++.||||+++... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-----EE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence 367999999999999999999999999999999996432 3345678899999999999999999998754 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+.+|+|.+++.... .+++..++.++.|++.||.|||+. +||||||||+||+++.++.+||+||
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF 159 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNV------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDF 159 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEecc
Confidence 7899999999999999998754 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCC---CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG---GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
|+++..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....
T Consensus 160 G~a~~~~~~---------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~ 228 (384)
T 4fr4_A 160 NIAAMLPRE---------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEI 228 (384)
T ss_dssp TTCEECCTT---------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHHH
T ss_pred ceeeeccCC---------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHHH
Confidence 999876432 22334679999999999864 45899999999999999999999999743222 12222
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC-HHHHH
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME-MTDVV 994 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt-~~evl 994 (1009)
...... .....+ ..+...+.+++.+|++.||++||+ ++++.
T Consensus 229 ~~~~~~---------~~~~~p-----------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 229 VHTFET---------TVVTYP-----------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp HHHHHH---------CCCCCC-----------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred HHHHhh---------cccCCC-----------CcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 111100 000000 122345789999999999999998 66554
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=361.47 Aligned_cols=270 Identities=26% Similarity=0.401 Sum_probs=210.8
Q ss_pred HhccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeecccc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 772 (1009)
..++|.+.+.||+|+||.||+|++. .+++.||||+++.... ...+.+.+|++++++++||||+++++++..
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV--- 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc---
Confidence 4578999999999999999999997 3458999999975432 224678999999999999999999999754
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCC------------------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCce
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQL------------------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIV 834 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 834 (1009)
....++||||+++|+|.+++....... ....+++.+++.++.|++.||.|||++ +|+
T Consensus 122 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 122 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred --CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 367899999999999999998753210 013589999999999999999999999 999
Q ss_pred ecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHH
Q 047768 835 HGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIF 914 (1009)
Q Consensus 835 Hrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ell 914 (1009)
||||||+||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||+
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 270 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADY------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCcc------ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHH
Confidence 999999999999999999999999987643211 11222356789999999999999999999999999999999
Q ss_pred h-CCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 047768 915 T-RRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDV 993 (1009)
Q Consensus 915 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~ev 993 (1009)
+ |+.||..... .+..... .+......+ ..++.++.+++.+||+.||++||++.|+
T Consensus 271 t~g~~p~~~~~~-----~~~~~~~--------~~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~~ 326 (343)
T 1luf_A 271 SYGLQPYYGMAH-----EEVIYYV--------RDGNILACP-----------ENCPLELYNLMRLCWSKLPADRPSFCSI 326 (343)
T ss_dssp TTTCCTTTTSCH-----HHHHHHH--------HTTCCCCCC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCcCCCCCh-----HHHHHHH--------hCCCcCCCC-----------CCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 9 9999974321 1211111 111111111 1233468899999999999999999999
Q ss_pred HHHHHHHHHhhhc
Q 047768 994 VVKLCHARQNFLG 1006 (1009)
Q Consensus 994 l~~L~~i~~~~~~ 1006 (1009)
++.|+++.+.+..
T Consensus 327 ~~~L~~~~~~~~~ 339 (343)
T 1luf_A 327 HRILQRMCERAEG 339 (343)
T ss_dssp HHHHHHTTC----
T ss_pred HHHHHHHHhhhhh
Confidence 9999998887654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=349.97 Aligned_cols=272 Identities=19% Similarity=0.277 Sum_probs=202.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|++.+.||+|+||+||+|+++.+++.||||+++..... ..+.+.+|++++++++||||+++++++... ...
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEE
Confidence 5789999999999999999999999999999999755432 236788999999999999999999997643 678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++ ++.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCC-CHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 999999975 67776665433 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCC-CCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE-ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++...... .......||+.|+|||++.+.. ++.++||||+||++|||++|+.||.................
T Consensus 148 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~ 219 (292)
T 3o0g_A 148 ARAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp CEECCSCC--------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred ceecCCcc--------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 98764321 2223456899999999988766 79999999999999999999888653322222222222211
Q ss_pred ccch------hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEK------VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~------~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... .....+..-...... .............++.+++.+|++.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 220 GTPTEEQWPSMTKLPDYKPYPMYPA-TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCTTTCTTGGGSTTCCCCCCCCT-TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCChhhhhhhcccccccccccccC-CcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1100 000000000000000 00000011123346789999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=346.82 Aligned_cols=271 Identities=20% Similarity=0.265 Sum_probs=214.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|++++++++|++++..+.++.. .....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccC----CCCceE
Confidence 468999999999999999999998899999999986543 34578999999999999888887777643 236789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee---CCCCceEEecc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDF 856 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Df 856 (1009)
+||||+ +++|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+||
T Consensus 82 lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred EEEEec-CCCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 999999 9999999985443 389999999999999999999999 99999999999999 48899999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCC--ccHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEG--LTLHEFA 934 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~--~~~~~~~ 934 (1009)
|+++........... .........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......
T Consensus 153 g~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 3uzp_A 153 GLAKKYRDARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp TTCEECBCTTTCCBC-CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred CCccccccccccccc-ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence 999877654321111 1112345679999999999999999999999999999999999999998643221 1222222
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFL 1005 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~ 1005 (1009)
........... ...++.++.+++.+||+.||++|||++|+++.|+++.++..
T Consensus 232 ~~~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 232 EKKMSTPIEVL-------------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHHHSCHHHH-------------------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccccCCchHHH-------------------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 11111111000 01223568899999999999999999999999999887643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=353.01 Aligned_cols=277 Identities=24% Similarity=0.346 Sum_probs=209.1
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc--CCCCcceEEeeeeccccCCC
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI--RHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~~~~ 775 (1009)
...++|.+.+.||+|+||.||+|++. ++.||||++.... ...+.+|.+++... +||||+++++++... ....
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~-~~~~ 107 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG-TGSW 107 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES-CGGG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC-CCCC
Confidence 34578999999999999999999885 8999999985432 34555666666655 899999999997653 2223
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCceecCCCCCceeeCCCCc
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHC-----QPPIVHGDLKPSNVLLDHDMV 850 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivHrdlk~~Nill~~~~~ 850 (1009)
...++||||+++|+|.++++... +++.+++.++.|++.||+|||+++ .++|+||||||+||+++.++.
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CceEEEEeccCCCcHHHHhhccC-------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 57899999999999999997643 899999999999999999999752 348999999999999999999
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCc------ccchHHHHHHHHHHhC--------
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMR------GGVYSYGILLLEIFTR-------- 916 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwS~Gvvl~elltg-------- 916 (1009)
+||+|||+++......... ........||+.|+|||++.+...+.+ +|||||||++|||+||
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEV----DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp EEECCCTTCEECC-------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred EEEEeCCCceeeccccccc----cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 9999999998765432111 111224579999999999988777665 9999999999999999
Q ss_pred --CCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 047768 917 --RRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVV 994 (1009)
Q Consensus 917 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl 994 (1009)
+.||..................... ..+... ......++..++.+++.+||+.||++|||+.|++
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYEDMREIVCIKK--------LRPSFP-----NRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323 (337)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSC--------CCCCCC-----GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cccccHhhhcCCCCchhhhHHHHhhhc--------cCcccc-----ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence 5666544433333333322111111 111000 1122336778899999999999999999999999
Q ss_pred HHHHHHHHhh
Q 047768 995 VKLCHARQNF 1004 (1009)
Q Consensus 995 ~~L~~i~~~~ 1004 (1009)
+.|+++.+.-
T Consensus 324 ~~L~~l~~~~ 333 (337)
T 3mdy_A 324 KTLAKMSESQ 333 (337)
T ss_dssp HHHHHHHHTT
T ss_pred HHHHHHHhhc
Confidence 9999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=351.08 Aligned_cols=278 Identities=21% Similarity=0.300 Sum_probs=192.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|.+.+.||+|+||+||+|.++.+|+.||||+++.... ...+.+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-----ENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-----TTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-----CCeE
Confidence 4689999999999999999999998999999999975433 234678899999999999999999999654 3678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||++ |+|.+++...........+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGL 154 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcc
Confidence 99999997 69999997654322233589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .........
T Consensus 155 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~ 225 (317)
T 2pmi_A 155 ARAFGIPV--------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIM 225 (317)
T ss_dssp CEETTSCC--------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred ceecCCCc--------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHh
Confidence 98764321 11223568999999999876 468999999999999999999999997543211 111111111
Q ss_pred c--cchhhhccCC------CCCChhh--hhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 L--PEKVMEIVDP------SLLPLEE--ERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~--~~~~~~~~d~------~l~~~~~--~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. ++.....+.. .....+. .+.............++.+++.+|++.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0110000000 0000000 0000000011122346889999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=353.19 Aligned_cols=262 Identities=26% Similarity=0.418 Sum_probs=195.9
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
..++|++.+.||+|+||+||+|++. ..||||+++..... ..+.+.+|++++++++||||+++++++.. .
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~ 92 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------P 92 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------C
Confidence 3568999999999999999999864 35999999654332 24678999999999999999999997543 4
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++++|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df 164 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDF 164 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCC
T ss_pred ccEEEEEecCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccc
Confidence 57899999999999999976543 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccC---CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL---GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
|+++....... ........||+.|+|||++. +..++.++||||||+++|||++|+.||.............
T Consensus 165 g~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 238 (289)
T 3og7_A 165 GLATEKSRWSG------SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238 (289)
T ss_dssp C------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH
T ss_pred eeccccccccc------cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence 99986543211 11223456899999999986 5678889999999999999999999997543221111111
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQ 1002 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~ 1002 (1009)
........... ....++.++.+++.+|++.||++|||+.|+++.|+++.+
T Consensus 239 ~~~~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 239 GRGSLSPDLSK-------------------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHTSCCCCTTS-------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cccccCcchhh-------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11111111000 011234568899999999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=359.35 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=203.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||.||+|.++.+++.||||+++..... ..+.+.+|++++++++||||+++++++.. ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence 46899999999999999999999989999999999754322 23578899999999999999999998754 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC---CceEEe
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHVS 854 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~ 854 (1009)
.++||||+++|+|.+++.... .+++.++..++.|++.||.|||++ +|+||||||+||+++.+ +.+||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~ 173 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA 173 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEe
Confidence 899999999999999998654 389999999999999999999999 99999999999999865 459999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....
T Consensus 174 DfG~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----~~~~ 239 (362)
T 2bdw_A 174 DFGLAIEVNDS---------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLY 239 (362)
T ss_dssp CCTTCBCCTTC---------CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH
T ss_pred ecCcceEecCC---------cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHH
Confidence 99999876532 122346799999999999999999999999999999999999999974321 1111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
...... ... .+.. .......++.+++.+|++.||++|||+.|+++.
T Consensus 240 ~~i~~~--------~~~-~~~~-------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 240 AQIKAG--------AYD-YPSP-------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHT--------CCC-CCTT-------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHhC--------CCC-CCcc-------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111000 000 0000 001223457899999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=360.72 Aligned_cols=270 Identities=24% Similarity=0.332 Sum_probs=213.4
Q ss_pred hccCccCCcccccCCceEEEEEEec-------CCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeecc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHE-------NGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSSI 770 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 770 (1009)
.++|.+.+.||+|+||+||+|++.. .+..||||+++.... ...+.+.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4689999999999999999999753 336899999965432 2236788999999999 999999999997643
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCC----------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCC
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQL----------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKP 840 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~ 840 (1009)
...++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||+. +|+||||||
T Consensus 148 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 219 (382)
T 3tt0_A 148 -----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 219 (382)
T ss_dssp -----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred -----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence 56799999999999999998764211 113489999999999999999999999 999999999
Q ss_pred CceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCC
Q 047768 841 SNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRP 919 (1009)
Q Consensus 841 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p 919 (1009)
+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p 293 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYY------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTT------CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ceEEEcCCCcEEEcccCccccccccccc------ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999876543211 12233567899999999999999999999999999999999 9999
Q ss_pred CcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 920 TESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
|.... ..+......... .... ...+..++.+++.+||+.||++|||+.|+++.|++
T Consensus 294 ~~~~~-----~~~~~~~~~~~~--------~~~~-----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 349 (382)
T 3tt0_A 294 YPGVP-----VEELFKLLKEGH--------RMDK-----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349 (382)
T ss_dssp STTCC-----HHHHHHHHHTTC--------CCCC-----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCC-----HHHHHHHHHcCC--------CCCC-----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 87432 112211110000 0000 01233468899999999999999999999999999
Q ss_pred HHHhhhcC
Q 047768 1000 ARQNFLGQ 1007 (1009)
Q Consensus 1000 i~~~~~~~ 1007 (1009)
+......+
T Consensus 350 ~~~~~~~~ 357 (382)
T 3tt0_A 350 IVALTSNQ 357 (382)
T ss_dssp HHHHSCSC
T ss_pred HHHHHhcC
Confidence 98765544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=349.33 Aligned_cols=261 Identities=21% Similarity=0.341 Sum_probs=198.9
Q ss_pred hccCccCCcccccCCceEEEEEEec---CCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHE---NGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|.+.+.||+|+||.||+|.+.. .+..||||+++.... ...+.+.+|+.++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 87 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc------
Confidence 4688999999999999999999864 356799999864322 234678899999999999999999998642
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++|+|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 159 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 159 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CccEEEEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECc
Confidence 457899999999999999987643 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 934 (1009)
||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... .....
T Consensus 160 fg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i 230 (281)
T 1mp8_A 160 FGLSRYMEDSTY-------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRI 230 (281)
T ss_dssp --------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH
T ss_pred cccccccCcccc-------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHH
Confidence 999987654321 11223456789999999998999999999999999999997 999997543221 11111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFL 1005 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~ 1005 (1009)
. ....... ...++..+.+++.+|++.||++|||+.|+++.|+++.++..
T Consensus 231 ~-----------~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 231 E-----------NGERLPM-----------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp H-----------TTCCCCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred H-----------cCCCCCC-----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1 1000000 11234567899999999999999999999999999987654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=359.22 Aligned_cols=255 Identities=20% Similarity=0.272 Sum_probs=202.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-----ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-----KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
++|.+.+.||+|+||+||+|.++.+++.||||+++... ....+.+.+|++++++++||||+++++++...
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 98 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD----- 98 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----
Confidence 57999999999999999999999999999999996432 12357799999999999999999999987653
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc---eE
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV---AH 852 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---~k 852 (1009)
...++||||+++|+|.+++...... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +|
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vk 173 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVK 173 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEE
T ss_pred CEEEEEEeCCCCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEE
Confidence 6789999999999999888654321 12489999999999999999999999 9999999999999987654 99
Q ss_pred EeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHH
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHE 932 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~ 932 (1009)
|+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..
T Consensus 174 l~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~ 239 (351)
T 3c0i_A 174 LGGFGVAIQLGESG--------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------ER 239 (351)
T ss_dssp ECCCTTCEECCTTS--------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH------HH
T ss_pred EecCcceeEecCCC--------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH------HH
Confidence 99999998765421 12234579999999999999999999999999999999999999997421 11
Q ss_pred HHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... +........+.. ......++.+++.+|++.||++|||+.|+++
T Consensus 240 ~~~~--------i~~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 240 LFEG--------IIKGKYKMNPRQ--------WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHH--------HHHTCCCCCHHH--------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHH--------HHcCCCCCCccc--------cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111 111111111100 0012346789999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=356.32 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=188.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||.||+|+++.+++.||||+++... ..+.+.+|++++++++||||+++++++.. ....+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~ 124 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PTEIS 124 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec-----CCeEE
Confidence 467999999999999999999999889999999996443 34678899999999999999999999764 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC---CCceEEecc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVSDF 856 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Df 856 (1009)
+||||+++|+|.+++.... .+++.+++.++.|++.||.|||+. +|+||||||+||+++. ++.+||+||
T Consensus 125 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKG------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp EEECCCCSCBHHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccC
Confidence 9999999999999998754 389999999999999999999999 9999999999999975 889999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............
T Consensus 196 g~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~-- 264 (349)
T 2w4o_A 196 GLSKIVEHQ---------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL-- 264 (349)
T ss_dssp C-------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH--
T ss_pred ccccccCcc---------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH--
Confidence 999865432 112245689999999999999999999999999999999999999964322211111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... .....+.. .....++.+++.+|++.||++|||+.|+++
T Consensus 265 --~~~-~~~~~~~~---------------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 265 --NCE-YYFISPWW---------------DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp --TTC-CCCCTTTT---------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --hCC-CccCCchh---------------hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00000000 122345789999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=356.77 Aligned_cols=272 Identities=22% Similarity=0.369 Sum_probs=196.5
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCe---EEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGM---LVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 773 (1009)
..++|.+.+.||+|+||+||+|++..++. .||||+++... ....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45689999999999999999999876654 89999996542 23356799999999999999999999997653211
Q ss_pred -CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceE
Q 047768 774 -GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 852 (1009)
Q Consensus 774 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 852 (1009)
.....++||||+++|+|.+++...........+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 1123489999999999999997654332233589999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHH
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLH 931 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~ 931 (1009)
|+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 178 l~Dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~ 249 (323)
T 3qup_A 178 VADFGLSRKIYSGDYY------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIY 249 (323)
T ss_dssp ECCCCC-----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHH
T ss_pred Eeeccccccccccccc------cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHH
Confidence 9999999876543211 12223457889999999999999999999999999999999 89998754322 111
Q ss_pred HHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 932 EFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
... ........ ...+..++.+++.+|++.||++|||+.|+++.|+++.+.
T Consensus 250 ~~~-----------~~~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 250 NYL-----------IGGNRLKQ-----------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HHH-----------HTTCCCCC-----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHH-----------hcCCCCCC-----------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111 11000000 112334688999999999999999999999999988754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.70 Aligned_cols=260 Identities=24% Similarity=0.362 Sum_probs=204.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeE----EEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGML----VAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
.++|.+.+.||+|+||+||+|++..+++. ||+|++.... ......+.+|+.++++++||||+++++++..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 86 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG----- 86 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-----
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----
Confidence 35788999999999999999999877765 7777774332 2234567889999999999999999998743
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
...++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 87 -~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~ 157 (325)
T 3kex_A 87 -SSLQLVTQYLPLGSLLDHVRQHRG-----ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVA 157 (325)
T ss_dssp -SSEEEEEECCTTCBSHHHHHSSGG-----GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEEC
T ss_pred -CccEEEEEeCCCCCHHHHHHHccc-----cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEEC
Confidence 457899999999999999987543 388899999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 933 (1009)
|||+++........ .......||..|+|||++.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 158 Dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~ 229 (325)
T 3kex_A 158 DFGVADLLPPDDKQ------LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDL 229 (325)
T ss_dssp SCSGGGGSCCCTTC------CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHH
T ss_pred CCCcccccCccccc------ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHH
Confidence 99999977543211 12234567889999999999999999999999999999999 99999754322 11111
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
....... ..+ ..+..++.+++.+||+.||.+|||+.|+++.|+.+.+.
T Consensus 230 ~~~~~~~-----------~~~-----------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 230 LEKGERL-----------AQP-----------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HHTTCBC-----------CCC-----------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHcCCCC-----------CCC-----------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1110000 000 01122467899999999999999999999999987653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=360.29 Aligned_cols=245 Identities=23% Similarity=0.291 Sum_probs=195.8
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 774 (1009)
..++|.+.+.||+|+||+||+|+++.+++.||||+++.. .....+.+.+|+++++.+ +||||+++++++..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----- 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT----- 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-----
Confidence 457899999999999999999999999999999999754 223456788999999988 79999999998654
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
....++||||+++|+|.+++..... +++.+++.++.|++.||+|||++ +||||||||+|||++.++.+||+
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~ 166 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKSRR------FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLA 166 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEc
Confidence 3678999999999999999987653 89999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+|+...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....
T Consensus 167 DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~ 233 (353)
T 3txo_A 167 DFGMCKEGICNG--------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----DDLF 233 (353)
T ss_dssp CCTTCBCSCC-----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH
T ss_pred cccceeecccCC--------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----HHHH
Confidence 999998543221 223346799999999999999999999999999999999999999974321 1111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~ 990 (1009)
...... ... .+ ......+.+++.+|++.||++||++
T Consensus 234 ~~i~~~--------~~~-~p-----------~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 234 EAILND--------EVV-YP-----------TWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp HHHHHC--------CCC-CC-----------TTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred HHHHcC--------CCC-CC-----------CCCCHHHHHHHHHHhhhCHHHccCC
Confidence 111111 000 00 0122346789999999999999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.09 Aligned_cols=277 Identities=23% Similarity=0.398 Sum_probs=204.4
Q ss_pred HHHhccCccCCcccccCCceEEEEEEec---CCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccc
Q 047768 697 SKATNEFSSSNTIGRGSFGFVYKGVLHE---NGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSID 771 (1009)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 771 (1009)
....++|.+.+.||+|+||.||+|.+.. ++..||||+++..... ..+.+.+|++++++++||||+++++++....
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 3445789999999999999999998874 4568999998654322 2357889999999999999999999987643
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCce
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 851 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 851 (1009)
.......++||||+++|+|.+++...........+++.+++.++.|++.||.|||++ +|+||||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence 333345699999999999999996543322334599999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccH
Q 047768 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTL 930 (1009)
Q Consensus 852 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~ 930 (1009)
||+|||+++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..
T Consensus 187 kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~ 258 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYY------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EM 258 (313)
T ss_dssp EECSCSCC----------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GH
T ss_pred EEeecCcceeccccccc------CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HH
Confidence 99999999876543211 11223457889999999999999999999999999999999 88888653322 11
Q ss_pred HHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 047768 931 HEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLG 1006 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~ 1006 (1009)
..... ....... ...+..++.+++.+|++.||++|||+.|+++.|+++.+..++
T Consensus 259 ~~~~~-----------~~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 259 YDYLL-----------HGHRLKQ-----------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp HHHHH-----------TTCCCCC-----------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HHHHH-----------cCCCCCC-----------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 11111 1000000 112334688999999999999999999999999999887654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=360.84 Aligned_cols=253 Identities=19% Similarity=0.251 Sum_probs=204.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||+||+|.++.+++.||+|++..........+.+|++++++++||||+++++++.. ....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----CCEEE
Confidence 3579999999999999999999999999999999975544445678999999999999999999999754 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC--CCceEEeccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH--DMVAHVSDFG 857 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~--~~~~kl~DfG 857 (1009)
+||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 125 lv~E~~~gg~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG 196 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 196 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence 99999999999999986543 389999999999999999999999 9999999999999974 5789999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......
T Consensus 197 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~i 262 (387)
T 1kob_A 197 LATKLNPDE---------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETLQNV 262 (387)
T ss_dssp TCEECCTTS---------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHH
T ss_pred cceecCCCc---------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-----HHHHHHH
Confidence 998765421 12234689999999999999999999999999999999999999974321 1111111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..... ..... .......++.+++.+|++.||++|||+.|+++
T Consensus 263 ~~~~~-~~~~~---------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 263 KRCDW-EFDED---------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHCCC-CCCSS---------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhCCC-CCCcc---------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000 00000 00112345789999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=351.41 Aligned_cols=263 Identities=25% Similarity=0.428 Sum_probs=214.3
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
...++|.+.+.||+|+||+||+|.++.++..||||+++... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 83 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPP 83 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCC
Confidence 35678999999999999999999999899999999986432 345778999999999999999999999754 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++++|.+++..... ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG 156 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEEEEEcCCCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCc
Confidence 8999999999999999987543 2489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+++....... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...... ........
T Consensus 157 ~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~ 227 (288)
T 3kfa_A 157 LSRLMTGDTY-------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEK 227 (288)
T ss_dssp GGGTSCSSSS-------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHT
T ss_pred cceeccCCcc-------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhc
Confidence 9987654321 22234567889999999999999999999999999999999 99998753222 11111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
. ... .....++.++.+++.+|++.||.+|||+.|+++.|+.+.++.
T Consensus 228 ~------------~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 228 D------------YRM----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp T------------CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred c------------CCC----------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1 000 001123356889999999999999999999999999877653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=350.07 Aligned_cols=246 Identities=24% Similarity=0.289 Sum_probs=202.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||+||+|+.+.+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-----CC
Confidence 467999999999999999999999899999999997542 2345678899999999999999999998754 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|.+++..... +++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Df 150 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQR------FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF 150 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSS------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEeCCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeec
Confidence 78999999999999999987543 89999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......
T Consensus 151 g~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~ 214 (318)
T 1fot_A 151 GFAKYVPDV-----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEK 214 (318)
T ss_dssp SSCEECSSC-----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHH
T ss_pred CcceecCCc-----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHH
Confidence 999865431 224579999999999999999999999999999999999999996432 1111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~ 995 (1009)
.... ... .+ .....++.+++.+|++.||++|| +++|+++
T Consensus 215 i~~~--------~~~-~p-----------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 215 ILNA--------ELR-FP-----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHC--------CCC-CC-----------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHhC--------CCC-CC-----------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1111 110 00 01123577999999999999999 8888764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=347.33 Aligned_cols=269 Identities=22% Similarity=0.309 Sum_probs=200.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||+||+|++. +++.||||+++..... ..+.+.+|++++++++||||+++++++.. ...
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 93 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-----ERC 93 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-----SSC
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-----CCE
Confidence 468999999999999999999985 6899999999654322 24678899999999999999999999754 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||++ |+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 94 LTLVFEFME-KDLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp EEEEEECCS-EEHHHHHHTCTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEcCCC-CCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCc
Confidence 899999997 589888877654 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+++...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ........
T Consensus 165 ~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~ 235 (311)
T 3niz_A 165 LARAFGIPV--------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSI 235 (311)
T ss_dssp TCEETTSCC--------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHH
T ss_pred CceecCCCc--------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence 998764321 12233568999999999876 568999999999999999999999997644332 22222221
Q ss_pred hcc---chhhhcc------CCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALP---EKVMEIV------DPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~---~~~~~~~------d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... ....... +........... .........++.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 236 LGTPNPREWPQVQELPLWKQRTFQVFEKKPW---SSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HCCCCTTTSGGGTTSHHHHSCCCCCCCCCCH---HHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HCCCChHHhhhhhccchhhhcccccccCCcH---HHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111 1111100 000000000000 0000112346789999999999999999999976
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=376.55 Aligned_cols=259 Identities=24% Similarity=0.432 Sum_probs=209.0
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
..++|.+.+.||+|+||+||+|.++ ++..||||+++... ...+.+.+|+++|++++||||+++++++.. ...
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~~ 257 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPI 257 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSC
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC------Ccc
Confidence 3467888999999999999999986 57889999997543 346789999999999999999999998752 457
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++|+|.++++.... ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred EEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 899999999999999986432 1388999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++....... .......+|+.|+|||++....++.++|||||||++|||+| |+.||...... +.....
T Consensus 331 a~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i 398 (454)
T 1qcf_A 331 ARVIEDNEY-------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIRAL 398 (454)
T ss_dssp GGGBCCHHH-------HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHHH
T ss_pred ceEcCCCce-------eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH
Confidence 987643210 11223456889999999998999999999999999999999 99999754321 111110
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
. .....+ .+..++.++.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 399 -----~---~~~~~~-----------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 399 -----E---RGYRMP-----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -----H---HTCCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -----H---cCCCCC-----------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 0 000000 1113445688999999999999999999999999887654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=362.78 Aligned_cols=268 Identities=24% Similarity=0.405 Sum_probs=200.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCC---eEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENG---MLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
..|.+.+.||+|+||+||+|++..++ ..||||+++.... ...+.+.+|++++++++||||++++++|... ..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~~ 164 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EG 164 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----SS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----CC
Confidence 34667789999999999999986432 4689999864322 3346789999999999999999999987432 35
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|.++++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DF 236 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF 236 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred CeEEEEECCCCCCHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeec
Confidence 67899999999999999987554 388999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++........ .........+|+.|+|||++.+..++.++|||||||++|||+| |..||...... .......
T Consensus 237 G~a~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~ 310 (373)
T 3c1x_A 237 GLARDMYDKEFD----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL 310 (373)
T ss_dssp -------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHH
T ss_pred cccccccccccc----cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHH
Confidence 999876543211 1112234567889999999999999999999999999999999 66777643222 1111111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcCC
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQR 1008 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~~~ 1008 (1009)
.. ..... +..++..+.+++.+||+.||++|||+.|+++.|+++.+.+.++.
T Consensus 311 ~~-----------~~~~~-----------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 311 QG-----------RRLLQ-----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp TT-----------CCCCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred cC-----------CCCCC-----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 10 00000 11233468899999999999999999999999999998887653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=354.02 Aligned_cols=264 Identities=23% Similarity=0.354 Sum_probs=202.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeecccc------
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDF------ 772 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 772 (1009)
.++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++||||+++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 4679999999999999999999998999999999975433 235679999999999999999999998754311
Q ss_pred ----------------------------------------------CCCceEEEEEeccCCCCHHHHHhccCCCCCccCC
Q 047768 773 ----------------------------------------------KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNL 806 (1009)
Q Consensus 773 ----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l 806 (1009)
......++||||+++|+|.+++...... ...
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~ 161 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL---EDR 161 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG---GGS
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc---cch
Confidence 1123479999999999999999876532 346
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCCCCCCcc----ccCCccccccc
Q 047768 807 SLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVV----ETPSSSIGVKG 882 (1009)
Q Consensus 807 ~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~----~~~~~~~~~~g 882 (1009)
++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........... ..........|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 7778999999999999999999 9999999999999999999999999999887654211100 00122334679
Q ss_pred cccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccc
Q 047768 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRR 962 (1009)
Q Consensus 883 t~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~ 962 (1009)
|+.|+|||++.+..++.++||||+||++|||++|..|+... ..... ....... +.
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~--------~~~~~~~-~~--------- 293 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIIT--------DVRNLKF-PL--------- 293 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHH--------HHHTTCC-CH---------
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHH--------HhhccCC-Cc---------
Confidence 99999999999999999999999999999999998775321 01100 0111000 00
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 963 VRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 963 ~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.......++.+++.+|++.||++|||+.|+++
T Consensus 294 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 294 -LFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp -HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred -ccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 11133445689999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=347.02 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=196.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--------------------------cchHHHHHHHHHHH
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--------------------------GGSKSFAAECEALR 753 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 753 (1009)
.++|.+.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999999998999999999964321 11356889999999
Q ss_pred hcCCCCcceEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 047768 754 SIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPI 833 (1009)
Q Consensus 754 ~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 833 (1009)
+++||||+++++++... .....++||||+++++|.+++... .+++.+++.++.|++.||+|||++ +|
T Consensus 92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i 158 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPTLK-------PLSEDQARFYFQDLIKGIEYLHYQ---KI 158 (298)
T ss_dssp TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSCSS-------CCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 99999999999997642 246789999999999998765432 389999999999999999999999 99
Q ss_pred eecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCC---CCCcccchHHHHHH
Q 047768 834 VHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE---ASMRGGVYSYGILL 910 (1009)
Q Consensus 834 vHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvvl 910 (1009)
+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++
T Consensus 159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l 230 (298)
T 2zv2_A 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230 (298)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHH
T ss_pred eccCCCHHHEEECCCCCEEEecCCCcccccccc--------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHH
Confidence 999999999999999999999999998765321 1223457999999999987765 47889999999999
Q ss_pred HHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 047768 911 LEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990 (1009)
Q Consensus 911 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~ 990 (1009)
|||++|+.||.... ........... ... .+. ......++.+++.+|++.||++|||+
T Consensus 231 ~~l~~g~~pf~~~~-----~~~~~~~~~~~--------~~~-~~~---------~~~~~~~l~~li~~~l~~dp~~R~s~ 287 (298)
T 2zv2_A 231 YCFVFGQCPFMDER-----IMCLHSKIKSQ--------ALE-FPD---------QPDIAEDLKDLITRMLDKNPESRIVV 287 (298)
T ss_dssp HHHHHSSCSSCCSS-----HHHHHHHHHHC--------CCC-CCS---------SSCCCHHHHHHHHHHTCSCTTTSCCH
T ss_pred HHHHHCCCCCCCcc-----HHHHHHHHhcc--------cCC-CCC---------ccccCHHHHHHHHHHhhcChhhCCCH
Confidence 99999999996432 11111111000 000 000 00123457899999999999999999
Q ss_pred HHHHH
Q 047768 991 TDVVV 995 (1009)
Q Consensus 991 ~evl~ 995 (1009)
.|+++
T Consensus 288 ~e~l~ 292 (298)
T 2zv2_A 288 PEIKL 292 (298)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99875
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=368.32 Aligned_cols=355 Identities=18% Similarity=0.183 Sum_probs=252.6
Q ss_pred CeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEec
Q 047768 70 QRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSA 149 (1009)
Q Consensus 70 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l 149 (1009)
.+++.|+|+++.+++. | .++.+++|++|+|++|++++ +| ++.+++|++|+|++|++++. | ++++++|++|++
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence 4688999999999986 3 79999999999999999996 45 99999999999999999974 4 999999999999
Q ss_pred ccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCC
Q 047768 150 HRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFS 229 (1009)
Q Consensus 150 ~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 229 (1009)
++|++++ +| + ..+++|++|++++|++++. + ++++++|++|++++|+..+.+ .+..+++|++|++++|+++
T Consensus 114 ~~N~l~~-l~--~--~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~ 183 (457)
T 3bz5_A 114 DTNKLTK-LD--V--SQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKIT 183 (457)
T ss_dssp CSSCCSC-CC--C--TTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCC
T ss_pred CCCcCCe-ec--C--CCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccc
Confidence 9999986 45 2 6789999999999999974 3 889999999999999766666 5889999999999999998
Q ss_pred CCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccccccccc
Q 047768 230 GTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINF 309 (1009)
Q Consensus 230 ~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f 309 (1009)
+ +| +..+++|++|++++|++++ ++ +..+++|++|++++|++++ +| +..+++|++|++++|++++.+.
T Consensus 184 ~-l~--l~~l~~L~~L~l~~N~l~~-~~---l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~--- 250 (457)
T 3bz5_A 184 E-LD--VSQNKLLNRLNCDTNNITK-LD---LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV--- 250 (457)
T ss_dssp C-CC--CTTCTTCCEEECCSSCCSC-CC---CTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC---
T ss_pred e-ec--cccCCCCCEEECcCCcCCe-ec---cccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH---
Confidence 5 44 6666666666666666662 32 3345556666666666555 23 5555555555555555554321
Q ss_pred ccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCcccc
Q 047768 310 NGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIA 389 (1009)
Q Consensus 310 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~ 389 (1009)
..+++|+.|++++|+
T Consensus 251 ------------------------------~~l~~L~~L~l~~n~----------------------------------- 265 (457)
T 3bz5_A 251 ------------------------------STLSKLTTLHCIQTD----------------------------------- 265 (457)
T ss_dssp ------------------------------TTCTTCCEEECTTCC-----------------------------------
T ss_pred ------------------------------HHCCCCCEEeccCCC-----------------------------------
Confidence 223445555554442
Q ss_pred CcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCcccc
Q 047768 390 NLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFF 469 (1009)
Q Consensus 390 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l 469 (1009)
|+.|++++|.+.+.+| ++.+++|+.|+|++|.+.+.+|. ....|+.|++++| ++|++
T Consensus 266 ----L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~- 322 (457)
T 3bz5_A 266 ----LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVY- 322 (457)
T ss_dssp ----CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCE-
T ss_pred ----CCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCE-
Confidence 2333444444443333 23455566666666655555553 2344555555544 23332
Q ss_pred ccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccc
Q 047768 470 FAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSF 549 (1009)
Q Consensus 470 ~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 549 (1009)
|++++|++++ ++ ++++++|+.|++++|+|++ ++.|+.|++++|++
T Consensus 323 ------------------------L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l 367 (457)
T 3bz5_A 323 ------------------------LYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNF 367 (457)
T ss_dssp ------------------------EECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSE
T ss_pred ------------------------EECCCCcccc-cc--cccCCcCcEEECCCCCCCC--------ccccccccccCCcE
Confidence 5556666655 22 7778888888888888885 25677778888988
Q ss_pred ccccccccccccccceEcCCCccccccccccccc
Q 047768 550 SGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLEN 583 (1009)
Q Consensus 550 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 583 (1009)
+|. +++..|+.++|++|+++|.+|..+..
T Consensus 368 ~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~ 396 (457)
T 3bz5_A 368 EAE-----GQTITMPKETLTNNSLTIAVSPDLLD 396 (457)
T ss_dssp EEE-----EEEEECCCBCCBTTBEEEECCTTCBC
T ss_pred Eec-----ceeeecCccccccCcEEEEcChhHhc
Confidence 876 46677888999999999999876543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=361.15 Aligned_cols=278 Identities=23% Similarity=0.306 Sum_probs=212.1
Q ss_pred hccCccCCcccccCCceEEEEEE----ecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVL----HENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|.+.+.||+|+||.||+|++ ..+++.||||++........+.+.+|++++++++||||+++++++.. .+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCC
Confidence 36899999999999999999995 46789999999976554455679999999999999999999998753 234
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++++|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcc
Confidence 678999999999999999987543 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++....... .........||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......
T Consensus 171 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~ 243 (327)
T 3lxl_A 171 FGLAKLLPLDKD-----YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF--LRMMGC 243 (327)
T ss_dssp GGGCEECCTTCS-----EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHCC-
T ss_pred cccceecccCCc-----cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh--hhhccc
Confidence 999987654321 1112223568889999999999999999999999999999999999986432110 000000
Q ss_pred Hhcc---chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 047768 936 RALP---EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFL 1005 (1009)
Q Consensus 936 ~~~~---~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~ 1005 (1009)
.... ..+.+.+..... ......+..++.+++.+|++.||++|||+.|+++.|+++.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 244 ERDVPALSRLLELLEEGQR----------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp ---CCHHHHHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred ccccccHHHHHHHhhcccC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 0000 001111111100 01112344568899999999999999999999999998876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=363.17 Aligned_cols=259 Identities=19% Similarity=0.245 Sum_probs=205.3
Q ss_pred HHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhcCCCCcceEEeeeecc
Q 047768 694 KELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRNLIKIVTICSSI 770 (1009)
Q Consensus 694 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 770 (1009)
.++....++|.+.+.||+|+||+||+|+++.+++.||+|+++.. .....+.+.+|+++++.++||||+++++++..
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~- 140 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD- 140 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-
Confidence 34445568999999999999999999999999999999999643 22334568899999999999999999999754
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV 850 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 850 (1009)
....++||||+++|+|.++++... +++..++.++.|++.||+|||++ +||||||||+|||++.++.
T Consensus 141 ----~~~~~lV~E~~~gg~L~~~l~~~~-------~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ 206 (410)
T 3v8s_A 141 ----DRYLYMVMEYMPGGDLVNLMSNYD-------VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH 206 (410)
T ss_dssp ----SSEEEEEECCCTTEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred ----CCEEEEEEeCCCCCcHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCC
Confidence 378899999999999999997643 88999999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCC----CCCcccchHHHHHHHHHHhCCCCCcccccC
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE----ASMRGGVYSYGILLLEIFTRRRPTESMFNE 926 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~elltg~~p~~~~~~~ 926 (1009)
+||+|||+|+....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 207 ikL~DFG~a~~~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-- 277 (410)
T 3v8s_A 207 LKLADFGTCMKMNKEGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-- 277 (410)
T ss_dssp EEECCCTTCEECCTTSE-------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--
T ss_pred EEEeccceeEeeccCCc-------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--
Confidence 99999999987654210 1223467999999999987765 8899999999999999999999997432
Q ss_pred CccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 047768 927 GLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFD--RMEMTDVVV 995 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--Rpt~~evl~ 995 (1009)
............. .+.-+.. .....++.+++.+|++.+|.+ ||+++||++
T Consensus 278 ---~~~~~~~i~~~~~-~~~~p~~---------------~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 278 ---LVGTYSKIMNHKN-SLTFPDD---------------NDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp ---HHHHHHHHHTHHH-HCCCCTT---------------CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ---hhhHHHHHHhccc-cccCCCc---------------ccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1111111111000 0000000 011235679999999999988 999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=357.99 Aligned_cols=273 Identities=21% Similarity=0.331 Sum_probs=208.7
Q ss_pred HhccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeeccc-ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQ-KGGSKSFAAECEALRSI-RHRNLIKIVTICSSID 771 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 771 (1009)
..++|.+.+.||+|+||.||+|++. .++..||||+++... ....+.+.+|+++++++ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 4578999999999999999999973 356789999996442 23457899999999999 89999999999754
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCCC-----------------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCce
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQL-----------------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIV 834 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 834 (1009)
....++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||++ +|+
T Consensus 121 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 194 (344)
T 1rjb_A 121 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 194 (344)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ---CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 356899999999999999998754310 012378999999999999999999999 999
Q ss_pred ecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHH
Q 047768 835 HGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIF 914 (1009)
Q Consensus 835 Hrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ell 914 (1009)
||||||+||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 268 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSN------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCcc------ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHH
Confidence 999999999999999999999999987654321 11223456788999999999999999999999999999999
Q ss_pred h-CCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 047768 915 T-RRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDV 993 (1009)
Q Consensus 915 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~ev 993 (1009)
| |+.||....... ............ .. ...+..++.+++.+||+.||.+|||+.|+
T Consensus 269 t~g~~p~~~~~~~~-~~~~~~~~~~~~-----------~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l 325 (344)
T 1rjb_A 269 SLGVNPYPGIPVDA-NFYKLIQNGFKM-----------DQ-----------PFYATEEIYIIMQSCWAFDSRKRPSFPNL 325 (344)
T ss_dssp TTSCCSSTTCCCSH-HHHHHHHTTCCC-----------CC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCCCCCcccCCcHH-HHHHHHhcCCCC-----------CC-----------CCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 8 999997543221 111111111000 00 01223467899999999999999999999
Q ss_pred HHHHHHHHHhhhcCC
Q 047768 994 VVKLCHARQNFLGQR 1008 (1009)
Q Consensus 994 l~~L~~i~~~~~~~~ 1008 (1009)
++.|+.+.+...+++
T Consensus 326 ~~~l~~~~~~~~~~~ 340 (344)
T 1rjb_A 326 TSFLGCQLADAEEAM 340 (344)
T ss_dssp HHHHHHHC-------
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999888766543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=353.36 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=198.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|.+.+.||+|+||.||+|+++.+++.||||+++..... ..+.+.+|+++++++ +||||+++++++.. .
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----C
Confidence 35799999999999999999999999999999999754322 235678899999988 89999999998654 3
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++|+|.+++..... +++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~D 153 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRK------LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 153 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEe
Confidence 678999999999999999987543 89999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCC----ccHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEG----LTLH 931 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~----~~~~ 931 (1009)
||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....
T Consensus 154 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 225 (345)
T 3a8x_A 154 YGMCKEGLRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 225 (345)
T ss_dssp GGGCBCSCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHH
T ss_pred ccccccccCCC--------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHH
Confidence 99998543211 22334679999999999999999999999999999999999999996432211 0111
Q ss_pred HHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 047768 932 EFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~ 990 (1009)
..... +...... .+ .....++.+++.+|++.||++||++
T Consensus 226 ~~~~~--------i~~~~~~-~p-----------~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 226 YLFQV--------ILEKQIR-IP-----------RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHH--------HHHCCCC-CC-----------TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHH--------HHcCCCC-CC-----------CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11110 0000000 01 1122457799999999999999996
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.64 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=201.9
Q ss_pred HHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhc-CCCCcceEEeeeecccc
Q 047768 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 772 (1009)
....++|.+.+.||+|+||.||+|+++.+++.||||+++... ......+..|.++++.+ +||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--- 89 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--- 89 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC---
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe---
Confidence 345678999999999999999999999999999999997542 33456788899999887 99999999998654
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceE
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 852 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 852 (1009)
....++||||+++|+|.+++..... +++.++..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 90 --~~~~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vk 158 (345)
T 1xjd_A 90 --KENLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIK 158 (345)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred --CCEEEEEEeCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEE
Confidence 3678999999999999999987543 89999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHH
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHE 932 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~ 932 (1009)
|+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..
T Consensus 159 L~DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~ 225 (345)
T 1xjd_A 159 IADFGMCKENMLGD--------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EE 225 (345)
T ss_dssp ECCCTTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH
T ss_pred EeEChhhhhcccCC--------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HH
Confidence 99999998543221 223356799999999999999999999999999999999999999974321 11
Q ss_pred HHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 047768 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMT-DVV 994 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~-evl 994 (1009)
........ ...+ + .....++.+++.+|++.||++||++. |+.
T Consensus 226 ~~~~i~~~------~~~~---p-----------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 226 LFHSIRMD------NPFY---P-----------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHHHHC------CCCC---C-----------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHHHHhC------CCCC---C-----------cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11111000 0000 0 01123567899999999999999997 554
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=359.57 Aligned_cols=247 Identities=21% Similarity=0.254 Sum_probs=195.3
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEecc
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYM 785 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 785 (1009)
.+.||+|+||.||+|++..+|+.||||+++.......+.+.+|++++++++||||+++++++... ...++||||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~E~~ 168 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-----NDIVLVMEYV 168 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEeCC
Confidence 56899999999999999989999999999765544567899999999999999999999997643 6789999999
Q ss_pred CCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee--CCCCceEEeccccccccC
Q 047768 786 QNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL--DHDMVAHVSDFGLAKFLS 863 (1009)
Q Consensus 786 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill--~~~~~~kl~DfGla~~~~ 863 (1009)
++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 169 ~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 169 DGGELFDRIIDESY-----NLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp TTCEEHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 99999999876543 389999999999999999999999 99999999999999 677899999999998765
Q ss_pred CCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhh
Q 047768 864 ASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVM 943 (1009)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1009)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..
T Consensus 241 ~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~-------- 302 (373)
T 2x4f_A 241 PRE---------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILA-------- 302 (373)
T ss_dssp TTC---------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHH--------
T ss_pred Ccc---------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh--------
Confidence 431 122346899999999999999999999999999999999999999743211 01111111
Q ss_pred hccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 944 EIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 944 ~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
........ .......++.+++.+|++.||.+|||+.|+++
T Consensus 303 ----~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 303 ----CRWDLEDE--------EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ----TCCCSCSG--------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----ccCCCChh--------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01100000 00122346789999999999999999999987
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=366.65 Aligned_cols=345 Identities=28% Similarity=0.382 Sum_probs=188.4
Q ss_pred CCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHh
Q 047768 168 FNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYL 247 (1009)
Q Consensus 168 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 247 (1009)
.+|+.|++++|.++. +|. +..+++|++|+|++|.+.+..+ +..+++|++|++++|++++..| +.++++|++|++
T Consensus 46 ~~l~~L~l~~~~i~~-l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 119 (466)
T 1o6v_A 46 DQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119 (466)
T ss_dssp HTCCEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred ccccEEecCCCCCcc-Ccc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEEC
Confidence 344555555555442 332 4455555555555555543332 5555555555555555553222 444444444444
Q ss_pred hCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCC
Q 047768 248 YGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGN 327 (1009)
Q Consensus 248 ~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~ 327 (1009)
++|+++ .+|. +.++++|++|++++|.+++. + .+.++++|++|+++ |.+.+..+ |..+++|+.|++++|.+..
T Consensus 120 ~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~ 191 (466)
T 1o6v_A 120 FNNQIT-DIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD 191 (466)
T ss_dssp CSSCCC-CCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred CCCCCC-CChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCC
Confidence 444444 2332 33455555555555555532 1 25555555555553 33332221 3333333333333333322
Q ss_pred CCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCC
Q 047768 328 GAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGT 407 (1009)
Q Consensus 328 ~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 407 (1009)
. ..+..+++|++|+ +++|++++..| +..+++|+.|++++|++++.
T Consensus 192 ~--------~~l~~l~~L~~L~-------------------------l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 236 (466)
T 1o6v_A 192 I--------SVLAKLTNLESLI-------------------------ATNNQISDITP--LGILTNLDELSLNGNQLKDI 236 (466)
T ss_dssp C--------GGGGGCTTCSEEE-------------------------CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred C--------hhhccCCCCCEEE-------------------------ecCCccccccc--ccccCCCCEEECCCCCcccc
Confidence 1 1133444444444 44444443332 44555666666666666532
Q ss_pred CCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhh
Q 047768 408 IPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEI 487 (1009)
Q Consensus 408 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~ 487 (1009)
..+..+++|++|++++|++++..| +..+++|++|++++|++++..| +..+++|+.|++++|+++
T Consensus 237 --~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~---------- 300 (466)
T 1o6v_A 237 --GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE---------- 300 (466)
T ss_dssp --GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCS----------
T ss_pred --hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCccc----------
Confidence 245566666666666666664433 5666666666666666664333 555555554433333333
Q ss_pred ccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEc
Q 047768 488 TTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELD 567 (1009)
Q Consensus 488 ~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 567 (1009)
+..| ++.+++|+.|++++|++++..| +..+++|+.|++++|++++. ..++++++|++|+
T Consensus 301 ---------------~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 359 (466)
T 1o6v_A 301 ---------------DISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLS 359 (466)
T ss_dssp ---------------CCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEE
T ss_pred ---------------Cchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEe
Confidence 2222 5566777777777777776555 66777777778877777754 3677777888888
Q ss_pred CCCcccccccccccccccccCceecccccCccc
Q 047768 568 LSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGE 600 (1009)
Q Consensus 568 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ 600 (1009)
+++|++++.+| +..+++|++|++++|++++.
T Consensus 360 l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 360 AGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp CCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred CCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence 88888777666 77777788888888877763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=361.46 Aligned_cols=280 Identities=17% Similarity=0.166 Sum_probs=206.1
Q ss_pred HhccCccCCccccc--CCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 699 ATNEFSSSNTIGRG--SFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
..++|++.+.||+| +||+||+|+++.+++.||||+++..... ..+.+.+|++++++++||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 98 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD---- 98 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET----
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC----
Confidence 35689999999999 9999999999999999999999755422 246788899999999999999999997653
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
...++||||+++|+|.+++...... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 99 -~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 170 (389)
T 3gni_B 99 -NELWVVTSFMAYGSAKDLICTHFMD----GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLS 170 (389)
T ss_dssp -TEEEEEEECCTTCBHHHHHHHTCTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred -CEEEEEEEccCCCCHHHHHhhhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEc
Confidence 6789999999999999999875322 389999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCC--CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG--GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHE 932 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~ 932 (1009)
|||.+........... ..........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......... .
T Consensus 171 dfg~~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~ 248 (389)
T 3gni_B 171 GLRSNLSMISHGQRQR-VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-E 248 (389)
T ss_dssp CGGGCEECEETTEECS-CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH-H
T ss_pred ccccceeecccccccc-ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-H
Confidence 9999876543211110 01122233578999999999988 678999999999999999999999997543322111 1
Q ss_pred HHHHhccchhhhccCCCC-------------------CC---hhhhhhh----ccccccHHHHHHHHHHHhhccCCCCCC
Q 047768 933 FAKRALPEKVMEIVDPSL-------------------LP---LEEERTN----SRRVRNEECLVAVIKTGVACSIESPFD 986 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l-------------------~~---~~~~r~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~ 986 (1009)
...... ..+.+... .. ....++. ...........++.+++.+||+.||++
T Consensus 249 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 324 (389)
T 3gni_B 249 KLNGTV----PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324 (389)
T ss_dssp C------------------------------------------------------------CCHHHHHHHHHHTCSCTTT
T ss_pred HhcCCC----CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCccc
Confidence 110000 00000000 00 0000000 000111223456889999999999999
Q ss_pred CCCHHHHHHH
Q 047768 987 RMEMTDVVVK 996 (1009)
Q Consensus 987 Rpt~~evl~~ 996 (1009)
|||++|+++.
T Consensus 325 Rpta~ell~h 334 (389)
T 3gni_B 325 RPSASTLLNH 334 (389)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhcC
Confidence 9999999853
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=368.36 Aligned_cols=274 Identities=19% Similarity=0.202 Sum_probs=199.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccc-cCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSID-FKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 776 (1009)
.++|.+.+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+++++.++||||+++++++.... .....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999999999999999996442 223467889999999999999999999986532 13345
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++ ++.+.+.. .+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeCCCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEE
Confidence 78999999965 57776643 288999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+......
T Consensus 209 G~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~ 278 (464)
T 3ttj_A 209 GLARTAGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQ 278 (464)
T ss_dssp CCC-----C---------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred EeeeecCCC---------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh
Confidence 999866432 1233467999999999999999999999999999999999999999753211 111111111
Q ss_pred hc----------cchhhhccCCCCC----Chhhhhhhc----cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 AL----------PEKVMEIVDPSLL----PLEEERTNS----RRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~----------~~~~~~~~d~~l~----~~~~~r~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. .......++..-. ..+...+.. ..........++.+++.+|++.||++|||++|+++
T Consensus 279 lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 10 0111111111000 000000000 00011122456889999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=355.31 Aligned_cols=265 Identities=20% Similarity=0.335 Sum_probs=198.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccc---hHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG---SKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||+||+|++..+++.||||+++...... ...+.+|++++++++||||+++++++.... ....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 357999999999999999999999899999999997543322 346889999999999999999999876532 2223
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++++|.++++... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 160 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 160 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred ccEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence 5699999999999999998754 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++....... .........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus 161 g~a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~~~~ 230 (311)
T 3ork_A 161 GIARAIADSGN-----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQ 230 (311)
T ss_dssp SCC-----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHH
T ss_pred cCccccccccc-----ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHH
Confidence 99987654321 111223456899999999999999999999999999999999999999743211 11111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHH-HHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVV-VKLCHA 1000 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl-~~L~~i 1000 (1009)
... ........ .......++.+++.+|++.||++||++.+++ ..+.++
T Consensus 231 ~~~--------~~~~~~~~--------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 231 HVR--------EDPIPPSA--------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHH--------CCCCCHHH--------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred Hhc--------CCCCCccc--------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 100 00000000 0012334678999999999999999766655 444443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.88 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=192.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc----cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK----GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|++.+.||+|+||.||+|.+. ++.||||+++.... ...+.+.+|+++++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE----- 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----
Confidence 357889999999999999999984 89999999864432 2246789999999999999999999997543
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC--------
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH-------- 847 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-------- 847 (1009)
...++||||+++++|.+++... .+++..++.++.|++.|++|||++...+|+||||||+||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~ 151 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSGK-------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTSS-------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred CceEEEEEcCCCCCHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccccc
Confidence 5679999999999999999643 2899999999999999999999982122999999999999986
Q ss_pred CCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCC
Q 047768 848 DMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEG 927 (1009)
Q Consensus 848 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~ 927 (1009)
++.+||+|||+++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 152 ~~~~kl~Dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~- 220 (271)
T 3dtc_A 152 NKILKITDFGLAREWHRTT----------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL- 220 (271)
T ss_dssp SCCEEECCCCC-----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-
T ss_pred CcceEEccCCccccccccc----------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 7789999999998654321 12346899999999999999999999999999999999999999753211
Q ss_pred ccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 928 LTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
......... ..... ....+..++.+++.+|++.||++|||+.|+++.|+++
T Consensus 221 ----~~~~~~~~~--------~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 221 ----AVAYGVAMN--------KLALP----------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----HHHHHHHTS--------CCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----HHHHhhhcC--------CCCCC----------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111110000 00000 0112334688999999999999999999999999754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=360.85 Aligned_cols=286 Identities=19% Similarity=0.237 Sum_probs=217.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|.+.+.||+|+||+||+|+++.+++.||||+++... ....+.+.+|++++++++||||+++++++... .....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCee
Confidence 357999999999999999999999899999999997543 23356788999999999999999999987643 23467
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee----CCCCceEEe
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVS 854 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~~~kl~ 854 (1009)
++||||+++|+|.+++...... ..+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred EEEEecCCCCCHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEe
Confidence 9999999999999999875432 2389999999999999999999999 99999999999999 788889999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCC--------CCCCCcccchHHHHHHHHHHhCCCCCcccccC
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG--------GEASMRGGVYSYGILLLEIFTRRRPTESMFNE 926 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~ 926 (1009)
|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 159 DFG~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~ 229 (396)
T 4eut_A 159 DFGAARELEDD---------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (396)
T ss_dssp CGGGCEECCCG---------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred cCCCceEccCC---------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 99999876532 12234568999999998765 56788999999999999999999999754433
Q ss_pred CccHHHHHHH--hccch-hhhccCCCCCCh-hhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 047768 927 GLTLHEFAKR--ALPEK-VMEIVDPSLLPL-EEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQ 1002 (1009)
Q Consensus 927 ~~~~~~~~~~--~~~~~-~~~~~d~~l~~~-~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~ 1002 (1009)
.......... ..+.. ...+....-... ..................+.+++.+|++.||++||++.|+++.++.+.+
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp TTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred cchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 2222222111 11111 111111000000 0000011112335667788999999999999999999999999988765
Q ss_pred h
Q 047768 1003 N 1003 (1009)
Q Consensus 1003 ~ 1003 (1009)
.
T Consensus 310 ~ 310 (396)
T 4eut_A 310 R 310 (396)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=352.04 Aligned_cols=267 Identities=22% Similarity=0.334 Sum_probs=211.0
Q ss_pred HhccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeecccc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 772 (1009)
..++|.+.+.||+|+||.||+|.+. .+++.||||+++.... ...+.+.+|++++++++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence 3568999999999999999999984 3558999999964432 234678899999999999999999999754
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCC------------------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCce
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQL------------------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIV 834 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 834 (1009)
....++||||+++|+|.+++....... ....+++.+++.++.|++.||.|||++ +|+
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iv 172 (314)
T 2ivs_A 98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLV 172 (314)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCc
Confidence 356899999999999999998754310 112388999999999999999999999 999
Q ss_pred ecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHH
Q 047768 835 HGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIF 914 (1009)
Q Consensus 835 Hrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ell 914 (1009)
||||||+||+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++||||+||++|||+
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 246 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDS------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSC------EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred ccccchheEEEcCCCCEEEcccccccccccccc------ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHH
Confidence 999999999999999999999999987654321 11122345788999999999999999999999999999999
Q ss_pred h-CCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 047768 915 T-RRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDV 993 (1009)
Q Consensus 915 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~ev 993 (1009)
+ |+.||...... .......... ... ....+..++.+++.+|++.||++||++.|+
T Consensus 247 t~g~~p~~~~~~~--~~~~~~~~~~-----------~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 302 (314)
T 2ivs_A 247 TLGGNPYPGIPPE--RLFNLLKTGH-----------RME-----------RPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302 (314)
T ss_dssp TTSCCSSTTCCGG--GHHHHHHTTC-----------CCC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hCCCCCCCCCCHH--HHHHHhhcCC-----------cCC-----------CCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9 99999754322 1111111100 000 001233468899999999999999999999
Q ss_pred HHHHHHHHHh
Q 047768 994 VVKLCHARQN 1003 (1009)
Q Consensus 994 l~~L~~i~~~ 1003 (1009)
++.|+++.++
T Consensus 303 ~~~l~~~~~~ 312 (314)
T 2ivs_A 303 SKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHhh
Confidence 9999998765
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=366.60 Aligned_cols=279 Identities=29% Similarity=0.409 Sum_probs=136.3
Q ss_pred CCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCe
Q 047768 93 LSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQG 172 (1009)
Q Consensus 93 l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~ 172 (1009)
+++|+.|+++++.++ .+|. +..+++|++|||++|.+++..| ++++++|++|++++|.+.+..| + ..+++|++
T Consensus 45 l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~--~~l~~L~~ 116 (466)
T 1o6v_A 45 LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--L--ANLTNLTG 116 (466)
T ss_dssp HHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--G--TTCTTCCE
T ss_pred hccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--h--cCCCCCCE
Confidence 445566666666655 3443 5556666666666666654333 5556666666666555553333 1 34555566
Q ss_pred EeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCcc
Q 047768 173 LSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRF 252 (1009)
Q Consensus 173 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 252 (1009)
|++++|++++..+ ++++++|++|++++|++.+. + .+..+++|++|+++ |.+.+.. .+.++
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l------------- 176 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANL------------- 176 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTC-------------
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccC-------------
Confidence 6666666554322 56666666666666666532 2 35666666666664 3333211 13333
Q ss_pred CCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCCCCCCC
Q 047768 253 TGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAAND 332 (1009)
Q Consensus 253 ~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~ 332 (1009)
++|++|++++|.+++. ..+..+++|++|++++|++.+..+ +..+++|+.|++++|.+...
T Consensus 177 ------------~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~---- 236 (466)
T 1o6v_A 177 ------------TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI---- 236 (466)
T ss_dssp ------------TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC----
T ss_pred ------------CCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc----
Confidence 4444444444444332 124445555555555555544332 22222222222222222211
Q ss_pred cchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCc
Q 047768 333 LDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVI 412 (1009)
Q Consensus 333 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 412 (1009)
..+..+++|++|++++|.+++. .+ +..+++|+.|++++|++++..+ +
T Consensus 237 ----~~l~~l~~L~~L~l~~n~l~~~-------------------------~~--~~~l~~L~~L~l~~n~l~~~~~--~ 283 (466)
T 1o6v_A 237 ----GTLASLTNLTDLDLANNQISNL-------------------------AP--LSGLTKLTELKLGANQISNISP--L 283 (466)
T ss_dssp ----GGGGGCTTCSEEECCSSCCCCC-------------------------GG--GTTCTTCSEEECCSSCCCCCGG--G
T ss_pred ----hhhhcCCCCCEEECCCCccccc-------------------------hh--hhcCCCCCEEECCCCccCcccc--c
Confidence 1133344444444444444322 11 4445555555555555554333 5
Q ss_pred CCcccccceecccccccCCCCcccccccccccccccCccccc
Q 047768 413 GELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQG 454 (1009)
Q Consensus 413 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 454 (1009)
..+++|++|+|++|++++..| +..+++|++|++++|++++
T Consensus 284 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~ 323 (466)
T 1o6v_A 284 AGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323 (466)
T ss_dssp TTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSC
T ss_pred cCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCC
Confidence 555555555555555554322 4455555555555555543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.59 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=201.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeE----EEEEEeecc-cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGML----VAVKVINLE-QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
.++|.+.+.||+|+||+||+|++..+++. ||+|.+... .....+.+.+|++++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 36799999999999999999999877765 466666433 23345789999999999999999999999764
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
...++|+||+.+|+|.+++..... .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+
T Consensus 89 -~~~~~v~~~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~ 159 (327)
T 3lzb_A 89 -STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp -SSEEEEECCCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred -CCceEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEc
Confidence 347899999999999999987654 389999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 933 (1009)
|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 160 DfG~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~ 231 (327)
T 3lzb_A 160 DFGLAKLLGAEEK------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSI 231 (327)
T ss_dssp CTTC----------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH
T ss_pred cCcceeEccCccc------cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHH
Confidence 9999987654321 112223457889999999999999999999999999999999 99999754322 11111
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
..... .... ...+..++.+++.+||+.||.+||++.|+++.|+++.+.
T Consensus 232 ~~~~~-----------~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 232 LEKGE-----------RLPQ-----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHTTC-----------CCCC-----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHcCC-----------CCCC-----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11100 0000 112234578999999999999999999999999998753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.26 Aligned_cols=271 Identities=23% Similarity=0.350 Sum_probs=213.6
Q ss_pred HhccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeeccc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSSID 771 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 771 (1009)
..++|.+.+.||+|+||.||+|++. .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~- 99 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG- 99 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-
Confidence 3468999999999999999999963 4678999999975432 2346789999999999 999999999997543
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCC------------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCC
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQ------------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLK 839 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk 839 (1009)
...++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||++ +|+|||||
T Consensus 100 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk 172 (313)
T 1t46_A 100 ----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 172 (313)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred ----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence 5679999999999999999875431 0112489999999999999999999999 99999999
Q ss_pred CCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCC
Q 047768 840 PSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRR 918 (1009)
Q Consensus 840 ~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~ 918 (1009)
|+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||+| |+.
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 246 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTS------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccc------eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999876543211 11223557889999999999999999999999999999999 999
Q ss_pred CCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 919 PTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 919 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
||....... .......... ... ....+..++.+++.+|++.||.+|||+.|+++.|+
T Consensus 247 p~~~~~~~~-~~~~~~~~~~--------~~~--------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 303 (313)
T 1t46_A 247 PYPGMPVDS-KFYKMIKEGF--------RML--------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (313)
T ss_dssp SSTTCCSSH-HHHHHHHHTC--------CCC--------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCcccchh-HHHHHhccCC--------CCC--------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 987543221 1111111110 000 00122346789999999999999999999999999
Q ss_pred HHHHhhhc
Q 047768 999 HARQNFLG 1006 (1009)
Q Consensus 999 ~i~~~~~~ 1006 (1009)
++.++...
T Consensus 304 ~~~~~~~~ 311 (313)
T 1t46_A 304 KQISESTN 311 (313)
T ss_dssp HHHHHTCC
T ss_pred HHHHHhhc
Confidence 98887543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=354.79 Aligned_cols=254 Identities=24% Similarity=0.284 Sum_probs=194.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||+||+|+++.+++.||||++.... ...+.+.+|+.++++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEee-----CCEEE
Confidence 468999999999999999999999999999999996433 235678899999999999999999999764 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc--eEEeccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV--AHVSDFG 857 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~--~kl~DfG 857 (1009)
+||||+++|+|.+++..... +++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||+|||
T Consensus 93 lv~e~~~~~~L~~~l~~~~~------~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGR------FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred EEEEeCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecC
Confidence 99999999999999977543 89999999999999999999999 9999999999999987765 9999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCc-ccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMR-GGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+++..... .......||+.|+|||++.+..++.+ +||||+||++|||++|+.||....... ........
T Consensus 164 ~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~ 233 (361)
T 3uc3_A 164 YSKSSVLH---------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQR 233 (361)
T ss_dssp CC------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHH
T ss_pred cccccccc---------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHH
Confidence 99743321 12234569999999999988887655 899999999999999999997543321 22222221
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.. ........ ......++.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~--------~~~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 234 IL--------SVKYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HH--------TTCCCCCT----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred Hh--------cCCCCCCC----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11 11110000 00122457799999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=345.36 Aligned_cols=268 Identities=21% Similarity=0.311 Sum_probs=198.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|.+.+.||+|+||+||+|++ .+++.||||+++.... ...+.+.+|++++++++||||+++++++.. ....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence 4788999999999999999998 5789999999964432 234678899999999999999999999754 3678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++ +|.+++..... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (288)
T ss_dssp EEEEECCSE-EHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EEEEEecCC-CHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence 999999975 99999987543 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||....... .........
T Consensus 147 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~ 217 (288)
T 1ob3_A 147 ARAFGIPV--------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRIL 217 (288)
T ss_dssp HHHHCC-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred ccccCccc--------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHH
Confidence 98764321 122235689999999998764 58999999999999999999999997543221 111111111
Q ss_pred ccc---hhhhc-----cCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPE---KVMEI-----VDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~---~~~~~-----~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... ..... .++...... +............++.+++.+|++.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 218 GTPNSKNWPNVTELPKYDPNFTVYE---PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCC---CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhchhhhccccccccccccc---CccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 00000 000000000 00000001123346789999999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=349.29 Aligned_cols=276 Identities=24% Similarity=0.337 Sum_probs=215.3
Q ss_pred HHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHh--cCCCCcceEEeeeeccccC
Q 047768 696 LSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRS--IRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~ 773 (1009)
.....++|.+.+.||+|+||.||+|++ +++.||||+++.. ..+.+.+|+++++. ++||||+++++++.... .
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~ 110 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-G 110 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-S
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-C
Confidence 344567899999999999999999988 4899999998643 34677889999887 68999999999976531 1
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCceecCCCCCceee
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH--------HHCQPPIVHGDLKPSNVLL 845 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivHrdlk~~Nill 845 (1009)
.....++||||+++|+|.+++.... +++.+++.++.|++.||+||| +. +|+||||||+||++
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV 180 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred ccceeEEEEeecCCCcHHHHHhccC-------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence 1237899999999999999997643 899999999999999999999 66 99999999999999
Q ss_pred CCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCC------CCCCcccchHHHHHHHHHHhC---
Q 047768 846 DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG------EASMRGGVYSYGILLLEIFTR--- 916 (1009)
Q Consensus 846 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltg--- 916 (1009)
+.++.+||+|||+++........ .........||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~ 256 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDT----IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTE----EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred CCCCCEEEEECCCceeccccccc----cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCc
Confidence 99999999999999876543210 00122345799999999998776 334789999999999999999
Q ss_pred -------CCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC
Q 047768 917 -------RRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME 989 (1009)
Q Consensus 917 -------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt 989 (1009)
+.||............+...... ..+.+.... .....++...+.+++.+||+.||++|||
T Consensus 257 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps 323 (342)
T 1b6c_B 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCE--------QKLRPNIPN-----RWQSCEALRVMAKIMRECWYANGAARLT 323 (342)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHHHHHHTT--------SCCCCCCCG-----GGGTSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred CCcccccccCccccCcCcccHHHHHHHHHH--------HHhCCCCcc-----cccchhHHHHHHHHHHHHhccChhhCCC
Confidence 77876554444444444332211 111111111 1123467778999999999999999999
Q ss_pred HHHHHHHHHHHHHhh
Q 047768 990 MTDVVVKLCHARQNF 1004 (1009)
Q Consensus 990 ~~evl~~L~~i~~~~ 1004 (1009)
+.||++.|+.+.++.
T Consensus 324 ~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 324 ALRIKKTLSQLSQQE 338 (342)
T ss_dssp HHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHh
Confidence 999999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=340.03 Aligned_cols=251 Identities=25% Similarity=0.266 Sum_probs=204.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||+||+|.++.++..||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-----NTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCeEE
Confidence 4579999999999999999999998999999999987666667889999999999999999999999754 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee---CCCCceEEecc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDF 856 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Df 856 (1009)
+||||+++++|.+++..... +++.+++.++.|++.|++|||++ +|+||||||+||++ +.++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~~~~------~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRV------FRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEeccCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 99999999999999987553 89999999999999999999999 99999999999999 78899999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|++....... ......||+.|+|||++.+. ++.++||||+|+++|||++|+.||...... .....
T Consensus 154 g~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~ 218 (277)
T 3f3z_A 154 GLAARFKPGK---------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-----EVMLK 218 (277)
T ss_dssp TTCEECCTTS---------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH
T ss_pred ccceeccCcc---------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH-----HHHHH
Confidence 9998765431 22235689999999997654 899999999999999999999999753211 11111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
+...... .+... .......+.+++.+|++.||++|||+.|+++
T Consensus 219 --------~~~~~~~-~~~~~-------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 219 --------IREGTFT-FPEKD-------WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --------HHHCCCC-CCHHH-------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --------HHhCCCC-CCchh-------hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 00000 0012346789999999999999999999986
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=373.75 Aligned_cols=348 Identities=21% Similarity=0.216 Sum_probs=242.1
Q ss_pred HHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccc
Q 047768 245 IYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNF 324 (1009)
Q Consensus 245 L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~ 324 (1009)
++.+++.++ .+|..+. ++++.|+|++|++++..|..|.++++|++|+|++|+++++.+..|.++++|+.|+|++|.
T Consensus 16 v~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 16 VLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp EECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEeCCCCcC-cCCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 344555555 5665443 467777777777777777778888888888888888777777666666666666666666
Q ss_pred cCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCC
Q 047768 325 LGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRL 404 (1009)
Q Consensus 325 l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 404 (1009)
+..++. ..|.++++|++|+|++|++++..|..+..+ .+|+.|+|++|.+++..+..|.++++|+.|+|++|++
T Consensus 92 l~~~~~------~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 164 (477)
T 2id5_A 92 LKLIPL------GVFTGLSNLTKLDISENKIVILLDYMFQDL-YNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL 164 (477)
T ss_dssp CCSCCT------TSSTTCTTCCEEECTTSCCCEECTTTTTTC-TTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCC
T ss_pred CCccCc------ccccCCCCCCEEECCCCccccCChhHcccc-ccCCEEECCCCccceeChhhccCCCCCCEEECCCCcC
Confidence 655443 234556666666666666665555555444 3455555555555555555555555555555555555
Q ss_pred CCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhh
Q 047768 405 TGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQI 484 (1009)
Q Consensus 405 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~ 484 (1009)
++..+..|..+++|+.|+|++|.+++..+..|..+++|++|++++|.+.+.+|.......+|+
T Consensus 165 ~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~----------------- 227 (477)
T 2id5_A 165 TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT----------------- 227 (477)
T ss_dssp SSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCS-----------------
T ss_pred cccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCcccc-----------------
Confidence 544444555555555555555555555555555555555555555555544444443333333
Q ss_pred hhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccc
Q 047768 485 LEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIK 564 (1009)
Q Consensus 485 ~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 564 (1009)
.|++++|++++..+..|.++++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..|.+|.++++|+
T Consensus 228 --------~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 299 (477)
T 2id5_A 228 --------SLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLR 299 (477)
T ss_dssp --------EEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCC
T ss_pred --------EEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCC
Confidence 377777777744445688899999999999999988888899999999999999999999999999999999
Q ss_pred eEcCCCcccccccccccccccccCceecccccCcccCCCCCcccCccccccccCCCcCCCCCCC
Q 047768 565 ELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDEL 628 (1009)
Q Consensus 565 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~~~~ 628 (1009)
+|||++|+|++..+..|..+++|++|+|++|++.+.++..+.+.......+.++...|+.|...
T Consensus 300 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~~ 363 (477)
T 2id5_A 300 VLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEFV 363 (477)
T ss_dssp EEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESGGG
T ss_pred EEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCchHH
Confidence 9999999999877788999999999999999999988765544444445667788888877654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=352.71 Aligned_cols=246 Identities=21% Similarity=0.241 Sum_probs=203.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|+++.+|+.||||+++... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----CC
Confidence 368999999999999999999999899999999996442 2345678899999999999999999998654 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|.+++..... +++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF 185 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGR------FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEcCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccc
Confidence 78999999999999999987543 89999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......
T Consensus 186 g~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~ 249 (350)
T 1rdq_E 186 GFAKRVKGR-----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEK 249 (350)
T ss_dssp TTCEECSSC-----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH
T ss_pred ccceeccCC-----------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-----HHHHHHH
Confidence 999866432 224579999999999999999999999999999999999999997432 1111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME-----MTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt-----~~evl~ 995 (1009)
.... ... .+ .....++.+++.+|++.||++||+ ++|+++
T Consensus 250 i~~~--------~~~-~p-----------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 250 IVSG--------KVR-FP-----------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHC--------CCC-CC-----------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHcC--------CCC-CC-----------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1111 000 00 012345789999999999999998 777764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=356.70 Aligned_cols=278 Identities=25% Similarity=0.353 Sum_probs=211.8
Q ss_pred cCccCCcccccCCceEEEEEEe----cCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLH----ENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.|.+.+.||+|+||+||+|.+. .+++.||||+++.... ...+.+.+|++++++++||||+++++++... +..
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 108 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAA 108 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTT
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCc
Confidence 3488999999999999888763 4788999999975432 2346789999999999999999999998642 346
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|.+++.... +++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Df 178 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDF 178 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCG
T ss_pred eEEEEEecccCCcHHHHHhhCC-------CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCc
Confidence 7899999999999999997653 89999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH-H
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA-K 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~-~ 935 (1009)
|+++....... .........||..|+|||++.+..++.++||||+|+++|||++|+.||............+. .
T Consensus 179 g~a~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 253 (318)
T 3lxp_A 179 GLAKAVPEGHE-----YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253 (318)
T ss_dssp GGCEECCTTCS-----EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCH
T ss_pred ccccccccccc-----ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccccc
Confidence 99987754321 11122335578899999999999999999999999999999999999864321100000000 0
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcC
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQ 1007 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~~ 1007 (1009)
......+.+.++..... .....+..++.+++.+||+.||++|||+.|+++.|+++.+.+..+
T Consensus 254 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 254 QMTVLRLTELLERGERL----------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred chhHHHHHHHHhcccCC----------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 00000111111111110 111233456889999999999999999999999999999998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=356.07 Aligned_cols=273 Identities=19% Similarity=0.245 Sum_probs=204.8
Q ss_pred hccCccCCcccccCCceEEEEEEec---CCeEEEEEEeeccccc-----------chHHHHHHHHHHHhcCCCCcceEEe
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHE---NGMLVAVKVINLEQKG-----------GSKSFAAECEALRSIRHRNLIKIVT 765 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 765 (1009)
.++|.+.+.||+|+||+||+|.+.. ++..||||++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3579999999999999999999976 7889999998644321 1234667888999999999999999
Q ss_pred eeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee
Q 047768 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL 845 (1009)
Q Consensus 766 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill 845 (1009)
++... +.+....++||||+ +++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||++
T Consensus 116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 184 (345)
T 2v62_A 116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLL 184 (345)
T ss_dssp EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred ccccc-cCCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEE
Confidence 98763 34457889999999 999999998765 389999999999999999999999 99999999999999
Q ss_pred CCCC--ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 047768 846 DHDM--VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 846 ~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
+.++ .+||+|||+++.+......... .........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQY-QENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCC-CCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred ccCCCCcEEEEeCCCceecccccccccc-hhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9887 9999999999877543211100 112224467999999999999999999999999999999999999999643
Q ss_pred ccCCccHHHHHHH---hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 924 FNEGLTLHEFAKR---ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 924 ~~~~~~~~~~~~~---~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
............. ..+........ ...++.++.+++.+||+.||++||++.||++.|+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 264 LKDPVAVQTAKTNLLDELPQSVLKWAP-----------------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp TTCHHHHHHHHHHHHHTTTHHHHHHSC-----------------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred ccccHHHHHHHHhhcccccHHHHhhcc-----------------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 3222111111111 11111111110 012334688999999999999999999999999764
Q ss_pred H
Q 047768 1001 R 1001 (1009)
Q Consensus 1001 ~ 1001 (1009)
.
T Consensus 327 ~ 327 (345)
T 2v62_A 327 G 327 (345)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=352.59 Aligned_cols=243 Identities=26% Similarity=0.371 Sum_probs=201.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--------cchHHHHHHHHHHHhcCCCCcceEEeeeeccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--------GGSKSFAAECEALRSIRHRNLIKIVTICSSID 771 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 771 (1009)
.++|.+.+.||+|+||+||+|+++.+++.||||+++.... ...+.+.+|++++++++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 4689999999999999999999999999999999975432 123467789999999999999999999754
Q ss_pred cCCCceEEEEEeccCCC-CHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc
Q 047768 772 FKGVDFKALVYEYMQNG-SLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV 850 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 850 (1009)
....++||||+.+| +|.+++..... +++..++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 101 ---~~~~~lv~e~~~~g~~l~~~~~~~~~------l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 101 ---QGFFQLVMEKHGSGLDLFAFIDRHPR------LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp ---SSEEEEEEECCTTSCBHHHHHHTCCC------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSC
T ss_pred ---CCEEEEEEEeCCCCccHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCc
Confidence 36789999999777 99999987653 89999999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCcccccCCcc
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESMFNEGLT 929 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~ 929 (1009)
+||+|||+++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 169 ~kL~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---- 235 (335)
T 3dls_A 169 IKLIDFGSAAYLERGK---------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---- 235 (335)
T ss_dssp EEECCCTTCEECCTTC---------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----
T ss_pred EEEeecccceECCCCC---------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----
Confidence 9999999998765431 2234568999999999988887 8899999999999999999999964211
Q ss_pred HHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 930 LHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
........ + .....++.+++.+|++.||++|||+.|+++.
T Consensus 236 ---------------~~~~~~~~-~-----------~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ---------------TVEAAIHP-P-----------YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---------------GTTTCCCC-S-----------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---------------HHhhccCC-C-----------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111100 0 0123457899999999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=360.60 Aligned_cols=214 Identities=27% Similarity=0.349 Sum_probs=182.8
Q ss_pred cccCCccCHHHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-----CCC
Q 047768 685 EQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-----HRN 759 (1009)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~n 759 (1009)
+.....+++++.....++|.+.++||+|+||+||+|++..+++.||||+++.. ....+.+..|+++++.++ |||
T Consensus 19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 33445556666666678999999999999999999999989999999998632 223456788999999986 999
Q ss_pred cceEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCC
Q 047768 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLK 839 (1009)
Q Consensus 760 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk 839 (1009)
|+++++++... ...++||||+ +++|.+++...... .+++.+++.++.|++.||+|||++ +|||||||
T Consensus 98 iv~~~~~~~~~-----~~~~lv~e~~-~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlk 164 (360)
T 3llt_A 98 IVKYHGKFMYY-----DHMCLIFEPL-GPSLYEIITRNNYN----GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLK 164 (360)
T ss_dssp BCCEEEEEEET-----TEEEEEECCC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred eecccceeeEC-----CeeEEEEcCC-CCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCC
Confidence 99999997653 6789999999 99999999876532 489999999999999999999999 99999999
Q ss_pred CCceeeCC-------------------------CCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCC
Q 047768 840 PSNVLLDH-------------------------DMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG 894 (1009)
Q Consensus 840 ~~Nill~~-------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 894 (1009)
|+|||++. ++.+||+|||+++..... .....||+.|+|||++.+
T Consensus 165 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~ 233 (360)
T 3llt_A 165 PENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----------HGSIINTRQYRAPEVILN 233 (360)
T ss_dssp GGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----------CCSCCSCGGGCCHHHHTT
T ss_pred cccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----------CcCccCcccccCcHHHcC
Confidence 99999975 789999999999864432 123568999999999999
Q ss_pred CCCCCcccchHHHHHHHHHHhCCCCCccc
Q 047768 895 GEASMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 895 ~~~~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
..++.++||||+||++|||++|+.||...
T Consensus 234 ~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 234 LGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999999999753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=347.95 Aligned_cols=245 Identities=22% Similarity=0.249 Sum_probs=192.2
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.++||+|+||+||+|+++.+++.||||++...... .......|+..+.++ +||||++++++|... ..
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-----~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-----GI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-----CE
Confidence 5799999999999999999999989999999998543322 223455566666555 899999999997653 77
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+ +++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred EEEEEecc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence 89999999 7799999887654 399999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+++...... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+... ..+.
T Consensus 203 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-------~~~~--- 262 (311)
T 3p1a_A 203 LLVELGTAG---------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-------EGWQ--- 262 (311)
T ss_dssp TCEECC---------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-------HHHH---
T ss_pred eeeecccCC---------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-------cHHH---
Confidence 998765421 2223568999999998876 7899999999999999999997765421 1110
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.+......... ......++.+++.+|++.||++|||++|+++
T Consensus 263 ------~~~~~~~~~~~----------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 263 ------QLRQGYLPPEF----------TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ------HHTTTCCCHHH----------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------HHhccCCCccc----------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11111110000 0122356889999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=345.89 Aligned_cols=268 Identities=25% Similarity=0.412 Sum_probs=207.3
Q ss_pred hccCccCCcccccCCceEEEEEEecC---CeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHEN---GMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
..+|.+.+.||+|+||+||+|++..+ ...||||+++.... ...+.+.+|++++++++||||++++++|.. ..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SE 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----CC
Confidence 35688889999999999999997533 34689998864322 234678899999999999999999998643 23
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++|+|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 171 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVAD 171 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECS
T ss_pred CceEEEEeCCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECc
Confidence 567899999999999999986543 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhC-CCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTR-RRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg-~~p~~~~~~~~~~~~~~~ 934 (1009)
||+++....... ..........||+.|+|||.+.+..++.++||||+|+++|||++| ..||...... ......
T Consensus 172 fg~a~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~ 245 (298)
T 3f66_A 172 FGLARDMYDKEY----YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL 245 (298)
T ss_dssp CGGGCCCSCGGG----CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHH
T ss_pred ccccccccccch----hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHH
Confidence 999987654321 111223345688999999999999999999999999999999995 5555432221 111111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcC
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQ 1007 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~~ 1007 (1009)
... ..... +..++..+.+++.+|++.||++|||+.|+++.|+++.+.+.++
T Consensus 246 ~~~-----------~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 246 LQG-----------RRLLQ-----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp HTT-----------CCCCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred hcC-----------CCCCC-----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 110 00000 0112345789999999999999999999999999999988765
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=348.25 Aligned_cols=270 Identities=24% Similarity=0.359 Sum_probs=207.4
Q ss_pred hccCccCCcccccCCceEEEEEE----ecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVL----HENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
.++|++.+.||+|+||.||+|++ ..+++.||||+++.... ...+.+.+|++++++++||||+++++++... +
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence 34688899999999999999994 46789999999974432 3357899999999999999999999997642 2
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
....++||||+++|+|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEEC
Confidence 3567899999999999999976543 389999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+++....... .........||..|+|||++.+..++.++||||+|+++|||++|+.|+..... ...
T Consensus 169 Dfg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~ 237 (302)
T 4e5w_A 169 DFGLTKAIETDKE-----YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA------LFL 237 (302)
T ss_dssp CCTTCEECCTTCC-----EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HHH
T ss_pred cccccccccCCCc-----ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh------HHh
Confidence 9999987654321 11122345688899999999999999999999999999999999998653211 010
Q ss_pred HHhcc-------chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 935 KRALP-------EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 935 ~~~~~-------~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
....+ ..+...+.... .......+..++.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 238 KMIGPTHGQMTVTRLVNTLKEGK----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHCSCCGGGHHHHHHHHHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCCcccccCHHHHHHHHhccC----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00000 00000000000 00011133456889999999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=352.29 Aligned_cols=280 Identities=20% Similarity=0.252 Sum_probs=213.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||.||+|+...+++.||||++........+.+.+|++++++++||||+++++++... .......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCceeE
Confidence 46899999999999999999999889999999998765555567889999999999999999999998642 22345789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++|+|.+++...... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEeCCCCcHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 999999999999999863221 12489999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCcc-ccCCccccccccccccCccccCCCC---CCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 860 KFLSASPLGNVV-ETPSSSIGVKGTIGYVAPEYGLGGE---ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 860 ~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
+........... ..........||+.|+|||++.+.. ++.++||||||+++|||++|+.||...............
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 261 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence 765421100000 0000112345799999999987654 689999999999999999999999753332222222111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcC
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQ 1007 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~~ 1007 (1009)
... ..+ ....+..++.+++.+||+.||.+|||+.|+++.|+.+....+.+
T Consensus 262 ~~~-----------~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 262 NQL-----------SIP-----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp CC-------------CC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred ccC-----------CCC-----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 100 000 00122346889999999999999999999999999887665544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=351.57 Aligned_cols=263 Identities=29% Similarity=0.458 Sum_probs=201.3
Q ss_pred ccCccCCcccccCCceEEEEEEecCC----eEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENG----MLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
++|.+.+.||+|+||+||+|.++.++ ..||||+++.... .....+.+|++++++++||||+++++++.. .
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 118 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----Y 118 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-----C
Confidence 46777899999999999999987443 4699999965432 224578899999999999999999999754 3
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++|+|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D 190 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD 190 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECC
Confidence 678999999999999999987543 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 934 (1009)
||+++........ ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ....
T Consensus 191 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~ 260 (333)
T 1mqb_A 191 FGLSRVLEDDPEA-----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVM 260 (333)
T ss_dssp CCC----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHH
T ss_pred CCcchhhcccccc-----ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----HHHH
Confidence 9999876543211 111223456889999999999999999999999999999999 9999964321 1111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFL 1005 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~ 1005 (1009)
... .+....+. ...+..++.+++.+||+.||++||++.|+++.|+++.+...
T Consensus 261 ~~~--------~~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 261 KAI--------NDGFRLPT-----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp HHH--------HTTCCCCC-----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred HHH--------HCCCcCCC-----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 111 11000000 11233467899999999999999999999999999877543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=341.33 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=208.7
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.... ..+.+.+|++++++++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeE
Confidence 467889999999999999999986 688999999975432 35689999999999999999999999754 35689
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++..... .+++..++.++.|++.|+.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 80 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~ 151 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT 151 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred EEEeCCCCCcHHHHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccc
Confidence 99999999999999987643 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+...... ........+|..|+|||++.+..++.++||||+|+++|||++ |+.||.... ........
T Consensus 152 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~i- 218 (267)
T 3t9t_A 152 RFVLDDQ-------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSEVVEDI- 218 (267)
T ss_dssp GGBCCHH-------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHH-
T ss_pred ccccccc-------ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC-----HHHHHHHH-
Confidence 8654321 012223457889999999998899999999999999999999 899987432 11111111
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
........+ ..+...+.+++.+|++.||++|||++|+++.|+++.+.
T Consensus 219 -------~~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 219 -------STGFRLYKP-----------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -------HTTCCCCCC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------hcCCcCCCC-----------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 000000000 01234578999999999999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=371.11 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=203.2
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
..++|.+.+.||+|+||+||+|.++ .+..||||+++... ...+.+.+|+++|++++||||+++++++.. ...
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~ 253 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI 253 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cce
Confidence 3467888999999999999999996 46789999997543 345789999999999999999999999753 457
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++|+|.++++.... ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~ 326 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL 326 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred EEEehhhcCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcc
Confidence 899999999999999975421 1389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +.....
T Consensus 327 a~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i 394 (452)
T 1fmk_A 327 ARLIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQV 394 (452)
T ss_dssp TC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHH
T ss_pred ceecCCCce-------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH
Confidence 987653211 11223457889999999999999999999999999999999 99999754221 111111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
......+ .+..++..+.+++.+||+.||++|||++++++.|+.+...
T Consensus 395 --------~~~~~~~-----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 395 --------ERGYRMP-----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp --------HTTCCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred --------HcCCCCC-----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 0000000 1113445688999999999999999999999999877543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=358.21 Aligned_cols=261 Identities=23% Similarity=0.273 Sum_probs=203.5
Q ss_pred HHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeecc
Q 047768 694 KELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSI 770 (1009)
Q Consensus 694 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 770 (1009)
++.....++|.+.+.||+|+||+||+|+.+.+|+.||||+++... ....+.+.+|++++.+++||||+++++++..
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~- 132 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD- 132 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-
Confidence 344455689999999999999999999999899999999996432 2234568899999999999999999998654
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV 850 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 850 (1009)
....++||||+++|+|.+++.+... .+++..++.++.|++.||+|||++ +||||||||+|||++.++.
T Consensus 133 ----~~~~~lVmE~~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 133 ----ENYLYLVMEYYVGGDLLTLLSKFGE-----RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp ----SSEEEEEECCCCSCBHHHHHHHHSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred ----CCEEEEEEcCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCC
Confidence 3788999999999999999987543 389999999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccC-------CCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-------GGEASMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
+||+|||+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 201 vkL~DFGla~~~~~~~~-------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGT-------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp EEECCCTTCEECCTTSC-------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred EEEeechhheeccCCCc-------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 99999999987654211 1223467999999999987 467899999999999999999999999743
Q ss_pred ccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 047768 924 FNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDR---MEMTDVVV 995 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---pt~~evl~ 995 (1009)
.. .+......... ....-+.. ......++.+++.+|++ +|.+| |+++|+++
T Consensus 274 ~~-----~~~~~~i~~~~-~~~~~p~~--------------~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 274 ST-----AETYGKIVHYK-EHLSLPLV--------------DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp SH-----HHHHHHHHTHH-HHCCCC------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CH-----HHHHHHHHhcc-cCcCCCcc--------------ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 21 11111111000 00000000 01123457799999999 99988 58888754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=342.51 Aligned_cols=258 Identities=21% Similarity=0.354 Sum_probs=207.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeecccc-------
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDF------- 772 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------- 772 (1009)
..+|.+.+.||+|+||.||+|.+..+++.||||+++... +.+.+|++++++++||||+++++++....+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 457999999999999999999998899999999996432 457789999999999999999998754221
Q ss_pred ----CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC
Q 047768 773 ----KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD 848 (1009)
Q Consensus 773 ----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 848 (1009)
......++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 123567999999999999999986532 2489999999999999999999999 99999999999999999
Q ss_pred CceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCc
Q 047768 849 MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGL 928 (1009)
Q Consensus 849 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~ 928 (1009)
+.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|..|+...
T Consensus 159 ~~~kl~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----- 224 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG---------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----- 224 (284)
T ss_dssp TEEEECCCTTCEESSCCS---------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----
T ss_pred CCEEECcchhheeccccc---------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----
Confidence 999999999998765431 122346899999999999999999999999999999999999986421
Q ss_pred cHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 047768 929 TLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLG 1006 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~ 1006 (1009)
..... .+.+..+.. .....+.+++.+|++.||++|||+.|+++.++.+++....
T Consensus 225 --~~~~~--------~~~~~~~~~--------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 225 --SKFFT--------DLRDGIISD--------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp --HHHHH--------HHHTTCCCT--------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred --HHHHH--------Hhhcccccc--------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 11111 011111100 1123467899999999999999999999999988776544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=340.91 Aligned_cols=261 Identities=21% Similarity=0.354 Sum_probs=205.8
Q ss_pred HhccCccCCcccccCCceEEEEEEec---CCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHE---NGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
..++|.+.+.||+|+||+||+|++.. ++..||||+++.... ...+.+.+|++++++++||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 84 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----- 84 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence 34689999999999999999999763 235699999865422 235678999999999999999999998643
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
...++||||+++++|.+++..... .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLG 155 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEEC
T ss_pred -CCCEEEEecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeC
Confidence 345899999999999999987653 389999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 933 (1009)
|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ....
T Consensus 156 Dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~ 226 (281)
T 3cc6_A 156 DFGLSRYIEDEDY-------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGV 226 (281)
T ss_dssp CCCGGGCC----------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHH
T ss_pred ccCCCcccccccc-------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHH
Confidence 9999987654321 11223457889999999998999999999999999999998 999997433221 1111
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
...... ...+ ..+...+.+++.+|++.||++|||+.|+++.|+.+.+.-
T Consensus 227 ~~~~~~-----------~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 227 LEKGDR-----------LPKP-----------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp HHHTCC-----------CCCC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HhcCCC-----------CCCC-----------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 111000 0000 112345789999999999999999999999999887653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=346.92 Aligned_cols=272 Identities=21% Similarity=0.272 Sum_probs=198.2
Q ss_pred ccCccC-CcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSS-NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
+.|.+. +.||+|+||+||+|++..+++.||||+++.........+.+|++++.++ +||||+++++++... ...
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-----~~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-----DRF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CEE
Confidence 467774 7899999999999999889999999999766555567899999999995 799999999997643 678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc---eEEec
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV---AHVSD 855 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---~kl~D 855 (1009)
++||||+++|+|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++. +||+|
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred EEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEE
Confidence 99999999999999998764 389999999999999999999999 9999999999999998776 99999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCC-----CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-----GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL 930 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~ 930 (1009)
||+++........... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+...
T Consensus 158 fg~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 236 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPI-STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236 (316)
T ss_dssp TTCCC--------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC
T ss_pred ccCccccccCCccccc-cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc
Confidence 9999866432111100 1112223569999999999875 568899999999999999999999997643322110
Q ss_pred HHHHH-Hhccch-hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 931 HEFAK-RALPEK-VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 931 ~~~~~-~~~~~~-~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..... ...... ...+...... .+... ......++.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~i~~~~~~-~~~~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 237 DRGEACPACQNMLFESIQEGKYE-FPDKD-------WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp ----CCHHHHHHHHHHHHHCCCC-CCHHH-------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccchhHHHHHHHHHhccCcc-cCchh-------cccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00000 000000 0011111110 11000 0012346789999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=357.39 Aligned_cols=276 Identities=22% Similarity=0.326 Sum_probs=214.3
Q ss_pred HHHHhccCccCCcccccCCceEEEEEEecCC-----eEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeee
Q 047768 696 LSKATNEFSSSNTIGRGSFGFVYKGVLHENG-----MLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICS 768 (1009)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 768 (1009)
.....++|.+.+.||+|+||.||+|.+..++ +.||||+++.... ...+.+.+|+++++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3344578999999999999999999987555 3799999965432 2346788999999999 8999999999975
Q ss_pred ccccCCCceEEEEEeccCCCCHHHHHhccCCC--------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCC
Q 047768 769 SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQ--------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKP 840 (1009)
Q Consensus 769 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~ 840 (1009)
.. ...++||||+++|+|.+++...... .....+++..++.++.|++.||+|||++ +|+||||||
T Consensus 121 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 192 (333)
T 2i1m_A 121 HG-----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAA 192 (333)
T ss_dssp SS-----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred cC-----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCccc
Confidence 43 5689999999999999999764310 0012479999999999999999999999 999999999
Q ss_pred CceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCC
Q 047768 841 SNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRP 919 (1009)
Q Consensus 841 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p 919 (1009)
+||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+| |..|
T Consensus 193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 266 (333)
T 2i1m_A 193 RNVLLTNGHVAKIGDFGLARDIMNDSN------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266 (333)
T ss_dssp GGCEEEGGGEEEBCCCGGGCCGGGCTT------SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred ceEEECCCCeEEECccccccccccccc------eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999986644321 011223557889999999999999999999999999999999 8999
Q ss_pred CcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 920 TESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
|....... ............ .. +..++..+.+++.+||+.||.+|||+.|+++.|++
T Consensus 267 ~~~~~~~~-~~~~~~~~~~~~-----------~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 267 YPGILVNS-KFYKLVKDGYQM-----------AQ-----------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp STTCCSSH-HHHHHHHHTCCC-----------CC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcccchhH-HHHHHHhcCCCC-----------CC-----------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 87543221 111111111000 00 01123457899999999999999999999999999
Q ss_pred HHHhhhcCC
Q 047768 1000 ARQNFLGQR 1008 (1009)
Q Consensus 1000 i~~~~~~~~ 1008 (1009)
+.++...+|
T Consensus 324 ~~~~~~~~r 332 (333)
T 2i1m_A 324 QAQEDRRER 332 (333)
T ss_dssp HHHHHHHHC
T ss_pred HHHhhhccC
Confidence 888765543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=356.00 Aligned_cols=255 Identities=21% Similarity=0.278 Sum_probs=194.3
Q ss_pred ccCccC-CcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHh-cCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSS-NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRS-IRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|.+. +.||+|+||+||+|.++.+++.||||+++. ...+.+|++++.+ .+||||+++++++... +.+....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcEE
Confidence 456665 689999999999999999999999999852 3567889998754 4899999999987642 2344678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC---CCceEEec
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVSD 855 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~D 855 (1009)
++||||+++|+|.+++..... ..+++.++..++.|++.||.|||+. +||||||||+|||++. ++.+||+|
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeCCCCcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence 999999999999999987542 2489999999999999999999999 9999999999999998 78999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCc--cHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGL--TLHEF 933 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~--~~~~~ 933 (1009)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....
T Consensus 208 FG~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 278 (400)
T 1nxk_A 208 FGFAKETTSH---------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 278 (400)
T ss_dssp CTTCEECC--------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH
T ss_pred cccccccCCC---------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH
Confidence 9999865432 122346789999999999999999999999999999999999999975432211 11111
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.... ...+..+. ...+..++.+++.+||+.||++|||+.|+++.
T Consensus 279 i~~~----~~~~~~~~---------------~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 279 IRMG----QYEFPNPE---------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHHT----CCCCCTTT---------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHcC----cccCCCcc---------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1100 00000000 01223457899999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=378.47 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=202.0
Q ss_pred cccccCCceEEEEEEe--cCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEEec
Q 047768 708 TIGRGSFGFVYKGVLH--ENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEY 784 (1009)
Q Consensus 708 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 784 (1009)
.||+|+||.||+|.++ .++..||||+++.... ...+.+.+|+++|++++||||++++++|.. +..++||||
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~~lv~E~ 416 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEM 416 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSEEEEEEC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCeEEEEEe
Confidence 7999999999999886 3567899999975432 345789999999999999999999999753 357999999
Q ss_pred cCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCC
Q 047768 785 MQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSA 864 (1009)
Q Consensus 785 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 864 (1009)
+++|+|.+++..... .+++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+++....
T Consensus 417 ~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 417 AGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp CTTCBHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999976543 389999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccchhh
Q 047768 865 SPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPEKVM 943 (1009)
Q Consensus 865 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1009)
... .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+...
T Consensus 489 ~~~-----~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~------ 555 (613)
T 2ozo_A 489 DDS-----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQG------ 555 (613)
T ss_dssp ------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHTT------
T ss_pred CCc-----eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcC------
Confidence 211 0011122346789999999999999999999999999999998 99999754322 111111110
Q ss_pred hccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 047768 944 EIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLG 1006 (1009)
Q Consensus 944 ~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~ 1006 (1009)
.... .+..++.++.+++.+||+.||++||++.+|++.|+.+......
T Consensus 556 -----~~~~-----------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 556 -----KRME-----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp -----CCCC-----------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred -----CCCC-----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 0000 1113446788999999999999999999999999998876543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=351.96 Aligned_cols=245 Identities=20% Similarity=0.252 Sum_probs=199.1
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 774 (1009)
..++|.+.+.||+|+||.||+|+++.+++.||||+++... ....+.+.+|.+++..+ +||+|+++++++..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----- 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----- 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-----
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-----
Confidence 4578999999999999999999999889999999997542 23456788999999988 89999999998654
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
....++||||+++|+|.+++..... +++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~ 163 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVGR------FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA 163 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEE
Confidence 3688999999999999999987543 89999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+..
T Consensus 164 DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~ 230 (353)
T 2i0e_A 164 DFGMCKENIWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----EDELF 230 (353)
T ss_dssp CCTTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHH
T ss_pred eCCcccccccCC--------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC-----HHHHH
Confidence 999998543211 22334679999999999999999999999999999999999999997432 11221
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~ 990 (1009)
...... ... .+ .....++.+++.+|++.||++||++
T Consensus 231 ~~i~~~--------~~~-~p-----------~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 231 QSIMEH--------NVA-YP-----------KSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp HHHHHC--------CCC-CC-----------TTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred HHHHhC--------CCC-CC-----------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111111 000 00 0122457799999999999999964
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=346.42 Aligned_cols=252 Identities=22% Similarity=0.284 Sum_probs=204.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc------chHHHHHHHHHHHhcCCCCcceEEeeeeccccC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG------GSKSFAAECEALRSIRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 773 (1009)
.++|.+.+.||+|+||.||+|+++.+|+.||||+++..... ..+.+.+|++++++++||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 86 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN---- 86 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 35799999999999999999999989999999999754322 24679999999999999999999999754
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC----
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM---- 849 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---- 849 (1009)
....++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 87 -RTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcC
Confidence 367899999999999999998654 389999999999999999999999 999999999999999888
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCcc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLT 929 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~ 929 (1009)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 157 ~~kl~Dfg~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---- 223 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDGV---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---- 223 (321)
T ss_dssp CEEECCCTTCEECCTTC---------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----
T ss_pred CEEEccCccceecCccc---------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH----
Confidence 79999999998765421 12235689999999999999999999999999999999999999964321
Q ss_pred HHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 930 LHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...... +........+.. .......+.+++.+|++.||++|||+.|+++
T Consensus 224 -~~~~~~--------i~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 224 -QETLAN--------ITSVSYDFDEEF--------FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -HHHHHH--------HHTTCCCCCHHH--------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -HHHHHH--------HHhcccccChhh--------hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111111 111011000000 0012345789999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=347.83 Aligned_cols=253 Identities=21% Similarity=0.343 Sum_probs=202.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCC-------eEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeecccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENG-------MLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 772 (1009)
.++|.+.+.||+|+||+||+|+++.++ ..||+|+++.......+.+.+|++++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG-- 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT--
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC--
Confidence 457899999999999999999998666 57999999766655667899999999999999999999997643
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc--
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV-- 850 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~-- 850 (1009)
...++||||+++|+|.+++..... .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.
T Consensus 85 ---~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 153 (289)
T 4fvq_A 85 ---DENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRK 153 (289)
T ss_dssp ---TCCEEEEECCTTCBHHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGG
T ss_pred ---CCCEEEEECCCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccc
Confidence 567899999999999999987653 389999999999999999999999 9999999999999998887
Q ss_pred ------eEEeccccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCccc
Q 047768 851 ------AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 851 ------~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
+||+|||+++..... ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+...
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 154 TGNPPFIKLSDPGISITVLPK------------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp GTBCCEEEECCCCSCTTTSCH------------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccccceeeeccCcccccccCc------------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 999999998754321 12457899999999887 77899999999999999999965554322
Q ss_pred ccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 047768 924 FNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQ 1002 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~ 1002 (1009)
... ........ .....+. ....++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 222 ~~~----~~~~~~~~--------~~~~~~~-------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 222 LDS----QRKLQFYE--------DRHQLPA-------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp SCH----HHHHHHHH--------TTCCCCC-------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred cch----HHHHHHhh--------ccCCCCC-------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 11110000 0000000 011246799999999999999999999999987654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.65 Aligned_cols=253 Identities=21% Similarity=0.338 Sum_probs=203.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||.||+|.++.+++.||+|++...... ..+.+.+|++++++++||||+++++++.. ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-----CCE
Confidence 46899999999999999999999989999999999754322 23578899999999999999999999754 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc---eEEe
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV---AHVS 854 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---~kl~ 854 (1009)
.++||||+++++|.+++..... +++.++..++.|++.|++|||+. +|+||||||+||+++.++. +||+
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEecCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 8999999999999999887643 89999999999999999999999 9999999999999976655 9999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||++...... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ....
T Consensus 151 Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~ 216 (284)
T 3kk8_A 151 DFGLAIEVNDS---------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLY 216 (284)
T ss_dssp CCTTCEECCSS---------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH
T ss_pred eceeeEEcccC---------ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-----hHHH
Confidence 99999866542 122345789999999999999999999999999999999999999964321 1111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.... ........+.. .....++.+++.+|++.||++|||++|+++.
T Consensus 217 ~~~~-~~~~~~~~~~~---------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 217 AQIK-AGAYDYPSPEW---------------DTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHH-HTCCCCCTTTT---------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHH-hccccCCchhh---------------cccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1110 00000000000 1123457899999999999999999999873
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=340.51 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=200.6
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
+.|.+.+.||+|+||+||+|.+..++..||+|++..... ...+.+.+|++++++++||||+++++++... ..+....
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceE
Confidence 457778899999999999999999999999999975432 2346788999999999999999999987653 3345678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCceeeC-CCCceEEec
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPP--IVHGDLKPSNVLLD-HDMVAHVSD 855 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrdlk~~Nill~-~~~~~kl~D 855 (1009)
++||||+++|+|.+++..... +++..++.++.|++.||.|||+. + |+||||||+||+++ .++.+||+|
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~D 175 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred EEEEEecCCCCHHHHHHHccC------CCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEee
Confidence 999999999999999987543 89999999999999999999998 7 99999999999997 789999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++..... ......||+.|+|||++. +.++.++||||+|+++|||++|+.||...... .....
T Consensus 176 fg~~~~~~~~----------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~ 240 (290)
T 1t4h_A 176 LGLATLKRAS----------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYR 240 (290)
T ss_dssp TTGGGGCCTT----------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHH
T ss_pred CCCccccccc----------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH----HHHHH
Confidence 9999754332 222356899999999876 45899999999999999999999999743221 11111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... ...... .......++.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~~---------~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 241 RVTS---------GVKPAS---------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHTT---------TCCCGG---------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhc---------cCCccc---------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1110 000000 00111245789999999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=363.38 Aligned_cols=248 Identities=27% Similarity=0.381 Sum_probs=203.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|++..+|+.||||+++... ......+.+|+++++.++||||+++++++... .
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----S 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence 357899999999999999999999899999999996442 22346789999999999999999999997543 6
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DF 160 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 160 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEec
Confidence 7899999999999999998654 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++...... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... .....
T Consensus 161 G~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~~~~~ 226 (476)
T 2y94_A 161 GLSNMMSDGE---------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----PTLFK 226 (476)
T ss_dssp SSCEECCTTC---------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----HHHHH
T ss_pred cchhhccccc---------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----HHHHH
Confidence 9998765421 1234579999999999988776 7899999999999999999999974321 11111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. +.+.... .+ .....++.+++.+|++.||++|||+.|+++
T Consensus 227 ~--------i~~~~~~-~p-----------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 227 K--------ICDGIFY-TP-----------QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp H--------HHTTCCC-CC-----------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H--------HhcCCcC-CC-----------ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1 1111110 00 011235779999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=362.28 Aligned_cols=207 Identities=25% Similarity=0.349 Sum_probs=160.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||+||+|+++.+++.||||++..... ...+.+.+|++++++++||||+++++++..........
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 3689999999999999999999999999999999854322 23467889999999999999999999986654555577
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+ +|+|.+++.... .+++..++.++.|++.||+|||+. +||||||||+|||++.++.+||+|||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFG 201 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG 201 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecc-ccchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccc
Confidence 89999998 579999997654 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCcc-------------------ccCCccccccccccccCcccc-CCCCCCCcccchHHHHHHHHHHhC
Q 047768 858 LAKFLSASPLGNVV-------------------ETPSSSIGVKGTIGYVAPEYG-LGGEASMRGGVYSYGILLLEIFTR 916 (1009)
Q Consensus 858 la~~~~~~~~~~~~-------------------~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~elltg 916 (1009)
+|+........... .......+.+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 99877533211000 001123456789999999976 566799999999999999999994
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=350.41 Aligned_cols=249 Identities=22% Similarity=0.276 Sum_probs=179.7
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCceEEEEEec
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDFKALVYEY 784 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~ 784 (1009)
.+.||+|+||+||+|.++.+++.||||+++.. ....+.+|+++++.+. ||||+++++++.. ....++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-----~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD-----QLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-----CCEEEEEEEc
Confidence 47899999999999999999999999998643 3467889999999997 9999999999754 3678999999
Q ss_pred cCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC---ceEEeccccccc
Q 047768 785 MQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHVSDFGLAKF 861 (1009)
Q Consensus 785 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---~~kl~DfGla~~ 861 (1009)
+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++.
T Consensus 88 ~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 88 LNGGELFERIKKKK------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp CCSCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 99999999998764 389999999999999999999999 999999999999997765 899999999986
Q ss_pred cCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccC--CccHHHHHHHhcc
Q 047768 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNE--GLTLHEFAKRALP 939 (1009)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~ 939 (1009)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.....
T Consensus 159 ~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-- 228 (325)
T 3kn6_A 159 KPPDN--------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-- 228 (325)
T ss_dssp CCC------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH--
T ss_pred cCCCC--------CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH--
Confidence 54321 1223456899999999999999999999999999999999999999754321 11112221111
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.......... .......++.+++.+|++.||++|||++|+++
T Consensus 229 ------~~~~~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 229 ------KKGDFSFEGE--------AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp ------TTTCCCCCSH--------HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ------HcCCCCCCcc--------cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 1111110000 00122356789999999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=350.26 Aligned_cols=274 Identities=24% Similarity=0.379 Sum_probs=213.3
Q ss_pred hccCccCCcccccCCceEEEEEE----ecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVL----HENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|.+.+.||+|+||.||+|++ ..+++.||||++........+.+.+|++++++++||||+++++++... +.
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---CC
Confidence 45788999999999999999995 457899999999765554557899999999999999999999987542 23
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++++|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~D 188 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 188 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred CceEEEEECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEec
Confidence 467899999999999999987653 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++........ ........++..|+|||++.+..++.++||||||+++|||+||+.|+..... .+..
T Consensus 189 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~------~~~~ 257 (326)
T 2w1i_A 189 FGLTKVLPQDKEY-----YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMR 257 (326)
T ss_dssp CTTCEECCSSCSE-----EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH------HHHH
T ss_pred Ccchhhccccccc-----cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH------HHHH
Confidence 9999876543210 0112234577889999999998999999999999999999999999763211 1110
Q ss_pred Hhcc--------chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 047768 936 RALP--------EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFL 1005 (1009)
Q Consensus 936 ~~~~--------~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~ 1005 (1009)
.... ..+.+.+..... ......++.++.+++.+||+.||++|||+.|+++.|+++++.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 258 MIGNDKQGQMIVFHLIELLKNNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHCTTCCTHHHHHHHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hhccccchhhhHHHHHHHhhcCCC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 0000 001111111000 01112344568899999999999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=342.40 Aligned_cols=263 Identities=25% Similarity=0.426 Sum_probs=209.6
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
..++|.+.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~ 82 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPI 82 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC------CCc
Confidence 3468899999999999999999975 67889999986443 346789999999999999999999998653 347
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++++|.+++..... ..+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 155 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGL 155 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcc
Confidence 899999999999999976431 1389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.....
T Consensus 156 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~~~ 223 (279)
T 1qpc_A 156 ARLIEDNEY-------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEVIQNL 223 (279)
T ss_dssp CEECSSSCE-------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHH
T ss_pred cccccCccc-------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-----HHHHHHH
Confidence 987654321 11223457889999999998899999999999999999999 8999874321 1111111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcC
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQ 1007 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~~ 1007 (1009)
. ...... ....+..++.+++.+|++.||++|||+.++++.|+++......+
T Consensus 224 ~--------~~~~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 224 E--------RGYRMV-----------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp H--------TTCCCC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred h--------cccCCC-----------CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 0 000000 01123346889999999999999999999999999988776543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=339.54 Aligned_cols=250 Identities=23% Similarity=0.388 Sum_probs=183.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----SN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----SS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----CC
Confidence 467999999999999999999998899999999996442 2234678999999999999999999999754 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++++|.+++..... .+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~df 156 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVK-----PFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADF 156 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecCCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEee
Confidence 78999999999999999987543 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .
T Consensus 157 g~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~--- 220 (278)
T 3cok_A 157 GLATQLKMPH--------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----T--- 220 (278)
T ss_dssp TTCEECC------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------
T ss_pred cceeeccCCC--------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----H---
Confidence 9998764321 11223568999999999999999999999999999999999999997432211 0
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.......... .+ .....++.+++.+|++.||++|||++|+++
T Consensus 221 -----~~~~~~~~~~-~~-----------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 221 -----LNKVVLADYE-MP-----------SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --------CCSSCCC-CC-----------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----HHHHhhcccC-Cc-----------cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0011100000 00 112345789999999999999999999976
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=347.73 Aligned_cols=264 Identities=23% Similarity=0.346 Sum_probs=206.5
Q ss_pred HhccCccCC-cccccCCceEEEEEE--ecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccC
Q 047768 699 ATNEFSSSN-TIGRGSFGFVYKGVL--HENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 699 ~~~~~~~~~-~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 773 (1009)
..++|.+.+ .||+|+||+||+|.+ ..+++.||||+++..... ..+.+.+|++++++++||||+++++++..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 89 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---- 89 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES----
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC----
Confidence 346788877 999999999999965 456789999999654322 24678999999999999999999999732
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEE
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 853 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 853 (1009)
...++||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 90 --~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl 158 (291)
T 1xbb_A 90 --ESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKI 158 (291)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEE
T ss_pred --CCcEEEEEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEE
Confidence 56789999999999999998754 389999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHH
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHE 932 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 932 (1009)
+|||+++....... .........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ....
T Consensus 159 ~Dfg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~ 231 (291)
T 1xbb_A 159 SDFGLSKALRADEN-----YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTA 231 (291)
T ss_dssp CCCTTCEECCTTCS-----EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH
T ss_pred ccCCcceeeccCCC-----cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHH
Confidence 99999987654321 0011222446789999999998899999999999999999999 99999753221 1111
Q ss_pred HHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 047768 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLG 1006 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~ 1006 (1009)
..... .... ....+...+.+++.+||+.||++||++.|+++.|+++.....+
T Consensus 232 ~~~~~-----------~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 232 MLEKG-----------ERMG-----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp HHHTT-----------CCCC-----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHcC-----------CCCC-----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 11100 0000 0112345688999999999999999999999999998876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=342.58 Aligned_cols=263 Identities=23% Similarity=0.375 Sum_probs=208.7
Q ss_pred ccCccCC-cccccCCceEEEEEEe--cCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 701 NEFSSSN-TIGRGSFGFVYKGVLH--ENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 701 ~~~~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
++|.+.+ .||+|+||.||+|.+. .++..||||+++.... ...+.+.+|++++++++||||+++++++.. .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC------C
Confidence 4566665 8999999999999864 4678899999975432 234678999999999999999999999732 4
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++++|.+++..... .+++.+++.++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Df 154 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF 154 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred CcEEEEEeCCCCCHHHHHHhCCc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcc
Confidence 57999999999999999976543 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++....... .........||+.|+|||++.+..++.++||||||+++|||++ |+.||...... .......
T Consensus 155 g~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i~ 227 (287)
T 1u59_A 155 GLSKALGADDS-----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIE 227 (287)
T ss_dssp TTCEECTTCSC-----EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHH
T ss_pred cceeeeccCcc-----eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHh
Confidence 99987654321 0111223457899999999988899999999999999999999 99999754321 1111111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLG 1006 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~ 1006 (1009)
.. ..... +..++.++.+++.+||+.||++||++.|+++.|+++..+...
T Consensus 228 ~~-----------~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 228 QG-----------KRMEC-----------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp TT-----------CCCCC-----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred cC-----------CcCCC-----------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 10 00000 112345688999999999999999999999999999887654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=342.82 Aligned_cols=268 Identities=24% Similarity=0.374 Sum_probs=208.7
Q ss_pred cCccCCcccccCCceEEEEEEecCCe---EEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGM---LVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.|...+.||+|+||+||+|.+..++. .||+|+++.... ...+.+.+|++++++++||||+++++++... ...
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP----EGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----SSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----CCC
Confidence 45667899999999999999865443 799999864332 2346788999999999999999999997542 244
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++|+||+.+|+|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg 169 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQR-----NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFG 169 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTT
T ss_pred cEEEEecccCCCHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCC
Confidence 5899999999999999987543 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+++....... ..........+|+.|+|||.+.+..++.++||||||+++|||++|..|+...... ..........
T Consensus 170 ~~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~ 244 (298)
T 3pls_A 170 LARDILDREY----YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQG 244 (298)
T ss_dssp SSCTTTTGGG----GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHHHTT
T ss_pred CcccccCCcc----cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHhhcC
Confidence 9986643211 1112223456889999999999999999999999999999999966665432221 1111111111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcCC
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQR 1008 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~~~ 1008 (1009)
.. ... ...+...+.+++.+|++.||.+|||+.|+++.|+++.+.+....
T Consensus 245 ~~-----------~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 245 RR-----------LPQ-----------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp CC-----------CCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred CC-----------CCC-----------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 00 000 01223467899999999999999999999999999998876543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.00 Aligned_cols=263 Identities=20% Similarity=0.232 Sum_probs=199.2
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccc---hHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG---SKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
..++|.+.+.||+|+||.||+|++..+++.||||+++...... .+.+.+|++++++++||||+++++++...
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~----- 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID----- 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-----
Confidence 3578999999999999999999999899999999996543322 36788999999999999999999997653
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~D 177 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVD 177 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred CeEEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEec
Confidence 67899999999999999998754 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......
T Consensus 178 fg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~ 248 (309)
T 2h34_A 178 FGIASATTDEKL-------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHIN 248 (309)
T ss_dssp CCC-----------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHH
T ss_pred CccCcccccccc-------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhc
Confidence 999986654221 1122356899999999999999999999999999999999999999743211 1111110
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHhh
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-EMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-t~~evl~~L~~i~~~~ 1004 (1009)
. .... +. .....++.++.+++.+||+.||++|| +++++++.|+.+.+..
T Consensus 249 ----~--------~~~~-~~-------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 249 ----Q--------AIPR-PS-------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp ----S--------CCCC-GG-------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ----c--------CCCC-cc-------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0 0000 00 00112234578999999999999999 9999999998765544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=338.39 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=204.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||+||+|++. ++.||||+++.... ...+.+.+|++++++++||||+++++++... ....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence 457899999999999999999984 89999999975432 2345789999999999999999999997542 2356
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCceeeCCCCceEEec
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPP--IVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
.++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||++ + |+||||||+||+++.++.++++|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred eEeeecccCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEe
Confidence 7999999999999999987543 2489999999999999999999998 7 99999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCC---cccchHHHHHHHHHHhCCCCCcccccCCccHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASM---RGGVYSYGILLLEIFTRRRPTESMFNEGLTLHE 932 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~ 932 (1009)
||++..... ....||+.|+|||++.+..++. ++|||||||++|||++|+.||...... .
T Consensus 157 ~~~~~~~~~-------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~ 218 (271)
T 3kmu_A 157 ADVKFSFQS-------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-----E 218 (271)
T ss_dssp GGSCCTTSC-------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-----H
T ss_pred ccceeeecc-------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-----H
Confidence 998764322 1246899999999988776554 799999999999999999999743221 1
Q ss_pred HHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 047768 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQ 1002 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~ 1002 (1009)
......... ..+.. +..+..++.+++.+||+.||++|||++|+++.|+++.+
T Consensus 219 ~~~~~~~~~----~~~~~--------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 219 IGMKVALEG----LRPTI--------------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHSC----CCCCC--------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHhcC----CCCCC--------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111110000 00000 01223457899999999999999999999999998865
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=359.27 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=194.0
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--------cchHHHHHHHHHHHhcCCCCcceEEeeeecc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--------GGSKSFAAECEALRSIRHRNLIKIVTICSSI 770 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 770 (1009)
..++|.+.+.||+|+||+||+|.++.+++.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 35689999999999999999999999999999999965421 112358899999999999999999998643
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC--
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD-- 848 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-- 848 (1009)
...++||||+++|+|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 212 -----~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 212 -----EDYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp -----SEEEEEEECCTTCBGGGGTSSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSS
T ss_pred -----CceEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCC
Confidence 45789999999999999887654 389999999999999999999999 99999999999999654
Q ss_pred -CceEEeccccccccCCCCCCCccccCCccccccccccccCccccCC---CCCCCcccchHHHHHHHHHHhCCCCCcccc
Q 047768 849 -MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG---GEASMRGGVYSYGILLLEIFTRRRPTESMF 924 (1009)
Q Consensus 849 -~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~ 924 (1009)
+.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 278 ~~~~kl~DFG~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGET---------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp SCCEEECCSSTTTSCC--------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred cceEEEeecccceecCCC---------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 45999999999876532 12234679999999999864 678899999999999999999999997533
Q ss_pred cCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 925 NEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... ......... .....+.. ......++.+++.+|++.||++|||++|+++
T Consensus 349 ~~~-~~~~~i~~~-----------~~~~~~~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 349 TQV-SLKDQITSG-----------KYNFIPEV--------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SSC-CHHHHHHTT-----------CCCCCHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred chH-HHHHHHhcC-----------CCCCCchh--------hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 221 222221111 00000100 0012346789999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=359.81 Aligned_cols=269 Identities=22% Similarity=0.275 Sum_probs=208.7
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||.||+|++..+++.||||+++.... ...+.+|+++++.++|++.+..+.++.. .....+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEE
Confidence 3689999999999999999999988999999998865433 3568899999999987554444444322 236789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee---CCCCceEEecc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDF 856 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Df 856 (1009)
+||||+ +++|.+++..... .+++.+++.|+.||+.||+|||++ +||||||||+|||+ +.++.+||+||
T Consensus 80 lvme~~-g~sL~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred EEEECC-CCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeC
Confidence 999999 9999999986543 399999999999999999999999 99999999999999 68899999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCC--ccHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEG--LTLHEFA 934 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~--~~~~~~~ 934 (1009)
|+++........... .........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+.
T Consensus 151 Gla~~~~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHI-PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (483)
T ss_dssp TTCEECBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH
T ss_pred CcceeccCCcccccc-ccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh
Confidence 999887654321111 1122235679999999999999999999999999999999999999997643321 1111111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
..........+. ..++.++.+++..||+.||++||++.+|++.|+++...
T Consensus 230 ~~~~~~~~~~l~-------------------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 230 EKKVATSIEALC-------------------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHHHHSCHHHHH-------------------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred hccccccHHHHh-------------------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 111111111110 12245688999999999999999999999999988654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=345.19 Aligned_cols=267 Identities=22% Similarity=0.301 Sum_probs=200.7
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|.+..+|+.||||+++.... .....+.+|++++++++||||+++++++... .
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----N 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----C
Confidence 4579999999999999999999988999999999975322 2345788999999999999999999997653 6
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++++|.+++...... ...+++.+++.++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Df 180 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQ--KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL 180 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred cEEEEEecCCCCCHHHHHHHhccc--ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEec
Confidence 789999999999999999753211 12489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++...... .......|++.|+|||++.+..++.++||||||+++|||++|+.||...... .......
T Consensus 181 g~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~ 249 (310)
T 2wqm_A 181 GLGRFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKK 249 (310)
T ss_dssp --------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC---HHHHHHH
T ss_pred cceeeecCCC--------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh---HHHHHHH
Confidence 9998654321 1122356899999999999999999999999999999999999998643211 1111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFL 1005 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~ 1005 (1009)
.... .....+ ...+..++.+++.+||+.||++|||+.||++.|++++....
T Consensus 250 ~~~~--------~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 250 IEQC--------DYPPLP----------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HHTT--------CSCCCC----------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hhcc--------cCCCCc----------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 1000 000000 01223467899999999999999999999999999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=348.56 Aligned_cols=269 Identities=22% Similarity=0.345 Sum_probs=209.8
Q ss_pred HhccCccCCcccccCCceEEEEEEe-------cCCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeec
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLH-------ENGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSS 769 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 769 (1009)
..++|.+.+.||+|+||.||+|++. .++..||||+++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578999999999999999999985 3567899999965432 2345788999999999 89999999999754
Q ss_pred cccCCCceEEEEEeccCCCCHHHHHhccCCCC----------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCC
Q 047768 770 IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQL----------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLK 839 (1009)
Q Consensus 770 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk 839 (1009)
....++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||+. +|+|||||
T Consensus 113 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlk 184 (334)
T 2pvf_A 113 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLA 184 (334)
T ss_dssp -----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred -----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCc
Confidence 357899999999999999998754211 112489999999999999999999999 99999999
Q ss_pred CCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCC
Q 047768 840 PSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRR 918 (1009)
Q Consensus 840 ~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~ 918 (1009)
|+||+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 258 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDY------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSS------EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cceEEEcCCCCEEEcccccccccccccc------ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999987654321 011223457889999999998999999999999999999999 999
Q ss_pred CCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 047768 919 PTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLC 998 (1009)
Q Consensus 919 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~ 998 (1009)
||.... ..+........ . .... ...+..++.+++.+||+.||.+|||+.|+++.|+
T Consensus 259 p~~~~~-----~~~~~~~~~~~-----~---~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 314 (334)
T 2pvf_A 259 PYPGIP-----VEELFKLLKEG-----H---RMDK-----------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314 (334)
T ss_dssp SSTTCC-----HHHHHHHHHHT-----C---CCCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcCcCC-----HHHHHHHHhcC-----C---CCCC-----------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 986432 11211111000 0 0000 0123346789999999999999999999999999
Q ss_pred HHHHhhh
Q 047768 999 HARQNFL 1005 (1009)
Q Consensus 999 ~i~~~~~ 1005 (1009)
++.+...
T Consensus 315 ~l~~~~~ 321 (334)
T 2pvf_A 315 RILTLTT 321 (334)
T ss_dssp HHHHHHC
T ss_pred HHHhccc
Confidence 9877554
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=352.19 Aligned_cols=247 Identities=26% Similarity=0.327 Sum_probs=198.4
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
+.|...+.||+|+||+||+|++..+++.||||++...... ..+.+.+|++++++++||||+++++++... ..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence 4588889999999999999999889999999999754322 235688999999999999999999997653 67
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+. |++.+++..... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 199 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 199 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred EEEEEecCC-CCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence 899999996 789888875543 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccC---CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL---GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
+++..... ....||+.|+|||++. ++.++.++|||||||++|||++|+.||...... ...
T Consensus 200 ~a~~~~~~------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-----~~~ 262 (348)
T 1u5q_A 200 SASIMAPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SAL 262 (348)
T ss_dssp TCBSSSSB------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHH
T ss_pred CceecCCC------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHH
Confidence 99865421 2356899999999874 577899999999999999999999998643211 111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
...... ..+... ...+...+.+++.+||+.||++|||++|+++.
T Consensus 263 ~~~~~~-----~~~~~~-------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 263 YHIAQN-----ESPALQ-------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHHS-----CCCCCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHhc-----CCCCCC-------------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 110000 000000 01223457799999999999999999999754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=378.86 Aligned_cols=255 Identities=25% Similarity=0.344 Sum_probs=201.5
Q ss_pred CcccccCCceEEEEEEe--cCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLH--ENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
+.||+|+||+||+|.+. .+++.||||+++.... ...+.+.+|++++++++||||++++++|.. ...++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence 47999999999999764 4568999999975433 235789999999999999999999999853 3478999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.++++... .+++.+++.++.|++.||+|||++ +||||||||+|||++.++.+||+|||+++..
T Consensus 449 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred EccCCCCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 9999999999998654 389999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccch
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPEK 941 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
...... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +........
T Consensus 520 ~~~~~~-----~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----~~~~~i~~~- 588 (635)
T 4fl3_A 520 RADENY-----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EVTAMLEKG- 588 (635)
T ss_dssp TC------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHHTT-
T ss_pred ccCccc-----cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcC-
Confidence 543211 112223457889999999999999999999999999999999 99999754321 111110000
Q ss_pred hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 047768 942 VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFL 1005 (1009)
Q Consensus 942 ~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~ 1005 (1009)
.... .+..++.++.+++..||+.||++||++++|++.|+.+..+..
T Consensus 589 -------~~~~-----------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 589 -------ERMG-----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp -------CCCC-----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred -------CCCC-----------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 0000 011344568899999999999999999999999999887654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=340.55 Aligned_cols=249 Identities=22% Similarity=0.355 Sum_probs=201.2
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
+.++|.+.+.||+|+||+||+|.+..+++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA----- 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-----
Confidence 3568999999999999999999999999999999986432 22356789999999999999999999997543
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++|+|.+++..... +++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~------~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~D 152 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLSK------FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 152 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEe
Confidence 678999999999999999987643 89999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.... ......
T Consensus 153 fg~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~ 217 (279)
T 3fdn_A 153 FGWSVHAPSS----------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYK 217 (279)
T ss_dssp CCEESCC------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHH
T ss_pred ccccccCCcc----------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc-----HHHHHH
Confidence 9998654332 1223568999999999999999999999999999999999999997432 111111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.. ... .... +......+.+++.+|++.||++|||+.|+++.
T Consensus 218 ~~-----~~~-~~~~--------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 218 RI-----SRV-EFTF--------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HH-----HHT-CCCC--------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HH-----HhC-CCCC--------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 10 000 0000 01123457799999999999999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=337.06 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=204.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|++.+.||+|+||.||+|+++.+++.||||+++.... ...+.+.+|+++++.++||||+++++++... ...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----CEE
Confidence 4689999999999999999999998999999999975543 2346789999999999999999999997643 678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 151 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 151 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCC
Confidence 99999999999999987643 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+........ ........||+.|+|||++.+..+ +.++||||||+++|||++|+.||............+...
T Consensus 152 ~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~- 224 (276)
T 2yex_A 152 ATVFRYNNR------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK- 224 (276)
T ss_dssp CEECEETTE------ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-
T ss_pred ccccCCCcc------hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-
Confidence 986643211 112234568999999999988775 789999999999999999999997544332222222110
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.....+ .......+.+++.+|++.||++|||++|+++
T Consensus 225 -----------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 225 -----------KTYLNP----------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -----------CTTSTT----------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----------ccccCc----------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000000 0112345779999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=350.28 Aligned_cols=275 Identities=21% Similarity=0.305 Sum_probs=195.0
Q ss_pred HHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
....++|.+.+.||+|+||+||+|++..+++.||||+++..... ..+.+.+|++++++++||||+++++++...
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 105 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN---- 105 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET----
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC----
Confidence 34567899999999999999999999999999999999644322 245678999999999999999999997643
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee-----CCCC
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL-----DHDM 849 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill-----~~~~ 849 (1009)
...++||||++ |+|.+++..... +++.+++.++.|++.||+|||++ +|+||||||+||++ +.++
T Consensus 106 -~~~~lv~e~~~-~~L~~~~~~~~~------~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 174 (329)
T 3gbz_A 106 -HRLHLIFEYAE-NDLKKYMDKNPD------VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETP 174 (329)
T ss_dssp -TEEEEEEECCS-EEHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CC
T ss_pred -CEEEEEEecCC-CCHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccc
Confidence 67899999997 599999987653 89999999999999999999999 99999999999999 4556
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGL 928 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~ 928 (1009)
.+||+|||+++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||......+
T Consensus 175 ~~kl~Dfg~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~- 245 (329)
T 3gbz_A 175 VLKIGDFGLARAFGIPI--------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID- 245 (329)
T ss_dssp EEEECCTTHHHHHC-------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred eEEECcCCCccccCCcc--------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-
Confidence 69999999998764321 122335689999999998875 48999999999999999999999997532211
Q ss_pred cHHHHHHHh-ccch--hhhc--cCCCCCChhhhhh-hccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 929 TLHEFAKRA-LPEK--VMEI--VDPSLLPLEEERT-NSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 929 ~~~~~~~~~-~~~~--~~~~--~d~~l~~~~~~r~-~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
......... .+.. .... ........+..+. ............++.+++.+|++.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 246 QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 111111111 1110 0000 0000000000000 0000001112356789999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=354.51 Aligned_cols=249 Identities=24% Similarity=0.269 Sum_probs=192.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHH-HHhcCCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEA-LRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|.+.+.||+|+||.||+|+++.+++.||||+++.... .....+.+|..+ ++.++||||+++++++.. .
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-----~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----A 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-----C
Confidence 4679999999999999999999999999999999975432 223456667766 567899999999998654 3
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++|+|.+++.+... +++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~D 182 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERC------FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTD 182 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEee
Confidence 688999999999999999987543 88999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+...
T Consensus 183 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~ 249 (373)
T 2r5t_A 183 FGLCKENIEHN--------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TAEMYD 249 (373)
T ss_dssp CCBCGGGBCCC--------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-----HHHHHH
T ss_pred CccccccccCC--------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHH
Confidence 99998643221 22335679999999999999999999999999999999999999997432 112111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... ...+.. + ......+.+++.+|++.||.+||++.+.++
T Consensus 250 ~i~--------~~~~~~-~-----------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 250 NIL--------NKPLQL-K-----------PNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp HHH--------HSCCCC-C-----------SSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred HHH--------hcccCC-C-----------CCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 111 111100 0 012235779999999999999999864433
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=351.09 Aligned_cols=267 Identities=20% Similarity=0.245 Sum_probs=201.8
Q ss_pred HHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-----ccchHHHHHHHHHHHhcCCCCcceEEeeeecc
Q 047768 696 LSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-----KGGSKSFAAECEALRSIRHRNLIKIVTICSSI 770 (1009)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 770 (1009)
+....++|.+.+.||+|+||+||+|.++.+++.||||+++... ....+.+.+|++++++++||||+++++++..
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 99 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED- 99 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-
Confidence 3445678999999999999999999999999999999996442 2334688999999999999999999999754
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCC----------------------------------CccCCCHHHHHHHHH
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQL----------------------------------GICNLSLIQRLNIVI 816 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------------------------------~~~~l~~~~~~~i~~ 816 (1009)
....++||||+++|+|.+++....... ....+++..++.++.
T Consensus 100 ----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 100 ----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp ----SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred ----CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 367899999999999999996321100 011245777889999
Q ss_pred HHHHHHHHHhhcCCCCceecCCCCCceeeCCCC--ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCC
Q 047768 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM--VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG 894 (1009)
Q Consensus 817 ~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 894 (1009)
|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++......... ........||+.|+|||++.+
T Consensus 176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE----YYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC------------CCCGGGCCHHHHTC
T ss_pred HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccc----cccccccCCCccccCchhhcc
Confidence 999999999999 999999999999998776 89999999998765422111 112234579999999999875
Q ss_pred --CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHH
Q 047768 895 --GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAV 972 (1009)
Q Consensus 895 --~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l 972 (1009)
..++.++|||||||++|||++|+.||...... ..... +.......... .......++
T Consensus 249 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~--------~~~~~~~~~~~--------~~~~~~~~~ 307 (345)
T 3hko_A 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA-----DTISQ--------VLNKKLCFENP--------NYNVLSPLA 307 (345)
T ss_dssp SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH--------HHHCCCCTTSG--------GGGGSCHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH-----HHHHH--------HHhcccccCCc--------ccccCCHHH
Confidence 67899999999999999999999999753221 11111 11111100000 001123467
Q ss_pred HHHHhhccCCCCCCCCCHHHHHH
Q 047768 973 IKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 973 ~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.+++.+|++.||.+|||+.|+++
T Consensus 308 ~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 308 RDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCCCHHHHhc
Confidence 89999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=352.82 Aligned_cols=274 Identities=15% Similarity=0.135 Sum_probs=209.5
Q ss_pred hccCccCCcccccCCceEEEEEEec--------CCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcce---------
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHE--------NGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIK--------- 762 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 762 (1009)
.++|.+.+.||+|+||.||+|++.. .++.||||+++.. +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999986 4789999998633 46889999999999999998
Q ss_pred ------EEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceec
Q 047768 763 ------IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHG 836 (1009)
Q Consensus 763 ------l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHr 836 (1009)
+++++.. .....++||||+ +++|.+++..... ..+++.+++.++.|++.||+|||++ +|+||
T Consensus 116 ~~~i~~~~~~~~~----~~~~~~lv~e~~-~~~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~ 183 (352)
T 2jii_A 116 LLAIPTCMGFGVH----QDKYRFLVLPSL-GRSLQSALDVSPK----HVLSERSVLQVACRLLDALEFLHEN---EYVHG 183 (352)
T ss_dssp TCSCCCCCEEEEE----TTTEEEEEEECC-CEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHT---TCBCS
T ss_pred ccCccchhhcccc----CCcEEEEEecCC-CcCHHHHHHhCCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCC
Confidence 4455432 246789999999 9999999987521 2499999999999999999999999 99999
Q ss_pred CCCCCceeeCCCC--ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHH
Q 047768 837 DLKPSNVLLDHDM--VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIF 914 (1009)
Q Consensus 837 dlk~~Nill~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ell 914 (1009)
||||+||+++.++ .+||+|||+++.......... ..........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 184 Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 262 (352)
T 2jii_A 184 NVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA-YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262 (352)
T ss_dssp CCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCC-CCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCceEEEecCcceeeccCCCcccc-ccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 9999999999998 999999999987654321110 0112223457999999999999999999999999999999999
Q ss_pred hCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 047768 915 TRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVV 994 (1009)
Q Consensus 915 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl 994 (1009)
+|+.||................ .......+.+.... ......++.+++.+|++.||++|||++|++
T Consensus 263 ~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 328 (352)
T 2jii_A 263 YGFLPWTNCLPNTEDIMKQKQK-FVDKPGPFVGPCGH-------------WIRPSETLQKYLKVVMALTYEEKPPYAMLR 328 (352)
T ss_dssp HSCCTTGGGTTCHHHHHHHHHH-HHHSCCCEECTTSC-------------EECCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred hCCCCcccCCcCHHHHHHHHHh-ccCChhhhhhhccc-------------cCCCcHHHHHHHHHHHhCChhhCCCHHHHH
Confidence 9999998654222122221111 11111111111110 001234688999999999999999999999
Q ss_pred HHHHHHHHhhh
Q 047768 995 VKLCHARQNFL 1005 (1009)
Q Consensus 995 ~~L~~i~~~~~ 1005 (1009)
+.|+++.+...
T Consensus 329 ~~L~~~~~~~~ 339 (352)
T 2jii_A 329 NNLEALLQDLR 339 (352)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHhcC
Confidence 99999987754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=346.34 Aligned_cols=271 Identities=21% Similarity=0.297 Sum_probs=198.4
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|.+.+.||+|+||+||+|++..+|+.||||++...... ..+.+.+|++++++++||||+++++++... ...
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----CeE
Confidence 5789999999999999999999989999999998544322 245688999999999999999999997643 678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 148 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQR------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGF 148 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCchHHHHHhhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence 99999999999999887654 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++...... .......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||......+ .........
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~ 219 (311)
T 4agu_A 149 ARLLTGPS--------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD-QLYLIRKTL 219 (311)
T ss_dssp CEECC--------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred chhccCcc--------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 98765321 12224568999999999876 678999999999999999999999997543221 111111100
Q ss_pred --ccchhh------hccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 --LPEKVM------EIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 --~~~~~~------~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...... ........+.+..... ...........+.+++.+|++.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEP-LELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CSCCHHHHHHHHTCGGGTTCCCCCCSSCCC-HHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccccCcCCCccccch-hhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 0000000000000000 00000123345789999999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=347.04 Aligned_cols=249 Identities=21% Similarity=0.270 Sum_probs=191.4
Q ss_pred hccCccCCcccccCCceEEEEEEe---cCCeEEEEEEeeccc----ccchHHHHHHHHHHHhcCCCCcceEEeeeecccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLH---ENGMLVAVKVINLEQ----KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 772 (1009)
.++|.+.+.||+|+||.||+|+.. .+++.||||+++... ......+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 92 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--- 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---
Confidence 468999999999999999999985 578999999996432 2234567889999999999999999998754
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceE
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 852 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 852 (1009)
....++||||+++|+|.+++..... +++.++..++.|++.||.|||++ +|+||||||+||+++.++.+|
T Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~k 161 (327)
T 3a62_A 93 --GGKLYLILEYLSGGELFMQLEREGI------FMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVK 161 (327)
T ss_dssp --SSCEEEEEECCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEE
T ss_pred --CCEEEEEEeCCCCCcHHHHHHhCCC------CCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEE
Confidence 3678999999999999999987543 88999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHH
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHE 932 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~ 932 (1009)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 162 l~Dfg~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~ 228 (327)
T 3a62_A 162 LTDFGLCKESIHDG--------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-----KK 228 (327)
T ss_dssp ECCCSCC------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HH
T ss_pred EEeCCcccccccCC--------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-----HH
Confidence 99999997543221 122345799999999999999999999999999999999999999974321 11
Q ss_pred HHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 047768 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVV 995 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~ 995 (1009)
...... ..... .+ .....++.+++.+|++.||++|| ++.|+++
T Consensus 229 ~~~~i~--------~~~~~-~p-----------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 229 TIDKIL--------KCKLN-LP-----------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHH--------HTCCC-CC-----------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHH--------hCCCC-CC-----------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 111111 00000 00 01224577999999999999999 6667654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=351.80 Aligned_cols=274 Identities=21% Similarity=0.355 Sum_probs=212.6
Q ss_pred CHHHHHHHhccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEe
Q 047768 692 SYKELSKATNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVT 765 (1009)
Q Consensus 692 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~ 765 (1009)
..+++....++|.+.+.||+|+||.||+|.++ .+++.||||+++.... .....+.+|++++++++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 33445556788999999999999999999986 3578899999864432 22356889999999999999999999
Q ss_pred eeeccccCCCceEEEEEeccCCCCHHHHHhccCCC----CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 047768 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQ----LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPS 841 (1009)
Q Consensus 766 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~ 841 (1009)
++.. ....++||||+++|+|.+++...... .....+++..++.++.|++.||.|||++ +|+||||||+
T Consensus 96 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~ 167 (322)
T 1p4o_A 96 VVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAAR 167 (322)
T ss_dssp EECS-----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGG
T ss_pred EEcc-----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccc
Confidence 9754 35679999999999999999764310 0112478999999999999999999999 9999999999
Q ss_pred ceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCC
Q 047768 842 NVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPT 920 (1009)
Q Consensus 842 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~ 920 (1009)
||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||+|+++|||++ |+.||
T Consensus 168 NIli~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 241 (322)
T 1p4o_A 168 NCMVAEDFTVKIGDFGMTRDIYETDY------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241 (322)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGC------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred eEEEcCCCeEEECcCccccccccccc------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcc
Confidence 99999999999999999986643211 111223457889999999999999999999999999999999 88998
Q ss_pred cccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 921 ESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
..... ........ ....... ...+...+.+++.+|++.||.+|||+.|+++.|+++
T Consensus 242 ~~~~~-----~~~~~~~~--------~~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 242 QGLSN-----EQVLRFVM--------EGGLLDK-----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp TTSCH-----HHHHHHHH--------TTCCCCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred ccCCH-----HHHHHHHH--------cCCcCCC-----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 64321 11111111 1111111 112334678999999999999999999999999876
Q ss_pred HHh
Q 047768 1001 RQN 1003 (1009)
Q Consensus 1001 ~~~ 1003 (1009)
.+.
T Consensus 298 ~~~ 300 (322)
T 1p4o_A 298 MEP 300 (322)
T ss_dssp SCT
T ss_pred hcc
Confidence 543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=356.63 Aligned_cols=211 Identities=24% Similarity=0.361 Sum_probs=166.0
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~ 775 (1009)
..++|.+.+.||+|+||+||+|.++.+|+.||||++.... ....+.+.+|+.+++++. ||||+++++++... +.
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---ND 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CC
Confidence 3578999999999999999999999999999999985332 223456788999999997 99999999997642 33
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||++ |+|.+++.... +++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~~~-------~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~D 152 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRANI-------LEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVAD 152 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred CEEEEEecccC-cCHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecC
Confidence 56899999997 69999997642 88999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCC-------------ccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCc
Q 047768 856 FGLAKFLSASPLGN-------------VVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTE 921 (1009)
Q Consensus 856 fGla~~~~~~~~~~-------------~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~ 921 (1009)
||+|+......... ............||+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus 153 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp CTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 99998764321100 0001122344679999999999887 678999999999999999999999997
Q ss_pred cc
Q 047768 922 SM 923 (1009)
Q Consensus 922 ~~ 923 (1009)
..
T Consensus 233 ~~ 234 (388)
T 3oz6_A 233 GS 234 (388)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=337.83 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=196.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
++|.+.+.||+|+||+||+|.++.++..||+|++..... ...+.+.+|++++++++||||+++++++.. ....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-----YHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-----CCeEE
Confidence 579999999999999999999998999999999976543 345789999999999999999999999754 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee---CCCCceEEecc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDF 856 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Df 856 (1009)
+||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQAR--GKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEeCCCCcHHHHHHhhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEee
Confidence 999999999999998653211 12489999999999999999999999 99999999999999 55688999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++..... .......||+.|+|||++. +.++.++||||+|+++|||++|+.||..... ......
T Consensus 172 g~a~~~~~~---------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-----~~~~~~ 236 (285)
T 3is5_A 172 GLAELFKSD---------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-----EEVQQK 236 (285)
T ss_dssp CCCCC-------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred ecceecCCc---------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-----HHHHhh
Confidence 999865432 1223456899999999875 5789999999999999999999999974321 111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... ......... .+...++.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~------~~~~~~~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 237 ATY------KEPNYAVEC-----------RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHH------CCCCCCC-------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred hcc------CCccccccc-----------CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000000000 012245779999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=335.83 Aligned_cols=259 Identities=22% Similarity=0.294 Sum_probs=204.6
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc------chHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG------GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
++|.+.+.||+|+||.||+|+++.+++.||||+++..... ..+.+.+|++++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN----- 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence 5789999999999999999999989999999999754321 35679999999999999999999999764
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC----c
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM----V 850 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~----~ 850 (1009)
....++||||+++++|.+++.... .+++.+++.++.|++.||.|||++ +|+||||||+||+++.++ .
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~ 150 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPR 150 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCC
T ss_pred CCeEEEEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCc
Confidence 367899999999999999998654 389999999999999999999999 999999999999998877 8
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccH
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL 930 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~ 930 (1009)
+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 151 ~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----- 216 (283)
T 3bhy_A 151 IKLIDFGIAHKIEAGN---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK----- 216 (283)
T ss_dssp EEECCCTTCEECC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----
T ss_pred eEEEecccceeccCCC---------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-----
Confidence 9999999998764321 12235689999999999999999999999999999999999999974321
Q ss_pred HHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHHHHh
Q 047768 931 HEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV--KLCHARQN 1003 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~--~L~~i~~~ 1003 (1009)
...... +........... .......+.+++.+|++.||++|||+.|+++ .++.+++.
T Consensus 217 ~~~~~~--------~~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 217 QETLTN--------ISAVNYDFDEEY--------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp HHHHHH--------HHTTCCCCCHHH--------HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred HHHHHH--------hHhcccCCcchh--------cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 111111 000000000000 0112345789999999999999999999997 45555443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=340.87 Aligned_cols=255 Identities=31% Similarity=0.396 Sum_probs=199.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||.||+|++. |+.||||+++.. ...+.+.+|++++++++||||+++++++.. .....+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCceE
Confidence 468999999999999999999874 899999998643 245789999999999999999999998643 234679
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++..... ..+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred EEEecCCCCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccc
Confidence 99999999999999986532 1378999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+..... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ......
T Consensus 165 ~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~---- 227 (278)
T 1byg_A 165 KEASST-----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRV---- 227 (278)
T ss_dssp ----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHH----
T ss_pred cccccc-----------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH----
Confidence 755432 112357889999999999999999999999999999998 99998753221 111111
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
...... .....+...+.+++.+||+.||++|||+.|+++.|++++...
T Consensus 228 --------~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 228 --------EKGYKM----------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp --------TTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --------hcCCCC----------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 000000 001123356889999999999999999999999999998754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=346.98 Aligned_cols=267 Identities=19% Similarity=0.242 Sum_probs=204.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|++.+.||+|+||+||+|++..+++.||||+++. ...+.+.+|++++++++ ||||+++++++... .....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCce
Confidence 3689999999999999999999998999999999863 23578999999999997 99999999997642 24668
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC-ceEEeccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFG 857 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~DfG 857 (1009)
++||||+++++|.++++. +++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 109 ~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg 176 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT---------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWG 176 (330)
T ss_dssp EEEEECCCCCCHHHHGGG---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeccCchhHHHHHHh---------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence 999999999999999853 78899999999999999999999 999999999999999776 89999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+++...... ......||..|+|||++.+ ..++.++||||+||++|||++|+.||................
T Consensus 177 ~a~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~ 247 (330)
T 3nsz_A 177 LAEFYHPGQ---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247 (330)
T ss_dssp TCEECCTTC---------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred CceEcCCCC---------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHh
Confidence 998765432 1223568999999999877 678999999999999999999999996433322222222222
Q ss_pred hccchhhhccCC---------------CCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPEKVMEIVDP---------------SLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~---------------~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...+...+.++. ........ ............++.+++.+|++.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGG--GCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCchhhhHHHHhccccccchhhhhhhccccchhh--hccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111111111111 00000000 0000111123456889999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=350.26 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=192.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCC--CCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRH--RNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~ 775 (1009)
.++|.+.+.||+|+||.||+|.+. +++.||||+++..... ..+.+.+|++++++++| |||+++++++...
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~----- 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD----- 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-----
Confidence 457999999999999999999885 6889999999754332 23678999999999976 9999999997643
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++|||+ .+|+|.+++.... .+++.++..++.|++.||.|||++ +|+||||||+|||++ ++.+||+|
T Consensus 82 ~~~~lv~e~-~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~D 150 (343)
T 3dbq_A 82 QYIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID 150 (343)
T ss_dssp SEEEEEECC-CSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECC
T ss_pred CEEEEEEeC-CCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEee
Confidence 678999994 5889999998754 389999999999999999999999 999999999999997 67899999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCC-----------CCCCCcccchHHHHHHHHHHhCCCCCcccc
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-----------GEASMRGGVYSYGILLLEIFTRRRPTESMF 924 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~elltg~~p~~~~~ 924 (1009)
||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 151 FG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 151 FGIANQMQPDTT------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp CSSSCCC------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccccCcccc------cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 999987654321 112234579999999999864 678999999999999999999999997432
Q ss_pred cCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 925 NEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.. .... ...++....... +.....++.+++.+||+.||.+|||+.|+++.
T Consensus 225 ~~---~~~~---------~~~~~~~~~~~~----------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 225 NQ---ISKL---------HAIIDPNHEIEF----------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp SH---HHHH---------HHHHCTTSCCCC----------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hH---HHHH---------HHHhcCCcccCC----------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 21 1111 111111111000 00112357799999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=349.05 Aligned_cols=271 Identities=21% Similarity=0.239 Sum_probs=194.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-CCCcceEEeeeeccc---cCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVTICSSID---FKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~---~~~~ 775 (1009)
..+|.+.+.||+|+||.||+|++..+++.||||++........+.+.+|+.+++++. ||||+++++++.... ....
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 458999999999999999999999899999999986555445677899999999996 999999999985321 1344
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCceeeCCCCceEE
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPP--IVHGDLKPSNVLLDHDMVAHV 853 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrdlk~~Nill~~~~~~kl 853 (1009)
...++||||+. |+|.+++...... ..+++.+++.++.|++.||+|||+. + |+||||||+||+++.++.+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESR---GPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTT---CSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred ceEEEEEEecC-CCHHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 66899999995 7999998763221 2489999999999999999999998 7 999999999999999999999
Q ss_pred eccccccccCCCCCCCccc----cCCccccccccccccCcccc---CCCCCCCcccchHHHHHHHHHHhCCCCCcccccC
Q 047768 854 SDFGLAKFLSASPLGNVVE----TPSSSIGVKGTIGYVAPEYG---LGGEASMRGGVYSYGILLLEIFTRRRPTESMFNE 926 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~ 926 (1009)
+|||+++............ .........||+.|+|||++ .+..++.++|||||||++|||++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9999998775432111000 00111245689999999998 5677899999999999999999999999642211
Q ss_pred CccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 927 GLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
.. ........+. ......+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 260 -----~~------------~~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 260 -----RI------------VNGKYSIPPH----------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -----------------------CCCCTT----------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -----Hh------------hcCcccCCcc----------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 00 0100100000 011123678999999999999999999999999987654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.41 Aligned_cols=263 Identities=27% Similarity=0.409 Sum_probs=205.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEE--EEEEeeccc-ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLV--AVKVINLEQ-KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 776 (1009)
++|.+.+.||+|+||.||+|+++.++..+ |||+++... ....+.+.+|+++++++ +||||+++++++... .
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-----C
Confidence 57889999999999999999999888865 999886432 23456789999999999 899999999997653 6
Q ss_pred eEEEEEeccCCCCHHHHHhccCCC----------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQ----------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD 846 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 846 (1009)
..++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||++ +|+||||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence 789999999999999999865410 0112489999999999999999999999 999999999999999
Q ss_pred CCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCccccc
Q 047768 847 HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFN 925 (1009)
Q Consensus 847 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~ 925 (1009)
.++.+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~- 246 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT- 246 (327)
T ss_dssp GGGCEEECCTTCEESSCEE---------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-
T ss_pred CCCeEEEcccCcCcccccc---------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc-
Confidence 9999999999999743321 11223456889999999998899999999999999999998 999996432
Q ss_pred CCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 926 EGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
........ ... ..... ...+..++.+++.+|++.||++|||++|+++.|+++.++.
T Consensus 247 ----~~~~~~~~-~~~-------~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 247 ----CAELYEKL-PQG-------YRLEK-----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp ----HHHHHHHG-GGT-------CCCCC-----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ----HHHHHHHh-hcC-------CCCCC-----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 11221111 110 00000 0122346789999999999999999999999999987754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=365.80 Aligned_cols=249 Identities=23% Similarity=0.269 Sum_probs=194.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|+++.+|+.||||+++... ......+.+|+++++.++||||+++++++... .
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----D 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----T
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----C
Confidence 467999999999999999999999999999999997542 22345678899999999999999999997653 6
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCceeeCCCCceEEec
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
..++||||+++|+|.+++..... +++..+..++.|++.||+|||+ . +||||||||+|||++.++.+||+|
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~D 292 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERV------FSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITD 292 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEcc
Confidence 78999999999999999987553 8999999999999999999998 7 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 293 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~ 359 (446)
T 4ejn_A 293 FGLCKEGIKDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFE 359 (446)
T ss_dssp CCCCCTTCC-------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH
T ss_pred CCCceeccCCC--------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHH
Confidence 99998543221 223346799999999999999999999999999999999999999964321 11111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~ 995 (1009)
...... . ..+ .....++.+++.+|++.||++|| +++|+++
T Consensus 360 ~i~~~~--------~-~~p-----------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 360 LILMEE--------I-RFP-----------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHCC--------C-CCC-----------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHhCC--------C-CCC-----------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 111100 0 000 01224578999999999999999 9999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=361.92 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=204.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|+++.+|+.||||+++... ......+.+|++++++++||||+++++++.. ..
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----CC
Confidence 467999999999999999999999999999999996432 2345678899999999999999999998654 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+||
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence 88999999999999999986542 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........
T Consensus 331 Gla~~~~~~---------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~~~ 400 (576)
T 2acx_A 331 GLAVHVPEG---------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVERL 400 (576)
T ss_dssp TTCEECCTT---------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHHHH
T ss_pred ccceecccC---------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHHHH
Confidence 999876532 12234579999999999999999999999999999999999999997543221 11111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~ 995 (1009)
.. .. ...+ + .....++.+++.+|++.||++|| +++|+++
T Consensus 401 i~-----~~-~~~~---p-----------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 401 VK-----EV-PEEY---S-----------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HH-----HC-CCCC---C-----------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred hh-----cc-cccC---C-----------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 10 00 0000 0 01224577999999999999999 6788764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=349.43 Aligned_cols=271 Identities=21% Similarity=0.277 Sum_probs=194.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
++|.+.+.||+|+||+||+|+++.+++.||||+++..... ....+.+|++++++++||||+++++++.. ....+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence 5789999999999999999999989999999999644322 12345679999999999999999999754 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||++ |+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 77 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA 147 (324)
T ss_dssp EEEECCS-EEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred EEecccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccc
Confidence 9999997 699999987654 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ....... ..
T Consensus 148 ~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~-~~ 217 (324)
T 3mtl_A 148 RAKSIPT--------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFR-IL 217 (324)
T ss_dssp ECC--------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH-HH
T ss_pred ccccCCc--------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-Hh
Confidence 8654321 12234568999999999876 568999999999999999999999997533221 1111111 11
Q ss_pred cchhhhccCCCCCChhhhhh-------hccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERT-------NSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~-------~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.......+............ ............++.+++.+|++.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 218 GTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 10000000000000000000 0000000122345789999999999999999999976
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=349.44 Aligned_cols=253 Identities=24% Similarity=0.309 Sum_probs=199.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|.+.+.||+|+||+||+|.++.+++.||||+++.... ...+|++++.++ +||||+++++++.. ....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDD-----GKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEEC-----SSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEc-----CCEE
Confidence 4579999999999999999999999999999999964432 345788888888 79999999999754 3788
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC----CceEEe
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHVS 854 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~----~~~kl~ 854 (1009)
++||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||++..+ +.+||+
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~ 162 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRIC 162 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred EEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEE
Confidence 99999999999999998754 389999999999999999999999 99999999999998443 359999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+..
T Consensus 163 Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~ 232 (342)
T 2qr7_A 163 DFGFAKQLRAEN--------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEIL 232 (342)
T ss_dssp CCTTCEECBCTT--------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHHHHH
T ss_pred ECCCcccCcCCC--------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHHHHH
Confidence 999998765421 122345789999999999888899999999999999999999999974322 1222222
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
........ ....... .....++.+++.+|++.||++|||+.|+++.
T Consensus 233 ~~i~~~~~-~~~~~~~---------------~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 233 ARIGSGKF-SLSGGYW---------------NSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHCCC-CCCSTTT---------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHccCCc-ccCcccc---------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 21111100 0000000 0123457799999999999999999998763
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=340.17 Aligned_cols=251 Identities=24% Similarity=0.309 Sum_probs=200.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|.+.+.||+|+||.||+|+++.+|+.||||+++.......+.+.+|++++++++||||+++++++.. ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-----TTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-----CCEEE
Confidence 4579999999999999999999998999999999976544445678999999999999999999998754 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee---CCCCceEEecc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDF 856 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Df 856 (1009)
+||||+++++|.+++.... .+++.++..++.|++.|+.|||+. +|+||||||+||++ +.++.+||+||
T Consensus 83 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp EEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred EEEEcCCCccHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccC
Confidence 9999999999999997754 389999999999999999999999 99999999999999 78899999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++..... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ......
T Consensus 154 g~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~ 218 (304)
T 2jam_A 154 GLSKMEQNG----------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----SKLFEK 218 (304)
T ss_dssp STTCCCCCB----------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHH
T ss_pred CcceecCCC----------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH
Confidence 998754321 12235689999999999999999999999999999999999999964321 111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. ........+. ......++.+++.+|++.||++|||+.|+++
T Consensus 219 i~-~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 219 IK-EGYYEFESPF---------------WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HH-HCCCCCCTTT---------------TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HH-cCCCCCCccc---------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0000000000 0122345789999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=346.80 Aligned_cols=282 Identities=21% Similarity=0.314 Sum_probs=204.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeecccc---CC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDF---KG 774 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~ 774 (1009)
.++|.+.+.||+|+||+||+|+++.+|+.||||++..... .....+.+|++++++++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4689999999999999999999998999999999864432 234678899999999999999999999875321 11
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
....++||||++ |+|.+.+..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEeccC-CCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence 356899999997 488888876543 389999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
|||+++........ .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .....
T Consensus 167 Dfg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i 241 (351)
T 3mi9_A 167 DFGLARAFSLAKNS----QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALI 241 (351)
T ss_dssp CCTTCEECCCCSSS----SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred cchhcccccccccc----cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Confidence 99999876543211 1122334678999999998876 567999999999999999999999997532211 11111
Q ss_pred HHHh--ccchhhhc------cCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 934 AKRA--LPEKVMEI------VDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 934 ~~~~--~~~~~~~~------~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... .+.....- .+..-......+..............+.+++.+|++.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1110 11111000 00000000000000000000011245789999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=346.38 Aligned_cols=278 Identities=21% Similarity=0.308 Sum_probs=215.5
Q ss_pred HHHHHHHhccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeeccccc-chHHHHHHHHHHHhc-CCCCcceEEe
Q 047768 693 YKELSKATNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKG-GSKSFAAECEALRSI-RHRNLIKIVT 765 (1009)
Q Consensus 693 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~ 765 (1009)
..++....++|.+.+.||+|+||+||+|++. .+++.||||+++..... ..+.+.+|+++++++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 3444555689999999999999999999864 46689999999654322 245788999999999 7999999999
Q ss_pred eeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCC----------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 047768 766 ICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLG----------ICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVH 835 (1009)
Q Consensus 766 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH 835 (1009)
++... ....++||||+++|+|.+++........ ...+++.+++.++.|++.||.|||++ +|+|
T Consensus 99 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H 171 (316)
T 2xir_A 99 ACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH 171 (316)
T ss_dssp EECCT----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred EEecC----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 97542 3457999999999999999987653210 11278999999999999999999999 9999
Q ss_pred cCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh
Q 047768 836 GDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915 (1009)
Q Consensus 836 rdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt 915 (1009)
|||||+||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||+|
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t 245 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTT------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ccCccceEEECCCCCEEECCCccccccccCcc------ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence 99999999999999999999999987654321 112234567899999999999999999999999999999998
Q ss_pred -CCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 047768 916 -RRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVV 994 (1009)
Q Consensus 916 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl 994 (1009)
|+.||........ ........... ..+ ..+..++.+++.+||+.||.+|||+.|++
T Consensus 246 ~g~~p~~~~~~~~~-~~~~~~~~~~~-----------~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~ell 302 (316)
T 2xir_A 246 LGASPYPGVKIDEE-FCRRLKEGTRM-----------RAP-----------DYTTPEMYQTMLDCWHGEPSQRPTFSELV 302 (316)
T ss_dssp TSCCSSTTCCCSHH-HHHHHHHTCCC-----------CCC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCcccchhHH-HHHHhccCccC-----------CCC-----------CCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 9999875432211 11111110000 000 01234578999999999999999999999
Q ss_pred HHHHHHHHhhhc
Q 047768 995 VKLCHARQNFLG 1006 (1009)
Q Consensus 995 ~~L~~i~~~~~~ 1006 (1009)
+.|+.+.+....
T Consensus 303 ~~L~~~~~~~~~ 314 (316)
T 2xir_A 303 EHLGNLLQANAQ 314 (316)
T ss_dssp HHHHHHHHHHC-
T ss_pred HHHHHHHhhhcc
Confidence 999999877644
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=356.12 Aligned_cols=212 Identities=24% Similarity=0.327 Sum_probs=172.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||+||+|+++.+++.||||+++.... ...+.+.+|++++++++||||+++++++..........
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4589999999999999999999999999999999964322 23467889999999999999999999987654444467
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||++ |+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCC-cCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence 899999996 69999998654 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCcc--------------ccCCccccccccccccCcccc-CCCCCCCcccchHHHHHHHHHHhCCCCCc
Q 047768 858 LAKFLSASPLGNVV--------------ETPSSSIGVKGTIGYVAPEYG-LGGEASMRGGVYSYGILLLEIFTRRRPTE 921 (1009)
Q Consensus 858 la~~~~~~~~~~~~--------------~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~elltg~~p~~ 921 (1009)
+|+........... ..........||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 99977543211000 000123457899999999985 55679999999999999999998665553
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=348.43 Aligned_cols=262 Identities=14% Similarity=0.079 Sum_probs=205.1
Q ss_pred HhccCccCCcccccCCceEEEEE-----EecCCeEEEEEEeecccccchHHHHHHHHHHHhcC---CCCcceEEeeeecc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGV-----LHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR---HRNLIKIVTICSSI 770 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 770 (1009)
..++|.+.+.||+|+||+||+|. ...+++.||||+++.. ....+.+|++++++++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45689999999999999999994 5567899999998633 3567888999998886 99999999997643
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC---
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH--- 847 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~--- 847 (1009)
+..++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||++ +||||||||+|||++.
T Consensus 140 -----~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 140 -----NGSVLVGELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp -----SCEEEEECCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGT
T ss_pred -----CCcEEEEeccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEeccccc
Confidence 6779999999999999999753211 112499999999999999999999999 9999999999999998
Q ss_pred --------CCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCC
Q 047768 848 --------DMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919 (1009)
Q Consensus 848 --------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p 919 (1009)
++.+||+|||+|+.+..... ........||+.|+|||++.+..++.++|||||||++|||+||+.|
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 284 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPK------GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCT------TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCC
T ss_pred CccccccccCCEEEeeCchhhhhhccCC------CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCc
Confidence 89999999999986543211 1223446799999999999999999999999999999999999999
Q ss_pred CcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHHH
Q 047768 920 TESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDR-MEMTDVVVKLC 998 (1009)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R-pt~~evl~~L~ 998 (1009)
|....... ..+...+...+ ..+.+.+++..|++.+|.+| |+++++.+.|+
T Consensus 285 f~~~~~~~----------------~~~~~~~~~~~-------------~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 285 KVKNEGGE----------------CKPEGLFRRLP-------------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp CEEEETTE----------------EEECSCCTTCS-------------SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred cccCCCCc----------------eeechhccccC-------------cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 86432210 00111111110 12245678889999999988 57888888888
Q ss_pred HHHHhhhcC
Q 047768 999 HARQNFLGQ 1007 (1009)
Q Consensus 999 ~i~~~~~~~ 1007 (1009)
++.+....+
T Consensus 336 ~~l~~~~~~ 344 (365)
T 3e7e_A 336 KVFQQHYTN 344 (365)
T ss_dssp HHHHHHTTT
T ss_pred HHHHHhhhh
Confidence 877664433
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=336.65 Aligned_cols=253 Identities=24% Similarity=0.332 Sum_probs=197.8
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALV 781 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 781 (1009)
+|.....||+|+||.||+|.+..+++.||||+++.......+.+.+|+.++++++||||+++++++... ...++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEEE
Confidence 344456899999999999999989999999999766555567899999999999999999999997643 678999
Q ss_pred EeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC-CCceEEecccccc
Q 047768 782 YEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLAK 860 (1009)
Q Consensus 782 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~DfGla~ 860 (1009)
|||+++++|.+++...... ..+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+++
T Consensus 98 ~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~ 171 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGP---LKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK 171 (295)
T ss_dssp EECCSEEEHHHHHHHTTCC---CTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred EEeCCCCCHHHHHHhhccC---CCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccc
Confidence 9999999999999875321 2467889999999999999999999 9999999999999987 8999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCC--CCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE--ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
...... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||................
T Consensus 172 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-- 241 (295)
T 2clq_A 172 RLAGIN--------PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF-- 241 (295)
T ss_dssp ESCC-------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--
T ss_pred ccCCCC--------CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--
Confidence 764321 1122456899999999987654 7899999999999999999999997432221111110000
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
-..+.+ ...+..++.+++.+|++.||++||++.|+++
T Consensus 242 ------~~~~~~--------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 242 ------KVHPEI--------------PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ------CCCCCC--------------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ------cccccc--------------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000 1122345789999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=335.26 Aligned_cols=247 Identities=22% Similarity=0.335 Sum_probs=203.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-----RK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----CC
Confidence 468999999999999999999999899999999996432 2334678999999999999999999999754 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|.+++..... +++.+++.++.|++.|+.|||++ +|+||||||+||+++.++.+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGR------FDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecc
Confidence 78999999999999999987643 89999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|++...... ......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ......
T Consensus 159 g~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~ 223 (284)
T 2vgo_A 159 GWSVHAPSL----------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-----TETHRR 223 (284)
T ss_dssp TTCEECSSS----------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH
T ss_pred cccccCccc----------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-----hHHHHH
Confidence 999765432 12235689999999999999999999999999999999999999974321 111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. ...... .+ .....++.+++.+|++.||.+|||+.|+++
T Consensus 224 ~--------~~~~~~-~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 224 I--------VNVDLK-FP-----------PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp H--------HTTCCC-CC-----------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred H--------hccccC-CC-----------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1 110000 00 012245779999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=352.65 Aligned_cols=251 Identities=22% Similarity=0.353 Sum_probs=193.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcC--CCCcceEEeeeeccccCCCc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIR--HRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~ 776 (1009)
++|.+.+.||+|+||+||+|.+. +++.||||++..... ...+.+.+|++++++++ ||||+++++++... .
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-----~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----Q 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----S
T ss_pred CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----C
Confidence 46999999999999999999986 489999999975432 23467899999999996 59999999987643 6
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||| +.+++|.+++.... .+++.+++.++.|++.||.|||+. +|+||||||+|||++ ++.+||+||
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DF 198 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDF 198 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCC
T ss_pred EEEEEEe-cCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEec
Confidence 6899999 56889999998765 388999999999999999999999 999999999999995 589999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCC-----------CCCCCcccchHHHHHHHHHHhCCCCCccccc
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-----------GEASMRGGVYSYGILLLEIFTRRRPTESMFN 925 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~ 925 (1009)
|+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 199 G~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 272 (390)
T 2zmd_A 199 GIANQMQPDTT------SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272 (390)
T ss_dssp SSSCCC---------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CccccccCCCc------cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH
Confidence 99987654211 112234579999999999865 4688999999999999999999999974322
Q ss_pred CCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 926 EGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
. ... +..+++........ . ....++.+++.+||+.||++|||+.|+++.
T Consensus 273 ~---~~~---------~~~~~~~~~~~~~~------~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 273 Q---ISK---------LHAIIDPNHEIEFP------D----IPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp H---HHH---------HHHHHCTTSCCCCC------C----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H---HHH---------HHHHhCccccCCCC------c----cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1 111 11112111110000 0 012357799999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=346.94 Aligned_cols=267 Identities=22% Similarity=0.346 Sum_probs=203.3
Q ss_pred hccCccCCcccccCCceEEEEE-----EecCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGV-----LHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 773 (1009)
.++|.+.+.||+|+||.||+|+ ...+++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 105 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS--- 105 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC---
Confidence 4689999999999999999999 44567899999996432 22345788999999999999999999997543
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCC-CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC---CC
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQL-GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH---DM 849 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~ 849 (1009)
...++||||+++|+|.+++....... ....+++.+++.++.|++.||.|||++ +|+||||||+||+++. +.
T Consensus 106 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 106 --LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred --CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence 56799999999999999998764321 123489999999999999999999999 9999999999999984 45
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGL 928 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~ 928 (1009)
.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 251 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYY------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--- 251 (327)
T ss_dssp CEEECCCHHHHHHHC------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred eEEECcccccccccccccc------ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---
Confidence 6999999999866433211 11223567899999999999999999999999999999999 9999864321
Q ss_pred cHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 929 TLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
.......... ..... ...+...+.+++.+||+.||.+||++.|+++.++.+.+..
T Consensus 252 --~~~~~~~~~~--------~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 252 --QEVLEFVTSG--------GRMDP-----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp --HHHHHHHHTT--------CCCCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred --HHHHHHHhcC--------CCCCC-----------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 1111111000 00000 0122346789999999999999999999999999887643
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=373.39 Aligned_cols=258 Identities=27% Similarity=0.447 Sum_probs=207.2
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
..++|.+.+.||+|+||+||+|.++ .+..||||+++... ...+.+.+|+++|++++||||+++++++.. ...
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~ 336 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI 336 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred chhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccc
Confidence 3467888999999999999999996 46789999997543 345789999999999999999999999753 457
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++|+|.++++.... ..+++.+++.++.|++.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred eEeeehhcCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccc
Confidence 899999999999999975421 1389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+.....
T Consensus 410 a~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-----~~~~~~i 477 (535)
T 2h8h_A 410 ARLIEDNE-------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQV 477 (535)
T ss_dssp TTTCCCHH-------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-----HHHHHHH
T ss_pred ceecCCCc-------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH
Confidence 98654311 011223457889999999999999999999999999999999 9999975422 1111111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQ 1002 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~ 1002 (1009)
....... ....+...+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 478 --------~~~~~~~-----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 478 --------ERGYRMP-----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp --------HTTCCCC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred --------HcCCCCC-----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 0000000 011344568899999999999999999999999987654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=336.56 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=205.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.+.|.+.+.||+|+||.||+|.+..+++.||||+++.... ...+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeE
Confidence 3578999999999999999999988999999999975542 3457899999999999999999999987653 678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++++|.+++... .+++.++..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 96 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV 165 (303)
T ss_dssp EEEEECCTTEEHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeeccc
Confidence 9999999999999999753 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ......
T Consensus 166 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~- 231 (303)
T 3a7i_A 166 AGQLTDTQ--------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-----KVLFLI- 231 (303)
T ss_dssp CEECBTTB--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHH-
T ss_pred ceecCccc--------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-----HHHHHh-
Confidence 98765431 1223456899999999999999999999999999999999999998743211 111100
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
.....+.+ ...+...+.+++.+|++.||++|||+.|+++..
T Consensus 232 ----~~~~~~~~--------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 232 ----PKNNPPTL--------------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ----HHSCCCCC--------------CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ----hcCCCCCC--------------ccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 00000000 011234578999999999999999999998753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=345.86 Aligned_cols=276 Identities=22% Similarity=0.267 Sum_probs=197.7
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc-----chHHHHHHHHHHHhcCCCCcceEEeeeecccc
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-----GSKSFAAECEALRSIRHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 772 (1009)
...++|.+.+.||+|+||.||+|++..+|+.||||+++..... ..+.+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 83 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--- 83 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee---
Confidence 3457899999999999999999999988999999999643221 13578899999999999999999999754
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceE
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 852 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 852 (1009)
....++||||+++ +|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 84 --~~~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 152 (346)
T 1ua2_A 84 --KSNISLVFDFMET-DLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLK 152 (346)
T ss_dssp --TTCCEEEEECCSE-EHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred --CCceEEEEEcCCC-CHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEE
Confidence 3678999999975 89999877543 388889999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHH
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLH 931 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~ 931 (1009)
|+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||...... ..+.
T Consensus 153 l~Dfg~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~ 223 (346)
T 1ua2_A 153 LADFGLAKSFGSPN--------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLT 223 (346)
T ss_dssp ECCCGGGSTTTSCC--------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH
T ss_pred EEecccceeccCCc--------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHH
Confidence 99999998764321 122345689999999998764 5799999999999999999999998653221 1112
Q ss_pred HHHHHhccchhhhccCCCCCChh---hhhhhc-cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 932 EFAKRALPEKVMEIVDPSLLPLE---EERTNS-RRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~d~~l~~~~---~~r~~~-~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
...............+..-.... ...+.. ..........++.+++.+|++.||++|||+.|+++.
T Consensus 224 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 224 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 22211111100000000000000 000000 000001223568899999999999999999999863
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=347.42 Aligned_cols=275 Identities=20% Similarity=0.213 Sum_probs=206.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++...........
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 4589999999999999999999999999999999964332 223678899999999999999999999876544555678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||++ |+|.+++.... +++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 106 ~iv~e~~~-~~L~~~l~~~~-------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQH-------LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp EEEEECCS-EEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEcccC-cCHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence 99999996 59999997643 89999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++....... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .........
T Consensus 175 a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~ 248 (364)
T 3qyz_A 175 ARVADPDHD-----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGIL 248 (364)
T ss_dssp CEECCGGGC-----BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHH
T ss_pred eEecCCCCC-----ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHh
Confidence 987654311 1112234579999999998654 558999999999999999999999997543221 122221111
Q ss_pred ccch---hhhcc--------CCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEK---VMEIV--------DPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~---~~~~~--------d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... +.... ........ ............++.+++.+|++.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 249 GSPSQEDLNCIINLKARNYLLSLPHKNK----VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCC----CCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHhhhhhHHHHHHhcCCccC----CCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1100 10000 00000000 0000000112346789999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=338.49 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=204.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++.. ..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-----ND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-----CC
Confidence 4689999999999999999999998999999999965432 234578899999999999999999999754 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++++|.+++.... .+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 159 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 159 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEec
Confidence 7899999999999999987754 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++...... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... .+....
T Consensus 160 g~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~ 226 (294)
T 2rku_A 160 GLATKVEYDG--------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYLR 226 (294)
T ss_dssp TTCEECCSTT--------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH
T ss_pred cCceecccCc--------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence 9998764321 112235689999999999999999999999999999999999999974321 111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
. ..... ..+ ......+.+++.+|++.||++|||++|+++.
T Consensus 227 ~--------~~~~~-~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 227 I--------KKNEY-SIP-----------KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp H--------HTTCC-CCC-----------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred H--------hhccC-CCc-----------cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 00000 000 0122357799999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=343.58 Aligned_cols=256 Identities=24% Similarity=0.345 Sum_probs=202.9
Q ss_pred HHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--------chHHHHHHHHHHHhc-CCCCcceEEee
Q 047768 696 LSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--------GSKSFAAECEALRSI-RHRNLIKIVTI 766 (1009)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~~~ 766 (1009)
.....++|.+.+.||+|+||.||+|+++.+|+.||||+++..... ..+.+.+|+++++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 344457899999999999999999999888999999999754321 134678899999999 79999999998
Q ss_pred eeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC
Q 047768 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD 846 (1009)
Q Consensus 767 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 846 (1009)
+.. ....++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++
T Consensus 169 ~~~-----~~~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~ 234 (365)
T 2y7j_A 169 YES-----SSFMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLD 234 (365)
T ss_dssp EEB-----SSEEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred Eee-----CCEEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 754 367899999999999999998654 389999999999999999999999 999999999999999
Q ss_pred CCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCC------CCCCCcccchHHHHHHHHHHhCCCCC
Q 047768 847 HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG------GEASMRGGVYSYGILLLEIFTRRRPT 920 (1009)
Q Consensus 847 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~Gvvl~elltg~~p~ 920 (1009)
.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 235 ~~~~ikl~DfG~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf 305 (365)
T 2y7j_A 235 DNMQIRLSDFGFSCHLEPGE---------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305 (365)
T ss_dssp TTCCEEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCCEEEEecCcccccCCCc---------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCC
Confidence 99999999999998765421 2234578999999998753 36889999999999999999999999
Q ss_pred cccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 921 ESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..... ...... +........... .......+.+++.+|++.||++|||+.|+++
T Consensus 306 ~~~~~-----~~~~~~--------i~~~~~~~~~~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 306 WHRRQ-----ILMLRM--------IMEGQYQFSSPE--------WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCSSH-----HHHHHH--------HHHTCCCCCHHH--------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCH-----HHHHHH--------HHhCCCCCCCcc--------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 64321 111110 000001000000 0012345789999999999999999999976
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.11 Aligned_cols=258 Identities=21% Similarity=0.282 Sum_probs=203.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|++.+.||+|+||.||+|+++.+++.||+|+++.... ...+.+.+|++++++++||||+++++++... ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence 4689999999999999999999998999999999975432 2346788999999999999999999987532 2367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----ceecCCCCCceeeCCCCceE
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPP-----IVHGDLKPSNVLLDHDMVAH 852 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-----ivHrdlk~~Nill~~~~~~k 852 (1009)
.++||||+++++|.+++...... ...+++.+++.++.|++.||+|||+. + |+||||||+||+++.++.+|
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~k 156 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVK 156 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEE
T ss_pred EEEEEeCCCCCCHHHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEE
Confidence 89999999999999999764321 12489999999999999999999998 7 99999999999999999999
Q ss_pred EeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHH
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHE 932 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~ 932 (1009)
|+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..
T Consensus 157 l~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~ 223 (279)
T 2w5a_A 157 LGDFGLARILNHDT--------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KE 223 (279)
T ss_dssp ECCCCHHHHC---C--------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH
T ss_pred EecCchheeecccc--------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----HH
Confidence 99999998764321 112235689999999999999999999999999999999999999975321 11
Q ss_pred HHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
........ .....+ ..+..++.+++.+||+.||++||++.|+++.+
T Consensus 224 ~~~~i~~~--------~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 224 LAGKIREG--------KFRRIP-----------YRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHHHHHHT--------CCCCCC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred HHHHHhhc--------ccccCC-----------cccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 11111000 000000 12234678999999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=357.15 Aligned_cols=258 Identities=16% Similarity=0.145 Sum_probs=191.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHH---HHHhcCCCCcceEEe-------e
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECE---ALRSIRHRNLIKIVT-------I 766 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~l~~-------~ 766 (1009)
.++|.+.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|++ .+++++||||+++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999999888999999999743 2233477889994 555568999999984 3
Q ss_pred eecccc-------CCCc-----eEEEEEeccCCCCHHHHHhccCCCC-CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 047768 767 CSSIDF-------KGVD-----FKALVYEYMQNGSLEEWLHQRDDQL-GICNLSLIQRLNIVIDVASAVEYLHHHCQPPI 833 (1009)
Q Consensus 767 ~~~~~~-------~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 833 (1009)
+..... .+.. ..++||||+ +|+|.+++....... ....+++..++.++.|++.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 322100 0001 378999999 689999998643210 011244588889999999999999999 99
Q ss_pred eecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCC-----------CCCCccc
Q 047768 834 VHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-----------EASMRGG 902 (1009)
Q Consensus 834 vHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~D 902 (1009)
+||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++.+. .++.++|
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D 295 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD 295 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----------cccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence 9999999999999999999999999985332 2234567 999999999887 8999999
Q ss_pred chHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCC
Q 047768 903 VYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIE 982 (1009)
Q Consensus 903 vwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~ 982 (1009)
||||||++|||++|+.||....... ....+... . ..+..++.+++.+||+.
T Consensus 296 vwSlG~il~elltg~~Pf~~~~~~~-------------~~~~~~~~-~---------------~~~~~~~~~li~~~L~~ 346 (377)
T 3byv_A 296 AWALGLVIYWIWCADLPITKDAALG-------------GSEWIFRS-C---------------KNIPQPVRALLEGFLRY 346 (377)
T ss_dssp HHHHHHHHHHHHHSSCCC------C-------------CSGGGGSS-C---------------CCCCHHHHHHHHHHTCS
T ss_pred HHHHHHHHHHHHHCCCCCccccccc-------------chhhhhhh-c---------------cCCCHHHHHHHHHHcCC
Confidence 9999999999999999996432110 01111110 0 01234578999999999
Q ss_pred CCCCCCCHHHHHH--HHHHHHH
Q 047768 983 SPFDRMEMTDVVV--KLCHARQ 1002 (1009)
Q Consensus 983 dp~~Rpt~~evl~--~L~~i~~ 1002 (1009)
||++|||+.|+++ .+.++.+
T Consensus 347 dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 347 PKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp SGGGCCCHHHHHTSHHHHHHHH
T ss_pred CchhCCCHHHHhhChHHHHHHH
Confidence 9999999999986 4444444
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=345.07 Aligned_cols=273 Identities=23% Similarity=0.327 Sum_probs=199.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|++++++++||||+++++++... ..
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-----KR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-----CE
Confidence 46899999999999999999999989999999998644332 235678999999999999999999997653 67
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++++|.++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 169 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPN------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG 169 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCcchHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCC
Confidence 899999999999988876544 289999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||....... ........
T Consensus 170 ~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~ 240 (331)
T 4aaa_A 170 FARTLAAPG--------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMC 240 (331)
T ss_dssp TC--------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH
T ss_pred CceeecCCc--------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHH
Confidence 998654321 122235689999999998875 78999999999999999999999997543221 11111110
Q ss_pred h--ccchhhh------ccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 937 A--LPEKVME------IVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 937 ~--~~~~~~~------~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
. ..+.... .......+....+.. .......+..++.+++.+|++.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREP-LERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HCSCCHHHHHHHHHCGGGTTCCCCCCSSCCC-HHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hCCCChhhhhHhhhccccccccCccccccch-hhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0000000 000000000000000 000011234568899999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=346.81 Aligned_cols=270 Identities=21% Similarity=0.258 Sum_probs=196.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccc-cCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSID-FKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|++++++++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4578999999999999999999998999999999854322 22467889999999999999999999976532 12224
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+ +++|.++++... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~-------l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHEK-------LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecC-CCCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEee
Confidence 569999999 889999997632 89999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+.....
T Consensus 173 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~ 240 (367)
T 1cm8_A 173 GLARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMK 240 (367)
T ss_dssp TTCEECCSS-----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH
T ss_pred ecccccccc-----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 999865421 224578999999999877 67899999999999999999999999743221 11111111
Q ss_pred Hhc--cchhhhccCCC--------CCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RAL--PEKVMEIVDPS--------LLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~--~~~~~~~~d~~--------l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... +.+....+... +...... ............+.+++.+|++.||++|||++|+++
T Consensus 241 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKK---DFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCC---CGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCCCHHHHHHhhhHHHHHHHHhCCCCCCC---CHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 110 11111000000 0000000 000001122346789999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=349.39 Aligned_cols=275 Identities=19% Similarity=0.210 Sum_probs=195.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccc-cCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSID-FKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3689999999999999999999998999999999965322 22457889999999999999999999976532 12334
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||++ |+|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEcCC-CCHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEe
Confidence 7899999996 588888853 288999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........
T Consensus 172 g~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~ 241 (371)
T 2xrw_A 172 GLARTAGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQ 241 (371)
T ss_dssp CC-------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-
T ss_pred ecccccccc---------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 999865432 12234578999999999999999999999999999999999999997532210 01111100
Q ss_pred h----------ccchhhhccC--CCCCCh--hhhhh----hccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 937 A----------LPEKVMEIVD--PSLLPL--EEERT----NSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 937 ~----------~~~~~~~~~d--~~l~~~--~~~r~----~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
. ........+. +..... ....+ ............++.+++.+|++.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 0000000000 000000 00000 00000112235678999999999999999999999863
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=370.99 Aligned_cols=117 Identities=18% Similarity=0.230 Sum_probs=81.4
Q ss_pred CCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCccccccccccccccc
Q 047768 506 PLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLS 585 (1009)
Q Consensus 506 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 585 (1009)
|..|+++++|+.|+|++|.+++ +|..+..+++|+.|+|++|+++ .+|..++.+++|++|+|++|.|++. | +..++
T Consensus 271 ~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~ 345 (597)
T 3oja_B 271 YHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHH 345 (597)
T ss_dssp SGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTC
T ss_pred HHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcC
Confidence 3344455566666666666663 4556666777777777777777 5667777788888888888888753 3 56778
Q ss_pred ccCceecccccCcccCCCCCcccCccccccccCCCcCCCCCCC
Q 047768 586 FLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDEL 628 (1009)
Q Consensus 586 ~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~~~~ 628 (1009)
+|++|+|++|+++|.++. ..+..+....+.++...|+.+...
T Consensus 346 ~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~~~~ 387 (597)
T 3oja_B 346 TLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDYQL 387 (597)
T ss_dssp CCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTTCEE
T ss_pred CCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcchhc
Confidence 888888888888877543 245555666677888899875543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=344.66 Aligned_cols=250 Identities=20% Similarity=0.270 Sum_probs=203.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|++++++++||||+++++++.. ..
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-----ND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CC
Confidence 4689999999999999999999998999999999965432 234678899999999999999999999764 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++++|.+++.... .+++.+++.++.|++.||.|||++ +|+||||||+||+++.++.+||+||
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 185 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecCCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeec
Confidence 7899999999999999988754 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......
T Consensus 186 g~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~ 252 (335)
T 2owb_A 186 GLATKVEYDG--------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYLR 252 (335)
T ss_dssp TTCEECCSTT--------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH
T ss_pred cCceecccCc--------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----HHHHHH
Confidence 9998765321 112235689999999999999999999999999999999999999974321 111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.... ... .+ ..+...+.+++.+|++.||++|||++|+++.
T Consensus 253 ~~~~--------~~~-~~-----------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 253 IKKN--------EYS-IP-----------KHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHT--------CCC-CC-----------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HhcC--------CCC-CC-----------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 000 00 0122357789999999999999999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=332.57 Aligned_cols=249 Identities=26% Similarity=0.385 Sum_probs=195.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|+++.+++.||||+++... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----PT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence 468999999999999999999998899999999996542 2335678999999999999999999999754 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++++|.+++..... +++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGR------VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeccCCCcHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence 78999999999999999987643 89999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|++....... ......||+.|+|||++.+..+ +.++||||+|+++|||++|+.||.... ......
T Consensus 156 g~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~ 221 (276)
T 2h6d_A 156 GLSNMMSDGE---------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-----VPTLFK 221 (276)
T ss_dssp CGGGCCCC----------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH
T ss_pred ccccccCCCc---------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-----HHHHHH
Confidence 9998664321 1223468999999999988765 689999999999999999999996432 111111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
... .. ....+ ......+.+++.+|++.||++|||+.|+++.
T Consensus 222 ~~~-~~--------~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 222 KIR-GG--------VFYIP-----------EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHH-HC--------CCCCC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Hhh-cC--------cccCc-----------hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 100 00 00000 0122457899999999999999999999873
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=358.14 Aligned_cols=251 Identities=26% Similarity=0.320 Sum_probs=200.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||+||+|+++.+++.||||+++... ......+.+|++++++++||||+++++++.. ...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSS 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-----CCE
Confidence 357999999999999999999999899999999996432 2345788999999999999999999999764 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC---CCCceEEe
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHVS 854 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~---~~~~~kl~ 854 (1009)
.++||||+++|+|.+++..... +++.++..++.|++.||.|||++ +|+||||||+||+++ .++.+||+
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEE
Confidence 8999999999999999977643 89999999999999999999999 999999999999995 56689999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+++..... .......||+.|+|||++.+ .++.++||||+||++|||++|+.||..... ....
T Consensus 167 Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~ 231 (486)
T 3mwu_A 167 DFGLSTCFQQN---------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDIL 231 (486)
T ss_dssp SCSCTTTBCCC-------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH
T ss_pred ECCcCeECCCC---------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence 99999866432 12234579999999999875 589999999999999999999999974321 1111
Q ss_pred HHhccchhhhccCCCCC-ChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLL-PLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~-~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.... ..... ..+. ......++.+++.+|++.||.+|||+.|+++.
T Consensus 232 ~~i~--------~~~~~~~~~~---------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 232 KRVE--------TGKYAFDLPQ---------WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHH--------HTCCCSCSGG---------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHH--------hCCCCCCCcc---------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1110 00000 0000 01223457899999999999999999999873
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=357.39 Aligned_cols=252 Identities=26% Similarity=0.368 Sum_probs=202.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|+++.+|+.||||+++... ......+.+|++++++++||||+++++++.. ..
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-----KT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----CC
Confidence 367888999999999999999999899999999996442 2334678899999999999999999998654 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+||
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTT--SCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEEeccCCCHHHHHHHhhcc--cccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeec
Confidence 789999999999999999765421 12489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .........
T Consensus 334 Gla~~~~~~~--------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~~~~~~ 404 (543)
T 3c4z_A 334 GLAVELKAGQ--------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQR 404 (543)
T ss_dssp TTCEECCTTC--------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHHHHHHH
T ss_pred ceeeeccCCC--------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHHHHHHH
Confidence 9998765431 1223457999999999999999999999999999999999999999754221 122222221
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~ 990 (1009)
..... . ..+ ......+.+++.+|++.||++||++
T Consensus 405 i~~~~--------~-~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 405 VLEQA--------V-TYP-----------DKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HHHCC--------C-CCC-----------TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred Hhhcc--------c-CCC-----------cccCHHHHHHHHHhccCCHhHCCCC
Confidence 11110 0 000 1123457799999999999999976
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=347.22 Aligned_cols=201 Identities=26% Similarity=0.378 Sum_probs=175.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|.+.+.||+|+||+||+|.+..+++.||+|+++.... ...+.+.+|++++++++||||+++++++... ...
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----TEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CEE
Confidence 3679999999999999999999998999999999975432 2346789999999999999999999997653 678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++++|.+++..... +++..+..++.+++.|++|||+++ +|+||||||+||+++.++.+||+|||+
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 178 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV 178 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred EEEEECCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCC
Confidence 999999999999999987653 899999999999999999999842 799999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 179 ~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 179 SGQLIDS----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp CHHHHHH----------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred Ccccccc----------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9765321 122356899999999999999999999999999999999999999753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=338.92 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=198.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|++.+.||+|+||.||+|+++.+++.||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 92 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKLW 92 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeEE
Confidence 46899999999999999999999988999999999766555668899999999999999999999997643 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++++|.+++..... .+++.+++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 93 lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred EEEEeCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 99999999999999886543 389999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCccccCCccccccccccccCcccc-----CCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYG-----LGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
...... ........||+.|+|||++ .+..++.++||||||+++|||++|+.||...... ...
T Consensus 165 ~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~ 231 (302)
T 2j7t_A 165 AKNLKT--------LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVL 231 (302)
T ss_dssp HHHHHH--------HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHH
T ss_pred cccccc--------ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-----HHH
Confidence 643211 0112235689999999987 4677899999999999999999999999753211 111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
....... .+.. .....+..++.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~-----~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 232 LKIAKSD-----PPTL------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHSC-----CCCC------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHhccC-----Cccc------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1100000 0000 001123346789999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=340.41 Aligned_cols=252 Identities=24% Similarity=0.291 Sum_probs=197.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--------cchHHHHHHHHHHHhcCCCCcceEEeeeeccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--------GGSKSFAAECEALRSIRHRNLIKIVTICSSID 771 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 771 (1009)
.++|.+.+.||+|+||.||+|.++.+++.||||+++.... .....+.+|++++++++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 4689999999999999999999998999999999864321 122458899999999999999999998753
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc-
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV- 850 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~- 850 (1009)
...++||||+++++|.+++.... .+++.+++.++.|++.||.|||++ +|+||||||+||+++.++.
T Consensus 87 ----~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 87 ----EDYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp ----SSEEEEEECCTTEETHHHHSTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSS
T ss_pred ----CceEEEEecCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCC
Confidence 23799999999999999997654 389999999999999999999999 9999999999999987664
Q ss_pred --eEEeccccccccCCCCCCCccccCCccccccccccccCccccC---CCCCCCcccchHHHHHHHHHHhCCCCCccccc
Q 047768 851 --AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL---GGEASMRGGVYSYGILLLEIFTRRRPTESMFN 925 (1009)
Q Consensus 851 --~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~ 925 (1009)
+||+|||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 154 ~~~kl~Dfg~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 154 CLIKITDFGHSKILGET---------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp CCEEECCCTTCEECCCC---------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred CeEEEccCccceecccc---------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 999999999866432 1122356899999999863 56789999999999999999999999975433
Q ss_pred CCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 926 EGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. .......... ....+.. ......++.+++.+|++.||++|||++|+++
T Consensus 225 ~~-~~~~~~~~~~-----------~~~~~~~--------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 225 QV-SLKDQITSGK-----------YNFIPEV--------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SS-CHHHHHHHTC-----------CCCCHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HH-HHHHHHHhCc-----------cccCchh--------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 22 2222211110 0000100 0122346789999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=336.61 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=199.4
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
..++|.+.+.||+|+||.||+|.++.+|+.||||++.... ..+.+.+|++++++++||||+++++++... ...
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEE
Confidence 4568999999999999999999999889999999996543 357889999999999999999999997643 678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++++|.+++..... .+++.+++.++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 171 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV 171 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEeecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeeccc
Confidence 999999999999999975433 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....
T Consensus 172 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~-- 236 (314)
T 3com_A 172 AGQLTDTM--------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----RAIFM-- 236 (314)
T ss_dssp CEECBTTB--------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHH--
T ss_pred chhhhhhc--------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----HHHHH--
Confidence 98765321 1223456899999999999999999999999999999999999999743211 11100
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
......+... ....+...+.+++.+|++.||.+|||+.|+++
T Consensus 237 ---~~~~~~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 237 ---IPTNPPPTFR------------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---HHHSCCCCCS------------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---HhcCCCcccC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000010 01122346789999999999999999999976
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=358.54 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=197.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||+||+|+++.++..||||+++... ......+.+|+++++.++||||+++++++.. ...
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-----KRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence 347999999999999999999999999999999996543 2335788999999999999999999999764 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC---CCceEEe
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVS 854 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~ 854 (1009)
.++||||+++|+|.+++..... +++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRMK------FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEecCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEE
Confidence 8999999999999999887643 89999999999999999999999 9999999999999976 4569999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+++..... .......||+.|+|||++. +.++.++||||+||++|||++|+.||..... .+..
T Consensus 182 DfG~a~~~~~~---------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~ 246 (494)
T 3lij_A 182 DFGLSAVFENQ---------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----QEIL 246 (494)
T ss_dssp CCTTCEECBTT---------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH
T ss_pred ECCCCeECCCC---------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence 99999876532 1223457999999999876 5699999999999999999999999975322 1111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
..... ........ ........+.+++.+|++.||.+|||+.|+++.
T Consensus 247 ~~i~~--------~~~~~~~~--------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 247 RKVEK--------GKYTFDSP--------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHH--------TCCCCCSG--------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHh--------CCCCCCch--------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11100 00000000 000123457799999999999999999999853
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=341.68 Aligned_cols=261 Identities=18% Similarity=0.233 Sum_probs=201.6
Q ss_pred HHHHHHHhccCccC-CcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhc-CCCCcceEEeeee
Q 047768 693 YKELSKATNEFSSS-NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSI-RHRNLIKIVTICS 768 (1009)
Q Consensus 693 ~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 768 (1009)
++....-.++|.+. +.||+|+||+||+|.++.+++.||||+++.... .....+.+|+.+++++ .||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33334445677776 889999999999999998999999999975432 2356889999999999 5699999999975
Q ss_pred ccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC-
Q 047768 769 SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH- 847 (1009)
Q Consensus 769 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~- 847 (1009)
. ....++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 100 ~-----~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~ 167 (327)
T 3lm5_A 100 N-----TSEIILILEYAAGGEIFSLCLPELA----EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSI 167 (327)
T ss_dssp C-----SSEEEEEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCB
T ss_pred e-----CCeEEEEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecC
Confidence 4 3678999999999999999865432 2489999999999999999999999 9999999999999998
Q ss_pred --CCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCccccc
Q 047768 848 --DMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFN 925 (1009)
Q Consensus 848 --~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~ 925 (1009)
++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 168 ~~~~~~kL~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 238 (327)
T 3lm5_A 168 YPLGDIKIVDFGMSRKIGHAC---------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238 (327)
T ss_dssp TTBCCEEECCGGGCEEC------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCCcEEEeeCccccccCCcc---------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 7899999999998765321 12235689999999999999999999999999999999999999964322
Q ss_pred CCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 926 EGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. ....... ......... ....+...+.+++.+|++.||++|||++|+++
T Consensus 239 ~-----~~~~~i~-~~~~~~~~~---------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 239 Q-----ETYLNIS-QVNVDYSEE---------------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp H-----HHHHHHH-HTCCCCCTT---------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred h-----HHHHHHH-hcccccCch---------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1 1110000 000000000 00122345789999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=344.44 Aligned_cols=280 Identities=20% Similarity=0.220 Sum_probs=204.4
Q ss_pred HHHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccc-----------hHHHHHHHHHHHhcCCCCcc
Q 047768 693 YKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG-----------SKSFAAECEALRSIRHRNLI 761 (1009)
Q Consensus 693 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv 761 (1009)
..++....++|.+.+.||+|+||.||+|.+. +|+.||||++....... .+.+.+|++++++++||||+
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567778899999999999999999999986 58999999985432211 26789999999999999999
Q ss_pred eEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 047768 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPS 841 (1009)
Q Consensus 762 ~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~ 841 (1009)
++++++...........++||||++ |+|.+++..... .+++..+..++.|++.||.|||++ +|+||||||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 163 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI-----VISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPG 163 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChH
Confidence 9999986544344567899999997 699998886543 389999999999999999999999 9999999999
Q ss_pred ceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCC
Q 047768 842 NVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPT 920 (1009)
Q Consensus 842 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~ 920 (1009)
||+++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 234 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTAD---------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234 (362)
T ss_dssp GEEECTTCCEEECCTTC------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred HEEEcCCCCEEEEecCcccccccc---------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence 999999999999999999754432 12234568999999999877 67899999999999999999999999
Q ss_pred cccccCCccHHHHHHHhcc-----------chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC
Q 047768 921 ESMFNEGLTLHEFAKRALP-----------EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME 989 (1009)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~-----------~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt 989 (1009)
...... ............ ....+.+.......+...... ........+.+++.+|++.||++|||
T Consensus 235 ~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt 310 (362)
T 3pg1_A 235 RGSTFY-NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTA---VVPTADPVALDLIAKMLEFNPQRRIS 310 (362)
T ss_dssp CCSSHH-HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHH---HSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCHH-HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHh---hCCCCCHHHHHHHHHHhcCChhhCCC
Confidence 753211 111111111111 111222222222211111100 01122345789999999999999999
Q ss_pred HHHHHH
Q 047768 990 MTDVVV 995 (1009)
Q Consensus 990 ~~evl~ 995 (1009)
+.|+++
T Consensus 311 ~~ell~ 316 (362)
T 3pg1_A 311 TEQALR 316 (362)
T ss_dssp HHHHHT
T ss_pred HHHHHc
Confidence 999976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.85 Aligned_cols=265 Identities=25% Similarity=0.357 Sum_probs=197.0
Q ss_pred hccCccCCcccccCCceEEEEEEec-CC--eEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHE-NG--MLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 773 (1009)
.++|.+.+.||+|+||+||+|++.. ++ ..||||+++... ....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 92 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 92 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence 4589999999999999999999753 23 369999986542 2234678899999999999999999999754
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEE
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 853 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 853 (1009)
...++|+||+++++|.+++..... .+++.++..++.|++.|+.|||++ +|+||||||+||+++.++.+||
T Consensus 93 --~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl 162 (291)
T 1u46_A 93 --PPMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKI 162 (291)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEE
T ss_pred --CCceeeEecccCCCHHHHHHhccC-----CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEE
Confidence 236899999999999999987543 389999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHH
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHE 932 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 932 (1009)
+|||+++........ ........+|..|+|||++.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 163 ~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~ 232 (291)
T 1u46_A 163 GDFGLMRALPQNDDH-----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQ 232 (291)
T ss_dssp CCCTTCEECCC-CCE-----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HH
T ss_pred ccccccccccccccc-----hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----HH
Confidence 999999876543210 011223457889999999998899999999999999999999 9999974321 11
Q ss_pred HHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 047768 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLG 1006 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~ 1006 (1009)
.......... ... ....+..++.+++.+|++.||++|||+.|+++.|+++...-..
T Consensus 233 ~~~~~~~~~~-------~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 288 (291)
T 1u46_A 233 ILHKIDKEGE-------RLP-----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288 (291)
T ss_dssp HHHHHHTSCC-------CCC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred HHHHHHccCC-------CCC-----------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchh
Confidence 1111100000 000 0112335688999999999999999999999999988765443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=339.12 Aligned_cols=279 Identities=21% Similarity=0.310 Sum_probs=205.4
Q ss_pred HhccCccCCcccccCCceEEEEEEe-cCCeEEEEEEeecccc--cchHHHHHHHHHHHhc---CCCCcceEEeeeecccc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLH-ENGMLVAVKVINLEQK--GGSKSFAAECEALRSI---RHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~ 772 (1009)
..++|.+.+.||+|+||.||+|++. .+++.||||+++.... .....+.+|+++++.+ +||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999995 6789999999965432 2234677888887776 89999999999874333
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceE
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 852 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 852 (1009)
......++||||++ |+|.+++...... .+++.+++.++.|++.||.|||++ +|+||||||+||+++.++.+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence 44577899999997 6999999875432 389999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHH
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHE 932 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~ 932 (1009)
|+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....
T Consensus 161 l~Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~ 230 (326)
T 1blx_A 161 LADFGLARIYSFQ---------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGK 230 (326)
T ss_dssp ECSCCSCCCCCGG---------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH
T ss_pred EecCcccccccCC---------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHH
Confidence 9999999865421 12234568999999999999999999999999999999999999997532211 1111
Q ss_pred HHHHhccchhhhccCCCCCChhh---hhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 933 FAKRALPEKVMEIVDPSLLPLEE---ERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l~~~~~---~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...........+........... ................+.+++.+|++.||++|||+.|+++
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11111100000000000000000 0000000011123456789999999999999999999985
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=359.92 Aligned_cols=330 Identities=22% Similarity=0.218 Sum_probs=212.9
Q ss_pred CCCCCC-C--CccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCcccccccccccc
Q 047768 52 ACVNLC-Q--HWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANN 128 (1009)
Q Consensus 52 ~~~~~c-~--~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N 128 (1009)
.|+..| | .|..|.|... +++ .+|..+. +++++|+|++|++++..|..|.++++|++|+|++|
T Consensus 2 ~Cp~~C~C~~~~~~v~c~~~------------~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 66 (477)
T 2id5_A 2 GCPPRCECSAQDRAVLCHRK------------RFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66 (477)
T ss_dssp CCSTTCEEETTTTEEECCSC------------CCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cccCCCeECCCCCEEEeCCC------------CcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCC
Confidence 477667 2 3567777543 333 2344443 57899999999999888889999999999999999
Q ss_pred ccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCC
Q 047768 129 SFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKI 208 (1009)
Q Consensus 129 ~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 208 (1009)
.+++..|..|+++++|++|+|++|+++ +..+..|+++++|++|+|++|++.+..
T Consensus 67 ~i~~~~~~~~~~l~~L~~L~L~~n~l~--------------------------~~~~~~~~~l~~L~~L~Ls~n~i~~~~ 120 (477)
T 2id5_A 67 IVSAVEPGAFNNLFNLRTLGLRSNRLK--------------------------LIPLGVFTGLSNLTKLDISENKIVILL 120 (477)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCC--------------------------SCCTTSSTTCTTCCEEECTTSCCCEEC
T ss_pred ccCEeChhhhhCCccCCEEECCCCcCC--------------------------ccCcccccCCCCCCEEECCCCccccCC
Confidence 999888888888888888777776665 223334455555555555555555555
Q ss_pred CcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcc
Q 047768 209 PITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNA 288 (1009)
Q Consensus 209 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 288 (1009)
|..|..+++|++|+|++|.+++..|..|.++++|++|+|++|+++ .+|...+.++++|+.|+|++|.+.+..+..|..+
T Consensus 121 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l 199 (477)
T 2id5_A 121 DYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199 (477)
T ss_dssp TTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS-SCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSC
T ss_pred hhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc-ccChhHhcccCCCcEEeCCCCcCcEeChhhcccC
Confidence 555555555555556555555555555555555566666666665 5666666667777778888777777777778888
Q ss_pred cccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcc
Q 047768 289 SNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLST 368 (1009)
Q Consensus 289 ~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 368 (1009)
++|++|++++|.+.+..+..+... .+|++|+|++|++++..+..+..+ .
T Consensus 200 ~~L~~L~l~~~~~~~~~~~~~~~~------------------------------~~L~~L~l~~n~l~~~~~~~~~~l-~ 248 (477)
T 2id5_A 200 YRLKVLEISHWPYLDTMTPNCLYG------------------------------LNLTSLSITHCNLTAVPYLAVRHL-V 248 (477)
T ss_dssp TTCCEEEEECCTTCCEECTTTTTT------------------------------CCCSEEEEESSCCCSCCHHHHTTC-T
T ss_pred cccceeeCCCCccccccCcccccC------------------------------ccccEEECcCCcccccCHHHhcCc-c
Confidence 888888888776655443322222 245555555555553333344444 4
Q ss_pred cceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCccccccccccccccc
Q 047768 369 ALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFG 448 (1009)
Q Consensus 369 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 448 (1009)
.|+.|+|++|.+++..+..|.++++|+.|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 249 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 328 (477)
T 2id5_A 249 YLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILD 328 (477)
T ss_dssp TCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECC
T ss_pred ccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEcc
Confidence 45555555555555555556666666666666666666666666666666666666666665555556666666666666
Q ss_pred Cccccc
Q 047768 449 ANNLQG 454 (1009)
Q Consensus 449 ~N~l~~ 454 (1009)
+|.+..
T Consensus 329 ~N~l~c 334 (477)
T 2id5_A 329 SNPLAC 334 (477)
T ss_dssp SSCEEC
T ss_pred CCCccC
Confidence 666653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=348.81 Aligned_cols=285 Identities=21% Similarity=0.251 Sum_probs=201.3
Q ss_pred HHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeecccc----
Q 047768 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDF---- 772 (1009)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 772 (1009)
....++|.+.+.||+|+||+||+|++..+|+.||||++.... ....+|+++++.++||||+++++++.....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999999999999999986432 223479999999999999999999754321
Q ss_pred -----------------------------CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHH
Q 047768 773 -----------------------------KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823 (1009)
Q Consensus 773 -----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~ 823 (1009)
......++||||++ |+|.+.+...... ...+++..++.++.|++.||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS--GRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHH
Confidence 23455889999997 5888777642111 124899999999999999999
Q ss_pred HHhhcCCCCceecCCCCCceeeC-CCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcc
Q 047768 824 YLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRG 901 (1009)
Q Consensus 824 ~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 901 (1009)
|||++ +|+||||||+||+++ .++.+||+|||+|+...... ......||+.|+|||++.+. .++.++
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---------PSVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---------CCCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---------CCcCcccCCCccCHHHhcCCCCCCcch
Confidence 99999 999999999999997 68999999999998764431 22345689999999998775 489999
Q ss_pred cchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccc---hhhhccCCCCCC--hhhh-hhhccccccHHHHHHHHHH
Q 047768 902 GVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE---KVMEIVDPSLLP--LEEE-RTNSRRVRNEECLVAVIKT 975 (1009)
Q Consensus 902 DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~d~~l~~--~~~~-r~~~~~~~~~~~~~~l~~l 975 (1009)
||||+||++|||++|+.||...... ............. .+... ++.... .+.. ..............++.++
T Consensus 224 DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 301 (383)
T 3eb0_A 224 DLWSIGCVFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRM-NPHYTEVRFPTLKAKDWRKILPEGTPSLAIDL 301 (383)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHH-CTTC--CCCCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred hhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHh-CcccccccCCccCcccHHhhCCCCCCHHHHHH
Confidence 9999999999999999999753222 1122222111111 01110 000000 0000 0000001111234568899
Q ss_pred HhhccCCCCCCCCCHHHHHH--HHHHHHH
Q 047768 976 GVACSIESPFDRMEMTDVVV--KLCHARQ 1002 (1009)
Q Consensus 976 ~~~cl~~dp~~Rpt~~evl~--~L~~i~~ 1002 (1009)
+.+|++.||++|||+.|+++ .+.++++
T Consensus 302 i~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 302 LEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 99999999999999999985 3444443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=346.55 Aligned_cols=269 Identities=19% Similarity=0.240 Sum_probs=185.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeecc-ccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSI-DFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+++++.++||||+++++++... ......
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3689999999999999999999999999999999864322 2346788999999999999999999997643 122335
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++|+||+ +++|.++++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CCEEEEECC-CEECC-----C-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred eEEEEeccc-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence 679999999 78999988753 289999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+.....
T Consensus 177 G~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~ 244 (367)
T 2fst_X 177 GLARHTADE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILR 244 (367)
T ss_dssp -------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH
T ss_pred ccccccccc-----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 999865321 224578999999999887 67899999999999999999999999753221 11111111
Q ss_pred Hhccc--h---------hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPE--K---------VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~--~---------~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..... + ....+...- ..+.... ..........+.+++.+|++.||++|||+.|+++
T Consensus 245 ~~g~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 245 LVGTPGAELLKKISSESARNYIQSLT-QMPKMNF---ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHCSCCHHHHTTCCCHHHHHHHHTSC-CCCCCCH---HHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCCHHHHHHhhhHHHHHHHhccC-CCCCCCH---HHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 11100 0 111110000 0000000 0000012345789999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=357.19 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=199.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-------------cchHHHHHHHHHHHhcCCCCcceEEee
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-------------GGSKSFAAECEALRSIRHRNLIKIVTI 766 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 766 (1009)
.++|.+.++||+|+||+||+|+++.+++.||||+++.... ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4689999999999999999999999999999999964321 234678899999999999999999999
Q ss_pred eeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC
Q 047768 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD 846 (1009)
Q Consensus 767 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 846 (1009)
+.. ....++||||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 115 ~~~-----~~~~~lv~e~~~gg~L~~~l~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 115 FED-----KKYFYLVTEFYEGGELFEQIINRHK------FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLE 180 (504)
T ss_dssp EEC-----SSEEEEEEECCTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEES
T ss_pred EEc-----CCEEEEEEecCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEe
Confidence 754 3778999999999999999987643 89999999999999999999999 999999999999998
Q ss_pred CCC---ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 047768 847 HDM---VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 847 ~~~---~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
.++ .+||+|||+++..... .......||+.|+|||++. +.++.++||||+||++|||++|+.||...
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 250 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKD---------YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ 250 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTT---------SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCCccEEEEECCCCEEcCCC---------CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 776 6999999999876542 1223456999999999976 56899999999999999999999999753
Q ss_pred ccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 924 FNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.. ........ .......... ......++.+++.+|++.||.+|||++|+++.
T Consensus 251 ~~-----~~~~~~i~--------~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 251 ND-----QDIIKKVE--------KGKYYFDFND--------WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp SH-----HHHHHHHH--------HCCCCCCHHH--------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CH-----HHHHHHHH--------cCCCCCCccc--------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 21 11111110 0000000000 00123457899999999999999999999753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=359.67 Aligned_cols=252 Identities=26% Similarity=0.334 Sum_probs=202.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||+||+|+++.+++.||||++.... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-----KG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence 357999999999999999999999999999999996442 2345789999999999999999999999754 36
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee---CCCCceEE
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHV 853 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl 853 (1009)
..++||||+.+|+|.+++..... +++.+++.++.|++.||.|||++ +|+||||||+||++ +.++.+||
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 170 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKR------FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRI 170 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSC------CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred EEEEEEecCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEE
Confidence 88999999999999999987543 89999999999999999999999 99999999999999 56789999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
+|||+++..... .......||+.|+|||++.+ .++.++||||+||++|||++|+.||..... ...
T Consensus 171 ~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~ 235 (484)
T 3nyv_A 171 IDFGLSTHFEAS---------KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-----YDI 235 (484)
T ss_dssp CCTTHHHHBCCC---------CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH
T ss_pred EeeeeeEEcccc---------cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-----HHH
Confidence 999999876543 12234579999999999866 689999999999999999999999974321 111
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
..... ........ ........++.+++.+|++.||.+|||+.|+++.
T Consensus 236 ~~~i~--------~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 236 LKKVE--------KGKYTFEL--------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHH--------HCCCCCCS--------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHH--------cCCCCCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 11110 00000000 0001223457899999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=341.05 Aligned_cols=271 Identities=21% Similarity=0.267 Sum_probs=184.6
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
...++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 86 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----D 86 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS-----S
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----C
Confidence 44578999999999999999999998889999999986543 23346788999999999999999999987643 5
Q ss_pred eEEEEEeccCCCCHHHHHhccCCC--CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQ--LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
..++||||+++++|.+++...... .....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEE
Confidence 689999999999999999752110 0112489999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
|||+++........ ..........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ....
T Consensus 164 dfg~~~~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~ 238 (303)
T 2vwi_A 164 DFGVSAFLATGGDI---TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--VLML 238 (303)
T ss_dssp CCHHHHHCC------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHH
T ss_pred eccchheeccCCCc---cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--HHHH
Confidence 99999876543110 01112234578999999999876 568999999999999999999999997543221 1111
Q ss_pred HHHhccchhhh-ccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 934 AKRALPEKVME-IVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 934 ~~~~~~~~~~~-~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.....+..... ..+... ...+..++.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 239 TLQNDPPSLETGVQDKEM--------------LKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHTSSCCCTTC-----CC--------------CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhccCCCccccccccchh--------------hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11100100000 000000 0112345789999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=351.20 Aligned_cols=259 Identities=11% Similarity=-0.010 Sum_probs=182.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhc--CCCCcceEEe-------ee
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSI--RHRNLIKIVT-------IC 767 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~~-------~~ 767 (1009)
...|.+.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|+++++.+ +||||++++. ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3468899999999999999999998999999999976443 2245677886555555 6999888552 22
Q ss_pred ecccc------------CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHH------HHHHHHHHHHHHHHhhcC
Q 047768 768 SSIDF------------KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQR------LNIVIDVASAVEYLHHHC 829 (1009)
Q Consensus 768 ~~~~~------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~ 829 (1009)
..... ......++||||++ |+|.+++...... +.+..+ ..++.|++.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-----~~~~~~~~~~vk~~i~~qi~~aL~~LH~~- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV-----YVFRGDEGILALHILTAQLIRLAANLQSK- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc-----cchhhhhhhhhHHHHHHHHHHHHHHHHHC-
Confidence 21100 00145799999998 8999999875322 444555 77889999999999999
Q ss_pred CCCceecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCC--CCCCCcccchHHH
Q 047768 830 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG--GEASMRGGVYSYG 907 (1009)
Q Consensus 830 ~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~G 907 (1009)
+||||||||+|||++.++.+||+|||+|+..... .....+|+.|+|||++.+ ..++.++||||||
T Consensus 214 --~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG 280 (371)
T 3q60_A 214 --GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----------GPASSVPVTYAPREFLNASTATFTHALNAWQLG 280 (371)
T ss_dssp --TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHH
T ss_pred --CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----------ccCccCCcCCcChhhccCCCCCcCccccHHHHH
Confidence 9999999999999999999999999999865421 113456799999999987 7789999999999
Q ss_pred HHHHHHHhCCCCCcccccCCccHHHHHHHhccc-hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCC
Q 047768 908 ILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE-KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFD 986 (1009)
Q Consensus 908 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~ 986 (1009)
|++|||++|+.||......... .... ........... ..........+.+++.+||+.||++
T Consensus 281 ~il~elltg~~Pf~~~~~~~~~-------~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~L~~dP~~ 343 (371)
T 3q60_A 281 LSIYRVWCLFLPFGLVTPGIKG-------SWKRPSLRVPGTDSLA----------FGSCTPLPDFVKTLIGRFLNFDRRR 343 (371)
T ss_dssp HHHHHHHHSSCSTTBCCTTCTT-------CCCBCCTTSCCCCSCC----------CTTSSCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHhCCCCCCCcCccccc-------chhhhhhhhccccccc----------hhhccCCCHHHHHHHHHHcCCChhh
Confidence 9999999999999754322100 0000 00000000000 0000123456789999999999999
Q ss_pred CCCHHHHHH
Q 047768 987 RMEMTDVVV 995 (1009)
Q Consensus 987 Rpt~~evl~ 995 (1009)
|||+.|+++
T Consensus 344 Rpt~~e~l~ 352 (371)
T 3q60_A 344 RLLPLEAME 352 (371)
T ss_dssp CCCHHHHTT
T ss_pred CCCHHHHhc
Confidence 999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=351.63 Aligned_cols=199 Identities=26% Similarity=0.325 Sum_probs=172.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc------CCCCcceEEeeeeccccC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI------RHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 773 (1009)
..+|.+.+.||+|+||+||+|.+..+++.||||+++... ...+.+.+|+++++.+ +|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~--- 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR--- 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET---
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC---
Confidence 357999999999999999999999899999999996432 2345677899888887 577999999987653
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc--e
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV--A 851 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~--~ 851 (1009)
...++||||+. ++|.+++...... .+++..++.++.|++.||+|||++ +||||||||+|||++.++. +
T Consensus 172 --~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 172 --NHICMTFELLS-MNLYELIKKNKFQ----GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp --TEEEEEECCCC-CBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCE
T ss_pred --CeEEEEEeccC-CCHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcce
Confidence 67899999995 6999999876532 489999999999999999999999 9999999999999999987 9
Q ss_pred EEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 047768 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 852 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 242 kL~DFG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 242 KVIDFGSSCYEHQR-----------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EECCCTTCEETTCC-----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeecccceecCCc-----------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999764422 22357899999999999999999999999999999999999999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=332.27 Aligned_cols=253 Identities=22% Similarity=0.292 Sum_probs=202.0
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---------cchHHHHHHHHHHHhcC-CCCcceEEeeee
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---------GGSKSFAAECEALRSIR-HRNLIKIVTICS 768 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 768 (1009)
-.++|.+.+.||+|+||.||+|.++.+++.||||+++.... ...+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 35689999999999999999999998999999999975431 12356789999999995 999999999975
Q ss_pred ccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC
Q 047768 769 SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD 848 (1009)
Q Consensus 769 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 848 (1009)
. ....++||||+++++|.+++.... .+++.+++.++.|++.||.|||++ +|+||||||+||+++.+
T Consensus 95 ~-----~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~ 160 (298)
T 1phk_A 95 T-----NTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD 160 (298)
T ss_dssp C-----SSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred c-----CCeEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCC
Confidence 4 367899999999999999998754 389999999999999999999999 99999999999999999
Q ss_pred CceEEeccccccccCCCCCCCccccCCccccccccccccCccccC------CCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 849 MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL------GGEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 849 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
+.+||+|||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 161 ~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGE---------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp CCEEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CcEEEecccchhhcCCCc---------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 999999999998765421 122356899999999874 45789999999999999999999999964
Q ss_pred cccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 923 MFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... ......... ....... ........++.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~-----~~~~~~~~~--------~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 232 RKQ-----MLMLRMIMS--------GNYQFGS--------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp SSH-----HHHHHHHHH--------TCCCCCT--------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccH-----HHHHHHHhc--------CCcccCc--------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 321 111111000 0000000 000123346889999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=343.43 Aligned_cols=283 Identities=23% Similarity=0.249 Sum_probs=203.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|.+.+.||+|+||.||+|++..+|+.||||+++.... .....+.+|++++++++||||+++++++....+......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4689999999999999999999998999999999964322 224567899999999999999999999876555556788
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+. |+|.+++.... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 90 ~lv~e~~~-~~L~~~~~~~~-------~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQM-------LSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp EEEECCCS-EEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEeccC-ccHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 99999996 69999987642 89999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccc--cCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 859 AKFLSASPLGNVVE--TPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 859 a~~~~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
++............ .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .......
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~ 237 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFG 237 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHH
Confidence 98775432111100 0112234578999999998754 778999999999999999999999997532211 0111111
Q ss_pred HhccchhhhccCCCCCCh-hhhh--------hhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPL-EEER--------TNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~-~~~r--------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
............ ..... ..+. .............++.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLR-CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTT-TCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhcccc-ccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000 00000 0000 00000000123456789999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=333.67 Aligned_cols=255 Identities=20% Similarity=0.255 Sum_probs=185.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|++.+.||+|+||+||+|++..+++.||||+++..... ..+.+.++...++.++||||+++++++... ..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----GD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----CC
Confidence 46899999999999999999999989999999999654322 123344555567888999999999997643 67
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||++ |+|.+++...... ...+++..++.++.|++.|++|||+++ +|+||||||+||+++.++.+||+|||
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVIDK--GQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred EEEEEehhc-cchHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecC
Confidence 899999997 5998887652111 124899999999999999999999853 89999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCcccc----CCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYG----LGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
+++...... ......||+.|+|||++ .+..++.++||||+||++|||++|+.||.............
T Consensus 156 ~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 226 (290)
T 3fme_A 156 ISGYLVDDV---------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226 (290)
T ss_dssp -----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH
T ss_pred Ccccccccc---------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH
Confidence 998664421 12234689999999995 56678999999999999999999999997432221111111
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... .....+ ...+..++.+++.+|++.||++|||+.|+++
T Consensus 227 ~~~------------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 227 VEE------------PSPQLP----------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHS------------CCCCCC----------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcc------------CCCCcc----------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 110 000000 0122345789999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=341.63 Aligned_cols=278 Identities=19% Similarity=0.260 Sum_probs=197.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeecc---------
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSI--------- 770 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 770 (1009)
.++|.+.+.||+|+||.||+|.+..+++.||||++........+.+.+|++++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 35789999999999999999999988999999999765555567889999999999999999999987432
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC-CCC
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD-HDM 849 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~ 849 (1009)
........++||||++ |+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||+++ +++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG-------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC-------CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence 1234467899999997 6999999753 288999999999999999999999 999999999999997 567
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGL 928 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~ 928 (1009)
.+||+|||+++....... .........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.......
T Consensus 159 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 232 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYS-----HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE- 232 (320)
T ss_dssp EEEECCCTTCBCC-------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred eEEEccCccccccCCCcc-----cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-
Confidence 999999999987643211 1112233567999999998765 678999999999999999999999997543211
Q ss_pred cHHHHHHHhc--c-chhhhccCCCCCChhhhhhh----ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 929 TLHEFAKRAL--P-EKVMEIVDPSLLPLEEERTN----SRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 929 ~~~~~~~~~~--~-~~~~~~~d~~l~~~~~~r~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.......... . +...++.+. +......... ...........++.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 233 QMQLILESIPVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHSCCCCHHHHHHHHTT-SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhcCCCchhhhhhhhhc-CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1111111100 0 001111100 0000000000 000000123456889999999999999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=340.86 Aligned_cols=285 Identities=20% Similarity=0.245 Sum_probs=194.7
Q ss_pred HHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeecccc-
Q 047768 694 KELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDF- 772 (1009)
Q Consensus 694 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 772 (1009)
.+.....++|.+.+.||+|+||+||+|+++.+++.||||++.... .......+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455677789999999999999999999999899999999985433 234567788888999999999999999865322
Q ss_pred -CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHh--hcCCCCceecCCCCCceeeCC-C
Q 047768 773 -KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH--HHCQPPIVHGDLKPSNVLLDH-D 848 (1009)
Q Consensus 773 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~~~ivHrdlk~~Nill~~-~ 848 (1009)
......++||||+++ +|.+.+...... ...+++..+..++.|++.|+.||| +. +|+||||||+||+++. +
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRR--QVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence 223347899999976 555544421110 124889999999999999999999 77 9999999999999997 8
Q ss_pred CceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCC-CCCcccchHHHHHHHHHHhCCCCCcccccCC
Q 047768 849 MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE-ASMRGGVYSYGILLLEIFTRRRPTESMFNEG 927 (1009)
Q Consensus 849 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~ 927 (1009)
+.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||......
T Consensus 169 ~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~- 238 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSE---------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA- 238 (360)
T ss_dssp TEEEECCCTTCBCCCTTS---------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred CcEEEeeCCCceecCCCC---------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-
Confidence 999999999998765431 222456899999999987654 899999999999999999999999753221
Q ss_pred ccHHHHHHHhc--cchhhhccCCCCCChhhhh------hhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 928 LTLHEFAKRAL--PEKVMEIVDPSLLPLEEER------TNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 928 ~~~~~~~~~~~--~~~~~~~~d~~l~~~~~~r------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
........... +......+++......... ..........+..++.+++.+|++.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11112211111 1111111111111100000 00000111124567889999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=342.60 Aligned_cols=255 Identities=23% Similarity=0.320 Sum_probs=200.0
Q ss_pred hccCccCCcccccCCceEEEEEEe---cCCeEEEEEEeeccc----ccchHHHHHHHHHHHhc-CCCCcceEEeeeeccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLH---ENGMLVAVKVINLEQ----KGGSKSFAAECEALRSI-RHRNLIKIVTICSSID 771 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 771 (1009)
.++|.+.+.||+|+||+||+|+.. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 368999999999999999999984 478999999986432 22345677899999999 699999999987543
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCce
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 851 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 851 (1009)
...++||||+++|+|.+++..... +++.+++.++.|++.||.|||++ +|+||||||+||+++.++.+
T Consensus 132 ----~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 198 (355)
T 1vzo_A 132 ----TKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV 198 (355)
T ss_dssp ----TEEEEEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred ----ceEEEEeecCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcE
Confidence 678999999999999999987643 89999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCCCccccCCccccccccccccCccccCC--CCCCCcccchHHHHHHHHHHhCCCCCcccccCCcc
Q 047768 852 HVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG--GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLT 929 (1009)
Q Consensus 852 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~ 929 (1009)
||+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..
T Consensus 199 kl~DfG~a~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~ 270 (355)
T 1vzo_A 199 VLTDFGLSKEFVADE-------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NS 270 (355)
T ss_dssp EESCSSEEEECCGGG-------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CC
T ss_pred EEeeCCCCeecccCC-------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc-ch
Confidence 999999998654321 122234679999999999886 34789999999999999999999999743222 12
Q ss_pred HHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 047768 930 LHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVVK 996 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~~ 996 (1009)
...+....... .+. ........+.+++.+|++.||++|| +++|+++.
T Consensus 271 ~~~~~~~~~~~------~~~--------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 271 QAEISRRILKS------EPP--------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHHHHHHHHHC------CCC--------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHHHHhcc------CCC--------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 22222111100 000 0012234577999999999999999 89998764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.34 Aligned_cols=247 Identities=18% Similarity=0.255 Sum_probs=196.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||+||+|++..+++.||||+++.... .....+.+|+..+.++ +||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----D 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----T
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----C
Confidence 4689999999999999999999998999999999975432 2346788899999999 999999999997643 6
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC--------
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD-------- 848 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-------- 848 (1009)
..++||||+++++|.+++...... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~ 159 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRI--MSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASE 159 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------
T ss_pred eEEEEEEecCCCcHHHHHHhhccc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccc
Confidence 789999999999999999865311 12389999999999999999999999 99999999999999844
Q ss_pred -----------CceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhC
Q 047768 849 -----------MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTR 916 (1009)
Q Consensus 849 -----------~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg 916 (1009)
..+||+|||.++...... ...||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~ 227 (289)
T 1x8b_A 160 EGDEDDWASNKVMFKIGDLGHVTRISSPQ------------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227 (289)
T ss_dssp ----------CCCEEECCCTTCEETTCSC------------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTC
T ss_pred ccccccccCCceEEEEcccccccccCCcc------------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcC
Confidence 479999999998764321 23489999999998876 567899999999999999999
Q ss_pred CCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 917 RRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 917 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..|+.... ..... ........+ ..+..++.+++.+|++.||++|||+.|+++
T Consensus 228 ~~~~~~~~----~~~~~------------~~~~~~~~~-----------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 228 EPLPRNGD----QWHEI------------RQGRLPRIP-----------QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCCCSSSH----HHHHH------------HTTCCCCCS-----------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCcchh----HHHHH------------HcCCCCCCC-----------cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 88764211 11111 111110011 112345789999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=366.38 Aligned_cols=245 Identities=21% Similarity=0.257 Sum_probs=200.7
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 774 (1009)
..++|.+.+.||+|+||.||+|+++.+++.||||+++.. .....+.+..|.+++..+ +||+|+++++++. .
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~-----~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----T 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB-----C
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE-----e
Confidence 456899999999999999999999999999999999743 233456788899999988 7999999999854 3
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
....++||||+++|+|.++++.... +++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVGR------FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEEC
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEe
Confidence 4788999999999999999987653 89999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+..
T Consensus 485 DFGla~~~~~~~--------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-----~~~~~ 551 (674)
T 3pfq_A 485 DFGMCKENIWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----EDELF 551 (674)
T ss_dssp CCTTCEECCCTT--------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHH
T ss_pred ecceeeccccCC--------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC-----HHHHH
Confidence 999998643221 22335679999999999999999999999999999999999999997432 12222
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~ 990 (1009)
.... ..... .+ .....++.+++.+|++.||++||++
T Consensus 552 ~~i~--------~~~~~-~p-----------~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 552 QSIM--------EHNVA-YP-----------KSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp HHHH--------SSCCC-CC-----------TTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred HHHH--------hCCCC-CC-----------ccCCHHHHHHHHHHccCCHHHCCCC
Confidence 2111 11110 11 0122457899999999999999998
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=345.33 Aligned_cols=276 Identities=19% Similarity=0.239 Sum_probs=204.7
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC--------CCCcceEEeeeeccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR--------HRNLIKIVTICSSID 771 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~~~ 771 (1009)
.++|.+.+.||+|+||+||+|++..+++.||||+++... ...+.+.+|++++++++ |+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~- 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS- 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE-
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec-
Confidence 367999999999999999999999899999999996432 23467889999999985 78899999987632
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC--
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM-- 849 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-- 849 (1009)
.......++||||+ ++++.+++..... ..+++..++.++.|++.||+|||+++ +||||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence 12346789999999 6677777665432 13899999999999999999999864 799999999999999775
Q ss_pred -----------------------------------------------ceEEeccccccccCCCCCCCccccCCccccccc
Q 047768 850 -----------------------------------------------VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882 (1009)
Q Consensus 850 -----------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~g 882 (1009)
.+||+|||+++..... .....|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----------~~~~~g 255 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----------FTEDIQ 255 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----------SCSCCS
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----------CccCCC
Confidence 7999999999866432 223468
Q ss_pred cccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHH-----HHHHHh--ccchh-------hhccCC
Q 047768 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLH-----EFAKRA--LPEKV-------MEIVDP 948 (1009)
Q Consensus 883 t~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~-----~~~~~~--~~~~~-------~~~~d~ 948 (1009)
|+.|+|||++.+..++.++|||||||++|||++|+.||........... ...... .+... .+....
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 335 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence 9999999999999999999999999999999999999976443322111 111100 11110 000000
Q ss_pred C--CCChh-------hhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 949 S--LLPLE-------EERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 949 ~--l~~~~-------~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. +.... ............+....+.+++.+|++.||++|||++|+++
T Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 00000 00000111233456678999999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=338.52 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=199.6
Q ss_pred HHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccC
Q 047768 695 ELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 695 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 773 (1009)
++....++|.+.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+++++++ +||||+++++++......
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 33445678999999999999999999998899999999996543 3457889999999999 899999999998653211
Q ss_pred -CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceE
Q 047768 774 -GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 852 (1009)
Q Consensus 774 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 852 (1009)
.....++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred cccceEEEEEEcCCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence 13678999999999999999987532 2489999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccCCccccccccccccCccccC-----CCCCCCcccchHHHHHHHHHHhCCCCCcccccCC
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-----GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEG 927 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~ 927 (1009)
|+|||++....... .......||+.|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 170 l~Dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~- 240 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM- 240 (326)
T ss_dssp ECCCTTTC---------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-
T ss_pred EeeCcCceecCcCc--------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-
Confidence 99999998654321 1122356899999999987 567899999999999999999999999643211
Q ss_pred ccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 928 LTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
......... ..+.. ....+...+.+++.+|++.||.+||+++|+++
T Consensus 241 ----~~~~~~~~~-----~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 241 ----RALFLIPRN-----PAPRL-------------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ----HHHHHHHHS-----CCCCC-------------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----HHHHHhhcC-----ccccC-------------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111000000 00000 00112345789999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=349.55 Aligned_cols=274 Identities=23% Similarity=0.311 Sum_probs=196.8
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeecccc-CCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDF-KGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~ 779 (1009)
.+|.+.+.||+|+||+||+|+++.+|+.||||++.... ....+|++++++++||||+++++++..... ......+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999999899999999985432 233479999999999999999998754321 2234567
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC-CceEEecccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGL 858 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~DfGl 858 (1009)
+||||+++ ++.+.+...... ...+++..++.++.|+++||+|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eehhcccc-cHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence 99999975 676666532110 12489999999999999999999999 99999999999999965 6789999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.++....
T Consensus 204 a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~l 273 (420)
T 1j1b_A 204 AKQLVRGE---------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVL 273 (420)
T ss_dssp CEECCTTC---------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred hhhcccCC---------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh
Confidence 98764321 12235789999999998765 7899999999999999999999999753221 1222222211
Q ss_pred cc---chhhhccCCCCCCh--hhhhh-hccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LP---EKVMEIVDPSLLPL--EEERT-NSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~---~~~~~~~d~~l~~~--~~~r~-~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. +.+... .+..... +.... ............++.+++.+|++.||++|||+.|+++
T Consensus 274 g~p~~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 274 GTPTREQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CSCCHHHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 11 111111 1111000 00000 0000001122356789999999999999999999975
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=345.57 Aligned_cols=350 Identities=15% Similarity=0.122 Sum_probs=207.4
Q ss_pred CCCCccCCCCCCCCCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCcccccccc
Q 047768 45 TSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLV 124 (1009)
Q Consensus 45 ~~sW~~~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~ 124 (1009)
+++|... .+||+.|.+..|.....+ +............-..++++++|++++|.++...+..|.++++|++|+
T Consensus 3 ~~~~~~~--~~C~~~~~~~~c~~~~~~-----i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~ 75 (390)
T 3o6n_A 3 VKPRQPE--YKCIDSNLQYDCVFYDVH-----IDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLN 75 (390)
T ss_dssp ----CCE--ECBCC------EEEESCE-----ECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEE
T ss_pred cCCCCCc--cceehhhhhhccceeeee-----eecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEE
Confidence 5789765 356766666666432212 222222222223334578999999999999844444579999999999
Q ss_pred ccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcc
Q 047768 125 LANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRL 204 (1009)
Q Consensus 125 Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 204 (1009)
|++|.+++..|..|+++++|++|++++|.+.+..|..+ ..+++|++|+|++|+++...+..|+++++|++|++++|++
T Consensus 76 L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~--~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l 153 (390)
T 3o6n_A 76 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF--QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNL 153 (390)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTT--TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHh--cCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCcc
Confidence 99999998777889988888888888877765444433 4456666666666666643333456666666666666666
Q ss_pred cCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCC
Q 047768 205 WGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDS 284 (1009)
Q Consensus 205 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~ 284 (1009)
.+..|..|..+++|++|++++|++++ ++. ..+++|+.|++++|.+++
T Consensus 154 ~~~~~~~~~~l~~L~~L~l~~n~l~~-------------------------~~~---~~l~~L~~L~l~~n~l~~----- 200 (390)
T 3o6n_A 154 ERIEDDTFQATTSLQNLQLSSNRLTH-------------------------VDL---SLIPSLFHANVSYNLLST----- 200 (390)
T ss_dssp CBCCTTTTSSCTTCCEEECCSSCCSB-------------------------CCG---GGCTTCSEEECCSSCCSE-----
T ss_pred CccChhhccCCCCCCEEECCCCcCCc-------------------------ccc---ccccccceeecccccccc-----
Confidence 55555556666666666666665552 221 124556666666665553
Q ss_pred cCcccccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhh
Q 047768 285 FSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIA 364 (1009)
Q Consensus 285 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 364 (1009)
+...++|++|++++|++....... . ++|+.|++++|.+++. ..+.
T Consensus 201 ~~~~~~L~~L~l~~n~l~~~~~~~---~------------------------------~~L~~L~l~~n~l~~~--~~l~ 245 (390)
T 3o6n_A 201 LAIPIAVEELDASHNSINVVRGPV---N------------------------------VELTILKLQHNNLTDT--AWLL 245 (390)
T ss_dssp EECCSSCSEEECCSSCCCEEECCC---C------------------------------SSCCEEECCSSCCCCC--GGGG
T ss_pred cCCCCcceEEECCCCeeeeccccc---c------------------------------ccccEEECCCCCCccc--HHHc
Confidence 222346667777777666543221 1 3444555555555432 2333
Q ss_pred hhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCccccccccccc
Q 047768 365 NLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTY 444 (1009)
Q Consensus 365 ~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 444 (1009)
.+ +.|++|+|++|.+++..|..|.++++|+.|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|++
T Consensus 246 ~l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~ 322 (390)
T 3o6n_A 246 NY-PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 322 (390)
T ss_dssp GC-TTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSE
T ss_pred CC-CCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCE
Confidence 33 345555555555555556666666777777777777763 4555566677777777777776 45556666777777
Q ss_pred ccccCcccccccCCCCCCCCCccccccCCCCcc
Q 047768 445 LSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLT 477 (1009)
Q Consensus 445 L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 477 (1009)
|++++|++++. | +..+++|+.|++++|+++
T Consensus 323 L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~ 352 (390)
T 3o6n_A 323 LYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWD 352 (390)
T ss_dssp EECCSSCCCCC-C--CCTTCCCSEEECCSSCEE
T ss_pred EECCCCcccee-C--chhhccCCEEEcCCCCcc
Confidence 77777777632 3 556666666666666665
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=341.30 Aligned_cols=203 Identities=24% Similarity=0.295 Sum_probs=170.7
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-CC-----CcceEEeeeeccc
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HR-----NLIKIVTICSSID 771 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~ 771 (1009)
...++|.+.+.||+|+||+||+|.++.+++.||||+++... .....+.+|+++++.++ |+ +++++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~- 128 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR- 128 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-
Confidence 34578999999999999999999999899999999996332 23456778999998885 55 489999887643
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC--CCC
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD--HDM 849 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~--~~~ 849 (1009)
...++||||++ |+|.+++...... .+++..+..++.|++.||.|||++ ..+||||||||+|||++ .++
T Consensus 129 ----~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 129 ----NHLCLVFEMLS-YNLYDLLRNTNFR----GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp ----TEEEEEEECCC-CBHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSC
T ss_pred ----CceEEEEecCC-CCHHHHHhhcCcC----CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCC
Confidence 67899999995 5999999876422 389999999999999999999952 22899999999999995 478
Q ss_pred ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 047768 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 850 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 199 ~~kL~DFG~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQR-----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CEEECCCTTCEETTCC-----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cEEEEeccCceecccc-----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 8999999999876432 12356899999999999999999999999999999999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=364.91 Aligned_cols=261 Identities=22% Similarity=0.352 Sum_probs=205.7
Q ss_pred HhccCccCCcccccCCceEEEEEEec---CCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHE---NGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
..++|.+.+.||+|+||.||+|.+.. .+..||||+++.... ...+.+.+|+.++++++||||+++++++..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 462 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 462 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 35678999999999999999999864 356899999864322 223678999999999999999999998743
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
...++||||+++|+|.++++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEE
Confidence 457899999999999999986543 389999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 933 (1009)
|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 534 DFG~a~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~~ 601 (656)
T 2j0j_A 534 DFGLSRYMEDSTY-------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DV 601 (656)
T ss_dssp CCCCCCSCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HH
T ss_pred ecCCCeecCCCcc-------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-----HH
Confidence 9999987654321 11223457889999999999999999999999999999997 99998743221 11
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
.... ........ +..++..+.+++.+||+.||++|||+.|+++.|+.+.++-
T Consensus 602 ~~~i--------~~~~~~~~-----------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 602 IGRI--------ENGERLPM-----------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp HHHH--------HHTCCCCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHH--------HcCCCCCC-----------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 1110 00000000 1123456889999999999999999999999999987654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=330.58 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=199.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc----ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ----KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|.+.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 468999999999999999999998899999999996542 2235678999999999999999999998743 233
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||++++ +.+++...... .+++.+++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~d 152 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEK----RFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISA 152 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred CeEEEEehhccCC-HHHHHHhCccc----ccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeec
Confidence 5789999999876 87877764322 489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCC--CCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE--ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
||+++........ .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.... ....
T Consensus 153 fg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~ 221 (305)
T 2wtk_C 153 LGVAEALHPFAAD------DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKL 221 (305)
T ss_dssp CTTCEECCTTCSS------CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHH
T ss_pred cccccccCccccc------cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHH
Confidence 9999876542211 1223456899999999987654 3789999999999999999999997422 1111
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
....... .. .. ...+...+.+++.+|++.||++|||+.|+++.
T Consensus 222 ~~~i~~~--------~~-~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 222 FENIGKG--------SY-AI-----------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHC--------CC-CC-----------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHhcC--------CC-CC-----------CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111000 00 00 01223457799999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=341.00 Aligned_cols=272 Identities=19% Similarity=0.219 Sum_probs=196.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeecccc-CCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDF-KGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 776 (1009)
.++|.+.+.||+|+||+||+|.++.+|+.||||+++..... ..+.+.+|++++++++||||+++++++..... ....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 35888999999999999999999999999999999654322 24678899999999999999999999865321 1122
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+. ++|.+++.. .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECST
T ss_pred eEEEEEcccc-ccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEec
Confidence 3489999996 689888743 289999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .......
T Consensus 189 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~ 256 (371)
T 4exu_A 189 GLARHADAE-----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK 256 (371)
T ss_dssp TCC-------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH
T ss_pred CcccccccC-----------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH
Confidence 999855421 223568999999999887 688999999999999999999999997532211 1111111
Q ss_pred Hhc--cchhhhccCCCCCChhhhhh-hcc----ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RAL--PEKVMEIVDPSLLPLEEERT-NSR----RVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~--~~~~~~~~d~~l~~~~~~r~-~~~----~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... +......+............ ... ......+...+.+++.+|++.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 257 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 110 00011000000000000000 000 0000122456889999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=338.78 Aligned_cols=265 Identities=21% Similarity=0.315 Sum_probs=201.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccch-----------------HHHHHHHHHHHhcCCCCcce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS-----------------KSFAAECEALRSIRHRNLIK 762 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------------~~~~~E~~~l~~l~h~niv~ 762 (1009)
.++|.+.+.||+|+||.||+|.+ +++.||||++........ +.+.+|++++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999998 799999999975432211 78999999999999999999
Q ss_pred EEeeeeccccCCCceEEEEEeccCCCCHHHH------HhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCcee
Q 047768 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEW------LHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH-HCQPPIVH 835 (1009)
Q Consensus 763 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH 835 (1009)
+++++... ...++||||+++|+|.++ +.... ...+++..++.++.|++.||.|||+ . +|+|
T Consensus 108 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H 175 (348)
T 2pml_X 108 CEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNY----TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICH 175 (348)
T ss_dssp CSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSS----CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred EEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhccC---CEee
Confidence 99997643 678999999999999998 54421 1359999999999999999999999 8 9999
Q ss_pred cCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCC-CCCC-cccchHHHHHHHHH
Q 047768 836 GDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASM-RGGVYSYGILLLEI 913 (1009)
Q Consensus 836 rdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwS~Gvvl~el 913 (1009)
|||||+||+++.++.+||+|||.++..... ......||+.|+|||++.+. .++. ++||||||+++|||
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l 245 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTT----------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHH
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccc----------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHH
Confidence 999999999999999999999999875432 22335689999999999887 6666 99999999999999
Q ss_pred HhCCCCCcccccCCccHHHHHHHhccchhh--hccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHH
Q 047768 914 FTRRRPTESMFNEGLTLHEFAKRALPEKVM--EIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMT 991 (1009)
Q Consensus 914 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~ 991 (1009)
++|+.||...... ............. ............ ............++.+++.+|++.||.+|||++
T Consensus 246 ~~g~~pf~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ 318 (348)
T 2pml_X 246 FYNVVPFSLKISL----VELFNNIRTKNIEYPLDRNHFLYPLTN---KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318 (348)
T ss_dssp HHSSCSSCCSSCS----HHHHHHHTSCCCCCCCSSSSSTTTTCC-----------CCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HhCCCCCCCCCcH----HHHHHHHhccCcCCccchhhhhccccc---cccccchhhcCHHHHHHHHHHccCChhhCCCHH
Confidence 9999999754321 1111111111000 000000000000 000001122345688999999999999999999
Q ss_pred HHHH
Q 047768 992 DVVV 995 (1009)
Q Consensus 992 evl~ 995 (1009)
|+++
T Consensus 319 e~l~ 322 (348)
T 2pml_X 319 DALK 322 (348)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=334.55 Aligned_cols=257 Identities=21% Similarity=0.284 Sum_probs=175.3
Q ss_pred hccCccCC-cccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSN-TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
.++|.+.+ .||+|+||+||+|.++.+++.||||++... .....+....++.++||||+++++++... ..+....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENM-HHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhc-cCCCceE
Confidence 45788854 699999999999999989999999998532 22223333345667999999999997653 2234568
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC---CCceEEec
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVSD 855 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~D 855 (1009)
++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+|
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence 999999999999999987643 2489999999999999999999999 9999999999999976 45699999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............ .
T Consensus 175 fg~~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~ 242 (336)
T 3fhr_A 175 FGFAKETTQN----------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--K 242 (336)
T ss_dssp CTTCEEC--------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred cccceecccc----------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH--H
Confidence 9999865432 122356899999999999999999999999999999999999999754322110000 0
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
............+ ....+..++.+++.+|++.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~---------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 243 RRIRLGQYGFPNP---------------EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --------CCCTT---------------TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhhccccccCch---------------hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000000000 00122345789999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=333.60 Aligned_cols=270 Identities=18% Similarity=0.248 Sum_probs=202.2
Q ss_pred hccCccCCcccccCCceEEEEEE-ecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCC------cceEEeeeecccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVL-HENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRN------LIKIVTICSSIDF 772 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 772 (1009)
.++|.+.+.||+|+||+||+|.+ +.+++.||||+++... ...+.+.+|+++++.++|++ ++++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~-- 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH-- 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET--
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC--
Confidence 35899999999999999999998 4678999999986432 23467889999999987654 89999987543
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC-----
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH----- 847 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~----- 847 (1009)
...++||||+ +++|.+++..... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 90 ---~~~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 90 ---GHICIVFELL-GLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp ---TEEEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEE
T ss_pred ---CcEEEEEcCC-CCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccc
Confidence 6889999999 8999999987643 2488999999999999999999999 9999999999999987
Q ss_pred --------------CCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHH
Q 047768 848 --------------DMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEI 913 (1009)
Q Consensus 848 --------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el 913 (1009)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 227 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY 227 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTSC-----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHH
T ss_pred ccCCccccccccccCCCceEeeCcccccCccc-----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHH
Confidence 678999999999864422 1235689999999999999999999999999999999
Q ss_pred HhCCCCCcccccCCccHHHHHH--HhccchhhhccCC---------CCCCh-hhh--------hhhccccccHHHHHHHH
Q 047768 914 FTRRRPTESMFNEGLTLHEFAK--RALPEKVMEIVDP---------SLLPL-EEE--------RTNSRRVRNEECLVAVI 973 (1009)
Q Consensus 914 ltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~d~---------~l~~~-~~~--------r~~~~~~~~~~~~~~l~ 973 (1009)
++|+.||....... ....... ...+.....-... .+... ... +..........+..++.
T Consensus 228 ~~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 306 (339)
T 1z57_A 228 YLGFTVFPTHDSKE-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLF 306 (339)
T ss_dssp HHSSCSCCCSCHHH-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred HhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHH
Confidence 99999997543211 1111111 1111111100000 00000 000 00001112234567899
Q ss_pred HHHhhccCCCCCCCCCHHHHHH
Q 047768 974 KTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 974 ~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
+++.+|++.||++|||++|+++
T Consensus 307 ~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 307 DLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHhCcCcccccCHHHHhc
Confidence 9999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.41 Aligned_cols=251 Identities=26% Similarity=0.317 Sum_probs=200.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||.||+|+++.+++.||||++..... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CCe
Confidence 4689999999999999999999988999999999965432 345688999999999999999999999754 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC---CceEEe
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHVS 854 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~ 854 (1009)
.++|+||+++++|.+++.... .+++.+++.++.|++.||.|||++ +|+||||||+||+++.+ +.+||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~ 166 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKII 166 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEEccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEe
Confidence 899999999999999987654 389999999999999999999999 99999999999999764 479999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+++...... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||..... ....
T Consensus 167 Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~ 231 (287)
T 2wei_A 167 DFGLSTCFQQNT---------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDIL 231 (287)
T ss_dssp STTGGGTBCCCS---------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH
T ss_pred ccCcceeecCCC---------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence 999998664321 1223458999999998765 489999999999999999999999975321 1111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
......... ...+. ......++.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~-------~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 232 KRVETGKYA-------FDLPQ---------WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHCCCC-------CCSGG---------GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCC-------CCchh---------hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 111000000 00000 0122345789999999999999999999987
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=344.09 Aligned_cols=335 Identities=19% Similarity=0.208 Sum_probs=201.7
Q ss_pred cCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHH
Q 047768 167 LFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIY 246 (1009)
Q Consensus 167 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 246 (1009)
+.+++.|++++|.++...+..|.++++|++|+|++|++.+..+..|..+++|++|+|++|++++..|..|.++++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 45566666666666644344456677777777777777666666777777777777777777766566666666666666
Q ss_pred hhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccC
Q 047768 247 LYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLG 326 (1009)
Q Consensus 247 L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~ 326 (1009)
|++|+++ .+|..++.++++|++|++++|.+++..|..|.++++|++|++++|++++..
T Consensus 124 L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--------------------- 181 (390)
T 3o6n_A 124 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--------------------- 181 (390)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---------------------
T ss_pred CCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---------------------
Confidence 6666666 677776667777888888888877777777777777888887777776432
Q ss_pred CCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCC
Q 047768 327 NGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTG 406 (1009)
Q Consensus 327 ~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 406 (1009)
+..+++|+.|++++|.+++. ...++|+.|++++|+++.
T Consensus 182 ------------~~~l~~L~~L~l~~n~l~~~------------------------------~~~~~L~~L~l~~n~l~~ 219 (390)
T 3o6n_A 182 ------------LSLIPSLFHANVSYNLLSTL------------------------------AIPIAVEELDASHNSINV 219 (390)
T ss_dssp ------------GGGCTTCSEEECCSSCCSEE------------------------------ECCSSCSEEECCSSCCCE
T ss_pred ------------cccccccceeeccccccccc------------------------------CCCCcceEEECCCCeeee
Confidence 12335556666666555421 111244455555555442
Q ss_pred CCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhh
Q 047768 407 TIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILE 486 (1009)
Q Consensus 407 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~ 486 (1009)
. |.. ..++|+.|+|++|++++. ..+..+++|++|++++|.+++..
T Consensus 220 ~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~------------------------------ 264 (390)
T 3o6n_A 220 V-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIM------------------------------ 264 (390)
T ss_dssp E-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEE------------------------------
T ss_pred c-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcC------------------------------
Confidence 2 211 124455555555555432 23444455554444444444332
Q ss_pred hccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceE
Q 047768 487 ITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKEL 566 (1009)
Q Consensus 487 ~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 566 (1009)
|..|..+++|++|++++|++++ +|..+..+++|+.|+|++|+++ .+|..++.+++|++|
T Consensus 265 -------------------~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L 323 (390)
T 3o6n_A 265 -------------------YHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323 (390)
T ss_dssp -------------------SGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred -------------------hhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEE
Confidence 3334445555555555555552 4555556666777777777766 455566677777777
Q ss_pred cCCCcccccccccccccccccCceecccccCcccCCCCCcccCccccccccCCCcCCCC
Q 047768 567 DLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGL 625 (1009)
Q Consensus 567 ~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~ 625 (1009)
+|++|++++. | +..+++|++|++++|++++.... ..+.......+.++...|+.+
T Consensus 324 ~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~ 378 (390)
T 3o6n_A 324 YLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 378 (390)
T ss_dssp ECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred ECCCCcccee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence 7777777643 3 56677777777777777765432 233444444556666677643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=343.08 Aligned_cols=273 Identities=21% Similarity=0.266 Sum_probs=193.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeecccc-CCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDF-KGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~ 778 (1009)
..+|.+.+.||+|+||+||+|++..++ .||+|++.... ....+|+++++.++||||+++++++..... ......
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~-~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTE-EEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCC-eEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 357999999999999999999997555 48888875332 223479999999999999999999865422 334457
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC-CCCceEEeccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFG 857 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~DfG 857 (1009)
++||||++++.+......... ...+++..++.++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKL---KQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEeeccCccHHHHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 899999976544333221110 12489999999999999999999999 999999999999999 79999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+|+...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+..+...
T Consensus 188 ~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~ 257 (394)
T 4e7w_A 188 SAKILIAGE---------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKV 257 (394)
T ss_dssp TCEECCTTC---------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred CcccccCCC---------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH
Confidence 998764331 12245689999999998765 5899999999999999999999999753221 112222211
Q ss_pred hccc---hhhh----ccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPE---KVME----IVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~---~~~~----~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... .+.. .....+...... ............++.+++.+|++.||++|||+.|+++
T Consensus 258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 258 LGTPSREQIKTMNPNYMEHKFPQIRPH--PFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCCCCHHHHHHHCGGGSSSCCCCCCCC--CHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hCCCCHHHHHhhChhhhhhccccccCC--cHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 1110 0110 011000000000 0000011123356889999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=330.35 Aligned_cols=264 Identities=22% Similarity=0.278 Sum_probs=194.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccc--------
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSID-------- 771 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 771 (1009)
.++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+.+|++++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457999999999999999999998899999999996432 23467889999999999999999999875421
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCce
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 851 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 851 (1009)
.......++||||+++|+|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENL-----NQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCG-----GGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred cccCCceEEEEecCCCCCHHHhhhcccc-----ccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCE
Confidence 1234678999999999999999986543 378899999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCCCc------cccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccc
Q 047768 852 HVSDFGLAKFLSASPLGNV------VETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMF 924 (1009)
Q Consensus 852 kl~DfGla~~~~~~~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~ 924 (1009)
||+|||+++.......... ...........||+.|+|||++.+. .++.++|||||||++|||++ ||....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 9999999987653210000 0001222345689999999998764 68999999999999999998 554211
Q ss_pred cCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 925 NEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. ...... +. ..... .+. ......+..+.+++.+|++.||.+|||+.|+++
T Consensus 233 ~~----~~~~~~-----~~---~~~~~-~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ER----VNILKK-----LR---SVSIE-FPP-------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH----HHHHHH-----HH---STTCC-CCT-------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hH----HHHHHh-----cc---ccccc-cCc-------cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11 111111 00 00000 000 011123345789999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=343.77 Aligned_cols=209 Identities=23% Similarity=0.331 Sum_probs=157.6
Q ss_pred ccCcc-CCcccccCCceEEEEEEe--cCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSS-SNTIGRGSFGFVYKGVLH--ENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~-~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
+.|.+ .++||+|+||+||+|+++ .+++.||||+++.. .....+.+|++++++++||||+++++++.. .....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLS---HADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCe
Confidence 34665 568999999999999976 46889999998533 234678899999999999999999999753 23467
Q ss_pred EEEEEeccCCCCHHHHHhccCCC---CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee----CCCCc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQ---LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL----DHDMV 850 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~~ 850 (1009)
.++||||++ |+|.+++...... .....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence 899999996 5888888643211 1122489999999999999999999999 99999999999999 77899
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCccc
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
+||+|||+|+....... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 171 ~kl~Dfg~a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EEECCTTCCC---------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEEEECCCceecCCCCc-----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999999987653211 11222346789999999998874 5899999999999999999999999643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=334.86 Aligned_cols=242 Identities=21% Similarity=0.307 Sum_probs=198.1
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc------chHHHHHHHHHHHhcC--CCCcceEEeeeecc
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG------GSKSFAAECEALRSIR--HRNLIKIVTICSSI 770 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 770 (1009)
..++|.+.+.||+|+||.||+|++..+++.||||+++..... ....+.+|++++++++ |+||+++++++..
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~- 119 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER- 119 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec-
Confidence 456899999999999999999999989999999999755322 2345778999999996 5999999999764
Q ss_pred ccCCCceEEEEEeccCC-CCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC-CC
Q 047768 771 DFKGVDFKALVYEYMQN-GSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD-HD 848 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~ 848 (1009)
....++|+||+.+ ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++ ++
T Consensus 120 ----~~~~~lv~e~~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 120 ----PDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR 186 (320)
T ss_dssp ----SSEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTT
T ss_pred ----CCcEEEEEEcCCCCccHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCC
Confidence 3678999999976 89999998754 389999999999999999999999 999999999999999 78
Q ss_pred CceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCcccccCC
Q 047768 849 MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESMFNEG 927 (1009)
Q Consensus 849 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~ 927 (1009)
+.+||+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus 187 ~~~kL~Dfg~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~---- 252 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTV----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---- 252 (320)
T ss_dssp TEEEECCCTTCEECCSSC----------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----
T ss_pred CCEEEeeCcccccccccc----------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----
Confidence 999999999998765321 223568999999999887766 78899999999999999999999632
Q ss_pred ccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 928 LTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
........ ... .....++.+++.+||+.||++|||++|+++
T Consensus 253 ---~~~~~~~~----------~~~--------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 253 ---EEIIRGQV----------FFR--------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---HHHHHCCC----------CCS--------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---hhhhcccc----------ccc--------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111000 000 012245789999999999999999999976
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=334.08 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=198.2
Q ss_pred HHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
....++|.+.+.||+|+||.||+|.++. .||+|+++.... ...+.+.+|++++++++||||+++++++...
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 101 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP---- 101 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS----
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC----
Confidence 3345789999999999999999998853 499999865432 2345678899999999999999999997643
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
...++||||+++++|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++ ++.+||+
T Consensus 102 -~~~~iv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~ 171 (319)
T 2y4i_B 102 -PHLAIITSLCKGRTLYSVVRDAKI-----VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVIT 171 (319)
T ss_dssp -SCEEEECBCCCSEEHHHHTTSSCC-----CCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEEC
T ss_pred -CceEEEeecccCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEe
Confidence 568999999999999999987543 388999999999999999999999 999999999999998 6799999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCC---------CCCCCcccchHHHHHHHHHHhCCCCCccccc
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG---------GEASMRGGVYSYGILLLEIFTRRRPTESMFN 925 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~ 925 (1009)
|||+++........ ..........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 172 Dfg~~~~~~~~~~~---~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 248 (319)
T 2y4i_B 172 DFGLFSISGVLQAG---RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248 (319)
T ss_dssp CCSCCC-------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH
T ss_pred ecCCcccccccccc---ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99998765432111 11122234568999999999864 4578899999999999999999999974321
Q ss_pred CCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 926 EGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
.......... ..+.... ..+..++.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 249 -----~~~~~~~~~~-----~~~~~~~-------------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 249 -----EAIIWQMGTG-----MKPNLSQ-------------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp -----HHHHHHHHTT-----CCCCCCC-------------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred -----HHHHHHhccC-----CCCCCCc-------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111000 0111100 01223477999999999999999999999999887665
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=337.89 Aligned_cols=276 Identities=17% Similarity=0.230 Sum_probs=202.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-----------CCCcceEEeeee
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-----------HRNLIKIVTICS 768 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 768 (1009)
.++|.+.+.||+|+||+||+|++..+++.||||+++... ...+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 358999999999999999999998899999999986332 23467889999999886 899999999976
Q ss_pred ccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC--
Q 047768 769 SIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD-- 846 (1009)
Q Consensus 769 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-- 846 (1009)
.. .......++||||+ +++|.+++...... .+++..++.++.|++.||+|||+++ +|+||||||+||+++
T Consensus 97 ~~-~~~~~~~~lv~e~~-~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 97 HK-GPNGVHVVMVFEVL-GENLLALIKKYEHR----GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EE-ETTEEEEEEEECCC-CEEHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred cc-CCCCceEEEEEecC-CCCHHHHHHHhhcc----CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence 53 12334789999999 89999999875432 3899999999999999999999953 899999999999994
Q ss_pred ----CCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 847 ----HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 847 ----~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH-----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CCCcCcceEEEcccccccccCCC-----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 4458999999999866432 1234689999999999999999999999999999999999999975
Q ss_pred cccCC-----ccHHHHHHHh--ccchh-------hhccCC---------CCCChhhhhhhccccccHHHHHHHHHHHhhc
Q 047768 923 MFNEG-----LTLHEFAKRA--LPEKV-------MEIVDP---------SLLPLEEERTNSRRVRNEECLVAVIKTGVAC 979 (1009)
Q Consensus 923 ~~~~~-----~~~~~~~~~~--~~~~~-------~~~~d~---------~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~c 979 (1009)
..... .......... .+... ...+.. .-.................+..++.+++.+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 317 (373)
T 1q8y_A 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 317 (373)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred CcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHH
Confidence 43211 0111111110 01100 000000 0000000001111123346677899999999
Q ss_pred cCCCCCCCCCHHHHHH
Q 047768 980 SIESPFDRMEMTDVVV 995 (1009)
Q Consensus 980 l~~dp~~Rpt~~evl~ 995 (1009)
++.||++|||++|+++
T Consensus 318 L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 318 LQLDPRKRADAGGLVN 333 (373)
T ss_dssp GCSSTTTCBCHHHHHT
T ss_pred hccCccccCCHHHHhh
Confidence 9999999999999976
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.25 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=193.0
Q ss_pred HHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcC--CCCcceEEeeeeccccC
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIR--HRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~ 773 (1009)
...++|.+.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|++++++++ ||||+++++++...
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--- 100 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--- 100 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS---
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC---
Confidence 34578999999999999999999985 6889999999654322 3467899999999997 59999999987643
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEE
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 853 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 853 (1009)
...++||| +.+++|.+++.... .+++.+++.++.|++.||.|||++ +|+||||||+||++++ +.+||
T Consensus 101 --~~~~lv~e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 101 --QYIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp --SEEEEEEC-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEE
T ss_pred --CEEEEEEe-cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEE
Confidence 67899999 56889999998754 389999999999999999999999 9999999999999964 89999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCC-----------CCCCCcccchHHHHHHHHHHhCCCCCcc
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-----------GEASMRGGVYSYGILLLEIFTRRRPTES 922 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~elltg~~p~~~ 922 (1009)
+|||+++....... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 168 ~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 168 IDFGIANQMQPDTT------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp CCCSSSCC--------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eeccccccccCccc------cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 99999987654321 111224568999999999875 4788899999999999999999999975
Q ss_pred cccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 923 MFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
..... ... ...++....... ......++.+++.+||+.||++||+++|+++.
T Consensus 242 ~~~~~---~~~---------~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 242 IINQI---SKL---------HAIIDPNHEIEF----------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CCSHH---HHH---------HHHHCTTSCCCC----------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHH---HHH---------HHHHhcccccCC----------cccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 33221 111 111111111000 00112357899999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=332.27 Aligned_cols=259 Identities=22% Similarity=0.257 Sum_probs=176.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHH-HHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECE-ALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||.||+|.++.+|+.||||+++.... .....+..|+. +++.++||||+++++++... +.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----GD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----SE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----Cc
Confidence 4688899999999999999999998999999999975432 22345556666 66778999999999997643 67
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++ +|.+++...... ....+++..+..++.|++.|+.|||+.. +|+||||||+||+++.++.+||+|||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred eEEEEeecCC-ChHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCC
Confidence 8999999974 888887641100 0124899999999999999999999853 79999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCcccc----CCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYG----LGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
+++...... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||....... .
T Consensus 172 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~- 237 (327)
T 3aln_A 172 ISGQLVDSI---------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----D- 237 (327)
T ss_dssp SSCC---------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------
T ss_pred Cceeccccc---------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----H-
Confidence 998664321 11234689999999998 46678999999999999999999999997432110 0
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
....+........+ ......+...+.+++.+||+.||++|||+.|+++
T Consensus 238 -------~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 238 -------QLTQVVKGDPPQLS-------NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---------CCCCCSCCCCCC-------CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------HHHHHhcCCCCCCC-------CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 01111111000000 0001123346889999999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=330.67 Aligned_cols=244 Identities=23% Similarity=0.336 Sum_probs=191.8
Q ss_pred HHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc------chHHHHHHHHHHHhc----CCCCcceEEee
Q 047768 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG------GSKSFAAECEALRSI----RHRNLIKIVTI 766 (1009)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~ 766 (1009)
..-.++|.+.+.||+|+||.||+|.+..+++.||||+++..... ....+.+|+++++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34457899999999999999999999889999999999644321 223466799999998 89999999998
Q ss_pred eeccccCCCceEEEEEec-cCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee
Q 047768 767 CSSIDFKGVDFKALVYEY-MQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL 845 (1009)
Q Consensus 767 ~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill 845 (1009)
+.. ....++|+|| +.+++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||++
T Consensus 107 ~~~-----~~~~~~v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 172 (312)
T 2iwi_A 107 FET-----QEGFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILI 172 (312)
T ss_dssp C----------CEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEE
T ss_pred Eec-----CCeEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEE
Confidence 654 3567899999 78999999998754 389999999999999999999999 99999999999999
Q ss_pred C-CCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCccc
Q 047768 846 D-HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 846 ~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
+ .++.+||+|||+++...... .....||..|+|||++.+..+ +.++||||+|+++|||++|+.||...
T Consensus 173 ~~~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 173 DLRRGCAKLIDFGSGALLHDEP----------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp ETTTTEEEECCCSSCEECCSSC----------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred eCCCCeEEEEEcchhhhcccCc----------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 9 88999999999998765421 223568999999999877666 45899999999999999999999632
Q ss_pred ccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 924 FNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...... ... .+ .....++.+++.+|++.||++|||++|+++
T Consensus 243 -------~~~~~~------------~~~-~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 243 -------QEILEA------------ELH-FP-----------AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -------HHHHHT------------CCC-CC-----------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------HHHhhh------------ccC-Cc-----------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111110 000 00 012235779999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=329.87 Aligned_cols=269 Identities=20% Similarity=0.234 Sum_probs=196.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeecccc-CCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDF-KGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 776 (1009)
.++|.+.+.||+|+||.||+|.++.+|+.||||++...... ..+.+.+|+.++++++||||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 35788999999999999999999989999999999643222 24578899999999999999999999765311 1123
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||++ ++|.+++.. .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 170 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF 170 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECST
T ss_pred eEEEEecccc-CCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeec
Confidence 4589999997 688877643 288999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .......
T Consensus 171 g~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~ 238 (353)
T 3coi_A 171 GLARHADAE-----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK 238 (353)
T ss_dssp TCTTC-------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHH
T ss_pred ccccCCCCC-----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 999864321 223568999999999877 678999999999999999999999997532211 1111111
Q ss_pred Hhc--cchhhhccCC--------CCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RAL--PEKVMEIVDP--------SLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~--~~~~~~~~d~--------~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... +......+.. .+...+.. . ..........++.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 239 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRK--D-FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHCBCCHHHHTTCSCHHHHHHHHTSCBCSSC--C-TTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhCCCCHHHHHHHhhHHHHHHHHhCcCCCCc--c-HHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 100 0000000000 00000000 0 00011123456889999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=331.42 Aligned_cols=270 Identities=19% Similarity=0.266 Sum_probs=199.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCC-eEEEEEEeecccccchHHHHHHHHHHHhcCCCC------cceEEeeeecccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENG-MLVAVKVINLEQKGGSKSFAAECEALRSIRHRN------LIKIVTICSSIDF 772 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 772 (1009)
.++|.+.+.||+|+||+||+|.++.++ +.||||+++... ...+.+.+|++++++++|++ ++.+.+++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~--- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE---
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee---
Confidence 368999999999999999999997666 799999996432 23467888999999997666 8888887654
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee-------
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL------- 845 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill------- 845 (1009)
....++||||+ ++++.+++..... ..+++.+++.++.|++.||+|||++ +|+||||||+||++
T Consensus 94 --~~~~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 94 --HGHMCIAFELL-GKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEE
T ss_pred --CCeEEEEEecc-CCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccc
Confidence 36789999999 7788888776542 2489999999999999999999999 99999999999999
Q ss_pred ------------CCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHH
Q 047768 846 ------------DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEI 913 (1009)
Q Consensus 846 ------------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el 913 (1009)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 232 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSC-----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred cccccccccccccCCCcEEEeecCcccccccc-----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHH
Confidence 56789999999999864332 1235689999999999999999999999999999999
Q ss_pred HhCCCCCcccccCCccHHHHHH--HhccchhhhccCC---------CCCCh-hhh--------hhhccccccHHHHHHHH
Q 047768 914 FTRRRPTESMFNEGLTLHEFAK--RALPEKVMEIVDP---------SLLPL-EEE--------RTNSRRVRNEECLVAVI 973 (1009)
Q Consensus 914 ltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~d~---------~l~~~-~~~--------r~~~~~~~~~~~~~~l~ 973 (1009)
++|+.||....... ....... ...+.....-... .+... ... ..............++.
T Consensus 233 ~~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 311 (355)
T 2eu9_A 233 YRGFTLFQTHENRE-HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF 311 (355)
T ss_dssp HHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred HhCCCCCCCCCHHH-HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHH
Confidence 99999997533211 0111111 1111111100000 00000 000 00001112234456789
Q ss_pred HHHhhccCCCCCCCCCHHHHHH
Q 047768 974 KTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 974 ~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
+++.+|++.||++|||++|+++
T Consensus 312 ~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 312 DLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHhcCChhhCcCHHHHhc
Confidence 9999999999999999999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=351.72 Aligned_cols=273 Identities=21% Similarity=0.305 Sum_probs=200.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccc-cCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSID-FKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~ 777 (1009)
.++|.+.+.||+|+||+||+|.+..+|+.||||+++... ....+.+.+|++++++++||||+++++++.... +.....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 468999999999999999999998899999999986442 223467889999999999999999999875421 223567
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc---eEEe
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV---AHVS 854 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---~kl~ 854 (1009)
.++||||+++|+|.+++...... ..+++..++.++.+++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~---~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENC---CGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCT---TCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred EEEEEEeCCCCCHHHHHHhcccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence 79999999999999999875431 2388889999999999999999999 9999999999999997764 9999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...|.
T Consensus 167 DFG~a~~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~ 233 (676)
T 3qa8_A 167 DLGYAKELDQGE---------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWH 233 (676)
T ss_dssp SCCCCCBTTSCC---------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSS
T ss_pred cccccccccccc---------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhh
Confidence 999998765432 22345789999999999999999999999999999999999999964211 11111
Q ss_pred HHhccch-----hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 047768 935 KRALPEK-----VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDV 993 (1009)
Q Consensus 935 ~~~~~~~-----~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~ev 993 (1009)
....... ..+......... ................+.+++.+|++.||++|||++|+
T Consensus 234 ~~i~~~~~~~~~~~~~l~g~~~~~--~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 234 GKVREKSNEHIVVYDDLTGAVKFS--SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp TTCC------CCSCCCCSSSCCCC--SSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhcccchhhhhhhhhccccccc--cccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0000000 001111111000 00001111223456678999999999999999999884
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=325.89 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=179.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccc--hHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG--SKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||.||+|+++.+|+.||||++....... .+.+.++..+++.++||||+++++++... ..
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-----TD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----Cc
Confidence 467889999999999999999999899999999997543221 23344555677888999999999997643 67
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
.++||||+ ++.+..+...... .+++..++.++.|++.||.|||+ . +|+||||||+||+++.++.+||+||
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQG-----PIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecc-CCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEEC
Confidence 89999999 5566666554332 38999999999999999999998 5 8999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccC-----CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-----GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLH 931 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~ 931 (1009)
|+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... .
T Consensus 170 g~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~ 236 (318)
T 2dyl_A 170 GISGRLVDDK---------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD----F 236 (318)
T ss_dssp TTC-----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH----H
T ss_pred CCchhccCCc---------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc----H
Confidence 9997654321 122346899999999984 567889999999999999999999999743221 1
Q ss_pred HHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 932 EFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.......... .+.+.. ...+..++.+++.+||+.||.+||+++|+++.
T Consensus 237 ~~~~~~~~~~-----~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 237 EVLTKVLQEE-----PPLLPG------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHHHHHHSC-----CCCCCS------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHhccC-----CCCCCc------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111111000 000000 00123457899999999999999999999873
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.59 Aligned_cols=256 Identities=30% Similarity=0.469 Sum_probs=178.5
Q ss_pred ceEEEcCCCcccc--CCCccccCcCccCEEEccC-CCCCCCCCCCcCCcccccceecccccccCCCCccccccccccccc
Q 047768 370 LIDFNLGKNQIYG--TIPPGIANLVNLNSLRMEA-NRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLS 446 (1009)
Q Consensus 370 L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 446 (1009)
++.|+|++|.+++ .+|..|.++++|++|+|++ |.+.+.+|..|+.+++|++|+|++|++++.+|..|.++++|++|+
T Consensus 52 l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 131 (313)
T 1ogq_A 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEe
Confidence 3344444444444 3444444444444444442 444444444444444444444444444444444444444444444
Q ss_pred ccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccC
Q 047768 447 FGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFS 526 (1009)
Q Consensus 447 L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 526 (1009)
+++|++++.+|..+..+++|++|++++|++++.+|..+.........|++++|++++.+|..+..++ |++|++++|+++
T Consensus 132 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~ 210 (313)
T 1ogq_A 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEE
T ss_pred CCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCccc
Confidence 4444444444444444444444445555444444444444432333477788888778888888887 999999999999
Q ss_pred CCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceecccccCcccCCCCCc
Q 047768 527 GQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGI 606 (1009)
Q Consensus 527 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~ 606 (1009)
+.+|..+..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|++|+|++|+++|.+|..+.
T Consensus 211 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~ 289 (313)
T 1ogq_A 211 GDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred CcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCcc
Confidence 99999999999999999999999977776 88899999999999999999999999999999999999999999999888
Q ss_pred ccCccccccccCCCcCCCCCC
Q 047768 607 FKNKTGFSIVGNGKLCGGLDE 627 (1009)
Q Consensus 607 ~~~~~~~~~~~n~~lc~~~~~ 627 (1009)
+.++....+.+|+++||.|.+
T Consensus 290 l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 290 LQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp GGGSCGGGTCSSSEEESTTSS
T ss_pred ccccChHHhcCCCCccCCCCC
Confidence 888888999999999997654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=335.73 Aligned_cols=257 Identities=20% Similarity=0.230 Sum_probs=183.7
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceEEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
.|.+.+.||+|+||+||.+.. .+|+.||||++... ..+.+.+|+++++++ +||||+++++++.. ....++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~~~~l 86 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETT-----DRFLYI 86 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-----SSEEEE
T ss_pred eeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCeEEE
Confidence 455568899999999987543 57999999998643 245678999999987 89999999998654 367899
Q ss_pred EEeccCCCCHHHHHhccCCCCCc-cCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC-----------
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGI-CNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD----------- 848 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~----------- 848 (1009)
||||+. |+|.+++......... ...++..++.++.|++.||+|||++ +||||||||+||+++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCC
Confidence 999995 6999999875432110 1113345678999999999999999 99999999999999754
Q ss_pred --CceEEeccccccccCCCCCCCccccCCccccccccccccCccccCC-------CCCCCcccchHHHHHHHHHHh-CCC
Q 047768 849 --MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-------GEASMRGGVYSYGILLLEIFT-RRR 918 (1009)
Q Consensus 849 --~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~ellt-g~~ 918 (1009)
+.+||+|||+++........ .........||+.|+|||++.+ ..++.++|||||||++|||++ |+.
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSS----FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp CSCEEEECCCTTCEECCC------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred CceEEEEcccccceecCCCCcc----ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 48999999999877543210 0011234579999999999876 678999999999999999999 999
Q ss_pred CCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 919 PTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 919 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
||...... ........ .+.. . ...........++.+++.+|++.||++|||+.|+++
T Consensus 239 Pf~~~~~~---~~~i~~~~--------~~~~--~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 239 PFGDKYSR---ESNIIRGI--------FSLD--E-------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TTCSTTTH---HHHHHHTC--------CCCC--C-------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCchhh---HHHHhcCC--------CCcc--c-------ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 99643211 11111110 0000 0 001112345567889999999999999999999985
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=328.91 Aligned_cols=274 Identities=23% Similarity=0.275 Sum_probs=210.6
Q ss_pred cCChhhHHHHHHHHHhc-CCCCCCCCCCcc--CCCCCCCCCccceeeCC--------CCCeEEEEEeecCCcccccCccc
Q 047768 22 LSNETDCLSLLAIKSQL-HDPLGVTSSWNR--SACVNLCQHWTGVTCGR--------RNQRVTKLDLRNQSIGGILSPYV 90 (1009)
Q Consensus 22 ~~~~~d~~aLl~~k~~~-~~~~~~~~sW~~--~~~~~~c~~w~gv~C~~--------~~~~v~~l~l~~~~l~~~~~~~~ 90 (1009)
.+..+|+.||++||+++ .||.+.+++|.. ....++| .|.||.|+. ...+|+.|+|++++++ .+|+.+
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~-~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE-TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC-CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhccccccccccc-ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 35578999999999997 678777889941 1123445 799999952 3468999999999998 778889
Q ss_pred cCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhh------
Q 047768 91 GNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELIS------ 164 (1009)
Q Consensus 91 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~------ 164 (1009)
+.+++|++|+|++|.++ .+|..|+++++|++|+|++|.++ .+|..++++++|++|++++|++.+.+|..+..
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 99999999999999999 99999999999999999999999 88999999999999999999999999887631
Q ss_pred -hccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHH
Q 047768 165 -RRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLV 243 (1009)
Q Consensus 165 -~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 243 (1009)
..+.+|++|+|++|+++ .+|..++++++|++|+|++|++++ +|..|..+++|++|+|++|++.+.+|..+.++++|+
T Consensus 179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~ 256 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256 (328)
T ss_dssp EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence 23677777777777777 667777777777777777777764 455677777777777777777777777777777777
Q ss_pred HHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccc
Q 047768 244 EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFR 302 (1009)
Q Consensus 244 ~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 302 (1009)
+|+|++|++.+.+|..+ .++++|++|+|++|++.+.+|..|.++++|+.+++..|.+.
T Consensus 257 ~L~L~~n~~~~~~p~~~-~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 257 RLILKDCSNLLTLPLDI-HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp EEECTTCTTCCBCCTTG-GGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred EEECCCCCchhhcchhh-hcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 77777666666666554 34666666666666666666666666666666666655544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=332.74 Aligned_cols=251 Identities=24% Similarity=0.296 Sum_probs=182.7
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCceE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
..+|.+.+.||+|+||+||... ..+++.||||++.... ...+.+|+++++++ +||||+++++++.. ....
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~-~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-----~~~~ 93 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKD-----RQFQ 93 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEE-ESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEE-----TTEE
T ss_pred cEEEecCCeeecCcCEEEEEEE-EeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCEE
Confidence 3568888999999999966433 3478999999985432 23457899999999 89999999998654 3678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC-----CCceEE
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH-----DMVAHV 853 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-----~~~~kl 853 (1009)
++||||+. |+|.+++...... ..+.+++.++.|++.||+|||+. +|+||||||+||+++. ...+||
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL 164 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDFA-----HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMI 164 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSCC-----CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred EEEEECCC-CCHHHHHHhcCCC-----ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEE
Confidence 99999995 6999999876532 44456678999999999999999 9999999999999953 236889
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccC---CCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCcc
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL---GGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLT 929 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~ 929 (1009)
+|||+|+....... .........||+.|+|||++. ...++.++||||+||++|||++ |+.||......
T Consensus 165 ~DFG~a~~~~~~~~-----~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--- 236 (432)
T 3p23_A 165 SDFGLCKKLAVGRH-----SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--- 236 (432)
T ss_dssp CCTTEEECC-----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---
T ss_pred ecccceeeccCCCc-----ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---
Confidence 99999987654321 112233467999999999987 4567889999999999999999 89998632211
Q ss_pred HHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 930 LHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. ........... ... ........+.+++.+|++.||++|||+.||++
T Consensus 237 --~-~~~~~~~~~~~----~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 237 --Q-ANILLGACSLD----CLH------------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp --H-HHHHTTCCCCT----TSC------------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --H-HHHHhccCCcc----ccC------------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 00000000000 000 01123345779999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=309.50 Aligned_cols=235 Identities=11% Similarity=0.036 Sum_probs=183.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccc---hHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGG---SKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|.+.+.||+|+||.||+|.+..+++.||||+++...... .+.+.+|++++++++||||+++++++... +.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-----AG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-----Cc
Confidence 57999999999999999999999889999999997553322 36789999999999999999999997653 67
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++++|.++++.. ....++..++.|++.||+|||++ +|+||||||+||+++.++.+||+++|
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred EEEEEEecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc
Confidence 89999999999999999542 34557889999999999999999 99999999999999999999998543
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
|++ .++.++|||||||++|||+||+.||.........
T Consensus 175 ----------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-------- 211 (286)
T 3uqc_A 175 ----------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-------- 211 (286)
T ss_dssp ----------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS--------
T ss_pred ----------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh--------
Confidence 333 3688999999999999999999999754321100
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFL 1005 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~ 1005 (1009)
......+...... +. ........++.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 212 --~~~~~~~~~~~~~-~~-------~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 212 --APAERDTAGQPIE-PA-------DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp --EECCBCTTSCBCC-HH-------HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred --HHHHHHhccCCCC-hh-------hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0000000000000 00 0011234568899999999999999 99999999998876543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.92 Aligned_cols=236 Identities=20% Similarity=0.308 Sum_probs=181.4
Q ss_pred ccCccC-CcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHH-HhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSS-NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEAL-RSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|.+. +.||+|+||.||+|.++.+++.||||+++. ...+.+|++++ +..+||||+++++++... ..+....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCceE
Confidence 467666 779999999999999998999999999852 35678899988 555999999999987652 2334678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC---CCceEEec
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVSD 855 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~D 855 (1009)
++||||+++|+|.+++...... .+++.+++.++.|++.||.|||++ +|+||||||+||+++. ++.+||+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEeecCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence 9999999999999999876432 489999999999999999999999 9999999999999998 78999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+++... +..++.++||||+||++|||++|+.||.......
T Consensus 164 fg~a~~~~------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-------- 205 (299)
T 3m2w_A 164 FGFAKETT------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------- 205 (299)
T ss_dssp CTTCEECT------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------
T ss_pred cccccccc------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh--------
Confidence 99987432 2346789999999999999999999996432110
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
........+.......+.. ....+..++.+++.+|++.||++|||+.|+++.
T Consensus 206 --~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 206 --ISPGMKTRIRMGQYEFPNP-------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp ----CCSCCSSCTTCCSSCHH-------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --hhHHHHHHHhhccccCCch-------hcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000001110000000000 001234568899999999999999999999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=346.76 Aligned_cols=247 Identities=20% Similarity=0.285 Sum_probs=195.6
Q ss_pred ccCccCCcccccCCceEEEEEEec-CCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHE-NGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|.+.+.||+|+||+||+|.++. +++.||||++..... .....+.+|++++++++||||+++++++......+....
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 689999999999999999999975 789999999864322 234578899999999999999999999876533333346
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+++++|.+++.. .+++.+++.++.|++.||.|||++ +||||||||+||+++.+ .+||+|||+
T Consensus 160 ~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 999999999999987754 289999999999999999999999 99999999999999986 999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
++..... ....||+.|+|||++.+.. +.++|||||||++|||++|..||.......
T Consensus 228 a~~~~~~------------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------- 283 (681)
T 2pzi_A 228 VSRINSF------------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------- 283 (681)
T ss_dssp CEETTCC------------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------
T ss_pred chhcccC------------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------
Confidence 9865432 2356899999999987654 889999999999999999988875321110
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHh
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-EMTDVVVKLCHARQN 1003 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-t~~evl~~L~~i~~~ 1003 (1009)
.....+ .......+.+++.+|++.||++|| +++++...+..+.++
T Consensus 284 ----------~~~~~~----------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 284 ----------LPEDDP----------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp ----------CCTTCH----------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred ----------cccccc----------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 000000 112335678999999999999999 566777777766544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=316.85 Aligned_cols=306 Identities=27% Similarity=0.406 Sum_probs=168.6
Q ss_pred cCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCc
Q 047768 91 GNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNL 170 (1009)
Q Consensus 91 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L 170 (1009)
..+++|++|++++|.++ .+|. +..+++|++|+|++|++++..+ +.++++|++|++++|.+++ +| .+ ..+++|
T Consensus 41 ~~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~--~~l~~L 112 (347)
T 4fmz_A 41 EELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-AL--QNLTNL 112 (347)
T ss_dssp HHHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GG--TTCTTC
T ss_pred hhcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HH--cCCCcC
Confidence 34555666666666665 3443 5566666666666666653322 5566666666666665543 22 11 445566
Q ss_pred CeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCC
Q 047768 171 QGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGN 250 (1009)
Q Consensus 171 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 250 (1009)
++|++++|++++..+ +..+++|++|++++|.....++ .+..+++|++|++++|.+++..+ +..+++|++|++++|
T Consensus 113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187 (347)
T ss_dssp SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred CEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence 666666666653322 5566666666666664433332 25666666666666666653222 555555555555555
Q ss_pred ccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCCCCC
Q 047768 251 RFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAA 330 (1009)
Q Consensus 251 ~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~ 330 (1009)
+++ .++. +..+++|+.|++++|.+++..+ +..+++|++|++++|++++..+ +..+++|+.|++++|.+...
T Consensus 188 ~l~-~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-- 258 (347)
T 4fmz_A 188 QIE-DISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI-- 258 (347)
T ss_dssp CCC-CCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--
T ss_pred ccc-cccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--
Confidence 555 3333 3345666666666666654433 5556666666666666554433 44444444444444443322
Q ss_pred CCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCC
Q 047768 331 NDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPH 410 (1009)
Q Consensus 331 ~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 410 (1009)
+.+..+++ |+.|++++|++++. +.+..+++|+.|++++|++++..|.
T Consensus 259 ------~~~~~l~~-------------------------L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~ 305 (347)
T 4fmz_A 259 ------NAVKDLTK-------------------------LKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDME 305 (347)
T ss_dssp ------GGGTTCTT-------------------------CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHH
T ss_pred ------hhHhcCCC-------------------------cCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChh
Confidence 12333444 44444445544432 3455666777777777777666666
Q ss_pred CcCCcccccceecccccccCCCCcccccccccccccccCcccc
Q 047768 411 VIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453 (1009)
Q Consensus 411 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 453 (1009)
.+..+++|++|+|++|++++..| +..+++|++|++++|.|+
T Consensus 306 ~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred HhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 66677777777777777765544 666777777777777664
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=325.25 Aligned_cols=251 Identities=17% Similarity=0.141 Sum_probs=182.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc---cchHHHHHHHHHHHhcCC-CCcceEE---------ee
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK---GGSKSFAAECEALRSIRH-RNLIKIV---------TI 766 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~---------~~ 766 (1009)
...|...+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|+.+++.++| +|..... ..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3467778899999999999999999999999999873332 235789999999999987 3221111 11
Q ss_pred e------------eccccCCCceEEEEEeccCCCCHHHHHhccCC-CCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 047768 767 C------------SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDD-QLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPI 833 (1009)
Q Consensus 767 ~------------~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 833 (1009)
+ ...........+++|+++ +++|.++++.... ......+++..++.++.|++.||+|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 1 100000123456777765 7899999852210 00012478889999999999999999999 99
Q ss_pred eecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCcccc----------CCCCCCCcccc
Q 047768 834 VHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYG----------LGGEASMRGGV 903 (1009)
Q Consensus 834 vHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv 903 (1009)
|||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv 300 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT 300 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----------cccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence 99999999999999999999999999865421 233567 999999998 66678999999
Q ss_pred hHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCC
Q 047768 904 YSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIES 983 (1009)
Q Consensus 904 wS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~d 983 (1009)
|||||++|||++|+.||....... ....++.... ..+.++.+++.+||+.|
T Consensus 301 wSlGvil~elltg~~Pf~~~~~~~-------------~~~~~~~~~~----------------~~~~~~~~li~~~l~~d 351 (413)
T 3dzo_A 301 WTLGLAIYWIWCADLPNTDDAALG-------------GSEWIFRSCK----------------NIPQPVRALLEGFLRYP 351 (413)
T ss_dssp HHHHHHHHHHHHSSCCCCTTGGGS-------------CSGGGGSSCC----------------CCCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHHHHCCCCCCCcchhh-------------hHHHHHhhcc----------------cCCHHHHHHHHHHccCC
Confidence 999999999999999997532211 0111111000 11245889999999999
Q ss_pred CCCCCCHHHHHH
Q 047768 984 PFDRMEMTDVVV 995 (1009)
Q Consensus 984 p~~Rpt~~evl~ 995 (1009)
|++||++.|+++
T Consensus 352 P~~Rpt~~~~l~ 363 (413)
T 3dzo_A 352 KEDRLLPLQAME 363 (413)
T ss_dssp GGGSCCHHHHTT
T ss_pred hhhCcCHHHHHh
Confidence 999999877754
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=342.76 Aligned_cols=312 Identities=16% Similarity=0.132 Sum_probs=232.1
Q ss_pred CCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcC
Q 047768 92 NLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQ 171 (1009)
Q Consensus 92 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~ 171 (1009)
.+++++.|++++|.+++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..+ ..+++|+
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~--~~l~~L~ 126 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF--QNVPLLT 126 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTT--TTCTTCC
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHH--cCCCCCC
Confidence 46778888888888885555557888888888888888888777788888888888888888887665554 5678888
Q ss_pred eEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCc
Q 047768 172 GLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNR 251 (1009)
Q Consensus 172 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 251 (1009)
+|+|++|.+++..+..|+++++|++|+|++|.+.+..|..|..+++|++|+|++|.+++. .+..+++|+.|++++|.
T Consensus 127 ~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~ 203 (597)
T 3oja_B 127 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNL 203 (597)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSC
T ss_pred EEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCc
Confidence 888888888866666678888888888888888888888888888888888888888854 25567788888888888
Q ss_pred cCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCCCCCC
Q 047768 252 FTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAAN 331 (1009)
Q Consensus 252 l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~ 331 (1009)
+++ + ...++|+.|++++|.++...+..+ ++|+.|+|++|.+++. ..+..+++|+.|+|++|.+....
T Consensus 204 l~~-l-----~~~~~L~~L~ls~n~l~~~~~~~~---~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~-- 270 (597)
T 3oja_B 204 LST-L-----AIPIAVEELDASHNSINVVRGPVN---VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIM-- 270 (597)
T ss_dssp CSE-E-----ECCTTCSEEECCSSCCCEEECSCC---SCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEE--
T ss_pred ccc-c-----cCCchhheeeccCCcccccccccC---CCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCC--
Confidence 872 2 235678888888888875544332 5788888888888874 56788888888888888887543
Q ss_pred CcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCC
Q 047768 332 DLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHV 411 (1009)
Q Consensus 332 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 411 (1009)
+..|..+++|+.|+|++|.+++. |..+..+++|+.|+|++|.++ .+|..
T Consensus 271 ----~~~~~~l~~L~~L~Ls~N~l~~l--------------------------~~~~~~l~~L~~L~Ls~N~l~-~i~~~ 319 (597)
T 3oja_B 271 ----YHPFVKMQRLERLYISNNRLVAL--------------------------NLYGQPIPTLKVLDLSHNHLL-HVERN 319 (597)
T ss_dssp ----SGGGTTCSSCCEEECTTSCCCEE--------------------------ECSSSCCTTCCEEECCSSCCC-CCGGG
T ss_pred ----HHHhcCccCCCEEECCCCCCCCC--------------------------CcccccCCCCcEEECCCCCCC-ccCcc
Confidence 35677888888888888887632 233344566666666666666 45555
Q ss_pred cCCcccccceecccccccCCCCcccccccccccccccCcccccc
Q 047768 412 IGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGN 455 (1009)
Q Consensus 412 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 455 (1009)
+..+++|++|+|++|++++. | +..+++|++|++++|.+.+.
T Consensus 320 ~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 320 QPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp HHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred cccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCCh
Confidence 66666677777777766643 2 45566677777777777643
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=309.39 Aligned_cols=305 Identities=26% Similarity=0.374 Sum_probs=182.2
Q ss_pred CCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccccccccccccccccc
Q 047768 238 NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSM 317 (1009)
Q Consensus 238 ~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~ 317 (1009)
.+++|++|++++|.++ .+|. +..+++|++|++++|++++..+ |.++++|++|++++|+++.+. .|.
T Consensus 42 ~l~~L~~L~l~~~~i~-~~~~--~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~~--~~~------- 107 (347)
T 4fmz_A 42 ELESITKLVVAGEKVA-SIQG--IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDIS--ALQ------- 107 (347)
T ss_dssp HHTTCSEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGT-------
T ss_pred hcccccEEEEeCCccc-cchh--hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCch--HHc-------
Confidence 4445555555555554 4432 2335555555555555553322 555555555555555554431 244
Q ss_pred ccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEE
Q 047768 318 LGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSL 397 (1009)
Q Consensus 318 L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 397 (1009)
++++|++|++++|.+++..+ +..+ ..|+.|++++|.....++ .+..+++|++|
T Consensus 108 -----------------------~l~~L~~L~l~~n~i~~~~~--~~~l-~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L 160 (347)
T 4fmz_A 108 -----------------------NLTNLRELYLNEDNISDISP--LANL-TKMYSLNLGANHNLSDLS-PLSNMTGLNYL 160 (347)
T ss_dssp -----------------------TCTTCSEEECTTSCCCCCGG--GTTC-TTCCEEECTTCTTCCCCG-GGTTCTTCCEE
T ss_pred -----------------------CCCcCCEEECcCCcccCchh--hccC-CceeEEECCCCCCccccc-chhhCCCCcEE
Confidence 44555555555555543222 3333 345555555554332222 25555555555
Q ss_pred EccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCcc
Q 047768 398 RMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLT 477 (1009)
Q Consensus 398 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 477 (1009)
++++|.+.+..+ +..+++|++|++++|.+++..+ +..+++|++|++++|.+++..+ +..+++|++|++++|+++
T Consensus 161 ~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~ 234 (347)
T 4fmz_A 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT 234 (347)
T ss_dssp ECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred EecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccC
Confidence 555555553332 4555555555555555553222 4555555555555555554333 455555555555555555
Q ss_pred CCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccccccccccc
Q 047768 478 GALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSL 557 (1009)
Q Consensus 478 ~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 557 (1009)
+..+ +... .....|++++|.+++. ..+..+++|++|++++|++++. +.+..+++|+.|+|++|++++..|..+
T Consensus 235 ~~~~--~~~l-~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l 307 (347)
T 4fmz_A 235 DLSP--LANL-SQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVI 307 (347)
T ss_dssp CCGG--GTTC-TTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHH
T ss_pred CCcc--hhcC-CCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHh
Confidence 3322 2222 2223477777777643 3578899999999999999864 468899999999999999999999999
Q ss_pred ccccccceEcCCCcccccccccccccccccCceecccccCc
Q 047768 558 SSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFE 598 (1009)
Q Consensus 558 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 598 (1009)
+.+++|++|+|++|++++..| +..+++|++|++++|+++
T Consensus 308 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 308 GGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 999999999999999997666 889999999999999885
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=307.10 Aligned_cols=200 Identities=23% Similarity=0.291 Sum_probs=114.5
Q ss_pred EEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccc
Q 047768 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRN 152 (1009)
Q Consensus 73 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n 152 (1009)
..+++++++++ .+|..+. ++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|++++|
T Consensus 36 ~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 36 RVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred CEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 34555555554 3344332 46666677666666555566666666666666666666666666666666666666666
Q ss_pred cccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCccc--CCCCcccccccccccccccCccCCC
Q 047768 153 NLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLW--GKIPITLSQLTSLAYLHVGDNHFSG 230 (1009)
Q Consensus 153 ~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~ 230 (1009)
.+. .+|..++ .+|++|++++|++++..+..|+++++|++|++++|.+. +..|..|..+ +|++|++++
T Consensus 113 ~l~-~l~~~~~----~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~----- 181 (332)
T 2ft3_A 113 HLV-EIPPNLP----SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISE----- 181 (332)
T ss_dssp CCC-SCCSSCC----TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCS-----
T ss_pred cCC-ccCcccc----ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcC-----
Confidence 655 4444331 34555555555555444444555555555555555553 2344444444 444444444
Q ss_pred CCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccccccccc
Q 047768 231 TIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINF 309 (1009)
Q Consensus 231 ~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f 309 (1009)
|+++ .+|..++ ++|++|++++|.+++..+..|.++++|++|+|++|++++..+..|
T Consensus 182 -------------------n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 237 (332)
T 2ft3_A 182 -------------------AKLT-GIPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSL 237 (332)
T ss_dssp -------------------SBCS-SCCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGG
T ss_pred -------------------CCCC-ccCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHh
Confidence 4444 3444332 466777777777777766777777777777777777766554433
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-32 Score=301.50 Aligned_cols=288 Identities=20% Similarity=0.248 Sum_probs=207.1
Q ss_pred hHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccc
Q 047768 241 SLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGL 320 (1009)
Q Consensus 241 ~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L 320 (1009)
+++.+++++|.++ .+|..++ ++|+.|++++|++++..|..|.++++|++|+|++|+++++.+..
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~------------ 97 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKA------------ 97 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGG------------
T ss_pred cCCEEECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhH------------
Confidence 4566666666666 5665543 45666666666666555556666666666666666666554444
Q ss_pred cccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEcc
Q 047768 321 ATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRME 400 (1009)
Q Consensus 321 ~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 400 (1009)
|.++++|++|+|++|+++ .+|..+. ..|++|++++|++++..+..|.++++|+.|+++
T Consensus 98 ------------------~~~l~~L~~L~L~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 155 (332)
T 2ft3_A 98 ------------------FSPLRKLQKLYISKNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMG 155 (332)
T ss_dssp ------------------STTCTTCCEEECCSSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECC
T ss_pred ------------------hhCcCCCCEEECCCCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECC
Confidence 445556666666666665 3333332 457777777777776666678888888888888
Q ss_pred CCCCC--CCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccC
Q 047768 401 ANRLT--GTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTG 478 (1009)
Q Consensus 401 ~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 478 (1009)
+|+++ +..|..+..+ +|++|++++|++++ +|..+. ++|++|++++|++++..|..+..+++|+.|++++|
T Consensus 156 ~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N---- 227 (332)
T 2ft3_A 156 GNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHN---- 227 (332)
T ss_dssp SCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSS----
T ss_pred CCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCC----
Confidence 88885 3677788877 88888888888884 555544 67888888888888777778888887776544444
Q ss_pred CCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccc
Q 047768 479 ALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLS 558 (1009)
Q Consensus 479 ~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 558 (1009)
++++..|..++.+++|++|++++|+++ .+|..+..+++|+.|+|++|+|++..+..|.
T Consensus 228 ---------------------~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 285 (332)
T 2ft3_A 228 ---------------------QIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFC 285 (332)
T ss_dssp ---------------------CCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSS
T ss_pred ---------------------cCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcc
Confidence 444455556778889999999999998 7888899999999999999999977777776
Q ss_pred cc------cccceEcCCCcccc--cccccccccccccCceeccccc
Q 047768 559 SL------TSIKELDLSQNNFS--GQIPKYLENLSFLQYLNLSYNH 596 (1009)
Q Consensus 559 ~l------~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~ls~N~ 596 (1009)
.. .+|+.|++++|.+. +..|..|..+++|+.+++++|+
T Consensus 286 ~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 286 PVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 53 67899999999987 6778889999999999999885
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-33 Score=311.33 Aligned_cols=247 Identities=16% Similarity=0.143 Sum_probs=185.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--------cchHHHHHHHHHHHhcC---------CCCcce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--------GGSKSFAAECEALRSIR---------HRNLIK 762 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~niv~ 762 (1009)
.++|.+.+.||+|+||+||+|++ +|+.||||+++.... ...+.+.+|+++++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999988 689999999975432 12377899999999886 888888
Q ss_pred EEeeeeccc-------------------------cCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHH
Q 047768 763 IVTICSSID-------------------------FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817 (1009)
Q Consensus 763 l~~~~~~~~-------------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ 817 (1009)
+.+++.... +......++||||+++|++.+.+.+. .+++.+++.++.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-------~~~~~~~~~i~~q 169 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-------LSSLATAKSILHQ 169 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-------CCCHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-------CCCHHHHHHHHHH
Confidence 777643110 11257889999999999776666442 2899999999999
Q ss_pred HHHHHHHHh-hcCCCCceecCCCCCceeeCCCC--------------------ceEEeccccccccCCCCCCCccccCCc
Q 047768 818 VASAVEYLH-HHCQPPIVHGDLKPSNVLLDHDM--------------------VAHVSDFGLAKFLSASPLGNVVETPSS 876 (1009)
Q Consensus 818 ia~~l~~LH-~~~~~~ivHrdlk~~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~ 876 (1009)
++.||+||| ++ +||||||||+|||++.++ .+||+|||+|+.....
T Consensus 170 i~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----------- 235 (336)
T 2vuw_A 170 LTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----------- 235 (336)
T ss_dssp HHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----------
T ss_pred HHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----------
Confidence 999999999 88 999999999999999887 9999999999866431
Q ss_pred cccccccccccCccccCCCCCCCcccchHHHHH-HHHHHhCCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhh
Q 047768 877 SIGVKGTIGYVAPEYGLGGEASMRGGVYSYGIL-LLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEE 955 (1009)
Q Consensus 877 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 955 (1009)
...||+.|+|||++.+.. +.++||||+|++ .+++++|..||... .|.... .+.+...........
T Consensus 236 --~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~-~~~~~~~~~~~~~~~-- 301 (336)
T 2vuw_A 236 --IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYL-TDKMLKQMTFKTKCN-- 301 (336)
T ss_dssp --EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHH-HHHHHHTCCCSSCCC--
T ss_pred --cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHH-HHhhhhhhccCcccc--
Confidence 247899999999988766 899999998777 78899999998531 111100 011110000000000
Q ss_pred hhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 047768 956 ERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVV 994 (1009)
Q Consensus 956 ~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl 994 (1009)
.........++.+++.+|++.| |++|++
T Consensus 302 ------~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 302 ------TPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp ------SHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred ------hhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 0112245678899999999976 998887
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4e-32 Score=302.73 Aligned_cols=216 Identities=23% Similarity=0.317 Sum_probs=147.6
Q ss_pred CCCCccCCCCCCC-CCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccc
Q 047768 45 TSSWNRSACVNLC-QHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETL 123 (1009)
Q Consensus 45 ~~sW~~~~~~~~c-~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L 123 (1009)
...|.. .|+..| |+|+.+.|+. ++++. +|..+. ++|++|+|++|++++..+..|+++++|++|
T Consensus 18 i~~~~~-~cp~~c~c~l~~l~~~~------------~~l~~-lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L 81 (330)
T 1xku_A 18 IEPMGP-VCPFRCQCHLRVVQCSD------------LGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTL 81 (330)
T ss_dssp ----CC-CCCTTCEEETTEEECTT------------SCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred cccccC-CCCCCCcCCCeEEEecC------------CCccc-cCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEE
Confidence 345643 355444 4676666653 34432 344443 688999999999997777789999999999
Q ss_pred cccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCc
Q 047768 124 VLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNR 203 (1009)
Q Consensus 124 ~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 203 (1009)
+|++|.+++..|..|+++++|++|++++|.++ .+|..++ .+|++|++++|++++..+..|.++++|++|++++|+
T Consensus 82 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~----~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 156 (330)
T 1xku_A 82 ILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP----KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP 156 (330)
T ss_dssp ECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC----TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSC
T ss_pred ECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc----ccccEEECCCCcccccCHhHhcCCccccEEECCCCc
Confidence 99999999888999999999999999999887 5665442 577777777777776666667777777777777777
Q ss_pred cc--CCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCC
Q 047768 204 LW--GKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSL 281 (1009)
Q Consensus 204 l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~ 281 (1009)
+. +..+..|..+++|++|++++|+++ .+|..++ ++|++|++++|.+++..
T Consensus 157 l~~~~~~~~~~~~l~~L~~L~l~~n~l~-------------------------~l~~~~~---~~L~~L~l~~n~l~~~~ 208 (330)
T 1xku_A 157 LKSSGIENGAFQGMKKLSYIRIADTNIT-------------------------TIPQGLP---PSLTELHLDGNKITKVD 208 (330)
T ss_dssp CCGGGBCTTGGGGCTTCCEEECCSSCCC-------------------------SCCSSCC---TTCSEEECTTSCCCEEC
T ss_pred CCccCcChhhccCCCCcCEEECCCCccc-------------------------cCCcccc---ccCCEEECCCCcCCccC
Confidence 74 255666666666666666666665 2332222 45666666666666666
Q ss_pred CCCcCccccccccccccccccccccccc
Q 047768 282 PDSFSNASNLEVLHLAENQFRGQVSINF 309 (1009)
Q Consensus 282 p~~~~~l~~L~~L~Ls~N~l~~~~~~~f 309 (1009)
|..|.++++|++|+|++|++++..+..|
T Consensus 209 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 236 (330)
T 1xku_A 209 AASLKGLNNLAKLGLSFNSISAVDNGSL 236 (330)
T ss_dssp TGGGTTCTTCCEEECCSSCCCEECTTTG
T ss_pred HHHhcCCCCCCEEECCCCcCceeChhhc
Confidence 6666666667777776666665544333
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-31 Score=299.37 Aligned_cols=288 Identities=21% Similarity=0.217 Sum_probs=154.6
Q ss_pred HHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccccccccccccccccccccc
Q 047768 242 LVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLA 321 (1009)
Q Consensus 242 L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~ 321 (1009)
++.++++++.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|+++++.+..|..+++|+.|+++
T Consensus 33 l~~l~~~~~~l~-~lp~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 33 LRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp TTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CeEEEecCCCcc-ccCccCC---CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 344444444444 4444332 455666666666666655566666666666666666666555555555555555555
Q ss_pred ccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCcccc--CCCccccCcCccCEEEc
Q 047768 322 TNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYG--TIPPGIANLVNLNSLRM 399 (1009)
Q Consensus 322 ~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L 399 (1009)
+|.+..++.. + .++|++|++++|.+++..+..+..+ ..|+.|++++|.+.. ..+..|.++++|+.|++
T Consensus 109 ~n~l~~l~~~-------~--~~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l 178 (330)
T 1xku_A 109 KNQLKELPEK-------M--PKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178 (330)
T ss_dssp SSCCSBCCSS-------C--CTTCCEEECCSSCCCBBCHHHHTTC-TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEEC
T ss_pred CCcCCccChh-------h--cccccEEECCCCcccccCHhHhcCC-ccccEEECCCCcCCccCcChhhccCCCCcCEEEC
Confidence 5544433221 0 1355555555555554444444443 344445555444432 34444444555555555
Q ss_pred cCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCC
Q 047768 400 EANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGA 479 (1009)
Q Consensus 400 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 479 (1009)
++|++++ +|..+. ++|++|++++|++++..|..+..+++|+.|
T Consensus 179 ~~n~l~~-------------------------l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L---------- 221 (330)
T 1xku_A 179 ADTNITT-------------------------IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKL---------- 221 (330)
T ss_dssp CSSCCCS-------------------------CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEE----------
T ss_pred CCCcccc-------------------------CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEE----------
Confidence 5555442 232222 445555555555554444444444444432
Q ss_pred CchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccccccccccccc
Q 047768 480 LPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSS 559 (1009)
Q Consensus 480 ~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 559 (1009)
++++|.+++..+..+..+++|++|++++|+++ .+|..+..+++|++|+|++|+|++..+..|..
T Consensus 222 ---------------~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~ 285 (330)
T 1xku_A 222 ---------------GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 285 (330)
T ss_dssp ---------------ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSC
T ss_pred ---------------ECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCC
Confidence 22223333233334555666667777777666 56666667777777777777777655555543
Q ss_pred ------ccccceEcCCCccccc--ccccccccccccCceeccccc
Q 047768 560 ------LTSIKELDLSQNNFSG--QIPKYLENLSFLQYLNLSYNH 596 (1009)
Q Consensus 560 ------l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ls~N~ 596 (1009)
.+.|+.|++++|.+.. ..|..|..+..|+.++|++|+
T Consensus 286 ~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 286 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred cccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 3667777888877753 456677778888888888774
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-36 Score=350.42 Aligned_cols=380 Identities=18% Similarity=0.154 Sum_probs=231.2
Q ss_pred CCcCeEeecCccCCCCCCcc-cCCccccceeecccCcccC----CCCcccccccccccccccCccCCCCCCCcccCCChH
Q 047768 168 FNLQGLSVGDNQLTGQLPAS-IGNLSALRVIDIRTNRLWG----KIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSL 242 (1009)
Q Consensus 168 ~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 242 (1009)
++|++|+|++|+++...... +..+++|++|+|++|++.. .++..+..+++|++|+|++|.+++..+.
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~-------- 74 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVH-------- 74 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHH--------
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHH--------
Confidence 46788888888887544333 6778888888888888763 3456677778888888888777632221
Q ss_pred HHHHhhCCccCCCCChhhccCCC----cccceeccccccCC----CCCCCcCcccccccccccccccccccccccc----
Q 047768 243 VEIYLYGNRFTGSLPIEIGKNLP----NLRNFVIYTNNFTG----SLPDSFSNASNLEVLHLAENQFRGQVSINFN---- 310 (1009)
Q Consensus 243 ~~L~L~~N~l~~~ip~~~~~~l~----~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~---- 310 (1009)
.++..++ +|++|+|++|+++. .++..|..+++|++|+|++|++++.....+.
T Consensus 75 ----------------~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~ 138 (461)
T 1z7x_W 75 ----------------CVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLL 138 (461)
T ss_dssp ----------------HHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHT
T ss_pred ----------------HHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHh
Confidence 1222233 57777777777773 4467778888888888888887754433322
Q ss_pred -cccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhh----cccceEEEcCCCccccC--
Q 047768 311 -GLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANL----STALIDFNLGKNQIYGT-- 383 (1009)
Q Consensus 311 -~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l----~~~L~~L~L~~N~l~~~-- 383 (1009)
..++|+.|++++|.++.... ..++..+..+++|++|++++|.+++..+..+... ...|++|++++|.+++.
T Consensus 139 ~~~~~L~~L~L~~n~l~~~~~--~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~ 216 (461)
T 1z7x_W 139 DPQCRLEKLQLEYCSLSAASC--EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC 216 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGH--HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHH
T ss_pred cCCCcceEEECCCCCCCHHHH--HHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHH
Confidence 24457777777776654221 1233456667778888888887765544444331 23667777777776653
Q ss_pred --CCccccCcCccCEEEccCCCCCCCC-----CCCcCCcccccceecccccccCC----CCcccccccccccccccCccc
Q 047768 384 --IPPGIANLVNLNSLRMEANRLTGTI-----PHVIGELKNLQLLHLHANFLQGT----IPSSLGNLTLLTYLSFGANNL 452 (1009)
Q Consensus 384 --~p~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l 452 (1009)
++..+..+++|+.|+|++|++++.. +..+..+++|++|+|++|++++. ++..+..+++|++|++++|.+
T Consensus 217 ~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i 296 (461)
T 1z7x_W 217 RDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296 (461)
T ss_dssp HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCC
T ss_pred HHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCC
Confidence 3555666677777777777665322 22223456666777777666643 455555566666666666666
Q ss_pred ccccCCCCCC-----CCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCC----CCCCccCCCCCCeeecccc
Q 047768 453 QGNIPFSLGN-----CKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGS----LPLGVGNLKSLVRLGIARN 523 (1009)
Q Consensus 453 ~~~~p~~~~~-----l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N 523 (1009)
++..+..+.. .++|+. |++++|.+++. +|..+..+++|++|++++|
T Consensus 297 ~~~~~~~l~~~l~~~~~~L~~-------------------------L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n 351 (461)
T 1z7x_W 297 GDEGARLLCETLLEPGCQLES-------------------------LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNN 351 (461)
T ss_dssp HHHHHHHHHHHHTSTTCCCCE-------------------------EECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSS
T ss_pred chHHHHHHHHHhccCCcccee-------------------------eEcCCCCCchHHHHHHHHHHhhCCCccEEEccCC
Confidence 5332221111 123333 45555554432 3444556677777888877
Q ss_pred ccCCCccccccC-----CCCccEEEecCccccc----ccccccccccccceEcCCCcccccccccccc-----cccccCc
Q 047768 524 QFSGQIPVTLGA-----CTSLEYVELQGNSFSG----TIPQSLSSLTSIKELDLSQNNFSGQIPKYLE-----NLSFLQY 589 (1009)
Q Consensus 524 ~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~ 589 (1009)
.+++..+..+.. .++|+.|+|++|++++ .+|..+..+++|++|||++|++++.-...+. ...+|+.
T Consensus 352 ~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~ 431 (461)
T 1z7x_W 352 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 431 (461)
T ss_dssp BCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCE
T ss_pred ccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhh
Confidence 777555544443 5677888888887775 6677777777788888888877653211111 1234555
Q ss_pred eecccccCc
Q 047768 590 LNLSYNHFE 598 (1009)
Q Consensus 590 L~ls~N~l~ 598 (1009)
|++.+|.+.
T Consensus 432 L~~~~~~~~ 440 (461)
T 1z7x_W 432 LVLYDIYWS 440 (461)
T ss_dssp EECTTCCCC
T ss_pred eeecccccC
Confidence 555555544
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-35 Score=347.61 Aligned_cols=358 Identities=16% Similarity=0.134 Sum_probs=218.4
Q ss_pred eEEEEEeecCCcccccCcc-ccCCCCCCeeeecCCcCCc----cCCccccCccccccccccccccCCCCCCCCcCCCcCc
Q 047768 71 RVTKLDLRNQSIGGILSPY-VGNLSFLRYINIADNDFHG----EIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLI 145 (1009)
Q Consensus 71 ~v~~l~l~~~~l~~~~~~~-~~~l~~L~~L~L~~n~~~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 145 (1009)
+++.|||+++.++...... +..+++|++|+|++|++++ .+|..+..+++|++|||++|.+++..
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~----------- 72 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVG----------- 72 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHH-----------
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHH-----------
Confidence 5566666666655433322 4455566666666666553 23445555555666666655554322
Q ss_pred EEecccccccCCCchHHhhhccC----CcCeEeecCccCCC----CCCcccCCccccceeecccCcccCCCCccccc---
Q 047768 146 TFSAHRNNLVGEIPEELISRRLF----NLQGLSVGDNQLTG----QLPASIGNLSALRVIDIRTNRLWGKIPITLSQ--- 214 (1009)
Q Consensus 146 ~L~l~~n~l~~~~p~~~~~~~l~----~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--- 214 (1009)
+..++ ..+. +|++|+|++|+++. .++..+..+++|++|+|++|.+....+..+..
T Consensus 73 -------------~~~l~-~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~ 138 (461)
T 1z7x_W 73 -------------VHCVL-QGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLL 138 (461)
T ss_dssp -------------HHHHH-HTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHT
T ss_pred -------------HHHHH-HHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHh
Confidence 22221 1222 35555555555542 23445555555555555555554332222221
Q ss_pred --ccccccccccCccCCCC----CCCcccCCChHHHHHhhCCccCCCCChhh----ccCCCcccceeccccccCCC----
Q 047768 215 --LTSLAYLHVGDNHFSGT----IPPSVYNISSLVEIYLYGNRFTGSLPIEI----GKNLPNLRNFVIYTNNFTGS---- 280 (1009)
Q Consensus 215 --l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~ip~~~----~~~l~~L~~L~L~~N~l~~~---- 280 (1009)
.++|++|+|++|++++. ++..+..+++|++|++++|.+++..+..+ ....++|++|++++|.++..
T Consensus 139 ~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 218 (461)
T 1z7x_W 139 DPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRD 218 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHH
T ss_pred cCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHH
Confidence 33455555555555532 23334445555555555555542212122 12356888888888888764
Q ss_pred CCCCcCccccccccccccccccccc-----ccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCC
Q 047768 281 LPDSFSNASNLEVLHLAENQFRGQV-----SINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGF 355 (1009)
Q Consensus 281 ~p~~~~~l~~L~~L~Ls~N~l~~~~-----~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 355 (1009)
++..+..+++|++|+|++|++.... +..+..+++|+.|++++|.++..+. ..++..+.++++|++|+|++|.+
T Consensus 219 l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~--~~l~~~l~~~~~L~~L~Ls~n~i 296 (461)
T 1z7x_W 219 LCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGC--GDLCRVLRAKESLKELSLAGNEL 296 (461)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHH--HHHHHHHHHCTTCCEEECTTCCC
T ss_pred HHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHH--HHHHHHHhhCCCcceEECCCCCC
Confidence 4666777888888888888887643 2333457788888888887764221 11345677788899999999988
Q ss_pred CCcCchhhhhh----cccceEEEcCCCccccC----CCccccCcCccCEEEccCCCCCCCCCCCcCC-----ccccccee
Q 047768 356 GGVLPHSIANL----STALIDFNLGKNQIYGT----IPPGIANLVNLNSLRMEANRLTGTIPHVIGE-----LKNLQLLH 422 (1009)
Q Consensus 356 ~~~~p~~~~~l----~~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~ 422 (1009)
++..+..+... ...|+.|++++|.+++. ++..+..+++|+.|+|++|++++..+..+.. .++|++|+
T Consensus 297 ~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~ 376 (461)
T 1z7x_W 297 GDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLW 376 (461)
T ss_dssp HHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred chHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEE
Confidence 76555555443 24788888888888765 4566677788888888888887655544432 56888888
Q ss_pred cccccccC----CCCcccccccccccccccCcccccc
Q 047768 423 LHANFLQG----TIPSSLGNLTLLTYLSFGANNLQGN 455 (1009)
Q Consensus 423 L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~ 455 (1009)
|++|++++ .+|..+..+++|++|++++|++++.
T Consensus 377 L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 377 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp CTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred CCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence 88888875 6777778888888888888888754
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-31 Score=290.82 Aligned_cols=254 Identities=18% Similarity=0.208 Sum_probs=163.2
Q ss_pred CCCCC-CCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccC
Q 047768 53 CVNLC-QHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFS 131 (1009)
Q Consensus 53 ~~~~c-~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~ 131 (1009)
|++.| |.|++|.|+... ++. +|..+ .++|++|+|++|+++...+..|+++++|++|+|++|.++
T Consensus 1 CP~~C~C~~~~l~c~~~~------------l~~-ip~~~--~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~ 65 (306)
T 2z66_A 1 CPSRCSCSGTEIRCNSKG------------LTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65 (306)
T ss_dssp CCTTCEEETTEEECCSSC------------CSS-CCSCC--CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC
T ss_pred CcCCCeeCCCEEEcCCCC------------ccc-CCCCC--CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccC
Confidence 44444 689999997542 221 22222 246677777777776333334667777777777777666
Q ss_pred C--CCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCC-cccCCccccceeecccCcccCCC
Q 047768 132 G--RIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLP-ASIGNLSALRVIDIRTNRLWGKI 208 (1009)
Q Consensus 132 ~--~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~ 208 (1009)
. .+|..+..+++|++|++++|.+. .+|..+ ..+++|++|++++|++++..+ ..+.++++|++|++++|++.+..
T Consensus 66 ~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~--~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 142 (306)
T 2z66_A 66 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF--LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 142 (306)
T ss_dssp EEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEE--ETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECS
T ss_pred cccCcccccccccccCEEECCCCccc-cChhhc--CCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccc
Confidence 2 23555566677777777777665 344443 456677777777777765544 46677777777777777777667
Q ss_pred CcccccccccccccccCccCCC-CCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCc
Q 047768 209 PITLSQLTSLAYLHVGDNHFSG-TIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSN 287 (1009)
Q Consensus 209 p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 287 (1009)
+..|..+++|++|+|++|.+++ .+|..+..+++|++|+|++|+++ .++...+..+++|++|+|++|.+++..+..|..
T Consensus 143 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 221 (306)
T 2z66_A 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221 (306)
T ss_dssp TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCSBCCSGGGTT
T ss_pred hhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcC-CcCHHHhcCCCCCCEEECCCCccCccChhhccC
Confidence 7777777777777777777765 46667777777777777777776 444444456777777777777777766667777
Q ss_pred cccccccccccccccccccccccccc-cccccccccccc
Q 047768 288 ASNLEVLHLAENQFRGQVSINFNGLK-DLSMLGLATNFL 325 (1009)
Q Consensus 288 l~~L~~L~Ls~N~l~~~~~~~f~~l~-~L~~L~L~~N~l 325 (1009)
+++|++|+|++|++++..+..|..++ +|+.|+|++|.+
T Consensus 222 l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~ 260 (306)
T 2z66_A 222 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260 (306)
T ss_dssp CTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCE
T ss_pred cccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCe
Confidence 77777777777777776665555542 444444444444
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=291.62 Aligned_cols=277 Identities=15% Similarity=0.166 Sum_probs=211.8
Q ss_pred CCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCC
Q 047768 58 QHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTN 137 (1009)
Q Consensus 58 ~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 137 (1009)
|.|.|+ |+ +++++++. +|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..
T Consensus 30 C~~~~~-c~----------~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 95 (353)
T 2z80_A 30 CDRNGI-CK----------GSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDS 95 (353)
T ss_dssp ECTTSE-EE----------CCSTTCSS-CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTT
T ss_pred CCCCeE-ee----------CCCCCccc-cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhh
Confidence 379887 64 35566654 455444 58999999999999766668999999999999999999888899
Q ss_pred CcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCC-cccCCccccceeecccC-cccCCCCcccccc
Q 047768 138 LSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLP-ASIGNLSALRVIDIRTN-RLWGKIPITLSQL 215 (1009)
Q Consensus 138 l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l 215 (1009)
|+++++|++|++++|++++ +|...+ ..+++|++|+|++|++++..+ ..|+++++|++|++++| .+.+..+..|..+
T Consensus 96 ~~~l~~L~~L~Ls~n~l~~-~~~~~~-~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l 173 (353)
T 2z80_A 96 FSSLGSLEHLDLSYNYLSN-LSSSWF-KPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173 (353)
T ss_dssp TTTCTTCCEEECCSSCCSS-CCHHHH-TTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred cCCCCCCCEEECCCCcCCc-CCHhHh-CCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCC
Confidence 9999999999999999985 555433 678999999999999995544 48999999999999999 5777778899999
Q ss_pred cccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcC---cccccc
Q 047768 216 TSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFS---NASNLE 292 (1009)
Q Consensus 216 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~ 292 (1009)
++|++|++++|++++..|..+.++++|++|++++|+++ .+|..++..+++|+.|++++|.+++..+..+. ..+.++
T Consensus 174 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~ 252 (353)
T 2z80_A 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252 (353)
T ss_dssp CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCC
T ss_pred CCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccccccccchhh
Confidence 99999999999999888999999999999999999997 88888887899999999999999987666543 345566
Q ss_pred cccccccccccc----cccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCC
Q 047768 293 VLHLAENQFRGQ----VSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGG 357 (1009)
Q Consensus 293 ~L~Ls~N~l~~~----~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 357 (1009)
.++|++|.+.+. .+..|..+++|+.|++++|.++.++. ..|.++++|++|+|++|.+.+
T Consensus 253 ~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~------~~~~~l~~L~~L~L~~N~~~~ 315 (353)
T 2z80_A 253 KFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPD------GIFDRLTSLQKIWLHTNPWDC 315 (353)
T ss_dssp EEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCT------TTTTTCTTCCEEECCSSCBCC
T ss_pred ccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCH------HHHhcCCCCCEEEeeCCCccC
Confidence 667776666542 22334444444444444444443322 122344444444444444443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-32 Score=331.45 Aligned_cols=455 Identities=16% Similarity=0.126 Sum_probs=206.9
Q ss_pred CCCCCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcC---CccCCcccc------------Cccc
Q 047768 55 NLCQHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDF---HGEIPDRIG------------NLFR 119 (1009)
Q Consensus 55 ~~c~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~---~~~~p~~~~------------~l~~ 119 (1009)
-.|+.|.++.+... + .+.+.+ .+...++..+..+++|++|+|+++.. .+.+|..++ .+++
T Consensus 39 ~vck~W~~~~~~~~--~--~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~ 113 (592)
T 3ogk_B 39 LVCRRWFKIDSETR--E--HVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQ 113 (592)
T ss_dssp TSCHHHHHHHHHHC--C--EEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTT
T ss_pred HHhHHHHHhhhccc--c--EEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCC
Confidence 34668999865322 1 222222 23334444566788899999987532 245555444 5666
Q ss_pred cccccccccccCCCCCCCCcCC--CcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCC----CCcccCCccc
Q 047768 120 LETLVLANNSFSGRIPTNLSHC--SKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQ----LPASIGNLSA 193 (1009)
Q Consensus 120 L~~L~Ls~N~l~~~~p~~l~~l--~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~ 193 (1009)
|++|+|++|.+++..+..++.. .+|++|++++|.-.....-......+++|++|+|++|.+++. ++..+.++++
T Consensus 114 L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~ 193 (592)
T 3ogk_B 114 LKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTS 193 (592)
T ss_dssp CCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCC
T ss_pred CCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCC
Confidence 6777776666665554444442 236666666554110000000112445555555555555433 2223344455
Q ss_pred cceeecccCcccC----CCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccc
Q 047768 194 LRVIDIRTNRLWG----KIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRN 269 (1009)
Q Consensus 194 L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~ 269 (1009)
|++|++++|.+++ .++..+..+++|++|+|++|.+.+ +|..+. ++++|++
T Consensus 194 L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~-------------------------~~~~L~~ 247 (592)
T 3ogk_B 194 LEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFK-------------------------AAANLEE 247 (592)
T ss_dssp CCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHH-------------------------HCTTCCE
T ss_pred ccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHh-------------------------hhhHHHh
Confidence 5555555555541 222233344455555555544442 233333 3445555
Q ss_pred eeccccccC---CCCCCCcCcccccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhcccccccc
Q 047768 270 FVIYTNNFT---GSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQ 346 (1009)
Q Consensus 270 L~L~~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~ 346 (1009)
|+++.+... ...+..+..+++|+.|+++++... ..+..+..+++|+.|+|++|.+... .+...+..+++|+
T Consensus 248 L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~-----~~~~~~~~~~~L~ 321 (592)
T 3ogk_B 248 FCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETE-----DHCTLIQKCPNLE 321 (592)
T ss_dssp EEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHH-----HHHHHHTTCTTCC
T ss_pred hcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHH-----HHHHHHHhCcCCC
Confidence 555432211 123344555556666666554222 2223333444444444444432210 1112344555666
Q ss_pred eEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEcc-----------CCCCCCCC-CCCcCC
Q 047768 347 YLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRME-----------ANRLTGTI-PHVIGE 414 (1009)
Q Consensus 347 ~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-----------~N~l~~~~-p~~~~~ 414 (1009)
+|+++ |.+....... .+..+++|+.|+++ .|.+++.. +..+..
T Consensus 322 ~L~L~-~~~~~~~l~~------------------------~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~ 376 (592)
T 3ogk_B 322 VLETR-NVIGDRGLEV------------------------LAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG 376 (592)
T ss_dssp EEEEE-GGGHHHHHHH------------------------HHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHH
T ss_pred EEecc-CccCHHHHHH------------------------HHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhh
Confidence 66665 3332221112 22334444455554 23333211 111223
Q ss_pred cccccceecccccccCCCCccccc-cccccccccc----Ccccccc-----cCCCCCCCCCccccccCCCCccCCCchhh
Q 047768 415 LKNLQLLHLHANFLQGTIPSSLGN-LTLLTYLSFG----ANNLQGN-----IPFSLGNCKNLMFFFAPRNKLTGALPQQI 484 (1009)
Q Consensus 415 l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~l~l~~N~l~~~~p~~~ 484 (1009)
+++|++|+++.|++++..+..+.. +++|++|+++ .|++++. ++..+.++++|+.|+++.+.
T Consensus 377 ~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~--------- 447 (592)
T 3ogk_B 377 CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQ--------- 447 (592)
T ss_dssp CTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCG---------
T ss_pred CccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCC---------
Confidence 444555555445544433333332 4445555553 3333321 11112223333333332111
Q ss_pred hhhccceeeEecCCCccCCCCCCCc-cCCCCCCeeeccccccCC-CccccccCCCCccEEEecCcccccc-ccccccccc
Q 047768 485 LEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGIARNQFSG-QIPVTLGACTSLEYVELQGNSFSGT-IPQSLSSLT 561 (1009)
Q Consensus 485 ~~~~~~~~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~ 561 (1009)
+.+++..+..+ ..+++|++|++++|++++ .++..+..+++|+.|+|++|++++. ++..+..++
T Consensus 448 --------------~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~ 513 (592)
T 3ogk_B 448 --------------GGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLP 513 (592)
T ss_dssp --------------GGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCS
T ss_pred --------------CCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcC
Confidence 00111111111 125567777777777665 2344456677777777777776644 333345667
Q ss_pred ccceEcCCCccccccccccc-ccccccCceeccc
Q 047768 562 SIKELDLSQNNFSGQIPKYL-ENLSFLQYLNLSY 594 (1009)
Q Consensus 562 ~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~ 594 (1009)
+|++|+|++|++++.-...+ ..++.+....+..
T Consensus 514 ~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~ 547 (592)
T 3ogk_B 514 SLRYLWVQGYRASMTGQDLMQMARPYWNIELIPS 547 (592)
T ss_dssp SCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECC
T ss_pred ccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecC
Confidence 77777777777764422222 2345454444443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-30 Score=286.16 Aligned_cols=282 Identities=17% Similarity=0.174 Sum_probs=152.7
Q ss_pred ccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccc
Q 047768 114 IGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSA 193 (1009)
Q Consensus 114 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 193 (1009)
-..++.....|+++|.++ .+|..+. ++|++|++++|++ ++..+..|+++++
T Consensus 27 ~~~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i--------------------------~~~~~~~~~~l~~ 77 (353)
T 2z80_A 27 SLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRI--------------------------TYISNSDLQRCVN 77 (353)
T ss_dssp CCEECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCC--------------------------CEECTTTTTTCTT
T ss_pred CCCCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcC--------------------------cccCHHHhccCCC
Confidence 334555555677777776 5555443 2555555555554 4333334455555
Q ss_pred cceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCCh-hhccCCCcccceec
Q 047768 194 LRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPI-EIGKNLPNLRNFVI 272 (1009)
Q Consensus 194 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~-~~~~~l~~L~~L~L 272 (1009)
|++|+|++|++++..|.+|.++++|++|+|++|++++..+..|.++++|++|+|++|+++ .+|. ..+.++++|++|++
T Consensus 78 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l 156 (353)
T 2z80_A 78 LQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRV 156 (353)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEE
T ss_pred CCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEEC
Confidence 555555555555444445555555555555555555322223445555555555555555 4444 44445566666666
Q ss_pred ccc-ccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEcc
Q 047768 273 YTN-NFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLA 351 (1009)
Q Consensus 273 ~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~ 351 (1009)
++| .++...+..|.++++|++|++++|++++..+..|..+++|+.|++++|.+...+. ..+..+++|++|+++
T Consensus 157 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~------~~~~~~~~L~~L~L~ 230 (353)
T 2z80_A 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLE------IFVDVTSSVECLELR 230 (353)
T ss_dssp EESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHH------HHHHHTTTEEEEEEE
T ss_pred CCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchh------hhhhhcccccEEECC
Confidence 655 3444455556666666666666666665555555555555555555555532211 223345666666666
Q ss_pred CCCCCCcCchhhhh--hcccceEEEcCCCcccc----CCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceeccc
Q 047768 352 DNGFGGVLPHSIAN--LSTALIDFNLGKNQIYG----TIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHA 425 (1009)
Q Consensus 352 ~N~l~~~~p~~~~~--l~~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 425 (1009)
+|.+++..+..+.. ....++.++|++|.+++ .+|..+..+++|+.|+|++|+|+...+..|..+++|++|+|++
T Consensus 231 ~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 310 (353)
T 2z80_A 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHT 310 (353)
T ss_dssp SCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeC
Confidence 66666544333221 12334555555555543 3456666777777777777777743333456777777777777
Q ss_pred ccccCC
Q 047768 426 NFLQGT 431 (1009)
Q Consensus 426 N~l~~~ 431 (1009)
|++++.
T Consensus 311 N~~~~~ 316 (353)
T 2z80_A 311 NPWDCS 316 (353)
T ss_dssp SCBCCC
T ss_pred CCccCc
Confidence 777643
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-29 Score=272.68 Aligned_cols=275 Identities=23% Similarity=0.288 Sum_probs=145.0
Q ss_pred cceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhcccccccce
Q 047768 268 RNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQY 347 (1009)
Q Consensus 268 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~ 347 (1009)
+.++.+++.++. +|..+. ++|++|+|++|+++.+++..|.. +++|++
T Consensus 10 ~~l~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~------------------------------l~~L~~ 56 (306)
T 2z66_A 10 TEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDK------------------------------LTQLTK 56 (306)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCCCCCTTTTTT------------------------------CTTCSE
T ss_pred CEEEcCCCCccc-CCCCCC--CCCCEEECCCCccCccCHhHhhc------------------------------cccCCE
Confidence 456677777763 344332 46777777777776555444444 444555
Q ss_pred EEccCCCCCCc--CchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCC-CCcCCcccccceecc
Q 047768 348 LYLADNGFGGV--LPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIP-HVIGELKNLQLLHLH 424 (1009)
Q Consensus 348 L~L~~N~l~~~--~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~ 424 (1009)
|+|++|.++.. .|..+..+ ..|++|+|++|.++ .+|..+.++++|++|++++|++++..+ ..+..+++|++|+++
T Consensus 57 L~L~~n~l~~~~~~~~~~~~~-~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~ 134 (306)
T 2z66_A 57 LSLSSNGLSFKGCCSQSDFGT-TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 134 (306)
T ss_dssp EECCSSCCCEEEEEEHHHHSC-SCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECT
T ss_pred EECCCCccCcccCcccccccc-cccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECC
Confidence 55555554421 13333333 34555555555554 344456666666666666666665444 456666666666666
Q ss_pred cccccCCCCcccccccccccccccCccccc-ccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCC
Q 047768 425 ANFLQGTIPSSLGNLTLLTYLSFGANNLQG-NIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNG 503 (1009)
Q Consensus 425 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~ 503 (1009)
+|.+++..|..+.++++|++|++++|.+++ .+|..+..+++|++ |++++|++++
T Consensus 135 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~-------------------------L~Ls~n~l~~ 189 (306)
T 2z66_A 135 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF-------------------------LDLSQCQLEQ 189 (306)
T ss_dssp TSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE-------------------------EECTTSCCCE
T ss_pred CCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCE-------------------------EECCCCCcCC
Confidence 666666666666666666666666666654 34544554444443 3333333333
Q ss_pred CCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccccccccccccccc-ccceEcCCCcccccccc--cc
Q 047768 504 SLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLT-SIKELDLSQNNFSGQIP--KY 580 (1009)
Q Consensus 504 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p--~~ 580 (1009)
..|..|..+++|++|++++|++++..+..+..+++|+.|+|++|++++..|..+..++ +|++|+|++|.+++..+ ..
T Consensus 190 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~ 269 (306)
T 2z66_A 190 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 269 (306)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHH
T ss_pred cCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHH
Confidence 3344445555555555555555544444555555555555555555555555555552 55555555555554321 11
Q ss_pred cccccccCceecccccCcccCC
Q 047768 581 LENLSFLQYLNLSYNHFEGEVP 602 (1009)
Q Consensus 581 ~~~l~~L~~L~ls~N~l~g~~p 602 (1009)
...+...+.+.+..|.+.+..|
T Consensus 270 ~~~l~~~~~~~~~~~~~~C~~p 291 (306)
T 2z66_A 270 LQWIKDQRQLLVEVERMECATP 291 (306)
T ss_dssp HHHHHHTGGGBSCGGGCBEEES
T ss_pred HHHHHhhhhhhccccccccCCc
Confidence 2223334444444455544444
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=272.90 Aligned_cols=225 Identities=20% Similarity=0.274 Sum_probs=175.5
Q ss_pred cccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCccccccee
Q 047768 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLH 422 (1009)
Q Consensus 343 ~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 422 (1009)
++++.|+|++|+++ .+|..+..+ ..|++|+|++|.++ .+|..+.++++|++|+|++|+++ .+|..+..+++|++|+
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l-~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRL-SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGG-TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred cceeEEEccCCCch-hcChhhhhC-CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 56777777777776 556666665 56777777777777 66777777777777777777777 6677777777777777
Q ss_pred cccccccCCCCccccc---------ccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceee
Q 047768 423 LHANFLQGTIPSSLGN---------LTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLS 493 (1009)
Q Consensus 423 L~~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~ 493 (1009)
|++|++.+.+|..+.. +++|++|++++|+++ .+|..++++++|++
T Consensus 157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~------------------------- 210 (328)
T 4fcg_A 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS------------------------- 210 (328)
T ss_dssp EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCE-------------------------
T ss_pred CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCE-------------------------
Confidence 7777776677766544 666666666666666 56666666665554
Q ss_pred EecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCccc
Q 047768 494 LDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNF 573 (1009)
Q Consensus 494 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 573 (1009)
|+|++|++++ +|..++.+++|++|++++|.+.+.+|..++.+++|++|+|++|++.+.+|..++++++|++|||++|++
T Consensus 211 L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~ 289 (328)
T 4fcg_A 211 LKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289 (328)
T ss_dssp EEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTT
T ss_pred EEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCc
Confidence 5666666663 566788899999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccCceecccccCc
Q 047768 574 SGQIPKYLENLSFLQYLNLSYNHFE 598 (1009)
Q Consensus 574 ~~~~p~~~~~l~~L~~L~ls~N~l~ 598 (1009)
.+.+|..+.++++|+.+++..|.+.
T Consensus 290 ~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 290 LSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred hhhccHHHhhccCceEEeCCHHHHH
Confidence 9999999999999999999987664
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=283.11 Aligned_cols=254 Identities=20% Similarity=0.216 Sum_probs=202.2
Q ss_pred cceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecc
Q 047768 345 LQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLH 424 (1009)
Q Consensus 345 L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 424 (1009)
...++.+++.++ .+|..+. ..++.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|++|+|+
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 456667777666 3454332 457777777777777777777777777777777777777777777777777777777
Q ss_pred cccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCC
Q 047768 425 ANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGS 504 (1009)
Q Consensus 425 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~ 504 (1009)
+|++++..+..|.++++|++|+|++|++++..+..|.++++|+.|++++|...+.+|...+.....+..|+|++|++++
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~- 210 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD- 210 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-
Confidence 7777766666677777777777777777766666777777777777777555445665544444444568888888885
Q ss_pred CCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccc
Q 047768 505 LPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENL 584 (1009)
Q Consensus 505 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 584 (1009)
+| .+..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..|.++++|+.|||++|+|++..+..|..+
T Consensus 211 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 289 (452)
T 3zyi_A 211 MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289 (452)
T ss_dssp CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence 44 58899999999999999999889999999999999999999999999999999999999999999998888889999
Q ss_pred cccCceecccccCcccCCCC
Q 047768 585 SFLQYLNLSYNHFEGEVPTK 604 (1009)
Q Consensus 585 ~~L~~L~ls~N~l~g~~p~~ 604 (1009)
++|+.|+|++|++.+.+...
T Consensus 290 ~~L~~L~L~~Np~~CdC~~~ 309 (452)
T 3zyi_A 290 RYLVELHLHHNPWNCDCDIL 309 (452)
T ss_dssp TTCCEEECCSSCEECSTTTH
T ss_pred cCCCEEEccCCCcCCCCCch
Confidence 99999999999999887653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=268.44 Aligned_cols=253 Identities=22% Similarity=0.217 Sum_probs=191.5
Q ss_pred ceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceeccc
Q 047768 346 QYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHA 425 (1009)
Q Consensus 346 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 425 (1009)
+.++.+++.++ .+|..+ ...++.|++++|.+++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++
T Consensus 14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 56777777777 344433 35678888888888877777888888888888888888877788888888888888888
Q ss_pred cc-ccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCC
Q 047768 426 NF-LQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGS 504 (1009)
Q Consensus 426 N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~ 504 (1009)
|+ ++...|..|..+++|++|++++|++++..|..+.++++|++|+ +++|++++.
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~-------------------------l~~n~l~~~ 144 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY-------------------------LQDNALQAL 144 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE-------------------------CCSSCCCCC
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEE-------------------------CCCCccccc
Confidence 87 7766677888888888888888888877777788787777644 444444444
Q ss_pred CCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccc
Q 047768 505 LPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENL 584 (1009)
Q Consensus 505 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 584 (1009)
.+..|+++++|++|++++|++++..+..+..+++|+.|+|++|++++..|..|+++++|+.|+|++|++++..|..+..+
T Consensus 145 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 224 (285)
T 1ozn_A 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL 224 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTC
T ss_pred CHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccC
Confidence 45557778888888888888886666678888888888888888888778888888888888888888887666778888
Q ss_pred cccCceecccccCcccCCCCCcccCccccccccCCCcCCCCCC
Q 047768 585 SFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDE 627 (1009)
Q Consensus 585 ~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~~~ 627 (1009)
++|++|++++|++.+.++..+.+..+.......+...|..|..
T Consensus 225 ~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 225 RALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp TTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGG
T ss_pred cccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCchH
Confidence 8888888888888887765433333333444456666665544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=281.26 Aligned_cols=254 Identities=19% Similarity=0.177 Sum_probs=188.3
Q ss_pred cceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecc
Q 047768 345 LQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLH 424 (1009)
Q Consensus 345 L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 424 (1009)
...++.+++.++ .+|..+. ..++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 345566666665 3444332 346666666666666666666666666666666666666666666666666666666
Q ss_pred cccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCC
Q 047768 425 ANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGS 504 (1009)
Q Consensus 425 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~ 504 (1009)
+|++++..+..|.++++|++|+|++|++++..+..|.++++|+.|++++|...+.++...+.....+..|+|++|+++ .
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~ 199 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-E 199 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-S
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-c
Confidence 666665555566666666666666666665555566666666666666644444555544433334445777777777 4
Q ss_pred CCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccc
Q 047768 505 LPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENL 584 (1009)
Q Consensus 505 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 584 (1009)
+| .+..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..|.++++|++|||++|+|++..+..|..+
T Consensus 200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 55 48889999999999999999889999999999999999999999999999999999999999999998888889999
Q ss_pred cccCceecccccCcccCCCC
Q 047768 585 SFLQYLNLSYNHFEGEVPTK 604 (1009)
Q Consensus 585 ~~L~~L~ls~N~l~g~~p~~ 604 (1009)
++|+.|+|++|++.+.+...
T Consensus 279 ~~L~~L~L~~Np~~CdC~l~ 298 (440)
T 3zyj_A 279 HHLERIHLHHNPWNCNCDIL 298 (440)
T ss_dssp TTCCEEECCSSCEECSSTTH
T ss_pred cCCCEEEcCCCCccCCCCch
Confidence 99999999999999877643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-29 Score=278.99 Aligned_cols=249 Identities=18% Similarity=0.168 Sum_probs=156.2
Q ss_pred cccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCcc-ccCCCcccc-------CcCccCEEEccCCCCCCCCCCCc
Q 047768 341 NCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQI-YGTIPPGIA-------NLVNLNSLRMEANRLTGTIPHVI 412 (1009)
Q Consensus 341 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l-~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~ 412 (1009)
..++|+.|++++|.+ .+|..+... ++.|+|++|++ ...+|..+. ++++|++|+|++|++++.+|..+
T Consensus 41 ~~~~L~~l~l~~n~l--~~p~~~~~~---L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 41 GGRSLEYLLKRVDTE--ADLGQFTDI---IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEECTTHHHHCCTT--CCCHHHHHH---HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred cCCCceeEeeccccc--ccHHHHHHH---HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 344455555555555 344443332 44455555555 223343333 45555555555555555555544
Q ss_pred --CCcccccceecccccccCCCCcccccc-----cccccccccCcccccccCCCCCCCCCccccccCCCCccCCC--chh
Q 047768 413 --GELKNLQLLHLHANFLQGTIPSSLGNL-----TLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGAL--PQQ 483 (1009)
Q Consensus 413 --~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~--p~~ 483 (1009)
..+++|++|+|++|++++. |..++.+ ++|++|++++|++++..|..++++++|++|++++|++++.+ |..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 5555555555555555544 5555555 55555666666555555555555555666666555554431 222
Q ss_pred h-hhhccceeeEecCCCccCC--CCC-CCccCCCCCCeeeccccccCCCcc-ccccCCCCccEEEecCcccccccccccc
Q 047768 484 I-LEITTLSLSLDLSDNLLNG--SLP-LGVGNLKSLVRLGIARNQFSGQIP-VTLGACTSLEYVELQGNSFSGTIPQSLS 558 (1009)
Q Consensus 484 ~-~~~~~~~~~L~Ls~N~l~~--~~p-~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 558 (1009)
+ +........|++++|++++ .++ ..+.++++|++|++++|++++.+| ..+..+++|++|+|++|+|+ .+|..+.
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~ 273 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC
T ss_pred HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc
Confidence 2 1222223346666666662 122 234577899999999999998775 56677899999999999998 7888777
Q ss_pred cccccceEcCCCcccccccccccccccccCceecccccCccc
Q 047768 559 SLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGE 600 (1009)
Q Consensus 559 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ 600 (1009)
++|++|||++|+|++. |. +..+++|++|+|++|+++++
T Consensus 274 --~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 274 --AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp --SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred --CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 8999999999999965 66 89999999999999999763
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-30 Score=285.35 Aligned_cols=247 Identities=18% Similarity=0.172 Sum_probs=126.9
Q ss_pred eEEEEEeecCCcccccCccccCCCCCCeeeecCCcC-CccCCcccc-------CccccccccccccccCCCCCCCC--cC
Q 047768 71 RVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDF-HGEIPDRIG-------NLFRLETLVLANNSFSGRIPTNL--SH 140 (1009)
Q Consensus 71 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~l--~~ 140 (1009)
+++.|++++|.+ .+|..+... |++|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..+ +.
T Consensus 44 ~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 119 (312)
T 1wwl_A 44 SLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT 119 (312)
T ss_dssp ECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCC
T ss_pred CceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhc
Confidence 445555555555 444433322 55555555555 334454444 45555555555555555555544 55
Q ss_pred CCcCcEEecccccccCCCchHHhhhcc-----CCcCeEeecCccCCCCCCcccCCccccceeecccCcccCC--CCccc-
Q 047768 141 CSKLITFSAHRNNLVGEIPEELISRRL-----FNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGK--IPITL- 212 (1009)
Q Consensus 141 l~~L~~L~l~~n~l~~~~p~~~~~~~l-----~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~- 212 (1009)
+++|++|++++|.+++. |..+ ..+ ++|++|+|++|++++..|..|+++++|++|+|++|++.+. .|..+
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~--~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 196 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWL--AELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC 196 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHH--HHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSC
T ss_pred CCCccEEEccCCCCcch-hHHH--HHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHH
Confidence 55555555555555544 4333 222 4555555555555544445555555555555555554332 12222
Q ss_pred -ccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCC-CCcCcccc
Q 047768 213 -SQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLP-DSFSNASN 290 (1009)
Q Consensus 213 -~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~ 290 (1009)
..+++|++|+|++|++++ ++ .++..++.++++|++|+|++|++++..| ..+..+++
T Consensus 197 ~~~l~~L~~L~L~~N~l~~-~~---------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~ 254 (312)
T 1wwl_A 197 PLKFPTLQVLALRNAGMET-PS---------------------GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254 (312)
T ss_dssp TTSCTTCCEEECTTSCCCC-HH---------------------HHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTT
T ss_pred hccCCCCCEEECCCCcCcc-hH---------------------HHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCC
Confidence 445555555555555441 10 2223334445566666666666655543 34445566
Q ss_pred cccccccccccccccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCC
Q 047768 291 LEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGG 357 (1009)
Q Consensus 291 L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 357 (1009)
|++|+|++|+|+.++...+ ++|+.|+|++|.|+..+ . +..+++|++|+|++|++++
T Consensus 255 L~~L~Ls~N~l~~ip~~~~---~~L~~L~Ls~N~l~~~p-------~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 255 LNSLNLSFTGLKQVPKGLP---AKLSVLDLSYNRLDRNP-------S-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCEEECTTSCCSSCCSSCC---SEEEEEECCSSCCCSCC-------C-TTTSCEEEEEECTTCTTTC
T ss_pred CCEEECCCCccChhhhhcc---CCceEEECCCCCCCCCh-------h-HhhCCCCCEEeccCCCCCC
Confidence 6666666666653333222 55666666666665442 1 4566777777777777764
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=293.81 Aligned_cols=100 Identities=21% Similarity=0.305 Sum_probs=52.5
Q ss_pred CCCCCCCccCCCCCCCCCccceeeC------CCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCcccc
Q 047768 42 LGVTSSWNRSACVNLCQHWTGVTCG------RRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIG 115 (1009)
Q Consensus 42 ~~~~~sW~~~~~~~~c~~w~gv~C~------~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~ 115 (1009)
...+++|... .+ ||.|+|..|. -....++.|++++++++ .+|..+. ++|++|+|++|+|+ .+|.
T Consensus 9 ~~~w~~W~~~--~~-~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~--- 78 (622)
T 3g06_A 9 DAVWSAWRRA--AP-AEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA--- 78 (622)
T ss_dssp -CHHHHHHHT--CC-GGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---
T ss_pred HHHHHHHHhc--CC-cchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---
Confidence 3455678654 23 4489775321 11123566666666665 4444443 56666666666666 4554
Q ss_pred CccccccccccccccCCCCCCCCcCCCcCcEEeccccccc
Q 047768 116 NLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLV 155 (1009)
Q Consensus 116 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~ 155 (1009)
.+++|++|||++|+|+ .+|. .+++|++|++++|+++
T Consensus 79 ~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~ 114 (622)
T 3g06_A 79 LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT 114 (622)
T ss_dssp CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC
T ss_pred cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC
Confidence 3456666666666665 3443 3344444444444443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-28 Score=280.34 Aligned_cols=247 Identities=21% Similarity=0.220 Sum_probs=139.8
Q ss_pred CcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccc
Q 047768 144 LITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHV 223 (1009)
Q Consensus 144 L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 223 (1009)
...++.+++.++ .+|..+ ..+|++|+|++|++++..|..|+++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 56 ~~~v~c~~~~l~-~iP~~~----~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 130 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGI----PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130 (452)
T ss_dssp SCEEECCSSCCS-SCCSCC----CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CcEEEECCCCcC-ccCCCC----CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence 455666666665 455443 245666666666666555666666666666666666666555566666666666666
Q ss_pred cCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccc-cccc
Q 047768 224 GDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAE-NQFR 302 (1009)
Q Consensus 224 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~ 302 (1009)
++|++++ +|...+.++++|++|+|++|+++.+.+..|.++++|++|+|++ |.+.
T Consensus 131 ~~n~l~~-------------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~ 185 (452)
T 3zyi_A 131 FDNWLTV-------------------------IPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE 185 (452)
T ss_dssp CSSCCSB-------------------------CCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCC
T ss_pred CCCcCCc-------------------------cChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCcc
Confidence 6666553 3333344445555555555555544444555555555555555 3333
Q ss_pred cccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCcccc
Q 047768 303 GQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYG 382 (1009)
Q Consensus 303 ~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~ 382 (1009)
.+.+..|.++++|+.|+|++|.+...+. +..+++|+.|+| ++|+|++
T Consensus 186 ~i~~~~~~~l~~L~~L~L~~n~l~~~~~--------~~~l~~L~~L~L-------------------------s~N~l~~ 232 (452)
T 3zyi_A 186 YISEGAFEGLFNLKYLNLGMCNIKDMPN--------LTPLVGLEELEM-------------------------SGNHFPE 232 (452)
T ss_dssp EECTTTTTTCTTCCEEECTTSCCSSCCC--------CTTCTTCCEEEC-------------------------TTSCCSE
T ss_pred ccChhhccCCCCCCEEECCCCccccccc--------ccccccccEEEC-------------------------cCCcCcc
Confidence 3333334444333333333333332211 233444444444 4445554
Q ss_pred CCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccc
Q 047768 383 TIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453 (1009)
Q Consensus 383 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 453 (1009)
..|..|.++++|+.|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus 233 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred cCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 55556666666777777777776666666666777777777777776655566666777777777777665
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-29 Score=290.33 Aligned_cols=215 Identities=20% Similarity=0.198 Sum_probs=113.1
Q ss_pred ccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceec
Q 047768 344 KLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHL 423 (1009)
Q Consensus 344 ~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 423 (1009)
+|++|+|++|.+++..|..+..+ +.|++|+|++|.+++..| |..+++|++|+|++|.|++..+ .++|++|+|
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L 106 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPF-TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA 106 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTC-TTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred CccEEEeeCCcCCCCCHHHHhCC-CCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence 45555555555554444444444 345555555555544333 4445555555555555442221 144555555
Q ss_pred ccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCC
Q 047768 424 HANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNG 503 (1009)
Q Consensus 424 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~ 503 (1009)
++|.+++..+. .+++|++|+|++|++++..|..++++++|+. |+|++|.+++
T Consensus 107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-------------------------L~Ls~N~l~~ 158 (487)
T 3oja_A 107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQY-------------------------LDLKLNEIDT 158 (487)
T ss_dssp CSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEE-------------------------EECTTSCCCE
T ss_pred cCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCE-------------------------EECCCCCCCC
Confidence 55555433332 2234444555555554444444444444444 5555555555
Q ss_pred CCCCCcc-CCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccc
Q 047768 504 SLPLGVG-NLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLE 582 (1009)
Q Consensus 504 ~~p~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 582 (1009)
..|..+. .+++|++|+|++|.|++. | .+..+++|+.|+|++|+|++.+| .++.+++|+.|||++|+|++ +|..+.
T Consensus 159 ~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~ 234 (487)
T 3oja_A 159 VNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALR 234 (487)
T ss_dssp EEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCC
T ss_pred cChHHHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhc
Confidence 5555554 566666666666666643 2 22246666666666666664333 36666666666666666663 555566
Q ss_pred cccccCceecccccCc
Q 047768 583 NLSFLQYLNLSYNHFE 598 (1009)
Q Consensus 583 ~l~~L~~L~ls~N~l~ 598 (1009)
.+++|+.|++++|++.
T Consensus 235 ~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 235 FSQNLEHFDLRGNGFH 250 (487)
T ss_dssp CCTTCCEEECTTCCBC
T ss_pred cCCCCCEEEcCCCCCc
Confidence 6666666666666665
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.2e-28 Score=278.45 Aligned_cols=247 Identities=22% Similarity=0.248 Sum_probs=142.6
Q ss_pred CcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccc
Q 047768 144 LITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHV 223 (1009)
Q Consensus 144 L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 223 (1009)
...++.+++.++ .+|..+ ..+++.|+|++|++++..+..|.++++|++|+|++|++.+..+..|.++++|++|+|
T Consensus 45 ~~~v~c~~~~l~-~iP~~~----~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGI----STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp SCEEECCSCCCS-SCCSCC----CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred CCEEEeCCCCcC-cCCCCC----CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 345666666555 455443 245556666666665555555566666666666666655555555555555555555
Q ss_pred cCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccc-cccc
Q 047768 224 GDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAE-NQFR 302 (1009)
Q Consensus 224 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~ 302 (1009)
++|+++ .+|...+.++++|++|+|++|.++.+.+..|.++++|++|+|++ |.+.
T Consensus 120 ~~n~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~ 174 (440)
T 3zyj_A 120 FDNRLT-------------------------TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS 174 (440)
T ss_dssp CSSCCS-------------------------SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCC
T ss_pred CCCcCC-------------------------eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcc
Confidence 555555 33333334445555555555555544445555555555555555 3333
Q ss_pred cccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCcccc
Q 047768 303 GQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYG 382 (1009)
Q Consensus 303 ~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~ 382 (1009)
.+.+..|.++++|+.|+|++|.+..++. +..+++ |+.|+|++|+|++
T Consensus 175 ~i~~~~~~~l~~L~~L~L~~n~l~~~~~--------~~~l~~-------------------------L~~L~Ls~N~l~~ 221 (440)
T 3zyj_A 175 YISEGAFEGLSNLRYLNLAMCNLREIPN--------LTPLIK-------------------------LDELDLSGNHLSA 221 (440)
T ss_dssp EECTTTTTTCSSCCEEECTTSCCSSCCC--------CTTCSS-------------------------CCEEECTTSCCCE
T ss_pred eeCcchhhcccccCeecCCCCcCccccc--------cCCCcc-------------------------cCEEECCCCccCc
Confidence 3333334444333333333333332211 233334 5555555555555
Q ss_pred CCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccc
Q 047768 383 TIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453 (1009)
Q Consensus 383 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 453 (1009)
..|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus 222 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp ECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred cChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 55666777777777777777777777777777777777777777777666667777777777777777776
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=282.79 Aligned_cols=69 Identities=22% Similarity=0.354 Sum_probs=44.8
Q ss_pred CCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCccccccccccccccc
Q 047768 512 LKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLS 585 (1009)
Q Consensus 512 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 585 (1009)
+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..|+++++|+.|+|++|.+++.+|..+..++
T Consensus 240 l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 240 PSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 456666667776666 3444 4566677777777776 5566666777777777777777766666655554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-30 Score=314.41 Aligned_cols=425 Identities=16% Similarity=0.113 Sum_probs=251.8
Q ss_pred CeEEEEEeecCCc---ccccCcccc------------CCCCCCeeeecCCcCCccCCccccCc--cccccccccccc-cC
Q 047768 70 QRVTKLDLRNQSI---GGILSPYVG------------NLSFLRYINIADNDFHGEIPDRIGNL--FRLETLVLANNS-FS 131 (1009)
Q Consensus 70 ~~v~~l~l~~~~l---~~~~~~~~~------------~l~~L~~L~L~~n~~~~~~p~~~~~l--~~L~~L~Ls~N~-l~ 131 (1009)
++++.|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+..++.+ .+|++|+|++|. ++
T Consensus 73 ~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~ 152 (592)
T 3ogk_B 73 PNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFT 152 (592)
T ss_dssp TTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEE
T ss_pred CCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcC
Confidence 3588999987432 234443333 78999999999999998888888774 459999999987 22
Q ss_pred C-CCCCCCcCCCcCcEEecccccccCCCchH--HhhhccCCcCeEeecCccCCC----CCCcccCCccccceeecccCcc
Q 047768 132 G-RIPTNLSHCSKLITFSAHRNNLVGEIPEE--LISRRLFNLQGLSVGDNQLTG----QLPASIGNLSALRVIDIRTNRL 204 (1009)
Q Consensus 132 ~-~~p~~l~~l~~L~~L~l~~n~l~~~~p~~--~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l 204 (1009)
. .++....++++|++|++++|.+++.-+.. .+...+++|++|++++|.+++ .++..+.++++|++|++++|.+
T Consensus 153 ~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~ 232 (592)
T 3ogk_B 153 TDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEI 232 (592)
T ss_dssp HHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBG
T ss_pred HHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccH
Confidence 1 12233458899999999999987663221 122578999999999999983 3455567899999999999999
Q ss_pred cCCCCcccccccccccccccCccCC---CCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCC
Q 047768 205 WGKIPITLSQLTSLAYLHVGDNHFS---GTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSL 281 (1009)
Q Consensus 205 ~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~ 281 (1009)
.+ +|..+..+++|++|+++.+... +..+..+.. +++|+.|+++++.. ..+
T Consensus 233 ~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~-------------------------~~~L~~L~l~~~~~-~~l 285 (592)
T 3ogk_B 233 LE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF-------------------------PRKLCRLGLSYMGP-NEM 285 (592)
T ss_dssp GG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC-------------------------CTTCCEEEETTCCT-TTG
T ss_pred HH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhc-------------------------cccccccCccccch-hHH
Confidence 75 7788999999999999864332 122233333 34455555544322 234
Q ss_pred CCCcCcccccccccccccccccccc-cccccccccccccccccccCCCCCCCcchhhhcccccccceEEccC--------
Q 047768 282 PDSFSNASNLEVLHLAENQFRGQVS-INFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLAD-------- 352 (1009)
Q Consensus 282 p~~~~~l~~L~~L~Ls~N~l~~~~~-~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~-------- 352 (1009)
|..+..+++|++|+|++|.+++... ..+..+++|+.|+++ |.+.. ..+......+++|++|++++
T Consensus 286 ~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~-----~~l~~~~~~~~~L~~L~L~~g~~~~~~~ 359 (592)
T 3ogk_B 286 PILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGD-----RGLEVLAQYCKQLKRLRIERGADEQGME 359 (592)
T ss_dssp GGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHH-----HHHHHHHHHCTTCCEEEEECCCCSSTTS
T ss_pred HHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCH-----HHHHHHHHhCCCCCEEEeecCccccccc
Confidence 4555556666666666666543322 224556666666666 32221 11223445677888888883
Q ss_pred ---CCCCCcCchhhhhhcccceEEEcCCCccccCCCccccC-cCccCEEEcc----CCCCCCCCCCCcCCcccccceecc
Q 047768 353 ---NGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIAN-LVNLNSLRME----ANRLTGTIPHVIGELKNLQLLHLH 424 (1009)
Q Consensus 353 ---N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~~p~~~~~l~~L~~L~L~ 424 (1009)
|.+++.....+.....+|++|+++.|++++..+..+.. +++|+.|+++ .|++++...+.
T Consensus 360 ~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~------------- 426 (592)
T 3ogk_B 360 DEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDN------------- 426 (592)
T ss_dssp STTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHH-------------
T ss_pred cccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHH-------------
Confidence 55553322222222234555555555554444434433 5555555554 44444321100
Q ss_pred cccccCCCCcccccccccccccccCc--ccccccCCCCC-CCCCccccccCCCCccCCCchhhhhhccceeeEecCCCcc
Q 047768 425 ANFLQGTIPSSLGNLTLLTYLSFGAN--NLQGNIPFSLG-NCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLL 501 (1009)
Q Consensus 425 ~N~l~~~~p~~~~~l~~L~~L~L~~N--~l~~~~p~~~~-~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l 501 (1009)
.++..+.++++|++|+++++ .+++..+..+. .+++|++|++++|++
T Consensus 427 ------~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l------------------------- 475 (592)
T 3ogk_B 427 ------GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGE------------------------- 475 (592)
T ss_dssp ------HHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCS-------------------------
T ss_pred ------HHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCC-------------------------
Confidence 01122333444444444321 23322221111 133344333333332
Q ss_pred CC-CCCCCccCCCCCCeeeccccccCCC-ccccccCCCCccEEEecCccccccccccc-ccccccceEcCCCc
Q 047768 502 NG-SLPLGVGNLKSLVRLGIARNQFSGQ-IPVTLGACTSLEYVELQGNSFSGTIPQSL-SSLTSIKELDLSQN 571 (1009)
Q Consensus 502 ~~-~~p~~~~~l~~L~~L~ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N 571 (1009)
++ .++..+..+++|++|++++|.+++. ++..+..+++|++|+|++|++++.-...+ ..++.+....+..+
T Consensus 476 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 476 SDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp SHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred CHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 22 1222345678899999999998754 34455678999999999999886533333 35666666655554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-29 Score=277.46 Aligned_cols=256 Identities=16% Similarity=0.205 Sum_probs=161.9
Q ss_pred CCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCCCCCCCcc
Q 047768 255 SLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLD 334 (1009)
Q Consensus 255 ~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~ 334 (1009)
..+..++..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+ |..+
T Consensus 24 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l---------------------- 79 (317)
T 3o53_A 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESL---------------------- 79 (317)
T ss_dssp HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTC----------------------
T ss_pred hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhc----------------------
Confidence 3444455556777777777777777777777777777777777777765443 4344
Q ss_pred hhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCC
Q 047768 335 FVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGE 414 (1009)
Q Consensus 335 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 414 (1009)
++|++|+|++|++++..+. ..|+.|++++|++++..+.. +++|+.|++++|++++..|..+..
T Consensus 80 --------~~L~~L~Ls~n~l~~l~~~------~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~ 142 (317)
T 3o53_A 80 --------STLRTLDLNNNYVQELLVG------PSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGC 142 (317)
T ss_dssp --------TTCCEEECCSSEEEEEEEC------TTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGG
T ss_pred --------CCCCEEECcCCccccccCC------CCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhc
Confidence 3444444444444321110 23344444444444332222 345566666666666555555555
Q ss_pred cccccceecccccccCCCCcccc-cccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceee
Q 047768 415 LKNLQLLHLHANFLQGTIPSSLG-NLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLS 493 (1009)
Q Consensus 415 l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~ 493 (1009)
+++|++|+|++|++++..|..+. .+++|++|++++|++++.
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-------------------------------------- 184 (317)
T 3o53_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-------------------------------------- 184 (317)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE--------------------------------------
T ss_pred cCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc--------------------------------------
Confidence 66666666666666554444432 445555555555554421
Q ss_pred EecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCccc
Q 047768 494 LDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNF 573 (1009)
Q Consensus 494 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 573 (1009)
| ....+++|++|+|++|++++ +|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+
T Consensus 185 ------------~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~ 249 (317)
T 3o53_A 185 ------------K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249 (317)
T ss_dssp ------------E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCC
T ss_pred ------------c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCc
Confidence 1 11236678888888888884 5556888888888888888888 5677888888899999999988
Q ss_pred c-cccccccccccccCceecc-cccCcccCCCC
Q 047768 574 S-GQIPKYLENLSFLQYLNLS-YNHFEGEVPTK 604 (1009)
Q Consensus 574 ~-~~~p~~~~~l~~L~~L~ls-~N~l~g~~p~~ 604 (1009)
+ +.+|..+..+++|+.|+++ .+.++|..|..
T Consensus 250 ~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp BHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred cCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence 8 7788888888889999888 55677776654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-27 Score=255.69 Aligned_cols=235 Identities=23% Similarity=0.225 Sum_probs=191.4
Q ss_pred cccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCC-CCCCCCCCcCCcccccce
Q 047768 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANR-LTGTIPHVIGELKNLQLL 421 (1009)
Q Consensus 343 ~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L 421 (1009)
++|++|+|++|++++..+..+..+ ..|++|+|++|.+++..|..|.++++|++|+|++|+ +++..|..|..+++|++|
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRAC-RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTC-TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCceEEEeeCCcCCccCHHHcccC-CCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 578888888888887666677666 578888888888888888889999999999999997 887778889999999999
Q ss_pred ecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCcc
Q 047768 422 HLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLL 501 (1009)
Q Consensus 422 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l 501 (1009)
+|++|++++..|..|.++++|++|++++|++++..+..+..+++|++|++++| ++
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-------------------------~l 165 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN-------------------------RI 165 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-------------------------CC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCC-------------------------cc
Confidence 99999999888888899999999999999998766677888888776544444 44
Q ss_pred CCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCccccccccccc
Q 047768 502 NGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYL 581 (1009)
Q Consensus 502 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 581 (1009)
++..+..|..+++|++|++++|.+++..|..+..+++|+.|+|++|++++..+..+..+++|++|+|++|.+....+..
T Consensus 166 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~- 244 (285)
T 1ozn_A 166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR- 244 (285)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-
T ss_pred cccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-
Confidence 4344455778889999999999999888899999999999999999999877778999999999999999998654432
Q ss_pred ccccccCceecccccCcccCCCC
Q 047768 582 ENLSFLQYLNLSYNHFEGEVPTK 604 (1009)
Q Consensus 582 ~~l~~L~~L~ls~N~l~g~~p~~ 604 (1009)
.-...++.+..+.|.+.+..|..
T Consensus 245 ~~~~~l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 245 PLWAWLQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp HHHHHHHHCCSEECCCBEEESGG
T ss_pred HHHHHHHhcccccCccccCCchH
Confidence 22345677778889998888864
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-28 Score=270.48 Aligned_cols=222 Identities=19% Similarity=0.197 Sum_probs=148.9
Q ss_pred cccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccc
Q 047768 341 NCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQL 420 (1009)
Q Consensus 341 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 420 (1009)
.+++|++|+|++|++++..|..+..+ ..|++|+|++|++++..+ +..+++|++|+|++|++++.. ..++|++
T Consensus 32 ~~~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~ 103 (317)
T 3o53_A 32 SAWNVKELDLSGNPLSQISAADLAPF-TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIET 103 (317)
T ss_dssp TGGGCSEEECTTSCCCCCCHHHHTTC-TTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCE
T ss_pred cCCCCCEEECcCCccCcCCHHHhhCC-CcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCE
Confidence 34455555555555555555555544 345555555555554333 555666666666666655322 2255666
Q ss_pred eecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCc
Q 047768 421 LHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNL 500 (1009)
Q Consensus 421 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~ 500 (1009)
|++++|++++..+.. +++|++|++++|++++..|..+..+++|++ |++++|.
T Consensus 104 L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~-------------------------L~Ls~N~ 155 (317)
T 3o53_A 104 LHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQY-------------------------LDLKLNE 155 (317)
T ss_dssp EECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEE-------------------------EECTTSC
T ss_pred EECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCE-------------------------EECCCCC
Confidence 666666665443332 345556666666665554555555555544 5556666
Q ss_pred cCCCCCCCc-cCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCccccccccc
Q 047768 501 LNGSLPLGV-GNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPK 579 (1009)
Q Consensus 501 l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 579 (1009)
+++..|..+ ..+++|++|++++|++++. |. ...+++|+.|+|++|++++ +|..+..+++|++|+|++|+|+ .+|.
T Consensus 156 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~ 231 (317)
T 3o53_A 156 IDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEK 231 (317)
T ss_dssp CCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECT
T ss_pred CCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhh
Confidence 555555555 4689999999999999954 43 3458999999999999995 4556999999999999999999 6888
Q ss_pred ccccccccCceecccccCc-ccCC
Q 047768 580 YLENLSFLQYLNLSYNHFE-GEVP 602 (1009)
Q Consensus 580 ~~~~l~~L~~L~ls~N~l~-g~~p 602 (1009)
.+..+++|++|++++|+++ +.+|
T Consensus 232 ~~~~l~~L~~L~l~~N~~~~~~~~ 255 (317)
T 3o53_A 232 ALRFSQNLEHFDLRGNGFHCGTLR 255 (317)
T ss_dssp TCCCCTTCCEEECTTCCCBHHHHH
T ss_pred HhhcCCCCCEEEccCCCccCcCHH
Confidence 9999999999999999999 4444
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-28 Score=289.46 Aligned_cols=187 Identities=14% Similarity=0.036 Sum_probs=131.6
Q ss_pred cccccCCceEEEEEEecCCeEEEEEEeecccc----------cchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCc
Q 047768 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQK----------GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 708 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 776 (1009)
..+.|++|.+..++....|+.||||++..... ...++|.+|+++|+++ .|+||+++++++.+ ..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-----~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-----AQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-----SS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-----CC
Confidence 35667777777777666789999999964321 1235699999999999 79999999999644 47
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..|+||||++|++|.+++..... ++.. .|+.||+.||+|+|++ |||||||||+|||++++|.+||+||
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~------l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DF 383 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEE------IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDF 383 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCC------CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhCCC------CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeec
Confidence 89999999999999999987653 5554 4899999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCC
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPT 920 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~ 920 (1009)
|+|+...... ......+||++|||||++.+ .+..++|+||+|++.+++.++..|+
T Consensus 384 GlAr~~~~~~--------~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 384 GSIVTTPQDC--------SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp TTEESCC-----------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred ccCeeCCCCC--------ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 9998665321 22345789999999999875 4677899999999998887765553
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=278.25 Aligned_cols=241 Identities=17% Similarity=0.182 Sum_probs=205.2
Q ss_pred cccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCc
Q 047768 307 INFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPP 386 (1009)
Q Consensus 307 ~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~ 386 (1009)
......++|+.|+|++|.+..... +.|..+++|++|+|++|.+++..| +..+ +.|++|+|++|.|++..+
T Consensus 28 ~l~~~~~~L~~L~Ls~n~l~~~~~------~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l-~~L~~L~Ls~N~l~~l~~- 97 (487)
T 3oja_A 28 SLRQSAWNVKELDLSGNPLSQISA------ADLAPFTKLELLNLSSNVLYETLD--LESL-STLRTLDLNNNYVQELLV- 97 (487)
T ss_dssp TTSTTGGGCCEEECCSSCCCCCCG------GGGTTCTTCCEEECTTSCCEEEEE--CTTC-TTCCEEECCSSEEEEEEE-
T ss_pred HhcccCCCccEEEeeCCcCCCCCH------HHHhCCCCCCEEEeeCCCCCCCcc--cccC-CCCCEEEecCCcCCCCCC-
Confidence 334455699999999999987553 568899999999999999997766 6666 689999999999996443
Q ss_pred cccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCC-CCCC
Q 047768 387 GIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLG-NCKN 465 (1009)
Q Consensus 387 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~ 465 (1009)
.++|+.|+|++|+|++..+.. +++|+.|+|++|.+++..|..++++++|++|+|++|.+++.+|..+. .+++
T Consensus 98 ----~~~L~~L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~ 170 (487)
T 3oja_A 98 ----GPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170 (487)
T ss_dssp ----CTTCCEEECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTT
T ss_pred ----CCCcCEEECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCc
Confidence 389999999999999776654 57899999999999999899999999999999999999998888776 6788
Q ss_pred ccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEec
Q 047768 466 LMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQ 545 (1009)
Q Consensus 466 L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~ 545 (1009)
|+.|++++|.++ +. | .+..+++|+.|+|++|.|++ +|+.+..+++|+.|+|+
T Consensus 171 L~~L~Ls~N~l~-------------------------~~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls 222 (487)
T 3oja_A 171 LEHLNLQYNFIY-------------------------DV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLR 222 (487)
T ss_dssp CCEEECTTSCCC-------------------------EE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECT
T ss_pred ccEEecCCCccc-------------------------cc-c-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEec
Confidence 776555555554 32 2 23358899999999999996 55569999999999999
Q ss_pred CcccccccccccccccccceEcCCCcccc-cccccccccccccCceecc
Q 047768 546 GNSFSGTIPQSLSSLTSIKELDLSQNNFS-GQIPKYLENLSFLQYLNLS 593 (1009)
Q Consensus 546 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls 593 (1009)
+|+|++ +|..++.+++|+.|+|++|.++ +.+|..+..++.|+.++++
T Consensus 223 ~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 223 NNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp TSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 999995 7888999999999999999998 7888999999999999987
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.6e-26 Score=244.56 Aligned_cols=228 Identities=20% Similarity=0.224 Sum_probs=186.6
Q ss_pred eEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccc
Q 047768 347 YLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHAN 426 (1009)
Q Consensus 347 ~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 426 (1009)
..+..+.+++ .+|..+ +..+++|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 11 ~~~c~~~~l~-~ip~~l---~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 86 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (276)
T ss_dssp EEECTTSCCS-SCCSSS---CTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred eEEecCCCcc-ccCCCC---CCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence 3455555555 344443 246888888888888777778888999999999999998777788888999999999999
Q ss_pred cccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCC-CC
Q 047768 427 FLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNG-SL 505 (1009)
Q Consensus 427 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~-~~ 505 (1009)
++++..+..|.++++|++|++++|++++..+..+.++++|++|++++| ++++ .+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-------------------------~l~~~~l 141 (276)
T 2z62_A 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN-------------------------LIQSFKL 141 (276)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSS-------------------------CCCCCCC
T ss_pred ccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCC-------------------------ccceecC
Confidence 998877788888999999999999988776667888888776555544 4443 35
Q ss_pred CCCccCCCCCCeeeccccccCCCccccccCCCCcc----EEEecCcccccccccccccccccceEcCCCccccccccccc
Q 047768 506 PLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLE----YVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYL 581 (1009)
Q Consensus 506 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 581 (1009)
|..++++++|++|++++|++++..+..+..+++|+ .|++++|++++..+..+.. .+|++|+|++|++++..+..|
T Consensus 142 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~ 220 (276)
T 2z62_A 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIF 220 (276)
T ss_dssp CGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTT
T ss_pred chhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHh
Confidence 77888999999999999999988788888888887 9999999999766665554 589999999999997777778
Q ss_pred ccccccCceecccccCcccCCCC
Q 047768 582 ENLSFLQYLNLSYNHFEGEVPTK 604 (1009)
Q Consensus 582 ~~l~~L~~L~ls~N~l~g~~p~~ 604 (1009)
..+++|++|++++|+++|.+|..
T Consensus 221 ~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 221 DRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp TTCCSCCEEECCSSCBCCCTTTT
T ss_pred cccccccEEEccCCcccccCCch
Confidence 99999999999999999999864
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=242.62 Aligned_cols=217 Identities=20% Similarity=0.294 Sum_probs=128.6
Q ss_pred CCCCCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCC
Q 047768 55 NLCQHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRI 134 (1009)
Q Consensus 55 ~~c~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 134 (1009)
+.| .|.|+.|.-. ..++.+++++++++. +|..+. ++|++|+|++|++++..+..|+++++|++|+|++|.+++..
T Consensus 3 ~~C-~~~~~~C~c~-~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 3 ALC-KKDGGVCSCN-NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCB-GGGTCSBEEE-TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred ccC-CCCCCCCEeC-CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 345 8999998632 234567777777764 444443 56777888888777555567777777777777777777544
Q ss_pred CCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCccccc
Q 047768 135 PTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQ 214 (1009)
Q Consensus 135 p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 214 (1009)
+..|.++++|++|++++|.+. +..+..|.++++|++|+|++|++++..+..|..
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~--------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 131 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQ--------------------------ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDS 131 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCC--------------------------CCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTT
T ss_pred hhhhcCCCCCCEEECCCCcCC--------------------------cCCHhHcccccCCCEEECCCCccCeeCHHHhCc
Confidence 445566666666666665554 333334445555555555555555444445555
Q ss_pred ccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccc
Q 047768 215 LTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVL 294 (1009)
Q Consensus 215 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 294 (1009)
+++|++|+|++|++++..+..|..+++|++|+|++|+++ .+|...+.++++|++|+|++|++++..+..|..+++|++|
T Consensus 132 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 210 (270)
T 2o6q_A 132 LTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML 210 (270)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCc-EeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEE
Confidence 555555555555555333333444444444444444444 4444444556666666666666665555566666666666
Q ss_pred ccccccccc
Q 047768 295 HLAENQFRG 303 (1009)
Q Consensus 295 ~Ls~N~l~~ 303 (1009)
+|++|.+..
T Consensus 211 ~l~~N~~~c 219 (270)
T 2o6q_A 211 QLQENPWDC 219 (270)
T ss_dssp ECCSSCBCC
T ss_pred EecCCCeeC
Confidence 666666543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.4e-30 Score=310.14 Aligned_cols=461 Identities=15% Similarity=0.154 Sum_probs=231.5
Q ss_pred CCCCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCc---cCCcc------------ccCcccc
Q 047768 56 LCQHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHG---EIPDR------------IGNLFRL 120 (1009)
Q Consensus 56 ~c~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~---~~p~~------------~~~l~~L 120 (1009)
.|+.|.++... ....+++.+.... .....+..+++|++|+|+++.... ..|.. ...+++|
T Consensus 33 vck~W~~~~~~----~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L 107 (594)
T 2p1m_B 33 VCKSWYEIERW----CRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107 (594)
T ss_dssp SCHHHHHHHHH----HCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HHHHHHHhhhh----hceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence 46678888321 2234555443211 112335677889999999875321 22322 2456788
Q ss_pred ccccccccccCCCCCCCCc-CCCcCcEEecccc-cccCCCchHHhhhccCCcCeEeecCccCCCCCCcccC----Ccccc
Q 047768 121 ETLVLANNSFSGRIPTNLS-HCSKLITFSAHRN-NLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIG----NLSAL 194 (1009)
Q Consensus 121 ~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~l~~n-~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~----~l~~L 194 (1009)
++|+|++|.+++..+..+. .+++|++|++++| .++......+ ...+++|++|+|++|.+++..+..+. .+++|
T Consensus 108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~-~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L 186 (594)
T 2p1m_B 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAI-AATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSL 186 (594)
T ss_dssp CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHH-HHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCC
T ss_pred CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHH-HHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcC
Confidence 8888888888776666665 6788888888887 4432212222 14577888888888877655444333 55678
Q ss_pred ceeecccCc--ccC-CCCcccccccccccccccCc-cCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccce
Q 047768 195 RVIDIRTNR--LWG-KIPITLSQLTSLAYLHVGDN-HFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNF 270 (1009)
Q Consensus 195 ~~L~L~~N~--l~~-~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L 270 (1009)
++|++++|. +.. .++..+..+++|++|+|++| .++ .+|..+..+++|++|+++.+...
T Consensus 187 ~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~----------------- 248 (594)
T 2p1m_B 187 VSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAE----------------- 248 (594)
T ss_dssp CEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCC-----------------
T ss_pred cEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCc-----------------
Confidence 888888776 210 11112234577777777776 333 24444555555555554333210
Q ss_pred eccccccCCCCCCCcCcccccccc-cccccccccccccccccccccccccccccccCCCCCCCcchhhhcccccccceEE
Q 047768 271 VIYTNNFTGSLPDSFSNASNLEVL-HLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLY 349 (1009)
Q Consensus 271 ~L~~N~l~~~~p~~~~~l~~L~~L-~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~ 349 (1009)
+..|.+.+ ++..+.++++|+.| .+.+.... ..+..+..+++|+.|++++|.+.. ..+...+..+++|+.|+
T Consensus 249 -~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~-~l~~~~~~~~~L~~L~L~~~~l~~-----~~l~~~~~~~~~L~~L~ 320 (594)
T 2p1m_B 249 -VRPDVYSG-LSVALSGCKELRCLSGFWDAVPA-YLPAVYSVCSRLTTLNLSYATVQS-----YDLVKLLCQCPKLQRLW 320 (594)
T ss_dssp -CCHHHHHH-HHHHHHTCTTCCEEECCBTCCGG-GGGGGHHHHTTCCEEECTTCCCCH-----HHHHHHHTTCTTCCEEE
T ss_pred -cchhhHHH-HHHHHhcCCCcccccCCcccchh-hHHHHHHhhCCCCEEEccCCCCCH-----HHHHHHHhcCCCcCEEe
Confidence 11222222 12234444555554 22222111 111122233344444444443221 01122234455555555
Q ss_pred ccCCCCCCcCchhhhhhcccceEEEcC---------CCccccCCCcccc-CcCccCEEEccCCCCCCCCCCCcCCccccc
Q 047768 350 LADNGFGGVLPHSIANLSTALIDFNLG---------KNQIYGTIPPGIA-NLVNLNSLRMEANRLTGTIPHVIGELKNLQ 419 (1009)
Q Consensus 350 L~~N~l~~~~p~~~~~l~~~L~~L~L~---------~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 419 (1009)
+++| ++......+....++|+.|++. .+.+++.....+. ++++|+.|.++.|.+++..+..+.
T Consensus 321 l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~------ 393 (594)
T 2p1m_B 321 VLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIA------ 393 (594)
T ss_dssp EEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHH------
T ss_pred CcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHH------
Confidence 5555 3211111111111334444431 1222211111111 234444444444444433222222
Q ss_pred ceecccccccCCCCccccccccccccccc--C----cccccc-----cCCCCCCCCCccccccCCCCccCCCchhhhhhc
Q 047768 420 LLHLHANFLQGTIPSSLGNLTLLTYLSFG--A----NNLQGN-----IPFSLGNCKNLMFFFAPRNKLTGALPQQILEIT 488 (1009)
Q Consensus 420 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~--~----N~l~~~-----~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~ 488 (1009)
..+++|++|+++ + |++++. ++..+..+++|+.|++++ .++
T Consensus 394 -----------------~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~----------- 444 (594)
T 2p1m_B 394 -----------------RNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLT----------- 444 (594)
T ss_dssp -----------------HHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCC-----------
T ss_pred -----------------hhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-ccc-----------
Confidence 123444444444 2 223210 111123344444444433 222
Q ss_pred cceeeEecCCCccCCCCCCCccC-CCCCCeeeccccccCCCccccc-cCCCCccEEEecCccccccccc-ccccccccce
Q 047768 489 TLSLSLDLSDNLLNGSLPLGVGN-LKSLVRLGIARNQFSGQIPVTL-GACTSLEYVELQGNSFSGTIPQ-SLSSLTSIKE 565 (1009)
Q Consensus 489 ~~~~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~ 565 (1009)
+..+..++. +++|++|+|++|.+++..+..+ ..+++|+.|+|++|++++..+. .+..+++|++
T Consensus 445 --------------~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~ 510 (594)
T 2p1m_B 445 --------------DKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRS 510 (594)
T ss_dssp --------------HHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSE
T ss_pred --------------HHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCE
Confidence 111122222 6778889999988876655555 6688999999999998765544 3456889999
Q ss_pred EcCCCccccccccccc-ccccccCceecccccCc
Q 047768 566 LDLSQNNFSGQIPKYL-ENLSFLQYLNLSYNHFE 598 (1009)
Q Consensus 566 L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~ 598 (1009)
|++++|+++..-...+ ..+++|+...+..+.-.
T Consensus 511 L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~ 544 (594)
T 2p1m_B 511 LWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAP 544 (594)
T ss_dssp EEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCG
T ss_pred EeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCcc
Confidence 9999998864434444 45677766666666543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-24 Score=233.14 Aligned_cols=186 Identities=24% Similarity=0.241 Sum_probs=126.5
Q ss_pred ccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccC
Q 047768 393 NLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAP 472 (1009)
Q Consensus 393 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~ 472 (1009)
+|+.|+|++|++++..+..|.++++|++|+|++|+++...+..|.++++|++|++++|++++..+..+..+++|++
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~---- 113 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAE---- 113 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCE----
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCE----
Confidence 4555555555555444445555555555555555555444444455555555555555555444444555555544
Q ss_pred CCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccc
Q 047768 473 RNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGT 552 (1009)
Q Consensus 473 ~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 552 (1009)
|++++|++++..|..|+++++|++|+|++|++++..+..|..+++|+.|+|++|++++.
T Consensus 114 ---------------------L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 114 ---------------------LRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp ---------------------EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred ---------------------EECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence 33333334434445567778888888888888876666788888999999999998877
Q ss_pred cccccccccccceEcCCCcccccccccccccccccCceecccccCcccCCC
Q 047768 553 IPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPT 603 (1009)
Q Consensus 553 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 603 (1009)
.+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++.+.++.
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 223 (270)
T 2o6q_A 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG 223 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence 777788899999999999999876666788899999999999999887763
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.9e-29 Score=299.45 Aligned_cols=414 Identities=15% Similarity=0.141 Sum_probs=222.6
Q ss_pred cccCccccccccccccccCC---CCCCCCcCCCcCcEEecccccccCCCch--HHhhhccCCcCeEeecCccCCCCCCcc
Q 047768 113 RIGNLFRLETLVLANNSFSG---RIPTNLSHCSKLITFSAHRNNLVGEIPE--ELISRRLFNLQGLSVGDNQLTGQLPAS 187 (1009)
Q Consensus 113 ~~~~l~~L~~L~Ls~N~l~~---~~p~~l~~l~~L~~L~l~~n~l~~~~p~--~~~~~~l~~L~~L~L~~n~l~~~~p~~ 187 (1009)
.+.++++|++|+|+++.... ..|..++. .... ..+...+++|++|+|++|.+++..+..
T Consensus 61 ~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~----------------~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~ 124 (594)
T 2p1m_B 61 VIRRFPKVRSVELKGKPHFADFNLVPDGWGG----------------YVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLEL 124 (594)
T ss_dssp HHHHCTTCCEEEEECSCGGGGGTCSCTTSCC----------------BCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHH
T ss_pred HHhhCCCceEEeccCCCchhhcccccccccc----------------hhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHH
Confidence 46678889999998875321 22222110 0000 001123344444444444444333333
Q ss_pred cC-CccccceeecccC-cccCC-CCcccccccccccccccCccCCCCCCCccc----CCChHHHHHhhCCccCCCCChh-
Q 047768 188 IG-NLSALRVIDIRTN-RLWGK-IPITLSQLTSLAYLHVGDNHFSGTIPPSVY----NISSLVEIYLYGNRFTGSLPIE- 259 (1009)
Q Consensus 188 ~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l~~L~~L~L~~N~l~~~ip~~- 259 (1009)
+. .+++|++|+|++| .++.. ++..+..+++|++|+|++|.+++..+..+. .+++|++|++++|. +.++..
T Consensus 125 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~--~~~~~~~ 202 (594)
T 2p1m_B 125 IAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA--SEVSFSA 202 (594)
T ss_dssp HHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC--SCCCHHH
T ss_pred HHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC--CcCCHHH
Confidence 32 3445555555544 22211 222233445555555555554433222222 22344444444443 122211
Q ss_pred ---hccCCCcccceecccc-ccCCCCCCCcCcccccccccccc-------cccccccccccccccccccccccccccCCC
Q 047768 260 ---IGKNLPNLRNFVIYTN-NFTGSLPDSFSNASNLEVLHLAE-------NQFRGQVSINFNGLKDLSMLGLATNFLGNG 328 (1009)
Q Consensus 260 ---~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-------N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~ 328 (1009)
+..++++|++|++++| .+.+ +|..+..+++|++|+++. |.+.+..+ .+.++++|+.|.
T Consensus 203 l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~-~l~~~~~L~~Ls--------- 271 (594)
T 2p1m_B 203 LERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSV-ALSGCKELRCLS--------- 271 (594)
T ss_dssp HHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHH-HHHTCTTCCEEE---------
T ss_pred HHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHH-HHhcCCCccccc---------
Confidence 1223566777777766 3333 555566666777776433 33333222 334444444441
Q ss_pred CCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCC-CccccCcCccCEEEccCCCCCCC
Q 047768 329 AANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTI-PPGIANLVNLNSLRMEANRLTGT 407 (1009)
Q Consensus 329 ~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~ 407 (1009)
.+.+... +.++..+..+ .+|+.|+|++|.+++.. +..+..+++|+.|++++| ++..
T Consensus 272 --------------------~~~~~~~-~~l~~~~~~~-~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~ 328 (594)
T 2p1m_B 272 --------------------GFWDAVP-AYLPAVYSVC-SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDA 328 (594)
T ss_dssp --------------------CCBTCCG-GGGGGGHHHH-TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHH
T ss_pred --------------------CCcccch-hhHHHHHHhh-CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHH
Confidence 2222111 1122222222 34555555555544221 112345667777777766 3311
Q ss_pred -CCCCcCCcccccceec---------ccccccCCCCcccc-cccccccccccCcccccccCCCCC-CCCCccccccC--C
Q 047768 408 -IPHVIGELKNLQLLHL---------HANFLQGTIPSSLG-NLTLLTYLSFGANNLQGNIPFSLG-NCKNLMFFFAP--R 473 (1009)
Q Consensus 408 -~p~~~~~l~~L~~L~L---------~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~l~l~--~ 473 (1009)
++.....+++|++|+| +.|.+++.....+. ++++|++|+++.|++++..+..+. .+++|+.|+++ +
T Consensus 329 ~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~ 408 (594)
T 2p1m_B 329 GLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIE 408 (594)
T ss_dssp HHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESS
T ss_pred HHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeeccc
Confidence 1112224667777776 33455533222333 478899998888988876555554 47888887777 3
Q ss_pred ----CCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccC-CCCccEEEecCcc
Q 047768 474 ----NKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGA-CTSLEYVELQGNS 548 (1009)
Q Consensus 474 ----N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~ 548 (1009)
|.+++...+ ..++..+..+++|+.|++++ .+++..+..++. +++|+.|+|++|.
T Consensus 409 ~~~~~~l~~~~~~--------------------~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~ 467 (594)
T 2p1m_B 409 PKAPDYLTLEPLD--------------------IGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAG 467 (594)
T ss_dssp TTCCCTTTCCCTH--------------------HHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCC
T ss_pred CCCcccccCCchh--------------------hHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCC
Confidence 333311100 01111245678999999987 777666666766 8999999999999
Q ss_pred ccccccccc-ccccccceEcCCCccccccccc-ccccccccCceecccccCcc
Q 047768 549 FSGTIPQSL-SSLTSIKELDLSQNNFSGQIPK-YLENLSFLQYLNLSYNHFEG 599 (1009)
Q Consensus 549 l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~g 599 (1009)
+++..+..+ ..+++|++|+|++|.+++..+. ....+++|++|++++|+++.
T Consensus 468 i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 468 DSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp SSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred CcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 987766666 6789999999999999765544 44569999999999999853
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=232.38 Aligned_cols=184 Identities=26% Similarity=0.272 Sum_probs=129.4
Q ss_pred cccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCc
Q 047768 387 GIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNL 466 (1009)
Q Consensus 387 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 466 (1009)
.+..+++|++|+|++|++++. ..+..+++|++|+|++|.+++..+..|.++++|++|++++|++++..|..+..+++|
T Consensus 58 ~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 135 (272)
T 3rfs_A 58 GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNL 135 (272)
T ss_dssp TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCC
Confidence 355566666666666666642 355666666666666666665555556666666666666666665555556666665
Q ss_pred cccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecC
Q 047768 467 MFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQG 546 (1009)
Q Consensus 467 ~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~ 546 (1009)
++ |++++|++++..|..++.+++|++|++++|++++..+..++.+++|+.|+|++
T Consensus 136 ~~-------------------------L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 190 (272)
T 3rfs_A 136 TY-------------------------LNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQ 190 (272)
T ss_dssp CE-------------------------EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CE-------------------------EECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCC
Confidence 54 33444444434444567778888888888888877777778888888888888
Q ss_pred cccccccccccccccccceEcCCCcccccccccccccccccCceecccccCcccCCCC
Q 047768 547 NSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK 604 (1009)
Q Consensus 547 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 604 (1009)
|++++..|..++.+++|++|+|++|.+.+. +++|+.|+++.|+++|.+|..
T Consensus 191 N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 191 NQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred CcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence 888887777788888888888888888754 446888888889999888864
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=233.22 Aligned_cols=230 Identities=24% Similarity=0.250 Sum_probs=183.6
Q ss_pred ccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCc
Q 047768 312 LKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANL 391 (1009)
Q Consensus 312 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l 391 (1009)
+..+..+++..+.+.... .+..+++|+.|++++|.++.. ..+..+ +.|++|++++|.+++. ..+..+
T Consensus 18 ~~~l~~l~l~~~~~~~~~--------~~~~l~~L~~L~l~~~~i~~~--~~l~~l-~~L~~L~l~~n~l~~~--~~l~~l 84 (272)
T 3rfs_A 18 FAETIKANLKKKSVTDAV--------TQNELNSIDQIIANNSDIKSV--QGIQYL-PNVRYLALGGNKLHDI--SALKEL 84 (272)
T ss_dssp HHHHHHHHHTCSCTTSEE--------CHHHHTTCCEEECTTSCCCCC--TTGGGC-TTCCEEECTTSCCCCC--GGGTTC
T ss_pred HHHHHHHHhcCccccccc--------ccccccceeeeeeCCCCcccc--cccccC-CCCcEEECCCCCCCCc--hhhcCC
Confidence 445556666666655432 256778899999999988743 345555 6789999999998863 478889
Q ss_pred CccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCcccccc
Q 047768 392 VNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFA 471 (1009)
Q Consensus 392 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l 471 (1009)
++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|++++|++++..|..+..+++|+.
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~--- 161 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTE--- 161 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE---
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCE---
Confidence 99999999999999888888899999999999999999877777889999999999999998777777788887765
Q ss_pred CCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccccc
Q 047768 472 PRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSG 551 (1009)
Q Consensus 472 ~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 551 (1009)
|++++|++++..+..++.+++|++|++++|++++..|..++.+++|+.|+|++|.+.+
T Consensus 162 ----------------------L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 162 ----------------------LDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp ----------------------EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ----------------------EECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 5555555555556667888999999999999998888888899999999999998875
Q ss_pred ccccccccccccceEcCCCcccccccccccccccc
Q 047768 552 TIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSF 586 (1009)
Q Consensus 552 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 586 (1009)
. +++|+.|+++.|.++|.+|..++.+..
T Consensus 220 ~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 220 T-------CPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp C-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred c-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence 4 446888999999999999988877654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6.3e-24 Score=230.80 Aligned_cols=206 Identities=21% Similarity=0.243 Sum_probs=129.5
Q ss_pred cccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccc
Q 047768 339 LTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNL 418 (1009)
Q Consensus 339 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 418 (1009)
+.++++++.+++++|+++ .+|..+. ..++.|+|++|+|++..+..|.++++|+.|+|++|+|++..+.
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-------- 73 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-------- 73 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--------
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--------
Confidence 345566777777777766 2333222 2344555555555444444444444455555444444432221
Q ss_pred cceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCC
Q 047768 419 QLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSD 498 (1009)
Q Consensus 419 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~ 498 (1009)
..+++|++|++++|+|+ .+|..+..+++|++ |++++
T Consensus 74 ------------------~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~-------------------------L~l~~ 109 (290)
T 1p9a_G 74 ------------------GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTV-------------------------LDVSF 109 (290)
T ss_dssp ------------------SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCE-------------------------EECCS
T ss_pred ------------------CCCCcCCEEECCCCcCC-cCchhhccCCCCCE-------------------------EECCC
Confidence 34444555555555554 34444444444443 44444
Q ss_pred CccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccc
Q 047768 499 NLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIP 578 (1009)
Q Consensus 499 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 578 (1009)
|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|
T Consensus 110 N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip 188 (290)
T 1p9a_G 110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188 (290)
T ss_dssp SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred CcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccC
Confidence 4444444456777778888888888888766777788888888888888888666667788888888888888887 677
Q ss_pred cccccccccCceecccccCcccC
Q 047768 579 KYLENLSFLQYLNLSYNHFEGEV 601 (1009)
Q Consensus 579 ~~~~~l~~L~~L~ls~N~l~g~~ 601 (1009)
..+..+.+|++|+|++|++.+.+
T Consensus 189 ~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 189 KGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp TTTTTTCCCSEEECCSCCBCCSG
T ss_pred hhhcccccCCeEEeCCCCccCcC
Confidence 77778888888888888887765
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=226.78 Aligned_cols=224 Identities=21% Similarity=0.208 Sum_probs=188.1
Q ss_pred EEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcc
Q 047768 372 DFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANN 451 (1009)
Q Consensus 372 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 451 (1009)
..+..+..++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|++++|+
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 4566777776 5676664 589999999999998888899999999999999999998878889999999999999999
Q ss_pred cccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCC-cc
Q 047768 452 LQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQ-IP 530 (1009)
Q Consensus 452 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~p 530 (1009)
+++..|..+.++++|++|++ ++|.+++..+..++++++|++|++++|++++. +|
T Consensus 88 l~~~~~~~~~~l~~L~~L~l-------------------------~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~ 142 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVA-------------------------VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142 (276)
T ss_dssp CCEECTTTTTTCTTCCEEEC-------------------------TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCC
T ss_pred cCccChhhhcCCccccEEEC-------------------------CCCCccccCchhcccCCCCCEEECcCCccceecCc
Confidence 99888888999888876554 45555545555688999999999999999874 69
Q ss_pred ccccCCCCccEEEecCcccccccccccccccccc----eEcCCCcccccccccccccccccCceecccccCcccCCCC-C
Q 047768 531 VTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIK----ELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTK-G 605 (1009)
Q Consensus 531 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~ 605 (1009)
..++.+++|+.|+|++|++++..+..+..+++|+ .|++++|++++..+..+. ..+|++|+|++|++++..+.. .
T Consensus 143 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~ 221 (276)
T 2z62_A 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFD 221 (276)
T ss_dssp GGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTT
T ss_pred hhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhc
Confidence 9999999999999999999988888999888888 899999999965555554 458999999999999766543 4
Q ss_pred cccCccccccccCCCcCCC
Q 047768 606 IFKNKTGFSIVGNGKLCGG 624 (1009)
Q Consensus 606 ~~~~~~~~~~~~n~~lc~~ 624 (1009)
.+.++....+.+|+..|+-
T Consensus 222 ~l~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 222 RLTSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp TCCSCCEEECCSSCBCCCT
T ss_pred ccccccEEEccCCcccccC
Confidence 5667777888999988864
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-24 Score=233.56 Aligned_cols=204 Identities=23% Similarity=0.256 Sum_probs=151.0
Q ss_pred ccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCC
Q 047768 90 VGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFN 169 (1009)
Q Consensus 90 ~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~ 169 (1009)
++++++++++++++|+++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|++++|.+++. +.. ..+++
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~---~~l~~ 78 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD---GTLPV 78 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC---SCCTT
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC---CCCCc
Confidence 556677777777777777 5665554 5677777777777766667777777777777777776642 221 35677
Q ss_pred cCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhC
Q 047768 170 LQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYG 249 (1009)
Q Consensus 170 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 249 (1009)
|++|+|++|+++ .+|..+.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++
T Consensus 79 L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 157 (290)
T 1p9a_G 79 LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157 (290)
T ss_dssp CCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCC
Confidence 777777778777 6677778888888888888888877777888888888888888888866666677777888888888
Q ss_pred CccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccc
Q 047768 250 NRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRG 303 (1009)
Q Consensus 250 N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 303 (1009)
|+++ .+|..++..+++|++|+|++|+++ .+|..+..+.+|+.|+|++|.+..
T Consensus 158 N~l~-~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 158 NNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp SCCS-CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CcCC-ccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 8887 777777777888888888888887 456666666778888888887653
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.2e-24 Score=235.27 Aligned_cols=228 Identities=17% Similarity=0.190 Sum_probs=168.5
Q ss_pred ccceEEccCCCCCCcCchhh---hhhcccceEEEcCCCccccCCCccc--cCcCccCEEEccCCCCCCCCC----CCcCC
Q 047768 344 KLQYLYLADNGFGGVLPHSI---ANLSTALIDFNLGKNQIYGTIPPGI--ANLVNLNSLRMEANRLTGTIP----HVIGE 414 (1009)
Q Consensus 344 ~L~~L~L~~N~l~~~~p~~~---~~l~~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~ 414 (1009)
.++.+.+.++.++...-..+ ... ..|++|++++|.+++..|..+ ..+++|+.|+|++|++++..+ ..+..
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAY-SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHH-SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhccc-CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 46677777776653211111 112 358888888888888888887 888889999999998887655 34457
Q ss_pred cccccceecccccccCCCCcccccccccccccccCcccccc--c--CCCCCCCCCccccccCCCCccCCCchhhhhhccc
Q 047768 415 LKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGN--I--PFSLGNCKNLMFFFAPRNKLTGALPQQILEITTL 490 (1009)
Q Consensus 415 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~ 490 (1009)
+++|++|+|++|++++..|..|+++++|++|+|++|++.+. + +..+..+++|++|++++|+++ .+|.....
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~---- 218 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAA---- 218 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHH----
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHH----
Confidence 88888999999988888788888888899999999887652 2 233467888888777777775 22221100
Q ss_pred eeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCC---CCccEEEecCcccccccccccccccccceEc
Q 047768 491 SLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGAC---TSLEYVELQGNSFSGTIPQSLSSLTSIKELD 567 (1009)
Q Consensus 491 ~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 567 (1009)
.++++++|++|||++|++++.+|..+..+ ++|++|+|++|+|+ .+|..+. ++|++||
T Consensus 219 -----------------l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~ 278 (310)
T 4glp_A 219 -----------------LAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLD 278 (310)
T ss_dssp -----------------HHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEE
T ss_pred -----------------HHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEE
Confidence 13566788888888888888778777776 58999999999988 6677765 7899999
Q ss_pred CCCcccccccccccccccccCceecccccCcc
Q 047768 568 LSQNNFSGQIPKYLENLSFLQYLNLSYNHFEG 599 (1009)
Q Consensus 568 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g 599 (1009)
|++|+|++. |. +..+++|++|+|++|+++.
T Consensus 279 Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 279 LSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 999999864 43 6788899999999998864
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.1e-24 Score=225.21 Aligned_cols=197 Identities=14% Similarity=0.164 Sum_probs=153.7
Q ss_pred CCCeeeecCCcCCccCCccccCccccccccccccc-cCCCCCCCCcCCCcCcEEeccc-ccccCCCchHHhhhccCCcCe
Q 047768 95 FLRYINIADNDFHGEIPDRIGNLFRLETLVLANNS-FSGRIPTNLSHCSKLITFSAHR-NNLVGEIPEELISRRLFNLQG 172 (1009)
Q Consensus 95 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~l~~-n~l~~~~p~~~~~~~l~~L~~ 172 (1009)
+|++|+|++|++++..+..|+++++|++|+|++|. +++..+..|+++++|++|++++ |++++..+..+ ..+++|++
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f--~~l~~L~~ 109 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL--KELPLLKF 109 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE--ECCTTCCE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh--CCCCCCCE
Confidence 77888888888886666678888888888888886 7766666788888888888887 77764333333 46778888
Q ss_pred EeecCccCCCCCCcccCCccccc---eeecccC-cccCCCCcccccccccc-cccccCccCCCCCCCcccCCChHHHHHh
Q 047768 173 LSVGDNQLTGQLPASIGNLSALR---VIDIRTN-RLWGKIPITLSQLTSLA-YLHVGDNHFSGTIPPSVYNISSLVEIYL 247 (1009)
Q Consensus 173 L~L~~n~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L 247 (1009)
|++++|++++ +|. |+.+++|+ +|++++| ++.+..+..|..+++|+ +|++++|+++ .+|......++|++|+|
T Consensus 110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L 186 (239)
T 2xwt_C 110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186 (239)
T ss_dssp EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEEC
T ss_pred EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEc
Confidence 8888888885 565 77888887 9999999 88877777888899999 9999999988 55655444488999999
Q ss_pred hCCc-cCCCCChhhccCC-CcccceeccccccCCCCCCCcCcccccccccccccc
Q 047768 248 YGNR-FTGSLPIEIGKNL-PNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQ 300 (1009)
Q Consensus 248 ~~N~-l~~~ip~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 300 (1009)
++|+ ++ .+|...+.++ ++|+.|++++|++++..+. .+++|+.|+++++.
T Consensus 187 ~~n~~l~-~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 187 NKNKYLT-VIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNTW 237 (239)
T ss_dssp TTCTTCC-EECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC-
T ss_pred CCCCCcc-cCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCcc
Confidence 9995 88 7888888888 9999999999999866554 56678888887763
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.4e-24 Score=252.58 Aligned_cols=191 Identities=18% Similarity=0.151 Sum_probs=142.5
Q ss_pred ccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--------chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 704 SSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--------GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 704 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
...+.||+|+||+||+|.. .++.+|+|+....... ..+.+.+|++++++++||||+++..++...
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~----- 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL----- 411 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-----
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-----
Confidence 4467899999999999954 5788999987432211 124578999999999999999544443322
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++++|.++++. +..++.|+++||.|||++ +|+||||||+|||++. .+||+|
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~D 472 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIID 472 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECC
T ss_pred CccEEEEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEE
Confidence 445999999999999999875 347999999999999999 9999999999999999 999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCC--CCCCCcccchHHHHHHHHHHhCCCCCc
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG--GEASMRGGVYSYGILLLEIFTRRRPTE 921 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~ 921 (1009)
||+++......... .+.........||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 473 FGla~~~~~~~~~~-~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 473 FGLGKISNLDEDKA-VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CTTCEECCCHHHHH-HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccCEECCCccccc-cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 99999765321000 000001235679999999999887 667888999999999999888877763
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.1e-26 Score=255.80 Aligned_cols=269 Identities=14% Similarity=0.144 Sum_probs=167.9
Q ss_pred EEeecCCcccccCccccCCCCCCeeeecCCcCCccCC----ccccCcc-ccccccccccccCCCCCCCCcCC-----CcC
Q 047768 75 LDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIP----DRIGNLF-RLETLVLANNSFSGRIPTNLSHC-----SKL 144 (1009)
Q Consensus 75 l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l-----~~L 144 (1009)
++|+.++++|.+|..+...++|++|||++|.+++..+ ..|.+++ +|++|+|++|.+++..+..++.+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 5677888888888777777778888888888886655 6777787 88888888888887777777665 888
Q ss_pred cEEecccccccCCCchHHhh--hcc-CCcCeEeecCccCCCCCCcccC----C-ccccceeecccCcccCCCC----ccc
Q 047768 145 ITFSAHRNNLVGEIPEELIS--RRL-FNLQGLSVGDNQLTGQLPASIG----N-LSALRVIDIRTNRLWGKIP----ITL 212 (1009)
Q Consensus 145 ~~L~l~~n~l~~~~p~~~~~--~~l-~~L~~L~L~~n~l~~~~p~~~~----~-l~~L~~L~L~~N~l~~~~p----~~~ 212 (1009)
++|++++|.+++..+..+.. ..+ .+|++|+|++|++++..+..+. . .++|++|+|++|++....+ ..+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 88888888887766665532 122 6788888888888766554433 3 2578888888888764333 333
Q ss_pred cccc-ccccccccCccCCCCCCCccc----CC-ChHHHHHhhCCccCCC----CChhhccCCCcccceeccccccCCCCC
Q 047768 213 SQLT-SLAYLHVGDNHFSGTIPPSVY----NI-SSLVEIYLYGNRFTGS----LPIEIGKNLPNLRNFVIYTNNFTGSLP 282 (1009)
Q Consensus 213 ~~l~-~L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~L~~N~l~~~----ip~~~~~~l~~L~~L~L~~N~l~~~~p 282 (1009)
..++ +|++|+|++|++++..+..+. .+ ++|++|+|++|++++. ++..+....++|++|+|++|.+++..+
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 242 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL 242 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCH
T ss_pred hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHH
Confidence 4444 788888888877755544333 22 3566666666655521 222222222345555555555544322
Q ss_pred ----CCcCcccccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCc
Q 047768 283 ----DSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGV 358 (1009)
Q Consensus 283 ----~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 358 (1009)
..+..+++|++|+|++|.+..+.+..+ ..+...+..+++|+.||+++|.+...
T Consensus 243 ~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~-----------------------~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 243 ENLKLLKDSLKHLQTVYLDYDIVKNMSKEQC-----------------------KALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHHTTTTTTTCSEEEEEHHHHTTCCHHHH-----------------------HHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHhcCCCccEEEeccCCccccCHHHH-----------------------HHHHHHhccCCceEEEecCCCcCCCc
Confidence 223334444444444444333222111 11223466777888888888888766
Q ss_pred Cchhhhhh
Q 047768 359 LPHSIANL 366 (1009)
Q Consensus 359 ~p~~~~~l 366 (1009)
.+..+.+.
T Consensus 300 ~~~~~~~~ 307 (362)
T 3goz_A 300 HSIPISNL 307 (362)
T ss_dssp GCHHHHHH
T ss_pred chHHHHHH
Confidence 55555444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=223.64 Aligned_cols=189 Identities=21% Similarity=0.278 Sum_probs=129.6
Q ss_pred CCCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCC
Q 047768 57 CQHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPT 136 (1009)
Q Consensus 57 c~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 136 (1009)
|+.|+|.+|... .+.+++++++++. +|..+. ++|++|+|++|++++..|..|+++++|++|+|++|.+++..|.
T Consensus 4 Cp~~~gC~C~~~---~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 77 (251)
T 3m19_A 4 CETVTGCTCNEG---KKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG 77 (251)
T ss_dssp CHHHHSSEEEGG---GTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred CCCCCceEcCCC---CeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHh
Confidence 558999999532 3457888888874 444444 6889999999999988888899999999999999999888888
Q ss_pred CCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCccccccc
Q 047768 137 NLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLT 216 (1009)
Q Consensus 137 ~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 216 (1009)
.|.++++|++|++++|++++..+..+ ..+.+|++|+|++|++++..+..|+++++|++|+|++|+|++..+..|..++
T Consensus 78 ~~~~l~~L~~L~L~~n~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 155 (251)
T 3m19_A 78 VFDDLTELGTLGLANNQLASLPLGVF--DHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT 155 (251)
T ss_dssp TTTTCTTCCEEECTTSCCCCCCTTTT--TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred HhccCCcCCEEECCCCcccccChhHh--cccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCc
Confidence 88888888888888877764333333 4456666666666666655555566666666666666666655555666666
Q ss_pred ccccccccCccCCCCCCCcccCCChHHHHHhhCCccC
Q 047768 217 SLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFT 253 (1009)
Q Consensus 217 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 253 (1009)
+|++|+|++|++++..+..|..+++|++|+|++|.++
T Consensus 156 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred CCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCcee
Confidence 6666666666666444444555555555555555444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.8e-23 Score=232.80 Aligned_cols=248 Identities=17% Similarity=0.124 Sum_probs=139.1
Q ss_pred CCCC-C-CCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCcccccccccccccc
Q 047768 53 CVNL-C-QHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSF 130 (1009)
Q Consensus 53 ~~~~-c-~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l 130 (1009)
|++. | |+|+.|.|++ ++++ .+|..+ .+++++|+|++|+|+...+..|.++++|++|||++|++
T Consensus 2 Cp~~~C~C~~~~v~C~~------------~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i 66 (350)
T 4ay9_X 2 CHHRICHCSNRVFLCQE------------SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66 (350)
T ss_dssp CCCSSSEEETTEEEEES------------TTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTT
T ss_pred CCCCccEeeCCEEEecC------------CCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCC
Confidence 6543 5 5677788854 3444 345444 35788999999999844445788899999999999988
Q ss_pred CCCCCC-CCcCCCcCcE-EecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCC
Q 047768 131 SGRIPT-NLSHCSKLIT-FSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKI 208 (1009)
Q Consensus 131 ~~~~p~-~l~~l~~L~~-L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 208 (1009)
.+.+|. .|.++++|.+ ++++.|+++ ...|..|.++++|++|++++|++.+..
T Consensus 67 ~~~i~~~~f~~L~~l~~~l~~~~N~l~--------------------------~l~~~~f~~l~~L~~L~l~~n~l~~~~ 120 (350)
T 4ay9_X 67 LEVIEADVFSNLPKLHEIRIEKANNLL--------------------------YINPEAFQNLPNLQYLLISNTGIKHLP 120 (350)
T ss_dssp CCEECTTSBCSCTTCCEEEEEEETTCC--------------------------EECTTSBCCCTTCCEEEEEEECCSSCC
T ss_pred CCccChhHhhcchhhhhhhcccCCccc--------------------------ccCchhhhhccccccccccccccccCC
Confidence 766654 5677777654 344444444 333444455555555555555554444
Q ss_pred CcccccccccccccccC-ccCCCCCCCcccCCC-hHHHHHhhCCccCCCCChhhccCCCcccceeccc-cccCCCCCCCc
Q 047768 209 PITLSQLTSLAYLHVGD-NHFSGTIPPSVYNIS-SLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYT-NNFTGSLPDSF 285 (1009)
Q Consensus 209 p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~-N~l~~~~p~~~ 285 (1009)
+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+ .||..+|. ..+|+.|++++ |.++.+.++.|
T Consensus 121 ~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f 198 (350)
T 4ay9_X 121 DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFN-GTQLDELNLSDNNNLEELPNDVF 198 (350)
T ss_dssp CCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSST-TEEEEEEECTTCTTCCCCCTTTT
T ss_pred chhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhcc-ccchhHHhhccCCcccCCCHHHh
Confidence 44444444444554433 334322333344432 3445555555555 45555543 34555555543 44444444455
Q ss_pred CcccccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCC
Q 047768 286 SNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADN 353 (1009)
Q Consensus 286 ~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N 353 (1009)
.++++|++|||++|+|+.+++..|.++++|+.+++ +.+..++ .+.++++|+.++++++
T Consensus 199 ~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~~lP--------~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 199 HGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLP--------TLEKLVALMEASLTYP 256 (350)
T ss_dssp TTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCCCCC--------CTTTCCSCCEEECSCH
T ss_pred ccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcCcCC--------CchhCcChhhCcCCCC
Confidence 66666666666666666655555555555555444 2233222 2456677777777654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=4e-23 Score=218.32 Aligned_cols=200 Identities=19% Similarity=0.205 Sum_probs=154.3
Q ss_pred ccceEEEcCCCccccCCCccccCcCccCEEEccCCC-CCCCCCCCcCCcccccceeccc-ccccCCCCcccccccccccc
Q 047768 368 TALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANR-LTGTIPHVIGELKNLQLLHLHA-NFLQGTIPSSLGNLTLLTYL 445 (1009)
Q Consensus 368 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L 445 (1009)
..+++|++++|++++..+..|.++++|+.|++++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 468888888888887777788888899999999887 8877777888888999999988 88887777788888888888
Q ss_pred cccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCC-ccCCCCCCCccCCCCCC-eeecccc
Q 047768 446 SFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDN-LLNGSLPLGVGNLKSLV-RLGIARN 523 (1009)
Q Consensus 446 ~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~ls~N 523 (1009)
++++|++++ +|. +..+++|+. ...|++++| .+++..+..|.++++|+ +|++++|
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~----------------------L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n 166 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDI----------------------FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN 166 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCS----------------------EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSC
T ss_pred eCCCCCCcc-ccc-ccccccccc----------------------ccEEECCCCcchhhcCcccccchhcceeEEEcCCC
Confidence 888888885 665 666666541 013666666 66655556688888888 8888888
Q ss_pred ccCCCccccccCCCCccEEEecCcc-cccccccccccc-cccceEcCCCcccccccccccccccccCceecccc
Q 047768 524 QFSGQIPVTLGACTSLEYVELQGNS-FSGTIPQSLSSL-TSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYN 595 (1009)
Q Consensus 524 ~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 595 (1009)
+++ .+|......++|+.|+|++|+ +++..+..|.++ ++|+.|||++|++++ +|.. .+++|+.|+++++
T Consensus 167 ~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 167 GFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT 236 (239)
T ss_dssp CCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred CCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence 888 555544344788888888884 886667788888 888888888888884 4544 5777888888776
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.2e-25 Score=252.59 Aligned_cols=253 Identities=17% Similarity=0.251 Sum_probs=166.4
Q ss_pred CCCCcCcccccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCC---CCCC
Q 047768 281 LPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADN---GFGG 357 (1009)
Q Consensus 281 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N---~l~~ 357 (1009)
++..+..+++|++|+|++|++....+.. +...+..+++|++|+|++| ++++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~--------------------------l~~~l~~~~~L~~L~Ls~~~~~~l~~ 77 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARW--------------------------LSENIASKKDLEIAEFSDIFTGRVKD 77 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHH--------------------------HHHTTTTCTTCCEEECCSCCTTSCGG
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHH--------------------------HHHHHHhCCCccEEeCcccccCcccc
Confidence 4445555666666666666665433221 1123445566666666664 3333
Q ss_pred cCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCC----CCCCCcCCcccccceecccccccCCCC
Q 047768 358 VLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTG----TIPHVIGELKNLQLLHLHANFLQGTIP 433 (1009)
Q Consensus 358 ~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p 433 (1009)
.+|..+..+ ...+..+++|++|+|++|++++ .+|..+..+++|++|+|++|.+++..+
T Consensus 78 ~~~~~~~~l------------------~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~ 139 (386)
T 2ca6_A 78 EIPEALRLL------------------LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 139 (386)
T ss_dssp GSHHHHHHH------------------HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred chhHHHHHH------------------HHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHH
Confidence 444444332 1234566777777777777765 355566667777777777777754333
Q ss_pred ccccc----c---------cccccccccCcccc-cccC---CCCCCCCCccccccCCCCccCCCchhhhhhccceeeEec
Q 047768 434 SSLGN----L---------TLLTYLSFGANNLQ-GNIP---FSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDL 496 (1009)
Q Consensus 434 ~~~~~----l---------~~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~L 496 (1009)
..+.. + ++|++|++++|+++ +.+| ..+..+++|+. |++
T Consensus 140 ~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~-------------------------L~L 194 (386)
T 2ca6_A 140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT-------------------------VKM 194 (386)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE-------------------------EEC
T ss_pred HHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCE-------------------------EEC
Confidence 33332 2 56666666666654 2222 23333444444 444
Q ss_pred CCCccC--C---CCCCCccCCCCCCeeeccccccC----CCccccccCCCCccEEEecCcccccc----ccccc--cccc
Q 047768 497 SDNLLN--G---SLPLGVGNLKSLVRLGIARNQFS----GQIPVTLGACTSLEYVELQGNSFSGT----IPQSL--SSLT 561 (1009)
Q Consensus 497 s~N~l~--~---~~p~~~~~l~~L~~L~ls~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~--~~l~ 561 (1009)
++|+++ | ..|..+..+++|++|+|++|.++ +.+|..+..+++|+.|+|++|++++. +|..+ +.++
T Consensus 195 ~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~ 274 (386)
T 2ca6_A 195 VQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI 274 (386)
T ss_dssp CSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSC
T ss_pred cCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCC
Confidence 444444 1 23446788899999999999996 67888999999999999999999876 56777 4489
Q ss_pred ccceEcCCCccccc----cccccc-ccccccCceecccccCcccCC
Q 047768 562 SIKELDLSQNNFSG----QIPKYL-ENLSFLQYLNLSYNHFEGEVP 602 (1009)
Q Consensus 562 ~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~ls~N~l~g~~p 602 (1009)
+|+.|+|++|.+++ .+|..+ .++++|++|++++|++++..|
T Consensus 275 ~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 275 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp CCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred CeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 99999999999997 588887 668999999999999987664
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.6e-22 Score=213.63 Aligned_cols=180 Identities=22% Similarity=0.247 Sum_probs=111.1
Q ss_pred ceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccC
Q 047768 370 LIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGA 449 (1009)
Q Consensus 370 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 449 (1009)
.++++++++.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 455666666666 4454443 4666666666666666666666666666666666666655555555566665555555
Q ss_pred cccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCc
Q 047768 450 NNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQI 529 (1009)
Q Consensus 450 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 529 (1009)
|++++..+ ..|..+++|++|+|++|+|++..
T Consensus 93 n~l~~~~~-------------------------------------------------~~~~~l~~L~~L~L~~N~l~~~~ 123 (251)
T 3m19_A 93 NQLASLPL-------------------------------------------------GVFDHLTQLDKLYLGGNQLKSLP 123 (251)
T ss_dssp SCCCCCCT-------------------------------------------------TTTTTCTTCCEEECCSSCCCCCC
T ss_pred CcccccCh-------------------------------------------------hHhcccCCCCEEEcCCCcCCCcC
Confidence 55553333 33445556666666666666555
Q ss_pred cccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceecccccCcccC
Q 047768 530 PVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEV 601 (1009)
Q Consensus 530 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~ 601 (1009)
+..|..+++|+.|+|++|+|++..+..|+.+++|++|+|++|+|++..|..|..+++|++|+|++|++++..
T Consensus 124 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 124 SGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred hhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence 555666666666666666666555556666666666666666666555556666666666777777666653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=208.44 Aligned_cols=185 Identities=19% Similarity=0.251 Sum_probs=144.9
Q ss_pred CCCCC-CCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccC
Q 047768 53 CVNLC-QHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFS 131 (1009)
Q Consensus 53 ~~~~c-~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~ 131 (1009)
|+..| |+|++|.|+.. +++. +|..+ .++|++|+|++|++++..+..|+++++|++|+|++|+++
T Consensus 1 Cp~~C~C~~~~v~c~~~------------~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 65 (208)
T 2o6s_A 1 CPSRCSCSGTTVECYSQ------------GRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ 65 (208)
T ss_dssp CCTTCEEETTEEECCSS------------CCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC
T ss_pred CcCCCEECCCEEEecCC------------CccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC
Confidence 44444 58999999754 2222 23322 468999999999999766777899999999999999999
Q ss_pred CCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcc
Q 047768 132 GRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPIT 211 (1009)
Q Consensus 132 ~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 211 (1009)
+..+..|.++++|++|++++|++++..+..+ ..+.+|++|+|++|++++..+..|.++++|++|+|++|++++..+..
T Consensus 66 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 143 (208)
T 2o6s_A 66 SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVF--DKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGV 143 (208)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTT--TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred ccChhhcCCCCCcCEEECCCCcCCccCHhHh--cCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHH
Confidence 7777778999999999999998885444333 56788888888888888777777888888888888888888777777
Q ss_pred cccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhc
Q 047768 212 LSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIG 261 (1009)
Q Consensus 212 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~ 261 (1009)
|..+++|++|+|++|.+.+ .+++|+.|+++.|+++|.+|..++
T Consensus 144 ~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~ 186 (208)
T 2o6s_A 144 FDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAG 186 (208)
T ss_dssp TTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTS
T ss_pred hccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCc
Confidence 8888888888888887764 345788888888888887776554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-23 Score=230.06 Aligned_cols=224 Identities=20% Similarity=0.198 Sum_probs=187.2
Q ss_pred eEEEEEeecCCcccccCc---cccCCCCCCeeeecCCcCCccCCccc--cCccccccccccccccCCCCC----CCCcCC
Q 047768 71 RVTKLDLRNQSIGGILSP---YVGNLSFLRYINIADNDFHGEIPDRI--GNLFRLETLVLANNSFSGRIP----TNLSHC 141 (1009)
Q Consensus 71 ~v~~l~l~~~~l~~~~~~---~~~~l~~L~~L~L~~n~~~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~l~~l 141 (1009)
++..+++.+..++...-. .+..+++|++|+|++|.+++.+|..+ +++++|++|+|++|.+++..| ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 577888888777542111 12345779999999999999999998 999999999999999998666 345689
Q ss_pred CcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCC--C--CcccCCccccceeecccCcccCCCCc----ccc
Q 047768 142 SKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQ--L--PASIGNLSALRVIDIRTNRLWGKIPI----TLS 213 (1009)
Q Consensus 142 ~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~ 213 (1009)
++|++|++++|.+.+..|..+ ..+++|++|+|++|++.+. + +..++++++|++|+|++|+++. ++. .+.
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~ 221 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQV--RAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAA 221 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSC--CCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHH
T ss_pred cCCCEEEeeCCCcchhhHHHh--ccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHh
Confidence 999999999999987766665 6789999999999998752 2 2345789999999999999963 333 357
Q ss_pred cccccccccccCccCCCCCCCcccCC---ChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccc
Q 047768 214 QLTSLAYLHVGDNHFSGTIPPSVYNI---SSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASN 290 (1009)
Q Consensus 214 ~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 290 (1009)
.+++|++|+|++|++++..|..+..+ ++|++|+|++|+++ .+|..++ ++|++|+|++|++++. |. +..+++
T Consensus 222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~---~~L~~L~Ls~N~l~~~-~~-~~~l~~ 295 (310)
T 4glp_A 222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP---AKLRVLDLSSNRLNRA-PQ-PDELPE 295 (310)
T ss_dssp HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC---SCCSCEECCSCCCCSC-CC-TTSCCC
T ss_pred cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc---CCCCEEECCCCcCCCC-ch-hhhCCC
Confidence 88999999999999998888888877 69999999999999 8998775 7999999999999975 33 788999
Q ss_pred ccccccccccccc
Q 047768 291 LEVLHLAENQFRG 303 (1009)
Q Consensus 291 L~~L~Ls~N~l~~ 303 (1009)
|++|+|++|+++.
T Consensus 296 L~~L~L~~N~l~~ 308 (310)
T 4glp_A 296 VDNLTLDGNPFLV 308 (310)
T ss_dssp CSCEECSSTTTSC
T ss_pred ccEEECcCCCCCC
Confidence 9999999999874
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-24 Score=244.28 Aligned_cols=233 Identities=17% Similarity=0.182 Sum_probs=122.7
Q ss_pred ceEEEcCCCccccCCC----ccccCcC-ccCEEEccCCCCCCCCCCCcCCc-----ccccceecccccccCCCCcccccc
Q 047768 370 LIDFNLGKNQIYGTIP----PGIANLV-NLNSLRMEANRLTGTIPHVIGEL-----KNLQLLHLHANFLQGTIPSSLGNL 439 (1009)
Q Consensus 370 L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l 439 (1009)
|++|+|++|.|++..+ ..|.+++ +|++|+|++|+|++..+..+..+ ++|++|+|++|++++..+..+...
T Consensus 24 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~ 103 (362)
T 3goz_A 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103 (362)
T ss_dssp CCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred ceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHH
Confidence 4444444444443333 3344444 44444444444444444433332 444444444444443333322222
Q ss_pred -----cccccccccCcccccccCCCC----CC-CCCccccccCCCCccCCCchhh----hhhccceeeEecCCCccCCCC
Q 047768 440 -----TLLTYLSFGANNLQGNIPFSL----GN-CKNLMFFFAPRNKLTGALPQQI----LEITTLSLSLDLSDNLLNGSL 505 (1009)
Q Consensus 440 -----~~L~~L~L~~N~l~~~~p~~~----~~-l~~L~~l~l~~N~l~~~~p~~~----~~~~~~~~~L~Ls~N~l~~~~ 505 (1009)
++|++|+|++|++++..+..+ .. .++|++|++++|.+++..+..+ .........|+|++|++++..
T Consensus 104 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~ 183 (362)
T 3goz_A 104 LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKN 183 (362)
T ss_dssp HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSC
T ss_pred HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhh
Confidence 444444444444443322221 11 1344445555554443222221 122213334666666666554
Q ss_pred CCCcc----CC-CCCCeeeccccccCCC----ccccccC-CCCccEEEecCcccccccc----cccccccccceEcCCCc
Q 047768 506 PLGVG----NL-KSLVRLGIARNQFSGQ----IPVTLGA-CTSLEYVELQGNSFSGTIP----QSLSSLTSIKELDLSQN 571 (1009)
Q Consensus 506 p~~~~----~l-~~L~~L~ls~N~l~~~----~p~~~~~-l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N 571 (1009)
+..+. .+ ++|++|||++|.+++. ++..+.. .++|+.|+|++|++++..+ ..+..+++|+.|+|++|
T Consensus 184 ~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n 263 (362)
T 3goz_A 184 CAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYD 263 (362)
T ss_dssp HHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHH
T ss_pred HHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccC
Confidence 44333 33 5788888888888752 4555555 3488888888888876544 34466788888888888
Q ss_pred cccc-------ccccccccccccCceecccccCcccCC
Q 047768 572 NFSG-------QIPKYLENLSFLQYLNLSYNHFEGEVP 602 (1009)
Q Consensus 572 ~l~~-------~~p~~~~~l~~L~~L~ls~N~l~g~~p 602 (1009)
.+.+ .++..+..+++|+.||+++|++.+..|
T Consensus 264 ~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 264 IVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred CccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 8443 234466777888888888888776533
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=7.9e-25 Score=244.45 Aligned_cols=215 Identities=17% Similarity=0.255 Sum_probs=116.2
Q ss_pred CCCCCccceeeCCCCCeEEEEEeecCCcccccCccccCC--CCCCeeeecCCcCCccCCccccCccccccccccccccCC
Q 047768 55 NLCQHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNL--SFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG 132 (1009)
Q Consensus 55 ~~c~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l--~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 132 (1009)
..|..|.++.|+.. .++.+|++++.+. +..+..+ +++++|++++|.+++..|. +.++++|++|+|++|.+++
T Consensus 34 ~vc~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~ 107 (336)
T 2ast_B 34 GVCKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV 107 (336)
T ss_dssp SSCHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH
T ss_pred HHHHHHHHHhcCch--hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH
Confidence 45778999988632 4566777776655 3344555 6677777777777655444 4456667777776666664
Q ss_pred C-CCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCc-cCCCC-CCcccCCccccceeecccC-cccCC-
Q 047768 133 R-IPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDN-QLTGQ-LPASIGNLSALRVIDIRTN-RLWGK- 207 (1009)
Q Consensus 133 ~-~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~- 207 (1009)
. +|..+.++++|++|++++|.+++..|..+ ..+++|++|+|++| .+++. ++..+.++++|++|++++| .+++.
T Consensus 108 ~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l--~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~ 185 (336)
T 2ast_B 108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTL--AKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKH 185 (336)
T ss_dssp HHHHHHHTTBCCCSEEECTTCBCCHHHHHHH--TTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHH
T ss_pred HHHHHHHhhCCCCCEEeCcCcccCHHHHHHH--hcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHH
Confidence 4 55555666666666666665554444443 23455555555555 34431 3334444555555555555 44332
Q ss_pred CCccccccc-ccccccccCccCCCCCCCcccCCChHHHHHhhCCccC-CCCChhhccCCCcccceeccccc-cCCCCCCC
Q 047768 208 IPITLSQLT-SLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFT-GSLPIEIGKNLPNLRNFVIYTNN-FTGSLPDS 284 (1009)
Q Consensus 208 ~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~ip~~~~~~l~~L~~L~L~~N~-l~~~~p~~ 284 (1009)
++..+..++ +|++|+|++|.+ .++ +.+|. .+..+++|++|++++|. +++..+..
T Consensus 186 ~~~~~~~l~~~L~~L~l~~~~~----------------------~~~~~~l~~-~~~~~~~L~~L~l~~~~~l~~~~~~~ 242 (336)
T 2ast_B 186 VQVAVAHVSETITQLNLSGYRK----------------------NLQKSDLST-LVRRCPNLVHLDLSDSVMLKNDCFQE 242 (336)
T ss_dssp HHHHHHHSCTTCCEEECCSCGG----------------------GSCHHHHHH-HHHHCTTCSEEECTTCTTCCGGGGGG
T ss_pred HHHHHHhcccCCCEEEeCCCcc----------------------cCCHHHHHH-HHhhCCCCCEEeCCCCCcCCHHHHHH
Confidence 334444444 455555444421 111 11222 12235556666666665 44444555
Q ss_pred cCcccccccccccccc
Q 047768 285 FSNASNLEVLHLAENQ 300 (1009)
Q Consensus 285 ~~~l~~L~~L~Ls~N~ 300 (1009)
+..+++|++|++++|.
T Consensus 243 l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 243 FFQLNYLQHLSLSRCY 258 (336)
T ss_dssp GGGCTTCCEEECTTCT
T ss_pred HhCCCCCCEeeCCCCC
Confidence 5566666666666663
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.8e-23 Score=229.58 Aligned_cols=241 Identities=16% Similarity=0.139 Sum_probs=187.3
Q ss_pred CeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeec
Q 047768 97 RYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVG 176 (1009)
Q Consensus 97 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~ 176 (1009)
++++.++++++ .||..+ .+++++|+|++|+|+...+..|+++++|++|+|++|++.
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~--------------------- 67 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL--------------------- 67 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTC---------------------
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCC---------------------
Confidence 56788888998 788776 357888999999988544456777777766666665543
Q ss_pred CccCCCCCC-cccCCccccce-eecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhC-CccC
Q 047768 177 DNQLTGQLP-ASIGNLSALRV-IDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYG-NRFT 253 (1009)
Q Consensus 177 ~n~l~~~~p-~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~ 253 (1009)
+.+| ..|.++++|+. +.++.|++....|..|..+++|++|++++|++++..+..+....++..|++.+ |++.
T Consensus 68 -----~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~ 142 (350)
T 4ay9_X 68 -----EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH 142 (350)
T ss_dssp -----CEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC
T ss_pred -----CccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc
Confidence 3333 45788888765 67778999999999999999999999999999977777777888888899876 5666
Q ss_pred CCCChhhccCCC-cccceeccccccCCCCCCCcCccccccccccc-ccccccccccccccccccccccccccccCCCCCC
Q 047768 254 GSLPIEIGKNLP-NLRNFVIYTNNFTGSLPDSFSNASNLEVLHLA-ENQFRGQVSINFNGLKDLSMLGLATNFLGNGAAN 331 (1009)
Q Consensus 254 ~~ip~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~ 331 (1009)
.+|...|..+. .++.|+|++|+|+.+.+..|. ..+|++|+++ +|.++.+++..|.++++|+.|+|++|.|+.++..
T Consensus 143 -~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~ 220 (350)
T 4ay9_X 143 -TIERNSFVGLSFESVILWLNKNGIQEIHNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY 220 (350)
T ss_dssp -EECTTSSTTSBSSCEEEECCSSCCCEECTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSS
T ss_pred -cccccchhhcchhhhhhccccccccCCChhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChh
Confidence 88888877775 689999999999976666664 5689999997 5889988889999999999999999999988762
Q ss_pred CcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCc
Q 047768 332 DLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQ 379 (1009)
Q Consensus 332 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~ 379 (1009)
.| .+|+.|.+.++.--..+|. +..+ .+|+.++++++.
T Consensus 221 ------~~---~~L~~L~~l~~~~l~~lP~-l~~l-~~L~~l~l~~~~ 257 (350)
T 4ay9_X 221 ------GL---ENLKKLRARSTYNLKKLPT-LEKL-VALMEASLTYPS 257 (350)
T ss_dssp ------SC---TTCCEEECTTCTTCCCCCC-TTTC-CSCCEEECSCHH
T ss_pred ------hh---ccchHhhhccCCCcCcCCC-chhC-cChhhCcCCCCc
Confidence 23 4455555544433335663 5555 678999998754
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-23 Score=245.35 Aligned_cols=208 Identities=24% Similarity=0.329 Sum_probs=148.5
Q ss_pred CCCCccCCCCCCCC----Cccce-eeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccc
Q 047768 45 TSSWNRSACVNLCQ----HWTGV-TCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFR 119 (1009)
Q Consensus 45 ~~sW~~~~~~~~c~----~w~gv-~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~ 119 (1009)
+.+|... ..+|. .|.|+ .|.. .+++.|+|++|++++ +|+.+. ++|++|+|++|+|+ .+| +.+++
T Consensus 33 l~~W~~~--~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~ 101 (571)
T 3cvr_A 33 WDKWEKQ--ALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPAS 101 (571)
T ss_dssp HHHHHTT--CCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTT
T ss_pred HHHHhcc--CCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCC
Confidence 4567543 23442 59999 7863 378999999999988 666663 88999999999999 788 55789
Q ss_pred cccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeec
Q 047768 120 LETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDI 199 (1009)
Q Consensus 120 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 199 (1009)
|++|+|++|+|++ +|. +.+ +|++|++++|++++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|
T Consensus 102 L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~-----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 167 (571)
T 3cvr_A 102 LEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE-----LPALLEYINADNNQLTM-LPE---LPTSLEVLSV 167 (571)
T ss_dssp CCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC-----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC-----cCccccEEeCCCCccCc-CCC---cCCCcCEEEC
Confidence 9999999999997 777 665 89999999999886 665 36788888888888885 555 5678888888
Q ss_pred ccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChH-------HHHHhhCCccCCCCChhhccCCCcccceec
Q 047768 200 RTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSL-------VEIYLYGNRFTGSLPIEIGKNLPNLRNFVI 272 (1009)
Q Consensus 200 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-------~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L 272 (1009)
++|+|++ +|. |. ++|++|+|++|+|+ .+|. |.. +| +.|+|++|+|+ .+|..++. +++|+.|+|
T Consensus 168 s~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~-l~~L~~L~L 237 (571)
T 3cvr_A 168 RNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILS-LDPTCTIIL 237 (571)
T ss_dssp CSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGG-SCTTEEEEC
T ss_pred CCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhc-CCCCCEEEe
Confidence 8888876 555 65 78888888888888 6666 543 44 55555555555 45554443 555555555
Q ss_pred cccccCCCCCCCcCc
Q 047768 273 YTNNFTGSLPDSFSN 287 (1009)
Q Consensus 273 ~~N~l~~~~p~~~~~ 287 (1009)
++|.+++.+|..|..
T Consensus 238 ~~N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 238 EDNPLSSRIRESLSQ 252 (571)
T ss_dssp CSSSCCHHHHHHHHH
T ss_pred eCCcCCCcCHHHHHH
Confidence 555554444444433
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=5.4e-22 Score=217.79 Aligned_cols=62 Identities=26% Similarity=0.379 Sum_probs=32.3
Q ss_pred ccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccc
Q 047768 509 VGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFS 574 (1009)
Q Consensus 509 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 574 (1009)
+..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..| +..+++|+.|+|++|.++
T Consensus 169 l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence 4445555555555555553322 4555555555555555553332 455555555555555554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=5.1e-25 Score=250.85 Aligned_cols=96 Identities=18% Similarity=0.194 Sum_probs=52.0
Q ss_pred cCCccccCccccccccccccccCCC----CCCCCcCCCcCcEEecccc---cccCCCchHHh-----hhccCCcCeEeec
Q 047768 109 EIPDRIGNLFRLETLVLANNSFSGR----IPTNLSHCSKLITFSAHRN---NLVGEIPEELI-----SRRLFNLQGLSVG 176 (1009)
Q Consensus 109 ~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~l~~n---~l~~~~p~~~~-----~~~l~~L~~L~L~ 176 (1009)
.++..+..+++|++|+|++|.+++. ++..+.++++|++|+|++| ++.+.+|..+. ...+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 4666677777777777777777654 3344667777777777774 34445555441 0223444444444
Q ss_pred CccCCC----CCCcccCCccccceeecccCcc
Q 047768 177 DNQLTG----QLPASIGNLSALRVIDIRTNRL 204 (1009)
Q Consensus 177 ~n~l~~----~~p~~~~~l~~L~~L~L~~N~l 204 (1009)
+|.+++ .+|..+.++++|++|+|++|.+
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l 134 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 134 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCC
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCC
Confidence 444443 2333344444444444444444
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-21 Score=215.44 Aligned_cols=191 Identities=24% Similarity=0.350 Sum_probs=141.8
Q ss_pred cceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCccccccccccccccc
Q 047768 369 ALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFG 448 (1009)
Q Consensus 369 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 448 (1009)
.|+.|++++|.++. +| .+..+++|+.|+|++|++++..+ +..+++|++|+|++|++++. + .+..+++|++|+++
T Consensus 42 ~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLT 115 (308)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECT
T ss_pred CcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECC
Confidence 34455555555542 33 46667777777777777775444 77777777777777777743 3 57777777777777
Q ss_pred CcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCC
Q 047768 449 ANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQ 528 (1009)
Q Consensus 449 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 528 (1009)
+|++++. |. +..+++|+.|++++| ++++..+ ++.+++|++|++++|++++.
T Consensus 116 ~n~l~~~-~~-l~~l~~L~~L~l~~n-------------------------~l~~~~~--l~~l~~L~~L~l~~n~l~~~ 166 (308)
T 1h6u_A 116 STQITDV-TP-LAGLSNLQVLYLDLN-------------------------QITNISP--LAGLTNLQYLSIGNAQVSDL 166 (308)
T ss_dssp TSCCCCC-GG-GTTCTTCCEEECCSS-------------------------CCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred CCCCCCc-hh-hcCCCCCCEEECCCC-------------------------ccCcCcc--ccCCCCccEEEccCCcCCCC
Confidence 7777753 32 666666665444444 4443222 77889999999999999964
Q ss_pred ccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceecccccCccc
Q 047768 529 IPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGE 600 (1009)
Q Consensus 529 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ 600 (1009)
.+ +..+++|+.|+|++|++++..+ +..+++|++|+|++|++++..| +..+++|++|++++|++++.
T Consensus 167 ~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 167 TP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp GG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred hh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence 44 9999999999999999996554 8999999999999999996553 89999999999999999863
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.6e-22 Score=214.57 Aligned_cols=164 Identities=18% Similarity=0.138 Sum_probs=126.2
Q ss_pred HHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc------------------chHHHHHHHHHHHhc
Q 047768 694 KELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG------------------GSKSFAAECEALRSI 755 (1009)
Q Consensus 694 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l 755 (1009)
..+......|.+.+.||+|+||.||+|.+ .+|+.||||+++..... ....+.+|+++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34445556677889999999999999999 78999999999643211 234688999999999
Q ss_pred CCCCcceEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 047768 756 RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVH 835 (1009)
Q Consensus 756 ~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH 835 (1009)
+| +++.+++.. ...++||||+++|+|.+ +.. .+...++.|++.|+.|||+. +|+|
T Consensus 162 ~~---~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH~~---giiH 216 (282)
T 1zar_A 162 QG---LAVPKVYAW------EGNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFYHR---GIVH 216 (282)
T ss_dssp TT---SSSCCEEEE------ETTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cC---CCcCeEEec------cceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHHHC---CCEe
Confidence 94 455554322 44589999999999988 422 12346999999999999999 9999
Q ss_pred cCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCC----------CCCCCcccchH
Q 047768 836 GDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG----------GEASMRGGVYS 905 (1009)
Q Consensus 836 rdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~DvwS 905 (1009)
|||||+||+++ ++.+||+|||+|+. +..|+|||++.. ..++.++|+|.
T Consensus 217 rDlkp~NILl~-~~~vkl~DFG~a~~---------------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 217 GDLSQYNVLVS-EEGIWIIDFPQSVE---------------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp SCCSTTSEEEE-TTEEEECCCTTCEE---------------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCCCHHHEEEE-CCcEEEEECCCCeE---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999999999 99999999999973 335788998654 34455556653
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.85 E-value=8.3e-23 Score=228.04 Aligned_cols=253 Identities=16% Similarity=0.174 Sum_probs=182.1
Q ss_pred ccceEEccCCCCCCcCchhhhhh-cccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCC-CCCCcCCcccccce
Q 047768 344 KLQYLYLADNGFGGVLPHSIANL-STALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGT-IPHVIGELKNLQLL 421 (1009)
Q Consensus 344 ~L~~L~L~~N~l~~~~p~~~~~l-~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L 421 (1009)
.++.+++++|.+. +..+..+ ...++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 3667777777665 3344433 24577777777777766554 45677888888888877655 66677777888888
Q ss_pred ecccccccCCCCcccccccccccccccCc-ccccc-cCCCCCCCCCccccccCCC-CccCC-CchhhhhhccceeeEecC
Q 047768 422 HLHANFLQGTIPSSLGNLTLLTYLSFGAN-NLQGN-IPFSLGNCKNLMFFFAPRN-KLTGA-LPQQILEITTLSLSLDLS 497 (1009)
Q Consensus 422 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~l~l~~N-~l~~~-~p~~~~~~~~~~~~L~Ls 497 (1009)
+|++|.+++..|..++.+++|++|++++| .+++. +|..+.++++|++|++++| .+++. ++..+.........|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 88888777777777777788888888887 56652 5555677777888888877 77653 444444444134458888
Q ss_pred CC--ccC-CCCCCCccCCCCCCeeeccccc-cCCCccccccCCCCccEEEecCcc-cccccccccccccccceEcCCCcc
Q 047768 498 DN--LLN-GSLPLGVGNLKSLVRLGIARNQ-FSGQIPVTLGACTSLEYVELQGNS-FSGTIPQSLSSLTSIKELDLSQNN 572 (1009)
Q Consensus 498 ~N--~l~-~~~p~~~~~l~~L~~L~ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~ 572 (1009)
+| .++ +.+|..+.++++|++|++++|. +++..+..+..+++|+.|+|++|. +.......++++++|+.|+|++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~- 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI- 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence 88 454 4566677889999999999999 777888899999999999999995 33332336888999999999998
Q ss_pred ccccccccccccc-ccCceecccccCcccCCCC
Q 047768 573 FSGQIPKYLENLS-FLQYLNLSYNHFEGEVPTK 604 (1009)
Q Consensus 573 l~~~~p~~~~~l~-~L~~L~ls~N~l~g~~p~~ 604 (1009)
++ ...+..+. .|+.|++++|++++..|..
T Consensus 283 i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 283 VP---DGTLQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp SC---TTCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred cC---HHHHHHHHhhCcceEEecccCccccCCc
Confidence 43 23455553 4888889999999988864
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=3e-21 Score=227.04 Aligned_cols=189 Identities=23% Similarity=0.355 Sum_probs=124.2
Q ss_pred ccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceec
Q 047768 344 KLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHL 423 (1009)
Q Consensus 344 ~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 423 (1009)
+|+.|+|++|++++ +|..+. ..|+.|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +.+ +|++|+|
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~---~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP---PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC---TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCc-cCHhHc---CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence 67777777777775 454442 45677777777776 445 345677777777777775 454 544 6777777
Q ss_pred ccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCC
Q 047768 424 HANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNG 503 (1009)
Q Consensus 424 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~ 503 (1009)
++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|+. |+|++|+|++
T Consensus 128 s~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~-------------------------L~Ls~N~L~~ 174 (571)
T 3cvr_A 128 DNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEV-------------------------LSVRNNQLTF 174 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCE-------------------------EECCSSCCSC
T ss_pred CCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCE-------------------------EECCCCCCCC
Confidence 7777765 444 45667777777777664 443 2334433 5555555554
Q ss_pred CCCCCccCCCCCCeeeccccccCCCccccccCCCCc-------cEEEecCcccccccccccccccccceEcCCCcccccc
Q 047768 504 SLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSL-------EYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQ 576 (1009)
Q Consensus 504 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 576 (1009)
+|. |. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|.|++.
T Consensus 175 -lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~ 245 (571)
T 3cvr_A 175 -LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSR 245 (571)
T ss_dssp -CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHH
T ss_pred -cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCc
Confidence 555 54 67888888888887 5666 554 66 88888888887 5777777788888888888888888
Q ss_pred cccccccccc
Q 047768 577 IPKYLENLSF 586 (1009)
Q Consensus 577 ~p~~~~~l~~ 586 (1009)
+|..+..+..
T Consensus 246 ~p~~l~~l~~ 255 (571)
T 3cvr_A 246 IRESLSQQTA 255 (571)
T ss_dssp HHHHHHHHHH
T ss_pred CHHHHHHhhc
Confidence 8877776654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=1e-20 Score=195.08 Aligned_cols=74 Identities=30% Similarity=0.291 Sum_probs=41.4
Q ss_pred CccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCC
Q 047768 392 VNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKN 465 (1009)
Q Consensus 392 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 465 (1009)
++|++|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|++++|++++..+..+.++++
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 101 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQ 101 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccC
Confidence 35666666666666555555666666666666666666544444555566666555555555333333333333
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.8e-23 Score=245.99 Aligned_cols=222 Identities=17% Similarity=0.155 Sum_probs=166.3
Q ss_pred CccceeeCCCCCeEEEEEeecCCccc-------------------------ccCc---cccCCCCCCeeeecCCcCCccC
Q 047768 59 HWTGVTCGRRNQRVTKLDLRNQSIGG-------------------------ILSP---YVGNLSFLRYINIADNDFHGEI 110 (1009)
Q Consensus 59 ~w~gv~C~~~~~~v~~l~l~~~~l~~-------------------------~~~~---~~~~l~~L~~L~L~~n~~~~~~ 110 (1009)
.|.++.|+....+|..+++..-.+.. .... .+...++|+.|+|++|+++ .+
T Consensus 286 ~W~~~~~~~~~~~vw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~L~~L~Ls~n~L~-~L 364 (567)
T 1dce_A 286 EWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VL 364 (567)
T ss_dssp CCBCTTSSCCSEEEEEEECCGGGTSTTSSEEEEEEEETTTTEEEEEEEETTCSEEEEECCSTTTTSSSCCCCHHHHH-HH
T ss_pred eeccCCcccccceeEEeecCccccccccccceEEEeeccCCCCccccccCCCchhhhcccccCccceeccCChhhHH-hh
Confidence 58888888777788888876543321 1111 1367889999999999998 89
Q ss_pred CccccCccccccccccccc-------------cCCCCCCCCcCCCcCcEEe-cccccccCCCchHHhhhccCCcCeEeec
Q 047768 111 PDRIGNLFRLETLVLANNS-------------FSGRIPTNLSHCSKLITFS-AHRNNLVGEIPEELISRRLFNLQGLSVG 176 (1009)
Q Consensus 111 p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~l~~l~~L~~L~-l~~n~l~~~~p~~~~~~~l~~L~~L~L~ 176 (1009)
|+.+++|++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+ .+|+.+.++
T Consensus 365 p~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-------------~~L~~l~l~ 431 (567)
T 1dce_A 365 QSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-------------DDLRSKFLL 431 (567)
T ss_dssp HHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH-------------HHHHHHHHH
T ss_pred HHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc-------------chhhhhhhh
Confidence 9999999999999998876 5677788888888888888 666543 245556666
Q ss_pred CccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCC
Q 047768 177 DNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSL 256 (1009)
Q Consensus 177 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i 256 (1009)
+|.++...+ ..|+.|+|++|+|++ +|. |+.+++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|+ .+
T Consensus 432 ~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~l 501 (567)
T 1dce_A 432 ENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NV 501 (567)
T ss_dssp HHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CC
T ss_pred cccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCC-CC
Confidence 676663222 247778888888865 455 778888888888888887 67777878888888888888887 46
Q ss_pred ChhhccCCCcccceeccccccCCCC-CCCcCcccccccccccccccccccc
Q 047768 257 PIEIGKNLPNLRNFVIYTNNFTGSL-PDSFSNASNLEVLHLAENQFRGQVS 306 (1009)
Q Consensus 257 p~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~ 306 (1009)
| .+.++++|+.|+|++|+|++.. |..|+++++|++|+|++|++++.++
T Consensus 502 p--~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 502 D--GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp G--GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred c--ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 6 3456888888888888888776 8888888888888888888887655
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-21 Score=237.09 Aligned_cols=234 Identities=21% Similarity=0.192 Sum_probs=134.0
Q ss_pred CChhhHHHHHHHHHhcCC-CCCCCCCCccCCCCCCCCCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCe---
Q 047768 23 SNETDCLSLLAIKSQLHD-PLGVTSSWNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRY--- 98 (1009)
Q Consensus 23 ~~~~d~~aLl~~k~~~~~-~~~~~~sW~~~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~--- 98 (1009)
....++++|+++..++.. ....-..|.... ..+..|.+++++. ++++.|+|.++++... +..+.....|+.
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~-~~~~l~~l~Ls~~~i 203 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDS--TPSGTATNSAVST--PLTPKIELFANGKDEA-NQALLQHKKLSQYSI 203 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCC--CccccCCCceecC--CccceEEeeCCCCCcc-hhhHhhcCccCcccc
Confidence 456889999999987522 222334675443 2234799998875 5899999999988774 333322222222
Q ss_pred --eeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeec
Q 047768 99 --INIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVG 176 (1009)
Q Consensus 99 --L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~ 176 (1009)
++++.|.+. ..|+.|..++.|+.|+|++|.+. .+|..+.++++|++|+|++|.++ .+|..+ ..+.+|++|+|+
T Consensus 204 ~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~--~~l~~L~~L~Ls 278 (727)
T 4b8c_D 204 DEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEI--KNLSNLRVLDLS 278 (727)
T ss_dssp -------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGG--GGGTTCCEEECT
T ss_pred cCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhh--hCCCCCCEEeCc
Confidence 233334444 56788999999999999999998 78888889999999999999998 888776 678999999999
Q ss_pred CccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCCh-HHHHHhhCCccCCC
Q 047768 177 DNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISS-LVEIYLYGNRFTGS 255 (1009)
Q Consensus 177 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~ 255 (1009)
+|.|+ .+|..|++|++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|++.+|..+..+.. +..|+|++|.++|.
T Consensus 279 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~ 356 (727)
T 4b8c_D 279 HNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIP 356 (727)
T ss_dssp TSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_pred CCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCc
Confidence 99999 77999999999999999999995 77888999999999999999999888888766543 34588999999887
Q ss_pred CChhhccCCCcccceecccc
Q 047768 256 LPIEIGKNLPNLRNFVIYTN 275 (1009)
Q Consensus 256 ip~~~~~~l~~L~~L~L~~N 275 (1009)
+|. .|+.|+++.|
T Consensus 357 ~p~-------~l~~l~l~~n 369 (727)
T 4b8c_D 357 LPH-------ERRFIEINTD 369 (727)
T ss_dssp CCC-------C---------
T ss_pred Ccc-------ccceeEeecc
Confidence 774 3556667666
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.2e-20 Score=194.04 Aligned_cols=182 Identities=16% Similarity=0.113 Sum_probs=144.3
Q ss_pred ccceecccccccCCCCcccccccccccccccCcccccccC-CCCCCCCCccccccCCCCccCCCchhhhhhccceeeEec
Q 047768 418 LQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIP-FSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDL 496 (1009)
Q Consensus 418 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~L 496 (1009)
-+.+++++|.++ .+|..+. ..+++|+|++|+|++..| ..|..+++|+. |+|
T Consensus 13 ~~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~-------------------------L~L 64 (220)
T 2v70_A 13 GTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRK-------------------------INF 64 (220)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCE-------------------------EEC
T ss_pred CCEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCE-------------------------EEC
Confidence 357899999998 4666553 356789999999987655 34677777665 556
Q ss_pred CCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccc
Q 047768 497 SDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQ 576 (1009)
Q Consensus 497 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 576 (1009)
++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++.
T Consensus 65 ~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 144 (220)
T 2v70_A 65 SNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTV 144 (220)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCB
T ss_pred CCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEE
Confidence 66666656667899999999999999999988888899999999999999999999999999999999999999999998
Q ss_pred cccccccccccCceecccccCcccCCCCCcccCccccccccCCCcCCCCCC
Q 047768 577 IPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDE 627 (1009)
Q Consensus 577 ~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~~~ 627 (1009)
.|..|..+++|++|+|++|+++|.++..+....+....+......|+.|..
T Consensus 145 ~~~~~~~l~~L~~L~L~~N~l~c~c~l~~l~~~~~~~~~~~~~~~C~~P~~ 195 (220)
T 2v70_A 145 APGAFDTLHSLSTLNLLANPFNCNCYLAWLGEWLRKKRIVTGNPRCQKPYF 195 (220)
T ss_dssp CTTTTTTCTTCCEEECCSCCEECSGGGHHHHHHHHHSCCBCCCCEEEESGG
T ss_pred CHHHhcCCCCCCEEEecCcCCcCCCchHHHHHHHHhcCccccCCccCCChH
Confidence 899999999999999999999998885432222221222223346766654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=3.5e-20 Score=192.52 Aligned_cols=156 Identities=19% Similarity=0.231 Sum_probs=96.6
Q ss_pred CEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCC
Q 047768 395 NSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRN 474 (1009)
Q Consensus 395 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N 474 (1009)
+.+++++|.++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+|++.
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~------------------- 71 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISEL------------------- 71 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEE-------------------
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCc-------------------
Confidence 45666666666 3444332 4556666666666554444555555555555555555443
Q ss_pred CccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccc
Q 047768 475 KLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIP 554 (1009)
Q Consensus 475 ~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 554 (1009)
.|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|
T Consensus 72 ------------------------------~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~ 121 (220)
T 2v9t_B 72 ------------------------------APDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRV 121 (220)
T ss_dssp ------------------------------CTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred ------------------------------CHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCH
Confidence 34455555666666666666664444456666777777777777776666
Q ss_pred cccccccccceEcCCCcccccccccccccccccCceecccccCcccCC
Q 047768 555 QSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVP 602 (1009)
Q Consensus 555 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p 602 (1009)
..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++.+.++
T Consensus 122 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 122 DAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred HHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 667777777777777777776666667777777777777777766554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=188.10 Aligned_cols=161 Identities=21% Similarity=0.317 Sum_probs=130.7
Q ss_pred CCCCCC-CCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCcccccccccccccc
Q 047768 52 ACVNLC-QHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSF 130 (1009)
Q Consensus 52 ~~~~~c-~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l 130 (1009)
.|+..| |.|..|.|.. ++++. +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|++
T Consensus 4 ~CP~~C~C~~~~v~c~~------------~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i 68 (220)
T 2v9t_B 4 HCPAACTCSNNIVDCRG------------KGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI 68 (220)
T ss_dssp CSCTTSEEETTEEECTT------------SCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCC
T ss_pred CCCCCCEECCCEEEcCC------------CCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcC
Confidence 466666 5677777754 34433 344443 6899999999999977777899999999999999999
Q ss_pred CCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCc
Q 047768 131 SGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPI 210 (1009)
Q Consensus 131 ~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 210 (1009)
++..|..|.++++|++|+|++|+++ .+|...+ ..+.+|++|+|++|+|++..|..|.++++|++|+|++|+|++..+.
T Consensus 69 ~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 146 (220)
T 2v9t_B 69 SELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLF-EGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKG 146 (220)
T ss_dssp CEECTTTTTTCSSCCEEECCSSCCC-CCCTTTT-TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred CCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHc-cCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHH
Confidence 9888999999999999999999988 4555443 5678888888888888888788888888888888888888888778
Q ss_pred ccccccccccccccCccCC
Q 047768 211 TLSQLTSLAYLHVGDNHFS 229 (1009)
Q Consensus 211 ~~~~l~~L~~L~L~~N~l~ 229 (1009)
.|..+++|++|+|++|.+.
T Consensus 147 ~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 147 TFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp TTTTCTTCCEEECCSSCEE
T ss_pred HHhCCCCCCEEEeCCCCcC
Confidence 8888888888888888876
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-19 Score=188.03 Aligned_cols=153 Identities=19% Similarity=0.222 Sum_probs=122.6
Q ss_pred EEEeecCCcccccCccccCCCCCCeeeecCCcCCccCC-ccccCccccccccccccccCCCCCCCCcCCCcCcEEecccc
Q 047768 74 KLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIP-DRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRN 152 (1009)
Q Consensus 74 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n 152 (1009)
.++++++.++. +|..+. ..+++|+|++|+|++..| ..|.++++|++|+|++|+|++..|..|+++++|++|++++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 35555666755 455553 456899999999997755 45899999999999999999888889999999999999999
Q ss_pred cccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCC
Q 047768 153 NLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGT 231 (1009)
Q Consensus 153 ~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 231 (1009)
++++..|..+ ..+.+|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+...
T Consensus 92 ~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 92 RLENVQHKMF--KGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CCCCCCGGGG--TTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred ccCccCHhHh--cCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 8886655544 5678888888888888877788888888888888888888877788888888888888888887643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-19 Score=204.14 Aligned_cols=179 Identities=21% Similarity=0.185 Sum_probs=100.1
Q ss_pred EEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcC-CcccccceecccccccCCCCcccccccccccccccCc
Q 047768 372 DFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIG-ELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGAN 450 (1009)
Q Consensus 372 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 450 (1009)
.+++++|.++ .+|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 4566666665 3444333 2355556666655555555554 5555555555555555444445555555555555555
Q ss_pred ccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCcc
Q 047768 451 NLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIP 530 (1009)
Q Consensus 451 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 530 (1009)
+|++..+ ..|.++++|++|+|++|+|++..|
T Consensus 99 ~l~~~~~-------------------------------------------------~~~~~l~~L~~L~L~~N~i~~~~~ 129 (361)
T 2xot_A 99 HLHTLDE-------------------------------------------------FLFSDLQALEVLLLYNNHIVVVDR 129 (361)
T ss_dssp CCCEECT-------------------------------------------------TTTTTCTTCCEEECCSSCCCEECT
T ss_pred cCCcCCH-------------------------------------------------HHhCCCcCCCEEECCCCcccEECH
Confidence 5543333 334555566666666666665555
Q ss_pred ccccCCCCccEEEecCccccccccccc---ccccccceEcCCCcccccccccccccccc--cCceecccccCcccCC
Q 047768 531 VTLGACTSLEYVELQGNSFSGTIPQSL---SSLTSIKELDLSQNNFSGQIPKYLENLSF--LQYLNLSYNHFEGEVP 602 (1009)
Q Consensus 531 ~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~ls~N~l~g~~p 602 (1009)
..|..+++|+.|+|++|+|++..+..| ..+++|+.|||++|+|++..+..+..++. |+.|+|++|++.+.+.
T Consensus 130 ~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 130 NAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp TTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred HHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 666666666666666666664333334 45666666666666666544455666655 3667777777665543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.8e-19 Score=185.97 Aligned_cols=156 Identities=21% Similarity=0.248 Sum_probs=119.9
Q ss_pred CCCCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCC
Q 047768 56 LCQHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIP 135 (1009)
Q Consensus 56 ~c~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 135 (1009)
.| +|++|.|+.. ++ +.+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|+|++..+
T Consensus 18 ~C-s~~~v~c~~~------------~l-~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~ 81 (229)
T 3e6j_A 18 SC-SGTTVDCRSK------------RH-ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPV 81 (229)
T ss_dssp EE-ETTEEECTTS------------CC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred EE-eCCEeEccCC------------Cc-CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcCh
Confidence 35 8999999753 22 23444343 889999999999998889999999999999999999986666
Q ss_pred CCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccc
Q 047768 136 TNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQL 215 (1009)
Q Consensus 136 ~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 215 (1009)
..|.++++|++|+|++|++++..+..+ ..+.+|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+
T Consensus 82 ~~~~~l~~L~~L~Ls~N~l~~l~~~~~--~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 158 (229)
T 3e6j_A 82 GVFDSLTQLTVLDLGTNQLTVLPSAVF--DRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRL 158 (229)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTT--TTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTC
T ss_pred hhcccCCCcCEEECCCCcCCccChhHh--CcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCC
Confidence 778889999988888888874444333 45777777777777777 667777777777777777777776666677777
Q ss_pred cccccccccCccCCC
Q 047768 216 TSLAYLHVGDNHFSG 230 (1009)
Q Consensus 216 ~~L~~L~L~~N~l~~ 230 (1009)
++|++|+|++|.+..
T Consensus 159 ~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 159 SSLTHAYLFGNPWDC 173 (229)
T ss_dssp TTCCEEECTTSCBCT
T ss_pred CCCCEEEeeCCCccC
Confidence 777777777777763
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.9e-19 Score=193.18 Aligned_cols=171 Identities=26% Similarity=0.358 Sum_probs=99.6
Q ss_pred CcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCcccc
Q 047768 390 NLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFF 469 (1009)
Q Consensus 390 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l 469 (1009)
.+++|+.|++++|.+++. + .+..+++|++|+|++|++++..+ +.++++|++|++++|++++ +| .+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence 344445555555554422 2 24445555555555555543322 4455555555555555543 22 24444444443
Q ss_pred ccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccc
Q 047768 470 FAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSF 549 (1009)
Q Consensus 470 ~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 549 (1009)
++++|+++ + + ..+..+++|+.|++++|++++. ..++.+++|+.|+|++|++
T Consensus 118 ~L~~n~i~-------------------------~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l 168 (291)
T 1h6t_A 118 SLEHNGIS-------------------------D-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI 168 (291)
T ss_dssp ECTTSCCC-------------------------C-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred ECCCCcCC-------------------------C-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcc
Confidence 33333332 2 1 2355667777777777777754 5677777777888887777
Q ss_pred ccccccccccccccceEcCCCcccccccccccccccccCceecccccCcc
Q 047768 550 SGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEG 599 (1009)
Q Consensus 550 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g 599 (1009)
++..| ++.+++|+.|+|++|+|++ +| .+..+++|+.|++++|+++.
T Consensus 169 ~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 169 SDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred ccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence 75544 7777788888888887774 44 37777888888888887765
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.6e-21 Score=229.12 Aligned_cols=192 Identities=20% Similarity=0.199 Sum_probs=157.1
Q ss_pred cCcCccCEEEccCCCCCCCCCCCcCCcccccceeccccc-------------ccCCCCccccccccccccc-ccCccccc
Q 047768 389 ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANF-------------LQGTIPSSLGNLTLLTYLS-FGANNLQG 454 (1009)
Q Consensus 389 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~ 454 (1009)
..+++|+.|+|++|+|+ .+|..++.+++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 45677777888888876 667777788888888876665 4566777778888888887 6666553
Q ss_pred ccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCcccccc
Q 047768 455 NIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLG 534 (1009)
Q Consensus 455 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 534 (1009)
+|..+++.+|.+++ +|.. ....|+|++|.|++ +|. |+++++|+.|+|++|+|+ .+|..++
T Consensus 424 ----------~L~~l~l~~n~i~~-l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~ 483 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLK-MEYA------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA 483 (567)
T ss_dssp ----------HHHHHHHHHHHHHH-HHHT------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred ----------hhhhhhhhcccccc-cCcc------CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh
Confidence 45566666676653 2211 12359999999996 676 999999999999999999 8899999
Q ss_pred CCCCccEEEecCcccccccccccccccccceEcCCCccccccc-ccccccccccCceecccccCcccCCCC
Q 047768 535 ACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQI-PKYLENLSFLQYLNLSYNHFEGEVPTK 604 (1009)
Q Consensus 535 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~g~~p~~ 604 (1009)
.+++|+.|+|++|+|++ +| .|+++++|+.|+|++|+|++.+ |..+..+++|++|+|++|++++.+|..
T Consensus 484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 99999999999999996 67 8999999999999999999887 999999999999999999999988754
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-19 Score=197.30 Aligned_cols=176 Identities=22% Similarity=0.295 Sum_probs=89.9
Q ss_pred cCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCc
Q 047768 91 GNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNL 170 (1009)
Q Consensus 91 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L 170 (1009)
..+++|++|++++|.++ .+| .+..+++|++|+|++|++++..| ++++++|++|++++|.+++ +|. + ..+.+|
T Consensus 43 ~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l--~~l~~L 114 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSS-L--KDLKKL 114 (291)
T ss_dssp HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGG-G--TTCTTC
T ss_pred hhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Chh-h--ccCCCC
Confidence 34555666666666665 333 25566666666666666654333 5555555555555555543 221 1 334444
Q ss_pred CeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCC
Q 047768 171 QGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGN 250 (1009)
Q Consensus 171 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 250 (1009)
++|+|++|++++. ..+..+++|++|++++|++++. ..+..+++|++|+|++|++++
T Consensus 115 ~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~-------------------- 170 (291)
T 1h6t_A 115 KSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-------------------- 170 (291)
T ss_dssp CEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC--------------------
T ss_pred CEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcccc--------------------
Confidence 5555555544432 2344445555555555554432 334444444444444444442
Q ss_pred ccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccccccc
Q 047768 251 RFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSI 307 (1009)
Q Consensus 251 ~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 307 (1009)
++. +..+++|+.|+|++|.+++. + .+..+++|+.|++++|++......
T Consensus 171 -----~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~~~~ 218 (291)
T 1h6t_A 171 -----IVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNKPIN 218 (291)
T ss_dssp -----CGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECCCEE
T ss_pred -----chh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCCccc
Confidence 222 33455555666666655543 2 356666666666666666654433
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1e-18 Score=208.03 Aligned_cols=192 Identities=22% Similarity=0.332 Sum_probs=126.9
Q ss_pred ChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccccccccccccccccccc
Q 047768 240 SSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLG 319 (1009)
Q Consensus 240 ~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~ 319 (1009)
..+..+.+..+.+.+.++. ..+++|+.|++++|.+... | .|..+++|+.|+|++|+++++.+ |..+++|+.|+
T Consensus 21 ~~l~~l~l~~~~i~~~~~~---~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 93 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAVTQ---NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHTTCSCTTSEECH---HHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred HHHHHHhccCCCcccccch---hcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence 3455555555555532222 2356666666666666643 2 46666777777777777666554 66666666666
Q ss_pred ccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEc
Q 047768 320 LATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRM 399 (1009)
Q Consensus 320 L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 399 (1009)
|++|.+...+ .+..+++|+.|+|++|.+++. ..+..+ ..|+.|+|++|+|++. ..+..+++|+.|+|
T Consensus 94 Ls~N~l~~l~--------~l~~l~~L~~L~Ls~N~l~~l--~~l~~l-~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~L 160 (605)
T 1m9s_A 94 LDENKIKDLS--------SLKDLKKLKSLSLEHNGISDI--NGLVHL-PQLESLYLGNNKITDI--TVLSRLTKLDTLSL 160 (605)
T ss_dssp CCSSCCCCCT--------TSTTCTTCCEEECTTSCCCCC--GGGGGC-TTCSEEECCSSCCCCC--GGGGSCTTCSEEEC
T ss_pred CcCCCCCCCh--------hhccCCCCCEEEecCCCCCCC--ccccCC-CccCEEECCCCccCCc--hhhcccCCCCEEEC
Confidence 6666665432 356677777777777777753 335555 4677777777777754 56777788888888
Q ss_pred cCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccc
Q 047768 400 EANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGN 455 (1009)
Q Consensus 400 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 455 (1009)
++|+|++..| +..+++|+.|+|++|+|++. +.+..+++|+.|+|++|++.+.
T Consensus 161 s~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 161 EDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred cCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 8888876655 77788888888888888753 3577778888888888887753
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-18 Score=181.62 Aligned_cols=156 Identities=23% Similarity=0.263 Sum_probs=105.2
Q ss_pred cCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCC
Q 047768 394 LNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPR 473 (1009)
Q Consensus 394 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~ 473 (1009)
.+.+++++++++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~------------------- 78 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA------------------- 78 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-------------------
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC-------------------
Confidence 455666666666 4444332 556666666666665555555555555555555555542
Q ss_pred CCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccccccc
Q 047768 474 NKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTI 553 (1009)
Q Consensus 474 N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 553 (1009)
..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+
T Consensus 79 ------------------------------i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~l 127 (229)
T 3e6j_A 79 ------------------------------LPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-EL 127 (229)
T ss_dssp ------------------------------CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SC
T ss_pred ------------------------------cChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-cc
Confidence 22233556677777777777777666666777778888888888877 67
Q ss_pred ccccccccccceEcCCCcccccccccccccccccCceecccccCcccCC
Q 047768 554 PQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVP 602 (1009)
Q Consensus 554 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p 602 (1009)
|..+..+++|++|+|++|+|++..+..|..+++|++|+|++|++.|.++
T Consensus 128 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 128 PRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 7777788888888888888876666677778888888888888877766
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=7.3e-19 Score=197.59 Aligned_cols=177 Identities=20% Similarity=0.185 Sum_probs=131.8
Q ss_pred cceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCcccc-CcCccCEEEccCCCCCCCCCCCcCCcccccceec
Q 047768 345 LQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIA-NLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHL 423 (1009)
Q Consensus 345 L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 423 (1009)
-+.+++++|+++. +|..+. ..++.|+|++|+|++..+..|. ++++|+.|+|++|+|++..+..|..+++|++|+|
T Consensus 20 ~~~l~c~~~~l~~-iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L 95 (361)
T 2xot_A 20 SNILSCSKQQLPN-VPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDL 95 (361)
T ss_dssp TTEEECCSSCCSS-CCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCEEEeCCCCcCc-cCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEEC
Confidence 3689999999984 666554 4589999999999998888888 9999999999999999888899999999999999
Q ss_pred ccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCC
Q 047768 424 HANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNG 503 (1009)
Q Consensus 424 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~ 503 (1009)
++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+
T Consensus 96 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~------------------------------------ 139 (361)
T 2xot_A 96 SSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQ------------------------------------ 139 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC------------------------------------
T ss_pred CCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCC------------------------------------
Confidence 99999988888899999999999999998866565555555544
Q ss_pred CCCCCccCCCCCCeeeccccccCCCccccc---cCCCCccEEEecCcccccccccccccccc--cceEcCCCcccc
Q 047768 504 SLPLGVGNLKSLVRLGIARNQFSGQIPVTL---GACTSLEYVELQGNSFSGTIPQSLSSLTS--IKELDLSQNNFS 574 (1009)
Q Consensus 504 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~ 574 (1009)
.|+|++|+|++..+..| ..+++|+.|+|++|+|++..+..+..++. |+.|+|++|.+.
T Consensus 140 -------------~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 140 -------------KLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp -------------EEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred -------------EEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 44444444443222222 34555666666666665444455555554 366666666665
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=9.5e-20 Score=222.70 Aligned_cols=91 Identities=23% Similarity=0.300 Sum_probs=47.1
Q ss_pred EcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccc
Q 047768 374 NLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453 (1009)
Q Consensus 374 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 453 (1009)
++..|.+. ..|..|..+++|+.|+|++|++. .+|..+..+++|++|+|++|.|+ .+|..|+++++|++|+|++|+|+
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 34444444 45566666666777777777666 55555556666666666666666 56666666666666666666665
Q ss_pred cccCCCCCCCCCccc
Q 047768 454 GNIPFSLGNCKNLMF 468 (1009)
Q Consensus 454 ~~~p~~~~~l~~L~~ 468 (1009)
.+|..|+++++|++
T Consensus 284 -~lp~~~~~l~~L~~ 297 (727)
T 4b8c_D 284 -SLPAELGSCFQLKY 297 (727)
T ss_dssp -SCCSSGGGGTTCSE
T ss_pred -ccChhhcCCCCCCE
Confidence 44555544444443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.6e-18 Score=206.31 Aligned_cols=107 Identities=26% Similarity=0.361 Sum_probs=51.0
Q ss_pred cccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccc
Q 047768 339 LTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNL 418 (1009)
Q Consensus 339 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 418 (1009)
+..+++|+.|+|++|++++..| +..+ ..|+.|+|++|+|++ + +.+..+++|+.|+|++|+|++. ..+..+++|
T Consensus 61 l~~l~~L~~L~Ls~N~l~~~~~--l~~l-~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L 133 (605)
T 1m9s_A 61 IQYLPNVTKLFLNGNKLTDIKP--LTNL-KNLGWLFLDENKIKD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQL 133 (605)
T ss_dssp GGGCTTCCEEECTTSCCCCCGG--GGGC-TTCCEEECCSSCCCC-C-TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTC
T ss_pred HccCCCCCEEEeeCCCCCCChh--hccC-CCCCEEECcCCCCCC-C-hhhccCCCCCEEEecCCCCCCC--ccccCCCcc
Confidence 4445566666666665554332 3333 344444444444442 1 1344555555555555555432 234445555
Q ss_pred cceecccccccCCCCcccccccccccccccCccccc
Q 047768 419 QLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQG 454 (1009)
Q Consensus 419 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 454 (1009)
+.|+|++|++++. ..+..+++|+.|+|++|+|++
T Consensus 134 ~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~ 167 (605)
T 1m9s_A 134 ESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 167 (605)
T ss_dssp SEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred CEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence 5555555555432 334444444444444444443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=1.7e-18 Score=175.72 Aligned_cols=135 Identities=27% Similarity=0.335 Sum_probs=101.2
Q ss_pred EecCCCccCCCCCC-CccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcc
Q 047768 494 LDLSDNLLNGSLPL-GVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNN 572 (1009)
Q Consensus 494 L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 572 (1009)
|++++|++++..+. .|+.+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|+++++|++|+|++|+
T Consensus 34 L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 113 (192)
T 1w8a_A 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQ 113 (192)
T ss_dssp EECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSC
T ss_pred EECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCc
Confidence 56666666554443 37778888888888888888778888888888888888888888888888888888888888888
Q ss_pred cccccccccccccccCceecccccCcccCCCCCcccCccccccccCCCcCCCCCCC
Q 047768 573 FSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDEL 628 (1009)
Q Consensus 573 l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~~~~ 628 (1009)
|++.+|..|..+++|++|+|++|+++|.++..+....+....+.++...|+.|...
T Consensus 114 l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~~l 169 (192)
T 1w8a_A 114 ISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV 169 (192)
T ss_dssp CCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTTT
T ss_pred CCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCChHH
Confidence 88888888888888888888888888887754322222223445566677766654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=3e-18 Score=182.54 Aligned_cols=139 Identities=22% Similarity=0.176 Sum_probs=108.3
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeE--EEEEEeeccccc------------------------chHHHHHHHHHHHh
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGML--VAVKVINLEQKG------------------------GSKSFAAECEALRS 754 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~ 754 (1009)
.-|.+.+.||+|+||.||+|.+..+|+. ||||+++..... ....+.+|++.+++
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3466788999999999999999778999 999997533111 01368899999999
Q ss_pred cCCCCc--ceEEeeeeccccCCCceEEEEEeccCC-C----CHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHh-
Q 047768 755 IRHRNL--IKIVTICSSIDFKGVDFKALVYEYMQN-G----SLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH- 826 (1009)
Q Consensus 755 l~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH- 826 (1009)
+.|+++ ..++++ ...++||||+.+ | +|.++... .++.++..++.|++.|+.|||
T Consensus 127 l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~ 188 (258)
T 1zth_A 127 AKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQ 188 (258)
T ss_dssp HHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHH
Confidence 988764 344432 345899999942 4 77776543 123456789999999999999
Q ss_pred hcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 827 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 827 ~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
+. +||||||||+|||++. .++|+|||+|...
T Consensus 189 ~~---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 189 EA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 88 9999999999999998 9999999999754
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-18 Score=185.82 Aligned_cols=168 Identities=23% Similarity=0.321 Sum_probs=102.1
Q ss_pred cceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCccccccccccccccc
Q 047768 369 ALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFG 448 (1009)
Q Consensus 369 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 448 (1009)
.+..+++++|.+++.. .+..+++|+.|++++|+++. +| .+..+++|++|+|++|++++..+ +.++++|++|+++
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence 3455666666666332 46666667777777776663 33 46666666666666666664333 5566666666666
Q ss_pred CcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCC
Q 047768 449 ANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQ 528 (1009)
Q Consensus 449 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 528 (1009)
+|++++ +|. +.. ++|++|++++|++++
T Consensus 94 ~N~l~~-l~~--------------------------------------------------~~~-~~L~~L~L~~N~l~~- 120 (263)
T 1xeu_A 94 RNRLKN-LNG--------------------------------------------------IPS-ACLSRLFLDNNELRD- 120 (263)
T ss_dssp SSCCSC-CTT--------------------------------------------------CCC-SSCCEEECCSSCCSB-
T ss_pred CCccCC-cCc--------------------------------------------------ccc-CcccEEEccCCccCC-
Confidence 665553 221 111 456666666666664
Q ss_pred ccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceecccccCccc
Q 047768 529 IPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGE 600 (1009)
Q Consensus 529 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ 600 (1009)
+| .+..+++|+.|+|++|++++. | .++.+++|++|+|++|++++. ..+..+++|++|++++|++++.
T Consensus 121 ~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 121 TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 22 466666777777777776643 3 566677777777777777654 5566677777777777776654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=4.1e-18 Score=182.04 Aligned_cols=170 Identities=22% Similarity=0.323 Sum_probs=102.4
Q ss_pred ccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccce
Q 047768 342 CTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLL 421 (1009)
Q Consensus 342 l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 421 (1009)
+.++..+++++|.+++.. .+..+ ..|+.|++++|.++ .+| .+..+++|+.|+|++|+|++..+ +..+++|++|
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l-~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKEL-SGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHH-TTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHhcCCCccccc--chhhc-CcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 344555556666655332 34444 45666666666666 334 67778888888888888886554 7888888888
Q ss_pred ecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCcc
Q 047768 422 HLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLL 501 (1009)
Q Consensus 422 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l 501 (1009)
+|++|++++ +|.. .. ++|++|++++|++++. | .+..+++|+.|++++|+++
T Consensus 91 ~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~------------------------ 141 (263)
T 1xeu_A 91 SVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLK------------------------ 141 (263)
T ss_dssp ECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCC------------------------
T ss_pred ECCCCccCC-cCcc-cc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCC------------------------
Confidence 888888875 3332 22 7777777777777642 2 3455555444333333332
Q ss_pred CCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccc
Q 047768 502 NGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGT 552 (1009)
Q Consensus 502 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 552 (1009)
+ +| .++.+++|++|++++|++++. ..+..+++|+.|+|++|++++.
T Consensus 142 -~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 142 -S-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -B-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred -C-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 2 12 345556666666666666644 4556666666666666666543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.4e-18 Score=192.87 Aligned_cols=265 Identities=13% Similarity=0.098 Sum_probs=179.2
Q ss_pred ccccceeecccCccc--CCCCcccccccccccccccCccCCCCCCCcccC--------CChHHHHHhhCCccCCCCChhh
Q 047768 191 LSALRVIDIRTNRLW--GKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYN--------ISSLVEIYLYGNRFTGSLPIEI 260 (1009)
Q Consensus 191 l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--------l~~L~~L~L~~N~l~~~ip~~~ 260 (1009)
+++|++|||++|++. ...+..+. .++.+.+..|.|. +..|.+ +++|++|+|.+ .++ .|+..+
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~---~~~~~~~~~~~I~---~~aF~~~~~~~~~g~~~L~~l~L~~-~i~-~I~~~a 119 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYP---NGKFYIYMANFVP---AYAFSNVVNGVTKGKQTLEKVILSE-KIK-NIEDAA 119 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSG---GGCCEEECTTEEC---TTTTEEEETTEEEECTTCCC-CBCT-TCC-EECTTT
T ss_pred hccCeEEecCcceeEEecCcccccc---ccccccccccccC---HHHhcccccccccccCCCcEEECCc-ccc-chhHHH
Confidence 566777777777765 22222222 2444444444332 344555 77777777777 676 777788
Q ss_pred ccCCCcccceeccccccCCCCCCCcCcccccccccccccc----cccccccccccccccc-cccccccccCCCCCCCcch
Q 047768 261 GKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQ----FRGQVSINFNGLKDLS-MLGLATNFLGNGAANDLDF 335 (1009)
Q Consensus 261 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~----l~~~~~~~f~~l~~L~-~L~L~~N~l~~~~~~~~~~ 335 (1009)
|.++++|+.|++++|.++.+.+.+|.++.++..+.+..+. ...+...+|.+...|+ .+.+.... .++. ..
T Consensus 120 F~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~--~l~~---~~ 194 (329)
T 3sb4_A 120 FKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG--KLED---EI 194 (329)
T ss_dssp TTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC--CHHH---HH
T ss_pred hhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC--cHHH---HH
Confidence 8888888888888888777777788887777777766532 2334445555555554 22222110 0000 00
Q ss_pred hhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCc
Q 047768 336 VDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGEL 415 (1009)
Q Consensus 336 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 415 (1009)
...-....+++.+.+.++- .......+......|+.++|++|+++.+.+.+|.++++|+.|+|.+| ++.+.+.+|.++
T Consensus 195 ~~~~~~~~~~~~l~~~~~l-~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~ 272 (329)
T 3sb4_A 195 MKAGLQPRDINFLTIEGKL-DNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNC 272 (329)
T ss_dssp HHTTCCGGGCSEEEEEECC-CHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTC
T ss_pred hhcccCccccceEEEeeee-cHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCC
Confidence 0011124566677766552 22222333333468999999999999787888999999999999998 887888899999
Q ss_pred cccc-ceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCcccccc
Q 047768 416 KNLQ-LLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFA 471 (1009)
Q Consensus 416 ~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l 471 (1009)
.+|+ .+++.+ .++.+.+..|.++++|+.+++++|+++...+..|.++++|+.++.
T Consensus 273 ~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 273 GRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp TTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred hhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 9999 999988 777677889999999999999999999777789999999988764
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=7.5e-18 Score=171.82 Aligned_cols=156 Identities=17% Similarity=0.214 Sum_probs=104.6
Q ss_pred cccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCc
Q 047768 387 GIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNL 466 (1009)
Q Consensus 387 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 466 (1009)
....+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~---------- 104 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDK---------- 104 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGG----------
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCccc----------
Confidence 3466777888888888887 445 5777777777777777654 2235666666666666666655433
Q ss_pred cccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecC
Q 047768 467 MFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQG 546 (1009)
Q Consensus 467 ~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~ 546 (1009)
|..++.+++|++|++++|++++..|..++.+++|++|+|++
T Consensus 105 ---------------------------------------~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~ 145 (197)
T 4ezg_A 105 ---------------------------------------IPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSY 145 (197)
T ss_dssp ---------------------------------------SCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCS
T ss_pred ---------------------------------------ChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccC
Confidence 34455566677777777777766677777777777777777
Q ss_pred cc-cccccccccccccccceEcCCCcccccccccccccccccCceecccccCcc
Q 047768 547 NS-FSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEG 599 (1009)
Q Consensus 547 N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g 599 (1009)
|+ ++ .+| .++.+++|++|++++|++++ ++ .+..+++|++|++++|++.+
T Consensus 146 n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 146 NGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 76 44 444 57777778888888888774 44 67777888888888887653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.3e-17 Score=169.98 Aligned_cols=153 Identities=17% Similarity=0.226 Sum_probs=108.6
Q ss_pred hhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccc
Q 047768 364 ANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLT 443 (1009)
Q Consensus 364 ~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 443 (1009)
..+ ..|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..+..+++|+
T Consensus 41 ~~l-~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 41 AQM-NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHH-HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhc-CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 444 57999999999999 556 7999999999999999776 345789999999999999999988889999999999
Q ss_pred cccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeecccc
Q 047768 444 YLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARN 523 (1009)
Q Consensus 444 ~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 523 (1009)
+|++++|++++..|..+..+ ++|++|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l-------------------------------------------------~~L~~L~L~~n 146 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTL-------------------------------------------------PKVNSIDLSYN 146 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTC-------------------------------------------------SSCCEEECCSC
T ss_pred EEEecCCccCcHhHHHHhhC-------------------------------------------------CCCCEEEccCC
Confidence 99999988886555444444 44555555555
Q ss_pred c-cCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccc
Q 047768 524 Q-FSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFS 574 (1009)
Q Consensus 524 ~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 574 (1009)
. ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|++|++++|++.
T Consensus 147 ~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 147 GAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp TBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred CCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 4 33 333 45555555555555555553 22 4555566666666666554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=3.3e-17 Score=166.14 Aligned_cols=177 Identities=20% Similarity=0.219 Sum_probs=104.8
Q ss_pred CEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCc-ccccccccccccccCcccccccCCCCCCCCCccccccCC
Q 047768 395 NSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPS-SLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPR 473 (1009)
Q Consensus 395 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~ 473 (1009)
+.+++++|+++ .+|..+.. +|++|+|++|++++..+. .|.++++|++|+|++|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~-------------------- 67 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-------------------- 67 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC--------------------
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCC--------------------
Confidence 56666666665 44444332 556666666666544332 2455555555444444444
Q ss_pred CCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccccccc
Q 047768 474 NKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTI 553 (1009)
Q Consensus 474 N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 553 (1009)
+..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++.+
T Consensus 68 -----------------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 118 (192)
T 1w8a_A 68 -----------------------------GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVM 118 (192)
T ss_dssp -----------------------------CBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEEC
T ss_pred -----------------------------CcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeC
Confidence 344555666677777777777777766677777778888888888887777
Q ss_pred ccccccccccceEcCCCcccccccccccccccccCceecccccCcccCCCCCcccCccccccccCCCcCCCCC
Q 047768 554 PQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLD 626 (1009)
Q Consensus 554 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~~ 626 (1009)
|..|+.+++|++|+|++|.+++..+... -...++...+..+...+.-|.. +.......+..+...|.+..
T Consensus 119 ~~~~~~l~~L~~L~L~~N~l~c~c~l~~-~~~~l~~~~~~~~~~~C~~P~~--l~~~~l~~l~~~~~~C~~~~ 188 (192)
T 1w8a_A 119 PGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSK--VRDVQIKDLPHSEFKCSSEN 188 (192)
T ss_dssp TTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSSTT--TTTSBGGGSCTTTCCCCCC-
T ss_pred HHHhhcCCCCCEEEeCCCCccCcCcchH-HHHHHHHcCCCCCCCCCCCChH--HcCCChhhCcHhhcCcCCCC
Confidence 7778888888888888888876654211 0112333345555555555542 33444444455555565443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=5.1e-18 Score=188.19 Aligned_cols=283 Identities=12% Similarity=0.053 Sum_probs=166.4
Q ss_pred ccccceeecccCcccCCCCccccc-ccccccccccCccCC--CCCCCcccCCChHHHHHhhCCccCCCCChhhccC----
Q 047768 191 LSALRVIDIRTNRLWGKIPITLSQ-LTSLAYLHVGDNHFS--GTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKN---- 263 (1009)
Q Consensus 191 l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~---- 263 (1009)
+.+|+.|.++++ +....-..+.. +++|++|||++|++. ...+..+ +.+..+.+..| .||...|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~----~I~~~aF~~~~~~ 95 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMAN----FVPAYAFSNVVNG 95 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTT----EECTTTTEEEETT
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---ccccccccccc----ccCHHHhcccccc
Confidence 556666766654 21111123333 788999999999998 2222222 22333334444 678888988
Q ss_pred ----CCcccceeccccccCCCCCCCcCccccccccccccccccccccccccccccccccccccccc----CCCCCCCcch
Q 047768 264 ----LPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFL----GNGAANDLDF 335 (1009)
Q Consensus 264 ----l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l----~~~~~~~~~~ 335 (1009)
+++|+.|+|.+ +++.+.+.+|.++++|+.|++++|.+..+.+.+|.+..++..+.+..+.. ..+..
T Consensus 96 ~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~----- 169 (329)
T 3sb4_A 96 VTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEH----- 169 (329)
T ss_dssp EEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTT-----
T ss_pred cccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccc-----
Confidence 99999999999 89888889999999999999999999999999999988887777665322 11111
Q ss_pred hhhcccccccc-eEEccCCCCCCcCchhhhhh---cccceEEEcCCCccccCCCccc-cCcCccCEEEccCCCCCCCCCC
Q 047768 336 VDLLTNCTKLQ-YLYLADNGFGGVLPHSIANL---STALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEANRLTGTIPH 410 (1009)
Q Consensus 336 ~~~l~~l~~L~-~L~L~~N~l~~~~p~~~~~l---~~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~ 410 (1009)
..|.++..|+ .+.+.... .++..+... ...+..+.+.++-.. .....+ ..+++|+.|+|++|+++.+.+.
T Consensus 170 -~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~ 244 (329)
T 3sb4_A 170 -FAFIEGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDF 244 (329)
T ss_dssp -SCEEESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTT
T ss_pred -cccccccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHh
Confidence 2355666776 55554322 233333221 123333433332111 000111 1245566666666666555555
Q ss_pred CcCCcccccceecccccccCCCCcccccccccc-cccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhcc
Q 047768 411 VIGELKNLQLLHLHANFLQGTIPSSLGNLTLLT-YLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITT 489 (1009)
Q Consensus 411 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~ 489 (1009)
+|.++.+|+.|+|.+| ++.+.+..|.++++|+ .+++.+ .++..
T Consensus 245 aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I---------------------------------- 288 (329)
T 3sb4_A 245 TFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAI---------------------------------- 288 (329)
T ss_dssp TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEE----------------------------------
T ss_pred hhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEE----------------------------------
Confidence 5555555666655555 4434444455555555 554444 33322
Q ss_pred ceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEE
Q 047768 490 LSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVE 543 (1009)
Q Consensus 490 ~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 543 (1009)
-+..|.++++|+.|++++|+++...+.+|.++++|+.|+
T Consensus 289 ---------------~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 289 ---------------EFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp ---------------CTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred ---------------chhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 234455666666667666666655556677777777665
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.9e-17 Score=165.53 Aligned_cols=134 Identities=21% Similarity=0.204 Sum_probs=105.4
Q ss_pred EecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCccc
Q 047768 494 LDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNF 573 (1009)
Q Consensus 494 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 573 (1009)
|++++|+++ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 36 L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l 114 (193)
T 2wfh_A 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDI 114 (193)
T ss_dssp EECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCC
Confidence 666666666 5677888899999999999999988888899999999999999999988888999999999999999999
Q ss_pred ccccccccccccccCceecccccCcccCCCCCcccCccccccccCCCcCCCCCCC
Q 047768 574 SGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDEL 628 (1009)
Q Consensus 574 ~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~~~~ 628 (1009)
++..+..|..+++|++|+|++|++.+.+...+............+...|..|...
T Consensus 115 ~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~~~~~~~~~~~~~~C~~P~~l 169 (193)
T 2wfh_A 115 SVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSDWVKSEYKEPGIARCAGPGEM 169 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHHHHHSSCCCSCCBEEESGGG
T ss_pred CeeChhhhhcCccccEEEeCCCCeecCCcCHHHHHHHHhccCCCCCcCcCCchHH
Confidence 9766677999999999999999999877643211111111122233467666554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.2e-16 Score=156.42 Aligned_cols=139 Identities=22% Similarity=0.258 Sum_probs=116.6
Q ss_pred CCCCCCeeeecCCcCC-ccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCc
Q 047768 92 NLSFLRYINIADNDFH-GEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNL 170 (1009)
Q Consensus 92 ~l~~L~~L~L~~n~~~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L 170 (1009)
..++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|++++|.+++.+|..+ ..+++|
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~--~~l~~L 97 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLA--EKLPNL 97 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHH--HHCTTC
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHH--hhCCCC
Confidence 3478999999999998 78898899999999999999999865 788899999999999999987777665 458899
Q ss_pred CeEeecCccCCCCC-CcccCCccccceeecccCcccCCCC---cccccccccccccccCccCCCCCCCc
Q 047768 171 QGLSVGDNQLTGQL-PASIGNLSALRVIDIRTNRLWGKIP---ITLSQLTSLAYLHVGDNHFSGTIPPS 235 (1009)
Q Consensus 171 ~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p~~ 235 (1009)
++|+|++|++++.. +..++.+++|++|++++|++++..+ ..|..+++|++|++++|.+. .+|.+
T Consensus 98 ~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 98 THLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp CEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred CEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 99999999998643 2778899999999999999976665 57888999999999999887 45543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.8e-16 Score=156.15 Aligned_cols=137 Identities=19% Similarity=0.261 Sum_probs=96.4
Q ss_pred CCCCC-CCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccC
Q 047768 53 CVNLC-QHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFS 131 (1009)
Q Consensus 53 ~~~~c-~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~ 131 (1009)
|++.| |+|++|.|+.. +++. +|..+ .++|++|++++|++++..+..|+++++|++|+|++|+++
T Consensus 1 Cp~~C~C~~~~l~~~~~------------~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 65 (177)
T 2o6r_A 1 CPSRCSCSGTEIRCNSK------------GLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ 65 (177)
T ss_dssp CCTTCEEETTEEECCSS------------CCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC
T ss_pred CcCCCEeCCCEEEecCC------------CCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcce
Confidence 44444 57999988653 3332 23322 368899999999998666667888999999999999988
Q ss_pred CCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcc
Q 047768 132 GRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPIT 211 (1009)
Q Consensus 132 ~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 211 (1009)
+..+..|+++++|++|++++|++ ++..+..|.++++|++|+|++|++++..+..
T Consensus 66 ~~~~~~~~~l~~L~~L~l~~N~l--------------------------~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 119 (177)
T 2o6r_A 66 SLPDGVFDKLTKLTILYLHENKL--------------------------QSLPNGVFDKLTQLKELALDTNQLKSVPDGI 119 (177)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCC--------------------------CCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred EeChhHccCCCccCEEECCCCCc--------------------------cccCHHHhhCCcccCEEECcCCcceEeCHHH
Confidence 66666677766666666665544 4444555667777777777777777666666
Q ss_pred cccccccccccccCccCCC
Q 047768 212 LSQLTSLAYLHVGDNHFSG 230 (1009)
Q Consensus 212 ~~~l~~L~~L~L~~N~l~~ 230 (1009)
|..+++|++|+|++|.+++
T Consensus 120 ~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 120 FDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp TTTCTTCCEEECCSSCBCC
T ss_pred hcCCcccCEEEecCCCeec
Confidence 6777777888888777764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=3.7e-16 Score=151.40 Aligned_cols=130 Identities=18% Similarity=0.213 Sum_probs=112.2
Q ss_pred CCCCCCeeeecCCcCC-ccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCc
Q 047768 92 NLSFLRYINIADNDFH-GEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNL 170 (1009)
Q Consensus 92 ~l~~L~~L~L~~n~~~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L 170 (1009)
..++|++|++++|.++ +.+|..++.+++|++|+|++|.+++. ..++++++|++|++++|.+++.+|..+ ..+++|
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~--~~l~~L 90 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLA--EKCPNL 90 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHH--HHCTTC
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHh--hhCCCC
Confidence 3478899999999998 88999899999999999999999866 788999999999999999988777765 568899
Q ss_pred CeEeecCccCCCC-CCcccCCccccceeecccCcccCCCC---cccccccccccccccC
Q 047768 171 QGLSVGDNQLTGQ-LPASIGNLSALRVIDIRTNRLWGKIP---ITLSQLTSLAYLHVGD 225 (1009)
Q Consensus 171 ~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~ 225 (1009)
++|++++|++++. .+..++++++|++|++++|++++..+ ..+..+++|++|++++
T Consensus 91 ~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 91 THLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999999864 34788999999999999999987766 5788999999999864
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=154.81 Aligned_cols=136 Identities=23% Similarity=0.321 Sum_probs=98.1
Q ss_pred CCCCCC-CCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCcccccccccccccc
Q 047768 52 ACVNLC-QHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSF 130 (1009)
Q Consensus 52 ~~~~~c-~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l 130 (1009)
.|+..| |.|+.|.| ++++++. +|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|.|
T Consensus 3 ~CP~~C~C~~~~l~~------------~~~~l~~-ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i 66 (193)
T 2wfh_A 3 RCPTECTCLDTVVRC------------SNKGLKV-LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRI 66 (193)
T ss_dssp -CCTTCEEETTEEEC------------TTSCCSS-CCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCC
T ss_pred CCCCCCEeCCCEEEc------------CCCCCCc-CCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcC
Confidence 466666 34544444 4555553 444443 57899999999998 7888899999999999999999
Q ss_pred CCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCc
Q 047768 131 SGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPI 210 (1009)
Q Consensus 131 ~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 210 (1009)
++..|..|.++++|++|+|++|.+ ++..|..|.++++|++|+|++|+|++..+.
T Consensus 67 ~~i~~~~f~~l~~L~~L~Ls~N~l--------------------------~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~ 120 (193)
T 2wfh_A 67 STLSNQSFSNMTQLLTLILSYNRL--------------------------RCIPPRTFDGLKSLRLLSLHGNDISVVPEG 120 (193)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCC--------------------------CBCCTTTTTTCTTCCEEECCSSCCCBCCTT
T ss_pred CEeCHhHccCCCCCCEEECCCCcc--------------------------CEeCHHHhCCCCCCCEEECCCCCCCeeChh
Confidence 877777787777776666666554 445556677777777777777777766666
Q ss_pred ccccccccccccccCccCC
Q 047768 211 TLSQLTSLAYLHVGDNHFS 229 (1009)
Q Consensus 211 ~~~~l~~L~~L~L~~N~l~ 229 (1009)
.|..+++|++|+|++|.+.
T Consensus 121 ~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 121 AFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp TTTTCTTCCEEECCSSCEE
T ss_pred hhhcCccccEEEeCCCCee
Confidence 7777778888888887776
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=7e-16 Score=152.76 Aligned_cols=90 Identities=21% Similarity=0.272 Sum_probs=52.3
Q ss_pred ccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccccccc-ccccccccccceEcCCCcccccccc---cccccc
Q 047768 509 VGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTI-PQSLSSLTSIKELDLSQNNFSGQIP---KYLENL 584 (1009)
Q Consensus 509 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l 584 (1009)
++.+++|++|++++|++++.+|..+..+++|++|+|++|++++.. +..++.+++|+.|+|++|.+++..+ ..+..+
T Consensus 67 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l 146 (168)
T 2ell_A 67 LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLL 146 (168)
T ss_dssp CCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTC
T ss_pred hccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhC
Confidence 344555555666666655555555555666666666666665432 2556666666666666666664333 356666
Q ss_pred cccCceecccccCc
Q 047768 585 SFLQYLNLSYNHFE 598 (1009)
Q Consensus 585 ~~L~~L~ls~N~l~ 598 (1009)
++|++|++++|.+.
T Consensus 147 ~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 147 PQLTYLDGYDREDQ 160 (168)
T ss_dssp SSCCEETTEETTSC
T ss_pred ccCcEecCCCCChh
Confidence 66666666666654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=8e-16 Score=149.00 Aligned_cols=128 Identities=22% Similarity=0.283 Sum_probs=91.0
Q ss_pred cccccccccCcccc-cccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCee
Q 047768 440 TLLTYLSFGANNLQ-GNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRL 518 (1009)
Q Consensus 440 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L 518 (1009)
++|++|++++|.++ +.+|..+..+++|++|++++|.++ +. ..++++++|++|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~-------------------------~~--~~~~~l~~L~~L 69 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-------------------------SI--ANLPKLNKLKKL 69 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCC-------------------------CC--TTCCCCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCC-------------------------Cc--hhhhcCCCCCEE
Confidence 44555555555555 455555555555554333333333 22 456677888888
Q ss_pred eccccccCCCccccccCCCCccEEEecCcccccc-cccccccccccceEcCCCcccccccc---cccccccccCceeccc
Q 047768 519 GIARNQFSGQIPVTLGACTSLEYVELQGNSFSGT-IPQSLSSLTSIKELDLSQNNFSGQIP---KYLENLSFLQYLNLSY 594 (1009)
Q Consensus 519 ~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~ls~ 594 (1009)
++++|++++.+|..+..+++|++|+|++|++++. .|..++.+++|++|++++|++++..+ ..+..+++|++||+++
T Consensus 70 ~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 8888888877888888888888888888888864 45788888889999999998886655 4788888888888874
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.6e-15 Score=150.07 Aligned_cols=110 Identities=24% Similarity=0.279 Sum_probs=90.1
Q ss_pred EecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCccc
Q 047768 494 LDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNF 573 (1009)
Q Consensus 494 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 573 (1009)
|++++|++++..+..|+++++|++|++++|++++..+..+..+++|++|+|++|+|++..+..|+.+++|++|+|++|+|
T Consensus 33 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 112 (177)
T 2o6r_A 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQL 112 (177)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcc
Confidence 66666666655555677888888899999988876667788889999999999999877777788899999999999999
Q ss_pred ccccccccccccccCceecccccCcccCCC
Q 047768 574 SGQIPKYLENLSFLQYLNLSYNHFEGEVPT 603 (1009)
Q Consensus 574 ~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 603 (1009)
++..+..+..+++|++|++++|+++|.+|.
T Consensus 113 ~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 113 KSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred eEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 866666678889999999999999888774
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.58 E-value=3.4e-15 Score=168.86 Aligned_cols=271 Identities=11% Similarity=0.108 Sum_probs=180.7
Q ss_pred cCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHH
Q 047768 167 LFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIY 246 (1009)
Q Consensus 167 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 246 (1009)
...++.+.+.+ .++.+-..+|.+. +|+.+.+.+| +..+...+|.+ .+|+.+.|.+ .++..-+.+|.++++|+.++
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 35566666653 4554555667764 6888887766 66666677777 4677777775 55545556777777777777
Q ss_pred hhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccC
Q 047768 247 LYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLG 326 (1009)
Q Consensus 247 L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~ 326 (1009)
|++|+++ .||...|. ..+|+.+.|.. +++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+. |.+.
T Consensus 187 l~~n~l~-~I~~~aF~-~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~ 260 (401)
T 4fdw_A 187 LSKTKIT-KLPASTFV-YAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVT 260 (401)
T ss_dssp CTTSCCS-EECTTTTT-TCCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCC
T ss_pred cCCCcce-EechhhEe-ecccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCcc
Confidence 7777777 77777776 47788888874 366677778888888888888764 66677777777 677777773 3444
Q ss_pred CCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCC
Q 047768 327 NGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTG 406 (1009)
Q Consensus 327 ~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 406 (1009)
.++. .+|.+|++|+.+++.+|.+.. +.+....+.+|.++++|+.++|. |.++.
T Consensus 261 ~I~~------~aF~~c~~L~~l~l~~~~~~~--------------------~~~~~I~~~aF~~c~~L~~l~l~-~~i~~ 313 (401)
T 4fdw_A 261 NIAS------RAFYYCPELAEVTTYGSTFND--------------------DPEAMIHPYCLEGCPKLARFEIP-ESIRI 313 (401)
T ss_dssp EECT------TTTTTCTTCCEEEEESSCCCC--------------------CTTCEECTTTTTTCTTCCEECCC-TTCCE
T ss_pred EECh------hHhhCCCCCCEEEeCCccccC--------------------CcccEECHHHhhCCccCCeEEeC-CceEE
Confidence 4433 456777777777777765540 11112345667777777777777 44665
Q ss_pred CCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCC-CccccccCCCCcc
Q 047768 407 TIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCK-NLMFFFAPRNKLT 477 (1009)
Q Consensus 407 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~l~l~~N~l~ 477 (1009)
+...+|.++++|+.++|..| ++...+.+|.++ +|+.+++++|.+....+..|.+++ ++..+++..+.+.
T Consensus 314 I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 314 LGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp ECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred EhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 66667777777777777544 554556677777 777777777777655566666664 5666766665543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=4.5e-17 Score=166.16 Aligned_cols=89 Identities=17% Similarity=0.170 Sum_probs=61.5
Q ss_pred CCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccc-cccccccccceEcCCCcccccccccc----
Q 047768 506 PLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIP-QSLSSLTSIKELDLSQNNFSGQIPKY---- 580 (1009)
Q Consensus 506 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~---- 580 (1009)
|..+..+++|++|++++|++++ +| .++.+++|+.|+|++|++++..+ ..+..+++|++|++++|.+++.+|..
T Consensus 86 ~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~ 163 (198)
T 1ds9_A 86 ENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATS 163 (198)
T ss_dssp SSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHH
T ss_pred cchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchH
Confidence 3334445677777777777775 44 57777778888888887774332 46777788888888888887666543
Q ss_pred ------cccccccCceecccccCc
Q 047768 581 ------LENLSFLQYLNLSYNHFE 598 (1009)
Q Consensus 581 ------~~~l~~L~~L~ls~N~l~ 598 (1009)
+..+++|++|| +|+++
T Consensus 164 ~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 164 EYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHHHHHHCSSCSEEC--CGGGT
T ss_pred HHHHHHHHhCCCcEEEC--CcccC
Confidence 77788888776 66554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1.2e-14 Score=164.55 Aligned_cols=126 Identities=12% Similarity=0.097 Sum_probs=59.8
Q ss_pred CcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhh
Q 047768 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLY 248 (1009)
Q Consensus 169 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 248 (1009)
+|+.+.+.+ .++.+.+.+|.++++|+.++|++|+++.....+|. ..+|+.+.|.++ ++..-..+|.++++|+.+++.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~ 234 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP 234 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence 344455543 44434445556666666666666666544444554 355555555533 432333444444444444444
Q ss_pred CCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccc
Q 047768 249 GNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQF 301 (1009)
Q Consensus 249 ~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 301 (1009)
.| ++ .|+..+|.+ .+|+.+.+ .|+++.+...+|.++++|+.+++.+|.+
T Consensus 235 ~~-l~-~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~ 283 (401)
T 4fdw_A 235 EN-VS-TIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTF 283 (401)
T ss_dssp TT-CC-EECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCC
T ss_pred CC-cc-Ccccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccc
Confidence 32 33 444444443 44444444 2334434444444444444444444433
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.53 E-value=6e-15 Score=162.36 Aligned_cols=144 Identities=13% Similarity=0.182 Sum_probs=102.4
Q ss_pred HHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--------------chH--------HHHHHHHHH
Q 047768 695 ELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--------------GSK--------SFAAECEAL 752 (1009)
Q Consensus 695 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------~~~--------~~~~E~~~l 752 (1009)
.+.....-|.+...||+|+||.||+|... +|+.||||+++..... ... ...+|...|
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 33444445889999999999999999885 7999999998532110 011 123466666
Q ss_pred HhcCCCCcc--eEEeeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 047768 753 RSIRHRNLI--KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQ 830 (1009)
Q Consensus 753 ~~l~h~niv--~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ 830 (1009)
.++.+.++. ..+++ ...++||||+++++|.++... .....++.|++.++.|||+.
T Consensus 168 ~rL~~~gv~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~------------~~~~~l~~qll~~l~~lH~~-- 224 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSV------------PDPASLYADLIALILRLAKH-- 224 (397)
T ss_dssp HHHHHTTCSCCCEEEE---------ETTEEEEECCSCEEGGGCCCC------------SCHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHhcCCCCCeeeec---------cCceEEEEecCCccHhhhccc------------HHHHHHHHHHHHHHHHHHHC--
Confidence 666544432 22222 223799999999888654321 12356889999999999998
Q ss_pred CCceecCCCCCceeeCCCC----------ceEEeccccccccC
Q 047768 831 PPIVHGDLKPSNVLLDHDM----------VAHVSDFGLAKFLS 863 (1009)
Q Consensus 831 ~~ivHrdlk~~Nill~~~~----------~~kl~DfGla~~~~ 863 (1009)
+||||||||.|||+++++ .+.|+||+-+....
T Consensus 225 -gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 225 -GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp -TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred -CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 999999999999998876 38999999776543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.53 E-value=1.8e-14 Score=142.66 Aligned_cols=108 Identities=22% Similarity=0.276 Sum_probs=98.3
Q ss_pred eEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcc
Q 047768 493 SLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNN 572 (1009)
Q Consensus 493 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 572 (1009)
.+++++|.++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 13 ~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 4899999998 4777664 889999999999998889999999999999999999998888889999999999999999
Q ss_pred cccccccccccccccCceecccccCcccCCC
Q 047768 573 FSGQIPKYLENLSFLQYLNLSYNHFEGEVPT 603 (1009)
Q Consensus 573 l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 603 (1009)
|++..|..|..+++|++|+|++|++++.++.
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 9987777899999999999999999998874
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.8e-14 Score=140.74 Aligned_cols=108 Identities=21% Similarity=0.288 Sum_probs=97.3
Q ss_pred eEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcc
Q 047768 493 SLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNN 572 (1009)
Q Consensus 493 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 572 (1009)
.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|+.+++|++|+|++|+|++..+..|.++++|++|||++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 4899999996 6787765 899999999999999889999999999999999999998777778999999999999999
Q ss_pred cccccccccccccccCceecccccCcccCCC
Q 047768 573 FSGQIPKYLENLSFLQYLNLSYNHFEGEVPT 603 (1009)
Q Consensus 573 l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 603 (1009)
|++..+..|..+++|++|+|++|++.+.++.
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~ 123 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWDCECRD 123 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred cceeCHHHhccccCCCEEEeCCCCccccccc
Confidence 9976666799999999999999999987763
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.50 E-value=1.4e-16 Score=162.54 Aligned_cols=151 Identities=23% Similarity=0.330 Sum_probs=96.7
Q ss_pred cceEEEcCCCccccCCCc------cccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCccccccccc
Q 047768 369 ALIDFNLGKNQIYGTIPP------GIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLL 442 (1009)
Q Consensus 369 ~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 442 (1009)
.++.++++.|.+++..|. .+..+++|++|+|++|++++ +| .+..+++|++|+|++|+++ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 445555555555555554 55555555555555555553 33 5555555555555555555 344444444555
Q ss_pred ccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccc
Q 047768 443 TYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIAR 522 (1009)
Q Consensus 443 ~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 522 (1009)
++|++++|++++ +| .++.+++|++|++++
T Consensus 96 ~~L~L~~N~l~~--------------------------------------------------l~-~~~~l~~L~~L~l~~ 124 (198)
T 1ds9_A 96 EELWISYNQIAS--------------------------------------------------LS-GIEKLVNLRVLYMSN 124 (198)
T ss_dssp SEEEEEEEECCC--------------------------------------------------HH-HHHHHHHSSEEEESE
T ss_pred CEEECcCCcCCc--------------------------------------------------CC-ccccCCCCCEEECCC
Confidence 555555554442 22 355667888899999
Q ss_pred cccCCCcc-ccccCCCCccEEEecCcccccccccc----------cccccccceEcCCCccccc
Q 047768 523 NQFSGQIP-VTLGACTSLEYVELQGNSFSGTIPQS----------LSSLTSIKELDLSQNNFSG 575 (1009)
Q Consensus 523 N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~~L~~L~Ls~N~l~~ 575 (1009)
|++++..+ ..+..+++|++|++++|++++.+|.. +..+++|+.|| +|.++.
T Consensus 125 N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 125 NKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp EECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred CcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 98885333 47888999999999999998777653 88899999998 677763
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=2e-14 Score=143.43 Aligned_cols=134 Identities=16% Similarity=0.222 Sum_probs=101.2
Q ss_pred ccccCCCCCCeeeecCCcCCccCCccccCcc-ccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhc
Q 047768 88 PYVGNLSFLRYINIADNDFHGEIPDRIGNLF-RLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRR 166 (1009)
Q Consensus 88 ~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~ 166 (1009)
+.+.+..+|++|+|++|+++ .+|. +..+. +|++|||++|.+++. ..|+++++|++|++++|.+++ +|..++ ..
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~-~~~~~~-~~ 86 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR-IGEGLD-QA 86 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE-ECSCHH-HH
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccc-cCcchh-hc
Confidence 44677888999999999998 5565 55554 899999999999864 678888888888888888874 443332 46
Q ss_pred cCCcCeEeecCccCCCCCCc--ccCCccccceeecccCcccCCCCc----ccccccccccccccCccCC
Q 047768 167 LFNLQGLSVGDNQLTGQLPA--SIGNLSALRVIDIRTNRLWGKIPI----TLSQLTSLAYLHVGDNHFS 229 (1009)
Q Consensus 167 l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~ 229 (1009)
+++|++|+|++|+++ .+|. .++.+++|++|++++|.+. .+|. .+..+++|++||+++|.+.
T Consensus 87 l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 87 LPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 778888888888886 4554 6778888888888888886 3454 3777888888888877764
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.1e-13 Score=157.26 Aligned_cols=77 Identities=14% Similarity=0.226 Sum_probs=37.1
Q ss_pred ccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccC
Q 047768 509 VGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQ 588 (1009)
Q Consensus 509 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 588 (1009)
|.++.+|+.++|.++ ++..-..+|.+|.+|+.+++..| ++..-..+|.++++|+.+++..| ++ .+...|.++++|+
T Consensus 316 F~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~ 391 (394)
T 4fs7_A 316 FESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFK 391 (394)
T ss_dssp TTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEE
T ss_pred hcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCc
Confidence 444455555555432 33233445555555555555544 44344455555555555555433 22 2334455555554
Q ss_pred c
Q 047768 589 Y 589 (1009)
Q Consensus 589 ~ 589 (1009)
.
T Consensus 392 ~ 392 (394)
T 4fs7_A 392 W 392 (394)
T ss_dssp E
T ss_pred E
Confidence 3
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.49 E-value=1.7e-14 Score=143.89 Aligned_cols=101 Identities=22% Similarity=0.231 Sum_probs=72.9
Q ss_pred EecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccccccccc--ccccccccceEcCCCc
Q 047768 494 LDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQ--SLSSLTSIKELDLSQN 571 (1009)
Q Consensus 494 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N 571 (1009)
|++++|.+++. ..++.+++|++|++++|+|++..|..+..+++|++|+|++|+|+ .+|. .++.+++|+.|+|++|
T Consensus 47 L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N 123 (176)
T 1a9n_A 47 IDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRN 123 (176)
T ss_dssp EECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSS
T ss_pred EECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCC
Confidence 44444444432 35667778888888888887544445578888888888888886 4555 7788888888888888
Q ss_pred ccccccccc----cccccccCceecccccCc
Q 047768 572 NFSGQIPKY----LENLSFLQYLNLSYNHFE 598 (1009)
Q Consensus 572 ~l~~~~p~~----~~~l~~L~~L~ls~N~l~ 598 (1009)
.++ .+|.. +..+++|++||+++|...
T Consensus 124 ~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 124 PVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp GGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 887 45664 788888888888888765
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.47 E-value=5.9e-13 Score=151.32 Aligned_cols=307 Identities=13% Similarity=0.054 Sum_probs=174.8
Q ss_pred CcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCC
Q 047768 185 PASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNL 264 (1009)
Q Consensus 185 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l 264 (1009)
..+|.++++|+.++|.++ ++.+...+|.++.+|+.+.+..+ +...-..+|.+...+..... +... .+....|.++
T Consensus 87 ~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~--~~~~-~i~~~aF~~c 161 (394)
T 4fs7_A 87 EFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIP--EGVT-VIGDEAFATC 161 (394)
T ss_dssp TTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECC--TTCC-EECTTTTTTC
T ss_pred hhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccccccccC--cccc-ccchhhhccc
Confidence 445666666666666544 44445556666666666655443 22123333433322211111 1112 3444555566
Q ss_pred CcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhcccccc
Q 047768 265 PNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTK 344 (1009)
Q Consensus 265 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~ 344 (1009)
++|+.+.+..+. ..+....|.++.+|+.+++..| ++.+...+|.+...|+.+.+..+...-. +......+
T Consensus 162 ~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~--------~~~~~~~~ 231 (394)
T 4fs7_A 162 ESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLG--------DFALSKTG 231 (394)
T ss_dssp TTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEEC--------TTTTTTCC
T ss_pred CCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEee--------hhhcccCC
Confidence 666666665432 3344556666666666666554 4445555555555555554443321110 01111223
Q ss_pred cceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecc
Q 047768 345 LQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLH 424 (1009)
Q Consensus 345 L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 424 (1009)
|+.+.+..+ ++......|.++.+|+.+.+..+... +....|..+..++.+...
T Consensus 232 -------------------------l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~ 284 (394)
T 4fs7_A 232 -------------------------VKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYG 284 (394)
T ss_dssp -------------------------CCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEEC
T ss_pred -------------------------CceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccC
Confidence 344444322 22233456677777777777766544 566677777777777776
Q ss_pred cccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCC
Q 047768 425 ANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGS 504 (1009)
Q Consensus 425 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~ 504 (1009)
.+.+. ...|..+.+|+.+.+.++ ++..-..+|.++++|+.+.+..+ ++ ..
T Consensus 285 ~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-------------------------~I 334 (394)
T 4fs7_A 285 SVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-------------------------EI 334 (394)
T ss_dssp SSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-------------------------EE
T ss_pred ceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-------------------------EE
Confidence 65432 345667777777777654 55455567777777776655432 22 12
Q ss_pred CCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceE
Q 047768 505 LPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKEL 566 (1009)
Q Consensus 505 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 566 (1009)
-...|.++.+|+.+++..| ++..-..+|.+|++|+.+++..| ++ .+..+|.+.++|+.+
T Consensus 335 ~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 335 GKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp CTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred hHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 2345778888999988877 66455678999999999999865 33 445678888888765
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.36 E-value=1.4e-12 Score=128.88 Aligned_cols=105 Identities=25% Similarity=0.240 Sum_probs=57.1
Q ss_pred cceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecc
Q 047768 345 LQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLH 424 (1009)
Q Consensus 345 L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 424 (1009)
.+.+++++|+++. +|..+. ..++.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 11 ~~~l~~s~n~l~~-ip~~~~---~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGIP---TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp TTEEECTTSCCSS-CCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcCc-cCccCC---CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 4566666666663 343332 345555555555555555555555555555555555555555555555555555555
Q ss_pred cccccCCCCcccccccccccccccCcccc
Q 047768 425 ANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453 (1009)
Q Consensus 425 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 453 (1009)
+|+|++..+..|.++++|++|+|++|.++
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 55555444444555555555555555554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.1e-12 Score=146.52 Aligned_cols=130 Identities=19% Similarity=0.183 Sum_probs=105.8
Q ss_pred EecCCC-ccCCCCCCCccCCCCCCeeeccc-cccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCc
Q 047768 494 LDLSDN-LLNGSLPLGVGNLKSLVRLGIAR-NQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQN 571 (1009)
Q Consensus 494 L~Ls~N-~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 571 (1009)
++++++ .|+ .+|. +..+++|++|+|++ |+|++..|..|+++++|+.|+|++|+|++..|..|++|++|++|||++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 788888 888 4888 99999999999996 9999888899999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccCceecccccCcccCCCCCc--ccCccccccccCCCcCCCCC
Q 047768 572 NFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGI--FKNKTGFSIVGNGKLCGGLD 626 (1009)
Q Consensus 572 ~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~--~~~~~~~~~~~n~~lc~~~~ 626 (1009)
+|++..|..|..++ |+.|+|++|+|.+.+...+. +.......+..+...|..+.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 99976666777776 99999999999987663211 11111222334556676554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.4e-12 Score=127.70 Aligned_cols=104 Identities=27% Similarity=0.308 Sum_probs=53.8
Q ss_pred ceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceeccc
Q 047768 346 QYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHA 425 (1009)
Q Consensus 346 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 425 (1009)
+.+++++|+++ .+|..+. ..|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~~~~---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP---TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCCCcC---CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 45666666664 3343332 3455555555555555555555555555555555555544444445555555555555
Q ss_pred ccccCCCCcccccccccccccccCcccc
Q 047768 426 NFLQGTIPSSLGNLTLLTYLSFGANNLQ 453 (1009)
Q Consensus 426 N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 453 (1009)
|+|++..+..|..+++|++|+|++|.+.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcc
Confidence 5555433334555555555555555544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.32 E-value=1.5e-12 Score=145.46 Aligned_cols=113 Identities=19% Similarity=0.302 Sum_probs=85.4
Q ss_pred CCCCC--CCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecC-CcCCccCCccccCccccccccccccc
Q 047768 53 CVNLC--QHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIAD-NDFHGEIPDRIGNLFRLETLVLANNS 129 (1009)
Q Consensus 53 ~~~~c--~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~-n~~~~~~p~~~~~l~~L~~L~Ls~N~ 129 (1009)
|+..| |.|.+|.|++. |++++ +|+ |..+++|++|+|++ |.|++..|..|++|++|++|+|++|+
T Consensus 1 cp~~c~~C~~~~v~~~~~-----------n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 67 (347)
T 2ifg_A 1 CPDACCPHGSSGLRCTRD-----------GALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67 (347)
T ss_dssp CCSSSCCSSSSCEECCSS-----------CCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSC
T ss_pred CCCcCccccCCEEEcCCC-----------CCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCc
Confidence 45556 57888888642 15655 666 99999999999996 99997777899999999999999999
Q ss_pred cCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCC
Q 047768 130 FSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLT 181 (1009)
Q Consensus 130 l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~ 181 (1009)
|++..|..|+++++|++|+|++|++++ +|...+ ..+ .|+.|+|++|.+.
T Consensus 68 l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~-~~~-~L~~l~l~~N~~~ 116 (347)
T 2ifg_A 68 LRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTV-QGL-SLQELVLSGNPLH 116 (347)
T ss_dssp CCEECTTGGGSCSCCCEEECCSSCCSC-CCSTTT-CSC-CCCEEECCSSCCC
T ss_pred cceeCHHHhcCCcCCCEEeCCCCccce-eCHHHc-ccC-CceEEEeeCCCcc
Confidence 999888899999988888888888773 333332 122 2555555555555
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=8.9e-14 Score=155.72 Aligned_cols=64 Identities=17% Similarity=0.233 Sum_probs=29.0
Q ss_pred CCCCCeeeccccccCCC----ccccccCCCCccEEEecCcccccc----cccccccccccceEcCCCccccc
Q 047768 512 LKSLVRLGIARNQFSGQ----IPVTLGACTSLEYVELQGNSFSGT----IPQSLSSLTSIKELDLSQNNFSG 575 (1009)
Q Consensus 512 l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 575 (1009)
.++|++|||++|.|++. ++..+..+++|+.|+|++|.|++. ++..+...++|++|||++|.|++
T Consensus 182 ~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 182 NTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp CSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred CCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 34455555555555421 133344444555555555555432 22223333455555555555543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.23 E-value=4.3e-11 Score=135.90 Aligned_cols=109 Identities=16% Similarity=0.221 Sum_probs=53.4
Q ss_pred cccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccc
Q 047768 235 SVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKD 314 (1009)
Q Consensus 235 ~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~ 314 (1009)
+|.++.+|+.+.+..+ ++ .|+...|.+..+|+.+.+..+ +..+....|.++.+|+.+.+..+ ++.+...+|.. ..
T Consensus 109 aF~~c~~L~~i~~~~~-~~-~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~ 183 (394)
T 4gt6_A 109 AFMFCSELTDIPILDS-VT-EIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TA 183 (394)
T ss_dssp TTTTCTTCCBCGGGTT-CS-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CC
T ss_pred hchhcccceeeccCCc-cc-eehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cc
Confidence 3444444444443322 33 455555556666666666432 33344556666666666666543 44455555543 34
Q ss_pred cccccccccccCCCCCCCcchhhhcccccccceEEccCCCC
Q 047768 315 LSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGF 355 (1009)
Q Consensus 315 L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 355 (1009)
|+.+.+..+... +. ..+|.++.+++......+..
T Consensus 184 l~~i~ip~~~~~-i~------~~af~~c~~l~~~~~~~~~~ 217 (394)
T 4gt6_A 184 LTQIHIPAKVTR-IG------TNAFSECFALSTITSDSESY 217 (394)
T ss_dssp CSEEEECTTCCE-EC------TTTTTTCTTCCEEEECCSSS
T ss_pred eeEEEECCcccc-cc------cchhhhccccceeccccccc
Confidence 555554433211 11 12345556666655554443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=5.3e-13 Score=149.40 Aligned_cols=162 Identities=16% Similarity=0.199 Sum_probs=107.0
Q ss_pred cccccceecccccccCCCCcccccc-----cccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhcc
Q 047768 415 LKNLQLLHLHANFLQGTIPSSLGNL-----TLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITT 489 (1009)
Q Consensus 415 l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~ 489 (1009)
+++|+.|+|++|.++......+... ++|++|+|++|.++... ...+.....
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~------------------------~~~l~~~L~ 126 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAG------------------------LRTLLPVFL 126 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHH------------------------HHHTHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHH------------------------HHHHHHHHH
Confidence 3456677777777664333333222 45666666666554321 112222112
Q ss_pred ceeeEecCCCccCCCCCCCc-----cCCCCCCeeeccccccCC----CccccccCCCCccEEEecCcccccc----cccc
Q 047768 490 LSLSLDLSDNLLNGSLPLGV-----GNLKSLVRLGIARNQFSG----QIPVTLGACTSLEYVELQGNSFSGT----IPQS 556 (1009)
Q Consensus 490 ~~~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~ 556 (1009)
....|+|++|.++......+ ...++|++|+|++|.|+. .++..+..+++|++|+|++|+|++. ++..
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~ 206 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQ 206 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence 23346666666653222222 235789999999999974 2455567889999999999999863 3667
Q ss_pred cccccccceEcCCCccccc----ccccccccccccCceecccccCccc
Q 047768 557 LSSLTSIKELDLSQNNFSG----QIPKYLENLSFLQYLNLSYNHFEGE 600 (1009)
Q Consensus 557 ~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~g~ 600 (1009)
+...++|++|||++|.|++ .++..+...++|++|||++|+++..
T Consensus 207 L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 207 LDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp GGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred HhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 7788899999999999985 3455566779999999999998643
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.5e-10 Score=131.44 Aligned_cols=86 Identities=15% Similarity=0.183 Sum_probs=47.7
Q ss_pred CCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccc
Q 047768 507 LGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSF 586 (1009)
Q Consensus 507 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 586 (1009)
..|.++.+|+.++|..+ ++..-..+|.+|.+|+.+.+..+ ++..-..+|.++++|+.+++.+|.... ..+.....
T Consensus 305 ~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~ 379 (394)
T 4gt6_A 305 SVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSG 379 (394)
T ss_dssp TTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCC
T ss_pred eeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCC
Confidence 34666677777777654 44344556777777777777544 554445667777777777777665431 35556666
Q ss_pred cCceecccccC
Q 047768 587 LQYLNLSYNHF 597 (1009)
Q Consensus 587 L~~L~ls~N~l 597 (1009)
|+.+.+..|.+
T Consensus 380 L~~i~i~~~~~ 390 (394)
T 4gt6_A 380 LQNLPVAPGSI 390 (394)
T ss_dssp C----------
T ss_pred CCEEEeCCCCE
Confidence 66666655543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=2.4e-10 Score=121.88 Aligned_cols=148 Identities=18% Similarity=0.160 Sum_probs=113.9
Q ss_pred HHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-CCCcceEEeeeeccccC
Q 047768 695 ELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 695 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 773 (1009)
.+......|.+....+.|+.+.||++.. .++.+++|+...........+.+|+++++.+. |..+.++++++..
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~---- 81 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH---- 81 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE----
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec----
Confidence 3445566788888899999999999975 36789999986533233456899999999984 6778888888653
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhc-------------------------
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH------------------------- 828 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------- 828 (1009)
.+..++||||++|.++.+.... ..+...++.+++++++.||+.
T Consensus 82 -~~~~~lv~e~i~G~~l~~~~~~-----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (263)
T 3tm0_A 82 -DGWSNLLMSEADGVLCSEEYED-----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND 149 (263)
T ss_dssp -TTEEEEEEECCSSEEHHHHCCT-----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred -CCceEEEEEecCCeehhhccCC-----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcc
Confidence 2577999999999999876321 112346888999999999981
Q ss_pred -------------------------------CCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 829 -------------------------------CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 829 -------------------------------~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
..+.++|+|+++.||+++++..+.|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01358999999999999877667899999775
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.87 E-value=3.5e-11 Score=126.18 Aligned_cols=144 Identities=15% Similarity=0.170 Sum_probs=67.7
Q ss_pred CccceeeCCCCCeEEEEEeec---CCcccccCc-cccCCCCCCeeeecCCcCCccCCc-cccCcccccc--ccccccccC
Q 047768 59 HWTGVTCGRRNQRVTKLDLRN---QSIGGILSP-YVGNLSFLRYINIADNDFHGEIPD-RIGNLFRLET--LVLANNSFS 131 (1009)
Q Consensus 59 ~w~gv~C~~~~~~v~~l~l~~---~~l~~~~~~-~~~~l~~L~~L~L~~n~~~~~~p~-~~~~l~~L~~--L~Ls~N~l~ 131 (1009)
.|.|+.|+..+.+|+.+...+ ..+.+.+.+ .+..++. .|....|.-++.++- .|...+.|.. ++++.|+..
T Consensus 79 ~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 79 AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 799999998777887776655 233344432 1222221 223333333333322 2555555555 556666322
Q ss_pred ---CCCCCCCcCCCcCcEEecccccccC--CCchHHhhhccCCcCeEeecCccCCCCCCcccCCcc--ccceeecccCcc
Q 047768 132 ---GRIPTNLSHCSKLITFSAHRNNLVG--EIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLS--ALRVIDIRTNRL 204 (1009)
Q Consensus 132 ---~~~p~~l~~l~~L~~L~l~~n~l~~--~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~--~L~~L~L~~N~l 204 (1009)
+.++....++++|++|+|++|++++ .+|..+ ..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+
T Consensus 157 ~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~--~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl 232 (267)
T 3rw6_A 157 CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIV--QKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSL 232 (267)
T ss_dssp HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHH--HHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTT
T ss_pred HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHH--hhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcC
Confidence 1111112344555555555555554 222222 3445555555555555533 1222222 455555555555
Q ss_pred cCCC
Q 047768 205 WGKI 208 (1009)
Q Consensus 205 ~~~~ 208 (1009)
.+..
T Consensus 233 ~~~~ 236 (267)
T 3rw6_A 233 CDTF 236 (267)
T ss_dssp GGGC
T ss_pred cccc
Confidence 4433
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.84 E-value=6.6e-09 Score=110.51 Aligned_cols=136 Identities=15% Similarity=0.112 Sum_probs=96.4
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCC--cceEEeeeeccccCCCceEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRN--LIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~ 779 (1009)
.+.+....+.|..+.||++.. .+|+.+++|+.... ....+.+|+++++.+.+.+ +.+++++... .+..+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~ 91 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDW 91 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCE
Confidence 444433334566799999965 46778999987533 2356789999999986544 4557776543 24579
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHC------------------------------ 829 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------ 829 (1009)
+||||++|.++. ... .+ ...++.++++.++.||+..
T Consensus 92 ~v~e~i~G~~l~--~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD 157 (264)
T ss_dssp EEEECCSSEETT--TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred EEEEecCCcccC--cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence 999999998873 211 11 1256777888888888641
Q ss_pred -------------------------CCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 830 -------------------------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 830 -------------------------~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
.+.++|+|++|.||+++.++.+.|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887777899999875
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.81 E-value=2.2e-08 Score=112.94 Aligned_cols=165 Identities=12% Similarity=0.091 Sum_probs=78.8
Q ss_pred cCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccc
Q 047768 389 ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMF 468 (1009)
Q Consensus 389 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 468 (1009)
....++..+.+..+.-. .....+....+|+.+.+..+ ++......|.++..|+.+.+..+ ++..-...|.++.+|+.
T Consensus 191 ~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~ 267 (379)
T 4h09_A 191 PAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKT 267 (379)
T ss_dssp CTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCE
T ss_pred cccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcc
Confidence 33344444444332221 33444555555665555443 22233444555555555555443 33233344444444443
Q ss_pred cccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcc
Q 047768 469 FFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNS 548 (1009)
Q Consensus 469 l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 548 (1009)
+.+..+ +...-...|.++.+|+.+++.++.++..-..+|.+|.+|+.+.|..+
T Consensus 268 i~l~~~--------------------------i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~- 320 (379)
T 4h09_A 268 LNFYAK--------------------------VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA- 320 (379)
T ss_dssp EEECCC--------------------------CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-
T ss_pred cccccc--------------------------ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-
Confidence 332211 11111223555666666666666665444556666666666666543
Q ss_pred cccccccccccccccceEcCCCcccccccccccccc
Q 047768 549 FSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENL 584 (1009)
Q Consensus 549 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 584 (1009)
++..-..+|.++++|+.+.+..+ ++..-..+|.+.
T Consensus 321 l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 321 LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 44344456666666666666543 442223444443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.79 E-value=3.3e-10 Score=125.54 Aligned_cols=158 Identities=11% Similarity=0.125 Sum_probs=99.9
Q ss_pred CCeEEEEEeecCCccc-c-------cCccccCCCCCCeeeecCCcCC---------ccCCccccCccccccccccccccC
Q 047768 69 NQRVTKLDLRNQSIGG-I-------LSPYVGNLSFLRYINIADNDFH---------GEIPDRIGNLFRLETLVLANNSFS 131 (1009)
Q Consensus 69 ~~~v~~l~l~~~~l~~-~-------~~~~~~~l~~L~~L~L~~n~~~---------~~~p~~~~~l~~L~~L~Ls~N~l~ 131 (1009)
..+|+.|.+...++.| . +..++..+++|+.|.+.++... +.++..+..+++|+.|+|++|.-.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 3478888888766553 2 2344667889999999765431 235556678899999999988311
Q ss_pred CCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecC--ccCCCC-----CCccc--CCccccceeecccC
Q 047768 132 GRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGD--NQLTGQ-----LPASI--GNLSALRVIDIRTN 202 (1009)
Q Consensus 132 ~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~--n~l~~~-----~p~~~--~~l~~L~~L~L~~N 202 (1009)
.+|. +. +++|++|++..+.+.......+....+++|++|+|+. |...+. +...+ ..+++|++|+|++|
T Consensus 186 -~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~ 262 (362)
T 2ra8_A 186 -SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDA 262 (362)
T ss_dssp -BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESC
T ss_pred -eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCC
Confidence 2343 43 8899999998888765444445444688899988853 221111 11122 24677888888777
Q ss_pred cccCCCCcccc---cccccccccccCccCC
Q 047768 203 RLWGKIPITLS---QLTSLAYLHVGDNHFS 229 (1009)
Q Consensus 203 ~l~~~~p~~~~---~l~~L~~L~L~~N~l~ 229 (1009)
.+....+..+. .+++|++|+|+.|.++
T Consensus 263 ~i~~~~~~~la~a~~~~~L~~LdLs~n~L~ 292 (362)
T 2ra8_A 263 EEQNVVVEMFLESDILPQLETMDISAGVLT 292 (362)
T ss_dssp TTHHHHHHHHHHCSSGGGCSEEECCSSCCB
T ss_pred CCchHHHHHHHhCccCCCCCEEECCCCCCC
Confidence 77543333332 3566777777777665
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.77 E-value=3.5e-09 Score=117.23 Aligned_cols=84 Identities=15% Similarity=0.273 Sum_probs=56.3
Q ss_pred CCCCCCeeeccccccCCCccccc---cCCCCccEEEecCcccccc----cccccccccccceEcCCCccccccccccccc
Q 047768 511 NLKSLVRLGIARNQFSGQIPVTL---GACTSLEYVELQGNSFSGT----IPQSLSSLTSIKELDLSQNNFSGQIPKYLEN 583 (1009)
Q Consensus 511 ~l~~L~~L~ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 583 (1009)
.+++|++|+|++|.+.+..+..+ ..+++|+.|+|+.|.|++. ++..+.++++|+.|+|++|.|+...-..+..
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~ 329 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence 46788888888888765443333 2477888888888888764 3444456788888888888887543333332
Q ss_pred -ccccCceeccccc
Q 047768 584 -LSFLQYLNLSYNH 596 (1009)
Q Consensus 584 -l~~L~~L~ls~N~ 596 (1009)
+ ...+++++|+
T Consensus 330 al--g~~~~~~~~~ 341 (362)
T 2ra8_A 330 SL--PMKIDVSDSQ 341 (362)
T ss_dssp HC--CSEEECCSBC
T ss_pred Hc--CCEEEecCCc
Confidence 2 2457777776
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.76 E-value=7.6e-08 Score=108.44 Aligned_cols=317 Identities=14% Similarity=0.126 Sum_probs=151.5
Q ss_pred ccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhcc
Q 047768 88 PYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRL 167 (1009)
Q Consensus 88 ~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l 167 (1009)
|++..-.+|+.+.+.. .++..-..+|.++++|+.++|..+ ++..-...|.++ +|+.+.+..+ +. .++...|..
T Consensus 40 ~~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~-~I~~~aF~~-- 112 (379)
T 4h09_A 40 PWYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VK-KFGDYVFQG-- 112 (379)
T ss_dssp TTGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CC-EECTTTTTT--
T ss_pred cccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-ee-Eeccceecc--
Confidence 4455566677777753 455333456777888888877644 553344456665 5666655432 22 333333321
Q ss_pred CCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHh
Q 047768 168 FNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYL 247 (1009)
Q Consensus 168 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 247 (1009)
.+|+.+.+.++ ++......|.+. +|+.+.+..+ ++......|....+++...+..+.........+.
T Consensus 113 ~~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~---------- 179 (379)
T 4h09_A 113 TDLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVL---------- 179 (379)
T ss_dssp CCCSEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEE----------
T ss_pred CCcccccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeeccccee----------
Confidence 35666666544 222333344443 4444444432 3334455566666666655554432211000000
Q ss_pred hCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCC
Q 047768 248 YGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGN 327 (1009)
Q Consensus 248 ~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~ 327 (1009)
.+... .+ ...+.....+..+.+..+ ........|....+|+.+.+..+ +..+...+|.+...|+.+.+..+ +..
T Consensus 180 -~~~~~-~~-~~~~~~~~~~~~~~~~~~-~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~ 253 (379)
T 4h09_A 180 -YNKNK-TI-LESYPAAKTGTEFTIPST-VKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTS 253 (379)
T ss_dssp -EETTS-SE-EEECCTTCCCSEEECCTT-CCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCE
T ss_pred -ccccc-ce-eccccccccccccccccc-eeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccE
Confidence 00000 00 001111222222222221 11133344555555555555433 33333444444444444433322 111
Q ss_pred CCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCC
Q 047768 328 GAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGT 407 (1009)
Q Consensus 328 ~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 407 (1009)
++. .+|.++.+ |+.+.+..+ +.......|.++++|+.+.+.++.++.+
T Consensus 254 I~~------~aF~~~~~-------------------------l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I 301 (379)
T 4h09_A 254 IGS------FLLQNCTA-------------------------LKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETL 301 (379)
T ss_dssp ECT------TTTTTCTT-------------------------CCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEE
T ss_pred eCc------cccceeeh-------------------------hcccccccc-ceecccccccccccccccccccccccee
Confidence 111 12333333 344444322 3323445677777777777777777766
Q ss_pred CCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCC
Q 047768 408 IPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCK 464 (1009)
Q Consensus 408 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 464 (1009)
...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+..+ ++..-..+|.++.
T Consensus 302 ~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 302 EPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred hhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 6677777777777777644 55445566777777777776544 4433444555543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.71 E-value=2.7e-08 Score=111.17 Aligned_cols=145 Identities=15% Similarity=0.221 Sum_probs=105.5
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEee--cccc-cchHHHHHHHHHHHhcC--CCCcceEEeeeeccccCCCceEEE
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVIN--LEQK-GGSKSFAAECEALRSIR--HRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
.+.++.|.++.||+.... +..+++|+.. .... .....+.+|+++++.+. +..+.++++++..... .+..++
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~--~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV--IGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--TSSCEE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--cCCeEE
Confidence 467899999999998764 5678888765 2221 12356888999999996 4567888888764321 134689
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHC------------------------------- 829 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------- 829 (1009)
||||+++..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 119 vme~v~G~~l~~~~--------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS--------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE 190 (359)
T ss_dssp EEECCCCBCCCCTT--------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred EEEecCCeecCCCc--------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence 99999987764311 113678888899999999999999731
Q ss_pred ------------------------CCCceecCCCCCceeeCCCCc--eEEecccccccc
Q 047768 830 ------------------------QPPIVHGDLKPSNVLLDHDMV--AHVSDFGLAKFL 862 (1009)
Q Consensus 830 ------------------------~~~ivHrdlk~~Nill~~~~~--~kl~DfGla~~~ 862 (1009)
.+.++|+|+++.||+++.++. +.|+||+.+..-
T Consensus 191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999997753 699999988743
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.67 E-value=1.4e-08 Score=110.62 Aligned_cols=195 Identities=15% Similarity=0.144 Sum_probs=122.5
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-CCC--cceEEeeeeccccCCCceEEEEE
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRN--LIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
.+.++.|....||+.. ..+++|+.... .....+.+|+++++.+. +.. +.+++.++... ......++||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceEEE
Confidence 4568999999999863 45888986422 23467889999998883 332 34455443221 1112347899
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhc----------------------------------
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH---------------------------------- 828 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------------------------------- 828 (1009)
|+++|.++.+.... .++..++..++.+++..++.||+.
T Consensus 96 ~~i~G~~l~~~~~~--------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 96 TKIKGVPLTPLLLN--------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp ECCCCEECCHHHHH--------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred cccCCeECCccccc--------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 99999888653321 267777888888888888888861
Q ss_pred ---------------------CCCCceecCCCCCceeeCC--CCceEEeccccccccCCCCCCCccccCC--------cc
Q 047768 829 ---------------------CQPPIVHGDLKPSNVLLDH--DMVAHVSDFGLAKFLSASPLGNVVETPS--------SS 877 (1009)
Q Consensus 829 ---------------------~~~~ivHrdlk~~Nill~~--~~~~kl~DfGla~~~~~~~~~~~~~~~~--------~~ 877 (1009)
..+.++|+|+++.||+++. +..+.|+||+.+....+.. +...... ..
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DFISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HHHTTCCTTTSCCHHHH
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HHHHHHhhccccCHHHH
Confidence 1245899999999999998 5678999999987543210 0000000 00
Q ss_pred ccccccccccC-ccccCCCCCCCcccchHHHHHHHHHHhCCCCCc
Q 047768 878 IGVKGTIGYVA-PEYGLGGEASMRGGVYSYGILLLEIFTRRRPTE 921 (1009)
Q Consensus 878 ~~~~gt~~y~a-PE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~ 921 (1009)
.......++.. |+.... .....+.|++|.++|++.+|..+|.
T Consensus 246 ~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 00000011111 222111 1122589999999999999988753
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.49 E-value=1.1e-08 Score=107.10 Aligned_cols=79 Identities=20% Similarity=0.368 Sum_probs=46.2
Q ss_pred CCCCCCeeeccccccCC--CccccccCCCCccEEEecCccccccccccccccc--ccceEcCCCccccccccc-------
Q 047768 511 NLKSLVRLGIARNQFSG--QIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLT--SIKELDLSQNNFSGQIPK------- 579 (1009)
Q Consensus 511 ~l~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~------- 579 (1009)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+++.+|.
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 45566666666666665 3345555666666666666666643 2233333 666666666666655542
Q ss_pred ccccccccCcee
Q 047768 580 YLENLSFLQYLN 591 (1009)
Q Consensus 580 ~~~~l~~L~~L~ 591 (1009)
.+..+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 345566666554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.30 E-value=2.4e-08 Score=99.65 Aligned_cols=123 Identities=13% Similarity=0.089 Sum_probs=66.6
Q ss_pred ccCccccCCCCCCeeeecCC-cCCcc----CCccccCccccccccccccccCCC----CCCCCcCCCcCcEEeccccccc
Q 047768 85 ILSPYVGNLSFLRYINIADN-DFHGE----IPDRIGNLFRLETLVLANNSFSGR----IPTNLSHCSKLITFSAHRNNLV 155 (1009)
Q Consensus 85 ~~~~~~~~l~~L~~L~L~~n-~~~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~l~~n~l~ 155 (1009)
.+...+...++|++|+|++| .+... +...+...++|++|||++|.|... +...+...++|++|+|++|.+.
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 34445666777788888877 77632 334455556677777777766531 1222333344444444444443
Q ss_pred CCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeec--ccCcccCC----CCcccccccccccccccCccCC
Q 047768 156 GEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDI--RTNRLWGK----IPITLSQLTSLAYLHVGDNHFS 229 (1009)
Q Consensus 156 ~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 229 (1009)
..--. .+...+...++|++|+| ++|.|... +...+...++|++|+|++|.+.
T Consensus 107 ~~g~~----------------------~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 107 GSGIL----------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHH----------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHH----------------------HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 21111 12334555566677777 66666432 2334445567777777777764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.27 E-value=1.6e-07 Score=93.76 Aligned_cols=89 Identities=18% Similarity=0.267 Sum_probs=56.9
Q ss_pred cCCCCCCeeeccccccCCC----ccccccCCCCccEEEecCcccccc----cccccccccccceEcC--CCcccccc---
Q 047768 510 GNLKSLVRLGIARNQFSGQ----IPVTLGACTSLEYVELQGNSFSGT----IPQSLSSLTSIKELDL--SQNNFSGQ--- 576 (1009)
Q Consensus 510 ~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~~--- 576 (1009)
...++|++|+|++|.|... +...+...++|++|+|++|+|+.. +..++...+.|++|+| ++|.|...
T Consensus 62 ~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~ 141 (185)
T 1io0_A 62 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM 141 (185)
T ss_dssp TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH
T ss_pred HhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHH
Confidence 3345677777777776532 234445556777777777777653 3455666677777777 67777643
Q ss_pred -cccccccccccCceecccccCc
Q 047768 577 -IPKYLENLSFLQYLNLSYNHFE 598 (1009)
Q Consensus 577 -~p~~~~~l~~L~~L~ls~N~l~ 598 (1009)
+...+...+.|++|+|++|.+.
T Consensus 142 ~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 142 EIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCCCcCEEeccCCCCC
Confidence 3344555577788888777764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=8.7e-06 Score=86.69 Aligned_cols=135 Identities=19% Similarity=0.119 Sum_probs=98.0
Q ss_pred cccccCCc-eEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCceEEEEEecc
Q 047768 708 TIGRGSFG-FVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDFKALVYEYM 785 (1009)
Q Consensus 708 ~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 785 (1009)
.+..|..| .||+.....++..++||+-... ....+.+|.+.|+.+. +--+.++++++... +..++|||++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEee
Confidence 45556655 6898877767778999986432 3457889999998884 33466777776543 5679999999
Q ss_pred CCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 047768 786 QNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHC------------------------------------ 829 (1009)
Q Consensus 786 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------ 829 (1009)
++.++.+...... .....++.+++..++.||...
T Consensus 103 ~G~~~~~~~~~~~----------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 103 PGKTAFQVLEEYP----------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp CSEEHHHHHHHCG----------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred CCccccccccCCH----------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 9988877654322 123456677777777777531
Q ss_pred -------------------CCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 830 -------------------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 830 -------------------~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
.+.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1247999999999999988778899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=1.7e-05 Score=85.90 Aligned_cols=137 Identities=19% Similarity=0.199 Sum_probs=92.1
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCC---CcceEEeeeeccccCCCceEEEEE
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHR---NLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
.+.++.|....||+. |..++||+... ......+.+|+++|+.+.+. .+.+++.++.. ..+..++||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEEEE
Confidence 356788888899987 45688888521 12346789999999999642 35566666531 224568999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhc----------------------------------
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH---------------------------------- 828 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------------------------------- 828 (1009)
||++|.++.+..-. .++..+...++.++++.++.||+.
T Consensus 93 e~i~G~~l~~~~~~--------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l 164 (306)
T 3tdw_A 93 RKVQGQILGEDGMA--------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL 164 (306)
T ss_dssp ECCCSEECHHHHHT--------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred eccCCeECchhhhh--------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence 99999887663211 134444555555555555555542
Q ss_pred -----------------------CCCCceecCCCCCceeeCC---CCc-eEEeccccccc
Q 047768 829 -----------------------CQPPIVHGDLKPSNVLLDH---DMV-AHVSDFGLAKF 861 (1009)
Q Consensus 829 -----------------------~~~~ivHrdlk~~Nill~~---~~~-~kl~DfGla~~ 861 (1009)
..+.++|+|+.+.||+++. ++. +.|+||+.+..
T Consensus 165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999987 344 58999998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=8.5e-05 Score=82.50 Aligned_cols=84 Identities=8% Similarity=0.027 Sum_probs=55.4
Q ss_pred CCcc-cccCCceEEEEEEe--c----CCeEEEEEEeeccc---ccchHHHHHHHHHHHhcC-C--CCcceEEeeeecccc
Q 047768 706 SNTI-GRGSFGFVYKGVLH--E----NGMLVAVKVINLEQ---KGGSKSFAAECEALRSIR-H--RNLIKIVTICSSIDF 772 (1009)
Q Consensus 706 ~~~l-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~ 772 (1009)
.+.| +.|....+|+.... . +++.+++|+..... ......+.+|+++++.+. + -.+.++++++.....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999988653 1 15678899864332 112356788999998884 3 356778877643211
Q ss_pred CCCceEEEEEeccCCCCHH
Q 047768 773 KGVDFKALVYEYMQNGSLE 791 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~ 791 (1009)
.+..++||||++|..+.
T Consensus 105 --~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 --LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp --TSSCEEEEECCCCBCCC
T ss_pred --cCCceEEEEecCCCChh
Confidence 13457999999886653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.63 E-value=2.1e-05 Score=76.18 Aligned_cols=84 Identities=15% Similarity=0.084 Sum_probs=62.9
Q ss_pred CCCCeeeccccccCCCccccccCCCCccEEEecCcc-cccccccccccc----cccceEcCCCcc-cccccccccccccc
Q 047768 513 KSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNS-FSGTIPQSLSSL----TSIKELDLSQNN-FSGQIPKYLENLSF 586 (1009)
Q Consensus 513 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 586 (1009)
..|+.||++++.++..--..+.++++|+.|+|+++. ++..--..++.+ ++|++|||++|. ++..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 468888888888876655667888889999999884 776544556554 478999998874 77544456778888
Q ss_pred cCceeccccc
Q 047768 587 LQYLNLSYNH 596 (1009)
Q Consensus 587 L~~L~ls~N~ 596 (1009)
|++|+|++++
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999988774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00014 Score=82.11 Aligned_cols=76 Identities=16% Similarity=0.117 Sum_probs=48.9
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeecccc-------cchHHHHHHHHHHHhcCC--C-CcceEEeeeeccccCCC
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-------GGSKSFAAECEALRSIRH--R-NLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~~ 775 (1009)
.+.+|.|..+.||++....+++.|+||....... .....+..|.++++.+.. + .+.+++.+..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~------- 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT------- 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcC-------
Confidence 4579999999999997655578899998643211 123567889999988742 3 3445554421
Q ss_pred ceEEEEEeccCCC
Q 047768 776 DFKALVYEYMQNG 788 (1009)
Q Consensus 776 ~~~~lv~e~~~~g 788 (1009)
...++||||+++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 2347999999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00035 Score=74.82 Aligned_cols=78 Identities=17% Similarity=0.174 Sum_probs=57.0
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-C--CCcceEEeeeeccccCCCceE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-H--RNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~~~~~ 778 (1009)
+....+.+|.|..+.||+.+.. +|+.|+||+...........+.+|++.|+.+. . --+.+++++. ..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~ 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DR 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TT
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cc
Confidence 4555678999999999999874 78999999875444444567899999999884 2 2345556542 23
Q ss_pred EEEEeccCCCC
Q 047768 779 ALVYEYMQNGS 789 (1009)
Q Consensus 779 ~lv~e~~~~gs 789 (1009)
++||||++.+.
T Consensus 86 ~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 TLAMEWVDERP 96 (288)
T ss_dssp EEEEECCCCCC
T ss_pred eEEEEeecccC
Confidence 78999998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00078 Score=74.08 Aligned_cols=148 Identities=18% Similarity=0.133 Sum_probs=80.4
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC--CCCcceEEeeeeccc-cCCCceEEEEEe
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR--HRNLIKIVTICSSID-FKGVDFKALVYE 783 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~-~~~~~~~~lv~e 783 (1009)
+.++.|..+.||+.... +..+++|+... ....+..|.++++.+. .-.+.+++....... ....+..++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34666778999998763 44589998854 2244556666666653 122334443110000 011346789999
Q ss_pred ccCCCCHH--------------HHHhccCCCC----C----ccCCCHHHH------------------------------
Q 047768 784 YMQNGSLE--------------EWLHQRDDQL----G----ICNLSLIQR------------------------------ 811 (1009)
Q Consensus 784 ~~~~gsL~--------------~~l~~~~~~~----~----~~~l~~~~~------------------------------ 811 (1009)
|++|..+. ..++...... . ...-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99886432 1122211100 0 001123211
Q ss_pred -HHHHHHHHHHHHHHhh----------cCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 812 -LNIVIDVASAVEYLHH----------HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 812 -~~i~~~ia~~l~~LH~----------~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
..+...+..++.+|+. ...+.++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445666663 124589999999999999888899999999775
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.26 E-value=7.4e-05 Score=72.32 Aligned_cols=34 Identities=6% Similarity=0.075 Sum_probs=15.7
Q ss_pred CcCeEeecCcc-CCCCCCcccCCccccceeecccC
Q 047768 169 NLQGLSVGDNQ-LTGQLPASIGNLSALRVIDIRTN 202 (1009)
Q Consensus 169 ~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~L~~N 202 (1009)
+|++|+|++|. ++..--..+.++++|++|+|+++
T Consensus 115 ~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c 149 (176)
T 3e4g_A 115 SMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDL 149 (176)
T ss_dssp HCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESC
T ss_pred CCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCC
Confidence 35555555542 44322233444555555555554
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0022 Score=69.00 Aligned_cols=141 Identities=21% Similarity=0.198 Sum_probs=89.9
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC---CCCcceEEeeeeccccCCCceEEEEE
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR---HRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
.+.++.|....+|+... ++..++||+.... ....+.+|.+.|+.+. ...+.++++++... +..++||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-----g~~~lvm 110 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-----GHSFLLL 110 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-----SEEEEEE
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-----CceEEEE
Confidence 45789999999999875 4678889987532 3567889999998883 35677888876432 5679999
Q ss_pred eccCCCCHH--------H---HHhccCC--CCCc--------------cCCCHHHHH---HHHH----------------
Q 047768 783 EYMQNGSLE--------E---WLHQRDD--QLGI--------------CNLSLIQRL---NIVI---------------- 816 (1009)
Q Consensus 783 e~~~~gsL~--------~---~l~~~~~--~~~~--------------~~l~~~~~~---~i~~---------------- 816 (1009)
||+++..+. . .++.... ..+. ..-+|.+.. ++..
T Consensus 111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~ 190 (312)
T 3jr1_A 111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID 190 (312)
T ss_dssp ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence 999987541 1 2333221 1110 012454321 1111
Q ss_pred HHH-HHHHHHhh-cCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 817 DVA-SAVEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 817 ~ia-~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.+. .....|.. ...+.+||+|+.+.|++++.++ +.|.||.
T Consensus 191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 11223321 2256899999999999999887 8899974
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.00067 Score=62.58 Aligned_cols=60 Identities=22% Similarity=0.371 Sum_probs=38.0
Q ss_pred EEEecCcccc-cccccccccccccceEcCCCcccccccccccccccccCceecccccCcccCC
Q 047768 541 YVELQGNSFS-GTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVP 602 (1009)
Q Consensus 541 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p 602 (1009)
.++.+++.|+ ..+|..+. ++|+.|||++|+|+...+..|..+++|++|+|++|++.+.+-
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~ 72 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCR 72 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGG
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCc
Confidence 5566666664 24444332 356777777777775555667777777777777777766544
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0035 Score=71.02 Aligned_cols=78 Identities=15% Similarity=0.249 Sum_probs=49.2
Q ss_pred CCCceecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccc--cccccCccccCCC---CCCCcccch
Q 047768 830 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG--TIGYVAPEYGLGG---EASMRGGVY 904 (1009)
Q Consensus 830 ~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~Dvw 904 (1009)
.+.++|+|+++.||+++.++ ++++||+.+..-.+. .+- ..... ...|++|+..... ......++.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-----~Dl----a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-----FDI----GAYLGNLILAFFAQDGHATQENDRKEYKQWIL 300 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-----HHH----HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-----HHH----HHHHHHHHHHHHhcccccccccchHHHHHHHH
Confidence 34899999999999998876 999999988754321 000 00000 1346777655321 112234556
Q ss_pred HHHHHHHHHHhCC
Q 047768 905 SYGILLLEIFTRR 917 (1009)
Q Consensus 905 S~Gvvl~elltg~ 917 (1009)
+....+|+.++++
T Consensus 301 ~~~~~~~~~y~~~ 313 (420)
T 2pyw_A 301 RTIEQTWNLFNKR 313 (420)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 7888888887754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.60 E-value=0.00023 Score=70.18 Aligned_cols=42 Identities=10% Similarity=0.093 Sum_probs=23.0
Q ss_pred ccCcCccCEEEccCCCC---CCC----CCCCcCCcccccceeccccccc
Q 047768 388 IANLVNLNSLRMEANRL---TGT----IPHVIGELKNLQLLHLHANFLQ 429 (1009)
Q Consensus 388 ~~~l~~L~~L~L~~N~l---~~~----~p~~~~~l~~L~~L~L~~N~l~ 429 (1009)
+..-+.|+.|+|++|.. ... +.+.+..-+.|+.|+|+.|.+.
T Consensus 122 L~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 122 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 44445677777765533 211 2233445566777777766653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0011 Score=65.38 Aligned_cols=86 Identities=15% Similarity=0.213 Sum_probs=50.0
Q ss_pred CCCCCeeeccccccCCC----ccccccCCCCccEEEecCccccccc----ccccccccccceEcCCCc---cccc----c
Q 047768 512 LKSLVRLGIARNQFSGQ----IPVTLGACTSLEYVELQGNSFSGTI----PQSLSSLTSIKELDLSQN---NFSG----Q 576 (1009)
Q Consensus 512 l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N---~l~~----~ 576 (1009)
-+.|+.|+|++|+|... +...+..-+.|+.|+|++|+|+..- -+++..-+.|++|+|++| .+.. .
T Consensus 69 N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ 148 (197)
T 1pgv_A 69 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMD 148 (197)
T ss_dssp CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHH
T ss_pred CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHH
Confidence 35667777777776532 2333445567777777777776432 233444456777777654 3332 2
Q ss_pred cccccccccccCceecccccC
Q 047768 577 IPKYLENLSFLQYLNLSYNHF 597 (1009)
Q Consensus 577 ~p~~~~~l~~L~~L~ls~N~l 597 (1009)
+-..+..-+.|+.|+++.|..
T Consensus 149 ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 149 MMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHhCCCcCeEeccCCCc
Confidence 334555566777777766643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0034 Score=57.74 Aligned_cols=37 Identities=22% Similarity=0.381 Sum_probs=22.2
Q ss_pred CccEEEecCcccccccccccccccccceEcCCCcccc
Q 047768 538 SLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFS 574 (1009)
Q Consensus 538 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 574 (1009)
+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4556666666666444555666666666666666553
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.37 E-value=0.01 Score=63.77 Aligned_cols=71 Identities=11% Similarity=0.122 Sum_probs=43.6
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCc-ceEEeeeeccccCCCceEEEEEec
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNL-IKIVTICSSIDFKGVDFKALVYEY 784 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~ 784 (1009)
.+.++.|....+|+. ..+++|+...... ......+|+.+++.+...++ .++++++. +.-++|+||
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~~-------~~~~~v~e~ 88 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVDP-------ATGVMVTRY 88 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT-------TTCCEEEEC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEEC-------CCCEEEEee
Confidence 677889999999998 3588888753211 11234568888887742222 45665421 223689999
Q ss_pred c-CCCCH
Q 047768 785 M-QNGSL 790 (1009)
Q Consensus 785 ~-~~gsL 790 (1009)
+ ++.++
T Consensus 89 i~~g~~l 95 (301)
T 3dxq_A 89 IAGAQTM 95 (301)
T ss_dssp CTTCEEC
T ss_pred cCCCccC
Confidence 9 55443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.34 E-value=0.012 Score=63.94 Aligned_cols=167 Identities=13% Similarity=0.126 Sum_probs=89.3
Q ss_pred ccCHHHHHHHhccCccC-----CcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCC--cce
Q 047768 690 MVSYKELSKATNEFSSS-----NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRN--LIK 762 (1009)
Q Consensus 690 ~~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 762 (1009)
.++.+++.....+|... +.++.|....+|+.... +| .+++|+.... .....+..|+++++.+...+ +.+
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCc
Confidence 34556666555566542 34667888899998764 33 6889988542 12356777888888774222 333
Q ss_pred EEeeeecccc-CCCceEEEEEeccCCCCHH-----H---------HHhccCCCCCcc---CC---CHHHHHH--------
Q 047768 763 IVTICSSIDF-KGVDFKALVYEYMQNGSLE-----E---------WLHQRDDQLGIC---NL---SLIQRLN-------- 813 (1009)
Q Consensus 763 l~~~~~~~~~-~~~~~~~lv~e~~~~gsL~-----~---------~l~~~~~~~~~~---~l---~~~~~~~-------- 813 (1009)
++.......+ ...+..+++++|++|..+. . .++......... .. .|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3322110000 0124568999999875431 0 122211110000 01 1221100
Q ss_pred ----HHHHHHHHHHHHhhc----CCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 814 ----IVIDVASAVEYLHHH----CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 814 ----i~~~ia~~l~~LH~~----~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
+...+...+++++.. .+.+++|+|+.+.||+++.+..+.++||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455555532 23479999999999999987767899999775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.34 E-value=0.034 Score=60.34 Aligned_cols=168 Identities=15% Similarity=0.135 Sum_probs=90.3
Q ss_pred CCccCHHHHHHHhccCcc-----CCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCC--Cc
Q 047768 688 FPMVSYKELSKATNEFSS-----SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHR--NL 760 (1009)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--ni 760 (1009)
+...+.+++......|.+ ...++ |....||+.... +|+.+++|+..... .....+..|..+++.+... .+
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCee
Confidence 344555555555555533 23466 888899987653 56679999985321 2346777888888887422 23
Q ss_pred ceEEeeeeccc-cCCCceEEEEEeccCCCCHH-----H------H---HhccCCCC---CccCCCHHHH----HH-----
Q 047768 761 IKIVTICSSID-FKGVDFKALVYEYMQNGSLE-----E------W---LHQRDDQL---GICNLSLIQR----LN----- 813 (1009)
Q Consensus 761 v~l~~~~~~~~-~~~~~~~~lv~e~~~~gsL~-----~------~---l~~~~~~~---~~~~l~~~~~----~~----- 813 (1009)
.+++.. .... ....+..++|+||++|..+. . . ++...... .....++... ..
T Consensus 85 p~~~~~-~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 163 (328)
T 1zyl_A 85 AAPVAF-NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDA 163 (328)
T ss_dssp CCCCCB-TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTC
T ss_pred cceeec-CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhc
Confidence 444443 1100 01134567899999874321 1 1 11111000 0111222111 00
Q ss_pred ----------HHHHHHHHHHHHhhc----CCCCceecCCCCCceeeCCCCceEEeccccccc
Q 047768 814 ----------IVIDVASAVEYLHHH----CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861 (1009)
Q Consensus 814 ----------i~~~ia~~l~~LH~~----~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~ 861 (1009)
+...+...++.+... .+..++|+|+++.||+++ + .+.++||+.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 164 TLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 111111222333221 234689999999999999 4 899999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.18 E-value=0.015 Score=64.27 Aligned_cols=145 Identities=12% Similarity=0.156 Sum_probs=82.4
Q ss_pred CcccccCCceEEEEEEec-------CCeEEEEEEeecccccchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCceE
Q 047768 707 NTIGRGSFGFVYKGVLHE-------NGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
+.+..|-...+|+..... +++.+++|+... .........+|.++++.+. +.-..++++++..
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--------- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE--------- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT---------
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC---------
Confidence 567778889999988642 346899998622 1223456778999998884 3333566665421
Q ss_pred EEEEeccCCCCHH--------------HH---HhccCCCCCccCC-CHHHHHHHHHHHHH-------------------H
Q 047768 779 ALVYEYMQNGSLE--------------EW---LHQRDDQLGICNL-SLIQRLNIVIDVAS-------------------A 821 (1009)
Q Consensus 779 ~lv~e~~~~gsL~--------------~~---l~~~~~~~~~~~l-~~~~~~~i~~~ia~-------------------~ 821 (1009)
.+|+||++|..+. +. ++......+..+. -+.++.++..++.. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 2899999875442 11 1211111111111 23444444443321 2
Q ss_pred HHHHhh----c-CCCCceecCCCCCceeeCCC----CceEEeccccccc
Q 047768 822 VEYLHH----H-CQPPIVHGDLKPSNVLLDHD----MVAHVSDFGLAKF 861 (1009)
Q Consensus 822 l~~LH~----~-~~~~ivHrdlk~~Nill~~~----~~~kl~DfGla~~ 861 (1009)
+..|.+ . .+..++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 333322 1 23468999999999999876 7899999998863
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.09 E-value=0.02 Score=65.03 Aligned_cols=74 Identities=12% Similarity=0.080 Sum_probs=46.4
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCc-ceEEeeeeccccCCCceEEEEEec
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNL-IKIVTICSSIDFKGVDFKALVYEY 784 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~ 784 (1009)
.+.|+.|-...+|+......+..+++|+...... ..-...+|..+++.+...++ .++++++. . ..|+||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~-------~--G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT-------N--GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET-------T--EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC-------C--eEEEEe
Confidence 3568888889999998753347899998743221 11123689999998864444 56666542 1 259999
Q ss_pred cCCCC
Q 047768 785 MQNGS 789 (1009)
Q Consensus 785 ~~~gs 789 (1009)
+++.+
T Consensus 183 I~G~~ 187 (458)
T 2qg7_A 183 MDGYA 187 (458)
T ss_dssp CCSEE
T ss_pred eCCcc
Confidence 98644
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.00 E-value=0.015 Score=65.80 Aligned_cols=73 Identities=19% Similarity=0.165 Sum_probs=48.3
Q ss_pred CCcccccCCceEEEEEEec-------CCeEEEEEEeecccccchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCce
Q 047768 706 SNTIGRGSFGFVYKGVLHE-------NGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.+.|+.|....||++.... ++..+++|+.... .....+.+|..+++.+. +.-..++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~-----~--- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS-----G--- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T---
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC-----C---
Confidence 3568888889999998752 2568999987321 12256668999998884 332356666532 1
Q ss_pred EEEEEeccCCCC
Q 047768 778 KALVYEYMQNGS 789 (1009)
Q Consensus 778 ~~lv~e~~~~gs 789 (1009)
.+|+||+++.+
T Consensus 148 -g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 -GRLEEYIPSRP 158 (429)
T ss_dssp -EEEECCCCEEE
T ss_pred -CEEEEEeCCcc
Confidence 28899997533
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.93 E-value=0.052 Score=59.05 Aligned_cols=145 Identities=13% Similarity=0.053 Sum_probs=73.5
Q ss_pred CcccccCCce-EEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCC--CCcceEEeeeeccccCCCceEEEEEe
Q 047768 707 NTIGRGSFGF-VYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRH--RNLIKIVTICSSIDFKGVDFKALVYE 783 (1009)
Q Consensus 707 ~~lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e 783 (1009)
+.++.|+... +|+... .+|+.+++|...... ...+..|+++++.+.. -.+.+++.++.. . + +++||
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~----~-g--~ll~e 92 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHA----R-G--LLLIE 92 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETT----T-T--EEEEC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCC----C-C--EEEEe
Confidence 4565555544 666643 236677777643221 1345567777776632 235566665321 1 2 68999
Q ss_pred ccCCCCHHHHHhccCCC--------------------CCccCCCHHHHH-------H-H------------HHHHHHHHH
Q 047768 784 YMQNGSLEEWLHQRDDQ--------------------LGICNLSLIQRL-------N-I------------VIDVASAVE 823 (1009)
Q Consensus 784 ~~~~gsL~~~l~~~~~~--------------------~~~~~l~~~~~~-------~-i------------~~~ia~~l~ 823 (1009)
++.+..+.+++...... .....++..... . + ...+...++
T Consensus 93 ~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~ 172 (333)
T 3csv_A 93 DLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFA 172 (333)
T ss_dssp CCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHH
T ss_pred eCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 99777776554321110 001112211100 0 0 011112222
Q ss_pred HHhh---cCCCCceecCCCCCceeeCCC----CceEEecccccccc
Q 047768 824 YLHH---HCQPPIVHGDLKPSNVLLDHD----MVAHVSDFGLAKFL 862 (1009)
Q Consensus 824 ~LH~---~~~~~ivHrdlk~~Nill~~~----~~~kl~DfGla~~~ 862 (1009)
.+.. ...+.++|||+.+.||+++.+ +.+.|+||+.+..-
T Consensus 173 ~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 173 QILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 2211 124479999999999999875 68999999988743
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.83 E-value=0.097 Score=51.78 Aligned_cols=103 Identities=17% Similarity=0.147 Sum_probs=67.9
Q ss_pred CCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccccCCCCC
Q 047768 788 GSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPL 867 (1009)
Q Consensus 788 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 867 (1009)
-||.+.|+.... +++++++|.++.|.+.+|.-.-.+.. . ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~~~-----PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ-----PINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred ccHHHHHHHcCC-----CcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-------
Confidence 379999998875 49999999999999999877622111 1 1333457899999999988764 1111
Q ss_pred CCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCC
Q 047768 868 GNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919 (1009)
Q Consensus 868 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p 919 (1009)
.....+.|||... ...+.+.=|||+|+++|.-+-=..|
T Consensus 98 -------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123467888753 3556778899999999998874443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.32 E-value=0.019 Score=63.57 Aligned_cols=73 Identities=11% Similarity=0.114 Sum_probs=43.0
Q ss_pred CcccccCCceEEEEEEec--------CCeEEEEEEeecccccchHHHHHHHHHHHhcCCCC-cceEEeeeeccccCCCce
Q 047768 707 NTIGRGSFGFVYKGVLHE--------NGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRN-LIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~~ 777 (1009)
+.++.|....+|+..... .+..+++|+...... .......|.++++.+...+ +.++++.. .
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~---- 108 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF-----N---- 108 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec-----C----
Confidence 467788889999998753 126788898643221 1113467888888884333 44666542 1
Q ss_pred EEEEEeccCCCC
Q 047768 778 KALVYEYMQNGS 789 (1009)
Q Consensus 778 ~~lv~e~~~~gs 789 (1009)
-++||||+++..
T Consensus 109 ~~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 GGRIEEWLYGDP 120 (369)
T ss_dssp TEEEEECCCSEE
T ss_pred CcEEEEEecCCc
Confidence 258999998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.03 E-value=0.044 Score=59.77 Aligned_cols=33 Identities=18% Similarity=0.327 Sum_probs=28.6
Q ss_pred CCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 830 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 830 ~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
...++|+|+.+.||+++.++.+.++||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 347999999999999998889999999877643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.71 E-value=0.17 Score=56.52 Aligned_cols=73 Identities=10% Similarity=0.091 Sum_probs=46.9
Q ss_pred CcccccCCceEEEEEEecC-------CeEEEEEEeecccccchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCceE
Q 047768 707 NTIGRGSFGFVYKGVLHEN-------GMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
+.+..|-...+|+...... ++.+++|+..... ...-...+|.++++.+. +.-..++++.+. -
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~---------~ 145 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP---------E 145 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET---------T
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC---------C
Confidence 4577788899999987521 5778899863321 12223467888888884 333455555321 2
Q ss_pred EEEEeccCCCC
Q 047768 779 ALVYEYMQNGS 789 (1009)
Q Consensus 779 ~lv~e~~~~gs 789 (1009)
+.|+||++|..
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 68999998865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.18 E-value=1.3 Score=49.20 Aligned_cols=30 Identities=23% Similarity=0.429 Sum_probs=25.4
Q ss_pred CceecCCCCCceee------CCCCceEEeccccccc
Q 047768 832 PIVHGDLKPSNVLL------DHDMVAHVSDFGLAKF 861 (1009)
Q Consensus 832 ~ivHrdlk~~Nill------~~~~~~kl~DfGla~~ 861 (1009)
.++|+|+.+.||++ +++..+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567899999998864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.48 E-value=0.59 Score=32.94 Aligned_cols=18 Identities=22% Similarity=0.479 Sum_probs=9.2
Q ss_pred eeehhhhHHHHHHHHhhh
Q 047768 647 KVVIPVIGGSCLILSVCI 664 (1009)
Q Consensus 647 ~~~~~~~~~~~~~~~v~~ 664 (1009)
.++..+++|+++++++++
T Consensus 12 ~IA~gVVgGv~~~~ii~~ 29 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVAL 29 (44)
T ss_dssp SSTHHHHHHHHHHHHHHH
T ss_pred eEEeehhHHHHHHHHHHH
Confidence 355566665555444433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1009 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-45 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-37 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-14 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 6e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 5e-57
Identities = 70/302 (23%), Positives = 126/302 (41%), Gaps = 47/302 (15%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHR 758
+ + IG GSFG VYKG H + VAVK++N+ ++F E LR RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
N++ + ++ A+V ++ + SL LH + + +I+ ++I
Sbjct: 65 NILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIETKF-----EMIKLIDIARQT 113
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
A ++YLH I+H DLK +N+ L D+ + DFGLA S + E
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ----- 165
Query: 879 GVKGTIGYVAPEYGLGGEA---SMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935
+ G+I ++APE + S + VY++GI+L E+ T + P ++ N + +
Sbjct: 166 -LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224
Query: 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995
L + ++ C A+ + C + +R ++
Sbjct: 225 GYLSPDLSKV-------------------RSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
Query: 996 KL 997
+
Sbjct: 266 SI 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (474), Expect = 1e-53
Identities = 72/325 (22%), Positives = 136/325 (41%), Gaps = 52/325 (16%)
Query: 692 SYKELSKATNEFSSS---------NTIGRGSFGFVYKGVLHENG---MLVAVKVINLEQ- 738
++++ ++A EF+ IG G FG V G L G + VA+K +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 739 KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRD 798
+ + F +E + H N+I + + + ++ E+M+NGSL+ +L Q D
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV-----MIITEFMENGSLDSFLRQND 122
Query: 799 DQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858
++IQ + ++ +A+ ++YL VH DL N+L++ ++V VSDFGL
Sbjct: 123 -----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174
Query: 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR 918
++FL T +S++G K I + APE + + V+SYGI++ E+ +
Sbjct: 175 SRFLED---DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
Query: 919 PTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVA 978
+ V+ ++ + R +C A+ + +
Sbjct: 232 RPYWDMT-------------NQDVINAIEQ----------DYRLPPPMDCPSALHQLMLD 268
Query: 979 CSIESPFDRMEMTDVVVKLCHARQN 1003
C + R + +V L +N
Sbjct: 269 CWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 4e-53
Identities = 66/306 (21%), Positives = 117/306 (38%), Gaps = 25/306 (8%)
Query: 696 LSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKS-FAAECEALRS 754
+ ++F + +G G+ G V+K +G+++A K+I+LE K ++ E + L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 755 IRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNI 814
++ S ++ E+M GSL++ L + + +
Sbjct: 61 CNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKAG------RIPEQILGKV 109
Query: 815 VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETP 874
I V + YL I+H D+KPSN+L++ + DFG++ L S + V
Sbjct: 110 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--- 164
Query: 875 SSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL-HEF 933
GT Y++PE G S++ ++S G+ L+E+ R P + L L
Sbjct: 165 -------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217
Query: 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDV 993
+ PL +SR L+ I + S +E D
Sbjct: 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277
Query: 994 VVKLCH 999
V K
Sbjct: 278 VNKCLI 283
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 9e-52
Identities = 62/248 (25%), Positives = 102/248 (41%), Gaps = 22/248 (8%)
Query: 709 IGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTI 766
IGRGSF VYKG+ E + VA + + K + F E E L+ ++H N+++
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
S KG LV E M +G+L+ +L + + + + + +++LH
Sbjct: 77 WES-TVKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLH 129
Query: 827 HHCQPPIVHGDLKPSNVLL-DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
PPI+H DLK N+ + + D GLA AS V+ GT
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----------GTPE 178
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEI 945
++APE + VY++G+ +LE+ T P N P ++
Sbjct: 179 FMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237
Query: 946 VDPSLLPL 953
P + +
Sbjct: 238 AIPEVKEI 245
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-51
Identities = 66/303 (21%), Positives = 122/303 (40%), Gaps = 33/303 (10%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTIC 767
+IG+G FG V++G G VAVK+ + ++ S AE +RH N++ +
Sbjct: 10 SIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAAD 66
Query: 768 SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH 827
+ + LV +Y ++GSL ++L++ +++ + + + AS + +LH
Sbjct: 67 NKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHM 118
Query: 828 HC-----QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
+P I H DLK N+L+ + ++D GLA ++ + G
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT----DTIDIAPNHRVG 174
Query: 883 TIGYVAPEY------GLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF--A 934
T Y+APE E+ R +Y+ G++ EI R + L ++ +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVV 994
++ E + + L P R S E L + K C + R+ +
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQS-----CEALRVMAKIMRECWYANGAARLTALRIK 289
Query: 995 VKL 997
L
Sbjct: 290 KTL 292
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 7e-51
Identities = 68/297 (22%), Positives = 126/297 (42%), Gaps = 45/297 (15%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNL 760
+G G FG V+ G + VAVK + + +F AE ++ ++H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRL 70
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
+++ + + + ++ EYM+NGSL ++L L++ + L++ +A
Sbjct: 71 VRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAE 120
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
+ ++ +H DL+ +N+L+ + ++DFGLA+ + + ++ G
Sbjct: 121 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN-------EYTAREGA 170
Query: 881 KGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940
K I + APE G +++ V+S+GILL EI T R G+T E + E
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI----PYPGMTNPEVIQNL--E 224
Query: 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997
+ +V P P E L +++ C E P DR + L
Sbjct: 225 RGYRMVRPDNCPEE--------------LYQLMR---LCWKERPEDRPTFDYLRSVL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (453), Expect = 7e-51
Identities = 72/314 (22%), Positives = 137/314 (43%), Gaps = 45/314 (14%)
Query: 684 MEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSK 743
M+ P +Y + + + + +G G +G VY+GV + + VAVK + E +
Sbjct: 2 MDPSSP--NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVE 58
Query: 744 SFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGI 803
F E ++ I+H NL++++ +C+ ++ E+M G+L ++L + + Q
Sbjct: 59 EFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNRQ--- 110
Query: 804 CNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863
+S + L + ++SA+EYL +H DL N L+ + + V+DFGL++ ++
Sbjct: 111 -EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166
Query: 864 ASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923
+T ++ G K I + APE + S++ V+++G+LL EI T
Sbjct: 167 G-------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219
Query: 924 FNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIES 983
+ +V E+++ R R E C V + AC +
Sbjct: 220 ID-------------LSQVYELLEKDY----------RMERPEGCPEKVYELMRACWQWN 256
Query: 984 PFDRMEMTDVVVKL 997
P DR ++
Sbjct: 257 PSDRPSFAEIHQAF 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-50
Identities = 67/310 (21%), Positives = 123/310 (39%), Gaps = 46/310 (14%)
Query: 694 KELSKATNEFSSSNT-IGRGSFGFVYKGVLHE--NGMLVAVKVINLE-QKGGSKSFAAEC 749
K+L + ++ +G G+FG V +GV + VA+KV+ +K ++ E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 750 EALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLI 809
+ + + + +++++ +C + LV E G L ++L + +++ +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLVGKREEI-----PVS 109
Query: 810 QRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGN 869
++ V+ ++YL VH DL NVLL + A +SDFGL+K L A
Sbjct: 110 NVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--- 163
Query: 870 VVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLT 929
++ K + + APE + S R V+SYG+ + E + + + +
Sbjct: 164 --SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK----PYKKMK 217
Query: 930 LHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME 989
E K ME P P E L A++ C I DR +
Sbjct: 218 GPEVMAFIEQGKRMEC--PPECPPE--------------LYALMS---DCWIYKWEDRPD 258
Query: 990 MTDVVVKLCH 999
V ++
Sbjct: 259 FLTVEQRMRA 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-49
Identities = 65/307 (21%), Positives = 118/307 (38%), Gaps = 43/307 (14%)
Query: 706 SNTIGRGSFGFVYKGVLHEN---GMLVAVKVIN-LEQKGGSKSFAAECEALRSIRHRNLI 761
+ IGRG FG VY G L +N + AVK +N + G F E ++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
++ IC + +V YM++G L ++ N ++ + + VA
Sbjct: 92 SLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKG 142
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
+ VH DL N +LD V+DFGLA+ + ++ + G K
Sbjct: 143 ---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----FDSVHNKTGAK 195
Query: 882 GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEK 941
+ ++A E + + + V+S+G+LL E+ TR P + + L
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLL--- 248
Query: 942 VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001
R ++ E C + + + C R +++V ++
Sbjct: 249 ----------------QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292
Query: 1002 QNFLGQR 1008
F+G+
Sbjct: 293 STFIGEH 299
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 5e-49
Identities = 83/303 (27%), Positives = 121/303 (39%), Gaps = 49/303 (16%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNL 760
E TIG+G FG V G G VAVK I + +++F AE + +RH NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNL 62
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
++++ + + +V EYM GSL ++L R + L L +DV
Sbjct: 63 VQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCE 114
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
A+EYL + VH DL NVL+ D VA VSDFGL K S S+
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----------STQDTG 160
Query: 881 KGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940
K + + APE + S + V+S+GILL EI++ R + L + R
Sbjct: 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKG 216
Query: 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000
M+ D C AV + C R + +L H
Sbjct: 217 YKMDAPD-------------------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
Query: 1001 RQN 1003
+ +
Sbjct: 258 KTH 260
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 9e-49
Identities = 56/253 (22%), Positives = 100/253 (39%), Gaps = 23/253 (9%)
Query: 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE--QKGGSKSFAAECEALRS 754
S+A + + TIG GS+G K +G ++ K ++ + + +E LR
Sbjct: 1 SRAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 59
Query: 755 IRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNI 814
++H N+++ + +V EY + G L + + + L L +
Sbjct: 60 LKHPNIVRYYDRIIDRTNTTL---YIVMEYCEGGDLASVITKGTKERQ--YLDEEFVLRV 114
Query: 815 VIDVASAVEYLHHH--CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVE 872
+ + A++ H ++H DLKP+NV LD + DFGLA+ L+
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--------H 166
Query: 873 TPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHE 932
S + GT Y++PE + + ++S G LL E+ P + E
Sbjct: 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP-----FTAFSQKE 221
Query: 933 FAKRALPEKVMEI 945
A + K I
Sbjct: 222 LAGKIREGKFRRI 234
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-48
Identities = 65/297 (21%), Positives = 112/297 (37%), Gaps = 47/297 (15%)
Query: 707 NTIGRGSFGFVYKGVLHEN--GMLVAVKVINLE--QKGGSKSFAAECEALRSIRHRNLIK 762
+G G+FG V KG VAVK++ E AE ++ + + +++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 763 IVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
++ IC + LV E + G L ++L Q ++ + +V V+ +
Sbjct: 73 MIGICE------AESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGM 120
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
+YL VH DL NVLL A +SDFGL+K L A + K
Sbjct: 121 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKW 172
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKV 942
+ + APE + S + V+S+G+L+ E F+ + G+ E +
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK----PYRGMKGSEVTAMLEKGER 228
Query: 943 MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999
M P+ P E + ++ C +R V ++L +
Sbjct: 229 MGC--PAGCPRE--------------MYDLMN---LCWTYDVENRPGFAAVELRLRN 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-48
Identities = 66/297 (22%), Positives = 121/297 (40%), Gaps = 45/297 (15%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNL 760
+G+G FG V+ G VA+K + ++F E + ++ +RH L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKL 74
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
+++ + S + +V EYM GSL ++L + Q +++ +AS
Sbjct: 75 VQLYAVVS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIAS 124
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
+ Y+ VH DL+ +N+L+ ++V V+DFGLA+ + + ++ G
Sbjct: 125 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGA 174
Query: 881 KGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940
K I + APE L G +++ V+S+GILL E+ T+ R
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------------NR 221
Query: 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997
+V++ V+ R EC ++ C + P +R + L
Sbjct: 222 EVLDQVERGY----------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-48
Identities = 68/302 (22%), Positives = 128/302 (42%), Gaps = 46/302 (15%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENG----MLVAVKVINLEQ-KGGSKSFAAECEALRSI 755
+ + IG G FG VYKG+L + + VA+K + + F E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 756 RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
H N+I++ + S ++ EYM+NG+L+++L ++D S++Q + ++
Sbjct: 67 SHHNIIRLEGVISKYKPM-----MIITEYMENGALDKFLREKD-----GEFSVLQLVGML 116
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
+A+ + + VH DL N+L++ ++V VSDFGL++ L P E
Sbjct: 117 RGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATY 168
Query: 876 SSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935
++ G K I + APE + + V+S+GI++ E+ T +
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------- 218
Query: 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995
+VM+ ++ R +C A+ + + C + R + D+V
Sbjct: 219 ---NHEVMKAINDGF----------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
Query: 996 KL 997
L
Sbjct: 266 IL 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 5e-48
Identities = 63/297 (21%), Positives = 118/297 (39%), Gaps = 45/297 (15%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNL 760
+E + IG G FG V+ G N VA+K I E + F E E + + H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
+++ +C LV+E+M++G L ++L + + L + +DV
Sbjct: 63 VQLYGVCLE-----QAPICLVFEFMEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCE 112
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
+ + + ++H DL N L+ + V VSDFG+ +F+ + +SS G
Sbjct: 113 G---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGT 162
Query: 881 KGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940
K + + +PE S + V+S+G+L+ E+F+ + + + +
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI------S 216
Query: 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997
+ P L + ++ C E P DR + ++ +L
Sbjct: 217 TGFRLYKPRLASTH--------------VYQIMN---HCWKERPEDRPAFSRLLRQL 256
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 8e-47
Identities = 58/257 (22%), Positives = 94/257 (36%), Gaps = 33/257 (12%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS---KSFAAECEALRSIRHRN 759
FS IG GSFG VY N +VA+K ++ K + + E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
I+ LV EY + + + L ++ +
Sbjct: 77 TIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGAL 125
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
+ YLH H ++H D+K N+LL + + DFG A + + +
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------------APANS 170
Query: 880 VKGTIGYVAPEYGLG---GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936
GT ++APE L G+ + V+S GI +E+ R+ P +M L+ A+
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQN 229
Query: 937 ALPEKVMEIVDPSLLPL 953
P
Sbjct: 230 ESPALQSGHWSEYFRNF 246
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 9e-47
Identities = 69/330 (20%), Positives = 119/330 (36%), Gaps = 61/330 (18%)
Query: 692 SYKELSKATNEFSSSNTIGRGSFGFVYKGVL-----HENGMLVAVKVINLE-QKGGSKSF 745
L N IG G+FG V++ +E +VAVK++ E F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 746 AAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQL---- 801
E + + N++K++ +C+ L++EYM G L E+L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPM-----CLLFEYMAYGDLNEFLRSMSPHTVCSL 118
Query: 802 --------------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH 847
G LS ++L I VA+ + YL VH DL N L+
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175
Query: 848 DMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYG 907
+MV ++DFGL++ + ++ + + I ++ PE + V++YG
Sbjct: 176 NMVVKIADFGLSRNIYSA------DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 229
Query: 908 ILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEE 967
++L EIF+ + A E + + D ++L E
Sbjct: 230 VVLWEIFSYGLQP------------YYGMAHEEVIYYVRDGNILAC-----------PEN 266
Query: 968 CLVAVIKTGVACSIESPFDRMEMTDVVVKL 997
C + + C + P DR + L
Sbjct: 267 CPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-46
Identities = 63/297 (21%), Positives = 114/297 (38%), Gaps = 45/297 (15%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNL 760
+ + +G G FG V G VA+K+I E F E + + ++ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
+++ +C+ ++ EYM NG L +L + + Q L + DV
Sbjct: 62 VQLYGVCTKQRPI-----FIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCE 111
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
A+EYL +H DL N L++ V VSDFGL++++ +SS+G
Sbjct: 112 AMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGS 161
Query: 881 KGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940
K + + PE + + S + ++++G+L+ EI++ + F
Sbjct: 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------------NS 208
Query: 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997
+ E + L R R V +C E +R ++ +
Sbjct: 209 ETAEHIAQGL----------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-46
Identities = 66/301 (21%), Positives = 121/301 (40%), Gaps = 48/301 (15%)
Query: 702 EFSSSNTIGRGSFGFVYKGVLHENG----MLVAVKVINLEQ-KGGSKSFAAECEALRSIR 756
EF +G G+FG VYKG+ G + VA+K + +K E + S+
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 757 HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI 816
+ ++ +++ IC + + L+ + M G L +++ + D N+ LN +
Sbjct: 70 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCV 118
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
+A + YL +VH DL NVL+ ++DFGLAK L A E
Sbjct: 119 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEYH 169
Query: 877 SIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936
+ G K I ++A E L + + V+SYG+ + E+ T +G+
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----PYDGIP------- 218
Query: 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996
++ I++ R + C + V V C + R + +++++
Sbjct: 219 --ASEISSILEK----------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
Query: 997 L 997
Sbjct: 267 F 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-45
Identities = 60/316 (18%), Positives = 106/316 (33%), Gaps = 55/316 (17%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQKGGS-KSFAAECEALRS 754
N S T+G G+FG V + + + M VAVK++ ++ +E + L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 755 I-RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQL------------ 801
+ H N++ ++ C+ ++ EY G L +L ++ D
Sbjct: 83 LGNHMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 802 GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861
L L L+ VA + +L +H DL N+LL H + + DFGLA+
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTE 921
+ + + ++APE + V+SYGI L E+F+
Sbjct: 195 IKND------SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 922 SMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSI 981
K +++ R + E + C
Sbjct: 249 PGMPV------------DSKFYKMIKEGF----------RMLSPEHAPAEMYDIMKTCWD 286
Query: 982 ESPFDRMEMTDVVVKL 997
P R +V +
Sbjct: 287 ADPLKRPTFKQIVQLI 302
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-45
Identities = 68/324 (20%), Positives = 122/324 (37%), Gaps = 61/324 (18%)
Query: 688 FPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKS 744
+P++ + N+ + IG G+FG V K + ++G+ + + +++ K +
Sbjct: 4 YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 745 FAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRD----- 798
FA E E L + H N+I ++ C + L EY +G+L ++L +
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETD 111
Query: 799 -----DQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 853
LS Q L+ DVA + + Q +H DL N+L+ + VA +
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKI 168
Query: 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEI 913
+DFGL++ E + + ++A E + V+SYG+LL EI
Sbjct: 169 ADFGLSRG---------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219
Query: 914 FTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVI 973
+ G+T E ++ +E C V
Sbjct: 220 VSLGGT----PYCGMTCAELYEKLPQGYRLEK-------------------PLNCDDEVY 256
Query: 974 KTGVACSIESPFDRMEMTDVVVKL 997
C E P++R ++V L
Sbjct: 257 DLMRQCWREKPYERPSFAQILVSL 280
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-45
Identities = 55/253 (21%), Positives = 100/253 (39%), Gaps = 31/253 (12%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTI 766
+G G+FG VYK E +L A KVI+ + + + + E + L S H N++K++
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
+ ++ E+ G+++ + + + L+ Q + A+ YLH
Sbjct: 78 FYY-----ENNLWILIEFCAGGAVDAVMLELERP-----LTESQIQVVCKQTLDALNYLH 127
Query: 827 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGY 886
+ I+H DLK N+L D ++DFG++ + T GT +
Sbjct: 128 DN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--------RTIQRRDSFIGTPYW 176
Query: 887 VAPEYGLGGEASMRG-----GVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEK 941
+APE + + R V+S GI L+E+ P + L + +
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-----HHELNPMRVLLKIAKSE 231
Query: 942 VMEIVDPSLLPLE 954
+ PS
Sbjct: 232 PPTLAQPSRWSSN 244
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-45
Identities = 57/336 (16%), Positives = 114/336 (33%), Gaps = 62/336 (18%)
Query: 686 QQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENG-----MLVAVKVINLE-QK 739
+++ E + +G G+FG V + + VAVK++ +
Sbjct: 24 REYEYDLKWEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS 81
Query: 740 GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRD 798
++ +E + + + H N++ ++ C+ L++EY G L +L +
Sbjct: 82 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPI-----YLIFEYCCYGDLLNYLRSKR 136
Query: 799 DQL-----------------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPS 841
++ + L+ L VA +E+L VH DL
Sbjct: 137 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193
Query: 842 NVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRG 901
NVL+ H V + DFGLA+ + + + + ++APE G +++
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMSD------SNYVVRGNARLPVKWMAPESLFEGIYTIKS 247
Query: 902 GVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSR 961
V+SYGILL EIF+ + + +++ +
Sbjct: 248 DVWSYGILLWEIFSLGVNP------------YPGIPVDANFYKLIQNGF----------K 285
Query: 962 RVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997
+ + +C R ++ L
Sbjct: 286 MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 4e-45
Identities = 55/255 (21%), Positives = 100/255 (39%), Gaps = 22/255 (8%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRN 759
++ T+G G++G V V VAVK++++++ ++ E + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
++K + + L EY G L + + + +
Sbjct: 65 VVKFYGHRREGNIQ-----YLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLM 113
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
+ V YLH I H D+KP N+LLD +SDFGLA + ++
Sbjct: 114 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 164
Query: 880 VKGTIGYVAPEYGLGGE-ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938
+ GT+ YVAPE E + V+S GI+L + P + + ++ ++
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 224
Query: 939 PEKVMEIVDPSLLPL 953
+ +D + L L
Sbjct: 225 YLNPWKKIDSAPLAL 239
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 2e-44
Identities = 58/262 (22%), Positives = 110/262 (41%), Gaps = 27/262 (10%)
Query: 679 SNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ 738
S+ +E+ +VS + K +++ IG+G+ G VY + G VA++ +NL+Q
Sbjct: 1 SDEEILEKLRSIVSVGDPKK---KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 739 KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRD 798
+ + E +R ++ N++ + D +V EY+ GSL + + +
Sbjct: 58 QPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTETC 112
Query: 799 DQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858
Q + + A+E+LH + ++H D+K N+LL D ++DFG
Sbjct: 113 M-------DEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF 162
Query: 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR 918
++ S + GT ++APE + ++S GI+ +E+
Sbjct: 163 CAQIT--------PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 919 PTESMFNEGLTLHEFAKRALPE 940
P + N L+ A PE
Sbjct: 215 PYLNE-NPLRALYLIATNGTPE 235
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (402), Expect = 4e-44
Identities = 53/246 (21%), Positives = 98/246 (39%), Gaps = 28/246 (11%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRH 757
+F +G+G FG VY ++ ++A+KV+ LE+ G E E +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
N++++ L+ EY G++ L + + + +
Sbjct: 66 PNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITE 114
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
+A+A+ Y H ++H D+KP N+LL ++DFG + +S +
Sbjct: 115 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------ 165
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM-FNEGLTLHEFAKR 936
GT+ Y+ PE G + ++S G+L E + P E+ + E +
Sbjct: 166 ----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 221
Query: 937 ALPEKV 942
P+ V
Sbjct: 222 TFPDFV 227
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-44
Identities = 69/301 (22%), Positives = 107/301 (35%), Gaps = 47/301 (15%)
Query: 707 NTIGRGSFGFVYKGVLHE---NGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRHRNL 760
+G GSFG V +G + VAVK + L Q F E A+ S+ HRNL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
I++ + + K +V E GSL + L + + L + VA
Sbjct: 74 IRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAE 122
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
+ YL +H DL N+LL + + DFGL + L + V++
Sbjct: 123 GMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-----HR 174
Query: 881 KGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940
K + APE S + +G+ L E+FT + N
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------------GS 221
Query: 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000
+++ +D L R E+C + V C P DR + L A
Sbjct: 222 QILHKIDKEGERLP---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
Query: 1001 R 1001
+
Sbjct: 273 Q 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-43
Identities = 54/307 (17%), Positives = 116/307 (37%), Gaps = 47/307 (15%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQ-KGGSKSFAAECEALRS 754
+ + S +G+GSFG VY+GV E VA+K +N F E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 755 IRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLG----ICNLSLIQ 810
++++++ + S ++ E M G L+ +L + + SL +
Sbjct: 80 FNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 811 RLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNV 870
+ + ++A + YL+ + VH DL N ++ D + DFG+ + + +
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET----- 186
Query: 871 VETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL 930
+ + +++PE G + V+S+G++L EI T +GL+
Sbjct: 187 -DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----PYQGLSN 241
Query: 931 HEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEM 990
+ + + +++ D C + + C +P R
Sbjct: 242 EQVLRFVMEGGLLDKPD-------------------NCPDMLFELMRMCWQYNPKMRPSF 282
Query: 991 TDVVVKL 997
+++ +
Sbjct: 283 LEIISSI 289
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 156 bits (394), Expect = 3e-42
Identities = 46/249 (18%), Positives = 89/249 (35%), Gaps = 25/249 (10%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTIC 767
+G G+FG V++ G A K + + ++ E + + +RH L+ +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 768 SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH 827
+ ++YE+M G L E + ++ +S + + + V + ++H
Sbjct: 93 EDD-----NEMVMIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHMHE 142
Query: 828 HCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
+ VH DLKP N++ + DFGL L + S GT
Sbjct: 143 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---------DPKQSVKVTTGTAE 190
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFN-EGLTLHEFAKRALPEKVME 944
+ APE G ++S G+L + + P + E L + + +
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 250
Query: 945 IVDPSLLPL 953
+
Sbjct: 251 GISEDGKDF 259
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 8e-41
Identities = 49/225 (21%), Positives = 86/225 (38%), Gaps = 23/225 (10%)
Query: 698 KATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRS 754
K +F +G GSF V A+K++ ++ E + +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 755 IRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNI 814
+ H +K+ + Y +NG L +++ + +
Sbjct: 65 LDHPFFVKLYFTFQD-----DEKLYFGLSYAKNGELLKYIRKIG------SFDETCTRFY 113
Query: 815 VIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETP 874
++ SA+EYLH I+H DLKP N+LL+ DM ++DFG AK LS
Sbjct: 114 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQ 164
Query: 875 SSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
+ + GT YV+PE A +++ G ++ ++ P
Sbjct: 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 150 bits (379), Expect = 3e-40
Identities = 49/249 (19%), Positives = 87/249 (34%), Gaps = 25/249 (10%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTIC 767
+G G+FG V++ V G + K IN + E + + H LI +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 768 SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH 827
L+ E++ G L + + D + +S + +N + ++++H
Sbjct: 96 ED-----KYEMVLILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEGLKHMHE 145
Query: 828 HCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H IVH D+KP N++ + + V DFGLA L+ T
Sbjct: 146 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN---------PDEIVKVTTATAE 193
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFN-EGLTLHEFAKRALPEKVME 944
+ APE +++ G+L + + P + E L + E
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253
Query: 945 IVDPSLLPL 953
V P
Sbjct: 254 SVSPEAKDF 262
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 147 bits (372), Expect = 5e-40
Identities = 58/289 (20%), Positives = 107/289 (37%), Gaps = 35/289 (12%)
Query: 697 SKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALR 753
S ++ + +G G V+ VAVKV+ + F E +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 754 SIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLN 813
++ H ++ + + G +V EY+ +L + +H ++ + +
Sbjct: 63 ALNHPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIE 115
Query: 814 IVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVET 873
++ D A+ + H + I+H D+KP+N+++ V DFG+A+ ++ S +
Sbjct: 116 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG-----NS 167
Query: 874 PSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP---------TESMF 924
+ + V GT Y++PE G R VYS G +L E+ T P
Sbjct: 168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227
Query: 925 NEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNS--------RRVRN 965
E L + +V +L E R + RV N
Sbjct: 228 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 55/294 (18%), Positives = 108/294 (36%), Gaps = 48/294 (16%)
Query: 708 TIGRGSFGFVYKGVLH---ENGMLVAVKVINLEQKGGSKS-FAAECEALRSIRHRNLIKI 763
IG G FG V++G+ + VA+K + F E +R H +++K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 764 VTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVE 823
+ + + + ++ E G L +L R +L L + +++A
Sbjct: 74 IGVITE------NPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTA-- 120
Query: 824 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
L + VH D+ NVL+ + + DFGL++++ S T + K
Sbjct: 121 -LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-------TYYKASKGKLP 172
Query: 884 IGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVM 943
I ++APE + V+ +G+ + EI +G+ ++ R + +
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK----PFQGVKNNDVIGRIENGERL 228
Query: 944 EIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997
+ P P L +++ C P R T++ +L
Sbjct: 229 PM--PPNCPPT--------------LYSLMT---KCWAYDPSRRPRFTELKAQL 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-38
Identities = 58/313 (18%), Positives = 108/313 (34%), Gaps = 50/313 (15%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQ-KGGSKSFAAECEALRS 754
+ +GRG+FG V + VAVK++ ++ +E + L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 755 IRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICN--------- 805
I H + V + + G ++ E+ + G+L +L + ++
Sbjct: 73 IGHHLNV--VNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 806 -LSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSA 864
L+L + VA +E+L +H DL N+LL V + DFGLA+ +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 865 SPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMF 924
P + + ++APE +++ V+S+G+LL EIF+
Sbjct: 187 DP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240
Query: 925 NEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESP 984
K + + P + +T + C P
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEM----------------------YQTMLDCWHGEP 278
Query: 985 FDRMEMTDVVVKL 997
R +++V L
Sbjct: 279 SQRPTFSELVEHL 291
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 7e-38
Identities = 65/316 (20%), Positives = 113/316 (35%), Gaps = 56/316 (17%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLH-------ENGMLVAVKVINLEQ-KGGSKSFAAECEAL 752
+ +G G+FG V VAVK++ + + +E E +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 753 RSI-RHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQR----------DDQL 801
+ I +H+N+I ++ C+ ++ EY G+L E+L R
Sbjct: 73 KMIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 802 GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861
LS ++ VA + + +H DL NVL+ D V ++DFGLA+
Sbjct: 128 PEEQLSSKDLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTE 921
+ + + + + ++APE + + V+S+G+LL EIFT
Sbjct: 185 IHHI------DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-- 236
Query: 922 SMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSI 981
G+ + E K M+ PS E L +++ C
Sbjct: 237 --PYPGVPVEELFKLLKEGHRMDK--PSNCTNE--------------LYMMMR---DCWH 275
Query: 982 ESPFDRMEMTDVVVKL 997
P R +V L
Sbjct: 276 AVPSQRPTFKQLVEDL 291
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 138 bits (349), Expect = 5e-37
Identities = 55/229 (24%), Positives = 92/229 (40%), Gaps = 39/229 (17%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINL---------EQKGGSKSFAAECEALRSIR- 756
+GRG V + + AVK+I++ E + ++ E + LR +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 757 HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI 816
H N+I++ + F LV++ M+ G L ++L ++ LS + I+
Sbjct: 69 HPNIIQLKDTYETN-----TFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMR 117
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
+ + LH IVH DLKP N+LLD DM ++DFG + L
Sbjct: 118 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---------EK 165
Query: 877 SIGVKGTIGYVAPEYGLGGEASMRGG------VYSYGILLLEIFTRRRP 919
V GT Y+APE G ++S G+++ + P
Sbjct: 166 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (351), Expect = 6e-37
Identities = 52/263 (19%), Positives = 88/263 (33%), Gaps = 22/263 (8%)
Query: 693 YKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEA 751
+K+ + + + +G G+F V LVA+K I + +G S E
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 752 LRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQR 811
L I+H N++ + I S L+ + + G L + + ++ +
Sbjct: 61 LHKIKHPNIVALDDIYES-----GGHLYLIMQLVSGGELFDRIVEKG------FYTERDA 109
Query: 812 LNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVV 871
++ V AV+YLH LD D +SDFGL+K
Sbjct: 110 SRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG------ 163
Query: 872 ETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFN-EGLTL 930
S GT GYVAPE S +S G++ + P + +
Sbjct: 164 ---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ 220
Query: 931 HEFAKRALPEKVMEIVDPSLLPL 953
A+ + + S
Sbjct: 221 ILKAEYEFDSPYWDDISDSAKDF 243
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (348), Expect = 9e-37
Identities = 50/222 (22%), Positives = 85/222 (38%), Gaps = 19/222 (8%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTIC 767
IG GSFG +Y G G VA+K+ ++ K E + + ++ I + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 768 SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH 827
+ D+ +V E + + + SL L + + S +EY+H
Sbjct: 72 GAEG----DYNVMVMELLGPSLEDLFNFCSR------KFSLKTVLLLADQMISRIEYIHS 121
Query: 828 HCQPPIVHGDLKPSNVL---LDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
+H D+KP N L + ++ DFGLAK + + + + GT
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK-NLTGTA 177
Query: 885 GYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNE 926
Y + LG E S R + S G +L+ P + +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-36
Identities = 45/249 (18%), Positives = 96/249 (38%), Gaps = 26/249 (10%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTIC 767
+GRG FG V++ V + K + ++ E L RHRN++ +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESF 70
Query: 768 SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH 827
S ++ +++E++ + E ++ + L+ + ++ V V A+++LH
Sbjct: 71 ES-----MEELVMIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEALQFLHS 120
Query: 828 HCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLSASPLGNVVETPSSSIGVKGTIG 885
H I H D++P N++ + + +FG A+ L + +
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---------LFTAPE 168
Query: 886 YVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEG-LTLHEFAKRALPEKVME 944
Y APE S ++S G L+ + + P + N+ + A+ E+ +
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228
Query: 945 IVDPSLLPL 953
+ +
Sbjct: 229 EISIEAMDF 237
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 139 bits (352), Expect = 1e-36
Identities = 63/281 (22%), Positives = 101/281 (35%), Gaps = 33/281 (11%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN---LEQKGGSKSFAAECEALRSIRH 757
N+FS IGRG FG VY + G + A+K ++ ++ K G E L +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
+ IV + + F D + + + M G L L Q S +
Sbjct: 64 GDCPFIVCMSYA--FHTPDKLSFILDLMNGGDLHYHLSQHGVF------SEADMRFYAAE 115
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
+ +E++H+ +V+ DLKP+N+LLD +SD GLA S
Sbjct: 116 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS----------KKKP 162
Query: 878 IGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936
GT GY+APE G A +S G +L ++ P + +
Sbjct: 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 222
Query: 937 ALPEKVMEIVDPSLLPL--------EEERTNSRRVRNEECL 969
+ ++ + P L L R +E
Sbjct: 223 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 263
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 137 bits (347), Expect = 2e-36
Identities = 57/277 (20%), Positives = 102/277 (36%), Gaps = 33/277 (11%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRH 757
+F T+G GSFG V+ NG A+KV+ E + + E L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
+I++ ++ +Y++ G L L + +
Sbjct: 64 PFIIRMWGTFQD-----AQQIFMIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAE 112
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
V L + I++ DLKP N+LLD + ++DFG AK++ P +
Sbjct: 113 VC---LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----------PDVT 158
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP-----TESMFNEGLTLHE 932
+ GT Y+APE + +S+GIL+ E+ P T + + L
Sbjct: 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 218
Query: 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECL 969
E V +++ + +R + + E+
Sbjct: 219 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 255
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-36
Identities = 49/223 (21%), Positives = 85/223 (38%), Gaps = 26/223 (11%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEAL-RSIR 756
+F +G+GSFG V+ + A+K + + + E L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 757 HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI 816
H L + + + V EY+ G L + L +
Sbjct: 62 HPFLTHMFCTFQT-----KENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAA 110
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSS 876
++ +++LH IV+ DLK N+LLD D ++DFG+ K +
Sbjct: 111 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM--------LGDAK 159
Query: 877 SIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
+ GT Y+APE LG + + +S+G+LL E+ + P
Sbjct: 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 9e-36
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 22/220 (10%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIK 762
++ + IG GSFG VY+ L ++G LVA+K + ++ + E + +R + H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 763 IVTIC-SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
+ SS + K + LV +Y+ H + L +I + + +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 134
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
+ Y+H I H D+KP N+LLD D V + DFG AK L ++
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---------EPNVSY 182
Query: 881 KGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRP 919
+ Y APE G + V+S G +L E+ +
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 2e-35
Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 18/222 (8%)
Query: 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVIN-LEQKGGSKSFAAECEALRSIRHR 758
+++ + IG G++G V + N + VA+K I+ E + + E + L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 759 NLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDV 818
N+I I I + + + LV M L + L + +LS + +
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQ-------HLSNDHICYFLYQI 118
Query: 819 ASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
++Y+H ++H DLKPSN+LL+ + DFGLA+ +
Sbjct: 119 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-----DHTGFLT 170
Query: 879 GVKGTIGYVAPEYGLGGEASMRGG-VYSYGILLLEIFTRRRP 919
T Y APE L + + ++S G +L E+ + R
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 4e-35
Identities = 49/251 (19%), Positives = 96/251 (38%), Gaps = 26/251 (10%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEAL-RSIRHRNLIKIVTI 766
+G G G V + A+K++ E E R+ + ++++IV +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 767 CSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLH 826
++ + G +V E + G L + R DQ + + I+ + A++YLH
Sbjct: 74 YENL-YAGRKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH 128
Query: 827 HHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGT 883
I H D+KP N+L + + ++DFG AK ++ +S T
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---------NSLTTPCYT 176
Query: 884 IGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVM 943
YVAPE + ++S G+++ + P S ++ + + +
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236
Query: 944 EIVDPSLLPLE 954
+ S + E
Sbjct: 237 PNPEWSEVSEE 247
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-34
Identities = 53/230 (23%), Positives = 98/230 (42%), Gaps = 23/230 (10%)
Query: 696 LSKATNEFSSSNTIGRGSFGFVYKGV-LHENGMLVAVKVINLE--QKGGSKSFAAECEAL 752
L +A ++ IG G++G V+K L G VA+K + ++ ++G S E L
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 753 R---SIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLI 809
R + H N++++ +C+ LV+E++ + +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTE 116
Query: 810 QRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGN 869
+++ + +++LH H +VH DLKP N+L+ ++DFGLA+ S
Sbjct: 117 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS------ 167
Query: 870 VVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
+ V T+ Y APE L + ++S G + E+F R+
Sbjct: 168 ---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 62/306 (20%), Positives = 130/306 (42%), Gaps = 26/306 (8%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE--QKGGSKSFAAECEALRSIRHR 758
+++ IG+G+FG V+K + G VA+K + +E ++G + E + L+ ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 759 NLIKIVTICSSIDFKGVDFKA---LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIV 815
N++ ++ IC + K LV+++ ++ + +L + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVM 123
Query: 816 IDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPS 875
+ + L++ + I+H D+K +NVL+ D V ++DFGLA+ S + +
Sbjct: 124 QMLLNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 876 SSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRP-TESMFNEGLTLHEF 933
T+ Y PE LG ++ G ++ E++TR + L L
Sbjct: 181 ----RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236
Query: 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVA------CSIESPFDR 987
++ +V VD L + E ++ + ++ L A ++ A + P R
Sbjct: 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 296
Query: 988 MEMTDV 993
++ D
Sbjct: 297 IDSDDA 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 128 bits (323), Expect = 2e-33
Identities = 44/224 (19%), Positives = 77/224 (34%), Gaps = 21/224 (9%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTIC 767
IG GSFG +++G N VA+K + E + + I V
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 768 SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH 827
LV + + G E L + S+ + + V+ +H
Sbjct: 70 GQEG----LHNVLVIDLL--GPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIHE 119
Query: 828 HCQPPIVHGDLKPSNVLLD-----HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKG 882
+V+ D+KP N L+ + + +V DFG+ KF + + G
Sbjct: 120 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK-NLSG 175
Query: 883 TIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNE 926
T Y++ LG E S R + + G + + P + +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 7e-33
Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 28/219 (12%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLE-----QKGGSKSFAAECEALRSIRHRNLI 761
+ +G G F VYK +VA+K I L + G +++ E + L+ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
++ +LV+++M+ L+ ++
Sbjct: 64 GLLDAFGH-----KSNISLVFDFMETDLEVIIKDNS------LVLTPSHIKAYMLMTLQG 112
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
+EYLH H I+H DLKP+N+LLD + V ++DFGLAK +
Sbjct: 113 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG--------SPNRAYTHQV 161
Query: 882 GTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRP 919
T Y APE G + +++ G +L E+ R
Sbjct: 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 46/257 (17%), Positives = 87/257 (33%), Gaps = 34/257 (13%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGS------KSFAAECEALRSIRHRNLI 761
+G G F V K G+ A K I + S + E L+ I+H N+I
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 762 KIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASA 821
+ + + L+ E + G L ++L +++ ++++
Sbjct: 77 TLHEVYEN-----KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--------- 122
Query: 822 VEYLHHHCQPPIVHGDLKPSNVLLDHDMVA----HVSDFGLAKFLSASPLGNVVETPSSS 877
+ +++ I H DLKP N++L V + DFGLA + +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---------NEF 173
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFN-EGLTLHEFAKR 936
+ GT +VAPE + ++S G++ + + P E L
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233
Query: 937 ALPEKVMEIVDPSLLPL 953
++
Sbjct: 234 EFEDEYFSNTSALAKDF 250
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-32
Identities = 57/277 (20%), Positives = 99/277 (35%), Gaps = 30/277 (10%)
Query: 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRH 757
N+F +G+G+FG V G A+K++ E K E L++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 758 RNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVID 817
L + + D V EY G L L + + + +
Sbjct: 65 PFLTALKYAFQT-----HDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAE 113
Query: 818 VASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSS 877
+ SA L + +V+ D+K N++LD D ++DFGL K + ++
Sbjct: 114 IVSA---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--------ISDGATM 162
Query: 878 IGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP-----TESMFNEGLTLHE 932
GT Y+APE + + G+++ E+ R P E +F L
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222
Query: 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECL 969
R L + ++ L ++R +E +
Sbjct: 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 2e-31
Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 24/220 (10%)
Query: 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNL 760
F IG G++G VYK G +VA+K I L+ +G + E L+ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 761 IKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVAS 820
+K++ + + + LV+E++ + L + D + + L + + +
Sbjct: 64 VKLLDVIHT-----ENKLYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 821 AVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGV 880
+ + H H ++H DLKP N+L++ + ++DFGLA+ +
Sbjct: 114 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG--------VPVRTYTHE 162
Query: 881 KGTIGYVAPE-YGLGGEASMRGGVYSYGILLLEIFTRRRP 919
T+ Y APE S ++S G + E+ TRR
Sbjct: 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (311), Expect = 2e-31
Identities = 55/306 (17%), Positives = 108/306 (35%), Gaps = 49/306 (16%)
Query: 672 RRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAV 731
++ S NT+Q++Q + + +G GSFG V E+G A+
Sbjct: 28 KKWETPSQNTAQLDQ------FDRIKT----------LGTGSFGRVMLVKHKESGNHYAM 71
Query: 732 KVINLEQKGGSK---SFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNG 788
K+++ ++ K E L+++ L+K+ + V EY+ G
Sbjct: 72 KILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM-----VMEYVAGG 126
Query: 789 SLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD 848
+ L + S + EYLH +++ DLKP N+L+D
Sbjct: 127 EMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQ 177
Query: 849 MVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGI 908
V+DFG AK + + GT +APE L + ++ G+
Sbjct: 178 GYIQVTDFGFAKR-----------VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGV 226
Query: 909 LLLEIFTRRRP-----TESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRV 963
L+ E+ P ++ + ++ + +++ L +R + +
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKN 286
Query: 964 RNEECL 969
+
Sbjct: 287 GVNDIK 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-31
Identities = 49/268 (18%), Positives = 91/268 (33%), Gaps = 34/268 (12%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLE------QKGGSKSFAAECEALRSIR--HRN 759
+G G FG VY G+ + + VA+K + + + E L+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
+I+++ D L+ E + L + V
Sbjct: 71 VIRLLDWFER-----PDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVL 120
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAKFLSASPLGNVVETPSSSI 878
AV + H+ ++H D+K N+L+D + + DFG L + +
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------- 170
Query: 879 GVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937
GT Y PE+ V+S GILL ++ P E E + F ++
Sbjct: 171 ---GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-EEIIRGQVFFRQR 226
Query: 938 LPEKVMEIVDPSLLPLEEERTNSRRVRN 965
+ + ++ L +R ++N
Sbjct: 227 VSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 122 bits (306), Expect = 7e-31
Identities = 56/292 (19%), Positives = 113/292 (38%), Gaps = 30/292 (10%)
Query: 672 RRSAHKSSNTSQMEQQFPMVSYKELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAV 731
R + NT + + + S+ +++ +GRG + V++ + N V V
Sbjct: 6 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 65
Query: 732 KVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSL 790
K++ +K K E + L ++R N+I + I + ALV+E++ N
Sbjct: 66 KILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTP---ALVFEHVNNTDF 119
Query: 791 EEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD-M 849
++ L+ + ++ A++Y H I+H D+KP NV++DH+
Sbjct: 120 KQLYQ---------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHR 167
Query: 850 VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGI 908
+ D+GLA+F + + PE + + ++S G
Sbjct: 168 KLRLIDWGLAEFYHPG---------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC 218
Query: 909 LLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNS 960
+L + R+ P + L AK E + + +D + L+ +
Sbjct: 219 MLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 270
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-30
Identities = 45/248 (18%), Positives = 93/248 (37%), Gaps = 23/248 (9%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIV 764
IG G++G V+K E +VA+K + L+ +G S E L+ ++H+N++++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
+ S LV+E+ + + G + +++ + + + +
Sbjct: 68 DVLHS-----DKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKS--FLFQLLKGLGF 116
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
H ++H DLKP N+L++ + +++FGLA+ + S V
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG-------IPVRCYSAEVVTLW 166
Query: 885 GYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVME 944
S ++S G + E+ RP + L + +
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226
Query: 945 IVDPSLLP 952
+ LP
Sbjct: 227 WPSMTKLP 234
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-30
Identities = 51/236 (21%), Positives = 92/236 (38%), Gaps = 30/236 (12%)
Query: 692 SYKELSKATNEFSSS----NTIGRGSFGFVYKGVLHENGMLVAVKVIN--LEQKGGSKSF 745
+E++K E + +G G++G V V G VA+K + + + +K
Sbjct: 5 YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA 64
Query: 746 AAECEALRSIRHRNLIKIVTICSSID-FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGIC 804
E L+ +RH N+I ++ + + + LV +M + H++
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK------- 117
Query: 805 NLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSA 864
L + +V + + Y+H H DLKP N+ ++ D + DFGLA+
Sbjct: 118 -LGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQAD- 172
Query: 865 SPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE-ASMRGGVYSYGILLLEIFTRRRP 919
S G T Y APE L + ++S G ++ E+ T +
Sbjct: 173 ----------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 115 bits (289), Expect = 6e-29
Identities = 57/300 (19%), Positives = 109/300 (36%), Gaps = 33/300 (11%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIV 764
IG G++G VYK + G A+K I LE+ +G + E L+ ++H N++K+
Sbjct: 8 EKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
+ + LV+E++ + L + + ++ + + + Y
Sbjct: 67 DVIHTKKRL-----VLVFEHLDQDLKKLLDVCE------GGLESVTAKSFLLQLLNGIAY 115
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
H ++H DLKP N+L++ + ++DFGLA+ T+
Sbjct: 116 CH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG--------IPVRKYTHEIVTL 164
Query: 885 GYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEKVM 943
Y AP+ +G + S ++S G + E+ + + F P
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224
Query: 944 EIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGV----ACSIESPFDRMEMTDVVVKLCH 999
L + T + E L + ++G+ P R+ L H
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA---LEH 281
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-28
Identities = 49/238 (20%), Positives = 92/238 (38%), Gaps = 28/238 (11%)
Query: 689 PMVSYKELSKATNEFSSS----NTIGRGSFGFVYKGVLHENGMLVAVKVIN--LEQKGGS 742
P +EL+K E + +G G++G V + G+ VAVK ++ + +
Sbjct: 2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 743 KSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLG 802
K E L+ ++H N+I ++ + + + ++ L + +
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----- 116
Query: 803 ICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862
L+ ++ + ++Y+H H DLKPSN+ ++ D + DFGLA+
Sbjct: 117 --KLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHT 171
Query: 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE-ASMRGGVYSYGILLLEIFTRRRP 919
G T Y APE L + ++S G ++ E+ T R
Sbjct: 172 DDEMTGY-----------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (288), Expect = 3e-28
Identities = 47/218 (21%), Positives = 84/218 (38%), Gaps = 15/218 (6%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTIC 767
+G G F V+ N VA+K++ + K +++ E + L+ + + K ++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 768 SSIDFKGVDF-----KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAV 822
++ K +D V+ M L E L + + LI I + +
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 823 EYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVK 881
+Y+H C I+H D+KP NVL++ D ++ +A GN
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADL------GNACWYDEHYTNSI 190
Query: 882 GTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
T Y +PE LG ++S L+ E+ T
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 9e-28
Identities = 44/215 (20%), Positives = 84/215 (39%), Gaps = 24/215 (11%)
Query: 708 TIGRGSFGFVYKGVLHENGMLVAVKVIN--LEQKGGSKSFAAECEALRSIRHRNLIKIVT 765
IG G+ G V VA+K ++ + + +K E ++ + H+N+I ++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 766 ICSSID-FKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEY 824
+ + + LV E M + + D + + ++ + +++
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE---------RMSYLLYQMLCGIKH 134
Query: 825 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTI 884
LH +H DLKPSN+++ D + DFGLA+ S + T
Sbjct: 135 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---------YVVTR 182
Query: 885 GYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRP 919
Y APE LG ++S G ++ E+ +
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-27
Identities = 59/244 (24%), Positives = 102/244 (41%), Gaps = 30/244 (12%)
Query: 707 NTIGRGSFGFVYKG---VLHENGMLVAVKVIN----LEQKGGSKSFAAECEALRSIRHRN 759
+G G++G V+ H+ G L A+KV+ +++ ++ E + L IR
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 760 LIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVA 819
+ + F+ L+ +Y+ G L L QR+ + I V
Sbjct: 90 FLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRE---------RFTEHEVQIYVG 136
Query: 820 SAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIG 879
V L H + I++ D+K N+LLD + ++DFGL+K A +
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-------TERAYD 189
Query: 880 VKGTIGYVAPEYGLGGEASMRGGV--YSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937
GTI Y+AP+ GG++ V +S G+L+ E+ T P E + E ++R
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD-GEKNSQAEISRRI 248
Query: 938 LPEK 941
L +
Sbjct: 249 LKSE 252
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 107 bits (267), Expect = 6e-26
Identities = 76/309 (24%), Positives = 118/309 (38%), Gaps = 16/309 (5%)
Query: 22 LSNETDCLSLLAIKSQLHDPLGVTSSWNRSACVNLCQH-WTGVTCGRRNQ--RVTKLDLR 78
L N D +LL IK L +P SSW + + C W GV C Q RV LDL
Sbjct: 2 LCNPQDKQALLQIKKDLGNP-TTLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLS 58
Query: 79 NQSIGGI--LSPYVGNLSFLRYINIADND-FHGEIPDRIGNLFRLETLVLANNSFSGRIP 135
++ + + NL +L ++ I + G IP I L +L L + + + SG IP
Sbjct: 59 GLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118
Query: 136 TNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALR 195
LS L+T N L G +P + S N+++G +P S G+ S L
Sbjct: 119 DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD--GNRISGAIPDSYGSFSKLF 176
Query: 196 VIDIRT-NRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTG 254
+ NRL GKIP T + L + + ++ +
Sbjct: 177 TSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF- 235
Query: 255 SLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKD 314
+ NL + N G+LP + L L+++ N G++ L+
Sbjct: 236 --DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQR 292
Query: 315 LSMLGLATN 323
+ A N
Sbjct: 293 FDVSAYANN 301
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 91.4 bits (225), Expect = 2e-20
Identities = 70/267 (26%), Positives = 108/267 (40%), Gaps = 9/267 (3%)
Query: 370 LIDFNLGKNQIYG--TIPPGIANLVNLNSLRMEAN-RLTGTIPHVIGELKNLQLLHLHAN 426
+ + +L + IP +ANL LN L + L G IP I +L L L++
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 427 FLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILE 486
+ G IP L + L L F N L G +P S+ + NL+ N+++GA+P
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 487 ITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQG 546
+ L S+ +S N L G +P NL + + + +
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 547 NSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGI 606
+ LS + DL N G +P+ L L FL LN+S+N+ GE+P G
Sbjct: 232 SLAFDLGKVGLSKNLNGL--DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289
Query: 607 FKNKTGFSIVGNGKLCGGLDELHLPSC 633
+ + N LCG LP+C
Sbjct: 290 LQRFDVSAYANNKCLCGS----PLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 75.6 bits (184), Expect = 3e-15
Identities = 60/280 (21%), Positives = 104/280 (37%), Gaps = 15/280 (5%)
Query: 187 SIGNLSALRVIDIRTNRLWGKIPI--TLSQLTSLAYLHVGDNH-FSGTIPPSVYNISSLV 243
+ + +D+ L PI +L+ L L +L++G + G IPP++ ++ L
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 244 EIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRG 303
+Y+ +G++P + + L N +G+LP S S+ NL + N+ G
Sbjct: 105 YLYITHTNVSGAIPDFLSQI-KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 304 QVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSI 363
+ ++ L + N L T +
Sbjct: 164 AIPDSYGSFSKLFTSMTISR-------NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVL 216
Query: 364 ANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHL 423
+L KN + + + NLN L + NR+ GT+P + +LK L L++
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGKVGLSK-NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 424 HANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNC 463
N L G IP GNL ++ N P L C
Sbjct: 276 SFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP--LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.8 bits (169), Expect = 2e-13
Identities = 52/256 (20%), Positives = 81/256 (31%), Gaps = 3/256 (1%)
Query: 323 NFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYG 382
+ G L N L +LY+ T L + + G
Sbjct: 56 DLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG 115
Query: 383 TIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLL 442
IP ++ + L +L N L+GT+P I L NL + N + G IP S G+ + L
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175
Query: 443 TYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLN 502
+ N NL F RN L G ++L
Sbjct: 176 FTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 503 GSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTS 562
+G+ + + L N+ G +P L L + + N+ G IP +L
Sbjct: 236 DLGKVGLSKNLNGLDL--RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQR 292
Query: 563 IKELDLSQNNFSGQIP 578
+ N P
Sbjct: 293 FDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 64.8 bits (156), Expect = 1e-11
Identities = 53/271 (19%), Positives = 82/271 (30%), Gaps = 11/271 (4%)
Query: 213 SQLTSLAYLHVGDNHFSG--TIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNF 270
+Q + L + + IP S+ N+ L +Y+ G L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 271 VIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAA 330
I N +G++PD S L L + N G + + + L +L + N +
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 331 NDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIAN 390
+ L + L ++ F + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL--------AFVDLSRNMLEGDASVLFG 218
Query: 391 LVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGAN 450
A +G KNL L L N + GT+P L L L L+ N
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 451 NLQGNIPFSLGNCKNLMFFFAPRNKLTGALP 481
NL G IP GN + NK P
Sbjct: 279 NLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 107 bits (267), Expect = 2e-25
Identities = 76/392 (19%), Positives = 124/392 (31%), Gaps = 30/392 (7%)
Query: 210 ITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRN 269
T + L +G + + T+ + ++ + + +E L NL
Sbjct: 16 FTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVE---YLNNLTQ 70
Query: 270 FVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGA 329
N T P N + L + + NQ + L +
Sbjct: 71 INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 128
Query: 330 ANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIP---- 385
N + L + + + ++ NL +
Sbjct: 129 KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188
Query: 386 --PGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLT 443
+A L NL SL N+++ P I NL L L+ N L+ +L +LT LT
Sbjct: 189 DISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLT 244
Query: 444 YLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNG 503
L N + P S L N+++ P L T N
Sbjct: 245 DLDLANNQISNLAPLS--GLTKLTELKLGANQISNISPLAGLTALTNL-----ELNENQL 297
Query: 504 SLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSI 563
+ NLK+L L + N S P + + T L+ + N S SL++LT+I
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNI 353
Query: 564 KELDLSQNNFSGQIPKYLENLSFLQYLNLSYN 595
L N S P L NL+ + L L+
Sbjct: 354 NWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 99.3 bits (246), Expect = 1e-22
Identities = 91/406 (22%), Positives = 153/406 (37%), Gaps = 44/406 (10%)
Query: 167 LFNLQGLSVGDNQLTGQLPAS-IGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGD 225
L +G +T + + + ++ L+ + + G + L +L ++ +
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75
Query: 226 NHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSF 285
N + P + N++ LV+I + N+ P+ NL L F +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID------- 126
Query: 286 SNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKL 345
L ++ ++ N + D+S L T+ N + + L N T L
Sbjct: 127 ---------PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTL 177
Query: 346 QYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLT 405
+ L ++ N + + +LI N NQI P GI NL+ L + N+L
Sbjct: 178 ERLDISSNKVSDISVLAKLTNLESLIATN---NQISDITPLGILT--NLDELSLNGNQLK 232
Query: 406 GTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKN 465
+ L NL L L N + P L LT LT L GAN + P +
Sbjct: 233 D--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA--GLTA 286
Query: 466 LMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQF 525
L N+L P L+ T L L N ++ P+ +L L RL A N+
Sbjct: 287 LTNLELNENQLEDISPISNLKNLTY---LTLYFNNISDISPV--SSLTKLQRLFFANNKV 341
Query: 526 SGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQN 571
S +L T++ ++ N S P L++LT I +L L+
Sbjct: 342 SD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.5 bits (205), Expect = 1e-17
Identities = 78/397 (19%), Positives = 135/397 (34%), Gaps = 43/397 (10%)
Query: 70 QRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNS 129
K L ++ +S +L + + D + L L + +NN
Sbjct: 22 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQ 77
Query: 130 FSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIG 189
+ P L + +KL+ + N + P ++ + + +
Sbjct: 78 LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK------ 129
Query: 190 NLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYG 249
++ T+S +++L+ L G + +++L +
Sbjct: 130 --------NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLD 181
Query: 250 NRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINF 309
I + L NL + + N + P +NL+ L L NQ +
Sbjct: 182 ISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTL 237
Query: 310 NGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTA 369
L +L+ L LA N + N + L+ TKL L L N + P + T
Sbjct: 238 ASLTNLTDLDLANNQISN--------LAPLSGLTKLTELKLGANQISNISPLAGLTALT- 288
Query: 370 LIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQ 429
NL N+ I+NL NL L + N ++ P + L LQ L N +
Sbjct: 289 ----NLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS 342
Query: 430 GTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNL 466
SSL NLT + +LS G N + P L N +
Sbjct: 343 D--VSSLANLTNINWLSAGHNQISDLTP--LANLTRI 375
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.5 bits (179), Expect = 3e-14
Identities = 42/223 (18%), Positives = 76/223 (34%), Gaps = 19/223 (8%)
Query: 53 CVNLCQHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPD 112
+ ++ + + L N I I L+ L +++ N
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IG 235
Query: 113 RIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQG 172
+ +L L L LANN S P LS +KL N + P ++
Sbjct: 236 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLEL- 292
Query: 173 LSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTI 232
N+ + + I NL L + + N + P+ S LT L L +N S
Sbjct: 293 -----NENQLEDISPISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD-- 343
Query: 233 PPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTN 275
S+ N++++ + N+ + P+ NL + +
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTPLA---NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 71.6 bits (174), Expect = 1e-13
Identities = 51/215 (23%), Positives = 85/215 (39%), Gaps = 25/215 (11%)
Query: 139 SHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVID 198
+ + L + A N + P +++ NL LS+ NQL ++ +L+ L +D
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT----NLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 199 IRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPI 258
+ N++ P LS LT L L +G N S P ++ L + I
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLEDI 300
Query: 259 EIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSML 318
NL NL +Y NN + P S+ + L+ L A N+ S L +++ L
Sbjct: 301 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSS--LANLTNINWL 356
Query: 319 GLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADN 353
N + + + L N T++ L L D
Sbjct: 357 SAGHNQISD--------LTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.8 bits (159), Expect = 8e-12
Identities = 74/362 (20%), Positives = 121/362 (33%), Gaps = 38/362 (10%)
Query: 238 NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLA 297
++ ++ L T ++ +L + S+ D +NL ++ +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFS 74
Query: 298 ENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGG 357
NQ L L + + + + +T L L
Sbjct: 75 NNQLTD--ITPLKNLTKLVDIL-----------MNNNQIADITPLANLTNLTGLTLFNNQ 121
Query: 358 VLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKN 417
+ T L L N I I+ L L SL+ + T + L
Sbjct: 122 ITDIDPLKNLTNLNRLELSSNTISD-----ISALSGLTSLQQLSFGNQVTDLKPLANLTT 176
Query: 418 LQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLT 477
L+ L + +N + + LT L L N + P NL N+L
Sbjct: 177 LERLDISSNKVSDISVLA--KLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLK 232
Query: 478 GALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACT 537
+ +T L+ LDL++N ++ PL L L L + NQ S P L T
Sbjct: 233 D--IGTLASLTNLT-DLDLANNQISNLAPLS--GLTKLTELKLGANQISNISP--LAGLT 285
Query: 538 SLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHF 597
+L +EL N P S +L ++ L L NN S P + +L+ LQ L + N
Sbjct: 286 ALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV 341
Query: 598 EG 599
Sbjct: 342 SD 343
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 7e-04
Identities = 14/66 (21%), Positives = 24/66 (36%), Gaps = 4/66 (6%)
Query: 543 ELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVP 602
L + + T+ Q+ L + L + +E L+ L +N S N P
Sbjct: 28 VLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP 83
Query: 603 TKGIFK 608
K + K
Sbjct: 84 LKNLTK 89
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.9 bits (224), Expect = 2e-20
Identities = 54/290 (18%), Positives = 90/290 (31%), Gaps = 24/290 (8%)
Query: 52 ACVNLCQ-HWTGVTCGRRN---------QRVTKLDLRNQSIGGILSPYVGNLSFLRYINI 101
C CQ H V C LDL+N I I NL L + +
Sbjct: 3 VCPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLIL 62
Query: 102 ADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEE 161
+N P L +LE L L+ N +L + +
Sbjct: 63 INNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNG 122
Query: 162 LISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYL 221
L + L + +G + + L I I + I SL L
Sbjct: 123 LNQMIVVELGTNP---LKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTEL 176
Query: 222 HVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSL 281
H+ N + S+ +++L ++ L N + N P+LR + N
Sbjct: 177 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV-DNGSLANTPHLRELHLNNNKLVKV- 234
Query: 282 PDSFSNASNLEVLHLAENQFRGQVSINFNG------LKDLSMLGLATNFL 325
P ++ ++V++L N S +F S + L +N +
Sbjct: 235 PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.9 bits (206), Expect = 4e-18
Identities = 45/230 (19%), Positives = 74/230 (32%), Gaps = 8/230 (3%)
Query: 393 NLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNL 452
+L ++ L +P + + LL L N + NL L L N +
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 453 QGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNL 512
P + L + +N+L + + L + + + N
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVF--NGLNQ 125
Query: 513 KSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNN 572
+V LG + SG L Y+ + + + TIPQ L S+ EL L N
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNK 182
Query: 573 FSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLC 622
+ L+ L+ L L LS+N + N KL
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.9 bits (206), Expect = 5e-18
Identities = 47/236 (19%), Positives = 81/236 (34%), Gaps = 7/236 (2%)
Query: 383 TIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLL 442
+P + + L ++ N++T LKNL L L N + P + L L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 443 TYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLN 502
L N L+ + L K+ ++ + ++ + L + +
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI--VVELGTNPLKSS 139
Query: 503 GSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTS 562
G +K L + IA + + G SL + L GN + SL L +
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 563 IKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGN 618
+ +L LS N+ S L N L+ L+L+ N K + N
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN 252
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.0 bits (201), Expect = 2e-17
Identities = 48/236 (20%), Positives = 91/236 (38%), Gaps = 6/236 (2%)
Query: 364 ANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHL 423
+L +L N+I NL NL++L + N+++ P L L+ L+L
Sbjct: 27 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86
Query: 424 HANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQ 483
N L+ L L ++ ++ F+ N ++ K +G
Sbjct: 87 SKNQLKELPEKMPKTLQELRVHENEITKVRKSV-FNGLNQMIVVELGTNPLKSSGIENGA 145
Query: 484 ILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVE 543
+ LS ++D + + G SL L + N+ + +L +L +
Sbjct: 146 FQGMKKLSYI-RIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201
Query: 544 LQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEG 599
L NS S SL++ ++EL L+ N ++P L + ++Q + L N+
Sbjct: 202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.4 bits (176), Expect = 3e-14
Identities = 47/268 (17%), Positives = 85/268 (31%), Gaps = 37/268 (13%)
Query: 337 DLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNS 396
N L L L +N + P + A L L
Sbjct: 49 GDFKNLKNLHTLILINNKISKISPGAFAPLV-------------------------KLER 83
Query: 397 LRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNI 456
L + N+L + L+ L++ ++ ++ + L + ++ L G
Sbjct: 84 LYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIE 142
Query: 457 PFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLV 516
+ K L + +T +PQ + T L L N + + L +L
Sbjct: 143 NGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNLA 198
Query: 517 RLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSG- 575
+LG++ N S +L L + L N +P L+ I+ + L NN S
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257
Query: 576 -----QIPKYLENLSFLQYLNLSYNHFE 598
P Y + ++L N +
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.5 bits (216), Expect = 3e-20
Identities = 28/167 (16%), Positives = 50/167 (29%), Gaps = 29/167 (17%)
Query: 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLE----------QKGGSKSFAAECEALRSIR 756
+G G V+ E VK + + G F+
Sbjct: 6 KLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 757 HRNLIKIVTICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVI 816
R L K+ + + A++ E + L + D+ ++
Sbjct: 65 FRALQKLQGLAV-PKVYAWEGNAVLMELIDAKELYRVRVENPDE-------------VLD 110
Query: 817 DVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLS 863
+ V +H IVHGDL NVL+ + + DF + +
Sbjct: 111 MILEEVAKFYHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVG 153
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (213), Expect = 4e-19
Identities = 47/257 (18%), Positives = 78/257 (30%), Gaps = 5/257 (1%)
Query: 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEAN 402
Q ++L N V S I + + +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 403 RLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGN 462
+L P L L LHL LQ P L L YL N LQ + +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 463 CKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIAR 522
NL F N+++ + + +L L N + P +L L+ L +
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 523 NQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLE 582
N S L +L+Y+ L N + + +++ S + +P+ L
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLA 269
Query: 583 NLSFLQYLNLSYNHFEG 599
L+ N +G
Sbjct: 270 GRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (192), Expect = 2e-16
Identities = 50/274 (18%), Positives = 86/274 (31%), Gaps = 15/274 (5%)
Query: 157 EIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLT 216
+P + + Q + + N+++ AS L ++ + +N L + L
Sbjct: 25 AVPVGIPA----ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA 80
Query: 217 SLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNN 276
L L + DN ++ P+ ++ + L + + L L+ + N
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA 140
Query: 277 FTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFV 336
D+F + NL L L N+ F GL L L L N + + + +
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 337 DLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNS 396
L LP AL L N L
Sbjct: 201 GRLMTLYLFANNLS-------ALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQK 252
Query: 397 LRMEANRLTGTIPHVIGELKNLQLLHLHANFLQG 430
R ++ + ++P L L L AN LQG
Sbjct: 253 FRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (160), Expect = 3e-12
Identities = 46/252 (18%), Positives = 72/252 (28%), Gaps = 27/252 (10%)
Query: 402 NRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLG 461
L +P I Q + LH N + +S LT L +N L +
Sbjct: 21 QGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77
Query: 462 NCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSD----------------------- 498
L N ++ +L L
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137
Query: 499 -NLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSL 557
N L +L +L L + N+ S SL+ + L N + P +
Sbjct: 138 DNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197
Query: 558 SSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVG 617
L + L L NN S + L L LQYL L+ N + + + ++ F
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSS 257
Query: 618 NGKLCGGLDELH 629
+ C L
Sbjct: 258 SEVPCSLPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.1 bits (123), Expect = 1e-07
Identities = 33/182 (18%), Positives = 53/182 (29%), Gaps = 6/182 (3%)
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG 132
L L + + L+ L+Y+ + DN D +L L L L N S
Sbjct: 108 HTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS 167
Query: 133 RIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLS 192
L H+N + P R L L L + N L+ ++ L
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAF--RDLGRLMTLYLFANNLSALPTEALAPLR 225
Query: 193 ALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRF 252
AL+ + + N L + ++P + L N
Sbjct: 226 ALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRDLK---RLAANDL 281
Query: 253 TG 254
G
Sbjct: 282 QG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.2 bits (152), Expect = 2e-11
Identities = 44/210 (20%), Positives = 74/210 (35%), Gaps = 8/210 (3%)
Query: 388 IANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSF 447
++ + + + + LT +P + K+ +LHL N L ++L T LT L+
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 448 GANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPL 507
+ + G L N+L LD+S N L
Sbjct: 63 --DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL--TVLDVSFNRLTSLPLG 118
Query: 508 GVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELD 567
+ L L L + N+ P L LE + L N+ + L+ L ++ L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 568 LSQNNFSGQIPKYLENLSFLQYLNLSYNHF 597
L +N+ IPK L + L N +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 44/219 (20%), Positives = 69/219 (31%), Gaps = 15/219 (6%)
Query: 235 SVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVL 294
V ++S +E+ T +LP ++ K+ L + N + + L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTILH---LSENLLYTFSLATLMPYTRLTQL 60
Query: 295 HLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNG 354
+L ++ L L L L+ N L + L L
Sbjct: 61 NL--DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT----- 113
Query: 355 FGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGE 414
LP L + L N++ P + L L + N LT ++
Sbjct: 114 ---SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170
Query: 415 LKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQ 453
L+NL L L N L TIP LL + N
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 9e-08
Identities = 38/217 (17%), Positives = 70/217 (32%), Gaps = 16/217 (7%)
Query: 139 SHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVID 198
S + + + + NL +P +L + L + +N L A++ + L ++
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPK----DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 199 IRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPI 258
+ +R L L L + N + + + SLP+
Sbjct: 62 L--DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPA--LTVLDVSFNRLTSLPL 117
Query: 259 EIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSML 318
+ L L+ + N P + LE L LA N + NGL++L L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 319 GLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGF 355
L N + L + +L N +
Sbjct: 178 LLQEN-------SLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 6e-07
Identities = 37/199 (18%), Positives = 62/199 (31%), Gaps = 15/199 (7%)
Query: 63 VTCGRRN---------QRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDR 113
V C +RN + T L L + + + L +N+ + D
Sbjct: 15 VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD- 73
Query: 114 IGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGL 173
L L + S + L + + R L LQ L
Sbjct: 74 ----GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129
Query: 174 SVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIP 233
+ N+L P + L + + N L L+ L +L L + +N TIP
Sbjct: 130 YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188
Query: 234 PSVYNISSLVEIYLYGNRF 252
+ L +L+GN +
Sbjct: 189 KGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 7e-07
Identities = 41/213 (19%), Positives = 68/213 (31%), Gaps = 10/213 (4%)
Query: 90 VGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSA 149
V ++ +N + +P + L L+ N L ++L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQL-- 60
Query: 150 HRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIP 209
NL +L + G + LP L AL V+D+ NRL
Sbjct: 61 ---NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 210 ITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRN 269
L L L L++ N P + L ++ L N T + L NL
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN-GLENLDT 176
Query: 270 FVIYTNNFTGSLPDSFSNASNLEVLHLAENQFR 302
++ N+ ++P F + L L N +
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 46/226 (20%), Positives = 69/226 (30%), Gaps = 19/226 (8%)
Query: 368 TALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANF 427
I GK+ + T+ A+L + +L +T TI + L NL L L N
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ 74
Query: 428 LQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEI 487
+ P L GN ++ L T L
Sbjct: 75 ITDLAPLK-------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127
Query: 488 TTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGN 547
+ L L N + PL + L + L ++ N
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLS----IGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 548 SFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLS 593
S P L+SL ++ E+ L N S P L N S L + L+
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 3e-07
Identities = 40/217 (18%), Positives = 77/217 (35%), Gaps = 16/217 (7%)
Query: 238 NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLA 297
+++ ++I + T ++ +L + + T + +NL L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 298 ENQFRGQVSI-NFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFG 356
+NQ + N + +L + G + A LT+ LA
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 357 GVL------PHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPH 410
VL +I+ L+ L + +ANL L +L+ + N+++ P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 411 VIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSF 447
+ L NL +HL N + P L N + L ++
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 5e-05
Identities = 34/221 (15%), Positives = 66/221 (29%), Gaps = 22/221 (9%)
Query: 92 NLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHR 151
L+ I ++ + +L + TL + + + + LI
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 152 NNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGK---- 207
N + P + +++ + N SI L L G
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 208 --------IPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIE 259
I ++ + + + N+S L + N+ + P+
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA 192
Query: 260 IGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQ 300
+LPNL + N + P +N SNL ++ L NQ
Sbjct: 193 ---SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 37/229 (16%), Positives = 70/229 (30%), Gaps = 20/229 (8%)
Query: 341 NCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRME 400
+ + + + A+L + + + T G+ L NL L ++
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDG-ITTLSAFGTGV--TTIEGVQYLNNLIGLELK 71
Query: 401 ANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSL 460
N++T P KNL + S + ++
Sbjct: 72 DNQITDLAPL-----KNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 461 GNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGI 520
G + + I + L+ LS S + NL L L
Sbjct: 127 GLSNLQVLYLDLNQ------ITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKA 180
Query: 521 ARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLS 569
N+ S P L + +L V L+ N S P L++ +++ + L+
Sbjct: 181 DDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 9e-04
Identities = 33/214 (15%), Positives = 58/214 (27%), Gaps = 17/214 (7%)
Query: 389 ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFG 448
L N + + +T T+ +L + L + + L L L
Sbjct: 16 PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 449 ANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLG 508
N + KNL + +LDL+ + PL
Sbjct: 72 DNQITDLA-----PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 509 VGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDL 568
+ ++ QI L + + L++L+ + L
Sbjct: 127 GLSNLQVL------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKA 180
Query: 569 SQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVP 602
N S P L +L L ++L N P
Sbjct: 181 DDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.7 bits (130), Expect = 2e-08
Identities = 35/278 (12%), Positives = 74/278 (26%), Gaps = 8/278 (2%)
Query: 195 RVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTG 254
+ +D+ L + L + + + + + + L +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 255 SLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVL--HLAENQFRGQVSINFNGL 312
S I L+N + + + ++ + SNL L + +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 313 KDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALID 372
L L L+ F + + T+L N L + +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 373 FNLGKNQIYGTIPPGIANLVNLNSLRME-ANRLTGTIPHVIGELKNLQLLHLHANFLQGT 431
+ L L L + + +GE+ L+ L + GT
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 432 IPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFF 469
+ L L ++ ++GN KN +
Sbjct: 241 LQLLKEALPHLQINC---SHFTTIARPTIGNKKNQEIW 275
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 3e-06
Identities = 39/250 (15%), Positives = 77/250 (30%), Gaps = 15/250 (6%)
Query: 344 KLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI-ANLVNLNSLRMEAN 402
+ + L + + +L + I + GI + L +L +E
Sbjct: 24 GVIAFRCPRSFMDQPLAEHFSPFR--VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81
Query: 403 RLTGTIPHVIGELKNLQLLHLHANFLQGTIPS--------SLGNLTLLTYLSFGANNLQG 454
RL+ I + + + NL L+L L L L F ++Q
Sbjct: 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV 141
Query: 455 NIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKS 514
+ L +N L + L +L L
Sbjct: 142 AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 201
Query: 515 LVRLGIAR-NQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNF 573
L L ++R + + LG +L+ +++ G GT+ +L L ++ ++F
Sbjct: 202 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHF 258
Query: 574 SGQIPKYLEN 583
+ + N
Sbjct: 259 TTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 4e-06
Identities = 34/230 (14%), Positives = 77/230 (33%), Gaps = 12/230 (5%)
Query: 374 NLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHL-HANFLQGTI 432
+L ++ + + + + + R + + + + +Q + L ++ T+
Sbjct: 6 DLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTL 63
Query: 433 PSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNL-------MFFFAPRNKLTGALPQQIL 485
L + L LS L I +L NL F+ T L
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123
Query: 486 EITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQ 545
+ LS D ++ + ++ + L G +N + + C +L +++L
Sbjct: 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183
Query: 546 GN-SFSGTIPQSLSSLTSIKELDLSQ-NNFSGQIPKYLENLSFLQYLNLS 593
+ Q L ++ L LS+ + + L + L+ L +
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 233
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 42/301 (13%), Positives = 84/301 (27%), Gaps = 31/301 (10%)
Query: 73 TKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSG 132
LDL +++ ++ + + + + + + + FR++ + L+N+
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV 60
Query: 133 R-IPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNL 191
+ LS CSKL S L I L + NL L++
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTL--AKNSNLVRLNLSGCSG----------- 107
Query: 192 SALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNR 251
+ L +L + H + I+ L N
Sbjct: 108 -----FSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNL 162
Query: 252 FTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAE-NQFRGQVSINFN 310
L + + + + + F + L+ L L+ + +
Sbjct: 163 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 222
Query: 311 GLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTAL 370
+ L L + G D L LQ + + F + +I N
Sbjct: 223 EIPTLKTLQV------FGIVPDGTLQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQE 273
Query: 371 I 371
I
Sbjct: 274 I 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.003
Identities = 27/199 (13%), Positives = 63/199 (31%), Gaps = 10/199 (5%)
Query: 409 PHVIGELKNLQLLHLH-ANFLQGTIPSSLGNLTLLTYLSFGANNLQGN-IPFSLGNCKNL 466
P V G L + ++ + + + ++ + ++ + + L C L
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 73
Query: 467 MFFFAPRNKLTGALPQQILEITTL-SLSLDLSDNLLNGSLPLGVGNLKSLVRL------G 519
+L+ + + + + L L+L +L + + L L
Sbjct: 74 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133
Query: 520 IARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQN-NFSGQIP 578
+ T L + N + + ++ LDLS +
Sbjct: 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 193
Query: 579 KYLENLSFLQYLNLSYNHF 597
+ L++LQ+L+LS +
Sbjct: 194 QEFFQLNYLQHLSLSRCYD 212
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 5e-08
Identities = 18/92 (19%), Positives = 36/92 (39%), Gaps = 11/92 (11%)
Query: 536 CTSLEYVELQGNSFSGT----IPQSLSSLTSIKELDLSQNNFSGQIPKYL-----ENLSF 586
+ L + L S + + +L + S++ELDLS N L +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 587 LQYLNLSYNHFEGEVPT--KGIFKNKTGFSIV 616
L+ L L ++ E+ + + K+K ++
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 5e-07
Identities = 16/97 (16%), Positives = 30/97 (30%), Gaps = 13/97 (13%)
Query: 511 NLKSLVRLGIARNQFS-GQIPVTLGACTSLEYVELQGNSFSG----TIPQSLSSLTSIKE 565
+++SL I + S + L + V L + I +L ++ E
Sbjct: 3 DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 566 LDLSQNNFSGQIPKYL-----ENLSFLQYLNLSYNHF 597
L+L N + +Q L+L
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 6e-07
Identities = 17/83 (20%), Positives = 28/83 (33%), Gaps = 9/83 (10%)
Query: 511 NLKSLVRLGIARNQFSGQ----IPVTLGACTSLEYVELQGNSFSGTIPQSLSS-----LT 561
L L +A S + TL A SL ++L N L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 562 SIKELDLSQNNFSGQIPKYLENL 584
+++L L +S ++ L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 7e-07
Identities = 12/68 (17%), Positives = 21/68 (30%), Gaps = 5/68 (7%)
Query: 538 SLEYVELQGNSFSGT-IPQSLSSLTSIKELDLSQNNFSGQ----IPKYLENLSFLQYLNL 592
++ +++Q S + L L + + L + I L L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 593 SYNHFEGE 600
N
Sbjct: 63 RSNELGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 2e-05
Identities = 14/96 (14%), Positives = 30/96 (31%), Gaps = 11/96 (11%)
Query: 489 TLSL-SLDLSDNLLNGS-LPLGVGNLKSLVRLGIARNQFSGQ----IPVTLGACTSLEYV 542
+L + SLD+ L+ + + L+ + + + I L +L +
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 543 ELQGNSFSGTIPQSLSSL-----TSIKELDLSQNNF 573
L+ N + I++L L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 4e-05
Identities = 14/77 (18%), Positives = 29/77 (37%), Gaps = 5/77 (6%)
Query: 392 VNLNSLRMEANRLTGT-IPHVIGELKNLQLLHLHANFLQG----TIPSSLGNLTLLTYLS 446
+++ SL ++ L+ ++ L+ Q++ L L I S+L L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 447 FGANNLQGNIPFSLGNC 463
+N L +
Sbjct: 62 LRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 4e-05
Identities = 19/96 (19%), Positives = 31/96 (32%), Gaps = 7/96 (7%)
Query: 308 NFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGG----VLPHSI 363
L +L LA + + + + L L L+ L L++N G L S+
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSL--AATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 364 ANLSTALIDFNLGKNQIYGTIPPGIANLV-NLNSLR 398
L L + + L + SLR
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 2e-04
Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 8/100 (8%)
Query: 314 DLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANL---STAL 370
D+ L + L D + +LL + Q + L D G I++ + AL
Sbjct: 3 DIQSLDIQCEELS-----DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 57
Query: 371 IDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPH 410
+ NL N++ + + S +++ L
Sbjct: 58 AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 14/119 (11%), Positives = 30/119 (25%), Gaps = 29/119 (24%)
Query: 241 SLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTG----SLPDSFSNASNLEVLHL 296
+ + + + + E+ L + + T + + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 297 AENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGF 355
N+ G+ + L T K+Q L L +
Sbjct: 63 RSNELGDV------GVHCVLQG-------------------LQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 14/94 (14%), Positives = 30/94 (31%), Gaps = 10/94 (10%)
Query: 169 NLQGLSVGDNQLT-GQLPASIGNLSALRVIDIRTNRL----WGKIPITLSQLTSLAYLHV 223
++Q L + +L+ + + L +V+ + L I L +LA L++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 224 GDNHFSGTIPPSV-----YNISSLVEIYLYGNRF 252
N V + ++ L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 16/105 (15%), Positives = 35/105 (33%), Gaps = 9/105 (8%)
Query: 48 WNRSACVNLCQHWTGVTCGRRNQRVTKLDLRNQSIGGI----LSPYVGNLSFLRYINIAD 103
+ + + G+ + L L + + L+ + LR +++++
Sbjct: 347 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 406
Query: 104 NDFHGEIPDRIGNLFR-----LETLVLANNSFSGRIPTNLSHCSK 143
N ++ R LE LVL + +S + L K
Sbjct: 407 NCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 9/48 (18%), Positives = 17/48 (35%), Gaps = 4/48 (8%)
Query: 557 LSSLTSIKELDLSQNNFSGQ----IPKYLENLSFLQYLNLSYNHFEGE 600
+ ++ L L+ + S + L L+ L+LS N
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 19/111 (17%), Positives = 31/111 (27%), Gaps = 11/111 (9%)
Query: 98 YINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGR----IPTNLSHCSKLITFSAHRNN 153
+ D L L LA+ S + L L N
Sbjct: 349 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 408
Query: 154 LVGEIPEEL---ISRRLFNLQGLSVGDNQLTGQLPASIGNLSA----LRVI 197
L +L + + L+ L + D + ++ + L LRVI
Sbjct: 409 LGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 50.6 bits (119), Expect = 5e-07
Identities = 42/336 (12%), Positives = 85/336 (25%), Gaps = 31/336 (9%)
Query: 315 LSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANL---STALI 371
S+ G + ++ +L ++ + L+ N G ++ L
Sbjct: 3 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62
Query: 372 DFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGT 431
L L ++ +L Q +
Sbjct: 63 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122
Query: 432 IPSSL---GNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEIT 488
+ L + + N L RN+L ++ +
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182
Query: 489 TLSLSLDLSDNLLNG------------SLPLGVGNLKSLVRLGIARNQFSGQIPVTLGAC 536
L + NG L ++ + S + + L +
Sbjct: 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242
Query: 537 TSLEYVELQGNSFSGTIPQSLS------SLTSIKELDLSQNNFSGQIPKYL-----ENLS 585
+L + L S ++ ++ L L N + L E +
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 302
Query: 586 FLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKL 621
L +L L+ N F E + + + FS G G+L
Sbjct: 303 DLLFLELNGNRFSEE--DDVVDEIREVFSTRGRGEL 336
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 1e-06
Identities = 24/108 (22%), Positives = 42/108 (38%), Gaps = 6/108 (5%)
Query: 494 LDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTI 553
L L+ L ++ + L + L ++ N+ P L A LE ++ N+
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNAL--EN 57
Query: 554 PQSLSSLTSIKELDLSQNNF-SGQIPKYLENLSFLQYLNLSYNHFEGE 600
+++L ++EL L N + L + L LNL N E
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 27/110 (24%), Positives = 40/110 (36%), Gaps = 7/110 (6%)
Query: 419 QLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTG 478
++LHL L T+ L L L+T+L N L+ P +L + L A N L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 479 ALPQQILEITTLSLSLDLSDNLLNG-SLPLGVGNLKSLVRLGIARNQFSG 527
L L L +N L + + + LV L + N
Sbjct: 58 VDGVANLPRLQ---ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 6e-06
Identities = 27/107 (25%), Positives = 39/107 (36%), Gaps = 5/107 (4%)
Query: 173 LSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTI 232
L + LT + L + +D+ NRL P L+ L L L DN
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNAL--EN 57
Query: 233 PPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTG 279
V N+ L E+ L NR S I+ + P L + N+
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 1e-04
Identities = 19/110 (17%), Positives = 39/110 (35%), Gaps = 7/110 (6%)
Query: 195 RVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTG 254
RV+ + L + L QL + +L + N P +++L + +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNA 54
Query: 255 SLPIEIGKNLPNLRNFVIYTNNFTG-SLPDSFSNASNLEVLHLAENQFRG 303
++ NLP L+ ++ N + + L +L+L N
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.9 bits (90), Expect = 5e-04
Identities = 17/120 (14%), Positives = 41/120 (34%), Gaps = 7/120 (5%)
Query: 75 LDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRI 134
L L ++ + + ++ L + +++++ N P + L LE L ++N+
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59
Query: 135 PTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSAL 194
+ + NN + + L L++ N L L+ +
Sbjct: 60 GVANLPRLQELLLC---NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 4e-06
Identities = 17/93 (18%), Positives = 35/93 (37%), Gaps = 9/93 (9%)
Query: 496 LSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQ 555
N + + SL L ++ N+ ++P LE + N + +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 321
Query: 556 SLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQ 588
+L K+L + N + P E++ L+
Sbjct: 322 LPQNL---KQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 6e-06
Identities = 18/77 (23%), Positives = 32/77 (41%), Gaps = 8/77 (10%)
Query: 523 NQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLE 582
N S +I SLE + + N +P L + L S N+ + ++P+ +
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELPQ 324
Query: 583 NLSFLQYLNLSYNHFEG 599
NL + L++ YN
Sbjct: 325 NL---KQLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 24/93 (25%), Positives = 35/93 (37%), Gaps = 11/93 (11%)
Query: 104 NDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELI 163
N EI LE L ++NN +P +LI N + E+PE
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIA----SFNHLAEVPELP- 323
Query: 164 SRRLFNLQGLSVGDNQLTGQLPASIGNLSALRV 196
NL+ L V N L + P ++ LR+
Sbjct: 324 ----QNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 50/318 (15%), Positives = 89/318 (27%), Gaps = 18/318 (5%)
Query: 152 NNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPIT 211
N + +PE +L+ L N LT +LP +L +L V + L P+
Sbjct: 47 NLGLSSLPELP-----PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLL 100
Query: 212 LSQLTSLAYLHVGDNHFSGTIPPSVY--NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRN 269
S L + + + N S L + + + LP L+N
Sbjct: 101 EYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQN 160
Query: 270 FVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSM-LGLATNFLGNG 328
T + + L + + + L L+
Sbjct: 161 LPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLP 220
Query: 329 AANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGI 388
+ + L + + +I + + L N I
Sbjct: 221 DLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLC 280
Query: 389 ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFG 448
+L L + N+L +P L+ L N L +P N L L
Sbjct: 281 DLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPELPQN---LKQLHVE 332
Query: 449 ANNLQGNIPFSLGNCKNL 466
N L+ P + ++L
Sbjct: 333 YNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.4 bits (103), Expect = 5e-05
Identities = 51/328 (15%), Positives = 94/328 (28%), Gaps = 17/328 (5%)
Query: 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHF 228
L + + L+ LP +L +L N L ++P L SL +
Sbjct: 39 QAHELELNNLGLS-SLPELPPHLESL---VASCNSL-TELPELPQSLKSLLVDNNNLKAL 93
Query: 229 SGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNA 288
S P Y S ++ S I + +L+ + +
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153
Query: 289 SNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVD---LLTNCTKL 345
E+ +L + + L DL + + N + + L T
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213
Query: 346 QYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLT 405
L + + ++ + + + L L N +
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273
Query: 406 GTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKN 465
I + +L+ L++ N L +P+ L L SF N+L +P N K
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL-IASF--NHLA-EVPELPQNLKQ 328
Query: 466 LMFFFAPRNKLTGALPQQILEITTLSLS 493
L N L P + L ++
Sbjct: 329 LHVE---YNPLRE-FPDIPESVEDLRMN 352
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 2e-05
Identities = 32/202 (15%), Positives = 61/202 (30%), Gaps = 17/202 (8%)
Query: 389 ANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFG 448
L + +T T+ +L + L + + L LT ++F
Sbjct: 15 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFS 70
Query: 449 ANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLG 508
N L P + + L + ++D +L
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT-- 128
Query: 509 VGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDL 568
NL L + S +T + ++ + L++LT+++ LD+
Sbjct: 129 --NLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD-------LKPLANLTTLERLDI 179
Query: 569 SQNNFSGQIPKYLENLSFLQYL 590
S N S L L+ L+ L
Sbjct: 180 SSNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 29/191 (15%), Positives = 57/191 (29%), Gaps = 14/191 (7%)
Query: 238 NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLA 297
++ ++ L T ++ +L + S+ D +NL ++ +
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFS 70
Query: 298 ENQFRGQVSI-------NFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYL 350
NQ + + + L N L + L
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130
Query: 351 ADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPH 410
I+ LS L + T +ANL L L + +N+++
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--IS 188
Query: 411 VIGELKNLQLL 421
V+ +L NL+ L
Sbjct: 189 VLAKLTNLESL 199
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 33/200 (16%), Positives = 62/200 (31%), Gaps = 17/200 (8%)
Query: 370 LIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQ 429
I NL K + + L +++ + + + I L N+ L L+ N L
Sbjct: 26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT 81
Query: 430 GTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITT 489
P L NL L +L N ++ + L +
Sbjct: 82 DIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESL 139
Query: 490 LSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSF 549
+ ++D + L + + I L T L+ + L N
Sbjct: 140 YLGNNKITDITVLSRLTK--------LDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHI 190
Query: 550 SGTIPQSLSSLTSIKELDLS 569
S ++L+ L ++ L+L
Sbjct: 191 SD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 4e-05
Identities = 37/208 (17%), Positives = 72/208 (34%), Gaps = 20/208 (9%)
Query: 386 PGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYL 445
A + N ++ +T + EL ++ + + + ++ + L +T L
Sbjct: 21 DAFAETIKDN---LKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKL 73
Query: 446 SFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSL 505
N L P + +F + K +L + S S
Sbjct: 74 FLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSL-------SLEHNGISD 126
Query: 506 PLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKE 565
G+ +L L L + N+ + ++ + + N S +P L+ LT ++
Sbjct: 127 INGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSL--EDNQISDIVP--LAGLTKLQN 182
Query: 566 LDLSQNNFSGQIPKYLENLSFLQYLNLS 593
L LS+N+ S + L L L L L
Sbjct: 183 LYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 23/194 (11%), Positives = 53/194 (27%), Gaps = 14/194 (7%)
Query: 238 NISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLA 297
+ ++ L T ++ L ++ + ++ N+ L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLN 76
Query: 298 ENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGG 357
N+ + L + + L + + +
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 358 VLPHSIANLSTALIDFN-------LGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPH 410
+ N T + + L + +A L L +L + N ++ +
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLRA 195
Query: 411 VIGELKNLQLLHLH 424
+ LKNL +L L
Sbjct: 196 -LAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 10/60 (16%), Positives = 23/60 (38%), Gaps = 2/60 (3%)
Query: 540 EYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEG 599
E ++ S T + + L SI ++ + ++ ++ L + L L+ N
Sbjct: 25 ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD 82
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 8e-05
Identities = 30/214 (14%), Positives = 56/214 (26%), Gaps = 5/214 (2%)
Query: 383 TIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLL 442
IP + N LR +L +L+ + + N + I + + +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 443 T---YLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDN 499
+ N L N + +I + + L + + N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 500 LLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSS 559
+ VG V L + +N E N+
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 560 LTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLS 593
+ LD+S+ LENL L+ +
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 31/239 (12%), Positives = 60/239 (25%), Gaps = 16/239 (6%)
Query: 56 LCQ-HWTGVTCGRRN---------QRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADND 105
+C C + +L + I L I I+ ND
Sbjct: 5 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 64
Query: 106 FHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRN--NLVGEIPEELI 163
I + + + + + + + + + I
Sbjct: 65 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 124
Query: 164 SRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHV 223
L + N T + + +G ++ + N + +
Sbjct: 125 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLS 184
Query: 224 GDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLP 282
+N+ + S V + + R SLP +NL LR T N LP
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLR--ARSTYNLK-KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 7e-04
Identities = 39/213 (18%), Positives = 63/213 (29%), Gaps = 3/213 (1%)
Query: 109 EIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLF 168
EIP + L S L +N+++ I ++ S
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHF 228
+ N L P + NL L+ + I + + L + DN
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 229 SGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLP-DSFSN 287
TI + + S + L+ N+ N L + NN LP D F
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 288 ASNLEVLHLAENQFRGQVSINFNGLKDLSMLGL 320
AS +L ++ + S LK L
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 11/63 (17%), Positives = 17/63 (26%), Gaps = 4/63 (6%)
Query: 536 CT-SLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSY 594
C S Q + + IP L + EL L+ + +S
Sbjct: 6 CHCSNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQ 62
Query: 595 NHF 597
N
Sbjct: 63 NDV 65
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 1e-04
Identities = 20/152 (13%), Positives = 38/152 (25%), Gaps = 3/152 (1%)
Query: 140 HCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDI 199
R+ + + L + L + L LR + I
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIE-NQQHLQHLELRDLRGLGELRNLTI 63
Query: 200 RTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIE 259
+ L P L+ L++ N ++ SL E+ L GN S +
Sbjct: 64 VKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALR 122
Query: 260 IGKNLPNLRNFVIYTNNFTGSLPDSFSNASNL 291
+ + ++ N
Sbjct: 123 WLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 6e-04
Identities = 6/65 (9%), Positives = 15/65 (23%), Gaps = 2/65 (3%)
Query: 536 CTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYL-ENLSFLQYLNLSY 594
+ + L ++ EL + + L L+ L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 595 NHFEG 599
+
Sbjct: 66 SGLRF 70
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 3e-04
Identities = 29/187 (15%), Positives = 53/187 (28%), Gaps = 41/187 (21%)
Query: 53 CVNLCQ-HWTGVTCGRRN---------QRVTKLDLR-NQSIGGILSPYVGNLSFLRYIN- 100
C +C T V C R T+L L N+ G L L +
Sbjct: 2 CPAMCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLEL 61
Query: 101 -----------------------IADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTN 137
+ +N L +L+TL L +N S +P +
Sbjct: 62 KRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGS 121
Query: 138 LSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVI 197
H + L + + N + L+ S+ P+ + +++
Sbjct: 122 FEHLNSLTSLNLASNPFNCNCHLAWFAE---WLRKKSLNGGAARCGAPSK---VRDVQIK 175
Query: 198 DIRTNRL 204
D+ +
Sbjct: 176 DLPHSEF 182
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 0.001
Identities = 8/42 (19%), Positives = 13/42 (30%), Gaps = 1/42 (2%)
Query: 556 SLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHF 597
++ +ELDL I L ++ S N
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.4 bits (85), Expect = 0.004
Identities = 20/67 (29%), Positives = 29/67 (43%), Gaps = 8/67 (11%)
Query: 537 TSLEYVELQGNSFSGTIP------QSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYL 590
S+ E + G IP +LS+L + K L LS NN +I L + L+ L
Sbjct: 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRIL 75
Query: 591 NLSYNHF 597
+L N
Sbjct: 76 SLGRNLI 82
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1009 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.45 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.43 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.43 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.41 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.41 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.37 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.3 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.3 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.29 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.18 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.44 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.36 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.23 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.45 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.32 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.2 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.2 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.54 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.26 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.07 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.92 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.63 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=426.57 Aligned_cols=263 Identities=27% Similarity=0.419 Sum_probs=205.9
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.+.||+|+||+||+|+++ ..||||+++... ....+.|.+|++++++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence 467999999999999999999864 359999996443 2334689999999999999999999998753 35
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++..... .+++.++..++.|+|+||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG 149 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG 149 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred EEEEEecCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccc
Confidence 7899999999999999976543 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCC---CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG---GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
+|+....... ........||+.|||||++.+ ..|+.++|||||||++|||+||+.||........ .....
T Consensus 150 la~~~~~~~~------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~ 222 (276)
T d1uwha_ 150 LATVKSRWSG------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMV 222 (276)
T ss_dssp CSCC------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHH
T ss_pred ceeeccccCC------cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHHHH
Confidence 9987654321 122334679999999999864 3579999999999999999999999975432211 11111
Q ss_pred HHh-ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 047768 935 KRA-LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFL 1005 (1009)
Q Consensus 935 ~~~-~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~ 1005 (1009)
... .+.... .....+++++.+++.+||+.||++||||+|+++.|+.+.+..+
T Consensus 223 ~~~~~~p~~~-------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 223 GRGYLSPDLS-------------------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp HHTSCCCCGG-------------------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred hcCCCCCcch-------------------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 111 111110 0112344578899999999999999999999999999988754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-48 Score=413.71 Aligned_cols=250 Identities=21% Similarity=0.278 Sum_probs=207.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
++|++.+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|++++++++||||+++++++... +..++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CEEEE
Confidence 4799999999999999999999999999999999876666677899999999999999999999997653 67899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
||||+++|+|.+++.+.. +++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 95 vmEy~~gg~L~~~~~~~~-------l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEECCTTCBHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecCCCcHHHHhhccC-------CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 999999999999887643 89999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
...... .......||+.|||||++.+..++.++||||+||++|||+||+.||...... .........
T Consensus 165 ~~~~~~--------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~~~~~ 231 (293)
T d1yhwa1 165 QITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLIATN 231 (293)
T ss_dssp ECCSTT--------CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHH
T ss_pred eecccc--------ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-----HHHHHHHhC
Confidence 765432 2233467999999999999999999999999999999999999999643211 111111000
Q ss_pred hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 941 ~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. .+.+ ..+ .....++.+++.+||+.||++|||++|+++
T Consensus 232 ~-----~~~~-~~~-----------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 232 G-----TPEL-QNP-----------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp C-----SCCC-SSG-----------GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred C-----CCCC-CCc-----------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000 000 122345779999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-49 Score=423.54 Aligned_cols=264 Identities=25% Similarity=0.427 Sum_probs=213.1
Q ss_pred HHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 696 LSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
++...++|++.+.||+|+||+||+|+++.+++.||||+++... ...+++.+|+++|++++||||++++++|...
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~----- 85 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE----- 85 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeC-----
Confidence 3344568999999999999999999999899999999986443 3467899999999999999999999997643
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
+..++||||+++|+|.+++..... ..+++..+..++.|+|.||+|||++ +||||||||+|||+++++.+||+|
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~D 158 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVAD 158 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred CeeEEEeecccCcchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcc
Confidence 678999999999999999976543 2489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+|+....... ....+..||+.|||||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 159 FG~a~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----~~~~~~ 227 (287)
T d1opja_ 159 FGLSRLMTGDTY-------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYE 227 (287)
T ss_dssp CCCTTTCCSSSS-------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHHH
T ss_pred ccceeecCCCCc-------eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----HHHHHH
Confidence 999987654321 223345689999999999999999999999999999999998777643221 111111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQ 1002 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~ 1002 (1009)
.+...... ..+..++.++.+++.+||+.||++||||+||++.|+.+.+
T Consensus 228 ---------~i~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 228 ---------LLEKDYRM----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ---------HHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ---------HHhcCCCC----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11111100 0011234568899999999999999999999999987644
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=413.73 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=199.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
++|++.+.||+|+||+||+|.++ +++.||||+++.. ....+++.+|++++++++||||++++|+|... +..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEE
Confidence 57888999999999999999986 6788999999643 33467899999999999999999999998643 56799
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
||||+++|+|.+++..... .+++..+..++.|+|.||+|||++ +|+||||||+||++++++.+||+|||+|+
T Consensus 78 v~E~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 149 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 149 (263)
T ss_dssp EEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred EEEecCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhe
Confidence 9999999999999887654 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPE 940 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
....... .......||+.|||||++.+..++.++|||||||++|||+|+..|+.... ...+.......
T Consensus 150 ~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~----~~~~~~~~i~~- 217 (263)
T d1sm2a_ 150 FVLDDQY-------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----SNSEVVEDIST- 217 (263)
T ss_dssp ----------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC----CHHHHHHHHHH-
T ss_pred eccCCCc-------eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC----CHHHHHHHHHh-
Confidence 7654321 22234578999999999999999999999999999999999544443221 11222111100
Q ss_pred hhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 941 KVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 941 ~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
. ..... +..+..++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 218 ~-------~~~~~-----------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 218 G-------FRLYK-----------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp T-------CCCCC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c-------CCCCC-----------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 0 00000 112334678999999999999999999999999999764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=413.97 Aligned_cols=253 Identities=23% Similarity=0.297 Sum_probs=202.7
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----ceeE
Confidence 579999999999999999999999999999999965432 2345789999999999999999999997653 7889
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++|+|.+++.... .+++.+++.++.|++.||+|||++ +||||||||+|||+++++.+||+|||+|
T Consensus 80 ivmEy~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a 150 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA 150 (271)
T ss_dssp EEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEeccCCCcHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhh
Confidence 9999999999999997654 399999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+...... ........+||+.|||||++.+..+ +.++||||+||++|||+||+.||................
T Consensus 151 ~~~~~~~------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~-- 222 (271)
T d1nvra_ 151 TVFRYNN------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-- 222 (271)
T ss_dssp EECEETT------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT--
T ss_pred eeeccCC------ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--
Confidence 8765432 1122345689999999999988876 678999999999999999999997543332222111110
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.....+. .....++.+++.+|++.||++|||++|+++
T Consensus 223 ----------~~~~~~~----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 223 ----------KTYLNPW----------KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----------CTTSTTG----------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----------CCCCCcc----------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000000 012235678999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-48 Score=421.04 Aligned_cols=263 Identities=28% Similarity=0.442 Sum_probs=197.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCCe---EEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGM---LVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
++|++.+.||+|+||+||+|+++.+++ .||||++..... ...+.|.+|+++|++++|||||+++|+|... +
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----T 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----C
Confidence 456677899999999999999975553 689998854332 2346799999999999999999999997543 6
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|.+++..... .+++.++..++.|+|+||+|||++ +||||||||+|||++.++++||+||
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DF 172 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDF 172 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEEecCCCcceeeeccccC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCc
Confidence 78999999999999999887554 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+|+........ .......+..||+.|||||++.++.++.++|||||||++|||+| |+.||...... +...
T Consensus 173 Gla~~~~~~~~~---~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-----~~~~ 244 (299)
T d1jpaa_ 173 GLSRFLEDDTSD---PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-----DVIN 244 (299)
T ss_dssp --------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHH
T ss_pred ccceEccCCCCc---ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-----HHHH
Confidence 999877643211 11122334568999999999999999999999999999999998 89999754321 1111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
.. ......+ .+.+++.++.+++.+||+.||++||||+||++.|+++.++
T Consensus 245 ~i--------~~~~~~~-----------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 245 AI--------EQDYRLP-----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HH--------HTTCCCC-----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HH--------HcCCCCC-----------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11 0000000 1123455688999999999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=406.80 Aligned_cols=246 Identities=22% Similarity=0.350 Sum_probs=205.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||+||+|+++.+++.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----ATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-----CCE
Confidence 5799999999999999999999999999999998643 23345788999999999999999999999764 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++.+... +++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~------l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSK------FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEEEEeecCCCcHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccc
Confidence 8999999999999999987653 89999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+|+..... ......||+.|||||++.+..++.++|||||||++|||++|+.||.... ..+.....
T Consensus 152 ~a~~~~~~----------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i 216 (263)
T d2j4za1 152 WSVHAPSS----------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRI 216 (263)
T ss_dssp SCSCCCCC----------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHH
T ss_pred eeeecCCC----------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-----HHHHHHHH
Confidence 99865432 1234679999999999999999999999999999999999999996432 22222111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... . ..+ ....+++.+++.+|++.||++|||++|+++
T Consensus 217 ~~~~--------~-~~p-----------~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 217 SRVE--------F-TFP-----------DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HTTC--------C-CCC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HcCC--------C-CCC-----------ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1110 0 000 012345778999999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-48 Score=412.74 Aligned_cols=263 Identities=23% Similarity=0.372 Sum_probs=209.7
Q ss_pred ccCccCC-cccccCCceEEEEEEe--cCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 701 NEFSSSN-TIGRGSFGFVYKGVLH--ENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 701 ~~~~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
++|.+.+ +||+|+||+||+|.++ .++..||||+++.... ...+.|.+|+++|++++|||||+++|+|.. +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence 4566666 4999999999999876 3456899999964432 234679999999999999999999999753 3
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|.+++..... .+++.++..++.|+|+||+|||++ +||||||||+||+++.++.+||+||
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DF 153 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF 153 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred eEEEEEEeCCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccc
Confidence 57899999999999999876543 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+|+....... .........||+.|||||++.++.++.++|||||||++|||+| |+.||...... .....+.
T Consensus 154 Gla~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~ 226 (285)
T d1u59a_ 154 GLSKALGADDS-----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIE 226 (285)
T ss_dssp TTCEECTTCSC-----EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHH
T ss_pred hhhhccccccc-----ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence 99998764321 1122234568999999999999999999999999999999998 99999754321 1111111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLG 1006 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~ 1006 (1009)
. ..... .+..++.++.+++.+||+.||++||||.+|++.|+.+..+...
T Consensus 227 ~-----------~~~~~-----------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 227 Q-----------GKRME-----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp T-----------TCCCC-----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred c-----------CCCCC-----------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 1 00000 1113345688999999999999999999999999988766544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=410.40 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=206.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|++.+.||+|+||+||+|+++ +++.||||+++... ...+.|.+|++++++++|||||+++|+|.. +..+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~ 83 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY 83 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeE
Confidence 467889999999999999999986 67899999996433 346789999999999999999999998753 3468
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++|+|.+++..... ..+++.++..|+.|+|+||.|||++ +|+||||||+|||+++++.+||+|||+|
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccce
Confidence 99999999999998875442 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
+....... .......||+.|||||++.++.++.++|||||||++|||+||..|+..... ..+.....
T Consensus 157 ~~~~~~~~-------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----~~~~~~~i-- 223 (272)
T d1qpca_ 157 RLIEDNEY-------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEVIQNL-- 223 (272)
T ss_dssp EECSSSCE-------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHH--
T ss_pred EEccCCcc-------ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----HHHHHHHH--
Confidence 97754321 222345789999999999999999999999999999999997666543221 11111110
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
........ +..+++++.+++.+||+.||++||||+||++.|+.+-
T Consensus 224 ------~~~~~~~~-----------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 224 ------ERGYRMVR-----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ------HTTCCCCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HhcCCCCC-----------cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 00000000 1123456889999999999999999999999988764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=403.71 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=198.8
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
|.+.++||+|+||+||+|+++.+++.||+|++..... ...+.+.+|+++|++++||||+++++++... ..+....++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEE
Confidence 3566789999999999999999999999999975432 2345789999999999999999999997653 334467899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC-CCCceEEeccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLA 859 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~DfGla 859 (1009)
||||+++|+|.+++.+... +++.++..++.|+++||+|||++ .++||||||||+|||++ +++.+||+|||+|
T Consensus 90 vmE~~~~g~L~~~l~~~~~------~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEeCCCCCcHHHHHhcccc------ccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 9999999999999987653 89999999999999999999998 11399999999999996 5789999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
+..... ......||+.|||||++.+ .++.++|||||||++|||++|+.||...... .........
T Consensus 163 ~~~~~~----------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~----~~~~~~i~~ 227 (270)
T d1t4ha_ 163 TLKRAS----------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVTS 227 (270)
T ss_dssp GGCCTT----------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHTT
T ss_pred eeccCC----------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH----HHHHHHHHc
Confidence 864321 2234679999999998865 6999999999999999999999999643211 111111110
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...+.. ....+.+++.+++.+||+.||++|||++|+++
T Consensus 228 ---------~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 228 ---------GVKPAS---------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---------TCCCGG---------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---------CCCCcc---------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 000000 00112235779999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=409.85 Aligned_cols=259 Identities=20% Similarity=0.282 Sum_probs=194.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++||||+++++++.+. ....
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCE
Confidence 3679999999999999999999999999999999965432 2245688999999999999999999987532 2356
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcC--CCCceecCCCCCceeeCCCCceEEec
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHC--QPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
.++||||+++|+|.+++.+.... ...+++.+++.++.|++.||.|||++. ..+||||||||+|||++.++.+||+|
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D 157 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence 79999999999999998753211 124999999999999999999999872 12499999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+|+...... .......||+.|||||++.+..++.++|||||||++|||+||+.||..... .+...
T Consensus 158 FG~a~~~~~~~--------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~~~~~ 224 (269)
T d2java1 158 FGLARILNHDT--------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAG 224 (269)
T ss_dssp HHHHHHC-------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHH
T ss_pred ccceeecccCC--------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----HHHHH
Confidence 99999765421 222346799999999999999999999999999999999999999975322 12211
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..... .....+ ..+.+++.+++.+||+.||++|||++|+++
T Consensus 225 ~i~~~--------~~~~~~-----------~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 225 KIREG--------KFRRIP-----------YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHT--------CCCCCC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcC--------CCCCCC-----------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11111 110011 122345789999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=410.07 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=205.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
+.|++.+.||+|+||+||+|+++.+++.||||+++.......+.+.+|+++|++++||||+++++++... ...++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeEEE
Confidence 4688999999999999999999999999999999766555667899999999999999999999997653 67899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
||||+++|+|.+++.+... .+++.++..++.|++.||.|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 87 vmEy~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhh
Confidence 9999999999999876543 399999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccC-----CCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGL-----GGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
..... ........||+.|||||++. +..|+.++||||+||++|||+||+.||....... .......
T Consensus 159 ~~~~~--------~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~ 229 (288)
T d2jfla1 159 KNTRT--------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAK 229 (288)
T ss_dssp ECHHH--------HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHH
T ss_pred ccCCC--------cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHc
Confidence 65421 11223467999999999874 4568999999999999999999999997543221 1111111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. + +.+ . ....+..++.+++.+||+.||++|||++|+++
T Consensus 230 ~~-~--------~~~-~-----------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 230 SE-P--------PTL-A-----------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SC-C--------CCC-S-----------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC-C--------CCC-C-----------ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 000 0 01123346789999999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=408.51 Aligned_cols=262 Identities=28% Similarity=0.456 Sum_probs=200.8
Q ss_pred ccCccCCcccccCCceEEEEEEecCC----eEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENG----MLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
++|+..+.||+|+||+||+|.++.++ ..||||+++..... ..+.|.+|++++++++|||||+++|+|...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~----- 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY----- 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-----
Confidence 56888899999999999999987544 47999999644322 245789999999999999999999997643
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+.+|++.+++..... .+++.++..++.|++.|+.|||++ +|+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~D 153 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD 153 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred CceEEEEEecccCcchhhhhcccc-----cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcc
Confidence 678999999999999998877654 399999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
||+|+........ .....+..||+.|||||++.++.++.++|||||||++|||++|..|+...... .+...
T Consensus 154 FGla~~~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~~~~~ 224 (283)
T d1mqba_ 154 FGLSRVLEDDPEA-----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMK 224 (283)
T ss_dssp CCC----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHH
T ss_pred cchhhcccCCCcc-----ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----HHHHH
Confidence 9999876543211 12233456899999999999999999999999999999999976665432211 11111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
. +.+....+. +..++.++.+++.+||+.||++||||.||++.|+++.+.
T Consensus 225 ~--------i~~~~~~~~-----------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 225 A--------INDGFRLPT-----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp H--------HHTTCCCCC-----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred H--------HhccCCCCC-----------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1 111111111 112345688999999999999999999999999988764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=400.52 Aligned_cols=254 Identities=25% Similarity=0.408 Sum_probs=209.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|++.++||+|+||+||+|+++ +++.||||+++... ...+.+.+|++++++++||||++++|+|... ...+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~ 75 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIF 75 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceE
Confidence 368999999999999999999985 78899999997543 3467899999999999999999999997643 6789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++|+|.+++..... .+++..++.++.|+|+||+|||++ +|+||||||+||++++++.+||+|||++
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a 147 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLS 147 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSC
T ss_pred EEEEccCCCcHHHhhhcccc-----CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhh
Confidence 99999999999999876554 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +.....
T Consensus 148 ~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-----~~~~~i- 214 (258)
T d1k2pa_ 148 RYVLDDEY-------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEHI- 214 (258)
T ss_dssp CBCSSSSC-------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHHHHH-
T ss_pred eeccCCCc-------eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-----HHHHHH-
Confidence 87654322 22334678999999999999999999999999999999998 89999754322 221111
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
.+......+ ..+.+++.+++.+||+.||++|||++|+++.|..
T Consensus 215 -------~~~~~~~~p-----------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 215 -------AQGLRLYRP-----------HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -------HTTCCCCCC-----------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -------HhCCCCCCc-----------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 111101111 1223468899999999999999999999998854
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=407.30 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=200.8
Q ss_pred CcccccCCceEEEEEEec--CCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEEE
Q 047768 707 NTIGRGSFGFVYKGVLHE--NGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALVY 782 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 782 (1009)
++||+|+||+||+|.++. +++.||||+++.... ...+.+.+|+++|++++||||++++|+|.. +..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 469999999999998763 457899999964432 224679999999999999999999999753 3468999
Q ss_pred eccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccccc
Q 047768 783 EYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 862 (1009)
Q Consensus 783 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~~ 862 (1009)
||+++|+|.+++++... +++.++..++.|+|.||+|||++ +||||||||+|||++.++.+||+|||+|+..
T Consensus 87 E~~~~g~L~~~l~~~~~------l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNRH------VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp ECCTTEEHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EcCCCCcHHHHHhhccC------CCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhc
Confidence 99999999999987653 89999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhccch
Q 047768 863 SASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRALPEK 941 (1009)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
..... .........||+.|||||++.+..++.++|||||||++|||+| |+.||..... .+......
T Consensus 158 ~~~~~-----~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-----~~~~~~i~--- 224 (277)
T d1xbba_ 158 RADEN-----YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLE--- 224 (277)
T ss_dssp CTTCS-----EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHH---
T ss_pred ccccc-----ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-----HHHHHHHH---
Confidence 54321 1122234578999999999999999999999999999999998 8999975322 11111110
Q ss_pred hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 942 VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 942 ~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
.....+ .+..++.++.+++.+||+.||++|||++||++.|+....+.
T Consensus 225 -----~~~~~~-----------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 225 -----KGERMG-----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp -----TTCCCC-----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred -----cCCCCC-----------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 000000 11133456889999999999999999999999998876544
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=415.49 Aligned_cols=202 Identities=26% Similarity=0.375 Sum_probs=177.9
Q ss_pred HhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 699 ATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
..++|++.+.||+|+||+||+|+++.+|+.||||+++.... .....+.+|+++|++++|||||++++++... ..
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----SE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CE
Confidence 35689999999999999999999999999999999975433 2346789999999999999999999997643 67
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++.+... +++..++.++.|++.||.|||+++ +|+||||||+|||++.++.+||+|||
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~------l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFG 150 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG 150 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred EEEEEEcCCCCcHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCC
Confidence 8999999999999999987653 899999999999999999999732 89999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESM 923 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~ 923 (1009)
+|+..... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...
T Consensus 151 la~~~~~~----------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 151 VSGQLIDS----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp CCHHHHHH----------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred CccccCCC----------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99876432 223468999999999999999999999999999999999999999753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=402.45 Aligned_cols=251 Identities=20% Similarity=0.285 Sum_probs=203.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|++++++++||||+++++++.. ...
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-----SSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-----CCE
Confidence 5799999999999999999999999999999999643 23345679999999999999999999998654 377
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|+|.+++..... +++.+++.++.|++.||+|||++ +||||||||+||++++++.+||+|||
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~------l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEccCCCCHHHhhhccCC------CCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence 8999999999999999987653 99999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+|+....... ........||+.|||||++.+..++.++||||+||++|||++|+.||.... ........
T Consensus 154 ~a~~~~~~~~------~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i 222 (288)
T d1uu3a_ 154 TAKVLSPESK------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EYLIFQKI 222 (288)
T ss_dssp TCEECC----------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHH
T ss_pred cceecccCCc------ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-----HHHHHHHH
Confidence 9997754321 122334679999999999999999999999999999999999999997432 11221111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.... . ..+. ...+++.+++.+|++.||++|||++|+...
T Consensus 223 ~~~~--------~-~~p~-----------~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 223 IKLE--------Y-DFPE-----------KFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HTTC--------C-CCCT-----------TCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred HcCC--------C-CCCc-----------cCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1110 0 0010 122357799999999999999999997553
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=410.36 Aligned_cols=262 Identities=22% Similarity=0.352 Sum_probs=205.6
Q ss_pred hccCccCCcccccCCceEEEEEEecCC-----eEEEEEEeeccc-ccchHHHHHHHHHHHhc-CCCCcceEEeeeecccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENG-----MLVAVKVINLEQ-KGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 772 (1009)
.++|++.+.||+|+||+||+|+++..+ ..||||++.... ......+.+|+++++++ +|||||++++++...
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-- 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--
Confidence 467899999999999999999987543 379999985432 33456789999999998 899999999997643
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCC-----------------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQL-----------------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVH 835 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH 835 (1009)
...++||||+++|+|.++++.+.... ....+++.+++.++.|+++||+|||++ +|||
T Consensus 114 ---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH 187 (325)
T d1rjba_ 114 ---GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 187 (325)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred ---CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 67899999999999999998754321 113489999999999999999999999 9999
Q ss_pred cCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh
Q 047768 836 GDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT 915 (1009)
Q Consensus 836 rdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt 915 (1009)
|||||+||+++.++.+||+|||+|+....... ........||+.|||||++.++.++.++|||||||++|||+|
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt 261 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSN------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTT------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCc------eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHh
Confidence 99999999999999999999999987654321 112234568999999999999999999999999999999998
Q ss_pred -CCCCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 047768 916 -RRRPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVV 994 (1009)
Q Consensus 916 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl 994 (1009)
|+.||...... ..+.+...... .. ..+..+.+++.+++.+||+.||++||||+||+
T Consensus 262 ~g~~Pf~~~~~~-~~~~~~~~~~~------------~~----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 262 LGVNPYPGIPVD-ANFYKLIQNGF------------KM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp TSCCSSTTCCCS-HHHHHHHHTTC------------CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCCCCCHH-HHHHHHHhcCC------------CC----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 89999754322 11222221111 00 01112345688999999999999999999999
Q ss_pred HHHH
Q 047768 995 VKLC 998 (1009)
Q Consensus 995 ~~L~ 998 (1009)
+.|.
T Consensus 319 ~~L~ 322 (325)
T d1rjba_ 319 SFLG 322 (325)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 9985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-46 Score=402.23 Aligned_cols=251 Identities=24% Similarity=0.275 Sum_probs=188.4
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
+.|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+++|++++||||+++++++.. ....+
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-----GGHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-----SSEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence 569999999999999999999999999999999965432 234568899999999999999999999654 37889
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC---CCCceEEecc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHVSDF 856 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~---~~~~~kl~Df 856 (1009)
+||||+++|+|.+++.+.. .+++.++..++.|++.||+|||++ +||||||||+||++. +++.+||+||
T Consensus 84 lvmE~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp EEECCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEeccCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEecc
Confidence 9999999999999998754 399999999999999999999999 999999999999994 5789999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+|+..... ......+||+.|||||++.+..++.++||||+||++|||++|+.||..... ......
T Consensus 155 G~a~~~~~~---------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~ 220 (307)
T d1a06a_ 155 GLSKMEDPG---------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-----AKLFEQ 220 (307)
T ss_dssp ---------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHH
T ss_pred ceeEEccCC---------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence 999866432 122346799999999999999999999999999999999999999974321 111111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... ....... .......+++.+++.+|++.||++|||++|+++
T Consensus 221 i~~--------~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 221 ILK--------AEYEFDS--------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHT--------TCCCCCT--------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred Hhc--------cCCCCCC--------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111 1100000 000112345789999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-46 Score=404.54 Aligned_cols=246 Identities=25% Similarity=0.311 Sum_probs=199.3
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
+.|+..+.||+|+||+||+|+++.+++.||||+++..... ..+.+.+|+++|++++|||||++++++... ..
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CE
Confidence 3588999999999999999999999999999999754332 235688999999999999999999997653 67
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++|||||++|++..++.... .+++.+++.++.|++.||.|||++ +||||||||+|||++.++.+||+|||
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred EEEEEEecCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecc
Confidence 899999999999987776554 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCC---CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG---GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
+|+..... ....||+.|||||++.+ +.|+.++|||||||++|||++|+.||..... ....
T Consensus 161 ~a~~~~~~------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-----~~~~ 223 (309)
T d1u5ra_ 161 SASIMAPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSAL 223 (309)
T ss_dssp TCBSSSSB------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHH
T ss_pred cccccCCC------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-----HHHH
Confidence 99865432 23579999999999864 4689999999999999999999999964321 1111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
........ +... ...+.+++.+++.+||+.||++|||++|+++
T Consensus 224 ~~i~~~~~-----~~~~-------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 224 YHIAQNES-----PALQ-------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHSCC-----CCCS-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHhCCC-----CCCC-------------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11110000 0000 0122345789999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-45 Score=408.03 Aligned_cols=253 Identities=19% Similarity=0.264 Sum_probs=206.0
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence 3589999999999999999999999999999999976554456788999999999999999999999764 37889
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC--CCceEEeccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH--DMVAHVSDFG 857 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~--~~~~kl~DfG 857 (1009)
+||||+++|+|.+++..... .+++.++..++.||+.||.|||++ +||||||||+|||++. ++.+||+|||
T Consensus 100 ivmE~~~gg~L~~~l~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTS-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecc
Confidence 99999999999999976543 389999999999999999999999 9999999999999964 6789999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+|+..... .......||+.|||||++.+..++.++||||+||++|||++|+.||.... ..+.....
T Consensus 172 ~a~~~~~~---------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i 237 (350)
T d1koaa2 172 LTAHLDPK---------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----DDETLRNV 237 (350)
T ss_dssp TCEECCTT---------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHH
T ss_pred hheecccc---------cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHH
Confidence 99876543 22334679999999999999999999999999999999999999996432 11111111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. ......... ......+++.+++.+|++.||++|||++|+++
T Consensus 238 ~--------~~~~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 238 K--------SCDWNMDDS--------AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp H--------HTCCCSCCG--------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred H--------hCCCCCCcc--------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000000 00112245779999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=405.20 Aligned_cols=259 Identities=25% Similarity=0.434 Sum_probs=204.7
Q ss_pred ccCccCCcccccCCceEEEEEEecCCe----EEEEEEeecc-cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGM----LVAVKVINLE-QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.+|++.+.||+|+||+||+|++..+|+ +||||+++.. .....+.+.+|++++++++||||++++|+|..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 469999999999999999999987665 6888888543 23346789999999999999999999999864
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++++||+.+|+|.+++..... .+++..++.++.|+|.||+|||++ +||||||||+||+++.++.+||+|
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~D 154 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 154 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred CCeeEEEEeccCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeec
Confidence 346788999999999999887654 399999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 934 (1009)
||+|+....... ........||+.|||||++.++.++.++|||||||++|||+| |+.||...... .+....
T Consensus 155 FGla~~~~~~~~------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i 226 (317)
T d1xkka_ 155 FGLAKLLGAEEK------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSIL 226 (317)
T ss_dssp CSHHHHTTTTCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHH
T ss_pred cccceecccccc------cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHH
Confidence 999997754321 122234568999999999999999999999999999999999 78888754322 122222
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
..... .+ .+..++.++.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 227 ~~~~~-----------~~-----------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 227 EKGER-----------LP-----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHTCC-----------CC-----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HcCCC-----------CC-----------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 11100 00 0112345688999999999999999999999999887654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=398.12 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=200.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|++.+.||+|+||+||+|+++ +++.||||+++... ...+.|.+|+.++++++|||||+++|+|.. +..+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~ 87 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 87 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeE
Confidence 467999999999999999999986 55779999996443 346789999999999999999999999743 3468
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++|+|..++...... .++|.++..++.|+|.||+|||+. +|+||||||+|||++.++++||+|||+|
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~----~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EEEEecCCCchhhhhhhcccc----cchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchh
Confidence 999999999999998764321 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
+....... .......||+.|+|||++.++.++.++|||||||++|||++|+.|+...... .+......
T Consensus 161 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~----~~~~~~i~- 228 (285)
T d1fmka3 161 RLIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQVE- 228 (285)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHH-
T ss_pred hhccCCCc-------eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH----HHHHHHHH-
Confidence 87654321 2223456899999999999999999999999999999999977776543221 11111110
Q ss_pred chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 047768 940 EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHAR 1001 (1009)
Q Consensus 940 ~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~ 1001 (1009)
. .... .....+.+++.+++.+||+.||++||||++|+++|+...
T Consensus 229 -------~-~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 229 -------R-GYRM----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp -------T-TCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -------h-cCCC----------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 0 0000 011133456889999999999999999999998887644
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=392.47 Aligned_cols=253 Identities=31% Similarity=0.402 Sum_probs=198.5
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
.++|++.+.||+|+||.||+|+++ |+.||||+++.. ...+.+.+|++++++++||||++++|+|... ....+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~ 77 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY 77 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcEE
Confidence 457888999999999999999984 889999999643 3457899999999999999999999987532 24579
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
+||||+++|+|.+++..+.. ..+++..++.++.|++.||.|||+. +||||||||+||+++.++.+|++|||++
T Consensus 78 lv~ey~~~g~L~~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s 150 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 150 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred EEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccc
Confidence 99999999999999976532 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+..... .....+|+.|+|||++.++.++.++|||||||++|||+| |+.||...... .....+..
T Consensus 151 ~~~~~~-----------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~-- 215 (262)
T d1byga_ 151 KEASST-----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEK-- 215 (262)
T ss_dssp ----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTT--
T ss_pred eecCCC-----------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc--
Confidence 865432 122457899999999999999999999999999999999 67777643222 12211111
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQ 1002 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~ 1002 (1009)
.... ..+..+..++.+++.+||+.||++||||.|++++|++++.
T Consensus 216 ----------~~~~----------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 216 ----------GYKM----------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ----------TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------CCCC----------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 0000 0111233567899999999999999999999999998864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=394.45 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=204.0
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc------cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK------GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+++|++++||||+++++++..
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----- 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----- 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----
Confidence 579999999999999999999999999999999964321 124679999999999999999999999754
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC----c
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM----V 850 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~----~ 850 (1009)
....++|||||++|+|.+++.+... +++.+++.++.|++.||+|||++ +||||||||+||+++.++ .
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~~------l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCC
T ss_pred CCEEEEEEEcCCCccccchhccccc------cchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccc
Confidence 3788999999999999999987653 99999999999999999999999 999999999999998876 5
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccH
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL 930 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~ 930 (1009)
+|++|||+|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 156 vkl~DfG~a~~~~~~---------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----- 221 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFG---------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----- 221 (293)
T ss_dssp EEECCCTTCEECTTS---------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred eEecchhhhhhcCCC---------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-----
Confidence 999999999876543 222345789999999999999999999999999999999999999974321
Q ss_pred HHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 931 HEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.+.... +........... .......+.+++.+||+.||++|||++|+++
T Consensus 222 ~~~~~~--------i~~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 222 QETLAN--------VSAVNYEFEDEY--------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHH--------HHTTCCCCCHHH--------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHH--------HHhcCCCCCchh--------cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 111111100000 0112345779999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-45 Score=401.62 Aligned_cols=267 Identities=25% Similarity=0.393 Sum_probs=209.7
Q ss_pred HHhccCccCCcccccCCceEEEEEEec-----CCeEEEEEEeeccccc-chHHHHHHHHHHHhcCCCCcceEEeeeeccc
Q 047768 698 KATNEFSSSNTIGRGSFGFVYKGVLHE-----NGMLVAVKVINLEQKG-GSKSFAAECEALRSIRHRNLIKIVTICSSID 771 (1009)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 771 (1009)
...++|++.+.||+|+||+||+|+++. +++.||||+++..... ..+.+.+|++++++++||||++++++|...
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~- 88 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG- 88 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC-
Confidence 345689999999999999999999863 4689999999754332 246799999999999999999999998653
Q ss_pred cCCCceEEEEEeccCCCCHHHHHhccCCC------------------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 047768 772 FKGVDFKALVYEYMQNGSLEEWLHQRDDQ------------------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPI 833 (1009)
Q Consensus 772 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 833 (1009)
...++||||+++|+|.++++..... .....+++.++..|+.|++.||+|||++ +|
T Consensus 89 ----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 89 ----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred ----CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 6779999999999999999764321 1123489999999999999999999999 99
Q ss_pred eecCCCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHH
Q 047768 834 VHGDLKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEI 913 (1009)
Q Consensus 834 vHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el 913 (1009)
|||||||+|||++.++.+||+|||+|+....... ........||+.|+|||.+.+..++.++|||||||++|||
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~el 235 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADY------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCcc------ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHH
Confidence 9999999999999999999999999987654321 1222345689999999999999999999999999999999
Q ss_pred HhCC-CCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 047768 914 FTRR-RPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTD 992 (1009)
Q Consensus 914 ltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~e 992 (1009)
++|. .||..... .+..... .+...... +..++.++.+++.+||+.||++||||.|
T Consensus 236 l~~~~~p~~~~~~-----~e~~~~v--------~~~~~~~~-----------p~~~~~~~~~li~~cl~~~P~~RPt~~e 291 (301)
T d1lufa_ 236 FSYGLQPYYGMAH-----EEVIYYV--------RDGNILAC-----------PENCPLELYNLMRLCWSKLPADRPSFCS 291 (301)
T ss_dssp HTTTCCTTTTSCH-----HHHHHHH--------HTTCCCCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HccCCCCCCCCCH-----HHHHHHH--------HcCCCCCC-----------CccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 9986 56654321 2222111 11111111 1123456889999999999999999999
Q ss_pred HHHHHHHHHH
Q 047768 993 VVVKLCHARQ 1002 (1009)
Q Consensus 993 vl~~L~~i~~ 1002 (1009)
|+++|++|.+
T Consensus 292 v~~~L~~i~~ 301 (301)
T d1lufa_ 292 IHRILQRMCE 301 (301)
T ss_dssp HHHHHHHTTC
T ss_pred HHHHHHHhcC
Confidence 9999998753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=398.41 Aligned_cols=273 Identities=23% Similarity=0.313 Sum_probs=205.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHH--HHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAA--ECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|...+.||+|+||+||+|++ +|+.||||+++... .+.+.+ |+..+.+++||||++++++|... .......
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~-~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKD-NGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE-CSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeC-CCcceEE
Confidence 4677889999999999999987 58999999996442 234444 44455678999999999998764 2333578
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCceecCCCCCceeeCCCCceEE
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHC-----QPPIVHGDLKPSNVLLDHDMVAHV 853 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivHrdlk~~Nill~~~~~~kl 853 (1009)
++||||+++|+|.+++++.. ++|.++..++.|+|.|++|+|+.. .++||||||||+|||++.++.+||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~~-------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl 149 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred EEEEecccCCCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence 99999999999999998753 899999999999999999999731 349999999999999999999999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCCCC------CCCcccchHHHHHHHHHHhCCCCCcccccCC
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE------ASMRGGVYSYGILLLEIFTRRRPTESMFNEG 927 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~ 927 (1009)
+|||+++....... ..........||+.|||||++.+.. ++.++|||||||++|||+||..||.......
T Consensus 150 ~DFGl~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~ 225 (303)
T d1vjya_ 150 ADLGLAVRHDSATD----TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225 (303)
T ss_dssp CCCTTCEEEETTTT----EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred EecCccccccCCCc----ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence 99999987754321 1112233567999999999987643 6778999999999999999998875432211
Q ss_pred ----------ccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 047768 928 ----------LTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKL 997 (1009)
Q Consensus 928 ----------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L 997 (1009)
........ ...+..+.+.. .......+.+..+.+++.+||+.||++||||.||++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~p~~-----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L 292 (303)
T d1vjya_ 226 LPYYDLVPSDPSVEEMRK--------VVCEQKLRPNI-----PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp CTTTTTSCSSCCHHHHHH--------HHTTSCCCCCC-----CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred cchhhcccccchHHHHHH--------HHhccccCCCC-----CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 11111111 11121221111 11223345677899999999999999999999999999
Q ss_pred HHHHHh
Q 047768 998 CHARQN 1003 (1009)
Q Consensus 998 ~~i~~~ 1003 (1009)
+++.+.
T Consensus 293 ~~i~~~ 298 (303)
T d1vjya_ 293 SQLSQQ 298 (303)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 998864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.3e-45 Score=404.69 Aligned_cols=252 Identities=19% Similarity=0.259 Sum_probs=205.6
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
++|++.+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|++++++++||||+++++++.. ....++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence 579999999999999999999999999999999976554445678899999999999999999998654 478899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC--CCCceEEecccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD--HDMVAHVSDFGL 858 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~--~~~~~kl~DfGl 858 (1009)
|||||++|+|.+++..... .+++.+++.|+.||+.||+|||++ +||||||||+|||++ .++.+||+|||+
T Consensus 104 vmE~~~gg~L~~~~~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp EEECCCCCBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEcCCCChHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeeccc
Confidence 9999999999998876543 389999999999999999999999 999999999999998 678999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
|+..... .......||+.|||||++.+..++.++||||+||++|||+||+.||..... ........
T Consensus 176 a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~ 241 (352)
T d1koba_ 176 ATKLNPD---------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETLQNVK 241 (352)
T ss_dssp CEECCTT---------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHH
T ss_pred ceecCCC---------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH
Confidence 9877543 223346789999999999999999999999999999999999999974321 11111110
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... ...... ......++.+++.+|++.||++|||++|+++
T Consensus 242 ~~~~-~~~~~~---------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 242 RCDW-EFDEDA---------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HCCC-CCCSST---------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hCCC-CCCccc---------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000000 0112245779999999999999999999976
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-45 Score=395.67 Aligned_cols=264 Identities=25% Similarity=0.407 Sum_probs=208.6
Q ss_pred CCcccccCCceEEEEEEecCC---eEEEEEEeecc-cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEEE
Q 047768 706 SNTIGRGSFGFVYKGVLHENG---MLVAVKVINLE-QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKALV 781 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 781 (1009)
.++||+|+||+||+|++..++ ..||||+++.. .....++|.+|+++|++++||||++++|+|... ....++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCceEEE
Confidence 468999999999999986433 46999998643 223346799999999999999999999997643 2578999
Q ss_pred EeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccccc
Q 047768 782 YEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 861 (1009)
Q Consensus 782 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~~ 861 (1009)
|||+++|+|.+++..... ..++.++..++.|+|.||.|+|+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 108 ~E~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 179 (311)
T ss_dssp EECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred EEEeecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhh
Confidence 999999999999987654 378899999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhccch
Q 047768 862 LSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALPEK 941 (1009)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
........ ........||+.|+|||.+.++.++.++||||||+++|||+||+.||............. ..
T Consensus 180 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i-~~----- 249 (311)
T d1r0pa_ 180 MYDKEFDS----VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQ----- 249 (311)
T ss_dssp TTTTTCCC----TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH-HT-----
T ss_pred cccccccc----ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH-Hc-----
Confidence 76543211 122334678999999999999999999999999999999999888876433221111111 10
Q ss_pred hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcCC
Q 047768 942 VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNFLGQR 1008 (1009)
Q Consensus 942 ~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~~~~~ 1008 (1009)
...... +..+++++.+++.+||+.||++||+|.||++.|+++.+.|..++
T Consensus 250 ------g~~~~~-----------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 250 ------GRRLLQ-----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp ------TCCCCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred ------CCCCCC-----------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 000000 11233568899999999999999999999999999999887653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=393.44 Aligned_cols=260 Identities=21% Similarity=0.343 Sum_probs=199.3
Q ss_pred hccCccCCcccccCCceEEEEEEecC---CeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHEN---GMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGV 775 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 775 (1009)
.++|.+.+.||+|+||+||+|++..+ +..||||+++.... ...+.+.+|++++++++||||++++|++..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 35789999999999999999998643 45789998854332 234679999999999999999999999743
Q ss_pred ceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEec
Q 047768 776 DFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 855 (1009)
Q Consensus 776 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 855 (1009)
...++||||+++|+|.+++..... .+++.+++.++.|+++||.|||++ +||||||||+||+++.++.+||+|
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~D 151 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 151 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CeEEEEEEeccCCcHHhhhhccCC-----CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEcc
Confidence 457899999999999999876554 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHHH
Q 047768 856 FGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 856 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 934 (1009)
||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+...+
T Consensus 152 fG~a~~~~~~~~-------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i 222 (273)
T d1mp8a_ 152 FGLSRYMEDSTY-------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRI 222 (273)
T ss_dssp --------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH
T ss_pred chhheeccCCcc-------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHH
Confidence 999987654321 12234568999999999999999999999999999999998 88898754322 111111
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
.. ....+. +..++.++.+++.+||+.||++|||+.||++.|+.+.++-
T Consensus 223 ~~-----------~~~~~~-----------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 223 EN-----------GERLPM-----------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp HT-----------TCCCCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred Hc-----------CCCCCC-----------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11 000011 1123456889999999999999999999999999988763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=393.98 Aligned_cols=273 Identities=22% Similarity=0.323 Sum_probs=202.4
Q ss_pred HHHHHhccCccCCcccccCCceEEEEEEec-----CCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeee
Q 047768 695 ELSKATNEFSSSNTIGRGSFGFVYKGVLHE-----NGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTIC 767 (1009)
Q Consensus 695 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 767 (1009)
++....++|++.+.||+|+||+||+|++.. +++.||||+++.... ...+.+.+|+..+.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 333345689999999999999999999864 347899999864332 2345678888888877 689999999987
Q ss_pred eccccCCCceEEEEEeccCCCCHHHHHhccCCCC----------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecC
Q 047768 768 SSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQL----------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGD 837 (1009)
Q Consensus 768 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrd 837 (1009)
.. .....++||||+++|+|.++++...... ....+++.++..++.|+++||.|||++ +|||||
T Consensus 87 ~~----~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrD 159 (299)
T d1ywna1 87 TK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 159 (299)
T ss_dssp CS----TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred cc----CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCc
Confidence 54 2356799999999999999997653211 112488999999999999999999999 999999
Q ss_pred CCCCceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCC
Q 047768 838 LKPSNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRR 917 (1009)
Q Consensus 838 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~ 917 (1009)
|||+|||+++++++||+|||+|+....... ........||+.|||||++.++.++.++|||||||++|||+||.
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~ 233 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 233 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTT------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCccceeECCCCcEEEccCcchhhcccccc------ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCC
Confidence 999999999999999999999987654321 12233467999999999999999999999999999999999975
Q ss_pred -CCCcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 918 -RPTESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 918 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
.||...... ..+.......... .. +..+.+++.+++.+||+.||++||||+|+++.
T Consensus 234 ~~p~~~~~~~-~~~~~~~~~~~~~-----------~~-----------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 234 ASPYPGVKID-EEFCRRLKEGTRM-----------RA-----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CCSSTTCCCS-HHHHHHHHHTCCC-----------CC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHH-HHHHHHHhcCCCC-----------CC-----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 566543222 1111211111100 00 01233467899999999999999999999999
Q ss_pred HHHHHHh
Q 047768 997 LCHARQN 1003 (1009)
Q Consensus 997 L~~i~~~ 1003 (1009)
|+.+.+.
T Consensus 291 L~~ilq~ 297 (299)
T d1ywna1 291 LGNLLQA 297 (299)
T ss_dssp HHHHHHH
T ss_pred HHHHHhC
Confidence 9998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-44 Score=387.69 Aligned_cols=266 Identities=21% Similarity=0.326 Sum_probs=205.4
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|++++++++||||+++++++... .....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~-~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE-TPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-CSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec-cCCCc
Confidence 35799999999999999999999999999999999754332 235789999999999999999999997653 22335
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..|+||||+++|+|.+++..... +++.+++.++.|++.||+|||++ +||||||||+||+++.++.++++||
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~------l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~ 155 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGP------MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 155 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCC
T ss_pred eEEEEEECCCCCEehhhhcccCC------CCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehh
Confidence 68999999999999999987653 89999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|.++....... .........||+.|||||++.+..++.++||||+||++|||+||+.||.... ..+....
T Consensus 156 ~~~~~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~~ 225 (277)
T d1o6ya_ 156 GIARAIADSGN-----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----PVSVAYQ 225 (277)
T ss_dssp TTCEECC---------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHH
T ss_pred hhhhhhccccc-----cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-----HHHHHHH
Confidence 99876654321 1123345679999999999999999999999999999999999999997432 1122111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-EMTDVVVKLCHAR 1001 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-t~~evl~~L~~i~ 1001 (1009)
...... .. +. .......+++.+++.+|++.||++|| |++|+.+.|.+++
T Consensus 226 ~~~~~~--------~~-~~-------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 226 HVREDP--------IP-PS-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHCCC--------CC-GG-------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHhcCC--------CC-Cc-------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 111100 00 00 00012234678999999999999999 8999999998875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=390.66 Aligned_cols=258 Identities=25% Similarity=0.334 Sum_probs=196.7
Q ss_pred ccCccCCcccccCCceEEEEEEecC---CeEEEEEEeeccc---ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCC
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHEN---GMLVAVKVINLEQ---KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKG 774 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 774 (1009)
++|++.+.||+|+||+||+|++..+ ...||||+++... ....+.|.+|+++|++++||||++++|+|..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 5799999999999999999997633 2479999986442 2234679999999999999999999999853
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
...++||||+++|++.+++..+.. .+++..+..++.|+|.||.|||++ +|+||||||+||+++.++.+||+
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~ 153 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG 153 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred -cchheeeeeecCcchhhhhhcccC-----CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeec
Confidence 346899999999999998887654 399999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCCCcccccCCccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 933 (1009)
|||+++........ ........||..|+|||++.+..++.++|||||||++|||+| |+.||..... .+.
T Consensus 154 DfGl~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-----~~~ 223 (273)
T d1u46a_ 154 DFGLMRALPQNDDH-----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQI 223 (273)
T ss_dssp CCTTCEECCC-CCE-----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHH
T ss_pred cchhhhhcccCCCc-----ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-----HHH
Confidence 99999987553211 122234567889999999999999999999999999999998 8999974322 222
Q ss_pred HHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 934 AKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
........ ... .....++.++.+++.+||+.||++||||+||++.|.+.
T Consensus 224 ~~~i~~~~--------~~~----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 224 LHKIDKEG--------ERL----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHTSC--------CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhCC--------CCC----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 21111111 000 00112334688999999999999999999999988764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=394.68 Aligned_cols=249 Identities=23% Similarity=0.278 Sum_probs=205.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
.++|.+.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+++|++++||||+++++++.. ..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-----cc
Confidence 46799999999999999999999999999999999743 23345778999999999999999999998654 47
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|.+++..... +++..++.++.|++.||+|||++ +||||||||+|||++.+|.+||+||
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~~------~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRERV------FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ccccceeccCCCchhhhhhcccC------CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeec
Confidence 89999999999999999988653 89999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+|+...... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+....
T Consensus 150 G~a~~~~~~~--------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-----~~~~~~ 216 (337)
T d1o6la_ 150 GLCKEGISDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFEL 216 (337)
T ss_dssp TTCBCSCCTT--------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred ccccccccCC--------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-----HHHHHH
Confidence 9998654321 223457899999999999999999999999999999999999999975321 122111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME-----MTDVVV 995 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt-----~~evl~ 995 (1009)
..... . ..+. ....++.+++.+|++.||++||+ ++|+++
T Consensus 217 i~~~~--------~-~~p~-----------~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 217 ILMEE--------I-RFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHCC--------C-CCCT-----------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HhcCC--------C-CCCc-----------cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11110 0 0010 12234678999999999999995 777765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-44 Score=390.86 Aligned_cols=245 Identities=24% Similarity=0.298 Sum_probs=203.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-----CCe
Confidence 5799999999999999999999999999999999643 23345788999999999999999999999654 478
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+++|++.+++..... +++..+..++.|++.|++|||++ +||||||||+|||++.++.+||+|||
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~------~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQR------FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSS------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred eeeEeeecCCcccccccccccc------ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCc
Confidence 8999999999999999987654 78899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+|+..... .....||+.|||||++.+..++.++||||+||++|||+||+.||.... ..+.....
T Consensus 150 ~a~~~~~~-----------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i 213 (316)
T d1fota_ 150 FAKYVPDV-----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEKI 213 (316)
T ss_dssp SCEECSSC-----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHH
T ss_pred cceEeccc-----------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-----HHHHHHHH
Confidence 99876532 224679999999999999999999999999999999999999997432 12222111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~ 995 (1009)
.... .. .+ .....++.+++.+|+..||.+|| |++|+++
T Consensus 214 ~~~~--------~~-~p-----------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 214 LNAE--------LR-FP-----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHCC--------CC-CC-----------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HcCC--------CC-CC-----------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1110 00 00 01223577999999999999996 8888875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=393.24 Aligned_cols=257 Identities=20% Similarity=0.253 Sum_probs=200.6
Q ss_pred hccCccCC-cccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSN-TIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|.+.. .||+|+||+||+|+++.+++.||||+++. .+.+.+|++++.++ +||||+++++++... ......
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence 35788764 69999999999999999999999999852 35678899987665 899999999987542 233467
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC---CCceEEe
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVS 854 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~ 854 (1009)
.|+|||||++|+|.+++.++.. ..+++.+++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC----CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEECCCCCcHHHHHHhcCC----CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence 8999999999999999987542 2489999999999999999999999 9999999999999985 5679999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFA 934 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 934 (1009)
|||+|+...... ......||+.|||||++.+..|+.++||||+||++|||+||+.||........ .....
T Consensus 157 DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~~ 226 (335)
T d2ozaa1 157 DFGFAKETTSHN---------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMK 226 (335)
T ss_dssp CCTTCEECCCCC---------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------
T ss_pred ccceeeeccCCC---------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHHH
Confidence 999998765432 22345799999999999999999999999999999999999999975332210 00000
Q ss_pred HHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 935 KRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 935 ~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. +..... ..+. .......+++.+++.+|++.||++|||+.|+++
T Consensus 227 -~~-------i~~~~~-~~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 227 -TR-------IRMGQY-EFPN-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --C-------CCSCSS-SCCT-------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HH-------HhcCCC-CCCC-------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00 000000 0000 011123456889999999999999999999976
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=392.15 Aligned_cols=262 Identities=27% Similarity=0.412 Sum_probs=204.7
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeE--EEEEEeecc-cccchHHHHHHHHHHHhc-CCCCcceEEeeeeccccCCCc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGML--VAVKVINLE-QKGGSKSFAAECEALRSI-RHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 776 (1009)
++|++.+.||+|+||+||+|+++.+|.. ||||+++.. .....+.+.+|+++|+++ +||||++++|+|... .
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----C
Confidence 6788899999999999999999988764 677777533 233456799999999999 799999999998753 6
Q ss_pred eEEEEEeccCCCCHHHHHhccCC----------CCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeC
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDD----------QLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLD 846 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 846 (1009)
..++||||+++|+|.++++.... ......+++.++..++.|+|.|+.|+|++ +||||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence 78999999999999999976521 01123589999999999999999999999 999999999999999
Q ss_pred CCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCC-CCccccc
Q 047768 847 HDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRR-PTESMFN 925 (1009)
Q Consensus 847 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~-p~~~~~~ 925 (1009)
.++.+||+|||+|+..... .......||..|+|||.+.++.++.++|||||||++|||++|.. ||...
T Consensus 162 ~~~~~kl~DfG~a~~~~~~---------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-- 230 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-- 230 (309)
T ss_dssp GGGCEEECCTTCEESSCEE---------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--
T ss_pred CCCceEEcccccccccccc---------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--
Confidence 9999999999999865432 12223568999999999999999999999999999999999765 55432
Q ss_pred CCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 926 EGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
...+...... +..... .+..+.+++.+++.+||+.||++||||.||++.|+.+.++
T Consensus 231 ---~~~~~~~~i~--------~~~~~~-----------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 231 ---TCAELYEKLP--------QGYRLE-----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp ---CHHHHHHHGG--------GTCCCC-----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---CHHHHHHHHH--------hcCCCC-----------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 2222221111 100000 0112345688999999999999999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-43 Score=378.18 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=201.7
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc---------chHHHHHHHHHHHhcC-CCCcceEEeeeecc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG---------GSKSFAAECEALRSIR-HRNLIKIVTICSSI 770 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 770 (1009)
++|++.+.||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|++++++++ ||||+++++++..
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 5789999999999999999999999999999999654321 1236889999999997 9999999999754
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCc
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMV 850 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 850 (1009)
.+..++||||+++|+|.++++.+. .+++.+++.++.||++||+|||++ +||||||||+||+++.++.
T Consensus 82 ----~~~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 82 ----NTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMN 148 (277)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred ----CcceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCC
Confidence 478999999999999999998765 399999999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCC------CCCCCcccchHHHHHHHHHHhCCCCCcccc
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG------GEASMRGGVYSYGILLLEIFTRRRPTESMF 924 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~Gvvl~elltg~~p~~~~~ 924 (1009)
+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 149 ~kl~DFG~a~~~~~~---------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 149 IKLTDFGFSCQLDPG---------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp EEECCCTTCEECCTT---------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eEEccchheeEccCC---------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 999999999876543 12234679999999998753 457889999999999999999999997532
Q ss_pred cCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 925 NEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. ........... .. +.+ ......+++.+++.+|++.||++|||++||++
T Consensus 220 ~~-----~~~~~i~~~~~-~~------~~~---------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 220 QM-----LMLRMIMSGNY-QF------GSP---------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HH-----HHHHHHHHTCC-CC------CTT---------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HH-----HHHHHHHhCCC-CC------CCc---------ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11 11111111000 00 000 01122346789999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-43 Score=393.15 Aligned_cols=250 Identities=24% Similarity=0.290 Sum_probs=197.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc---ccchHHHHHH---HHHHHhcCCCCcceEEeeeeccccC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ---KGGSKSFAAE---CEALRSIRHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~ 773 (1009)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... ......+.+| +++++.++||||+++++++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~---- 78 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---- 78 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE----
Confidence 368999999999999999999999999999999996432 2223344444 566677789999999998654
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEE
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 853 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 853 (1009)
.+..++||||+++|+|.+++.+... +++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||
T Consensus 79 -~~~~~ivmE~~~gg~L~~~l~~~~~------~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl 148 (364)
T d1omwa3 79 -PDKLSFILDLMNGGDLHYHLSQHGV------FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 148 (364)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEE
T ss_pred -CCEEEEEEEecCCCcHHHHHHhccc------ccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEE
Confidence 3778999999999999999987653 88999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHH
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHE 932 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~ 932 (1009)
+|||+|+..... ......||+.|||||++.. ..++.++||||+||++|||+||+.||...... ....
T Consensus 149 ~DFGla~~~~~~----------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~ 216 (364)
T d1omwa3 149 SDLGLACDFSKK----------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHE 216 (364)
T ss_dssp CCCTTCEECSSS----------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHH
T ss_pred eeeceeeecCCC----------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHH
Confidence 999999876543 1234579999999999875 56899999999999999999999999754322 1222
Q ss_pred HHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 047768 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME-----MTDVVV 995 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt-----~~evl~ 995 (1009)
.......... ..+ ....+++.+++.+|++.||++||| ++|+++
T Consensus 217 ~~~~~~~~~~---------~~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 217 IDRMTLTMAV---------ELP-----------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHSSSCCC---------CCC-----------SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHhcccCCC---------CCC-----------CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 2211111100 000 012245789999999999999999 577764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=387.08 Aligned_cols=268 Identities=22% Similarity=0.337 Sum_probs=211.3
Q ss_pred hccCccCCcccccCCceEEEEEEe-----cCCeEEEEEEeecccc-cchHHHHHHHHHHHhc-CCCCcceEEeeeecccc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLH-----ENGMLVAVKVINLEQK-GGSKSFAAECEALRSI-RHRNLIKIVTICSSIDF 772 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 772 (1009)
.++|++.+.||+|+||.||+|+++ .+++.||||+++.... .....+.+|+.+++++ +||||++++++|...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-- 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-- 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC--
Confidence 468889999999999999999974 3567999999975433 2345788999999999 699999999998653
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCC------------CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCC
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQ------------LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKP 840 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~ 840 (1009)
...++||||+++|+|.++++..... .....+++.++..++.||++|++|||++ +||||||||
T Consensus 100 ---~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 100 ---GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ---CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 5689999999999999999865432 1123589999999999999999999999 999999999
Q ss_pred CceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCC
Q 047768 841 SNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPT 920 (1009)
Q Consensus 841 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~ 920 (1009)
+||+++.++.+|++|||.++....... ........||+.|+|||++.++.++.++|||||||++|||+|++.|+
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~ 247 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSN------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTT------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ccccccccCcccccccchheeccCCCc------ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence 999999999999999999987654321 12223467999999999999999999999999999999999955554
Q ss_pred cccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 047768 921 ESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHA 1000 (1009)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i 1000 (1009)
.........+.+......+.. .+..+..++.+++.+||+.||++||||+||+++|+++
T Consensus 248 ~~~~~~~~~~~~~i~~~~~~~----------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 248 YPGMPVDSKFYKMIKEGFRML----------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp STTCCSSHHHHHHHHHTCCCC----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCC----------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 332222222222222211110 0112335688999999999999999999999999987
Q ss_pred HHh
Q 047768 1001 RQN 1003 (1009)
Q Consensus 1001 ~~~ 1003 (1009)
.++
T Consensus 306 i~~ 308 (311)
T d1t46a_ 306 ISE 308 (311)
T ss_dssp HHH
T ss_pred hcc
Confidence 665
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-44 Score=386.57 Aligned_cols=265 Identities=24% Similarity=0.347 Sum_probs=204.8
Q ss_pred hccCccCCcccccCCceEEEEEEecCC-------eEEEEEEeeccccc-chHHHHHHHHHHHhc-CCCCcceEEeeeecc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENG-------MLVAVKVINLEQKG-GSKSFAAECEALRSI-RHRNLIKIVTICSSI 770 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 770 (1009)
.++|.+.+.||+|+||.||+|+....+ ..||||+++..... ....+.+|+..+.++ +||||++++++|...
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 468889999999999999999986443 47999999654432 346788899999888 899999999998643
Q ss_pred ccCCCceEEEEEeccCCCCHHHHHhccCCCC----------CccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCC
Q 047768 771 DFKGVDFKALVYEYMQNGSLEEWLHQRDDQL----------GICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKP 840 (1009)
Q Consensus 771 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~ 840 (1009)
...++||||+++|+|.+++..+.... ....+++.+++.++.|++.||.|||+. +||||||||
T Consensus 92 -----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp 163 (299)
T d1fgka_ 92 -----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 163 (299)
T ss_dssp -----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred -----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence 67899999999999999998764321 123589999999999999999999999 999999999
Q ss_pred CceeeCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHh-CCCC
Q 047768 841 SNVLLDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFT-RRRP 919 (1009)
Q Consensus 841 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p 919 (1009)
+|||++.++.+||+|||+++....... ........||+.|+|||.+.++.|+.++|||||||++|||++ |..|
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p 237 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDY------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCT------TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cceeecCCCCeEeccchhhcccccccc------ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCC
Confidence 999999999999999999997765422 122334678999999999999999999999999999999998 6888
Q ss_pred CcccccCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 047768 920 TESMFNEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCH 999 (1009)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~ 999 (1009)
|..... ..... .+....... .+..+..++.+++.+||+.||++||||.||++.|++
T Consensus 238 ~~~~~~-----~~~~~---------~i~~~~~~~----------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 238 YPGVPV-----EELFK---------LLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp STTCCH-----HHHHH---------HHHTTCCCC----------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCH-----HHHHH---------HHHcCCCCC----------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 764322 11111 111000000 001223468899999999999999999999999998
Q ss_pred HHH
Q 047768 1000 ARQ 1002 (1009)
Q Consensus 1000 i~~ 1002 (1009)
+.+
T Consensus 294 i~a 296 (299)
T d1fgka_ 294 IVA 296 (299)
T ss_dssp HHH
T ss_pred Hhh
Confidence 854
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-43 Score=391.94 Aligned_cols=245 Identities=21% Similarity=0.243 Sum_probs=203.3
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+++|++++||||+++++++.. ...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-----ccc
Confidence 5799999999999999999999999999999999643 22345678999999999999999999998654 367
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.++||||+.+|+|.+++.+... +++.+++.++.|++.||.|||++ +||||||||+|||++.++.+||+|||
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~------l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGR------FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cccccccccccchhhhHhhcCC------CCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence 8999999999999999987653 89999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+|+..... .....||+.|||||++.+..++.++||||+||++|||+||+.||.... ........
T Consensus 187 ~a~~~~~~-----------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i 250 (350)
T d1rdqe_ 187 FAKRVKGR-----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKI 250 (350)
T ss_dssp TCEECSSC-----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHH
T ss_pred eeeecccc-----------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-----HHHHHHHH
Confidence 99876532 224679999999999999999999999999999999999999997431 11221111
Q ss_pred ccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 047768 938 LPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRM-----EMTDVVV 995 (1009)
Q Consensus 938 ~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----t~~evl~ 995 (1009)
... ... .+ .....++.+++.+|++.||.+|+ |++|+++
T Consensus 251 ~~~--------~~~-~p-----------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 251 VSG--------KVR-FP-----------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHC--------CCC-CC-----------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred hcC--------CCC-CC-----------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 110 000 00 01234577999999999999994 8999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=387.22 Aligned_cols=251 Identities=20% Similarity=0.289 Sum_probs=203.2
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
++|.+.+.||+|+||+||+|+++.+|+.||||+++.... ....+.+|+++|++++||||+++++++.. ....|+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~l 78 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFES-----MEELVM 78 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEE
Confidence 579999999999999999999999999999999965432 34568899999999999999999998654 378999
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCC--CceEEecccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHD--MVAHVSDFGL 858 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~--~~~kl~DfGl 858 (1009)
|||||++|+|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+|||++.+ ..+||+|||+
T Consensus 79 vmE~~~gg~L~~~i~~~~~-----~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccch
Confidence 9999999999999987653 389999999999999999999999 99999999999999854 4899999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
++..... .......||+.|+|||...+..++.++||||+||++|||++|+.||..... ......
T Consensus 151 ~~~~~~~---------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-----~~~~~~-- 214 (321)
T d1tkia_ 151 ARQLKPG---------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQIIEN-- 214 (321)
T ss_dssp CEECCTT---------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH--
T ss_pred hhccccC---------CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-----HHHHHH--
Confidence 9876432 122345789999999999999999999999999999999999999975321 111111
Q ss_pred cchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 PEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 ~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
+........... ......++.+++.+|+..||++|||++|+++
T Consensus 215 ------i~~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 215 ------IMNAEYTFDEEA--------FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ------HHHTCCCCCHHH--------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------HHhCCCCCChhh--------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111110000 0012235779999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=386.73 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=200.4
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecc---cccchHHHHHHHHHHH-hcCCCCcceEEeeeeccccCCCc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLE---QKGGSKSFAAECEALR-SIRHRNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~ 776 (1009)
++|.+.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+..|+.++. .++||||+++++++.. ..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-----~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----KE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----SS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-----CC
Confidence 5799999999999999999999999999999999643 2333456677777765 6899999999999764 37
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+++|+|.++++.... +++.+++.++.||+.||+|||++ +||||||||+|||+++++.+||+||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~------~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ceeEEEeecCCCcHHHHhhccCC------CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence 78999999999999999987653 89999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
|+|+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+....
T Consensus 148 G~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~ 214 (320)
T d1xjda_ 148 GMCKENMLGD--------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFHS 214 (320)
T ss_dssp TTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred chhhhccccc--------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence 9998654321 223346799999999999999999999999999999999999999974321 121111
Q ss_pred hccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 047768 937 ALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMT-DVV 994 (1009)
Q Consensus 937 ~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~-evl 994 (1009)
.... .+.. + .....++.+++.+|++.||++|||+. |++
T Consensus 215 i~~~------~~~~---p-----------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 215 IRMD------NPFY---P-----------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp HHHC------CCCC---C-----------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHcC------CCCC---C-----------ccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 1000 0000 0 01223577999999999999999995 664
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=390.03 Aligned_cols=270 Identities=20% Similarity=0.346 Sum_probs=211.2
Q ss_pred HHHHhccCccCCcccccCCceEEEEEEec-----CCeEEEEEEeecccc-cchHHHHHHHHHHHhcCCCCcceEEeeeec
Q 047768 696 LSKATNEFSSSNTIGRGSFGFVYKGVLHE-----NGMLVAVKVINLEQK-GGSKSFAAECEALRSIRHRNLIKIVTICSS 769 (1009)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 769 (1009)
+....++|.+.+.||+|+||+||+|.++. +++.||||+++.... .....+.+|++++++++||||++++|+|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 33445788999999999999999999862 357899999964332 223568999999999999999999999864
Q ss_pred cccCCCceEEEEEeccCCCCHHHHHhccCCC----CCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceee
Q 047768 770 IDFKGVDFKALVYEYMQNGSLEEWLHQRDDQ----LGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLL 845 (1009)
Q Consensus 770 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill 845 (1009)
. ...++||||+++|+|.+++...... .....+++..+..++.|+|+||.|||++ +||||||||+|||+
T Consensus 95 ~-----~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 95 G-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 166 (308)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred C-----CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceee
Confidence 3 5679999999999999998754211 1123478999999999999999999999 99999999999999
Q ss_pred CCCCceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCC-CCCcccc
Q 047768 846 DHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRR-RPTESMF 924 (1009)
Q Consensus 846 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~-~p~~~~~ 924 (1009)
++++++||+|||+|+....... ........||+.|+|||.+.++.++.++|||||||++|||+||+ .||...
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~- 239 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDY------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL- 239 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGC------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-
T ss_pred cCCceEEEeecccceeccCCcc------eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-
Confidence 9999999999999987654321 12233456899999999999999999999999999999999985 666532
Q ss_pred cCCccHHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 047768 925 NEGLTLHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQN 1003 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~ 1003 (1009)
...+..... .+....+.+ ..++..+.+++.+||+.+|++||||.||++.|++..+.
T Consensus 240 ----~~~~~~~~i--------~~~~~~~~p-----------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 240 ----SNEQVLRFV--------MEGGLLDKP-----------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp ----CHHHHHHHH--------HTTCCCCCC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ----CHHHHHHHH--------HhCCCCCCc-----------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 222222211 111111111 12335688999999999999999999999999876543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=381.84 Aligned_cols=274 Identities=22% Similarity=0.295 Sum_probs=199.7
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++||||+++++++.. ....
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence 579999999999999999999999999999999965432 235789999999999999999999999765 3788
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++||||+.+ ++.+++..... ..+++.++..++.|++.||.|||++ +||||||||+|||++.++.+||+|||.
T Consensus 77 ~iv~e~~~~-~~~~~~~~~~~----~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp EEEEECCSE-EHHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred eEEEeecCC-chhhhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence 999999965 55555543322 1399999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
|+...... .......||+.|+|||......+ +.++||||+||++|||++|+.||......+ .........
T Consensus 149 a~~~~~~~--------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~ 219 (298)
T d1gz8a_ 149 ARAFGVPV--------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTL 219 (298)
T ss_dssp HHHHCCCS--------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred ceeccCCc--------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhc
Confidence 98765321 23334679999999998777664 889999999999999999999997432211 111111111
Q ss_pred c--cchhhhccCC---CCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 938 L--PEKVMEIVDP---SLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 938 ~--~~~~~~~~d~---~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
. .+.....+.. .....+................++.+++.+|++.||++|||++|+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 220 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1 1111100000 000000000000000011222457889999999999999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=382.92 Aligned_cols=278 Identities=21% Similarity=0.281 Sum_probs=203.7
Q ss_pred hccCccCCcccccCCceEEEEEEecC-CeEEEEEEeecccc--cchHHHHHHHHHHHhc---CCCCcceEEeeeeccccC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHEN-GMLVAVKVINLEQK--GGSKSFAAECEALRSI---RHRNLIKIVTICSSIDFK 773 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~ 773 (1009)
.++|++.+.||+|+||+||+|++..+ ++.||||+++.... .....+.+|+.+++.+ +||||+++++++......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999654 67899999965432 2344677888887766 799999999998765455
Q ss_pred CCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEE
Q 047768 774 GVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 853 (1009)
Q Consensus 774 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 853 (1009)
.....++++||++++++......... .+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cCceEEEEEEeccCCchhhhhhccCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence 56788999999988777655544433 389999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 854 SDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 854 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
+|||+++..... .......||+.|||||++.+..|+.++||||+||++|||++|+.||...... ..+...
T Consensus 158 ~dfg~~~~~~~~---------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i 227 (305)
T d1blxa_ 158 ADFGLARIYSFQ---------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKI 227 (305)
T ss_dssp CSCCSCCCCCGG---------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH
T ss_pred cchhhhhhhccc---------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHH
Confidence 999998755432 2334567999999999999999999999999999999999999999753221 112222
Q ss_pred HHHhccchhhhccCCCCCChh---hhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 934 AKRALPEKVMEIVDPSLLPLE---EERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 934 ~~~~~~~~~~~~~d~~l~~~~---~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
..........++......... ...............+.+.+++.+|++.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 221111111111000000000 00000000001112245678999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-43 Score=381.75 Aligned_cols=264 Identities=22% Similarity=0.243 Sum_probs=193.6
Q ss_pred CCcccccCCceEEEEEEecCCeEEEEEEeeccccc-----chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 706 SNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG-----GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
.+.||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|++++++++||||+++++++.. ....++
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~~i 77 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNISL 77 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCCEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCceee
Confidence 46899999999999999999999999998644321 13578899999999999999999999754 367899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
||||+.++++..+..... .+++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 78 vmE~~~~~~~~~~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 78 VFDFMETDLEVIIKDNSL------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 148 (299)
T ss_dssp EEECCSEEHHHHHTTCCS------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred hhhhhcchHHhhhhhccc------CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCcccc
Confidence 999998887776665443 388889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhcc
Q 047768 861 FLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRALP 939 (1009)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 939 (1009)
...... .......||+.|+|||++.+. .++.++||||+||++|||+||+.||...... ..+.........
T Consensus 149 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~~~ 219 (299)
T d1ua2a_ 149 SFGSPN--------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGT 219 (299)
T ss_dssp TTTSCC--------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCC
T ss_pred ccCCCc--------ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHHHHHhcCC
Confidence 665432 222345799999999998654 5799999999999999999999998643221 112222221111
Q ss_pred chhhhccCCC-------CCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 940 EKVMEIVDPS-------LLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 940 ~~~~~~~d~~-------l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.......+.. ....+.. + .........+++.+++.+|++.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 220 PTEEQWPDMCSLPDYVTFKSFPGI-P--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCC-C--HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CChhhccchhccchhhhhccCCCC-C--hHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 1110000000 0000000 0 00000012245789999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=376.10 Aligned_cols=240 Identities=21% Similarity=0.305 Sum_probs=195.2
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc------chHHHHHHHHHHHhcC--CCCcceEEeeeecccc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG------GSKSFAAECEALRSIR--HRNLIKIVTICSSIDF 772 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 772 (1009)
++|++.+.||+|+||+||+|+++.+|+.||||+++..... ....+.+|+.++++++ ||||+++++++..
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~--- 80 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--- 80 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC---
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee---
Confidence 5799999999999999999999999999999999644221 1244678999999996 8999999999654
Q ss_pred CCCceEEEEEeccCC-CCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC-CCc
Q 047768 773 KGVDFKALVYEYMQN-GSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH-DMV 850 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~ 850 (1009)
....++||||+.+ +++.+++..... +++.+++.++.|++.||+|||++ +||||||||+||+++. ++.
T Consensus 81 --~~~~~lv~e~~~~~~~l~~~~~~~~~------l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 81 --PDSFVLILERPEPVQDLFDFITERGA------LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp --SSEEEEEEECCSSEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTE
T ss_pred --CCeEEEEEEeccCcchHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCe
Confidence 3788999999976 688888877543 89999999999999999999999 9999999999999985 479
Q ss_pred eEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCC-CCcccchHHHHHHHHHHhCCCCCcccccCCcc
Q 047768 851 AHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEA-SMRGGVYSYGILLLEIFTRRRPTESMFNEGLT 929 (1009)
Q Consensus 851 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~ 929 (1009)
+||+|||+|+..... ......||+.|||||++.+..+ +.++||||+||++|||+||+.||...
T Consensus 150 vkl~DFG~a~~~~~~----------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------ 213 (273)
T d1xwsa_ 150 LKLIDFGSGALLKDT----------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------ 213 (273)
T ss_dssp EEECCCTTCEECCSS----------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------
T ss_pred EEECccccceecccc----------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------
Confidence 999999999865432 2234679999999999887765 67799999999999999999999742
Q ss_pred HHHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 930 LHEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.+...... .+.. ....++.+++.+|++.||++|||++|+++
T Consensus 214 -~~i~~~~~----------~~~~--------------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 214 -EEIIRGQV----------FFRQ--------------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -HHHHHCCC----------CCSS--------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -hHHhhccc----------CCCC--------------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11111000 0000 11235779999999999999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-41 Score=370.82 Aligned_cols=267 Identities=21% Similarity=0.274 Sum_probs=204.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKAL 780 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 780 (1009)
++|++.+.||+|+||+||+|++..+|+.||||++.... ..+++.+|+++++.++|++++..+..|.. .....++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEE
Confidence 47999999999999999999999999999999986543 23568899999999988877766665543 2367899
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC---CCceEEeccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFG 857 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~DfG 857 (1009)
||||+ ++++.+.+..... .+++..+..++.|++.||+|||++ +||||||||+||+++. +..+|++|||
T Consensus 81 vme~~-~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEc-CCchhhhhhhccC-----CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence 99999 6677777765543 389999999999999999999999 9999999999999854 5579999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCcc--HHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLT--LHEFAK 935 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~--~~~~~~ 935 (1009)
+|+........... .........||+.|||||++.+..++.++|||||||++|||+||+.||......... ......
T Consensus 152 ~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 152 LAKKYRDARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp SCEECBCTTTCCBC-CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred cceeccccccccce-eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence 99987654332211 112334567999999999999999999999999999999999999999764433211 111111
Q ss_pred HhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 047768 936 RALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQ 1002 (1009)
Q Consensus 936 ~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~ 1002 (1009)
...+...... ...++.++.+++..||+.+|++||+++++.+.|+.+..
T Consensus 231 ~~~~~~~~~~-------------------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 231 KKMSTPIEVL-------------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHSCHHHH-------------------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCCChhHh-------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 1111101000 11234568899999999999999999999998887654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.8e-42 Score=379.15 Aligned_cols=294 Identities=29% Similarity=0.467 Sum_probs=262.5
Q ss_pred cCChhhHHHHHHHHHhcCCCCCCCCCCccCCCCCCCC-CccceeeCCCC--CeEEEEEeecCCccc--ccCccccCCCCC
Q 047768 22 LSNETDCLSLLAIKSQLHDPLGVTSSWNRSACVNLCQ-HWTGVTCGRRN--QRVTKLDLRNQSIGG--ILSPYVGNLSFL 96 (1009)
Q Consensus 22 ~~~~~d~~aLl~~k~~~~~~~~~~~sW~~~~~~~~c~-~w~gv~C~~~~--~~v~~l~l~~~~l~~--~~~~~~~~l~~L 96 (1009)
.|.++|++||++||+++.||. .+++|..+ .|||. .|.||+|+..+ +||+.|||++++++| .+|+++++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~--~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT--SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCCC--CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence 489999999999999999875 68999754 46663 59999998754 489999999999988 578999999999
Q ss_pred CeeeecC-CcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEee
Q 047768 97 RYINIAD-NDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSV 175 (1009)
Q Consensus 97 ~~L~L~~-n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L 175 (1009)
++|+|++ |+++|.+|++|++|++|++|||++|+|.+..|..+..+.+|+.+++++|.+.+.+|..+ ..++.|+++++
T Consensus 79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l--~~l~~L~~l~l 156 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI--SSLPNLVGITF 156 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGG--GGCTTCCEEEC
T ss_pred cccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhh--ccCcccceeec
Confidence 9999997 89999999999999999999999999999999999999999999999999999999988 67999999999
Q ss_pred cCccCCCCCCcccCCcccc-ceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCC
Q 047768 176 GDNQLTGQLPASIGNLSAL-RVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTG 254 (1009)
Q Consensus 176 ~~n~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 254 (1009)
++|.+++.+|..+..+..+ +.+++++|++++..|..+..+..+ ++++++|.+.+.+|..+..+++|+.+++++|.+++
T Consensus 157 ~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~ 235 (313)
T d1ogqa_ 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccc
Confidence 9999999999999888886 889999999999999999887655 69999999999999999999999999999999997
Q ss_pred CCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccc
Q 047768 255 SLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNF 324 (1009)
Q Consensus 255 ~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~ 324 (1009)
.+|. +..+++|+.|+|++|++++.+|..|+++++|++|+|++|+|+|.+|. +..+++|+.+++++|.
T Consensus 236 ~~~~--~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 236 DLGK--VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp BGGG--CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred cccc--cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 6653 34589999999999999999999999999999999999999987763 4556666666665554
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.4e-42 Score=369.73 Aligned_cols=271 Identities=18% Similarity=0.247 Sum_probs=197.6
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|.+.++||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+.+|++++||||+++++++... ...
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence 57999999999999999999986 78999999996543 23357899999999999999999999997643 678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++++||+.++.+..+.+... .+++.++..++.|++.||+|||+. +||||||||+|||++.++.+|++|||.
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred eEEEEeehhhhHHHHHhhcC------CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence 99999998777766665443 399999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
|....... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+ .........
T Consensus 147 a~~~~~~~--------~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~ 217 (286)
T d1ob3a_ 147 ARAFGIPV--------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRIL 217 (286)
T ss_dssp HHHHCC-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred ceecccCc--------cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhh
Confidence 98765432 222345689999999998764 56999999999999999999999997543221 111111111
Q ss_pred ccch---hhhccCC--CCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEK---VMEIVDP--SLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~---~~~~~d~--~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... ..+.... .......................+.+++.+|++.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1110 1000000 00000000000000011112345789999999999999999999974
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.4e-41 Score=363.82 Aligned_cols=268 Identities=17% Similarity=0.211 Sum_probs=210.4
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCC-CCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRH-RNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
++|.+.+.||+|+||+||+|++..+|+.||||+++... ..+.+.+|++.++.++| +|++.+++++.. ....+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~~ 77 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHNV 77 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeec-----CCccE
Confidence 57999999999999999999999999999999985432 34567889999999965 899999988654 36789
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCC-----CCceEEe
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDH-----DMVAHVS 854 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-----~~~~kl~ 854 (1009)
+||||+ +++|.++++.... .+++.++..++.|++.||+|||++ +||||||||+||+++. ++.+||+
T Consensus 78 ~vme~~-~~~l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred EEEEec-CCCHHHHHHhhcc-----chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEc
Confidence 999999 7899999987654 389999999999999999999999 9999999999999974 5789999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCcc--HHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLT--LHE 932 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~--~~~ 932 (1009)
|||+|+........... .........||+.|||||++.+..++.++|||||||++|||+||+.||......... ...
T Consensus 149 DFG~a~~~~~~~~~~~~-~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~ 227 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHI-PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227 (293)
T ss_dssp CCTTCEESBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred ccceeEEcccCccccce-eecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence 99999987654322211 112334568999999999999999999999999999999999999999754332111 111
Q ss_pred HHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047768 933 FAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVKLCHARQNF 1004 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~L~~i~~~~ 1004 (1009)
...........++ ...+++++.+++..|++.+|++||+++.+.+.++++.+..
T Consensus 228 i~~~~~~~~~~~l-------------------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 228 IGEKKQSTPLREL-------------------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHHHHHHSCHHHH-------------------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHhccCCCChHHh-------------------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 1111100011111 0123356889999999999999999999999998876643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-41 Score=369.88 Aligned_cols=282 Identities=20% Similarity=0.296 Sum_probs=198.3
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc--ccchHHHHHHHHHHHhcCCCCcceEEeeeeccc---cCC
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ--KGGSKSFAAECEALRSIRHRNLIKIVTICSSID---FKG 774 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~ 774 (1009)
.++|++.++||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999999999999999986443 234577899999999999999999999876532 122
Q ss_pred CceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEe
Q 047768 775 VDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 854 (1009)
Q Consensus 775 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 854 (1009)
....++||||++++.+..+..... .+++.+++.++.|++.||.|||++ +||||||||+|||++.++.+|++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~------~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~ 159 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 159 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEEeccCCCccchhhhccc------ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEee
Confidence 356899999998776665544333 388999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHH
Q 047768 855 DFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEF 933 (1009)
Q Consensus 855 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 933 (1009)
|||+++........ .........||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ......
T Consensus 160 dfg~~~~~~~~~~~----~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~i 234 (318)
T d3blha1 160 DFGLARAFSLAKNS----QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALI 234 (318)
T ss_dssp CCTTCEECCC---------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH
T ss_pred ecceeeeccccccc----ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-HHHHHH
Confidence 99999876543211 11222345799999999998765 6899999999999999999999999743221 111111
Q ss_pred HHHh--ccch-hhhccCCCCCChhhhhhhcc-----ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 934 AKRA--LPEK-VMEIVDPSLLPLEEERTNSR-----RVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 934 ~~~~--~~~~-~~~~~d~~l~~~~~~r~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... .+.. .................... ..........+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1111 1111 11111111100000000000 0001111235678999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-41 Score=371.78 Aligned_cols=272 Identities=21% Similarity=0.221 Sum_probs=198.4
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccc-ccchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-KGGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
++|++.+.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+++|++++||||+++++++....+......+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 57999999999999999999999999999999996433 22346788999999999999999999998765444444445
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 859 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla 859 (1009)
++ +|+.+|+|.+++..+. +++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 88 l~-~~~~~g~L~~~l~~~~-------l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 88 LV-THLMGADLYKLLKTQH-------LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp EE-EECCCEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EE-EeecCCchhhhhhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence 55 5667999999997643 89999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+....... .........||+.|+|||++.. ..++.++||||+||++|||++|+.||......+. .........
T Consensus 157 ~~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~~ 230 (345)
T d1pmea_ 157 RVADPDHD-----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILG 230 (345)
T ss_dssp EECCGGGC-----BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHC
T ss_pred eeccCCCc-----cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhhcc
Confidence 87654321 1122345679999999999755 5678999999999999999999999975322111 111111110
Q ss_pred cchhhh-----------cc--CCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 PEKVME-----------IV--DPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 ~~~~~~-----------~~--d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
...... .. .+.....+.. ........++.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWN------RLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH------HHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCChhhhhhhhhhhhhcccccCCccCCCCHH------HhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00 0000000000 000011135779999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=368.87 Aligned_cols=272 Identities=24% Similarity=0.298 Sum_probs=195.4
Q ss_pred cCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCcceEEeeeeccc-cCCCceEEE
Q 047768 702 EFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNLIKIVTICSSID-FKGVDFKAL 780 (1009)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~~l 780 (1009)
+|+..++||+|+||+||+|+++.+|+.||||+++... ....+|+++|++++||||+++++++.... ..+..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888899999999999999999999999999996443 23347999999999999999999976532 234456789
Q ss_pred EEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC-ceEEeccccc
Q 047768 781 VYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLA 859 (1009)
Q Consensus 781 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~DfGla 859 (1009)
||||++++.+..+...... ...+++.+++.++.|++.||+|||++ +||||||||+|||++.++ .+||+|||++
T Consensus 97 v~Ey~~~~~~~~l~~~~~~---~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRA---KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEECCSEEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEeccCCccHHHHHhhhhc---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 9999976544333321111 12499999999999999999999999 999999999999999775 8999999999
Q ss_pred cccCCCCCCCccccCCccccccccccccCccccCC-CCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHhc
Q 047768 860 KFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLG-GEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRAL 938 (1009)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 938 (1009)
+...... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+........
T Consensus 171 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g 240 (350)
T d1q5ka_ 171 KQLVRGE---------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLG 240 (350)
T ss_dssp EECCTTS---------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHC
T ss_pred hhccCCc---------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhC
Confidence 8765431 2234578999999998765 56899999999999999999999999743321 11111111110
Q ss_pred c---chhhhcc----CCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 939 P---EKVMEIV----DPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 939 ~---~~~~~~~----d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. +.+.... +..+...... + ...........++.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 241 TPTREQIREMNPNYTEFKFPQIKAH-P-WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CCCHHHHHHHCC---CCCCCCCCCC-C-GGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChHHhhhhhccchhhccccccccC-c-hhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0011111 0000000000 0 000111122345789999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=360.14 Aligned_cols=272 Identities=19% Similarity=0.260 Sum_probs=204.5
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCceE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
++|++.+.||+|+||+||+|+++.+++.||||+++.... ...+.+.+|+.++++++||||+++++++... ...
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cce
Confidence 579999999999999999999999999999999975533 2346889999999999999999999997653 678
Q ss_pred EEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecccc
Q 047768 779 ALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 858 (1009)
Q Consensus 779 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfGl 858 (1009)
++|+|++.++++..++..... +++..+..++.|++.||+|||++ +||||||||+|||++.++.+|++|||.
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~------~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGD------LDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTC------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred eEEeeeccccccccccccccc------cchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence 999999999999888876543 88999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCCC-CCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE-ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
|+...... .......++..|+|||.+.+.. ++.++||||+||++|||++|+.||....+............
T Consensus 148 a~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 219 (292)
T d1unla_ 148 ARAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp CEECCSCC--------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred hhcccCCC--------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhc
Confidence 98765432 1222345788999999987765 68999999999999999999999754332222222222111
Q ss_pred ccch------hhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LPEK------VMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~~~------~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.... .....+..-......+. ............+.+++.+|++.||.+||||+|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 220 GTPTEEQWPSMTKLPDYKPYPMYPATT-SLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCTTTCTTGGGSTTCCCCCCCCTTC-CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCChhhhhhhhhcccccccccccccc-hhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1100 01111100000000000 000111122245778999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-40 Score=365.95 Aligned_cols=271 Identities=21% Similarity=0.257 Sum_probs=195.2
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccc-cCCCc
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSID-FKGVD 776 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 776 (1009)
.++|.+.+.||+|+||+||+|.++.+|+.||||+++.... ...+.+.+|+++|++++|||||++++++...+ .....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 3589999999999999999999999999999999964322 22457889999999999999999999986542 12334
Q ss_pred eEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEecc
Q 047768 777 FKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 856 (1009)
Q Consensus 777 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 856 (1009)
..++||||+ +.+|..+.+... +++..++.++.|++.||.|||++ +||||||||+|||++.++.+|++||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~~-------l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHEK-------LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecc-cccHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccc
Confidence 679999999 668888776543 99999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHH
Q 047768 857 GLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAK 935 (1009)
Q Consensus 857 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 935 (1009)
|+|+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+.....
T Consensus 166 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~ 233 (346)
T d1cm8a_ 166 GLARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMK 233 (346)
T ss_dssp TTCEECCSS-----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH
T ss_pred cceeccCCc-----------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHh
Confidence 999865432 2346789999999998764 5689999999999999999999999753221 11111111
Q ss_pred Hhc--cchhhhccCCC--------CCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 047768 936 RAL--PEKVMEIVDPS--------LLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVVK 996 (1009)
Q Consensus 936 ~~~--~~~~~~~~d~~--------l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~~ 996 (1009)
... +.+..+..... +...... ............+.+++.+|++.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKK---DFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCC---CGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCCCcHHHHhhhcchhhhhhhccCCccccc---chHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 110 11110000000 0000000 0000001112346789999999999999999999863
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.2e-40 Score=365.63 Aligned_cols=266 Identities=19% Similarity=0.233 Sum_probs=198.9
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCceEE
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDFKA 779 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~ 779 (1009)
++|++.++||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+++|++++ ||||+++++++... .....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCcee
Confidence 5899999999999999999999999999999998632 3577899999999995 99999999987532 345689
Q ss_pred EEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCC-ceEEecccc
Q 047768 780 LVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGL 858 (1009)
Q Consensus 780 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~DfGl 858 (1009)
+||||+++++|.++.+ .+++.+++.++.||+.||+|||++ +||||||||+|||++.++ .+|++|||+
T Consensus 109 ~v~e~~~~~~L~~~~~---------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp EEEECCCSCBGGGTTT---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred EEEeecCCCcHHHHhc---------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence 9999999999976532 289999999999999999999999 999999999999998655 699999999
Q ss_pred ccccCCCCCCCccccCCccccccccccccCccccCCC-CCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 859 AKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG-EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 859 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
|+...... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.................
T Consensus 177 a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~ 247 (328)
T d3bqca1 177 AEFYHPGQ---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247 (328)
T ss_dssp CEECCTTC---------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred ceeccCCC---------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHH
Confidence 98765432 22345789999999997775 479999999999999999999999975432211111111110
Q ss_pred cc---------------chhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 LP---------------EKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~~---------------~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
.. ....+............ ............++.+++.+|++.||++|||++|+++
T Consensus 248 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGG--GCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhcccccCcccchhcccccccchhh--cccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00111111111100000 0000111122345789999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=361.79 Aligned_cols=273 Identities=19% Similarity=0.210 Sum_probs=193.4
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccc--cchHHHHHHHHHHHhcCCCCcceEEeeeeccc-cCCCce
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQK--GGSKSFAAECEALRSIRHRNLIKIVTICSSID-FKGVDF 777 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~ 777 (1009)
++|.+.++||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+.++++++||||+++++++.... .+....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 579999999999999999999999999999999975432 22356889999999999999999999976432 234578
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.|+||||+.++ +.+.+.. .+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+|++|||
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eEEEEeccchH-HHHhhhc--------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence 89999999654 4454432 288999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHHh
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKRA 937 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 937 (1009)
+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..........
T Consensus 165 ~~~~~~~~---------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~ 234 (355)
T d2b1pa1 165 LARTAGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQL 234 (355)
T ss_dssp C------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred hhhccccc---------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhc
Confidence 98865432 2233457899999999999999999999999999999999999999643211 1111111111
Q ss_pred c----------cchhhhccCCCC----CChhhhhhh----ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 938 L----------PEKVMEIVDPSL----LPLEEERTN----SRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 938 ~----------~~~~~~~~d~~l----~~~~~~r~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
. .....+..+... ...+...+. ............+.+++.+|++.||++||||+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 011111111110 000100000 001112234457889999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-40 Score=357.80 Aligned_cols=253 Identities=24% Similarity=0.322 Sum_probs=199.8
Q ss_pred ccCccCCcccccCCceEEEEEEe---cCCeEEEEEEeeccc----ccchHHHHHHHHHHHhcCC-CCcceEEeeeecccc
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLH---ENGMLVAVKVINLEQ----KGGSKSFAAECEALRSIRH-RNLIKIVTICSSIDF 772 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 772 (1009)
++|++.+.||+|+||+||+|+.. .+|+.||||+++... ....+.+.+|++++++++| |||+++++++...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-- 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence 57999999999999999999874 468999999985432 2335678899999999977 8999999986553
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceE
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 852 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 852 (1009)
...++||||+.+|+|.+++..... +++..+..++.|++.|+.|+|+. +||||||||+||+++.++.+|
T Consensus 102 ---~~~~~v~e~~~~~~L~~~i~~~~~------~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vk 169 (322)
T d1vzoa_ 102 ---TKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV 169 (322)
T ss_dssp ---TEEEEEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred ---CceeeeeecccccHHHHHHHhccc------ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEE
Confidence 688999999999999999987764 78899999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccCCccccccccccccCccccCCC--CCCCcccchHHHHHHHHHHhCCCCCcccccCCccH
Q 047768 853 VSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGG--EASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTL 930 (1009)
Q Consensus 853 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~ 930 (1009)
|+|||+|+...... ........|++.|+|||.+.+. .++.++||||+||++|||++|+.||....... ..
T Consensus 170 L~DFG~a~~~~~~~-------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-~~ 241 (322)
T d1vzoa_ 170 LTDFGLSKEFVADE-------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQ 241 (322)
T ss_dssp ESCSSEEEECCGGG-------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CH
T ss_pred Eeeccchhhhcccc-------cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 99999998765421 1223346799999999998765 46889999999999999999999997553332 22
Q ss_pred HHHHHHhccchhhhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 047768 931 HEFAKRALPEKVMEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRME-----MTDVVV 995 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt-----~~evl~ 995 (1009)
............ . .+..+..++.+++.+|++.||++||| ++|+++
T Consensus 242 ~~i~~~~~~~~~------~--------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 242 AEISRRILKSEP------P--------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHHHHCCC------C--------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHhcccCCC------C--------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 222221111000 0 00123346789999999999999994 778764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=363.13 Aligned_cols=270 Identities=17% Similarity=0.222 Sum_probs=197.1
Q ss_pred hccCccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc--chHHHHHHHHHHHhcCCCCcceEEeeeeccccCCCce
Q 047768 700 TNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG--GSKSFAAECEALRSIRHRNLIKIVTICSSIDFKGVDF 777 (1009)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 777 (1009)
.++|++.++||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|++++++++|||++++++++......+...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45799999999999999999999999999999999644322 3457889999999999999999999876543323344
Q ss_pred EEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCceeeCCCCceEEeccc
Q 047768 778 KALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 857 (1009)
Q Consensus 778 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~DfG 857 (1009)
.+++++|+.+|+|.++++... +++.+++.++.|++.||+|||++ +||||||||+|||++.++.+|++|||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~-------l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQK-------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred eEEEEEeecCCchhhhccccc-------ccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence 566778888999999996543 99999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCccccccccccccCccccCCCC-CCCcccchHHHHHHHHHHhCCCCCcccccCCccHHHHHHH
Q 047768 858 LAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGE-ASMRGGVYSYGILLLEIFTRRRPTESMFNEGLTLHEFAKR 936 (1009)
Q Consensus 858 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 936 (1009)
+|..... ......||+.|+|||...+.. ++.++||||+||++|||++|+.||....... ........
T Consensus 167 ~a~~~~~-----------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~ 234 (348)
T d2gfsa1 167 LARHTDD-----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRL 234 (348)
T ss_dssp ---CCTG-----------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH
T ss_pred hhcccCc-----------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence 9975432 223467899999999877654 5899999999999999999999996432111 11111111
Q ss_pred hcc--chh---------hhccCCCCCChhhhhhhccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 047768 937 ALP--EKV---------MEIVDPSLLPLEEERTNSRRVRNEECLVAVIKTGVACSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 937 ~~~--~~~---------~~~~d~~l~~~~~~r~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rpt~~evl~ 995 (1009)
... .+. ....... ...+..... ........++.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 235 VGTPGAELLKKISSESARNYIQSL-TQMPKMNFA---NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HCCCCHHHHTTCCCHHHHHHHTTS-CCCCCCCHH---HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCChHHhhhccchhhhhhhhhc-ccCCCcchh---hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 100 000 0000000 000000000 000012245679999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.2e-35 Score=326.61 Aligned_cols=273 Identities=17% Similarity=0.206 Sum_probs=190.1
Q ss_pred ccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-----------CCCcceEEeeeec
Q 047768 701 NEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-----------HRNLIKIVTICSS 769 (1009)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 769 (1009)
.+|++.++||+|+||+||+|+++.+|+.||||+++.... ..+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 359999999999999999999999999999999964322 2457788999988875 5789999988654
Q ss_pred cccCCCceEEEEEeccCCCCHH-HHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCceeeCC
Q 047768 770 IDFKGVDFKALVYEYMQNGSLE-EWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHH-HCQPPIVHGDLKPSNVLLDH 847 (1009)
Q Consensus 770 ~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~ 847 (1009)
. .....+++++++..+... ........ ..+++..++.++.|++.|++|||+ . +|+||||||+|||++.
T Consensus 92 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 92 K---GPNGVHVVMVFEVLGENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEI 161 (362)
T ss_dssp E---ETTEEEEEEEECCCCEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEE
T ss_pred c---cccceeeeeeecccccccccccccccc----cCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeec
Confidence 2 234556666666554433 32222221 248899999999999999999998 5 8999999999999987
Q ss_pred CC------ceEEeccccccccCCCCCCCccccCCccccccccccccCccccCCCCCCCcccchHHHHHHHHHHhCCCCCc
Q 047768 848 DM------VAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPEYGLGGEASMRGGVYSYGILLLEIFTRRRPTE 921 (1009)
Q Consensus 848 ~~------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~ 921 (1009)
++ .+|++|||.++..... .....||+.|+|||++.+..++.++||||+||+++||++|+.||.
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~ 230 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDEH-----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC-----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred cCcccccceeeEeecccccccccc-----------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence 65 3999999999865432 223569999999999999999999999999999999999999997
Q ss_pred ccccCC-c----cHHHHHHHh--ccchh-------hhccCCC---------CCChhhhhhhccccccHHHHHHHHHHHhh
Q 047768 922 SMFNEG-L----TLHEFAKRA--LPEKV-------MEIVDPS---------LLPLEEERTNSRRVRNEECLVAVIKTGVA 978 (1009)
Q Consensus 922 ~~~~~~-~----~~~~~~~~~--~~~~~-------~~~~d~~---------l~~~~~~r~~~~~~~~~~~~~~l~~l~~~ 978 (1009)
...... . ......... .+... ....+.. -....................++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 310 (362)
T d1q8ya_ 231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310 (362)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH
Confidence 432211 0 011111100 00000 0011000 00000000001112234566788999999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 047768 979 CSIESPFDRMEMTDVVV 995 (1009)
Q Consensus 979 cl~~dp~~Rpt~~evl~ 995 (1009)
|++.||.+||||+|+++
T Consensus 311 mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 311 MLQLDPRKRADAGGLVN 327 (362)
T ss_dssp GGCSSTTTCBCHHHHHT
T ss_pred HCCCChhHCcCHHHHhc
Confidence 99999999999999975
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.1e-33 Score=307.86 Aligned_cols=256 Identities=29% Similarity=0.457 Sum_probs=204.3
Q ss_pred ceEEEcCCCcccc--CCCccccCcCccCEEEccC-CCCCCCCCCCcCCcccccceecccccccCCCCccccccccccccc
Q 047768 370 LIDFNLGKNQIYG--TIPPGIANLVNLNSLRMEA-NRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLS 446 (1009)
Q Consensus 370 L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 446 (1009)
++.|+|++|.++| .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..|..+..+..|++++
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence 4555555555554 3566667777777777765 667666777777777777777777777766666666777777777
Q ss_pred ccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccC
Q 047768 447 FGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFS 526 (1009)
Q Consensus 447 L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 526 (1009)
+++|++.+.+|..+.+++.|+.+++++|.+++.+|..+.....+...+++++|++++..|..+.++..+ .+++++|.+.
T Consensus 132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~ 210 (313)
T d1ogqa_ 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred cccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence 777777767777777777777777777777777777666666665668899999998888888887655 7999999999
Q ss_pred CCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceecccccCcccCCCCCc
Q 047768 527 GQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVPTKGI 606 (1009)
Q Consensus 527 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~ 606 (1009)
|.+|..++.+++|+.|++++|.+++.+| .++.+++|+.|||++|+|+|.+|..|+++++|++|||++|+|+|.+|..+.
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~ 289 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred cccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCccc
Confidence 9999999999999999999999997765 688899999999999999999999999999999999999999999998888
Q ss_pred ccCccccccccCCCcCCCCCC
Q 047768 607 FKNKTGFSIVGNGKLCGGLDE 627 (1009)
Q Consensus 607 ~~~~~~~~~~~n~~lc~~~~~ 627 (1009)
++++....+.+|+.+||.|.+
T Consensus 290 L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 290 LQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp GGGSCGGGTCSSSEEESTTSS
T ss_pred CCCCCHHHhCCCccccCCCCC
Confidence 888888899999999998753
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=7.6e-29 Score=279.90 Aligned_cols=185 Identities=32% Similarity=0.405 Sum_probs=113.3
Q ss_pred ceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccC
Q 047768 370 LIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGA 449 (1009)
Q Consensus 370 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 449 (1009)
+..+++++|.+++..| +..+++|+.|++++|+++.. ..+..+++|+.|++++|++++..+ +..+++|++|++++
T Consensus 199 ~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~ 272 (384)
T d2omza2 199 LESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272 (384)
T ss_dssp CSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCS
T ss_pred cceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccC
Confidence 3444444444443222 23344555555555555421 234455555555555555553322 44455555555555
Q ss_pred cccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCc
Q 047768 450 NNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQI 529 (1009)
Q Consensus 450 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 529 (1009)
|++++..+ +..++.++. +++++|++++ +..+..+++++.|++++|++++..
T Consensus 273 ~~l~~~~~--~~~~~~l~~-------------------------l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~ 323 (384)
T d2omza2 273 NQISNISP--LAGLTALTN-------------------------LELNENQLED--ISPISNLKNLTYLTLYFNNISDIS 323 (384)
T ss_dssp SCCCCCGG--GTTCTTCSE-------------------------EECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG
T ss_pred cccCCCCc--ccccccccc-------------------------cccccccccc--ccccchhcccCeEECCCCCCCCCc
Confidence 55543221 233333332 5555555553 224667788888899999888653
Q ss_pred cccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccccccccCceecccc
Q 047768 530 PVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYN 595 (1009)
Q Consensus 530 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 595 (1009)
.+..+++|+.|+|++|+|++ ++ .++++++|++|||++|+|++.+| +.++++|+.|+|++|
T Consensus 324 --~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 324 --PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp --GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred --ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 37888899999999998874 44 68889999999999999986654 788899999999887
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=1.7e-27 Score=268.81 Aligned_cols=339 Identities=27% Similarity=0.342 Sum_probs=168.9
Q ss_pred eEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecc
Q 047768 71 RVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAH 150 (1009)
Q Consensus 71 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~ 150 (1009)
.++.|++++++|+.. +.+..|++|++|+|++|+|++ +|+ |+++++|++|+|++|++++..| ++++++|+.|+++
T Consensus 45 ~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~ 118 (384)
T d2omza2 45 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 118 (384)
T ss_dssp TCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCC-Ccc-ccCCcccccccccccccccccc--ccccccccccccc
Confidence 466677777666542 245666777777777777763 332 6677777777777777664322 6666666666666
Q ss_pred cccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCC
Q 047768 151 RNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSG 230 (1009)
Q Consensus 151 ~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 230 (1009)
.|.+++..+.. ....+..+....|.+....+.................. ...+...+.........|...
T Consensus 119 ~~~~~~~~~~~----~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~- 188 (384)
T d2omza2 119 NNQITDIDPLK----NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDISSNKVS- 188 (384)
T ss_dssp SSCCCCCGGGT----TCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----CGGGTTCTTCCEEECCSSCCC-
T ss_pred ccccccccccc----ccccccccccccccccccccccccccccccccccccch-----hhhhccccccccccccccccc-
Confidence 66665433321 23445555555555543332222221111111111111 112222333333333333322
Q ss_pred CCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccc
Q 047768 231 TIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFN 310 (1009)
Q Consensus 231 ~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~ 310 (1009)
.+..+..+++++.+++++|.+++..|. ...++|+.|++++|.++.. ..+..+++|+.|++++|++++..+
T Consensus 189 -~~~~~~~l~~~~~l~l~~n~i~~~~~~---~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~---- 258 (384)
T d2omza2 189 -DISVLAKLTNLESLIATNNQISDITPL---GILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP---- 258 (384)
T ss_dssp -CCGGGGGCTTCSEEECCSSCCCCCGGG---GGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG----
T ss_pred -cccccccccccceeeccCCccCCCCcc---cccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc----
Confidence 233344444455555555555422111 1234455555555554432 234444555555555555444332
Q ss_pred cccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccC
Q 047768 311 GLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIAN 390 (1009)
Q Consensus 311 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~ 390 (1009)
+..+++|++|++++|++++..+ +..+ ..+..+++++|++++ ...+..
T Consensus 259 ----------------------------~~~~~~L~~L~l~~~~l~~~~~--~~~~-~~l~~l~~~~n~l~~--~~~~~~ 305 (384)
T d2omza2 259 ----------------------------LSGLTKLTELKLGANQISNISP--LAGL-TALTNLELNENQLED--ISPISN 305 (384)
T ss_dssp ----------------------------GTTCTTCSEEECCSSCCCCCGG--GTTC-TTCSEEECCSSCCSC--CGGGGG
T ss_pred ----------------------------ccccccCCEeeccCcccCCCCc--cccc-ccccccccccccccc--ccccch
Confidence 3344555555555555543322 2222 234555555555553 223555
Q ss_pred cCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccc
Q 047768 391 LVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFF 470 (1009)
Q Consensus 391 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ 470 (1009)
+++++.|++++|++++..+ +..+++|++|+|++|+|++ ++ .+.++++|++|++++|+|++..| +.++++|+.|+
T Consensus 306 ~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~ 379 (384)
T d2omza2 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 379 (384)
T ss_dssp CTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEE
T ss_pred hcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEee
Confidence 5666666666666664322 5556666666666666653 22 45666666666666666665443 56666666666
Q ss_pred cCCC
Q 047768 471 APRN 474 (1009)
Q Consensus 471 l~~N 474 (1009)
+++|
T Consensus 380 L~~N 383 (384)
T d2omza2 380 LNDQ 383 (384)
T ss_dssp CCCE
T ss_pred CCCC
Confidence 6655
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=1.5e-27 Score=259.86 Aligned_cols=280 Identities=24% Similarity=0.298 Sum_probs=223.5
Q ss_pred CCCCCC-CCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCcccccccccccccc
Q 047768 52 ACVNLC-QHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSF 130 (1009)
Q Consensus 52 ~~~~~c-~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l 130 (1009)
.|+..| |.|++|.|++. +++ .+|+.+. +++++|+|++|+|+...+.+|.++++|++|++++|.+
T Consensus 3 ~~p~~c~c~~~~~~C~~~------------~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~ 67 (305)
T d1xkua_ 3 VCPFRCQCHLRVVQCSDL------------GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67 (305)
T ss_dssp CCCTTCEEETTEEECTTS------------CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCCCEecCCEEEecCC------------CCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccc
Confidence 477777 68999999753 343 3455553 6799999999999944445799999999999999999
Q ss_pred CCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCccc--CCC
Q 047768 131 SGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLW--GKI 208 (1009)
Q Consensus 131 ~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~ 208 (1009)
+...|..|.++++|++|++++|+++ .+|... ...++.|++.+|.+.+..+..+.....+..++...|... ...
T Consensus 68 ~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~----~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~ 142 (305)
T d1xkua_ 68 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM----PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142 (305)
T ss_dssp CCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC----CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBC
T ss_pred cccchhhhhCCCccCEecccCCccC-cCccch----hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCC
Confidence 9888889999999999999999987 566544 457899999999999777777888888899998888653 455
Q ss_pred CcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcc
Q 047768 209 PITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNA 288 (1009)
Q Consensus 209 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 288 (1009)
+..|..+++|+++++++|.++ .+|..+ +++|++|++++|..++ .+...+.+++.+++|++++|.+++..+..|.++
T Consensus 143 ~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~-~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l 218 (305)
T d1xkua_ 143 NGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 218 (305)
T ss_dssp TTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCE-ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS
T ss_pred ccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCC-CChhHhhcccccccccccccccccccccccccc
Confidence 677888999999999999988 566554 5778888888888884 444556678888888888888888888888888
Q ss_pred cccccccccccccccccccccccccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCC
Q 047768 289 SNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFG 356 (1009)
Q Consensus 289 ~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 356 (1009)
++|++|+|++|+|+.+ +..|..+++|+.|+|++|.|+.++...+..+..+..+.+|+.|+|++|.+.
T Consensus 219 ~~L~~L~L~~N~L~~l-p~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 219 PHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp TTCCEEECCSSCCSSC-CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred ccceeeeccccccccc-ccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 8899999998888866 457888888888888888888877766665566667777888888888765
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1.6e-25 Score=243.53 Aligned_cols=280 Identities=22% Similarity=0.233 Sum_probs=156.4
Q ss_pred HHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccc
Q 047768 245 IYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNF 324 (1009)
Q Consensus 245 L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~ 324 (1009)
++.++++++ ++|..++ +++++|+|++|+|+.+.+.+|.++++|++|++++|++..+.+..|..+++|+.|++++|.
T Consensus 15 ~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~ 90 (305)
T d1xkua_ 15 VQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90 (305)
T ss_dssp EECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred EEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCc
Confidence 344444555 5555443 345666666666665555566666666666666666666655556555555555555555
Q ss_pred cCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCcc--ccCCCccccCcCccCEEEccCC
Q 047768 325 LGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQI--YGTIPPGIANLVNLNSLRMEAN 402 (1009)
Q Consensus 325 l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l--~~~~p~~~~~l~~L~~L~L~~N 402 (1009)
+..++.. ....+..|++++|.+.+..+..+... ..+..++...|.. ....+..+..+++|+.+++++|
T Consensus 91 l~~l~~~---------~~~~l~~L~~~~n~l~~l~~~~~~~~-~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n 160 (305)
T d1xkua_ 91 LKELPEK---------MPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 160 (305)
T ss_dssp CSBCCSS---------CCTTCCEEECCSSCCCBBCHHHHTTC-TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred cCcCccc---------hhhhhhhhhccccchhhhhhhhhhcc-ccccccccccccccccCCCccccccccccCccccccC
Confidence 5544321 12456677777777765444443333 3455566665543 2234455666667777777777
Q ss_pred CCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCch
Q 047768 403 RLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQ 482 (1009)
Q Consensus 403 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 482 (1009)
.++ .+|..+ +++|+.|++++|..++..+..|.+++.+++|++++|.+++..+..
T Consensus 161 ~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~----------------------- 214 (305)
T d1xkua_ 161 NIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS----------------------- 214 (305)
T ss_dssp CCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTT-----------------------
T ss_pred Ccc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccc-----------------------
Confidence 666 334332 456666666666666555556666666666655555555443433
Q ss_pred hhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccccccccc------c
Q 047768 483 QILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQ------S 556 (1009)
Q Consensus 483 ~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~------~ 556 (1009)
+.++++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+..... .
T Consensus 215 --------------------------~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~ 267 (305)
T d1xkua_ 215 --------------------------LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267 (305)
T ss_dssp --------------------------GGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSC
T ss_pred --------------------------ccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcch
Confidence 444555555555555555 3455555566666666666665533222 2
Q ss_pred cccccccceEcCCCcccc--cccccccccccccCcee
Q 047768 557 LSSLTSIKELDLSQNNFS--GQIPKYLENLSFLQYLN 591 (1009)
Q Consensus 557 ~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~ 591 (1009)
...+.+|+.|+|++|.++ ...|..|..+.....+.
T Consensus 268 ~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~~~~ 304 (305)
T d1xkua_ 268 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304 (305)
T ss_dssp CTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEE
T ss_pred hcccCCCCEEECCCCcCccCcCCHhHhcccccCcccc
Confidence 345566777777777764 23355555554444443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1e-25 Score=242.27 Aligned_cols=253 Identities=23% Similarity=0.211 Sum_probs=193.9
Q ss_pred eEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceec-cc
Q 047768 347 YLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHL-HA 425 (1009)
Q Consensus 347 ~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L-~~ 425 (1009)
.++.++++++ .+|..+ ++.+++|+|++|+|++..+..|.++++|++|++++|++.+..+..+..+..++.++. ..
T Consensus 15 ~v~c~~~~L~-~iP~~i---p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp EEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCCC-ccCCCC---CCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 4566666666 455543 345778888888888666677888888888888888888777777777777777765 46
Q ss_pred ccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCC
Q 047768 426 NFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSL 505 (1009)
Q Consensus 426 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~ 505 (1009)
|.++...|..|.++++|++|++++|.+....+..+...++|+. +++++|++++..
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~-------------------------l~l~~N~l~~i~ 145 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY-------------------------LYLQDNALQALP 145 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE-------------------------EECCSSCCCCCC
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccch-------------------------hhhccccccccC
Confidence 6676666777888888888888888877655666666666554 666666666555
Q ss_pred CCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCccccccccccccccc
Q 047768 506 PLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLS 585 (1009)
Q Consensus 506 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 585 (1009)
+..|..+++|+.|++++|++++..|..|.++++|+.+++++|++++..|..|.++++|++||+++|++++..|..|..++
T Consensus 146 ~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~ 225 (284)
T d1ozna_ 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred hhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccccccc
Confidence 66788888999999999999988888899999999999999999988899999999999999999999988888899999
Q ss_pred ccCceecccccCcccCCCCCcccCccccccccCCCcCCCCCCC
Q 047768 586 FLQYLNLSYNHFEGEVPTKGIFKNKTGFSIVGNGKLCGGLDEL 628 (1009)
Q Consensus 586 ~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~~~~ 628 (1009)
+|++|++++|++.|.++..+............+...|..|.+.
T Consensus 226 ~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p~~l 268 (284)
T d1ozna_ 226 ALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL 268 (284)
T ss_dssp TCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGG
T ss_pred ccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCchHH
Confidence 9999999999999888764333334444445566667555443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=5e-25 Score=236.81 Aligned_cols=266 Identities=21% Similarity=0.255 Sum_probs=165.8
Q ss_pred hhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccC
Q 047768 247 LYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLG 326 (1009)
Q Consensus 247 L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~ 326 (1009)
.++++++ ++|..++ +++++|+|++|+|+++.+.+|.++++|++|++++|++..+.+..+..+
T Consensus 18 c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~-------------- 79 (284)
T d1ozna_ 18 CPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL-------------- 79 (284)
T ss_dssp CCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC--------------
T ss_pred cCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccc--------------
Confidence 3445555 6665543 345667777777766666667777777777777776665554443332
Q ss_pred CCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCC
Q 047768 327 NGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTG 406 (1009)
Q Consensus 327 ~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 406 (1009)
+.+..++.. ..|.++...+..|.++++|++|++++|.+.+
T Consensus 80 ----------------~~~~~l~~~------------------------~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~ 119 (284)
T d1ozna_ 80 ----------------ALLEQLDLS------------------------DNAQLRSVDPATFHGLGRLHTLHLDRCGLQE 119 (284)
T ss_dssp ----------------TTCCEEECC------------------------SCTTCCCCCTTTTTTCTTCCEEECTTSCCCC
T ss_pred ----------------ccccccccc------------------------cccccccccchhhcccccCCEEecCCccccc
Confidence 223333221 2333444456667777777777777777776
Q ss_pred CCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhh
Q 047768 407 TIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILE 486 (1009)
Q Consensus 407 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~ 486 (1009)
..+..+....+|+.+++++|+|++..+..|..+++|+.|++++|++++..+..|.++++|+.
T Consensus 120 ~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~------------------ 181 (284)
T d1ozna_ 120 LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR------------------ 181 (284)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE------------------
T ss_pred ccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccch------------------
Confidence 66677777777777777777777666666777777777777777777666666666666554
Q ss_pred hccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceE
Q 047768 487 ITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKEL 566 (1009)
Q Consensus 487 ~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 566 (1009)
+++++|++++..|..|.++++|++||+++|++++..|..|+.+++|++|+|++|.+...-+ .-.-...++.+
T Consensus 182 -------l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~ 253 (284)
T d1ozna_ 182 -------LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKF 253 (284)
T ss_dssp -------EECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHC
T ss_pred -------hhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHHHhC
Confidence 3444444444455666667777777777777777777777777777777777777764322 11122345666
Q ss_pred cCCCcccccccccccccccccCceecccccCcc
Q 047768 567 DLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEG 599 (1009)
Q Consensus 567 ~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g 599 (1009)
....+++....|..+.+ ....+++.+.|+|
T Consensus 254 ~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 254 RGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp CSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred cCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 66667776666666543 3444566666654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.8e-23 Score=221.94 Aligned_cols=181 Identities=23% Similarity=0.224 Sum_probs=120.2
Q ss_pred ccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccC
Q 047768 393 NLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAP 472 (1009)
Q Consensus 393 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~ 472 (1009)
+|++|+|++|+|++..+.+|.++++|++|+|++|+|+. +| .++.+++|++|+|++|+++ .++..+.++++|++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~---- 104 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTV---- 104 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCE----
T ss_pred CCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccccccc-cccccccccccccc----
Confidence 45555555555554444455555555555555555542 22 2345555555555555555 23444555555444
Q ss_pred CCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccc
Q 047768 473 RNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGT 552 (1009)
Q Consensus 473 ~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 552 (1009)
|++++|.+.+..+..+..+.++++|++++|.+++..+..+..+++|+.|++++|+|++.
T Consensus 105 ---------------------L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 105 ---------------------LDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (266)
T ss_dssp ---------------------EECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred ---------------------ccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccccc
Confidence 33333333334445566677788888888888876677777888888888888888877
Q ss_pred cccccccccccceEcCCCcccccccccccccccccCceecccccCcccCC
Q 047768 553 IPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVP 602 (1009)
Q Consensus 553 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p 602 (1009)
.+..|+.+++|++|||++|+|+ .+|+.+..+++|+.|+|++|++.+.+.
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred CccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 7788888888888888888888 788888888888888888888877653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=3.1e-22 Score=212.23 Aligned_cols=201 Identities=23% Similarity=0.206 Sum_probs=167.4
Q ss_pred cccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccc
Q 047768 341 NCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQL 420 (1009)
Q Consensus 341 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 420 (1009)
+...+...+.++++++ .+|..+. +.+++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.+++|++
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGT 81 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccc
Confidence 3456667789999998 4676553 568999999999998777889999999999999999984 33 3578999999
Q ss_pred eecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCc
Q 047768 421 LHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNL 500 (1009)
Q Consensus 421 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~ 500 (1009)
|+|++|+++ ..+..+.++++|++|++++|.+.+..+..+..+.++++ |++++|.
T Consensus 82 L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~-------------------------L~l~~n~ 135 (266)
T d1p9ag_ 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQE-------------------------LYLKGNE 135 (266)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCE-------------------------EECTTSC
T ss_pred ccccccccc-ccccccccccccccccccccccceeecccccccccccc-------------------------ccccccc
Confidence 999999998 56778999999999999999999777777777777665 4555555
Q ss_pred cCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccc
Q 047768 501 LNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFS 574 (1009)
Q Consensus 501 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 574 (1009)
+++..+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus 136 l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 55455566777889999999999999888888999999999999999998 78888888999999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=3.7e-22 Score=200.01 Aligned_cols=166 Identities=17% Similarity=0.133 Sum_probs=121.0
Q ss_pred CccCCcccccCCceEEEEEEecCCeEEEEEEeeccccc------------------chHHHHHHHHHHHhcCCCCcceEE
Q 047768 703 FSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKG------------------GSKSFAAECEALRSIRHRNLIKIV 764 (1009)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~l~ 764 (1009)
+.+.++||+|+||+||+|++. +|+.||||+++..... ......+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 356789999999999999985 7999999987532110 013445688899999999999988
Q ss_pred eeeeccccCCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCcee
Q 047768 765 TICSSIDFKGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHCQPPIVHGDLKPSNVL 844 (1009)
Q Consensus 765 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nil 844 (1009)
++. ..+++|||+++..+.+ ++......++.|++.|++|||++ +|+||||||+|||
T Consensus 81 ~~~---------~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NIL 135 (191)
T d1zara2 81 AWE---------GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 135 (191)
T ss_dssp EEE---------TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred Eec---------CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhhee
Confidence 762 2379999998754422 34445567999999999999999 9999999999999
Q ss_pred eCCCCceEEeccccccccCCCCCCCccccCCccccccccccccCcc-----ccCCCCCCCcccchHHHHHHH
Q 047768 845 LDHDMVAHVSDFGLAKFLSASPLGNVVETPSSSIGVKGTIGYVAPE-----YGLGGEASMRGGVYSYGILLL 911 (1009)
Q Consensus 845 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DvwS~Gvvl~ 911 (1009)
++++ .++++|||.|+....... ..|.... ....+.|+.++|+||..--+.
T Consensus 136 v~~~-~~~liDFG~a~~~~~~~~----------------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 136 VSEE-GIWIIDFPQSVEVGEEGW----------------REILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp EETT-EEEECCCTTCEETTSTTH----------------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred eeCC-CEEEEECCCcccCCCCCc----------------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 9965 488999999986543210 0111110 012367788999999865443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=5.2e-20 Score=203.94 Aligned_cols=305 Identities=22% Similarity=0.301 Sum_probs=157.8
Q ss_pred CCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHh
Q 047768 168 FNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYL 247 (1009)
Q Consensus 168 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 247 (1009)
.++++|+|++|.++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .++|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 36788888888887 56654 467788888888885 556543 46777777777776 33321 123444444
Q ss_pred hCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCC
Q 047768 248 YGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGN 327 (1009)
Q Consensus 248 ~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~ 327 (1009)
++|.++ .+|. ++.+++|++|++++|.+..... ....+..+.+..+....
T Consensus 106 ~~n~l~-~lp~--------------------------~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~ 154 (353)
T d1jl5a_ 106 SNNQLE-KLPE--------------------------LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEE 154 (353)
T ss_dssp CSSCCS-SCCC--------------------------CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSS
T ss_pred cccccc-cccc--------------------------hhhhccceeecccccccccccc----ccccccchhhccccccc
Confidence 444444 3432 3445555555555554443221 11222333333222221
Q ss_pred CCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCC
Q 047768 328 GAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGT 407 (1009)
Q Consensus 328 ~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 407 (1009)
. ..+..++.++.+++++|.+...... ......+..+++.+. .++ .+..++.|+.+++++|... .
T Consensus 155 ~--------~~l~~l~~l~~L~l~~n~~~~~~~~-----~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~ 218 (353)
T d1jl5a_ 155 L--------PELQNLPFLTAIYADNNSLKKLPDL-----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-T 218 (353)
T ss_dssp C--------CCCTTCTTCCEEECCSSCCSSCCCC-----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-S
T ss_pred c--------ccccccccceecccccccccccccc-----ccccccccccccccc-ccc-ccccccccccccccccccc-c
Confidence 1 1234556677777777776532211 122334455554444 222 3456667777777776665 2
Q ss_pred CCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhh
Q 047768 408 IPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEI 487 (1009)
Q Consensus 408 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~ 487 (1009)
.|.. ..++..+++.+|.+.. .+... ..+...++..|.+.+. +. ++.
T Consensus 219 ~~~~---~~~l~~~~~~~~~~~~-~~~~~---~~l~~~~~~~~~~~~l-~~---------------------l~~----- 264 (353)
T d1jl5a_ 219 LPDL---PPSLEALNVRDNYLTD-LPELP---QSLTFLDVSENIFSGL-SE---------------------LPP----- 264 (353)
T ss_dssp CCSC---CTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSEE-SC---------------------CCT-----
T ss_pred cccc---cccccccccccccccc-ccccc---cccccccccccccccc-cc---------------------ccc-----
Confidence 3332 3345555666665552 22221 2233333333333210 00 000
Q ss_pred ccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEc
Q 047768 488 TTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELD 567 (1009)
Q Consensus 488 ~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 567 (1009)
.....++..|.+.+. ...+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|++|+
T Consensus 265 --~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~ 330 (353)
T d1jl5a_ 265 --NLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLH 330 (353)
T ss_dssp --TCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEE
T ss_pred --hhcccccccCccccc----cccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEE
Confidence 011245555554421 123467777777777777 45643 456777777777776 45543 34677777
Q ss_pred CCCcccccccccc
Q 047768 568 LSQNNFSGQIPKY 580 (1009)
Q Consensus 568 Ls~N~l~~~~p~~ 580 (1009)
|++|+|+ .+|..
T Consensus 331 L~~N~L~-~lp~~ 342 (353)
T d1jl5a_ 331 VEYNPLR-EFPDI 342 (353)
T ss_dssp CCSSCCS-SCCCC
T ss_pred CcCCcCC-CCCcc
Confidence 7777776 55653
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=6.3e-20 Score=203.23 Aligned_cols=308 Identities=24% Similarity=0.322 Sum_probs=152.7
Q ss_pred EEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEeccc
Q 047768 72 VTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHR 151 (1009)
Q Consensus 72 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~ 151 (1009)
++.|||++++++. +|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.- .+.|++|++++
T Consensus 40 l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~ 107 (353)
T d1jl5a_ 40 AHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN 107 (353)
T ss_dssp CSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred CCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence 4556666666653 3432 345666666666666 556543 34555566666555 22211 02345555555
Q ss_pred ccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCC
Q 047768 152 NNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGT 231 (1009)
Q Consensus 152 n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 231 (1009)
|.+. .+|. ++.+++|+.|++++|.+... +.. ...+..+.+..+...
T Consensus 108 n~l~-~lp~---------------------------~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~-- 153 (353)
T d1jl5a_ 108 NQLE-KLPE---------------------------LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLE-- 153 (353)
T ss_dssp SCCS-SCCC---------------------------CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS--
T ss_pred cccc-cccc---------------------------hhhhccceeecccccccccc-ccc---cccccchhhcccccc--
Confidence 5443 2332 34444555555554444321 111 122333333333322
Q ss_pred CCCcccCCChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccccccccccc
Q 047768 232 IPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNG 311 (1009)
Q Consensus 232 ~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~ 311 (1009)
.+..+..++.++.|++++|.+. .++.. ....+.+....+.+. .++ .+..++.|+.+++++|...... ..
T Consensus 154 ~~~~l~~l~~l~~L~l~~n~~~-~~~~~----~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~~~----~~ 222 (353)
T d1jl5a_ 154 ELPELQNLPFLTAIYADNNSLK-KLPDL----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLP----DL 222 (353)
T ss_dssp SCCCCTTCTTCCEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCC----SC
T ss_pred ccccccccccceeccccccccc-ccccc----ccccccccccccccc-ccc-cccccccccccccccccccccc----cc
Confidence 1223334444444444444444 22211 112233333333333 222 2445566666666666554322 12
Q ss_pred ccccccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCc
Q 047768 312 LKDLSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANL 391 (1009)
Q Consensus 312 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l 391 (1009)
..++..+.+..|.+..... ....+...++..|.+.+. ..+.......++..|.+.+. ...+
T Consensus 223 ~~~l~~~~~~~~~~~~~~~----------~~~~l~~~~~~~~~~~~l-----~~l~~~~~~~~~~~~~~~~~----~~~~ 283 (353)
T d1jl5a_ 223 PPSLEALNVRDNYLTDLPE----------LPQSLTFLDVSENIFSGL-----SELPPNLYYLNASSNEIRSL----CDLP 283 (353)
T ss_dssp CTTCCEEECCSSCCSCCCC----------CCTTCCEEECCSSCCSEE-----SCCCTTCCEEECCSSCCSEE----CCCC
T ss_pred ccccccccccccccccccc----------cccccccccccccccccc-----ccccchhcccccccCccccc----cccC
Confidence 3344445555554443221 123455566665555421 12223345566666666532 2335
Q ss_pred CccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCC
Q 047768 392 VNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCK 464 (1009)
Q Consensus 392 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 464 (1009)
++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|++|++++|+|+ .+|.....+.
T Consensus 284 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~~L~ 347 (353)
T d1jl5a_ 284 PSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPESVE 347 (353)
T ss_dssp TTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCTTCC
T ss_pred CCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccccccC
Confidence 67888888888887 45543 567888888888887 55643 456788888888887 5665444333
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.5e-19 Score=188.80 Aligned_cols=211 Identities=15% Similarity=0.098 Sum_probs=121.6
Q ss_pred cCCcccccCccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCC-CCCcCCCcCcEEeccc-ccccC
Q 047768 79 NQSIGGILSPYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIP-TNLSHCSKLITFSAHR-NNLVG 156 (1009)
Q Consensus 79 ~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~l~~-n~l~~ 156 (1009)
+.+++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+| ..|.++++++++++.. |++..
T Consensus 17 ~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~ 93 (242)
T d1xwdc1 17 ESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY 93 (242)
T ss_dssp SCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCE
T ss_pred CCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccc
Confidence 34454 4555442 578999999999985445578999999999999998876554 4678888888887764 44443
Q ss_pred CCchHHhhhccCCcCeEeecCccCCCCCC-cccCCccccceeecccCcccCCCCccccccc-ccccccccCccCCCCCCC
Q 047768 157 EIPEELISRRLFNLQGLSVGDNQLTGQLP-ASIGNLSALRVIDIRTNRLWGKIPITLSQLT-SLAYLHVGDNHFSGTIPP 234 (1009)
Q Consensus 157 ~~p~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~ 234 (1009)
..+..+ ..+++|++|++++|+++...+ ..+..++.|..+...++++....+..|.+++ .++.|++++|+++. ++.
T Consensus 94 ~~~~~~--~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~-i~~ 170 (242)
T d1xwdc1 94 INPEAF--QNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHN 170 (242)
T ss_dssp ECTTSE--ECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECT
T ss_pred cccccc--cccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc-ccc
Confidence 333333 456666777777666653322 2234455555555566666555555555543 56666666666652 333
Q ss_pred cccCCChHHH-HHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCcccccccccc
Q 047768 235 SVYNISSLVE-IYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHL 296 (1009)
Q Consensus 235 ~~~~l~~L~~-L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 296 (1009)
...+.+++++ +++++|+++ .+|...|.++++|++|+|++|+|+.+.+..|.++++|+++++
T Consensus 171 ~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 171 CAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp TTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred ccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 2223333222 234444454 455444444455555555555544444444444444444443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=3.6e-19 Score=185.73 Aligned_cols=222 Identities=16% Similarity=0.138 Sum_probs=121.1
Q ss_pred CeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCC
Q 047768 171 QGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGN 250 (1009)
Q Consensus 171 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 250 (1009)
+.++.+++.++ .+|+.+- +++++|+|++|+|+...+.+|.++++|++|+|++|.+...
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~------------------- 68 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV------------------- 68 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCE-------------------
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccce-------------------
Confidence 45666666666 5554432 3566666666666655555666666666666666665532
Q ss_pred ccCCCCChhhccCCCcccceecc-ccccCCCCCCCcCcccccccccccccccccccccccccccccccccccccccCCCC
Q 047768 251 RFTGSLPIEIGKNLPNLRNFVIY-TNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLGLATNFLGNGA 329 (1009)
Q Consensus 251 ~l~~~ip~~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~ 329 (1009)
+|...|.++++++++.+. .|++....+..|.++++|++|++++|++....+..
T Consensus 69 -----i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~--------------------- 122 (242)
T d1xwdc1 69 -----IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH--------------------- 122 (242)
T ss_dssp -----ECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCT---------------------
T ss_pred -----eeccccccccccccccccccccccccccccccccccccccccchhhhccccccc---------------------
Confidence 333344445555555543 24455555555666666666666666554332211
Q ss_pred CCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCC
Q 047768 330 ANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIP 409 (1009)
Q Consensus 330 ~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 409 (1009)
.+..+..+..+..+++.+....+..+..+...+..|++++|+++...+..+.....++.+++++|+|+...+
T Consensus 123 --------~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~ 194 (242)
T d1xwdc1 123 --------KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPN 194 (242)
T ss_dssp --------TTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCT
T ss_pred --------ccccccccccccccccccccccccccccccccceeeecccccccccccccccchhhhccccccccccccccH
Confidence 122233444444444444444444444444456666666666664444333332223333456666765555
Q ss_pred CCcCCcccccceecccccccCCCCccccccccccccccc
Q 047768 410 HVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFG 448 (1009)
Q Consensus 410 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 448 (1009)
..|.++++|++|+|++|+|+...+..|.++++|+++++.
T Consensus 195 ~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp TTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred HHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 566677777777777777765445556666666666654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=7e-19 Score=176.00 Aligned_cols=138 Identities=20% Similarity=0.299 Sum_probs=97.7
Q ss_pred CCCCCC-CCccceeeCCCCCeEEEEEeecCCcccccCccccCCCCCCeeeecCCcCCccC-CccccCccccccccccccc
Q 047768 52 ACVNLC-QHWTGVTCGRRNQRVTKLDLRNQSIGGILSPYVGNLSFLRYINIADNDFHGEI-PDRIGNLFRLETLVLANNS 129 (1009)
Q Consensus 52 ~~~~~c-~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~-p~~~~~l~~L~~L~Ls~N~ 129 (1009)
+|+..| |+|+.|.|++ ++++ .+|+.+. +++++|+|++|+|++.+ +..|+++++|++|+|++|.
T Consensus 1 ~CP~~C~C~~~~v~Cs~------------~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~ 65 (192)
T d1w8aa_ 1 DCPAMCHCEGTTVDCTG------------RGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65 (192)
T ss_dssp CCCTTSEEETTEEECTT------------SCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSC
T ss_pred CcCCCCEEcCCEEEEeC------------CCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccc
Confidence 466666 4677666653 3444 3444442 57788888888887644 4457788888888888888
Q ss_pred cCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCC
Q 047768 130 FSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIP 209 (1009)
Q Consensus 130 l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 209 (1009)
+.+..+..+..+++|++|+|++ |+|+...|..|.++++|++|+|++|+|++..+
T Consensus 66 i~~~~~~~~~~~~~L~~L~Ls~--------------------------N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~ 119 (192)
T d1w8aa_ 66 LTGIEPNAFEGASHIQELQLGE--------------------------NKIKEISNKMFLGLHQLKTLNLYDNQISCVMP 119 (192)
T ss_dssp CCCBCTTTTTTCTTCCEEECCS--------------------------CCCCEECSSSSTTCTTCCEEECCSSCCCEECT
T ss_pred cccccccccccccccceeeecc--------------------------ccccccCHHHHhCCCcccccccCCccccccCH
Confidence 8777777776666555555555 55555556778888888888888888888888
Q ss_pred cccccccccccccccCccCCC
Q 047768 210 ITLSQLTSLAYLHVGDNHFSG 230 (1009)
Q Consensus 210 ~~~~~l~~L~~L~L~~N~l~~ 230 (1009)
++|..+++|++|+|++|.+..
T Consensus 120 ~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 120 GSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp TSSTTCTTCCEEECTTCCBCC
T ss_pred HHhcCCccccccccccccccc
Confidence 888888888888888888763
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=3.8e-22 Score=229.92 Aligned_cols=391 Identities=18% Similarity=0.184 Sum_probs=223.4
Q ss_pred CCcCeEeecCccCCCCC-CcccCCccccceeecccCcccC----CCCcccccccccccccccCccCCCCCCCcccCCChH
Q 047768 168 FNLQGLSVGDNQLTGQL-PASIGNLSALRVIDIRTNRLWG----KIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSL 242 (1009)
Q Consensus 168 ~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 242 (1009)
.+|+.||++.|++++.. ...+..+++|++|+|++|.++. .+...+..+++|++|||++|+|+.. . .
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~---~------~ 72 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDV---G------V 72 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHH---H------H
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChH---H------H
Confidence 46899999999998532 3346678889999999998862 3455677888899999998887521 0 0
Q ss_pred HHHHhhCCccCCCCChhhccCCCcccceeccccccCCC----CCCCcCccccccccccccccccccccccccc-ccc---
Q 047768 243 VEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGS----LPDSFSNASNLEVLHLAENQFRGQVSINFNG-LKD--- 314 (1009)
Q Consensus 243 ~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~-l~~--- 314 (1009)
+.+ ...+.....+|++|+|++|+++.. ++..+..+++|++|+|++|++.......+.. +..
T Consensus 73 ~~l-----------~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~ 141 (460)
T d1z7xw1 73 HCV-----------LQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC 141 (460)
T ss_dssp HHH-----------HHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred HHH-----------HHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhccccccc
Confidence 100 000111234577777777776533 3445667778888888888776533222211 111
Q ss_pred -cccccccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcC----chhhhhhcccceEEEcCCCccccC----CC
Q 047768 315 -LSMLGLATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVL----PHSIANLSTALIDFNLGKNQIYGT----IP 385 (1009)
Q Consensus 315 -L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~~L~~L~L~~N~l~~~----~p 385 (1009)
..........+... ........+.....++.++++++.+.... ...+.........+++..+.+... ..
T Consensus 142 ~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~ 219 (460)
T d1z7xw1 142 RLEKLQLEYCSLSAA--SCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC 219 (460)
T ss_dssp CCCEEECTTSCCBGG--GHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHH
T ss_pred ccccccccccccchh--hhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhccc
Confidence 11111111111100 00112233455677888888887765321 112222233456677777765421 11
Q ss_pred ccccCcCccCEEEccCCCCCC-----CCCCCcCCcccccceecccccccCC----CCcccccccccccccccCccccccc
Q 047768 386 PGIANLVNLNSLRMEANRLTG-----TIPHVIGELKNLQLLHLHANFLQGT----IPSSLGNLTLLTYLSFGANNLQGNI 456 (1009)
Q Consensus 386 ~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~ 456 (1009)
..+...+.++.+++++|++.. ..+........++.|++++|.+... ....+...+.++.+++++|.++...
T Consensus 220 ~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~ 299 (460)
T d1z7xw1 220 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 299 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHH
T ss_pred ccccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 234456778888888887642 1223344566788888888877632 2223445667777778877775321
Q ss_pred CCCC-----CCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCC---
Q 047768 457 PFSL-----GNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQ--- 528 (1009)
Q Consensus 457 p~~~-----~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~--- 528 (1009)
...+ .....|+.+++++|.++......+ ...+....+|++|||++|++++.
T Consensus 300 ~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l---------------------~~~~~~~~~L~~L~Ls~N~i~~~g~~ 358 (460)
T d1z7xw1 300 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHF---------------------SSVLAQNRFLLELQISNNRLEDAGVR 358 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH---------------------HHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred cchhhccccccccccccccccccchhhhhhhhc---------------------ccccccccchhhhheeeecccCcccc
Confidence 1111 122344444444444432111111 11223456788888888888642
Q ss_pred -cccccc-CCCCccEEEecCcccccc----cccccccccccceEcCCCccccccccccc----c-cccccCceecccccC
Q 047768 529 -IPVTLG-ACTSLEYVELQGNSFSGT----IPQSLSSLTSIKELDLSQNNFSGQIPKYL----E-NLSFLQYLNLSYNHF 597 (1009)
Q Consensus 529 -~p~~~~-~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~-~l~~L~~L~ls~N~l 597 (1009)
++..+. ..+.|++|+|++|+|+.. ++..+...++|++|||++|+|+......+ . +...|+.|++++|++
T Consensus 359 ~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~ 438 (460)
T d1z7xw1 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 438 (460)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCC
T ss_pred hhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCC
Confidence 333343 356788888888888743 44556667888888888888875333332 2 234688888888887
Q ss_pred cccC
Q 047768 598 EGEV 601 (1009)
Q Consensus 598 ~g~~ 601 (1009)
..+.
T Consensus 439 ~~~~ 442 (460)
T d1z7xw1 439 SEEM 442 (460)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 6543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=1.5e-18 Score=178.90 Aligned_cols=208 Identities=23% Similarity=0.312 Sum_probs=143.6
Q ss_pred cccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCccccccee
Q 047768 343 TKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLH 422 (1009)
Q Consensus 343 ~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 422 (1009)
.++..++++.+++++.. .+..+ ..|+.|++.+|.|+. + ..+..+++|+.|++++|++++..| +..+++|++++
T Consensus 19 ~~~~~~~l~~~~~~d~~--~~~~l-~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 19 ANAIKIAAGKSNVTDTV--TQADL-DGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHTTCSSTTSEE--CHHHH-HTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHhCCCCcCCcC--CHHHc-CCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence 34445567777776543 33344 457777777777764 3 347777777777777777765433 66777777777
Q ss_pred cccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccC
Q 047768 423 LHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLN 502 (1009)
Q Consensus 423 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~ 502 (1009)
+++|.++. ++ .+.++++|++++++++...+..+ +...+.+. .+.++.+.+.
T Consensus 92 ~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~~--~~~~~~~~-------------------------~l~~~~~~~~ 142 (227)
T d1h6ua2 92 LSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQ-------------------------VLYLDLNQIT 142 (227)
T ss_dssp CCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGG--GTTCTTCC-------------------------EEECCSSCCC
T ss_pred cccccccc-cc-cccccccccccccccccccccch--hccccchh-------------------------hhhchhhhhc
Confidence 77777662 32 45666777777777666653222 22222222 3666666665
Q ss_pred CCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcccccccccccc
Q 047768 503 GSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLE 582 (1009)
Q Consensus 503 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 582 (1009)
... .+.+.++|+.|++++|.+++.. .++++++|+.|+|++|++++ +| .++++++|++|+|++|+|++ +| .+.
T Consensus 143 ~~~--~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~-i~-~l~ 214 (227)
T d1h6ua2 143 NIS--PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISD-VS-PLA 214 (227)
T ss_dssp CCG--GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCB-CG-GGT
T ss_pred hhh--hhccccccccccccccccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCC-Cc-ccc
Confidence 332 3677889999999999997533 38899999999999999985 43 38899999999999999985 44 388
Q ss_pred cccccCceeccc
Q 047768 583 NLSFLQYLNLSY 594 (1009)
Q Consensus 583 ~l~~L~~L~ls~ 594 (1009)
++++|++|++++
T Consensus 215 ~l~~L~~L~lsn 226 (227)
T d1h6ua2 215 NTSNLFIVTLTN 226 (227)
T ss_dssp TCTTCCEEEEEE
T ss_pred cCCCCCEEEeeC
Confidence 999999999974
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=3.9e-18 Score=170.48 Aligned_cols=175 Identities=21% Similarity=0.196 Sum_probs=96.7
Q ss_pred EEEccCCCCCCCCCCCcCCcccccceecccccccCC-CCcccccccccccccccCcccccccCCCCCCCCCccccccCCC
Q 047768 396 SLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGT-IPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRN 474 (1009)
Q Consensus 396 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N 474 (1009)
.++.++|+++ .+|..+. +++++|+|++|+|++. .+..|.++++|++|+|++|++.+..+..+..+++|++
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~------ 82 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQE------ 82 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCE------
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccce------
Confidence 4455555554 3333332 3455555555555432 2334455555555555555555444444444444433
Q ss_pred CccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccc
Q 047768 475 KLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIP 554 (1009)
Q Consensus 475 ~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 554 (1009)
|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+
T Consensus 83 -------------------L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 83 -------------------LQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp -------------------EECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred -------------------eeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 3333333333344456666777777777777776666677777777777777777764322
Q ss_pred cccccccccceEcCCCcccccccccccccccccCceecccccCcccCC
Q 047768 555 QSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSYNHFEGEVP 602 (1009)
Q Consensus 555 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p 602 (1009)
. ..-...++.+.+..|.++...|..+ ..++.++|+.|.|.+..+
T Consensus 144 ~-~~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 144 L-AWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp G-HHHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCCCCC
T ss_pred h-HHHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcCCCC
Confidence 1 1112345666777777776666543 445566777777765444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=6.6e-18 Score=171.33 Aligned_cols=164 Identities=26% Similarity=0.326 Sum_probs=92.4
Q ss_pred CccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCcccccc
Q 047768 392 VNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFA 471 (1009)
Q Consensus 392 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l 471 (1009)
.+|+.|++++|.+++.. .+..+++|++|+|++|++++.. .++.+++|++|++++|++++ +| .+.++++|+.+++
T Consensus 46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccccc
Confidence 34444444444444221 2344444555555555444321 13444555555555555542 22 2444444444333
Q ss_pred CCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccccc
Q 047768 472 PRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSG 551 (1009)
Q Consensus 472 ~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 551 (1009)
++|.+. .+ ..+..++.|+.+++++|.+++ +..+..+++|+.+++++|++++
T Consensus 120 ~~~~~~--------------------------~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~ 170 (210)
T d1h6ta2 120 EHNGIS--------------------------DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD 170 (210)
T ss_dssp TTSCCC--------------------------CC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC
T ss_pred cccccc--------------------------cc-ccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 333322 11 135556677777777777763 3356677788888888888874
Q ss_pred ccccccccccccceEcCCCcccccccccccccccccCceeccc
Q 047768 552 TIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYLNLSY 594 (1009)
Q Consensus 552 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 594 (1009)
. + .++++++|++|+|++|+|+ .+| .+..+++|++|+|++
T Consensus 171 i-~-~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 171 I-V-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp C-G-GGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred c-c-cccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence 3 3 3777888888888888887 354 577888888888764
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=8.5e-18 Score=173.14 Aligned_cols=207 Identities=22% Similarity=0.295 Sum_probs=134.2
Q ss_pred ChHHHHHhhCCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccccccccccccccccccccccc
Q 047768 240 SSLVEIYLYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAENQFRGQVSINFNGLKDLSMLG 319 (1009)
Q Consensus 240 ~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~ 319 (1009)
.++..++++.+++++.++. ..+.+|+.|++.+|+|+.. ..+..+++|++|++++|++++..+ |..+++|+.++
T Consensus 19 ~~~~~~~l~~~~~~d~~~~---~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 19 ANAIKIAAGKSNVTDTVTQ---ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHTTCSSTTSEECH---HHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHhCCCCcCCcCCH---HHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence 3444455666655533221 2355666667777766643 246667777777777777665543 66666777777
Q ss_pred ccccccCCCCCCCcchhhhcccccccceEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEc
Q 047768 320 LATNFLGNGAANDLDFVDLLTNCTKLQYLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRM 399 (1009)
Q Consensus 320 L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 399 (1009)
+++|.++.+. .+.++++|+.++++++...+..+ +... ..+..+.++++.+... ..+.++++|+.|++
T Consensus 92 ~~~n~~~~i~--------~l~~l~~L~~l~l~~~~~~~~~~--~~~~-~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l 158 (227)
T d1h6ua2 92 LSGNPLKNVS--------AIAGLQSIKTLDLTSTQITDVTP--LAGL-SNLQVLYLDLNQITNI--SPLAGLTNLQYLSI 158 (227)
T ss_dssp CCSCCCSCCG--------GGTTCTTCCEEECTTSCCCCCGG--GTTC-TTCCEEECCSSCCCCC--GGGGGCTTCCEEEC
T ss_pred cccccccccc--------cccccccccccccccccccccch--hccc-cchhhhhchhhhhchh--hhhccccccccccc
Confidence 7766665432 35667777888887777764432 2222 4567777777777643 34667778888888
Q ss_pred cCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccC
Q 047768 400 EANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAP 472 (1009)
Q Consensus 400 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~ 472 (1009)
++|.+++.. .+.++++|++|+|++|++++ ++ .+.++++|++|+|++|++++..| +.++++|+.|+++
T Consensus 159 ~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 159 GNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp CSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred cccccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 888876433 37778888888888888874 33 37788888888888888875433 6777777776654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=4.5e-21 Score=220.80 Aligned_cols=400 Identities=17% Similarity=0.158 Sum_probs=185.6
Q ss_pred ccccccccccccCCCC-CCCCcCCCcCcEEecccccccCCCchHHh--hhccCCcCeEeecCccCCCC----CCcccC-C
Q 047768 119 RLETLVLANNSFSGRI-PTNLSHCSKLITFSAHRNNLVGEIPEELI--SRRLFNLQGLSVGDNQLTGQ----LPASIG-N 190 (1009)
Q Consensus 119 ~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~l~~n~l~~~~p~~~~--~~~l~~L~~L~L~~n~l~~~----~p~~~~-~ 190 (1009)
+|+.||+++|++++.. ..-+..++++++|+|++|.++..-...+. ....++|++|+|++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6788888888887532 23355667777777777776532211111 14456777777777776421 112222 2
Q ss_pred ccccceeecccCcccCC----CCcccccccccccccccCccCCCCCCCcccCCChHHHHHhhCCccCCCCChhhccCCCc
Q 047768 191 LSALRVIDIRTNRLWGK----IPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLYGNRFTGSLPIEIGKNLPN 266 (1009)
Q Consensus 191 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~ 266 (1009)
.++|++|+|++|+++.. ++..+..+++|++|+|++|.++...... +.. .+..+.. .
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~------l~~-~l~~~~~-------------~ 142 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQL------LCE-GLLDPQC-------------R 142 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHH------HHH-HHTSTTC-------------C
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhh------hhh-ccccccc-------------c
Confidence 24677777777777532 3445666677777777777665211000 000 0111100 0
Q ss_pred ccceeccccccCCC----CCCCcCccccccccccccccccccccccc-----ccccccccccccccccCCCCCCCcchhh
Q 047768 267 LRNFVIYTNNFTGS----LPDSFSNASNLEVLHLAENQFRGQVSINF-----NGLKDLSMLGLATNFLGNGAANDLDFVD 337 (1009)
Q Consensus 267 L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~f-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 337 (1009)
..........+... ....+.....++.++++++.+.......+ ........+++..+.+..... ..+..
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~--~~~~~ 220 (460)
T d1z7xw1 143 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC--RDLCG 220 (460)
T ss_dssp CCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHH--HHHHH
T ss_pred cccccccccccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhh--hcccc
Confidence 11111111111100 00112233455556666555432111100 011122233333333322111 11223
Q ss_pred hcccccccceEEccCCCCCCcC----chhhhhhcccceEEEcCCCccccC----CCccccCcCccCEEEccCCCCCCCCC
Q 047768 338 LLTNCTKLQYLYLADNGFGGVL----PHSIANLSTALIDFNLGKNQIYGT----IPPGIANLVNLNSLRMEANRLTGTIP 409 (1009)
Q Consensus 338 ~l~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p 409 (1009)
.+...+.++.+++++|.+.... ..........+..+++++|.+... ....+...+.++.+++++|.++....
T Consensus 221 ~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~ 300 (460)
T d1z7xw1 221 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 300 (460)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred cccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3445566666666666553211 111111223455555555554321 11223334455555555555432111
Q ss_pred CCc-----CCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhh
Q 047768 410 HVI-----GELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQI 484 (1009)
Q Consensus 410 ~~~-----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~ 484 (1009)
..+ .....|+.+++++|.++......+. ..+...++|++|++++|+++..-...+
T Consensus 301 ~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~--------------------~~~~~~~~L~~L~Ls~N~i~~~g~~~l 360 (460)
T d1z7xw1 301 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFS--------------------SVLAQNRFLLELQISNNRLEDAGVREL 360 (460)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH--------------------HHHHHCSSCCEEECCSSBCHHHHHHHH
T ss_pred chhhccccccccccccccccccchhhhhhhhcc--------------------cccccccchhhhheeeecccCcccchh
Confidence 111 1123444444544444422111111 112233455556666665542111111
Q ss_pred hhhccceeeEecCCCccCCCCCCCc-cCCCCCCeeeccccccCCC----ccccccCCCCccEEEecCcccccccccccc-
Q 047768 485 LEITTLSLSLDLSDNLLNGSLPLGV-GNLKSLVRLGIARNQFSGQ----IPVTLGACTSLEYVELQGNSFSGTIPQSLS- 558 (1009)
Q Consensus 485 ~~~~~~~~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~- 558 (1009)
.. .+ ...+.|++|+|++|.|+.. ++..+..+++|++|+|++|+|+......+.
T Consensus 361 ~~---------------------~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~ 419 (460)
T d1z7xw1 361 CQ---------------------GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419 (460)
T ss_dssp HH---------------------HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHH
T ss_pred hh---------------------hhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHH
Confidence 11 11 1235678888888888642 445566778888888888888754333332
Q ss_pred ----cccccceEcCCCccccccccccc
Q 047768 559 ----SLTSIKELDLSQNNFSGQIPKYL 581 (1009)
Q Consensus 559 ----~l~~L~~L~Ls~N~l~~~~p~~~ 581 (1009)
+...|+.|++++|.+....+..+
T Consensus 420 ~l~~~~~~L~~l~l~~~~~~~~~~~~l 446 (460)
T d1z7xw1 420 SVRQPGCLLEQLVLYDIYWSEEMEDRL 446 (460)
T ss_dssp HHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred HHHhCCCccCEEECCCCCCCHHHHHHH
Confidence 33478999999998876554443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=1.3e-17 Score=169.05 Aligned_cols=182 Identities=26% Similarity=0.316 Sum_probs=133.9
Q ss_pred eEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccc
Q 047768 347 YLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHAN 426 (1009)
Q Consensus 347 ~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 426 (1009)
...++.+.+++.++. ..+ ..++.|++++|.++.. + .+..+++|++|+|++|+|++.. .++.+++|++|++++|
T Consensus 28 ~~~l~~~~~~~~~~~--~~L-~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n 100 (210)
T d1h6ta2 28 KDNLKKKSVTDAVTQ--NEL-NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDEN 100 (210)
T ss_dssp HHHTTCSCTTSEECH--HHH-HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSS
T ss_pred HHHhCcCccCCccCH--HHh-cCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccc
Confidence 345555666555443 223 4577788888887743 2 4778889999999999998644 3678899999999999
Q ss_pred cccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCC
Q 047768 427 FLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLP 506 (1009)
Q Consensus 427 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p 506 (1009)
++++ +| .+.++++|+.|++++|.+.. + ..+..+++++.++++.|.++ + +
T Consensus 101 ~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~-------------------------~--~ 149 (210)
T d1h6ta2 101 KVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKIT-------------------------D--I 149 (210)
T ss_dssp CCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCC-------------------------C--C
T ss_pred cccc-cc-cccccccccccccccccccc-c-cccccccccccccccccccc-------------------------c--c
Confidence 9984 44 57888999999999998863 2 24666666666555555443 2 2
Q ss_pred CCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCC
Q 047768 507 LGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQ 570 (1009)
Q Consensus 507 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 570 (1009)
..+..+++|+.+++++|++++. + .+.++++|+.|+|++|+|+ .+| .+.++++|++|+|++
T Consensus 150 ~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 150 TVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred cccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence 2456788999999999999854 3 3888999999999999998 455 589999999999874
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=4.1e-17 Score=163.92 Aligned_cols=162 Identities=29% Similarity=0.384 Sum_probs=95.4
Q ss_pred CcCccCEEEccCCCCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCcccc
Q 047768 390 NLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFF 469 (1009)
Q Consensus 390 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l 469 (1009)
.+.+++.|++++|.++.. +.+..+++|++|+|++|++++..| ++++++|++|++++|.+.. ++ .+.+++.|+.+
T Consensus 38 ~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccc
Confidence 344555555555555422 224455555555555555553322 5555555555555555542 22 24444444443
Q ss_pred ccCCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccc
Q 047768 470 FAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSF 549 (1009)
Q Consensus 470 ~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 549 (1009)
++++|.+. .. ..+..+++|+.|++++|++.. +| .+..+++|+.|++++|++
T Consensus 112 ~l~~~~~~-------------------------~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l 162 (199)
T d2omxa2 112 TLFNNQIT-------------------------DI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQV 162 (199)
T ss_dssp ECCSSCCC-------------------------CC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCC
T ss_pred cccccccc-------------------------cc--cccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccc
Confidence 33333332 11 125566778888888888763 33 577788888888888888
Q ss_pred ccccccccccccccceEcCCCcccccccccccccccccCce
Q 047768 550 SGTIPQSLSSLTSIKELDLSQNNFSGQIPKYLENLSFLQYL 590 (1009)
Q Consensus 550 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 590 (1009)
++. + .++++++|++|++++|++++ +| .++.+++|+.|
T Consensus 163 ~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 163 TDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp CCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 753 2 37788888888888888874 44 46777777765
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=6.9e-17 Score=162.27 Aligned_cols=178 Identities=26% Similarity=0.354 Sum_probs=125.0
Q ss_pred eEEccCCCCCCcCchhhhhhcccceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCCCCCCcCCcccccceecccc
Q 047768 347 YLYLADNGFGGVLPHSIANLSTALIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGTIPHVIGELKNLQLLHLHAN 426 (1009)
Q Consensus 347 ~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 426 (1009)
.+.++.+.+++.++. ..+ ..++.|++++|.++. + +.+..+++|++|++++|+|++..| ++++++|++|++++|
T Consensus 22 ~~~l~~~~~~~~~~~--~~l-~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n 94 (199)
T d2omxa2 22 KTVLGKTNVTDTVSQ--TDL-DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 94 (199)
T ss_dssp HHHTTCSSTTSEECH--HHH-TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHhCCCCCCCccCH--HHh-cCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccc
Confidence 344555555544322 223 356667777777663 2 347778888888888888885543 788888888888888
Q ss_pred cccCCCCcccccccccccccccCcccccccCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCCCCC
Q 047768 427 FLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLP 506 (1009)
Q Consensus 427 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p 506 (1009)
.+.. ++ .+.+++.|++|++++|.+.... .+..+++|+.+++++|+ +. .+|
T Consensus 95 ~~~~-~~-~l~~l~~L~~L~l~~~~~~~~~--~~~~l~~L~~L~l~~n~-------------------------l~-~~~ 144 (199)
T d2omxa2 95 QIAD-IT-PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNT-------------------------IS-DIS 144 (199)
T ss_dssp CCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSC-------------------------CC-CCG
T ss_pred cccc-cc-cccccccccccccccccccccc--ccchhhhhHHhhhhhhh-------------------------hc-ccc
Confidence 8873 33 4788888888888888887432 35666766654444444 43 222
Q ss_pred CCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceE
Q 047768 507 LGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKEL 566 (1009)
Q Consensus 507 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 566 (1009)
.+..+++|+.|++++|++++. + .++++++|+.|++++|++++ ++ .++++++|++|
T Consensus 145 -~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 145 -ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp -GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred -cccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 466788899999999999854 3 48889999999999999985 44 57888888876
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=1.3e-14 Score=139.43 Aligned_cols=131 Identities=17% Similarity=0.186 Sum_probs=100.4
Q ss_pred ccccCCCCCCeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhcc
Q 047768 88 PYVGNLSFLRYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRL 167 (1009)
Q Consensus 88 ~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l 167 (1009)
+.+.+...|++|||++|+|+ .+|+.+..+++|++||||+|+|+ .+ +.|..+++|++|++++|++++ +|..++ ..+
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l-~~~~~l~~L~~L~ls~N~i~~-l~~~~~-~~l 86 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICR-IGEGLD-QAL 86 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EE-CCCCCCSSCCEEECCSSCCCE-ECSCHH-HHC
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-cc-CCcccCcchhhhhcccccccC-CCcccc-ccc
Confidence 45678888999999999998 67877788999999999999998 44 358889999999999998874 443332 457
Q ss_pred CCcCeEeecCccCCCCCC-cccCCccccceeecccCcccCCC---Ccccccccccccccc
Q 047768 168 FNLQGLSVGDNQLTGQLP-ASIGNLSALRVIDIRTNRLWGKI---PITLSQLTSLAYLHV 223 (1009)
Q Consensus 168 ~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~---p~~~~~l~~L~~L~L 223 (1009)
++|++|++++|+++.... ..+..+++|++|++++|.++... +..+..+++|++||-
T Consensus 87 ~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 87 PDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp TTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred cccccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence 888888888888874322 45778888888888888885332 124677788887763
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.47 E-value=5.2e-14 Score=128.30 Aligned_cols=104 Identities=24% Similarity=0.307 Sum_probs=90.8
Q ss_pred eEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcc
Q 047768 493 SLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNN 572 (1009)
Q Consensus 493 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 572 (1009)
.|||++|+++ .++ .++.+++|++||+++|+|+ .+|+.++.+++|+.|++++|+|++ +| .++.+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 4899999998 455 5899999999999999998 678889999999999999999994 45 58999999999999999
Q ss_pred ccccc-ccccccccccCceecccccCcccC
Q 047768 573 FSGQI-PKYLENLSFLQYLNLSYNHFEGEV 601 (1009)
Q Consensus 573 l~~~~-p~~~~~l~~L~~L~ls~N~l~g~~ 601 (1009)
|+... +..+..+++|++|++++|++++..
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~ 106 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 106 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence 98543 257899999999999999998543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.45 E-value=6.1e-14 Score=127.83 Aligned_cols=102 Identities=22% Similarity=0.314 Sum_probs=58.8
Q ss_pred CeeeecCCcCCccCCccccCccccccccccccccCCCCCCCCcCCCcCcEEecccccccCCCchHHhhhccCCcCeEeec
Q 047768 97 RYINIADNDFHGEIPDRIGNLFRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNNLVGEIPEELISRRLFNLQGLSVG 176 (1009)
Q Consensus 97 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~ 176 (1009)
|+|||++|+++ .+|. ++++++|++|||++|+|+ .+|+.++.+++|++|++++|.+++ +|. + ..+++|++|+++
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~~-~--~~l~~L~~L~l~ 73 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-V--ANLPRLQELLLC 73 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGG-G--TTCSSCCEEECC
T ss_pred CEEEcCCCCCC-CCcc-cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cCc-c--ccccccCeEECC
Confidence 46677777776 4443 666777777777777776 455566666666666666666552 232 1 344555555555
Q ss_pred CccCCCCC-CcccCCccccceeecccCccc
Q 047768 177 DNQLTGQL-PASIGNLSALRVIDIRTNRLW 205 (1009)
Q Consensus 177 ~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 205 (1009)
+|+|+... ...++.+++|++|++++|+++
T Consensus 74 ~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 74 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 55555322 134555566666666666554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=6.1e-15 Score=156.67 Aligned_cols=201 Identities=14% Similarity=0.157 Sum_probs=102.7
Q ss_pred ceEEEcCCCccccCCCccccCcCccCEEEccCCCCCCC-CCCCcCCcccccceecccccccCCCCccccccccccccccc
Q 047768 370 LIDFNLGKNQIYGTIPPGIANLVNLNSLRMEANRLTGT-IPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFG 448 (1009)
Q Consensus 370 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 448 (1009)
+..+.++...+..... ......+|++|+|++|.++.. ++..+..+++|++|+|+++.+++..+..+..+++|++|+++
T Consensus 25 ~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls 103 (284)
T d2astb2 25 VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103 (284)
T ss_dssp CSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence 3444455444442222 223344666666666665532 23334556666666666666665555556666666666666
Q ss_pred Cc-ccccc-cCCCCCCCCCccccccCCC-CccCC-CchhhhhhccceeeEecCCCc--cCC-CCCCCccCCCCCCeeecc
Q 047768 449 AN-NLQGN-IPFSLGNCKNLMFFFAPRN-KLTGA-LPQQILEITTLSLSLDLSDNL--LNG-SLPLGVGNLKSLVRLGIA 521 (1009)
Q Consensus 449 ~N-~l~~~-~p~~~~~l~~L~~l~l~~N-~l~~~-~p~~~~~~~~~~~~L~Ls~N~--l~~-~~p~~~~~l~~L~~L~ls 521 (1009)
++ .++.. +.....++++|++|+++++ .++.. ++..+.........|+++++. ++. .+...+.++++|++|+++
T Consensus 104 ~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~ 183 (284)
T d2astb2 104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183 (284)
T ss_dssp TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECT
T ss_pred ccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccc
Confidence 63 44321 1111234556666666553 23211 111111222223345555431 221 111122345667777776
Q ss_pred cc-ccCCCccccccCCCCccEEEecC-cccccccccccccccccceEcCCCc
Q 047768 522 RN-QFSGQIPVTLGACTSLEYVELQG-NSFSGTIPQSLSSLTSIKELDLSQN 571 (1009)
Q Consensus 522 ~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N 571 (1009)
+| .+++.....+..+++|++|+|++ +.+++.....++++++|+.|+++++
T Consensus 184 ~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 64 35655666666677777777776 3566555556666677777777665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=5e-14 Score=135.23 Aligned_cols=82 Identities=20% Similarity=0.125 Sum_probs=51.9
Q ss_pred ccCCCCCCeeeccccccCCCccccccCCCCccEEEecCcccccccc-cccccccccceEcCCCccccccccc----cccc
Q 047768 509 VGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSGTIP-QSLSSLTSIKELDLSQNNFSGQIPK----YLEN 583 (1009)
Q Consensus 509 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~ 583 (1009)
|..+++|++|++++|+++...+..+..+++|+.|+|++|+|+.... ..+..+++|++|++++|.++. .|. .+..
T Consensus 59 ~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~ 137 (162)
T d1a9na_ 59 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYK 137 (162)
T ss_dssp CCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHH
T ss_pred cccCcchhhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHH
Confidence 4556667777777777764444445567777777777777763221 356677777777777777763 332 4666
Q ss_pred ccccCcee
Q 047768 584 LSFLQYLN 591 (1009)
Q Consensus 584 l~~L~~L~ 591 (1009)
+++|++||
T Consensus 138 lp~L~~LD 145 (162)
T d1a9na_ 138 VPQVRVLD 145 (162)
T ss_dssp CTTCSEET
T ss_pred CCCcCeeC
Confidence 77777766
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=2.8e-15 Score=159.32 Aligned_cols=257 Identities=14% Similarity=0.142 Sum_probs=132.0
Q ss_pred CeEeecCccCCCCCCcccCCcc--ccceeecccCcccCCCCcccccccccccccccCccCCCCCCCcccCCChHHHHHhh
Q 047768 171 QGLSVGDNQLTGQLPASIGNLS--ALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTIPPSVYNISSLVEIYLY 248 (1009)
Q Consensus 171 ~~L~L~~n~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 248 (1009)
+.|||+++.+. |+.++.+. .+..+.++...+...... .....+|++|||+++.+++
T Consensus 3 ~~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~------------------ 60 (284)
T d2astb2 3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV------------------ 60 (284)
T ss_dssp SEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH------------------
T ss_pred CEEECCCCCCC---chHHHHHHhccceEeeccccccccchhh-hccCCCCCEEECCCCccCH------------------
Confidence 46777777664 23322222 234444544444322222 2234566666666666542
Q ss_pred CCccCCCCChhhccCCCcccceeccccccCCCCCCCcCccccccccccccc-cccccc-cccccccccccccccccc-cc
Q 047768 249 GNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDSFSNASNLEVLHLAEN-QFRGQV-SINFNGLKDLSMLGLATN-FL 325 (1009)
Q Consensus 249 ~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~-~~~f~~l~~L~~L~L~~N-~l 325 (1009)
.....++.++++|++|+|+++.++...+..++.+++|++|+|+++ .++... ...+.++++|+.|+++++ .+
T Consensus 61 ------~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~ 134 (284)
T d2astb2 61 ------STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDF 134 (284)
T ss_dssp ------HHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTC
T ss_pred ------HHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccccccccccc
Confidence 111223344555556666555555444455555666666666653 343211 111234555555555542 22
Q ss_pred CCCCCCCcchhhhccc-ccccceEEccCC--CCCCcCchhhhhhcccceEEEcCCC-ccccCCCccccCcCccCEEEccC
Q 047768 326 GNGAANDLDFVDLLTN-CTKLQYLYLADN--GFGGVLPHSIANLSTALIDFNLGKN-QIYGTIPPGIANLVNLNSLRMEA 401 (1009)
Q Consensus 326 ~~~~~~~~~~~~~l~~-l~~L~~L~L~~N--~l~~~~p~~~~~l~~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~ 401 (1009)
+. ......+.. .++|+.|+++++ .++......+....++|++|++++| .+++.....+.++++|++|+|++
T Consensus 135 ~~-----~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~ 209 (284)
T d2astb2 135 TE-----KHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR 209 (284)
T ss_dssp CH-----HHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred cc-----ccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCC
Confidence 11 001112222 356777777754 3332222223222356777777764 46666666777777888888877
Q ss_pred C-CCCCCCCCCcCCcccccceecccccccCCCCcccccc-cccccccccCcccccccCCCCCCCC
Q 047768 402 N-RLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNL-TLLTYLSFGANNLQGNIPFSLGNCK 464 (1009)
Q Consensus 402 N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~ 464 (1009)
+ .+++.....++++++|++|+++++ ++ ...+..+ ..+..|.+..+++++..++.+++..
T Consensus 210 C~~i~~~~l~~L~~~~~L~~L~l~~~-~~---d~~l~~l~~~lp~L~i~~~~ls~~~~~~~~~~~ 270 (284)
T d2astb2 210 CYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGNKK 270 (284)
T ss_dssp CTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSSTT
T ss_pred CCCCChHHHHHHhcCCCCCEEeeeCC-CC---HHHHHHHHHhCccccccCccCCCCCCCccCccc
Confidence 3 566555566777778888888776 32 1222222 2344455666777766666555443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.41 E-value=4.3e-15 Score=163.14 Aligned_cols=187 Identities=19% Similarity=0.258 Sum_probs=112.8
Q ss_pred ccCcCccCEEEccCCCCCCCCC----CCcCCcccccceecccccccCCCCccc-------------ccccccccccccCc
Q 047768 388 IANLVNLNSLRMEANRLTGTIP----HVIGELKNLQLLHLHANFLQGTIPSSL-------------GNLTLLTYLSFGAN 450 (1009)
Q Consensus 388 ~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~-------------~~l~~L~~L~L~~N 450 (1009)
+..+++|+.|+|++|.++.... ..+...++|++|++++|.+.......+ ...+.|+.+++++|
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n 168 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 168 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence 4455667777777777664322 233355667777777776642111111 12233444555554
Q ss_pred ccccc----cCCCCCCCCCccccccCCCCccCCCchhhhhhccceeeEecCCCccCC-----CCCCCccCCCCCCeeecc
Q 047768 451 NLQGN----IPFSLGNCKNLMFFFAPRNKLTGALPQQILEITTLSLSLDLSDNLLNG-----SLPLGVGNLKSLVRLGIA 521 (1009)
Q Consensus 451 ~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~ls 521 (1009)
+++.. +...+..++.|+ .|+|++|+++. .+...+...++|+.|+|+
T Consensus 169 ~i~~~~~~~l~~~l~~~~~L~-------------------------~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls 223 (344)
T d2ca6a1 169 RLENGSMKEWAKTFQSHRLLH-------------------------TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 223 (344)
T ss_dssp CCTGGGHHHHHHHHHHCTTCC-------------------------EEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECC
T ss_pred cccccccccccchhhhhhhhc-------------------------ccccccccccccccccchhhhhcchhhhcccccc
Confidence 44311 111112223333 35555555542 123456778899999999
Q ss_pred ccccCCC----ccccccCCCCccEEEecCccccccccccc----cc--ccccceEcCCCcccccc----cccccc-cccc
Q 047768 522 RNQFSGQ----IPVTLGACTSLEYVELQGNSFSGTIPQSL----SS--LTSIKELDLSQNNFSGQ----IPKYLE-NLSF 586 (1009)
Q Consensus 522 ~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~--l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~ 586 (1009)
+|.++.. +...+..+++|++|+|++|.|++.-...+ .. .+.|++|||++|+|+.. +...+. ++++
T Consensus 224 ~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~ 303 (344)
T d2ca6a1 224 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303 (344)
T ss_dssp SSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTT
T ss_pred cccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCC
Confidence 9998633 44567788999999999999986533333 22 36799999999998742 333443 5788
Q ss_pred cCceecccccCcc
Q 047768 587 LQYLNLSYNHFEG 599 (1009)
Q Consensus 587 L~~L~ls~N~l~g 599 (1009)
|++|+|++|++..
T Consensus 304 L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 304 LLFLELNGNRFSE 316 (344)
T ss_dssp CCEEECTTSBSCT
T ss_pred CCEEECCCCcCCC
Confidence 9999999999864
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.37 E-value=1.3e-14 Score=159.20 Aligned_cols=67 Identities=19% Similarity=0.268 Sum_probs=45.9
Q ss_pred ccCCCCCCeeeccccccCCCcccc----cc--CCCCccEEEecCcccccc----cccccc-cccccceEcCCCccccc
Q 047768 509 VGNLKSLVRLGIARNQFSGQIPVT----LG--ACTSLEYVELQGNSFSGT----IPQSLS-SLTSIKELDLSQNNFSG 575 (1009)
Q Consensus 509 ~~~l~~L~~L~ls~N~l~~~~p~~----~~--~l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~ 575 (1009)
+...++|++|+|++|.|++.-... +. ..+.|+.|++++|+|+.. +...+. ++++|+.|+|++|++..
T Consensus 239 l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred ccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 445677888888888877542222 22 235788999999988753 233442 56789999999999863
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=1.9e-12 Score=123.04 Aligned_cols=106 Identities=17% Similarity=0.071 Sum_probs=91.1
Q ss_pred EecCCCccCCCCCCCccCCCCCCeeecccc-ccCCCccccccCCCCccEEEecCcccccccccccccccccceEcCCCcc
Q 047768 494 LDLSDNLLNGSLPLGVGNLKSLVRLGIARN-QFSGQIPVTLGACTSLEYVELQGNSFSGTIPQSLSSLTSIKELDLSQNN 572 (1009)
Q Consensus 494 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 572 (1009)
++.+++.+. ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|++..|.+|..+++|++|||++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 777777777 57888999999999999876 4886667889999999999999999998889999999999999999999
Q ss_pred cccccccccccccccCceecccccCcccC
Q 047768 573 FSGQIPKYLENLSFLQYLNLSYNHFEGEV 601 (1009)
Q Consensus 573 l~~~~p~~~~~l~~L~~L~ls~N~l~g~~ 601 (1009)
|+...+..|. ..+|++|+|++|++.+.+
T Consensus 92 l~~l~~~~~~-~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 92 LESLSWKTVQ-GLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp CSCCCSTTTC-SCCCCEEECCSSCCCCCG
T ss_pred CcccChhhhc-cccccccccCCCcccCCc
Confidence 9954444454 457999999999997655
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.30 E-value=4.5e-14 Score=140.57 Aligned_cols=41 Identities=27% Similarity=0.246 Sum_probs=21.1
Q ss_pred CCCCCCeeeccccccCCCcc-ccccCCCCccEEEecCccccc
Q 047768 511 NLKSLVRLGIARNQFSGQIP-VTLGACTSLEYVELQGNSFSG 551 (1009)
Q Consensus 511 ~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~ 551 (1009)
++++|+.|++++|+++.... ..+..+++|+.|+|++|++..
T Consensus 113 ~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 113 KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 34455555555555552211 245555555555555555543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.29 E-value=2.8e-14 Score=142.13 Aligned_cols=143 Identities=20% Similarity=0.260 Sum_probs=91.7
Q ss_pred cCEEEccCC--CCCCCCCCCcCCcccccceecccccccCCCCcccccccccccccccCcccccccCCCCCCCCCcccccc
Q 047768 394 LNSLRMEAN--RLTGTIPHVIGELKNLQLLHLHANFLQGTIPSSLGNLTLLTYLSFGANNLQGNIPFSLGNCKNLMFFFA 471 (1009)
Q Consensus 394 L~~L~L~~N--~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l 471 (1009)
++.+++.++ .+. .+|..+..+++|++|+|++|+|+. ++ .+.++++|++|+|++|+|+.
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~----------------- 84 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK----------------- 84 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECS-----------------
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhccccccc-----------------
Confidence 444555443 222 334455666666666666666663 33 35566666666666665541
Q ss_pred CCCCccCCCchhhhhhccceeeEecCCCccCCCCCCCccCCCCCCeeeccccccCCCccccccCCCCccEEEecCccccc
Q 047768 472 PRNKLTGALPQQILEITTLSLSLDLSDNLLNGSLPLGVGNLKSLVRLGIARNQFSGQIPVTLGACTSLEYVELQGNSFSG 551 (1009)
Q Consensus 472 ~~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 551 (1009)
+|..+..+++|++|++++|+++. ++ .+..+++|+.|+|++|+|+.
T Consensus 85 ---------------------------------i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~~ 129 (198)
T d1m9la_ 85 ---------------------------------IENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN 129 (198)
T ss_dssp ---------------------------------CSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEESEEECCC
T ss_pred ---------------------------------ccccccccccccccccccccccc-cc-cccccccccccccccchhcc
Confidence 22222234567888888888874 33 47788899999999999874
Q ss_pred ccc-cccccccccceEcCCCcccccccccc----------cccccccCcee
Q 047768 552 TIP-QSLSSLTSIKELDLSQNNFSGQIPKY----------LENLSFLQYLN 591 (1009)
Q Consensus 552 ~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L~ 591 (1009)
... ..++.+++|++|+|++|.+....+.. +..+++|++||
T Consensus 130 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 130 WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 322 46888899999999999887554432 56678888876
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=6.1e-12 Score=119.52 Aligned_cols=107 Identities=18% Similarity=0.116 Sum_probs=49.0
Q ss_pred cccccccccccccCCCCCCCCcCCCcCcEEeccccc-ccCCCchHHhhhccCCcCeEeecCccCCCCCCcccCCccccce
Q 047768 118 FRLETLVLANNSFSGRIPTNLSHCSKLITFSAHRNN-LVGEIPEELISRRLFNLQGLSVGDNQLTGQLPASIGNLSALRV 196 (1009)
Q Consensus 118 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~-l~~~~p~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 196 (1009)
...+.++.+++.+. .+|..+..+++|++|++++|+ ++ .++...| ..+.+|+.|+|++|+|+.+.|.+|.++++|++
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f-~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQ-HLELRDL-RGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCC-EECGGGS-CSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCcccc-ccCchhh-ccccccCcceeeccccCCcccccccccccccc
Confidence 34455666666665 456666666666666655443 32 2322221 23444444444444444333444444444444
Q ss_pred eecccCcccCCCCcccccccccccccccCccC
Q 047768 197 IDIRTNRLWGKIPITLSQLTSLAYLHVGDNHF 228 (1009)
Q Consensus 197 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 228 (1009)
|+|++|+|+...+..|..+ +|++|+|++|.+
T Consensus 85 L~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~ 115 (156)
T d2ifga3 85 LNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115 (156)
T ss_dssp EECCSSCCSCCCSTTTCSC-CCCEEECCSSCC
T ss_pred eeccCCCCcccChhhhccc-cccccccCCCcc
Confidence 4444444433333333222 344444444443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=5.9e-09 Score=99.22 Aligned_cols=121 Identities=16% Similarity=0.115 Sum_probs=63.3
Q ss_pred CcCeEeecCccCCCCCCcccCCccccceeecccCcccCCCCcccccccccccccccCccCCCCC--CCcccCCChHHHHH
Q 047768 169 NLQGLSVGDNQLTGQLPASIGNLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFSGTI--PPSVYNISSLVEIY 246 (1009)
Q Consensus 169 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~ 246 (1009)
..+.|+++++... ..+..+..+..++..+|.. ..++..+..+++|++|+|++|+|+..- +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~-~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMA-ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHH-HHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHh-hhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3444555544322 1233444455555555444 334445556777777777777776431 23345566666666
Q ss_pred hhCCccCCCCChhhccCCCcccceeccccccCCCCCCC-------cCccccccccc
Q 047768 247 LYGNRFTGSLPIEIGKNLPNLRNFVIYTNNFTGSLPDS-------FSNASNLEVLH 295 (1009)
Q Consensus 247 L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~-------~~~l~~L~~L~ 295 (1009)
|++|+++ .++...+....+|+.|++++|.+....... +..+++|++||
T Consensus 98 Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 98 LSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 6666666 554433333445666666666665443321 34455555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=2.7e-08 Score=94.49 Aligned_cols=40 Identities=18% Similarity=0.239 Sum_probs=15.1
Q ss_pred CccccceeecccCcccCCCCcccccccccccccccCccCC
Q 047768 190 NLSALRVIDIRTNRLWGKIPITLSQLTSLAYLHVGDNHFS 229 (1009)
Q Consensus 190 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 229 (1009)
.+++|+.|+|++|+|+...+..+....+|+.|++++|.++
T Consensus 89 ~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 89 KAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred hCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence 3344444444444443222222222233444444444443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.23 E-value=2.3e-06 Score=88.17 Aligned_cols=149 Identities=18% Similarity=0.171 Sum_probs=103.3
Q ss_pred HHHHHHhccCccCCcccccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcC-CCCcceEEeeeecccc
Q 047768 694 KELSKATNEFSSSNTIGRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDF 772 (1009)
Q Consensus 694 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 772 (1009)
.++......|.+.+..+-++.+.||+... ++..++||+...........+.+|...++.+. +--+.+++.++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--- 81 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--- 81 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE---
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec---
Confidence 45666667777766655555678998754 56678889886555545566888999988773 4335666766433
Q ss_pred CCCceEEEEEeccCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------
Q 047768 773 KGVDFKALVYEYMQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHHC----------------------- 829 (1009)
Q Consensus 773 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----------------------- 829 (1009)
.+..++||+++++.++.+...... ....++.++++.++.||+..
T Consensus 82 --~~~~~lv~~~l~G~~~~~~~~~~~-----------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (263)
T d1j7la_ 82 --DGWSNLLMSEADGVLCSEEYEDEQ-----------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN 148 (263)
T ss_dssp --TTEEEEEEECCSSEEHHHHTTTCS-----------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred --CCceEEEEEecccccccccccccc-----------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence 256789999999988866543211 12335666667777777431
Q ss_pred ---------------------------------CCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 830 ---------------------------------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 830 ---------------------------------~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
.+.++|+|+.|.||++++++.+-|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1247999999999999987777899999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.45 E-value=7.3e-05 Score=75.98 Aligned_cols=130 Identities=15% Similarity=0.117 Sum_probs=81.8
Q ss_pred cccccCC-ceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCC--CCcceEEeeeeccccCCCceEEEEEec
Q 047768 708 TIGRGSF-GFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRH--RNLIKIVTICSSIDFKGVDFKALVYEY 784 (1009)
Q Consensus 708 ~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~ 784 (1009)
.+..|.. +.||+.... ++..+++|..... ....+.+|++.++.+.. -.+.++++++.. .+..++||+|
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEEEe
Confidence 3445554 678988764 5667888976433 23457788888887743 335566766443 2567899999
Q ss_pred cCCCCHHHHHhccCCCCCccCCCHHHHHHHHHHHHHHHHHHhhc------------------------------------
Q 047768 785 MQNGSLEEWLHQRDDQLGICNLSLIQRLNIVIDVASAVEYLHHH------------------------------------ 828 (1009)
Q Consensus 785 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------------ 828 (1009)
+++.++.+. ..+. ...+.++++.++-||+.
T Consensus 88 i~G~~~~~~-----------~~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (255)
T d1nd4a_ 88 VPGQDLLSS-----------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 153 (255)
T ss_dssp CSSEETTTS-----------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred eeccccccc-----------cccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence 987654221 0111 11223333444444421
Q ss_pred -------------------CCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 829 -------------------CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 829 -------------------~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
.++.++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 12347999999999999988778899999775
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.32 E-value=4.7e-05 Score=71.78 Aligned_cols=88 Identities=17% Similarity=0.200 Sum_probs=56.7
Q ss_pred cCCCCCCeeeccccccCCC----ccccccCCCCccEEEecCccccccc----ccccccccccceEcCCCccccc------
Q 047768 510 GNLKSLVRLGIARNQFSGQ----IPVTLGACTSLEYVELQGNSFSGTI----PQSLSSLTSIKELDLSQNNFSG------ 575 (1009)
Q Consensus 510 ~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~------ 575 (1009)
...+.|++|+|++|.+... +...+...+.|+.|+|++|.|+..- -.++..-+.|++|+|++|.+..
T Consensus 41 ~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~ 120 (167)
T d1pgva_ 41 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVE 120 (167)
T ss_dssp TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHH
T ss_pred hhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHH
Confidence 3446677888888877632 2334455677888888888877532 2345555778888888776542
Q ss_pred -ccccccccccccCceecccccC
Q 047768 576 -QIPKYLENLSFLQYLNLSYNHF 597 (1009)
Q Consensus 576 -~~p~~~~~l~~L~~L~ls~N~l 597 (1009)
.+...+...+.|+.|+++++..
T Consensus 121 ~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 121 MDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHhCCCccEeeCcCCCc
Confidence 1344556667788888776643
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.20 E-value=2.2e-05 Score=74.11 Aligned_cols=40 Identities=10% Similarity=-0.017 Sum_probs=20.6
Q ss_pred ccCcCccCEEEccCCCCCCCC-------CCCcCCcccccceeccccc
Q 047768 388 IANLVNLNSLRMEANRLTGTI-------PHVIGELKNLQLLHLHANF 427 (1009)
Q Consensus 388 ~~~l~~L~~L~L~~N~l~~~~-------p~~~~~l~~L~~L~L~~N~ 427 (1009)
+...++|++|+|++|++...- ...+...++|+.|+++.+.
T Consensus 96 L~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 96 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 444566777777776655321 1223334555555555443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.20 E-value=0.00059 Score=73.77 Aligned_cols=76 Identities=16% Similarity=0.132 Sum_probs=48.7
Q ss_pred CcccccCCceEEEEEEecCCeEEEEEEeeccc-------ccchHHHHHHHHHHHhcC-C--CCcceEEeeeeccccCCCc
Q 047768 707 NTIGRGSFGFVYKGVLHENGMLVAVKVINLEQ-------KGGSKSFAAECEALRSIR-H--RNLIKIVTICSSIDFKGVD 776 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~~~ 776 (1009)
+.+|.|....||+.....+++.|+||.-.... .....+...|.+.++.+. + ..+.+++.+.. .
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~-------~ 104 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT-------E 104 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------T
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-------C
Confidence 46899999999999877677889999764221 112345667888887762 2 34566666532 2
Q ss_pred eEEEEEeccCCCC
Q 047768 777 FKALVYEYMQNGS 789 (1009)
Q Consensus 777 ~~~lv~e~~~~gs 789 (1009)
..++|||++++..
T Consensus 105 ~~~lvmE~L~~~~ 117 (392)
T d2pula1 105 MAVTVMEDLSHLK 117 (392)
T ss_dssp TTEEEECCCTTSE
T ss_pred CCEEEEeccCCcc
Confidence 3478999997654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.54 E-value=0.00032 Score=65.80 Aligned_cols=89 Identities=18% Similarity=0.273 Sum_probs=62.2
Q ss_pred ccCCCCCCeeeccccccCCC----ccccccCCCCccEEEecCcccccc----cccccccccccce--EcCCCccccc---
Q 047768 509 VGNLKSLVRLGIARNQFSGQ----IPVTLGACTSLEYVELQGNSFSGT----IPQSLSSLTSIKE--LDLSQNNFSG--- 575 (1009)
Q Consensus 509 ~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~--L~Ls~N~l~~--- 575 (1009)
+...+.|++|+|++|.++.. +-..+...++++.|++++|.++.. +-..+...++|+. |++++|.+..
T Consensus 42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~ 121 (166)
T d1io0a_ 42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE 121 (166)
T ss_dssp HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH
T ss_pred HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHH
Confidence 34567788888888888643 223455678899999999888643 3355667788886 4456777753
Q ss_pred -ccccccccccccCceecccccC
Q 047768 576 -QIPKYLENLSFLQYLNLSYNHF 597 (1009)
Q Consensus 576 -~~p~~~~~l~~L~~L~ls~N~l 597 (1009)
.+...+...+.|+.|+++.|+.
T Consensus 122 ~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 122 MEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHhCCCcCEEeCcCCCC
Confidence 3455667788899999887754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.26 E-value=0.0094 Score=62.14 Aligned_cols=142 Identities=13% Similarity=0.120 Sum_probs=77.2
Q ss_pred ceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCc--ceEEeeeeccccCCCceEEEEEeccCCCCH--
Q 047768 715 GFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNL--IKIVTICSSIDFKGVDFKALVYEYMQNGSL-- 790 (1009)
Q Consensus 715 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~gsL-- 790 (1009)
-.||++... +|+.|++|+.+.. ....+++..|.+.+..+....+ +..+.......+......+.++++++|..+
T Consensus 36 N~vy~v~~~-dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcC-CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 589999874 7888999997543 2245778889999888743222 222221111112234667889999875431
Q ss_pred ---HHH---------Hhcc---CCCCCccCCCHH-------------------HHHHHHHHHHHHHHHHhh----cCCCC
Q 047768 791 ---EEW---------LHQR---DDQLGICNLSLI-------------------QRLNIVIDVASAVEYLHH----HCQPP 832 (1009)
Q Consensus 791 ---~~~---------l~~~---~~~~~~~~l~~~-------------------~~~~i~~~ia~~l~~LH~----~~~~~ 832 (1009)
..+ ++.. .........++. ....+...+...++.+.. ....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 111 1110 000001111111 111122222233333322 23457
Q ss_pred ceecCCCCCceeeCCCCceEEecccccc
Q 047768 833 IVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 833 ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
+||+|+.+.|||++++ ..++||+-+.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eecCCCCcccEEEeCC--ceEEechhcc
Confidence 8999999999999744 4589999876
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.07 E-value=0.00034 Score=65.59 Aligned_cols=19 Identities=11% Similarity=0.062 Sum_probs=10.8
Q ss_pred hcccccccceEEccCCCCC
Q 047768 338 LLTNCTKLQYLYLADNGFG 356 (1009)
Q Consensus 338 ~l~~l~~L~~L~L~~N~l~ 356 (1009)
.+...++|++|+|++|.++
T Consensus 41 al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 41 ALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp HHTTCCSCCEEECTTSCCC
T ss_pred HHhcCCccCeeeccCCccc
Confidence 3444556666666666555
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.92 E-value=0.038 Score=59.06 Aligned_cols=72 Identities=18% Similarity=0.164 Sum_probs=48.4
Q ss_pred CcccccCCceEEEEEEec-------CCeEEEEEEeecccccchHHHHHHHHHHHhcC-CCCcceEEeeeeccccCCCceE
Q 047768 707 NTIGRGSFGFVYKGVLHE-------NGMLVAVKVINLEQKGGSKSFAAECEALRSIR-HRNLIKIVTICSSIDFKGVDFK 778 (1009)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~ 778 (1009)
+.|+.|-.-.+|++.... ..+.|.+++.- . ........+|..+++.+. +.=..++++++..
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--------- 116 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG--------- 116 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---------
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---------
Confidence 568888889999998753 23567777763 2 223345678999998884 4444577777532
Q ss_pred EEEEeccCCCC
Q 047768 779 ALVYEYMQNGS 789 (1009)
Q Consensus 779 ~lv~e~~~~gs 789 (1009)
.+|+||+++..
T Consensus 117 g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 GRLEEYIPSRP 127 (395)
T ss_dssp EEEECCCCEEE
T ss_pred ceEEEEecccc
Confidence 57899997643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.63 E-value=0.1 Score=53.58 Aligned_cols=166 Identities=11% Similarity=0.023 Sum_probs=82.7
Q ss_pred cCHHHHHHHhccCccCCcc-----cccCCceEEEEEEecCCeEEEEEEeecccccchHHHHHHHHHHHhcCCCCc--ceE
Q 047768 691 VSYKELSKATNEFSSSNTI-----GRGSFGFVYKGVLHENGMLVAVKVINLEQKGGSKSFAAECEALRSIRHRNL--IKI 763 (1009)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l 763 (1009)
.+.+++..-..+|.+++.. ..|---+.|+.+.. +..+++|++.... ..+.+..|++++..+.+.++ ...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence 4567777777888775543 35555778988764 3458999985432 34566777888777743222 221
Q ss_pred Eeeeeccc-cCCCceEEEEEeccCCCCHH--------------HHHhccCCCC---CccCCC------------------
Q 047768 764 VTICSSID-FKGVDFKALVYEYMQNGSLE--------------EWLHQRDDQL---GICNLS------------------ 807 (1009)
Q Consensus 764 ~~~~~~~~-~~~~~~~~lv~e~~~~gsL~--------------~~l~~~~~~~---~~~~l~------------------ 807 (1009)
+....... ..-......++.+..+.... ..++...... ......
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 11100000 00123345566665543211 0011000000 000000
Q ss_pred HHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCceeeCCCCceEEecccccc
Q 047768 808 LIQRLNIVIDVASAVEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 860 (1009)
Q Consensus 808 ~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~DfGla~ 860 (1009)
.......+......+.-.+. ..+.++||+|+.++||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 00111112222222222221 234589999999999999998888999999885
|